PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, ZY; Mobley, JA; DeLucas, LJ; Kahn, RA; West, AB				Liu, Zhiyong; Mobley, James A.; DeLucas, Lawrence J.; Kahn, Richard A.; West, Andrew B.			LRRK2 autophosphorylation enhances its GTPase activity	FASEB JOURNAL			English	Article						G-protein; phosphorylation; GTP-hydrolysis; ROC; Parkinson disease	DISEASE-ASSOCIATED MUTATIONS; KINASE 2 LRRK2; PARKINSONS-DISEASE; NEURONAL TOXICITY; BINDING PROTEINS; STRUCTURAL BASIS; ATP-BINDING; ROC DOMAIN; P-LOOP; DYNAMIN	The leucine-rich repeat kinase (LRRK)-2 protein contains nonoverlapping GTPase and kinase domains, and mutation in either domain can cause Parkinson disease. GTPase proteins are critical upstream modulators of many effector protein kinases. In LRRK2, this paradigm may be reversed, as the kinase domain phosphorylates its own GTPase domain. In this study, we found that the ameba LRRK2 ortholog ROCO4 phosphorylates the GTPase domain [termed Ras-of-complex (ROC) domain in this family] of human LRRK2 on the same residues as the human LRRK2 kinase. Phosphorylation of ROC enhances its rate of GTP hydrolysis [from k(cat) (catalytic constant) 0.007 to 0.016 min(-1)], without affecting GTP or GDP dissociation kinetics [k(off) = 0.093 and 0.148 min(-1) for GTP and GDP, respectively). Phosphorylation also promotes the formation of ROC dimers, although GTPase activity appears to be equivalent between purified dimers and monomers. Modeling experiments show that phosphorylation induces conformational changes at the critical p-loop structure. Finally, ROC appears to be one of many GTPases phosphorylated in p-loop residues, as revealed by alignment of LRRK2 autophosphorylation sites with GTPases annotated in the phosphoproteome database. These results provide an example of a novel mechanism for kinase-mediated control of GTPase activity.	[Liu, Zhiyong; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Liu, Zhiyong; DeLucas, Lawrence J.] Univ Alabama Birmingham, Struct Biol Ctr, Dept Optometry, Birmingham, AL USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	West, AB (corresponding author), Civitan Int Res Bldg,5th Floor,1719 6th Ave South, Birmingham, AL 35233 USA.	abwest@uab.edu	Kahn, Richard/ABD-2666-2020; liu, zhao/GXV-6141-2022	Kahn, Richard/0000-0002-0259-0601; West, Andrew/0000-0002-3034-4061	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R01 NS064934]; NIH National Cancer Institute [P30 CA13148]; UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148, P30 CA013148] Funding Source: Medline; NINDS NIH HHS [R01 NS064934] Funding Source: Medline	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank C. Deivanayagam and D. Chattopadhyay [Center for Structural Biology, Department of Optometry, The University of Alabama at Birmingham (UAB)] for useful discussions and guidance in the experiments. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant R01 NS064934 (to A.B.W.); NIH National Cancer Institute Grant P30 CA13148 (to L.J.D.); and by the UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility. The authors declare no conflicts of interest.	Anand VS, 2009, FEBS J, V276, P6428, DOI 10.1111/j.1742-4658.2009.07341.x; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BURSTEIN ES, 1992, BIOCHEM J, V282, P387, DOI 10.1042/bj2820387; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P2674, DOI 10.1073/pnas.81.9.2674; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gomez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Kahn Richard A, 2011, Cell Logist, V1, P49; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602318; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ray S, 2014, J BIOL CHEM, V289, P13042, DOI 10.1074/jbc.M113.537811; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Terheyden S, 2015, BIOCHEM J, V465, P139, DOI 10.1042/BJ20141095; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	49	39	39	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					336	347		10.1096/fj.15-277095	http://dx.doi.org/10.1096/fj.15-277095			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396237	Green Published			2022-12-26	WOS:000367621000032
J	Nariai, Y; Mizuguchi, H; Ogasawara, T; Nagai, H; Sasaki, Y; Okamoto, Y; Yoshimura, Y; Kitamura, Y; Nemoto, H; Takeda, N; Fukui, H				Nariai, Yuki; Mizuguchi, Hiroyuki; Ogasawara, Takeyasu; Nagai, Hiroaki; Sasaki, Yohei; Okamoto, Yasunobu; Yoshimura, Yoshiyuki; Kitamura, Yoshiaki; Nemoto, Hisao; Takeda, Noriaki; Fukui, Hiroyuki			Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase C delta (PKC delta) Interaction by (-)-Maackiain Suppresses Histamine H-1 Receptor Gene Transcription in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESEASONAL PROPHYLACTIC TREATMENT; FLUORESCENCE POLARIZATION ASSAY; UP-REGULATION; ALLERGIC RHINITIS; MESSENGER-RNA; NASAL-MUCOSA; HISTIDINE-DECARBOXYLASE; MOLECULAR CHAPERONE; SIGNALING PATHWAY; HSP90	Background: The molecular mechanism of anti-allergic (-)-maackiain remains unknown. Results: (-)-Maackiain and Hsp90 inhibitors inhibited PKC delta activation and suppressed H1R gene expression. Conclusion: (-)-Maackiain is a novel Hsp90 pathway inhibitor, and its anti-allergic activity underlies the disruption of Hsp90-PKC delta interaction. Significance: Hsp90 is involved in H1R gene up-regulation, and its inhibition could be a novel therapeutic strategy for allergic rhinitis. The histamine H-1 receptor (H1R) gene is an allergic disease sensitive gene, and its expression level is strongly correlated with the severity of allergic symptoms. (-)-Maackiain was identified as a Kujin-derived anti-allergic compound that suppresses the up-regulation of the H1R gene. However, the underlying mechanism of H1R gene suppression remains unknown. Here, we sought to identify a target protein of (-)-maackiain and investigate its mechanism of action. A fluorescence quenching assay and immunoblot analysis identified heat shock protein 90 (Hsp90) as a target protein of (-)-maackiain. A pull-down assay revealed that (-)-maackiain disrupted the interaction of Hsp90 with PKC delta, resulting in the suppression of phorbol 12-myristate 13-acetate (PMA)-induced up-regulation of H1R gene expression in HeLa cells. Additional Hsp90 inhibitors, including 17-(allylamino)-17-demethoxygeldanamycin, celastrol, and novobiocin also suppressed PMA-induced H1R gene up-regulation. 17-(Allylamino)-17-demethoxygeldanamycin inhibited PKC delta translocation to the Golgi and phosphorylation of Tyr(311) on PKC delta. These data suggest that (-)-maackiain is a novel Hsp90 pathway inhibitor. The underlying mechanism of the suppression of PMA-induced up-regulation of H1R gene expression by (-)-maackiain and Hsp90 inhibitors is the inhibition of PKC delta activation through the disruption of Hsp90-PKC delta interaction. Involvement of Hsp90 in H1R gene up-regulation suggests that suppression of the Hsp90 pathway could be a novel therapeutic strategy for allergic rhinitis.	[Nariai, Yuki; Mizuguchi, Hiroyuki; Ogasawara, Takeyasu; Nagai, Hiroaki; Sasaki, Yohei; Okamoto, Yasunobu] Univ Tokushima, Grad Sch, Dept Mol Pharmacol, Inst Biomed Sci, Tokushima 7708505, Japan; [Yoshimura, Yoshiyuki] Univ Tokushima, Grad Sch, Dept Clin Pharm, Inst Biomed Sci, Tokushima 7708505, Japan; [Kitamura, Yoshiaki; Takeda, Noriaki] Univ Tokushima, Grad Sch, Dept Otolaryngol, Inst Biomed Sci, Tokushima 7708505, Japan; [Nemoto, Hisao] Univ Tokushima, Grad Sch, Dept Pharmaceut Chem, Inst Biomed Sci, Tokushima 7708505, Japan; [Fukui, Hiroyuki] Univ Tokushima, Grad Sch, Dept Mol Studies Incurable Dis, Inst Biomed Sci, Tokushima 7708505, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University	Mizuguchi, H (corresponding author), Univ Tokushima, Grad Sch, Dept Mol Pharmacol, Inst Biomed Sci, Tokushima 7708505, Japan.	guchi003@tokushima-u.ac.jp			Ministry of Health Labor and Welfare of Japan [10103185]; Japan Society for the Promotion of Science [26305004, 22580132, 15K07933]; Osaka Medical Research Foundation	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation	This work was supported in part by Grant-in-Aid 10103185 for Research on Allergic Disease and Immunology from the Ministry of Health Labor and Welfare of Japan (to H. F.), Grants-in-Aid for Scientific Research (B) 26305004 (to H. F.) and Scientific Research (C) 22580132 (to H. M.) and 15K07933 (to H. M.) from the Japan Society for the Promotion of Science, and by a grant from the Osaka Medical Research Foundation for Incurable Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Bohl M, 2005, ANAL BIOCHEM, V346, P295, DOI 10.1016/j.ab.2005.08.037; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Church M. K., 2012, ALLERGY, P147; Das AK, 2007, J PHARMACOL SCI, V103, P374, DOI 10.1254/jphs.FP0061411; Dev S, 2009, J PHARMACOL SCI, V109, P606, DOI 10.1254/jphs.09003FP; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hattori M, 2013, INT IMMUNOPHARMACOL, V15, P232, DOI 10.1016/j.intimp.2012.12.030; HONDA G, 1982, PLANTA MED, V46, P122, DOI 10.1055/s-2007-970034; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kim J, 2004, J BIOMOL SCREEN, V9, P375, DOI 10.1177/1087057104265995; Kitamura Y, 2004, ACTA OTO-LARYNGOL, V124, P1053, DOI 10.1080/00016480410022525; Kitamura Y, 2012, ACTA OTO-LARYNGOL, V132, P434, DOI 10.3109/00016489.2011.644804; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Matsushita C., 2008, Journal of Traditional Medicines, V25, P133; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; Mizuguchi H, 2010, METHOD FIND EXP CLIN, V32, P745, DOI 10.1358/mf.2010.32.10.1533687; Mizuguchi H., PHARM RES PERSPECT, V3; Mizuguchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00916; Mizuguchi H, 2011, J BIOL CHEM, V286, P30542, DOI 10.1074/jbc.M111.253104; Mizuguchi H, 2008, J PHARMACOL SCI, V108, P480, DOI 10.1254/jphs.08222FP; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Nathan RA, 1997, J ALLERGY CLIN IMMUN, V99, pS808, DOI 10.1016/S0091-6749(97)80040-1; Nurul IM, 2011, INT IMMUNOPHARMACOL, V11, P1766, DOI 10.1016/j.intimp.2011.07.003; Okubo K, 2014, ALLERGOL INT, V63, P357, DOI 10.2332/allergolint.14-RAI-0768; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Shahriar M, 2009, J IMMUNOL, V183, P2133, DOI 10.4049/jimmunol.0901058; SHIBATA S, 1963, CHEM PHARM BULL, V11, P167; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532	42	15	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27393	27402		10.1074/jbc.M115.657023	http://dx.doi.org/10.1074/jbc.M115.657023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391399	Green Published, hybrid			2022-12-26	WOS:000364794000045
J	Magistro, D; Takeuchi, H; Nejad, KK; Taki, Y; Sekiguchi, A; Nouchi, R; Kotozaki, Y; Nakagawa, S; Miyauchi, M; Iizuka, K; Yokoyama, R; Shinada, T; Yamamoto, Y; Hanawa, S; Araki, T; Hashizume, H; Sassa, Y; Kawashima, R				Magistro, Daniele; Takeuchi, Hikaru; Nejad, Keyvan Kashkouli; Taki, Yasuyuki; Sekiguchi, Atsushi; Nouchi, Rui; Kotozaki, Yuka; Nakagawa, Seishu; Miyauchi, Makoto; Iizuka, Kunio; Yokoyama, Ryoichi; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Araki, Tsuyoshi; Hashizume, Hiroshi; Sassa, Yuko; Kawashima, Ryuta			The Relationship between Processing Speed and Regional White Matter Volume in Healthy Young People	PLOS ONE			English	Article							WORKING-MEMORY; CONDUCTION-VELOCITY; COGNITIVE PERFORMANCE; GENERAL INTELLIGENCE; DIFFUSION; INTEGRITY; AGE; CHILDHOOD; ABILITIES; INTERFERENCE	Processing speed is considered a key cognitive resource and it has a crucial role in all types of cognitive performance. Some researchers have hypothesised the importance of white matter integrity in the brain for processing speed; however, the relationship at the whole-brain level between white matter volume (WMV) and processing speed relevant to the modality or problem used in the task has never been clearly evaluated in healthy people. In this study, we used various tests of processing speed and Voxel-Based Morphometry (VBM) analyses, it is involves a voxel-wise comparison of the local volume of gray and white, to assess the relationship between processing speed and regional WMV (rWMV). We examined the association between processing speed and WMV in 887 healthy young adults (504 men and 383 women; mean age, 20.7 years, SD, 1.85). We performed three different multiple regression analyses: we evaluated rWMV associated with individual differences in the simple processing speed task, word-colour and colour-word tasks (processing speed tasks with words) and the simple arithmetic task, after adjusting for age and sex. The results showed a positive relationship at the whole-brain level between rWMV and processing speed performance. In contrast, the processing speed performance did not correlate with rWMV in any of the regions examined. Our results support the idea that WMV is associated globally with processing speed performance regardless of the type of processing speed task.	[Magistro, Daniele; Nejad, Keyvan Kashkouli; Nakagawa, Seishu; Miyauchi, Makoto; Iizuka, Kunio; Yokoyama, Ryoichi; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Taki, Yasuyuki; Yokoyama, Ryoichi; Hashizume, Hiroshi; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sekiguchi, Atsushi] Tohoku Univ, Devis Meidcal Neuroimaging Anal, Dept Community Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Dept Radiol & Nucl Med, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 980, Japan; [Kotozaki, Yuka; Araki, Tsuyoshi; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Society for the Promotion of Science	Magistro, D (corresponding author), Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	danielemagistro@gmail.com	Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020; Takeuchi, Hikaru/D-1057-2011; Nouchi, Rui/GQH-1608-2022	Kotozaki, Yuka/0000-0002-4659-1200; Nouchi, Rui/0000-0002-2078-9518; Magistro, Daniele/0000-0002-2554-3701; Takeuchi, Hikaru/0000-0002-8022-9694; xing zhi, shi zhi/0000-0003-3289-5681	JST/RISTEX; JST/CREST; Ministry of Education, Culture, Sports, Science, and Technology [KAKENHI 23700306, KAKENHI 25700012]; JSPS Postdoctoral Fellowship Program for Foreigner Researchers	JST/RISTEX(Japan Science & Technology Agency (JST)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Postdoctoral Fellowship Program for Foreigner Researchers	This study was supported by JST/RISTEX, JST/CREST, a Grant-in-Aid for Young Scientists (B) (KAKENHI 23700306) and a Grant-in-Aid for Young Scientists (A) (KAKENHI 25700012) from the Ministry of Education, Culture, Sports, Science, and Technology. JSPS Postdoctoral Fellowship Program for Foreigner Researchers FY2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borghesani PR, 2013, NEUROPSYCHOLOGIA, V51, P1435, DOI 10.1016/j.neuropsychologia.2013.03.005; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Colom R, 2007, COGN NEUROPSYCHOL, V24, P867, DOI 10.1080/02643290701781557; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; DeLuca J, 2013, INFORM PROCESSING SP; Dow C, 2004, EPILEPSY BEHAV, V5, P919, DOI 10.1016/j.yebeh.2004.08.007; Ellingsen DG, 2001, NEUROTOXICOLOGY, V22, P249, DOI 10.1016/S0161-813X(01)00012-2; Fields RD, 2008, SCI AM, V298, P54; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hakoda Y., 1990, KYOIKUSHINRIGAKUKENK, V38, P389, DOI DOI 10.5926/JJEP1953.38.4_; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Peters BD, 2014, BIOL PSYCHIAT, V75, P248, DOI 10.1016/j.biopsych.2013.05.020; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/twin.6.2.131; Raven J. C., 1998, RAVENS PROGR MATRICE; Salthouse T. A, 2013, 10 INFORM PROCESSING, P221; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takeuchi H, 2013, BRAIN STRUCT FUNCT, V218, P1017, DOI 10.1007/s00429-012-0444-z; Takeuchi H, 2013, NEUROIMAGE, V77, P222, DOI 10.1016/j.neuroimage.2013.04.004; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Tanaka K., 2003, MANUAL NEW TANAKA B; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P241, DOI 10.1111/j.1475-1313.1992.tb00298.x; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; VOINESKOS AN, 2012, NEUROBIOL AGING, V33, P21, DOI DOI 10.1016/j.neurobiolaging.2010.02.009; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wessels AM, 2007, DIABETOLOGIA, V50, P1763, DOI 10.1007/s00125-007-0714-0	64	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136386	10.1371/journal.pone.0136386	http://dx.doi.org/10.1371/journal.pone.0136386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397946	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000361797500010
J	Choi, KS; Son, O; Park, S				Choi, Kyoung Su; Son, OGyeong; Park, SeonJoo			The Chloroplast Genome of Elaeagnus macrophylla and trnH Duplication Event in Elaeagnaceae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INVERTED REPEAT; NDH GENES; EVOLUTION; ANGIOSPERMS; PHYLOGENY; DNA; EXPANSION; LOSSES; EXTANT	Elaeagnaceae, which harbor nitrogen-fixing actinomycetes, is a plant family of the Rosales and sister to Rhamnaceae, Barbeyaceae and Dirachmaceae. The results of previous molecular studies have not strongly supported the families of Elaeagnaceae, Rhamnaceae, Barbeyaceae and Dirachmaceae. However, chloroplast genome studies provide valuable phylogenetic information; therefore, we determined the chloroplast genome of Elaeaganus macrophylla and compared it to that of Rosales such as IR junction and infA gene. The chloroplast genome of Elaeagnus macrophylla is 152,224 bp in length and the infA gene of E. macrophylla was psuedogenation. Phylogenetic analyses based on 79 genes in 30 species revealed that Elaeagnus was closely related to Morus. Comparison of the IR junction in six other rosids revealed that the trnH gene contained the LSC region, whereas E. macrophylla contained a trnH gene duplication in the IR region. Comparison of the LSC/IRb (J(LB)) and the IRa/LSC (J(LA)) regions of Elaeagnaceae (Elaeagnus and Shephedia) and Rhamnaceae (Rhamnus) showed that trnH gene duplication only occurred in the Elaeagnaceae. The complete chloroplast genome of Elaeagnus macrophylla provides unique characteristics in rosids. The infA gene has been lost or transferred to the nucleus in rosids, while E. macrophylla lost the infA gene. Evaluation of the chloroplast genome of Elaeagnus revealed trnH gene duplication for the first time in rosids. The availability of Elaeagnus cp genomes provides valuable information describing the relationship of Elaeagnaceae, Barbeyaceae and Dirachmaceae, IR junction that will be valuable to future systematics studies.	[Choi, Kyoung Su; Son, OGyeong; Park, SeonJoo] Yeungnam Univ, Dept Life Sci, Kyongsan 712749, Gyeongsangbuk D, South Korea	Yeungnam University	Park, S (corresponding author), Yeungnam Univ, Dept Life Sci, Kyongsan 712749, Gyeongsangbuk D, South Korea.	sjpark01@ynu.ac.kr			Ministry of Environment in Korea (Daegu Regional Environmental Office)	Ministry of Environment in Korea (Daegu Regional Environmental Office)	This research was supported by the Ministry of Environment in Korea (Daegu Regional Environmental Office, 2014).	Allan GC, 2006, NATURE PROTOCOLS, V1, P2320; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Endress PK, 2006, PLANT SYST EVOL, V260, P83, DOI 10.1007/s00606-006-0438-5; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heywood VH., 2007, FLOWERING PLANT FAMI, P135; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Hupfer H, 2000, MOL GEN GENET, V263, P581, DOI 10.1007/s004380051204; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Jung Sook, 2010, BMC Res Notes, V3, P168, DOI 10.1186/1756-0500-3-168; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma J, 2013, GENE, V528, P120, DOI 10.1016/j.gene.2013.07.037; Mabberly DJ, 1998, PLANT BOOK; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; PALMER JD, 1990, TRENDS GENET, V6, P115, DOI 10.1016/0168-9525(90)90125-P; Plunkett GM, 2000, SYST BOT, V25, P648, DOI 10.2307/2666726; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2007, TREE GENET GENOMES, V3, P49, DOI 10.1007/s11295-006-0051-3; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Soltis DE, 2007, INT J PLANT SCI, V168, P137, DOI 10.1086/509788; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Su HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113049; Sun MA, 2010, J SYST EVOL, V48, P356, DOI 10.1111/j.1759-6831.2010.00085.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	45	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138727	10.1371/journal.pone.0138727	http://dx.doi.org/10.1371/journal.pone.0138727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394223	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100093
J	Chutake, YK; Costello, WN; Lam, CC; Parikh, AC; Hughes, TT; Michalopulos, MG; Pook, MA; Bidichandani, SI				Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina C.; Parikh, Aniruddha C.; Hughes, Tamara T.; Michalopulos, Michael G.; Pook, Mark A.; Bidichandani, Sanjay I.			FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia	PLOS ONE			English	Article							TRIPLET-REPEAT EXPANSION; FRATAXIN GENE; TRANSCRIPTION; DNA; METHYLATION; LENGTH; INTRON-1	Background Friedreich ataxia is caused by an expanded GAA triplet-repeat sequence in intron 1 of the FXN gene that results in epigenetic silencing of the FXN promoter. This silencing mechanism is seen in patient-derived lymphoblastoid cells but it remains unknown if it is a widespread phenomenon affecting multiple cell types and tissues. Methodology / Principal Findings The humanized mouse model of Friedreich ataxia (YG8sR), which carries a single transgenic insert of the human FXN gene with an expanded GAA triplet-repeat in intron 1, is deficient for FXN transcript when compared to an isogenic transgenic mouse lacking the expanded repeat (Y47R). We found that in YG8sR the deficiency of FXN transcript extended both upstream and downstream of the expanded GAA triplet-repeat, suggestive of deficient transcriptional initiation. This pattern of deficiency was seen in all tissues tested, irrespective of whether they are known to be affected or spared in disease pathogenesis, in both neuronal and non-neuronal tissues, and in cultured primary fibroblasts. FXN promoter function was directly measured via metabolic labeling of newly synthesized transcripts in fibroblasts, which revealed that the YG8sR mouse was significantly deficient in transcriptional initiation compared to the Y47R mouse. Conclusions / Significance Deficient transcriptional initiation accounts for FXN transcriptional deficiency in the humanized mouse model of Friedreich ataxia, similar to patient-derived cells, and the mechanism underlying promoter silencing in Friedreich ataxia is widespread across multiple cell types and tissues.	[Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina C.; Parikh, Aniruddha C.; Hughes, Tamara T.; Michalopulos, Michael G.; Bidichandani, Sanjay I.] Univ Oklahoma, Coll Med, Dept Pediat, Oklahoma City, OK 73104 USA; [Bidichandani, Sanjay I.] Univ Oklahoma, Coll Med, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Pook, Mark A.] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Ataxia Res Grp,Div Biosci, Uxbridge UB8 3PH, Middx, England	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Brunel University	Bidichandani, SI (corresponding author), Univ Oklahoma, Coll Med, Dept Pediat, Oklahoma City, OK 73104 USA.	Sanjay-Bidichandani@ouhsc.edu	Costello, Whitney/W-1204-2018	Costello, Whitney/0000-0001-6731-8978; Bidichandani, Sanjay/0000-0001-6191-6475	National Institutes of Health [R01 NS072418]; Muscular Dystrophy Association; Million Dollar Bike Ride Grant Program of the Orphan Disease Center at University of Pennsylvania; American College of Medical Genetics Foundation; OUHSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Million Dollar Bike Ride Grant Program of the Orphan Disease Center at University of Pennsylvania; American College of Medical Genetics Foundation; OUHSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (R01 NS072418), and the Muscular Dystrophy Association to S.I.B. Y.K.C. is supported by a postdoctoral research fellowship from the Million Dollar Bike Ride Grant Program of the Orphan Disease Center at University of Pennsylvania. T.T.H. was supported by the American College of Medical Genetics Foundation. A.C.P. and M.G.M. were supported by the SURE and OSCTR programs at OUHSC, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidichandani S.I., 1993, GENEREVIEWS; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chutake YK, HISTONE DEACET UNPUB; Chutake YK, 2014, ANN NEUROL, V76, P522, DOI 10.1002/ana.24249; Chutake YK, 2014, J BIOL CHEM, V289, P15194, DOI 10.1074/jbc.M114.566414; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kumari D, 2011, J BIOL CHEM, V286, P4209, DOI 10.1074/jbc.M110.194035; Metz G, 2013, BRAIN, V136, P259, DOI 10.1093/brain/aws309; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Regner SR, 2012, J CHILD NEUROL, V27, P1152, DOI 10.1177/0883073812448462; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Virmouni SA, 2015, DIS MODEL MECH, V8, P225, DOI 10.1242/dmm.018952; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191	28	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138437	10.1371/journal.pone.0138437	http://dx.doi.org/10.1371/journal.pone.0138437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393353	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100060
J	Liu, FD; Liu, YH; Wang, GM; Song, Y; Liu, Q; Li, DS; Mao, PL; Zhang, H				Liu, Fude; Liu, Yuhong; Wang, Guangmei; Song, Ye; Liu, Qing; Li, Desheng; Mao, Peili; Zhang, Hua			Seasonal Variations of C: N: P Stoichiometry and Their Trade-Offs in Different Organs of Suaeda salsa in Coastal Wetland of Yellow River Delta, China	PLOS ONE			English	Article							LEAF TRAIT RELATIONSHIPS; BIOLOGICAL STOICHIOMETRY; TERRESTRIAL ECOSYSTEMS; PRIMARY PRODUCTIVITY; NUTRIENT LIMITATION; PLANT-GROWTH; NITROGEN; RATIOS; LEAVES; TEMPERATURE	Variations of plant C: N: P stoichiometry could be affected by both some environmental fluctuations and plant physiological processes. However, the trade-off mechanism between them and their influencial factors were not understood completely. In this study, C, N, P contents and their stoichiometry of S. salsa's plant organs (leaves, stems, and roots), together with their environmental factors including salinity, pH, soil N and soil P, were examined in the intertidal and supratidal habitats of coastal wetlands during the different sampling times (May, July, September, November). The results showed that both plant organ and sampling times affected C, N, and P and stoichiometry of S. salsa in the intertidal and supratidal habitats, however, their influencial conditions and mechanisms were different. In the intertidal habitat, the different slopes of C-P and N-P within interspecific organs suggested that plant P, C: P and N: P of S. salsa were modulated by P concentrations that allocated in the specific organs. However, the slopes of C-N were found to be not significant within interspecific organs, but during the sampling times. These differences of plant N and C: N were related with the physiological demand for N in the specific life history stage. In the supratidal habitat, no significant differences were found in the slopes of C-N, C-P, and N-P within interspecific organs. However, different slopes of C-N among the sampling times also indicated a self-regulation strategy for plant N and C: N of S. salsa in different ontogenetic stages. In contrast to the intertidal habitat, seasonal variations of P, C: P and N: P ratios within interspecific organs reflected the soil P characteristics in the supratidal habitat. Our results showed that the stoichiometric constraint strategy of plant S. salsa in this region was strongly correlated with the local soil nutrient conditions.	[Liu, Fude; Li, Desheng] Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China; [Liu, Yuhong; Wang, Guangmei; Mao, Peili; Zhang, Hua] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Song, Ye] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Liu, Qing] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Peoples R China	Tianjin University of Technology; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Beijing Forestry University; Qingdao Agricultural University	Liu, YH (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	yu_hong_liu@263.net	wang, gm/GWV-1237-2022		National Natural Science Foundation of China [41303057, 40901029, 31370474]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCYBJC23000]; Shandong Natural Science Funds [2007BSA06018, 2008ZRA06061]; Open Research Fund Program of Shandong Provincial Key Laboratory of Eco-Environmental Science for Yellow River Delta [2010KFJJ04]; Key Research Program of the Chinese Academy of Sciences [KZZD-EW-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; Shandong Natural Science Funds; Open Research Fund Program of Shandong Provincial Key Laboratory of Eco-Environmental Science for Yellow River Delta; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	Funding: This work was supported by the National Natural Science Foundation of China (No. 41303057, 40901029, 31370474), Tianjin Research Program of Application Foundation and Advanced Technology (No. 14JCYBJC23000), the Shandong Natural Science Funds (No. 2007BSA06018 and 2008ZRA06061), the Open Research Fund Program of Shandong Provincial Key Laboratory of Eco-Environmental Science for Yellow River Delta (2010KFJJ04), and the Key Research Program of the Chinese Academy of Sciences (No. KZZD-EW-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cui QA, 2010, PLANT SOIL, V334, P209, DOI 10.1007/s11104-010-0375-5; Drenovsky RE, 2004, PLANT SOIL, V259, P59, DOI 10.1023/B:PLSO.0000020945.09809.3d; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Falkowski PG, 2004, NATURE, V431, P131, DOI 10.1038/431131a; Falster D.S., 2006, S MATR STANDARDISED; Franklin O, 2002, FUNCT ECOL, V16, P727, DOI 10.1046/j.1365-2435.2002.00674.x; Frigstad H, 2011, BIOGEOSCIENCES, V8, P2917, DOI 10.5194/bg-8-2917-2011; Guo LL, 2012, SCI WORLD J, P1; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2009, ECOLOGY, V90, P2779, DOI 10.1890/08-1126.1; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Li W, 2008, SEED SCI TECHNOL, V36, P122, DOI 10.15258/sst.2008.36.1.13; Liu FD, 2010, EUR J FOREST RES, V129, P1093, DOI 10.1007/s10342-010-0394-z; Liu FD, 2010, ACTA OECOL, V36, P149, DOI 10.1016/j.actao.2009.11.004; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; [毛培利 MAO Peili], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1214; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Mendez M, 2005, ECOLOGY, V86, P982, DOI 10.1890/04-0354; [牟晓杰 MOU Xiao-Jie], 2010, [湿地科学, Wetland Science], V8, P57; Niklas KJ, 2005, AM J BOT, V92, P1256, DOI 10.3732/ajb.92.8.1256; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.2307/2334971; Redfield AC, 1934, ON THE PROPORTIONS O, P176; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2012, BIOGEOCHEMISTRY, V111, P1, DOI 10.1007/s10533-011-9640-9; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Verhoeven JTA, 2014, J ENVIRON MANAGE, V139, P217, DOI 10.1016/j.jenvman.2014.02.035; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Vrede T, 2009, FRESHWATER BIOL, V54, P331, DOI 10.1111/j.1365-2427.2008.02118.x; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang XG, 2014, ECOL ENG, V70, P154, DOI 10.1016/j.ecoleng.2014.05.015; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xia CX, 2014, ECOL ENG, V70, P406, DOI 10.1016/j.ecoleng.2014.06.018; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhang CF, 2003, J PLANT NUTR, V26, P2453, DOI 10.1081/PLN-120025472; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060360; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750	56	70	76	8	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138169	10.1371/journal.pone.0138169	http://dx.doi.org/10.1371/journal.pone.0138169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393356	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100033
J	Liu, SF; Kuo, HC; Tseng, CW; Huang, HT; Chen, YC; Tseng, CC; Lin, MC				Liu, Shih-Feng; Kuo, Ho-Chang; Tseng, Ching-Wan; Huang, Hung-Tu; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih			Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; QUADRICEPS; ENDURANCE	Background Oxidative stress is known to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Evidence suggests that leukocytes mitochondria DNA (mtDNA) is susceptible to undergo mutations, insertions, or depletion in response to reactive oxidative stress (ROS). We hypothesize that mtDNA copy number is associated with the development of COPD. Methodology/Principal Findings Relative mtDNA copy number was measured by a quantitative realtime PCR assay using DNA extracted from peripheral leukocytes. MtDNA copy number of peripheral leukocytes in the COPD group (n = 86) is significantly decreased compared with nonsmoker group (n = 77) (250.3 +/- 21.5 VS. 464.2 +/- 49.9, P<0.001). MtDNA copy number in the COPD group was less than that in the healthy smoking group, but P value nearly achieved significance (250.3 +/- 21.5 VS. 404.0 +/- 76.7, P = 0.08) MtDNA copy number has no significance with age, gender, body mass index, current smoking, and pack-years in COPD group, healthy smoker group and no smoker group, respectively. Serum glutathione level in the COPD group is significantly decreased compared with healthy smoker and nonsmoker groups (4.5 +/- 1.3 VS. 6.2 +/- 1.9 and 4.5 +/- 1.3 VS. 7.1 +/- 1.1 mU/mL; P<0.001 respectively). Pearson correlation test shows a significant liner correlation between mtDNA copy number and serum glutathione level (R = 0.2, P = 0.009). Conclusions/Significance COPD is associated with decreased leukocyte mtDNA copy number and serum glutathione. COPD is a regulatory disorder of leukocytes mitochondria. However, further studies are needed to determine the real mechanisms about the gene and the function of mitochondria.	[Liu, Shih-Feng; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Shih-Feng; Kuo, Ho-Chang; Tseng, Ching-Wan; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan; [Liu, Shih-Feng; Kuo, Ho-Chang; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Hung-Tu] Kaohsiung Med Univ, Sch Med, Dept Anat, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University	Liu, SF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.	liuphysico@yahoo.com.tw; mengchih@adm.cgmh.org.tw	Chen, Yung-Che/AAL-5167-2020; Kuo, Ho-Chang/AAQ-6644-2020	Chen, Yung-Che/0000-0001-8695-5227; Kuo, Ho-Chang/0000-0002-3295-2984; Liu, Shih-Feng/0000-0003-1394-5401	Chang Gung Memorial Hospital [CMRPG891051]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a grant from the Chang Gung Memorial Hospital (CMRPG891051).	Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002; Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636; Barnes PJ, 1999, THORAX, V54, P245, DOI 10.1136/thx.54.3.245; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Engelen MPKJ, 2000, AM J RESP CRIT CARE, V161, P98, DOI 10.1164/ajrccm.161.1.9901031; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P543, DOI 10.1513/pats.200708-142ET; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Langen RCJ, 2003, FREE RADICAL BIO MED, V35, P226, DOI 10.1016/S0891-5849(03)00316-2; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082739; Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; Sandri M, 2002, CURR OPIN CLIN NUTR, V5, P249, DOI 10.1097/00075197-200205000-00003; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Yamagata T, 2007, CHEST, V132, P890, DOI 10.1378/chest.07-0569	34	36	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138716	10.1371/journal.pone.0138716	http://dx.doi.org/10.1371/journal.pone.0138716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394041	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100091
J	Rule, JA; Hynan, LS; Attar, N; Sanders, C; Korzun, WJ; Lee, WM				Rule, Jody A.; Hynan, Linda S.; Attar, Nahid; Sanders, Corron; Korzun, William J.; Lee, William M.		Acute Liver Failure Study Grp	Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SERUM PROCALCITONIN; DIAGNOSTIC-VALUE; MARKER; SEPSIS; INTERLEUKIN-6; PERITONITIS; EXPRESSION	Background Because acute liver failure (ALF) patients share many clinical features with severe sepsis and septic shock, identifying bacterial infection clinically in ALF patients is challenging. Procalcitonin (PCT) has proven to be a useful marker in detecting bacterial infection. We sought to determine whether PCT discriminated between presence and absence of infection in patients with ALF. Method Retrospective analysis of data and samples of 115 ALF patients from the United States Acute Liver Failure Study Group randomly selected from 1863 patients were classified for disease severity and ALF etiology. Twenty uninfected chronic liver disease (CLD) subjects served as controls. Results Procalcitonin concentrations in most samples were elevated, with median values for all ALF groups near or above a 2.0 ng/mL cut-off that generally indicates severe sepsis. While PCT concentrations increased somewhat with apparent liver injury severity, there were no differences in PCT levels between the pre-defined severity groups-non-SIRS and SIRS groups with no documented infections and Severe Sepsis and Septic Shock groups with documented infections, (p = 0.169). PCT values from CLD patients differed from all ALF groups (median CLD PCT value 0.104 ng/mL, (p <= 0.001)). Subjects with acetaminophen (APAP) toxicity, many without evidence of infection, demonstrated median PCT > 2.0 ng/mL, regardless of SIRS features, while some culture positive subjects had PCT values < 2.0 ng/mL. Summary/Conclusions While PCT appears to be a robust assay for detecting bacterial infection in the general population, there was poor discrimination between ALF patients with or without bacterial infection presumably because of the massive inflammation observed. Severe hepatocyte necrosis with inflammation results in elevated PCT levels, rendering this biomarker unreliable in the ALF setting.	[Rule, Jody A.; Attar, Nahid; Sanders, Corron; Lee, William M.] UT Southwestern Med Ctr, Div Digest Dis, Dept Internal Med, Dallas, TX 75235 USA; [Hynan, Linda S.] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA; [Hynan, Linda S.] UT Southwestern Med Ctr, Dept Psychiat, Div Biostat, Dallas, TX USA; [Rule, Jody A.; Korzun, William J.] Virginia Commonwealth Univ, Dept Clin Lab Sci, Sch Allied Hlth, Richmond, VA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University	Rule, JA (corresponding author), UT Southwestern Med Ctr, Div Digest Dis, Dept Internal Med, Dallas, TX 75235 USA.	jody.rule@utsouthwestern.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769	National Institutes of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [U-01 DK58369]; Siemens Healthcare Diagnostics, Tarrytown, NY; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK058369] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health; Siemens Healthcare Diagnostics, Tarrytown, NY; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, W. M. Lee, Principal Investigator [grant U-01 DK58369]. Additional support was provided by Siemens Healthcare Diagnostics, Tarrytown, NY. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Bota DP, 2005, J LAB CLIN MED, V146, P347, DOI 10.1016/j.lab.2005.08.005; BRACQ S, 1993, FEBS LETT, V331, P15, DOI 10.1016/0014-5793(93)80288-6; Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016; Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728; Carrol ED, 2002, INT J ANTIMICROB AG, V20, P1, DOI 10.1016/S0924-8579(02)00047-X; Connert S, 2003, Z GASTROENTEROL, V41, P165, DOI 10.1055/s-2003-37314; Domenech VS, 2001, J INVEST MED, V49, P514, DOI 10.2310/6650.2001.33628; Dragomir AC, 2011, TOXICOL APPL PHARM, V253, P170, DOI 10.1016/j.taap.2011.04.003; Elefsiniotis IS, 2006, EUR J GASTROEN HEPAT, V18, P525, DOI 10.1097/00042737-200605000-00012; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Jackson N, 2000, ABSTRACT BRIT J ANAE, V84, p92P; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Luyt CE, 2005, AM J RESP CRIT CARE, V171, P48, DOI 10.1164/rccm.200406-746Oc; Matzaraki V, 2007, CLIN BIOCHEM, V40, P336, DOI 10.1016/j.clinbiochem.2006.10.027; Meisner M, 1998, INTENS CARE MED, V24, P680, DOI 10.1007/s001340050644; Muller B, 2001, SWISS MED WKLY, V131, P595; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; Siemens Healthcare Diagnostics Ltd, 2010, ADV CENT ADV CENT XP; Spahr L, 2001, HEPATO-GASTROENTEROL, V48, P502; Stravitz RT, 2008, CHEST, V134, P1092, DOI 10.1378/chest.08-1071; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Viallon A, 2000, INTENS CARE MED, V26, P1082, DOI 10.1007/s001340051321; Wade J, 2003, J HOSP INFECT, V53, P144, DOI 10.1053/jhin.2002.1363; Whang KT, 1999, SHOCK, V12, P268, DOI 10.1097/00024382-199910000-00004	31	38	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138566	10.1371/journal.pone.0138566	http://dx.doi.org/10.1371/journal.pone.0138566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393924	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100072
J	Scanlon, V; Soung, DY; Adapala, NS; Morgan, E; Hansen, MF; Drissi, H; Sanjay, A				Scanlon, Vanessa; Do Yu Soung; Adapala, Naga Suresh; Morgan, Elise; Hansen, Marc F.; Drissi, Hicham; Sanjay, Archana			Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OSTEOBLAST DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; C-CBL; OSTEOCLAST SURVIVAL; CHONDROCYTE DIFFERENTIATION; FACTOR-I; GROWTH; MICE; OSTERIX	Mice in which Cbl is unable to bind PI3K (YF mice) display increased bone volume due to enhanced bone formation and repressed bone resorption during normal bone homeostasis. We investigated the effects of disrupted Cbl-PI3K interaction on fracture healing to determine whether this interaction has an effect on bone repair. Mid-diaphyseal femoral fractures induced in wild type (WT) and YF mice were temporally evaluated via micro-computed tomography scans, biomechanical testing, histological and histomorphometric analyses. Imaging analyses revealed no change in soft callus formation, increased bony callus formation, and delayed callus remodeling in YF mice compared to WT mice. Histomorphometric analyses showed significantly increased osteoblast surface per bone surface and osteoclast numbers in the calluses of YF fractured mice, as well as increased incorporation of dynamic bone labels. Furthermore, using laser capture micro-dissection of the fracture callus we found that cells lacking Cbl-PI3K interaction have higher expression of Osterix, TRAP, and Cathepsin K. We also found increased expression of genes involved in propagating PI3K signaling in cells isolated from the YF fracture callus, suggesting that the lack of Cbl-PI3K interaction perhaps results in enhanced PI3K signaling, leading to increased bone formation, but delayed remodeling in the healing femora.	[Scanlon, Vanessa; Do Yu Soung; Adapala, Naga Suresh; Drissi, Hicham; Sanjay, Archana] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Morgan, Elise] Boston Univ, Dept Mech Engn, Boston, MA USA; [Hansen, Marc F.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Hansen, Marc F.; Drissi, Hicham; Sanjay, Archana] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT USA	University of Connecticut; Boston University; University of Connecticut; University of Connecticut	Drissi, H (corresponding author), Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.	drissi@uchc.edu; asanjay@uchc.edu	Morgan, Elise F/L-1706-2013	Scanlon, Vanessa/0000-0002-5569-6901; drissi, hicham/0000-0002-3322-281X	Skeletal, Craniofacial, and Oral Biology Training Grant [5T90DE021989-02]; United States National Institutes of Health [AR060867, AR055601]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	Skeletal, Craniofacial, and Oral Biology Training Grant; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: VS was supported by the Skeletal, Craniofacial, and Oral Biology Training Grant 5T90DE021989-02. Study was supported by United States National Institutes of Health grant AR060867 (HD) and AR055601 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala NS, 2014, BONE, V67, P1, DOI 10.1016/j.bone.2014.06.013; Adapala NS, 2014, J CELL BIOCHEM, V115, P1277, DOI 10.1002/jcb.24779; Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; Adapala NS, 2010, ANN NY ACAD SCI, V1192, P376, DOI 10.1111/j.1749-6632.2009.05346.x; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Brennan T, 2011, CALCIFIED TISSUE INT, V89, P396, DOI 10.1007/s00223-011-9531-z; Burgers TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063857; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi YH, 2015, BONE, V75, P201, DOI 10.1016/j.bone.2015.02.026; Choi YH, 2011, BIOCHEM BIOPH RES CO, V411, P637, DOI 10.1016/j.bbrc.2011.07.009; DeBlasi G, 2002, J BONE MINER RES, V17, pS350; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feshchenko EA, 1999, ONCOGENE, V18, P3703, DOI 10.1038/sj.onc.1202672; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Fukuyama R, 2004, BIOCHEM BIOPH RES CO, V315, P636, DOI 10.1016/j.bbrc.2004.01.104; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8; Grey A, 2000, ENDOCRINOLOGY, V141, P2129, DOI 10.1210/en.141.6.2129; Grey A, 2003, ENDOCRINOLOGY, V144, P4886, DOI 10.1210/en.2003-0350; Grey A, 2010, BIOCHEM BIOPH RES CO, V391, P564, DOI 10.1016/j.bbrc.2009.11.099; Guenou H, 2006, AM J PATHOL, V169, P1303, DOI 10.2353/ajpath.2006.060102; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lane SW, 2012, BLOOD, V119, P736, DOI 10.1182/blood-2011-07-368753; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OGURA N, 1991, J PERIODONTOL, V62, P284, DOI 10.1902/jop.1991.62.4.284; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Severe N, 2012, J BONE MINER RES, V27, P2108, DOI 10.1002/jbmr.1667; Severe N, 2011, J BIOL CHEM, V286, P24443, DOI 10.1074/jbc.M110.197525; Shinohara M, 2012, J BONE MINER RES, V27, P2464, DOI 10.1002/jbmr.1703; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Soung DY, 2012, J BONE MINER RES, V27, P1585, DOI 10.1002/jbmr.1601; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Ueno H, 1998, BLOOD, V91, P46, DOI 10.1182/blood.V91.1.46.46_46_53; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Wu XH, 2011, J BIOL CHEM, V286, P13512, DOI 10.1074/jbc.M110.187351; Xi Y, 2013, BIOCHEM BIOPH RES CO, V440, P132, DOI 10.1016/j.bbrc.2013.09.043; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138194	10.1371/journal.pone.0138194	http://dx.doi.org/10.1371/journal.pone.0138194			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393915	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100036
J	Lancellotti, P; Dulgheru, R; Magne, J; Henri, C; Servais, L; Bouznad, N; Ancion, A; Martinez, C; Davin, L; Le Goff, C; Nchimi, A; Pierard, L; Oury, C				Lancellotti, Patrizio; Dulgheru, Raluca; Magne, Julien; Henri, Christine; Servais, Laurence; Bouznad, Nassim; Ancion, Arnaud; Martinez, Christophe; Davin, Laurent; Le Goff, Caroline; Nchimi, Alain; Pierard, Luc; Oury, Cecile			Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; RECEPTOR; DEATH	B-type natriuretic peptide (BNP) is often used as a complementary finding in the diagnostic work-up of patients with aortic stenosis (AS). Whether soluble ST2, a new biomarker of cardiac stretch, is associated with symptomatic status and outcome in asymptomatic AS is unknown. sST2 and BNP levels were measured in 86 patients (74 +/- 13 years; 59 asymptomatic, 69%) with AS (< 1.5 cm(2)) and preserved left ventricular ejection fraction who were followed-up for 26 +/- 16 months. Both BNP and sST2 were associated with NYHA class but sST2 (> 23 ng/mL, AUC = 0.68, p< 0.01) was more accurate to identify asymptomatic patients or those who developed symptoms during follow-up. sST2 was independently related to left atrial index (p< 0.0001) and aortic valve area (p = 0.004; model R-2 = 0.32). A modest correlation was found with BNP (r = 0.4, p< 0.01). During follow-up, 29 asymptomatic patients (34%) developed heart failure symptoms. With multivariable analysis, peak aortic jet velocity (HR = 2.7, p = 0.007) and sST2 level (HR = 1.04, p = 0.03) were independent predictors of cardiovascular events. In AS, sST2 levels could provide complementary information regarding symptomatic status, new onset heart failure symptoms and outcome. It might become a promising biomarker in these patients.	[Lancellotti, Patrizio; Dulgheru, Raluca; Henri, Christine; Servais, Laurence; Bouznad, Nassim; Ancion, Arnaud; Martinez, Christophe; Davin, Laurent; Le Goff, Caroline; Nchimi, Alain; Pierard, Luc; Oury, Cecile] Univ Liege Hosp, Dept Cardiol & Radiol, Heart Valve Clin, GIGA Cardiovasc Sci, Liege, Belgium; [Lancellotti, Patrizio; Dulgheru, Raluca; Henri, Christine; Servais, Laurence; Bouznad, Nassim; Ancion, Arnaud; Martinez, Christophe; Davin, Laurent; Le Goff, Caroline; Nchimi, Alain; Pierard, Luc; Oury, Cecile] Univ Liege, Liege, Belgium; [Lancellotti, Patrizio] Grp Villa Maria Care & Res, Lugo, RA, Italy; [Magne, Julien] CHU Dupuytren, Dept Cardiol, Limoges, France; [Magne, Julien] Fac Med Limoges, INSERM 1094, Limoges, France	University of Liege; University of Liege; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lancellotti, P (corresponding author), Univ Liege Hosp, Dept Cardiol & Radiol, Heart Valve Clin, GIGA Cardiovasc Sci, Liege, Belgium.	plancellotti@chu.ulg.ac.be; anchimi@chu.ulg.ac.be; cecile.oury@ulg.ac.be	Le Goff, Caroline/AAE-8177-2021	Nchimi, Alain/0000-0002-1747-9156; Oury, Cecile/0000-0002-7561-0132	Belgian National Fund for Scientific Research (F.R.SFNRS) [T.0028.14]; Montreal Heart Institute Foundation (Bourse du Bal du Coeur); Department of Medicine of the University of Montreal; Association des Cardiologues du Quebec; FRIA fellowship	Belgian National Fund for Scientific Research (F.R.SFNRS)(Fonds de la Recherche Scientifique - FNRS); Montreal Heart Institute Foundation (Bourse du Bal du Coeur); Department of Medicine of the University of Montreal; Association des Cardiologues du Quebec; FRIA fellowship(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian National Fund for Scientific Research (F.R.SFNRS T.0028.14). C.O. is a Senior Research Associate at the F.R.S.-FNRS. C.D. holds a FRIA fellowship. C.H. received grants from the Montreal Heart Institute Foundation (Bourse du Bal du Coeur), the Department of Medicine of the University of Montreal and the Association des Cardiologues du Quebec.	Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18; Clavel MA, 2014, J AM COLL CARDIOL, V63, P2016, DOI 10.1016/j.jacc.2014.02.581; Demyanets S, 2013, J MOL CELL CARDIOL, V60, P16, DOI 10.1016/j.yjmcc.2013.03.020; Felker GM, 2013, CIRC-HEART FAIL, V6, P1172, DOI 10.1161/CIRCHEARTFAILURE.113.000207; Gruson D, 2014, INT J CARDIOL, V172, pE250, DOI 10.1016/j.ijcard.2013.12.101; Henri C, 2014, AM J CARDIOL, V114, P441, DOI 10.1016/j.amjcard.2014.04.053; Henri C, 2014, INT J CARDIOL, V172, P611, DOI 10.1016/j.ijcard.2014.01.084; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Lancellotti P, 2010, HEART, V96, P1364, DOI 10.1136/hrt.2009.190942; Lim P, 2004, EUR HEART J, V25, P2048, DOI 10.1016/j.ehj.2004.09.033; Martinez-Martinez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079176; Mildner M, 2010, CARDIOVASC RES, V87, P769, DOI 10.1093/cvr/cvq104; Monin JL, 2009, CIRCULATION, V120, P69, DOI 10.1161/CIRCULATIONAHA.108.808857; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; O'Connor K, 2010, AM J CARDIOL, V106, P1157, DOI 10.1016/j.amjcard.2010.06.029; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Pascual-Figal DA, 2009, J AM COLL CARDIOL, V54, P2174, DOI 10.1016/j.jacc.2009.07.041; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sawada H, 2013, INT J CARDIOL, V168, P529, DOI 10.1016/j.ijcard.2012.12.059; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE	28	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138940	10.1371/journal.pone.0138940	http://dx.doi.org/10.1371/journal.pone.0138940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390433	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000060
J	Xu, XL; Yu, HQ; Hu, W; Song, Q; Mao, WM				Xu, Xiao-Ling; Yu, Hui-Qin; Hu, Wei; Song, Qian; Mao, Wei-Min			A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROTEIN-LEVELS; LUNG-CANCER; SURVIVAL; VALIDATION; RESECTION; SYSTEM	Background Inflammation-based prognostic scores such as the neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), Glasgow prognostic score (GPS), and modified GPS (mGPS) have been reported to have prognostic value in patients with many types of cancer, including esophageal squamous cell carcinoma (ESCC). However, the role of the C-reactive protein/Albumin (CRP/Alb) ratio in ESCC has not yet been evaluated. Methods A total of 468 patients suffering from histologically proven ESCC were enrolled between January 2000 and July 2010. The GPS, mGPS, NLR, PLR and CRP/Alb ratios were tested together with established prognostic factors in univariate and multivariate Cox regression analyses of overall survival (OS). Results The optimal cutoff level for the CRP/Alb ratio was 0.50. The CRP/Alb ratio (continuous) had higher AUC values at 12 months (0.796), 24 months (0.805), and 36 months (0.815) than the NLR, GPS and mGPS. In univariate analysis, the 5-year OS rate for patients with a CRP/Alb ratio > 0.50 was 43.4%, while the rate for patients with a CRP/Alb ratio <= 0.50 was 17.7% (P < 0.0001). In multivariate analysis, patients with a CRP/Alb ratio > 0.50 had worse survival than patients with a CRP/Alb ratio <= 0.50 (HR: 2.44; 95% CI: 1.82-3.26; P < 0.0001). Conclusion In summary, to the best of our knowledge, this is the first study to identify the CRP/Alb ratio as a novel inflammation-based prognostic factor in a large group of ESCC patients. The prognostic value of the CRP/Alb ratio needs to be verified in prospective multicenter studies.	[Xu, Xiao-Ling] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Yu, Hui-Qin] Hanggan Hosp, Digest Dept, Hangzhou, Zhejiang, Peoples R China; [Hu, Wei] Second Yuhang Peoples Hosp, Dept Respirat, Hangzhou, Zhejiang, Peoples R China; [Song, Qian; Mao, Wei-Min] Zhejiang Canc Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Mao, WM (corresponding author), Zhejiang Canc Hosp, Dept Clin Lab, 38 Guangji Rd, Hangzhou, Zhejiang, Peoples R China.	maowm1418@163.com			Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program) [2011C13039-1]	Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program)	This work was supported by the Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program 2011), No. 2011C13039-1.	Chen ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-539; Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dutta S, 2011, ANN SURG ONCOL, V18, P2808, DOI 10.1245/s10434-011-1676-5; Fairclough E, 2009, CLIN MED, V9, P30, DOI 10.7861/clinmedicine.9-1-30; Ferlay J, 2010, IARC CANCERBASE; Findlay JM, 2015, ANN ONCOL, V26, P624, DOI 10.1093/annonc/mdu449; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Groblewska M, 2012, CLIN CHIM ACTA, V413, P1583, DOI 10.1016/j.cca.2012.05.009; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Kinoshita A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-52; Kobayashi T, 2008, SURGERY, V144, P729, DOI 10.1016/j.surg.2008.08.015; Lindenmann J, 2014, J SURG ONCOL, V110, P645, DOI 10.1002/jso.23711; MacDonald Neil, 2007, J Support Oncol, V5, P157; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Sobin LH., 2010, TNM CLASSIFICATION M; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Wang Chia-Siu, 2009, Chang Gung Med J, V32, P471; Wang J, 2014, WORLD J GASTROENTERO, V20, P18397, DOI 10.3748/wjg.v20.i48.18397; Wei XL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1379-6; Xu XL, 2014, ANN THORAC SURG, V97, P1037, DOI 10.1016/j.athoracsur.2013.10.042	33	67	72	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138657	10.1371/journal.pone.0138657	http://dx.doi.org/10.1371/journal.pone.0138657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390126	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000048
J	Fedriani, JM; Garrote, PJ; Delgado, MD; Penteriani, V				Fedriani, Jose M.; Garrote, Pedro Jose; Delgado, Maria del Mar; Penteriani, Vincenzo			Subtle Gardeners: Inland Predators Enrich Local Topsoils and Enhance Plant Growth	PLOS ONE			English	Article							SEED DISPERSAL; FOREST FLOOR; SOIL; VEGETATION; NITROGEN; BIRDS; VARIABILITY; RECRUITMENT; PATTERNS; SALMON	Inland vertebrate predators could enrich of nutrients the local top soils in the area surrounding their nests and dens by depositing faeces, urine, and prey remains and, thus, alter the dynamics of plant populations. Surprisingly, and in contrast with convincing evidence from coastal habitats, whether and how this phenomenon occurs in inland habitats is largely uncertain even though these habitats represent a major fraction of the earth's surface. We investigated during two consecutive breeding seasons the potential enrichment of the top-soils associated with inland ground-nesting eagle owls Bubo bubo, as well as its possible consequences in the growth of two common annual grasses in southern Spain. Top-soils associated with owl nests differed strongly and significantly from control top-soils in chemical parameters, mainly fertility-related properties. Specifically, levels of available phosphorus, total nitrogen, organic matter, and available potassium were 49.1, 5.6, 3.1, and 2.7 times higher, respectively, in top-soils associated with owl nests as compared to control top-soils. Germination experiments in chambers indicated that nutrient enrichment by nesting owls enhanced seedling growth in both annual grasses (Phalaris canariensis and Avena sativa), with seedling size being 1.4-1.3 times higher in owl nest top-soils than in control top-soils. Our experimental study revealed that pervasive inland, predatory birds can profoundly enrich the topsoil around their nests and, thus, potentially enhance local vegetation growth. Because diverse inland vertebrate predators are widespread in most habitats they have a strong potential to enhance spatial heterogeneity, impinge on plant communities, and exert an overlooked effect on primary productivity worldwide.	[Fedriani, Jose M.] Univ Lisbon, Inst Super Agron, Ctr Appl Ecol Prof Baeta Neves InBIO, P-1699 Lisbon, Portugal; [Fedriani, Jose M.; Garrote, Pedro Jose; Penteriani, Vincenzo] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Delgado, Maria del Mar; Penteriani, Vincenzo] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Delgado, Maria del Mar; Penteriani, Vincenzo] Univ Oviedo, Res Unit Biodivers, UMIB, UO CSIC PA, Mieres, Spain	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo	Fedriani, JM (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Appl Ecol Prof Baeta Neves InBIO, P-1699 Lisbon, Portugal.	fedriani@ebd.csic.es; penteriani@ebd.csic.es	Fedriani, Jose/R-1328-2018	Fedriani, Jose/0000-0002-1581-2621; Delgado, Maria del Mar/0000-0002-3009-738X	Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]; Kone Foundation [44-6977]	Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Program for Centres of Excellence in R+D+I; Kone Foundation	This work has been financed by the Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Program for Centres of Excellence in R+D+I (SEV-2012-0262; internal EBD call 'Microproyectos'). MD was funded by the Kone Foundation (#44-6977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 1999, ENVIRON GEOCHEM HLTH, V21, P353, DOI 10.1023/A:1006744603461; Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; ARP PA, 1984, CAN J SOIL SCI, V64, P423, DOI 10.4141/cjss84-043; ARP PA, 1984, CAN J SOIL SCI, V64, P457, DOI 10.4141/cjss84-046; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; Bremner JM, 1995, FERT RES, V42, P321, DOI 10.1007/BF00750524; Bruun HH, 2005, ECOGRAPHY, V28, P81, DOI 10.1111/j.0906-7590.2005.04033.x; Castellanos BPI, 2005, THE ECOLOGY OF PREDA; Da Silva H, 2013, POLIBOTANICA, V36, P95; Dean WRJ, 1999, J ARID ENVIRON, V41, P61, DOI 10.1006/jare.1998.0455; Delgado MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077557; DICKSON RL, 1990, WEED SCI, V38, P54, DOI 10.1017/S0043174500056113; Dzwonko Z, 2002, ANN BOT-LONDON, V90, P245, DOI 10.1093/aob/mcf178; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Ellis JC, 2011, SEABIRD ISLANDS ECOL; Espana, 2004, SIERRA, P10058; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fedriani JM, 2014, ECOLOGY, V95, P514, DOI 10.1890/13-0718.1; Fedriani JM, 2012, ECOLOGY, V93, P575, DOI 10.1890/11-0429.1; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Helfield JM, 2006, ECOSYSTEMS, V9, P167, DOI 10.1007/s10021-004-0063-5; Herrera CM, 2002, OIKOS, V97, P260, DOI 10.1034/j.1600-0706.2002.970212.x; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; JENKINSON DS, 1985, J SOIL SCI, V36, P425, DOI 10.1111/j.1365-2389.1985.tb00348.x; Kurek P, 2014, ECOL RES, V29, P1, DOI 10.1007/s11284-013-1094-1; Liebman M, 2000, WEED RES, V40, P27, DOI 10.1046/j.1365-3180.2000.00164.x; Little RC, 2006, SAS MIXED MODELS; Mulder C.P.H., 2011, SEABIRD ISLANDS ECOL; Nogales M, 2007, J ECOL, V95, P1394, DOI 10.1111/j.1365-2745.2007.01305.x; Page A. L., 1982, METHODS OF SOIL ANAL; Penteriani V, 2008, J AVIAN BIOL, V39, P215, DOI 10.1111/j.0908-8857.2008.04280.x; Penteriani V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003014; [Pesca y Alimentacion Ministerio de Agricultura], 1986, MET OF AN SUEL, pIII; Pilbeam DJ, 2015, HANDBOOK OF PLANT NU; Polis GA, 2004, FOOD WEBS AT THE LAN; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; SAS Institute Inc, 2014, SAS VERSION 9 3; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Schmitz OJ., 2010, RESOLVING ECOSYSTEM; SOBEY DG, 1979, J ECOL, V67, P469, DOI 10.2307/2259108; Therneau T.M., 2000, MODELING SURVIVAL DA; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Turnbull LA, 2012, ECOLOGY, V93, P1283, DOI 10.1890/11-0261.1; VALDES B., 2008, LAGASCALIA, V28, P117; WEBSTER R, 1976, AUST J SOIL RES, V14, P1, DOI 10.1071/SR9760001	48	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138273	10.1371/journal.pone.0138273	http://dx.doi.org/10.1371/journal.pone.0138273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383647	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200085
J	He, YJ; Chen, WH; Hu, YC; Luo, B; Wu, L; Qiao, Y; Mo, Q; Xu, RG; Zhou, YC; Ren, ZH; Zuo, ZC; Deng, JL; Peng, GN; He, W; Wei, YH				He, Yajun; Chen, Weihong; Hu, Yanchun; Luo, Biao; Wu, Lei; Qiao, Yan; Mo, Quan; Xu, Ruiguang; Zhou, Yancheng; Ren, Zhihua; Zuo, Zhicai; Deng, Junliang; Peng, Guangneng; He, Wei; Wei, Yahui			E. adenophorum Induces Cell Cycle and Apoptosis of Renal Cells through Mitochondrial Pathway and Caspase Activation in Saanen Goat	PLOS ONE			English	Article							EUPATORIUM-ADENOPHORUM; CYTOCHROME-C; BCL-2; P53; HEPATOTOXICITY; CPP32; 9-OXO-10,11-DEHYDROAGERAPHORONE; SARCOPTES; EXTRACTS; CLEAVAGE	The cytotoxicity effects of E. adenophorum on cell cycle and apoptosis of renal cells in Saanen goat was evaluated by TUNEL, DAPI, AO/EB staining, DNA fragmentation assay, Caspase activity, Western-blot, qRT-PCR and flow cytometry analysis. 16 saanen goats randomly divided into four groups were fed on 0%, 40%, 60% and 80% E. adenophorum diets. The Results showed that E. adenophorum induced typical apoptotic features of renal cells. E. adenophorum significantly suppressed renal cells viability, caused cell cycle activity arrest and induced typical apoptotic features in a dose-dependent manner. However, the protein levels of Fas/FasL, Bid and caspase-8 did not appear significant changes in the process of E. adenophorum-induced apoptosis. Moreover, E. adenophorum administration slightly decreased Bcl-2 expression, promoted Bax translocation to mitochondria, triggered the release of Cyt c from mitochondria into cytosol and activated caspase-9, -3, and cleaved PARP. The mitochondrial p53 translocation was significantly activated, accompanied by a significant increase in the loss of Delta psi m, Cyt c release and caspase-9 activation. Above all, these data suggest that E. adenophorum induces renal cells apoptosis via the activation of mitochondria-mediated apoptosis pathway in renal cells. These findings may provide new insights to understand the mechanisms involved in E. adenophorum-caused cytotoxicity of renal cells.	[He, Yajun; Chen, Weihong; Hu, Yanchun; Luo, Biao; Wu, Lei; Qiao, Yan; Mo, Quan; Xu, Ruiguang; Zhou, Yancheng; Ren, Zhihua; Zuo, Zhicai; Deng, Junliang; Peng, Guangneng] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Wenjiang, Sichuan, Peoples R China; [He, Wei; Wei, Yahui] Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Sch Life Sci, Xian, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University; Northwest University Xi'an	Hu, YC (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Wenjiang, Sichuan, Peoples R China.	hychun114@163.com; weiyahui@nwu.edu.cn			Special Fund for Agroscientific Research in the Public Interest [201203062]; Chang-jiang Scholars and the Innovative Research Team in University [IRT0848]	Special Fund for Agroscientific Research in the Public Interest; Chang-jiang Scholars and the Innovative Research Team in University	Special Fund for Agroscientific Research in the Public Interest (Grant No. 201203062) and Chang-jiang Scholars and the Innovative Research Team in University (Grant No. IRT0848). Yanchun Hu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj R, 2001, J BIOCHEM MOL TOXIC, V15, P279, DOI 10.1002/jbt.10001; Boulakia CA, 1996, ONCOGENE, V12, P529; Chakravarty AK, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq033; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; GONG JP, 1993, J CELL PHYSIOL, V157, P263; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guo SH, 2009, PROCESS SAF ENVIRON, V87, P343, DOI 10.1016/j.psep.2009.06.003; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Katoch R, 2000, TOXICON, V38, P309, DOI 10.1016/S0041-0101(99)00151-8; Kaushal V, 2001, TOXICON, V39, P615, DOI 10.1016/S0041-0101(00)00173-2; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; Kundu A, 2013, TOXICOL ENVIRON CHEM, V95, P127, DOI 10.1080/02772248.2012.759577; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li ZC, 2012, INT J BIOL SCI, V8, P394, DOI 10.7150/ijbs.3882; Liao Fei, 2014, Asian Journal of Chemistry, V26, P7321; Liao F, 2014, EXP PARASITOL, V140, P8, DOI 10.1016/j.exppara.2014.02.009; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2004, ACTA PHYTOECOLOGICAL, V29, P1029; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Neopane S, 1992, PERFORMANCE GOATS GI; Nicholson DW, 1995, IDENTIFICATION AND I; Nong X, 2013, VET PARASITOL, V195, P157, DOI 10.1016/j.vetpar.2013.02.020; OBrien IEW, 1997, CYTOMETRY, V29, P28, DOI 10.1002/(SICI)1097-0320(19970901)29:1<28::AID-CYTO2>3.0.CO;2-9; Oelrichs Peter B., 1995, Natural Toxins, V3, P350, DOI 10.1002/nt.2620030505; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Sahoo A, 2011, LIVEST SCI, V136, P175, DOI 10.1016/j.livsci.2010.08.019; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sani Y., 1992, Poisonous plants. Proceedings of the Third International Symposium., P626; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Seddiek SA, 2013, PARASITOL RES, V112, P2319, DOI 10.1007/s00436-013-3395-2; Sharma Om P., 1998, Natural Toxins, V6, P1, DOI 10.1002/(SICI)1522-7189(199802)6:1<1::AID-NT3>3.0.CO;2-E; Singh D., 2011, INT J RES PHYTOCHEM, V1, P165; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Tong XH, 2004, CANCER LETT, V212, P21, DOI 10.1016/j.canlet.2004.03.035; Verma A., 1987, INDIAN J ANIMAL NUTR; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Xu YF, 2009, CANCER LETT, V284, P229, DOI 10.1016/j.canlet.2009.04.028; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	47	13	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138504	10.1371/journal.pone.0138504	http://dx.doi.org/10.1371/journal.pone.0138504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382060	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200118
J	Niu, TH; Tian, Y; Cai, Q; Ren, Q; Wei, LZ				Niu, Tianhui; Tian, Yan; Cai, Qing; Ren, Qu; Wei, Lizhao			Red Light Combined with Blue Light Irradiation Regulates Proliferation and Apoptosis in Skin Keratinocytes in Combination with Low Concentrations of Curcumin	PLOS ONE			English	Article							FACTOR-KAPPA-B; TREATED HACAT CELLS; PHOTODYNAMIC THERAPY; VISIBLE-LIGHT; CANCER CELLS; IN-VITRO; GROWTH; ALPHA; BIOAVAILABILITY; PSORIASIS	Curcumin is a widely known natural phytochemical from plant Curcuma longa. In recent years, curcumin has received increasing attention because of its capability to induce apoptosis and inhibit cell proliferation as well as its anti-inflammatory properties in different cancer cells. However, the therapeutic benefits of curcumin are severely hampered due to its particularly low absorption via trans-dermal or oral bioavailability. Phototherapy with visible light is gaining more and more support in dermatological therapy. Red light is part of the visible light spectrum, which is able to deeply penetrate the skin to about 6 mm, and directly affect the fibroblast of the skin dermis. Blue light is UV-free irradiation which is fit for treating chronic inflammation diseases. In this study, we show that curcumin at low concentrations (1.25-3.12 mu M) has a strong anti-proliferative effect on TNF-alpha-induced psoriasis-like inflammation when applied in combination with light-emitting-diode devices. The treatment was especially effective when LED blue light at 405 nm was combined with red light at 630 or 660 nm, which markedly amplified the anti-proliferative and apoptosis-inducing effects of curcumin. The experimental results demonstrated that this treatment reduced the viability of human skin keratinocytes, decreased cell proliferation, induced apoptosis, inhibited NF-kappa B activity and activated caspase-8 and caspase-9 while preserving the cell membrane integrity. Moreover, the combined treatment also down-regulated the phosphorylation level of Akt and ERK. Taken together, our results indicated that the combination of curcumin with LED blue light united red light irradiation can attain a higher efficiency of regulating proliferation and apoptosis in skin keratinocytes.	[Niu, Tianhui] Gen Hosp Air Force, Aviat Med Res Lab, Beijing, Peoples R China; [Tian, Yan] Gen Hosp Air Force, Dept Dermatol, Beijing, Peoples R China; [Cai, Qing; Ren, Qu; Wei, Lizhao] Gen Hosp Air Force, Clin Examinat Dept, Beijing, Peoples R China		Niu, TH (corresponding author), Gen Hosp Air Force, Aviat Med Res Lab, Beijing, Peoples R China.	niuhui81@126.com			National Science Foundation of China [31300638, 81101177]; Foundation of The General Hospital of the Air Force [kz2013041]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of The General Hospital of the Air Force	Funding: This work was supported by the National Science Foundation of China from Tianhui Niu, No. 31300638-in the study of data collection and analysis, decision to publish; the National Science Foundation of China from Yan Tian, No. 81101177-in the research desigh; the Foundation of The General Hospital of the Air Force from Tianhui Niu, No. kz2013041-in the study of preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aziz-Jalali MH, 2012, INDIAN J DERMATOL, V57, P128, DOI [DOI 10.4103/0019-5154.94283, 10.4103/0019-5154.94283]; Babilas P, 2005, PHOTODERMATOL PHOTO, V21, P142, DOI 10.1111/j.1600-0781.2005.00147.x; Babilas P, 2006, EUR J DERMATOL, V16, P340; Banerjee S, 2012, CHEM COMMUN, V48, P7702, DOI 10.1039/c2cc33576j; Becker D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020566; Bernd A, 2014, PHYTOCHEM REV, V13, P183, DOI 10.1007/s11101-013-9296-2; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bruzell EM, 2005, PHOTOCH PHOTOBIO SCI, V4, P523, DOI 10.1039/b503397g; Buss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079748; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Cho HJ, 2013, J AGR FOOD CHEM, V61, P4089, DOI 10.1021/jf400192v; Cho JW, 2007, INT J MOL MED, V19, P469; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; Ribeiro APD, 2013, LASER MED SCI, V28, P391, DOI 10.1007/s10103-012-1064-9; Dujic J, 2007, J INVEST DERMATOL, V127, P1992, DOI 10.1038/sj.jid.5700801; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kleinpenning MM, 2012, J EUR ACAD DERMATOL, V26, P219, DOI 10.1111/j.1468-3083.2011.04039.x; Kleinpenning MM, 2010, PHOTODERMATOL PHOTO, V26, P16, DOI 10.1111/j.1600-0781.2009.00474.x; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Koon HK, 2006, J ENVIRON PATHOL TOX, V25, P205, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.120; Krutmann J., 2001, DERMATOLOGICAL PHOTO; Lee SY, 2007, LASER SURG MED, V39, P180, DOI 10.1002/lsm.20412; Liebmann J, 2010, J INVEST DERMATOL, V130, P259, DOI 10.1038/jid.2009.194; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Narayan S, 2004, J MOL HISTOL, V35, P301, DOI 10.1023/B:HIJO.0000032361.98815.bb; Niu TH, 2014, PHOTOCHEM PHOTOBIOL, V90, P1349, DOI 10.1111/php.12316; Park K, 2007, ONCOL REP, V17, P537; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SCHRAUFSTATTER E, 1949, NATURE, V164, P456, DOI 10.1038/164456a0; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Stadler I, 2000, LASER SURG MED, V27, P255, DOI 10.1002/1096-9101(2000)27:3<255::AID-LSM7>3.0.CO;2-L; Sun J, 2012, INT IMMUNOPHARMACOL, V13, P170, DOI 10.1016/j.intimp.2012.03.025; Leite DPV, 2014, PHOTOMED LASER SURG, V32, P627, DOI 10.1089/pho.2014.3805; Weiss RA, 2005, DERMATOL SURG, V31, P1199; Wu XW, 2001, ARTHRITIS RHEUM, V44, P2642, DOI 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86	48	36	37	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138754	10.1371/journal.pone.0138754	http://dx.doi.org/10.1371/journal.pone.0138754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382065	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200158
J	Ye, X; Liu, GH; Li, ZS; Wang, H; Zeng, Y				Ye, Xin; Liu, Guohua; Li, Zongshan; Wang, Hao; Zeng, Yuan			Assessing Local and Surrounding Threats to the Protected Area Network in a Biodiversity Hotspot: The Hengduan Mountains of Southwest China	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; LAND-USE CHANGE; TROPICAL FORESTS; NATIONAL-PARKS; CONSERVATION; VULNERABILITY; DEFORESTATION; DEGRADATION; MANAGEMENT; VEGETATION	Protected areas (PAs) not only serve as refuges of biodiversity conservation but are also part of large ecosystems and are vulnerable to change caused by human activity from surrounding lands, especially in biodiversity hotspots. Assessing threats to PAs and surrounding areas is therefore a critical step in effective conservation planning. We apply a threat framework as a means of quantitatively assessing local and surrounding threats to different types of PAs with gradient buffers, and to main ecoregions in the Hengduan Mountain Hotspot of southwest China. Our findings show that national protected areas (NPAs) have lower and significantly lower threat values (p< 0.05) than provincial protected areas (PPAs) and other protected areas (OPAs), respectively, which indicates that NPAs are lands with a lower threat level and higher levels of protection and management. PAs have clear edge effects, as the proportion of areas with low threat levels decline dramatically in the 5-kilometer buffers just outside the PAs. However, NPAs suffered greater declines (58.3%) than PPAs (34.8%) and OPAs (33.4%) in the 5-kilometer buffers. Moreover, a significant positive correlation was found between the size of PAs and the proportion of areas with low threat levels that they contained in both PAs and PA buffers (p< 0.01). To control or mitigate current threats at the regional scale, PA managers often require quantitative information related to threat intensities and spatial distribution. The threat assessment in the Hengduan Mountain Hotspot will be useful to policy makers and managers in their efforts to establish effective plans and target-oriented management strategies.	[Ye, Xin; Liu, Guohua; Li, Zongshan; Wang, Hao] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Ye, Xin; Wang, Hao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zeng, Yuan] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Liu, GH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	ghliu@rcees.ac.cn			National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2011BAC09B00, 2011BAC09B08]	National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was supported by National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (Nos. 2011BAC09B00 and 2011BAC09B08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Bicknell JE, 2015, FRONT ECOL ENVIRON, V13, P73, DOI 10.1890/15.WB.001; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brun C, 2015, GLOBAL ENVIRON CHANG, V31, P285, DOI 10.1016/j.gloenvcha.2015.02.004; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butsic V, 2012, CONSERV BIOL, V26, P883, DOI 10.1111/j.1523-1739.2012.01887.x; Coetzee BWT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105824; Davis CR, 2011, ECOL APPL, V21, P3299, DOI 10.1890/10-2404.1; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Dowhaniuk N, 2014, ENVIRON MANAGE, V54, P596, DOI 10.1007/s00267-014-0305-z; Fan ZM, 2013, J GEOGR SCI, V23, P258, DOI 10.1007/s11442-013-1008-8; Fu W, 2010, LANDSCAPE URBAN PLAN, V95, P122, DOI 10.1016/j.landurbplan.2009.12.009; Gross JE, 2012, UPSTREAM LANDSCAPE D; Hajkowicz S, 2007, WATER RESOUR MANAG, V21, P1553, DOI 10.1007/s11269-006-9112-5; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hamilton CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055737; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hansen AJ, 2014, ECOL APPL, V24, P484, DOI 10.1890/13-0905.1; Jarvis A., HOLE FILLED SRTM GLO; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu SL, 2014, CHINESE GEOGR SCI, V24, P5, DOI 10.1007/s11769-014-0651-z; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonald RI, 2007, CONSERV BIOL, V21, P1526, DOI 10.1111/j.1523-1739.2007.00799.x; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Meng JH, 2011, INT J REMOTE SENS, V32, P9051, DOI 10.1080/01431161.2010.549847; MEP, 2012, CHIN NAT RES LIST EN; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Neke KS, 2004, CONSERV BIOL, V18, P466; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; NOSS RF, 1986, ENVIRON MANAGE, V10, P299, DOI 10.1007/BF01867252; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Piekielek NB, 2012, BIOL CONSERV, V155, P13, DOI 10.1016/j.biocon.2012.05.003; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Reyers B., 2001, Diversity and Distributions, V7, P79, DOI 10.1046/j.1472-4642.2001.00098.x; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Salerno JD, 2014, CONSERV BIOL, V28, P841, DOI 10.1111/cobi.12237; Seiferling IS, 2012, CONSERV BIOL, V26, P610, DOI 10.1111/j.1523-1739.2011.01674.x; Silveira L, 2014, LANDSCAPE ECOL, V29, P1213, DOI 10.1007/s10980-014-0057-4; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Stork NE, 2014, J BIOGEOGR, V41, P421, DOI 10.1111/jbi.12223; Tardieu L, 2013, ECOSYST SERV, V4, P73, DOI 10.1016/j.ecoser.2013.02.007; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2003, CONSERV BIOL, V17, P1624, DOI 10.1111/j.1523-1739.2003.00250.x; Tobler, 1993, 931 U CAL NAT CTR GE; Vina A, 2007, ECOL APPL, V17, P1019, DOI 10.1890/05-1288; Vu QM, 2014, GLOBAL PLANET CHANGE, V121, P64, DOI 10.1016/j.gloplacha.2014.07.007; Wade AA, 2011, LANDSCAPE URBAN PLAN, V101, P215, DOI 10.1016/j.landurbplan.2011.02.027; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Weckerle CS, 2006, ECON BOT, V60, P3, DOI 10.1663/0013-0001(2006)60[3:PKOTSI]2.0.CO;2; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; Wiens JA, 2009, LANDSCAPE ECOL, V24, P1053, DOI 10.1007/s10980-008-9284-x; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson TS, 2014, REG ENVIRON CHANGE, P1; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wood EM, 2014, ECOL APPL, V24, P1445, DOI 10.1890/12-1992.1; [吴炳方 Wu Bingfang], 2014, [第四纪研究, Quaternary Sciences], V34, P723; Wulder MA, 2011, REMOTE SENS ENVIRON, V115, P747, DOI 10.1016/j.rse.2010.11.002; [张磊 Zhang Lei], 2014, [生态学报, Acta Ecologica Sinica], V34, P7158	67	12	13	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138533	10.1371/journal.pone.0138533	http://dx.doi.org/10.1371/journal.pone.0138533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382763	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200121
J	Zhai, B; Hu, FL; Yan, HJ; Zhao, DL; Jin, X; Fang, TS; Pan, SH; Sun, XY; Xu, LS				Zhai, Bo; Hu, Fengli; Yan, Haijiang; Zhao, Dali; Jin, Xin; Fang, Taishi; Pan, Shangha; Sun, Xueying; Xu, Lishan			Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							AUTOPHAGIC CELL-DEATH; OVARIAN-CANCER CELLS; ARSENIC TRIOXIDE; ACQUIRED-RESISTANCE; INDUCED APOPTOSIS; BREAST-CANCER; UP-REGULATION; CROSS-TALK; PATHWAYS; CONTRIBUTES	Sorafenib is the standard first-line therapeutic treatment for patients with advanced hepatocellular carcinoma (HCC), but its use is hampered by the development of drug resistance. The activation of Akt by sorafenib is thought to be responsible for this resistance. Bufalin is the major active ingredient of the traditional Chinese medicine Chan su, which inhibits Akt activation; therefore, Chan su is currently used in the clinic to treat cancer. The present study aimed to investigate the ability of bufalin to reverse both inherent and acquired resistance to sorafenib. Bufalin synergized with sorafenib to inhibit tumor cell proliferation and induce apoptosis. This effect was at least partially due to the ability of bufalin to inhibit Akt activation by sorafenib. Moreover, the ability of bufalin to inactivate Akt depended on endoplasmic reticulum (ER) stress mediated by inositol-requiring enzyme 1 (IRE1). Silencing IRE1 with siRNA blocked the bufalin-induced Akt inactivation, but silencing eukaryotic initiation factor 2 (eIF2) or C/EBP-homologous protein (CHOP) did not have the same effect. Additionally, silencing Akt did not influence IRE1, CHOP or phosphorylated eIF2 alpha expression. Two sorafenib-resistant HCC cell lines, which were established from human HCC HepG2 and Huh7 cells, were refractory to sorafenib-induced growth inhibition but were sensitive to bufalin. Thus, Bufalin reversed acquired resistance to sorafenib by downregulating phosphorylated Akt in an ER-stress-dependent manner via the IRE1 pathway. These findings warrant further studies to examine the utility of bufalin alone or in combination with sorafenib as a first-or second-line treatment after sorafenib failure for advanced HCC.	[Zhai, Bo; Yan, Haijiang; Jin, Xin; Fang, Taishi; Xu, Lishan] Harbin Med Univ, Affiliated Hosp 4, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Hu, Fengli] Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Heilongjiang, Peoples R China; [Zhao, Dali; Pan, Shangha; Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Xu, LS (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China.	xulishan001@126.com		Sun, Xueying/0000-0002-8065-8747	National Natural Scientific Foundation of China [81401975]; Natural Science Foundation of Heilongjiang Province [D201250]; Youth Scientific Fund of Heilongjiang Province [QC2013C103]; Heilongjiang Postdoctoral Fund [LBH-Z14219]; Scientific Research Project of Heilongjiang Medical Science Institute [201502]; Science and Technology Research Project of Heilongjiang Province Education Department [12541329]; Heilongjiang Province Health Bureau, China [2014-399]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Youth Scientific Fund of Heilongjiang Province; Heilongjiang Postdoctoral Fund; Scientific Research Project of Heilongjiang Medical Science Institute; Science and Technology Research Project of Heilongjiang Province Education Department; Heilongjiang Province Health Bureau, China	This work was supported in part by grants from the National Natural Scientific Foundation of China (81401975), Natural Science Foundation of Heilongjiang Province (D201250), The Youth Scientific Fund of Heilongjiang Province (QC2013C103), Heilongjiang Postdoctoral Fund (LBH-Z14219), Scientific Research Project of Heilongjiang Medical Science Institute (201502), Science and Technology Research Project of Heilongjiang Province Education Department (12541329), and Heilongjiang Province Health Bureau (2014-399), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Brozovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076397; Chen J, 2012, LEUKEMIA RES, V36, P1526, DOI 10.1016/j.leukres.2012.08.018; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen YY, 2015, ENVIRON TOXICOL, V30, P74, DOI 10.1002/tox.21896; Chow SE, 2014, APOPTOSIS, V19, P527, DOI 10.1007/s10495-013-0945-0; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Dong XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092864; Fan LL, 2013, J PINEAL RES, V55, P184, DOI 10.1111/jpi.12061; Fan LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062627; Gao Y, 2012, MOL BIOL REP, V39, P1683, DOI 10.1007/s11033-011-0908-x; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gu W, 2014, ONCOL REP, V31, P216, DOI 10.3892/or.2013.2817; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Holz MS, 2013, MOL CANCER THER, V12, P173, DOI 10.1158/1535-7163.MCT-12-0532; Hsui CM, 2013, INT J ONCOL, V43, P338, DOI 10.3892/ijo.2013.1942; Hu FL, 2014, APOPTOSIS, V19, P210, DOI 10.1007/s10495-013-0914-7; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Jiang HC, 2010, CANCER SCI, V101, P975, DOI 10.1111/j.1349-7006.2009.01464.x; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Lei Y, 2015, ONCOGENE, V34, P485, DOI 10.1038/onc.2013.566; Liu N, 2013, ONCOL REP, V30, P2677, DOI 10.3892/or.2013.2771; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; McCloy RA, 2013, BRIT J CANCER, V109, P3034, DOI 10.1038/bjc.2013.693; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Piguet AC, 2011, MOL CANCER THER, V10, P1007, DOI 10.1158/1535-7163.MCT-10-0666; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; Rong XF, 2014, INFLAMMATION, V37, P1050, DOI 10.1007/s10753-014-9828-y; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Shen SY, 2014, INT J BIOL SCI, V10, P212, DOI 10.7150/ijbs.8056; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai SC, 2012, INT J ONCOL, V41, P1431, DOI 10.3892/ijo.2012.1579; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang JZ, 2011, J HEPATOL, V55, P359, DOI 10.1016/j.jhep.2010.10.043; Wang WA, 2014, BBA-MOL CELL RES, V1843, P2143, DOI 10.1016/j.bbamcr.2014.01.012; Wei Z, 2013, TUMOR BIOL, V34, P181, DOI 10.1007/s13277-012-0527-8; Xiu P, 2013, CANCER SCI, V104, P375, DOI 10.1111/cas.12088; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516; Zhai B, 2015, TUMOR BIOL, V36, P2323, DOI 10.1007/s13277-014-2839-3; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang DM, 2012, EUR J PHARMACOL, V692, P19, DOI 10.1016/j.ejphar.2012.06.045; Zhang ZJ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-57; Zhao DL, 2014, CELL SIGNAL, V26, P1030, DOI 10.1016/j.cellsig.2014.01.026; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhu AX, 2010, ANN SURG ONCOL, V17, P1247, DOI 10.1245/s10434-010-0975-6	56	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138485	10.1371/journal.pone.0138485	http://dx.doi.org/10.1371/journal.pone.0138485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381511	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200114
J	Bentley, KT; Schindler, DE; Armstrong, JB; Cline, TJ; Brooks, GT				Bentley, Kale T.; Schindler, Daniel E.; Armstrong, Jonathan B.; Cline, Timothy J.; Brooks, Gabriel T.			Inter-Tributary Movements by Resident Salmonids across a Boreal Riverscape	PLOS ONE			English	Article							RAINBOW-TROUT; POPULATION DIVERSITY; SOCKEYE-SALMON; BROWN TROUT; HABITAT USE; BULL TROUT; STREAM; FISH; DYNAMICS; ECOLOGY	Stream-dwelling fishes inhabit river networks where resources are distributed heterogeneously across space and time. Current theory emphasizes that fishes often perform largescale movements among habitat patches for reproduction and seeking refugia, but assumes that fish are relatively sedentary during growth phases of their life cycle. Using stationary passive integrated transponder (PIT)-tag antennas and snorkel surveys, we assessed the individual and population level movement patterns of two species of fish across a network of tributaries within the Wood River basin in southwestern Alaska where summer foraging opportunities vary substantially among streams, seasons, and years. Across two years, Arctic grayling (Thymallus arcticus) and rainbow trout (Oncorhynchus mykiss) exhibited kilometer-scale movements among streams during the summer growing season. Although we monitored movements at a small fraction of all tributaries used by grayling and rainbow trout, approximately 50% of individuals moved among two or more streams separated by at least 7 km within a single summer. Movements were concentrated in June and July, and subsided by early August. The decline in movements coincided with spawning by anadromous sockeye salmon, which offer a high-quality resource pulse of food to resident species. Inter-stream movements may represent prospecting behavior as individuals seek out the most profitable foraging opportunities that are patchily distributed across space and time. Our results highlight that large-scale movements may not only be necessary for individuals to fulfill their life-cycle, but also to exploit heterogeneously spaced trophic resources. Therefore, habitat fragmentation and homogenization may have strong, but currently undescribed, ecological effects on the access to critical food resources in stream-dwelling fish populations.	[Bentley, Kale T.; Schindler, Daniel E.; Armstrong, Jonathan B.; Cline, Timothy J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Armstrong, Jonathan B.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Brooks, Gabriel T.] NOAA, Fish Ecol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Wyoming; National Oceanic Atmospheric Admin (NOAA) - USA	Bentley, KT (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	bentley2@uw.edu			National Science Foundation; National Science Foundation Coupled Natural and Human systems program grant [1114918]; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Coupled Natural and Human systems program grant; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding was provided by National Science Foundation Graduate Research Fellowship to KTB, National Science Foundation Coupled Natural and Human systems program grant to DES (Diversification, Portfolio Effects, and the Sustainability of Fishing Communities, proposal # 1114918), Gordon and Betty Moore Foundation grant to DES (Title: Improve scientific understanding biocomplexity and how it promotes resilience and productivity in salmon ecosystems).	Albanese B, 2004, CAN J FISH AQUAT SCI, V61, P857, DOI 10.1139/F04-096; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Armstrong JB, 2013, ECOLOGY, V94, P2066, DOI 10.1890/12-1200.1; Armstrong JB, 2010, CAN J FISH AQUAT SCI, V67, P2052, DOI 10.1139/F10-127; Baker TT, 2009, FISHERY MANUSCRIPT S; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Bentley KT, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00231.1; Bentley KT, 2013, T AM FISH SOC, V142, P747, DOI 10.1080/00028487.2013.769899; Berg OK, 2011, J FISH BIOL, V79, P1156, DOI 10.1111/j.1095-8649.2011.03097.x; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Bond MH, 2007, T AM FISH SOC, V136, P562, DOI 10.1577/T06-084.1; Brink SR, 1995, SUMMER HABITAT ECOLO; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CUNJAK RA, 1987, J FISH BIOL, V31, P493, DOI 10.1111/j.1095-8649.1987.tb05254.x; Delgado MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2851; Duffield JW, 2007, EC WILD SALMON ECOSY; Dye JE, 2005, FISHERY MANUSCRIPT S; Eastman DE, 1996, RESPONSE FRESHWATER; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Eide NE, 2004, J ANIM ECOL, V73, P1056, DOI 10.1111/j.0021-8790.2004.00885.x; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; GOWAN C, 1994, CAN J FISH AQUAT SCI, V51, P2626, DOI 10.1139/f94-262; HEGGENES J, 1988, T AM FISH SOC, V117, P336, DOI 10.1577/1548-8659(1988)117<0336:EOSFFO>2.3.CO;2; Lapointe N.W.R., 2013, ENVIRON REV, V22, P1; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Meka JM, 2003, T AM FISH SOC, V132, P717, DOI 10.1577/T01-166; Moore JW, 2008, ECOLOGY, V89, P306, DOI 10.1890/07-1269.1; Moore JW, 2008, J ANIM ECOL, V77, P275, DOI 10.1111/j.1365-2656.2007.01336.x; Morita K, 2002, CONSERV BIOL, V16, P1318, DOI 10.1046/j.1523-1739.2002.01476.x; Muhlfeld CC, 2005, N AM J FISH MANAGE, V25, P797, DOI 10.1577/M04-045.1; Northcote T. G., 1997, North American Journal of Fisheries Management, V17, P1029, DOI 10.1577/1548-8675(1997)017<1029:PISAMI>2.3.CO;2; Porto L. M., 1999, North American Journal of Fisheries Management, V19, P1028, DOI 10.1577/1548-8675(1999)019<1028:LHBDRT>2.0.CO;2; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; Reynolds HV, 1987, BEARS THEIR BIOL MAN, V7, P59, DOI DOI 10.2307/3872608; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; Ruff CP, 2011, ECOLOGY, V92, P2073, DOI 10.1890/10-1762.1; Sawyer H., 2014, RED DESERT HOBACK MU; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Scheuerell MD, 2007, FRESHWATER BIOL, V52, P1944, DOI 10.1111/j.1365-2427.2007.01823.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schindler DE, 2013, BIOL LETT, V9; Schlosser IJ, 1995, AM FISH S S, V17, P392; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Schmetterling DA, 2003, N AM J FISH MANAGE, V23, P721, DOI 10.1577/M01-216; Stanford JA, 2005, INT VER THEOR ANGEW, V29, P123; Tockner K, 2006, SPEC PUBL INT ASS SE, V36, P339; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Warren ML, 1998, T AM FISH SOC, V127, P637, DOI 10.1577/1548-8659(1998)127<0637:RCABTS>2.0.CO;2; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x	55	12	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136985	10.1371/journal.pone.0136985	http://dx.doi.org/10.1371/journal.pone.0136985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379237	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400011
J	Ningappa, M; So, J; Glessner, J; Ashokkumar, C; Ranganathan, S; Min, J; Higgs, BW; Sun, Q; Haberman, K; Schmitt, L; Vilarinho, S; Mistry, PK; Vockley, G; Dhawan, A; Gittes, GK; Hakonarson, H; Jaffe, R; Subramaniam, S; Shin, DH; Sindhi, R				Ningappa, Mylarappa; So, Juhoon; Glessner, Joseph; Ashokkumar, Chethan; Ranganathan, Sarangarajan; Min, Jun; Higgs, Brandon W.; Sun, Qing; Haberman, Kimberly; Schmitt, Lori; Vilarinho, Silvia; Mistry, Pramod K.; Vockley, Gerard; Dhawan, Anil; Gittes, George K.; Hakonarson, Hakon; Jaffe, Ronald; Subramaniam, Shankar; Shin, Donghun; Sindhi, Rakesh			The Role of ARF6 in Biliary Atresia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTRAHEPATIC BILE-DUCTS; GROWTH-FACTOR; SUSCEPTIBILITY; ZEBRAFISH; CELLS; ACTIVATION; SYSTEM; SIGNAL; EPITHELIA	Background & Aims Altered extrahepatic bile ducts, gut, and cardiovascular anomalies constitute the variable phenotype of biliary atresia (BA). Methods To identify potential susceptibility loci, Caucasian children, normal (controls) and with BA (cases) at two US centers were compared at >550000 SNP loci. Systems biology analysis was carried out on the data. In order to validate a key gene identified in the analysis, biliary morphogenesis was evaluated in 2-5-day post-fertilization zebrafish embryos after morpholino-antisense oligonucleotide knockdown of the candidate gene ADP ribosylation factor-6 (ARF6, Mo-arf6). Results Among 39 and 24 cases at centers 1 and 2, respectively, and 1907 controls, which clustered together on principal component analysis, the SNPs rs3126184 and rs10140366 in a 3' flanking enhancer region for ARF6 demonstrated higher minor allele frequencies (MAF) in each cohort, and 63 combined cases, compared with controls (0.286 vs. 0.131, P = 5.94x10(-7), OR 2.66; 0.286 vs. 0.13, P = 5.57x10(-7), OR 2.66). Significance was enhanced in 77 total cases, which included 14 additional BA genotyped at rs3126184 only (p = 1.58x10(-2), OR = 2.66). Pathway analysis of the 1000 top-ranked SNPs in CHP cases revealed enrichment of genes for EGF regulators (p<1 x10(-7)), ERK/MAPK and CREB canonical pathways (p<1 x10(-34)), and functional networks for cellular development and proliferation (p<1 x10(-45)), further supporting the role of EGFR-ARF6 signaling in BA. In zebrafish embryos, Mo-arf6 injection resulted in a sparse intrahepatic biliary network, several biliary epithelial cell defects, and poor bile excretion to the gall bladder compared with uninjected embryos. Biliary defects were reproduced with the EGFR-blocker AG1478 alone or with Mo-arf6 at lower doses of each agent and rescued with arf6 mRNA. Conclusions The BA-associated SNPs identify a chromosome 14q21.3 susceptibility locus encompassing the ARF6 gene. arf6 knockdown in zebrafish implicates early biliary dysgenesis as a basis for BA, and also suggests a role for EGFR signaling in BA pathogenesis.	[Ningappa, Mylarappa; Ashokkumar, Chethan; Higgs, Brandon W.; Sun, Qing; Haberman, Kimberly; Sindhi, Rakesh] Univ Pittsburgh, Med Ctr UPMC, Childrens Hosp Pittsburgh, Hillman Ctr Pediat Transplantat, Pittsburgh, PA 15224 USA; [So, Juhoon; Shin, Donghun] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15261 USA; [So, Juhoon; Shin, Donghun] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Div Pediat Pathol, Dept Pathol, Pittsburgh, PA 15224 USA; [Schmitt, Lori; Jaffe, Ronald] UPMC, Childrens Hosp Pittsburgh, Histol Core Lab, Pittsburgh, PA 15224 USA; [Vilarinho, Silvia; Mistry, Pramod K.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Dhawan, Anil] Kings Coll Hosp London, Paediat Liver GI & Nutr, London WC2R 2L5, England; [Gittes, George K.] UPMC, Childrens Hosp Pittsburgh, Pediat Gen & Thorac Surg, Pittsburgh, PA 15224 USA; [Min, Jun; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92013 USA; [Vockley, Gerard] UPMC, Childrens Hosp Pittsburgh, Dept Pediat & Human Genet, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; King's College Hospital NHS Foundation Trust; King's College Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sindhi, R (corresponding author), Univ Pittsburgh, Med Ctr UPMC, Childrens Hosp Pittsburgh, Hillman Ctr Pediat Transplantat, Pittsburgh, PA 15224 USA.	rakesh.sindhi@chp.edu	Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vilarinho, Silvia/0000-0002-2099-4212; Ranganathan, Sarangarajan/0000-0001-6214-9167; Higgs, Brandon/0000-0002-2951-0245; Glessner, Joseph/0000-0001-5131-2811; Dhawan, Anil/0000-0002-4942-0845	Hillman Foundation of Pittsburgh; American Liver Foundation; Team Transplant; Herridge family; Giventer-Braff family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Hillman Foundation of Pittsburgh; American Liver Foundation; Team Transplant; Herridge family; Giventer-Braff family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Hillman Foundation of Pittsburgh, The American Liver Foundation, Team Transplant, the Herridge and Giventer-Braff families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Azar G, 2002, J PEDIATR GASTR NUTR, V34, P212, DOI 10.1097/00005176-200202000-00020; Balistreri WF, 1996, HEPATOLOGY, V23, P1682, DOI 10.1002/hep.510230652; Bu LN, 2002, J PEDIATR SURG, V37, P1183, DOI 10.1053/jpsu.2002.34468; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Cheng G, 2013, J HEPATOL, V59, P1285, DOI 10.1016/j.jhep.2013.07.021; Chung WS, 2008, DEV CELL, V14, P582, DOI 10.1016/j.devcel.2008.02.012; Yamaguti DCC, 2011, EUR J GASTROEN HEPAT, V23, P759, DOI 10.1097/MEG.0b013e32832e9df0; Cui S, 2013, GASTROENTEROLOGY, V144, P1107, DOI 10.1053/j.gastro.2013.01.022; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Desmet VJ, 1998, MAYO CLIN PROC, V73, P80; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Grisaru S, 2001, DEV BIOL, V231, P31, DOI 10.1006/dbio.2000.0127; Guttman OR, 2011, LIVER INT, V31, P1485, DOI 10.1111/j.1478-3231.2011.02578.x; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hu ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038777; Iguchi H, 2011, ENDOCR J, V58, P747, DOI 10.1507/endocrj.K11E-104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karrer FM, 1996, ARCH SURG-CHICAGO, V131, P493; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Koster RW, 2004, METHOD CELL BIOL, V76, P207; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Lambaerts K, 2012, J CELL SCI, V125, P1129, DOI 10.1242/jcs.089987; Landing B H, 1974, Prog Pediatr Surg, V6, P113; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Leyva-Vega M, 2010, AM J MED GENET A, V152A, P886, DOI 10.1002/ajmg.a.33332; Lorent K, 2010, DEV DYNAM, V239, P855, DOI 10.1002/dvdy.22220; Mack CL, 2006, HEPATOLOGY, V44, P1231, DOI 10.1002/hep.21366; Matys V, NUCL ACIDS RES, V31, P374; Mazalouskas MD, 2014, J BIOL CHEM, V289, P4219, DOI 10.1074/jbc.M113.518514; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nakanuma Y, 2010, HISTOL HISTOPATHOL, V25, P223, DOI 10.14670/HH-25.223; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; OHYA T, 1995, J PEDIATR SURG, V30, P515, DOI 10.1016/0022-3468(95)90120-5; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; RAWEILY EA, 1990, HISTOPATHOLOGY, V17, P521, DOI 10.1111/j.1365-2559.1990.tb00791.x; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Russo P, 2011, CLIN GASTROENTEROL H, V9, P357, DOI 10.1016/j.cgh.2011.01.003; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Schwarz KB, 2013, HEPATOLOGY, V58, P1724, DOI 10.1002/hep.26512; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Tarr PI, 1996, PEDIATRICS, V97, P828; Tsai EA, 2014, HUM GENET, V133, P235, DOI 10.1007/s00439-013-1368-2; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	68	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138381	10.1371/journal.pone.0138381	http://dx.doi.org/10.1371/journal.pone.0138381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379158	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000361769400094
J	Koyano-Nakagawa, N; Shi, XZ; Rasmussen, TL; Das, S; Walter, CA; Garry, DJ				Koyano-Nakagawa, Naoko; Shi, Xiaozhong; Rasmussen, Tara L.; Das, Satyabrata; Walter, Camille A.; Garry, Daniel J.			Feedback Mechanisms Regulate Ets Variant 2 (Etv2) Gene Expression and Hematoendothelial Lineages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; ACTIVATED T-CELLS; TRANSCRIPTION FACTOR; VASCULAR DEVELOPMENT; PRIMITIVE MESODERM; EMBRYONIC STEM; NUCLEAR FACTOR; NF-ATC; VEGF	Etv2 is an essential transcriptional regulator of hematoendothelial lineages during embryogenesis. Although Etv2 downstream targets have been identified, little is known regarding the upstream transcriptional regulation of Etv2 gene expression. In this study, we established a novel methodology that utilizes the differentiating ES cell and embryoid body system to define the modules and enhancers embedded within the Etv2 promoter. Using this system, we defined an autoactivating role for Etv2 that is mediated by two adjacent Ets motifs in the proximal promoter. In addition, we defined the role of VEGF/Flk1-Calcineurin-NFAT signaling cascade in the transcriptional regulation of Etv2. Furthermore, we defined an Etv2-Flt1-Flk1 cascade that serves as a negative feedback mechanism to regulate Etv2 gene expression. To complement and extend these studies, we demonstrated that the Flt1 null embryonic phenotype was partially rescued in the Etv2 conditional knockout background. In summary, these studies define upstream and downstream networks that serve as a transcriptional rheostat to regulate Etv2 gene expression.	[Koyano-Nakagawa, Naoko; Shi, Xiaozhong; Rasmussen, Tara L.; Das, Satyabrata; Walter, Camille A.; Garry, Daniel J.] Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Garry, DJ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 2231 6th St,SE,4-146 CCRB, Minneapolis, MN 55455 USA.	garry@umn.edu	Regan, Clinton/E-6250-2012; Das, Satyabrata/J-2629-2019		National Institutes of Health [U01 HL100407, 1R01 HL122576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL122576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U01 HL100407 and 1R01 HL122576 to D. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Hayashi M, 2012, EXP HEMATOL, V40, P738, DOI 10.1016/j.exphem.2012.05.012; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Kataoka H, 2013, EXP HEMATOL, V41, P567, DOI 10.1016/j.exphem.2013.02.009; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kim JY, 2014, BLOOD, V124, P2948, DOI 10.1182/blood-2014-03-556332; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Neuhaus H, 2010, DEV DYNAM, V239, P3436, DOI 10.1002/dvdy.22487; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rasmussen TL, 2013, GENESIS, V51, P471, DOI 10.1002/dvg.22396; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Schupp MO, 2014, DEV BIOL, V393, P71, DOI 10.1016/j.ydbio.2014.06.019; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi XZ, 2015, J BIOL CHEM, V290, P9614, DOI 10.1074/jbc.M114.614628; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Veldman MB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001590; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176	60	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28107	28119		10.1074/jbc.M115.662197	http://dx.doi.org/10.1074/jbc.M115.662197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396195	Green Published, hybrid			2022-12-26	WOS:000365761900007
J	Ozer, HK; Dlouhy, AC; Thornton, JD; Hu, JJ; Liu, YL; Barycki, JJ; Balk, J; Outten, CE				Ozer, Hatice K.; Dlouhy, Adrienne C.; Thornton, Jeremy D.; Hu, Jingjing; Liu, Yilin; Barycki, Joseph J.; Balk, Janneke; Outten, Caryn E.			Cytosolic Fe-S Cluster Protein Maturation and Iron Regulation Are Independent of the Mitochondrial Erv1/Mia40 Import System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE PROTEINS; SULFHYDRYL OXIDASE ERV1; SACCHAROMYCES-CEREVISIAE; SULFUR PROTEINS; TRANSCRIPTION FACTORS; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; FUNCTIONAL-LINK; GENE-EXPRESSION	The sulfhydryl oxidase Erv1 partners with the oxidoreductase Mia40 to import cysteine-rich proteins in the mitochondrial intermembrane space. In Saccharomyces cerevisiae, Erv1 has also been implicated in cytosolic Fe-S protein maturation and iron regulation. To investigate the connection between Erv1/Mia40-dependent mitochondrial protein import and cytosolic Fe-S cluster assembly, we measured Mia40 oxidation and Fe-S enzyme activities in several erv1 and mia40 mutants. Although all the erv1 and mia40 mutants exhibited defects in Mia40 oxidation, only one erv1 mutant strain (erv1-1) had significantly decreased activities of cytosolic Fe-S enzymes. Further analysis of erv1-1 revealed that it had strongly decreased glutathione (GSH) levels, caused by an additional mutation in the gene encoding the glutathione biosynthesis enzyme glutamate cysteine ligase (GSH1). To address whether Erv1 or Mia40 plays a role in iron regulation, we measured iron-dependent expression of Aft1/2-regulated genes and mitochondrial iron accumulation in erv1 and mia40 strains. The only strain to exhibit iron mis-regulation is the GSH-deficient erv1-1 strain, which is rescued with addition of GSH. Together, these results confirm that GSH is critical for cytosolic Fe-S protein biogenesis and iron regulation, whereas ruling out significant roles for Erv1 or Mia40 in these pathways.	[Ozer, Hatice K.; Dlouhy, Adrienne C.; Hu, Jingjing; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Thornton, Jeremy D.; Balk, Janneke] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Thornton, Jeremy D.; Balk, Janneke] Univ E Anglia, Norwich NR4 7UH, Norfolk, England; [Liu, Yilin; Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Liu, Yilin; Barycki, Joseph J.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Outten, CE (corresponding author), Univ S Carolina, 631 Sumter St, Columbia, SC 29208 USA.	outten@mailbox.sc.edu	Outten, Caryn E./I-9433-2019; Regan, Clinton/E-6250-2012	Outten, Caryn E./0000-0003-0335-6531; 	National Institutes of Health [GM086619, GM077289]; Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289, R01GM086619] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K008838/1, BBS/E/J/000C0657] Funding Source: researchfish; BBSRC [BB/K008838/1, BBS/E/J/000C0657] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086619 (to C. E. O.) and GM077289 (to J. J. B.) and the Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes) (to J. B.).	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bedekovics T, 2011, J BIOL CHEM, V286, P40878, DOI 10.1074/jbc.M111.270082; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Biterova EI, 2009, J BIOL CHEM, V284, P32700, DOI 10.1074/jbc.M109.025114; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; DAUM G, 1982, J BIOL CHEM, V257, P3028; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Fischer Manuel, 2013, Int J Cell Biol, V2013, P742923, DOI 10.1155/2013/742923; Guo PC, 2012, J BIOL CHEM, V287, P34961, DOI 10.1074/jbc.M112.394759; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; SIKORSKI RS, 1989, GENETICS, V122, P19; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Spiller MP, 2013, BIOCHEM J, V455, P27, DOI 10.1042/BJ20130442; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; THORVALDSEN JL, 1993, J BIOL CHEM, V268, P12512; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	57	16	16	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27829	27840		10.1074/jbc.M115.682179	http://dx.doi.org/10.1074/jbc.M115.682179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396185	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000365757500033
J	Ji, C; Zhang, YD; Xu, PY; Xu, T; Lou, XL				Ji, Chen; Zhang, Yongdeng; Xu, Pingyong; Xu, Tao; Lou, Xuelin			Nanoscale Landscape of Phosphoinositides Revealed by Specific Pleckstrin Homology (PH) Domains Using Single-molecule Superresolution Imaging in the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SECRETORY GRANULES; INSULIN-SECRETION; SYNTAXIN CLUSTERS; LIVE CELLS; LOCALIZATION MICROSCOPY; FLUORESCENCE MICROSCOPY; ACTIN DYNAMICS; MULTIPLE POOLS	Background: Phosphatidylinositides in the plasma membrane (PM) are pivotal for cellular functions. Results: Superresolution imaging reveals homogeneous distribution of PI(4,5)P-2, PI4P, and PI(3,4,5)P-3 in the major area of the PM. Conclusion: Phosphatidylinositides detected by PH domains are uniformly distributed in the major regions of the PM, with limited concentration gradients. Significance: This result may imply a new working model of phosphatidylinositides at nanometer scale. Both phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) are independent plasma membrane (PM) determinant lipids that are essential for multiple cellular functions. However, their nanoscale spatial organization in the PM remains elusive. Using single-molecule superresolution microscopy and new photoactivatable fluorescence probes on the basis of pleckstrin homology domains that specifically recognize phosphatidylinositides in insulin-secreting INS-1 cells, we report that the PI(4,5)P-2 probes exhibited a remarkably uniform distribution in the major regions of the PM, with some sparse PI(4,5)P-2-enriched membrane patches/domains of diverse sizes (383 +/- 14 nm on average). Quantitative analysis revealed a modest concentration gradient that was much less steep than previously thought, and no densely packed PI(4,5)P-2 nanodomains were observed. Live-cell superresolution imaging further demonstrated the dynamic structural changes of those domains in the flat PM and membrane protrusions. PI4P and phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P-3) showed similar spatial distributions as PI(4,5)P-2. These data reveal the nanoscale landscape of key inositol phospholipids in the native PM and imply a framework for local cellular signaling and lipid-protein interactions at a nanometer scale.	[Ji, Chen; Lou, Xuelin] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Yongdeng; Xu, Pingyong; Xu, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, XL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA.	xlou3@wisc.edu	Regan, Clinton/E-6250-2012; Zhang, Yongdeng/L-6333-2016	Ji, Chen/0000-0002-9016-6623; Zhang, Yongdeng/0000-0002-4569-8137	National Institutes of Health [R01DK093953, P30NS069271, BRFSG-2014-07]; American Heart Association Predoctoral Fellowship [14PRE20380168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01DK093953, P30NS069271, and BRFSG-2014-07 (to X.L.) and American Heart Association Predoctoral Fellowship 14PRE20380168 (to C.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chang H, 2012, P NATL ACAD SCI USA, V109, P4455, DOI 10.1073/pnas.1113770109; Cheng KKY, 2012, P NATL ACAD SCI USA, V109, P8919, DOI 10.1073/pnas.1202435109; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Ester M, 1996, KDD; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Golebiewska U, 2011, MOL BIOL CELL, V22, P3498, DOI 10.1091/mbc.E11-02-0114; Hagren OI, 2006, J BIOL CHEM, V281, P39121, DOI 10.1074/jbc.M607445200; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Huang P, 2011, DIABETES, V60, P454, DOI 10.2337/db10-0614; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Kolic J, 2014, J BIOL CHEM, V289, P32109, DOI 10.1074/jbc.M114.577510; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Osborne SL, 2001, J CELL SCI, V114, P2501; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; PETERS KR, 1985, J CELL BIOL, V101, P2233, DOI 10.1083/jcb.101.6.2233; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SANAN DA, 1991, J HISTOCHEM CYTOCHEM, V39, P1017, DOI 10.1177/39.8.1906908; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Sengupta P, 2012, DEV CELL, V23, P1092, DOI 10.1016/j.devcel.2012.09.022; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Khuong TM, 2013, NEURON, V77, P1097, DOI 10.1016/j.neuron.2013.01.025; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Wuttke A, 2010, J CELL SCI, V123, P1492, DOI 10.1242/jcs.060525; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yaradanakul A, 2008, J MEMBRANE BIOL, V221, P175, DOI 10.1007/s00232-008-9095-7; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhang YD, 2010, PROG BIOCHEM BIOPHYS, V37, P1144, DOI 10.3724/SP.J.1206.2010.00202	90	40	40	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26978	26993		10.1074/jbc.M115.663013	http://dx.doi.org/10.1074/jbc.M115.663013			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396197	Green Published, hybrid			2022-12-26	WOS:000364794000009
J	Drozd, VM; Saenko, VA; Brenner, AV; Drozdovitch, V; Pashkevich, VI; Kudelsky, AV; Demidchik, YE; Branovan, I; Shiglik, N; Rogounovitch, TI; Yamashita, S; Biko, J; Reiners, C				Drozd, Valentina M.; Saenko, Vladimir A.; Brenner, Alina V.; Drozdovitch, Vladimir; Pashkevich, Vasilii I.; Kudelsky, Anatoliy V.; Demidchik, Yuri E.; Branovan, Igor; Shiglik, Nikolay; Rogounovitch, Tatiana I.; Yamashita, Shunichi; Biko, Johannes; Reiners, Christoph			Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?	PLOS ONE			English	Article							IODINE NUTRITION; SKIN HEMANGIOMA; POOLED ANALYSIS; RISK; CHILDREN; RADIATION; EXPOSURE; RADIOTHERAPY; ADOLESCENTS; UKRAINE	One of the major health consequences of the Chernobyl Nuclear Power Plant accident in 1986 was a dramatic increase in incidence of thyroid cancer among those who were aged less than 18 years at the time of the accident. This increase has been directly linked in several analytic epidemiological studies to iodine-131 (I-131) thyroid doses received from the accident. However, there remains limited understanding of factors that modify the I-131-related risk. Focusing on post-Chernobyl pediatric thyroid cancer in Belarus, we reviewed evidence of the effects of radiation, thyroid screening, and iodine deficiency on regional differences in incidence rates of thyroid cancer. We also reviewed current evidence on content of nitrate in groundwater and thyroid cancer risk drawing attention to high levels of nitrates in open well water in several contaminated regions of Belarus, i.e. Gomel and Brest, related to the usage of nitrogen fertilizers. In this hypothesis generating study, based on ecological data and biological plausibility, we suggest that nitrate pollution may modify the radiation-related risk of thyroid cancer contributing to regional differences in rates of pediatric thyroid cancer in Belarus. Analytic epidemiological studies designed to evaluate joint effect of nitrate content in groundwater and radiation present a promising avenue of research and may provide useful insights into etiology of thyroid cancer.	[Drozd, Valentina M.; Biko, Johannes; Reiners, Christoph] Int Fund Help Patients Radiat Induced Thyroid Can, Minsk, BELARUS; [Drozd, Valentina M.] Belarusian Med Acad Postgrad Educ, Dept Endocrinol, Minsk, BELARUS; [Saenko, Vladimir A.; Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Mol Epidemiol, Nagasaki 852, Japan; [Brenner, Alina V.; Drozdovitch, Vladimir] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Pashkevich, Vasilii I.; Kudelsky, Anatoliy V.] Natl Acad Sci, Inst Nat Management, Lab Hydrogeol & Hydroecol, Minsk, BELARUS; [Demidchik, Yuri E.] Belarusian Med Acad Postgrad Educ, Dept Oncol, Minsk, BELARUS; [Branovan, Igor; Shiglik, Nikolay] Project Chernobyl, Brooklyn, NY USA; [Rogounovitch, Tatiana I.] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 852, Japan; [Biko, Johannes; Reiners, Christoph] Univ Wurzburg, Clin & Polyclin Nucl Med, D-97070 Wurzburg, Germany	Nagasaki University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Academy of Sciences of Belarus (NASB); Institute for Nature Management of the National Academy of Sciences of Belarus; Nagasaki University; Nagasaki University; University of Wurzburg	Saenko, VA (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Mol Epidemiol, Nagasaki 852, Japan.	saenko@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Drozdovitch, Vladimir/0000-0002-7952-379X; Yamashita, Shunichi/0000-0001-6399-6261	Japan Society for the Promotion of Science [25257508, 26670460]; NATIONAL CANCER INSTITUTE [ZIACP010132] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research grants 25257508 and 26670460 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to SY. This work has received no other funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ASS IOD DEF DIS MON; Arinchin A, 2000, IDD NEWSL, V16, P7; Ashizawa K, 1997, J CLIN ENDOCR METAB, V82, P3430, DOI 10.1210/jc.82.10.3430; Astakhova LN, 1998, RADIAT RES, V150, P349, DOI 10.2307/3579983; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Capen CC, 1997, TOXICOL PATHOL, V25, P39, DOI 10.1177/019262339702500109; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davis S, 2004, RADIAT RES, V162, P241, DOI 10.1667/RR3233; Drozd V, 2002, J PEDIATR ENDOCR MET, V15, P979; Drozd V, 1993, P 25 ANN M EUR SOC R, P123; Drozd VM, 1993, P 6 INT C INT ULTR 1, P110; Drozdova EV, 2010, HLTH ENV, V15, P56; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Eskiocak S, 2005, CLIN EXP MED, V5, P66, DOI 10.1007/s10238-005-0068-1; FAVUS MJ, 1976, NEW ENGL J MED, V294, P1019, DOI 10.1056/NEJM197605062941901; Furukawa K, 2013, INT J CANCER, V132, P1222, DOI 10.1002/ijc.27749; Gatseva P, 1997, Folia Med (Plovdiv), V39, P65; Gatseva PD, 2008, INT J HYG ENVIR HEAL, V211, P555, DOI 10.1016/j.ijheh.2007.10.002; Haddy N, 2009, RADIOTHER ONCOL, V93, P377, DOI 10.1016/j.radonc.2009.05.011; Hampel R, 2003, MED KLIN, V98, P547, DOI 10.1007/s00063-003-1303-8; Hatch M, 2011, THYROID, V21, P429, DOI 10.1089/thy.2010.0143; International Atomic Energy Agency, 1991, INT CHERN PROJ TECHN; Ivanov VK, 2012, RADIAT PROT DOSIM, V151, P489, DOI 10.1093/rpd/ncs019; Jacob P, 2006, J RADIOL PROT, V26, P51, DOI 10.1088/0952-4746/26/1/003; Jacob P, 2006, RADIAT RES, V165, P1, DOI 10.1667/RR3479.1; Jacob P, 1999, BRIT J CANCER, V80, P1461, DOI 10.1038/sj.bjc.6690545; Jacob P, 2014, RADIAT ENVIRON BIOPH, V53, P391, DOI 10.1007/s00411-013-0508-3; KANNO J, 1990, TOXICOL PATHOL, V18, P239, DOI 10.1177/019262339001800202; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; Kudelsky AV, 2009, NATURAL RESOURCES, V1, P53; Likhtarov I, 2006, RADIAT RES, V166, P375, DOI 10.1667/RR3593.1; LINDBERG S, 1995, ACTA ONCOL, V34, P735, DOI 10.3109/02841869509127180; Little MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085723; Lozovsky LI, 1971, MICROELEMENTS SOILS, P224; LUNDELL M, 1994, RADIAT RES, V140, P334, DOI 10.2307/3579110; Merlo DF, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S9; METTLER FA, 1992, JAMA-J AM MED ASSOC, V268, P616, DOI 10.1001/jama.268.5.616; Ministry of Ukraine of Emergencies and Affairs of Population Protection from the Consequences of Chornobyl Catastrophe and All Ukrainian Research Institute of Population and Territories Civil Defense from Technogenic and Natural Emergencies, 2006, 20 YEARS CHERNOBYL C, P68; Radikova Z, 2008, THYROID, V18, P353, DOI 10.1089/thy.2007.0182; Reiners C, 2014, NAT REV ENDOCRINOL, V10, P69, DOI 10.1038/nrendo.2013.247; Robbins J, 2001, THYROID, V11, P487, DOI 10.1089/105072501300176444; RON E, 1989, RADIAT RES, V120, P516, DOI 10.2307/3577801; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Schneider AB, 2013, WERNER INGBARS THYRO, P665; Shakhtarin VV, 2003, INT J EPIDEMIOL, V32, P584, DOI 10.1093/ije/dyg205; SHORE RE, 1985, J NATL CANCER I, V74, P1177; SOCOLOW EL, 1963, NEW ENGL J MED, V268, P406, DOI 10.1056/NEJM196302212680803; Stezhko VA, 2004, RADIAT RES, V161, P481, DOI 10.1667/3148; Tajtakova M, 2006, CHEMOSPHERE, V62, P559, DOI 10.1016/j.chemosphere.2005.06.030; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, SOURC EFF ION RAD UN; VANMAANEN JMS, 1994, TOXICOL LETT, V72, P365, DOI 10.1016/0378-4274(94)90050-7; VanMiddlesworth L, 2002, INT CONGR SER, V1234, P163, DOI 10.1016/S0531-5131(01)00605-7; Veiga LHS, 2012, RADIAT RES, V178, P365, DOI 10.1667/RR2889.1; Ward Mary H., 2009, Reviews on Environmental Health, V24, P357; Ward MH, 2010, EPIDEMIOLOGY, V21, P389, DOI 10.1097/EDE.0b013e3181d6201d; World Health Organization, 1996, MED CONS CHERN ACC S; World Health Organization. International Agency for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, V94; World Health Organization (WHO), 1995, WHO TECHN REP SER, V859; Yamashita S., 1999, RAD THYROID CANC, P369; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Zablotska LB, 2015, CANCER-AM CANCER SOC, V121, P457, DOI 10.1002/cncr.29073; Zimmermann MB, 2013, WERNER INGBARS THYRO, P217; Zimmermann MB, 2012, NUTR REV, V70, P553, DOI 10.1111/j.1753-4887.2012.00528.x	65	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137226	10.1371/journal.pone.0137226	http://dx.doi.org/10.1371/journal.pone.0137226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397978	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500024
J	Wu, SD; Lin, L; Li, HL; Yu, SX; Zhang, LJ; Wang, W				Wu, Sheng-Dan; Lin, Li; Li, Hong-Lei; Yu, Sheng-Xiang; Zhang, Lin-Jing; Wang, Wei			Evolution of Asian Interior Arid-Zone Biota: Evidence from the Diversification of Asian Zygophyllum (Zygophyllaceae)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; TIBETAN PLATEAU UPLIFT; TROPICAL RAIN-FORESTS; PHYLOGENETIC-RELATIONSHIPS; CLIMATE-CHANGE; EOLIAN DEPOSITION; QAIDAM BASIN; NEW-WORLD; ARIDIFICATION; HISTORY	The Asian interior arid zone is the largest desert landform system in the Northern Hemisphere, and has high biodiversity. Little is currently known about the evolutionary history of its biota. In this study, we used Zygophyllum, an important and characteristic component of the Asian interior arid zone, to provide new insights into the evolution of this biota. By greatly enlarged taxon sampling, we present the phylogenetic analysis of Asian Zygophyllum based on two plastid and one nuclear markers. Our phylogenetic analyses indicate that Asian Zygophyllum and Sarcozygium form a clade and Sarcozygium is further embedded within the shrub subclade. An integration of phylogenetic, biogeographic, and molecular dating methods indicates that Zygophyllum successfully colonized the Asian interior from Africa in the early Oligocene, and Asian Zygophyllum became differentiated in the early Miocene and underwent a burst of diversification in the late Miocene associated with the expansion of Asian interior arid lands due to orogenetic and climatic changes. Combining diversification patterns of other important components of the Asian interior arid zone, we propose a multi-stage evolution model for this biota: the late Eocene-early Oligocene origin, the early Miocene expansion, and the middle-late Miocene rapid expansion to the whole Asian interior arid zone. This study also demonstrates that, for Zygophyllum and perhaps other arid-adapted organisms, arid biomes are evolutionary cradles of diversity.	[Wu, Sheng-Dan; Zhang, Lin-Jing] Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China; [Wu, Sheng-Dan; Lin, Li; Li, Hong-Lei; Yu, Sheng-Xiang; Wang, Wei] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China; [Li, Hong-Lei] Fairylake Bot Garden, Key Lab Southern Subtrop Plant Divers, Shenzhen, Peoples R China; [Li, Hong-Lei] Chinese Acad Sci, Shenzhen, Peoples R China	Shanxi Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences	Zhang, LJ (corresponding author), Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China.	linjingzh@aliyun.com; wangwei1127@ibcas.ac.cn	Wu, Shengdan/L-7193-2019; Wu, Sheng-Dan/AAM-4003-2021	Wu, Shengdan/0000-0003-1481-4825	National Basic Research Program of China [2014CB954100]; National Natural Science Foundation of China [41571499, 31270269, 31470315]; Opening Foundation of the Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University); Ministry of Education [ZS12014]; Shanxi Scholarship Council of China [[2010]14-62]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University); Ministry of Education; Shanxi Scholarship Council of China	This research was partially supported by the National Basic Research Program of China (grant no. 2014CB954100), the National Natural Science Foundation of China (grant nos. 41571499, 31270269, 31470315), the Opening Foundation of the Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), and the Ministry of Education (ZS12014), Shanxi Scholarship Council of China [2010]14-62.	An Z., 2014, LATE CENOZOIC CLIMAT; [安芷生 An Zhisheng], 2006, [第四纪研究, Quaternary Sciences], V26, P678; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2013, FRONT BIOGEOGR; [Anonymous], 2014, TRACER V1 6; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Beier BA, 2003, PLANT SYST EVOL, V240, P11, DOI 10.1007/s00606-003-0007-0; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bellstedt DU, 2008, MOL PHYLOGENET EVOL, V47, P932, DOI 10.1016/j.ympev.2008.02.019; Bellstedt DU, 2012, SYST BOT, V37, P951, DOI 10.1600/036364412X656608; Borisova AG, 1949, FLORA USSR, P178; Bosboom RE, 2011, PALAEOGEOGR PALAEOCL, V299, P385, DOI 10.1016/j.palaeo.2010.11.019; Bunge DA, 1843, LINNAEA, V17, P7; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; [陈曦 Chen Xi], 2013, [干旱区研究, Arid Zone Research], V30, P385; Christin PA, 2011, J EXP BOT, V62, P3171, DOI 10.1093/jxb/err041; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Crisp MD, 2013, ANNU REV ECOL EVOL S, V44, P303, DOI 10.1146/annurev-ecolsys-110512-135910; Dettman DL, 2003, EARTH PLANET SC LETT, V214, P267, DOI 10.1016/S0012-821X(03)00383-2; Drummond A, 2011, GENEIOUS V6 0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ENGLER A., 1931, NATURLICHEN PFLANZ A, V19, p[144, 187]; Gao Q, 2008, J INNER MONGOLIA AGR, V29, P2; Guerrero PC, 2013, P NATL ACAD SCI USA, V110, P11469, DOI 10.1073/pnas.1308721110; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hough BG, 2011, GEOL SOC AM BULL, V123, P168, DOI 10.1130/B30090.1; Hrbek T, 2003, J EVOLUTION BIOL, V16, P17, DOI 10.1046/j.1420-9101.2003.00475.x; [胡汝骥 Hu Ruji], 2014, [干旱区研究, Arid Zone Research], V31, P1; Jian X, 2014, PALAEOGEOGR PALAEOCL, V414, P320, DOI 10.1016/j.palaeo.2014.09.011; Li GJ, 2011, GEOLOGY, V39, P199, DOI 10.1130/G31734.1; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; Li JX, 2014, PALAEOGEOGR PALAEOCL, V411, P30, DOI 10.1016/j.palaeo.2014.06.017; Liu XD, 2013, CHINESE SCI BULL, V58, P4277, DOI 10.1007/s11434-013-5987-8; Liu YX, 2008, FLORA CHINA, P45; Liu YX, 1998, FLORA REIPUBLICAE PO, P116; Loera I, 2012, MOL PHYLOGENET EVOL, V65, P437, DOI 10.1016/j.ympev.2012.06.025; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Lu H, 2010, GEOL SOC SPEC PUBL, V342, P29, DOI 10.1144/SP342.4; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; McGinnies W. G., 1979, Arid-land ecosystems: structure, functioning and management. Volume 1., P5; Meigs P., 1953, REV RES ARID ZONE HY, P203; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Miao YF, 2011, QUATERN INT, V236, P3, DOI 10.1016/j.quaint.2010.08.014; Molnar P, 2010, ANNU REV EARTH PL SC, V38, P77, DOI 10.1146/annurev-earth-040809-152456; Moore MJ, 2006, MOL PHYLOGENET EVOL, V39, P668, DOI 10.1016/j.ympev.2006.01.020; Muhaidat R, 2007, AM J BOT, V94, P362, DOI 10.3732/ajb.94.3.362; Mulch A, 2006, NATURE, V439, P670, DOI 10.1038/439670a; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; Pennington RT, 2004, PHILOS T R SOC B, V359, P1455, DOI 10.1098/rstb.2004.1539; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; REA DK, 1994, REV GEOPHYS, V32, P159, DOI 10.1029/93RG03257; Rolland Jonathan, 2012, Biol Lett, V8, P692, DOI 10.1098/rsbl.2011.1024; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sheahan M. C., 2007, FAMILIES GENERA VASC, P488, DOI DOI 10.1007/978-3-540-32219-1_56; SHEAHAN MC, 1993, BOT J LINN SOC, V113, P227, DOI 10.1111/j.1095-8339.1993.tb00339.x; Sheahan MC, 2000, SYST BOT, V25, P371, DOI 10.2307/2666648; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Shi YF, 1998, SCI CHINA SER D, V28, P263; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Sun YB, 2002, SCI CHINA SER D, V45, P420, DOI 10.1360/02yd9044; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tao J.-R., 1992, ACTA PHYTOTAXON SIN, V30, P25; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Thiv M, 2011, AM J BOT, V98, P76, DOI 10.3732/ajb.1000339; Topel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050358; Walter H., 1979, VEGETATION EARTH ECO; Wang W, 2012, NEW PHYTOL, V195, P470, DOI 10.1111/j.1469-8137.2012.04158.x; Wang Yan-ge, 2007, Journal of Plant Resources and Environment, V16, P1; [吴敬禄 Wu Jinglu], 2004, [第四纪研究, Quaternary Sciences], V24, P585; Yang Shu-min, 2006, Journal of Forestry Research (Harbin), V17, P247, DOI 10.1007/s11676-006-0056-7; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zhang ML, 2014, J INTEGR PLANT BIOL, V56, P1125, DOI 10.1111/jipb.12226; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang XS, 1980, CHINESE VEGETATION, P583; Zhang ZS, 2007, PALAEOGEOGR PALAEOCL, V245, P317, DOI 10.1016/j.palaeo.2006.08.003; Zhuang GS, 2011, AM J SCI, V311, P116, DOI 10.2475/02.2011.02	97	13	13	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138697	10.1371/journal.pone.0138697	http://dx.doi.org/10.1371/journal.pone.0138697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393796	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100089
J	Zitouni-Haouar, FEH; Alvarado, P; Sbissi, I; Boudabous, A; Fortas, Z; Moreno, G; Manjon, JL; Gtari, M				Zitouni-Haouar, Fatima El-Houaria; Alvarado, Pablo; Sbissi, Imed; Boudabous, Abdellatif; Fortas, Zohra; Moreno, Gabriel; Luis Manjon, Jose; Gtari, Maher			Contrasted Genetic Diversity, Relevance of Climate and Host Plants, and Comments on the Taxonomic Problems of the Genus Picoa (Pyronemataceae, Pezizales)	PLOS ONE			English	Article							DESERT TRUFFLES; PHYLOGENETIC INFERENCE; PHAEANGIUM-LEFEBVREI; HYPOGEOUS FUNGI; TERFEZIA; SEQUENCES; LINEAGES; TIRMANIA; PAT.	The species concept within the genus Picoa Vittad. is here revisited in light of new molecular and ecological data obtained from samples collected throughout the Mediterranean basin. Two highly diverse widespread clades and four additional minor lineages were significantly supported by three genes dataset (ITS, 28s LSU and RPB2) inferences for 70 specimens. The two widespread clades occur in very different geographical and ecological areas associated with exclusive host plants in the genus Helianthemum. SEM study of spore surface morphology in these lineages revealed the existence of smooth ascospores in the majority of these clades. However the most frequent lineage in Europe and coastal North Africa displayed either smooth or verrucose spores. Hence this morphological criterion cannot be reliably used to discriminate between the different clades. In addition, SEM observations made on ascospores from several original collections of P. juniperi and P. lefebvrei supported the hypothesis that ornamentation depends on the degree of maturity in some of these lineages. Geographical and ecological, rather than morphological data are here suggested as the most useful characters to separate the different lineages in Picoa. Further studies focusing on these features are needed before the names P. juniperi and P. lefebvrei can be unambiguously linked with the genetic lineages observed.	[Zitouni-Haouar, Fatima El-Houaria; Fortas, Zohra] Univ Oran 1, Fac Sci Nat & Vie, Lab Biol Microorganismes & Biotechnol, Dept Biotechnol, Ahmed Ben Bella, Algeria; [Alvarado, Pablo; Moreno, Gabriel; Luis Manjon, Jose] Univ Alcala, Dept Ciencias Vida, Madrid 28871, Spain; [Sbissi, Imed] Inst Reg Arides, Lab Ecol Pastorale, Medenine 4119, Tunisia; [Sbissi, Imed; Boudabous, Abdellatif; Gtari, Maher] Univ Tunis El Manar, Lab Microorganismes & Biomol Act, Tunis 2092, Tunisia; [Sbissi, Imed; Boudabous, Abdellatif; Gtari, Maher] Univ Carthage, Tunis 2092, Tunisia	Universidad de Alcala; Institut des Regions Arides; Universite de Tunis-El-Manar; Universite de Carthage	Zitouni-Haouar, FEH (corresponding author), Univ Oran 1, Fac Sci Nat & Vie, Lab Biol Microorganismes & Biotechnol, Dept Biotechnol, Ahmed Ben Bella, Algeria.	sbissimed@gmail.com	Alvarado, Pablo/K-4736-2014; ZITOUNI-HAOUAR, Fatima El-Houaria/AAA-4312-2022; Moreno, Gabriel/K-8537-2017; Gtari, Maher/W-6673-2019	Alvarado, Pablo/0000-0001-7462-5271; ZITOUNI-HAOUAR, Fatima El-Houaria/0000-0002-4959-2516; Gtari, Maher/0000-0001-6946-6907; SBISSI, Imed/0000-0002-5703-5760	Tunisian Ministry of Higher Education and Scientific Research [LR03ES03]; Algerian Ministry of Higher Education and Scientific Research; Spanish Ministry of Education and Culture FPU grant [AP2006-00890]; "Subprograma AGR del Ministerio de Ciencia y Innovacion (Plan Nacional I+D+I)" Research Project [AGL2009-12884-C03-03]	Tunisian Ministry of Higher Education and Scientific Research; Algerian Ministry of Higher Education and Scientific Research; Spanish Ministry of Education and Culture FPU grant; "Subprograma AGR del Ministerio de Ciencia y Innovacion (Plan Nacional I+D+I)" Research Project	This work was supported by the Tunisian Ministry of Higher Education and Scientific Research (LR03ES03); Algerian Ministry of Higher Education and Scientific Research; Spanish Ministry of Education and Culture FPU grant AP2006-00890, and the "Subprograma AGR del Ministerio de Ciencia y Innovacion (Plan Nacional I+D+I)" Research Project AGL2009-12884-C03-03.	ALSHEIKH AM, 1983, CAN J BOT, V61, P1919, DOI 10.1139/b83-204; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado P, 2012, B SOC MICOL MADRID, V36, P23; Alvarado P, 2012, MYCOLOGIA, V104, P894, DOI 10.3852/11-254; Ammarellou A, 2011, INT J ENVIRON RES, V5, P509; Bawadekji A, 2012, MYCOTAXON, V122, P243, DOI 10.5248/122.243; Bordallo JJ, 2013, MYCOTAXON, V124, P189, DOI 10.5248/124.189; Calonge FD, 2003, MYCOLOGIA ITALIANA, V2, P45; Chevalier G, 2014, EUROPEAN DESERT TRUF, V38, P121, DOI [10.1007/978-3-642-40096-4_9, DOI 10.1007/978-3-642-40096-4_9]; Claridge AW, 2014, SOIL BIOLOGY, V38, P203, DOI DOI 10.1007/978-3-642-40096-4_; Diez J, 2002, MYCOLOGIA, V94, P247, DOI 10.2307/3761801; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guecin F, 2010, BIOL DIVERSITY CONSE, V3, P23; Guevara-Guerrero G, 2012, MYCOL PROG, V11, P711, DOI 10.1007/s11557-011-0781-y; Gutierrez A, 2003, MYCORRHIZA, V13, P299, DOI 10.1007/s00572-003-0236-7; HONRUBIA M, 1992, PERSOONIA, V14, P647; Jamali S, 2012, J AGR SCI TECH-IRAN, V14, P1379; Jamali S, 2013, MOL BIOL REP, V40, P5701, DOI 10.1007/s11033-013-2672-6; Kagan-Zur V, 2014, DESERT TRUFFLES, P159, DOI [10.1007/978-3-, DOI 10.1007/978-3-642-40096-4_11]; Kovacs GM, 2011, MYCOLOGIA, V103, P841, DOI 10.3852/10-312; Kovacs GM, 2008, MYCOLOGIA, V100, P930, DOI 10.3852/08-023; Laessoe T, 2007, MYCOL RES, V111, P1075, DOI 10.1016/j.mycres.2007.08.004; Li LT, 1997, INT J PLANT SCI, V158, P189, DOI 10.1086/297430; Maire R, 1906, ANN MYCOL, V4, P329; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Montecchi A, 2000, FUNGHI IPOGEI EUROPA; Moreno G, 2000, MYCOL RES, V104, P378, DOI 10.1017/S0953756299001227; Moreno G, 2000, B FED ASS MYCOL MEDI, V18, P87; Nylander J.A.A, 2004, MRMODELTEST V2; ODonnell K, 1997, MYCOLOGIA, V89, P48, DOI 10.2307/3761172; Pacioni G, 1994, MICOLOGIA VEGETAZION, V9, P69; Parejo-Farnes C., 2013, BOT COMPLUT, V37, P83, DOI DOI 10.5209/REV_BOCM.2013.V37.42272; Patouillard N, 1894, J BOT, V8, P153; Perry BA, 2007, MYCOL RES, V111, P549, DOI 10.1016/j.mycres.2007.03.014; Peruzzi L, 2004, TAXON, V53, P543, DOI 10.2307/4135636; Riousset L, 1989, IL FUNGO, V3, P9; Riousset L, 1996, IL FUNGO S, V3, P15; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccardo PA., 1889, SYLLOGE FUNGORUM, P900; Sanchez-Gomez P, 2011, ANN BOT FENN, V48, P49, DOI 10.5735/085.048.0107; Sbissi I, 2010, ANTON LEEUW INT J G, V98, P429, DOI 10.1007/s10482-010-9456-y; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2013, MYCOL PROG, V12, P675, DOI 10.1007/s11557-012-0875-1; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tamm H, 2010, MYCOL PROG, V9, P509, DOI 10.1007/s11557-010-0659-4; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turkoglu A, 2014, TURK J BOT, V38, P406, DOI 10.3906/bot-1303-24; Urdvardy MDF, 1975, 18 IUCN; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vittadini C., 1831, MONOGRAPHIA TUBERACE; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	53	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138513	10.1371/journal.pone.0138513	http://dx.doi.org/10.1371/journal.pone.0138513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390223	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000033
J	Ai, MR; Mills, H; Kanai, M; Lai, J; Deng, JJ; Schreiter, E; Looger, L; Neubert, T; Suh, G				Ai, Minrong; Mills, Holly; Kanai, Makoto; Lai, Jason; Deng, Jingjing; Schreiter, Eric; Looger, Loren; Neubert, Thomas; Suh, Greg			Green-to-Red Photoconversion of GCaMP	PLOS ONE			English	Article							ENCODED CALCIUM INDICATORS; FLUORESCENT PROTEIN; NEURAL ACTIVITY; CA2+ INDICATORS; PHOTOACTIVATION; CONVERSION; MECHANISM; TRACKING; LIGHT; CELL	Genetically encoded calcium indicators (GECIs) permit imaging intracellular calcium transients. Among GECIs, the GFP-based GCaMPs are the most widely used because of their high sensitivity and rapid response to changes in intracellular calcium concentrations. Here we report that the fluorescence of GCaMPs-including GCaMP3, GCaMP5 and GCaMP6-can be converted from green to red following exposure to blue-green light (450500 nm). This photoconversion occurs in both insect and mammalian cells and is enhanced in a low oxygen environment. The red fluorescent GCaMPs retained calcium responsiveness, albeit with reduced sensitivity. We identified several amino acid residues in GCaMP important for photoconversion and generated a GCaMP variant with increased photoconversion efficiency in cell culture. This light-induced spectral shift allows the ready labeling of specific, targeted sets of GCaMP-expressing cells for functional imaging in the red channel. Together, these findings indicate the potential for greater utility of existing GCaMP reagents, including transgenic animals.	[Ai, Minrong; Mills, Holly; Kanai, Makoto; Lai, Jason; Suh, Greg] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA; [Deng, Jingjing; Neubert, Thomas] NYU, Sch Med, Dept Biochem & Mol Pharmacol, Skirball Inst Biomol Med, New York, NY USA; [Schreiter, Eric; Looger, Loren] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA	New York University; New York University; Howard Hughes Medical Institute	Ai, MR (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	minrongai@gmail.com; greg.suh@med.nyu.edu	Suh, Seong Bae/K-2434-2016	Schreiter, Eric/0000-0002-2864-7469; neubert, Thomas/0000-0001-7049-2088	NRSA; NIH RO1 [NIGMS: RO1GM08946-01, NIDCD: RO1DC01279-01]; Irma T. Hirschl/Weill Caulier Trust; NIH [P30 NS050276, S10RR027990]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Weill Caulier Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by NRSA to MA and NIH RO1 grants (NIGMS: RO1GM08946-01 and NIDCD: RO1DC01279-01) and the Irma T. Hirschl/Weill Caulier Trust Award to GSBS, and NIH P30 NS050276 and S10RR027990 to TAN.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baker SM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-15; Berlin S, 2015, NAT METHODS, V12, P852, DOI [10.1038/nmeth.3480, 10.1038/NMETH.3480]; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Henderson JN, 2009, J AM CHEM SOC, V131, P4176, DOI 10.1021/ja808851n; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hoi H, 2013, J AM CHEM SOC, V135, P46, DOI 10.1021/ja310184a; Jakobs S, 2003, FEBS LETT, V554, P194, DOI 10.1016/S0014-5793(03)01170-0; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; McEvoy AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051314; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Pakhomov AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P901, DOI 10.1023/B:BIRY.0000040223.09641.29; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Sawin KE, 1997, CURR BIOL, V7, pR606, DOI 10.1016/S0960-9822(06)00313-7; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	38	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138127	10.1371/journal.pone.0138127	http://dx.doi.org/10.1371/journal.pone.0138127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382605	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200060
J	Cao, RH; Ye, X; Chen, XG; Zhang, L; Chen, XW; Tian, YH; Hu, PP; Wang, K				Cao, Ruihua; Ye, Xing; Chen, Xingui; Zhang, Long; Chen, Xianwen; Tian, Yanghua; Hu, Panpan; Wang, Kai			Exploring Biological Motion Processing in Parkinson's Disease Using Temporal Dilation	PLOS ONE			English	Article							NEURAL MECHANISMS; CEREBELLAR LESIONS; VISUAL-PERCEPTION; STROKE PATIENTS; FUSIFORM GYRUS; MOTOR DEFICITS; HUMAN-BODY; MOVEMENTS; DOPAMINE; REHABILITATION	Biological motion (BM) perception is the compelling ability of the visual system to perceive complex animated movements effortlessly and promptly. A recent study has shown that BM can automatically lengthen perceived temporal duration independent of global configuration. The present study aimed mainly to investigate this temporal dilation effect of BM signals in Parkinson's disease (PD) patients. We used the temporal dilation effect as an implicit measure of visual processing of BM. In all, 32 PD patients (under off-therapy conditions) and 32 healthy controls (HCs) participated in our study. In each trial, an upright BM sequence and an inverted BM sequence were presented within an interval in the center of the screen. We tested both canonical and scrambled BM sequences; the scrambled ones were generated by disturbing the global configuration of the canonical ones but preserving exactly the same local motion components. Observers were required to make a verbal two-alternative forced choice response to indicate which interval (the first or the second) appeared longer. Statistical analyses were conducted on the points of subjective equality (PSEs). We found that the temporal dilation effect was significantly reduced for PD patients compared with HCs in both canonical and scrambled BM conditions. Moreover, no temporal dilation effects of scrambled BM were shown in both early-and late-stage PD patients, while the temporal dilation effect of canonical BM was relatively preserved in the early stages.	[Cao, Ruihua] Anhui Prov Hosp, Dept Geriatr Med, Hefei, Anhui, Peoples R China; [Ye, Xing; Chen, Xingui; Zhang, Long; Chen, Xianwen; Tian, Yanghua; Hu, Panpan; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University	Hu, PP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	hpppanda9@126.com; wangkai1964@126.com	Wang, Dapeng/HGD-4818-2022; hu, panpan/ABD-5695-2021	Tian, Yanghua/0000-0001-5038-0599	National Natural Science Foundation of China [91232717, 31000503]; National Basic Research Program of China [2011CB707805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Key Project of the National Natural Science Foundation of China (91232717), the National Basic Research Program of China (2011CB707805), the National Natural Science Foundation of China (31000503) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, NEUROPSYCHOLOGIA, V44, P161, DOI 10.1016/j.neuropsychologia.2005.05.018; Alegre M, 2010, CLIN NEUROPHYSIOL, V121, P414, DOI 10.1016/j.clinph.2009.11.013; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bhasin A, 2012, NEUROL INDIA, V60, P570, DOI 10.4103/0028-3886.105188; Bodis-Wollner I, 2003, PARKINSONISM RELAT D, V9, pS83, DOI 10.1016/S1353-8020(03)00022-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Dayan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030369; de-Wit LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016232; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ertelt D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-42; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028087; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Koch G, 2004, NEUROLOGY, V63, P2405, DOI 10.1212/01.WNL.0000147336.19972.82; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Lewis MM, 2013, CAN J NEUROL SCI, V40, P299, DOI 10.1017/S0317167100014232; Marceglia S, 2009, NEUROSCIENCE, V161, P1027, DOI 10.1016/j.neuroscience.2009.04.018; Marsili L, 2014, PARKINSONISM RELAT D, V20, P370, DOI 10.1016/j.parkreldis.2014.01.013; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pavlova M, 2003, BRAIN, V126, P692, DOI 10.1093/brain/awg062; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Poliakoff E, 2013, J NEUROPSYCHOL, V7, P241, DOI 10.1111/jnp.12005; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; SCATTON B, 1982, NEUROLOGY, V32, P1039, DOI 10.1212/WNL.32.9.1039; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Sokolov AA, 2014, CEREB CORTEX, V24, P626, DOI 10.1093/cercor/bhs346; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; van der Hoorn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095861; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Wang L, 2012, P NATL ACAD SCI USA, V109, pE673, DOI 10.1073/pnas.1115515109; Wang L, 2010, PSYCHOL SCI, V21, P1083, DOI 10.1177/0956797610376072; Wearden JH, 1996, Q J EXP PSYCHOL-B, V49, P24, DOI 10.1080/713932615; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360	59	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138502	10.1371/journal.pone.0138502	http://dx.doi.org/10.1371/journal.pone.0138502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381888	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200117
J	Castellani, M; Heino, M; Gilbey, J; Araki, H; Svasand, T; Glover, KA				Castellani, Marco; Heino, Mikko; Gilbey, John; Araki, Hitoshi; Svasand, Terje; Glover, Kevin A.			IBSEM: An Individual-Based Atlantic Salmon Population Model	PLOS ONE			English	Article							LENGTH-FREQUENCY-DISTRIBUTION; GENE-TRANSCRIPTION PROFILES; SALAR L.; LIFE-HISTORY; FARMED SALMON; WILD SALMON; QUANTITATIVE GENETICS; NATIVE POPULATIONS; LOCAL ADAPTATION; REACTION NORMS	Ecology and genetics can influence the fate of individuals and populations in multiple ways. However, to date, few studies consider them when modelling the evolutionary trajectory of populations faced with admixture with non-local populations. For the Atlantic salmon, a model incorporating these elements is urgently needed because many populations are challenged with gene-flow from non-local and domesticated conspecifics. We developed an Individual-Based Salmon Eco-genetic Model (IBSEM) to simulate the demographic and population genetic change of an Atlantic salmon population through its entire life-cycle. Processes such as growth, mortality, and maturation are simulated through stochastic procedures, which take into account environmental variables as well as the genotype of the individuals. IBSEM is based upon detailed empirical data from salmon biology, and parameterized to reproduce the environmental conditions and the characteristics of a wild population inhabiting a Norwegian river. Simulations demonstrated that the model consistently and reliably reproduces the characteristics of the population. Moreover, in absence of farmed escapees, the modelled populations reach an evolutionary equilibrium that is similar to our definition of a 'wild' genotype. We assessed the sensitivity of the model in the face of assumptions made on the fitness differences between farm and wild salmon, and evaluated the role of straying as a buffering mechanism against the intrusion of farm genes into wild populations. These results demonstrate that IBSEM is able to capture the evolutionary forces shaping the life history of wild salmon and is therefore able to model the response of populations under environmental and genetic stressors.	[Castellani, Marco; Heino, Mikko; Svasand, Terje; Glover, Kevin A.] Inst Marine Res, N-5817 Bergen, Norway; [Castellani, Marco] Univ Birmingham, Sch Mech Engn, Birmingham B15 2TT, W Midlands, England; [Heino, Mikko; Glover, Kevin A.] Univ Bergen, Dept Biol, Bergen, Norway; [Heino, Mikko] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Gilbey, John] Marine Scotland Sci, Freshwater Lab, Faskally PH16 5LB, Pitlochry, Scotland; [Araki, Hitoshi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Institute of Marine Research - Norway; University of Birmingham; University of Bergen; International Institute for Applied Systems Analysis (IIASA); Marine Scotland Science (MSS); Hokkaido University	Castellani, M (corresponding author), Inst Marine Res, POB 1870, N-5817 Bergen, Norway.	M.Castellani@bham.ac.uk; kevin.glover@imr.no	Heino, Mikko P/C-7241-2009; Castellani, Marco/ABE-2850-2020	Heino, Mikko P/0000-0003-2928-3940; Castellani, Marco/0000-0002-5623-7491; Svasand, Terje/0000-0003-4659-7511	Research Council of Norway (Norwegian: Norges forskningsrad): project INTERACT	Research Council of Norway (Norwegian: Norges forskningsrad): project INTERACT	The work was funded by the Research Council of Norway (Norwegian: Norges forskningsrad): project INTERACT. KAG received the funding. (url: www.forskingsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas O., 2011, ATLANTIC SALMON ECOL; [Anonymous], 2013, AQUACULTURE STAT; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; ATCHLEY WR, 1980, EVOLUTION, V34, P1161, DOI 10.1111/j.1558-5646.1980.tb04061.x; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; ATCHLEY WR, 1991, EVOLUTION, V45, P891, DOI [10.2307/2409697, 10.1111/j.1558-5646.1991.tb04358.x]; Atchley WR, 1997, GENETICS, V147, P765; Berglund I, 1995, CAN J FISH AQUAT SCI, V52, P2682, DOI 10.1139/f95-857; Besnier F, 2015, HEREDITY, V115, P47, DOI 10.1038/hdy.2015.15; Bicskei B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-884; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Carlin B, 1969, 2 SWED SALM RES I, V4, P14; Castellani M, 2013, ECOL MODEL, V251, P173, DOI 10.1016/j.ecolmodel.2012.12.006; CHEVERUD JM, 1983, EVOLUTION, V37, P895, DOI 10.1111/j.1558-5646.1983.tb05619.x; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; COWLEY DE, 1992, EVOLUTION, V46, P495, DOI [10.2307/2409867, 10.1111/j.1558-5646.1992.tb02054.x]; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Dunlop ES, 2009, ECOL APPL, V19, P1815, DOI 10.1890/08-1404.1; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Elliott JM, 1997, FUNCT ECOL, V11, P592, DOI 10.1046/j.1365-2435.1997.00130.x; Elson P. F., 1957, Canadian Fish Culturist, VNo. 21, P1; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Forseth T, 2001, FRESHWATER BIOL, V46, P173, DOI 10.1046/j.1365-2427.2001.00631.x; Fraser DJ, 2010, CAN J FISH AQUAT SCI, V67, P1768, DOI 10.1139/F10-094; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gilbey J, 2006, DIS AQUAT ORGAN, V71, P119, DOI 10.3354/dao071119; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gjedrem T, 2010, REV AQUACULT, V2, P2, DOI 10.1111/j.1753-5131.2010.01011.x; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hedger RD, 2013, ECOL MODEL, V248, P119, DOI 10.1016/j.ecolmodel.2012.10.003; Heino M, 2015, AQUACULT ENV INTERAC, V6, P185, DOI 10.3354/aei00126; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Huse G, 1998, FISH RES, V37, P163, DOI 10.1016/S0165-7836(98)00134-9; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; Jonsson B, 2003, J FISH BIOL, V62, P641, DOI 10.1046/j.1095-8649.2003.00053.x; Jonsson N, 1996, FUNCT ECOL, V10, P89, DOI 10.2307/2390266; JONSSON N, 1991, J ANIM ECOL, V60, P937, DOI 10.2307/5423; Jonsson N, 1998, J FISH BIOL, V52, P638, DOI 10.1111/j.1095-8649.1998.tb02023.x; Jonsson N, 1998, J ANIM ECOL, V67, P751, DOI 10.1046/j.1365-2656.1998.00237.x; KallioNyberg I, 1997, AQUACULTURE, V153, P207, DOI 10.1016/S0044-8486(97)00023-9; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; KRISTINSSON JB, 1985, AQUACULTURE, V45, P1, DOI 10.1016/0044-8486(85)90254-6; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; MYERS RA, 1986, CAN J FISH AQUAT SCI, V43, P1242, DOI 10.1139/f86-154; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Pedersen S, 2007, FISHERIES MANAG ECOL, V14, P21, DOI 10.1111/j.1365-2400.2006.00520.x; Piche J, 2008, P ROY SOC B-BIOL SCI, V275, P1571, DOI 10.1098/rspb.2008.0251; Piou C, 2012, ECOL MODEL, V231, P37, DOI 10.1016/j.ecolmodel.2012.01.025; Post JR, 1999, ECOL MONOGR, V69, P155, DOI 10.1890/0012-9615(1999)069[0155:DDPISF]2.0.CO;2; Radgivende Biologer AS, 2012, 1527 RADG BIOL AS; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Satake A, 2012, THEOR ECOL-NETH, V5, P283, DOI 10.1007/s12080-011-0128-y; SCHAFFER WM, 1975, ECOLOGY, V56, P577, DOI 10.2307/1935492; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; SKILBREI OT, 1988, AQUACULTURE, V69, P129, DOI 10.1016/0044-8486(88)90192-5; SKILBREI OT, 1991, CAN J FISH AQUAT SCI, V48, P2163, DOI 10.1139/f91-255; Skilbrei OT, 2011, AQUACULTURE, V311, P168, DOI 10.1016/j.aquaculture.2010.12.004; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; Solberg MF, 2015, APPL ANIM BEHAV SCI, V162, P67, DOI 10.1016/j.applanim.2014.11.012; Solberg MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113697; Solberg MF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-234; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; STABELL OB, 1984, BIOL REV, V59, P333, DOI 10.1111/j.1469-185X.1984.tb00709.x; STAHL G, 1987, POPULATION GENETICS, P121; SYMONS PEK, 1979, J FISH RES BOARD CAN, V36, P132, DOI 10.1139/f79-022; Taranger GL, 2015, ICES J MAR SCI, V72, P997, DOI 10.1093/icesjms/fsu132; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; THORPE JE, 1980, J FISH BIOL, V17, P13, DOI 10.1111/j.1095-8649.1980.tb02738.x; THORPE JE, 1981, CAN J FISH AQUAT SCI, V38, P1576, DOI 10.1139/f81-208; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Verspoor E, 2005, J FISH BIOL, V67, P3, DOI 10.1111/j.0022-1112.2005.00838.x; Verspoor E, 2005, SIMULATION MODELLING; Whalen KG, 1999, CAN J FISH AQUAT SCI, V56, P79, DOI 10.1139/cjfas-56-1-79; YOUNGSON A, 1996, LIVES SALMON ILLUSTR	88	16	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138444	10.1371/journal.pone.0138444	http://dx.doi.org/10.1371/journal.pone.0138444			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383256	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361790200104
J	D'Ippoliti, D; Santelli, E; De Sario, M; Scortichini, M; Davoli, M; Michelozzi, P				D'Ippoliti, Daniela; Santelli, Enrica; De Sario, Manuela; Scortichini, Matteo; Davoli, Marina; Michelozzi, Paola			Arsenic in Drinking Water and Mortality for Cancer and Chronic Diseases in Central Italy, 1990-2010	PLOS ONE			English	Article							LUNG-CANCER; LIFETIME EXPOSURE; CERAMIC WORKERS; SKIN-LESIONS; RISK; ASSOCIATION; METABOLISM; COHORT; CONTAMINATION; POPULATION	Background In several volcanic areas of Italy, arsenic levels exceed European regulatory limits (10 mu g/L in drinking water). There is still uncertainty about health risks from arsenic at low-medium doses (< 100 mu g/L). Objectives A large population-based study using an administrative cohort of residents in the Viterbo province (Central Italy), chronically exposed to low-medium arsenic levels via drinking water, was investigated to evaluate the effects of a lifetime exposure to arsenic on mortality from cancers and chronic diseases. Methods The study population consisted of 165,609 residents of 17 municipalities, followed from 1990 until 2010. Average individual arsenic exposure at the first residence (AsI) was estimated through a space-time modeling approach using residential history and arsenic concentrations from water supply. A time-dependent Cumulative Arsenic dose Indicator (CAI) was calculated, accounting for daily water intake and exposure duration. Mortality Hazard Ratios (HR) were estimated by gender for different diseases using Cox proportional models, adjusting for individual and area-level confounders. A flexible non-parametric approach was used to investigate dose-response relationships. Results Mean AsI exposure was 19.3 mu g/L, and average exposure duration was 39.5 years. Associations of AsI and CAI indicators with several diseases were found, with greatest risks found for lung cancer in both sexes (HR = 2.61 males; HR = 2.09 females), myocardial infarction, peripheral arterial disease and COPD in males (HR = 2.94; HR = 2.44; HR = 2.54 respectively) and diabetes in females (HR = 2.56). For lung cancer and cardiovascular diseases dose-response relationship is modelled by piecewise linear functions revealing effects even for doses lower than 10 mu g/L, and no threshold dose value was identified as safe for health. Conclusions Results provide new evidence for risk assessment of low-medium concentrations of arsenic and contribute to the ongoing debate about the threshold-dose of effect, suggesting that even concentrations below 10 mu g/L carry a mortality risk. Policy actions are urgently needed in areas exposed to arsenic like in the Viterbo province, to comply with current EU regulations.	[D'Ippoliti, Daniela; Santelli, Enrica; De Sario, Manuela; Scortichini, Matteo; Davoli, Marina; Michelozzi, Paola] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy		D'Ippoliti, D (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	d.dippoliti@deplazio.it	Michelozzi, Paola/J-8608-2016; SCORTICHINI, MATTEO/AAB-6323-2019; Davoli, Marina/K-1975-2016; De sario, Manuela/K-1932-2016; D'Ippoliti, Daniela/J-8230-2016	Michelozzi, Paola/0000-0002-1646-2555; SCORTICHINI, MATTEO/0000-0002-6413-7706; Davoli, Marina/0000-0003-4521-032X; De sario, Manuela/0000-0002-1117-2735; D'Ippoliti, Daniela/0000-0001-9180-6074	Department of Epidemiology; Lazio Region, Department of Environment	Department of Epidemiology; Lazio Region, Department of Environment	The research was supported by internal funding of the Department of Epidemiology and by the Lazio Region, Department of Environment.	Ahsan H, 2006, AM J EPIDEMIOL, V163, P1138, DOI 10.1093/aje/kwj154; Alexander J, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1351; Amster ED, 2011, J TOXICOL ENV HEAL A, V74, P716, DOI 10.1080/15287394.2011.556060; Angelone M, 2009, HYDROGEOL J, V17, P901, DOI 10.1007/s10040-008-0401-3; Baastrup R, 2008, ENVIRON HEALTH PERSP, V116, P231, DOI 10.1289/ehp.10623; Baldi P., 1973, GEOTHERMICS, V2, P124, DOI [10.1016/0375-6505(73)90020-5, DOI 10.1016/0375-6505(73)90020-5]; Begum M, 2012, ASIA-PAC J PUBLIC HE; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Brauner EV, 2014, ENVIRON HEALTH PERSP, V122, P1059, DOI 10.1289/ehp.1408198; Bustaffa E, 2014, EPIDEMIOL PREV S1, V38, P1; Canchola AJ., 2003, W USERS SAS SOFTWARE; Caranci N, 2010, EPIDEMIOL PREV, V34, P167; Cavariani F, 1995, SCAND J WORK ENV HEA, V21, P58; Celik I, 2008, ENVIRON RES, V108, P48, DOI 10.1016/j.envres.2008.04.001; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chiou JM, 2005, INT J EPIDEMIOL, V34, P936, DOI 10.1093/ije/dyi108; COX DR, 1972, J R STAT SOC B, V34, P187; Cubadda F, 2010, J AGR FOOD CHEM, V58, P10176, DOI 10.1021/jf102084p; DALLAGLIO M, 1994, J HYDROL, V154, P195, DOI 10.1016/0022-1694(94)90217-8; Department of Epidemiology of Lazio Region, 2010, HLTH STAT POP ROM LA; Department of Epidemiology of Lazio Region, 2012, EP EV EFF HLTH REL C; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Environmental Protection Agency of Lazio Region (ARPA Lazio), 2014, RAD HOM; Environmental Protection Agency of Lazio Region (ARPA Lazio), DAT REP WAT SAMPL MO; *ESRI, 2009, ARCGIS 9 2 DESKT HEL; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3597; FORASTIERE F, 1993, SCAND J WORK ENV HEA, V19, P382, DOI 10.5271/sjweh.1458; FORASTIERE F, 1986, AM J IND MED, V10, P363, DOI 10.1002/ajim.4700100404; FORASTIERE F, 1985, SCI TOTAL ENVIRON, V45, P519, DOI 10.1016/0048-9697(85)90257-8; Garcia-Esquinas E, 2013, CANCER EPIDEM BIOMAR, V22, P1944, DOI 10.1158/1055-9965.EPI-13-0234-T; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gibb H, 2011, ENVIRON HEALTH PERSP, V119, P284, DOI 10.1289/ehp.1002427; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P1718, DOI 10.1289/ehp.0900566; Hough RL, 2010, INT ARCH OCC ENV HEA, V83, P471, DOI 10.1007/s00420-010-0519-1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; INRAN (National Institute of Research for Food and Nutrition), 2012, ONL REP ITAL FOOD CO; Italian Institute of Health (ISS), 2010, ONL PAG INF NOT DER; James KA, 2013, ENVIRON RES, V123, P33, DOI 10.1016/j.envres.2013.02.005; Jones RR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-37; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Jovanovic D, 2013, INT J HYG ENVIR HEAL, V216, P50, DOI 10.1016/j.ijheh.2012.01.001; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Leonardi G, 2012, ENVIRON HEALTH PERSP, V120, P721, DOI 10.1289/ehp.1103534; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lindberg AL, 2008, TOXICOL APPL PHARM, V230, P9, DOI 10.1016/j.taap.2008.02.001; Lindberg AL, 2007, ENVIRON HEALTH PERSP, V115, P1081, DOI 10.1289/ehp.10026; Lucentini L., 2013, Notiziario dell'Istituto Superiore di Sanita, V26, P11; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Meliker JR, 2007, INT ARCH OCC ENV HEA, V80, P184, DOI 10.1007/s00420-006-0119-2; Mink PJ, 2008, REGUL TOXICOL PHARM, V52, P299, DOI 10.1016/j.yrtph.2008.08.010; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Morales KH, 2000, ENVIRON HEALTH PERSP, V108, P655, DOI 10.2307/3434887; Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875; Orloff K, 2009, J TOXICOL ENV HEAL B, V12, P509, DOI 10.1080/10937400903358934; Parvez F, 2008, ENVIRON HEALTH PERSP, V116, P190, DOI 10.1289/ehp.9507; Parvez F, 2013, AM J RESP CRIT CARE, V188, P813, DOI 10.1164/rccm.201212-2282OC; Parvez F, 2010, THORAX, V65, P528, DOI 10.1136/thx.2009.119347; Piscopo V, 2011, AQUA MUNDI, V2, P131, DOI [10.4409/Am-035-11-0035, DOI 10.4409/AM-035-11-0035]; Preziosi E, 2010, ENVIRON EARTH SCI, V61, P885, DOI 10.1007/s12665-009-0404-y; Ruiz-Navarro ML, 1998, SCI TOTAL ENVIRON, V216, P55, DOI 10.1016/S0048-9697(98)00136-3; Sauve S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-465; Schmidt CW, 2014, ENVIRON HEALTH PERSP, V122, pA130, DOI 10.1289/ehp.122-A130; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Steinmaus C, 2007, J TOXICOL ENV HEAL A, V70, P159, DOI 10.1080/15287390600755240; Tseng CH, 2009, TOXICOL APPL PHARM, V235, P338, DOI 10.1016/j.taap.2008.12.016; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; Wadhwa SK, 2013, J ENVIRON SCI HEAL A, V48, P1776, DOI 10.1080/10934529.2013.823332; *WHO, 1993, GUID DRINK WAT QUAL, V1; Wu Fen, 2014, Curr Environ Health Rep, V1, P148	73	66	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138182	10.1371/journal.pone.0138182	http://dx.doi.org/10.1371/journal.pone.0138182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383851	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200066
J	Martin, AL; Steurer, MA; Aronstam, RS				Martin, Adam L.; Steurer, Michael A.; Aronstam, Robert S.			Constitutive Activity among Orphan Class-A G Protein Coupled Receptors	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; GPR119 AGONISTS; M-2 RECEPTORS; CYCLIC-AMP; CHO CELLS; IDENTIFICATION; ACTIVATION; LIGANDS; COMPLEX; FAMILY	The purpose of this study was to evaluate the extent of constitutive activity among orphan class-A G protein coupled receptors within the cAMP signaling pathway. Constitutive signaling was revealed by changes in gene expression under control of the cAMP response element. Gene expression was measured in Chinese hamster ovary cells transiently co-transfected with plasmids containing a luciferase reporter and orphan receptor. Criteria adopted for defining constitutive activation were: 1) 200% elevation over baseline reporter gene expression; 2) 40% inhibition of baseline expression; and 3) 40% inhibition of expression stimulated by 3 mu M forskolin. Five patterns of activity were noted: 1) inhibition under both baseline and forskolin stimulated expression (GPR15, GPR17, GPR18, GPR20, GPR25, GPR27, GPR31, GPR32, GPR45, GPR57, GPR68, GPR83, GPR84, GPR132, GPR150, GPR176); 2) no effect on baseline expression, but inhibition of forskolin stimulated expression (GPR4, GPR26, GPR61, GPR62, GPR78, GPR101, GPR119); 3) elevation of baseline signaling coupled with inhibition of forskolin stimulated expression (GPR6, GPR12); 4) elevation of baseline signaling without inhibition of forskolin stimulated expression (GPR3, GPR21, GPR52, GPR65); and 5) no effect on expression (GPR1, GPR19, GPR22, GPR34, GPR35, GPR39, GPR63, GPR82, GPR85, GPR87). Constitutive activity was observed in 75% of the orphan class-A receptors examined (30 of 40). This constitutive signaling cannot be explained by simple overexpression of the receptor. Inhibition of cAMP mediated expression was far more common (65%) than stimulation of expression (15%). Orphan receptors that were closely related based on amino acid homology tended to have similar effects on gene expression. These results suggest that identification of inverse agonists may be a fruitful approach for categorizing these orphan receptors and targeting them for pharmacological intervention.	[Martin, Adam L.; Steurer, Michael A.; Aronstam, Robert S.] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO 65409 USA	University of Missouri System; Missouri University of Science & Technology	Martin, AL (corresponding author), Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO 65409 USA.	amartin@mst.edu			cDNA Resource Center; Department of Biological Sciences at MST	cDNA Resource Center; Department of Biological Sciences at MST	Funding was provided by the cDNA Resource Center and Department of Biological Sciences at MS&T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, GUID PHARM; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Barreda-Gomez G, 2010, METHOD ENZYMOL, V485, P261, DOI [10.1016/S0076-6879(10)85015-3, 10.1016/B978-0-12-381296-4.00015-4]; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; Ford DJ, 2002, J PHARMACOL EXP THER, V300, P810, DOI 10.1124/jpet.300.3.810; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hamid E, 2014, J NEUROSCI, V34, P260, DOI 10.1523/JNEUROSCI.3633-12.2014; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Kakarala KK, 2014, MOL PHYLOGENET EVOL, V74, P66, DOI 10.1016/j.ympev.2014.01.022; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; MAENHAUT C, 1990, BIOCHEM BIOPH RES CO, V173, P1169, DOI 10.1016/S0006-291X(05)80909-X; Michal P, 2007, J PHARMACOL EXP THER, V320, P607, DOI 10.1124/jpet.106.114314; Michal P, 2001, BRIT J PHARMACOL, V132, P1217, DOI 10.1038/sj.bjp.0703931; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Ozawa A, 2010, AAPS J, V12, P378, DOI 10.1208/s12248-010-9198-9; Pauwels PJ, 1998, MOL NEUROBIOL, V17, P109, DOI 10.1007/BF02802027; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Shah U, 2009, CURR OPIN DRUG DISC, V12, P519; Shannon EK, 2015, BMC PHARM T IN PRESS; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Tang TH, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-48; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Tucek S, 2001, LIFE SCI, V68, P2501, DOI 10.1016/S0024-3205(01)01045-1; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419	32	74	74	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138463	10.1371/journal.pone.0138463	http://dx.doi.org/10.1371/journal.pone.0138463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384023	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200107
J	Sato, K; Yamamoto, H; Nomura, T; Matsumoto, I; Miyasaka, T; Zong, T; Kanno, E; Uno, K; Ishii, K; Kawakami, K				Sato, Ko; Yamamoto, Hideki; Nomura, Toshiki; Matsumoto, Ikumi; Miyasaka, Tomomitsu; Zong, Tong; Kanno, Emi; Uno, Kazuko; Ishii, Keiko; Kawakami, Kazuyoshi			Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs	PLOS ONE			English	Article							PULMONARY INFECTION; DENDRITIC CELLS; IFN-ALPHA; LISTERIA-MONOCYTOGENES; MACROPHAGE ACTIVATION; GAMMA PRODUCTION; T2 IMMUNITY; INDUCTION; HOST; BETA	Type I interferons (IFNs) are secreted by many cell types upon stimulation via pattern recognition receptors and bind to IFN-alpha/beta receptor (IFNAR), which is composed of IFNAR1 and IFNAR2. Although type I IFNs are well known as anti-viral cytokines, limited information is available on their role during fungal infection. In the present study, we addressed this issue by examining the effect of IFNAR1 defects on the host defense response to Cryptococcus neoformans. In IFNAR1KO mice, the number of live colonies was lower and the host immune response mediated not only by Th1 but also by Th2 and Th17-related cytokines was more accelerated in the infected lungs than in WT mice. In addition, mucin production by bronchoepithelial cells and expression of MUC5AC, a major core protein of mucin in the lungs, were significantly higher in IFNAR1KO mice than in WT mice. This increase in mucin and MUC5AC production was significantly inhibited by treatment with neutralizing anti-IL-4 mAb. In contrast, administration of recombinant IFN-alpha A/D significantly suppressed the production of IL-4, but not of IFN-gamma and IL-17A, in the lungs of WT mice after cryptococcal infection. These results indicate that defects of IFNAR1 led to improved clearance of infection with C. neoformans and enhanced synthesis of IFN-gamma and the IL-4-dependent production of mucin. They also suggest that type I IFNs may be involved in the negative regulation of early host defense to this infection.	[Sato, Ko; Yamamoto, Hideki; Nomura, Toshiki; Matsumoto, Ikumi; Miyasaka, Tomomitsu; Zong, Tong; Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan; [Kanno, Emi] Tohoku Univ, Grad Sch Med, Dept Sci Nursing Practice, Sendai, Miyagi 980, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan	Tohoku University; Tohoku University	Kawakami, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan.	kawakami@med.tohoku.ac.jp	Miyasaka, Tomomitsu/AAK-1676-2021	Miyasaka, Tomomitsu/0000-0001-7218-6981; Kanno, Emi/0000-0003-2339-122X; Sato, Ko/0000-0002-5548-6285; Yamamoto, Hideki/0000-0002-5714-5644	Ministry of Education, Culture, Sports, Science and Technology of Japan [23390263, 15H04867]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23390263) and (15H04867) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED.	Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Atan O, 2010, TURK J GASTROENTEROL, V21, P401, DOI 10.4318/tjg.2010.0127; BANNAI H, 1986, JPN J MED SCI BIOL, V39, P185, DOI 10.7883/yoken1952.39.185; Biondo C, 2011, EUR J IMMUNOL, V41, P1969, DOI 10.1002/eji.201141490; Bourgeois C, 2011, J IMMUNOL, V186, P3104, DOI 10.4049/jimmunol.1002599; Chen GH, 2010, AM J PATHOL, V177, P2459, DOI 10.2353/ajpath.2010.100141; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Cunha BA, 2001, INFECT DIS CLIN N AM, V15, P567, DOI 10.1016/S0891-5520(05)70160-4; Dalton DK, 1993, SCIENCE, V178, P2243; Damdinsuren B, 2007, INT J ONCOL, V30, P201; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Domanski P, 1998, J BIOL CHEM, V273, P3144, DOI 10.1074/jbc.273.6.3144; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Grahnert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087341; GRANGER DL, 1988, J CLIN INVEST, V81, P1129, DOI 10.1172/JCI113427; Hardison SE, 2012, J IMMUNOL, V189, P4060, DOI 10.4049/jimmunol.1103455; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hauber Hans-Peter, 2006, Can Respir J, V13, P327; Hernandez Y, 2005, J IMMUNOL, V174, P1027, DOI 10.4049/jimmunol.174.2.1027; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Inglis DO, 2010, INFECT IMMUN, V78, P3871, DOI 10.1128/IAI.00204-10; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; KAWAKAMI K, 1994, CLIN EXP IMMUNOL, V96, P230, DOI 10.1111/j.1365-2249.1994.tb06547.x; Kawakami K, 2000, J IMMUNOL, V165, P941, DOI 10.4049/jimmunol.165.2.941; Kim KC, 2012, PULM PHARMACOL THER, V25, P415, DOI 10.1016/j.pupt.2011.12.003; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LIM TS, 1980, INFECT IMMUN, V30, P5, DOI 10.1128/IAI.30.1.5-11.1980; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Piehler D, 2013, MUCOSAL IMMUNOL, V6, P405, DOI 10.1038/mi.2012.84; Platanias LC, 1996, J BIOL CHEM, V271, P23630, DOI 10.1074/jbc.271.39.23630; Qureshi A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00193; Ramirez-Ortiz ZG, 2011, CELL HOST MICROBE, V9, P415, DOI 10.1016/j.chom.2011.04.007; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rocha JDB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08008; Sarah EH, 2010, AM J PATHOL, V176, P774, DOI [10.2353/ajpath.2010.090634, DOI 10.2353/AJPATH.2010.090634]; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; STEVENS DA, 1990, BRIT J CLIN PRACT, V44, P11; Tabata Y, 1999, J INTERF CYTOK RES, V19, P287, DOI 10.1089/107999099314225; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Tian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041879; Tohyama M, 1996, CLIN EXP IMMUNOL, V103, P436; Touzot M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4987; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uno K, 1998, J INTERF CYTOK RES, V18, P1011, DOI 10.1089/jir.1998.18.1011; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Yamamoto H, 2014, INFECT IMMUN, V82, P1606, DOI 10.1128/IAI.01089-13; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530; Zuyderduyn S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-59	69	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138291	10.1371/journal.pone.0138291	http://dx.doi.org/10.1371/journal.pone.0138291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384031	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200087
J	Shojo, H; Tanaka, M; Takahashi, R; Kakuda, T; Adachi, N				Shojo, Hideki; Tanaka, Mayumi; Takahashi, Ryohei; Kakuda, Tsuneo; Adachi, Noboru			A Unique Primer with an Inosine Chain at the 5 '-Terminus Improves the Reliability of SNP Analysis Using the PCR-Amplified Product Length Polymorphism Method	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MITOCHONDRIAL-DNA ANALYSIS; SEQUENCING DATA; MICROARRAY HYBRIDIZATION; JOMON SKELETONS; DEOXYINOSINE; DISCOVERY; APLP; DEGENERATE; FRAMEWORK	Polymerase chain reaction-amplified product length polymorphism (PCR-APLP) is one of the most convenient and reliable methods for single nucleotide polymorphism (SNP) analysis. This method is based on PCR, but uses allele-specific primers containing SNP sites at the 3'-terminus of each primer. To use this method at least two allele-specific primers and one "counter-primer", which serves as a common forward or reverse primer of the allele-specific primers, are required. The allele-specific primers have SNP sites at the 30-terminus, and another primer should have a few non-complementary flaps at the 5'-terminus to detect SNPs by determining the difference of amplicon length by PCR and subsequent electrophoresis. A major disadvantage of the addition of a non-complementary flap is the non-specific annealing of the primer with non-complementary flaps. However, a design principle for avoiding this undesired annealing has not been fully established, therefore, it is often difficult to design effective APLP primers. Here, we report allele-specific primers with an inosine chain at the 5'-terminus for PCR-APLP analysis. This unique design improves the competitiveness of allele-specific primers and the reliability of SNP analysis when using the PCR-APLP method.	[Shojo, Hideki; Tanaka, Mayumi; Takahashi, Ryohei; Kakuda, Tsuneo; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Yamanashi 4093898, Japan	University of Yamanashi	Adachi, N (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan.	nadachi@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23570280]; Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North)	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North)	This study was supported by a Grant-in-Aid (No. 23570280) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North).	Adachi N, 2004, J ARCHAEOL SCI, V31, P1339, DOI 10.1016/j.jas.2004.02.011; Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aoshima T, 1998, ELECTROPHORESIS, V19, P659, DOI 10.1002/elps.1150190508; Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; Binladen J, 2007, BIOTECHNIQUES, V42, P172, DOI 10.2144/000112316; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; Chen N, 2014, GENETICS, V198, P847, DOI 10.1534/genetics.114.169052; Chizhikov V, 2002, J CLIN MICROBIOL, V40, P2398, DOI 10.1128/JCM.40.7.2398-2407.2002; CORFIELD PWR, 1987, NUCLEIC ACIDS RES, V15, P7935, DOI 10.1093/nar/15.19.7935; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferraro MB, 2014, J COMPUT BIOL, V21, P665, DOI 10.1089/cmb.2014.0037; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gondro C, 2014, ANIM GENET, V45, P758, DOI 10.1111/age.12198; KNOTH K, 1988, NUCLEIC ACIDS RES, V16, P10932, DOI 10.1093/nar/16.22.10932; Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108818; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; LOAKES D, 1995, NUCLEIC ACIDS RES, V23, P2361, DOI 10.1093/nar/23.13.2361; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Martino A, 2010, J BIOMOL SCREEN, V15, P623, DOI 10.1177/1087057110365900; MIURA N, 1985, GENE, V38, P271; NICHOLS R, 1994, NATURE, V369, P492, DOI 10.1038/369492a0; PALVA A, 1994, J MICROBIOL METH, V19, P315, DOI 10.1016/0167-7012(94)90034-5; PATIL RV, 1990, NUCLEIC ACIDS RES, V18, P3080, DOI 10.1093/nar/18.10.3080; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; SantaLucia John Jr., 2007, V402, P3; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; Sun XJ, 2010, J ORG CHEM, V75, P1848, DOI 10.1021/jo9023683; UESUGI S, 1987, J BIOL CHEM, V262, P6965; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; Uricaru R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1187; Wang J, 1998, ANAL CHIM ACTA, V375, P197, DOI 10.1016/S0003-2670(98)00503-0; Watanabe G, 1997, HUM GENET, V99, P34; Watanabe G, 2001, ELECTROPHORESIS, V22, P418; Watanabe G, 1999, INT J LEGAL MED, V112, P134, DOI 10.1007/s004140050216; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wei T, 2008, J VIROL METHODS, V153, P16, DOI 10.1016/j.jviromet.2008.06.020	45	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136995	10.1371/journal.pone.0136995	http://dx.doi.org/10.1371/journal.pone.0136995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381262	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200012
J	Sugimoto, M; Takagi, T; Suzuki, R; Konno, N; Watanabe, K; Nakamura, J; Kikuchi, H; Waragai, Y; Asama, H; Takasumi, M; Hikichi, T; Watanabe, H; Obara, K; Ohira, H				Sugimoto, Mitsuru; Takagi, Tadayuki; Suzuki, Rei; Konno, Naoki; Watanabe, Ko; Nakamura, Jun; Kikuchi, Hitomi; Waragai, Yuichi; Asama, Hiroyuki; Takasumi, Mika; Hikichi, Takuto; Watanabe, Hiroshi; Obara, Katsutoshi; Ohira, Hiromasa			Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study	PLOS ONE			English	Article							LONG-TERM PROGNOSIS; METHYLPREDNISOLONE; DISEASE; CORTICOSTEROIDS; ASSOCIATION	Autoimmune pancreatitis (AIP) is treatable with steroids, but relapse is frequent. The efficacy of steroid pulse therapy has been shown for various autoimmune diseases, but has not become established therapy. In this study, we reviewed the efficacy of steroid pulse therapy in 24 subjects who were diagnosed with AIP type 1 at our hospital. Patient characteristics, time-course of serum IgG4, and the cumulative relapse-free survival rate were compared between patients who received oral steroid therapy (oral group) and those who were treated with steroid pulse therapy (pulse group). Serum IgG4 was reduced significantly after therapy in both groups and the 5-year cumulative relapse-free survival rates in the two groups did not differ significantly (oral group 46.9%, pulse group 77.8%). However, in a subset of cases with diffuse pancreatic swelling, this rate was significantly lower in the oral group (33.3% vs. 100.0%, p = 0.046). These results suggest that steroid pulse therapy is effective for prevention of relapse in AIP patients with diffuse pancreatic swelling.	[Sugimoto, Mitsuru; Takagi, Tadayuki; Suzuki, Rei; Konno, Naoki; Watanabe, Ko; Nakamura, Jun; Kikuchi, Hitomi; Waragai, Yuichi; Asama, Hiroyuki; Takasumi, Mika; Watanabe, Hiroshi; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Hikichi, Takuto; Obara, Katsutoshi] Fukushima Med Univ Hosp, Dept Endoscopy, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Takagi, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan.	daccho@fmu.ac.jp	Suzuki, Rei/S-8531-2017	Suzuki, Rei/0000-0002-4049-0484; Sugimoto, Mitsuru/0000-0002-4223-613X				BAETHGE BA, 1992, ANN PHARMACOTHER, V26, P316, DOI 10.1177/106002809202600301; CATHCART ES, 1976, LANCET, V1, P163; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hart PA, 2012, GUT, V0, P1; Haugeberg G, 2004, ANN RHEUM DIS, V63, P940, DOI 10.1136/ard.2003.011734; Hirano K, 2007, GUT, V56, P1719, DOI 10.1136/gut.2006.115246; Kamisawa T, 2011, EXPERT OPIN PHARMACO, V12, P2149, DOI 10.1517/14656566.2011.595710; Kamisawa T, 2010, J GASTROENTEROL, V45, P471, DOI 10.1007/s00535-010-0221-9; Kawa S, 2009, CLIN GASTROENTEROL H, V7, pS18, DOI 10.1016/j.cgh.2009.07.041; Klein-Gitelman MS, 1998, J RHEUMATOL, V25, P1995; KOUNTZ SL, 1969, LANCET, V1, P338; Kubota K, 2011, J GASTROENTEROL, V46, P834, DOI 10.1007/s00535-011-0393-y; Kuruma S, 2013, GUT LIVER, V7, P96, DOI 10.5009/gnl.2013.7.1.96; Maire F, 2011, AM J GASTROENTEROL, V106, P151, DOI 10.1038/ajg.2010.314; Matsubayashi H, 2011, DIGEST LIVER DIS, V43, P731, DOI 10.1016/j.dld.2011.03.006; Matsushita M, 2007, AM J GASTROENTEROL, V102, P220; Melamud B, 2014, ISR MED ASSOC J, V16, P180; Naitoh I, 2010, PANCREAS, V39, pE1, DOI 10.1097/MPA.0b013e3181bd64a1; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Takuma K, 2011, EUR J GASTROEN HEPAT, V23, P146, DOI 10.1097/MEG.0b013e3283431e23; Tomiyama T, 2011, J GASTROENTEROL, V46, P696, DOI 10.1007/s00535-010-0361-y; VICHYANOND P, 1989, J ALLERGY CLIN IMMUN, V84, P867, DOI 10.1016/0091-6749(89)90381-3; Wakabayashi T, 2005, PANCREAS, V30, P31; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	28	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138604	10.1371/journal.pone.0138604	http://dx.doi.org/10.1371/journal.pone.0138604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381760	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200136
J	Yang, DW; Liu, GP; Wang, KZ				Yang, Dawei; Liu, Guangpeng; Wang, Kunzheng			miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; PROSTATE-CANCER; BREAST-CANCER; CERVICAL-CANCER; BLADDER-CANCER; OVARIAN-CANCER; INVASION; PROLIFERATION; METASTASIS	microRNAs (miRNAs), small noncoding RNAs of 19-25 nt, play an important roles in the pathological processes of tumorigenesis. The object of this study was to study the expression and function of miR-203 and to found its target gene in osteosarcoma. In our study, we found the expression level of miR-203 was significantly downregulated in osteosarcoma cell lines and tissues. In addition, overexpression of miR-203 inhibited the osteosarcoma cell proliferation and migration and inhibited Mesenchymal-to-Epithelial reversion Transition (MErT). Moreover, we identified RAB22A as a direct target of miR-203 and RAB22A overexpression blocks the roles of miR-203 in osteosarcoma cell. Furthermore, we demonstrated that RAB22A expression was upregulated in human osteosarcoma cell lines and tissues. Take together, our results demonstrated that miR-203 act as a tumor suppressor miRNA through regulating RAB22A expression and suggested its involvement in osteosarcoma progression and carcinogenesis.	[Yang, Dawei; Wang, Kunzheng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian 710004, Shan Xi, Peoples R China; [Yang, Dawei] Harbin Med Univ, Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China; [Liu, Guangpeng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China	Xi'an Jiaotong University; Harbin Medical University; Tongji University	Wang, KZ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian 710004, Shan Xi, Peoples R China.	wkzpl1@163.com			Natural Science Foundation of China [81171475, 31271027]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (81171475 and 31271027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Fan L, 2012, ACTA BIOCH BIOPH SIN, V44, P407, DOI 10.1093/abbs/gms019; FEI B, 2013, ONCOL RES, V20, P557, DOI DOI 10.3727/096504013X13775486749254; Guo SB, 2014, TUMOR BIOL, V35, P7025, DOI 10.1007/s13277-014-1965-2; Hailer A, 2014, ONCOTARGET, V5, P4144, DOI 10.18632/oncotarget.1928; Han G, 2012, ONCOL RES, V20, P149, DOI 10.3727/096504012X13522227232237; Han K, 2015, ONCOTARGET; Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kong WQ, 2012, FEBS J, V279, P1252, DOI 10.1111/j.1742-4658.2012.08519.x; Kulkarni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042895; Lee SA, 2015, J BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2015.02.002, DOI 10.1016/J.JBI0SC.2015.02.002]; Li T, 2015, ONCOL REP, V33, P607, DOI 10.3892/or.2014.3646; Li Z, 2015, ONCOTARGET; Li ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116170; Li Z, 2015, ONCOTARGET, V6, P17559, DOI 10.18632/oncotarget.2755; Li Z, 2015, CELL PROLIFERAT, V48, P278, DOI 10.1111/cpr.12180; Li Z, 2015, CELL PROLIFERAT, V48, P1, DOI 10.1111/cpr.12160; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Liang JQ, 2013, ONCOL RES, V21, P83, DOI 10.3727/096504013X13775486749218; Liao HZ, 2015, ONCOTARGET, V6, P8914, DOI 10.18632/oncotarget.3563; Luo X, 2013, CELL PROLIFERAT, V46, P436, DOI 10.1111/cpr.12038; Miah S, 2012, BRIT J CANCER, V107, P123, DOI 10.1038/bjc.2012.221; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Salah Z, 2015, ONCOTARGET, V6, P4920, DOI 10.18632/oncotarget.3025; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Tang J, 2014, CELL PROLIFERAT, V47, P427, DOI 10.1111/cpr.12129; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Wang W, 2013, INDIAN J BIOCHEM BIO, V50, P87; Wang Y, 2013, MOL CELL BIOCHEM, V384, P121, DOI 10.1007/s11010-013-1789-1; Xiang J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0125-x; Xiao XC, 2012, ONCOL RES, V20, P537, DOI 10.3727/096504013X13775486749335; Xu MX, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0255-7; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang ZY, 2014, INT J CLIN EXP PATHO, V7, P7563; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Yu X, 2015, CELL PROLIFERAT, V48, P271, DOI 10.1111/cpr.12179; Yu X, 2014, INT J MOL MED, V34, P923, DOI 10.3892/ijmm.2014.1853; Zhang Y, 2014, ONCOTARGET, V5, P12291, DOI 10.18632/oncotarget.2577; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao S, 2013, ASIAN PAC J CANCER P, V14, P2289, DOI 10.7314/APJCP.2013.14.4.2289; Zhou J, 2012, ONCOL RES, V20, P197, DOI 10.3727/096504013X13589503482734; Zhou X, 2013, BIOCHEM BIOPH RES CO, V437, P653, DOI 10.1016/j.bbrc.2013.07.033; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	48	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0132225	10.1371/journal.pone.0132225	http://dx.doi.org/10.1371/journal.pone.0132225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382657	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200001
J	Garcia-Etxebarria, K; Bracho, MA; Galan, JC; Pumarola, T; Castilla, J; de Lejarazu, RO; Rodriguez-Dominguez, M; Quintela, I; Bonet, N; Garcia-Garcera, M; Dominguez, A; Gonzalez-Candelas, F; Calafell, F				Garcia-Etxebarria, Koldo; Alma Bracho, Maria; Carlos Galan, Juan; Pumarola, Tomas; Castilla, Jesus; Ortiz de Lejarazu, Raul; Rodriguez-Dominguez, Mario; Quintela, Ines; Bonet, Nuria; Garcia-Garcera, Marc; Dominguez, Angela; Gonzalez-Candelas, Fernando; Calafell, Francesc		CIBERESP Cases Controls Pandemic I	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS-INFECTION; POPULATION; POLYMORPHISMS; LINKAGE; TNF	While most patients affected by the influenza A(H1N1) pandemic experienced mild symptoms, a small fraction required hospitalization, often without concomitant factors that could explain such a severe course. We hypothesize that host genetic factors could contribute to aggravate the disease. To test this hypothesis, we compared the allele frequencies of 547,296 genome-wide single nucleotide polymorphisms (SNPs) between 49 severe and 107 mild confirmed influenza A cases, as well as against a general population sample of 549 individuals. When comparing severe vs. mild influenza A cases, only one SNP was close to the conventional p = 5x10(-8). This SNP, rs28454025, sits in an intron of the GSK233 gene, which is involved in a neural development, but seems not to have any connections with immunological or inflammatory functions. Indirectly, a previous association reported with CD55 was replicated. Although sample sizes are low, we show that the statistical power in our design was sufficient to detect highly-penetrant, quasi-Mendelian genetic factors. Hence, and assuming that rs28454025 is likely to be a false positive, no major genetic factor was detected that could explain poor influenza A course.	[Garcia-Etxebarria, Koldo; Bonet, Nuria; Garcia-Garcera, Marc; Calafell, Francesc] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Alma Bracho, Maria; Gonzalez-Candelas, Fernando] Unidad Mixta Invest Genom & Salud CSISP UVEG Inst, Valencia, Spain; [Alma Bracho, Maria; Carlos Galan, Juan; Castilla, Jesus; Dominguez, Angela; Gonzalez-Candelas, Fernando] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Carlos Galan, Juan; Rodriguez-Dominguez, Mario] Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain; [Carlos Galan, Juan; Rodriguez-Dominguez, Mario] Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain; [Pumarola, Tomas] Univ Autonoma Barcelona, Dept Microbiol, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, E-08193 Barcelona, Spain; [Castilla, Jesus] Inst Salud Publ Navarra, Pamplona, Spain; [Ortiz de Lejarazu, Raul] Hosp Clin Univ, Dept Microbiol & Immunol, Valladolid, Spain; [Rodriguez-Dominguez, Mario] Red Espanola Invest Patol Infecciosa, Madrid, Spain; [Quintela, Ines] Univ Santiago de Compostela, Grp Med Xenom, Ctr Nacl Genotipado,Inst Salud Carlos 3,CeGen PRB, Plataforma Recursos Biomol & Bioinformat, Santiago De Compostela, Spain; [Dominguez, Angela] Univ Barcelona, Dept Salut Publ, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Public Health Institute of Navarra; Universidade de Santiago de Compostela; University of Barcelona	Calafell, F (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain.	franoeso.calafell@upf.edu	Pumarola, Tomàs/AAB-5532-2019; Calafell, Francesc/C-8595-2014; Garcia-Etxebarria, Koldo/AAQ-4638-2021; Castilla, Jesus/B-9048-2008; Candelas, Fernando Gonzalez/G-5681-2010; Bracho, Maria/K-6018-2014; Suñe, Tomàs Pumarola/F-7583-2017; Rodriguez-Dominguez, Mario/J-4431-2015	Pumarola, Tomàs/0000-0002-5171-7461; Calafell, Francesc/0000-0002-1083-9438; Garcia-Etxebarria, Koldo/0000-0002-6107-9416; Castilla, Jesus/0000-0002-6396-7265; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Bracho, Maria/0000-0002-9204-5526; Suñe, Tomàs Pumarola/0000-0002-5171-7461; Rodriguez-Dominguez, Mario/0000-0002-1783-9318; Quintela, Ines/0000-0002-0239-7975; Garcia-Garcera, Marc/0000-0001-6408-7561	Instituto de Salud Carlos III (Madrid, Spain) [GR09/0032]	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III)	Fundign for this work came from Instituto de Salud Carlos III (Madrid, Spain; www.isciii.es) grant GR09/0032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Esteban-Vasallo MD, 2012, EUR J PUBLIC HEALTH, V22, P792, DOI 10.1093/eurpub/ckr171; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Ferdinands JM, 2011, EMERG INFECT DIS, V17, P2294, DOI 10.3201/eid1712.111002; Gonzalez-Candelas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033139; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Radhakrishnan P, 2011, BIOCHEM BIOPH RES CO, V409, P436, DOI 10.1016/j.bbrc.2011.05.019; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; WHO, CDC PROT REALT RTPCR; Zhou J, 2012, J INFECT DIS, V206, P495, DOI 10.1093/infdis/jis378; Zuniga J, 2012, EUR RESPIR J, V39, P604, DOI 10.1183/09031936.00020611	23	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0135983	10.1371/journal.pone.0135983	http://dx.doi.org/10.1371/journal.pone.0135983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379185	Green Published, gold			2022-12-26	WOS:000361769400003
J	Huang, SY; Lin, HH; Yao, M; Tang, JL; Wu, SJ; Hou, HA; Chou, WC; Chou, SC; Hsu, SC; Ko, BS; Lu, HY; Tsay, W; Tien, HF				Huang, Shang-Yi; Lin, Hsiu-Hsia; Yao, Ming; Tang, Jih-Luh; Wu, Shang-Ju; Hou, Hsin-An; Chou, Wen-Chien; Chou, Sheng-Chieh; Hsu, Szu-Chun; Ko, Bor-Sheng; Lu, Hsiao-Yun; Tsay, Woei; Tien, Hwei-Fang			Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study	PLOS ONE			English	Article							MULTIPLE-MYELOMA; EXTRACELLULAR-MATRIX; PROTEOGLYCANS; INHIBITION; DEFICIENCY	The growth of myeloma cells depends on bone marrow (BM) stroma consisting of stromal cells, secreted cytokines and the extracellular matrix (ECM). Decorin, a small leucine-rich proteoglycan in the ECM, is a signaling ligand and native anti-tumor agent. However, the role of decorin in patients with myeloma is not clear. We evaluated the correlation between the decorin levels measured by enzyme-linked immunosorbent assay in BM plasma from 121 patients with newly diagnosed myeloma based on their clinical features and treatment response. The median decorin levels in the patients and the normal control group were 12.31 ng/mL [standard deviation (SD), 7.50 ng/mL; range, 2.45 to 44.46 ng/mL] and 10.31 ng/mL (SD, 2.42 ng/mL; range, 4.85-15.14 ng/mL), respectively (P <0.001). Using 15.15 ng/mL as a cut-off, 46 patients (38%) exhibited higher decorin levels (H-DCN), whereas the other patients exhibited normal to lower decorin levels (NL-DCN). Except for the median age, which was significantly younger in the H-DCN than in the NL-DCN group (60.6 14.0 vs. 65.8 12.2 years, respectively; P = 0.034), there were no differences between the two groups. However, in 79 patients who had received novel agent-based induction, the overall response rate was significantly better in the H-DCN than in the NL-DCN (97 vs. 63%, respectively; P < 0.001), as was the depth of responses (P = 0.008), which were not observed in those who had received chemotherapeutic agents alone. Progression-free survival (PFS) was significantly longer in H-DCN than NL-DCN (not reached vs. 19.5 mo, respectively; P = 0.0003). Multivariate analyses indicated that H-DCN, as a significantly independent factor, was associated with better treatment response (odds ratio, 20.014; 95% Cl, 2.187-183.150; P = 0.008) and longer PFS (hazard ratio, 0.135; 95% Cl, 0.051 0.361; P < 0.001). These findings disclose the potential role of decorin in myeloma and provide a basis for further study on possible synergistic anti-myeloma effects between decorin and the novel agents that target BM stroma.	[Huang, Shang-Yi; Lin, Hsiu-Hsia; Yao, Ming; Tang, Jih-Luh; Wu, Shang-Ju; Hou, Hsin-An; Chou, Sheng-Chieh; Ko, Bor-Sheng; Lu, Hsiao-Yun; Tsay, Woei; Tien, Hwei-Fang] Natl Taiwan Univ, Dept Internal Med, Med Coll & Hosp, Taipei, Taiwan; [Chou, Wen-Chien; Hsu, Szu-Chun] Natl Taiwan Univ, Dept Lab Med, Med Coll & Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Huang, SY (corresponding author), Natl Taiwan Univ, Dept Internal Med, Med Coll & Hosp, Taipei, Taiwan.	syhuang55@ntuh.gov.tw		Huang, Shang-Yi/0000-0001-5688-3410; TIEN, HWEI-FANG/0000-0002-1384-5593; CHOU, WEN-CHIEN/0000-0003-2967-698X; TANG, JIH-LUH/0000-0003-4021-3281; YAO, MING/0000-0003-2932-0019; CHOU, SHENG-CHIEH/0000-0002-4121-019X; KO, BOR-SHENG/0000-0002-7965-7579; HOU, HSIN-AN/0000-0003-2780-4845	National Science Council [NSC97-2314-B-002-036-MY3, NSC101-2314-B-002-086, NSC102-2628-B-002-052-MY3]; National Taiwan University Hospital [NTUH 99-S1031, 100-S1659, 101-S1801, 102-S2161, 103-S2435, 104-S2720]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	Shang-Yi Huang received funding from National Science Council (NSC97-2314-B-002-036-MY3; NSC101-2314-B-002-086; NSC102-2628-B-002-052-MY3) and National Taiwan University Hospital (NTUH 99-S1031, 100-S1659, 101-S1801, 102-S2161, 103-S2435, 104-S2720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Anderson KC, 2011, CLIN CANCER RES, V17, P1225, DOI 10.1158/1078-0432.CCR-10-3366; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bozoky B, 2014, CANCER MED-US, V3, P485, DOI 10.1002/cam4.231; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen SJ, 2013, AM J PATHOL, V183, P247, DOI 10.1016/j.ajpath.2013.04.001; Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004; Horvath Z, 2014, MATRIX BIOL, V35, P194, DOI 10.1016/j.matbio.2013.11.004; HOSMER DW, 2000, WILEY PS TX, P1; Huang SY, 2005, ANN ONCOL, V16, P1530, DOI 10.1093/annonc/mdi273; Huang SY, 2004, AM J PATHOL, V164, P747, DOI 10.1016/S0002-9440(10)63162-8; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Kristensen IB, 2013, EUR J HAEMATOL, V91, P196, DOI 10.1111/ejh.12125; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kwan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123054; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Li X, 2012, J BONE MINER RES, V27, P1635, DOI 10.1002/jbmr.1620; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Ludwig H, 2013, J CLIN ONCOL, V31, P247, DOI 10.1200/JCO.2011.39.5137; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Munz C, 1999, EUR J IMMUNOL, V29, P1032; Nash MA, 1999, CANCER RES, V59, P6192; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nemani N, 2015, J BONE MINER RES, V30, P533, DOI 10.1002/jbmr.2371; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Patel CG, 2014, CLIN CANCER RES, V20, P3955, DOI 10.1158/1078-0432.CCR-14-0434; Pennisi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015233; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Shintani K, 2008, ONCOL REP, V19, P1533; Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137552	10.1371/journal.pone.0137552	http://dx.doi.org/10.1371/journal.pone.0137552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379028	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400016
J	Kim, KR; An, JU; Lee, SH; Oh, DK				Kim, Kyoung-Rok; An, Jung-Ung; Lee, Seon-Hwa; Oh, Deok-Kun			Selective Production of 9R-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid from alpha-Linolenic Acid in Perilla Seed Oil Hydrolyzate by a Lipoxygenase from Nostoc Sp SAG 25.82	PLOS ONE			English	Article							FATTY-ACIDS; SOYBEAN LIPOXYGENASE-1; HYDROPEROXIDE PRODUCTION; METHYL-ESTER; SYSTEM; HYDROXYLATION; OPTIMIZATION; ENZYMES; LEAVES; CELLS	Hydroxy fatty acids (HFAs) derived from omega-3 polyunsaturated fatty acids have been known as versatile bioactive molecules. However, its practical production from omega-3 or omega-3 rich oil has not been well established. In the present study, the stereo-selective enzymatic production of 9R-hydroxy-1 0E,12Z,15Z-octadecatrienoic acid (9R-HOTE) from a-linolenic acid (ALA) in perilla seed oil (PO) hydrolyzate was achieved using purified recombinant 9R-lipoxygenase (9R-LOX) from Nostoc sp. SAG 25.82. The specific activity of the enzyme followed the order linoleic acid (LA) > ALA > y-linolenic acid (GLA). A total of 75% fatty acids (ALA and LA) were used as a substrate for 9R-LOX from commercial PO by hydrolysis of Candida rugosa lipase. The optimal reaction conditions for the production of 9R-HOTE from ALA using 9R-LOX were pH 8.5, 15 degrees C, 5% (v/v) acetone, 0.2% (w/v) Tween 80, 40 g/L ALA, and 1 g/L enzyme. Under these conditions, 9R-LOX produced 37.6 g/L 9RHOTE from 40 g/L ALA for 1 h, with a conversion yield of 94% and a productivity of 37.6 g/U h; and the enzyme produced 34 g/L 9R-HOTE from 40 g/L ALA in PO hydrolyzate for 1 h, with a conversion yields of 85% and a productivity of 34 g/Uh. The enzyme also converted 9R-hydroxy-1 0E,12Z-octadecadienoic acid (9R-HODE) from 40 g/L LA for 1.0 h, with a conversion yield of 95% and a productivity of 38.4 g/L. This is the highest productivity of HFA from both ALA and ALA-rich vegetable oil using LOX ever reported. Therefore, our result suggests an efficient method for the production of 9R-HFA5 from LA and ALA in vegetable oil using recombinant LOX in biotechnology.	[Kim, Kyoung-Rok; An, Jung-Ung; Lee, Seon-Hwa; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	deokkun@konkuk.ac.kr	An, Jungung/GYQ-7327-2022		Ministry for Agriculture, Food and Rural Affairs [112002-3]; Ministry for Health & Welfare, Republic of Korea [2012-009]	Ministry for Agriculture, Food and Rural Affairs; Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Bio-industry Technology Development Program, Ministry for Agriculture, Food and Rural Affairs (No. 112002-3), and the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (No. 2012-009).	Akakabe Y, 2002, BIOORGAN MED CHEM, V10, P3171, DOI 10.1016/S0968-0896(02)00212-2; An JU, 2015, APPL MICROBIOL BIOT, P1; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; Berry H, 1998, J BIOL CHEM, V273, P2769, DOI 10.1074/jbc.273.5.2769; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Ciftci ON, 2012, EUR J LIPID SCI TECH, V114, P794, DOI 10.1002/ejlt.201100207; Dong M, 2000, BIOSCI BIOTECH BIOCH, V64, P882, DOI 10.1271/bbb.64.882; DROUET P, 1994, TETRAHEDRON LETT, V35, P3923, DOI 10.1016/S0040-4039(00)76703-7; Elshof MBW, 1998, FETT-LIPID, V100, P246; Fauconnier ML, 1996, BIOTECHNOL TECH, V10, P839, DOI 10.1007/BF00154668; Gao BL, 2010, BBA-MOL CELL BIOL L, V1801, P58, DOI 10.1016/j.bbalip.2009.09.004; Gargouri M, 2002, BIOTECHNOL LETT, V24, P915, DOI 10.1023/A:1015588008300; Gargouri M, 1997, ENZYME MICROB TECH, V21, P79, DOI 10.1016/S0141-0229(96)00229-3; Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Hou CT, 2000, ADV APPL MICROBIOL, V47, P201, DOI 10.1016/S0065-2164(00)47005-X; IACAZIO G, 1990, J ORG CHEM, V55, P1690, DOI 10.1021/jo00292a056; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jo YS, 2014, J AGR FOOD CHEM, V62, P6736, DOI 10.1021/jf501081z; Joo YC, 2012, BIOTECHNOL ADV, V30, P1524, DOI 10.1016/j.biotechadv.2012.04.004; Kim KR, 2014, J MOL CATAL B-ENZYM, V104, P56, DOI 10.1016/j.molcatb.2014.03.009; Kim KR, 2013, BIOTECHNOL ADV, V31, P1473, DOI 10.1016/j.biotechadv.2013.07.004; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; KUHN H, 1989, EUR J BIOCHEM, V186, P155, DOI 10.1111/j.1432-1033.1989.tb15190.x; Marques G, 2011, BIORESOURCE TECHNOL, V102, P1338, DOI 10.1016/j.biortech.2010.08.112; MARTINI D, 1994, BIOCATALYSIS, V11, P47, DOI 10.3109/10242429409034376; Marzo V, 1996, EXPERIENTIA, V52, P120; MURAKAMI N, 1992, LIPIDS, V27, P776, DOI 10.1007/BF02535848; NAMAI T, 1993, BIOSCI BIOTECH BIOCH, V57, P611, DOI 10.1271/bbb.57.611; Noordermeer MA, 2002, J AGR FOOD CHEM, V50, P4270, DOI 10.1021/jf0202685; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; Pinto MD, 1997, BIOTECHNOL PROGR, V13, P394, DOI 10.1021/bp9700465; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SHIMURA M, 1983, AGR BIOL CHEM TOKYO, V47, P1983, DOI 10.1080/00021369.1983.10865897; SHIN HS, 1994, J AM OIL CHEM SOC, V71, P619, DOI 10.1007/BF02540589; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Villaverde JJ, 2013, CHEM ENG J, V231, P519, DOI 10.1016/j.cej.2013.07.064; Villaverde JJ, 2013, CHEM ENG J, V217, P82, DOI 10.1016/j.cej.2012.11.090; Wang X, 2014, J AGR FOOD CHEM; Zhang C, 2012, APPL MICROBIOL BIOT, V94, P949, DOI 10.1007/s00253-012-3895-5; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	45	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137785	10.1371/journal.pone.0137785	http://dx.doi.org/10.1371/journal.pone.0137785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379279	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400026
J	Wang, WR; Wang, JW; Qu, M; Li, XJ; Zhang, JY; Zhang, HH; Wu, JX; Yu, B; Wu, H; Kong, W; Yu, XH				Wang, Weiran; Wang, Jiawen; Qu, Meng; Li, Xiaojun; Zhang, Jingyao; Zhang, Haihong; Wu, Jiaxin; Yu, Bin; Wu, Hui; Kong, Wei; Yu, Xianghui			Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-kappa B Activation	PLOS ONE			English	Article							VIRUS ENVELOPE GLYCOPROTEIN; IMMUNODEFICIENCY VIRUS; HIV-1 INFECTION; INHIBITS HIV-1; RETROVIRAL SEQUENCES; APOBEC3 FAMILY; FACTOR SAMHD1; VPU PROTEIN; HOST-CELL; TETHERIN	BST2 (CD317, tetherin, HM1.24) is an interferon-inducible transmembrane protein which can directly inhibit the release of enveloped virus particles from infected cells, and its antiviral activity is reported to be related to the specific topological arrangement of its four structural domains. The N-terminal cytoplasmic tail of feline BST2 (fBST2) is characterized by a shorter N-terminal region compared to those of other known homologs. In this study, we investigated the functional impact of modifying the cytoplasmic tail region of fBST2 and its molecular mechanism. The fBST2 protein with the addition of a peptide at the N-terminus retained anti-release activity against human immunodeficiency virus type-1 and pseudovirus based on feline immunodeficiency virus at a weaker level compared with the wild-type fBST2. However, the fBST2 protein with addition of a peptide internally in the ectodomain proximal to the GPI anchor still retained its anti-viral activity well. Notably, the N-glycosylation state and the cell surface level of the N-terminally modified variants were unlike those of the wild-type protein, while no difference was observed in their intracellular localizations. However, in contrast to human BST2, the wild-type fBST2 did not show the ability to activate NF-kappa B. Consistent with previous reports, our findings showed that adding a peptide in the cytoplasmic tail region of fBST2 may influence its anti-viral activity. The shorter N-terminal cytoplasmic region of fBST2 compared with human BST2 did not apparently affect its antiviral activity, which is independent of its N-glycosylation and ability to activate NF-kappa B.	[Wang, Weiran; Wang, Jiawen; Qu, Meng; Li, Xiaojun; Zhang, Jingyao; Zhang, Haihong; Wu, Jiaxin; Yu, Bin; Wu, Hui; Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China; [Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Jilin Province, Peoples R China; [Wang, Jiawen] Changchun Univ Chinese Med, Ctr New Med Res, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Changchun University of Chinese Medicine	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China.	weikong@jlu.edu.cn; xianghui@jlu.edu.cn	Wu, Jiaxin/GVT-3486-2022; wang, weiran/HGU-3350-2022		National Natural Science Foundation of China [31270807, 81261120385]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2013ZX10004608-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	Support was provided by National Natural Science Foundation of China 31270807 XHY; National Natural Science Foundation of China 81261120385 XHY; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period 2013ZX10004608-003 XHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Dietrich I, 2011, J VIROL, V85, P5840, DOI 10.1128/JVI.00071-11; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Jia B, 2009, PLOS PATHOG, V5, P15; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Lv MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111422; Lv MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020890; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Pecon-Slattery J, 2008, VET IMMUNOL IMMUNOP, V123, P32, DOI 10.1016/j.vetimm.2008.01.010; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; REEVES RH, 1985, J VIROL, V56, P303, DOI 10.1128/JVI.56.1.303-306.1985; REEVES RH, 1984, J VIROL, V52, P164, DOI 10.1128/JVI.52.1.164-171.1984; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; TOMONAGA K, 1992, J VIROL, V66, P6181, DOI 10.1128/JVI.66.10.6181-6185.1992; Troyer JL, 2008, VET IMMUNOL IMMUNOP, V123, P159, DOI 10.1016/j.vetimm.2008.01.023; Troyer JL, 2004, J VIROL, V78, P3777, DOI 10.1128/JVI.78.7.3777-3791.2004; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	59	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138190	10.1371/journal.pone.0138190	http://dx.doi.org/10.1371/journal.pone.0138190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379128	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400066
J	Cheng, YH; Rao, V; Tu, AY; Lindert, S; Wang, D; Oxenford, L; McCulloch, AD; McCammon, JA; Regnier, M				Cheng, Yuanhua; Rao, Vijay; Tu, An-yue; Lindert, Steffen; Wang, Dan; Oxenford, Lucas; McCulloch, Andrew D.; McCammon, J. Andrew; Regnier, Michael			Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RABBIT SKELETAL-MUSCLE; MOLECULAR-DYNAMICS; RELAXATION KINETICS; STRIATED-MUSCLE; CONFORMATIONAL TRANSITION; PKA PHOSPHORYLATION; CALCIUM SENSITIVITY; SINGLE MYOFIBRILS; REGULATORY DOMAIN	Two hypertrophic cardiomyopathy-associated cardiac troponin I (cTnI) mutations, R146G and R21C, are located in different regions of cTnI, the inhibitory peptide and the cardiac-specific N terminus. We recently reported that these regions may interact when Ser-23/Ser-24 are phosphorylated, weakening the interaction of cTnI with cardiac TnC. Little is known about how these mutations influence the affinity of cardiac TnC for cTnI (KC-I) or contractile kinetics during beta-adrenergic stimulation. Here, we tested how cTnI(R146G) or cTnI(R21C) influences contractile activation and relaxation and their response to protein kinase A (PKA). Both mutations significantly increased Ca2+ binding affinity to cTn (K-Ca) and KC-I. PKA phosphorylation resulted in a similar reduction of K-Ca for all complexes, but KC-I was reduced only with cTnI(WT). cTnI(WT), cTnI(R146G), and cTnI(R21C) were complexed into cardiac troponin and exchanged into rat ventricular myofibrils, and contraction/relaxation kinetics were measured +/- PKA phosphorylation. Maximal tension (T-max) was maintained for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils, and Ca2+ sensitivity of tension (pCa(50)) was increased. PKA phosphorylation decreased pCa(50) for cTnI(WT)-exchanged myofibrils but not for either mutation. PKA phosphorylation accelerated the early slow phase relaxation for cTnI(WT) myofibrils, especially at Ca2+ levels that the heart operates in vivo. Importantly, this effect was blunted for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils. Molecular dynamics simulations suggest both mutations inhibit formation of intra-subunit contacts between the N terminus and the inhibitory peptide of cTnI that is normally seen with WT-cTn upon PKA phosphorylation. Together, our results suggest that cTnI(R146G) and cTnI(R21C) blunt PKA modulation of activation and relaxation kinetics by prohibiting cardiac-specific N-terminal interaction with the cTnI inhibitory peptide.	[Cheng, Yuanhua; Rao, Vijay; Tu, An-yue; Wang, Dan; Oxenford, Lucas; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA; [Cheng, Yuanhua; McCulloch, Andrew D.; McCammon, J. Andrew] Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA; [McCulloch, Andrew D.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lindert, Steffen; McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Regnier, Michael] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Regnier, M (corresponding author), Univ Washington, Dept Bioengn, Box 358056,850 Republican St, Seattle, WA 98195 USA.	mregnier@uw.edu	McCammon, J. Andrew/AAG-1832-2021; Regan, Clinton/E-6250-2012	McCammon, J. Andrew/0000-0003-3065-1456	National Institutes of Health [R01 HL-111197, P41 GM103426]; American Heart Association [15POST25080292, 11POST7400069, 12POST11570005]; National Science Foundation; Howard Hughes Medical Institution; National Science Foundation Supercomputer Centers; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111197, U01HL122199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103426, R01GM031749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institution(Howard Hughes Medical Institute); National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 HL-111197 (to M. R.) and P41 GM103426 (to NBCR), by American Heart Association Grants 15POST25080292 (to Y. C.), 11POST7400069 (to V. R.), and 12POST11570005 (to S. L.), and by grants from National Science Foundation, National Institutes of Health, Howard Hughes Medical Institution, and the National Science Foundation Supercomputer Centers (to the J. A. M. group). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brunet NM, 2014, ARCH BIOCHEM BIOPHYS, V552, P11, DOI 10.1016/j.abb.2013.12.021; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; Colomo F, 1997, J PHYSIOL-LONDON, V500, P535, DOI 10.1113/jphysiol.1997.sp022039; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dohet C, 1995, FEBS LETT, V377, P131, DOI 10.1016/0014-5793(95)01319-9; Dong WJ, 2000, PROTEINS, V41, P438, DOI 10.1002/1097-0134(20001201)41:4<438::AID-PROT20>3.0.CO;2-E; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dweck D, 2014, J BIOL CHEM, V289, P23097, DOI 10.1074/jbc.M114.561472; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; George SE, 1996, BIOCHEMISTRY-US, V35, P8307, DOI 10.1021/bi960495y; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 1997, J MUSCLE RES CELL M, V18, P643, DOI 10.1023/A:1018631806182; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUXLEY AF, 1970, J PHYSIOL-LONDON, V210, pP32; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kohler J, 2003, PHYSIOL GENOMICS, V14, P117, DOI 10.1152/physiolgenomics.00101.2002; KRESS M, 1986, J MOL BIOL, V188, P325, DOI 10.1016/0022-2836(86)90158-0; Kreutziger KL, 2008, J PHYSIOL-LONDON, V586, P3683, DOI 10.1113/jphysiol.2008.152181; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Liang JS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/742536; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c; Luo Y, 2003, ADV EXP MED BIOL, V538, P573; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Martyn DA, 2001, BIOPHYS J, V80, P360, DOI 10.1016/S0006-3495(01)76020-1; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Rao V, 2014, BIOPHYS J, V107, P1196, DOI 10.1016/j.bpj.2014.07.027; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Regnier M, 2000, CIRC RES, V86, P1211, DOI 10.1161/01.RES.86.12.1211; Reiffert SU, 1998, BIOCHEMISTRY-US, V37, P13516, DOI 10.1021/bi980280j; Reis S, 2008, PFLUG ARCH EUR J PHY, V457, P17, DOI 10.1007/s00424-008-0487-4; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tesi C, 2002, BIOPHYS J, V83, P2142, DOI 10.1016/S0006-3495(02)73974-X; Tesi C, 2000, BIOPHYS J, V78, P3081, DOI 10.1016/S0006-3495(00)76845-7; Wang D, 2013, ARCH BIOCHEM BIOPHYS, V535, P68, DOI 10.1016/j.abb.2013.02.006; Wang D, 2012, BIOCHEMISTRY-US, V51, P4473, DOI 10.1021/bi3003007; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhou ZQ, 2013, ARCH BIOCHEM BIOPHYS, V535, P56, DOI 10.1016/j.abb.2012.12.007	72	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27749	27766		10.1074/jbc.M115.683045	http://dx.doi.org/10.1074/jbc.M115.683045			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26391394	Green Published, hybrid			2022-12-26	WOS:000365757500027
J	Mahanic, CS; Budhavarapu, V; Graves, JD; Li, G; Lin, WC				Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin			Regulation of E2 Promoter Binding Factor 1 (E2F1) Transcriptional Activity through a Deubiquitinating Enzyme, UCH37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL HYDROLASE 37; FAMILY-MEMBERS; CANCER-THERAPY; DNA-DAMAGE; PROTEASOME; P53; APOPTOSIS; ROLES; DISTINCT; TOPBP1	E2F1 is tightly controlled by multiple mechanisms, but whether ubiquitination regulates its transcriptional activity remains unknown. Here we identify UCH37 as the first, to our knowledge, deubiquitinating enzyme for E2F1. UCH37 does not deubiquitinate UbK48 chains or affect E2F1 protein stability. Instead, UCH37, but not a catalytically dead mutant, decreases the Lys-63-linked ubiquitination of E2F1 and activates its transcriptional activity. UCH37 depletion reduces the gene expression of both proliferative and pro-apoptotic E2F1 target genes. UCH37 depletion also decreases both cell proliferation and apoptosis induction in functional assays. Interestingly, UCH37 expression is induced by E2F1, and its level rises in G(1)/S transition and S phase, suggesting a positive feedback loop between UCH37 and E2F1. UCH37 protein and mRNA levels are also induced after DNA damage. UCH37 localizes to the promoters of E2F1 pro-apoptotic target genes such as caspase 3, caspase 7, PARP1, and Apaf-1 and activates their expression after DNA damage. Moreover, the expression of E2F1 proliferative and pro-apoptotic genes is correlated with the levels of UCH37 in many primary tumors. These results uncover a novel mechanism for E2F1 transcriptional activation through removal of its Lys-63-linked ubiquitination by UCH37.	[Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Hematol Oncol Sect, Houston, TX 77030 USA; [Mahanic, Christina S.; Graves, Joshua D.; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Mahanic, Christina S.; Graves, Joshua D.; Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), 1 Baylor Pl,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Li, Gang/H-5714-2015; Regan, Clinton/E-6250-2012		National Institutes of Health [AI036211, CA125123, RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA138641, R01CA100857] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Joan Conaway, Chittaranjan Das, Dong-Er Zhang, and Ze'ev Ronai for plasmids and members of the W. C. L. and Fang-Tsyr (Fannie) Lin laboratories for discussions. We also thank the Cytometry and Cell Sorting Core at Baylor College of Medicine (with funding from the National Institutes of Health (AI036211, CA125123, and RR024574) and Joel M. Sederstrom for assistance.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Budhavarapu VN, 2012, CELL CYCLE, V11, P2030, DOI 10.4161/cc.20643; Cao AR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217158; Chen ZW, 2011, CELL BIOCHEM FUNCT, V29, P142, DOI 10.1002/cbf.1734; Chowdhury P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6476; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DeGregori J, 2006, CURR MOL MED, V6, P739; Fang Y, 2013, BBA-MOL CELL RES, V1833, P559, DOI 10.1016/j.bbamcr.2012.11.020; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Paik JC, 2010, J BIOL CHEM, V285, P6348, DOI 10.1074/jbc.M109.072074; Peart MJ, 2010, CELL CYCLE, V9, P3956, DOI 10.4161/cc.9.19.13162; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	33	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26508	26522		10.1074/jbc.M115.659425	http://dx.doi.org/10.1074/jbc.M115.659425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26396186	Green Published, hybrid			2022-12-26	WOS:000364793600019
J	Collet, B; Urquhart, K; Monte, M; Collins, C; Perez, SG; Secombes, CJ; Hall, M				Collet, Bertrand; Urquhart, Katy; Monte, Milena; Collins, Catherine; Perez, Sandro Garcia; Secombes, Chris J.; Hall, Malcolm			Individual Monitoring of Immune Response in Atlantic Salmon Salmo salar following Experimental Infection with Infectious Salmon Anaemia Virus (ISAV)	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; BLOOD-VOLUME; EXPRESSION; CELL; FISH; HSP90; GENE; INTERLEUKIN-10; ASSOCIATION; INTERFERON	Monitoring the immune response in fish over the progression of a disease is traditionally carried out by experimental infection whereby animals are killed at regular intervals and samples taken. We describe here a novel approach to infectiology for salmonid fish where blood samples are collected repeatedly in a small group of PIT-tagged animals. This approach contributes to the reduction of animals used in research and to improved data quality. Two groups of 12 PIT-tagged Atlantic salmon (Salmo salar) were i.p infected with Infectious Salmon Anaemia Virus (ISAV) or culture medium and placed in 1 m(3) tanks. Blood samples were collected at 0, 4, 8, 12, 16, 21 and 25 days post infection. The viral load, immune and stress response were determined in individual fish by real-time quantitative PCR (QPCR) on the blood cells, as well as the haematocrit used as an indicator of haemolysis, a clinical consequence of ISAV infection. "In-tank" anaesthesia was used in order to reduce the stress related to chase and netting prior to sampling. The data were analysed using a statistical approach which is novel with respect to its use in fish immunology. The repeated blood collection procedure did not induce stress response as measured by HSP70 and HSP90 gene expression in the un-infected animals. A strong increase in viraemia as well as a significant induction of Mx and gamma IP gene expression were observed in the infected group. Interleukin 10 was found induced at the later stage of the infection whereas no induction of CD8 or gamma IFN could be detected. These results and the advantages of this approach are discussed.	[Collet, Bertrand; Urquhart, Katy; Collins, Catherine; Perez, Sandro Garcia; Hall, Malcolm] Marine Scotland, Aquaculture & Fish Hlth, Aberdeen, Scotland; [Monte, Milena; Secombes, Chris J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Marine Scotland Science (MSS); University of Aberdeen	Collet, B (corresponding author), Marine Scotland, Aquaculture & Fish Hlth, Aberdeen, Scotland.	Bertrand.Collet@scotland.gsi.gov.uk	Collet, Bertrand/C-1113-2012	Collet, Bertrand/0000-0003-2795-2653	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G1100675]; National Centre for the Replacement [G1100675/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, grant G1100675). The web page of the project is located at https://www.nc3rs.org.uk/development-non-lethal-sampling-method-monitor-immune-response-and-disease-progression-salmonid-fish.	Aamelfot M, 2013, J ANAT, V222, P547, DOI 10.1111/joa.12033; Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; [Anonymous], 2014, R LANG ENV STAT COMP; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Baker RF, 2004, T AM FISH SOC, V133, P568, DOI 10.1577/T03-012.1; Billett HH., 1990, HEMOGLOBIN HEMATOCRI; Bruno D, 2007, AQUACULTURE, V269, P114, DOI 10.1016/j.aquaculture.2007.04.057; CARRAGHER JF, 1990, PROG CLIN BIOL RES, V342, P487; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Collet B, 2008, FISH SHELLFISH IMMUN, V25, P861, DOI 10.1016/j.fsi.2008.01.011; Collet B, 2014, DEV COMP IMMUNOL, V43, P160, DOI 10.1016/j.dci.2013.08.017; Collet B, 2013, J VIROL METHODS, V191, P113, DOI 10.1016/j.jviromet.2013.04.009; Collet B, 2009, VET IMMUNOL IMMUNOP, V130, P92, DOI 10.1016/j.vetimm.2008.12.022; Collet B, 2009, DEV COMP IMMUNOL, V33, P821, DOI 10.1016/j.dci.2009.01.007; CONTE FP, 1963, AM J PHYSIOL, V205, P533, DOI 10.1152/ajplegacy.1963.205.3.533; Cornwell ER, 2013, J VET DIAGN INVEST, V25, P203, DOI 10.1177/1040638713476865; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Drennan JD, 2007, J FISH DIS, V30, P367, DOI 10.1111/j.1365-2761.2007.00817.x; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Ellis AE, 2010, J FISH DIS, V33, P803, DOI 10.1111/j.1365-2761.2010.01174.x; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; GINGERICH WH, 1987, COMP BIOCHEM PHYS A, V87, P251, DOI 10.1016/0300-9629(87)90119-8; Grant CFJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-68; Jorgensen SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-179; Kelly MH, 2006, N AM J FISH MANAGE, V26, P921, DOI 10.1577/M05-084.1; KLONTZ GW, 1995, J ANIM SCI, V73, P3485, DOI 10.2527/1995.73113485x; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Moneke E, 2005, DIS AQUAT ORGAN, V66, P153, DOI 10.3354/dao066153; Murray AG, 2002, EMERG INFECT DIS, V8, P1, DOI 10.3201/eid0801.010144; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Raida MK, 2011, FISH SHELLFISH IMMUN, V30, P1257, DOI 10.1016/j.fsi.2011.03.022; Sathiyaa R, 2001, COMP BIOCHEM PHYS B, V129, P679, DOI 10.1016/S1096-4959(01)00373-6; Searle S.R., 1971, LINEAR MODELS; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Snow M, 2002, DIS AQUAT ORGAN, V50, P13, DOI 10.3354/dao050013; Steiner E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-45; Tsai TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-40; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; WEDEMEYER G, 1972, J FISH RES BOARD CAN, V29, P1780, DOI 10.1139/f72-284; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5; Wiles S, 2006, NAT REV MICROBIOL, V4, P307, DOI 10.1038/nrmicro1386; Workenhe ST, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-13; Yee TW, 2010, J STAT SOFTW, V32, P1	48	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137767	10.1371/journal.pone.0137767	http://dx.doi.org/10.1371/journal.pone.0137767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397117	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500048
J	Gu, HG; Zhao, ZG				Gu, Huaguang; Zhao, Zhiguo			Dynamics of Time Delay-Induced Multiple Synchronous Behaviors in Inhibitory Coupled Neurons	PLOS ONE			English	Article							NEURAL INFORMATION; SYNCHRONIZATION; OSCILLATIONS; MODULATION; RHYTHMS; BURSTS; MOTIFS; CHAOS; SPIKE; PHASE	The inhibitory synapse can induce synchronous behaviors different from the anti-phase synchronous behaviors, which have been reported in recent studies. In the present paper, synchronous behaviors are investigated in the motif model composed of reciprocal inhibitory coupled neurons with endogenous bursting and time delay. When coupling strength is weak, synchronous behavior appears at a single interval of time delay within a bursting period. When coupling strength is strong, multiple synchronous behaviors appear at different intervals of time delay within a bursting period. The different bursting patterns of synchronous behaviors, and time delays and coupling strengths that can induce the synchronous bursting patterns can be well interpreted by the dynamics of the endogenous bursting pattern of isolated neuron, which is acquired by the fast-slow dissection method, combined with the inhibitory coupling current. For an isolated neuron, when a negative impulsive current with suitable strength is applied at different phases of the bursting, multiple different bursting patterns can be induced. For a neuron in the motif, the inhibitory coupling current, of which the application time and strength is modulated by time delay and coupling strength, can cause single or multiple synchronous firing patterns like the negative impulsive current when time delay and coupling strength is suitable. The difference compared to the previously reported multiple synchronous behaviors that appear at time delays wider than a period of the endogenous firing is discussed. The results present novel examples of synchronous behaviors in the neuronal network with inhibitory synapses and provide a reasonable explanation.	[Gu, Huaguang; Zhao, Zhiguo] Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China	Tongji University	Gu, HG (corresponding author), Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China.	guhuaguang@tongji.edu.cn	Gu, Huaguang/E-3562-2013; Gu, Huaguang/ABA-5898-2020; Zhiguo, Zhao/Q-8480-2018	Gu, Huaguang/0000-0003-0815-1447; Gu, Huaguang/0000-0003-0815-1447; Zhiguo, Zhao/0000-0002-0041-724X	National Nature Science Foundation of China [11372224]; Fundamental Research Funds for Central Universities [1330219127]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Nature Science Foundation of China under Grant No. 11372224, and the Fundamental Research Funds for Central Universities designated to Tongji University under Grant No. 1330219127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Belykh I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078102; BERTRAM R, 1995, B MATH BIOL, V57, P413, DOI 10.1007/BF02460633; Buric N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036211; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Elson RC, 2002, J NEUROPHYSIOL, V88, P1166, DOI 10.1152/jn.2002.88.3.1166; Ernst U, 1998, PHYS REV E, V57, P2150, DOI 10.1103/PhysRevE.57.2150; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gu HG, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/50003; Gu HG, 2014, SCI CHINA TECHNOL SC, V57, P864, DOI 10.1007/s11431-014-5526-0; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jalil S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.045201; Jia B, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.240505; Kandel E., 2000, PRINCIPLES NEURAL SC; Kunec S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021908; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Perez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019900; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Rubin J, 2000, NEURAL COMPUT, V12, P597, DOI 10.1162/089976600300015727; Rubin J, 2002, SIAM J APPL DYN SYST, V1, P146, DOI 10.1137/S111111110240323X; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Szucs A, 2003, J NEUROPHYSIOL, V89, P1363, DOI 10.1152/jn.00732.2002; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wojcik J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056209; Zhang N, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/11/110501; Zhang X, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/58001; Zhou CS, 2003, CHAOS, V13, P401, DOI 10.1063/1.1493096	43	33	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138593	10.1371/journal.pone.0138593	http://dx.doi.org/10.1371/journal.pone.0138593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394224	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100075
J	Huang, LP; Lou, YH; Ju, HM; Zhang, L; Pan, JSC; Ross, A; Sun, YX; Truong, LD; Sheikh-Hamad, D				Huang, Luping; Lou, Yahuan; Ju, Huiming; Zhang, Lin; Pan, Jenny Szu-Chin; Ross, April; Sun, Yuxiang; Truong, Luan D.; Sheikh-Hamad, David			Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1	PLOS ONE			English	Article							EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; BASEMENT-MEMBRANE GLOMERULONEPHRITIS; MIGRATION INHIBITORY FACTOR; GBM GLOMERULONEPHRITIS; MICE; CELLS; EXPRESSION; RECEPTOR; RAT; CHEMOKINE	Background Inflammation is the hallmark of nephrotoxic nephritis. Stanniocalcin-1 (STC1), a pro-survival factor, inhibits macrophages, stabilizes endothelial barrier function, and diminishes transendothelial migration of leukocytes; consistently, transgenic (Tg) overexpression of STC1 protects from nephrotoxic nephritis. Herein, we sought to determine the phenotype of nephrotoxic nephritis after conditional and kidney-specific knockdown of STC1. Methods We used Tg mice that, express either STC1 shRNA (70% knockdown of STC1 within 4d) or scrambled shRNA (control) upon delivery of Cre-expressing plasmid to the kidney using ultrasound microbubble technique. Sheep anti-mouse GBM antibody was administered 4d after shRNA activation; and mice were euthanized 10 days later for analysis. Results Serum creatinine, proteinuria, albuminuria and urine output were similar 10 days after anti-GBM delivery in both groups; however, anti-GBM antibody delivery to mice with kidney-specific knockdown of STC1 produced severe nephrotoxic nephritis, characterized by severe tubular necrosis, glomerular hyalinosis/necrosis and massive cast formation, while control mice manifested mild tubular injury and crescentic glomerulonephritis. Surprisingly, the expression of cytokines/chemokines and infiltration with T-cells and macrophages were also diminished in STC1 knockdown kidneys. Staining for sheep anti-mouse GBM antibody, deposition of mouse C-3 and IgG in the kidney, and antibody response to sheep IgG were equal. Conclusions nephrotoxic nephritis after kidney-specific knockdown of STC1 is characterized by severe tubular and glomerular necrosis, possibly due to loss of STC1-mediated pro-survival factors, and we attribute the paucity of inflammation to diminished release of cytokines/chemokines/growth factors from the necrotic epithelium.	[Huang, Luping; Pan, Jenny Szu-Chin; Sheikh-Hamad, David] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Lou, Yahuan; Ross, April] Univ Texas Hlth Sci Ctr Houston, Dent Branch, Houston, TX 77030 USA; [Ju, Huiming] Yangzhou Univ, Coll Vet Med, Yangzhou 25009, Jiangsu, Peoples R China; [Zhang, Lin] Chengdu Mil Area Command, Chengdu Gen Hosp, Ctr Gen Surg, Chengdu, Peoples R China; [Sun, Yuxiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Truong, Luan D.] Weill Cornell Med Coll, Methodist Hosp, Pathol & Lab Med, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Yangzhou University; Baylor College of Medicine; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Sheikh-Hamad, D (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	sheikh@bcm.tmc.edu			Veterans Administration [BX002006-01]; National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health [R01 DK080306, T32 DK062706]; USDA/CRIS [3092-5-001-059]; American Diabetes Association [1-15-BS-177]; Pathology and Histology Core at Baylor College of Medicine; NIH [NCI P30-CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080306, T32DK062706] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002006] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); USDA/CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); American Diabetes Association(American Diabetes Association); Pathology and Histology Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the Veterans Administration [BX002006-01], National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health [R01 DK080306; T32 DK062706], and a generous gift from Dr. and Mrs. Harold Selzman. This project was also supported by USDA/CRIS 3092-5-001-059 and American Diabetes Association #1-15-BS-177 (YS), and the Pathology and Histology Core at Baylor College of Medicine with funding from the NIH (NCI P30-CA125123) and the expert assistance of Michael Ittmann, MD PhD.	Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Coelho SN, 1997, KIDNEY INT, V51, P646, DOI 10.1038/ki.1997.94; Cohen Hannah C, 2011, J RNAi Gene Silencing, V7, P456; De Niu P, 2000, MOL CELL ENDOCRINOL, V162, P131, DOI 10.1016/S0303-7207(00)00199-4; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Feith GW, 1996, NEPHROL DIAL TRANSPL, V11, P599, DOI 10.1093/oxfordjournals.ndt.a027347; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Hattori T, 1994, Nihon Jinzo Gakkai Shi, V36, P1228; HILL PA, 1994, KIDNEY INT, V45, P32, DOI 10.1038/ki.1994.4; HILL PA, 1994, KIDNEY INT, V45, P700, DOI 10.1038/ki.1994.94; Hopfer H, 2003, FASEB J, V17, P860, DOI 10.1096/fj.02-0746com; Huang L, 2014, J AM SOC NEPHROL; Huang L, 2012, KIDNEY INT; Huang LP, 2012, KIDNEY INT, V82, P867, DOI 10.1038/ki.2012.223; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Huang XR, 1997, CLIN EXP IMMUNOL, V109, P134, DOI 10.1046/j.1365-2249.1997.4091307.x; Huang XR, 1997, KIDNEY INT, V51, P94, DOI 10.1038/ki.1997.12; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; LAN HY, 1993, KIDNEY INT, V43, P479, DOI 10.1038/ki.1993.70; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakhoul N, 2011, CONTRIB NEPHROL, V169, P37, DOI 10.1159/000313944; NEUGARTEN J, 1995, J AM SOC NEPHROL, V5, P1903; Odobasic D, 2005, J AM SOC NEPHROL, V16, P2012, DOI 10.1681/ASN.2004060437; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Re RN, 2010, AM J PHYSIOL-HEART C, V299, pH577, DOI 10.1152/ajpheart.00421.2010; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Sazonova O, 2008, AM J PHYSIOL-RENAL, V294, pF788, DOI 10.1152/ajprenal.00553.2007; Schena FP, 1998, KIDNEY INT, V53, pS11; TIPPING PG, 1985, KIDNEY INT, V27, P530, DOI 10.1038/ki.1985.43; Wang YL, 2009, J LEUKOCYTE BIOL, V86, P981, DOI 10.1189/jlb.0708454; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Yang NS, 1998, MOL MED, V4, P413, DOI 10.1007/BF03401748; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8	46	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138440	10.1371/journal.pone.0138440	http://dx.doi.org/10.1371/journal.pone.0138440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393521	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100061
J	Martorana, GM; Schaefer, JL; Levine, MA; Lukowski, ZL; Min, J; Meyers, CA; Schultz, GS; Sherwood, MB				Martorana, Gina M.; Schaefer, Jamie L.; Levine, Monica A.; Lukowski, Zachary L.; Min, Jeff; Meyers, Craig A.; Schultz, Gregory S.; Sherwood, Mark B.			Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model	PLOS ONE			English	Article							MITOMYCIN-C; TRABECULECTOMY; ANTIBODY; ACID	To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma filtration surgery (GFS) in a rabbit model. Thirty-two New Zealand White rabbits (eight rabbits per group) underwent GFS in the left eye. Group 1 received a perioperative injection of both Saratin and Bevacizumab, and later, subconjuctival injections of Ilomastat on days 8 and 15. Group 2 received only Saratin perioperatively, and also received Ilomastat injections on days 8 and 15. Group 3, the negative control, received a single perioperative injection of Balanced Saline Solution (BSS) along with post-operative BSS injections on days 8 and 15. Group 4, the positive control, received topical treatment with Mitomycin-C (MMC) at the time of surgery with no further treatment. Blebs were evaluated by an observer masked to treatment every third day. Histology was obtained on two eyes in each group on post-op day twelve as well as all eyes following bleb failure. Eyes in group 1 had a mean bleb survival time of 29 +/- 2.7 days, whereas those in group 2 that received the experimental treatment without Bevacizumab had a mean survival time of 25.5 +/- 2.7 days. An ANOVA test showed that the Saratin/Ilomastat/Bevacizumab group demonstrated a significant prolongation of bleb survival compared to the BSS control -mean survival time of 19.7 +/- 2.7 days-(p = 0.0252) and was not significantly different from the MMC positive control group (p = 0.4238)-mean survival time of 32.5 +/- 3.3. From tissue histology at day 12, the four different groups showed marked differences in the cellularity and capsule fibrosis. The MMC eyes showed minimal cellularity, were avascular and had minimal fibrous tissue. BSS group showed high cellularity, moderate to high fibrosis, and thicker and more defined capsules than either of the treatment groups and the positive control. Both the Saratin/Ilomastat/Bevacizumab and Saratin/Ilomastat only eyes showed moderate cellularity with minimal fibrosis, with less cellularity and fibrosis present in the triple treatment group. Sequential therapy with multiple agents, including Bevacizumab, prolonged bleb function following GFS in the rabbit model and were significantly better than the negative BSS control. The experimental group did not show the same surface tissue histological thinning and side effects associated with MMC treatment.	[Martorana, Gina M.; Schaefer, Jamie L.; Levine, Monica A.; Lukowski, Zachary L.; Min, Jeff; Meyers, Craig A.; Sherwood, Mark B.] Univ Florida, COM, Dept Ophthalmol, Gainesville, FL 32610 USA; [Schultz, Gregory S.] Univ Florida, COM, Dept Ob Gyn, Gainesville, FL 32610 USA; [Schultz, Gregory S.] Univ Florida, COM, Inst Wound Healing, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sherwood, MB (corresponding author), Univ Florida, COM, Dept Ophthalmol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	Sherwood@ufl.edu		Min, Jeff/0000-0003-4633-6792				Blalock TD, 2012, INVEST OPHTH VIS SCI, V53, P3387, DOI 10.1167/iovs.12-9425; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Duch S, 2009, J GLAUCOMA, V18, P140, DOI 10.1097/IJG.0b013e318170a747; Ekinci M, 2014, J GLAUCOMA, V23, P372, DOI 10.1097/IJG.0000000000000052; Gibson DJ, 2013, METHODS MOL BIOL, V1037, P277, DOI 10.1007/978-1-62703-505-7_16; Kahook MY, 2010, AM J OPHTHALMOL, V150, P399, DOI 10.1016/j.ajo.2010.03.025; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; KHAW PT, 1992, ARCH OPHTHALMOL-CHIC, V110, P1150, DOI 10.1001/archopht.1992.01080200130040; Kim TH, 2010, ARCH PHARM RES, V33, P1261, DOI 10.1007/s12272-010-0817-x; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; MIGDAL C, 1986, T OPHTHAL SOC UK, V105, P653; Mills R P, 1998, Trans Am Ophthalmol Soc, V96, P753; Min J, 2012, INVEST OPHTH VIS SCI, V53, P7625, DOI 10.1167/iovs.12-10120; Min J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035627; Patel JB, 2004, J MED CHEM, V47, P6716, DOI 10.1021/jm0401457; Sherwood Mark Brian, 2006, Trans Am Ophthalmol Soc, V104, P478; Shin DH, 1996, OPHTHALMOLOGY, V103, P1925, DOI 10.1016/S0161-6420(96)30406-5; Siriwardena D, 2002, OPHTHALMOLOGY, V109, P427, DOI 10.1016/S0161-6420(01)00997-6; Van Bergen T, 2011, EXP EYE RES, V93, P689, DOI 10.1016/j.exer.2011.08.016; Vogel R, 2007, OPHTHALMOLOGY, V114, P1822, DOI 10.1016/j.ophtha.2007.03.050; Wong TTL, 2005, INVEST OPHTH VIS SCI, V46, P2018, DOI 10.1167/iovs.04-0820; Yousefi S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.076015	23	11	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138054	10.1371/journal.pone.0138054	http://dx.doi.org/10.1371/journal.pone.0138054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394037	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100028
J	Wang, R; Yan, ZR; Liang, YJ; Tan, ECK; Cai, CZ; Jiang, H; Song, AQ; Qiu, CX				Wang, Rui; Yan, Zhongrui; Liang, Yajun; Tan, Edwin C. K.; Cai, Chuanzhu; Jiang, Hui; Song, Aiqin; Qiu, Chengxuan			Prevalence and Patterns of Chronic Disease Pairs and Multimorbidity among Older Chinese Adults Living in a Rural Area	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; DEPRESSIVE SYMPTOMS; PEOPLE; BURDEN; INFLAMMATION; METAANALYSIS; POPULATIONS; PROFILE; WOMEN	Background The burden of chronic diseases in China is substantial now. Data on patterns of chronic diseases and multimorbidity among older adults, especially among those living in rural areas, are sparse. Objective We aim to investigate the prevalence and patterns of chronic disease pairs and multimorbidity in elderly people living in rural China. Methods This population-based study included 1480 adults aged 60 years and over (mean age 68.5 years, 59.4% women) living in a rural community. Data were derived from the Confucius Hometown Aging Project in Shandong, China (June 2010-July 2011). Chronic diseases were diagnosed through face-to-face interviews, clinical examinations, and laboratory tests. Patterns of chronic disease pairs and multimorbidity were explored using logistic regression and exploratory factor analyses. Results The prevalence of individual chronic diseases ranged from 3.0% for tumor to 76.4% for hypertension, and each disease was often accompanied with three or more other chronic diseases. The observed prevalence of pairs of chronic conditions exceeded the expected prevalence for several conditions, such as cardiovascular diseases and metabolic disorders, as well as pulmonary diseases and degenerative disorders. Chronic multimorbidity (>= 2 chronic diseases) affected more than 90% of subjects, and two patterns of chronic multimorbidity were identified: cardiopulmonary-mental-degenerative disorder pattern (overall prevalence, 58.2%), and cerebrovascular-metabolic disorder pattern (62.6%). Prevalence of the cardiopulmonary-mental-degenerative disorder pattern increased with age, and was higher in men than women; whereas prevalence of the cerebrovascular-metabolic disorder pattern was higher in women than in men but did not vary by age. Conclusion Chronic multimorbidity was highly prevalent among older Chinese adults living in rural areas, and there were specific patterns of the co-occurrence of chronic diseases. Effort is needed to identify possible preventative strategies based on the potential clustering of chronic diseases.	[Wang, Rui; Liang, Yajun; Tan, Edwin C. K.; Qiu, Chengxuan] Stockholm Univ, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci & Soc, S-10691 Stockholm, Sweden; [Yan, Zhongrui] Jining 1 Peoples Hosp, Dept Neurol, Jining, Shandong, Peoples R China; [Liang, Yajun; Song, Aiqin] Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China; [Tan, Edwin C. K.] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia; [Cai, Chuanzhu; Jiang, Hui] Xing Long Zhuang Hosp, Yankuang Grp, Dezhou, Shandong, Peoples R China	Karolinska Institutet; Stockholm University; Jining Medical University; Monash University	Wang, R (corresponding author), Stockholm Univ, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci & Soc, S-10691 Stockholm, Sweden.	rui.wang@ki.se; chengxuan.qiu@ki.se	Tan, Edwin/F-8082-2018; Wang, Rui/HGE-4083-2022; Tan, Edwin/AAD-5967-2019	Tan, Edwin/0000-0003-2922-8837; Wang, Rui/0000-0001-7209-741X; 	Department of Science and Technology [2008GG30002058]; Department of Health [2009-067]; Natural Science Foundation in Shandong, China [ZR2010HL031]; Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet, Stockholm, Sweden; Swedish Research Council [K2012-99X-21967-01-3]; Swedish Research Council for Health, Working Life and Welfare [2014-1382]; Karolinska Institutet, Stockholm, Sweden	Department of Science and Technology(Department of Science & Technology (India)); Department of Health; Natural Science Foundation in Shandong, China; Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet, Stockholm, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet, Stockholm, Sweden	The Confucius Hometown Aging Project (CHAP) was supported in part by grants from the Department of Science and Technology (2008GG30002058), the Department of Health (2009-067), the Natural Science Foundation (ZR2010HL031) in Shandong, China, and by the Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet, Stockholm, Sweden. CQ received grants from the Swedish Research Council (K2012-99X-21967-01-3), the Swedish Research Council for Health, Working Life and Welfare (2014-1382), and Karolinska Institutet, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Chen R, 1999, INT J GERIATR PSYCH, V14, P821, DOI 10.1002/(SICI)1099-1166(199910)14:10<821::AID-GPS21>3.0.CO;2-0; Chi I, 2005, AM J GERIAT PSYCHIAT, V13, P409, DOI 10.1176/appi.ajgp.13.5.409; Cui GH, 2011, ACTA NEUROL SCAND, V124, P361, DOI 10.1111/j.1600-0404.2010.01484.x; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Dybicz SB, 2011, AM J GERIATR PHARMAC, V9, P212, DOI 10.1016/j.amjopharm.2011.05.001; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hu XL, 2015, GERIATR GERONTOL INT, V15, P1, DOI 10.1111/ggi.12340; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; John R, 2003, GERONTOLOGIST, V43, P649, DOI 10.1093/geront/43.5.649; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Li D, 2014, ARCH GERONTOL GERIAT, V58, P1, DOI 10.1016/j.archger.2013.07.016; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liang Y, 2015, GERIATR GERONTOL INT; Liang YJ, 2014, INT J BEHAV MED, V21, P590, DOI 10.1007/s12529-013-9358-2; Liang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085927; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ozcan M, 2002, RHEUMATOL INT, V22, P16, DOI 10.1007/s00296-002-0185-z; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; SCHEIDTNAVE C, 1990, CIRCULATION, V81, P899, DOI 10.1161/01.CIR.81.3.899; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Song AQ, 2014, EUR J PREV CARDIOL, V21, P1267, DOI 10.1177/2047487313487621; Wang HHX, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0188-0; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119582; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang XF, 2004, STROKE, V35, P1052, DOI 10.1161/01.STR.0000125305.12859.ff; Zhou BA, 2011, J APPL GERONTOL, V30, P199, DOI 10.1177/0733464810361346	46	54	58	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138521	10.1371/journal.pone.0138521	http://dx.doi.org/10.1371/journal.pone.0138521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26394368	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100067
J	Yang, Z; Soderholm, A; Lung, TWF; Giogha, C; Hill, MM; Brown, NF; Hartland, E; Teasdale, RD				Yang, Zhe; Soderholm, Amelia; Lung, Tania Wong Fok; Giogha, Cristina; Hill, Michelle M.; Brown, Nathaniel F.; Hartland, Elizabeth; Teasdale, Rohan D.			SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host's NF-kappa B Signalling Activity	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; E3 UBIQUITIN LIGASES; DYSTROPHY TYPE 2H; PROTEIN; INFECTION; VIRULENCE; CELLS	Salmonella Typhimurium employs an array of type III secretion system effectors that facilitate intracellular survival and replication during infection. The Salmonella effector SseK3 was originally identified due to amino acid sequence similarity with NleB; an effector secreted by EPEC/EHEC that possesses N-acetylglucoasmine (GlcNAc) transferase activity and modifies death domain containing proteins to block extrinsic apoptosis. In this study, immunoprecipitation of SseK3 defined a novel molecular interaction between SseK3 and the host protein, TRIM32, an E3 ubiquitin ligase. The conserved DxD motif within SseK3, which is essential for the GlcNAc transferase activity of NleB, was required for TRIM32 binding and for the capacity of SseK3 to suppress TNF-stimulated activation of NF-kappa B pathway. However, we did not detect GlcNAc modification of TRIM32 by SseK3, nor did the SseK3-TRIM32 interaction impact on TRIM32 ubiquitination that is associated with its activation. In addition, lack of sseK3 in Salmonella had no effect on production of the NF-kappa B dependent cytokine, IL-8, in HeLa cells even though TRIM32 knockdown suppressed TNF-induced NF-kappa B activity. Ectopically expressed SseK3 partially co-localises with TRIM32 at the trans-Golgi network, but SseK3 is not recruited to Salmonella induced vacuoles or Salmonella induced filaments during Salmonella infection. Our study has identified a novel effector-host protein interaction and suggests that SseK3 may influence NF-kappa B activity. However, the lack of GlcNAc modification of TRIM32 suggests that SseK3 has further, as yet unidentified, host targets.	[Yang, Zhe; Soderholm, Amelia; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Teasdale, Rohan D.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Hill, Michelle M.] Univ Queensland, Translat Res Inst, Univ Queensland Diamantina Inst, Woolloongabba, Qld, Australia; [Lung, Tania Wong Fok; Giogha, Cristina; Hartland, Elizabeth] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Brown, Nathaniel F.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of Queensland; University of Queensland; University of Melbourne; University of British Columbia	Teasdale, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	R.Teasdale@uq.edu.au	Teasdale, Rohan/AAD-6698-2019; Yang, Zhe/O-3489-2019; Teasdale, Rohan D/B-2538-2009; Lung, Tania Wong Fok/ABD-3992-2020; Hill, Michelle Mei Chih/G-4417-2010	Teasdale, Rohan/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Teasdale, Rohan D/0000-0001-7455-5269; Lung, Tania Wong Fok/0000-0002-9318-9572; Hill, Michelle Mei Chih/0000-0003-1134-0951; Giogha, Cristina/0000-0002-9075-9840	National Health and Medical Research Council (NHMRC) of Australia [606788, 628858]; NHMRC [APP1041929]; Australian Research Council [FT120100251]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (606788, 628858). RDT is supported by NHMRC Senior Research Fellowship (APP1041929). MH is supported by Australian Research Council Future Fellowship (FT120100251). Microscopy was carried out at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience (IMB) Dynamic Imaging Facility for Cancer Biology.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bhavsar AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003518; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Buckner MMC, 2011, VIRULENCE, V2, P208, DOI 10.4161/viru.2.3.15894; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Gleeson PA, 1996, J CELL SCI, V109, P2811; Goldberg M B, 1988, Infect Dis Clin North Am, V2, P571; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Herrero-Fresno A, 2014, J MED MICROBIOL, V63, P331, DOI 10.1099/jmm.0.068221-0; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ichimura T, 2013, J CELL SCI, V126, P2014, DOI 10.1242/jcs.122069; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Kidwai AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070753; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pilar AVC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002773; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	35	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138529	10.1371/journal.pone.0138529	http://dx.doi.org/10.1371/journal.pone.0138529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394407	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100068
J	Harmse, L; Dahan-Farkas, N; Panayides, JL; van Otterlo, W; Penny, C				Harmse, Leonie; Dahan-Farkas, Nurit; Panayides, Jenny-Lee; van Otterlo, Willem; Penny, Clement			Aberrant Apoptotic Response of Colorectal Cancer Cells to Novel Nucleoside Analogues	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; COLON-CANCER; DRUG-RESISTANCE; WILD-TYPE; MITOCHONDRIA; DEATH; P53; BAX; MECHANISMS; BCL-2	Despite the increased understanding of colorectal cancer and the introduction of targeted drug therapy, the metastatic phase of the disease remains refractory to treatment. Since the deregulation of normal apoptosis contributes to the pathogenesis of colorectal cancer, novel nucleoside analogues were synthesized here and evaluated for their ability to induce apoptosis and cause cell death in two colorectal adeno-carcinoma cell lines, Caco-2 and HT-29. Three novel nucleoside analogues assessed here showed cytotoxic activity, as measured by the MTT assay against both cell lines: the IC50 values ranged between 3 and 37 mu M, with Caco-2 cells being more sensitive than HT-29 cells. Compared to camptothecin, the positive control, the nucleoside analogues were significantly less toxic to normal unstimulated leukocytes (p>0.05). Moreover, the nucleosides were able to induce apoptosis as measured by an increase in caspase 8 and caspase 3 activity above that of the control. This was additionally supported by data derived from Annexin V-FITC assays. Despite marginal changes to the mitochondrial membrane potential, all three nucleosides caused a significant increase in cytosolic cytochrome c (p>0.05), with a corresponding decrease in mitochondrial cytochrome c. Morphological analysis of both cell lines showed the rapid appearance of vacuoles following exposure to two of the nucleosides, while a third caused cellular detachment, delayed cytoplasmic vacuolisation and nuclear abnormalities. Preliminary investigations, using the autophagic indicator monodansylcadaverine and chloroquine as positive control, showed that two of the nucleosides induced the formation of autophagic vacuoles. In summary, the novel nucleoside analogues showed selective cytotoxicity towards both cancer cell lines and are effective initiators of an unusual apoptotic response, demonstrating their potential to serve as structural scaffolds for more potent analogues.	[Harmse, Leonie; Dahan-Farkas, Nurit] Univ Witwatersrand, Div Pharmacol, Dept Pharm & Pharmacol, Fac Hlth Sci, ZA-2193 Parktown, South Africa; [Panayides, Jenny-Lee; van Otterlo, Willem] Univ Witwatersrand, Inst Mol Sci, Sch Chem, Fac Sci, ZA-2050 Johannesburg, South Africa; [van Otterlo, Willem] Univ Stellenbosch, Dept Chem & Polymer Sci, ZA-7602 Matieland, South Africa; [Penny, Clement] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, ZA-2193 Parktown, South Africa	University of Witwatersrand; University of Witwatersrand; Stellenbosch University; University of Witwatersrand	Harmse, L (corresponding author), Univ Witwatersrand, Div Pharmacol, Dept Pharm & Pharmacol, Fac Hlth Sci, 7 York Rd, ZA-2193 Parktown, South Africa.	Leonie.Harmse@wits.ac.za			Research Niche Areas Program of the National Research Foundation (NRF) of South Africa; University of the Witwatersrand Faculty of Health Sciences Research Committee; NRF Scarce Skill Program	Research Niche Areas Program of the National Research Foundation (NRF) of South Africa; University of the Witwatersrand Faculty of Health Sciences Research Committee; NRF Scarce Skill Program	This work was supported by the Research Niche Areas Program of the National Research Foundation (NRF) of South Africa and the University of the Witwatersrand Faculty of Health Sciences Research Committee. JLP was supported by the NRF Scarce Skill Program for studies towards a Ph.D. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bedner E, 2000, CYTOMETRY, V41, P83, DOI 10.1002/1097-0320(20001001)41:2<83::AID-CYTO1>3.0.CO;2-R; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Carrato A, 2013, J CLIN ONCOL, V31, P1341, DOI 10.1200/JCO.2012.45.1930; Chabner BA, 2011, GOODMAN GILMANS PHAR, P1695; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FADOK VA, 1992, J IMMUNOL, V148, P2207; Feng L, 2000, INT J MOL MED, V5, P597; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hajdo L, 2010, DRUG DEVELOP RES, V71, P383, DOI 10.1002/ddr.20390; Hatok J, 2009, CLIN EXP MED, V9, P1, DOI 10.1007/s10238-008-0011-3; HEIDELBERGER C, 1983, ADV ENZYMOL RAMB, V54, P57; Huerta S, 2006, AM J SURG, V191, P517, DOI 10.1016/j.amjsurg.2005.11.009; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lamberti M, 2015, INT J ONCOL, V46, P1893, DOI 10.3892/ijo.2015.2904; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Marshman E, 2001, J PATHOL, V195, P285; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munafo DB, 2001, J CELL SCI, V114, P3619; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Portier BP, 2006, J BIOL CHEM, V281, P40493, DOI 10.1074/jbc.M606181200; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; SPROAT BS, 1994, J CHEM SOC PERK T 1, P419, DOI 10.1039/p19940000419; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Wang LM, 2008, CHEM-BIOL INTERACT, V176, P165, DOI 10.1016/j.cbi.2008.07.005; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Watson AJM, 2004, GUT, V53, P1701, DOI 10.1136/gut.2004.052704; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yang SY, 2009, TRENDS MOL MED, V15, P225, DOI 10.1016/j.molmed.2009.03.003; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zhang W, 2005, WORLD J GASTROENTERO, V11, P3632, DOI 10.3748/wjg.v11.i23.3632; Zhang ZW, 2000, ANTI-CANCER DRUG, V11, P757, DOI 10.1097/00001813-200010000-00013; Zong D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.62	55	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138607	10.1371/journal.pone.0138607	http://dx.doi.org/10.1371/journal.pone.0138607			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390405	Green Published, gold			2022-12-26	WOS:000361791000043
J	Liu, J; Wang, LJ; Zhao, FF; Tseng, S; Narayanan, C; Shura, L; Willingham, S; Howard, M; Prohaska, S; Volkmer, J; Chao, M; Weissman, IL; Majeti, R				Liu, Jie; Wang, Lijuan; Zhao, Feifei; Tseng, Serena; Narayanan, Cyndhavi; Shura, Lei; Willingham, Stephen; Howard, Maureen; Prohaska, Susan; Volkmer, Jens; Chao, Mark; Weissman, Irving L.; Majeti, Ravindra			Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential	PLOS ONE			English	Article							REGULATORY PROTEIN-ALPHA; PROMOTE PHAGOCYTOSIS; PROGNOSTIC-FACTOR; STEM-CELLS; CD47; TARGET; CANCER; MACROPHAGES; SYNERGIZES; APOPTOSIS	CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis mediated by cells of the innate immune system, such as macrophages and dendritic cells. CD47 serves as the ligand for a receptor on these innate immune cells, SIRP-alpha, which in turn delivers an inhibitory signal for phagocytosis. We previously found increased expression of CD47 on primary human acute myeloid leukemia (AML) stem cells, and demonstrated that blocking monoclonal antibodies directed against CD47 enabled the phagocytosis and elimination of AML, non-Hodgkin's lymphoma (NHL), and many solid tumors in xenograft models. Here, we report the development of a humanized anti-CD47 antibody with potent efficacy and favorable toxicokinetic properties as a candidate therapeutic. A novel monoclonal anti-human CD47 antibody, 5F9, was generated, and antibody humanization was carried out by grafting its complementarity determining regions (CDRs) onto a human IgG4 format. The resulting humanized 5F9 antibody (Hu5F9-G4) bound monomeric human CD47 with an 8 nM affinity. Hu5F9-G4 induced potent macrophage-mediated phagocytosis of primary human AML cells in vitro and completely eradicated human AML in vivo, leading to long-term disease-free survival of patient-derived xenografts. Moreover, Hu5F9-G4 synergized with rituximab to eliminate NHL engraftment and cure xenografted mice. Finally, toxicokinetic studies in non-human primates showed that Hu5F9-G4 could be safely administered intravenously at doses able to achieve potentially therapeutic serum levels. Thus, Hu5F9-G4 is actively being developed for and has been entered into clinical trials in patients with AML and solid tumors.	[Liu, Jie; Wang, Lijuan; Zhao, Feifei; Tseng, Serena; Narayanan, Cyndhavi; Shura, Lei; Willingham, Stephen; Howard, Maureen; Prohaska, Susan; Volkmer, Jens; Chao, Mark; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Liu, Jie; Wang, Lijuan; Zhao, Feifei; Tseng, Serena; Narayanan, Cyndhavi; Shura, Lei; Willingham, Stephen; Howard, Maureen; Prohaska, Susan; Volkmer, Jens; Chao, Mark; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Sch Med, Ludwig Canc Ctr, Stanford, CA USA; [Majeti, Ravindra] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu; rmajeti@stanford.edu		Majeti, Ravindra/0000-0002-5814-0984	California Institute for Regenerative Medicine; Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the California Institute for Regenerative Medicine and funding from the Virginia and D. K. Ludwig Fund for Cancer Research.	ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bloom JW, 1997, PROTEIN SCI, V6, P407; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chao MP, 2009, BLOOD, V114, P1063; Chao MP, 2010, SCI TRANSL MED, V2; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kikuchi Y, 2004, BIOCHEM BIOPH RES CO, V315, P912, DOI 10.1016/j.bbrc.2004.01.128; Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2010, ONCOGENE, P1; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Majeti R, 2008, BLOOD, V112, P284, DOI 10.1182/blood.V112.11.766.766; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg PA, 2004, LEUKEMIA LYMPHOMA, V45, P1319, DOI 10.1080/1042819042000201989; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Soto-Pantoja DR, 2012, P NATL ACAD SCI USA, V109, pE2842, DOI 10.1073/pnas.1205441109; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Uno S, 2007, ONCOL REP, V17, P1189; van Meer PJK, 2013, MABS-AUSTIN, V5, P810, DOI 10.4161/mabs.25234; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	46	204	237	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137345	10.1371/journal.pone.0137345	http://dx.doi.org/10.1371/journal.pone.0137345			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390038	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000007
J	Ruiter, MS; van Tiel, CM; Doornbos, A; Marinkovic, G; Strang, AC; Attevelt, NJM; de Waard, V; de Winter, RJ; Steendam, R; de Vries, CJM				Ruiter, Matthijs S.; van Tiel, Claudia M.; Doornbos, Albert; Marinkovic, Goran; Strang, Aart C.; Attevelt, Nico J. M.; de Waard, Vivian; de Winter, Robbert J.; Steendam, Rob; de Vries, Carlie J. M.			Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; ORPHAN RECEPTOR; HYPERPLASIA; MACROPHAGES; ACTIVATION; INJURY; NURR1; ATHEROSCLEROSIS; DIFFERENTIATION; INHIBITION	Background The introduction of drug-eluting stents (DES) has dramatically reduced restenosis rates compared with bare metal stents, but in-stent thrombosis remains a safety concern, necessitating prolonged dual anti-platelet therapy. The drug 6-Mercaptopurine (6-MP) has been shown to have beneficial effects in a cell-specific fashion on smooth muscle cells (SMC), endothelial cells and macrophages. We generated and analyzed a novel bioresorbable polymer coated DES, releasing 6-MP into the vessel wall, to reduce restenosis by inhibiting SMC proliferation and decreasing inflammation, without negatively affecting endothelialization of the stent surface. Methods Stents spray-coated with a bioresorbable polymer containing 0, 30 or 300 mu g 6-MP were implanted in the iliac arteries of 17 male New Zealand White rabbits. Animals were euthanized for stent harvest 1 week after implantation for evaluation of cellular stent coverage and after 4 weeks for morphometric analyses of the lesions. Results Four weeks after implantation, the high dose of 6-MP attenuated restenosis with 16% compared to controls. Reduced neointima formation could at least partly be explained by an almost 2-fold induction of the cell cycle inhibiting kinase p27(Kip1). Additionally, inflammation score, the quantification of RAM11-positive cells in the vessel wall, was significantly reduced in the high dose group with 23% compared to the control group. Evaluation with scanning electron microscopy showed 6-MP did not inhibit strut coverage 1 week after implantation. Conclusion We demonstrate that novel stents coated with a bioresorbable polymer coating eluting 6-MP inhibit restenosis and attenuate inflammation, while stimulating endothelial coverage. The 6-MP-eluting stents demonstrate that inhibition of restenosis without leaving uncovered metal is feasible, bringing stents without risk of late thrombosis one step closer to the patient.	[Ruiter, Matthijs S.; van Tiel, Claudia M.; Marinkovic, Goran; de Waard, Vivian; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Doornbos, Albert; Steendam, Rob] InnoCore Pharmaceut, Groningen, Netherlands; [Strang, Aart C.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Attevelt, Nico J. M.] Univ Utrecht, Fac Vet Med, Cent Lab, Anim Res Facil, Utrecht, Netherlands; [de Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.nl	Ruiter, Matthijs/H-4287-2017; Marinkovic, Goran/ABC-6786-2020	Ruiter, Matthijs/0000-0002-4834-4561; Marinkovic, Goran/0000-0002-3581-9900	Dutch Ministry of Economic Affairs; Netherlands Heart Foundation; InnoCore Pharmaceuticals	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Heart Foundation(Netherlands Heart Foundation); InnoCore Pharmaceuticals	This research forms part of the Project P1.02 NEXTREAM of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. The financial contribution of the Netherlands Heart Foundation is gratefully acknowledged. InnoCore Pharmaceuticals provided support in the form of salaries for authors AD and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bonta PI, 2007, TRENDS CARDIOVAS MED, V17, P105, DOI 10.1016/j.tcm.2007.02.001; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Chang CZ, 2011, ACTA NEUROCHIR, V153, P939, DOI 10.1007/s00701-010-0865-5; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Chin-Quee SL, 2010, BIOMATERIALS, V31, P648, DOI 10.1016/j.biomaterials.2009.09.079; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; de Heer F, 2013, HART EN VAATZIEKTEN; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; Drachman DE, 2009, CIRCULATION, V120, P101, DOI 10.1161/CIRCULATIONAHA.109.872473; Drouin J, 1998, J STEROID BIOCHEM, V65, P59, DOI 10.1016/S0960-0760(97)00180-5; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Klugherz BD, 2002, CORONARY ARTERY DIS, V13, P183, DOI 10.1097/00019501-200205000-00008; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lockwood NA, 2010, J BIOMAT SCI-POLYM E, V21, P529, DOI 10.1163/156856209X429175; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Marinkovic G, 2014, J IMMUNOL, V192, P4370, DOI 10.4049/jimmunol.1302527; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Pols TWH, 2010, ARTERIOSCL THROM VAS, V30, P1591, DOI 10.1161/ATVBAHA.110.205674; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4; Shao Q, 2010, J MOL CELL CARDIOL, V49, P304, DOI 10.1016/j.yjmcc.2010.03.023; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Wang LY, 2010, MOL CELL BIOCHEM, V341, P159, DOI 10.1007/s11010-010-0447-0; Yoo YG, 2007, ONCOGENE, V26, P3823, DOI 10.1038/sj.onc.1210149; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhang P, 2010, ACTA BIOCH BIOPH SIN, V42, P807, DOI 10.1093/abbs/gmq089	40	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138459	10.1371/journal.pone.0138459	http://dx.doi.org/10.1371/journal.pone.0138459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389595	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000029
J	Kavak, P; Yuksel, B; Aksu, S; Kulekci, MO; Gungor, T; Hach, F; Sahinalp, SC; Alkan, C; Sagiroglu, MS				Kavak, Pinar; Yuksel, Bayram; Aksu, Soner; Kulekci, M. Oguzhan; Gungor, Tunga; Hach, Faraz; Sahinalp, S. Cenk; Alkan, Can; Sagiroglu, Mahmut Samil		Turkish Human Genome Project	Robustness of Massively Parallel Sequencing Platforms	PLOS ONE			English	Article							GENOMES	The improvements in high throughput sequencing technologies (HTS) made clinical sequencing projects such as ClinSeq and Genomics England feasible. Although there are significant improvements in accuracy and reproducibility of HTS based analyses, the usability of these types of data for diagnostic and prognostic applications necessitates a near perfect data generation. To assess the usability of a widely used HTS platform for accurate and reproducible clinical applications in terms of robustness, we generated whole genome shotgun (WGS) sequence data from the genomes of two human individuals in two different genome sequencing centers. After analyzing the data to characterize SNPs and indels using the same tools (BWA, SAMtools, and GATK), we observed significant number of discrepancies in the call sets. As expected, the most of the disagreements between the call sets were found within genomic regions containing common repeats and segmental duplications, albeit only a small fraction of the discordant variants were within the exons and other functionally relevant regions such as promoters. We conclude that although HTS platforms are sufficiently powerful for providing data for first-pass clinical tests, the variant predictions still need to be confirmed using orthogonal methods before using in clinical applications.	[Kavak, Pinar; Gungor, Tunga] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey; [Kavak, Pinar; Kulekci, M. Oguzhan; Sagiroglu, Mahmut Samil] Sci & Technol Res Council Turkey TUBITAK, BILGEM, Adv Genom & Bioinformat Res Grp IGBAM, Gebze, Kocaeli, Turkey; [Yuksel, Bayram; Aksu, Soner] TUBITAK MAM GMBE Sci & Technol Res Council Turkey, Genet Engn & Biotechnol Inst, Gebze, Kocaeli, Turkey; [Hach, Faraz; Sahinalp, S. Cenk] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Alkan, Can] Bilkent Univ, Dept Comp Engn, Ankara, Turkey	Bogazici University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Simon Fraser University; Ihsan Dogramaci Bilkent University	Alkan, C (corresponding author), Bilkent Univ, Dept Comp Engn, Ankara, Turkey.	calkan@cs.bilkent.edu.tr; mahmut.sagiroglu@tubitak.gov.tr	Gungor, Tunga/H-7103-2012; Alkan, Can/D-2982-2009; Sahinalp, Suleyman Cenk/X-7843-2018; Aksu, Soner/ABI-6100-2020; kulekci, m. oguzhan/F-7512-2011; Gokcumen, Omer/J-6984-2013	Alkan, Can/0000-0002-5443-0706; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Aksu, Soner/0000-0001-6032-3328; kulekci, m. oguzhan/0000-0002-4583-6261; Gokcumen, Omer/0000-0003-4371-679X; Bekpen, Cemalettin/0000-0001-8576-9094; Hach, Faraz/0000-0003-1143-0172; OZOREN, NESRIN/0000-0002-8580-618X; Gungor, Tunga/0000-0001-9448-9422	Republic of Turkey Ministry of Development Infrastructure Grant [2011K120020]; BILGEM-TUBITAK (The Scientific and Technological Research Council of Turkey) [T439000]; Marie Curie Career Integration Grant [303772]; Republic of Turkey Ministry of Development Infrastructure [2011K120020]	Republic of Turkey Ministry of Development Infrastructure Grant(Turkiye Cumhuriyeti Kalkinma Bakanligi); BILGEM-TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marie Curie Career Integration Grant; Republic of Turkey Ministry of Development Infrastructure(Turkiye Cumhuriyeti Kalkinma Bakanligi)	The project is supported by the Republic of Turkey Ministry of Development Infrastructure Grant (no: 2011K120020) and BILGEM-TUBITAK (The Scientific and Technological Research Council of Turkey) (grant no: T439000) to M.S.S. and B.Y., and a Marie Curie Career Integration Grant (303772) to C.A. The funder Republic of Turkey Ministry of Development Infrastructure (Award Number: 2011K120020) provided financial support in the form of Illumina HiSeq 2000 sequencing machine and preparation kits for data production and the funder BILGEM-TUBITAK (The Scientific and Technological Research Council of Turkey) (Award Number: T439000) provided support in the form of salaries for authors (PK, MOK, MSS), and the funder Marie Curie Career Integration Grant (Award Number: 303772) provided support in the form of salaries for author (CA) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alkan C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-963; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews S, FASTQC QUALITY CONTR; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	12	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138259	10.1371/journal.pone.0138259	http://dx.doi.org/10.1371/journal.pone.0138259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382624	Green Published, gold			2022-12-26	WOS:000361790200080
J	Li, GQ; Zhao, DX; Xu, Y; Kuo, SH; Xu, HY; Hu, N; Zhao, GS; Monterola, C				Li, Guoqi; Zhao, Daxuan; Xu, Yi; Kuo, Shyh-Hao; Xu, Hai-Yan; Hu, Nan; Zhao, Guangshe; Monterola, Christopher			Entropy Based Modelling for Estimating Demographic Trends	PLOS ONE			English	Article							MAXIMUM-ENTROPY; POPULATION-DYNAMICS; JOINT DISTRIBUTIONS; DENSITY-DEPENDENCE; COMPLEX NETWORK; LEAST-SQUARES; IDENTIFICATION; ABUNDANCE; SYSTEMS	In this paper, an entropy-based method is proposed to forecast the demographical changes of countries. We formulate the estimation of future demographical profiles as a constrained optimization problem, anchored on the empirically validated assumption that the entropy of age distribution is increasing in time. The procedure of the proposed method involves three stages, namely: 1) Prediction of the age distribution of a country's population based on an "age-structured population model"; 2) Estimation the age distribution of each individual household size with an entropy-based formulation based on an "individual household size model"; and 3) Estimation the number of each household size based on a "total household size model". The last stage is achieved by projecting the age distribution of the country's population (obtained in stage 1) onto the age distributions of individual household sizes (obtained in stage 2). The effectiveness of the proposed method is demonstrated by feeding real world data, and it is general and versatile enough to be extended to other time dependent demographic variables.	[Li, Guoqi] Tsinghua Univ, Ctr Brain Inspired Comp Res, Dept Precis Instrument, Beijing 100084, Peoples R China; [Li, Guoqi; Zhao, Daxuan; Kuo, Shyh-Hao; Xu, Hai-Yan; Hu, Nan; Monterola, Christopher] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Zhao, Daxuan] Renmin Univ China, Sch Businesses, Beijing, Peoples R China; [Xu, Yi] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Zhao, Guangshe] Xi An Jiao Tong Univ, Sch Aerosp, Xian 710049, Peoples R China	Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Renmin University of China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Xi'an Jiaotong University	Li, GQ (corresponding author), Tsinghua Univ, Ctr Brain Inspired Comp Res, Dept Precis Instrument, Beijing 100084, Peoples R China.	liguoqi@mail.tsinghua.edu.cn; zhaogs@mail.xjtu.edu.cn; monterolac@ihpc.a-star.edu.sg	LI, Guoqi/AAG-7110-2020; Xu, Haiyan/K-7191-2012	LI, Guoqi/0000-0002-8994-431X; Xu, Haiyan/0000-0003-4480-402X; Zhao, Daxuan/0000-0002-9542-779X	Integrated City Planning Programme, Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR) [1325000001]; Complex Systems Programme, SERC, A*STAR [1224504056]	Integrated City Planning Programme, Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR); Complex Systems Programme, SERC, A*STAR	This work is supported by the Integrated City Planning Programme, Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR: http://www.astar.edu.sg/) (Grant no. 1325000001), and Complex Systems Programme, SERC, A*STAR (Grant no. 1224504056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2006, IEEE T ENG MANAGE, V53, P146, DOI 10.1109/TEM.2005.861803; Aster RC, 2019, PARAMETER ESTIMATION AND INVERSE PROBLEMS, 3RD EDITION; Beyene J, 2001, GENET EPIDEMIOL, V21, pS423, DOI 10.1002/gepi.2001.21.s1.s423; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Contreras-Reyes JE, 2014, PHYSICA A, V395, P200, DOI 10.1016/j.physa.2013.10.035; CSISZAR I, 1991, ANN STAT, V19, P2032, DOI 10.1214/aos/1176348385; Dennis B, 2000, J WILDLIFE MANAGE, V64, P388, DOI 10.2307/3803237; Fagan WF, 2001, ECOL LETT, V4, P132, DOI 10.1046/j.1461-0248.2001.00206.x; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; GUCKENHEIMER J, 1977, J MATH BIOL, V4, P101, DOI 10.1007/BF00275980; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Inchausti P, 2001, SCIENCE, V293, P655, DOI 10.1126/science.293.5530.655; Kot M., 2001, ELEMENTS OF MATHEMAT; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Leyk S, 2013, GEOGR ANAL, V45, P285, DOI 10.1111/gean.12011; Li GQ, 2015, SYST CONTROL LETT, V83, P28, DOI 10.1016/j.sysconle.2015.06.008; Li GQ, 2015, SYST CONTROL LETT, V79, P68, DOI 10.1016/j.sysconle.2015.01.003; Li GQ, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500196; Li GQ, 2012, IEEE T SIGNAL PROCES, V60, P3845, DOI 10.1109/TSP.2012.2190404; Link WA, 1997, ECOLOGY, V78, P2632; Markovsky I, 2007, SIGNAL PROCESS, V87, P2283, DOI 10.1016/j.sigpro.2007.04.004; Miller DJ, 2002, J ECONOMETRICS, V107, P259, DOI 10.1016/S0304-4076(01)00123-3; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; Owens J, 2000, ENVIRON BEHAV, V32, P637, DOI 10.1177/00139160021972711; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Saadi S., 2008, INT FINANCIAL MARKET, V18, P272, DOI [10.1016/j.intfin.2006.12.001, DOI 10.1016/J.INTFIN.2006.12.001]; Salois MJ, 2013, PHYSICA A, V392, P2893, DOI 10.1016/j.physa.2013.02.007; Salvo JJ, 2006, PAPER PRESENTED AT U; Smith SK, 2002, DEMOGRAPHY, V39, P697, DOI 10.1353/dem.2002.0040; Stephenson J, 2010, J PUBLIC HEALTH-UK, V32, P150, DOI 10.1093/pubmed/fdq038; Swanson DA, 2012, POPUL RES POLICY REV, V31, P235, DOI 10.1007/s11113-012-9227-8; Trawinski PR, 2010, VECTOR-BORNE ZOONOT, V10, P515, DOI 10.1089/vbz.2008.0063; Xu HY, 2014, GEN CROSS ENTROPY MO	38	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137324	10.1371/journal.pone.0137324	http://dx.doi.org/10.1371/journal.pone.0137324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26382594	Green Published, gold			2022-12-26	WOS:000361790200020
J	Lim, MS; Shin, MS; Lee, SY; Minn, YK; Hoh, JK; Cho, YH; Kim, DW; Lee, SH; Kim, CH; Park, CH				Lim, Mi-Sun; Shin, Min-Seop; Lee, Soo Young; Minn, Yang-Ki; Hoh, Jeong-Kyu; Cho, Youl-Hee; Kim, Dong-Wook; Lee, Sang-Hun; Kim, Chun-Hyung; Park, Chang-Hwan			Noggin Over-Expressing Mouse Embryonic Fibroblasts and MS5 Stromal Cells Enhance Directed Differentiation of Dopaminergic Neurons from Human Embryonic Stem Cells	PLOS ONE			English	Article							EFFICIENT NEURAL CONVERSION; IN-VITRO DIFFERENTIATION; SPEMANN ORGANIZER; PRECURSOR CELLS; MIDBRAIN; TRANSPLANTATION; INHIBITION; ANTAGONIST; ACTIVIN; DISEASE	Directed methods for differentiating human embryonic stem cells (hESCs) into dopaminergic (DA) precursor cells using stromal cells co-culture systems are already well established. However, not all of the hESCs differentiate into DA precursors using these methods. HSF6, H1, H7, and H9 cells differentiate well into DA precursors, but CHA13 and CHA15 cells hardly differentiate. To overcome this problem, we modified the differentiation system to include a co-culturing step that exposes the cells to noggin early in the differentiation process. This was done using.-irradiated noggin-overexpressing CF1-mouse embryonic fibroblasts (MEF-noggin) and MS5 stromal cells (MS5-noggin and MS5-sonic hedgehog). After directed differentiation, RT-PCR analyses revealed that engrailed-1 (En-1), Lmx1b, and Nurr1, which are midbrain DA markers, were expressed regardless of differentiation stage. Moreover, tyrosine hydroxylase (Th) and an A9 midbrain-specific DA marker (Girk2) were expressed during differentiation, whereas levels of Oct3/4, an undifferentiated marker, decreased. Immunocytochemical analyses revealed that protein levels of the neuronal markers TH and TuJ1 increased during the final differentiation stage. These results demonstrate that early noggin exposure may play a specific role in the directed differentiation of DA cells from human embryonic stem cells.	[Lim, Mi-Sun; Shin, Min-Seop; Park, Chang-Hwan] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lim, Mi-Sun; Park, Chang-Hwan] Hanyang Univ, Hanyang Biomed Res Inst, Seoul 133791, South Korea; [Lee, Soo Young; Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea; [Hoh, Jeong-Kyu] Hanyang Univ, Coll Med, Dept Obstet & Gynecol, Seoul 133791, South Korea; [Cho, Youl-Hee] Hanyang Univ, Coll Med, Dept Med Genet, Seoul 133791, South Korea; [Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Minn, Yang-Ki] Hallym Univ, Hangang Sacred Heart Hosp, Dept Neurol, Seoul, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Cell Therapy Ctr, Seoul, South Korea; [Kim, Chun-Hyung] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hallym University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kim, CH (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea.	chkim2@snu.ac.kr; chshpark@hanyang.ac.kr	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Dong-Wook, Kim/0000-0002-5025-1532; Hoh, Jeong Kyu/0000-0003-4783-2026	Medical Research Center through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning, Hanyang University [2008-0062190]; Basic Science Research Program [2011-0008952]; Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Hanyang University [201400000000578]; Rural Development Administration, Republic of Korea [PJ008022032012]	Medical Research Center through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning, Hanyang University; Basic Science Research Program; Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Hanyang University; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Medical Research Center (2008-0062190), the Basic Science Research Program (2011-0008952), and the Bio & Medical Technology Development Program (2012M3A9C7050126) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Hanyang University (201400000000578) and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ008022032012) Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; He XB, 2011, STEM CELLS, V29, P1861, DOI 10.1002/stem.739; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hsu Yi-Chao, 2013, Biomed J, V36, P98, DOI 10.4103/2319-4170.113226; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kim Yong-Sik, 2011, Int J Stem Cells, V4, P85; Ko JY, 2007, J NEUROCHEM, V103, P1417, DOI 10.1111/j.1471-4159.2007.04898.x; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Matulka K, 2013, CELL STEM CELL, V13, P706, DOI 10.1016/j.stem.2013.09.016; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Park CH, 2008, FEBS LETT, V582, P537, DOI 10.1016/j.febslet.2008.01.018; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Wattanapanitch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106952; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	31	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138460	10.1371/journal.pone.0138460	http://dx.doi.org/10.1371/journal.pone.0138460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383864	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200106
J	Lin, BR; Lin, YL; Lai, HS; Lee, PH; Chang, KJ; Liang, JT				Lin, Been-Ren; Lin, Yu-Lin; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung			Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY USE; COLORECTAL-CANCER; AGE; SURGERY; HARVEST	Background This study identified predictors of favorable overall survival (OS) for stage III colon cancer patients who had only one lymph node (LN) metastasis (N1a). Methods Variables, including preoperative carcinoembryonic antigen (CEA) level, LN sampling status, and the choices of postoperative adjuvant chemotherapy, were recorded. Prognostic significance was determined using the log-rank test and multivariate Cox regression analysis. Results The median 42-month follow-up period included 363 eligible patients. Among them, 230 (63.3%) received only 5-flurouracil (5-FU) adjuvant chemotherapy; 76 (20.9%) underwent oxaliplatin-based regimens; and 57 (15.7%) chose surgery alone. The 5-year survival rate of these evaluated patients was 75%, 63%, and 77%, respectively (P = 0.823). Multivariate analysis revealed that normal preoperative CEA level (<= 5 ng/mL) and adequate LN sampling (LN. 12) were significant predictors for higher 5-year OS (P < 0.001; P = 0.007, respectively). However, the use of postoperative adjuvant chemotherapy in these N1a colon cancer patients did not significantly affect their 5-year OS. Conclusions A preoperative CEA level of less than or equal to 5 ng/mL, and curative surgery with an adequate lymphadenectomy determined a favorable OS outcome in stage III colon cancer with only one LN metastasis.	[Lin, Been-Ren; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung] Natl Taiwan Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei 100, Taiwan; [Lin, Been-Ren; Lin, Yu-Lin; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung] Coll Med, Taipei, Taiwan; [Lin, Yu-Lin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liang, JT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Colorectal Surg, 7 Chung Shan South Rd, Taipei 100, Taiwan.	jintung@ntu.edu.tw		Liang, Jin-Tung/0000-0002-0264-7735; Lai, Hong-Shiee/0000-0002-7958-2183; Chang, King jen/0000-0001-9811-3422; LIN, BEEN-REN/0000-0001-8354-1758; LEE, PO-HUANG/0000-0001-5831-035X	National Research Program for Biopharmaceuticals (NRPB) at Ministry of science and Technology of Taiwan [MOST 103-2325-B-002-033]	National Research Program for Biopharmaceuticals (NRPB) at Ministry of science and Technology of Taiwan	This study was funded by National Research Program for Biopharmaceuticals (NRPB) at the Ministry of science and Technology of Taiwan; MOST 103-2325-B-002-033.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], 2009, ANN CANC REP TAIW CA; Baxter NN, 2009, J SURG ONCOL, V99, P265, DOI 10.1002/jso.21197; Berg M, 2013, MOL MED, V19, P286, DOI 10.2119/molmed.2013.00049; Chandrasinghe PC, 2014, INDIAN J GASTROENTER, V33, P249, DOI 10.1007/s12664-013-0406-2; Cianchi F, 2002, WORLD J SURG, V26, P384, DOI 10.1007/s00268-001-0236-8; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edge SB, 2010, AJCC CANC STAGING MA; Fakih MG, 2006, ONCOLOGY-NY, V20, P579; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; McCleary NJ, 2013, J CLIN ONCOL, V31, P2600, DOI 10.1200/JCO.2013.49.6638; Nedrebo BS, 2013, COLORECTAL DIS, V15, pE301, DOI 10.1111/codi.12245; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Shia J, 2012, J AM COLL SURGEONS, V214, P348, DOI 10.1016/j.jamcollsurg.2011.11.010; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Wright FC, 2009, J SURG ONCOL, V99, P248, DOI 10.1002/jso.21226	22	7	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137053	10.1371/journal.pone.0137053	http://dx.doi.org/10.1371/journal.pone.0137053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381396	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200013
J	Reid, R; Ezekowitz, JA; Brown, PM; McAlister, FA; Rowe, BH; Braam, B				Reid, Ryan; Ezekowitz, Justin A.; Brown, Paul M.; McAlister, Finlay A.; Rowe, Brian H.; Braam, Branko			The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DYSFUNCTION; IMPROVEMENT; OUTCOMES; CARE	Background Worsening and improving renal function during acute heart failure have been associated with adverse outcomes but few studies have considered the admission level of renal function upon which these changes are superimposed. Objectives The objective of this study was to evaluate definitions that incorporate both admission renal function and change in renal function. Methods 696 patients with acute heart failure with calculable eGFR were classified by admission renal function (Reduced [R, eGFR< 45 ml/min] or Preserved [P, eGFR >= 45 ml/min]) and change over hospital admission (worsening [WRF]: eGFR >= 20% decline; stable [SRF]; and improving [IRF]: eGFR >= 20% increase). The primary outcome was all-cause mortality. The prevalence of Pres and Red renal function was 47.8% and 52.2%. The frequency of RWRF, R-SRF, and R-IRF was 11.4%, 28.7%, and 12.1%, respectively; the incidence of PWRF, P-SRF, and P-IRF was 5.7%, 35.3%, and 6.8%, respectively. Survival was shorter for patients with R-WRF compared to R-IRF (median survival times 13.9 months (95% CI 7.7-24.9) and 32.5 months (95% CI 18.8-56.1), respectively), resulting in an acceleration factor of 2.3 (p = 0.016). Thus, an increase compared with a decrease in renal function was associated with greater than two times longer survival among patients with Reduced renal function.	[Reid, Ryan; Braam, Branko] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada; [Ezekowitz, Justin A.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Ezekowitz, Justin A.; Braam, Branko] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Ezekowitz, Justin A.; Brown, Paul M.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Patient Hlth Outcomes Res & Clin Effectiveness Un, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Braam, Branko] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Ezekowitz, JA (corresponding author), Univ Alberta, Div Cardiol, Edmonton, AB, Canada.	jae2@ualberta.ca	Brown, Paul M/E-2019-2016; Ezekowitz, Justin/C-4579-2013; McAlister, Finlay/C-4151-2013	Ezekowitz, Justin/0000-0002-2724-4086; Brown, Paul/0000-0002-2411-3312; McAlister, Finlay/0000-0001-7435-3341	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Alberta Innovates - Health Solutions (AIHS) and the Canadian Institutes of Health Research (CIHR) provided grant support for AHF-EM. The sponsor had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript, which is solely the responsibility of the authors. The authors had complete control and authority over the design, data analysis, interpretation, manuscript preparation, and the decision to submit this manuscript to PLOS One.	Aronson D, 2010, J CARD FAIL, V16, P541, DOI 10.1016/j.cardfail.2010.02.001; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; CARLSON KJ, 1985, J CHRON DIS, V38, P733, DOI 10.1016/0021-9681(85)90115-8; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Filippatos G, 2014, EUR HEART J, V35, P416, DOI 10.1093/eurheartj/eht515; Ghilagaber G, 2005, QUAL QUANT, V39, P71, DOI 10.1007/s11135-004-0435-0; Givertz MM, 2014, CIRC-HEART FAIL, V7, P59, DOI 10.1161/CIRCHEARTFAILURE.113.000556; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Gronda E, 2015, CARDIOL J, V22, P459, DOI 10.5603/CJ.a2015.0019; Lee DS, 2012, ANN INTERN MED, V156, P767, DOI 10.7326/0003-4819-156-11-201206050-00003; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McAlister FA, 2004, CIRCULATION; McAlister FA, 2012, CIRC-HEART FAIL, V5, P309, DOI 10.1161/CIRCHEARTFAILURE.111.966242; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Nunez J, 2017, EUR HEART J-ACUTE CA, V6, P430, DOI 10.1177/2048872614540094; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Patel K, 2006, PHARM STAT, V5, P213, DOI 10.1002/pst.213; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sarnak MJ, 2014, CLIN J AM SOC NEPHRO, V9, P1790, DOI 10.2215/CJN.11601113; Testani JM, 2011, J CARD FAIL, V17, P993, DOI 10.1016/j.cardfail.2011.08.009; Testani JM, 2010, AM J CARDIOL, V106, P1763, DOI 10.1016/j.amjcard.2010.07.050; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714	30	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138579	10.1371/journal.pone.0138579	http://dx.doi.org/10.1371/journal.pone.0138579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380982	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200130
J	Watt, SA; Dayal, JHS; Wright, S; Riddle, M; Pourreyron, C; McMillan, JR; Kimble, RM; Prisco, M; Gartner, U; Warbrick, E; McLean, WHI; Leigh, IM; McGrath, JA; Salas-Alanis, JC; Tolar, J; South, AP				Watt, Stephen A.; Dayal, Jasbani H. S.; Wright, Sheila; Riddle, Megan; Pourreyron, Celine; McMillan, James R.; Kimble, Roy M.; Prisco, Marco; Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin; Leigh, Irene M.; McGrath, John A.; Salas-Alanis, Julio C.; Tolar, Jakub; South, Andrew P.			Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANCHORING FIBRIL-COLLAGEN; VII COLLAGEN; DISEASE SEVERITY; LYSYL-HYDROXYLASE-3 LH3; MMP1 PROMOTER; GENE COL7A1; MUTATIONS; EXPRESSION; PHENOTYPE	Recessive dystrophic epidermolysis bullosa (RDEB) is caused by mutations in COL7A1 resulting in reduced or absent type VII collagen, aberrant anchoring fibril formation and subsequent dermal-epidermal fragility. Here, we identify a significant decrease in PLOD3 expression and its encoded protein, the collagen modifying enzyme lysyl hydroxylase 3 (LH3), in RDEB. We show abundant LH3 localising to the basement membrane in normal skin which is severely depleted in RDEB patient skin. We demonstrate expression is in-part regulated by endogenous type VII collagen and that, in agreement with previous studies, even small reductions in LH3 expression lead to significantly less secreted LH3 protein. Exogenous type VII collagen did not alter LH3 expression in cultured RDEB keratinocytes and we show that RDEB patients receiving bone marrow transplantation who demonstrate significant increase in type VII collagen do not show increased levels of LH3 at the basement membrane. Our data report a direct link between LH3 and endogenous type VII collagen expression concluding that reduction of LH3 at the basement membrane in patients with RDEB will likely have significant implications for disease progression and therapeutic intervention.	[Watt, Stephen A.; Dayal, Jasbani H. S.; Wright, Sheila; Pourreyron, Celine; Leigh, Irene M.; South, Andrew P.] Univ Dundee, Div Canc Res, Dundee, Scotland; [Riddle, Megan; Tolar, Jakub] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Riddle, Megan; Tolar, Jakub] Univ Minnesota, Pediat Blood & Marrow Transplantat, Minneapolis, MN USA; [McMillan, James R.; Kimble, Roy M.] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Ctr Childrens Burns Res, Brisbane, Qld, Australia; [Prisco, Marco; South, Andrew P.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Div Mol Med, Dundee, Scotland; [Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Salas-Alanis, Julio C.] Univ Monterrey, Sch Med, Dept Basic Sci, Monterrey, Mexico	University of Dundee; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Royal Children's Hospital Brisbane; University of Queensland; Jefferson University; University of Dundee; University of Dundee; University of London; King's College London; Universidad de Monterrey	South, AP (corresponding author), Univ Dundee, Div Canc Res, Dundee, Scotland.	Andrew.South@Jefferson.edu	Pourreyron, Celine/AAE-7362-2020; McGrath, John/D-6824-2012	Tolar, Jakub/0000-0002-0957-4380; McGrath, John/0000-0002-3708-9964	Dystrophic Epidermolysis Bullosa Research Association; British Skin Foundation; Cancer Research UK; European Research Council; Wellcome Trust; Royal Children's Hospital Foundation; New Staff Start-Up Grant from University of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; Cancer Research UK [13044] Funding Source: researchfish	Dystrophic Epidermolysis Bullosa Research Association; British Skin Foundation; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Children's Hospital Foundation; New Staff Start-Up Grant from University of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Research UK(Cancer Research UK)	The authors received no specific funding for this work but would like to acknowledge the following organizations who contributed to this study: the Dystrophic Epidermolysis Bullosa Research Association, The British Skin Foundation, Cancer Research UK, The European Research Council, a strategic grant from the Wellcome Trust, the Royal Children's Hospital Foundation and a New Staff Start-Up Grant from The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER EA, 1978, J EXP MED, V148, P1378, DOI 10.1084/jem.148.5.1378; BENTZ H, 1983, P NATL ACAD SCI-BIOL, V80, P3168, DOI 10.1073/pnas.80.11.3168; BRUCKNERTUDERMAN L, 1988, DERMATOLOGICA, V176, P57, DOI 10.1159/000248673; Chino T, 2008, AM J PATHOL, V173, P803, DOI 10.2353/ajpath.2008.070977; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; Dayal JHS, 2014, J CELL SCI, V127, P740, DOI 10.1242/jcs.128454; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heinonen S, 1999, J CELL SCI, V112, P3641; Hiremagalore R, 2015, BRIT J DERMATOL, V172, P384, DOI 10.1111/bjd.13305; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Kuttner V, 2014, J INVEST DERMATOL, V134, P2381, DOI 10.1038/jid.2014.185; Kuttner V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.17; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; MCGRATH JA, 1992, BRIT J DERMATOL, V127, P312, DOI 10.1111/j.1365-2133.1992.tb00447.x; McMillan JR, 2003, EXP DERMATOL, V12, P261, DOI 10.1034/j.1600-0625.2003.120305.x; Mellerio JE, 1997, J INVEST DERMATOL, V109, P246, DOI 10.1111/1523-1747.ep12319792; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Nystrom A, 2013, J CLIN INVEST, V123, P3498, DOI 10.1172/JCI68127; Odorisio T, 2014, HUM MOL GENET, V23, P3907, DOI 10.1093/hmg/ddu102; Pourreyron C, 2014, BRIT J DERMATOL, V170, P1256, DOI 10.1111/bjd.12715; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Remington J, 2009, MOL THER, V17, P26, DOI 10.1038/mt.2008.234; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050045; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SHIMIZU H, 1989, ARCH DERMATOL RES, V281, P443, DOI 10.1007/BF00510078; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Titeux M, 2008, HUM MUTAT, V29, P267, DOI 10.1002/humu.20647; Uitto J, 2010, J INVEST DERMATOL, V130, P1778, DOI 10.1038/jid.2010.90; Vanden Oever Michael J, 2014, F1000Prime Rep, V6, P35, DOI 10.12703/P6-35; Varki R, 2007, J MED GENET, V44, P181, DOI 10.1136/jmg.2006.045302; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Walker LC, 1999, MOL GENET METAB, V67, P74, DOI 10.1006/mgme.1999.2824; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996	48	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137639	10.1371/journal.pone.0137639	http://dx.doi.org/10.1371/journal.pone.0137639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380979	Green Published, gold			2022-12-26	WOS:000361790200030
J	Learmonth, G; Gallagher, A; Gibson, J; Thut, G; Harvey, M				Learmonth, Gemma; Gallagher, Aodhan; Gibson, Jamie; Thut, Gregor; Harvey, Monika			Intra- and Inter-Task Reliability of Spatial Attention Measures in Pseudoneglect	PLOS ONE			English	Article							TIME-ON-TASK; IN-LINE BISECTION; VIEWING PERCEPTUAL ASYMMETRIES; VISUOSPATIAL ATTENTION; HEMISPATIAL NEGLECT; RIGHTWARD SHIFT; CROSS-OVER; BIAS; SPACE; JUDGMENTS	Healthy young adults display a leftward asymmetry of spatial attention ("pseudoneglect") that has been measured with a wide range of different tasks. Yet at present there is a lack of systematic evidence that the tasks commonly used in research today are i) stable measures over time and ii) provide similar measures of spatial bias. Fifty right-handed young adults were tested on five tasks (manual line bisection, landmark, greyscales, gratingscales and lateralised visual detection) on two different days. All five tasks were found to be stable measures of bias over the two testing sessions, indicating that each is a reliable measure in itself. Surprisingly, no strongly significant inter-task correlations were found. However, principal component analysis revealed left-right asymmetries to be subdivided in 4 main components, namely asymmetries in size judgements (manual line bisection and landmark), luminance judgements (greyscales), stimulus detection (lateralised visual detection) and judgements of global/local features (manual line bisection and grating scales). The results align with recent research on hemispatial neglect which conceptualises the condition as multi-component rather than a single pathological deficit of spatial attention. We conclude that spatial biases in judgment of visual stimulus features in healthy adults (e.g., pseudone-glect) is also a multi-component phenomenon that may be captured by variations in task demands which engage task-dependent patterns of activation within the attention network.	[Learmonth, Gemma; Thut, Gregor] Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland; [Learmonth, Gemma; Gallagher, Aodhan; Gibson, Jamie; Harvey, Monika] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Learmonth, G (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland.	g.learmonth.1@research.gla.ac.uk	Learmonth, Gemma/J-7227-2019; Thut, Gregor/A-4374-2009	Learmonth, Gemma/0000-0003-4061-4464; Thut, Gregor/0000-0003-1313-4262	University of Glasgow College of Science and Engineering PhD scholarship	University of Glasgow College of Science and Engineering PhD scholarship	The study was supported by a University of Glasgow College of Science and Engineering PhD scholarship to GL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgrove MA, 2004, NEUROREPORT, V15, P1065, DOI 10.1097/00001756-200404290-00027; Benwell CSY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00113; Benwell CSY, 2014, NEUROIMAGE, V86, P370, DOI 10.1016/j.neuroimage.2013.10.014; Benwell CSY, 2013, NEUROPSYCHOLOGIA, V51, P2747, DOI 10.1016/j.neuropsychologia.2013.09.030; Benwell CSY, 2013, CORTEX, V49, P827, DOI 10.1016/j.cortex.2011.12.007; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; Bjoertomt O, 2009, J NEUROPSYCHOL, V3, P31, DOI 10.1348/174866408X394604; Bonato M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00162; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; Bonato M, 2010, NEUROPSYCHOLOGIA, V48, P3934, DOI 10.1016/j.neuropsychologia.2010.08.022; Borgo M, 2012, MATLAB FOR PSYCHOLOGISTS, P1, DOI 10.1007/978-1-4614-2197-9; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; CARRASCO M, 1986, PERCEPTION, V15, P553, DOI 10.1068/p150553; Chechlacz M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00230; Chen JQ, 2014, EXP BRAIN RES, V232, P4001, DOI 10.1007/s00221-014-4082-y; Cicek M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.007.2009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dambeck N, 2006, BRAIN RES, V1072, P194, DOI 10.1016/j.brainres.2005.05.075; Dellatolas G, 1996, COGNITIVE BRAIN RES, V4, P49, DOI 10.1016/0926-6410(96)00019-5; Dodds CM, 2008, NEUROPSYCHOLOGY, V22, P545, DOI 10.1037/0894-4105.22.4.545; Driver J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P589; Dufour A, 2007, EXP BRAIN RES, V176, P532, DOI 10.1007/s00221-006-0810-2; Ferre ER, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00660; Fimm B, 2006, NEUROPSYCHOLOGIA, V44, P1261, DOI 10.1016/j.neuropsychologia.2006.01.027; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Foulsham T, 2013, VISION RES, V78, P14, DOI 10.1016/j.visres.2012.12.001; Friedrich Trista E, 2014, Cult Brain, V2, P161; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; Green DM, 1966, SIGNAL DETECTION THE; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HALLIGAN PW, 1989, COGNITIVE NEUROPSYCH, V6, P423, DOI 10.1080/02643298908253291; Harvey M, 2002, NEUROPSYCHOLOGIA, V40, P705, DOI 10.1016/S0028-3932(01)00189-0; Harvey M, 2000, NEUROPSYCHOLOGIA, V38, P22, DOI 10.1016/S0028-3932(99)00055-X; Heber IA, 2010, BRAIN COGNITION, V73, P160, DOI 10.1016/j.bandc.2010.04.006; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M, 1977, Adv Neurol, V18, P41; Learmonth G, 2015, NEUROPSYCHOLOGIA, V74, P108, DOI 10.1016/j.neuropsychologia.2015.01.037; Loftus AM, 2012, NEUROPSYCHOLOGIA, V50, P2573, DOI 10.1016/j.neuropsychologia.2012.07.003; Loftus AM, 2009, CORTEX, V45, P537, DOI 10.1016/j.cortex.2007.12.011; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2015, NEUROPSYCHOLOGIA, V70, P350, DOI 10.1016/j.neuropsychologia.2014.10.035; Longo MR, 2010, BRAIN COGNITION, V72, P362, DOI 10.1016/j.bandc.2009.10.016; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Lourenco SF, 2009, COGNITION, V112, P451, DOI 10.1016/j.cognition.2009.05.011; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; Macmillan NA, 2005, DETECTION THEORY USE; Manly T, 2005, NEUROPSYCHOLOGIA, V43, P1721, DOI 10.1016/j.neuropsychologia.2005.02.009; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; Matthias E, 2010, J EXP PSYCHOL HUMAN, V36, P38, DOI 10.1037/a0017602; Mattingley JB, 2004, NEUROPSYCHOLOGIA, V42, P387, DOI 10.1016/j.neuropsychologia.2003.07.007; MATTINGLEY JB, 1992, BRAIN, V115, P1849, DOI 10.1093/brain/115.6.1849; MATTINGLEY JB, 1994, NEUROPSYCHOLOGIA, V32, P805, DOI 10.1016/0028-3932(94)90019-1; McCourt ME, 2001, BRAIN COGNITION, V45, P52, DOI 10.1006/brcg.2000.1255; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; McCourt ME, 2000, FRONT BIOSCI, V5, pD58; Meinhardt G, 2002, EXP BRAIN RES, V142, P539, DOI 10.1007/s00221-001-0945-0; MILNER AD, 1993, NEUROPSYCHOLOGIA, V31, P39, DOI 10.1016/0028-3932(93)90079-F; MILNER AD, 1992, NEUROPSYCHOLOGIA, V30, P515, DOI 10.1016/0028-3932(92)90055-Q; Monaghan P, 2004, PSYCHOL REV, V111, P283, DOI 10.1037/0033-295X.111.2.283; Newman DP, 2013, NEUROPSYCHOLOGIA, V51, P1215, DOI 10.1016/j.neuropsychologia.2013.03.027; Nicholls MER, 2002, CORTEX, V38, P113, DOI 10.1016/S0010-9452(08)70645-2; Nicholls MER, 1999, NEUROPSYCHOLOGIA, V37, P307, DOI 10.1016/S0028-3932(98)00074-8; Nicholls MER, 2014, ERGONOMICS, V57, P876, DOI 10.1080/00140139.2014.899633; Niemeier M, 2008, EXP BRAIN RES, V189, P411, DOI 10.1007/s00221-008-1438-1; Niemeier M, 2008, BRAIN COGNITION, V67, P115, DOI 10.1016/j.bandc.2007.12.002; Niemeier M, 2007, NEUROPSYCHOLOGIA, V45, P1029, DOI 10.1016/j.neuropsychologia.2006.09.006; Okubo M, 2006, EXP BRAIN RES, V172, P49, DOI 10.1007/s00221-005-0303-8; PELLI DG, 1987, VISION RES, V27, P119, DOI 10.1016/0042-6989(87)90148-9; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Perez A, 2008, PSICOLOGICA, V29, P35; Perez A, 2009, NEUROPSYCHOLOGIA, V47, P41, DOI 10.1016/j.neuropsychologia.2008.08.017; RAPCSAK SZ, 1989, ARCH NEUROL-CHICAGO, V46, P178, DOI 10.1001/archneur.1989.00520380082018; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rueckert L, 2002, NEUROPSYCHOLOGIA, V40, P162, DOI 10.1016/S0028-3932(01)00082-3; Russell C, 2013, CORTEX, V49, P1874, DOI 10.1016/j.cortex.2012.10.005; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; Singh VVW, 2011, CORTEX, V47, P547, DOI 10.1016/j.cortex.2010.03.006; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tomer R, 2008, NEUROPSYCHOLOGIA, V46, P2064, DOI 10.1016/j.neuropsychologia.2008.02.005; Tomer R, 2013, CEREB CORTEX, V23, P2899, DOI 10.1093/cercor/bhs277; Varnava A, 2002, NEUROPSYCHOLOGIA, V40, P1372, DOI 10.1016/S0028-3932(01)00204-4; Varnava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065851; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Vuilleumier P, 2007, J COGNITIVE NEUROSCI, V19, P1388, DOI 10.1162/jocn.2007.19.8.1388; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	93	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138379	10.1371/journal.pone.0138379	http://dx.doi.org/10.1371/journal.pone.0138379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378925	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000361769400092
J	Matson, DJ; Hamamoto, DT; Bregman, H; Cooke, M; DiMauro, EF; Huang, LY; Johnson, D; Li, XW; McDermott, J; Morgan, C; Wilenkin, B; Malmberg, AB; McDonough, SI; Simone, DA				Matson, David J.; Hamamoto, Darryl T.; Bregman, Howard; Cooke, Melanie; DiMauro, Erin F.; Huang, Liyue; Johnson, Danielle; Li, Xingwen; McDermott, Jeff; Morgan, Carrie; Wilenkin, Ben; Malmberg, Annika B.; McDonough, Stefan I.; Simone, Donald A.			Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; INFLAMMATORY PAIN; NEUROPATHIC PAIN; SLOW-INACTIVATION; DORSAL-HORN; DRG NEURONS; NA(V)1.7; RAT; EXPRESSION; INJURY	While genetic evidence shows that the Nav1.7 voltage-gated sodium ion channel is a key regulator of pain, it is unclear exactly how Nav1.7 governs neuronal firing and what biophysical, physiological, and distribution properties of a pharmacological Nav1.7 inhibitor are required to produce analgesia. Here we characterize a series of aminotriazine inhibitors of Nav1.7 in vitro and in rodent models of pain and test the effects of the previously reported "compound 52" aminotriazine inhibitor on the spiking properties of nociceptors in vivo. Multiple aminotriazines, including some with low terminal brain to plasma concentration ratios, showed analgesic efficacy in the formalin model of pain. Effective concentrations were consistent with the in vitro potency as measured on partially-inactivated Nav1.7 but were far below concentrations required to inhibit non-inactivated Nav1.7. Compound 52 also reversed thermal hyperalgesia in the complete Freund's adjuvant (CFA) model of pain. To study neuronal mechanisms, electrophysiological recordings were made in vivo from single nociceptive fibers from the rat tibial nerve one day after CFA injection. Compound 52 reduced the spontaneous firing of C-fiber nociceptors from approximately 0.7 Hz to 0.2 Hz and decreased the number of action potentials evoked by suprathreshold tactile and heat stimuli. It did not, however, appreciably alter the C-fiber thresholds for response to tactile or thermal stimuli. Surprisingly, compound 52 did not affect spontaneous activity or evoked responses of Ad-fiber nociceptors. Results suggest that inhibition of inactivated states of TTX-S channels, mostly likely Nav1.7, in the peripheral nervous system produces analgesia by regulating the spontaneous discharge of C-fiber nociceptors.	[Matson, David J.; Johnson, Danielle; McDermott, Jeff; Wilenkin, Ben; Malmberg, Annika B.; McDonough, Stefan I.] Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA; [Bregman, Howard; DiMauro, Erin F.] Amgen Inc, Dept Med Chem, Cambridge, MA USA; [Cooke, Melanie; Morgan, Carrie] Amgen Inc, Dept Pharmaceut Res & Dev, Cambridge, MA USA; [Huang, Liyue; Li, Xingwen] Amgen Inc, Dept Pharmacokinet & Drug Metab, Cambridge, MA USA; [Hamamoto, Darryl T.; Simone, Donald A.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	Amgen; Amgen; Amgen; Amgen; University of Minnesota System; University of Minnesota Twin Cities	McDonough, SI (corresponding author), Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA.	stefanm@amgen.com		McDermott, Jeff/0000-0002-6362-3307	Amgen Inc.	Amgen Inc.(Amgen)	Authors DJM, HB, MC, EFD, LH, DJ, XL, JM, CM, BW, ABM, and SIM were Amgen employees at the time the work was performed. This work was fully supported by Amgen Inc. Amgen Inc. provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Baker MD, 2012, J PHYSIOL-LONDON, V590, P1513, DOI 10.1113/jphysiol.2011.224436; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Bregman H, 2011, J MED CHEM, V54, P4427, DOI 10.1021/jm200018k; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chapman ML, 2012, SOC NEUR ANN M NEW O; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; De Col Roberto, 2012, J Physiol, V590, P725, DOI 10.1113/jphysiol.2011.220624; Dib-Hajj SD, 1999, PAIN, V83, P591, DOI 10.1016/S0304-3959(99)00169-4; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gee MD, 1996, NEUROSCIENCE, V73, P667, DOI 10.1016/0306-4522(96)00070-X; Gingras J, 2014, PLOS ONE IN PRESS; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldberg YP, 2012, CLIN GENET, V82, P367, DOI 10.1111/j.1399-0004.2012.01942.x; Goldberg YP, 2012, PAIN, V153, P80, DOI 10.1016/j.pain.2011.09.008; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Jukic M, 2014, CURR MED CHEM, V21, P164; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Luo S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-16; Macsari I, 2012, J MED CHEM, V55, P6866, DOI 10.1021/jm300623u; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Nardi A, 2012, CHEMMEDCHEM, V7, P1712, DOI 10.1002/cmdc.201200298; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; Saab CY, 2012, TRENDS NEUROSCI, V35, P629, DOI 10.1016/j.tins.2012.06.002; Scadding J. W., 2013, WALL MELZACKS TXB PA, P926, DOI DOI 10.1016/B0-443-07287-6/50067-9; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Shields SD, 2012, J NEUROSCI, V32, P10819, DOI 10.1523/JNEUROSCI.0304-12.2012; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Watson J, 2009, DRUG METAB DISPOS, V37, P753, DOI 10.1124/dmd.108.022814; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Waxman SG, 2012, J PHYSIOL-LONDON, V590, P2601, DOI 10.1113/jphysiol.2012.228460; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975	56	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138140	10.1371/journal.pone.0138140	http://dx.doi.org/10.1371/journal.pone.0138140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379236	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400060
J	Herrera, C; Tremblay, JM; Shoemaker, CB; Mantis, NJ				Herrera, Cristina; Tremblay, Jacqueline M.; Shoemaker, Charles B.; Mantis, Nicholas J.			Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVELY PROTECTS MICE; ANTHRAX TOXIN; BINDING; CHAIN; NANOBODIES; POLIOVIRUS; CHALLENGE; AFFINITY; IMMUNITY; LECTINS	Novel antibody constructs consisting of two or more different camelid heavy-chain only antibodies (VHHs) joined via peptide linkers have proven to have potent toxin-neutralizing activity in vivo against Shiga, botulinum, Clostridium difficile, anthrax, and ricin toxins. However, the mechanisms by which these so-called bispecific VHH heterodimers promote toxin neutralization remain poorly understood. In the current study we produced a new collection of ricin-specific VHH heterodimers, as well as VHH homodimers, and characterized them for their ability neutralize ricin in vitro and in vivo. We demonstrate that the VHH heterodimers, but not homodimers were able to completely protect mice against ricin challenge, even though the two classes of antibodies (heterodimers and homodimers) had virtually identical affinities for ricin holotoxin and similar IC50 values in a Vero cell cytotoxicity assay. The VHH heterodimers did differ from the homodimers in their ability to promote toxin aggregation in solution, as revealed through analytical ultracentrifugation. Moreover, the VHH heterodimers that were most effective at promoting ricin aggregation in solution were also the most effective at blocking ricin attachment to cell surfaces. Collectively, these data suggest that heterodimeric VHH-based neutralizing agents may function through the formation of antibody-toxin complexes that are impaired in their ability to access host cell receptors.	[Herrera, Cristina; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA; [Herrera, Cristina; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA.	nicholas.mantis@health.ny.gov	Regan, Clinton/E-6250-2012	Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health [R03 AI097688]; NIAID [HHSN272201400021C, U54-AI057159]; Carson Carr Diversity Scholarship from the University at Albany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Carson Carr Diversity Scholarship from the University at Albany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 AI097688 and Contract numbers HHSN272201400021C (to N. M. J.) and U54-AI057159 (to C. B. S.) from the NIAID. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NIAID or National Institutes of Health.; Supported by a Carson Carr Diversity Scholarship from the University at Albany.	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BRIOEN P, 1983, VIROLOGY, V127, P463, DOI 10.1016/0042-6822(83)90159-9; Chen C, 2015, MBIO, V6, DOI 10.1128/mBio.00734-15; Chow SK, 2013, CELL HOST MICROBE, V13, P417, DOI 10.1016/j.chom.2013.03.001; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FRENOY JP, 1986, BIOCHEM J, V240, P221, DOI 10.1042/bj2400221; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Mantis NJ, 2012, CURR TOP MICROBIOL, V354, P181, DOI 10.1007/82_2011_122; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Sully EK, 2014, CLIN VACCINE IMMUNOL, V21, P777, DOI 10.1128/CVI.00003-14; THOMAS AAM, 1986, J VIROL, V59, P479, DOI 10.1128/JVI.59.2.479-485.1986; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Unger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07850; Vance DJ, 2015, VACCINE, V33, P417, DOI 10.1016/j.vaccine.2014.11.036; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	38	24	27	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27880	+		10.1074/jbc.M115.658070	http://dx.doi.org/10.1074/jbc.M115.658070			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396190	Green Published, hybrid			2022-12-26	WOS:000365757500037
J	Brestoff, JR; Brodsky, T; Sosinsky, AZ; McLoughlin, R; Stansky, E; Fussell, L; Sheppard, A; DiSanto-Rose, M; Kershaw, EE; Reynolds, TH				Brestoff, Jonathan R.; Brodsky, Tim; Sosinsky, Alexandra Z.; McLoughlin, Ryan; Stansky, Elena; Fussell, Leila; Sheppard, Aaron; DiSanto-Rose, Maria; Kershaw, Erin E.; Reynolds, Thomas H.			Manganese [III] Tetrakis [5,10,15,20]-Benzoic Acid Porphyrin Reduces Adiposity and Improves Insulin Action in Mice with Pre-Existing Obesity	PLOS ONE			English	Article							REACTIVE OXYGEN; BODY-WEIGHT; LONG-TERM; KINASE-B; INDUCTION; GLUCOSE; SUPPLEMENTATION; PHOSPHORYLATION; OVEREXPRESSION; INFLAMMATION	The superoxide dismutase mimetic manganese [III] tetrakis [5,10,15,20]-benzoic acid porphyrin (MnTBAP) is a potent antioxidant compound that has been shown to limit weight gain during short-term high fat feeding without preventing insulin resistance. However, whether MnTBAP has therapeutic potential to treat pre-existing obesity and insulin resistance remains unknown. To investigate this, mice were treated with MnTBAP or vehicle during the last five weeks of a 24-week high fat diet (HFD) regimen. MnTBAP treatment significantly decreased body weight and reduced white adipose tissue (WAT) mass in mice fed a HFD and a low fat diet (LFD). The reduction in adiposity was associated with decreased caloric intake without significantly altering energy expenditure, indicating that MnTBAP decreases adiposity in part by modulating energy balance. MnTBAP treatment also improved insulin action in HFD-fed mice, a physiologic response that was associated with increased protein kinase B (PKB) phosphorylation and expression in muscle and WAT. Since MnTBAP is a metalloporphyrin molecule, we hypothesized that its ability to promote weight loss and improve insulin sensitivity was regulated by heme oxygenase-1 (HO-1), in a similar fashion as cobalt protoporphyrins. Despite MnTBAP treatment increasing HO-1 expression, administration of the potent HO-1 inhibitor tin mesoporphyrin (SnMP) did not block the ability of MnTBAP to alter caloric intake, adiposity, or insulin action, suggesting that MnTBAP influences these metabolic processes independent of HO-1. These data demonstrate that MnTBAP can ameliorate pre-existing obesity and improve insulin action by reducing caloric intake and increasing PKB phosphorylation and expression.	[Brestoff, Jonathan R.; Brodsky, Tim; Sosinsky, Alexandra Z.; McLoughlin, Ryan; Stansky, Elena; Fussell, Leila; Sheppard, Aaron; DiSanto-Rose, Maria; Reynolds, Thomas H.] Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol, Pittsburgh, PA USA	Skidmore College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, TH (corresponding author), Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA.	treynold@skidmore.edu	Brestoff, Jonathan R./I-7000-2019; Sosinsky, Alexandra Z/N-9092-2019; Kershaw, Erin E/G-9587-2013	Brestoff, Jonathan R./0000-0002-7018-7400; Sosinsky, Alexandra Z/0000-0003-2051-7333; Kershaw, Erin E/0000-0002-3887-4868; Reynolds, Thomas/0000-0002-0290-528X; DiSanto-Rose, Maria/0000-0003-2250-291X	National Institutes of Health [1 R15 DK090722-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, 1 R15 DK090722-01, awarded to THR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Boden MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE798, DOI 10.1152/ajpendo.00577.2011; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Cao J, 2012, HYPERTENSION, V60, P467, DOI 10.1161/HYPERTENSIONAHA.112.193805; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Csongradi E, 2012, INT J OBESITY, V36, P244, DOI 10.1038/ijo.2011.78; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; GALBRAITH RA, 1990, PHARMACOLOGY, V41, P292, DOI 10.1159/000138738; GALBRAITH RA, 1989, P NATL ACAD SCI USA, V86, P7653, DOI 10.1073/pnas.86.19.7653; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu DX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-23; Liu SM, 1999, JAMA-J AM MED ASSOC, V282, P1073, DOI 10.1001/jama.282.11.1073; Liu X, 2015, J HEPATOL; Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029; McCurdy CE, 2003, AM J PHYSIOL-ENDOC M, V285, pE693, DOI 10.1152/ajpendo.00224.2003; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P189, DOI [10.1001/jama.2014.6228, 10.1001/jama.2014.6219]; Okubo H, 2013, DIETARY TOTAL ANTIOX; Pires KM, 2014, OBESITY, V22, P178, DOI 10.1002/oby.20465; Reynolds TH, 2009, J APPL PHYSIOL, V107, P1479, DOI 10.1152/japplphysiol.00574.2009; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Vanella L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt176; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	31	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137388	10.1371/journal.pone.0137388	http://dx.doi.org/10.1371/journal.pone.0137388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397111	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000361797500034
J	Koptur, S; Jones, IM; Pena, JE				Koptur, Suzanne; Jones, Ian M.; Pena, Jorge E.			The Influence of Host Plant Extrafloral Nectaries on Multitrophic Interactions: An Experimental Investigation	PLOS ONE			English	Article							EXTRA-FLORAL NECTARIES; HERBIVORE INTERACTIONS; DEFENSIVE RESPONSE; SENNA LEGUMINOSAE; SEED PRODUCTION; ANT PROTECTION; FEEDING ANTS; AGENTS; FERN; ATTRACTION	A field experiment was conducted with outplantings of the native perennial shrub Senna mexicana var. chapmanii in a semi-natural area adjacent to native pine rockland habitat in southern Florida. The presence of ants and the availability of extrafloral nectar were manipulated in a stratified random design. Insect communities were monitored and recorded over a period of six months with a view to addressing three main questions. Do ants provide biotic defense against key herbivores on S. chapmanii? Is the presence of ants on S. chapmanii mediated by EFN? Finally, are there ecological costs associated with the presence of ants on S. chapmanii, such as a reduction in alternative predator or parasitoid numbers? Herbivores on S. chapmanii included immature stages of three pierid butterflies, and adult weevils. Eight species of ants were associated with the plants, and other predators included spiders, ladybugs, wasps, and hemipterans. Parasitic, haemolymph-sucking midges (Ceratopogonidae) and parasitoid flies were also associated with the caterpillar herbivores, and possibly the extrafloral nectaries of the plants. The presence of ants did not appear to influence oviposition by butterflies, as numbers of lepidopterans of all developmental stages did not differ among treatments. Significantly more late instar caterpillars, however, were observed on plants with ants excluded, indicating that ants remove small caterpillars from plants. Substantially more alternative predators (spiders, ladybugs, and wasps) were observed on plants with ants excluded. Rates of parasitization did not differ among the treatments, but there were substantially fewer caterpillars succumbing to virus among those collected from control plants. We provide a rare look at facultative ant-plant mutualisms in the context of the many other interactions with which they overlap. We conclude that ants provide some biotic defense against herbivores on S. chapmanii, and plants benefit overall from the presence of ants, despite negative impacts on non-ant predators.	[Koptur, Suzanne; Jones, Ian M.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Pena, Jorge E.] Univ Florida, Ctr Trop Res & Educ, Homestead, FL 33031 USA	State University System of Florida; Florida International University; State University System of Florida; University of Florida	Koptur, S (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	kopturs@fiu.edu	Peña, Jorge/GXI-0458-2022; Koptur, Suzanne/B-7809-2009	Koptur, Suzanne/0000-0002-6617-0171	College of Arts and Sciences at FIU	College of Arts and Sciences at FIU	Funding: Support was provided by sabbatical leave support and a subsequent research grant to SK from the College of Arts and Sciences at FIU.	Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; Belt T., 1874, NATURALIST NICARAGUA; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; BOECKLEN WJ, 1984, ECOL ENTOMOL, V9, P243, DOI 10.1111/j.1365-2311.1984.tb00848.x; Buchmann S.L., 1983, P73; Cuautle M, 2003, FUNCT ECOL, V17, P417, DOI 10.1046/j.1365-2435.2003.00732.x; Dattilo W, 2015, J ARID ENVIRON, V114, P104, DOI 10.1016/j.jaridenv.2014.12.001; Eubanks Micky D., 2005, P148, DOI 10.1017/CBO9780511542220.007; FONSECA CR, 1994, J ECOL, V82, P833, DOI 10.2307/2261447; Freitas L, 2000, FLORA, V195, P398; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Heil M, 2004, J TROP ECOL, V20, P573, DOI 10.1017/S0266467404001567; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Hernandez-Cumplido J, 2010, J TROP ECOL, V26, P555, DOI 10.1017/S0266467410000234; INOUYE DW, 1979, ECOLOGY, V60, P1, DOI 10.2307/1936460; Irwin H. S., 1982, The American Cassiinae: a synoptical revision of Leguminosae tribe Cassieae subtribe Cassiinae in the New World.; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jezorek H, 2011, BIOL INVASIONS, V13, P2261, DOI 10.1007/s10530-011-0038-3; Jones IM, 2015, AM J BOT, V102, P58, DOI 10.3732/ajb.1400381; KELLY CA, 1986, OECOLOGIA, V69, P600, DOI 10.1007/BF00410369; KOPTUR S, 1988, ECOLOGY, V69, P278, DOI 10.2307/1943183; KOPTUR S, 1984, ECOLOGY, V65, P1787, DOI 10.2307/1937775; Koptur S, 2013, ANN BOT-LONDON, V111, P1277, DOI 10.1093/aob/mct063; Koptur Suzanne, 1992, P81; Kost C, 2005, BASIC APPL ECOL, V6, P237, DOI 10.1016/j.baae.2004.11.002; Lanan MC, 2013, OECOLOGIA, V172, P779, DOI 10.1007/s00442-012-2528-0; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Leal IR, 2006, ECOSCIENCE, V13, P431, DOI 10.2980/1195-6860(2006)13[431:APAHAN]2.0.CO;2; Mackay DA, 1998, AUST J ENTOMOL, V37, P335, DOI 10.1111/j.1440-6055.1998.tb01593.x; Marazzi B, 2006, AM J BOT, V93, P288, DOI 10.3732/ajb.93.2.288; Marazzi B, 2007, INT J PLANT SCI, V168, P371, DOI 10.1086/512105; Marazzi B, 2013, ANN BOT-LONDON, V111, P1263, DOI 10.1093/aob/mcs226; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2006, ECOLOGY, V87, P912, DOI 10.1890/0012-9658(2006)87[912:IQAQOM]2.0.CO;2; Ness JH, 2006, OIKOS, V113, P506, DOI 10.1111/j.2006.0030-1299.14143.x; Oliveira PS, 1997, FUNCT ECOL, V11, P323, DOI 10.1046/j.1365-2435.1997.00087.x; Oliveira PS, 1996, ENTOMOLOGISTS MONTHL, V131, P77; OLOFSSON E, 1989, ENTOMOPHAGA, V34, P373, DOI 10.1007/BF02372476; PEMBERTON RW, 1993, P ENTOMOL SOC WASH, V95, P139; PIERCE NE, 1981, SCIENCE, V211, P1185, DOI 10.1126/science.211.4487.1185; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; Ruhren S, 2003, PLANT ECOL, V166, P189, DOI 10.1023/A:1023248431116; Ruhren S, 1999, OECOLOGIA, V119, P227, DOI 10.1007/s004420050780; Salisbury EJ, 1909, ANN BOT-LONDON, V23, P229, DOI 10.1093/oxfordjournals.aob.a089212; Salvato MH, 2012, J LEPID SOC, V66, P232; Sendoya SF, 2015, J ANIM ECOL, V84, P442, DOI 10.1111/1365-2656.12286; TEMPEL AS, 1983, ECOLOGY, V64, P1411, DOI 10.2307/1937495; Torres-Hernandez Leonel, 2000, Acta Zoologica Mexicana Nueva Serie, P13; Wackers F. L., 2005, PLANT PROVIDED FOOD; Wagner D, 1997, J ECOL, V85, P83, DOI 10.2307/2960629; Wagner D, 2010, J ECOL, V98, P614, DOI 10.1111/j.1365-2745.2010.01640.x; Weeks JA, 2003, ECOL ENTOMOL, V28, P228, DOI 10.1046/j.1365-2311.2003.00489.x; Young BL, 2005, SW NAT, V45, P289	60	23	24	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138157	10.1371/journal.pone.0138157	http://dx.doi.org/10.1371/journal.pone.0138157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394401	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100032
J	Niaudet, C; Hofmann, JJ; Mae, MA; Jung, BN; Gaengel, K; Vanlandewijck, M; Ekvarn, E; Salvado, MD; Mehlem, A; Al Sayegh, S; He, LQ; Lebouvier, T; Castro-Freire, M; Katayama, K; Hultenby, K; Moessinger, C; Tannenberg, P; Cunha, S; Pietras, K; Lavina, B; Hong, J; Berg, T; Betsholtz, C				Niaudet, Colin; Hofmann, Jennifer J.; Mae, Maarja A.; Jung, Bongnam; Gaengel, Konstantin; Vanlandewijck, Michael; Ekvarn, Elisabet; Salvado, M. Dolores; Mehlem, Annika; Al Sayegh, Sahar; He, Liqun; Lebouvier, Thibaud; Castro-Freire, Marco; Katayama, Kan; Hultenby, Kjell; Moessinger, Christine; Tannenberg, Philip; Cunha, Sara; Pietras, Kristian; Lavina, Barbara; Hong, JongWook; Berg, Tove; Betsholtz, Christer			Gpr116 Receptor Regulates Distinctive Functions in Pneumocytes and Vascular Endothelium	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; OXYGEN-INDUCED RETINOPATHY; SCHWANN-CELLS; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; IDENTIFICATION; POLARIZATION; MYELINATION; PERICYTES	Despite its known expression in both the vascular endothelium and the lung epithelium, until recently the physiological role of the adhesion receptor Gpr116/ADGRF5 has remained elusive. We generated a new mouse model of constitutive Gpr116 inactivation, with a large genetic deletion encompassing exon 4 to exon 21 of the Gpr116 gene. This model allowed us to confirm recent results defining Gpr116 as necessary regulator of surfactant homeostasis. The loss of Gpr116 provokes an early accumulation of surfactant in the lungs, followed by a massive infiltration of macrophages, and eventually progresses into an emphysemalike pathology. Further analysis of this knockout model revealed cerebral vascular leakage, beginning at around 1.5 months of age. Additionally, endothelial-specific deletion of Gpr116 resulted in a significant increase of the brain vascular leakage. Mice devoid of Gpr116 developed an anatomically normal and largely functional vascular network, surprisingly exhibited an attenuated pathological retinal vascular response in a model of oxygen-induced retinopathy. These data suggest that Gpr116 modulates endothelial properties, a previously unappreciated function despite the pan-vascular expression of this receptor. Our results support the key pulmonary function of Gpr116 and describe a new role in the central nervous system vasculature.	[Niaudet, Colin; Mae, Maarja A.; Jung, Bongnam; Gaengel, Konstantin; Vanlandewijck, Michael; Al Sayegh, Sahar; He, Liqun; Lebouvier, Thibaud; Castro-Freire, Marco; Lavina, Barbara; Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Hofmann, Jennifer J.; Ekvarn, Elisabet; Mehlem, Annika; Katayama, Kan; Moessinger, Christine; Tannenberg, Philip; Cunha, Sara; Pietras, Kristian; Hong, JongWook; Berg, Tove; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Salvado, M. Dolores] Karolinska Inst, Dept Med Biochem & Biophys, Physiol Chem 2, Stockholm, Sweden; [Hultenby, Kjell] Div Clin Res Ctr, Dept Lab Med, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Stockholm, Sweden; [Tannenberg, Philip] Karolinska Inst, Dept Mol Med & Surg, Div Vasc Surg, Stockholm, Sweden; [Pietras, Kristian] Lund Univ, Dept Lab Med, Lund, Sweden	Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Lund University	Niaudet, C (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	colin.niaudet@igp.uu.se	Pietras, Kristian/ABE-8727-2020; Sobrido, Maria/D-6697-2016; Lebouvier, Thibaud/G-7053-2018; Gaengel, Konstantin/AAD-4241-2020; Mehlem, Annika/AAB-4883-2022; Andaloussi Mäe, Maarja/AAA-9215-2022; Pietras, Kristian/ABG-2097-2021; Gaengel, Konstantin/AAP-1148-2020	Sobrido, Maria/0000-0003-2060-4410; Lebouvier, Thibaud/0000-0002-4386-6045; Gaengel, Konstantin/0000-0002-2682-2833; Pietras, Kristian/0000-0001-6738-4705; Gaengel, Konstantin/0000-0002-2682-2833; Jung, Bongnam/0000-0002-3833-938X; Vanlandewijck, Michael/0000-0002-0709-7808; Castro, Marco/0000-0001-7851-7446; He, Liqun/0000-0003-2127-7597	European Research Council (ERC-AdG) [294556]; European Union [ITN-2012-317250-VESSEL]; Swedish Cancer Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Leducq Foundation through Sphingonet transatlantic network; Uppsala University	European Research Council (ERC-AdG)(European Research Council (ERC)); European Union(European Commission); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation through Sphingonet transatlantic network(Leducq Foundation); Uppsala University	Funding: This study was supported by grants from the European Research Council (ERC-AdG #294556 BBBARRIER), the European Union (ITN-2012-317250-VESSEL), the Swedish Cancer Foundation and the Swedish Research Council, the Knut and Alice Wallenberg Foundation, and the Leducq Foundation through the Sphingonet transatlantic network. Grants were also provided by Uppsala University.	Abe J, 1999, J BIOL CHEM, V274, P19957, DOI 10.1074/jbc.274.28.19957; Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Ariestanti DM, 2015, J BIOL CHEM, V290, P11032, DOI 10.1074/jbc.M115.648311; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Bridges JP, 2013, AM J RESP CELL MOL, V49, P348, DOI 10.1165/rcmb.2012-0439OC; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fukuzawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069451; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hakansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026026; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu XL, 2010, INVEST OPHTH VIS SCI, V51, P6625, DOI 10.1167/iovs.09-4900; LUDWIN SK, 1985, LAB INVEST, V52, P20; Lutty GA, 2011, INVEST OPHTH VIS SCI, V52, P4039, DOI 10.1167/iovs.10-6798; Madamanchi A, 2014, INVEST OPHTH VIS SCI, V55, P4338, DOI 10.1167/iovs.14-14061; Mancuso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114713; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nie T, 2012, FEBS LETT, V586, P3618, DOI 10.1016/j.febslet.2012.08.006; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Saint-Geniez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096253; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Siegenthaler JA, 2013, CURR OPIN NEUROBIOL, V23, P1057, DOI 10.1016/j.conb.2013.06.006; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	55	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137949	10.1371/journal.pone.0137949	http://dx.doi.org/10.1371/journal.pone.0137949			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394398	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100023
J	Petri, A; Dybkaer, K; Bogsted, M; Thrue, CA; Hagedorn, PH; Schmitz, A; Bodker, JS; Johnsen, HE; Kauppinen, S				Petri, Andreas; Dybkaer, Karen; Bogsted, Martin; Thrue, Charlotte Albaek; Hagedorn, Peter H.; Schmitz, Alexander; Bodker, Julie Stove; Johnsen, Hans Erik; Kauppinen, Sakari			Long Noncoding RNA Expression during Human B-Cell Development	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; MECHANISMS; CANCER; ACTIVATION; REPRESSION; DIFFERENTIATION; SUBPOPULATIONS; IDENTIFICATION; PROLIFERATION	Long noncoding RNAs (lncRNAs) have emerged as important regulators of diverse cellular processes, but their roles in the developing immune system are poorly understood. In this study, we analysed lncRNA expression during human B-cell development by array-based expression profiling of eleven distinct flow-sorted B-cell subsets, comprising pre-B1, pre-B2, immature, naive, memory, and plasma cells from bone marrow biopsies (n = 7), and naive, centroblast, centrocyte, memory, and plasmablast cells from tonsil tissue samples (n = 6), respectively. A remapping strategy was used to assign the array probes to 37630 gene-level probe sets, reflecting recent updates in genomic and transcriptomic databases, which enabled expression profiling of 19579 long noncoding RNAs, comprising 3947 antisense RNAs, 5277 lincRNAs, 7625 pseudogenes, and 2730 additional lncRNAs. As a first step towards inferring the functions of the identified lncRNAs in developing B-cells, we analysed their co-expression with well-characterized protein-coding genes, a method known as "guilt by association". By using weighted gene co-expression network analysis, we identified 272 lincRNAs, 471 antisense RNAs, 376 pseudogene RNAs, and 64 lncRNAs within seven sub-networks associated with distinct stages of B-cell development, such as early B-cell development, B-cell proliferation, affinity maturation of antibody, and terminal differentiation. These data provide an important resource for future studies on the functions of lncRNAs in development of the adaptive immune response, and the pathogenesis of B-cell malignancies that originate from distinct B-cell subpopulations.	[Petri, Andreas; Thrue, Charlotte Albaek; Hagedorn, Peter H.; Kauppinen, Sakari] Aalborg Univ, Dept Clin Med, Ctr RNA Med, Copenhagen, Denmark; [Petri, Andreas; Dybkaer, Karen; Bogsted, Martin; Thrue, Charlotte Albaek; Hagedorn, Peter H.; Schmitz, Alexander; Bodker, Julie Stove; Johnsen, Hans Erik; Kauppinen, Sakari] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Dybkaer, Karen; Bogsted, Martin; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Dybkaer, Karen; Bogsted, Martin; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Kauppinen, S (corresponding author), Aalborg Univ, Dept Clin Med, Ctr RNA Med, Copenhagen, Denmark.	ska@dcm.aau.dk	Hagedorn, Peter H/M-6037-2019	Hagedorn, Peter H/0000-0002-8368-0181; Johnsen, Hans Erik/0000-0001-8253-2913; Thrue, Charlotte/0000-0003-1219-3447; Dybkaer, Karen/0000-0003-2488-435X; Bogsted, Martin/0000-0001-9192-1814	Karen Elise Jensen Foundation; Lundbeck Foundation [R151-2013-14476]; Novo Nordisk Foundation [6395]; EU FP6 MSCNET [LSHC-CT-2006-037602]; Danish Cancer Society; Danish Research Agency (CHEPRE) [2101-07-0007]; Novo Nordisk Fonden [NNF13OC0006395, NNF14SA0011351] Funding Source: researchfish	Karen Elise Jensen Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU FP6 MSCNET; Danish Cancer Society(Danish Cancer Society); Danish Research Agency (CHEPRE); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Karen Elise Jensen Foundation (2014-2015) (to S.K.), the Lundbeck Foundation (#R151-2013-14476) (to S.K.), the Novo Nordisk Foundation (#6395) (to S.K.), the EU FP6 MSCNET (LSHC-CT-2006-037602) (to K.D., M.B., and H.E.J.), the Danish Cancer Society (to K.D., M.B., and H.E.J.), the Danish Research Agency (CHEPRE #2101-07-0007) (to K.D., M.B., and H.E.J.), and the Karen Elise Jensen Foundation (2006-2010) (to K.D., M.B., and H.E.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; [Anonymous], 2014, R LANG ENV STAT COMP; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bergkvist KS, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-3; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Yebenes VG, 2013, IMMUNOL REV, V253, P25, DOI 10.1111/imr.12046; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Duda R.O., 2006, PATTERN CLASSIFICATI; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Ellis BC, 2014, BBA-MOL CELL RES, V1843, P372, DOI 10.1016/j.bbamcr.2013.10.016; Ellis Blake C., 2012, Frontiers in Genetics, V3, P270, DOI 10.3389/fgene.2012.00270; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frazer JK, 2000, EUR J IMMUNOL, V30, P3039, DOI 10.1002/1521-4141(200010)30:10<3039::AID-IMMU3039>3.0.CO;2-H; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Graham Lloyd D, 2011, Genes Cancer, V2, P829, DOI 10.1177/1947601911431081; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kjeldsen MK, 2011, AM J CLIN PATHOL, V136, P960, DOI 10.1309/AJCPDQNP2U5DZHVV; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee MS, 2004, INT IMMUNOL, V16, P1109, DOI 10.1093/intimm/dxh112; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364	83	56	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138236	10.1371/journal.pone.0138236	http://dx.doi.org/10.1371/journal.pone.0138236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394393	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100041
J	Ptitsyn, A; Temanni, R; Bouchard, C; Anderson, PAV				Ptitsyn, Andrey; Temanni, Ramzi; Bouchard, Christelle; Anderson, Peter A. V.			Semantic Assembly and Annotation of Draft RNAseq Transcripts without a Reference Genome	PLOS ONE			English	Article							SEQ DATA; ALIGNMENT; EXPRESSION; ULTRAFAST; NEURONS; TOOL	Transcriptomes are one of the first sources of high-throughput genomic data that have benefitted from the introduction of Next-Gen Sequencing. As sequencing technology becomes more accessible, transcriptome sequencing is applicable to multiple organisms for which genome sequences are unavailable. Currently all methods for de novo assembly are based on the concept of matching the nucleotide context overlapping between short fragments-reads. However, even short reads may still contain biologically relevant information which can be used as hints in guiding the assembly process. We propose a computational workflow for the reconstruction and functional annotation of expressed gene transcripts that does not require a reference genome sequence and can be tolerant to low coverage, high error rates and other issues that often lead to poor results of de novo assembly in studies of non-model organisms. We start with either raw sequences or the output of a context-based de novo transcriptome assembly. Instead of mapping reads to a reference genome or creating a completely unsupervised clustering of reads, we assemble the unknown transcriptome using nearest homologs from a public database as seeds. We consider even distant relations, indirectly linking protein-coding fragments to entire gene families in multiple distantly related genomes. The intended application of the proposed method is an additional step of semantic (based on relations between protein-coding fragments) scaffolding following traditional (i.e. based on sequence overlap) de novo assembly. The method we developed was effective in analysis of the jellyfish Cyanea capillata transcriptome and may be applicable in other studies of gene expression in species lacking a high quality reference genome sequence. Our algorithms are implemented in C and designed for parallel computation using a high-performance computer. The software is available free of charge via an open source license.	[Ptitsyn, Andrey; Temanni, Ramzi] Sidra Med & Res Ctr, Doha, Qatar; [Bouchard, Christelle] Univ South Florida Manatee, Sarasota, FL 34243 USA; [Anderson, Peter A. V.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Anderson, Peter A. V.] Univ Florida, Dept Physiol & Funct Genom, St Augustine, FL 32080 USA	Sidra Medical & Research Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ptitsyn, A (corresponding author), Sidra Med & Res Ctr, POB 26999, Doha, Qatar.	aptitsyn@sidra.org		Ptitsyn, Andrey/0000-0003-1196-8757; Bouchard, Christelle/0000-0002-0044-984X; TEMANNI, Mohamed Ramzi/0000-0001-9125-1136	 [IOS1021769];  [CNS-0821622]	; 	Funding: This study was supported by Grant IOS1021769 (nsf.gov) to Peter Anderson funded collection and sequencing of the tissue samples; Grant CNS-0821622 (NSF.gov) to UF Advanced Computing and Information Systems Laboratory created a computational facility, used in this study; however, it had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON PAV, 1985, J NEUROPHYSIOL, V53, P821, DOI 10.1152/jn.1985.53.3.821; ANDERSON PAV, 1987, J EXP BIOL, V133, P231; ANDERSON PAV, 1983, J NEUROPHYSIOL, V50, P671, DOI 10.1152/jn.1983.50.3.671; APaS WE, 1984, BIOL BULL, V166, P396; Appeltans W, 2012, WORLD REGISTER MARIN; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lesh-Laurie G.E., 1991, P185; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	23	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138006	10.1371/journal.pone.0138006	http://dx.doi.org/10.1371/journal.pone.0138006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393794	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100026
J	Whetzel, PL; Grethe, JS; Banks, DE; Martone, ME				Whetzel, Patricia L.; Grethe, Jeffrey S.; Banks, Davis E.; Martone, Maryann E.			The NIDDK Information Network: A Community Portal for Finding Data, Materials, and Tools for Researchers Studying Diabetes, Digestive, and Kidney Diseases	PLOS ONE			English	Article							NEUROSCIENCE; FRAMEWORK; INTEGRATION; ONTOLOGIES; RESOURCES	The NIDDK Information Network (dkNET; http://dknet.org) was launched to serve the needs of basic and clinical investigators in metabolic, digestive and kidney disease by facilitating access to research resources that advance the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). By research resources, we mean the multitude of data, software tools, materials, services, projects and organizations available to researchers in the public domain. Most of these are accessed via web-accessible databases or web portals, each developed, designed and maintained by numerous different projects, organizations and individuals. While many of the large government funded databases, maintained by agencies such as European Bioinformatics Institute and the National Center for Biotechnology Information, are well known to researchers, many more that have been developed by and for the biomedical research community are unknown or underutilized. At least part of the problem is the nature of dynamic databases, which are considered part of the "hidden" web, that is, content that is not easily accessed by search engines. dkNET was created specifically to address the challenge of connecting researchers to research resources via these types of community databases and web portals. dkNET functions as a "search engine for data", searching across millions of database records contained in hundreds of biomedical databases developed and maintained by independent projects around the world. A primary focus of dkNET are centers and projects specifically created to provide high quality data and resources to NIDDK researchers. Through the novel data ingest process used in dkNET, additional data sources can easily be incorporated, allowing it to scale with the growth of digital data and the needs of the dkNET community. Here, we provide an overview of the dkNET portal and its functions. We show how dkNET can be used to address a variety of use cases that involve searching for research resources.	[Whetzel, Patricia L.; Grethe, Jeffrey S.; Banks, Davis E.; Martone, Maryann E.] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Martone, Maryann E.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Martone, ME (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA.	mmartone@ucsd.edu		Grethe, Jeffrey/0000-0001-5212-7052	National Institute of Diabetes and Digestive and Kidney Diseases [5 U24 DK097771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097771] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by grant # 5 U24 DK097771 from the National Institute of Diabetes and Digestive and Kidney Diseases. As a cooperative agreement, Drs. Ron Margolis, Kristen Abraham and Arthur Castle from NIDDK serve on the advisory board for dkNET. They received a copy of the manuscript and provided comments.	[Anonymous], 2013, BD2K DATA DISCOVERY; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Cachat J, 2012, INT REV NEUROBIOL, V103, P39, DOI 10.1016/B978-0-12-388408-4.00003-4; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Gupta A, 2008, NEUROINFORMATICS, V6, P205, DOI 10.1007/s12021-008-9033-y; Gupta S, 2014, ADV INTELL SYST, V236, P821, DOI 10.1007/978-81-322-1602-5_87; Imam Fahim T., 2012, Frontiers in Genetics, V3, P111, DOI 10.3389/fgene.2012.00111; Marenco L, 2010, NEUROINFORMATICS, V8, P101, DOI 10.1007/s12021-010-9068-8; Marenco LN, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00058; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; McKenna NJ, 2012, MOL ENDOCRINOL, V26, P1675, DOI 10.1210/me.2012-1077; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Priem J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048753; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346	14	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0136206	10.1371/journal.pone.0136206	http://dx.doi.org/10.1371/journal.pone.0136206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393351	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100006
J	Hardelid, P; Rait, G; Gilbert, R; Petersen, I				Hardelid, Pia; Rait, Greta; Gilbert, Ruth; Petersen, Irene			Recording of Influenza-Like Illness in UK Primary Care 1995-2013: Cohort Study	PLOS ONE			English	Article							PANDEMIC INFLUENZA; RISK-FACTORS; SURVEILLANCE; VIRUS; HOSPITALIZATIONS; MORTALITY; SEVERITY; DATABASE; PERIODS; TRENDS	Background There is a lack of recent studies examining recording of influenza-like illness (ILI) in primary care in the UK over time and according to population characteristics. Our aim was to determine time trends and socio-demographic patterns of ILI recorded consultations in primary care. Methods We used The Health Improvement Network (THIN) UK primary care database and extracted data on all ILI consultations between 1995 and 2013. We estimated ILI recorded consultation rates per 100,000 person-weeks (pw) by age, gender, deprivation and winter season. Negative binomial regression models were used to examine time trends and the effect of socio-demographic characteristics. Trends in ILI recorded consultations were compared to trends in consultations with less specific symptoms (cough or fever) recorded. Results The study involved 7,682,908 individuals in 542 general practices. The ILI consultation rate decreased from 32.5/100,000 pw (95% confidence interval (CI) 32.1, 32.9) in 1995-98 to 15.5/100,000 pw (95% CI 15.4, 15.7) by 2010-13. The decrease occurred prior to 2002/3, and rates have remained largely stable since then. Declines were evident in all age groups. In comparison, cough or fever consultation rates increased from 169.4/100,000 pw (95% CI 168.6, 170.3) in 1995-98 to 237.7/100,000 pw (95% CI 237.2, 238.2) in 2010-13. ILI consultation rates were highest among individuals aged 15-44 years, higher in women than men, and in individuals from deprived areas. Conclusion There is substantial variation in ILI recorded consultations over time and by population socio-demographic characteristics, most likely reflecting changing recording behaviour by GPs. These results highlight the difficulties in using coded information from electronic primary care records to measure the severity of influenza epidemics across time and assess the relative burden of ILI in different population subgroups.	[Hardelid, Pia; Gilbert, Ruth] UCL, Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Hardelid, Pia; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Rait, Greta] UCL, Res Dept Primary Care & Populat Hlth, PRIMENT Clin Trials Unit, London, England; [Petersen, Irene] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark	University of London; University College London; University of London; University College London; University of London; University College London; Aarhus University	Hardelid, P (corresponding author), UCL, Inst Child Hlth, Populat Policy & Practice Programme, London, England.	p.hardelid@ucl.ac.uk	Petersen, Irene/C-5702-2009; Hardelid, Pia/K-3353-2013	Petersen, Irene/0000-0002-0037-7524; Hardelid, Pia/0000-0002-0154-1306; Rait, Greta/0000-0002-7216-7294; Gilbert, Ruth/0000-0001-9347-2709	National Institute for Health Research postdoctoral fellowship [PDF-2013-06-004]; National Institute for Health Research (NIHR); Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [PDF-2013-06-004] Funding Source: researchfish	National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	PH is funded by a National Institute for Health Research postdoctoral fellowship (number PDF-2013-06-004). This article represents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not those of the NHS, the NIHR or the Department of Health. RG and PH are members of the Farr Institute of Health Informatics Research London. The funders had no role in study design, collection, analysis, interpretation of data, or writing of the report.	Adler AJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-232; Benson Tim, 2011, Inform Prim Care, V19, P173; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; CSD Medical Research, 2014, HLTH IMPR NETW 2014; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Department of Health, 2014, US ANT INFL PAND SCI; Dierig A, 2014, INFLUENZA OTHER RESP, V8, P293, DOI 10.1111/irv.12229; Dijkstra F, 2009, EPIDEMIOL INFECT, V137, P473, DOI 10.1017/S095026880800126X; Elliot A J, 2006, Euro Surveill, V11, P249; European Centre for Disease Prevention and Control, 2014, INFL CAS DEF 2014; Falchi A, 2011, J MED VIROL, V83, P1451, DOI 10.1002/jmv.22113; FRANK AL, 1983, J INFECT DIS, V147, P120, DOI 10.1093/infdis/147.1.120; Goddard N L, 2003, Commun Dis Public Health, V6, P128; Green HK, 2015, EPIDEMIOL INFECT, V143, P1, DOI 10.1017/S0950268814001757; Harcourt SE, 2012, EPIDEMIOL INFECT, V140, P100, DOI 10.1017/S095026881100046X; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Harrell FE, 2001, REGRESSION MODELING; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; Hoschler K, 2012, EMERG INFECT DIS, V18, P1894, DOI 10.3201/eid1811.120720; Huang QS, 2008, INFLUENZA OTHER RESP, V2, P139, DOI 10.1111/j.1750-2659.2008.00050.x; Joint Formulary Committee, 2014, BRIT NAT FORM 66; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khieu TQT, 2015, VACCINE, V33, P4087, DOI 10.1016/j.vaccine.2015.06.080; Lian IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084239; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mayoral JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-118; McNulty C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000674; Meier CR, 2000, EUR J CLIN MICROBIOL, V19, P834, DOI 10.1007/s100960000376; Millett ERC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075131; Molbak K, 2015, EURO SURVEILL, V20; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Public Health England, 2013, SURV INFL OTH RESP V; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Ross A M, 2000, Commun Dis Public Health, V3, P256; Royal College of General Practitioners, WEEKL RET SERV ANN R; Rutter PD, 2012, INT J PUBLIC HEALTH, V57, P745, DOI 10.1007/s00038-012-0337-1; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; StataCorp, 2013, STAT STAT SOFTW REL; Storms AD, 2013, INFLUENZA OTHER RESP, V7, P1328, DOI 10.1111/irv.12106; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Zhao H, 2014, EURO SURVEILL, V19; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	51	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138659	10.1371/journal.pone.0138659	http://dx.doi.org/10.1371/journal.pone.0138659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390295	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000050
J	Ziuzina, D; Boehm, D; Patil, S; Cullen, PJ; Bourke, P				Ziuzina, Dana; Boehm, Daniela; Patil, Sonal; Cullen, P. J.; Bourke, Paula			Cold Plasma Inactivation of Bacterial Biofilms and Reduction of Quorum Sensing Regulated Virulence Factors	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; PSEUDOMONAS-AERUGINOSA VIRULENCE; HACAT KERATINOCYTES; NONTHERMAL PLASMA; PYOCYANIN; OXYGEN; FOOD; STERILIZATION; INHIBITION; MECHANISMS	The main objectives of this work were to investigate the effect of atmospheric cold plasma (ACP) against a range of microbial biofilms commonly implicated in foodborne and health-care associated human infections and against P. aeruginosa quorum sensing (QS)-regulated virulence factors, such as pyocyanin, elastase (Las B) and biofilm formation capacity post-ACP treatment. The effect of processing factors, namely treatment time and mode of plasma exposure on antimicrobial activity of ACP were also examined. Antibiofilm activity was assessed for E. coli, L. monocytogenes and S. aureus in terms of reduction of culturability and retention of metabolic activity using colony count and XTT assays, respectively. All samples were treated 'inpack' using sealed polypropylene containers with a high voltage dielectric barrier discharge ACP generated at 80 kV for 0, 60, 120 and 300 s and a post treatment storage time of 24 h. According to colony counts, ACP treatment for 60 s reduced populations of E. coli to undetectable levels, whereas 300 s was necessary to significantly reduce populations of L. monocytogenes and S. aureus biofilms. The results obtained from XTT assay indicated possible induction of viable but non culturable state of bacteria. With respect to P. aeruginosa QS-related virulence factors, the production of pyocyanin was significantly inhibited after short treatment times, but reduction of elastase was notable only after 300 s and no reduction in actual biofilm formation was achieved post-ACP treatment. Importantly, reduction of virulence factors was associated with reduction of the cytotoxic effects of the bacterial supernatant on CHO-K1 cells, regardless of mode and duration of treatment. The results of this study point to ACP technology as an effective strategy for inactivation of established biofilms and may play an important role in attenuation of virulence of pathogenic bacteria. Further investigation is warranted to propose direct evidence for the inhibition of QS and mechanisms by which this may occur.	[Ziuzina, Dana; Boehm, Daniela; Patil, Sonal; Bourke, Paula] Dublin Inst Technol, Sch Food Sci & Environm Hlth, Plasma Res Grp, Dublin 1, Ireland; [Cullen, P. J.] Univ New S Wales, Sch Chem Engn, Sydney, NSW, Australia	University of New South Wales Sydney	Bourke, P (corresponding author), Dublin Inst Technol, Sch Food Sci & Environm Hlth, Plasma Res Grp, Dublin 1, Ireland.	paula.bourke@dit.ie	Cullen, PJ/C-1901-2008; Cullen, PJ/W-9341-2019; Boehm, Daniela/AAD-7605-2020; Bourke, Paula/Y-2709-2019	Cullen, PJ/0000-0001-7654-6171; Boehm, Daniela/0000-0003-3188-5115; Bourke, Paula/0000-0002-5607-8021; Ziuzina, Dana/0000-0003-2142-9095	European Community [285820]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2207-2013) under grant agreement number 285820.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Amaya S, 2012, PHYTOMEDICINE, V19, P1173, DOI 10.1016/j.phymed.2012.07.003; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Ayrapetyan M, 2015, TRENDS MICROBIOL, V23, P7, DOI 10.1016/j.tim.2014.09.004; Bhardwaj Ashima K, 2013, Recent Pat Antiinfect Drug Discov, V8, P68; Brackman G, 2015, CURR PHARM DESIGN, V21, P5; Brelles-Marino G, 2012, J BIOPROCESS BIOTECH, V2, P2, DOI DOI 10.4172/2155-9821.1000E107; Bridier A, 2015, FOOD MICROBIOL, V45, P167, DOI 10.1016/j.fm.2014.04.015; Jose JFBD, 2014, FOOD CONTROL, V45, P36, DOI 10.1016/j.foodcont.2014.04.015; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Cady NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038492; Cathcart GRA, 2011, ANTIMICROB AGENTS CH, V55, P2670, DOI 10.1128/AAC.00776-10; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; Dobrynin D, 2011, PLASMA MED, V1, P241, DOI DOI 10.1615/PlasmaMed.2012005167; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; El-Mowafy SA, 2014, MICROB PATHOGENESIS, V74, P25, DOI 10.1016/j.micpath.2014.07.008; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Frohling A, 2012, INNOV FOOD SCI EMERG, V13, P142, DOI 10.1016/j.ifset.2011.11.002; Gellatly SL, 2012, INFECT IMMUN, V80, P3122, DOI 10.1128/IAI.00382-12; Giaouris E, 2014, MEAT SCI, V97, P298, DOI 10.1016/j.meatsci.2013.05.023; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Heslin, 2014, PLASMA MED, V4, P153, DOI [10.1615/PlasmaMed.2014011997, DOI 10.1615/PlasmaMed.2014011997]; Ishida T, 2007, APPL ENVIRON MICROB, V73, P3183, DOI 10.1128/AEM.02233-06; Jahid IK, 2014, FOOD RES INT, V55, P181, DOI 10.1016/j.foodres.2013.11.005; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Karatuna O, 2010, CLIN MICROBIOL INFEC, V16, P1770, DOI 10.1111/j.1469-0691.2010.03177.x; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; Kramer A, 2013, CLIN PLASMA MED, V1, P11, DOI 10.1016/j.cpme.2013.03.002; Lambert PA, 2002, J ROY SOC MED, V95, P22; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Le Berre R, 2008, CLIN MICROBIOL INFEC, V14, P337, DOI 10.1111/j.1469-0691.2007.01925.x; Leduc M, 2010, PLASMA PROCESS POLYM, V7, P899, DOI 10.1002/ppap.201000032; Lee K, 2006, J MICROBIOL, V44, P269; Lunov O, 2014, NATURE SCI REPORTS, V4, P1; Misra NN, 2015, FOOD HYDROCOLLOID, V44, P115, DOI 10.1016/j.foodhyd.2014.08.019; Mohammed HA, 2014, IRAQI J SCI, V55, P668; Moiseev T, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/6/065033; Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Priyaja P, 2016, CYTOTECHNOLOGY, V68, P143, DOI 10.1007/s10616-014-9765-5; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Reszka KJ, 2012, AM J PHYSIOL-LUNG C, V302, pL1044, DOI 10.1152/ajplung.00172.2011; Reszka KJ, 2010, PHOTOCHEM PHOTOBIOL, V86, P742, DOI 10.1111/j.1751-1097.2010.00728.x; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Rowan NJ, 2004, TRENDS FOOD SCI TECH, V15, P462, DOI 10.1016/j.tifs.2004.02.009; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001; Ulbin-Figlewicz N, 2015, ANN MICROBIOL, V65, P1537, DOI 10.1007/s13213-014-0992-y; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vandervoort KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108512; Venier AG, 2014, J HOSP INFECT, V88, P103, DOI 10.1016/j.jhin.2014.06.018; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Yu H, 2014, CAN J MICROBIOL, V60, P227, DOI 10.1139/cjm-2013-0667; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087; Ziuzina D., 2014, PLASMA MED, V4, P137, DOI [DOI 10.1615/PLASMAMED.2014011996, 10.1615/PlasmaMed.2014011996]	72	94	97	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138209	10.1371/journal.pone.0138209	http://dx.doi.org/10.1371/journal.pone.0138209			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390435	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000020
J	Grammatikos, G; Ferreiros, N; Waidmann, O; Bon, D; Schroeter, S; Koch, A; Herrmann, E; Zeuzem, S; Kronenberger, B; Pfeilschifter, J				Grammatikos, Georgios; Ferreiros, Nerea; Waidmann, Oliver; Bon, Dimitra; Schroeter, Sirkka; Koch, Alexander; Herrmann, Eva; Zeuzem, Stefan; Kronenberger, Bernd; Pfeilschifter, Josef			Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis	PLOS ONE			English	Article							CERAMIDE SYNTHASE 2; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; ACID SPHINGOMYELINASE; INDUCED AUTOPHAGY; CHAIN LENGTH; APOPTOSIS; METABOLISM; CELLS; MODEL	Background Sphingolipids constitute bioactive molecules with functional implications in liver homeostasis. Particularly, ablation of very long chain ceramides in a knockout mouse model has been shown to cause a severe hepatopathy. Methods We aimed to evaluate the serum sphingolipid profile of 244 patients with cirrhosis prospectively followed for a median period of 228 +/- 217 days via mass spectrometry. Results We thereby observed a significant decrease of long and very long chain ceramides, particularly of C24ceramide, in patients with increasing severity of cirrhosis (p<0.001). Additionally, hydropic decompensation, defined by clinical presentation of ascites formation, was significantly correlated to low C24ceramide levels (p<0.001) while a significant association to hepatic decompensation and poor overall survival was observed for low serum concentrations of C24ceramide (p<0.001) as well. Multivariate analysis further identified low serum C24ceramide to be independently associated to overall survival (standard beta = -0.001, p = 0.022). Conclusions In our current analysis serum levels of very long chain ceramides show a significant reciprocal correlation to disease severity and hepatic decompensation and are independently associated with overall survival in patients with cirrhosis. Serum sphingolipid metabolites and particularly C24ceramide may constitute novel molecular targets of disease severity, hepatic decompensation and overall prognosis in cirrhosis and should be further evaluated in basic research studies.	[Grammatikos, Georgios; Schroeter, Sirkka; Koch, Alexander; Pfeilschifter, Josef] Pharmazentrum Frankfurt, Inst Allgemeine Pharmakol & Toxikol, Frankfurt, Germany; [Grammatikos, Georgios; Waidmann, Oliver; Schroeter, Sirkka; Zeuzem, Stefan; Kronenberger, Bernd] Goethe Univ Hosp, Med Klin 1, Frankfurt, Germany; [Ferreiros, Nerea] Goethe Univ Hosp, Pharmazentrum Frankfurt, Inst Klin Pharmakol, Frankfurt, Germany; [Bon, Dimitra; Herrmann, Eva] Goethe Univ Frankfurt, Dept Med, Inst Biostat & Math Modelling, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Grammatikos, G (corresponding author), Pharmazentrum Frankfurt, Inst Allgemeine Pharmakol & Toxikol, Frankfurt, Germany.	georgios.grammatikos@kgu.de	Zeuzem, Stefan/AAE-7435-2019		German Research Foundation DFG [FOG784, PF361/5-2, PF361/7-1, GRK 1172, SFB 815, SFB 1039]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by the German Research Foundation DFG (FOG784, PF361/5-2, PF361/7-1, GRK 1172, SFB 815 and SFB 1039).	Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Deng G, 2013, WORLD J GASTROENTERO, V19, P7778, DOI 10.3748/wjg.v19.i43.7778; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Grammatikos G, 2015, HEPATOLOGY, V61, P812, DOI 10.1002/hep.27587; Grammatikos G, 2014, BBA-MOL CELL BIOL L, V1841, P1012, DOI 10.1016/j.bbalip.2014.04.007; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; Janusova B, 2011, BBA-MOL CELL BIOL L, V1811, P129, DOI 10.1016/j.bbalip.2010.12.003; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Klein RL, 2014, METABOLISM, V63, P1287, DOI 10.1016/j.metabol.2014.07.001; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Novotny J, 2009, BIOORG MED CHEM LETT, V19, P6975, DOI 10.1016/j.bmcl.2009.10.047; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Papatheodoridis GV, 2005, WORLD J GASTROENTERO, V11, P3099, DOI 10.3748/wjg.v11.i20.3099; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Precone V, 2013, LIVER INT, V33, P834, DOI 10.1111/liv.12169; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Tatematsu K, 2011, J MED VIROL, V83, P587, DOI 10.1002/jmv.21970; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Waidmann O, 2013, J HEPATOL, V58, P956, DOI 10.1016/j.jhep.2013.01.005; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	45	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138130	10.1371/journal.pone.0138130	http://dx.doi.org/10.1371/journal.pone.0138130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382760	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200061
J	Hashikin, NA; Yeong, CH; Abdullah, BJJ; Ng, KH; Chung, LY; Dahalan, R; Perkins, AC				Hashikin, Nurul Ab Aziz; Yeong, Chai-Hong; Abdullah, Basri Johan Jeet; Ng, Kwan-Hoong; Chung, Lip-Yong; Dahalan, Rehir; Perkins, Alan Christopher			Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities	PLOS ONE			English	Article							GLASS MICROSPHERES; HEPATIC-TUMORS; DELIVERY; LU-177; RESIN	Introduction Samarium-153 (Sm-153) styrene divinylbenzene microparticles were developed as a surrogate for Yttrium-90 (Y-90) microspheres in liver radioembolization therapy. Unlike the pure beta emitter Y-90, Sm-153 possess both therapeutic beta and diagnostic gamma radiations, making it possible for post-procedure imaging following therapy. Methods The microparticles were prepared using commercially available cation exchange resin, Amberlite IR-120 H+ (620-830 mu m), which were reduced to 20-40 mu m via ball mill grinding and sieve separation. The microparticles were labelled with Sm-152 via ion exchange process with (SmCl3)-Sm-152, prior to neutron activation to produce radioactive Sm-153 through Sm-152 (n,y) Sm-153 reaction. Therapeutic activity of 3 GBq was referred based on the recommended activity used in Y-90-microspheres therapy. The samples were irradiated in 1.494 x 10(12) n. cm(-2).s(-1) neutron flux for 6 h to achieve the nominal activity of 3.1 GBq. g(-1). Physicochemical characterisation of the microparticles, gamma spectrometry, and in vitro radiolabelling studies were carried out to study the performance and stability of the microparticles. Results Fourier Transform Infrared (FTIR) spectroscopy of the Amberlite IR-120 resins showed unaffected functional groups, following size reduction of the beads. However, as shown by the electron microscope, the microparticles were irregular in shape. The radioactivity achieved after 6 h neutron activation was 3.104 +/- 0.029 GBq. The specific activity per microparticle was 53.855 +/- 0.503 Bq. Gamma spectrometry and elemental analysis showed no radioactive impurities in the samples. Radiolabelling efficiencies of Sm-153-Amberlite in distilled water and blood plasma over 48 h were excellent and higher than 95%. Conclusion The laboratory work revealed that the Sm-153-Amberlite microparticles demonstrated superior characteristics for potential use in hepatic radioembolization.	[Hashikin, Nurul Ab Aziz; Yeong, Chai-Hong; Abdullah, Basri Johan Jeet; Ng, Kwan-Hoong] Univ Malaya, Fac Med, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Hashikin, Nurul Ab Aziz; Yeong, Chai-Hong; Abdullah, Basri Johan Jeet; Ng, Kwan-Hoong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Chung, Lip-Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Dahalan, Rehir] Agensi Nuklear Malaysia, Med Technol Div, Kajang, Selangor, Malaysia; [Perkins, Alan Christopher] Univ Nottingham, Sch Med, Radiol & Imaging Sci, Med Phys & Clin Engn, Nottingham, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; Agensi Nuklear Malaysia; University of Nottingham	Perkins, AC (corresponding author), Univ Nottingham, Sch Med, Radiol & Imaging Sci, Med Phys & Clin Engn, Nottingham, England.	alan.perkins@nottingham.ac.uk	HONG, YEONG CHAI/C-1083-2010; , ABC/AAD-1499-2019; Hashikin, Nurul/M-4448-2015; Ng, Kwan Hoong/D-2231-2009; CHUNG, LIP YONG/B-7764-2010	HONG, YEONG CHAI/0000-0003-1572-4143; Hashikin, Nurul/0000-0001-8890-1361; CHUNG, LIP YONG/0000-0002-3596-768X; Perkins, Alan/0000-0002-1054-8200	Ministry of Science, Technology and Innovation (MOSTI) [06-01-03-SF0966]; Institute of Research Management & Monitoring (Institut Pengurusan dan Pemantauan Penyelidikan (IPPP)), University of Malaya [PG104-2013B, RG459-12HTM]	Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Institute of Research Management & Monitoring (Institut Pengurusan dan Pemantauan Penyelidikan (IPPP)), University of Malaya	This work was supported by the Ministry of Science, Technology and Innovation (MOSTI) (Kementerian Sains, Teknologi dan Inovasi), ScienceFund, Grant No. 06-01-03-SF0966 to CHY (http://www.mosti.gov.my/en/funds-grants/science-fund/), the Institute of Research Management & Monitoring (Institut Pengurusan dan Pemantauan Penyelidikan (IPPP)), University of Malaya, Postgraduate Research Fund (PPP), Grant No. PG104-2013B to NAAH (http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=63&papar=1), and the Institute of Research Management & Monitoring (Institut Pengurusan dan Pemantauan Penyelidikan (IPPP)), University of Malaya, University of Malaya Research Grant (UMRG), Grant No. RG459-12HTM to BJJA (http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=62&papar=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AMBERLITETM IR 120 H; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; BTG International, 2013, ABOUT THERASPHERE; Elder DP, 2005, J CHEM EDUC, V82, P575, DOI 10.1021/ed082p575; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gupta T, 2008, RADIOLOGY, V249, P845, DOI 10.1148/radiol.2491072027; Hafeli UO, 2001, APPL RADIAT ISOTOPES, V54, P869, DOI 10.1016/S0969-8043(00)00313-4; Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9; Helfferich F., 1964, ION EXCHANGE; Hruby M, 2011, REACT FUNCT POLYM, V71, P1155, DOI 10.1016/j.reactfunctpolym.2011.09.003; IAEA, 2015, RES REACT DAT RES RE; Kim DH, 2015, THERANOSTICS, V5, P477, DOI 10.7150/thno.10823; Koch W, 2008, MED RADIOL DIAGN IMA, P75, DOI 10.1007/978-3-540-35423-9_8; Laboratoire National Henri Becquerel, 2014, REC DAT Z; Lokhande R.S., 2011, OJPC, V01, P45, DOI [10.4236/ojpc.2011.12007, DOI 10.4236/OJPC.2011.12007]; [Medical Ethics Committee (MEC) University Malaya Medical Centre (UMMC)], 2015, PK71QSU011E02 UMMC M, P1; MUMPER RJ, 1991, J NUCL MED, V32, P2139; Poorbaygi H, 2011, APPL RADIAT ISOTOPES, V69, P1407, DOI 10.1016/j.apradiso.2011.05.026; Qaim SM, 2001, RADIOCHIM ACTA, V89, P297, DOI 10.1524/ract.2001.89.4-5.297; Riaz A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00198; Schmidt JJ, 1974, TECHN REP SER, V156; Thermo Fisher Scientific, 2009, TN01704 THERM FISH S; TURNER JH, 1994, NUCL MED COMMUN, V15, P545, DOI 10.1097/00006231-199407000-00009; U.S. Food and Drug Administration (FDA), 2002, RES REACT DAT RES RE; University Malaya Medical Centre (UMMC), 2015, RES RES ETH UMMC MED; University Malaya Medical Centre (UMMC), 2014, DEP TRANSF MED JAB P; Wheaton R. M., 2000, FUNDAMENTALS ION EXC; Yeong CH, 2012, APPL RADIAT ISOTOPES, V70, P450, DOI 10.1016/j.apradiso.2011.11.056; Yeong CH, 2011, NUCL MED COMMUN, V32, P1256, DOI 10.1097/MNM.0b013e32834b3ac8	29	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138106	10.1371/journal.pone.0138106	http://dx.doi.org/10.1371/journal.pone.0138106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382059	Green Published, gold			2022-12-26	WOS:000361790200058
J	Huang, K; Bi, K; Liang, C; Lin, S; Wang, WJ; Yang, TZ; Liu, J; Zhang, R; Fan, DY; Wang, YG; Lei, M				Huang, K.; Bi, K.; Liang, C.; Lin, S.; Wang, W. J.; Yang, T. Z.; Liu, J.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.			Graphite Carbon-Supported Mo2C Nanocomposites by a Single-Step Solid State Reaction for Electrochemical Oxygen Reduction	PLOS ONE			English	Article							ANION-EXCHANGE MEMBRANES; MOLYBDENUM CARBIDE; CATALYTIC-ACTIVITY; METAL CARBIDES; FACILE ROUTE; FUEL-CELLS; ELECTROCATALYSTS; PERFORMANCE; NITRIDES; GRAPHENE	Novel graphite-molybdenum carbide nanocomposites (G-Mo2C) are synthesized by a typical solid state reaction with melamine and MoO3 as precursors under inert atmosphere. The characterization results indicate that G-Mo2C composites are composed of high crystallization and purity of Mo2C and few layers of graphite carbon. Mo2C nanoparticles with sizes ranging from 5 to 50 nm are uniformly supported by surrounding graphite layers. It is believed that Mo atom resulting from the reduction of MoO3 is beneficial to the immobilization of graphite carbon. Moreover, the electrocatalytic performances of G-Mo2C for ORR in alkaline medium are investigated by cyclic voltammetry (CV), rotating disk electrode (RDE) and chronoamperometry test with 3M methanol. The results show that G-Mo2C has a considerable catalytic activity and superior methanol tolerance performance for the oxygen reduction reaction (ORR) benefiting from the chemical interaction between the carbide nanoparticles and graphite carbon.	[Huang, K.; Bi, K.; Liang, C.; Lin, S.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.] Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing 100088, Peoples R China; [Huang, K.; Bi, K.; Liang, C.; Lin, S.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.] Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100088, Peoples R China; [Wang, W. J.; Yang, T. Z.] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China; [Liu, J.] Cent S Univ, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications; Chinese Academy of Sciences; Institute of Physics, CAS; Central South University	Wang, WJ (corresponding author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, POB 603, Beijing 100080, Peoples R China.	wjwang@iphy.ac.cn; minglei@bupt.edu.cn	Bi, Ke/C-1175-2011	Bi, Ke/0000-0002-3357-5754	National Basic Research Program of China [2013CB932901]; Program for New Century Excellent Talents in University [NCET-13-0684]; State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China); National Natural Science Foundation of China [61376018, 61377097, 51102019, 61177085, 51272031, 51472033]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The National Basic Research Program of China (Grant No. 2013CB932901), Program for New Century Excellent Talents in University (NCET-13-0684), Fund of State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China), and National Natural Science Foundation of China (Grant nos. 61376018,61377097,51102019, 61177085, 51272031,51472033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao R, 2012, ADV ENERGY MATER, V2, P816, DOI 10.1002/aenm.201200013; Cheekatamarla PK, 2005, APPL CATAL A-GEN, V287, P176, DOI 10.1016/j.apcata.2005.03.043; Cheekatamarla PK, 2006, J POWER SOURCES, V158, P477, DOI 10.1016/j.jpowsour.2005.09.009; Chen R, 2013, SCI ADV MATER, V5, P1788, DOI 10.1166/sam.2013.1632; Cheng FY, 2012, CHEM SOC REV, V41, P2172, DOI 10.1039/c1cs15228a; Politi JRD, 2013, PHYS CHEM CHEM PHYS, V15, P12617, DOI 10.1039/c3cp51389k; Gillan EG, 2000, CHEM MATER, V12, P3906, DOI 10.1021/cm000570y; Hardin WG, 2013, J PHYS CHEM LETT, V4, P1254, DOI 10.1021/jz400595z; Huang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11351; Jager R, 2013, ELECTROCHEM COMMUN, V35, P97, DOI 10.1016/j.elecom.2013.08.001; Jirkovsky JS, 2010, PHYS CHEM CHEM PHYS, V12, P8042, DOI 10.1039/c002416c; Jurgens B, 2003, J AM CHEM SOC, V125, P10288, DOI 10.1021/ja0357689; Kartachova O, 2014, J MATER CHEM A, V2, P12940, DOI 10.1039/c4ta00220b; Khabashesku VN, 2000, CHEM MATER, V12, P3264, DOI 10.1021/cm000328r; Kong AG, 2014, ACS CATAL, V4, P1793, DOI 10.1021/cs401257j; Lei M, 2009, J EUR CERAM SOC, V29, P195, DOI 10.1016/j.jeurceramsoc.2008.06.002; Lei M, 2008, J ALLOY COMPD, V460, P130, DOI 10.1016/j.jallcom.2007.05.076; Lei M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07415; Lei M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06013; Lei M, 2011, J ALLOY COMPD, V509, P5769, DOI 10.1016/j.jallcom.2011.02.029; Lei M, 2011, J POWER SOURCES, V196, P3548, DOI 10.1016/j.jpowsour.2010.12.026; Li JR, 2013, CHEM COMMUN, V49, P6537, DOI 10.1039/c3cc42011f; Liang C, 2014, J MATER CHEM A, V2, P753, DOI 10.1039/c3ta14064d; Liao L, 2014, PHYS CHEM CHEM PHYS, V16, P10088, DOI 10.1039/c3cp54754j; Lin BC, 2014, J POWER SOURCES, V266, P186, DOI 10.1016/j.jpowsour.2014.05.003; Lin L, 2014, J POWER SOURCES, V268, P269, DOI 10.1016/j.jpowsour.2014.06.062; Lotsch BV, 2005, CHEM MATER, V17, P3976, DOI 10.1021/cm050350q; Ma YF, 2014, J PHYS CHEM C, V118, P9485, DOI 10.1021/jp501021t; Pandey RP, 2014, J MEMBRANE SCI, V469, P478, DOI 10.1016/j.memsci.2014.06.046; Ren XM, 2014, ACS APPL MATER INTER, V6, P13330, DOI 10.1021/am503870g; Savinelli R, 2009, 21 NAM P W 68; Song B, 2008, PHYSICA B, V403, P2897, DOI 10.1016/j.physb.2008.02.032; Song B, 2007, CHEM MATER, V19, P1497, DOI 10.1021/cm062796s; Stottlemyer AL, 2012, SURF SCI REP, V67, P201, DOI 10.1016/j.surfrep.2012.07.001; Tominaga H, 2012, APPL CATAL A-GEN, V423, P192, DOI 10.1016/j.apcata.2012.02.041; Tuci G, 2014, CHEM MATER, V26, P3460, DOI 10.1021/cm500805c; Uhm S, 2011, ELECTROCHIM ACTA, V56, P9186, DOI 10.1016/j.electacta.2011.07.108; Vines F, 2007, J PHYS CHEM C, V111, P16982, DOI 10.1021/jp0754987; Wan C, 2014, ANGEW CHEM INT EDIT, V53, P6407, DOI 10.1002/anie.201402998; Wang JT, 2013, J POWER SOURCES, V240, P381, DOI 10.1016/j.jpowsour.2013.03.189; Wang SY, 2011, J AM CHEM SOC, V133, P5182, DOI 10.1021/ja1112904; Wu P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03968; Xia BY, 2012, ANGEW CHEM INT EDIT, V51, P7213, DOI 10.1002/anie.201201553; Yan ZX, 2013, ELECTROCHIM ACTA, V95, P218, DOI 10.1016/j.electacta.2013.02.031; Yang W, 2012, INT J HYDROGEN ENERG, V37, P942, DOI 10.1016/j.ijhydene.2011.03.103; Yang YQ, 2014, J MEMBRANE SCI, V467, P48, DOI 10.1016/j.memsci.2014.05.017; Zhao HZ, 2006, J MATER CHEM, V16, P4407, DOI 10.1039/b611381h	47	20	20	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138330	10.1371/journal.pone.0138330	http://dx.doi.org/10.1371/journal.pone.0138330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381266	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200092
J	Jeeves, RE; Marriott, AAN; Pullan, ST; Hatch, KA; Allnutt, JC; Freire-Martin, I; Hendon-Dunn, CL; Watson, R; Witney, AA; Tyler, RH; Arnold, C; Marsh, PD; McHugh, TD; Bacon, J				Jeeves, Rose E.; Marriott, Alice A. N.; Pullan, Steven T.; Hatch, Kim A.; Allnutt, Jon C.; Freire-Martin, Irene; Hendon-Dunn, Charlotte L.; Watson, Robert; Witney, Adam A.; Tyler, Richard H.; Arnold, Catherine; Marsh, Philip D.; McHugh, Timothy D.; Bacon, Joanna			Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser(315)	PLOS ONE			English	Article							CATALASE-PEROXIDASE; ANTITUBERCULOSIS DRUGS; MUTATION-RATE; RIFAMPICIN RESISTANCE; GENE-EXPRESSION; NONCODING RNA; IN-VITRO; INFECTION; EVOLUTION; RPOB	An important aim for improving TB treatment is to shorten the period of antibiotic therapy without increasing relapse rates or encouraging the development of antibiotic-resistant strains. In any M. tuberculosis population there is a proportion of bacteria that are drug-tolerant; this might be because of pre-existing populations of slow growing/non replicating bacteria that are protected from antibiotic action due to the expression of a phenotype that limits drug activity. We addressed this question by observing populations of either slow growing (constant 69.3h mean generation time) or fast growing bacilli (constant 23.1h mean generation time) in their response to the effects of isoniazid exposure, using controlled and defined growth in chemostats. Phenotypic differences were detected between the populations at the two growth rates including expression of efflux mechanisms and the involvement of antisense RNA/small RNA in the regulation of a drug-tolerant phenotype, which has not been explored previously for M. tuberculosis. Genotypic analyses showed that slow growing bacilli develop resistance to isoniazid through mutations specifically in katG codon Ser(315) which are present in approximately 50-90% of all isoniazid-resistant clinical isolates. The fast growing bacilli persisted as a mixed population with katG mutations distributed throughout the gene. Mutations in katG codon Ser(315) appear to have a fitness cost in vitro and particularly in fast growing cultures. Our results suggest a requirement for functional katG-encoded catalase-peroxide in the slow growers but not the fast-growing bacteria, which may explain why katG codon Ser(315) mutations are favoured in the slow growing cultures.	[Jeeves, Rose E.; Marriott, Alice A. N.; Pullan, Steven T.; Hatch, Kim A.; Allnutt, Jon C.; Freire-Martin, Irene; Hendon-Dunn, Charlotte L.; Watson, Robert; Marsh, Philip D.; Bacon, Joanna] Publ Hlth England, Salisbury, Wilts, England; [Witney, Adam A.; Tyler, Richard H.] Univ London, London, England; [Arnold, Catherine] Publ Hlth England, London, England; [McHugh, Timothy D.] UCL, Ctr Clin Microbiol, London, England	Public Health England; University of London; Public Health England; University of London; University College London	Bacon, J (corresponding author), Publ Hlth England, Salisbury, Wilts, England.	joanna.bacon@phe.gov.uk	McHugh, Timothy/O-3683-2019; McHugh, Timothy D/AAF-7231-2020	McHugh, Timothy D/0000-0003-4658-8594; Witney, Adam/0000-0003-4561-7170; Bacon, Joanna/0000-0002-2217-228X; Watson, Robert/0000-0003-3146-3457; Pullan, Steven/0000-0002-8983-599X	Innovative Medicines Initiative [115337]; European Union; Department of Health; National Institute of Health Research	Innovative Medicines Initiative; European Union(European Commission); Department of Health; National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement no115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. Funding was also received from the Department of Health Grant in Aid and National Institute of Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2005, CLIN MICROBIOL INFEC, V11, P122, DOI 10.1111/j.1469-0691.2004.01034.x; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Brandis G, 2013, J ANTIMICROB CHEMOTH, V68, P2493, DOI 10.1093/jac/dkt224; Colangeli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091024; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Dutta NK, 2014, MICROBIOL MOL BIOL R, V78, P343, DOI 10.1128/MMBR.00010-14; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; FOX MS, 1955, J GEN PHYSIOL, V39, P267, DOI 10.1085/jgp.39.2.267; Fu LM, 2007, TUBERCULOSIS, V87, P63, DOI 10.1016/j.tube.2006.04.001; Fu LM, 2006, TUBERCULOSIS, V86, P134, DOI 10.1016/j.tube.2005.07.004; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Gupta AK, 2010, INDIAN J MED RES, V132, P176; Haas WH, 1997, ANTIMICROB AGENTS CH, V41, P1601, DOI 10.1128/AAC.41.7.1601; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; James BW, 2000, J APPL MICROBIOL, V88, P669, DOI 10.1046/j.1365-2672.2000.01020.x; Jenkins C, 2009, J ANTIMICROB CHEMOTH, V63, P1118, DOI 10.1093/jac/dkp125; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Jousselin A, 2012, ANTIMICROB AGENTS CH, V56, P3629, DOI 10.1128/AAC.06264-11; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Mdluli K, 2015, COLD SPRING HARB PER, V5, P29; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Mitchison DA, 2004, CURR PHARM DESIGN, V10, P3285, DOI 10.2174/1381612043383269; Mitchison DA, 2007, J INFECT DIS, V195, P1871, DOI 10.1086/518046; NORTHROP JH, 1966, J GEN PHYSIOL, V50, P369, DOI 10.1085/jgp.50.2.369; Nystrom T, 2003, CELL MOL LIFE SCI, V60, P1333, DOI 10.1007/s00018-003-2310-X; O'Sullivan DM, 2008, J ANTIMICROB CHEMOTH, V62, P709, DOI 10.1093/jac/dkn259; Paramasivan CN, 2005, ANTIMICROB AGENTS CH, V49, P627, DOI 10.1128/AAC.49.2.627-631.2005; Pelly S, 2012, GENE, V500, P85, DOI 10.1016/j.gene.2012.03.044; Pope CF, 2010, METHODS MOL BIOL, V642, P113, DOI 10.1007/978-1-60327-279-7_9; Prax M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00148; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, P20; Rodrigues L, 2013, ANTIMICROB AGENTS CH, V57, P751, DOI 10.1128/AAC.01482-12; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Rodriguez-Verdugo A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-50; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Waddell SJ, 2004, TUBERCULOSIS, V84, P263, DOI 10.1016/j.tube.2003.12.005; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Wengenack NL, 1997, J INFECT DIS, V176, P722, DOI 10.1086/514096; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zhang M, 2005, J CLIN MICROBIOL, V43, P5477, DOI 10.1128/JCM.43.11.5477-5482.2005	57	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138253	10.1371/journal.pone.0138253	http://dx.doi.org/10.1371/journal.pone.0138253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382066	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200078
J	Koo, DH; Sehgal, SK; Friebe, B; Gill, BS				Koo, Dal-Hoe; Sehgal, Sunish K.; Friebe, Bernd; Gill, Bikram S.			Structure and Stability of Telocentric Chromosomes in Wheat	PLOS ONE			English	Article							CENTROMERIC RETROTRANSPOSONS; MAIZE CENTROMERES; CHROMATIN; REPEAT; DNA; HETEROCHROMATIN; NEOCENTROMERES; IDENTIFICATION; NOMENCLATURE; MISDIVISION	In most eukaryotes, centromeres assemble at a single location per chromosome. Naturally occurring telocentric chromosomes (telosomes) with a terminal centromere are rare but do exist. Telosomes arise through misdivision of centromeres in normal chromosomes, and their cytological stability depends on the structure of their kinetochores. The instability of telosomes may be attributed to the relative centromere size and the degree of completeness of their kinetochore. Here we test this hypothesis by analyzing the cytogenetic structure of wheat telosomes. We used a population of 80 telosomes arising from the misdivision of the 21 chromosomes of wheat that have shown stable inheritance overmany generations. We analyzed centromere size by probing with the centromere-specific histone H3 variant, CENH3. Comparing the signal intensity for CENH3 between the intact chromosome and derived telosomes showed that the telosomes had approximately half the signal intensity compared to that of normal chromosomes. Immunofluorescence of CENH3 in a wheat stock with 28 telosomes revealed that none of the telosomes received a complete CENH3 domain. Some of the telosomes lacked centromere specific retrotransposons of wheat in the CENH3 domain, indicating that the stability of telosomes depends on the presence of CENH3 chromatin and not on the presence of CRW repeats. In addition to providing evidence for centromere shift, we also observed chromosomal aberrations including inversions and deletions in the short arm telosomes of double ditelosomic 1D and 6D stocks. The role of centromere-flanking, pericentromeric heterochromatin in mitosis is discussed with respect to genome/chromosome integrity.	[Koo, Dal-Hoe; Friebe, Bernd; Gill, Bikram S.] Kansas State Univ, Throckmorton Plant Sci Ctr, Wheat Genet Resource Ctr, Dept Plant Pathol, Manhattan, KS 66506 USA; [Sehgal, Sunish K.] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	Kansas State University; South Dakota State University	Friebe, B (corresponding author), Kansas State Univ, Throckmorton Plant Sci Ctr, Wheat Genet Resource Ctr, Dept Plant Pathol, Manhattan, KS 66506 USA.	friebe@ksu.edu			Kansas Crop Association; National Science Foundation; Wheat Genetics Resource Center, Kansas State University	Kansas Crop Association; National Science Foundation(National Science Foundation (NSF)); Wheat Genetics Resource Center, Kansas State University	This research was financially supported by the Kansas Crop Association and by members of the Wheat Genetics Resource Center Industry/University Cooperative Research Center. The following companies and associations make up the membership: Bayer Cropscience, Dow AgroSciences, General Mills, Limagrain, Syngenta, Heartland Plant Innovations, DuPont Pioneer, Kansas Wheat Commission, Kansas Wheat Alliance, and the Kansas Department of Agriculture. The National Science Foundation also provided financial support. The public/private consortium is aimed at pre-competitive wheat genetics research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dal-Hoe Koo, Bernd Friebe and Bikram S. Gill are affiliated to Wheat Genetics Resource Center, University of Kansas. Wheat Genetics Resource Center, Kansas State University provided support in the form of salaries for authors DHK, BF and BSG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AragonAlcaide L, 1996, CHROMOSOMA, V105, P261, DOI 10.1007/BF02524643; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cheng ZK, 2001, GENETICS, V157, P361; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fu SL, 2013, P NATL ACAD SCI USA, V110, P6033, DOI 10.1073/pnas.1303944110; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gill KS, 1999, THEOR APPL GENET, V98, P1248, DOI 10.1007/s001220051190; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Ito H, 2004, GENOME, V47, P747, DOI 10.1139/G04-034; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Koo DH, 2009, PLANT J, V59, P509, DOI 10.1111/j.1365-313X.2009.03881.x; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Liu WX, 2011, CHROMOSOME RES, V19, P669, DOI 10.1007/s10577-011-9226-3; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Maggert KA, 2001, GENETICS, V158, P1615; MARKS GE, 1957, AM NAT, V91, P223, DOI 10.1086/281981; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mutti JS, 2010, MOL BREEDING, V26, P177, DOI 10.1007/s11032-009-9389-1; Naranjo T., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P115; Nasuda S, 2005, P NATL ACAD SCI USA, V102, P9842, DOI 10.1073/pnas.0504235102; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Rhoades MM, 1940, GENETICS, V25, P483; SCHUBERT I, 1990, GENETICA, V81, P67, DOI 10.1007/BF00055238; Scott KC, 2014, TRENDS GENET, V30, P66, DOI 10.1016/j.tig.2013.11.003; Sears E. R., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P427; Sears E.R., 1978, P 5 INT WHEAT GEN S, P389; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Sharp JA, 2003, CURR TOP MICROBIOL, V274, P23; Singh RJ, 2003, PLANT CYTOGENETICS, P216; SOUTHERN DI, 1969, CHROMOSOMA, V26, P140, DOI 10.1007/BF00326451; STEINITZSEARS LM, 1966, GENETICS, V54, P241; STRID A, 1968, BOT NOTISER, V121, P153; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Topp CN, 2009, CYTOGENET GENOME RES, V124, P228, DOI 10.1159/000218128; Tsuchiya R., 1972, Seiken Ziho, P47; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang K, 2014, GENOME RES, V24, P107, DOI 10.1101/gr.160887.113; Wanner G, 2015, CHROMOSOMA, V124, P503, DOI 10.1007/s00412-015-0521-1; WHITE M J D, 1973, P961; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Yu HG, 2000, TRENDS PLANT SCI, V5, P543, DOI 10.1016/S1360-1385(00)01789-1; Zhang P, 2001, CHROMOSOMA, V110, P335, DOI 10.1007/s004120100159	63	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137747	10.1371/journal.pone.0137747	http://dx.doi.org/10.1371/journal.pone.0137747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381743	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200036
J	van der Steen, M; Leenstra, T; Kluytmans, JAJW; van der Bij, AK				van der Steen, Matthijs; Leenstra, Tjalling; Kluytmans, Jan A. J. W.; van der Bij, Akke K.		ISIS-AR Study Grp	Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012	PLOS ONE			English	Article							BETA-LACTAMASES; RISK-FACTORS; CTX-M; BACTEREMIA; INFECTIONS; SEQUENCE; IMPACT; CARE	We investigated time trends in extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from different patient settings in The Netherlands from 2008-2012. E. coli and K. pneumoniae isolates from blood and urine samples of patients > = 18 years were selected from the Dutch Infectious Disease Surveillance System-Antimicrobial Resistance (ISIS-AR) database. We used multivariable Poisson regression to study the rate per year of blood stream infections by susceptible and resistant isolates, and generalized estimating equation (GEE) log-binomial regression for trends in the proportion of extended-spectrum cephalosporin-resistant isolates. Susceptibility data of 197,513 E. coli and 38,244 K. pneumoniae isolates were included. The proportion of extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates from urine and blood samples increased in all patient settings, except for K. pneumoniae isolates from patients admitted to intensive care units. For K. pneumoniae, there was a different time trend between various patient groups (p<0.01), with a significantly higher increase in extended-spectrum cephalosporin-resistant isolates from patients attending a general practitioner than in isolates from hospitalized patients. For E. coli, the increasing time trends did not differ among different patient groups. This nationwide study shows a general increase in extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates. However, differences in trends between E. coli en K. pneumoniae underline the importance of E. coli as a community-pathogen and its subsequent influence on hospital resistance level, while for K. pneumoniae the level of resistance within the hospital seems less influenced by the resistance trends in the community.	[van der Steen, Matthijs; Leenstra, Tjalling; van der Bij, Akke K.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands; [van der Steen, Matthijs] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Kluytmans, Jan A. J. W.] VU Med Ctr VUmc, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van der Bij, Akke K.] Reinier de Graaf Grp, Dept Med Microbiol, Delft, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Amphia Hospital; Reinier de Graaf Hospital	van der Bij, AK (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	bij@rdgg.nl			Dutch Ministry of Health	Dutch Ministry of Health	ISIS-AR is supported by the Dutch Ministry of Health. This study was conducted as part of the authors' routine work, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2013, INFECT CONT HOSP EP, V34, P361, DOI 10.1086/669865; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; CASEWELL MW, 1983, J HOSP INFECT, V4, P350, DOI 10.1016/0195-6701(83)90005-1; Dutch College of General Practitioners, GUID UR TRACT INF; Dutch Working party on Infection Prevention, DOCUMENTATION; ECDC, EUR ANT SURV NETW EA; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, BREAKPOINT TABLES IN; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kronenberg A, 2013, EURO SURVEILL, V18; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; The Dutch Working Party on Antibiotic Policy (SWAB), GUIDELINES; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214	25	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138088	10.1371/journal.pone.0138088	http://dx.doi.org/10.1371/journal.pone.0138088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381746	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200056
J	Wachtel, MS; Yang, SP; Dissanaike, S; Margenthaler, JA				Wachtel, Mitchell S.; Yang, Shengping; Dissanaike, Sharmila; Margenthaler, Julie A.			Hormone Replacement Therapy, Likely Neither Angel Nor Demon	PLOS ONE			English	Article							BREAST-CANCER CHEMOPREVENTION; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; IN-SITU; TAMOXIFEN; PREVENTION; RALOXIFENE; CARCINOMA; LETROZOLE; ESTROGEN	Purpose A decline in breast cancer incidence has been attributed to the reduction in hormone replacement therapy (HRT) prescriptions since the publication of the landmark WHIT paper in 2003. Concurrently, a relationship between HRT and cerebrovascular disease incidence has also been suggested. No generalized analysis of HRT prescription rates and breast cancer incidence rates that included more than seven years of data. We hypothesized that detailed analysis of SEER data would clarify the relationship between HRT use and breast cancer incidence. Given the large decline in HRT prescription rates uncovered, analyses of potential complications were also conducted, with the understanding that a small effect or one limited to a subpopulation, such as a single race, might not be detected. Methods Incidence rates (per 100,000 women) and standard errors for ductal and lobular breast carcinomas, and endometrioid/endometrial carcinomas in women over 50 years were obtained from the Surveillance, Epidemiology, and End Results (SEER) database 1992-2012. From the Medical Expenditure Panel Survey 1996-2012 weighted counts and standard errors of hormone replacement therapy (HRT) prescriptions for women over 50 years were obtained. Using the National Hospital Discharge Survey (NHDS), 1996-2010 weighted counts and standard errors of femoral neck fractures, total hip replacements, acute myocardial infarctions, and cerebral infarctions were obtained for 50+ year men and women. Weighted counts and standard errors were divided by US census figures and multiplied by 100,000. Joinpoint regression was used to analyze rates. Main Results Beginning 2001, HRT prescription rates dropped dramatically, 2001-2012 AAPC -14.9 (95% CI -17.4, -12.4). Breast cancer rates, which began to decline in 1999, increased after 2003; 2012 rates were similar to those seen in 2001 for both ductal, AAPC 0.1 (-0.4, 0.6) and lobular, AAPC 0.5 (-0.4, 1.5), carcinoma. Endometrial carcinoma rates increased, 2001-2012 AAPC 3.5 (3.1, 3.8), arguing against a negative effect of HRT discontinuation of endometrial carcinoma. Tests for parallelism failed to detect APC differences among genders for femoral neck fractures (P = 0.24), for total hip replacements (P = 0.11), for myocardial infarctions (P = 0.10), or for cerebral infarctions (P = 0.19), precluding any assignment of general effect on these disorders by HRT. Conclusions Using SEER data, we demonstrated that changes in breast cancer rates cannot be explained by HRT prescription rate changes.	[Wachtel, Mitchell S.; Yang, Shengping] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Dissanaike, Sharmila] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Margenthaler, Julie A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Washington University (WUSTL)	Wachtel, MS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA.	mitchell.wachtel@ttuhsc.edu						Agency for Healthcare Research and Quality, 2014, HOUSEHOLD COMPONENT; [Anonymous], 2014, SURVEILLANCE RESEARC; [Anonymous], 2014, OVERVIEW OF THE SEER; [Anonymous], 2015, SURVEILLANCE EPIDEMI; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bluming AZ, 2007, NEW ENGL J MED, V357, P509; Buerger H, 2000, J CLIN PATHOL-MOL PA, V53, P118, DOI 10.1136/mp.53.3.118; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chlebowski RT, 2015, JAMA ONCOLOGY; Elfenbein GJ, 2007, NEW ENGL J MED, V357, P509; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Howell A, 2012, LANCET ONCOL, V13, P437, DOI 10.1016/S1470-2045(12)70110-9; Kliewer EV, 2007, NEW ENGL J MED, V357, P509; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; R Core Team, 2014, R A LANGUAGE AND ENV; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Stagnitti M, 2011, AGENCY FOR HEALTHCAR; Statistical Methodology and Applications Branch, 2013, MARYLAND SURVEILLANC; Statistics. NCfH, 2014, MICRODATA; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Wachtel MS, 2011, J SURG RES, V166, P19, DOI 10.1016/j.jss.2010.05.016; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2; Waters EA, 2010, CANCER EPIDEM BIOMAR, V19, P443, DOI 10.1158/1055-9965.EPI-09-0930; Wickerham DL, 2009, RECENT RESULTS CANC, V181, P113	28	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138556	10.1371/journal.pone.0138556	http://dx.doi.org/10.1371/journal.pone.0138556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384022	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200127
J	Belotti, E; Weder, N; Bufka, L; Kaldhusdal, A; Kuchenhoff, H; Seibold, H; Woelfing, B; Heurich, M				Belotti, Elisa; Weder, Nicole; Bufka, Ludek; Kaldhusdal, Arne; Kuechenhoff, Helmut; Seibold, Heidi; Woelfing, Benno; Heurich, Marco			Patterns of Lynx Predation at the Interface between Protected Areas and Multi-Use Landscapes in Central Europe	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; DEER CAPREOLUS-CAPREOLUS; HOME-RANGE SIZE; EURASIAN LYNX; ROE DEER; RED DEER; LARGE CARNIVORES; NATIONAL-PARK; WILDLIFE MANAGEMENT; PARTIAL MIGRATION	In Central Europe, protected areas are too small to ensure survival of populations of large carnivores. In the surrounding areas, these species are often persecuted due to competition with game hunters. Therefore, understanding how predation intensity varies spatio-temporally across areas with different levels of protection is fundamental. We investigated the predation patterns of Eurasian lynx (Lynx lynx) on roe deer (Capreolus capreolus) and red deer (Cervus elaphus) in both protected areas and multi-use landscapes of the Bohemian Forest Ecosystem. Based on 359 roe and red deer killed by 10 GPS-collared lynx, we calculated the species-specific annual kill rates and tested for effects of season and lynx age, sex and reproductive status. Because roe and red deer in the study area concentrate in unprotected lowlands during winter, we modeled spatial distribution of kills separately for summer and winter and calculated-the probability of a deer killed by lynx and-the expected number of kills for areas with different levels of protection. Significantly more roe deer (46.05-74.71/year/individual lynx) were killed than red deer (1.57-9.63/year/individual lynx), more deer were killed in winter than in summer, and lynx family groups had higher annual kill rates than adult male, single adult female and subadult female lynx. In winter the probability of a deer killed and the expected number of kills were higher outside the most protected part of the study area than inside; in summer, this probability did not differ between areas, and the expected number of kills was slightly larger inside than outside the most protected part of the study area. This indicates that the intensity of lynx predation in the unprotected part of the Bohemian Forest Ecosystem increases in winter, thus mitigation of conflicts in these areas should be included as a priority in the lynx conservation strategy.	[Belotti, Elisa; Bufka, Ludek] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Prague 16521 6, Czech Republic; [Belotti, Elisa; Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Kasperske Hory 34192, Czech Republic; [Weder, Nicole; Woelfing, Benno; Heurich, Marco] Bavarian Forest Natl Pk, Dept Res & Documentat, D-94481 Grafenau, Germany; [Kaldhusdal, Arne; Kuechenhoff, Helmut; Seibold, Heidi] Ludwig Maximilians Univ Munchen, Dept Stat, D-80539 Munich, Germany; [Heurich, Marco] Univ Freiburg, Fac Environm & Nat Resources, Wildlife Ecol & Management, D-79106 Freiburg, Germany	Czech University of Life Sciences Prague; University of Munich; University of Freiburg	Belotti, E (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Kamycka 1176, Prague 16521 6, Czech Republic.	belotti@fld.czu.cz	Heurich, Marco/O-4653-2014	Heurich, Marco/0000-0003-0051-2930; Seibold, Heidi/0000-0002-8960-9642; Kuchenhoff, Helmut/0000-0002-6372-2487	EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria) [18]; World Wide Fund for Nature Section Germany [533500/53000/10120]; Internal Grant Agency of the Czech University of Life Sciences Prague [IGA CZU 2011 4315013123113]	EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria); World Wide Fund for Nature Section Germany; Internal Grant Agency of the Czech University of Life Sciences Prague	Financial support was provided by EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria, grant n. 18), by the World Wide Fund for Nature Section Germany (grant n. 533500/53000/10120) and by the Internal Grant Agency of the Czech University of Life Sciences Prague (grant IGA CZU 2011 4315013123113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andera M, 1994, ACTA SCI NATURALIUM, V28; Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; Andren H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120570; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; BREITENMOSER U, 1987, Z SAUGETIERKD, V52, P168; BREITENMOSER U, 1993, J WILDLIFE MANAGE, V57, P135, DOI 10.2307/3809010; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Breitenmoser Urs, 2010, P493; Bretz F., 2010, MULTIPLE COMP USING; Bunnefeld N, 2006, J ZOOL, V270, P31, DOI 10.1111/j.1469-7998.2006.00107.x; Cagnacci F, 2015, ANIMAL ECOLOGY UNPUB; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Carroll C, 2004, CONSERV BIOL, V18, P1110, DOI 10.1111/j.1523-1739.2004.00083.x; Cerveny J., 2002, ACTA ZOOL LITUANICA, V12, P362; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; DEVRIES MFW, 1995, CONSERV BIOL, V9, P25; EEA European Environment Agency, 2009, COR LAND COV 2000 CL; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ersson L., 2011, THESIS SWEDISH U AGR; European Environment Agency, 2012, EEA REP, V5, P1, DOI [10.2800/55955, DOI 10.2800/55955]; Festetics A., 1981, Saugetierkundliche Mitteilungen, V29, P21; Gerner J, 2011, J NAT CONSERV, V19, P319, DOI 10.1016/j.jnc.2011.06.002; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hartova-Nentvichova M, 2010, MAMM BIOL, V75, P334, DOI 10.1016/j.mambio.2009.09.003; Hebblewhite M, 2005, J ANIM ECOL, V74, P226, DOI 10.1111/j.1365-2656.2004.00909.x; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Heurich M, 2015, PLOSONE IN PRESS; Heurich M, 2005, WALDER NATIONALPARKS; Heurich M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114143; Heurich M, 2012, EUR J WILDLIFE RES, V58, P567, DOI 10.1007/s10344-011-0606-y; Hosmer D. W., 2011, APPL SURVIVAL ANAL R; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jedrzejewski W, 2002, ANN ZOOL FENN, V39, P29; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jobin A, 2000, ACTA THERIOL, V45, P243, DOI 10.4098/AT.arch.00-26; Kaczensky P, 2013, STATUS MANAGEMENT DI; Kalbfleisch J.D., 2011, STAT ANAL FAILURE TI, DOI DOI 10.1016/0197-2456(81)90009-X; Kamler JF, 2007, WILDLIFE BIOL, V13, P48, DOI 10.2981/0909-6396(2007)13[48:SACMOR]2.0.CO;2; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9_1; Koubek Petr, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P1; Krofel M, 2013, ECOLOGICAL RES, V28, P1; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Krofel M, 2011, ACTA THERIOL, V56, P315, DOI 10.1007/s13364-011-0032-2; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Luccarini S, 2006, ETHOL ECOL EVOL, V18, P127, DOI 10.1080/08927014.2006.9522718; Ludwig M, 2012, ERDKUNDE, V66, P143, DOI 10.3112/erdkunde.2012.02.04; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; Mayer Kathrin, 2012, Saeugetierkundliche Informationen, V8, P447; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Moa PF, 2006, WILDLIFE BIOL, V12, P63, DOI 10.2981/0909-6396(2006)12[63:DTSDOL]2.0.CO;2; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Molinari-Jobin A, 2007, WILDLIFE BIOL, V13, P393, DOI 10.2981/0909-6396(2007)13[393:VIDPSA]2.0.CO;2; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2013, ECOLOGY, V94, P1257, DOI 10.1890/12-0505.1; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Nowicki Piotr, 1997, Journal of Wildlife Research, V2, P161; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; OKARMA H, 1984, ACTA THERIOL, V29, P283, DOI 10.4098/AT.arch.84-28; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Ordiz A, 2013, BIOL CONSERV, V168, P128, DOI 10.1016/j.biocon.2013.09.024; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Powell R.A., 1997, ECOLOGY BEHAV N AM B; PULLIAINEN E, 1995, ACTA THERIOL, V40, P181, DOI 10.4098/AT.arch.95-19; Ray RR, 2014, ANIM BIODIV CONSERV, V37, P77; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; Schmidt K, 1999, J ZOOL, V249, P417, DOI 10.1017/S0952836999009851; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Siebert U, 2013, REHWILDZAHLUNG UNPUB; Stahl P, 2001, J APPL ECOL, V38, P674, DOI 10.1046/j.1365-2664.2001.00625.x; Sunquist ME, 2002, WILD CATS WORLD; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; Weingarth K, 2015, BIODIVERSIT IN PRESS; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wienke A., 2010, FRAILTY MODELS SURVI; WILSON RP, 1991, COMP BIOCHEM PHYS A, V100, P151, DOI 10.1016/0300-9629(91)90198-L; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zatloukal V, 2001, SILVA GABRETA S1, P77	101	15	16	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138139	10.1371/journal.pone.0138139	http://dx.doi.org/10.1371/journal.pone.0138139			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379142	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000361769400059
J	Li, J; Yang, Y; Dubern, JF; Li, H; Halliday, N; Chernin, L; Gao, KX; Camara, M; Liu, XG				Li, Jun; Yang, Yang; Dubern, Jean-Frederic; Li, Hui; Halliday, Nigel; Chernin, Leonid; Gao, Kexiang; Camara, Miguel; Liu, Xiaoguang			Regulation of GacA in Pseudomonas chlororaphis Strains Shows a Niche Specificity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; SENSOR KINASE GACS; BIOFILM FORMATION; SECONDARY METABOLISM; SERRATIA-PLYMUTHICA; HOMOSERINE LACTONE; PROTEOMIC ANALYSIS; AERUGINOSA; O6; BIOCONTROL	The GacS/GacA two-component system plays a central role in the regulation of a broad range of biological functions in many bacteria. In the biocontrol organism Pseudomonas chlororaphis, the Gac system has been shown to positively control quorum sensing, biofilm formation, and phenazine production, but has an overall negative impact on motility. These studies have been performed with strains originated from the rhizosphere predominantly. To investigate the level of conservation between the GacA regulation of biocontrol-related traits in P. chlororaphis isolates from different habitats, the studies presented here focused on the endophytic isolate G5 of P. chlororaphis subsp. aurantiaca. A gacA mutant deficient in the production of N-acylhomoserine lactones (AHLs) and phenazine was isolated through transposon mutagenesis. Further phenotypic characterization revealed that in strain G5, similar to other P. chlororaphis strains, a gacA mutation caused inability to produce biocontrol factors such as phenazine, HCN and proteases responsible for antifungal activity, but overproduced siderophores. LC-MS/MS analysis revealed that AHL production was also practically abolished in this mutant. However, the wild type exhibited an extremely diverse AHL pattern which has never been identified in P. chlororaphis. In contrast to other isolates of this organism, GacA in strain G5 was shown to negatively regulate biofilm formation and oxidative stress response whilst positively regulating cell motility and biosynthesis of indole3-acetic acid (IAA). To gain a better understanding of the overall impact of GacA in G5, a comparative proteomic analysis was performed revealing that, in addition to some of the traits like phenazine mentioned above, GacA also negatively regulated lipopolysaccharide (LPS) and trehalose biosynthesis whilst having a positive impact on energy metabolism, an effect not previously described in P. chlororaphis. Consequently, GacA regulation shows a differential strain dependency which is likely to be in line with their niche of origin.	[Li, Jun] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China; [Li, Jun; Yang, Yang; Liu, Xiaoguang] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Peoples R China; [Dubern, Jean-Frederic; Halliday, Nigel; Camara, Miguel] Univ Nottingham, Ctr Biomol Sci, Sch Life Sci, Nottingham NG7 2RD, England; [Li, Hui; Gao, Kexiang] Shandong Agr Univ, Dept Plant Pathol, Tai An 271018, Shandong, Peoples R China; [Chernin, Leonid] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr, IL-76100 Rehovot, Israel	Jiangsu University; Jiangsu University; University of Nottingham; Shandong Agricultural University; Hebrew University of Jerusalem	Liu, XG (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Peoples R China.	xgliu66@yahoo.com		Camara, Miguel/0000-0003-4585-7385	EU [297882]; Jiangsu University [CX10B_022x]; National Natural Science Foundation of China (NSFC) [31240046]; Special Fund for Agro-Scientific Research in the Public Interest of China [201503110]; Priority Academic Program Development of Jiangsu Higher Education Institutions	EU(European Commission); Jiangsu University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was partially supported by the EU Marie Curie IIF project PROAGROBAC (297882), the Postgraduate Research and Innovation Project of Jiangsu University (CX10B_022x), the National Natural Science Foundation of China (NSFC no. 31240046), the Special Fund for Agro-Scientific Research in the Public Interest of China (201503110), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; Bouffartigues E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00630; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Chancey ST, 1999, APPL ENVIRON MICROB, V65, P2294; DASGUPTA T, 1994, INFECT IMMUN, V62, P809, DOI 10.1128/IAI.62.3.809-817.1994; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; GIWERCMAN B, 1992, FEMS MICROBIOL IMMUN, V89, P225, DOI 10.1016/0378-1097(92)90120-D; Green MR, 2012, MOL CLONING LAB MANU, V1; GULYAEVA NV, 1987, FEBS LETT, V211, P211, DOI 10.1016/0014-5793(87)81438-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Islam N, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-21; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; Kim CH, 2014, PLANT PATHOLOGY J, V30, P220, DOI 10.5423/PPJ.NT.02.2014.0012; Kim JS, 2014, PLANT PATHOLOGY J, V30, P215, DOI 10.5423/PPJ.NT.11.2013.0109; Kim JS, 2014, CAN J MICROBIOL, V60, P133, DOI 10.1139/cjm-2013-0736; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Li Hui, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P832; Liu X, 2010, WORLD J MICROB BIOT, V26, P1465, DOI 10.1007/s11274-010-0321-y; Liu XG, 2007, FEMS MICROBIOL LETT, V270, P299, DOI 10.1111/j.1574-6968.2007.00681.x; Liu XG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-26; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; Matthias U., 2009, BACTERIAL POLYSACCHA; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Poritsanos N, 2006, CAN J MICROBIOL, V52, P1177, DOI 10.1139/W06-079; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Sadykov MR, 2010, J BIOL CHEM, V285, P36616, DOI 10.1074/jbc.M110.152843; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seaton SC, 2013, APPL ENVIRON MICROB, V79, P5405, DOI 10.1128/AEM.00819-13; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; Selin C, 2010, FEMS MICROBIOL ECOL, V71, P73, DOI 10.1111/j.1574-6941.2009.00792.x; Takeuchi K, 2014, ENVIRON MICROBIOL, V16, P2538, DOI 10.1111/1462-2920.12394; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wang DP, 2013, MICROBIOLOGYOPEN, V2, P505, DOI 10.1002/mbo3.90; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Yang MM, 2011, PHYTOPATHOLOGY, V101, P1481, DOI 10.1094/PHYTO-04-11-0096	48	4	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137553	10.1371/journal.pone.0137553	http://dx.doi.org/10.1371/journal.pone.0137553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379125	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400017
J	Pfaffen, S; Bradley, JM; Abdulqadir, R; Firme, MR; Moore, GR; Le Brun, NE; Murphy, MEP				Pfaffen, Stephanie; Bradley, Justin M.; Abdulqadir, Raz; Firme, Marlo R.; Moore, Geoffrey R.; Le Brun, Nick E.; Murphy, Michael E. P.			A Diatom Ferritin Optimized for Iron Oxidation but Not Iron Storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; PHOTOOXIDATIVE STRESS; FERROXIDASE CENTER; CENTRAL CAVITY; BACTERIOFERRITIN; MINERALIZATION; EVOLUTION; BINDING; ECFTNA	Ferritin from the marine pennate diatom Pseudo-nitzschia multiseries (PmEr N) plays a key role in sustaining growth in iron-limited ocean environments. The di-iron catalytic ferroxidase center of PmFTN (sites A and B) has a nearby third iron site (site C) in an arrangement typically observed in prokaryotic ferritins. Here we demonstrate that Glu-44, a site C ligand, and Glu-130, a residue that bridges iron bound at sites B and C, limit the rate of post-oxidation reorganization of iron coordination and the rate at which Fe3+ exits the ferroxidase center for storage within the mineral core. The latter, in particular, severely limits the overall rate of iron mineralization. Thus, the diatom ferritin is optimized for initial Fe' + oxidation but not for mineralization, pointing to a role for this protein in buffering iron availability and facilitating iron-sparing rather than only longterm iron storage.	[Pfaffen, Stephanie; Firme, Marlo R.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Bradley, Justin M.; Abdulqadir, Raz; Moore, Geoffrey R.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of East Anglia	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk; michael.murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Abdulqadir, Raz/0000-0003-4014-8213; Le Brun, Nick/0000-0001-9780-4061	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Canadian Foundation for Innovation; United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I021884/1]; Emeritus Fellowship from the Leverhulme Trust [EM-2014-088]; Kurdistan local government; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I021884/1] Funding Source: researchfish; BBSRC [BB/I021884/1] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Emeritus Fellowship from the Leverhulme Trust; Kurdistan local government; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and the Canadian Foundation for Innovation (to M. E. P. M.) and the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) through Grant BB/I021884/1 (to G. R. M. and N. E. L. B.). This work was also supported by an Emeritus Fellowship from the Leverhulme Trust (EM-2014-088) (to G. R. M.) and a scholarship from the Kurdistan local government (to R. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2014, BIOCHEMISTRY-US, V53, P483, DOI 10.1021/bi401517f; Bradley JM, 2014, J BIOL INORG CHEM, V19, P775, DOI 10.1007/s00775-014-1136-3; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Glaesener AG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00337; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Long JC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1395, DOI 10.1111/j.1751-1097.2008.00451.x; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wong SG, 2015, J BIOL CHEM, V290, P3732, DOI 10.1074/jbc.M114.623082; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	27	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28416	28427		10.1074/jbc.M115.669713	http://dx.doi.org/10.1074/jbc.M115.669713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396187	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000365761900035
J	Follmer, C; Coelho-Cerqueira, E; Yatabe-Franco, DY; Araujo, GDT; Pinheiro, AS; Domont, GB; Eliezer, D				Follmer, Cristian; Coelho-Cerqueira, Eduardo; Yatabe-Franco, Danilo Y.; Araujo, Gabriel D. T.; Pinheiro, Anderson S.; Domont, Gilberto B.; Eliezer, David			Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of alpha-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE-B; PARKINSONS-DISEASE; SELECTIVE NEURODEGENERATION; AMINO-GROUPS; IN-VITRO; AGGREGATION; OXIDATION; MECHANISM; HELIX; INHIBITION	Oxidative deamination of dopamine produces the highly toxic aldehyde 3,4-dihydroxyphenylacetaldehyde (DOPAL), enhanced production of which is found in post-mortem brains of Parkinson disease patients. When injected into the substantia nigra of rat brains, DOPAL causes the loss of dopaminergic neurons accompanied by the accumulation of potentially toxic oligomers of the presynaptic protein alpha-synuclein (aS), potentially explaining the synergistic toxicity described for dopamine metabolism and aS aggregation. In this work, we demonstrate that DOPAL interacts with aS via formation of Schiff-base and Michael-addition adducts with Lys residues, in addition to causing oxidation of Met residues to Met-sulfoxide. DOPAL modification leads to the formation of small aS oligomers that may be cross-linked by DOPAL. Both monomeric and oligomeric DOPAL adducts potently inhibit the formation of mature amyloid fibrils by unmodified aS. The binding of aS to either lipid vesicles or detergent micelles, which results in a gain of alpha-helix structure in its N-terminal lipid-binding domain, protects the protein against DOPAL adduct formation and, consequently, inhibits DOPAL-induced aS oligomerization. Functionally, aS-DOPAL monomer exhibits a reduced affinity for small unilamellar vesicles with lipid composition similar to synaptic vesicles, in addition to diminished membrane-induced alpha-helical content in comparison with the unmodified protein. These results suggest that DOPAL could compromise the functionality of aS, even in the absence of protein oligomerization, by affecting the interaction of aS with lipid membranes and hence its role in the regulation of synaptic vesicle traffic in neurons.	[Follmer, Cristian; Coelho-Cerqueira, Eduardo; Yatabe-Franco, Danilo Y.] Univ Fed Rio de Janeiro, Dept Phys Chem, Inst Chem, BR-21941909 Rio De Janeiro, Brazil; [Araujo, Gabriel D. T.; Pinheiro, Anderson S.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, BR-21941909 Rio De Janeiro, Brazil; [Follmer, Cristian; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Cornell University	Follmer, C (corresponding author), Univ Fed Rio de Janeiro, Dept Phys Chem, BR-21941909 Rio De Janeiro, Brazil.	follmer@iq.ufrj.br; dae2005@med.cornell.edu	Pinheiro, Anderson S/B-6350-2014; Follmer, Cristian/O-6134-2016; Regan, Clinton/E-6250-2012; Pinheiro, Anderson/AAL-5299-2021	Follmer, Cristian/0000-0001-6178-0432; Pinheiro, Anderson/0000-0001-5118-6931	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Institutes of Health [R37AG019391]; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and National Institutes of Health Grant R37AG019391 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DG, 2011, J BIOL CHEM, V286, P26978, DOI 10.1074/jbc.M111.249532; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Carmo-Goncalves P, 2014, AMYLOID, V21, P163, DOI 10.3109/13506129.2014.912208; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; Coelho-Cerqueira E, 2013, FEBS J, V280, P4915, DOI 10.1111/febs.12471; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIXON HBF, 1968, BIOCHEM J, V109, P312, DOI 10.1042/bj1090312; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer David, 2012, Methods Mol Biol, V895, P127, DOI 10.1007/978-1-61779-927-3_10; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; FILLOUX F, 1993, EXP NEUROL, V119, P79, DOI 10.1006/exnr.1993.1008; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Follmer C, 2007, BIOCHEMISTRY-US, V46, P472, DOI 10.1021/bi061871+; Follmer C, 2014, EXPERT REV NEUROTHER, V14, P703, DOI 10.1586/14737175.2014.920235; Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Goldstein DS, 2013, J NEUROCHEM, V126, P591, DOI 10.1111/jnc.12345; Guang HM, 2006, ACTA PHARMACOL SIN, V27, P760, DOI 10.1111/j.1745-7254.2006.00336.x; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Rauniyar N, 2009, PROTEOMICS, V9, P5188, DOI 10.1002/pmic.200900116; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	62	71	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27660	27679		10.1074/jbc.M115.686584	http://dx.doi.org/10.1074/jbc.M115.686584			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26381411	hybrid, Green Published			2022-12-26	WOS:000365757500020
J	Moree, B; Yin, GW; Lazaro, DF; Munari, F; Strohaker, T; Giller, K; Becker, S; Outeiro, TF; Zweckstetter, M; Salafsky, J				Moree, Ben; Yin, Guowei; Lazaro, Diana F.; Munari, Francesca; Strohaeker, Timo; Giller, Karin; Becker, Stefan; Outeiro, Tiago F.; Zweckstetter, Markus; Salafsky, Joshua			Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric alpha-Synuclein and Reduce Its Aggregation in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; PARKINSONS-DISEASE; DRUG DISCOVERY; IN-VITRO; TOXICITY; NEURONS; MODELS; ORIENTATION; MICROSCOPY; TISSUES	Proteins are structurally dynamic molecules that perform specialized functions through unique conformational changes accessible in physiological environments. An ability to specifically and selectively control protein function via conformational modulation is an important goal for development of novel therapeutics and studies of protein mechanism in biological networks and disease. Here we applied a second-harmonic generation-based technique for studying protein conformation in solution and in real time to the intrinsically disordered, Parkinson disease related protein alpha-synuclein. From a fragment library, we identified small molecule modulators that bind to monomeric alpha-synuclein in vitro and significantly reduce alpha-synuclein aggregation in a neuronal cell culture model. Our results indicate that the conformation of alpha-synuclein is linked to the aggregation of protein in cells. They also provide support for a therapeutic strategy of targeting specific conformations of the protein to suppress or control its aggregation.	[Moree, Ben; Salafsky, Joshua] Biodesy Inc, San Francisco, CA 94080 USA; [Yin, Guowei; Munari, Francesca; Strohaeker, Timo; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Lazaro, Diana F.; Outeiro, Tiago F.] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37075 Gottingen, Germany; [Lazaro, Diana F.; Outeiro, Tiago F.] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany; [Munari, Francesca; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Salafsky, J (corresponding author), 384 Oyster Point Blvd 8, San Francisco, CA 94080 USA.	joshua.salafsky@biodesy.com	Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Zweckstetter, Markus/0000-0002-2536-6581; Moree, Ben/0000-0002-8811-7400; Munari, Francesca/0000-0002-8217-1481	Deutsche Forschungsgemeinschaft (DFG) [ZW 71/2-2, ZW 71/3-2]; Rapid Response Innovation Award grants; Biodesy from the Michael J. Fox Foundation for Parkinson's Research; DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rapid Response Innovation Award grants; Biodesy from the Michael J. Fox Foundation for Parkinson's Research; DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant ZW 71/2-2,3-2 (to M. Z.) and in part by three Rapid Response Innovation Award grants (to J. S.) and Biodesy from the Michael J. Fox Foundation for Parkinson's Research. B. M. is an employee of Biodesy, Inc. J. S. is the Founder and Chief Scientific Officer of Biodesy, Inc.; Supported by the DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Craik D J, 1997, Methods Mol Biol, V60, P195; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Erlanson DA, 2012, TOP CURR CHEM, V317, P1, DOI 10.1007/128_2011_180; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; GODDARD TD, 2007, SPARKY; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Heinz T. F., 1991, NONLINEAR SURFACE EL, P353; HEINZ TF, 1983, PHYS REV A, V28, P1883, DOI 10.1103/PhysRevA.28.1883; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huahai H., 2006, DATA MINING 2006, P885; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Moreaux L, 2003, OPT LETT, V28, P625, DOI 10.1364/OL.28.000625; Moree B, 2015, BIOPHYS J, V109, P806, DOI 10.1016/j.bpj.2015.07.016; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salafsky JS, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218846; Salafsky JS, 2007, PHYS CHEM CHEM PHYS, V9, P5704, DOI 10.1039/b710505c; Salafsky JS, 2008, J PHYS CHEM B, V112, P15103, DOI 10.1021/jp803703m; Salafsky JS, 2001, CHEM PHYS LETT, V342, P485, DOI 10.1016/S0009-2614(01)00623-6; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Toth G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087133; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Uversky VN, 2014, CHEM REV, V114, P6557, DOI 10.1021/cr500288y; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632	61	41	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27582	27593		10.1074/jbc.M114.636027	http://dx.doi.org/10.1074/jbc.M114.636027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396193	Green Published, hybrid			2022-12-26	WOS:000365757500014
J	Lueschow, A; Weber, JE; Carbon, CC; Deffke, I; Sander, T; Gruter, T; Gruter, M; Trahms, L; Curio, G				Lueschow, Andreas; Weber, Joachim E.; Carbon, Claus-Christian; Deffke, Iris; Sander, Tilmann; Grueter, Thomas; Grueter, Martina; Trahms, Lutz; Curio, Gabriel			The 170ms Response to Faces as Measured by MEG (M170) Is Consistently Altered in Congenital Prosopagnosia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; DEVELOPMENTAL PROSOPAGNOSIA; PROCESSING NETWORK; IMPAIRED FACE; HUMAN BRAIN; RECOGNITION; CORTEX; PERCEPTION; DISSOCIATION; AREA	Modularity of face processing is still a controversial issue. Congenital prosopagnosia (cPA), a selective and lifelong impairment in familiar face recognition without evidence of an acquired cerebral lesion, offers a unique opportunity to support this fundamental hypothesis. However, in spite of the pronounced behavioural impairment, identification of a functionally relevant neural alteration in congenital prosopagnosia by electrophysiogical methods has not been achieved so far. Here we show that persons with congenital prosopagnosia can be distinguished as a group from unimpaired persons using magnetoencephalography. Early face-selective MEG-responses in the range of 140 to 200ms (the M170) showed prolonged latency and decreased amplitude whereas responses to another category (houses) were indistinguishable between subjects with congenital prosopagnosia and unimpaired controls. Latency and amplitude of face-selective EEG responses (the N170) which were simultaneously recorded were statistically indistinguishable between subjects with cPA and healthy controls which resolves heterogeneous and partly conflicting results from existing studies. The complementary analysis of categorical differences (evoked activity to faces minus evoked activity to houses) revealed that the early part of the 170ms response to faces is altered in subjects with cPA. This finding can be adequately explained in a common framework of holistic and part-based face processing. Whereas a significant brain-behaviour correlation of face recognition performance and the size of the M170 amplitude is found in controls a corresponding correlation is not seen in subjects with cPA. This indicates functional relevance of the alteration found for the 170ms response to faces in cPA and pinpoints the impairment of face processing to early perceptual stages.	[Lueschow, Andreas; Weber, Joachim E.; Deffke, Iris; Curio, Gabriel] Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Carbon, Claus-Christian; Grueter, Thomas; Grueter, Martina] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Sander, Tilmann; Trahms, Lutz] Phys Tech Bundesanstalt, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto Friedrich University Bamberg; Physikalisch-Technische Bundesanstalt (PTB)	Lueschow, A (corresponding author), Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	andreas.lueschow@charite.de; joachim.weber@charite.de	Carbon, Claus-Christian/A-7494-2008; Weber, Joachim/AAL-2799-2020; Carbon, Claus-Christian/GLQ-6274-2022	Carbon, Claus-Christian/0000-0002-3446-9347; Weber, Joachim/0000-0002-1666-6021; Carbon, Claus-Christian/0000-0002-3446-9347; Gruter, Thomas/0000-0003-3529-9244; Gruter, Martina/0000-0002-2784-0486; Curio, Gabriel/0000-0002-3377-7735				Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Avidan G, 2014, CEREB CORTEX, V24, P1565, DOI 10.1093/cercor/bht007; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Benton A.L., 1994, CONTRIBUTIONS NEUROP; BOTZEL K, 1989, EXP BRAIN RES, V77, P349, DOI 10.1007/BF00274992; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Carbon CC, 2007, PERCEPTION, V36, P1635, DOI 10.1068/p5467; Carbon CC, 2010, VIS COGN, V18, P641, DOI 10.1080/13506280903462471; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Eimer M, 2012, BRAIN, V135, P542, DOI 10.1093/brain/awr347; Fodor J, 1983, MODULARITY MIND; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Furl N, 2011, J COGNITIVE NEUROSCI, V23, P1723, DOI 10.1162/jocn.2010.21545; Gazzaniga MS, 1999, NEW COGNITIVE NEUROS, P393; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Herzmann G, 2010, J COGNITIVE NEUROSCI, V22, P571, DOI 10.1162/jocn.2009.21249; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MCNEIL JE, 1991, Q J EXP PSYCHOL-A, V43, P267, DOI 10.1080/14640749108400970; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Nemeth K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101393; Pernet C, 2007, NEUROIMAGE, V35, P991, DOI 10.1016/j.neuroimage.2007.01.017; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Rivolta D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00045; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Sander TH, 2002, IEEE T BIO-MED ENG, V49, P345, DOI 10.1109/10.991162; Scheer HJ, 2006, PHYSIOL MEAS, V27, P109, DOI 10.1088/0967-3334/27/2/002; SERGENT J, 1992, PHILOS T ROY SOC B, V335, P55, DOI 10.1098/rstb.1992.0007; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Towler J, 2012, NEUROPSYCHOLOGIA, V50, P3588, DOI 10.1016/j.neuropsychologia.2012.10.017; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Warrington E.K., 1984, RECOGNITION MEMORY T	53	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137624	10.1371/journal.pone.0137624	http://dx.doi.org/10.1371/journal.pone.0137624			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393348	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100015
J	Zhang, HY; Li, YH; Hu, J; Shen, WJ; Singh, M; Hou, XM; Bittner, A; Bittner, S; Cortez, Y; Tabassum, J; Kraemer, FB; Azhar, S				Zhang, Haiyan; Li, Yihang; Hu, Jie; Shen, Wen-Jun; Singh, Madhurima; Hou, Xiaoming; Bittner, Alex; Bittner, Stefanie; Cortez, Yuan; Tabassum, Juveria; Kraemer, Fredric B.; Azhar, Salman			Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; PEROXISOMAL BETA-OXIDATION; INDUCED INSULIN-RESISTANCE; ELEMENT-BINDING PROTEIN; FATTY-ACID OXIDATION; NORDIHYDROGUAIARETIC ACID; DIABETES-MELLITUS; VLDL SECRETION; MALONYL-COA; DIET	Nordihydroguaiaretic acid (NDGA), the main metabolite of Creosote bush, has been shown to have profound effects on the core components of the metabolic syndrome (MetS), lowering blood glucose, free fatty acids (FFA) and triglyceride (TG) levels in several models of dyslipidemia, as well as improving body weight (obesity), insulin resistance, diabetes and hypertension, and ameliorating hepatic steatosis. In the present study, a high-fructose diet (HFrD) fed rat model of hypertriglyceridemia was employed to further delineate the underlying mechanism by which NDGA exerts its anti-hypertriglyceridemic action. In the HFrD treatment group, NDGA administration by oral gavage decreased plasma levels of TG, glucose, FFA, and insulin, increased hepatic mitochondrial fatty acid oxidation and attenuated hepatic TG accumulation. qRT-PCR measurements indicated that NDGA treatment increased the mRNA expression of key fatty acid transport (L-FABP, CD36), and fatty acid oxidation (ACOX1, CPT-2, and PPAR alpha transcription factor) genes and decreased the gene expression of enzymes involved in lipogenesis (FASN, ACC1, SCD1, L-PK and ChREBP and SREBP-1c transcription factors). Western blot analysis indicated that NDGA administration upregulated hepatic insulin signaling (P-Akt), AMPK activity (P-AMPK), MLYCD, and PPARa protein levels, but decreased SCD1, ACC1 and ACC2 protein content and also inactivated ACC1 activity (increased P-ACC1). These findings suggest that NDGA ameliorates hypertriglyceridemia and hepatic steatosis primarily by interfering with lipogenesis and promoting increased channeling of fatty acids towards their oxidation.	[Zhang, Haiyan; Li, Yihang; Hu, Jie; Shen, Wen-Jun; Singh, Madhurima; Hou, Xiaoming; Bittner, Alex; Bittner, Stefanie; Cortez, Yuan; Tabassum, Juveria; Kraemer, Fredric B.; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Zhang, Haiyan; Li, Yihang; Shen, Wen-Jun; Singh, Madhurima; Hou, Xiaoming; Kraemer, Fredric B.; Azhar, Salman] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Azhar, S (corresponding author), VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA.	salman.azhar@va.gov	Kraemer, Fredric/AAC-3633-2019	Shen, Wen-Jun/0000-0001-5150-1698; Kraemer, Fredric/0000-0003-2468-7807	National Institutes of Health, NHLBI [1R01HL92473]; Office of Research and Development, Medical Service, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092473] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research and Development, Medical Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Funding: This work was supported by National Institutes of Health, NHLBI Grant 1R01HL92473, and the Office of Research and Development, Medical Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Bassi N, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.06.035; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Gowri MS, 2000, AM J PHYSIOL-ENDOC M, V279, pE593, DOI 10.1152/ajpendo.2000.279.3.E593; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Guo S, 2014, J ENDOCRINOL, V220, P1, DOI DOI 10.1530/JOE-13-0327; Habets DDJ, 2009, BBA-MOL CELL BIOL L, V1791, P212, DOI 10.1016/j.bbalip.2008.12.009; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hashimoto T, 2000, CELL BIOCHEM BIOPHYS, V32, P63, DOI 10.1385/CBB:32:1-3:63; HENRY PJ, 1994, BRIT J PHARMACOL, V111, P561, DOI 10.1111/j.1476-5381.1994.tb14774.x; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Jornayvaz FR, 2010, ANNU REV NUTR, V30, P273, DOI 10.1146/annurev.nutr.012809.104726; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kelley GL, 2004, ENDOCRINOLOGY, V145, P548, DOI 10.1210/en.2003-1167; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Lee GY, 2004, BIOCHEM J, V378, P983, DOI 10.1042/BJ20031565; Lee MS, 2010, BIOCHEM BIOPH RES CO, V401, P92, DOI 10.1016/j.bbrc.2010.09.016; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Y, 2012, BRAIN RES, V1445, P73, DOI 10.1016/j.brainres.2012.01.031; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Reed MJ, 1999, DIABETOLOGIA, V42, P102, DOI 10.1007/s001250051121; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Scribner KA, 2000, METABOLISM, V49, P1106, DOI 10.1053/meta.2000.8604; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Sourianarayanane A, 2013, Minerva Gastroenterol Dietol, V59, P69; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Watts GF, 2013, NAT REV CARDIOL, V10, P648, DOI 10.1038/nrcardio.2013.140; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Yu XX, 1997, J NUTR, V127, P1814, DOI 10.1093/jn/127.9.1814; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang HY, 2013, AM J PHYSIOL-GASTR L, V304, pG72, DOI 10.1152/ajpgi.00328.2012	67	14	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138203	10.1371/journal.pone.0138203	http://dx.doi.org/10.1371/journal.pone.0138203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394137	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100038
J	Lania, G; Ferrentino, R; Baldini, A				Lania, Gabriella; Ferrentino, Rosa; Baldini, Antonio			TBX1 Represses Vegfr2 Gene Expression and Enhances the Cardiac Fate of VEGFR2+Cells	PLOS ONE			English	Article							PROGENITOR CELLS; FLK1 EXPRESSION; OUTFLOW TRACT; SMOOTH-MUSCLE; 2ND HEART; PATHWAYS; DEFECTS; FIELD; EMBRYOGENESIS; MORPHOGENESIS	The T-box transcription factor TBX1 has critical roles in maintaining proliferation and inhibiting differentiation of cardiac progenitor cells of the second heart field (SHF). Haploinsufficiency of the gene that encodes it is a cause of congenital heart disease. Here, we developed an embryonic stem (ES) cell-based model in which Tbx1 expression can be modulated by tetracycline. Using this model, we found that TBX1 down regulates the expression of VEGFR2, and we confirmed this finding in vivo during embryonic development. In addition, we found a Vegfr2 domain of expression, not previously described, in the posterior SHF and this expression is extended by loss of Tbx1. VEGFR2 has been previously described as a marker of a subpopulation of cardiac progenitors. Clonal analysis of ES-derived VEGFR2+ cells indicated that 12.5% of clones expressed three markers of cardiac lineage (cardiomyocyte, smooth muscle and endothelium). However, a pulse of Tbx1 expression was sufficient to increase the percentage to 20.8%. In addition, the percentage of clones expressing markers of multiple cardiac lineages increased from 41.6% to 79.1% after Tbx1 pulse. These results suggest that TBX1 plays a role in maintaining a progenitor state in VEGFR2+ cells.	[Lania, Gabriella; Ferrentino, Rosa; Baldini, Antonio] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Baldini, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Lania, G (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Via Pietro Castellino 111, I-80131 Naples, Italy.	gabriella.lania@igb.cnr.it; antonio.baldini@unina.it	lania, gabriella/AAX-3887-2020; Baldini, Antonio/M-2355-2015	lania, gabriella/0000-0003-3681-0251; Baldini, Antonio/0000-0002-5330-0256	Telethon Foundation [GGP14211]; Italian Ministry of Education and Research (MIUR) [PON_01-02342]; FareBio	Telethon Foundation(Fondazione Telethon); Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); FareBio	This project was funded by grants from the Telethon Foundation GGP14211 (www.telethon.it), from the Italian Ministry of Education and Research (MIUR) PON_01-02342 (www.istruzione.it), and FareBio (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs LE, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.006; Chen L, 2012, PLOS GENET, V8, DOI [10.1371/journal.pgen.1002571, DOI 10.1371/J0URNAL.PGEN.1002571]; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Drake CJ, 2006, DEV DYNAM, V235, P10, DOI 10.1002/dvdy.20539; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fulcoli FG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006049, DOI 10.1371/J0URNAL.P0NE.0006049]; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Ishitobi H, 2011, DEVELOPMENT, V138, P5357, DOI 10.1242/dev.065565; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Lacaud G, 2004, TRENDS CARDIOVAS MED, V14, P314, DOI 10.1016/j.tcm.2004.09.004; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Masui S, 2005, NUCLEIC ACIDS RES, V33, P1; Milgrom-Hoffman M, 2014, BIOL OPEN, V3, P679, DOI 10.1242/bio.20148078; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Ogawa K, 2010, J BIOMED BIOTECHNOL, DOI [10.1155/2010/380561, DOI 10.1155/2010/380561]; Pane LS, 2012, HUM MOL GENET, V21, P2485, DOI 10.1093/hmg/dds063; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Watanabe Y, 2010, ANN NY ACAD SCI, V1188, P15, DOI 10.1111/j.1749-6632.2009.05078.x; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539	33	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138525	10.1371/journal.pone.0138525	http://dx.doi.org/10.1371/journal.pone.0138525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382615	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200120
J	Maisuria, VB; Nerurkar, AS				Maisuria, Vimal B.; Nerurkar, Anuradha S.			Interference of Quorum Sensing by Delftia sp VM4 Depends on the Activity of a Novel N-Acylhomoserine Lactone-Acylase	PLOS ONE			English	Article							ERWINIA-CAROTOVORA; QUENCHING LACTONASE; CHROMOBACTERIUM-VIOLACEUM; DIRECTED EVOLUTION; SIGNAL MOLECULES; IDENTIFICATION; VIRULENCE; BACTERIA; ENZYME; DISRUPTION	Background Turf soil bacterial isolate Delftia sp. VM4 can degrade exogenous N-acyl homoserine lactone (AHL), hence it effectively attenuates the virulence of bacterial soft rot pathogen Pectobacterium carotovorum subsp. carotovorum strain BR1 (Pcc BR1) as a consequence of quorum sensing inhibition. Methodology/Principal Findings Isolated Delftia sp. VM4 can grow in minimal medium supplemented with AHL as a sole source of carbon and energy. It also possesses the ability to degrade various AHL molecules in a short time interval. Delftia sp. VM4 suppresses AHL accumulation and the production of virulence determinant enzymes by Pcc BR1 without interference of the growth during co-culture cultivation. The quorum quenching activity was lost after the treatment with trypsin and proteinase K. The protein with quorum quenching activity was purified by three step process. Matrix assisted laser desorption/ ionization-time of flight (MALDI-TOF) and Mass spectrometry (MS/MS) analysis revealed that the AHL degrading enzyme (82 kDa) demonstrates homology with the NCBI database hypothetical protein (Daci_4366) of D. acidovorans SPH-1. The purified AHL acylase of Delftia sp. VM4 demonstrated optimum activity at 20-40 degrees C and pH 6.2 as well as AHL acylase type mode of action. It possesses similarity with an alpha/beta-hydrolase fold protein, which makes it unique among the known AHL acylases with domains of the N-terminal nucleophile (Ntn)-hydrolase superfamily. In addition, the kinetic and thermodynamic parameters for hydrolysis of the different AHL substrates by purified AHL-acylase were estimated. Here we present the studies that investigate the mode of action and kinetics of AHL-degradation by purified AHL acylase from Delftia sp. VM4. Significance We characterized an AHL-inactivating enzyme from Delftia sp. VM4, identified as AHL acylase showing distinctive similarity with alpha/beta-hydrolase fold protein, described its biochemical and thermodynamic properties for the first time and revealed its potential application as an anti-virulence agent against bacterial soft rot pathogen Pectobacterium carotovorum subsp. carotovorum based on quorum quenching mechanism.	[Maisuria, Vimal B.; Nerurkar, Anuradha S.] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Fac Sci, Vadodara, Gujarat, India; [Maisuria, Vimal B.; Nerurkar, Anuradha S.] Maharaja Sayajirao Univ Baroda, Ctr Biotechnol, Fac Sci, Vadodara, Gujarat, India; [Maisuria, Vimal B.] Univ Hertfordshire, Fac Hlth & Human Sci, Sch Life Sci, Hatfield AL10 9AB, Herts, England	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; University of Hertfordshire	Nerurkar, AS (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Microbiol, Fac Sci, Vadodara, Gujarat, India.	anuner26@yahoo.com	Nerurkar, Anuradha/AAA-4099-2019		University Grants Commission (New Delhi, India) [F.4-1/2006/XI plans/BSR]; Commonwealth Scholarship Commission in the United Kingdom	University Grants Commission (New Delhi, India)(University Grants Commission, India); Commonwealth Scholarship Commission in the United Kingdom	VBM acknowledges the University Grants Commission (New Delhi, India) for a meritorious student research fellowship (UGC sanction No. F.4-1/2006/XI plans/BSR) and Commonwealth Scholarship Commission in the United Kingdom for the Commonwealth split-site doctoral scholarship-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; Bauer WD, 2002, CURR OPIN BIOTECH, V13, P234, DOI 10.1016/S0958-1669(02)00310-5; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Czajkowski R, 2011, ENV MICROBIOL REP, V3, P59, DOI 10.1111/j.1758-2229.2010.00188.x; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; d'Angelo-Picard C, 2005, ENVIRON MICROBIOL, V7, P1796, DOI 10.1111/j.1462-2920.2005.00886.x; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Hiblot J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08372; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Jafra S, 2006, CAN J MICROBIOL, V52, P1006, DOI 10.1139/W06-062; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lee SJ, 2002, APPL ENVIRON MICROB, V68, P3919, DOI 10.1128/AEM.68.8.3919-3924.2002; Liao CH, 2004, PHYTOPATHOLOGY, V94, P76, DOI 10.1094/PHYTO.2004.94.1.76; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; Maisuria VB, 2012, BIOCHEM ENG J, V63, P22, DOI 10.1016/j.bej.2012.01.007; Maisuria VB, 2010, J MICROBIOL BIOTECHN, V20, P1077, DOI 10.4014/jmb.0908.08008; Maisuria VB, 2013, EUR J PLANT PATHOL, V136, P87, DOI 10.1007/s10658-012-0140-0; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Morohoshi T, 2008, BIOSCI BIOTECH BIOCH, V72, P1887, DOI 10.1271/bbb.80139; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Romero M, 2008, FEMS MICROBIOL LETT, V280, P73, DOI 10.1111/j.1574-6968.2007.01046.x; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Shepherd RW, 2009, APPL ENVIRON MICROB, V75, P45, DOI 10.1128/AEM.01723-08; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Xu SY, 2005, BIOCHEM J, V387, P841, DOI 10.1042/BJ20041811; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	49	19	23	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138034	10.1371/journal.pone.0138034	http://dx.doi.org/10.1371/journal.pone.0138034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384328	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200049
J	McGuinness, LR; Wilkins, MJ; Williams, KH; Long, PE; Kerkhof, LJ				McGuinness, Lora R.; Wilkins, Michael J.; Williams, Kenneth H.; Long, Philip E.; Kerkhof, Lee J.			Identification of Bacteria Synthesizing Ribosomal RNA in Response to Uranium Addition During Biostimulation at the Rifle, CO Integrated Field Research Site	PLOS ONE			English	Article							MICROBIAL REDUCTION; SULFATE REDUCTION; GROWTH-RATE; ACETATE; BIOREMEDIATION; U(VI); IRON; COMMUNITIES; SEDIMENT; FE(III)	Understanding which organisms are capable of reducing uranium at historically contaminated sites provides crucial information needed to evaluate treatment options and outcomes. One approach is determination of the bacteria which directly respond to uranium addition. In this study, uranium amendments were made to groundwater samples from a site of ongoing biostimulation with acetate. The active microbes in the planktonic phase were deduced by monitoring ribosomes production via RT-PCR. The results indicated several microorganisms were synthesizing ribosomes in proportion with uranium amendment up to 2 mu M. Concentrations of U (VI) > 2 mu M were generally found to inhibit ribosome synthesis. Two active bacteria responding to uranium addition in the field were close relatives of Desulfobacter postgateii and Geobacter bemidjiensis. Since RNA content often increases with growth rate, our findings suggest it is possible to rapidly elucidate active bacteria responding to the addition of uranium in field samples and provides a more targeted approach to stimulate specific populations to enhance radionuclide reduction in contaminated sites.	[McGuinness, Lora R.; Kerkhof, Lee J.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Wilkins, Michael J.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Williams, Kenneth H.; Long, Philip E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Ohio State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kerkhof, LJ (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	lkerkhof@rutgers.edu	Long, Philip E/F-5728-2013; Wilkins, Michael/A-9358-2013; Williams, Kenneth Hurst/O-5181-2014	Long, Philip E/0000-0003-4152-5682; Williams, Kenneth Hurst/0000-0002-3568-1155; Wilkins, Michael/0000-0002-3595-0853; Kerkhof, Lee/0000-0001-9107-8695	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy [DE-AC06-76RLO-1830]	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	The Rifle IFC is funded by the Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy (Contract Number DE-AC06-76RLO-1830).	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Babcock DA, 2007, J MICROBIOL METH, V71, P156, DOI 10.1016/j.mimet.2007.07.015; Bargar JR, 2013, P NATL ACAD SCI USA, V110, P4506, DOI 10.1073/pnas.1219198110; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Chang YJ, 2005, ENVIRON SCI TECHNOL, V39, P9039, DOI 10.1021/es051218u; Druhan JL, 2008, ENVIRON SCI TECHNOL, V42, P7842, DOI 10.1021/es800414s; Druhan JL, 2012, ENVIRON SCI TECHNOL, V46, P8895, DOI 10.1021/es302016p; Fennell DE, 2004, APPL ENVIRON MICROB, V70, P1169, DOI 10.1128/AEM.70.2.1169-1175.2004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handley KM, 2015, ENVIRON MICROBIOL, V17, P622, DOI 10.1111/1462-2920.12467; Handley KM, 2013, ISME J, V7, P800, DOI 10.1038/ismej.2012.148; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Jeffrey WH, 1996, AQUAT MICROB ECOL, V10, P87, DOI 10.3354/ame010087; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; Kerkhof L, 1997, J BIOCHEM BIOPH METH, V34, P147, DOI 10.1016/S0165-022X(97)01212-8; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Kerkhof LJ, 2011, ENVIRON SCI TECHNOL, V45, P1250, DOI 10.1021/es102893r; Kerkhof Lee J., 2008, P55; Koribanics NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123378; LOVLEY DR, 1993, MAR GEOL, V113, P41, DOI 10.1016/0025-3227(93)90148-O; Luan F, 2014, ENVIRON SCI TECHNOL, V48, P2750, DOI 10.1021/es404885e; McGuinness LM, 2006, ENVIRON SCI TECHNOL, V40, P509, DOI 10.1021/es050900l; Moon HS, 2010, WATER RES, V44, P4015, DOI 10.1016/j.watres.2010.05.003; Newsome L, 2014, CHEM GEOL, V363, P164, DOI 10.1016/j.chemgeo.2013.10.034; Pietzsch K, 1999, J BASIC MICROB, V39, P365; Prakash O, 2010, INT J SYST EVOL MICR, V60, P546, DOI 10.1099/ijs.0.010843-0; Shelobolina ES, 2008, INT J SYST EVOL MICR, V58, P1075, DOI 10.1099/ijs.0.65377-0; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Spear JR, 2000, APPL ENVIRON MICROB, V66, P3711, DOI 10.1128/AEM.66.9.3711-3721.2000; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; VanEngelen MR, 2011, ENVIRON SCI TECHNOL, V45, P937, DOI 10.1021/es101754x; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074	35	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137270	10.1371/journal.pone.0137270	http://dx.doi.org/10.1371/journal.pone.0137270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382047	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200018
J	dos Santos, ADM; Kalume, DE; Camargo, R; Gomez-Mendoza, DP; Correa, JR; Charneau, S; de Sousa, MV; de Lima, BD; Ricart, CAO				Moreira dos Santos Junior, Agenor de Castro; Kalume, Dario Eluan; Camargo, Ricardo; Gomez-Mendoza, Diana Paola; Correa, Jose Raimundo; Charneau, Sebastien; de Sousa, Marcelo Valle; de Lima, Beatriz Dolabela; Ornelas Ricart, Carlos Andre			Unveiling the Trypanosoma cruzi Nuclear Proteome	PLOS ONE			English	Article							LEISHMANIA-DONOVANI; PROTEINS; BRUCEI; CELL; LOCALIZATION; EXPRESSION; PROTECTION; RESISTANT; DIVISION; STRAINS	Replication of Trypanosoma cruzi, the etiological agent of Chagas disease, displays peculiar features, such as absence of chromosome condensation and closed mitosis. Although previous proteome and subproteome analyses of T. cruzi have been carried out, the nuclear subproteome of this protozoan has not been described. Here, we report, for the first time to the best of our knowledge, the isolation and proteome analysis of T. cruzi nuclear fraction. For that, T. cruzi epimastigote cells were lysed and subjected to cell fractionation using two steps of sucrose density gradient centrifugation. The purity of the nuclear fraction was confirmed by phase contrast and fluorescence microscopy. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) allowed the identification of 864 proteins. Among those, 272 proteins were annotated as putative uncharacterized, and 275 had not been previously reported on global T. cruzi proteome analysis. Additionally, to support our enrichment method, bioinformatics analysis in DAVID was carried out. It grouped the nuclear proteins in 65 gene clusters, wherein the clusters with the highest enrichment scores harbor members with chromatin organization and DNA binding functions.	[Moreira dos Santos Junior, Agenor de Castro; Camargo, Ricardo; Gomez-Mendoza, Diana Paola; Correa, Jose Raimundo; Charneau, Sebastien; de Sousa, Marcelo Valle; de Lima, Beatriz Dolabela; Ornelas Ricart, Carlos Andre] Univ Brasilia, Inst Biol, Dept Cell Biol, BR-70910900 Brasilia, DF, Brazil; [Kalume, Dario Eluan] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040360 Rio De Janeiro, RJ, Brazil	Universidade de Brasilia; Fundacao Oswaldo Cruz	dos Santos, ADM (corresponding author), Univ Brasilia, Inst Biol, Dept Cell Biol, Campus Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.	agenor.unb@gmail.com	de Sousa, Marcelo Valle/H-1838-2016; Correa, Jose R/K-6270-2012; Charneau, Sébastien/AAD-1145-2019; Mendoza, Diana Paola Gómez/N-7075-2016	de Sousa, Marcelo Valle/0000-0002-2871-4430; Correa, Jose R/0000-0003-2752-5395; Charneau, Sébastien/0000-0002-9364-7289; Mendoza, Diana Paola Gómez/0000-0003-3318-3539; Camargo, Ricardo/0000-0003-0592-8396	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [563998/2010-5]; Fundacao de Amparo a Pesquisa do Estado de Goias; Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica (CAPES) [23038.005298/2011-83]; Financiadora de Estudos e Projetos	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias; Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica (CAPES); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant no 563998/2010-5), Fundacao de Amparo a Pesquisa do Estado de Goias, Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica (CAPES grant no: 23038.005298/2011-83) and Financiadora de Estudos e Projetos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PR, 2011, MEM I OSWALDO CRUZ, V106, P257, DOI 10.1590/S0074-02762011000300002; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Batista JAN, 1994, MOLECULAR; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; Camargo EP, 1964, REV I MED SAO PAULO; Carolina M, 2002, EUKARYOT CELL, V1, P944, DOI 10.1128/EC.1.6.944-953.2002; Chene A, 2012, NUCLEIC ACIDS RES, V40, P3066, DOI 10.1093/nar/gkr1215; El-Sayed NM, 2005, SCIENCE; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Frasch A, 2000, PARASITOL TODAY, V16, P1; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Guha R, 2013, VACCINE, V31, P1905, DOI 10.1016/j.vaccine.2013.02.025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lanz-Mendoza H, 2012, BIOMED RES; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Liu H, 2006, J CHROMATOGRAPHY; Mana-Capelli S, 2009, EUKARYOT CELL, V8, P1106, DOI 10.1128/EC.00025-09; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; MARTIN F, 1993, BIOCHEM BIOPH RES CO, V196, P1155, DOI 10.1006/bbrc.1993.2372; Paba J, 2004, PROTEOMICS; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Pizarro JC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002492; Queiroz RML, 2014, MOL CELL PROTEOMICS, V13, P3457, DOI 10.1074/mcp.M114.040329; Queiroz RML, 2014, J PROTEOME RES, V13, P3530, DOI 10.1021/pr401120y; Queiroz RML, 2013, J PROTEOME RES, V12, P3255, DOI 10.1021/pr400110h; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Rout MP, 2001, J BIOL CHEM, V276, P38261; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Sodre CL, 2009, ARCH MICROBIOL, V191, P177, DOI 10.1007/s00203-008-0439-6; SOLARI AJ, 1995, BIOCELL, V19, P65; Solari AJ, 1980, CHROMOSOMA; Souza W, 2002, CURRENT PHARM DESIGN; Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9; WHO, 2014, CHAG DIS 2014	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138667	10.1371/journal.pone.0138667	http://dx.doi.org/10.1371/journal.pone.0138667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383644	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200145
J	Larsen, B; Snow, R; Vincent, G; Tran, J; Wolkow, A; Aisbett, B				Larsen, Brianna; Snow, Rod; Vincent, Grace; Tran, Jacqueline; Wolkow, Alexander; Aisbett, Brad			Multiple Days of Heat Exposure on Firefighters' Work Performance and Physiology	PLOS ONE			English	Article							LONGITUDINAL DATA; PROJECT AQUARIUS; EXERCISE; STRESS; MODELS; TEMPERATURE; INGESTION; EXERTION; BUSHFIRE; CAFFEINE	This study assessed the accumulated effect of ambient heat on the performance of, and physiological and perceptual responses to, intermittent, simulated wildfire fighting tasks over three consecutive days. Firefighters (n = 36) were matched and allocated to either the CON (19 degrees C) or HOT (33 degrees C) condition. They performed three days of intermittent, self-paced simulated firefighting work, interspersed with physiological testing. Task repetitions were counted (and converted to distance or area) to determine work performance. Participants were asked to rate their perceived exertion and thermal sensation after each task. Heart rate, core temperature (Ts), and skin temperature (Tsk) were recorded continuously throughout the simulation. Fluids were consumed ad libitum. Urine volume was measured throughout, and urine specific gravity (USG) analysed, to estimate hydration. All food and fluid consumption was recorded. There was no difference in work output between experimental conditions. However, significant variation in performance responses between individuals was observed. All measures of thermal stress were elevated in the HOT, with core and skin temperature reaching, on average, 0.24 0.08 degrees C and 2.81 0.20 degrees C higher than the CON group. Participants' doubled their fluid intake in the HOT condition, and this was reflected in the USG scores, where the HOT participants reported significantly lower values. Heart rate was comparable between conditions at nearly all time points, however the peak heart rate reached each circuit was 7 3% higher in the CON trial. Likewise, RPE was slightly elevated in the CON trial for the majority of tasks. Participants' work output was comparable between the CON and HOT conditions, however the performance change over time varied significantly between individuals. It is likely that the increased fluid replacement in the heat, in concert with frequent rest breaks and task rotation, assisted with the regulation of physiological responses (e.g., heart rate, core temperature).	[Larsen, Brianna; Snow, Rod; Vincent, Grace; Wolkow, Alexander; Aisbett, Brad] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia; [Larsen, Brianna; Vincent, Grace; Wolkow, Alexander; Aisbett, Brad] Bushfire Cooperat Res Ctr, Melbourne, Australia; [Tran, Jacqueline] Deakin Univ, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia	Deakin University; Deakin University	Larsen, B (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia.	b.larsen@deakin.edu.au	Snow, Rod J/G-1673-2010; Aisbett, Brad/E-5178-2011	Snow, Rod J/0000-0002-4796-6916; Tran, Jacqueline/0000-0002-5588-542X; Aisbett, Brad/0000-0001-8077-0272; Wolkow, Alexander/0000-0001-7845-3104; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823	Bushfire Co-operative Research Centre; Deakin University	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Deakin University	The Bushfire Co-operative Research Centre funded this research as part of a broader study. The Bushfire CRC website is http://www.bushfirecrc.com/. The webpage directly discussing this body of work is http://www.bushfirecrc.com/projects/c-11-1/operational-readiness-rural-firefighters-during-bushfire-suppression. Dr. Brad Aisbett (last author) was one of the project leaders and was awarded the funding on behalf of Deakin University.	Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Aisbett B, 2007, AUST J EMERG MANAG, V22, P31; Bates Graham P, 2008, J Occup Med Toxicol, V3, P21, DOI 10.1186/1745-6673-3-21; Borg G, 1998, BORGS PERCEIVED EXER; Budd GM, 1997, INT J WILDLAND FIRE, V7, P119, DOI 10.1071/WF9970119; Budd GM, 1997, INT J WILDLAND FIRE, V7, P69, DOI 10.1071/WF9970069; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Castle P, 2011, J SPORT SCI, V29, P1125, DOI 10.1080/02640414.2011.583673; Cater H, 2007, FATIGUE FIREGROUND D; Cheung SS, 2000, SPORTS MED, V29, P329, DOI 10.2165/00007256-200029050-00004; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Field A, 2007, DISCOVERING STAT USI; Garrett AT, 2012, EUR J APPL PHYSIOL, V112, P1827, DOI 10.1007/s00421-011-2153-3; Garrett AT, 2009, EUR J APPL PHYSIOL, V107, P659, DOI 10.1007/s00421-009-1182-7; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; HAMILTON MT, 1991, J APPL PHYSIOL, V71, P871, DOI 10.1152/jappl.1991.71.3.871; Hargreaves M, 2008, J SCI MED SPORT, V11, P66, DOI 10.1016/j.jsams.2007.07.002; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kachman S, 2000, INTRO GENERALIZED LI, P59; Kenefick RW, 2012, NUTR REV, V70, pS137, DOI 10.1111/j.1753-4887.2012.00523.x; Lee S.M.C., 2000, CORE TEMPERATURE MEA; McCulloch CE, 2003, JSTOR, pi; McGregor SJ, 1999, J SPORT SCI, V17, P895, DOI 10.1080/026404199365452; MCLELLAN TM, 1993, AVIAT SPACE ENVIR MD, V64, P587; McLennan J., 2005, Environmental Hazards, V6, P101, DOI 10.1016/j.hazards.2005.10.003; Molenberghs G, 2001, STAT MODEL, V1, P235, DOI 10.1177/1471082X0100100402; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; PAYNE WR, 1994, AM IND HYG ASSOC J, V55, P529, DOI 10.1080/15428119491018808; Phillips M, 2011, BUSHF CRC AFAC C SYD, P205; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Raines J, 2013, APPL ERGON, V44, P404, DOI 10.1016/j.apergo.2012.10.002; Raines J, 2012, APPL ERGON, V43, P532, DOI 10.1016/j.apergo.2011.08.007; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Rodriguez-Marroyo JA, 2011, ERGONOMICS, V54, P1101, DOI 10.1080/00140139.2011.611895; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; SNOOK SH, 1974, AM IND HYG ASSOC J, V35, P681, DOI 10.1080/0002889748507088; Tasca GA, 2009, PSYCHOTHER RES, V19, P429, DOI 10.1080/10503300802641444; Teague B., 2010, 2009 VICTORIAN BUSHF; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Westfall P, 2013, UNDERSTANDING ADV ST; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218	48	23	23	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136413	10.1371/journal.pone.0136413	http://dx.doi.org/10.1371/journal.pone.0136413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379284	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400005
J	Wanga, S; Ceron, CS; Delgado, C; Joshi, SK; Spaulding, K; Walker, JP; Song, S; Olson, JL; Lovett, DH				Wanga, Shaynah; Ceron, Carla S.; Delgado, Cynthia; Joshi, Sunil K.; Spaulding, Kimberly; Walker, Joy P.; Song, Sangheon; Olson, Jean L.; Lovett, David H.			Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; TUBULOINTERSTITIAL INJURY; RENAL-TRANSPLANTATION; RISK-FACTORS; EXPRESSION; MATRIX-METALLOPROTEINASE-2; CELLS; MODEL; TRANSCRIPTION; INHIBITION	Delayed graft function (DGF) is a frequent complication of renal transplantation, particularly in the setting of transplantation of kidneys derived from deceased donors and expanded-criteria donors. DGF results from tubular epithelial cell injury and has immediate and long term consequences. These include requirement for post-transplantation dialysis, increased incidence of acute rejection, and poorer long-term outcomes. DGF represents one of the clearest clinical examples of renal acute ischemia/reperfusion injury. Experimental studies have demonstrated that ischemia/reperfusion injury induces the synthesis of the full length secreted isoform of matrix metalloproteinase-2 (FL-MMP-2), as well as an intracellular Nterminal truncated MMP-2 isoform (NTT-MMP-2) that initiates an innate immune response. We hypothesized that the two MMP-2 isoforms mediate tubular epithelial cell injury in DGF. Archival renal biopsy sections from 10 protocol biopsy controls and 41 cases with a clinical diagnosis of DGF were analyzed for the extent of tubular injury, expression of the FL-MMP2 and NTT-MMP-2 isoforms by immunohistochemistry (IHC), in situ hybridization, and qPCR to determine isoform abundance. Differences in transcript abundance were related to tubular injury score. Markers of MMP-2-mediated injury included TUNEL staining and assessment of peritubular capillary density. There was a clear relationship between tubular epithelial cell expression of both FL-MMP-2 and NTT-MMP-2 IHC with the extent of tubular injury. The MMP-2 isoforms were detected in the same tubular segments and were present at sites of tubular injury. qPCR demonstrated highly significant increases in both the FL-MMP-2 and NTT-MMP-2 transcripts. Statistical analysis revealed highly significant associations between FL-MMP-2 and NTT-MMP-2 transcript abundance and the extent of tubular injury, with NTT-MMP-2 having the strongest association. We conclude that two distinct MMP-2 isoforms are associated with tubular injury in DGF and offer novel therapeutic targets for the prevention of this disorder.	[Wanga, Shaynah; Ceron, Carla S.; Delgado, Cynthia; Joshi, Sunil K.; Song, Sangheon; Lovett, David H.] Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94117 USA; [Spaulding, Kimberly; Walker, Joy P.] Univ Calif San Francisco, Dept Surg, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Olson, Jean L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lovett, DH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94117 USA.	david.lovett@va.gov	Ceron, Carla Speroni/F-1160-2015	Ceron, Carla Speroni/0000-0001-8882-5792; Joshi, Sunil/0000-0003-2798-5762	Dutch Kidney Foundation; Ciencias sem Fronteiras; Department of Veterans Affairs [1IK2CX000527-01A2, I-1BX000593]; National Institute of Diabetes, Digestive and Kidney Disease [DK007219, RO1DK39776]; Pusan National University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007219, R01DK039776] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000527] Funding Source: NIH RePORTER	Dutch Kidney Foundation; Ciencias sem Fronteiras; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Diabetes, Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pusan National University School of Medicine(Pusan National University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	SW was supported by a Kolff Student Fellowship Abroad from the Dutch Kidney Foundation. CSC was supported by a Fellowship Grant from Ciencias sem Fronteiras. CD is supported by the Department of Veterans Affairs Clinical Science Research and Development Program under Career Development Award 1IK2CX000527-01A2. JPW was supported by National Institute of Diabetes, Digestive and Kidney Disease T32 Training Grant DK007219 (Lovett). SS was supported by a grant from Pusan National University School of Medicine. DHL was supported by Department of Veterans Affairs Merit Review Award I-1BX000593 and National Institute of Diabetes, Digestive and Kidney Disease grant RO1DK39776. CD's and DHL's contributions are the result of work supported with the resources and the use of facilities at the San Francisco VA Medical Center.	Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; [Anonymous], 2013, ORGAN PROCUREMENT TR; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bronzatto EJM, 2009, TRANSPL P, V41, P849, DOI 10.1016/j.transproceed.2009.02.004; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Ke QD, 2006, AM J PHYSIOL-LUNG C, V291, pL257, DOI 10.1152/ajplung.00007.2006; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lange PF, 2011, NAT METHODS, V8, P703, DOI 10.1038/nmeth.1669; Lee JG, 2005, P NATL ACAD SCI USA, V102, P16345, DOI 10.1073/pnas.0508085102; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu XH, 2012, J ORTHOP RES, V30, P1440, DOI 10.1002/jor.22096; Llnkermann A, 2013, P NATL ACAD SCI USA, V110, P12; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Novak KB, 2010, PEDIATR RES, V67, P257, DOI 10.1203/PDR.0b013e3181ca0aa2; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; van der Vliet JA, 2011, CLIN TRANSPLANT, V25, pE612, DOI 10.1111/j.1399-0012.2011.01510.x; Walker LM, 2000, J PHARMACOL EXP THER, V295, P417; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136276	10.1371/journal.pone.0136276	http://dx.doi.org/10.1371/journal.pone.0136276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379248	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400004
J	Blanco, FF; Jimbo, M; Wulfkuhle, J; Gallagher, I; Deng, J; Enyenihi, L; Meisner-Kober, N; Londin, E; Rigoutsos, I; Sawicki, JA; Risbud, MV; Witkiewicz, AK; Mccue, PA; Jiang, W; Rui, H; Yeo, CJ; Petricoin, E; Winter, JM; Brody, JR				Blanco, F. F.; Jimbo, M.; Wulfkuhle, J.; Gallagher, I.; Deng, J.; Enyenihi, L.; Meisner-Kober, N.; Londin, E.; Rigoutsos, I.; Sawicki, J. A.; Risbud, M. V.; Witkiewicz, A. K.; Mccue, P. A.; Jiang, W.; Rui, H.; Yeo, C. J.; Petricoin, E.; Winter, J. M.; Brody, J. R.			The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells	ONCOGENE			English	Article							PATHWAY ACTIVATION; STABILITY FACTOR; GENE-EXPRESSION; TUMOR HYPOXIA; KINASE PIM-1; C-MYC; GROWTH; GEMCITABINE; LEUKEMIA; TARGET	Previously, it has been shown that pancreatic ductal adenocarcinoma (PDA) tumors exhibit high levels of hypoxia, characterized by low oxygen pressure (pO(2)) and decreased O-2 intracellular perfusion. Chronic hypoxia is strongly associated with resistance to cytotoxic chemotherapy and chemoradiation in an understudied phenomenon known as hypoxia-induced chemoresistance. The hypoxia-inducible, pro-oncogenic, serine-threonine kinase PIM1 (Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key regulator of hypoxia-induced chemoresistance in PDA and other cancers. Although its role in therapeutic resistance has been described previously, the molecular mechanism behind PIM1 overexpression in PDA is unknown. Here, we demonstrate that cis-acting AU-rich elements (ARE) present within a 38-base pair region of the PIM1 mRNA 3'-untranslated region mediate a regulatory interaction with the mRNA stability factor HuR (Hu antigen R) in the context of tumor hypoxia. Predominantly expressed in the nucleus in PDA cells, HuR translocates to the cytoplasm in response to hypoxic stress and stabilizes the PIM1 mRNA transcript, resulting in PIM1 protein overexpression. A reverse-phase protein array revealed that HuR-mediated regulation of PIM1 protects cells from hypoxic stress through phosphorylation and inactivation of the apoptotic effector BAD and activation of MEK1/2. Importantly, pharmacological inhibition of HuR by MS-444 inhibits HuR homodimerization and its cytoplasmic translocation, abrogates hypoxia-induced PIM1 overexpression and markedly enhances PDA cell sensitivity to oxaliplatin and 5-fluorouracil under physiologic low oxygen conditions. Taken together, these results support the notion that HuR has prosurvival properties in PDA cells by enabling them with growth advantages in stressful tumor microenvironment niches. Accordingly, these studies provide evidence that therapeutic disruption of HuR's regulation of PIM1 may be a key strategy in breaking an elusive chemotherapeutic resistance mechanism acquired by PDA cells that reside in hypoxic PDA microenvironments.	[Blanco, F. F.] Thomas Jefferson Univ, Div Clin Pharmacol, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Blanco, F. F.; Jimbo, M.; Enyenihi, L.; Yeo, C. J.; Winter, J. M.; Brody, J. R.] Thomas Jefferson Univ, Dept Surg, 1015 Walnut St,Suite 618,Curtis Bldg, Philadelphia, PA 19107 USA; [Wulfkuhle, J.; Gallagher, I.; Deng, J.; Petricoin, E.] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Manassas, VA USA; [Meisner-Kober, N.] Novartis, Novartis Inst Biomed Res, Basel, Switzerland; [Londin, E.; Rigoutsos, I.] Thomas Jefferson Univ, Ctr Computat Med, Philadelphia, PA 19107 USA; [Sawicki, J. A.] Lankenau Inst Med Res, Philadelphia, PA USA; [Risbud, M. V.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Witkiewicz, A. K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Mccue, P. A.; Jiang, W.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Rui, H.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; George Mason University; Novartis; Jefferson University; Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Jefferson University	Brody, JR (corresponding author), Thomas Jefferson Univ, Dept Surg, 1015 Walnut St,Suite 618,Curtis Bldg, Philadelphia, PA 19107 USA.	jonathan.brody@jefferson.edu	Meisner-Kober, Nicole/AFL-9351-2022; Meisner-Kober, Nicole/AAH-1412-2022; Rigoutsos, Isidore/C-5381-2012	Rigoutsos, Isidore/0000-0003-1529-8631; Londin, Eric/0000-0003-4331-6366; Meisner-Kober, Nicole/0000-0003-0912-5902; Enyenihi, Liz/0000-0001-6952-1515	NIH-NIGMS [T32 GM008562 20]; NIH-NCI [R21 CA182692 01A1]; American Cancer Society [MRSG-14-019-01-CDD]; Mary Halinski Pancreatic Cancer Research Fund; Hirshberg Foundation; NATIONAL CANCER INSTITUTE [R21CA182692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008562] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Halinski Pancreatic Cancer Research Fund; Hirshberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the TJU's Bioimaging core for their assistance with confocal image acquisition and analysis. We also acknowledge Zachary Schoepflin at the TJU Department of Orthopedic Surgery for his assistance with hypoxia chambers. This work was supported by NIH-NIGMS T32 GM008562 20 (to FFB), NIH-NCI R21 CA182692 01A1 (to JRB), American Cancer Society MRSG-14-019-01-CDD (to JMW), the Mary Halinski Pancreatic Cancer Research Fund (to JRB) and the Hirshberg Foundation (to JRB, JW).	ACS, 2014, CANC FACTS FIG 2013; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Blanco FF, 2014, MOL CELL BIOL, V34, P180, DOI 10.1128/MCB.01020-13; Block KM, 2012, PANCREAS, V41, P773, DOI 10.1097/MPA.0b013e31823cdd10; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brody JR, 2011, WIRES RNA, V2, P435, DOI 10.1002/wrna.62; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chen J, 2009, AM J PATHOL, V175, P400, DOI 10.2353/ajpath.2009.080972; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chou CW, 2012, NEURO-ONCOLOGY, V14, P1227, DOI 10.1093/neuonc/nos195; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Hsi ED, 2008, LEUKEMIA LYMPHOMA, V49, P2081, DOI 10.1080/10428190802419640; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Improta G, 2011, J PROTEOME RES, V10, P3089, DOI 10.1021/pr200065t; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Lara PC, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-29; Liao WL, 2011, J BIOL CHEM, V286, P35499, DOI 10.1074/jbc.M111.263582; Liu L, 2014, MOL BIOL CELL, V25, P3308, DOI 10.1091/mbc.E14-03-0853; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Martelli M, 2008, CRIT REV ONCOL HEMAT, V68, P256, DOI 10.1016/j.critrevonc.2008.07.020; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Miyata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059095; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nabors LB, 2001, CANCER RES, V61, P2154; Pineda DM, 2012, CANCER BIOL THER, V13, P946, DOI 10.4161/cbt.20952; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Richards NG, 2010, ANN SURG, V252, P499, DOI 10.1097/SLA.0b013e3181f1fd44; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Shay KP, 2005, MOL CANCER RES, V3, P170; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Tholey RM, 2015, MOL CANCER RES, V13, P439, DOI 10.1158/1541-7786.MCR-14-0199; Tu ML, 2011, LIFE SCI, V88, P233, DOI 10.1016/j.lfs.2010.12.001; Vineis P, 2010, CARCINOGENESIS, V31, P1703, DOI 10.1093/carcin/bgq087; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang PY, 2010, BIOCHEM J, V426, P293, DOI 10.1042/BJ20091459; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Young LE, 2010, CURR COLORECT CANC R, V6, P60, DOI 10.1007/s11888-010-0044-3; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhu HF, 2015, MOL CANCER RES, V13, P809, DOI 10.1158/1541-7786.MCR-14-0241; Zhu Y, 2002, BRIT J HAEMATOL, V119, P905, DOI 10.1046/j.1365-2141.2002.03931.x; Zou J, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-3	69	70	74	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2529	2541		10.1038/onc.2015.325	http://dx.doi.org/10.1038/onc.2015.325			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26387536	Green Accepted			2022-12-26	WOS:000376165500011
J	Sanchez-Tillo, E; de Barrios, O; Valls, E; Darling, DS; Castells, A; Postigo, A				Sanchez-Tillo, E.; de Barrios, O.; Valls, E.; Darling, D. S.; Castells, A.; Postigo, A.			ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression	ONCOGENE			English	Article							APC TUMOR-SUPPRESSOR; VITAMIN-D-RECEPTOR; BETA-CATENIN; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; COREPRESSOR CTBP; E-CADHERIN; REPRESSION; ACTIVATION; INVASIVENESS	The canonical Wnt pathway (TCF4/beta-catenin) has important roles during normal differentiation and in disease. Some Wnt functions depend on signaling gradients requiring the pathway to be tightly regulated. A key Wnt target is the transcription factor ZEB1 whose expression by cancer cells promotes tumor invasiveness by repressing the expression of epithelial specification markers and activating mesenchymal genes, including a number of Wnt targets such as LAMC2 and uPA. The ability of ZEB1 to activate/repress its target genes depends on its recruitment of corepressors (CtBP, BRG1) or coactivators (p300) although conditions under which ZEB1 binds these cofactors are not elucidated. Here, we show that TCF4 and ZEB1 reciprocally modulate each other's transcriptional activity: ZEB1 enhances TCF4/beta-catenin-mediated transcription and, in turn, Wnt signaling switches ZEB1 from a repressor into an activator. In colorectal cancer (CRC) cells with active Wnt signaling, ZEB1 enhances transcriptional activation of LAMC2 and uPA by TCF4/beta-catenin. However, in CRC cells with inactive Wnt, ZEB1 represses both genes. Reciprocal modulation of ZEB1 and TCF4 activities involves their binding to DNA and mutual interaction. Wnt signaling turns ZEB1 into an activator by replacing binding of CtBP/BRG1 in favor of p300. Using a mouse model of Wnt-induced intestinal tumorigenesis, we found that downregulation of ZEB1 reduces the expression of LAMC2 in vivo. These results identify a mechanism through which Wnt and ZEB1 transcriptional activities are modulated, offering new approaches in cancer therapy.	[Sanchez-Tillo, E.; de Barrios, O.; Valls, E.; Postigo, A.] IDIBAPS, Dept Hematol & Oncol, Grp Transcript Regulat Gene Express, Barcelona, Spain; [Darling, D. S.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Darling, D. S.] Univ Louisville, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [Castells, A.] Hosp Clin Barcelona, Inst Metab & Digest Dis, Barcelona, Spain; [Castells, A.; Postigo, A.] Carlos III Hlth Inst ISCIII, Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Gastrointestinal & Pancreat Oncol Team, Barcelona, Spain; [Postigo, A.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Postigo, A.] ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Louisville; University of Louisville; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Louisville; ICREA	Postigo, A (corresponding author), Univ Barcelona, Sch Med, Dept Hematol & Oncol, IDIBAPS,Grp Transcript Regulat Gene Express, Cellex 1B,Casanova 143, E-08036 Barcelona, Spain.	idib412@clinic.ub.es	Darling, Douglas S/D-4573-2009; de Barrios, Oriol/AAO-6319-2021; Castells, Antoni/ABC-1002-2021	Castells, Antoni/0000-0001-8431-2033; de Barrios, Oriol/0000-0001-5076-1455; Darling, Douglas/0000-0002-9039-1169; Postigo, Antonio/0000-0003-4605-2634	Fundacio La Marato de TV3 [201330.10]; Ministry of Economy and Competitiveness [BFU2010-15163, SAF2014-52874-R]; Leukemia Research Foundation; Academy of Medical and Health Sciences of Catalonia; Balearic Islands, Avon Cosmetics S.A.U. (ACSAU); Catalan Agency for Management of University and Research Grants [AGAUR, 2014-SGR-475]; European Commission of the European Union; Olga Torres Foundation; La Caixa Foundation (LCF); Spanish Association Against Cancer; LCF; CIBERehd; ACSAU; Miguel Servet contract from Instituto de Salud Carlos III [MS13/00200]; Ministry of Education, Culture and Sports (FPU Program) [AP2010-5489]; ICREA Funding Source: Custom	Fundacio La Marato de TV3; Ministry of Economy and Competitiveness; Leukemia Research Foundation; Academy of Medical and Health Sciences of Catalonia; Balearic Islands, Avon Cosmetics S.A.U. (ACSAU); Catalan Agency for Management of University and Research Grants; European Commission of the European Union; Olga Torres Foundation; La Caixa Foundation (LCF); Spanish Association Against Cancer; LCF; CIBERehd; ACSAU; Miguel Servet contract from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministry of Education, Culture and Sports (FPU Program); ICREA(ICREA)	We are grateful to all researchers who provided us with reagents (see Materials and Methods and Supplementary Materials and Methods) and apologize to those whose work was cited indirectly through reviews owing to space limitations. This work was developed in the Centre de Recerca Biomedica Cellex at IDIBAPS. The different parts of this study were independently funded by grants to AP from Fundacio La Marato de TV3 (201330.10), Ministry of Economy and Competitiveness (BFU2010-15163 and SAF2014-52874-R), Leukemia Research Foundation, Academy of Medical and Health Sciences of Catalonia and the Balearic Islands, Avon Cosmetics S.A.U. (ACSAU), Catalan Agency for Management of University and Research Grants (AGAUR, 2014-SGR-475), European Commission of the European Union, Olga Torres Foundation, La Caixa Foundation (LCF), Spanish Association Against Cancer. EST's salary was subsequently funded by grants from LCF, CIBERehd, ACSAU, and a Miguel Servet contract (MS13/00200) from Instituto de Salud Carlos III. OdB is recipient of a PhD scholarship from the Ministry of Education, Culture and Sports (FPU Program, AP2010-5489).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Gilles C, 2003, CANCER RES, V63, P2658; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Hlubek F, 2001, CANCER RES, V61, P8089; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leclerc D, 2004, J CELL BIOCHEM, V93, P1242, DOI 10.1002/jcb.20236; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Memezawa A, 2007, ONCOGENE, V26, P5038, DOI 10.1038/sj.onc.1210320; Moore AC, 2008, MOL CELL BIOL, V28, P977, DOI 10.1128/MCB.01242-07; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sanchez-Tillo E, 2013, CLIN CANCER RES, V19, P1071, DOI 10.1158/1078-0432.CCR-12-2675; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sanchez-Tillo E, 2011, AM J CANCER RES, V1, P897; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Siles L, 2013, MOL CELL BIOL, V33, P1368, DOI 10.1128/MCB.01259-12; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takagi T, 1998, DEVELOPMENT, V125, P21; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	49	31	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5760	5770		10.1038/onc.2015.352	http://dx.doi.org/10.1038/onc.2015.352			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	26387539				2022-12-26	WOS:000364594600008
J	Brenner, S; Bercovich, Z; Feiler, Y; Keshet, R; Kahana, C				Brenner, Shirley; Bercovich, Zippi; Feiler, Yulia; Keshet, Rom; Kahana, Chaim			Dual Regulatory Role of Polyamines in Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; ADIPOCYTE DIFFERENTIATION; C/EBP-BETA; 3T3-L1 PREADIPOCYTES; PPAR-GAMMA; ORNITHINE-DECARBOXYLASE; GENE-EXPRESSION; ADIPOSE-TISSUE; CELL-LINE	Background: Polyamines are required for the process of adipogenesis. Results: Polyamine depletion causes inactivation of C/EBP that is correlated with elevation of CHOP, and independently causes inhibition of mitotic clonal expansion. Conclusion: Polyamines are required for both main hubs of adipogenesis; completion of MCE and activation of C/EBP. Significance: Our results assist clarifying the mechanism by which polyamines support adipogenesis. Adipogenesis is a complex process, accompanied by a chain of interdependent events. Disruption of key events in this cascade may interfere with the correct formation of adipose tissue. Polyamines were demonstrated necessary for adipogenesis; however, the underlying mechanism by which they act has not been established. Here, we examined the effect of polyamine depletion on the differentiation of 3T3-L1 preadipocytes. Our results demonstrate that polyamines are required early in the adipogenic process. Polyamine depletion inhibited the second division of the mitotic clonal expansion (MCE), and inhibited the expression of PPAR gamma and C/EBP alpha, the master regulators of adipogenesis. However, it did not affect the expression of their transcriptional activator, C/EBP beta. Additionally, polyamine depletion resulted in elevation of mRNA and protein levels of the stress-induced C/EBP homologous protein (CHOP), whose dominant negative function is known to inhibit C/EBP beta DNA binding activity. Conditional knockdown of CHOP in polyamine-depleted preadipocytes restored PPAR gamma and C/EBP alpha expression, but failed to recover MCE and differentiation. Thus, our results suggest that the need for MCE in the adipogenic process is independent from the requirement for PPAR gamma and C/EBP alpha expression. We conclude that de novo synthesis of polyamines during adipogenesis is required for down-regulation of CHOP to allow C/EBP beta activation, and for promoting MCE.	[Brenner, Shirley; Bercovich, Zippi; Feiler, Yulia; Keshet, Rom; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			Israel Academy of Science and Humanities	Israel Academy of Science and Humanities	This work was supported by a grant from the Israel Academy of Science and Humanities. The authors declare that they have no conflicts of interest with the contents of this article.	BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; BETHELL DR, 1981, BIOCHEM BIOPH RES CO, V102, P272, DOI 10.1016/0006-291X(81)91517-5; CANELLAKIS ZN, 1989, YALE J BIOL MED, V62, P481; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; ERWIN BG, 1984, AM J PHYSIOL, V246, pC293, DOI 10.1152/ajpcell.1984.246.3.C293; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Landau G, 2012, J BIOL CHEM, V287, P35825, DOI 10.1074/jbc.M112.381335; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Park MH, 1997, BIOL SIGNAL, V6, P115; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; POULIN R, 1992, J BIOL CHEM, V267, P150; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Zhang J, 2014, INT J MOL MED, V33, P1209, DOI 10.3892/ijmm.2014.1695; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	39	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27384	27392		10.1074/jbc.M115.686980	http://dx.doi.org/10.1074/jbc.M115.686980			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396188	Green Published, hybrid			2022-12-26	WOS:000364794000044
J	Mpakali, A; Giastas, P; Mathioudakis, N; Mavridis, IM; Saridakis, E; Stratikos, E				Mpakali, Anastasia; Giastas, Petros; Mathioudakis, Nikolas; Mavridis, Irene M.; Saridakis, Emmanuel; Stratikos, Efstratios			Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYLOSING-SPONDYLITIS; CRYSTAL-STRUCTURE; ERAP1; SUSCEPTIBILITY; ASSOCIATION; DISTINCT; DISEASE; COMPLEX; PROTEIN; POLYMORPHISM	Endoplasmic reticulum (ER) aminopeptidases process antigenic peptide precursors to generate epitopes for presentation by MHC class I molecules and help shape the antigenic peptide repertoire and cytotoxic T-cell responses. To perform this function, ER aminopeptidases have to recognize and process a vast variety of peptide sequences. To understand how these enzymes recognize substrates, we determined crystal structures of ER aminopeptidase 2 (ERAP2) in complex with a substrate analogue and a peptidic product to 2.5 and 2.7 angstrom, respectively, and compared them to the apo-form structure determined to 3.0 angstrom. The peptides were found within the internal cavity of the enzyme with no direct access to the outside solvent. The substrate analogue extends away from the catalytic center toward the distal end of the internal cavity, making interactions with several shallow pockets along the path. A similar configuration was evident for the peptidic product, although decreasing electron density toward its C terminus indicated progressive disorder. Enzymatic analysis confirmed that visualized interactions can either positively or negatively impact in vitro trimming rates. Opportunistic side-chain interactions and lack of deep specificity pockets support a limited-selectivity model for antigenic peptide processing by ERAP2. In contrast to proposed models for the homologous ERAP1, no specific recognition of the peptide C terminus by ERAP2 was evident, consistent with functional differences in length selection and self-activation between these two enzymes. Our results suggest that ERAP2 selects substrates by sequestering them in its internal cavity and allowing opportunistic interactions to determine trimming rates, thus combining substrate permissiveness with sequence bias.	[Mpakali, Anastasia; Giastas, Petros; Mathioudakis, Nikolas; Mavridis, Irene M.; Saridakis, Emmanuel; Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Athens 15310, Greece	National Centre of Scientific Research "Demokritos"	Saridakis, E (corresponding author), Natl Ctr Sci Res Demokritos, Athens 15310, Greece.	e.saridakis@inn.demokritos.gr; stratos@rrp.demokritos.gr	Giastas, Petros/AAD-8770-2021; Mpakali, Anastasia/AAW-9773-2021; Stratikos, Efstratios/N-2969-2014	Stratikos, Efstratios/0000-0002-3566-2309; Mpakali, Anastasia/0000-0003-0869-9680; Giastas, Petros/0000-0002-3490-8223	European Union (European Social Fund); Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant [ERC-14]; European Community [283570]	European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant; European Community(European Commission)	This work was supported by the European Union (European Social Fund) and Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant ERC-14. This work was also supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldhamen YA, 2015, J INNATE IMMUN, V7, P275, DOI 10.1159/000368899; AlexanderMiller MA, 1996, INT IMMUNOL, V8, P641, DOI 10.1093/intimm/8.5.641; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Cagliani R, 2010, HUM MOL GENET, V19, P4705, DOI 10.1093/hmg/ddq401; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evnouchidou I, 2012, J IMMUNOL, V189, P2383, DOI 10.4049/jimmunol.1200918; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Evnouchidou I, 2009, CURR PHARM DESIGN, V15, P3656, DOI 10.2174/138161209789271816; Evnouchidou I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003658; Fruci D, 2014, TISSUE ANTIGENS, V84, P177, DOI 10.1111/tan.12410; Gandhi A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00186; Garcia-Medel N, 2014, MOL CELL PROTEOMICS, V13, P3367, DOI 10.1074/mcp.M114.039214; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, P1416, DOI 10.1074/mcp.M112.019588; Georgiadou D, 2010, J IMMUNOL, V185, P1584, DOI 10.4049/jimmunol.0902502; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hattori A, 2012, BIOL PHARM BULL, V35, P601, DOI 10.1248/bpb.35.601; Hisatsune C, 2015, MOL CELL, V58, P1015, DOI 10.1016/j.molcel.2015.04.008; Infantes S, 2010, J IMMUNOL, V184, P3351, DOI 10.4049/jimmunol.0901560; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kenna TJ, 2015, RHEUMATOLOGY, V54, P1549, DOI 10.1093/rheumatology/kev218; Kim S, 2011, NAT IMMUNOL, V12, P984, DOI 10.1038/ni.2097; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Lazard S, 2015, MOL IMMUNOL, V68, P72, DOI 10.1016/j.molimm.2015.04.014; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Lorente E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079596; Maksymowych WP, 2009, ARTHRITIS RHEUM, V60, P1317, DOI 10.1002/art.24467; Mpakali A, 2015, J IMMUNOL, V195, P2842, DOI 10.4049/jimmunol.1501103; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Rastall DPW, 2014, INT IMMUNOL, V26, P685, DOI 10.1093/intimm/dxu078; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Saridakis E, 2000, PROTEIN SCI, V9, P755; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seregin SS, 2013, AUTOIMMUNITY, V46, P497, DOI 10.3109/08916934.2013.819855; Stamogiannos A, 2015, MOL IMMUNOL, V67, P426, DOI 10.1016/j.molimm.2015.07.010; Stratikos E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00363; Stratikos E, 2013, MOL IMMUNOL, V55, P212, DOI 10.1016/j.molimm.2013.03.002; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Weimershaus M, 2013, CURR OPIN IMMUNOL, V25, P90, DOI 10.1016/j.coi.2012.10.001; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zervoudi E, 2013, P NATL ACAD SCI USA, V110, P19890, DOI 10.1073/pnas.1309781110; Zervoudi E, 2011, BIOCHEM J, V435, P411, DOI 10.1042/BJ20102049	53	54	55	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26021	26032		10.1074/jbc.M115.685909	http://dx.doi.org/10.1074/jbc.M115.685909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26381406	Green Published, hybrid			2022-12-26	WOS:000363527300023
J	Fan, BC; Liu, X; Bai, J; Li, YF; Zhang, QY; Jiang, P				Fan, Baochao; Liu, Xing; Bai, Juan; Li, Yufeng; Zhang, Qiaoya; Jiang, Ping			The 15N and 46R Residues of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Enhance Regulatory T Lymphocytes Proliferation	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; IN-VITRO; PERSISTENT INFECTION; PSEUDORABIES VIRUS; CYTOKINE PROFILES; PIGS; SWINE; PRRSV	Porcine reproductive and respiratory syndrome virus (PRRSV) negatively modulates host immune responses, resulting in persistent infection and immunosuppression. PRRSV infection increases the number of PRRSV-specific regulatory T lymphocytes (Tregs) in infected pigs. However, the target antigens for Tregs proliferation in PRRSV infection have not been fully understood. In this study, we demonstrated that the highly pathogenic PRRSV (HPPRRSV) induced more CD4(+)CD25(+)Foxp3(+) Tregs than classical PRRSV (C-PRRSV) strain. Of the recombinant GP5, M and N proteins of HP-PRRSV expressed in baculovirus expression systems, only N protein induced Tregs proliferation. The Tregs assays showed that three amino-acid regions, 15-21, 42-48 and 88-94, in N protein played an important role in induction of Tregs proliferation with synthetic peptides covering the whole length of N protein. By using reverse genetic methods, it was firstly found that the 15N and 46R residues in PRRSV N protein were critical for induction of Tregs proliferation. The phenotype of induced Tregs closely resembled that of transforming-growth-factor-a-secreting T helper 3 Tregs in swine. These data should be useful for understanding the mechanism of immunity to PRRSV and development of infection control strategies in the future.	[Fan, Baochao; Liu, Xing; Bai, Juan; Li, Yufeng; Zhang, Qiaoya; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Dis Diagnost & Immunol, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Ping] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Jiang, P (corresponding author), Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Dis Diagnost & Immunol, Nanjing 210095, Jiangsu, Peoples R China.	jiangp@njau.edu.cn			National Natural Science Foundation [31230071]; Ministry of Education, China [313031, 20120097110043]; grant from the Ministry of Agriculture (CARS-36); priority academic program development of Jiangsu higher education institutions (PAPD)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); grant from the Ministry of Agriculture (CARS-36); priority academic program development of Jiangsu higher education institutions (PAPD)	This work was mainly supported by the National Natural Science Foundation (31230071), grants from the Ministry of Education, China (313031, 20120097110043) for PRRSV immunology, a grant from the Ministry of Agriculture (CARS-36) for techniques to control swine disease, and priority academic program development of Jiangsu higher education institutions (PAPD).	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Andreyev VG, 1997, ARCH VIROL, V142, P993, DOI 10.1007/s007050050134; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Butler JE, 2014, IMMUNOL RES, V59, P81, DOI 10.1007/s12026-014-8549-5; Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017; Cao J, 2013, VET MICROBIOL, V164, P261, DOI 10.1016/j.vetmic.2013.03.001; Cecere TE, 2012, VET MICROBIOL, V160, P233, DOI 10.1016/j.vetmic.2012.04.040; Cecere TE, 2012, VIRUSES-BASEL, V4, P833, DOI 10.3390/v4050833; Chang HC, 2008, VET MICROBIOL, V129, P281, DOI 10.1016/j.vetmic.2007.12.002; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Darwich L, 2010, VIRUS RES, V154, P123, DOI 10.1016/j.virusres.2010.07.017; De Bruin MGM, 2000, VET IMMUNOL IMMUNOP, V76, P125, DOI 10.1016/S0165-2427(00)00208-7; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Doan DNP, 2003, STRUCTURE, V11, P1445, DOI 10.1016/j.str.2003.09.018; Dwivedi V, 2011, VACCINE, V29, P4058, DOI 10.1016/j.vaccine.2011.03.006; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Gimeno M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-9; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jiang WM, 2006, VET IMMUNOL IMMUNOP, V113, P169, DOI 10.1016/j.vetimm.2006.05.001; Jiang YB, 2007, VACCINE, V25, P547, DOI 10.1016/j.vaccine.2006.07.032; Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4; Kaser T, 2008, VET IMMUNOL IMMUNOP, V122, P153, DOI 10.1016/j.vetimm.2007.08.002; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Koo HN, 2008, J MICROBIOL, V46, P709, DOI 10.1007/s12275-008-0224-x; Lamontagne L, 2003, VIRAL IMMUNOL, V16, P395, DOI 10.1089/088282403322396181; Lee C, 2006, VIROLOGY, V355, P30, DOI 10.1016/j.virol.2006.07.013; LeRoith T, 2011, VET IMMUNOL IMMUNOP, V140, P312, DOI 10.1016/j.vetimm.2010.12.011; Li H, 2003, VET MICROBIOL, V95, P295, DOI 10.1016/S0378-1135(03)00158-5; Li S, 2007, IMMUNOL CELL BIOL, V85, P197, DOI 10.1038/sj.icb.7100020; Liu X, 2015, J GEN VIROL, V96, P1276, DOI 10.1099/vir.0.000061; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; Martelli P, 2009, VACCINE, V27, P3788, DOI 10.1016/j.vaccine.2009.03.028; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Mateu E, 2006, VIRUS RES, V115, P198, DOI 10.1016/j.virusres.2005.09.008; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; MENG XJ, 1994, J GEN VIROL, V75, P1795, DOI 10.1099/0022-1317-75-7-1795; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Park JY, 2008, J MICROBIOL BIOTECHN, V18, P1709; Peng YT, 2009, VET MICROBIOL, V136, P359, DOI 10.1016/j.vetmic.2008.11.013; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Rodriguez MJ, 1997, J GEN VIROL, V78, P2269, DOI 10.1099/0022-1317-78-9-2269; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Rowland RRR, 2003, VET MICROBIOL, V96, P219, DOI 10.1016/j.vetmic.2003.07.006; Rowland RRR, 2003, VIROLOGY, V316, P135, DOI 10.1016/S0042-6822(03)00482-3; Sagong M, 2011, ARCH VIROL, V156, P2187, DOI 10.1007/s00705-011-1116-7; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Silva-Campa E, 2012, VIROLOGY, V430, P73, DOI 10.1016/j.virol.2012.04.009; Silva-Campa E, 2010, VIROLOGY, V396, P264, DOI 10.1016/j.virol.2009.10.024; Silva-Campa E, 2009, VIROLOGY, V387, P373, DOI 10.1016/j.virol.2009.02.033; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; Suradhat S, 2006, VACCINE, V24, P2634, DOI 10.1016/j.vaccine.2005.12.010; Suvas S, 2006, CURR OPIN IMMUNOL, V18, P344, DOI 10.1016/j.coi.2006.03.005; Thanawongnuwech R, 2000, VET PATHOL, V37, P143, DOI 10.1354/vp.37-2-143; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Weesendorp E, 2013, VET MICROBIOL, V167, P638, DOI 10.1016/j.vetmic.2013.09.021; Wesley RD, 2006, CAN J VET RES, V70, P176; Wills RW, 1997, VET MICROBIOL, V55, P231, DOI 10.1016/S0378-1135(96)01337-5; Wongyanin P, 2010, VET IMMUNOL IMMUNOP, V133, P170, DOI 10.1016/j.vetimm.2009.07.012; Wongyanin P, 2012, J GEN VIROL, V93, P1236, DOI 10.1099/vir.0.040287-0; Wootton SK, 1998, CLIN DIAGN LAB IMMUN, V5, P773, DOI 10.1128/CDLI.5.6.773-779.1998; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Zheng Q, 2007, VIRUS GENES, V35, P585, DOI 10.1007/s11262-007-0161-5	71	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138772	10.1371/journal.pone.0138772	http://dx.doi.org/10.1371/journal.pone.0138772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397116	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500104
J	Fu, QX; Tang, XJ; Juan, C; Su, L; Zhang, MJ; Wang, L; Jing, JJ; Zhou, L				Fu, Qianxi; Tang, Xiaojun; Chen, Juan; Su, Li; Zhang, Mingjun; Wang, Long; Jing, Jinjin; Zhou, Li			Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population	PLOS ONE			English	Article							LOCI; ASSOCIATION; CHOLESTEROL; BINDING	Background/Aim Recent genome-wide association studies have identified several loci influencing lipid levels. The present study focused on the triglycerides (TG)-associated locus, the APOA4-APOA5-ZNF259- BUD13 gene cluster on chromosome 11, to explore the role of genetic variants in this gene cluster in the development of increasing TG levels and coronary heart disease (CHD). Methodology/Principal Findings Six single nucleotide polymorphisms (SNPs), rs4417316, rs651821, rs6589566, rs7396835, rs964184 and rs17119975, in the APOA4-APOA5-ZNF259-BUD13 gene cluster were selected and genotyped in 5374 healthy Chinese subjects. There were strong significant associations between the six SNPs and TG levels (P<1.0x10(-8)). Moreover, a weighted genotype score was found to be associated with TG levels (P = 3.28x10(-13)). The frequencies of three common haplotypes were observed to be significantly different between the high TG group and the low TG group (P<0.05). However, no significant effects were found for the SNPs regarding susceptibility to CHD in the Chinese case-control populations. Conclusions/Significance This study highlights the genotypes, genotype scores and haplotypes of the APOA4-APOA5- ZNF259-BUD13 gene cluster that were associated with TG levels in a Chinese population; however, the genetic variants in this gene cluster did not increase the risk of CHD in the Chinese population.	[Fu, Qianxi; Tang, Xiaojun; Wang, Long; Zhou, Li] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Epidemiol, Chongqing 400016, Peoples R China; [Chen, Juan; Jing, Jinjin] Chongqing Med Univ, Chinese Minist Educ, Affiliated Hosp 2, Chongqing 400016, Peoples R China; [Chen, Juan; Jing, Jinjin] Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing 400016, Peoples R China; [Su, Li] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing 400010, Peoples R China; [Zhang, Mingjun] Chongqing Med Univ, Mol Med & Tumor Res Ctr, Chongqing 400016, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhou, L (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Dept Epidemiol, Chongqing 400016, Peoples R China.	zhouli_tj@163.com			National Natural Scientific Foundation of China [NSFC-81202274]; Funds for outstanding young scholars in Chongqing Medical University [CYYQ201304]; Chongqing Natural Science Foundation [cstc2014jcyjA10015]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for outstanding young scholars in Chongqing Medical University; Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work is supported by the National Natural Scientific Foundation of China (NSFC-81202274), the Funds for outstanding young scholars in Chongqing Medical University to LZ (CYYQ201304), the Chongqing Natural Science Foundation (cstc2014jcyjA10015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Aung LHH, 2014, INT J MED SCI, V11, P471, DOI 10.7150/ijms.8489; Aung LHH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05565; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braun TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037056; Brooks MA, 2009, NUCLEIC ACIDS RES, V37, P129, DOI 10.1093/nar/gkn894; Cui GL, 2014, J AM COLL CARDIOL, V64, P267, DOI 10.1016/j.jacc.2014.03.050; de Woestijne APV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101082; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lee MJ, 2013, CLIN CHIM ACTA, V416, P31, DOI 10.1016/j.cca.2012.10.054; Ling YC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-265; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082420; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	26	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138652	10.1371/journal.pone.0138652	http://dx.doi.org/10.1371/journal.pone.0138652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397108	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500090
J	Moran, JK; Dietrich, DR; Elbert, T; Pause, BM; Kubler, L; Weierstall, R				Moran, James K.; Dietrich, Daniel R.; Elbert, Thomas; Pause, Bettina M.; Kuebler, Lisa; Weierstall, Roland			The Scent of Blood: A Driver of Human Behavior?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; ODOR PERCEPTION; OLFACTORY SENSITIVITY; ORAL-CONTRACEPTIVES; STARTLE REFLEX; RESPONSES; IDENTIFICATION; EMOTION; STRESS; SMELL	The scent of blood is potentially one of the most fundamental and survival-relevant olfactory cues in humans. This experiment tests the first human parameters of perceptual threshold and emotional ratings in men and women of an artificially simulated smell of fresh blood in contact with the skin. We hypothesize that this scent of blood, with its association with injury, danger, death, and nutrition will be a critical cue activating fundamental motivational systems relating to either predatory approach behavior or prey-like withdrawal behavior, or both. The results show that perceptual thresholds are unimodally distributed for both sexes, with women being more sensitive. Furthermore, both women and men's emotional responses to simulated blood scent divide strongly into positive and negative valence ratings, with negative ratings in women having a strong arousal component. For women, this split is related to the phase of their menstrual cycle and oral contraception (OC). Future research will investigate whether this split in both genders is context-dependent or trait-like.	[Moran, James K.; Elbert, Thomas; Kuebler, Lisa; Weierstall, Roland] Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany; [Dietrich, Daniel R.] Univ Konstanz, Dept Human & Environm Toxicol, Constance, Baden Wurttembe, Germany; [Pause, Bettina M.] Univ Dusseldorf, Biol Psychol & Social Psychol, Dusseldorf, North Rhine Wes, Germany	University of Konstanz; University of Konstanz; Heinrich Heine University Dusseldorf	Moran, JK (corresponding author), Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany.	james.moran@uni-konstanz.de	Dietrich, Daniel/AAP-8698-2021; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939	Deutsche Forschungsgemeinschaft; European Research Council - MemoTV ERC-AG-SH4 - ERC Advanced Grant - The Human Mind and its complexity; Reinhart Koselleck Project	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council - MemoTV ERC-AG-SH4 - ERC Advanced Grant - The Human Mind and its complexity; Reinhart Koselleck Project	This work was supported by Deutsche Forschungsgemeinschaft, Reinhart Koselleck Project (http://gepris.dfg.de/gepris/projekt/175998462?language=en) and European Research Council - MemoTV ERC-AG-SH4 - ERC Advanced Grant - The Human Mind and its complexity (http://cordis.europa.eu/project/rcn/109534_en.html).	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; American Psychiatric Association, 2013, DSM 5; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bertomeu-Sanchez JR, 2015, ANN SCI, P1; Borg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044111; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; Buckley Thomas., 1988, BLOOD MAGIC; CAIN WS, 1991, J EXP PSYCHOL HUMAN, V17, P382, DOI 10.1037/0096-1523.17.2.382; Cappelle T, 2013, EVOL PSYCHOL-US, V11, P965; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Duarte RT, 1999, J AGR FOOD CHEM, V47, P231, DOI 10.1021/jf9806255; Duntley JD, 2011, AGGRESS VIOLENT BEH, V16, P399, DOI 10.1016/j.avb.2011.04.016; EHRLICHMAN H, 1995, PSYCHOPHYSIOLOGY, V32, P150, DOI 10.1111/j.1469-8986.1995.tb03306.x; Elbert 6Thomas, 2013, SEXUAL GENDER BASED; Elbert T, 2010, EUR ARCH PSY CLIN N, V260, pS100, DOI 10.1007/s00406-010-0144-8; Giebel G, 2013, EVOL PSYCHOL-US, V11, P248, DOI 10.1177/147470491301100122; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; Glindemann D, 2006, ANGEW CHEM INT EDIT, V45, P7006, DOI 10.1002/anie.200602100; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; Grossman David, 2009, KILLING PSYCHOL COST; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Im S, 2004, J AGR FOOD CHEM, V52, P300, DOI 10.1021/jf030337v; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1995, PSYCHONEUROENDOCRINO, V20, P509, DOI 10.1016/0306-4530(94)00078-O; Kirschbaum C, 1996, STRESS MEDICINE, V12, P137, DOI 10.1002/(SICI)1099-1700(199607)12:3<137::AID-SMI685>3.0.CO;2-C; Koos DS, 2005, NEUROREPORT, V16, P1929, DOI 10.1097/01.wnr.0000186597.72081.10; Laudien JH, 2008, NEUROIMAGE, V41, P1426, DOI 10.1016/j.neuroimage.2008.03.046; Lubke KT, 2015, HORM BEHAV, V68, P134, DOI 10.1016/j.yhbeh.2014.10.001; Lubke KT, 2014, PHYSIOL BEHAV, V123, P136, DOI 10.1016/j.physbeh.2013.10.016; MACKAYSIM A, 1981, PHYSIOL BEHAV, V27, P503, DOI 10.1016/0031-9384(81)90339-5; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; Nell V, 2006, BEHAV BRAIN SCI, V29, P211, DOI 10.1017/S0140525X06009058; Nielsen SE, 2013, BIOL PSYCHOL, V92, P257, DOI 10.1016/j.biopsycho.2012.10.007; Nilsson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112694; Ofori J.A., 2012, USE BLOOD DERIVED PR, DOI 10.5772/32374; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Radulescu AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068485; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Sarlo M, 2002, BIOL PSYCHOL, V60, P91, DOI 10.1016/S0301-0511(02)00030-3; Semin GR, 2013, TRENDS COGN SCI, V17, P427, DOI 10.1016/j.tics.2013.05.008; STEVENS DA, 1973, BEHAV BIOL, V8, P75, DOI 10.1016/S0091-6773(73)80008-2; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; Thomas-Danguin T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00504; Walla P, 2010, SENSORS-BASEL, V10, P8185, DOI 10.3390/s100908185; Weierstall R, 2014, INT J LAW PSYCHIAT, V37, P304, DOI 10.1016/j.ijlp.2013.11.016; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976	63	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137777	10.1371/journal.pone.0137777	http://dx.doi.org/10.1371/journal.pone.0137777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26397374	Green Submitted, gold, Green Published			2022-12-26	WOS:000361797500049
J	Islam, A; Mercer, CF; Leung, S; Dijkwel, PP; McManus, MT				Islam, Afsana; Mercer, Chris F.; Leung, Susanna; Dijkwel, Paul P.; McManus, Michael T.			Transcription of Biotic Stress Associated Genes in White Clover (Trifolium repens L.) Differs in Response to Cyst and Root-Knot Nematode Infection	PLOS ONE			English	Article							KUNITZ TRYPSIN-INHIBITOR; ORYZACYSTATIN-I; SOYBEAN KUNITZ; TRANSGENIC RESISTANCE; HETERODERA-SCHACHTII; CONFERS RESISTANCE; EXPRESSION; DEFENSE; PLANTS; TOBACCO	The transcription of four members of the Kunitz proteinase inhibitor (KPI) gene family of white clover (Trifolium repens L.), designated as Tr-KPI1, Tr-KPI2, Tr-KPI4 and Tr-KPI5, was investigated at both local infection (roots) and systemic (leaf tissue) sites in white clover in response to infection with the clover root knot nematode (CRKN) Meloidogyne trifoliophila and the clover cyst nematode (CCN) Heterodera trifolii. Invasion by the CRKN resulted in a significant decrease in transcript abundance of Tr-KPI4 locally at both 4 days post-infection (dpi) and at 8 dpi, and an increase in transcription of Tr-KPI1 systemically at 8 dpi. In contrast, an increase in transcript abundance of all four Tr-KPI genes locally at 4 and 8 dpi, and an increase of Tr-KPI1, Tr-KPI2, and Tr-KPI5 at 8 dpi systemically was observed in response to infection with the CCN. Challenge of a resistant (R) genotype and a susceptible (S) genotype of white clover with the CCN revealed a significant increase in transcript abundance of all four Tr-KPI genes locally in the R genotype, while an increase in abundance of only Tr-KPI1, Tr-KPI2, and Tr-KPI5 was observed in the S genotype, and only at 4 dpi. The transcript abundance of a member of the 1-AMINOCYCLOPROPANE-1-CARBOXYLATE (ACC) SYNTHASE gene family from white clover (Tr-ACS1) was significantly down-regulated locally in response to CRKN infection at 4 and 8 dpi and at 4 dpi, systemically, while abundance increased locally and systemically at 8 dpi in response to CCN challenge. Conversely, the abundance of the jasmonic acid (JA) signalling gene, CORONATINE-INSENSITIVE PROTEIN 1 from white clover (Tr-COI1) increased significantly at 8 dpi locally in response to CRKN infection, but decreased at 8 dpi in response to CCN infection. The significance of this differential regulation of transcription is discussed with respect to differences in infection strategy of the two nematode species.	[Islam, Afsana; Leung, Susanna; Dijkwel, Paul P.; McManus, Michael T.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Mercer, Chris F.] AgRes Grasslands, Palmerston North, New Zealand	Massey University; AgResearch - New Zealand	Islam, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime, Japan.	a.islam1@massey.ac.nz; p.dijkwel@massey.ac.nz			Massey University; AgResearch Grasslands	Massey University; AgResearch Grasslands	Funding: This work was supported by a Massey University Doctoral Scholarship to AI. AgResearch Grasslands provided support in the form of salary to CFM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Atkinson HJ, 2004, TRANSGENIC RES, V13, P135, DOI 10.1023/B:TRAG.0000026070.15253.88; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bird DM, 1996, J PARASITOL, V82, P881, DOI 10.2307/3284193; Bosch J. van den, 1996, Proceedings of the New Zealand Grassland Association, V58, P237; Cai DG, 2003, PLANT MOL BIOL, V51, P839, DOI 10.1023/A:1023089017906; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Chan YL, 2010, PLANT CELL REP, V29, P231, DOI 10.1007/s00299-009-0815-y; Chen S, 2012, ACTA PHYSIOL PLANT, V34, P1538; Falco MC, 2003, PLANT PHYSIOL BIOCH, V41, P761, DOI 10.1016/S0981-9428(03)00100-1; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Fujimoto T, 2011, J PLANT PHYSIOL, V168, P1084, DOI 10.1016/j.jplph.2010.12.002; Gao S, 2011, SCI HORTIC-AMSTERDAM, V128, P408, DOI 10.1016/j.scienta.2011.02.015; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; GLAZER I, 1985, J NEMATOL, V17, P145; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Harpaz-Saad S, 2012, ANNU PLANT REV, V44, P53, DOI 10.1002/9781118223086.ch3; Heibges A, 2003, MOL GENET GENOMICS, V269, P526, DOI 10.1007/s00438-003-0860-0; Hernandez-Nistal J, 2009, PLANT PHYSIOL BIOCH, V47, P181, DOI 10.1016/j.plaphy.2008.11.009; Hewezi T, 2013, MOL PLANT MICROBE IN, V26, P9, DOI 10.1094/MPMI-05-12-0106-FI; HOLM S, 1979, SCAND J STAT, V6, P65; Hunter DA, 2001, ACTA HORTIC, P147, DOI 10.17660/ActaHortic.2001.543.18; Islam A, 2015, NEW PHYTOLOGIST; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; JOFUKU KD, 1989, PLANT CELL, V1, P1079, DOI 10.1105/tpc.1.11.1079; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Klink VP, 2009, PLANT MOL BIOL, V71, P525, DOI 10.1007/s11103-009-9539-1; Kyndt T, 2012, PLANT BIOLOGY, V14, P73, DOI 10.1111/j.1438-8677.2011.00524.x; Kyndt T, 2012, NEW PHYTOL, V196, P887, DOI 10.1111/j.1469-8137.2012.04311.x; Laing W, 2002, ANN PLANT REV, V7, P77; Lee SI, 1999, MOL BREEDING, V5, P1; de Sa MEL, 2012, GENET MOL BIOL, V35, P272, DOI 10.1590/S1415-47572012000200008; Major IT, 2008, PLANT PHYSIOL, V146, P888, DOI 10.1104/pp.107.106229; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Marchetti S, 2000, THEOR APPL GENET, V101, P519, DOI 10.1007/s001220051511; McManus MT, 1999, TRANSGENIC RES, V8, P383, DOI 10.1023/A:1008957610872; Moser C, 2004, MOL BIOTECHNOL, V26, P95, DOI 10.1385/MB:26:2:95; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Norton G., 1991, TOXIC SUBSTANCES CRO, P68, DOI DOI 10.1533/9781845698454.68; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Philippe RN, 2009, NEW PHYTOL, V184, P865, DOI 10.1111/j.1469-8137.2009.03028.x; PUSZTAI A, 1972, PLANTA, V107, P121, DOI 10.1007/BF00387718; Puthoff DP, 2007, J EXP BOT, V58, P3407, DOI 10.1093/jxb/erm211; Rashed NA, 2008, J NEMATOL, V40, P138; RICHARDSON M, 1986, BIOCHIM BIOPHYS ACTA, V872, P134, DOI 10.1016/0167-4838(86)90156-1; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Samac DA, 2003, PHYTOPATHOLOGY, V93, P799, DOI 10.1094/PHYTO.2003.93.7.799; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Szakasits D, 2009, PLANT J, V57, P771, DOI 10.1111/j.1365-313X.2008.03727.x; Tucker ML, 2010, J EXP BOT, V61, P463, DOI 10.1093/jxb/erp317; Turra D, 2009, J PLANT PHYSIOL, V166, P762, DOI 10.1016/j.jplph.2008.10.005; Urwin PE, 2003, MOL BREEDING, V12, P263, DOI 10.1023/A:1026352620308; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Urwin PE, 2000, MOL BREEDING, V6, P257, DOI 10.1023/A:1009669325944; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; Urwin PE, 2000, ASPECTS APPL BIOL, V59, P27; Vain P, 1998, THEOR APPL GENET, V96, P266, DOI 10.1007/s001220050735; Vishnudasan D, 2005, TRANSGENIC RES, V14, P665, DOI 10.1007/s11248-005-5696-4; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wubben MJE, 2001, MOL PLANT MICROBE IN, V14, P1206, DOI 10.1094/MPMI.2001.14.10.1206; Xavier-Filho J., 1989, Toxicants of plant origin. Volume III. Proteins and amino acids., P1; Zydenbos SM, 2011, PASTURE PERSISTENCE, V15, P109	66	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137981	10.1371/journal.pone.0137981	http://dx.doi.org/10.1371/journal.pone.0137981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393362	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100024
J	Pal, R; Greene, S				Pal, Rekha; Greene, Stephanie			microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DOWN-REGULATION; BCL-2; APOPTOSIS; EXPRESSION; GLIOMA; GENE; ACTIVATION; INVASION; TARGET	This study demonstrates the effects of miRNA-10b on medulloblastoma proliferation through transcriptional induction of the anti-apoptotic protein BCL2. Using a cancer specific miRNAarray, high expression of miRNA-10b inmedulloblastoma cell lines compared to a normal cerebellar control was shown, and this was confirmed with real time PCR (RT-PCR). Two medulloblastoma cell lines (DAOY and UW228) were transiently transfected with control miRNA, miRNA-10b inhibitor or miRNA-10bmimic and subjected to RT-PCR, MTT, apoptosis, clonogenic assay and western blot analysis. Transfection ofmiRNA-10b inhibitor induced a significant down-regulation of miRNA-10b expression, inhibited proliferation, and induced apoptosis, while miRNA-10b mimic exerted an opposite effect. Inhibition of miRNA-10b abrogated the colony-forming capability of medulloblastoma cells, andmarkedly down-regulated the expression of BCL2. Down-regulation of BCL2 by antisense oligonucleotides or siRNA also significantly down-regulated miRNA-10b, suggesting that BCL2 is a major mediator of the effects of miRNA-10b. ABT-737 and ABT-199, potent inhibitors of BCL2, downregulated the expression of miRNA-10b and increased apoptosis. Analysis ofmiRNA-10b levels in 13 primary medulloblastoma samples revealed that the 2 patients with the highest levels of miRNA10b had multiple recurrences (4.5) and died within 8 years of diagnosis, compared with the 11 patients with low levels of miRNA-10b who had a mean of 1.2 recurrences and nearly 40% long-term survival. The data presented here indicate that miRNA-10b may act as an oncomir in medulloblastoma tumorigenesis, and reveal a previously unreported mechanismwith Bcl-2 as a mediator of the effects of miRNA-10b uponmedulloblastoma cell survival.	[Pal, Rekha; Greene, Stephanie] Univ Pittsburgh, Dept Neurol Surg, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greene, S (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	Stephanie.Greene@chp.edu		Greene, Stephanie/0000-0002-5858-4032	Walter L. Copeland Fund of the Pittsburgh Foundation [MR2013-66994]; Caring for Kids-the Carrie Martin Fund	Walter L. Copeland Fund of the Pittsburgh Foundation; Caring for Kids-the Carrie Martin Fund	Funding: The work was supported by Walter L. Copeland Fund of the Pittsburgh Foundation, MR2013-66994, http://pittsburghfoundation.org, and Caring for Kids-the Carrie Martin Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; [Anonymous], TCGA CANCER MOLECULA; [Anonymous], TCGA CANC MOL AN MIR; BIGNER SH, 1990, CANCER RES, V50, P2347; Blagosklonny MV, 2001, BIOESSAYS, V23, P947, DOI 10.1002/bies.1135; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gao HF, 2013, J NEURO-ONCOL, V113, P221, DOI 10.1007/s11060-013-1119-1; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Keles GE, 1995, ONCOL RES, V7, P493; KITADA S, 1994, ANTISENSE RES DEV, V4, P71, DOI 10.1089/ard.1994.4.71; Konopleva M, 2000, BLOOD, V95, P3929; Levesley J, 2011, NEURO-ONCOLOGY, V13, P1265, DOI 10.1093/neuonc/nor129; Lima RT, 2004, CANCER GENE THER, V11, P309, DOI 10.1038/sj.cgt.7700706; Lossi L, 1998, J COMP NEUROL, V399, P359; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ming M, 2012, J BIOL CHEM, V287, P22683, DOI 10.1074/jbc.M112.342089; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; Pecina-Slaus N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-22; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stavrou T, 2001, J PEDIAT HEMATOL ONC, V23, P431, DOI 10.1097/00043426-200110000-00008; Tanabe H, 1997, EUR J NEUROSCI, V9, P848, DOI 10.1111/j.1460-9568.1997.tb01434.x; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Yde CW, 2006, INT J ONCOL, V29, P1397; Zhi F, 2013, TUMOR BIOL, V34, P9, DOI 10.1007/s13277-012-0579-9	47	19	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137845	10.1371/journal.pone.0137845	http://dx.doi.org/10.1371/journal.pone.0137845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394044	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361792100019
J	Terrien, S; Gobin, P; Coutte, A; Thuaire, F; Iakimova, G; Mazzola-Pomietto, P; Besche-Richard, C				Terrien, Sarah; Gobin, Pamela; Coutte, Alexandre; Thuaire, Flavien; Iakimova, Galina; Mazzola-Pomietto, Pascale; Besche-Richard, Chrystel			Emotional Meaning in Context in Relation to Hypomanic Personality Traits: An ERP Study	PLOS ONE			English	Article							BIPOLAR DISORDER; MIND DEFICITS; RECOGNITION; MANIA; RISK	The ability to integrate contextual information is important for the comprehension of emotional and social situations. While some studies have shown that emotional processes and social cognition are impaired in people with hypomanic personality trait, no results have been reported concerning the neurophysiological processes mediating the processing of emotional information during the integration of contextual social information in this population. We therefore chose to conduct an ERP study dealing with the integration of emotional information in a population with hypomanic personality trait. Healthy participants were evaluated using the Hypomanic Personality Scale (HPS), and ERPs were recorded during a linguistic task in which participants silently read sentence pairs describing short social situations. The first sentence implicitly conveyed the positive or negative emotional state of a character. The second sentence was emotionally congruent or incongruent with the first sentence. We analyzed the difference in the modulation of two components (N400 and LPC) in response to the emotional word present at the end of the "target" sentences as a function of the HPS score and the emotional valence of the context. Our results showed a possible modulation of the N400 component in response to both positive and negative context among the participants who scored high on the Mood Volatility subscale of the Hypomanic Personality Scale. These results seem to indicate that the participants with hypomanic personality traits exhibited specificities in the integration of emotions at the level of the early-mobilized neurocognitive processes (N400). Participants with hypomanic personality traits found it difficult to integrate negative emotional contexts, while simultaneously exhibiting an enhanced integration of positive emotional contexts.	[Terrien, Sarah; Gobin, Pamela; Besche-Richard, Chrystel] Univ Reims, EA 6291, C2S, Lab Cognit Sante Socialisat, Reims, France; [Coutte, Alexandre; Iakimova, Galina] Univ Nice Sophia Antipolis, LAPCOS, EA 7278, Lab Anthropol & Psychol Cognit & Sociale, F-06189 Nice, France; [Thuaire, Flavien; Mazzola-Pomietto, Pascale] CNRS, Inst Neurosci Timone, UMR 7289, Marseille, France; [Besche-Richard, Chrystel] Inst Univ France, Paris, France	Universite de Reims Champagne-Ardenne; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut Universitaire de France	Besche-Richard, C (corresponding author), Univ Reims, EA 6291, C2S, Lab Cognit Sante Socialisat, Reims, France.	chrystel.besche@univ-reims.fr			French Agence Nationale de la Recherche (ANR) [ANR- 11-EMCO-001 01]; Conseil Regional Champagne-Ardenne	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional Champagne-Ardenne(Region Grand-Est)	This work was supported by the French Agence Nationale de la Recherche (ANR) (Grant number ANR- 11-EMCO-001 01) and the Conseil Regional Champagne-Ardenne.	AKHTAR S, 1988, INTEGRATIVE PSYCHIAT, V6, P37; Andreou C, 2013, J BEHAV THER EXP PSY, V44, P48, DOI 10.1016/j.jbtep.2012.07.014; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Bora E, 2005, ACTA PSYCHIAT SCAND, V112, P110, DOI 10.1111/j.1600-0447.2005.00570.x; Cermolacce M, 2014, J AFFECT DISORDERS, V158, P161, DOI 10.1016/j.jad.2013.11.013; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Deltour JJ, 2005, ECHELLE VOCABULAIRE; Demenescu LR, 2014, EXP AGING RES, V40, P187, DOI 10.1080/0361073X.2014.882210; ECKBLAD M, 1986, J ABNORM PSYCHOL, V95, P214, DOI 10.1037/0021-843X.95.3.214; Gruber J, 2008, EMOTION, V8, P23, DOI 10.1037/1528-3542.8.1.23; HAGOORT P, 1993, BRAIN LANG, V45, P189, DOI 10.1006/brln.1993.1043; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Heissler J, 2014, J AFFECT DISORDERS, V152, P83, DOI 10.1016/j.jad.2013.05.001; Holt DJ, 2009, J COGNITIVE NEUROSCI, V21, P2245, DOI 10.1162/jocn.2008.21151; Iakimova G, 2005, PSYCHOPHYSIOLOGY, V42, P380, DOI 10.1111/j.1469-8986.2005.00303.x; Martino DJ, 2011, PSYCHIAT RES, V189, P379, DOI 10.1016/j.psychres.2011.04.033; Johnson S. L., 2007, EMOTION PSYCHOPATHOL, P123, DOI DOI 10.1037/11562-006; Kerr N, 2003, J AFFECT DISORDERS, V73, P253, DOI 10.1016/S0165-0327(02)00008-3; Kohler CG, 2014, PSYCHIAT RES, V216, P206, DOI 10.1016/j.psychres.2014.01.023; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kwapil TR, 2000, J ABNORM PSYCHOL, V109, P222, DOI 10.1037/0021-843X.109.2.222; McCarthy-Jones S, 2012, CONSCIOUS COGN, V21, P1375, DOI 10.1016/j.concog.2012.07.004; Mill A, 2009, EMOTION, V9, P619, DOI 10.1037/a0016562; Miller CJ, 2011, J AFFECT DISORDERS, V128, P199, DOI 10.1016/j.jad.2010.07.012; Pratt NL, 2008, SOC NEUROSCI-UK, V3, P434, DOI 10.1080/17470910802188339; Ryu V, 2012, PROG NEURO-PSYCHOPH, V38, P194, DOI 10.1016/j.pnpbp.2012.03.009; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Schalet BD, 2011, PSYCHOL ASSESSMENT, V23, P504, DOI 10.1037/a0022301; Terrien S, 2014, PSYCHIAT RES, V215, P694, DOI 10.1016/j.psychres.2013.12.042; Van Rheenen TE, 2014, J INT NEUROPSYCH SOC, V20, P525, DOI 10.1017/S1355617714000253	31	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138877	10.1371/journal.pone.0138877	http://dx.doi.org/10.1371/journal.pone.0138877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26394230	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100111
J	Yamamoto, T; Uchiyama, T; Higuchi, Y; Asahina, M; Hirano, S; Yamanaka, Y; Kuwabara, S				Yamamoto, Tatsuya; Uchiyama, Tomoyuki; Higuchi, Yoshinori; Asahina, Masato; Hirano, Shigeki; Yamanaka, Yoshitaka; Kuwabara, Satoshi			Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; STRIATAL DOPAMINERGIC METABOLISM; SUBSTANTIA-NIGRA; DENERVATED RATS; INCREASES; LEVODOPA; RELEASE; NEURONS; HUMANS; PLASMA	Aims Although subthalamic nucleus deep brain stimulation (STN-DBS) is effective in patients with advanced Parkinson's disease (PD), its physiological mechanisms remain unclear. Because STN-DBS is effective in patients with PD whose motor symptoms are dramatically alleviated by L-3,4-dihydroxyphenylalanine (L-DOPA) treatment, the higher preoperative catecholamine levels might be related to the better clinical outcome after surgery. We aimed to examine the correlation between the preoperative catecholamine levels and postoperative clinical outcome after subthalamic nucleus deep brain stimulation. The effectiveness of STN-DBS in the patient who responded well to dopaminergic medication suggest the causal link between the dopaminergic system and STN-DBS. We also examined how catecholamine levels were modulated after subthalamic stimulation. Methods In total 25 patients with PD were enrolled (Mean age 66.2 +/- 6.7 years, mean disease duration 11.6 +/- 3.7 years). Mean levodopa equivalent doses were 1032 +/- 34.6 mg before surgery. Cerebrospinal fluid and plasma catecholamine levels were measured an hour after oral administration of antiparkinsonian drugs before surgery. The mean Unified Parkinson's Disease Rating Scale scores (UPDRS) and the Parkinson's disease Questionnaire-39 (PDQ-39) were obtained before and after surgery. Of the 25 patients, postoperative cerebrospinal fluid and plasma were collected an hour after oral administration of antiparkinsonian drugs during on stimulation at follow up in 11 patients. Results Mean levodopa equivalent doses significantly decreased after surgery with improvement in motor functions and quality of life. The preoperative catecholamine levels had basically negative correlations with postoperative motor scores and quality of life, suggesting that higher preoperative catecholamine levels were related to better outcome after STN-DBS. The preoperative plasma levels of L-DOPA had significantly negative correlations with postoperative UPDRS-III score in off phase three months after STN-DBS. The preoperative cerebrospinal fluid (CSF) 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxytryptamine (5-HT) levels had significantly negative correlations with postoperative UPDRS-III score in off phase one year after STN-DBS and the preoperative CSF homovanilic acid (HVA) levels had significant negative correlations with postoperative UPDRS-III score in on phase three months after STN-DBS. In PDQ-39 SI (summary index), preoperative plasma dopamine (DA) level had significantly negative correlations with postoperative PDQ-39 SI one year after STN-DBS suggesting that higher preoperative plasma DA level resulted in better quality of life (QOL) one year after STN-DBS. The stepwise multiple linear regression study revealed that higher preoperative plasma HVA levels had negative influence on the postoperative motor symptoms (i.e., increase in the score of UPDRS), whereas higher preoperative CSF L-DOPA levels had positive influence on the postoperative motor symptoms and QOL (decrease in the score of UPDRS and PDQ-39 SI) The catecholamine levels were not significantly reduced postoperatively in 11 patients despite the significant reduction in levodopa equivalent doses. Unexpectedly, CSF HVA levels significantly increased from 0.00089 +/- 0.0003 ng/mu l to 0.002 +/- 0.0008 ng/mu l after STN-DBS. Conclusion The preoperative catecholamine levels might affect the postoperative motor symptoms and quality of life. The catecholamine levels were not significantly reduced postoperatively despite the significant reduction in levodopa equivalent doses.	[Yamamoto, Tatsuya; Uchiyama, Tomoyuki; Asahina, Masato; Hirano, Shigeki; Yamanaka, Yoshitaka; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Higuchi, Yoshinori] Chiba Univ, Grad Sch Med, Dept Neurosurg, Chiba, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Coll, Dept Neurol, Mibu, Tochigi, Japan	Chiba University; Chiba University; Dokkyo Medical University	Yamamoto, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	tatsuya-yamamoto@mbc.nifty.com	Higuchi, Yoshinori/B-3459-2017	Higuchi, Yoshinori/0000-0001-5689-3416; Yamamoto, Tatsuya/0000-0003-4297-6354; Asahina, Masato/0000-0002-4177-2379; Kuwabara, Satoshi/0000-0002-4716-8578				Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bruet N, 2001, J NEUROPATH EXP NEUR, V60, P15, DOI 10.1093/jnen/60.1.15; Ebadi M, 2002, P W PHARMACOL SOC, V45, P36; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Hilker R, 2003, MOVEMENT DISORD, V18, P41, DOI 10.1002/mds.10297; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Humphries MD, 2012, EUR J NEUROSCI, V36, P2240, DOI 10.1111/j.1460-9568.2012.08085.x; Huot P, 2013, EXP BRAIN RES, V230, P463, DOI 10.1007/s00221-013-3621-2; Ishibashi K, 2010, ACTA NEUROL SCAND, V122, P46, DOI 10.1111/j.1600-0404.2009.01255.x; Jimenez-Jimenez FJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00369; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Lacombe E, 2007, EUR J NEUROSCI, V26, P1670, DOI 10.1111/j.1460-9568.2007.05747.x; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; Meissner W, 2001, NEUROSCI LETT, V303, P165, DOI 10.1016/S0304-3940(01)01758-X; Nomoto M, 2009, PARKINSONISM RELAT D, V15, pS21, DOI 10.1016/S1353-8020(09)70007-0; OLANOW CW, 1991, ANN NEUROL, V29, P556, DOI 10.1002/ana.410290516; Paul G, 2000, NEUROREPORT, V11, P441, DOI 10.1097/00001756-200002280-00003; Pazo JH, 2010, SYNAPSE, V64, P905, DOI 10.1002/syn.20809; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Sharma S, BIOMARKERS PARKINSON; Sharma SK, 2003, ANTIOXID REDOX SIGN, V5, P251, DOI 10.1089/152308603322110832; Sharma S, 2014, NEUROCHEM INT, V65, P40, DOI 10.1016/j.neuint.2013.12.009; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Walker RH, 2009, SYNAPSE, V63, P136, DOI 10.1002/syn.20592; Windels F, 2005, J NEUROSCI, V25, P5079, DOI 10.1523/JNEUROSCI.0360-05.2005; Windels F, 2003, J NEUROSCI RES, V72, P259, DOI 10.1002/jnr.10577; Yamamoto T, 2014, NEUROSCIENCE, V259, P43, DOI 10.1016/j.neuroscience.2013.11.034	28	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138462	10.1371/journal.pone.0138462	http://dx.doi.org/10.1371/journal.pone.0138462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394059	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100064
J	Vacchi-Suzzi, C; Eriksen, KT; Levine, K; McElroy, J; Tjonneland, A; Raaschou-Nielsen, O; Harrington, JM; Meliker, JR				Vacchi-Suzzi, Caterina; Eriksen, Kirsten T.; Levine, Keith; McElroy, Jane; Tjonneland, Anne; Raaschou-Nielsen, Ole; Harrington, James M.; Meliker, Jaymie R.			Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; PROSPECTIVE COHORT; BREAST-CANCER; ENVIRONMENTAL EXPOSURE; METAL ACCUMULATION; US POPULATION; RISK; BLOOD; HEALTH; AGE	Background Cadmium is a known carcinogen that can disrupt endocrine signalling. Cigarette smoking and food are the most common routes of non-occupational exposure to cadmium. Cadmium accumulates in the kidney and can be measured in urine, making urine cadmium (U-Cd) a biomarker of long-term exposure. However dietary-cadmium (D-Cd) intake estimates are often used as surrogate indicator of cadmium exposure in non-smoking subjects. It is therefore important to investigate the concordance between D-Cd estimates obtained with Food Frequency Questionnaires and U-Cd. Methods U-Cd levels were compared with estimated dietary-cadmium (D-Cd) intake in 1764 postmenopausal women from the Danish Diet, Cancer and Health cohort. For each participant, a food frequency questionnaire, and measures of cadmium content in standard recipes were used to judge the daily intake of cadmium, normalized by daily caloric intake. Cadmium was measured by ICP-MS in spot urine sampled at baseline and normalized by urinary creatinine. Information on diet, socio-demographics and smoking were self-reported at baseline. Results Linear regressions between U-Cd and D-Cd alone revealed minimal but significant positive correlation in never smokers (R-2 = 0.0076, beta = 1.5% increase per 1 ng Cd kcal(-1), p = 0.0085, n = 782), and negative correlation in current smokers (R-2 = 0.0184, beta = 7.1% decrease per 1 ng Cd kcal-1 change, p = 0.0006, n = 584). In the full study population, most of the variability in U-Cd was explained by smoking status (R2 = 0.2450, n = 1764). A forward selection model revealed that the strongest predictors of U-Cd were age in never smokers (Delta R-2 = 0.04), smoking duration in former smokers (Delta R-2 = 0.06) and pack-years in current smokers (Delta R-2 = 0.07). Food items that contributed to U-Cd were leafy vegetables and soy-based products, but explained very little of the variance in U-Cd. Conclusions Dietary-Cd intake estimated from food frequency questionnaires correlates only minimally with U-Cd biomarker, and its use as a Cd exposure indicator may be of limited utility in epidemiologic studies.	[Vacchi-Suzzi, Caterina; Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Vacchi-Suzzi, Caterina; Meliker, Jaymie R.] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA; [Eriksen, Kirsten T.; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Levine, Keith; Harrington, James M.] RTI Int Trace Inorgan Dept, Res Triangle Pk, NC USA; [McElroy, Jane] Univ Missouri, Family & Community Med, Columbia, MO USA; [Raaschou-Nielsen, Ole] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Danish Cancer Society; Research Triangle Institute; University of Missouri System; University of Missouri Columbia; Aarhus University	Vacchi-Suzzi, C (corresponding author), SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA.	caterina.vacchi-suzzi@stonybrook.edu	Harrington, James/AAZ-8445-2021; Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Meliker, Jaymie/0000-0002-6408-8596; Levine, Keith/0000-0001-7976-916X; Tjonneland, Anne/0000-0003-4385-2097; Harrington, James/0000-0002-8660-2613	NIEHS R01 grant [ES019209]; Danish Cancer Society; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019209] Funding Source: NIH RePORTER	NIEHS R01 grant; Danish Cancer Society(Danish Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIEHS R01 grant #ES019209 (ViCTER program) and the Danish Cancer Society. The funding sources did not play any role in the design and execution of the study.	Adams SV, 2014, ENVIRON HEALTH PERSP, V122, P594, DOI 10.1289/ehp.1307054; Adams SV, 2014, J EXPO SCI ENV EPID, V24, P163, DOI 10.1038/jes.2013.55; Adams SV, 2012, CANCER CAUSE CONTROL, V23, P845, DOI 10.1007/s10552-012-9953-6; Adams SV, 2011, SCI TOTAL ENVIRON, V409, P1632, DOI 10.1016/j.scitotenv.2011.01.037; Akerstrom M, 2014, J EXPO SCI ENV EPID, V24, P171, DOI 10.1038/jes.2013.58; Akerstrom M, 2013, TOXICOL APPL PHARM, V268, P286, DOI 10.1016/j.taap.2013.02.009; Akesson A, 2002, AM J PUBLIC HEALTH, V92, P284, DOI 10.2105/AJPH.92.2.284; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Amzal B, 2009, ENVIRON HEALTH PERSP, V117, P1293, DOI 10.1289/ehp.0800317; ATSDR (Agency for Toxic Substances and Disease Registry), 2011, TOX PROF CADM; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bjermo H, 2013, FOOD CHEM TOXICOL, V57, P161, DOI 10.1016/j.fct.2013.03.024; Cabrera C, 1998, Rev Environ Contam Toxicol, V154, P55; CADE JE, 1991, J EPIDEMIOL COMMUN H, V45, P270, DOI 10.1136/jech.45.4.270; Chaumont A, 2013, ENVIRON HEALTH PERSP, V121, P1047, DOI 10.1289/ehp.1306607; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622; Fransson MN, 2014, TOXICOL SCI, V141, P365, DOI 10.1093/toxsci/kfu129; Gallagher CM, 2008, ENVIRON HEALTH PERSP, V116, P1338, DOI 10.1289/ehp.11452; Garcia-Esquinas E, 2014, ENVIRON HEALTH PERSP, V122, P363, DOI 10.1289/ehp.1306587; Gunier RB, 2013, ENVIRON HEALTH PERSP, V121, P643, DOI 10.1289/ehp.1205524; HARALDSDOTTIR J, 1994, INT J EPIDEMIOL, V23, P787, DOI 10.1093/ije/23.4.787; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; *IARC, IARC MON EV CARC RIS; Ikeda M., 2005, Archives of Environmental Contamination and Toxicology, V48, P135; Itoh H, 2014, INT J HYG ENVIR HEAL, V217, P70, DOI 10.1016/j.ijheh.2013.03.010; JACQUES PF, 1993, AM J CLIN NUTR, V57, P182, DOI 10.1093/ajcn/57.2.182; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jorgensen K., 2001, CHEM CONTAMINANTS 2; Julin B, 2013, EPIDEMIOLOGY, V24, P880, DOI 10.1097/EDE.0b013e3182a777c9; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; Julin B, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-105; Keller A, 2002, J ENVIRON QUAL, V31, P175, DOI 10.2134/jeq2002.0175; KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3; Larsen EH, 2002, FOOD ADDIT CONTAM, V19, P33, DOI 10.1080/02652030110087447; Marano KM, 2012, REGUL TOXICOL PHARM, V64, P243, DOI 10.1016/j.yrtph.2012.07.008; Mason HJ, 1998, OCCUP ENVIRON MED, V55, P132, DOI 10.1136/oem.55.2.132; McElroy JA, 2007, J TOXICOL ENV HEAL A, V70, P1779, DOI 10.1080/15287390600754953; McElroy JA, 2007, SCI TOTAL ENVIRON, V382, P214, DOI 10.1016/j.scitotenv.2007.04.015; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Paschal DC, 2000, ARCH ENVIRON CON TOX, V38, P377, DOI 10.1007/s002449910050; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; PRESTON AM, 1991, PROG FOOD NUTR SCI, V15, P183; Quraishi SM, CADMIUM EXP IN PRESS; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Schaefer EJ, 2000, AM J CLIN NUTR, V71, P746, DOI 10.1093/ajcn/71.3.746; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Schutte R, 2008, ENVIRON HEALTH PERSP, V116, P777, DOI 10.1289/ehp.11167; Shimbo S, 2000, INT ARCH OCC ENV HEA, V73, P163, DOI 10.1007/s004200050023; Squarea Milles J.R, 2014, ADJUSTED R SQUARED; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Thomas LDK, 2014, INT J HYG ENVIR HEAL, V217, P720, DOI 10.1016/j.ijheh.2014.03.001; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; TJONNELAND A, 1992, INT J EPIDEMIOL, V21, P770, DOI 10.1093/ije/21.4.770; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Vahter Marie, 2004, J Br Menopause Soc, V10, P60, DOI 10.1258/136218004774202364; van Wijngaarden E, 2008, PROSTATE, V68, P122, DOI 10.1002/pros.20668; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yamagami T, 2008, INT ARCH OCC ENV HEA, V81, P263, DOI 10.1007/s00420-007-0206-z	65	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138784	10.1371/journal.pone.0138784	http://dx.doi.org/10.1371/journal.pone.0138784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390122	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000056
J	Fang, WP; Zhao, FA; Sun, Y; Xie, DY; Sun, L; Xu, ZZ; Zhu, W; Yang, LR; Zhao, YM; Lv, SP; Tang, ZJ; Nie, LH; Li, W; Hou, JN; Duan, ZZ; Yu, YB; Yang, XJ				Fang, Weiping; Zhao, Fu'an; Sun, Yao; Xie, Deyi; Sun, Li; Xu, Zhenzhen; Zhu, Wei; Yang, Lirong; Zhao, Yuanming; Lv, Shuping; Tang, Zhongjie; Nie, Lihong; Li, Wu; Hou, Jianan; Duan, Zhengzheng; Yu, Yuebo; Yang, Xiaojie			Transcriptomic Profiling Reveals Complex Molecular Regulation in Cotton Genic Male Sterile Mutant Yu98-8A	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; RNA-SEQ; BRASSICA-NAPUS; AUXIN BIOSYNTHESIS; POLLEN DEVELOPMENT; RICE; GIBBERELLIN; MAIZE; PROTEIN; GENOME	Although cotton genic male sterility (GMS) plays an important role in the utilization of hybrid vigor, its precise molecular mechanism remains unclear. To characterize the molecular events of pollen abortion, transcriptome analysis, combined with histological observations, was conducted in the cotton GMS line, Yu98-8A. A total of 2,412 genes were identified as significant differentially expressed genes (DEGs) before and during the critical pollen abortion stages. Bioinformatics and biochemical analysis showed that the DEGs mainly associated with sugars and starch metabolism, oxidative phosphorylation, and plant endogenous hormones play a critical and complicated role in pollen abortion. These findings extend a better understanding of the molecular events involved in the regulation of pollen abortion in genic male sterile cotton, which may provide a foundation for further research studies on cotton heterosis breeding.	[Fang, Weiping; Zhao, Fu'an; Sun, Yao; Xie, Deyi; Zhao, Yuanming; Lv, Shuping; Tang, Zhongjie; Nie, Lihong; Li, Wu; Hou, Jianan; Duan, Zhengzheng; Yu, Yuebo; Yang, Xiaojie] Henan Acad Agr Sci, Econ Crop Res Inst, Zhengzhou 450002, Henan Province, Peoples R China; [Sun, Li] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Xu, Zhenzhen] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang 455000, Henan Province, Peoples R China; [Zhu, Wei] Henan Agr Univ, Agron Coll, Zhengzhou 450002, Henan Province, Peoples R China; [Yang, Lirong] Henan Acad Agr Sci, Plant Protect Res Inst, Zhengzhou 450002, Henan Province, Peoples R China	Henan Academy of Agricultural Sciences; Texas Tech University System; Texas Tech University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Henan Agricultural University; Henan Academy of Agricultural Sciences	Fang, WP (corresponding author), Henan Acad Agr Sci, Econ Crop Res Inst, Zhengzhou 450002, Henan Province, Peoples R China.	hncot@163.com; yyxxjj7910@sina.com			Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2013YQ07]; Programs for Science and Technology Development of Henan Province [122102110057]; "863" Project of China [2012AA101108-02-11]; National transgenic major projects of R. P. of China [2014ZX08005005-006]	Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences; Programs for Science and Technology Development of Henan Province; "863" Project of China(National High Technology Research and Development Program of China); National transgenic major projects of R. P. of China	Funding was provided by: 1. The Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (Grant no. 2013YQ07). 2. The Programs for Science and Technology Development of Henan Province (Grant no. 122102110057). 3. The "863" Project of China (Grant No. 2012AA101108-02-11). 4. National transgenic major projects of R. P. of China (2014ZX08005005-006).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; BAGNALL DJ, 1992, AUST J PLANT PHYSIOL, V19, P401, DOI 10.1071/PP9920401; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corey KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027144; Cui DY, 2005, J EXP BOT, V56, P1327, DOI 10.1093/jxb/eri133; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Fu ZD, 2004, METABOLISM EXPERIMEN; Goetz M, 2001, P NATL ACAD SCI USA, V98, P6522, DOI 10.1073/pnas.091097998; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; Jiang PD, 2007, PLANT CELL REP, V26, P1627, DOI 10.1007/s00299-007-0351-6; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; King RW, 2006, PLANT PHYSIOL, V141, P498, DOI 10.1104/pp.106.076760; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lee DJ, 2007, PLANTA, V226, P35, DOI 10.1007/s00425-006-0463-1; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Ma JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049244; Ma Xiaoding, 2007, Journal of Genetics and Genomics, V34, P536, DOI 10.1016/S1673-8527(07)60059-9; Mamun EA, 2006, CELL BIOL INT, V30, P583, DOI 10.1016/j.cellbi.2006.03.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NELSON O, 1995, ANNU REV PLANT PHYS, V46, P475, DOI 10.1146/annurev.pp.46.060195.002355; NORMANLY J, 1995, PLANT PHYSIOL, V107, P323, DOI 10.1104/pp.107.2.323; Normanly J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001594; Oliver SN, 2005, PLANT CELL ENVIRON, V28, P1534, DOI 10.1111/j.1365-3040.2005.01390.x; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; Ross JJ, 2001, J PLANT GROWTH REGUL, V20, P346, DOI 10.1007/s003440010034; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Sakata T, 2014, PLANT PHYSIOL, V164, P2011, DOI 10.1104/pp.113.234401; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Sheng TZ, 1989, THESISES ON MALE STE; SHUKLA A, 1994, PHYSIOL PLANTARUM, V91, P522, DOI 10.1111/j.1399-3054.1994.tb02983.x; SINGH S, 1992, J EXP BOT, V43, P1497, DOI 10.1093/jxb/43.11.1497; Song XianLiang, 2003, Scientia Agricultura Sinica, V36, P861; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TSAI CY, 1970, PLANT PHYSIOL, V46, P299, DOI 10.1104/pp.46.2.299; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wang DX, 2010, PLANT J, V63, P939, DOI 10.1111/j.1365-313X.2010.04294.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Wolbang CM, 2004, PLANT PHYSIOL, V134, P769, DOI 10.1104/pp.103.030460; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112320; [杨晓杰 Yang Xiaojie], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P723; Yin CX, 2007, J EXP BOT, V58, P2441, DOI 10.1093/jxb/erm077; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668; Zhang XiaoQuan, 2007, Agricultural Sciences in China, V6, P529, DOI 10.1016/S1671-2927(07)60079-0; [赵海燕 Zhao Haiyan], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4130; [赵元明 Zhao Yuanming], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P98; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	57	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0133425	10.1371/journal.pone.0133425	http://dx.doi.org/10.1371/journal.pone.0133425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382878	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200002
J	Gui, YS; Wang, LM; Tian, XL; Li, X; Ma, AP; Zhou, WX; Zeng, N; Zhang, J; Cai, BQ; Zhang, HB; Chen, JY; Xu, KF				Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Li, Xue; Ma, Aiping; Zhou, Weixun; Zeng, Ni; Zhang, Ji; Cai, Baiqiang; Zhang, Hongbing; Chen, Jing-Yu; Xu, Kai-Feng			mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis	PLOS ONE			English	Article							ACUTE LUNG INJURY; MAMMALIAN TARGET; EPITHELIAL-CELLS; RAPAMYCIN; ACTIVATION; INHIBITION; EXPRESSION; SIROLIMUS; PATHWAY	The mammalian target of rapamycin (mTOR) signaling pathway in pulmonary fibrosis was investigated in cell and animal models. mTOR overactivation in alveolar epithelial cells (AECs) was achieved in the conditional and inducible Tsc1 knock-down mice SPC-rtTA/TetO-Cre/Tsc1fx/+(STT). Doxycycline caused Tsc1 knock-down and consequently mTOR activation in AECs for the STT mice. Mice treated with bleomycin exhibited increased mortality and pulmonary fibrosis compared with control mice. In wild-type C57BL/6J mice, pretreatment with rapamycin attenuated the bleomycin-mediated mortality and fibrosis. Rapamycin-mediated mouse survival benefit was inhibited by chloroquine, an autophagy inhibitor. Autophagosomes were decreased in the lungs after bleomycin exposure. Rapamycin induced the production of autophagosomes and diminished p62. We concluded that mTOR overactivation in AECs and compromised autophagy in the lungs are involved in the pathogenesis of pulmonary fibrosis. The suppression of mTOR and enhancement of autophagy may be used for treatment of pulmonary fibrosis.	[Gui, Yao-Song; Tian, Xinlun; Li, Xue; Ma, Aiping; Zeng, Ni; Cai, Baiqiang; Xu, Kai-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100021, Peoples R China; [Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Li, Xue; Ma, Aiping; Zhou, Weixun; Zeng, Ni; Cai, Baiqiang; Zhang, Hongbing; Xu, Kai-Feng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Lianmei; Zhang, Hongbing] Peking Union Med Coll, Inst Basic Med Sci, Dept Physiol & Pathophysiol, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Wang, Lianmei] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhou, Weixun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Zhang, Ji; Chen, Jing-Yu] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Thorac Surg, Wuxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Jiangnan University; Nanjing Medical University	Chen, JY (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Thorac Surg, Wuxi, Peoples R China.	chenjingyu333@sina.com; kaifeng.xu@gmail.com	Tian, Xinlun/AAF-5444-2019; Xu, Kai-Feng/AAO-2445-2020	Tian, Xinlun/0000-0003-4307-6665; chen, jingyu/0000-0002-0563-9749; Chen, Jingyu/0000-0002-2127-1788	State Key Program of National Natural Science Foundation of China [81430001]; 973 National Basic Research Program of China [2009CB522106]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 National Basic Research Program of China(National Basic Research Program of China)	This study was supported by (KFX) the State Key Program of National Natural Science Foundation of China (81430001) and (KFX) the 973 National Basic Research Program of China (2009CB522106).	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Buschhausen L, 2005, MED KLIN, V100, P161, DOI 10.1007/s00063-005-1015-3; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Chen G, 2012, RES J BIOTECHNOL, V7, P3; Curatolo P, 2012, EUR J PAEDIATR NEURO, V16, P582, DOI 10.1016/j.ejpn.2012.05.004; Dobashi Y, 2011, INT J CLIN EXP PATHO, V4, P476; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee JS, 2012, BIOTECHNOL BIOENG, V109, P3093, DOI 10.1002/bit.24567; Li X, 2013, ONCOL LETT, V5, P167, DOI 10.3892/ol.2012.986; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Malouf MA, 2011, RESPIROLOGY, V16, P776, DOI 10.1111/j.1440-1843.2011.01955.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Miyoshi K, 2013, AM J RESP CRIT CARE, V187, P262, DOI 10.1164/rccm.201205-0851OC; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ricci A, 2013, J CELL PHYSIOL, V228, P1516, DOI 10.1002/jcp.24307; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Simler NR, 2002, EUR RESPIR J, V19, P1124, DOI 10.1183/09031936.02.00281602; Sun JP, 2008, AM J PATHOL, V172, P571, DOI 10.2353/ajpath.2008.070286; Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931; Tulek B, 2011, CLIN INVEST MED, V34, pE341; Uhal BD, 2003, EUR RESPIR J, V22, p7S, DOI 10.1183/09031936.03.00000303; Weihl CC, 2013, AUTOPHAGY, V9; Whaley-Connell A, 2011, AM J NEPHROL, V34, P115, DOI 10.1159/000329327; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xie JL, 2012, CELL MOL LIFE SCI, V69, P1289, DOI 10.1007/s00018-011-0874-4; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yoshizaki A, 2010, ARTHRITIS RHEUM-US, V62, P2476, DOI 10.1002/art.27498; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Yu SY, 2013, THORAC CARDIOV SURG, V61, P223, DOI 10.1055/s-0032-1311548	45	62	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138625	10.1371/journal.pone.0138625	http://dx.doi.org/10.1371/journal.pone.0138625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382847	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200141
J	Lanham, S; Cagampang, FR; Oreffo, ROC				Lanham, Stuart; Cagampang, Felino R.; Oreffo, Richard O. C.			Maternal High Fat Diet Affects Offspring's Vitamin K-Dependent Proteins Expression Levels	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; BONE; METABOLISM; PERIOSTIN; HEALTH	Studies suggest bone growth & development and susceptibility to vascular disease in later life are influenced by maternal nutrition, during intrauterine and early postnatal life. There is evidence for a role of vitamin K-dependent proteins (VKDPs) including Osteocalcin, Matrix-gla protein, Periostin, and Gas6, in bone and vascular development. This study extends the analysis of VKDPs previously conducted in 6 week old offspring, into offspring of 30 weeks of age, to assess the longer term effects of a maternal and postnatal high fat (HF) diet on VKDP expression. Overall a HF maternal diet and offspring diet exacerbated the bone changes observed. Sex specific and tissue specific differences were observed in VKDP expression for both aorta and femoral tissues. In addition, significant correlations were observed between femoral OCN, Periostin Gas6, and Vkor expression levels and measures of femoral bone structure. Furthermore, MGP, OCN, Ggcx and Vkor expression levels correlated to mass and fat volume, in both sexes. In summary the current study has highlighted the importance of the long-term effects of maternal nutrition on offspring bone development and the correlation of VKDPs to bone structure.	[Lanham, Stuart; Oreffo, Richard O. C.] Univ Southampton, Fac Med, Inst Dev Sci, Bone & Joint Res Grp,Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Cagampang, Felino R.] Univ Southampton, Fac Med, Inst Dev Sci, Maternal Pregnancy & Child Res Grp,Human Dev & Hl, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Lanham, S (corresponding author), Univ Southampton, Fac Med, Inst Dev Sci, Bone & Joint Res Grp,Human Dev & Hlth, Southampton SO9 5NH, Hants, England.	S.A.Lanham@soton.ac.uk	Oreffo, Richard OC/A-4615-2011; Cagampang, Felino/AAG-5141-2019	Oreffo, Richard OC/0000-0001-5995-6726; Cagampang, Felino/0000-0003-4404-9853	Rosetrees Trust [M425]; Biotechnology and Biological Sciences Research Council [BB/G01812X/1]; BBSRC [BB/G01812X/1, BB/G010579/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: Rosetrees Trust, grant number M425 (http://www.rosetreestrust.co.uk) funded SL. Biotechnology and Biological Sciences Research Council, grant number BB/G01812X/1 (http://www.bbsrc.ac.uk) funded FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2011, NUTR REV, V69, P584, DOI 10.1111/j.1753-4887.2011.00372.x; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Cea V, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00209; Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748; El Asmar Margueritta S, 2014, Oman Med J, V29, P172, DOI 10.5001/omj.2014.44; Ferron M, 2015, J CELL BIOL, V208, P761, DOI 10.1083/jcb.201409111; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fusaro M, 2012, J BONE MINER RES, V27, P2271, DOI 10.1002/jbmr.1677; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey K M, 2001, Public Health Nutr, V4, P611; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Ismail-Beigi F, 2006, AM J PHYSIOL-ENDOC M, V291, pE439, DOI 10.1152/ajpendo.00105.2006; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Lanham SA, 2014, ENDOCRINOLOGY, V155, P4749, DOI 10.1210/en.2014-1188; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lindqvist PG, 2010, ACTA OBSTET GYN SCAN, V89, P22, DOI 10.3109/00016340903410899; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Motomura H, 2007, BIOCHEM BIOPH RES CO, V357, P997, DOI 10.1016/j.bbrc.2007.04.035; Novak DA, 2006, J MATERN-FETAL NEO M, V19, P591, DOI 10.1080/14767050600708233; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Shiba S, 2014, BIOCHEM BIOPH RES CO, V453, P350, DOI 10.1016/j.bbrc.2014.09.091; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Sun YM, 2005, BLOOD, V106, P3811, DOI 10.1182/blood-2005-06-2495; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Viegas CSB, 2013, J BIOL CHEM, V288, P27801, DOI 10.1074/jbc.M113.450213; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323	37	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138730	10.1371/journal.pone.0138730	http://dx.doi.org/10.1371/journal.pone.0138730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381752	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200156
J	Liu, H; Zhang, GM; Sun, WT; Shen, ZY; Shi, MJ				Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong; Shi, Mingji			ZnO Hierarchical Nanostructure Photoanode in a CdS Quantum Dot-Sensitized Solar Cell	PLOS ONE			English	Article							ZINC-OXIDE NANORODS; ELECTROCHEMICAL DEPOSITION; GROWTH-MECHANISM; AQUEOUS-SOLUTION; SINGLE-CRYSTALS; CHEMICAL BATH; EFFICIENCY; FABRICATION; ARRAYS; TIO2	A hierarchical array of ZnO nanocones covered with ZnO nanospikes was hydrothermally fabricated and employed as the photoanode in a CdS quantum dot-sensitized solar cell (QDSSC). This QDSSC outperformed the QDSSC based on a simple ZnO nanocone photoanode in all the four principal photovoltaic parameters. Using the hierarchical photoanode dramatically increased the short circuit current density and also slightly raised the open circuit voltage and the fill factor. As a result, the conversion efficiency of the QDSSC based on the hierarchical photoanode was more than twice that of the QDSSC based on the simple ZnO nanocone photoanode. This improvement is attributable to both the enlarged specific area of the photoanode and the reduction in the recombination of the photoexcited electrons.	[Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong] Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong] Peking Univ, Dept Elect, Beijing 100871, Peoples R China; [Zhang, Gengmin] SIP UCLA, Inst Technol Adv, Suzhou, Peoples R China; [Shi, Mingji] Nanyang Inst Technol, Sch Elect & Elect Engn, Nanyang, Henan Province, Peoples R China	Peking University; Peking University; Nanyang Institute of Technology	Zhang, GM (corresponding author), Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China.	zgmin@pku.edu.cn			National Natural Science Foundation of China [61171023, 61306079, 61271050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 61171023 (GMZ), 61306079 (WTS) and 61271050 (ZYS)) [http://www.nsfc.gov.cn].	Agarwal DC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035310; Anta JA, 2012, J PHYS CHEM C, V116, P11413, DOI 10.1021/jp3010025; Bierman MJ, 2009, ENERG ENVIRON SCI, V2, P1050, DOI 10.1039/b912095e; Cao BQ, 2006, CRYST GROWTH DES, V6, P1091, DOI 10.1021/cg050246l; Chatterjee A, 2006, DIAM RELAT MATER, V15, P664, DOI 10.1016/j.diamond.2005.11.007; Chen J, 2010, APPL SURF SCI, V256, P7438, DOI 10.1016/j.apsusc.2010.05.086; Chen J, 2009, APPL SURF SCI, V255, P7508, DOI 10.1016/j.apsusc.2009.03.091; Cheng HM, 2012, PHYS CHEM CHEM PHYS, V14, P13539, DOI [10.1039/c2cp41760j, 10.1039/C2CP41760J]; Chou TP, 2007, ADV MATER, V19, P2588, DOI 10.1002/adma.200602927; Dem'yanets LN, 2002, INORG MATER+, V38, P124, DOI 10.1023/A:1014008909633; Demianets LN, 2002, CRYSTALLOGR REP+, V47, pS86, DOI 10.1134/1.1529962; Deng JP, 2014, J COLLOID INTERF SCI, V418, P277, DOI 10.1016/j.jcis.2013.11.017; El Belghiti H, 2008, PHYS STATUS SOLIDI A, V205, P2360, DOI 10.1002/pssa.200879443; Fan K, 2011, J PHYS CHEM C, V115, P17213, DOI 10.1021/jp204725f; FORRO L, 1994, J APPL PHYS, V75, P633, DOI 10.1063/1.355801; Gao HM, 2008, MATER RES BULL, V43, P3345, DOI 10.1016/j.materresbull.2008.02.010; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Govender K, 2004, J MATER CHEM, V14, P2575, DOI 10.1039/b404784b; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Greene LE, 2006, INORG CHEM, V45, P7535, DOI 10.1021/ic0601900; Han C, 2015, ADV FUNCT MATER, V25, P221, DOI 10.1002/adfm.201402443; Hodes G, 2008, J PHYS CHEM C, V112, P17778, DOI 10.1021/jp803310s; Izaki M, 1996, J ELECTROCHEM SOC, V143, pL53, DOI 10.1149/1.1836529; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Jung SW, 2013, CURR APPL PHYS, V13, P1532, DOI 10.1016/j.cap.2013.05.015; Khajavi MR, 2012, ELECTROCHIM ACTA, V69, P181, DOI 10.1016/j.electacta.2012.02.096; Kilic B, 2014, APPL SURF SCI, V318, P32, DOI 10.1016/j.apsusc.2013.12.065; Ko SH, 2011, NANO LETT, V11, P666, DOI 10.1021/nl1037962; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Lee J.D., 1996, CONCISE INORGANIC CH; Li CM, 2013, APPL CATAL B-ENVIRON, V138, P175, DOI 10.1016/j.apcatb.2013.02.042; Li LB, 2013, ACS APPL MATER INTER, V5, P11865, DOI 10.1021/am4035653; Li QC, 2005, CHEM MATER, V17, P1001, DOI 10.1021/cm048144q; Li WJ, 1999, J CRYST GROWTH, V203, P186, DOI 10.1016/S0022-0248(99)00076-7; Li ZD, 2015, ELECTROCHIM ACTA, V152, P25, DOI 10.1016/j.electacta.2014.11.106; Li ZD, 2015, J POWER SOURCES, V274, P575, DOI 10.1016/j.jpowsour.2014.10.129; Liao JY, 2012, ENERG ENVIRON SCI, V5, P5750, DOI 10.1039/c1ee02766b; Liao JY, 2011, ENERG ENVIRON SCI, V4, P4079, DOI 10.1039/c1ee01574e; Lin SY, 2015, ELECTROCHIM ACTA, V152, P61, DOI 10.1016/j.electacta.2014.11.108; Liu BK, 2014, RSC ADV, V4, P32773, DOI 10.1039/c4ra05736h; Liu H, 2015, MATER RES BULL, V61, P492, DOI 10.1016/j.materresbull.2014.10.068; Look DC, 1998, SOLID STATE COMMUN, V105, P399, DOI 10.1016/S0038-1098(97)10145-4; Lopez R, 2012, J SOL-GEL SCI TECHN, V61, P1, DOI 10.1007/s10971-011-2582-9; Memarian N., 2011, ANGEW CHEM, V123, P12529, DOI DOI 10.1002/ANGE.201104605; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Park YC, 2011, ELECTROCHIM ACTA, V56, P7371, DOI 10.1016/j.electacta.2011.05.113; Pichot F, 2000, J PHYS CHEM B, V104, P6, DOI 10.1021/jp993035y; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Rodriguez-Fragoso P, 2010, APPL SURF SCI, V257, P581, DOI 10.1016/j.apsusc.2010.07.036; Sauvage F, 2010, NANO LETT, V10, P2562, DOI 10.1021/nl101198b; Seol M, 2010, CHEM COMMUN, V46, P5521, DOI 10.1039/c0cc00542h; Sharrna M, 2012, MATER RES BULL, V47, P1755, DOI 10.1016/j.materresbull.2012.03.044; Skompska M, 2014, ELECTROCHIM ACTA, V127, P467, DOI 10.1016/j.electacta.2014.02.049; Song J, 2013, ADV MATER, V25, P5678, DOI [10.1002/adma.201370252, DOI 10.1002/ADMA.201370252]; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P462, DOI 10.1002/anie.201408621; Song JZ, 2014, NANO LETT, V14, P6298, DOI 10.1021/nl502647k; Spoerke ED, 2009, J PHYS CHEM C, V113, P16329, DOI 10.1021/jp900564r; Srivastava S, 2015, J ALLOY COMPD, V644, P597, DOI 10.1016/j.jallcom.2015.04.220; Sugunan A, 2006, J SOL-GEL SCI TECHN, V39, P49, DOI 10.1007/s10971-006-6969-y; Sun SR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3318466; TAUC J, 1970, PHYS REV LETT, V25, P749, DOI 10.1103/PhysRevLett.25.749; Tian JJ, 2014, ACS APPL MATER INTER, V6, P4466, DOI 10.1021/am500209f; Vanalakar SA, 2011, MATER LETT, V65, P548, DOI 10.1016/j.matlet.2010.10.067; Wang J, 2013, J AM CHEM SOC, V135, P15913, DOI 10.1021/ja4079804; Wang Q, 2005, J PHYS CHEM B, V109, P14945, DOI 10.1021/jp052768h; Wang Z, 2004, J SOLID STATE CHEM, V177, P2144, DOI 10.1016/j.jssc.2003.10.026; Wang Z, 2004, LANGMUIR, V20, P3441, DOI 10.1021/la036098n; Willander M, 2009, J MATER CHEM, V19, P1006, DOI 10.1039/b816619f; Wu CT, 2011, J MATER CHEM, V21, P13605, DOI 10.1039/c1jm11681a; Wu LP, 2014, RSC ADV, V4, P20716, DOI 10.1039/c4ra00005f; Wu SJ, 2012, ORG ELECTRON, V13, P1569, DOI 10.1016/j.orgel.2012.04.018; Xu F, 2010, J PHYS CHEM C, V114, P2776, DOI 10.1021/jp910363w; Xu S, 2011, NANO RES, V4, P1013, DOI 10.1007/s12274-011-0160-7; Yan KY, 2013, J AM CHEM SOC, V135, P9531, DOI 10.1021/ja403756s; Ye MD, 2011, NANO LETT, V11, P3214, DOI 10.1021/nl2014845; Yin JB, 2012, SCI CHINA TECHNOL SC, V55, P3176, DOI 10.1007/s11431-012-4920-8; Yu LG, 2007, J CRYST GROWTH, V299, P184, DOI 10.1016/j.jcrysgro.2006.10.237; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang J, 2002, CHEM MATER, V14, P4172, DOI 10.1021/cm020077h; Zhang ML, 2014, RSC ADV, V4, P10462, DOI 10.1039/c3ra47146b; Zhang QF, 2009, ADV MATER, V21, P4087, DOI 10.1002/adma.200803827; Zheng HD, 2010, LANGMUIR, V26, P19148, DOI 10.1021/la103692y	84	5	6	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138298	10.1371/journal.pone.0138298	http://dx.doi.org/10.1371/journal.pone.0138298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379268	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400082
J	Li, LL; Wang, YJ; Gao, W; Yuan, C; Zhang, SN; Zhou, H; Huang, M; Yao, X				Li, Lingling; Wang, Yujie; Gao, Wei; Yuan, Cheng; Zhang, Sini; Zhou, Hong; Huang, Mao; Yao, Xin			Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROINFLAMMATORY CYTOKINE RELEASE; OXIDATIVE STRESS; EPITHELIAL-CELLS; ACTIVATION; PROTEIN; KIDNEY; SENESCENCE; EXPRESSION; COPD	Abnormal inflammation and accelerated decline in lung function occur in patients with chronic obstructive pulmonary disease (COPD). Klotho, an anti-aging protein, has an anti-inflammatory function. However, the role of Klotho has never been investigated in COPD. The aim of this study is to investigate the possible role of Klotho by alveolar macrophages in airway inflammation in COPD. Klotho levels were assessed in the lung samples and peripheral blood mononuclear cells of non-smokers, smokers, and patients with COPD. The regulation of Klotho expression by cigarette smoke extract (CSE) was studied in vitro, and small interfering RNA (siRNA) and recombinant Klotho were employed to investigate the role of Klotho on CSE-induced inflammation. Klotho expression was reduced in alveolar macrophages in the lungs and peripheral blood mononuclear cells of COPD patients. CSE decreased Klotho expression and release from MH-S cells. Knockdown of endogenous Klotho augmented the expression of the inflammatory mediators, such as MMP-9, IL-6, and TNF-alpha, by MH-S cells. Exogenous Klotho inhibited the expression of CSE-induced inflammatory mediators. Furthermore, we showed that Klotho interacts with I kappa B alpha of the NF-kappa B pathway. Dexamethasone treatment increased the expression and release level of Klotho in MH-S cells. Our findings suggest that Klotho plays a role in sustained inflammation of the lungs, which in turn may have therapeutic implications in COPD.	[Li, Lingling; Wang, Yujie; Gao, Wei; Yuan, Cheng; Zhang, Sini; Huang, Mao; Yao, Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing 210029, Jiangsu, Peoples R China; [Li, Lingling] Yijishan Hosp, Wannan Med Coll, Dept Resp Med, Wuhu 241000, Peoples R China; [Zhou, Hong] Nanjing Med Univ, Dept Immunol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Wannan Medical College; Nanjing Medical University	Yao, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	xyao1998@126.com			National Natural Science Foundation of China [81070025, 81470237]; Jiangsu Health Promotion Project; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Health Promotion Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81070025 and 81470237, the Jiangsu Health Promotion Project, and the Priority Academic Program Development of Jiangsu Higher Education Institutions Grant JX10231802. The authors declare that they have no conflicts of interest with the contents of this article.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Funada Yasuhiro, 2004, Kobe Journal of Medical Sciences, V50, P59; Gao W, 2015, CLIN SCI, V129, P1011, DOI 10.1042/CS20150273; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Imai M, 2004, ENDOCRINE, V25, P229, DOI 10.1385/ENDO:25:3:229; Jeffery PK, 2000, CHEST, V117, p251S, DOI 10.1378/chest.117.5_suppl_1.251S; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Oh HJ, 2015, PERITON DIALYSIS INT, V35, P43, DOI 10.3747/pdi.2013.00150; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Saetta M, 2000, AM J RESP CRIT CARE, V161, P1016, DOI 10.1164/ajrccm.161.3.9907080; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; SNIDER GL, 1989, ANNU REV MED, V40, P411; Tan SJ, 2014, NEPHROLOGY, V19, P439, DOI 10.1111/nep.12268; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED; Vogelmeier C, 2007, AM J RESP CRIT CARE, V175, P1217, DOI 10.1164/rccm.200703-513ED; Yang J, 2003, BIOCHEM BIOPH RES CO, V301, P424, DOI 10.1016/S0006-291X(02)03056-5; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	38	48	50	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27890	+		10.1074/jbc.M115.655431	http://dx.doi.org/10.1074/jbc.M115.655431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26385922	Green Published, hybrid			2022-12-26	WOS:000365757500038
J	Chakouch, MK; Charleux, F; Bensamoun, SF				Chakouch, Mashhour K.; Charleux, Fabrice; Bensamoun, Sabine F.			Quantifying the Elastic Property of Nine Thigh Muscles Using Magnetic Resonance Elastography	PLOS ONE			English	Article							ANISOTROPIC MECHANICAL-PROPERTIES; MR ELASTOGRAPHY; SKELETAL-MUSCLE; RAPID ACQUISITION; STIFFNESS; MULTIFREQUENCY; PALPATION; HEALTHY; TISSUE; LIVER	Background Pathologies of the muscles can manifest different physiological and functional changes. To adapt treatment, it is necessary to characterize the elastic property (shear modulus) of single muscles. Previous studies have used magnetic resonance elastography (MRE), a technique based on MRI technology, to analyze the mechanical behavior of healthy and pathological muscles. The purpose of this study was to develop protocols using MRE to determine the shear modulus of nine thigh muscles at rest. Methods Twenty-nine healthy volunteers (mean age = 26 +/- 3.41 years) with no muscle abnormalities underwent MRE tests (1.5 T MRI). Five MRE protocols were developed to quantify the shear moduli of the nine following thigh muscles at rest: rectus femoris (RF), vastus medialis (VM), vastus intermedius (VI), vastus lateralis (VL), sartorius (Sr), gracilis (Gr), semimembranosus (SM), semitendinosus (ST), and biceps (BC). In addition, the shear modulus of the subcutaneous adipose tissue was analyzed. Results The gracilis, sartorius, and semitendinosus muscles revealed a significantly higher shear modulus (mu_(Gr) = 6.15 +/- 0.45 kPa, mu_(Sr) = 5.15 +/- 0.19 kPa, and mu_(ST) = 5.32 +/- 0.10 kPa, respectively) compared to other tissues (from mu_(RF) = 3.91 +/- 0.16 kPa to mu_(VI) = 4.23 +/- 0.25 kPa). Subcutaneous adipose tissue had the lowest value (mu_(adipose tissue) = 3.04 +/- 0.12 kPa) of all the tissues tested. Conclusion The different elasticities measured between the tissues may be due to variations in the muscles' physiological and architectural compositions. Thus, the present protocol could be applied to injured muscles to identify their behavior of elastic property. Previous studies on muscle pathology found that quantification of the shear modulus could be used as a clinical protocol to identify pathological muscles and to follow-up effects of treatments and therapies. These data could also be used for modelling purposes.	[Chakouch, Mashhour K.; Bensamoun, Sabine F.] Univ Technol Compiegne, Univ Paris 04, UMR CNRS 7338, Biomech & Bioengn Lab, Compiegne, France; [Charleux, Fabrice] ACRIM Polyclin St Come, Compiegne, France	Picardie Universites; Universite de Technologie de Compiegne; UDICE-French Research Universities; Sorbonne Universite	Bensamoun, SF (corresponding author), Univ Technol Compiegne, Univ Paris 04, UMR CNRS 7338, Biomech & Bioengn Lab, Compiegne, France.	sabine.bensamoun@utc.fr						Ballyns JJ, 2012, J ULTRAS MED, V31, P1209; Bensamoun S., 2014, MAGNETIC RESONANCE E, P81; Bensamoun SF, 2007, J MAGN RESON IMAGING, V26, P708, DOI 10.1002/jmri.21073; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bensamoun SF, 2014, INNOVATION AND RESEA; Brauck K, 2007, EUR J ENDOCRINOL, V156, P673, DOI 10.1530/EJE-06-0694; Chakouch MK, 2014, COMPUT METHOD BIOMEC, V17, P32, DOI 10.1080/10255842.2014.931086; Chamarthi SK, 2014, MAGN RESON IMAGING, V32, P679, DOI 10.1016/j.mri.2014.02.013; Chen Q, 2007, ARCH PHYS MED REHAB, V88, P1658, DOI 10.1016/j.apmr.2007.07.020; Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713; Debernard L, 2011, CLIN BIOMECH, V26, P836, DOI 10.1016/j.clinbiomech.2011.04.004; Debernard L, 2011, J BIOMECH, V44, P397, DOI 10.1016/j.jbiomech.2010.10.025; Domire ZJ, 2009, J BIOMECH, V42, P537, DOI 10.1016/j.jbiomech.2008.11.034; Drakonaki EE, 2012, BRIT J RADIOL, V85, P1435, DOI 10.1259/bjr/93042867; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Fleiss J, 1986, JOURNAL OF APPLIED S, V13, P231, DOI DOI 10.1080/02664768600000037; Garteiser P, 2013, NMR BIOMED, V26, P1326, DOI 10.1002/nbm.2958; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964; Green MA, 2012, NMR BIOMED, V25, P852, DOI 10.1002/nbm.1801; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Hirsch S, 2014, MAGN RESON MED, V71, P267, DOI 10.1002/mrm.24674; Hsieh CYJ, 2000, ARCH PHYS MED REHAB, V81, P258, DOI 10.1016/S0003-9993(00)90068-6; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Lacourpaille L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053159; Lacourpaille L, 2013, J ELECTROMYOGR KINES, V23, P51, DOI 10.1016/j.jelekin.2012.06.010; Leclerc GE, 2013, J MAGN RESON IMAGING, V38, P422, DOI 10.1002/jmri.23986; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Lew P. C., 1997, Man Ther, V2, P87, DOI 10.1054/math.1997.0289; Li K, 2014, NMR BIOMED, V27, P1070, DOI 10.1002/nbm.3159; Manduca A, 2003, MED IMAGE ANAL, V7, P465, DOI 10.1016/S1361-8415(03)00038-0; McCullough MB, 2011, MUSCLE NERVE, V43, P585, DOI 10.1002/mus.21923; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Numano T, 2015, MAGN RESON IMAGING, V33, P31, DOI 10.1016/j.mri.2014.10.002; Numano T, 2013, MAGN RESON IMAGING, V31, P939, DOI 10.1016/j.mri.2013.02.001; Palacio-Torralba J, 2015, J MECH BEHAV BIOMED, V41, P149, DOI 10.1016/j.jmbbm.2014.09.027; Qin EC, 2011, PROC INTL SOC MAG RE, P39; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Scheel M, 2013, NMR BIOMED, V26, P1220, DOI 10.1002/nbm.2938; Williams SE, 2013, J MAGN RESON IMAGING, V38, P1292, DOI 10.1002/jmri.24045; Yeh CL, 2014, IEEE INT ULTRA SYM, P1132, DOI 10.1109/ULTSYM.2014.0278	44	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138873	10.1371/journal.pone.0138873	http://dx.doi.org/10.1371/journal.pone.0138873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397730	Green Submitted, gold, Green Published			2022-12-26	WOS:000361797500120
J	Huang, CL; Wu, YW; Wu, CC; Hwang, JJ; Yang, WS				Huang, Chi-Lun; Wu, Yen-Wen; Wu, Chih-Cheng; Hwang, Juey-Jen; Yang, Wei-Shiung			Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ADIPONECTIN; RISK; RESISTIN; ANGPTL2; OBESITY; PATHOGENESIS; INFLAMMATION; DYSFUNCTION	Objective Angiopoietin-like protein 2 (ANGPTL2), which is mainly expressed from adipose tissue, is demonstrated to be involved in obesity, metabolic syndrome, and atherosclerosis. Because several adipocytokines are known to be associated with heart failure (HF), here we investigated the association of ANGPTL2 and HF in Taiwanese subjects. Methods and Results A total of 170 symptomatic HF patients and 130 age-and sex-matched controls were enrolled from clinic. The echocardiography was analyzed in each patient, and stress myocardial perfusion study was performed for clinical suspicion of coronary artery disease. Detailed demographic information, medications, and biochemical data were recorded. Circulating adipocytokines, including tumor necrosis factor-alpha (TNF-alpha), adiponectin, adipocyte fatty acid-binding protein (A-FABP) and ANGPTL2, were analyzed. Compared with the control group subjects, serum ANGPTL2 concentrations were significantly higher in HF group patients. In correlation analyses, ANGPTL2 level was positively correlated to creatinine, fasting glucose, triglyceride, hsCRP, TNF-alpha, NT-proBNP and A-FABP levels, and negatively correlated with HDL-C and left ventricular ejection fraction. In multiple regression analysis, A-FABP, hsCRP, and HDL-C levels remained as independent predictors for ANGPTL2 level. To determine the association between serum ANGPTL2 concentrations and HF, multivariate logistic regression analyses were performed with subjects divided into tertiles by ANGPTL2 levels. For the subjects with ANGPTL2 levels in the highest tertile, their risk of HF was about 2.97 fold (95% CI = 1.24-7.08, P = 0.01) higher than those in the lowest tertile. Conclusion Our results demonstrate a higher circulating ANGPTL2 level in patients with HF, and the upregulating ANGPTL2 levels might be associated with metabolic derangements and inflammation.	[Huang, Chi-Lun] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Taoyuan, Taiwan; [Huang, Chi-Lun; Wu, Yen-Wen; Hwang, Juey-Jen; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Chih-Cheng] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wu, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wsyang@ntu.edu.tw; wuyw0502@gmail.com		WU, YEN-WEN/0000-0003-1520-1166; Hwang, Juey-Jen/0000-0001-6437-0455; YANG, WEI-SHIUNG/0000-0001-5087-373X; WU, CHIH-CHENG/0000-0002-9690-6573	Taoyuan General Hospital [PTH10412]; National Taiwan University Hospital [HCH102-28]; National Science Council of Taiwan [MOST 101-2314-B-418-012-MY3]	Taoyuan General Hospital; National Taiwan University Hospital(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants funded by Taoyuan General Hospital (PTH10412), National Taiwan University Hospital (HCH102-28), and National Science Council of Taiwan (MOST 101-2314-B-418-012-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Djousse L, 2013, EUR J HEART FAIL, V15, P394, DOI 10.1093/eurjhf/hfs196; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Dvorak RA, 2011, RADIOGRAPHICS, V31, P2041, DOI 10.1148/rg.317115090; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Gaddam KK, 2011, CURR HYPERTENS REP, V13, P142, DOI 10.1007/s11906-011-0179-x; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Jung CH, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0198-z; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li Q, 2013, DIABETES RES CLIN PR, V100, P385, DOI 10.1016/j.diabres.2013.03.028; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Ogata A, 2012, BIOCHEM BIOPH RES CO, V418, P494, DOI 10.1016/j.bbrc.2012.01.052; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Rame JE, 2012, CIRCULATION, V125, P2809, DOI 10.1161/CIRCULATIONAHA.112.108316; Rienstra M, 2012, AM HEART J, V163, P119, DOI 10.1016/j.ahj.2011.09.029; Santulli G, 2013, JCVD, V1, P1; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Shinmura K, 2010, HEART FAIL REV, V15, P457, DOI 10.1007/s10741-010-9159-5; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takeishi Y, 2007, CIRC J, V71, P460, DOI 10.1253/circj.71.460; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Tilkemeier Peter L, 2006, J Nucl Cardiol, V13, pe91, DOI 10.1016/j.nuclcard.2006.08.012; Wang ZQ, 2015, ARCH MED RES, V46, P257, DOI 10.1016/j.arcmed.2015.05.003; Wu YW, 2003, J NUCL CARDIOL, V10, P369, DOI 10.1016/S1071-3581(03)00456-2	34	20	21	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138678	10.1371/journal.pone.0138678	http://dx.doi.org/10.1371/journal.pone.0138678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397985	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500094
J	Yang, HB; Li, XX; Wang, WQ; Bai, CJ; Liu, GD				Yang, Hubiao; Li, Xiaoxia; Wang, Wenqiang; Bai, Changjun; Liu, Guodao			Carex jianfengensis (Carex sect. Rhomboidales, Cyperaceae), a New Species from Hainan, China	PLOS ONE			English	Article							TRIBE CARICEAE; ZHEJIANG; SEDGE	A new species of Carex sect. Rhomboidales, C. jianfengensis, is described and illustrated from Hainan, China. The new species is similar to C. zunyiensis but differs in having involucral bracts sparsely hispid and with ca.1 cm long sheaths; inflorescence with 4 spikes, terminal spike ca. 2.5 cm long, lateral spikes 2-3.5 x 0.7(-1) cm; staminate glumes narrowly ovate, ca. 5 mm; pistillate glumes triangular-lanceolate, 5-7 mm; perigynia 6-8 x 3 mm and pubescent on veins; nutlet 4-5 mm long, rhombic-ovoid, trigonous, base with shortly stipitate, apex abruptly contracted into a erect short beak, and not expanding into an annulate orifice.	[Yang, Hubiao; Wang, Wenqiang; Bai, Changjun; Liu, Guodao] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China; [Li, Xiaoxia] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Liu, GD (corresponding author), Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China.	liuguodao2008@163.com			Basic Scientific Research Business Expenses [1630032014030]; Earmarked Fund for China Agriculture Research System [CARS-35-03]; project of tropical forage germplasm resources protection [14RZZY-09]	Basic Scientific Research Business Expenses; Earmarked Fund for China Agriculture Research System; project of tropical forage germplasm resources protection	This research was financially supported by the Basic Scientific Research Business Expenses (1630032014030), the Earmarked Fund for China Agriculture Research System (CARS-35-03) and the project of tropical forage germplasm resources protection (14RZZY-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball PW, 2003, FLORA N AM N MEXICO, V23, P254; Blaser HW, 1944, AM J BOT, V31, P53, DOI 10.2307/2437667; Dai L.K., 2010, FLORA CHINA, V23, P285; Deng YF, 2014, PHYTOTAXA, V178, P181, DOI 10.11646/phytotaxa.178.3.3; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Jin SH, 2012, BRITTONIA, V64, P325, DOI 10.1007/s12228-012-9236-2; Jin XF, 2004, ACTA PHYTOTAXON SIN, V42, P541; Jin XF, 2012, SYST BOT, V37, P929, DOI 10.1600/036364412X656617; Jin XF, 2011, NORD J BOT, V29, P63, DOI 10.1111/j.1756-1051.2010.00977.x; Jin XF, 2010, NORD J BOT, V28, P709, DOI 10.1111/j.1756-1051.2010.00817.x; Koyama T, 1962, BOTANY, V8, P149; Kukenthal G., 1909, PFLANZENREICH 4; Li PC., 2000, FLORA REIPUBLICAE PO, V12, P56; Liu G.D., 2012, CYPERACEAE HAINAN; NELMES E., 1951, REINWARDTIA, V1, P221; Oda Jiro, 2003, APG Acta Phytotaxonomica et Geobotanica, V54, P127; Ohwi J., 1936, MEM COLL SCI KYOTO B, V11, P229; REZNICEK AA, 1990, CAN J BOT, V68, P1409, DOI 10.1139/b90-180; Shimizu Takahiro, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P67; Su S.W., 2009, J ANHUI U NATURAL SC, V33, P83; [苏宋旺 SU Song-wang], 2009, [安徽农业大学学报, Journal of Anhui Agricultural University], V36, P557; Thiers B., 2008, INDEX HERBARIORUM GL; Wang QL, 2012, PHYTOTAXA, V75, P65; Waterway Marcia J., 2007, Aliso, V23, P165; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; Yang HB, 2015, PHYTOTAXA, V201, P207, DOI 10.11646/phytotaxa.201.3.4; Yang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097658; Yu LiYing, 2012, Journal of Tropical and Subtropical Botany, V20, P403; Zhao YJ, 2011, NORD J BOT, V29, P670, DOI 10.1111/j.1756-1051.2011.01132.x; Zheng, 2013, TAXONOMY CAREX SECT	30	7	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136373	10.1371/journal.pone.0136373	http://dx.doi.org/10.1371/journal.pone.0136373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397809	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500009
J	Kim, YW; Lee, CH; Park, YS; Kim, YI; Ahn, CM; Kim, JO; Park, JH; Lee, SH; Kim, JY; Chun, EM; Jung, TH; Yoo, KH				Kim, Yeon Wook; Lee, Chang-Hoon; Park, Young Sik; Kim, Yu-Il; Ahn, Chul Min; Kim, Ju-Ock; Park, Joo Hun; Lee, Sang Haak; Kim, Jae Yeol; Chun, Eun Mi; Jung, Tae Hoon; Yoo, Kwang Ha			Effect of Exposure to Second-Hand Smoke on the Quality of Life: A Nationwide Population-Based Study from South Korea	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; EQ-5D HEALTH STATES; SECONDHAND SMOKE; RESPIRATORY SYMPTOMS; FUNCTIONAL HEALTH; PASSIVE SMOKING; CHRONIC DISEASE; NEVER SMOKERS; HEART-DISEASE; SF-36	Background Although exposure to second-hand smoke (SHS) has been associated with various medical conditions, only limited data are available on its association with health-related quality of life (HRQOL), particularly data obtained with the EQ-5D or EQ visual analogue scale (VAS). Methods This cross-sectional study evaluated 10,532 adult never-smokers who participated in the fifth Korea National Health and Nutrition Examination Survey. By using linear regression models to adjust for possible confounders and incorporating survey weights in analyses, the association between exposure to SHS and HRQOL-measured with the EQ-5D index and the EQ-VAS score-was evaluated. Data were further stratified by the amount of exposure time. Results After weighted analysis and adjustment, exposure to SHS was significantly associated with lower measures on the EQ-5D index (beta = -0.007, P = 0.005) and EQ-VAS score (beta = -1.936, P < 0.001). When comparing the unexposed group with the groups exposed < 2h/day and >= 2h/day, exposure to a longer duration of SHS was significantly associated with lower scores on the EQ-5D index and the EQ-VAS score. Conclusion In conclusion, exposure to SHS was associated with reduced HRQOL measured by the EQ-5D index and EQ-VAS score, revealing a dose-response relationship.	[Kim, Yeon Wook; Lee, Chang-Hoon; Park, Young Sik] Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Coll Med, Seoul 151, South Korea; [Kim, Yu-Il] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; [Ahn, Chul Min] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Ju-Ock] Chungnam Natl Univ, Dept Internal Med, Sch Med, Taejon, South Korea; [Park, Joo Hun] Ajou Univ, Sch Med, Dept Internal Med, Suwon 441749, South Korea; [Lee, Sang Haak] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Jae Yeol] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Chun, Eun Mi] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Jung, Tae Hoon] Chilgok Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Yoo, Kwang Ha] Konkuk Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Chonnam National University; Chonnam National University Hospital; Yonsei University; Yonsei University Health System; Chungnam National University; Ajou University; Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Ewha Womans University; Konkuk University; Konkuk University Medical Center	Park, YS (corresponding author), Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Coll Med, Seoul 151, South Korea.	mdyspark@gmail.com	Lee, Chang-Hoon/AAC-7650-2021; Kim, Yeon Wook/AAM-9025-2021	Kim, Yeon Wook/0000-0001-8333-4812				Berglund DJ, 1999, CHEST, V115, P49, DOI 10.1378/chest.115.1.49; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221; Bridevaux PO, 2007, ARCH INTERN MED, V167, P2516, DOI 10.1001/archinte.167.22.2516; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112389; Eisner Mark D, 2006, BMC Pulm Med, V6, P12, DOI 10.1186/1471-2466-6-12; EMMONS KM, 1994, PREV MED, V23, P35, DOI 10.1006/pmed.1994.1005; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Glantz SA, 2001, JAMA-J AM MED ASSOC, V286, P462, DOI 10.1001/jama.286.4.462; Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980; Hoilund-Carlsen PF, 2004, CLIN PHYSIOL FUNCT I, V24, P216, DOI 10.1111/j.1475-097X.2004.00551.x; Hornbrook MC, 1996, HEALTH SERV RES, V31, P283; Jo MW, 2008, VALUE HEALTH, V11, P1186, DOI 10.1111/j.1524-4733.2008.00348.x; Kim Semi, 2014, Genomics & Informatics, V12, P12, DOI 10.5808/GI.2014.12.1.12; KLAUSEN K, 1983, EUR J APPL PHYSIOL O, V51, P371, DOI 10.1007/BF00429074; Korea Centers for Disease Control and Prevention, 2012, 5 KOR NAT HLTH NUTR; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; Martinez JAB, 2004, CHEST, V125, P425, DOI 10.1378/chest.125.2.425; Ministry of Health and Welfare of Korea, 2014, 2013 KOR HLTH STAT; Myint PK, 2006, ANN EPIDEMIOL, V16, P492, DOI 10.1016/j.annepidem.2005.04.005; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; Robinson JD, 2006, BEHAV MED, V32, P13, DOI 10.3200/BMED.32.1.13-18; Rowen D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-27; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Weeks SG, 2011, ARCH INTERN MED, V171, P1887, DOI 10.1001/archinternmed.2011.518; Wilson D, 1999, PREV MED, V29, P139, DOI 10.1006/pmed.1999.0523; World Health Organization, 2012, WHO GLOB REP MORT AT; Wu AW, 2002, QUAL LIFE RES, V11, P273, DOI 10.1023/A:1015240103565	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138731	10.1371/journal.pone.0138731	http://dx.doi.org/10.1371/journal.pone.0138731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26394324	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100094
J	Phie, J; Haleagrahara, N; Newton, P; Constantinoiu, C; Sarnyai, Z; Chilton, L; Kinobe, R				Phie, James; Haleagrahara, Nagaraja; Newton, Patricia; Constantinoiu, Constantin; Sarnyai, Zoltan; Chilton, Lisa; Kinobe, Robert			Prolonged Subcutaneous Administration of Oxytocin Accelerates Angiotensin II-Induced Hypertension and Renal Damage in Male Rats	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HUMAN MYOMETRIAL CELLS; CAUSES WEIGHT-LOSS; PROTEIN-KINASE-C; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; RENIN SECRETION; CONSCIOUS RATS; BLOOD-PRESSURE; V1A RECEPTORS	Oxytocin and its receptor are synthesised in the heart and blood vessels but effects of chronic activation of this peripheral oxytocinergic system on cardiovascular function are not known. In acute studies, systemic administration of low dose oxytocin exerted a protective, preconditioning effect in experimental models of myocardial ischemia and infarction. In this study, we investigated the effects of chronic administration of low dose oxytocin following angiotensin II-induced hypertension, cardiac hypertrophy and renal damage. Angiotensin II (40 mu g/Kg/h) only, oxytocin only (20 or 100 ng/Kg/h), or angiotensin II combined with oxytocin (20 or 100 ng/Kg/h) were infused subcutaneously in adult male Sprague-Dawley rats for 28 days. At day 7, oxytocin or angiotensin-II only did not change hemodynamic parameters, but animals that received a combination of oxytocin and angiotensin-II had significantly elevated systolic, diastolic and mean arterial pressure compared to controls (P < 0.01). Hemodynamic changes were accompanied by significant left ventricular cardiac hypertrophy and renal damage at day 28 in animals treated with angiotensin II (P < 0.05) or both oxytocin and angiotensin II, compared to controls (P < 0.01). Prolonged oxytocin administration did not affect plasma concentrations of renin and atrial natriuretic peptide, but was associated with the activation of calcium-dependent protein phosphatase calcineurin, a canonical signalling mechanism in pressure overload-induced cardiovascular disease. These data demonstrate that oxytocin accelerated angiotensin-II induced hypertension and end-organ renal damage, suggesting caution should be exercised in the chronic use of oxytocin in individuals with hypertension.	[Phie, James; Haleagrahara, Nagaraja; Newton, Patricia; Constantinoiu, Constantin; Sarnyai, Zoltan; Chilton, Lisa; Kinobe, Robert] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Sarnyai, Zoltan; Kinobe, Robert] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Biodiscovery & Mol Dev Therapeut, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Kinobe, R (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia.	Robert.kinobe@jcu.edu.au	HALEAGRAHARA, NAGARAJA S/C-2033-2013; Sarnyai, Zoltan/A-3283-2009; Constantinoiu, Constantin/I-3978-2013	HALEAGRAHARA, NAGARAJA S/0000-0001-8702-0490; Constantinoiu, Constantin/0000-0001-5836-776X; Phie, James/0000-0001-6305-0003; Sarnyai, Zoltan/0000-0002-2380-7902	Australian Institute of Tropical Health and Medicine [2140-12005-0130]; James Cook University	Australian Institute of Tropical Health and Medicine; James Cook University	Funding: This work was supported by a research grant (2140-12005-0130 to RK & LC) from the Australian Institute of Tropical Health and Medicine, and James Cook University. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AM, 2010, PEPTIDES, V31, P1341, DOI 10.1016/j.peptides.2010.04.012; Anagnostou E, 2014, BRAIN RES, V1580, P188, DOI 10.1016/j.brainres.2014.01.049; Bakermans-Kranenburg MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.34; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Cassis LA, 1998, AM J PHYSIOL-ENDOC M, V274, pE867, DOI 10.1152/ajpendo.1998.274.5.E867; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Chen LM, 2010, J AM SOC NEPHROL, V21, P986, DOI 10.1681/ASN.2009030307; Cochran DM, 2013, HARVARD REV PSYCHIAT, V21, P219, DOI 10.1097/HRP.0b013e3182a75b7d; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Costa ADT, 2006, J BIOL CHEM, V281, P20801, DOI 10.1074/jbc.M600959200; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Cudnoch-Jedrzejewska A, 2007, REGUL PEPTIDES, V142, P86, DOI 10.1016/j.regpep.2007.01.010; Dam VP, 2012, EUR J PHARMACOL, V685, P165, DOI 10.1016/j.ejphar.2012.04.030; Faghihi M, 2012, PEPTIDES, V37, P314, DOI 10.1016/j.peptides.2012.08.001; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Garg V, 2007, AM J PHYSIOL-HEART C, V293, pH322, DOI 10.1152/ajpheart.01035.2006; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; Gutkowska J, 1997, P NATL ACAD SCI USA, V94, P11704, DOI 10.1073/pnas.94.21.11704; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Huang W, 2001, AM J PHYSIOL-REG I, V280, pR760, DOI 10.1152/ajpregu.2001.280.3.R760; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; INOUE T, 1994, J BIOL CHEM, V269, P32451; Jankowski M, 1998, P NATL ACAD SCI USA, V95, P14558, DOI 10.1073/pnas.95.24.14558; Jankowski M, 2010, BASIC RES CARDIOL, V105, P205, DOI 10.1007/s00395-009-0076-5; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Loichot C, 2001, N-S ARCH PHARMACOL, V363, P369, DOI 10.1007/s002100000372; MARTIN B, 1985, J BIOL CHEM, V260, P4932; Menaouar A, 2014, INT J CARDIOL, V175, P38, DOI 10.1016/j.ijcard.2014.04.174; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Monga M, 1999, AM J OBSTET GYNECOL, V181, P424, DOI 10.1016/S0002-9378(99)70573-9; Moorhead KT, 2011, COMPUT METH PROG BIO, V101, P173, DOI 10.1016/j.cmpb.2010.07.010; Morin V, 2008, J PHARM PHARM SCI, V11, P12; MORRIS M, 1995, J NEUROENDOCRINOL, V7, P455, DOI 10.1111/j.1365-2826.1995.tb00781.x; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Mukaddam-Daher S, 2001, HYPERTENSION, V38, P292, DOI 10.1161/01.HYP.38.2.292; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Petersson M, 1996, PHYSIOL BEHAV, V60, P1311, DOI 10.1016/S0031-9384(96)00261-2; Pinheiro J., 2006, MIXED EFFECTS MODELS; Plante E, 2015, ENDOCRINOLOGY, V156, P1416, DOI 10.1210/en.2014-1718; Pont JNA, 2012, MOL ENDOCRINOL, V26, P1743, DOI 10.1210/me.2012-1057; Rigatto K, 2003, HYPERTENSION, V42, P793, DOI 10.1161/01.HYP.0000090321.81218.7B; Rossger K, 2013, P NATL ACAD SCI USA, V110, P18150, DOI 10.1073/pnas.1312414110; SCHILTZ JC, 1997, AM J PHYSIOL-REG I, V273, pR1474; Squire IB, 2004, CLIN SCI, V107, P309, DOI 10.1042/CS20040087; Thibonnier M, 1999, ENDOCRINOLOGY, V140, P1301, DOI 10.1210/en.140.3.1301; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wsol A, 2014, STRESS, V17, P117, DOI 10.3109/10253890.2013.872620	49	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138048	10.1371/journal.pone.0138048	http://dx.doi.org/10.1371/journal.pone.0138048			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393919	gold, Green Accepted, Green Published			2022-12-26	WOS:000361792100027
J	Tompkins, AM; Caporaso, L; Biondi, R; Bell, JP				Tompkins, Adrian Mark; Caporaso, Luca; Biondi, Riccardo; Bell, Jean Pierre			A Generalized Deforestation and Land-Use Change Scenario Generator for Use in Climate Modelling Studies	PLOS ONE			English	Article							PROTECTED AREAS; COVER-CHANGE; TROPICAL DEFORESTATION; CHANGE TRAJECTORIES; USE TRANSITIONS; FOREST COVER; WOOD-HARVEST; IMPACT; AFRICAN; MODIS	A new deforestation and land-use change scenario generator model (FOREST-SAGE) is presented that is designed to interface directly with dynamic vegetation models used in latest generation earth system models. The model requires a regional-scale scenario for aggregate land-use change that may be time-dependent, provided by observational studies or by regional land-use change/economic models for future projections. These land-use categories of the observations/economic model are first translated into equivalent plant function types used by the particular vegetation model, and then FOREST-SAGE disaggregates the regional-scale scenario to the local grid-scale of the earth system model using a set of risk-rules based on factors such as proximity to transport networks, distance weighted population density, forest fragmentation and presence of protected areas and logging concessions. These rules presently focus on the conversion of forest to agriculture and pasture use, but could be generalized to other land use change conversions. After introducing the model, an evaluation of its performance is shown for the land-cover changes that have occurred in the Central African Basin from 2001-2010 using retrievals from MODerate Resolution Imaging Spectroradiometer Vegetation Continuous Field data. The model is able to broadly reproduce the spatial patterns of forest cover change observed by MODIS, and the use of the local-scale risk factors enables FOREST-SAGE to improve land use change patterns considerably relative to benchmark scenarios used in the latest Coupled Model Intercomparison Project integrations. The uncertainty to the various risk factors is investigated using an ensemble of investigations, and it is shown that the model is sensitive to the population density, forest fragmentation and reforestation factors specified.	[Tompkins, Adrian Mark; Caporaso, Luca; Biondi, Riccardo; Bell, Jean Pierre] Abdus Salam Int Ctr Theoret Phys ICTP, Earth Syst Phys, Trieste, Italy; [Biondi, Riccardo] Graz Univ, Wegener Ctr Climate & Global Change, Graz, Austria; [Bell, Jean Pierre] Univ Douala, Ctr Atom Mol Phys & Quantum Opt, Douala, Cameroon	Abdus Salam International Centre for Theoretical Physics (ICTP); University of Graz	Tompkins, AM (corresponding author), Abdus Salam Int Ctr Theoret Phys ICTP, Earth Syst Phys, Str Costiera 11, Trieste, Italy.	tompkins@ictp.it	Caporaso, Luca/N-4818-2019; Caporaso, Luca/K-1676-2017; Biondi, Riccardo/G-6256-2012; Tompkins, Adrian M/N-6472-2013	Caporaso, Luca/0000-0002-1370-693X; Caporaso, Luca/0000-0002-1370-693X; Biondi, Riccardo/0000-0003-3062-0326; Tompkins, Adrian M/0000-0003-0975-6691	European Union, HEALTHY FUTURES Grant [266327]; ICTP Sandwich Training Educational Programme (STEP)	European Union, HEALTHY FUTURES Grant; ICTP Sandwich Training Educational Programme (STEP)	Funding: This work was partly supported by the European Union FP7 project, HEALTHY FUTURES Grant agreement no. 266327, http://www.healthyfutures.eu/. LC, RB, and JPB were supported by this grant. JPB was also supported by ICTP Sandwich Training Educational Programme (STEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Akkermans T, 2014, J CLIMATE, V27, P2714, DOI 10.1175/JCLI-D-13-00361.1; Akkermans T, 2013, PHYS GEOGR, V34, P417, DOI 10.1080/02723646.2013.855698; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brovkin V, 2013, J CLIMATE, V26, P6859, DOI 10.1175/JCLI-D-12-00623.1; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; CARPE, 2005, FOR CONG BAS PREL AS; Carroll M, 2011, REMOTE SENS DIGIT IM, V11, P725, DOI 10.1007/978-1-4419-6749-7_32; Celine E, 2013, GLOBAL CHANGE BIOL, V19, P1173, DOI 10.1111/gcb.12092; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Cumming GS, 2012, ECOL COMPLEX, V11, P67, DOI 10.1016/j.ecocom.2012.03.002; Ferraz SFD, 2009, FOREST ECOL MANAG, V257, P1586, DOI 10.1016/j.foreco.2009.01.013; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; FAO, 2006, GLOB FOR RES ASS 200, V147; FAO, 2011, STAT WORLDS FOR 2011, P179; FAO ITTO., 2011, STAT FOR AM BAS CONG; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Freitas SR, 2010, FOREST ECOL MANAG, V259, P410, DOI 10.1016/j.foreco.2009.10.036; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Goldewijk KK, 2013, LANDSCAPE ECOL, V28, P861, DOI 10.1007/s10980-013-9877-x; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen JW, 2002, AGR SYST, V74, P309, DOI 10.1016/S0308-521X(02)00043-4; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Hansen MC, 2005, INT J REMOTE SENS, V26, P4359, DOI 10.1080/01431160500113435; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; HECHT SB, 1993, BIOSCIENCE, V43, P687, DOI 10.2307/1312340; Hijmans R.J., 2004, HUM SCI RES, DOI DOI 10.1044/LLE19.1.4; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Justice C, 2001, CLIM RES, V17, P229, DOI 10.3354/cr017229; Kaimowitz D, 1999, EC MODELS TROPICAL D, V14; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; LUDEKE AK, 1990, J ENVIRON MANAGE, V31, P247, DOI 10.1016/S0301-4797(05)80038-6; MARSAGLIA G, 1993, COMPUT MATH APPL, V26, P1, DOI 10.1016/0898-1221(93)90001-C; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; Mayaux P, 2000, REMOTE SENS ENVIRON, V71, P183, DOI 10.1016/S0034-4257(99)00073-5; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Mertens B, 1997, APPL GEOGR, V17, P143, DOI 10.1016/S0143-6228(97)00032-5; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Nogherotto R, 2013, ATMOS SCI LETT, V14, P45, DOI 10.1002/asl2.416; Oleson KW, 2000, J HYDROMETEOROL, V1, P431, DOI 10.1175/1525-7541(2000)001<0431:TEORSP>2.0.CO;2; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; POLCHER J, 1994, J HYDROL, V155, P389, DOI 10.1016/0022-1694(94)90179-1; Ramirez-Gomez SO, 2011, SPATIAL DRIVERS DEFO; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rogers J, 2011, THESIS COLUMBIA U, P139; Roy DP, 2006, IEEE GEOSCI REMOTE S, V3, P452, DOI 10.1109/LGRS.2006.875433; Semazzi FHM, 2001, CLIMATE RES, V17, P169, DOI 10.3354/cr017169; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Strengers B., 2004, GeoJournal, V61, P381, DOI 10.1007/s10708-004-5054-8; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Teixeira AMG, 2009, FOREST ECOL MANAG, V257, P1219, DOI 10.1016/j.foreco.2008.10.011; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Townshend JRG, 2011, COLLECTION, V5; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wertz-Kanounnikoff S, 2005, MEASURING THE INITIA, V3762; Zhang QF, 2005, ENVIRON MONIT ASSESS, V101, P69	84	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0136154	10.1371/journal.pone.0136154	http://dx.doi.org/10.1371/journal.pone.0136154			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394392	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100005
J	Aledavood, T; Lopez, E; Roberts, SGB; Reed-Tsochas, F; Moro, E; Dunbar, RIM; Saramaki, J				Aledavood, Talayeh; Lopez, Eduardo; Roberts, Sam G. B.; Reed-Tsochas, Felix; Moro, Esteban; Dunbar, Robin I. M.; Saramaki, Jari			Daily Rhythms in Mobile Telephone Communication	PLOS ONE			English	Article							GENDER; TALK	Circadian rhythms are known to be important drivers of human activity and the recent availability of electronic records of human behaviour has provided fine-grained data of temporal patterns of activity on a large scale. Further, questionnaire studies have identified important individual differences in circadian rhythms, with people broadly categorised into morning-like or evening-like individuals. However, little is known about the social aspects of these circadian rhythms, or how they vary across individuals. In this study we use a unique 18-month dataset that combines mobile phone calls and questionnaire data to examine individual differences in the daily rhythms of mobile phone activity. We demonstrate clear individual differences in daily patterns of phone calls, and show that these individual differences are persistent despite a high degree of turnover in the individuals' social networks. Further, women's calls were longer than men's calls, especially during the evening and at night, and these calls were typically focused on a small number of emotionally intense relationships. These results demonstrate that individual differences in circadian rhythms are not just related to broad patterns of morningness and eveningness, but have a strong social component, in directing phone calls to specific individuals at specific times of day.	[Aledavood, Talayeh; Saramaki, Jari] Aalto Univ, Sch Sci, Dept Comp Sci, Espoo, Finland; [Lopez, Eduardo; Reed-Tsochas, Felix] Univ Oxford, Said Business Sch, CABDyN Complex Ctr, Oxford, England; [Roberts, Sam G. B.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Reed-Tsochas, Felix] Univ Oxford, Dept Sociol, Oxford, England; [Moro, Esteban] Univ Carlos III Madrid, Dept Matemat, Leganos, Spain; [Moro, Esteban] Univ Carlos III Madrid, GISC, Leganos, Spain; [Dunbar, Robin I. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Aalto University; University of Oxford; University of Chester; University of Oxford; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; University of Oxford	Aledavood, T (corresponding author), Aalto Univ, Sch Sci, Dept Comp Sci, Espoo, Finland.	talayeh.aledavood@aalto.fi	Moro, Esteban/AAB-1159-2019; Saramaki, Jari P/E-5226-2011	Moro, Esteban/0000-0003-2894-1024; Lopez, Eduardo/0000-0003-3940-2608; Roberts, Sam/0000-0003-3986-0254	Academy of Finland [260427]; UK Engineering and Physical Sciences Research Council; Economic and Social Research Council [EP/D052114/2]; European Research Council [295663]; UK 381 EPSRC; ESRC; EPSRC [EP/E056997/1, EP/D052114/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E056997/1, EP/D052114/2] Funding Source: researchfish	Academy of Finland(Academy of Finland); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); UK 381 EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TA and JS were funded by The Academy of Finland, project No. 260427 (http://www.aka.fi) and the computational resources were provided by Aalto 379 Science-IT project. The study was funded by a grant from the UK Engineering and Physical Sciences Research Council and Economic and Social Research Council (grant No. EP/D052114/2). RD is funded by European Research Council (grant no. 295663). The 380 collection of the data by SGBR and RD was made possible by a grant from the UK 381 EPSRC and ESRC research councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund VP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062815; Cummings J, 2006, COMMUNICATION TECHNO; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DeBaillon L., 2005, International Journal of Mobile Communications, V3, P82, DOI 10.1504/IJMC.2005.005876; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Jo HH, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds10; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Keren H, 2010, BEHAV BRAIN RES, V212, P90, DOI 10.1016/j.bbr.2010.03.051; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Kouchaki M, 2014, PSYCHOL SCI, V25, P95, DOI 10.1177/0956797613498099; Kovanen L, 2013, P NATL ACAD SCI USA, V110, P18070, DOI 10.1073/pnas.1307941110; Ling R., 1998, SHE CALLS IT IS BOTH; Ling R., 2004, MOBILE CONNECTION CE; Llorente A, 2014, ARXIV14113140PHYSICS; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Mehl MR, 2007, SCIENCE, V317, P82, DOI 10.1126/science.1139940; Miritello G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.045102; Onnela JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06278; Oswald DL, 2003, PERS RELATIONSHIP, V10, P187, DOI 10.1111/1475-6811.00045; Palchykov V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00370; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Peruani F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028860; Preti A, 2001, J AFFECT DISORDERS, V65, P253, DOI 10.1016/S0165-0327(00)00232-9; Rakow L., 1992, GENDER LINE WOMEN TE; Refinetti R., 2005, J CIRCADIAN RHYTHMS, V3; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; SARCH A, 1993, J COMMUN, V43, P128, DOI 10.1111/j.1460-2466.1993.tb01266.x; Smoreda Z, 2000, SOC PSYCHOL QUART, V63, P238, DOI 10.2307/2695871; Stoica A, 2010, GENDER AND COMMUNICA; ten Thij M., 2014, DATA ANAL, P12; Tsaousis I, 2010, EUR J PERSONALITY, V24, P356, DOI 10.1002/per.754; Wiessner PW, 2014, P NATL ACAD SCI USA, V111, P14027, DOI 10.1073/pnas.1404212111; Yasseri T., 2013, P 9 INT S OP COLL, P13, DOI DOI 10.1145/2491055.2491068; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]; Yuxiao Dong, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference (ECML PKDD 2013). Proceedings: LNCS 8189, P16, DOI 10.1007/978-3-642-40991-2_2; Zainudeen A, 2010, NEW MEDIA SOC, V12, P549, DOI 10.1177/1461444809346721; Zhao R, 2014, ANN NONINVASIVE ELEC	39	65	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138098	10.1371/journal.pone.0138098	http://dx.doi.org/10.1371/journal.pone.0138098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZM	26390215	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361791000017
J	Jonas, RA; Wang, YX; Yang, H; Li, JJ; Xu, L; Panda-Jonas, S; Jonas, JB				Jonas, Rahul Arvo; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Panda-Jonas, Songhomitra; Jonas, Jost Bruno			Optic Disc - Fovea Distance, Axial Length and Parapapillary Zones. The Beijing Eye Study 2011	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL THICKNESS; MACULA DISTANCE; DIAMETER RATIO; RETINAL FEATURES; SIZE; ATROPHY; FUNDUS; DEGENERATION; GLAUCOMA; CHINA	Purpose To measure the distance between the optic disc center and the fovea (DFD) and to assess its associations. Methods The population-based cross-sectional Beijing Eye Study 2011 included 3468 individuals aged 50+ years. The DFD was measured on fundus photographs. Results Readable fundus photographs were available for 2836 (81.8%) individuals. Mean DFD was 4.76 +/- 0.34mm (median: 4.74 mm; range: 3.76-6.53mm). In multivariate analysis, longer DFD was associated with longer axial length (P<0.001; standardized correlation coefficient beta: 0.62), higher prevalence of axially high myopia (P<0.001; beta: 0.06), shallower anterior chamber depth (P<0.001; beta:-0.18), thinner lens thickness (P = 0.004; beta: -0.06), smaller optic disc-fovea angle (P = 0.02; beta: -0.04), larger parapapillary alpha zone (P = 0.008; beta: 0.05), larger parapapillary beta/gamma zone (P<0.001; beta: 0.11), larger optic disc area (P<0.001; beta: 0.08), lower degree of cortical cataract (P = 0.002; beta: -0.08), and lower prevalence of age-related macular degeneration (P = 0.001; beta: -0.06). Bruch's membrane opening-fovea distance (DFD minus disc radius minus parapapillary beta/gamma zone width) in non-glaucomatous eyes was not significantly (P = 0.60) related with axial length in emmetropic or axially myopic eyes (axial length >= 23.5 mm), while it increased significantly (P<0.001; r: 0.32) with longer axial length in eyes with an axial length of <23.5mm. Ratio of mean DFD to disc diameter was 2.65 +/- 0.30. If the ratio of disc-fovea distance to disc diameter was considered constant and if the individual disc diameter was calculated as the individual disc-fovea distance divided by the constant factor of 2.65, the resulting calculated disc diameter differed from the directly measured disc diameter by 0.16 +/- 0.13 mm (median: 0.13 mm, range: 0.00-0.89 mm) or 8.9 +/- 7.3% (median: 7.4%; range: 0.00-70%) of the measured disc diameter. Conclusions DFD (mean: 4.76mm) increases with longer axial length, larger parapapillary alpha zone and parapapillary beta/gamma zone, and larger disc area. The axial elongation associated increase in DFD was due to an enlargement of parapapillary beta/gamma zone while the Bruch's membrane opening-fovea distance did not enlarge with longer axial length. This finding may be of interest for the process of emmetropization and myopization. Due to its variability, the disc-fovea distance has only limited clinical value as a relative size unit for structures at the posterior pole.	[Jonas, Rahul Arvo; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Jonas, Jost Bruno] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China; [Jonas, Rahul Arvo; Panda-Jonas, Songhomitra; Jonas, Jost Bruno] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China.	yaxingw@gmail.com	Jonas, Rahul A/N-9304-2017; wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793; Jonas, Rahul/0000-0002-5389-3047	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]; Consultant for Allergan Inc.; Merck Sharp & Dohme Co., Inc.; Alimera Co.; Boehringer Ingelheim Co.; Sanofi Co.	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government; Consultant for Allergan Inc.(AbbVieAllergan); Merck Sharp & Dohme Co., Inc.; Alimera Co.; Boehringer Ingelheim Co.(Boehringer Ingelheim); Sanofi Co.	This work was supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). Jost B. Jonas has the following financial disclosures: Consultant for Allergan Inc.; Merck Sharp & Dohme Co., Inc.; Alimera Co.; Boehringer Ingelheim Co., Sanofi Co. Patent holder with CellMed AG, Alzenau, Germany.	Alvarez E, 1988, J Pediatr Ophthalmol Strabismus, V25, P151; Barr DB, 1999, OPHTHAL PHYSL OPT, V19, P365, DOI 10.1046/j.1475-1313.1999.00463.x; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; De Silva DJ, 2006, INVEST OPHTH VIS SCI, V47, P4683, DOI 10.1167/iovs.06-0152; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137, DOI 10.1016/0002-9394(89)90212-2; Jonas JB, 2006, AM J OPHTHALMOL, V142, P168, DOI 10.1016/j.ajo.2006.01.068; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Knaapi L, 2015, ACTA OPHTHALMOL, V93, P339, DOI 10.1111/aos.12554; Lee M, 2014, GRAEF ARCH CLIN EXP, V252, P307, DOI 10.1007/s00417-013-2513-2; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Mok KH, 2002, J GLAUCOMA, V11, P392, DOI 10.1097/00061198-200210000-00004; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Panda-Jonas S, 2014, ACTA OPHTHALMOL, V92, P59, DOI 10.1111/j.1755-3768.2012.02570.x; PAPASTATHOPOULOS KI, 1995, EXP EYE RES, V60, P459, DOI 10.1016/S0014-4835(05)80102-2; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; Shao L, 2015, INVEST OPHTH VIS SCI, V56, P810, DOI 10.1167/iovs.14-15736; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; WAKAKURA M, 1987, ACTA OPHTHALMOL, V65, P612; Wang YX, 2015, OPHTHALMOLOGY, V122, P2022, DOI 10.1016/j.ophtha.2015.06.005; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111320; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071	33	75	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138701	10.1371/journal.pone.0138701	http://dx.doi.org/10.1371/journal.pone.0138701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390438	Green Submitted, gold, Green Published			2022-12-26	WOS:000361791000052
J	Ferron, AJT; Jacobsen, BB; Ana, PG; de Campos, DHS; de Tomasi, LC; Luvizotto, RDM; Cicogna, AC; Leopoldo, AS; Lima-Leopoldo, AP				Togneri Ferron, Artur Junio; Jacobsen, Bruno Barcellos; St Ana, Paula Grippa; Salome de Campos, Dijon Henrique; de Tomasi, Loreta Casquel; Mello Luvizotto, Renata de Azevedo; Cicogna, Antonio Carlos; Leopoldo, Andre Soares; Lima-Leopoldo, Ana Paula			Cardiac Dysfunction Induced by Obesity Is Not Related to beta-Adrenergic System Impairment at the Receptor-Signalling Pathway	PLOS ONE			English	Article							HIGH-FAT-DIET; LEFT-VENTRICULAR MASS; PHOSPHOLAMBAN PHOSPHORYLATION; CONTRACTILE RESPONSE; SYSTOLIC FUNCTION; CYCLASE ACTIVITY; UP-REGULATION; RAT MODEL; ADRENOCEPTOR; HYPERTROPHY	Obesity has been shown to impair myocardial performance. Some factors have been suggested as responsible for possible cardiac abnormalities in models of obesity, among them beta-adrenergic (beta A) system, an important mechanism of regulation of myocardial contraction and relaxation. The objective of present study was to evaluate the involvement of beta A system components in myocardial dysfunction induced by obesity. Thirty-day-old male Wistar rats were distributed in control (C, n = 25) and obese (Ob, n = 25) groups. The C group was fed a standard diet and Ob group was fed four unsaturated high-fat diets for 15 weeks. Cardiac function was evaluated by isolated papillary muscle preparation and beta A system evaluated by using cumulative concentrations of isoproterenol and Western blot. After 15 weeks, the Ob rats developed higher adiposity index than C rats and several comorbidities; however, were not associated with changes in systolic blood pressure. Obesity caused structural changes and the myocardial responsiveness to post-rest contraction stimulus and increased extracellular calcium (Ca2+) was compromised. There were no changes in cardiac function between groups after beta A stimulation. The obesity was not accompanied by changes in protein expression of G protein subunit alpha (Gs alpha) and beta A receptors (beta(1)AR and beta(2)AR). In conclusion, the myocardial dysfunction caused by unsaturated high-fat diet-induced obesity, after 15 weeks, is not related to beta AR system impairment at the receptor-signalling pathway.	[Togneri Ferron, Artur Junio; Jacobsen, Bruno Barcellos; Leopoldo, Andre Soares; Lima-Leopoldo, Ana Paula] Univ Fed Espirito Santo, Dept Sports, Ctr Phys Educ & Sports, Vitoria, ES, Brazil; [St Ana, Paula Grippa; Salome de Campos, Dijon Henrique; de Tomasi, Loreta Casquel; Cicogna, Antonio Carlos] Univ Estadual Paulista, UNESP, Dept Clin & Cardiol, Sch Med, Botucatu, SP, Brazil; [Mello Luvizotto, Renata de Azevedo] Univ Fed Mato Grosso, Inst Ciencias Saude, Sinop, Mato Grosso, Brazil	Universidade Federal do Espirito Santo; Universidade Estadual Paulista; Universidade Federal de Mato Grosso	Lima-Leopoldo, AP (corresponding author), Univ Fed Espirito Santo, Dept Sports, Ctr Phys Educ & Sports, Vitoria, ES, Brazil.	ana.leopoldo@ufes.br	LIMA-LEOPOLDO, ANA PAULA/R-5196-2019; Ferron, Artur Junio/AAJ-9256-2020; Leopoldo, André/R-5214-2019; Leopoldo, Andre Soares/X-1072-2019; Leopoldo, Andre/AAF-6071-2019; Ferron, Artur Junio/M-5194-2017; Leopoldo, André Soares/F-9924-2012; Lima-Leopoldo, Ana Paula APLL/H-1086-2014	LIMA-LEOPOLDO, ANA PAULA/0000-0002-4049-4418; Ferron, Artur Junio/0000-0001-7089-3033; Leopoldo, Andre Soares/0000-0002-3131-2467; Leopoldo, Andre/0000-0001-5999-2671; Ferron, Artur Junio/0000-0001-7089-3033; Cicogna, Antonio Carlos/0000-0002-4402-6523	Fapes [53618009/2011]; Fapesp [2012/16647-0]	Fapes(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fapes process no 53618009/2011 and Fapesp process 2012/16647-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Ablorh NA, 2012, ANAL BIOCHEM, V425, P68, DOI 10.1016/j.ab.2012.01.028; Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; ALPERT MA, 1995, AM J CARDIOL, V76, P1194, DOI 10.1016/S0002-9149(99)80338-5; Barros R de A, 1999, Arq Bras Cardiol, V72, P641, DOI 10.1590/S0066-782X1999000500012; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bogeholz N, 2012, WIEN MED WOCHENSCHR, V162, P278, DOI 10.1007/s10354-012-0102-3; Boustany-Kari CM, 2007, INT J OBESITY, V31, P1652, DOI 10.1038/sj.ijo.0803426; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Brasil. Instituto Brasileiro de Geografia e Estatistica-IBGE, 2006, PESQ ORC FAM 2002 20; BRODDE OE, 1993, PHARMACOL THERAPEUT, V60, P405, DOI 10.1016/0163-7258(93)90030-H; Brum PC, 2006, AN ACAD BRAS CIENC, V78, P485, DOI 10.1590/S0001-37652006000300009; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cabrol P, 1998, ARCH MAL COEUR VAISS, V91, P1021; Carroll JF, 1996, AM J PHYSIOL-HEART C, V271, pH373, DOI 10.1152/ajpheart.1996.271.1.H373; Carroll JF, 2002, INT J OBESITY, V26, P627, DOI 10.1038/sj.ijo.0801957; Carroll JF, 1999, INT J OBESITY, V23, P863, DOI 10.1038/sj.ijo.0800964; Carroll JF, 1997, HYPERTENSION, V30, P1376, DOI 10.1161/01.HYP.30.6.1376; Carroll JF, 2006, HYPERTENSION, V48, P65, DOI 10.1161/01.HYP.0000224147.01024.77; David JS, 2002, ANESTHESIOLOGY, V96, P521; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Dincer UD, 2011, INT J GEN MED, V4, P493, DOI 10.2147/IJGM.S18175; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Evora P R, 1999, Arq Bras Cardiol, V72, P209, DOI 10.1590/S0066-782X1999000200009; Fioresi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096900; Fischer V, 2008, ANN NY ACAD SCI, V1148, P400, DOI 10.1196/annals.1410.013; Fitzgerald SM, 2001, AM J PHYSIOL-REG I, V281, pR547, DOI 10.1152/ajpregu.2001.281.2.R547; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Hanouz JL, 1997, ANESTHESIOLOGY, V86, P147, DOI 10.1097/00000542-199701000-00019; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Illiano G, 2002, AM J HYPERTENS, V15, P638, DOI 10.1016/S0895-7061(02)02925-4; Korner J, 2003, J CLIN INVEST, V111, P565, DOI [10.1172/JCI200317953, 10.1172/JCI17953]; Lamba S, 2000, Heart Fail Rev, V5, P7; Lee S, 2010, PHYSIOL RES, V59, P679, DOI 10.33549/physiolres.931851; Leifheit-Nestler M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-170; Leopoldo AS, 2011, J CELL PHYSIOL, V226, P2934, DOI 10.1002/jcp.22643; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Levin BE, 2000, AM J PHYSIOL-REG I, V279, pR1357, DOI 10.1152/ajpregu.2000.279.4.R1357; Lima-Leopoldo AP, 2014, J APPL PHYSIOL, V117, P669, DOI 10.1152/japplphysiol.00088.2014; Lima-Leopoldo AP, 2013, ARQ BRAS CARDIOL, V100, P229, DOI 10.5935/abc.20130045; Lima-Leopoldo AP, 2011, ARQ BRAS CARDIOL, V97, P232, DOI 10.1590/S0066-782X2011005000061; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; Lymperopoulos A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00240; Lymperopoulos A, 2012, PHARMACOGENOMICS, V13, P323, DOI [10.2217/PGS.11.178, 10.2217/pgs.11.178]; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Minhas MK, 2005, J PHYSL, V565, P463; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Nascimento Thiago Bruder, 2011, Arq. Bras. Cardiol., V97, P40; Opie LH, 1998, HEART PHYSL CELL CIR, V3rd, P209; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; Paulino EC, 2010, HYPERTENSION, V56, P629, DOI 10.1161/HYPERTENSIONAHA.110.156141; Pinotti MF, 2007, ARQ BRAS CARDIOL, V88, P346, DOI 10.1590/S0066-782X2007000300015; Pitombo C, 2006, J ENDOCRINOL, V191, P699, DOI 10.1677/joe.1.07069; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ponsard B, 1998, J AM OIL CHEM SOC, V75, P247, DOI 10.1007/s11746-998-0038-3; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Ren J, 2000, J BIOMED SCI, V7, P390, DOI 10.1007/BF02255814; Ren J, 2008, OBESITY, V16, P2417, DOI 10.1038/oby.2008.381; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; RIOU B, 1989, ANESTHESIOLOGY, V71, P116, DOI 10.1097/00000542-198907000-00020; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Santos Priscila Portugal Dos, 2014, PLoS One, V9, pe98895, DOI 10.1371/journal.pone.0098895; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Sayadi M, 2013, BBA-BIOMEMBRANES, V1828, P577, DOI 10.1016/j.bbamem.2012.08.017; SCAGLIONE R, 1992, EUR HEART J, V13, P738, DOI 10.1093/oxfordjournals.eurheartj.a060249; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; SULAKHE PV, 1995, MOL CELL BIOCHEM, V149, P103, DOI 10.1007/BF01076569; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; Wensley I, 2013, EXP PHYSIOL, V98, P1552, DOI 10.1113/expphysiol.2013.074948; White PAS, 2013, ARQ BRAS ENDOCRINOL, V57, P339, DOI 10.1590/S0004-27302013000500002; Zeidan A, 2008, CARDIOVASC RES, V77, P64, DOI 10.1093/cvr/cvm020; Zeidan A, 2011, MOL CELL BIOCHEM, V352, P99, DOI 10.1007/s11010-011-0744-2; ZHAO XL, 1994, BIOCHEM BIOPH RES CO, V198, P166, DOI 10.1006/bbrc.1994.1024	82	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138605	10.1371/journal.pone.0138605	http://dx.doi.org/10.1371/journal.pone.0138605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390297	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000042
J	Jacovas, VC; Rovaris, DL; Perez, O; de Azevedo, S; Macedo, GS; Sandoval, JR; Salazar-Granara, A; Villena, M; Dugoujon, JM; Bisso-Machado, R; Petzl-Erler, ML; Salzano, FM; Ashton-Prolla, P; Ramallo, V; Bortolini, MC				Jacovas, Vanessa Cristina; Rovaris, Diego Luiz; Perez, Orlando; de Azevedo, Soledad; Macedo, Gabriel Souza; Raul Sandoval, Jose; Salazar-Granara, Alberto; Villena, Mercedes; Dugoujon, Jean-Michel; Bisso-Machado, Rafael; Petzl-Erler, Maria Luiza; Salzano, Francisco Mauro; Ashton-Prolla, Patricia; Ramallo, Virginia; Bortolini, Maria Catira			Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TUMOR-SUPPRESSOR PATHWAY; P53 PATHWAY; P53-BINDING PROTEIN; NATURAL-SELECTION; BREAST-CANCER; MDM2; NETWORK; HUMANS; MAP	The diversity of the five single nucleotide polymorphisms located in genes of the TP53 pathway (TP53, rs1042522; MDM2, rs2279744; MDM4, rs1563828; USP7, rs1529916; and LIF, rs929271) were studied in a total of 282 individuals belonging to Quechua, Aymara, Chivay, Cabanaconde, Yanke, Taquile, Amantani, Anapia, Uros, Guarani Nandeva, and Guarani Kaiowa populations, characterized as Native American or as having a high level (> 90%) of Native American ancestry. In addition, published data pertaining to 100 persons from five other Native American populations (Surui, Karitiana, Maya, Pima, and Piapoco) were analyzed. The populations were classified as living in high altitude (>= 2,500 m) or in lowlands (< 2,500 m). Our analyses revealed that alleles USP7-G, LIF-T, and MDM2-T showed significant evidence that they were selected for in relation to harsh environmental variables related to high altitudes. Our results show for the first time that alleles of classical TP53 network genes have been evolutionary co-opted for the successful human colonization of the Andes.	[Jacovas, Vanessa Cristina; Rovaris, Diego Luiz; Macedo, Gabriel Souza; Bisso-Machado, Rafael; Salzano, Francisco Mauro; Ashton-Prolla, Patricia; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Perez, Orlando; de Azevedo, Soledad; Ramallo, Virginia] Consejo Nacl Invest Cient & Tecn, Puerto Madryn, Argentina; [Raul Sandoval, Jose; Salazar-Granara, Alberto] Univ San Martin Porres, Fac Med Humana, Lima, Peru; [Villena, Mercedes] Univ Mayor San Andres, Inst Boliviano Biol Altura, La Paz, Bolivia; [Dugoujon, Jean-Michel] Univ Toulouse 3, CNRS UMR 5288, Anthropol Mol & Imagerie Synth, F-31000 Toulouse, France; [Petzl-Erler, Maria Luiza] Univ Fed Parana, Dept Genet, Genet Mol Lab, BR-80060000 Curitiba, Parana, Brazil; [Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de San Martin de Porres; Universidad Mayor de San Andres; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidade Federal do Parana	Bortolini, MC (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Bisso-Machado, Rafael/F-4184-2011; Rovaris, Diego/I-1133-2013; Petzl-Erler, Maria Luiza/H-8221-2012; Ashton-Prolla, Patricia/T-3515-2019; Ashton-Prolla, Patricia/H-2927-2012; Macedo, Gabriel/T-3567-2019	Bisso-Machado, Rafael/0000-0003-1384-8054; Rovaris, Diego/0000-0002-8910-4927; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Macedo, Gabriel/0000-0002-8963-9577; Salazar-Granara, Alberto/0000-0003-1996-3176; Sandoval, Jose/0000-0003-2673-4937	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (Brazil)	This work was supported the by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (Brazil).	Alarcon R, 1999, CANCER RES, V59, P6046; Alazzouzi H, 2007, J MED GENET, V44, P75, DOI 10.1136/jmg.2006.042572; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bortolini MC, 2014, P NATL ACAD SCI USA, V111, pE213, DOI 10.1073/pnas.1321197111; Botcheva K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00447; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen Jiandong, 2012, Genes Cancer, V3, P274, DOI 10.1177/1947601912454733; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Eischen CM, 2014, HUM MUTAT, V35, P728, DOI 10.1002/humu.22524; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Fraga LR, 2014, MOL BIOL REP, V41, P1871, DOI 10.1007/s11033-014-3036-6; Gaya-Vidal M, 2010, AM J HUM BIOL, V22, P154, DOI 10.1002/ajhb.20967; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; Hunemeier T, 2012, P NATL ACAD SCI USA, V109, P73, DOI 10.1073/pnas.1118967109; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu JB, 2013, BREAST CANCER RES TR, V140, P151, DOI 10.1007/s10549-013-2615-x; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marrero AR, 2007, AM J PHYS ANTHROPOL, V132, P301, DOI 10.1002/ajpa.20515; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Millikan RC, 2006, CANCER EPIDEM BIOMAR, V15, P175, DOI 10.1158/1055-9965.EPI-05-0692; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Monge Carlos, 1948, ACCLIMATIZATION ANDE; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Paskulin DD, 2012, GENET MOL BIOL, V35, P939, DOI 10.1590/S1415-47572012000600008; Pei DS, 2012, ONCOTARGET, V3, P228; Rademaker K, 2014, SCIENCE, V346, P466, DOI 10.1126/science.1258260; Sandoval JR, 2013, J HUM GENET, V58, P627, DOI 10.1038/jhg.2013.73; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shan J, 2008, Ernst Schering Found Symp Proc, P127; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; Song Chuan-gui, 2012, Zhonghua Wai Ke Za Zhi, V50, P53; Soussi T, 2014, HUM MUTAT, V35, P641, DOI 10.1002/humu.22562; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Sun T, 2010, CLIN CANCER RES, V16, P5244, DOI 10.1158/1078-0432.CCR-10-1261; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Vitzthum VJ, 2013, AM J HUM BIOL, V25, P179, DOI 10.1002/ajhb.22357; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Weir BS, 1996, AM J HUM GENET, V59, P497; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xiong SB, 2013, CHIN J CANCER, V32, P371, DOI 10.5732/cjc.012.10286	63	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137823	10.1371/journal.pone.0137823	http://dx.doi.org/10.1371/journal.pone.0137823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382048	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200038
J	Gebre, M; Gebremariam, A; Abebe, TA				Gebre, Merihun; Gebremariam, Abebe; Abebe, Tsedach Alemu			Birth Preparedness and Complication Readiness among Pregnant Women in Duguna Fango District, Wolayta Zone, Ethiopia	PLOS ONE			English	Article								Background Birth Preparedness and Complication Readiness is a strategy to promote the timely use of skilled maternal and neonatal care, especially during childbirth, based on the theory that preparing for childbirth and being ready for complications reduces delays in obtaining this care. Objective This study was conducted to assess birth preparedness and complication readiness and its associated factors among pregnant woman in Duguna Fango District in Wolayta Zone, South Ethiopia. Methods A community based cross-sectional study was conducted in 2013, on a sample of 578 pregnant women. Data were collected using pre-tested and structured questionnaire. The collected data were analyzed by SPSS for windows version 16.0. The women were asked whether they followed the desired five steps while pregnant: identified a trained birth attendant, identified a health facility, arranged for transport, identified blood donor and saved money for emergency. Taking at least three steps was considered being well-prepared. Results Among 578 pregnant women only one tenth (10.7%) of pregnant women identified skilled provider. Only 103 (18.1%) arranged transportation to health facility. Two hundred forty eight (43.6%) identified health facility for delivery and/or for obstetric emergencies. more than half (54.1%) of families saved money for incurred costs of delivery and emergency if needed. only few 17(3%) identified potential blood donor in case of emergency. Two hundred sixty four (46.4%) of the respondents reported that they intended to deliver at home, and more than half (53.6) planned to deliver at health facilities. Overall less than one fifth 18.3% of pregnant women were well prepared. The adjusted multivariate model showed that significant predictors for being well-prepared were maternal availing of antenatal services (AOR = 2.95, 95% Cl: 1.62-5.37), being pregnant for the first time (AOR = 3.37, 95% Cl: 1.45-7.82), having knowledge of at least two danger signs during pregnancy (AOR = 2.81, 95% Cl: 1.69-4.67) and history of past obstetric complication (AOR = 2.98, 95% Cl: 1.35-6.58). Conclusion Birth preparedness practice in the study area was found to be low. Information, Education and Communication (IEC) on birth preparedness and complication readiness for young people should start early adolescence. The government officials and partners that are working in areas of maternal health should come up with strategies to improve birth preparedness at individual and community level.	[Gebre, Merihun] Duguna Fango Dist Hlth Off, Wolayta, Ethiopia; [Gebremariam, Abebe; Abebe, Tsedach Alemu] Jimma Univ, Coll Publ Hlth & Med Sci, Jimma, Ethiopia	Jimma University	Abebe, TA (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	tsedachalemu@yahoo.com			Jimma University, College of Public Health and Medical Sciences	Jimma University, College of Public Health and Medical Sciences	The authors would like to thank Jimma University, College of Public Health and Medical Sciences, for financial support in undertaking this research.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; [Anonymous], 2013, DUGUNA FANGO D UNPUB; [Anonymous], 2013, WOLAYTA ZONAL UNPUB; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hiluf M, 2007, ETHIOP J HEALTH DEV, V22, P14; Johns Hopkins Bloomberg School of Public Health Center for Communication Programs Family Care International Maternal and Neonatal Health, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Measure communication, 2000, MAK PREGN CHILDB SAF; Mutiso S M, 2008, East Afr Med J, V85, P275; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The White Ribbon Alliance for Safe Motherhood/India, 2002, WHIT RIBB ALL SAF MO; USAID SCA MOH UKaid UNFPA UNICEF EHNRI CDC., 2012, 5TH DEM HLTH SURV 20; Wang W, 2011, LEVELS TRENDS USE MA; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	16	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137570	10.1371/journal.pone.0137570	http://dx.doi.org/10.1371/journal.pone.0137570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379231	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400018
J	Hassan, M; Shamas, M; Khalil, M; El Falou, W; Wendling, F				Hassan, Mahmoud; Shamas, Mohamad; Khalil, Mohamad; El Falou, Wassim; Wendling, Fabrice			EEGNET: An Open Source Tool for Analyzing and Visualizing M/EEG Connectome	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RICH-CLUB ORGANIZATION; SCALE BRAIN NETWORKS; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; MATLAB TOOLBOX; MEG; DYNAMICS; SYNCHRONIZATION	The brain is a large-scale complex network often referred to as the "connectome". Exploring the dynamic behavior of the connectome is a challenging issue as both excellent time and space resolution is required. In this context Magneto/Electroencephalography (M/EEG) are effective neuroimaging techniques allowing for analysis of the dynamics of functional brain networks at scalp level and/or at reconstructed sources. However, a tool that can cover all the processing steps of identifying brain networks from M/EEG data is still missing. In this paper, we report a novel software package, called EEGNET, running under MATLAB (Math works, inc), and allowing for analysis and visualization of functional brain networks from M/EEG recordings. EEGNET is developed to analyze networks either at the level of scalp electrodes or at the level of reconstructed cortical sources. It includes i) Basic steps in preprocessing M/EEG signals, ii) the solution of the inverse problem to localize /reconstruct the cortical sources, iii) the computation of functional connectivity among signals collected at surface electrodes or/and time courses of reconstructed sources and iv) the computation of the network measures based on graph theory analysis. EEGNET is the unique tool that combines the M/EEG functional connectivity analysis and the computation of network measures derived from the graph theory. The first version of EEGNET is easy to use, flexible and user friendly. EEGNET is an open source tool and can be freely downloaded from this webpage: https://sites.google.com/site/eegnetworks/.	[Hassan, Mahmoud; Shamas, Mohamad; Wendling, Fabrice] INSERM, U1099, Rennes, France; [Hassan, Mahmoud; Shamas, Mohamad; Wendling, Fabrice] Univ Rennes 1, LTSI, F-35014 Rennes, France; [Shamas, Mohamad; Khalil, Mohamad; El Falou, Wassim] Lebanese Univ, AZM Ctr Biotechnol Res & Its Applicat, Tripoli, Libya	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Hassan, M (corresponding author), INSERM, U1099, Rennes, France.	mahmoud.hassan@univ-rennes1.fr	Wendling, Fabrice/F-8924-2013; WENDLING, Fabrice/P-9574-2019; Hassan, Mahmoud/AAF-4519-2019	WENDLING, Fabrice/0000-0003-2428-9665; Hassan, Mahmoud/0000-0003-0307-5086; Kahlil, Mohamad/0000-0002-9814-1949; Shamas, Mohamad/0000-0001-7564-0932	AZM and SAADE Association (Tripoli, Lebanon); Rennes University Hospital;  [ANR-10-LABX-07-01]	AZM and SAADE Association (Tripoli, Lebanon); Rennes University Hospital; 	This work was supported by AZM and SAADE Association (Tripoli, Lebanon) and the Rennes University Hospital (COREC Project named conneXion, 2012-14). The work has also received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future" program under reference ANR-10-LABX-07-01.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Amblard U, 2004, IEEE T BIO-MED ENG, V51, P427, DOI 10.1109/TBME.2003.820999; BARLOW JS, 1954, ELECTROEN CLIN NEURO, V6, P321, DOI 10.1016/0013-4694(54)90036-X; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Becker H, 2014, NEUROIMAGE, V96, P143, DOI 10.1016/j.neuroimage.2014.03.043; BRAZIER MAB, 1952, ELECTROEN CLIN NEURO, V4, P201, DOI 10.1016/0013-4694(52)90010-2; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caparos M, 2006, CLIN NEUROPHYSIOL, V117, P2414, DOI 10.1016/j.clinph.2006.07.305; Chowdhury RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055969; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dai YK, 2012, BRAIN TOPOGR, V25, P157, DOI 10.1007/s10548-011-0211-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hassan M, 2010, IRBM, V31, P182, DOI 10.1016/j.irbm.2009.12.004; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Jung TP, 1998, ADV NEUR IN, V10, P894; Kruschwitz JD, 2015, J NEUROSCI METH, V245, P107, DOI 10.1016/j.jneumeth.2015.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LaPlante RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113838; Li XL, 2007, J NEUROSCI METH, V160, P178, DOI 10.1016/j.jneumeth.2006.08.006; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lu YF, 2012, CLIN NEUROPHYSIOL, V123, P1275, DOI 10.1016/j.clinph.2011.11.007; Mallio CA, 2015, CNS NEUROSCI THER, V21, P837, DOI 10.1111/cns.12397; MARS NJI, 1983, ELECTROEN CLIN NEURO, V56, P194, DOI 10.1016/0013-4694(83)90074-3; Martinovic J, 2009, J COGNITIVE NEUROSCI, V21, P42, DOI 10.1162/jocn.2009.21004; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mheich A, 2015, J NEUROSCI METH, V242, P77, DOI 10.1016/j.jneumeth.2015.01.002; Mheich A, 2015, IFMBE PROC, V45, P934, DOI 10.1007/978-3-319-11128-5_232; Muller MM, 2001, VIS COGN, V8, P579, DOI 10.1080/13506280143000133; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PIJN JP, 1993, BASIC MECHANISMS OF THE EEG, P41; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scherg M, 1993, Brain Topogr, V5, P419, DOI 10.1007/BF01128700; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhou DL, 2009, NEUROIMAGE, V47, P1590, DOI 10.1016/j.neuroimage.2009.05.089	74	39	39	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138297	10.1371/journal.pone.0138297	http://dx.doi.org/10.1371/journal.pone.0138297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379232	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400081
J	Wang, H; Sethi, G; Loke, WK; Sim, MK				Wang, Hong; Sethi, Gautam; Loke, Weng-Keong; Sim, Meng-Kwoon			Des-Aspartate-Angiotensin I Attenuates Mortality of Mice Exposed to Gamma Radiation via a Novel Mechanism of Action	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; PROSTAGLANDIN-E SYNTHASE; STEM-CELL SURVIVAL; RECEPTOR; INFLAMMATION; EXPRESSION; INJURY; ENZYME; CYCLOOXYGENASE-1; IDENTIFICATION	ACE inhibitors and ARBs (angiotensin receptor blockers) have been shown to attenuate radiation injuries in animal models of lethal gamma irradiation. These two classes of drug act by curtailing the actions of angiotensin II-linked inflammatory pathways that are up-regulated during gamma radiation in organ systems such as the brain, lung, kidney, and bone marrow. ACE inhibitors inhibit ACE and attenuate the formation of angiotensin II from angiotensin I; ARBs block the angiotensin AT(1) receptor and attenuate the actions of angiotensin II that are elicited through the receptor. DAA-I (des-aspartate-angiotensin I), an orally active angiotensin peptide, also attenuates the deleterious actions of angiotensin II. It acts as an agonist on the angiotensin AT(1) receptor and elicits responses that oppose those of angiotensn II. Thus, DAA-I was investigated for its anticipated radioprotection in gamma irradiated mice. DAA-I administered orally at 800 nmole/kg/day for 30 days post exposure (6.4 Gy) attenuated the death of mice during the 30-day period. The attenuation was blocked by losartan (50 nmole/kg/day, i.p.) that was administered sequential to DAA-I administration. This shows that the radioprotection was mediated via the angiotensin AT(1) receptor. Furthermore, the radioprotection correlated to an increase in circulating PGE(2) of surviving animals, and this suggests that PGE(2) is involved in the radioprotection in DAA-I-treated mice. At the hematopoietic level, DAA-I significantly improved two syndromes of myelosuppression (leucopenia and lymphocytopenia), and mice pre-treated with DAA-I prior to gamma irradiation showed significant improvement in the four myelodysplastic syndromes that were investigated, namely leucopenia, lymphocytopenia, monocytopenia and thrombocytopenia. Based on the known ability of PGE(2) to attenuate the loss of functional hematopoietic stem and progenitor cells in radiation injury, we hypothesize that PGE(2) mediated the action of DAA-I. DAA-I completely attenuated the increase in circulating level of two inflammatory cytokines, TNF alpha and IL-6, in irradiated mice; and this shows that DAA-I exerted additional anti-inflammatory actions, which could also have contributed to its radioprotection. These findings show that DAA-I acts via a novel mechanism of action on the angiotensin AT(1) receptor to specifically release PGE(2), which mediates radioprotection in the gamma irradiated mice.	[Wang, Hong; Sethi, Gautam; Sim, Meng-Kwoon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Loke, Weng-Keong] DSO Natl Labs, Def & Environm Res Inst, Agent Diagnost & Therapeut Lab, Singapore, Singapore	National University of Singapore	Sim, MK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Block MD11,10 Med Dr, Singapore 117595, Singapore.	phcsimmk@nus.edu.sg	Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475	Defence Innovative Research Programme (DIRP); Defence Science Technology Agency (Singapore); National University of Singapore [MINDEF-NUS-DIRP/2011/01]	Defence Innovative Research Programme (DIRP); Defence Science Technology Agency (Singapore); National University of Singapore(National University of Singapore)	The research was supported by a grant from the Defence Innovative Research Programme (DIRP) that was co-funded by Defence Science Technology Agency (Singapore) and National University of Singapore (MINDEF-NUS-DIRP/2011/01).	Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Charrier S, 2004, BLOOD, V104, P978, DOI 10.1182/blood-2003-11-3828; Cohen EP, 2010, CURR DRUG TARGETS, V11, P1423; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Das U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097599; Davis TA, 2010, EXP HEMATOL, V38, P270, DOI 10.1016/j.exphem.2010.01.004; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Houchen CW, 2000, AM J PHYSIOL-GASTR L, V279, pG858, DOI 10.1152/ajpgi.2000.279.5.G858; Houchen CW, 2003, AM J PHYSIOL-GASTR L, V284, pG490, DOI 10.1152/ajpgi.00240.2002; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Kwoon SM, 2004, REGUL PEPTIDES, V117, P213, DOI 10.1016/j.regpep.2003.10.030; Mirzoeva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101161; Mishra S, 2016, ENVIRON TOXICOL, V31, P478, DOI 10.1002/tox.22061; Molteni A, 2007, CURR PHARM DESIGN, V13, P1307, DOI 10.2174/138161207780618777; Moore ED, 2014, RADIAT RES, V181, P21, DOI 10.1667/RR13475.1; Moulder JE, 2011, RADIAT RES, V175, P29, DOI 10.1667/RR2400.1; Murakami M, 2006, CURR PHARM DESIGN, V12, P943, DOI 10.2174/138161206776055912; Ng ETL, 2011, J APPL TOXICOL, V31, P568, DOI 10.1002/jat.1599; Noguchi K, 2000, ORAL MICROBIOL IMMUN, V15, P299, DOI 10.1034/j.1399-302x.2000.150505.x; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rodgers KE, 2002, CANCER CHEMOTH PHARM, V49, P403, DOI 10.1007/s00280-002-0434-6; Rosen EM, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00381; Sim MK, 2007, ENDOCRINOLOGY, V148, P5925, DOI 10.1210/en.2007-0606; Sim MK, 2015, EUR J PHARMACOL, V760, P36, DOI 10.1016/j.ejphar.2015.04.004; Sim MK, 1998, INT J CARDIOL, V63, P223, DOI 10.1016/S0167-5273(97)00324-0; Sim MK, 1996, BRIT J PHARMACOL, V117, P1504, DOI 10.1111/j.1476-5381.1996.tb15313.x; Sim MK, 2009, United States Patent No. US, Patent No. [7553,928, 7553928, US7,553,928B2]; Sim MK, 2013, United States Patent Application Publication, Patent No. [2013/0095,082 A1, 20130095082]; Sinha M, 2012, FREE RADICAL RES, V46, P842, DOI 10.3109/10715762.2012.684245; Sinha M, 2011, J MED FOOD, V14, P1167, DOI 10.1089/jmf.2010.1506; Takahashi HK, 2002, J IMMUNOL, V168, P4446, DOI 10.4049/jimmunol.168.9.4446; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Wen Q, 2004, REGUL PEPTIDES, V120, P149, DOI 10.1016/j.regpep.2004.03.003; Wen Q, 2011, EUR J PHARMACOL, V658, P193, DOI 10.1016/j.ejphar.2011.02.014; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Wong YC, 2011, BIOCHEM PHARMACOL, V82, P1198, DOI 10.1016/j.bcp.2011.07.080; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138009	10.1371/journal.pone.0138009	http://dx.doi.org/10.1371/journal.pone.0138009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378927	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400043
J	Gerstmeier, J; Weinigel, C; Rummler, S; Radmark, O; Werz, O; Garscha, U				Gerstmeier, Jana; Weinigel, Christina; Rummler, Silke; Radmark, Olof; Werz, Oliver; Garscha, Ulrike			Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes	FASEB JOURNAL			English	Article						eicosanoids; proximity-ligation assay; lipoxygenases; inflammation	HUMAN POLYMORPHONUCLEAR LEUKOCYTES; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONIC-ACID; ENZYME-ACTIVITY; BIOSYNTHESIS INHIBITOR; HUMAN NEUTROPHILS; MOLECULAR-BASIS; MEMBRANE; TRANSLOCATION; INACTIVATION	5-Lipoxygenase (5-LO) catalyzes the initial steps in the biosynthesis of proinflammatory leukotrienes. Upon cell activation, 5-LO translocates to the nuclear membrane where arachidonic acid is transferred by 5-LO-activating protein (FLAP) to 5-LO for metabolism. Although previous data indicate association of 5-LO with FLAP, the in situ assembly of native 5-LO/FLAP complexes remains elusive. Here, we show time-resolved 5-LO/FLAP colocalization by immunofluorescence microscopy and in situ 5-LO/FLAP interaction by proximity ligation assay at the nuclearmembrane of Ca2+-ionophoreA23187-activated human monocytes and neutrophils in relation to 5-LO activity. Although 5-LO translocation and product formation is completed within 1.5-3 min, 5-LO/FLAP interaction is delayed and proceeds up to 30 min. Though monocytes and neutrophils contain comparable amounts of 5-LO protein, neutrophils produce 3-5 times higher levels of 5-LO products due to prolonged activity, accompanied by delayed 5-LO nuclear membrane translocation. Arachidonic acid seemingly acts as adaptor for 5-LO/FLAP assembly, whereas FLAP inhibitors (MK886, 100 nM; BAY X 1005, 3 mu M) disrupt the complex. We conclude that FLAP may regulate 5-LO activity in 2 ways: first by inducing an initial flexible association for efficient 5-LO product synthesis, followed by the formation of a tight 5-LO/FLAP complex that terminates 5-LO activity.	[Gerstmeier, Jana; Werz, Oliver; Garscha, Ulrike] Univ Jena, Inst Pharm, Pharmaceut Med Chem, D-07743 Jena, Germany; [Weinigel, Christina; Rummler, Silke] Jena Univ Hosp, Inst Transfus Med, Jena, Germany; [Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Karolinska Institutet	Werz, O (corresponding author), Univ Jena, Inst Pharm, Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de; ulrike.garscha@uni-jena.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft (DFG) [SFB1127]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Heiner Atze for technical assistance. This work was supported by Deutsche Forschungsgemeinschaft (DFG) within the SFB1127, Chemical Mediators in complex Biosystems (ChemBioSys).	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Allain EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132607; Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; DeCarolis E, 1996, EUR J BIOCHEM, V235, P416; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; LEPLEY RA, 1994, J BIOL CHEM, V269, P2627; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; MULLERPEDDINGHAUS R, 1993, J LIPID MEDIATOR, V6, P245; PANOSSIAN A, 1982, FEBS LETT, V150, P511, DOI 10.1016/0014-5793(82)80801-6; Pergola C, 2014, BRIT J PHARMACOL, V171, P3051, DOI 10.1111/bph.12625; Pergola C, 2011, FASEB J, V25, P3377, DOI 10.1096/fj.11-182758; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; POWELL WS, 1984, J BIOL CHEM, V259, P3082; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schaible AM, 2013, PROSTAG LEUKOTR ESS, V89, P245, DOI 10.1016/j.plefa.2013.06.004; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; SHAK S, 1984, J BIOL CHEM, V259, P181; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strid T, 2009, BIOCHEM BIOPH RES CO, V381, P518, DOI 10.1016/j.bbrc.2009.02.074; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; VICKERS PJ, 1992, MOL PHARMACOL, V42, P94; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2003, ADV EXP MED BIOL, V525, P129; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030	48	42	42	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					276	285		10.1096/fj.15-278010	http://dx.doi.org/10.1096/fj.15-278010			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396238				2022-12-26	WOS:000367621000027
J	Shimizu, M; Kaneko, Y; Ishihara, S; Mochizuki, M; Sakai, K; Yamada, M; Murata, S; Itoh, E; Yamamoto, T; Sugimura, Y; Hirano, T; Takaya, N; Kobayashi, T; Kato, M				Shimizu, Motoyuki; Kaneko, Yuhei; Ishihara, Saaya; Mochizuki, Mai; Sakai, Kiyota; Yamada, Miyuki; Murata, Shunsuke; Itoh, Eriko; Yamamoto, Tatsuya; Sugimura, Yu; Hirano, Tatsuya; Takaya, Naoki; Kobayashi, Tetsuo; Kato, Masashi			Novel beta-1,4-Mannanase Belonging to a New Glycoside Hydrolase Family in Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN UTILIZATION SYSTEM; TRANSCRIPTIONAL REGULATOR; BIOCHEMICAL ANALYSES; BETA-MANNANASES; ENZYMES; MECHANISM; CELLULASE; MANR	Many filamentous fungi produce beta-mannan-degrading beta-1,4-mannanases that belong to the glycoside hydrolase 5 (GH5) and GH26 families. Here we identified a novel beta-1,4-mannanase (Man134A) that belongs to a new glycoside hydrolase (GH) family (GH134) in Aspergillus nidulans. Blast analysis of the amino acid sequence using the NCBI protein database revealed that this enzyme had no similarity to any sequences and no putative conserved domains. Protein homologs of the enzyme were distributed to limited fungal and bacterial species. Man134A released mannobiose (M-2), mannotriose (M-3), and mannotetraose (M-4) but not mannopentaose (M-5) or higher manno-oligosaccharides when galactose-free beta-mannan was the substrate from the initial stage of the reaction, suggesting that Man134A preferentially reacts with beta-mannan via a unique catalytic mode. Man134A had high catalytic efficiency (k(cat)/K-m) toward mannohexaose (M-6) compared with the endo-beta-1,4-mannanase Man5C and notably converted M-6 to M-2, M-3, and M-4, with M-3 being the predominant reaction product. The action of Man5C toward beta-mannans was synergistic. The growth phenotype of a Man134A disruptant was poor when beta-mannans were the sole carbon source, indicating that Man134A is involved in beta-mannan degradation in vivo. These findings indicate a hitherto undiscovered mechanism of beta-mannan degradation that is enhanced by the novel beta-1,4-mannanase, Man134A, when combined with other mannanolytic enzymes including various endo-beta-1,4-mannanases.	[Shimizu, Motoyuki; Kaneko, Yuhei; Ishihara, Saaya; Mochizuki, Mai; Sakai, Kiyota; Yamada, Miyuki; Murata, Shunsuke; Yamamoto, Tatsuya; Sugimura, Yu; Hirano, Tatsuya; Kato, Masashi] Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan; [Itoh, Eriko; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kobayashi, Tetsuo] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Meijo University; University of Tsukuba; Nagoya University	Shimizu, M (corresponding author), Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan.	moshimi@meijo-u.ac.jp	Kato, Masashi/AAG-3755-2021; Kobayashi, Tetsuo/I-6901-2014	Kato, Masashi/0000-0002-8951-3640; Kobayashi, Tetsuo/0000-0002-4008-454X	Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry;  [21380055];  [25450116]	Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry; ; 	This work was supported by a Grant-in-aids for Scientific Research (21380055 (to M. S.) and 25450116 (to M. K.). This work was also supported by the Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry. The authors declare that they have no conflicts of interest with the contents of this article.	Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Chiyanzu I, 2014, APPL BIOCHEM BIOTECH, V172, P3538, DOI 10.1007/s12010-014-0770-0; Coradetti ST, 2013, MICROBIOLOGYOPEN, V2, P595, DOI 10.1002/mbo3.94; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; JUE CK, 1985, J BIOCHEM BIOPH METH, V11, P109, DOI 10.1016/0165-022X(85)90046-6; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Li N., 2014, P 12 EUR C FUNG GEN, P219; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nunes FM, 2006, J AGR FOOD CHEM, V54, P3428, DOI 10.1021/jf052971+; Ogawa M, 2013, BIOSCI BIOTECH BIOCH, V77, P426, DOI 10.1271/bbb.120795; Ogawa M, 2012, FUNGAL GENET BIOL, V49, P987, DOI 10.1016/j.fgb.2012.09.006; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Recalde MP, 2012, PHYTOCHEMISTRY, V73, P57, DOI 10.1016/j.phytochem.2011.10.002; PULS J, 1993, PORT PR R M, V4, P1; Rosengren A, 2014, APPL MICROBIOL BIOT, V98, P10091, DOI 10.1007/s00253-014-5871-8; Schroder R, 2009, ANN BOT-LONDON, V104, P197, DOI 10.1093/aob/mcp120; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Shimizu M, 2013, BIOSCI BIOTECH BIOCH, V77, P1888, DOI 10.1271/bbb.130334; Shimizu M, 2012, MOL CELL BIOL, V32, P3743, DOI 10.1128/MCB.00032-12; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Simkovic I, 2013, CARBOHYD POLYM, V95, P697, DOI 10.1016/j.carbpol.2013.03.040; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Songsiriritthigul C, 2011, ACTA CRYSTALLOGR F, V67, P217, DOI 10.1107/S1744309110049067; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608	43	43	45	3	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27914	27927		10.1074/jbc.M115.661645	http://dx.doi.org/10.1074/jbc.M115.661645			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26385921	Green Published, hybrid			2022-12-26	WOS:000365757500040
J	Wu, CM; Ko, HC; Tsou, YT; Lin, YH; Lin, JL; Chen, CK; Chen, PL; Wu, CC				Wu, Che-Ming; Ko, Hui-Chen; Tsou, Yung-Ting; Lin, Yin-Hung; Lin, Ju-Li; Chen, Chin-Kuo; Chen, Pei-Lung; Wu, Chen-Chi			Long-Term Cochlear Implant Outcomes in Children with GJB2 and SLC26A4 Mutations	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; ENLARGED VESTIBULAR AQUEDUCT; SPEECH-PERCEPTION; AUDITORY PERFORMANCE; DEAF-CHILDREN; GENE; LANGUAGE; INTELLIGIBILITY; PREVALENCE; AGE	Objectives To investigate speech and language outcomes in children with cochlear implants (CIs) who had mutations in common deafness genes and to compare their performances with those without mutations. Study Design Prospective study. Methods Patients who received CIs before 18 years of age and had used CIs for more than 3 years were enrolled in this study. All patients underwent mutation screening of three common deafness genes: GJB2, SLC26A4 and the mitochondrial 12S rRNA gene. The outcomes with CIs were assessed at post-implant years 3 and 5 using the Categories of Auditory Performance (CAP) scale, Speech Intelligibility Rating (SIR) scale, speech perception tests and language skill tests. Results Forty-eight patients were found to have confirmative mutations in GJB2 or SLC26A4, and 123 without detected mutations were ascertained for comparison. Among children who received CIs before 3.5 years of age, patients with GJB2 or SLC26A4 mutations showed significantly higher CAP/SIR scores than those without mutations at post-implant year 3 (p = 0.001 for CAP; p = 0.004 for SIR) and year 5 (p = 0.035 for CAP; p = 0.038 for SIR). By contrast, among children who received CIs after age 3.5, no significant differences were noted in post-implant outcomes between patients with and without mutations (all p > 0.05). Conclusion GJB2 and SLC26A4 mutations are associated with good post-implant outcomes. However, their effects on CI outcomes may be modulated by the age at implantation: the association between mutations and CI outcomes is observed in young recipients who received CIs before age 3.5 years but not in older recipients.	[Wu, Che-Ming; Ko, Hui-Chen; Tsou, Yung-Ting; Chen, Chin-Kuo] Chang Gung Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp,Linkou Branch, Taoyuan, Taiwan; [Lin, Yin-Hung; Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, Yin-Hung; Chen, Pei-Lung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Lin, Ju-Li] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Div Genet & Endocrinol,Linkou Branch,Coll Med, Taoyuan, Taiwan; [Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Wu, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp,Linkou Branch, Taoyuan, Taiwan.	bobwu506@hotmail.com; chenchiwu@ntuh.gov.tw	Chen, Chin-Kuo/K-8195-2019; Chen, Pei-Lung/A-3520-2010	Chen, Chin-Kuo/0000-0001-8176-128X; CHE-MING, WU/0000-0001-5245-0482; Chen, Pei-Lung/0000-0002-5640-3074; WU, CHEN-CHI/0000-0002-5047-2204; TSOU, YUNG-TING/0000-0001-6557-5153	Chang-Gung Memorial Hospital Research Program [CMRPG3C1401, CMRPG3C1402, CMRPG3E0411]; National Health Research Institute of Taiwan [NHRI-EX104-10414PC]; National Taiwan University [UN103-032]	Chang-Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); National Taiwan University(National Taiwan University)	This study was supported by the Chang-Gung Memorial Hospital Research Program CMRPG3C1401, CMRPG3C1402 and CMRPG3E0411 (CMW), the National Health Research Institute of Taiwan NHRI-EX104-10414PC (CCW), and the National Taiwan University UN103-032 (CCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Angeli SI, 2011, OTOL NEUROTOL, V32, P1437, DOI 10.1097/MAO.0b013e31823387f9; Archbold S, 1998, BRIT J AUDIOL, V32, P7, DOI 10.3109/03005364000000045; Archbold S, 2008, INT J PEDIATR OTORHI, V72, P1471, DOI 10.1016/j.ijporl.2008.06.016; Bauer PW, 2003, LARYNGOSCOPE, V113, P2135, DOI 10.1097/00005537-200312000-00015; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Cullen RD, 2004, LARYNGOSCOPE, V114, P1415, DOI 10.1097/00005537-200408000-00019; Davcheva-Chakar M, 2014, BALK MED J, V31, P60, DOI 10.5152/balkanmedj.2014.9535; Ealy M, 2011, LARYNGOSCOPE, V121, P1184, DOI 10.1002/lary.21778; Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Fang HY, 2014, INT J PEDIATR OTORHI, V78, P799, DOI 10.1016/j.ijporl.2014.02.014; Geers A, 2003, EAR HEARING, V24, p24S, DOI 10.1097/01.AUD.0000051687.99218.0F; Green GE, 2002, AM J MED GENET, V109, P167, DOI 10.1002/ajmg.10330; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Huang CM, 2014, INT J PEDIATR OTORHI, V78, P14, DOI 10.1016/j.ijporl.2013.10.005; Hutchin T, 2005, CLIN GENET, V68, P506, DOI 10.1111/j.1399-0004.2005.00539.x; Karamert R, 2011, INT J PEDIATR OTORHI, V75, P1572, DOI 10.1016/j.ijporl.2011.09.010; Ko HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081568; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lin BG, 2007, ASSESSMENT SCH LANGU; Lin YH, 2015, MUTAT RES-FUND MOL M, V771, P1, DOI 10.1016/j.mrfmmm.2014.11.001; Matsushiro N, 2002, LARYNGOSCOPE, V112, P255, DOI 10.1097/00005537-200202000-00011; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nance WE, 2003, MENT RETARD DEV D R, V9, P109, DOI 10.1002/mrdd.10067; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749; SILVERMAN S R, 1955, Ann Otol Rhinol Laryngol, V64, P1234; Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Wang LT, 1979, J TAIWAN OTOLARYNGOL, P14; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Wu CM, 2011, AUDIOL NEURO-OTOL, V16, P359, DOI 10.1159/000322310; Wu CC, 2008, ARCH PEDIAT ADOL MED, V162, P269, DOI 10.1001/archpediatrics.2007.59; Wu CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001073; Wu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057369; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Yan YJ, 2013, EUR ARCH OTO-RHINO-L, V270, P2865, DOI 10.1007/s00405-012-2330-y; Yoshida H, 2013, AURIS NASUS LARYNX, V40, P435, DOI 10.1016/j.anl.2013.01.006	42	28	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138575	10.1371/journal.pone.0138575	http://dx.doi.org/10.1371/journal.pone.0138575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397989	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500080
J	Bae, YH; Shin, JS; Lee, J; Kim, MR; Park, KB; Cho, JH; Ha, IH				Bae, Young-Hyeon; Shin, Joon-Shik; Lee, Jinho; Kim, Me-riong; Park, Ki Byung; Cho, Jae-Heung; Ha, In-Hyuk			Association between Hypertension and the Prevalence of Low Back Pain and Osteoarthritis in Koreans: A Cross-Sectional Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-PRESSURE; RISK-FACTORS; MUSCULOSKELETAL COMPLAINTS; ALTERED PAIN; SENSITIVITY; DISEASE; PERCEPTION; MODULATION; HEADACHE	Background Hypertension and musculoskeletal disorders are highly prevalent in adult populations. The objective of this study was to investigate the association between hypertension and prevalence of low back pain (LBP) and osteoarthritis in Koreans. Methods A total 17,128 participants (age >= 20 years) who answered low back pain and osteoarthritis items in the 4th Korean National Health and Nutrition Examination Survey (2007-2009) were analyzed. Odds ratios were calculated using logistic regression and were adjusted for age, sex, income level, education, occupation, BMI, smoking status, alcohol consumption, and physical activity. Results Lifetime prevalence of LBP in hypertensive subjects was 34.4%, and that of osteoarthritis 26.2%. LBP prevalence was significantly lower in hypertensives (fully adjusted OR 0.79; 95% CI 0.70-0.90), and both LBP and osteoarthritis prevalence was significantly lower in participants with systolic blood pressure >= 140mmHg than those with <120mmHg (fully adjusted OR 0.81; 95% CI 0.70-0.94, and 0.81; 95% CI 0.68-0.96, respectively). Prevalence of LBP in subjects with diastolic blood pressure >= 90mmHg was also significantly lower than those with < 80mmHg (fully adjusted OR 0.73; 95% CI 0.63-0.85). LBP and osteoarthritis prevalence did not differ by systolic or diastolic blood pressure interval in respondents taking antihypertensive medication. LBP and osteoarthritis prevalence increased with longer hypertension duration (fully adjusted p for trend 0.028, and 0.0008, respectively). Conclusions Hypertension showed an inverse relationship with LBP and osteoarthritis prevalence, which may be ascribed to hypertension-associated hypalgesia, and antihypertensive medication intake and longer hypertension duration attenuated this association.	[Bae, Young-Hyeon; Shin, Joon-Shik; Lee, Jinho; Kim, Me-riong; Park, Ki Byung; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Cho, Jae-Heung] Kyung Hee Univ, Dept Korean Rehabil Med, Seoul, South Korea	Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com		Shin, Joon-Shik/0000-0001-5488-3273; Lee, Jinho/0000-0003-0672-6892; Bae, Young-Hyeon/0000-0003-4833-4336; HA, IN-HYUK/0000-0002-5020-6723	Jaseng Medical Foundation	Jaseng Medical Foundation	This work was supported by Jaseng Medical Foundation. Jaseng Medical Foundation had no involvement in study design, data collection, analysis and interpretation, manuscript writing, nor decision for manuscript publication. The authors thank Jaseng Medical Foundation for their support.	Arden NK, 2013, OSTEOARTHR CARTILAGE, V21, P1409, DOI 10.1016/j.joca.2013.06.021; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bragdon EE, 2002, PAIN, V96, P227, DOI 10.1016/S0304-3959(01)00451-1; Bruehl S, 2002, PAIN, V100, P191, DOI 10.1016/S0304-3959(02)00295-6; Bruehl S, 1999, NEUROSCI BIOBEHAV R, V23, P877, DOI 10.1016/S0149-7634(99)00039-1; Duschek S, 2009, J PSYCHOPHYSIOL, V23, P104, DOI 10.1027/0269-8803.23.3.104; DWORKIN BR, 1979, SCIENCE, V205, P1299, DOI 10.1126/science.472749; France CR, 1999, PSYCHOPHYSIOLOGY, V36, P683, DOI 10.1111/1469-8986.3660683; Ghione S, 1996, HYPERTENSION, V28, P494, DOI 10.1161/01.HYP.28.3.494; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Guasti L, 2002, AUTON NEUROSCI-BASIC, V99, P127, DOI 10.1016/S1566-0702(02)00052-8; Guasti L, 1999, PAIN, V82, P311, DOI 10.1016/S0304-3959(99)00059-7; Hagen K, 2005, ARCH INTERN MED, V165, P916, DOI 10.1001/archinte.165.8.916; Hagen K, 2002, J NEUROL NEUROSUR PS, V72, P463; Helkamaa T, 2003, J HYPERTENS, V21, P2365, DOI 10.1097/00004872-200312000-00026; Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197; Heuch I, 2014, EUR J PAIN, V18, P590, DOI 10.1002/j.1532-2149.2013.00398.x; Heuch I, 2010, EPIDEMIOLOGY, V21, P837, DOI 10.1097/EDE.0b013e3181f20808; Kerkhoff AC, 2012, J HYPERTENS, V30, P2112, DOI 10.1097/HJH.0b013e3283588268; Lambeek LC, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6414; LAWRENCE JS, 1975, ANN RHEUM DIS, V34, P451, DOI 10.1136/ard.34.5.451; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Lewkowski MD, 2008, PAIN, V135, P75, DOI 10.1016/j.pain.2007.05.003; Lundberg U, 1999, J Occup Health Psychol, V4, P245, DOI 10.1037/1076-8998.4.3.245; Maixner W, 1997, PSYCHOSOM MED, V59, P503, DOI 10.1097/00006842-199709000-00007; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Sarzi-Puttini P, 2005, SEMIN ARTHRITIS RHEU, V35, P1, DOI 10.1016/j.semarthrit.2005.01.013; SHEPS DS, 1992, AM J CARDIOL, V70, pF3, DOI 10.1016/0002-9149(92)90181-W; Shiri R, 2007, EUR SPINE J, V16, P2043, DOI 10.1007/s00586-007-0362-6; Stovner LJ, 2009, ACTA NEUROL SCAND, V120, P46, DOI 10.1111/j.1600-0404.2009.01215.x; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Tronvik E, 2008, NEUROLOGY, V70, P1329, DOI 10.1212/01.wnl.0000309222.79376.57; Tzourio C, 2003, CEPHALALGIA, V23, P914, DOI 10.1046/j.1468-2982.2003.00613.x; Wiehe M, 2002, J HYPERTENS, V20, P1303, DOI 10.1097/00004872-200207000-00016; ZAMIR N, 1980, BRAIN RES, V201, P471, DOI 10.1016/0006-8993(80)91055-0; ZAMIR N, 1979, BRAIN RES, V160, P170, DOI 10.1016/0006-8993(79)90614-0; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	37	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138790	10.1371/journal.pone.0138790	http://dx.doi.org/10.1371/journal.pone.0138790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393797	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100098
J	D'Aniello, E; Ravisankar, P; Waxman, JS				D'Aniello, Enrico; Ravisankar, Padmapriyadarshini; Waxman, Joshua S.			Rdh10a Provides a Conserved Critical Step in the Synthesis of Retinoic Acid during Zebrafish Embryogenesis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VITAMIN-A; BINDING-PROTEIN; EMBRYONIC-DEVELOPMENT; HINDBRAIN DEVELOPMENT; METABOLIZING ENZYME; DEHYDROGENASE 10; HEART; FEEDBACK; RECEPTOR	The first step in the conversion of vitamin A into retinoic acid (RA) in embryos requires retinol dehydrogenases (RDHs). Recent studies have demonstrated that RDH10 is a critical core component of the machinery that produces RA in mouse and Xenopus embryos. If the conservation of Rdh10 function in the production of RA extends to teleost embryos has not been investigated. Here, we report that zebrafish Rdh10a deficient embryos have defects consistent with loss of RA signaling, including anteriorization of the nervous system and enlarged hearts with increased cardiomyocyte number. While knockdown of Rdh10a alone produces relatively mild RA deficient phenotypes, Rdh10a can sensitize embryos to RA deficiency and enhance phenotypes observed when Aldh1a2 function is perturbed. Moreover, excess Rdh10a enhances embryonic sensitivity to retinol, which has relatively mild teratogenic effects compared to retinal and RA treatment. Performing Rdh10a regulatory expression analysis, we also demonstrate that a conserved teleost rdh10a enhancer requires Pax2 sites to drive expression in the eyes of transgenic embryos. Altogether, our results demonstrate that Rdh10a has a conserved requirement in the first step of RA production within vertebrate embryos.	[Waxman, Joshua S.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Mol Cardiovasc Biol Div, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Dev Biol Div, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Waxman, JS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Inst Heart, Mol Cardiovasc Biol Div, Cincinnati, OH 45229 USA.	joshua.waxman@cchmc.org		D'Aniello, Enrico/0000-0002-2627-0477	National Institutes of Health [R01 HL112893-A1]; March of Dimes [6-FY14-389]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JSW received funding from the National Institutes of Health, Grant R01 HL112893-A1, and the March of Dimes, Grant 6-FY14-389.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Ballester B, 2014, ELIFE, V3, DOI 10.7554/eLife.02626; Barber T, 2014, NUTRIENTS, V6, P4984, DOI 10.3390/nu6114984; Begemann G, 2001, DEVELOPMENT, V128, P3081; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Brand M, 1996, DEVELOPMENT, V123, P179; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; COHLAN SQ, 1953, AMA AM J DIS CHILD, V86, P348; COHLAN SQ, 1953, SCIENCE, V117, P535, DOI 10.1126/science.117.3046.535; Costaridis P, 1996, DEV DYNAM, V205, P41; D'Aniello E, 2015, DEV DYNAM, V244, P513, DOI 10.1002/dvdy.24232; D'Aniello E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003689; DAVID M, 1988, MED TOXICOL ADV DRUG, V3, P273, DOI 10.1007/BF03259940; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; KALTER H, 1961, AM J PATHOL, V38, P1; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Lupo G, 2011, P NATL ACAD SCI USA, V108, P8698, DOI 10.1073/pnas.1103802108; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mackereth MD, 2005, DEVELOPMENT, V132, P371, DOI 10.1242/dev.01587; Maden M, 1998, J NUTR, V128, p471S, DOI 10.1093/jn/128.2.471S; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; McCarroll MN, 2012, DEVELOPMENT, V139, P2740, DOI 10.1242/dev.076075; McMahon C, 2009, DEV BIOL, V332, P287, DOI 10.1016/j.ydbio.2009.05.577; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ribes V, 2007, DEV DYNAM, V236, P644, DOI 10.1002/dvdy.21057; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; Rydeen A, 2015, DEV BIOL, V405, P47, DOI 10.1016/j.ydbio.2015.06.008; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698; SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Sweet EM, 2011, DEV BIOL, V358, P113, DOI 10.1016/j.ydbio.2011.07.019; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Uhl JD, 2010, DEV BIOL, V343, P154, DOI 10.1016/j.ydbio.2010.04.004; Waxman JS, 2011, DEV BIOL, V352, P128, DOI 10.1016/j.ydbio.2011.01.022; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; WILSON JG, 1950, PEDIATRICS, V5, P708; WILSON JG, 1950, AM J DIS CHILD, V79, P963; WILSON JG, 1949, AM J ANAT, V85, P113, DOI 10.1002/aja.1000850106; WILSON JG, 1947, P SOC EXP BIOL MED, V64, P419, DOI 10.3181/00379727-64-15814; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; WILSON JG, 1947, ANAT REC, V97, P376	66	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138588	10.1371/journal.pone.0138588	http://dx.doi.org/10.1371/journal.pone.0138588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394147	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100074
J	Dever, JT; Kemp, MQ; Thompson, AL; Keller, HGK; Waksmonski, JC; Scholl, CD; Barnes, DM				Dever, Joseph T.; Kemp, Michael Q.; Thompson, Amber L.; Keller, Hana G. K.; Waksmonski, James C.; Scholl, Chris D.; Barnes, David M.			Survival and Diversity of Human Homologous Dietary MicroRNAs in Conventionally Cooked Top Sirloin and Dried Bovine Tissue Extracts	PLOS ONE			English	Article							DETECTABLE ORAL BIOAVAILABILITY; PLANT MICRORNAS; DIFFERENTIATION; EXPRESSION; STABILITY; DISEASE; MIRNAS; HEALTH; CELLS; MILK	Dietary microRNAs (miRNAs), notably those found in milk, are currently being investigated for their potential to elicit biological effects via canonical binding to human messenger RNA targets once ingested. Besides milk, beef and other bovine tissue-derived ingredients could also be a relevant source of potentially bioactive dietary miRNAs. In this study, we characterized the human homologous miRNA profiles in food-grade, bovine-sourced sirloin, heart and adrenal tissue (raw, cooked, and pasteurized, freeze-dried extracts) via deep-sequencing and quantitative reverse transcription PCR (RT-qPCR). A total of 198 human homologous miRNAs were detected at 10 or more normalized reads in all replicates (n = 3) of at least one preparation method. Tissue origin rather than preparation method was the major differentiating factor of miRNA profiles, and adrenal-based miRNA profiles were the most distinct. The ten most prevalent miRNAs in each tissue represented 71-93% of the total normalized counts for all annotated miRNAs. In cooked sirloin, the most abundant miRNAs were miR-10b-5p, (48.8% of total annotated miRNA reads) along with the muscle-specific miR-1 (24.1%) and miR-206 (4.8%). In dried heart extracts, miR-1 (17.0%), miR-100-5p (16.1%) and miR-99a-5p (11.0%) gave the highest normalized read counts. In dried adrenal extracts, miR-10b-5p (71.2%) was the most prominent followed by miR-143-3p (7.1%) and 146b-5p (3.7%). Sequencing results for five detected and two undetected miRNAs were successfully validated by RT-qPCR. We conclude that edible, bovine tissues contain unique profiles of human homologous dietary miRNAs that survive heat-based preparation methods.	[Dever, Joseph T.; Kemp, Michael Q.; Thompson, Amber L.; Keller, Hana G. K.; Waksmonski, James C.; Scholl, Chris D.; Barnes, David M.] Stand Proc Inc, Dept Res & Dev, Palmyra, VI 22963 USA		Thompson, AL (corresponding author), Stand Proc Inc, Dept Res & Dev, Palmyra, VI 22963 USA.	athompson@standardprocess.com			Standard Process, Inc.	Standard Process, Inc.	Standard Process, Inc. funded this work. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bimpaki EI, 2010, CLIN ENDOCRINOL, V72, P744, DOI 10.1111/j.1365-2265.2009.03725.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2013, NAT BIOTECHNOL, V31, P967, DOI 10.1038/nbt.2741; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; de la Garza-Rodea AS, 2014, FASEB J, V28, P506, DOI 10.1096/fj.13-233155; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han L, 2007, CANCER BIOL THER, V6, P1284; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Liang Gf, 2014, FOOD SCI NUTR, V2, P380, DOI 10.1002/fsn3.113; Loss G, 2011, J ALLERGY CLIN IMMUN, V129, P1470; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Miyasaka KY, 2011, MECH DEVELOP, V128, P18, DOI 10.1016/j.mod.2010.09.002; Persson E, 2004, J AGR FOOD CHEM, V52, P7561, DOI 10.1021/jf0493831; Sharma M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00239; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Witwer KW, 2012, RNA BIOL, V9, P1147, DOI 10.4161/rna.21619; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Yen ST, 2008, FOOD POLICY, V33, P631, DOI 10.1016/j.foodpol.2008.02.006; Zacharewicz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114009; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	33	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138275	10.1371/journal.pone.0138275	http://dx.doi.org/10.1371/journal.pone.0138275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394052	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100046
J	Lee, WY; Goh, G; Chia, J; Boey, A; Gunko, NV; Bard, F				Lee, Wan Yin; Goh, Germaine; Chia, Joanne; Boey, Adrian; Gunko, Natalia V.; Bard, Frederic			The Ubiquitin Ligase CBLC Maintains the Network Organization of the Golgi Apparatus	PLOS ONE			English	Article							SRC-FAMILY KINASES; ENDOPLASMIC-RETICULUM; SIGNALING PATHWAY; C-CBL; RETROGRADE TRANSPORT; SECRETORY PATHWAY; REGULATES GOLGI; ARP2/3 COMPLEX; RECEPTOR; PROTEIN	The Golgi apparatus plays a pivotal role in the sorting and post-translational modifications of secreted and membrane proteins. In mammalian cells, the Golgi is organized in stacks of cisternae linked together to form a network with a ribbon shape. Regulation of Golgi ribbon formation is poorly understood. Here we find in an image-based RNAi screen that depletion of the ubiquitin-ligase CBLC induces Golgi fragmentation. Depletions of the close homologues CBL and CBLB do not induce any visible defects. In CBLC-depleted cells, Golgi stacks appear relatively unperturbed at both the light and electron microscopy levels, suggesting that CBLC controls mostly network organization. CBLC partially localizes on Golgi membranes and this localization is enhanced after activation of the SRC kinase. Inhibition of SRC reverts CBLC depletion effects, suggesting interplay between the two. CBLC's regulation of Golgi network requires its ubiquitin ligase activity. However, SRC levels are not significantly affected by CBLC, and CBLC knockdown does not phenocopy SRC activation, suggesting that CBLC's action at the Golgi is not direct downregulation of SRC. Altogether, our results demonstrate a role of CBLC in regulating Golgi ribbon by antagonizing the SRC tyrosine kinase.	[Lee, Wan Yin; Goh, Germaine; Chia, Joanne; Boey, Adrian; Gunko, Natalia V.; Bard, Frederic] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Boey, Adrian; Gunko, Natalia V.] Inst Med Biol, Singapore, Singapore; [Lee, Wan Yin; Chia, Joanne; Bard, Frederic] Natl Univ Singapore, Dept Biochem, Singapore, Singapore; [Boey, Adrian; Gunko, Natalia V.] IMB IMCB Joint Electron Microscopy Suite, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bard, F (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	fbard@imcb.a-star.edu.sg	Boey, Adrian/AAC-4239-2022; Gounko, Natalia/N-4102-2019; Bard, Frederic Andre Jean/G-9914-2011	Gounko, Natalia/0000-0003-0791-9477; Bard, Frederic Andre Jean/0000-0002-3783-4805; Boey, Adrian/0000-0003-2835-6159	A*STAR	A*STAR(Agency for Science Technology & Research (A*STAR))	This research is entirely funded by A*STAR.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; Bilodeau N, 2010, J PROTEOME RES, V9, P708, DOI 10.1021/pr900481b; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Chia J, 2014, ELIFE, V3, DOI 10.7554/eLife.01828; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Havrylov S, 2008, TRAFFIC, V9, P798, DOI 10.1111/j.1600-0854.2008.00724.x; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Klumperman J., 2011, COLD SPRING HARB PER, V3; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Mayinger P., 2011, COLD SPRING HARB PER, V3, P3; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RAMBOURG A, 1987, BIOL CELL, V60, P103, DOI 10.1111/j.1768-322X.1987.tb00550.x; Rambourg A, 1997, THE GOLGI APPARATUS, P37, DOI [10.1007/978-3-0348-8876-9_2, DOI 10.1007/978-3-0348-8876-9_2]; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wang Y, 1999, J CELL BIOCHEM, V72, P119; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138789	10.1371/journal.pone.0138789	http://dx.doi.org/10.1371/journal.pone.0138789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393512	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100097
J	Park, N; Kim, HD; Cheon, S; Row, H; Lee, J; Han, DH; Cho, S; Kim, K				Park, Noheon; Kim, Hee-Dae; Cheon, Solmi; Row, Hansang; Lee, Jiyeon; Han, Dong-Hee; Cho, Sehyung; Kim, Kyungjin			A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms	PLOS ONE			English	Article							REV-ERB-ALPHA; CLOCK; TRANSCRIPTION; CRYPTOCHROME; DISRUPTION; MICE; DEGRADATION; COMPONENT; PROTEINS; BEHAVIOR	The mammalian circadian clock is an endogenous biological timer comprised of transcriptional/translational feedback loops of clock genes. Bmal1 encodes an indispensable transcription factor for the generation of circadian rhythms. Here, we report a new circadian mutant mouse from gene-trapped embryonic stem cells harboring a C-terminus truncated Bmal1 (Bmal1(GT Delta C)) allele. The homozygous mutant (Bmal1(GT Delta C/GT Delta C)) mice immediately lost circadian behavioral rhythms under constant darkness. The heterozygous (Bmal1(+/GT Delta C)) mice displayed a gradual loss of rhythms, in contrast to Bmal1+/-mice where rhythms were sustained. Bmal1(GT Delta C/GT Delta C) mice also showed arrhythmic mRNA and protein expression in the SCN and liver. Lack of circadian reporter oscillation was also observed in cultured fibroblast cells, indicating that the arrhythmicity of Bmal1(GT Delta C/GT Delta C) mice resulted from impaired molecular clock machinery. Expression of clock genes exhibited distinct responses to the mutant allele in Bmal1(+/GT Delta C) and Bmal1(GT Delta C/GT Delta C) mice. Despite normal cellular localization and heterodimerization with CLOCK, overexpressed BMAL1(GT Delta C) was unable to activate transcription of Per1 promoter and BMAL1-dependent CLOCK degradation. These results indicate that the C-terminal region of Bmal1 has pivotal roles in the regulation of circadian rhythms and the Bmal1(GT Delta C) mice constitute a novel model system to evaluate circadian functional mechanism of BMAL1.	[Park, Noheon; Kim, Hee-Dae; Row, Hansang; Lee, Jiyeon; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Cheon, Solmi; Kim, Kyungjin] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Han, Dong-Hee; Cho, Sehyung] Kyung Hee Univ, Dept Neurosci & Neurodegenerat Control, Res Ctr, Seoul, South Korea; [Cho, Sehyung] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Kim, Kyungjin] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Kyung Hee University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Kim, K (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	kyungjin@dgist.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3C7A1056731, NRF-2014R1A2A1A01003680]; National Research Foundation of Korea - Ministry of Education [10Z20130012420]; DGIST MIREBraiN Program of the Ministry of Science, ICT & Future Planning	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea - Ministry of Education; DGIST MIREBraiN Program of the Ministry of Science, ICT & Future Planning	This work was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3C7A1056731 and NRF-2014R1A2A1A01003680) and the BK21 Plus program through the National Research Foundation of Korea funded by the Ministry of Education (10Z20130012420). This work was also supported by the DGIST MIREBraiN Program of the Ministry of Science, ICT & Future Planning.	Akashi M, 2014, CELL REP, V7, P1056, DOI 10.1016/j.celrep.2014.03.072; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Andersen T, 2010, EUR SPINE J, V19, P2200, DOI 10.1007/s00586-010-1373-2; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cheon S, 2013, NUCLEIC ACIDS RES, V41, P6161, DOI 10.1093/nar/gkt307; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Jeong K, 2015, SCI REPORTS, P5; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Noguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037093; Park N, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.005; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stratmann M, 2012, MOL CELL, V48, P277, DOI 10.1016/j.molcel.2012.08.012; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138661	10.1371/journal.pone.0138661	http://dx.doi.org/10.1371/journal.pone.0138661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394143	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100083
J	Perez-Hernandez, J; Forner, MJ; Pinto, C; Chaves, FJ; Cortes, R; Redon, J				Perez-Hernandez, Javier; Forner, Maria J.; Pinto, Carolina; Chaves, Felipe J.; Cortes, Raquel; Redon, Josep			Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							CIRCULATING MICRORNAS; KIDNEY; EXPRESSION; REVEALS; BIOMARKERS; SIGNATURES; VESICLES; PLASMA; TARGET; SERUM	There is increased interest in using microRNAs (miRNAs) as biomarkers in different diseases. Present in body fluids, it is controversial whether or not they are mainly enclosed in exosomes, thus we studied if urinary miRNAs are concentrated inside exosomes and if the presence of systemic lupus erythematosus with or without lupus nephritis modifies their distribution pattern. We quantified specific miRNAs in urine of patients with systemic lupus erythematosus (n = 38) and healthy controls (n = 12) by quantitative reverse-transcription PCR in cell-free urine, exosome-depleted supernatant and exosome pellet obtained by ultracentrifugation. In control group, miR-335* and miR-302d were consistently higher in exosomes than in exosome-depleted supernatant, and miR-200c and miR-146a were higher in cellfree fraction. In lupus patients, all urinary miRNAs tested were mainly in exosomes with lower levels outside them (p<0.05 and p<0.01, respectively). This pattern is especially relevant in patients with active lupus nephritis compared to the control group or to the SLE patients in absence of lupus nephritis, with miR-146a being the most augmented (100-fold change, p<0.001). Among the exosomal miRNAs tested, only the miR-146a discriminates the presence of active lupus nephritis. In conclusion, urinary miRNAs are contained primarily in exosomes in systemic lupus erythematosus, and the main increment was found in the presence of active lupus nephritis. These findings underscore the attractiveness of exosomal miRNAs in urine, a non-invasive method, as potential renal disease markers.	[Perez-Hernandez, Javier; Cortes, Raquel] INCLIVA Biomed Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain; [Perez-Hernandez, Javier; Forner, Maria J.; Pinto, Carolina; Cortes, Raquel; Redon, Josep] INCLIVA Biomed Res Inst, Cardiometabol & Renal Unit, Valencia, Spain; [Chaves, Felipe J.] Inst Hlth Carlos III, Minist Hlth, CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain; [Forner, Maria J.; Pinto, Carolina; Redon, Josep] Inst Hlth Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Minist Hlth, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Cortes, R (corresponding author), INCLIVA Biomed Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain.	raquel.cortes@uv.es	CORTES, RAQUEL/K-2777-2014; REDON, JOSEP/E-1719-2019; Cortes, Raquel/GQH-6347-2022; Redon, Josep/L-5997-2019; Chaves-Martinez, Felipe Javier/ABC-3294-2021	CORTES, RAQUEL/0000-0001-9607-997X; Cortes, Raquel/0000-0001-9607-997X; Redon, Josep/0000-0001-8777-6773; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Perez-Hernandez, Javier/0000-0001-9712-2917	Carlos III Health Institute [PI12/02615]; FP7-HEALTH 11, European Commission [278249]	Carlos III Health Institute(Instituto de Salud Carlos III); FP7-HEALTH 11, European Commission	This work was supported by the funding for research in health sciences from Carlos III Health Institute (PI12/02615) and the FP7-HEALTH 11 number 278249, European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Faherty N, 2012, J CELL SCI, V125, P5621, DOI 10.1242/jcs.105528; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Miah S, 2012, BRIT J CANCER, V107, P123, DOI 10.1038/bjc.2012.221; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Neal CS, 2011, NEPHROL DIAL TRANSPL, V26, P3794, DOI 10.1093/ndt/gfr485; SUGIYAMA RH, 1981, BIOCHEMISTRY-US, V20, P2268, DOI 10.1021/bi00511a031; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang G, 2010, DIS MARKERS, V28, P79, DOI [10.1155/2010/396328, 10.3233/DMA-2010-0687]; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	43	112	124	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138618	10.1371/journal.pone.0138618	http://dx.doi.org/10.1371/journal.pone.0138618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390437	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000044
J	Whitby, PW; Seale, TW; Morton, DJ; Stull, TL				Whitby, Paul W.; Seale, Thomas W.; Morton, Daniel J.; Stull, Terrence L.			Antisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; PROTEIN-D; MODEL; IDENTIFICATION; MICROBIOLOGY; EPIDEMIOLOGY; PREDICTION; FREQUENCY; VIRULENCE	Nontypeable Haemophilus influenzae (NTHi) cause significant disease, including otitis media in children, exacerbations of chronic obstructive pulmonary disease, and invasive disease in susceptible populations. No vaccine is currently available to prevent NTHi disease. The interactions of NTHi and the human host are primarily mediated by lipooligosaccharide and a complex array of surface-exposed proteins (SEPs) that act as receptors, sensors and secretion systems. We hypothesized that certain SEPs are present in all NTHi strains and that a subset of these may be antibody accessible and represent protective epitopes. Initially we used 15 genomic sequences available in the GenBank database along with an additional 11 genomic sequences generated by ourselves to identify the core set of putative SEPs present in all strains. Using bioinformatics, 56 core SEPs were identified. Molecular modeling generated putative structures of the SEPs from which potential surface exposed regions were defined. Synthetic peptides corresponding to ten of these highly conserved surface-exposed regions were used to raise antisera in rats. These antisera were used to assess passive protection in the infant rat model of invasive NTHi infection. Five of the antisera were protective, thus demonstrating their in vivo antibody accessibility. These five peptide regions represent potential targets for peptide vaccine candidates to protect against NTHi infection.	[Whitby, Paul W.; Seale, Thomas W.; Morton, Daniel J.; Stull, Terrence L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Stull, Terrence L.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Whitby, PW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.	pwhitby@ouhsc.edu		Morton, Daniel/0000-0002-3931-5566	Oklahoma Center for the Advancement of Science and Technology [HR-06-080]	Oklahoma Center for the Advancement of Science and Technology	This work was supported in part by health research contract HR-06-080 from The Oklahoma Center for the Advancement of Science and Technology (www.ok.gov/ocast) to DJM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Alikhan MM, 2014, CURR OPIN PULM MED, V20, P159, DOI 10.1097/MCP.0000000000000023; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barenkamp HJ, 2004, PEDIATR INFECT DIS J, V23, P461, DOI 10.1097/01.inf.0000125892.66941.a9; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Blain A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu044; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; Cripps AW, 2005, VACCINE, V23, P2304, DOI 10.1016/j.vaccine.2005.01.023; Faden H, 2001, EUR J PEDIATR, V160, P407, DOI 10.1007/s004310100754; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Forsgren A, 2008, CLIN INFECT DIS, V46, P726, DOI 10.1086/527396; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; GIEBINK GS, 1989, PEDIATR INFECT DIS J, V8, pS18; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; HANSON MS, 1992, P NATL ACAD SCI USA, V89, P1973, DOI 10.1073/pnas.89.5.1973; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Hempel RJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-134; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; KARASIC RB, 1989, PEDIATR INFECT DIS J, V8, pS62; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ladhani SN, 2012, CLIN THER, V34, P385, DOI 10.1016/j.clinthera.2011.11.027; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Michel LV, 2013, J BACTERIOL, V195, P3252, DOI 10.1128/JB.00185-13; Michel LV, 2015, MICROBIOLOGY; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; Morton DJ, 2007, MICROBIOL-SGM, V153, P215, DOI 10.1099/mic.0.2006/000190-0; Morton DJ, 2004, MICROBIOL-SGM, V150, P3923, DOI 10.1099/mic.0.27238-0; Morton DJ, 1999, FEMS MICROBIOL LETT, V174, P303, DOI 10.1016/S0378-1097(99)00154-8; Murphy TF, 2015, CLIN VACCINE IMMUNOL, V22, P459, DOI 10.1128/CVI.00089-15; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; Nizet V, 1996, J INFECT DIS, V173, P180, DOI 10.1093/infdis/173.1.180; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Pisitkun T, 2012, AM J PHYSIOL-CELL PH, V302, pC154, DOI 10.1152/ajpcell.00325.2011; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Sabirov A, 2009, PEDIATR RES, V66, P565, DOI 10.1203/PDR.0b013e3181b4f8a6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAMUELSON A, 1995, SCAND J INFECT DIS, V27, P303, DOI 10.3109/00365549509032722; Schuerman L, 2009, VACCINE, V27, P5748, DOI 10.1016/j.vaccine.2009.07.070; Seale TW, 2006, INFECT IMMUN, V74, P6213, DOI 10.1128/IAI.00744-06; SMITH AL, 1973, INFECT IMMUN, V8, P278, DOI 10.1128/IAI.8.2.278-290.1973; SmithVaughan HC, 1997, INFECT IMMUN, V65, P1468, DOI 10.1128/IAI.65.4.1468-1474.1997; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; Veenhoven R, 2004, PEDIATR RES, V55, P159, DOI 10.1203/01.PDR.0000099776.66136.39; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	55	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0136867	10.1371/journal.pone.0136867	http://dx.doi.org/10.1371/journal.pone.0136867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390432	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000004
J	Ke, JT; Lou, J; Chen, XQ; Li, JY; Liu, C; Gong, YJ; Yang, Y; Zhu, Y; Zhang, Y; Gong, J				Ke, Juntao; Lou, Jiao; Chen, Xueqin; Li, Jiaoyuan; Liu, Cheng; Gong, Yajie; Yang, Yang; Zhu, Ying; Zhang, Yi; Gong, Jing			Identification of a Potential Regulatory Variant for Colorectal Cancer Risk Mapping to Chromosome 5q31.1: A Post-GWAS Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HOMEOBOX GENE-EXPRESSION; SUSCEPTIBILITY LOCI; CHINESE POPULATION; ENHANCER ACTIVITY; LUNG-CANCER; EAST ASIANS; PITX1; METAANALYSIS; STATE	Large-scale genome-wide association studies (GWAS) have established chromosome 5q31.1 as a susceptibility locus for colorectal cancer (CRC), which was still lack of causal genetic variants. We searched potentially regulatory single nucleotide polymorphisms (SNPs) in the overlap region between linkage disequilibrium (LD) block of 5q31.1 and regulatory elements predicted by histone modifications, then tested their association with CRC via a case-control study. Among three candidate common variants, we found rs17716310 conferred significantly (heterozygous model: OR = 1.273, 95% confidence interval (95% CI) = 1.016-1.595, P = 0.036) and marginally (dominant model: OR = 1.238, 95% CI = 1.000-1.532, P = 0.050) increase risk for CRC in a Chinese population including 695 cases and 709 controls. This variation was suggested to be regulatory altering the activity of enhancer that control PITX1 expression. Using epigenetic information such as chromatin immunoprecipitation- sequencing (ChIP-seq) data might help researchers to interpret the results of GWAS and locate causal variants for diseases in post-GWAS era.	[Gong, Jing] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Key Lab Environm & Hlth,Minist Environm Protect, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, J (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Key Lab Environm & Hlth,Minist Environm Protect, Wuhan 430074, Peoples R China.	gongj@hust.edu.cn	李, 娇元/GVS-6952-2022		National Natural Science Foundation of China [NSFC-81402744]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC-81402744) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2012, J BIOL CHEM, V287, P30885, DOI 10.1074/jbc.R112.365940; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hardison RC, 2012, J BIOL CHEM, V287, P30932, DOI 10.1074/jbc.R112.352427; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar S, 2015, ONCOGENE, V34, P2052, DOI 10.1038/onc.2014.154; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P1348, DOI 10.3109/10428194.2011.566391; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang B, 2014, INT J CANCER, V135, P948, DOI 10.1002/ijc.28733; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zhang XY, 2014, TRENDS GENET, V30, P140, DOI 10.1016/j.tig.2014.02.006; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	59	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138478	10.1371/journal.pone.0138478	http://dx.doi.org/10.1371/journal.pone.0138478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381143	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200111
J	Thomas, S; Hodge, W; Malvankar-Mehta, M				Thomas, Sera; Hodge, William; Malvankar-Mehta, Monali			The Cost-Effectiveness Analysis of Teleglaucoma Screening Device	PLOS ONE			English	Article							GLAUCOMA; PROGRAM; ALBERTA; HEALTH	Glaucoma is the leading cause of irreversible vision loss and costs the American economy $2.9 billion. Teleglaucoma remotely detects glaucoma improving access to ophthalmic care in rural areas. It helps manage glaucoma more efficiently to preserve vision and reduce healthcare costs. A cost-effectiveness analysis was conducted using healthcare provider or third-party payer perspective within rural Canada. The study population were patients at-risk of glaucoma which includes those with diabetes and/or hypertension, family history of glaucoma, adults older than 50 years, and concurrent ocular conditions in rural Alberta. Markov modelling was used to model glaucoma health states. Effectiveness was measured in Quality-Adjusted Life Years (QALYs) and costs were used in Canadian dollars. Using TreeAge Pro 2009, incremental cost-effectiveness ratios (ICER) were developed in dollars per QALYs. Deterministic and probabilistic sensitivity analyses were performed to assess the factors affecting cost-effectiveness. Teleglaucoma had a 20% increase in ophthalmologist-referral rate; it reduced patient travel times by 61 hours and physician wait times by 30% in comparison to in-person examination (standard of care). Teleglaucoma costs $872 per patient screened which was 80% less than in-person examination. Teleglaucoma had a greater incremental effectiveness providing an additional 0.12 QALY per patient examination. It was more sensitive (86.5%) and less specific (78.6%) than in-person examination. Teleglaucoma was more cost-effective than in-person examination with an ICER of $27,460/QALY. This indicated that teleglaucoma will save $27, 460 for each additional QALY gained. Long term benefits showed teleglaucoma prevents 24% cases of glaucoma blindness after 30 years. Teleglaucoma demonstrated improved health outcomes, as well as, cost benefits. It increases access to ophthalmic care and improves healthcare service efficiency, specifically in rural areas. Teleglaucoma is more cost-effective than current inperson examination and can improve the quality of life in glaucoma patients.	[Thomas, Sera; Hodge, William; Malvankar-Mehta, Monali] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Hodge, William; Malvankar-Mehta, Monali] St Josephs Hlth Care London, Ivey Eye Inst, Dept Ophthalmol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Thomas, S (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.	sthoma@uwo.ca			Lawson Internal Research Fund: Pilot Study Program	Lawson Internal Research Fund: Pilot Study Program	Funded by Lawson Internal Research Fund: Pilot Study Program granted to MMM (https://www.lawsonresearch.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Foundation for the Blind, 2008, KEY DEF STAT TERMS; Arcand A, 2012, C BOARD CAN; Arora S, 2014, TELEMED E-HEALTH, V20, P439, DOI 10.1089/tmj.2013.0241; Burr JM, 2007, OPTOMETRY VISION SCI, V84, P797, DOI 10.1097/OPX.0b013e3181339f30; CNIB and the Canadian Ophthalmology Society, 2008, COSTS VIS LOSS CAN S; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edejer T, 2003, MAKING CHOICES HLTH; Government of Alberta, 2014, MED PROC LISTS; Hatt S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006129.pub2; Kassam F, 2013, CLIN EXP OPTOM, V96, P577, DOI 10.1111/cxo.12065; Kassam Faazil, 2013, Middle East Afr J Ophthalmol, V20, P142, DOI 10.4103/0974-9233.110619; Kassam F, 2012, J TELEMED TELECARE, V18, P367, DOI 10.1258/jtt.2012.120313; Kumar S, 2007, CLIN EXP OPHTHALMOL, V35, P237, DOI 10.1111/j.1442-9071.2007.01457.x; Lee Walt JG, 2006, ARCH OPHTHALMOL-CHIC, P12; Li HK, 1999, TELEMED J, V5, P283, DOI 10.1089/107830299312032; Mayor S, 2007, BRIT MED J, V335, P1114, DOI 10.1136/bmj.39412.508993.94; Rachepelle S, 2013, AM ACAD OPHTHALMOLOG; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Rudinsky C, 2009, ALBERTA DISEASE SURV; Sogbesan E, 2010, CAN OPHTH SOC ANN M; Statistics Canada, 2011, 2011 CENS POP; Statistics Canada (StatsCan), 2014, EARN AV WEEKL PROV T; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Thomas SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113779; Tuulonen A, 1999, J GLAUCOMA, V8, P367; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Verma S, 2014, CAN J OPHTHALMOL, V49, P135, DOI 10.1016/j.jcjo.2013.11.005	27	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137913	10.1371/journal.pone.0137913	http://dx.doi.org/10.1371/journal.pone.0137913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382956	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200042
J	Chen, WC; Yang, GP; He, Y; Zhang, SM; Chen, HY; Shen, P; Chen, XD; Huang, YP				Chen, Wenchao; Yang, Guopeng; He, Yue; Zhang, Shaoming; Chen, Haiyan; Shen, Ping; Chen, Xiangdong; Huang, Yu-Ping			Nucleotides Flanking the Start Codon in hsp70 mRNAs with Very Short 5 '-UTRs Greatly Affect Gene Expression in Haloarchaea	PLOS ONE			English	Article							HALOPHILIC BETA-GALACTOSIDASE; TRANSLATION INITIATION; HALOFERAX-VOLCANII; REPORTER GENE; 70S RIBOSOMES; TRANSCRIPTION; SEQUENCES; ACETYLATION; MECHANISM; EUKARYOTE	Leaderless translation is prevalent in haloarchaea, with many of these leaderless transcripts possessing short 5'-untranslated regions (UTRs) less than 10 nucleotides. Whereas, little is known about the function of this very short 5'-UTR. Our previous studies determined that just four nucleotides preceded the start codon of hsp70 mRNA in Natrinema sp. J7, with residues -3A and +4G, relative to the A of the ATG start codon, acting as the preferred bases around the start codon of all known haloarchaeal hsp70 genes. Here, we examined the effects of nucleotides flanking the start codon on gene expression. The results revealed that shortening and deletion of the short 5'-UTR enhanced transcript levels; however, it led to significant reductions in overall translational efficiency. AUG was efficiently used as start codons, in both the presence and absence of short 5'-UTRs. GUG also could initiate translation, even though it was so inefficient that it would not be detected without considerably elevated transcript. Nucleotide substitutions at position -4 to +6 were shown to affect gene expression by transcript and/or translational levels. Notably, -3A and A/U nucleotides at position +4 similar to+6 were more optimal for gene expression. Nucleotide transversions of -3A to -3C and +4G to +4T with hsp70 promoter from either Haloferax volcanii DS70 or Halobacterium salinarum NRC-1 showed the same effects on gene expression as that of Natrinema sp. J7. Taken together, our results suggest that the nucleotides flanking the start codon in hsp70 mRNAs with very short 5'-UTRs play an important role in haloarchaeal gene expression.	[Chen, Wenchao; Yang, Guopeng; He, Yue; Zhang, Shaoming; Chen, Haiyan; Shen, Ping; Chen, Xiangdong; Huang, Yu-Ping] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China	Wuhan University	Huang, YP (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.	yphuang@whu.edu.cn	Chen, Haiyan/HGB-6216-2022		National Basic Research Program of China (973 Program) [2011CB808800]; National Natural Science Foundation of China [30970070, 30870133]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Basic Research Program of China (973 Program) (2011CB808800), National Natural Science Foundation of China (No. 30970070 and 30870133).	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; BLUM P, 1992, J BACTERIOL, V174, P7436, DOI 10.1128/jb.174.22.7436-7444.1992; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eichler J, 2013, FEMS MICROBIOL REV, V37, P583, DOI 10.1111/1574-6976.12012; Falb M, 2006, J MOL BIOL, V362, P915, DOI 10.1016/j.jmb.2006.07.086; French SL, 2007, MOL BIOL EVOL, V24, P893, DOI 10.1093/molbev/msm007; Gregor D, 2001, MICROBIOL-SGM, V147, P1745, DOI 10.1099/00221287-147-7-1745; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Hickey AJ, 2002, CRIT REV BIOCHEM MOL, V37, P537, DOI 10.1080/10409230290771555; Holmes ML, 1997, BBA-PROTEIN STRUCT M, V1337, P276, DOI 10.1016/S0167-4838(96)00174-4; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; Humbard MA, 2009, J BACTERIOL, V191, P3794, DOI 10.1128/JB.00090-09; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kramer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094979; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QH, 2008, NUCLEIC ACIDS RES, V36, P3031, DOI 10.1093/nar/gkn152; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; O'Donnell SA, 2002, J BACTERIOL, V184, P6730, DOI 10.1128/JB.184.23.6730-6733.2002; Patenge N, 2000, MOL MICROBIOL, V36, P105, DOI 10.1046/j.1365-2958.2000.01831.x; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; Reeve JN, 2005, CURR OPIN MICROBIOL, V8, P627, DOI 10.1016/j.mib.2005.10.017; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Srinivasan G, 2006, MOL MICROBIOL, V59, P1013, DOI 10.1111/j.1365-2958.2005.04992.x; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Sugimoto S, 2008, MICROBIOL-SGM, V154, P1876, DOI 10.1099/mic.0.2008/017376-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; Van Etten WJ, 1998, MOL MICROBIOL, V27, P987, DOI 10.1046/j.1365-2958.1998.00744.x; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zhang H, 2009, EXTREMOPHILES, V13, P669, DOI 10.1007/s00792-009-0251-5	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138473	10.1371/journal.pone.0138473	http://dx.doi.org/10.1371/journal.pone.0138473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379277	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400103
J	Gilbert, JL; Guthart, MJ; Gezan, SA; de Carvalho, MP; Schwieterman, ML; Colquhoun, TA; Bartoshuk, LM; Sims, CA; Clark, DG; Olmstead, JW				Gilbert, Jessica L.; Guthart, Matthew J.; Gezan, Salvador A.; de Carvalho, Melissa Pisaroglo; Schwieterman, Michael L.; Colquhoun, Thomas A.; Bartoshuk, Linda M.; Sims, Charles A.; Clark, David G.; Olmstead, James W.			Identifying Breeding Priorities for Blueberry Flavor Using Biochemical, Sensory, and Genotype by Environment Analyses	PLOS ONE			English	Article							VACCINIUM-CORYMBOSUM; VOLATILE COMPOSITION; INSTRUMENTAL MEASUREMENTS; AROMA; QUALITY; FRUIT; ODOR; TEXTURE; TASTE; IDENTIFICATION	Breeding for a subjective goal such as flavor is challenging, as many blueberry cultivars are grown worldwide, and identifying breeding targets relating to blueberry flavor biochemistry that have a high degree of genetic control and low environmental variability are priorities. A variety of biochemical compounds and physical characters induce the sensory responses of taste, olfaction, and somatosensation, all of which interact to create what is perceived flavor. The goal of this study was to identify the flavor compounds with a larger genetic versus environmental component regulating their expression over an array of cultivars, locations, and years. Over the course of three years, consumer panelists rated overall liking, texture, sweetness, sourness, and flavor intensity of 19 southern highbush blueberry (Vaccinium corymbosum hybrids) genotypes in 30 sensory panels. Significant positive correlations to overall liking of blueberry fruit (P<0.001) were found with sweetness (R-2 = 0.70), texture (R-2 = 0.68), and flavor (R-2 = 0.63). Sourness had a significantly negative relationship with overall liking (R-2 = 0.55). The relationship between flavor and texture liking was also linear (R-2 = 0.73, P<0.0001) demonstrating interaction between olfaction and somatosensation. Partial least squares analysis was used to identify sugars, acids, and volatile compounds contributing to liking and sensory intensities, and revealed strong effects of fructose, pH, and several volatile compounds upon all sensory parameters measured. To assess the feasibility of breeding for flavor components, a three year study was conducted to compare genetic and environmental influences on flavor biochemistry. Panelists could discern genotypic variation in blueberry sensory components, and many of the compounds affecting consumer favor of blueberries, such as fructose, pH, beta-caryophyllene oxide and 2-heptanone, were sufficiently genetically controlled that allocating resources for their breeding is worthwhile.	[Gilbert, Jessica L.; Schwieterman, Michael L.; Colquhoun, Thomas A.; Bartoshuk, Linda M.; Sims, Charles A.; Clark, David G.; Olmstead, James W.] Univ Florida, Inst Food & Agr Sci, Plant Innovat Ctr, Gainesville, FL 32611 USA; [Gilbert, Jessica L.; Guthart, Matthew J.; Olmstead, James W.] Univ Florida, Inst Food & Agr Sci, Dept Hort Sci, Gainesville, FL 32611 USA; [Gezan, Salvador A.; de Carvalho, Melissa Pisaroglo] Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Schwieterman, Michael L.; Colquhoun, Thomas A.; Clark, David G.] Univ Florida, Inst Food & Agr Sci, Dept Environm Hort, Gainesville, FL 32611 USA; [Bartoshuk, Linda M.; Sims, Charles A.] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Olmstead, JW (corresponding author), Univ Florida, Inst Food & Agr Sci, Plant Innovat Ctr, Gainesville, FL 32611 USA.	jwolmstead@ufl.edu			University of Florida Graduate Fellowship in Plant Molecular Breeding	University of Florida Graduate Fellowship in Plant Molecular Breeding	A University of Florida Graduate Fellowship in Plant Molecular Breeding was obtained by DGC and JWO in 2011 to fund this project. http://pmcb.ifas.ufl.edu/funding/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenar E, 2010, J SCI FOOD AGR, V90, P1121, DOI 10.1002/jsfa.3922; Badoc A., 1991, Journal of Essential Oil Research, V3, P269; BALLINGTON JR, 1984, J AM SOC HORTIC SCI, V109, P684; BALOGA DW, 1995, ACS SYM SER, V596, P235; Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322; Bartoshuk LM, 2005, CURR DIR PSYCHOL SCI, V14, P122, DOI 10.1111/j.0963-7214.2005.00346.x; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Benn SM, 1996, J AGR FOOD CHEM, V44, P557, DOI 10.1021/jf9504172; Blaker KM, 2014, J SCI FOOD AGR, V94, P2785, DOI 10.1002/jsfa.6626; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bojanowski V, 2012, PHYSIOL BEHAV, V107, P484, DOI 10.1016/j.physbeh.2012.03.001; Cebolla-Cornejo J, 2011, J AGR FOOD CHEM, V59, P2440, DOI 10.1021/jf1045427; Colquhoun TA, 2013, POSTHARVEST BIOL TEC, V86, P37, DOI 10.1016/j.postharvbio.2013.06.013; DARNELL RL, 1994, PHYSIOL PLANTARUM, V92, P336, DOI [10.1111/j.1399-3054.1994.tb05345.x, 10.1034/j.1399-3054.1994.920220.x]; de Kermadec F, 1997, FOOD QUAL PREFER, V8, P395, DOI 10.1016/S0950-3293(97)00026-8; DIMICK PS, 1983, CRC CR REV FOOD SCI, V18, P387, DOI 10.1080/10408398309527367; Du XF, 2011, J AGR FOOD CHEM, V59, P8347, DOI 10.1021/jf201184m; Eichholz I, 2011, FOOD CHEM, V126, P60, DOI 10.1016/j.foodchem.2010.10.071; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; Forney CF, 2001, HORTTECHNOLOGY, V11, P529, DOI 10.21273/HORTTECH.11.4.529; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; FRANKE W, 1961, ARCH MIKROBIOL, V40, P73, DOI 10.1007/BF00408834; GALLETTA GJ, 1971, J AM SOC HORTIC SCI, V96, P758; Gilbert JL, 2014, HORTSCIENCE, V49, P864, DOI 10.21273/HORTSCI.49.7.864; Gilbert JL, 2013, HORTSCIENCE, V48, P835, DOI 10.21273/HORTSCI.48.7.835; Golebiowski M, 2008, CHEM NAT COMPD+, V44, P794, DOI 10.1007/s10600-009-9171-y; Gould W.A., 1983, TOMATO PRODUCTION PR; HIRVI T, 1983, J SCI FOOD AGR, V34, P992, DOI 10.1002/jsfa.2740340916; Hongsoongnern P, 2008, J SENS STUD, V23, P205, DOI 10.1111/j.1745-459X.2007.00150.x; HORVAT RJ, 1985, J FOOD SCI, V50, P429, DOI 10.1111/j.1365-2621.1985.tb13419.x; Hough G, 1996, FOOD QUAL PREFER, V7, P47, DOI 10.1016/0950-3293(94)00000-X; KADER F, 1993, FOOD SCI TECHNOL-LEB, V26, P593, DOI 10.1006/fstl.1993.1114; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klesk K, 2004, J AGR FOOD CHEM, V52, P5155, DOI 10.1021/jf0498721; LARSEN M, 1992, Z LEBENSM UNTERS FOR, V195, P120, DOI 10.1007/BF01201770; Lawless H. T., 2010, SENSORY EVALUATION F; Mahawanich T, 2004, FOOD CHEM, V84, P169, DOI 10.1016/S0308-8146(03)00197-3; Mattheis JP, 1999, POSTHARVEST BIOL TEC, V15, P227, DOI 10.1016/S0925-5214(98)00087-8; Moore PP, 2002, ACTA HORTIC, P511, DOI 10.17660/ActaHortic.2002.585.82; MOSKOWIT.HR, 1970, PERCEPT PSYCHOPHYS, V7, P315, DOI 10.3758/BF03210175; MOSKOWITZ HR, 1971, AM J PSYCHOL, V84, P387, DOI 10.2307/1420470; Murthy CT, 2008, J FOOD ENG, V85, P18, DOI 10.1016/j.jfoodeng.2007.06.020; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; PANGBORN RM, 1960, FOOD TECHNOL-CHICAGO, V14, pB36; PARLIMENT TH, 1975, J FOOD SCI, V40, P762, DOI 10.1111/j.1365-2621.1975.tb00550.x; Paterson A, 2013, THEOR APPL GENET, V126, P33, DOI 10.1007/s00122-012-1957-9; Payne TJ, 2014, N AM HIGHBUSH BLUEBE; Pirbalouti AG, 2013, IND CROP PROD, V48, P43, DOI 10.1016/j.indcrop.2013.04.004; Qian MC, 2005, J FOOD SCI, V70, pC13, DOI 10.1111/j.1365-2621.2005.tb09013.x; Rohloff J, 2004, J FOOD AGRIC ENVIRON, V2, P74; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; Saftner R, 2008, POSTHARVEST BIOL TEC, V49, P19, DOI 10.1016/j.postharvbio.2008.01.008; Samykanno K, 2013, SCI HORTIC-AMSTERDAM, V164, P633, DOI 10.1016/j.scienta.2013.09.001; Sanchez G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-137; SCHIEBERLE P, 1988, J AGR FOOD CHEM, V36, P797, DOI 10.1021/jf00082a031; Schwieterman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088446; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; SZCZESNIAK AS, 1988, J TEXTURE STUD, V19, P61, DOI 10.1111/j.1745-4603.1988.tb00925.x; Taylor AJ, 2004, FLAVOR PERCEPTION; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Togari N, 1995, FOOD RES INT, V28, P485, DOI 10.1016/0963-9969(95)00028-3; Toscas PJ, 1999, MEAT SCI, V52, P173, DOI 10.1016/S0309-1740(98)00165-X; Troje ZS, 1997, J CHROMATOGR A, V775, P101; Van Opstaele F, 2013, J AGR FOOD CHEM, V61, P10555, DOI 10.1021/jf402496t; Vigues S, 2009, RESULTS PROBL CELL D, V47, P187, DOI 10.1007/400_2008_2; Wang L, 2004, J I BREWING, V110, P57, DOI 10.1002/j.2050-0416.2004.tb00181.x; Weel KGC, 2002, J AGR FOOD CHEM, V50, P5149, DOI 10.1021/jf0202786; Werkhoff P, 1998, J AGR FOOD CHEM, V46, P1076, DOI 10.1021/jf970655s; Wolken WAM, 2001, APPL MICROBIOL BIOT, V57, P731, DOI 10.1007/s002530100821; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; YU TH, 1989, J AGR FOOD CHEM, V37, P730, DOI 10.1021/jf00087a033	73	54	56	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138494	10.1371/journal.pone.0138494	http://dx.doi.org/10.1371/journal.pone.0138494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378911	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400106
J	Ito, D; Cao, PY; Kakihana, T; Sato, E; Suda, C; Muroya, Y; Ogawa, Y; Hu, GZ; Ishii, T; Ito, O; Kohzuki, M; Kiyomoto, H				Ito, Daisuke; Cao, Pengyu; Kakihana, Takaaki; Sato, Emiko; Suda, Chihiro; Muroya, Yoshikazu; Ogawa, Yoshiko; Hu, Gaizun; Ishii, Tadashi; Ito, Osamu; Kohzuki, Masahiro; Kiyomoto, Hideyasu			Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats	PLOS ONE			English	Article							GLOMERULAR PODOCYTE INJURY; OXIDATIVE STRESS; FATTY RATS; KIDNEY; ALBUMINURIA; INHIBITION; ACTIVATION; BLOCKADE; KINASE; ONSET	Exercise training is known to exert multiple beneficial effects including renal protection in type 2 diabetes mellitus and obesity. However, the mechanisms regulating these actions remain unclear. The present study evaluated the effects of chronic running exercise on the early stage of diabetic nephropathy, focusing on nitric oxide synthase (NOS), oxidative stress and glycation in the kidneys of Zucker diabetic fatty (ZDF) rats. Male ZDF rats (6 weeks old) underwent forced treadmill exercise for 8 weeks (Ex-ZDF). Sedentary ZDF (Sed-ZDF) and Zucker lean (Sed-ZL) rats served as controls. Exercise attenuated hyperglycemia (plasma glucose; 242 +/- 43 mg/dL in Sed-ZDF and 115 +/- 5 mg/dL in Ex-ZDF) with increased insulin secretion (plasma insulin; 2.3 +/- 0.7 and 5.3 +/- 0.9 ng/mL), reduced albumin excretion (urine albumin; 492 +/- 70 and 176 +/- 11 mg/g creatinine) and normalized creatinine clearance (9.7 +/- 1.4 and 4.5 +/- 0.8 mL/min per body weight) in ZDF rats. Endothelial (e) and neuronal (n) NOS expression in kidneys of Sed-ZDF rats were lower compared with Sed-ZL rats (p<0.01), while both eNOS and nNOS expression were upregulated by exercise (p<0.01). Furthermore, exercise decreased NADPH oxidase activity, p47(phox) expression (p<0.01) and alpha-oxoaldehydes (the precursors for advanced glycation end products) (p<0.01) in the kidneys of ZDF rats. Additionally, morphometric evidence indicated renal damage was reduced in response to exercise. These data suggest that upregulation of NOS expression, suppression of NADPH oxidase and alpha-oxoaldehydes in the kidneys may, at least in part, contribute to the renal protective effects of exercise in the early progression of diabetic nephropathy in ZDF rats. Moreover, this study supports the theory that chronic aerobic exercise could be recommended as an effective non-pharmacological therapy for renoprotection in the early stages of type 2 diabetes mellitus and obesity.	[Ito, Daisuke; Ishii, Tadashi; Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Miyagi Community Hlth Promot, Sendai, Miyagi 980, Japan; [Ito, Daisuke; Cao, Pengyu; Kakihana, Takaaki; Suda, Chihiro; Muroya, Yoshikazu; Ogawa, Yoshiko; Hu, Gaizun; Ito, Osamu; Kohzuki, Masahiro] Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan; [Sato, Emiko] Tohoku Univ, Tohoku Univ Grad Sch Pharmaceut Sci & Med, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi 980, Japan; [Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrated Nephrol & Telemed, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku Medical & Pharmaceutical University; Tohoku University; Tohoku University	Ito, D (corresponding author), Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Miyagi Community Hlth Promot, Sendai, Miyagi 980, Japan.	dairyoub4@hotmail.co.jp	Ito, Daisuke/F-4682-2015	Ito, Osamu/0000-0001-7583-5270; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23700593]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant to DI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23700593). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Aref ABM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/429154; BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849; Boor P, 2009, METABOLISM, V58, P1669, DOI 10.1016/j.metabol.2009.05.025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Delghingaro-Augusto V, 2012, AM J PHYSIOL-ENDOC M, V302, pE254, DOI 10.1152/ajpendo.00360.2011; Fujihara CK, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027354.12330.F4; Garvin JL, 2011, ANNU REV PHYSIOL, V73, P359, DOI 10.1146/annurev-physiol-012110-142247; Holdaas H., 2012, KIDNEY INT S, V2, P337, DOI [DOI 10.1038/KISUP.2012.46, 10.1038/kisup.2012.46]; Ihara G, 2010, J HYPERTENS, V28, P2289, DOI 10.1097/HJH.0b013e32833dfcda; Ito D, 2013, CLIN EXP PHARMACOL P, V40, P617, DOI 10.1111/1440-1681.12130; Ito D, 2013, CLIN EXP PHARMACOL P, V40, P74, DOI 10.1111/1440-1681.12040; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kamijo H, 2006, NEPHRON PHYSIOL, V104, P12, DOI 10.1159/000093276; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kiraly MA, 2008, AM J PHYSIOL-ENDOC M, V294, pE271, DOI 10.1152/ajpendo.00476.2007; Kiraly MA, 2010, AM J PHYSIOL-ENDOC M, V298, pE671, DOI 10.1152/ajpendo.90575.2008; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005; Mattson DL, 2000, HYPERTENSION, V35, P337, DOI 10.1161/01.HYP.35.1.337; Mizuno M, 2002, HYPERTENS RES, V25, P271, DOI 10.1291/hypres.25.271; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Muhammad AB, 2011, AM J PHYSIOL-RENAL, V300, pF98, DOI 10.1152/ajprenal.00386.2010; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; Rodrigues AM, 2011, EXP BIOL MED, V236, P1180, DOI 10.1258/ebm.2011.011005; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Sofue T, 2012, AM J HYPERTENS, V25, P604, DOI 10.1038/ajh.2012.1; Takenaka T, 2011, DIABETOLOGIA, V54, P2192, DOI 10.1007/s00125-011-2175-8; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Thent ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080436; Tojo A, 2006, MED MOL MORPHOL, V39, P2, DOI 10.1007/s00795-006-0310-2; Tufescu A, 2008, J HYPERTENS, V26, P312, DOI 10.1097/HJH.0b013e3282f2450b; VanHoose L, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-56; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Winiarska K, 2014, CHEM-BIOL INTERACT, V218, P12, DOI 10.1016/j.cbi.2014.04.005	42	46	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138037	10.1371/journal.pone.0138037	http://dx.doi.org/10.1371/journal.pone.0138037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379244	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400046
J	Chalermrujinanant, C; Michowski, W; Sittithumcharee, G; Esashi, F; Jirawatnotai, S				Chalermrujinanant, C.; Michowski, W.; Sittithumcharee, G.; Esashi, F.; Jirawatnotai, S.			Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation	ONCOGENE			English	Article							STRAND BREAK REPAIR; DNA-END RESECTION; HOMOLOGY-DIRECTED REPAIR; MANTLE CELL LYMPHOMA; GENOMIC STABILITY; DAMAGE REPAIR; CANCER; PROTEIN; GENE; RECOMBINATION	BRCA2 has an important role in the maintenance of genome stability by interacting with RAD51 recombinase through its C-terminal domain. This interaction is abrogated by cyclin A-CDK2-mediated phosphorylation of BRCA2 at serine 3291 (Ser3291). Recently, we showed that cyclin D1 facilitates RAD51 recruitment to BRCA2-containing DNA repair foci, and that downregulation of cyclin D1 leads to inefficient homologous-mediated DNA repair. Here, we demonstrate that cyclin D1, via amino acids 20-90, interacts with the C-terminal domain of BRCA2, and that this interaction is increased in response to DNA damage. Interestingly, CDK4-cyclin D1 does not phosphorylate Ser3291. Instead, cyclin D1 bars cyclin A from the C-terminus of BRCA2, prevents cyclin A-CDK2-dependent Ser3291 phosphorylation and facilitates RAD51 binding to the C-terminal domain of BRCA2. These findings indicate that the interplay between cyclin D1 and other cyclins such as cyclin A regulates DNA integrity through RAD51 interaction with the BRCA2 C-terminal domain.	[Chalermrujinanant, C.; Sittithumcharee, G.; Jirawatnotai, S.] Mahidol Univ, Siriraj Hosp, Fac Med, Lab Syst Pharmacol,Dept Pharmacol, 2 Prannok Rd,12th Floor Srisawarin Bldg, Bangkok 10700, Thailand; [Michowski, W.; Jirawatnotai, S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Esashi, F.] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England; [Jirawatnotai, S.] Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand	Mahidol University; Harvard University; Dana-Farber Cancer Institute; University of Oxford; Mahidol University	Jirawatnotai, S (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Lab Syst Pharmacol,Dept Pharmacol, 2 Prannok Rd,12th Floor Srisawarin Bldg, Bangkok 10700, Thailand.	siwanon.jir@mahidol.ac.th		Esashi, Fumiko/0000-0003-0902-2364	Thailand Research Fund [RSA5580018]; Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol University; Advanced Research on Pharmacology Fund, Siriraj Foundation [D003421]; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol University; Advanced Research on Pharmacology Fund, Siriraj Foundation; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	We thank Dr Piotr Sicinski, Dana-Farber Cancer Institute, in whose laboratory this work was initiated. This study was supported by Thailand Research Fund RSA5580018, Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol University, and the Advanced Research on Pharmacology Fund, Siriraj Foundation D003421. SJ was supported by the Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; BARTKOVA J, 1995, CANCER RES, V55, P949; BARTKOVA J, 1994, INT J CANCER, V58, P568, DOI 10.1002/ijc.2910580420; BARTKOVA J, 1995, ONCOGENE, V10, P775; BATES S, 1994, ONCOGENE, V9, P1633; Berman DB, 1996, CANCER RES, V56, P3409; Boonen GJJC, 1999, J BIOL CHEM, V274, P34676, DOI 10.1074/jbc.274.49.34676; BOSCH F, 1994, BLOOD, V84, P2726; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; DEBOER CJ, 1995, BLOOD, V86, P2715, DOI 10.1182/blood.V86.7.2715.bloodjournal8672715; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2012, EMBO REP, V13, P561, DOI 10.1038/embor.2012.58; GILLETT C, 1994, CANCER RES, V54, P1812; Goggins M, 1996, CANCER RES, V56, P5360; Gretarsdottir S, 1998, CANCER RES, V58, P859; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; JARES P, 1994, CANCER RES, V54, P4813; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; JavanMoghadam-Kamrani S, 2008, CELL CYCLE, V7, P2434, DOI 10.4161/cc.6364; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; JIANG W, 1992, CANCER RES, V52, P2980; Jirawatnotai S, 2012, CANCER RES, V72, P4289, DOI 10.1158/0008-5472.CAN-11-3549; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; KOMATSU H, 1993, BRIT J HAEMATOL, V85, P427, DOI 10.1111/j.1365-2141.1993.tb03194.x; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li ZP, 2014, CANCER RES, V74, P3959, DOI 10.1158/0008-5472.CAN-13-3137; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pefani DE, 2014, NAT CELL BIOL, V16, P962, DOI 10.1038/ncb3035; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shimura T, 2013, CELL CYCLE, V12, P2738, DOI 10.4161/cc.25746; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yata K, 2014, CELL REP, V7, P1547, DOI 10.1016/j.celrep.2014.04.023; Yata K, 2012, MOL CELL, V45, P371, DOI 10.1016/j.molcel.2011.12.028; Yu VPCC, 2000, GENE DEV, V14, P1400; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	60	12	12	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2815	2823		10.1038/onc.2015.354	http://dx.doi.org/10.1038/onc.2015.354			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387543	Green Accepted			2022-12-26	WOS:000377473700001
J	Chang, CC; Pirozzi, G; Wen, SH; Chung, IH; Chiu, BL; Errico, S; Luongo, M; Lombardi, ML; Ferrone, S				Chang, Chien-Chung; Pirozzi, Giuseppe; Wen, Shao-Hsuan; Chung, I-Hsin; Chiu, Bau-Lin; Errico, Simona; Luongo, Monica; Lombardi, Maria Luisa; Ferrone, Soldano			Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES; HLA HAPLOTYPE LOSS; ENDOPLASMIC-RETICULUM; IMMUNE SELECTION; MALIGNANT-CELLS; DOWN-REGULATION; SOLID TUMORS; LUNG-CANCER; TAPASIN	Scant information is available about the molecular basis of multiple HLA class I antigen-processing machinery defects in malignant cells, although this information contributes to our understanding of the molecular immunoescape mechanisms utilized by tumor cells and may suggest strategies to counteract them. In the present study we reveal a combination of IFN-gamma-irreversible structural and epigenetic defects in HLA class I antigen-processing machinery in a recurrent melanoma metastasis after immunotherapy. These defects include loss of tapasin and one HLA haplotype as well as selective silencing of HLA-A3 gene responsiveness to IFN-gamma. Tapasin loss is caused by a germline frameshift mutation in exon 3 (TAPBP(684delA)) along with a somatic loss of the other gene copy. Selective silencing of HLA-A3 gene and its IFN-gamma responsiveness is associated with promoter CpG methylation nearby site-alpha and TATA box, reversible after DNA methyltransferase 1 depletion. This treatment combined with tapasin reconstitution and IFN-gamma stimulation restored the highest level of HLA class I expression and its ability to elicit cytotoxic T cell responses. These results represent a novel tumor immune evasion mechanism through impairing multiple components at various levels in the HLA class I antigen presentation pathway. These findings may suggest a rational design of combinatorial cancer immunotherapy harnessing DNA demethylation and IFN-gamma response.	[Chang, Chien-Chung; Wen, Shao-Hsuan; Chung, I-Hsin; Chiu, Bau-Lin] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Pirozzi, Giuseppe; Errico, Simona; Luongo, Monica; Lombardi, Maria Luisa] Natl Canc Inst, Dept Expt Oncol, I-80131 Naples, Italy; [Ferrone, Soldano] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA; [Ferrone, Soldano] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02114 USA	National Tsing Hua University; IRCCS Fondazione Pascale; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chang, CC (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101 Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	ccchang@life.nthu.edu.tw		Errico, Simona/0000-0002-2873-9339	Ministry of Science and Technology [NSC97-2320-B-007-001-MY3, NSC98-2320-B-007-004-MY3, MOST 103-2320-B-007-005]; Department of Health and Human Services, Public Health Service, National Institutes of Health [RO1 CA138188]; MURST, Cluster 03; NATIONAL CANCER INSTITUTE [R01CA138188] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health and Human Services, Public Health Service, National Institutes of Health; MURST, Cluster 03(Ministry of Education, Universities and Research (MIUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ministry of Science and Technology Grants NSC97-2320-B-007-001-MY3, NSC98-2320-B-007-004-MY3, and MOST 103-2320-B-007-005 (to C.-C. C), Department of Health and Human Services, Public Health Service, National Institutes of Health Grant RO1 CA138188 (NCI; to S. F.), and MURST, Cluster 03 (to M. L. L). The authors declare that they have no conflicts of interest with the content of this article.	Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Belicha-Villanueva A, 2008, IMMUNOLOGY, V124, P112, DOI 10.1111/j.1365-2567.2007.02746.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Chang CC, 2005, ADV CANCER RES, V93, P189, DOI 10.1016/S0065-230X(05)93006-6; Chang CC, 2005, J IMMUNOL, V174, P1462, DOI 10.4049/jimmunol.174.3.1462; Chang CC, 2007, CANCER IMMUNOL IMMUN, V56, P227, DOI 10.1007/s00262-006-0183-1; Chang CC, 2006, J BIOL CHEM, V281, P18763, DOI 10.1074/jbc.M511525200; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dai W, 2015, CANCER MED-US, V4, P1079, DOI 10.1002/cam4.451; Dissemond J, 2003, ARCH DERMATOL RES, V295, P43, DOI 10.1007/s00403-003-0393-8; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gollob JA, 2006, CLIN CANCER RES, V12, P4619, DOI 10.1158/1078-0432.CCR-06-0883; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hsueh EC, 2003, SEMIN CANCER BIOL, V13, P401, DOI 10.1016/j.semcancer.2003.09.003; Jimenez P, 1999, INT J CANCER, V83, P91, DOI 10.1002/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.0.CO;2-4; Kloor M, 2005, CANCER RES, V65, P6418, DOI 10.1158/0008-5472.CAN-05-0044; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; KUSAMA M, 1989, J IMMUNOL, V143, P3844; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; Lee YG, 2013, BRIT J HAEMATOL, V161, P339, DOI 10.1111/bjh.12256; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Leonhardt RM, 2014, J IMMUNOL, V192, P2480, DOI 10.4049/jimmunol.1302637; Mani S, 2010, ADV GENET, V70, P327, DOI [10.1016/B978-0-12-380866-0.60012-5, 10.1016/S0065-2660(10)70012-2]; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; MoreauAubry A, 1997, INT J ONCOL, V10, P841; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Ogino T, 2003, TISSUE ANTIGENS, V62, P385, DOI 10.1034/j.1399-0039.2003.00114.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PEROSA F, 1988, HUM IMMUNOL, V23, P255, DOI 10.1016/0198-8859(88)90061-4; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Ramal LM, 2000, TISSUE ANTIGENS, V55, P443, DOI 10.1034/j.1399-0039.2000.550507.x; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rodriguez T, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-34; Seliger B, 2001, CANCER RES, V61, P8647; Sernee MF, 1998, MOL IMMUNOL, V35, P177, DOI 10.1016/S0161-5890(98)00026-1; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sheyhidin I, 2014, ASIAN PAC J CANCER P, V15, P10299, DOI 10.7314/APJCP.2014.15.23.10299; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Wang X, 2003, TISSUE ANTIGENS, V62, P139, DOI 10.1034/j.1399-0039.2003.00087.x; Wang XH, 2005, J IMMUNOL METHODS, V299, P139, DOI 10.1016/j.jim.2005.02.006; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yabe T, 2002, BLOOD, V100, P1496, DOI 10.1182/blood-2001-12-0252; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863, DOI 10.4049/jimmunol.174.11.6863	53	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26562	26575		10.1074/jbc.M115.676130	http://dx.doi.org/10.1074/jbc.M115.676130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26381407	hybrid, Green Published			2022-12-26	WOS:000364793600023
J	Cheng, CH; Lin, CT; Lee, MJ; Tsai, MJ; Huang, WH; Huang, MC; Lin, YL; Chen, CJ; Huang, WC; Cheng, H				Cheng, Chu-Hsun; Lin, Chi-Te; Lee, Meng-Jen; Tsai, May-Jywan; Huang, Wen-Hung; Huang, Ming-Chao; Lin, Yi-Lo; Chen, Ching-Jung; Huang, Wen-Cheng; Cheng, Henrich			Local Delivery of High-Dose Chondroitinase ABC in the Sub-Acute Stage Promotes Axonal Outgrowth and Functional Recovery after Complete Spinal Cord Transection	PLOS ONE			English	Article							SULFATE PROTEOGLYCANS NEUROCAN; INHIBITS NEURITE OUTGROWTH; GLIAL SCAR; CONTUSION INJURY; FIBROTIC SCAR; NOGO-A; REGENERATION; RAT; BRAIN; NUCLEUS	Chondroitin sulfate proteoglycans (CSPGs) are glial scar-associated molecules considered axonal regeneration inhibitors and can be digested by chondroitinase ABC (ChABC) to promote axonal regeneration after spinal cord injury (SCI). We previously demonstrated that intrathecal delivery of low-dose ChABC (1 U) in the acute stage of SCI promoted axonal regrowth and functional recovery. In this study, high-dose ChABC (50 U) introduced via intrathecal delivery induced subarachnoid hemorrhage and death within 48 h. However, most SCI patients are treated in the sub-acute or chronic stages, when the dense glial scar has formed and is minimally digested by intrathecal delivery of ChABC at the injury site. The present study investigated whether intraparenchymal delivery of ChABC in the sub-acute stage of complete spinal cord transection would promote axonal outgrowth and improve functional recovery. We observed no functional recovery following the low-dose ChABC (1 U or 5 U) treatments. Furthermore, animals treated with high-dose ChABC (50 U or 100 U) showed decreased CSPGs levels. The extent and area of the lesion were also dramatically decreased after ChABC treatment. The outgrowth of the regenerating axons was significantly increased, and some partially crossed the lesion site in the ChABC-treated groups. In addition, retrograde Fluoro-Gold (FG) labeling showed that the outgrowing axons could cross the lesion site and reach several brain stem nuclei involved in sensory and motor functions. The Basso, Beattie and Bresnahan (BBB) open field locomotor scores revealed that the ChABC treatment significantly improved functional recovery compared to the control group at eight weeks after treatment. Our study demonstrates that high-dose ChABC treatment in the sub-acute stage of SCI effectively improves glial scar digestion by reducing the lesion size and increasing axonal regrowth to the related functional nuclei, which promotes locomotor recovery. Thus, our results will aid in the treatment of spinal cord injury.	[Cheng, Chu-Hsun; Cheng, Henrich] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Cheng, Chu-Hsun; Cheng, Henrich] Acad Sinica, Taipei 115, Taiwan; [Cheng, Chu-Hsun; Cheng, Henrich] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Cheng, Chu-Hsun; Lin, Chi-Te; Lee, Meng-Jen; Tsai, May-Jywan; Huang, Wen-Hung; Huang, Ming-Chao; Lin, Yi-Lo; Chen, Ching-Jung; Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neural Regenerat Lab, Dept Neurosurg, Neurol Inst, Taipei, Taiwan; [Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Ctr Neural Regenerat, Neurol Inst, Taipei, Taiwan; [Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Huang, Wen-Cheng; Cheng, Henrich] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Huang, Ming-Chao] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan; [Huang, Ming-Chao] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lin, Yi-Lo] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Coll Vet Med, Taichung 40227, Taiwan; [Lee, Meng-Jen] Chaoyang Univ Technol, Dept Appl Chem, Taichung, Taiwan; [Lin, Chi-Te] Cent Taiwan Univ Sci & Technol, Dept Nursing, Taichung, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; National Chung Hsing University; Chaoyang University of Technology; Central Taiwan University Science & Technology	Huang, WC (corresponding author), Taipei Vet Gen Hosp, Neural Regenerat Lab, Dept Neurosurg, Neurol Inst, Taipei, Taiwan.	wchuang518@gmail.com	huang, wen/GXW-0661-2022	Huang, Wen-Cheng/0000-0003-4249-710X	National Science Council in Taiwan [NSC 98-2314-B-075-007-MY2, NSC103-2314-B-075-033, NSC103-2314-B-010-29]; Taipei Veterans General Hospital in Taiwan [VGH103-E6-001, VGH104-E6-001]; Ministry of Education	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital in Taiwan; Ministry of Education	This work was supported financially by research grants from the National Science Council in Taiwan (NSC 98-2314-B-075-007-MY2 and NSC103-2314-B-075-033 to W.C. Huang and NSC103-2314-B-010-29 to H. Cheng), the Taipei Veterans General Hospital in Taiwan (VGH103-E6-001 and VGH104-E6-001 to H. Cheng), and the Ministry of Education (Aim for the Top University Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; Demircan K, 2013, NEUROSCI LETT, V544, P25, DOI 10.1016/j.neulet.2013.02.064; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Huang WC, 2010, NEUROSCI LETT, V472, P79, DOI 10.1016/j.neulet.2010.01.012; Iseda T, 2008, J NEUROTRAUM, V25, P334, DOI 10.1089/neu.2007.0289; Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kuchler M, 2002, J COMP NEUROL, V448, P349, DOI 10.1002/cne.10259; Lee DH, 2013, NEUROSCI BULL, V29, P436, DOI 10.1007/s12264-013-1365-4; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Li HP, 2007, J NEUROSCI RES, V85, P536, DOI 10.1002/jnr.21141; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Milbreta U, 2014, J NEUROTRAUM, V31, P803, DOI 10.1089/neu.2013.3143; Min SH, 2011, SPINE, V36, pE155, DOI 10.1097/BRS.0b013e3181d8b92a; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; MOSKOWITZ PF, 1993, J NEUROSCI RES, V34, P129, DOI 10.1002/jnr.490340113; Mountney A, 2013, J NEUROTRAUM, V30, P181, DOI 10.1089/neu.2012.2353; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; Oertle T, 2003, J NEUROSCI, V23, P5393; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793; Seif GI, 2007, J NEUROTRAUM, V24, P1513, DOI 10.1089/neu.2007.0323; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006; Tom VJ, 2009, J NEUROTRAUM, V26, P2323, DOI 10.1089/neu.2009.1047; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Xia YZ, 2008, BIOCHEM BIOPH RES CO, V377, P562, DOI 10.1016/j.bbrc.2008.10.024; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang YG, 2009, J INT MED RES, V37, P1097, DOI 10.1177/147323000903700414; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yoshioka N, 2011, J NEUROSCI RES, V89, P381, DOI 10.1002/jnr.22552; Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276	65	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138705	10.1371/journal.pone.0138705	http://dx.doi.org/10.1371/journal.pone.0138705			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393921	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100090
J	Eich, A; Mildenberger, T; Laforsch, C; Weber, M				Eich, Andreas; Mildenberger, Tobias; Laforsch, Christian; Weber, Miriam			Biofilm and Diatom Succession on Polyethylene (PE) and Biodegradable Plastic Bags in Two Marine Habitats: Early Signs of Degradation in the Pelagic and Benthic Zone?	PLOS ONE			English	Article							POLYMERS; DEBRIS; SEA; PHOTOOXIDATION; ENVIRONMENT; ADHESION; LITTER	The production of biodegradable plastic is increasing. Given the augmented littering of these products an increasing input into the sea is expected. Previous laboratory experiments have shown that degradation of plastic starts within days to weeks. Little is known about the early composition and activity of biofilms found on biodegradable and conventional plastic debris and its correlation to degradation in the marine environment. In this study we investigated the early formation of biofilms on plastic shopper bags and its consequences for the degradation of plastic. Samples of polyethylene and biodegradable plastic were tested in the Mediterranean Sea for 15 and 33 days. The samples were distributed equally to a shallow benthic (sedimentary seafloor at 6 m water depth) and a pelagic habitat (3 m water depth) to compare the impact of these different environments on fouling and degradation. The amount of biofilm increased on both plastic types and in both habitats. The diatom abundance and diversity differed significantly between the habitats and the plastic types. Diatoms were more abundant on samples from the pelagic zone. We anticipate that specific surface properties of the polymer types induced different biofilm communities on both plastic types. Additionally, different environmental conditions between the benthic and pelagic experimental site such as light intensity and shear forces may have influenced unequal colonisation between these habitats. The oxygen production rate was negative for all samples, indicating that the initial biofilm on marine plastic litter consumes oxygen, regardless of the plastic type or if exposed in the pelagic or the benthic zone. Mechanical tests did not reveal degradation within one month of exposure. However, scanning electron microscopy (SEM) analysis displayed potential signs of degradation on the plastic surface, which differed between both plastic types. This study indicates that the early biofilm formation and composition are affected by the plastic type and habitat. Further, it reveals that already within two weeks biodegradable plastic shows signs of degradation in the benthic and pelagic habitat.	[Eich, Andreas; Mildenberger, Tobias] Univ Bremen, Dept Biol Chem, D-28359 Bremen, Germany; [Laforsch, Christian] Univ Bayreuth, Anim Ecol 1, D-95447 Bayreuth, Germany; [Laforsch, Christian] BayCEER, D-95447 Bayreuth, Germany; [Weber, Miriam] HYDRA Inst Marine Sci, Elba Field Stn, I-57034 Campo Nellelba, Italy	University of Bremen; University of Bayreuth; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Weber, M (corresponding author), HYDRA Inst Marine Sci, Elba Field Stn, I-57034 Campo Nellelba, Italy.	m.weber@hydra-institute.com	Mildenberger, Tobias/K-3951-2019	Mildenberger, Tobias/0000-0002-6631-7524; Eich, Andreas/0000-0002-9547-6487	Erasmus internship fund; University of Bayreuth; HYDRA Institute for Marine Sciences; Aqueis e.V.	Erasmus internship fund; University of Bayreuth; HYDRA Institute for Marine Sciences; Aqueis e.V.	Funding: This study was funded by an Erasmus internship fund (http://ec.europa.eu/programmes/erasmus-plus/index_en.htm) for AE and TM. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore the University of Bayreuth (http://www.en.uni-bayreuth.de/home/index.html), the HYDRA Institute for Marine Sciences (http://www.hydra-institute.com/en/) and Aqueis e.V. (http://www.aqueis.org/) contributed to project funding. MW (HYDRA) and CL (University of Bayreuth) contributed to experimental design, data analysis, writing and materials.	Abdel-Bary EM, 2003, HDB PLAST FILMS; Accinelli C, 2012, CHEMOSPHERE, V89, P136, DOI 10.1016/j.chemosphere.2012.05.028; Andrady A. L, 2003, PLASTICS ENV, P389, DOI DOI 10.1002/0471721557.CH10; [Anonymous], 2000, 13432 EN EUR COMM; Artham T, 2008, MACROMOL BIOSCI, V8, P14, DOI 10.1002/mabi.200700106; Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; ASTM International, 2000, D88300 ASTM INT; Bettighofer W, MICROSCOPE; COOKSEY KE, 1995, AQUAT MICROB ECOL, V9, P87, DOI 10.3354/ame009087; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; European Bioplastics, 2013, BIOPL FACTS FIG; Fox J., 2018, R COMPANION APPL REG, VThird; GEUSKENS G, 1979, PURE APPL CHEM, V51, P233, DOI 10.1351/pac197951020233; Goldberg ED, 1997, ENVIRON TECHNOL, V18, P195, DOI 10.1080/09593331808616527; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Imhof HK, 2013, CURR BIOL, V23, pR867, DOI 10.1016/j.cub.2013.09.001; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Katsanevakis S, 2007, MAR POLLUT BULL, V54, P771, DOI 10.1016/j.marpolbul.2006.12.016; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Maran JP, 2014, CARBOHYD POLYM, V101, P20, DOI 10.1016/j.carbpol.2013.08.080; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Morales M, 2012, SCIPLOT SCI GRAPHING; Muthukumar T., 2014, J MICROB BIOCH TECHN, V6, P116, DOI DOI 10.4172/1948-5948.1000131; [NOAA UNEP], 2011, HON STRAT A GLOB FRA; O'Brine T, 2010, MAR POLLUT BULL, V60, P2279, DOI 10.1016/j.marpolbul.2010.08.005; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Patil JS, 2005, BIOFOULING, V21, P181, DOI 10.1080/08927010500241726; Patil JS, 2005, BIOFOULING, V21, P189, DOI 10.1080/08927010500256757; PlasticsEurope, 2013, PLAST THE FACTS 2013; RAGHAVAN D, 1995, POLYM-PLAST TECHNOL, V34, P41, DOI 10.1080/03602559508017212; Rasband WS, 2012, IMAGE J; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rios LM, 2007, MAR POLLUT BULL, V54, P1230, DOI 10.1016/j.marpolbul.2007.03.022; Rutkowska M, 2002, POL J ENVIRON STUD, V11, P267; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sudhakar M, 2007, POLYM DEGRAD STABIL, V92, P1743, DOI 10.1016/j.polymdegradstab.2007.03.029; Sutherland DGJ, 1996, APPL PHYS LETT, V68, P2046, DOI 10.1063/1.116298; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Tosin M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00225; Tsukii Y, 2004, PROTIST INFORM SERVE; UNEP, 2011, UNEP YB; UNEP, 2001, MAR LITT TRASH KILLS; UNESCO, 1994, INTERGOV OCEANOGR CO, V42, P1; Williams AT, 1999, WATER AIR SOIL POLL, V112, P197, DOI 10.1023/A:1005000724803; YE S, 1991, Marine Pollution Bulletin, V22, P608, DOI 10.1016/0025-326X(91)90249-R; Zardus JD, 2008, BIOL BULL-US, V214, P91, DOI 10.2307/25066663; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	48	92	93	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137201	10.1371/journal.pone.0137201	http://dx.doi.org/10.1371/journal.pone.0137201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394047	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100010
J	Kawano, M; Tanaka, K; Itonaga, I; Iwasaki, T; Tsumura, H				Kawano, Masanori; Tanaka, Kazuhiro; Itonaga, Ichiro; Iwasaki, Tatsuya; Tsumura, Hiroshi			c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line	PLOS ONE			English	Article							COLORECTAL-CANCER; DOWN-REGULATION; EXPRESSION; FAMILY; LYMPHOMAS; PROTEIN; TARGET; GENE; METASTASIS; METABOLISM	Myc oncogenic transcription factor is known to inhibit tumor suppressive microRNAs (miRNAs), resulting in greater expression of their target protein related to cell cycle, invasion or anti-apoptotic factors in human cancer cells. To explore possible oncogenic factors in Ewing's sarcoma (ES), we conducted microarray-based approach to profile the changes in the expression of miRNAs and its downstream mRNAs in five ES cell lines and human mesenchymal stem cells (hMSCs). Three miRNAs, let-7a, miR-16 and miR-29b were significantly down-regulated, whereas c-Myc and cyclin D2 (CCND2) were significantly up-regulated in all tested ES cells compared with hMSCs. To verify that let-7a, miR16 and miR-29b were the targets of c-Myc in ES cell lines, we transfected siRNA against c-Myc and confirmed the coordinate up-regulation of let-7a, miR-16 and miR-29b through the repression of c-Myc. The ES cells transfected with c-Myc-siRNA and let-7a, miR-16 and miR-29b exhibited the inhibition of the cell cycle progression. The increased expression of let-7a, miR-16 and miR-29b resulted in the reduction of CCND2 protein expression. We also demonstrated that c-Myc-siRNA treatment of ES cells was associated with the decreased expression of CCND2 as a down-stream of three miRNAs. Furthermore, the introduction of let-7a, miR-16 and miR-29b in ES cells could inhibit the c-Myc-mediated up-regulation of CCND2 resulted in the prevention of cell cycle progression. In addition, the transfection of let-7a, miR-16 and miR-29b in ES cells suppressed tumor growth ex vivo treatment. These findings suggests that the up-regulation of c-Myc inhibited the expression of let-7a, miR-16 and miR-29b subsequently induced CCND2 expression in ES cells. The present study might identify a novel oncogenic axis that c-Myc regulates the expression of CCND2 via let-7a, miR-16 and miR-29b, leading to the development new therapeutic targets for ES.	[Kawano, Masanori; Tanaka, Kazuhiro; Itonaga, Ichiro; Iwasaki, Tatsuya; Tsumura, Hiroshi] Oita Univ, Fac Med, Dept Orthopaed Surg, Oita 87011, Japan	Oita University	Tanaka, K (corresponding author), Oita Univ, Fac Med, Dept Orthopaed Surg, Oita 87011, Japan.	ktanaka@oita-u.ac.jp	Tanaka, Kazuhiro/Q-7387-2019	Tanaka, Kazuhiro/0000-0002-5138-8952	National Cancer Center Research and Development Fund [26-A-4]; Health and Labour Sciences Research Expenses for Commission; Ministry of Health, Labour and Welfare [H26-084]; Japan Society for the Promotion of Science [24592250]; Grants-in-Aid for Scientific Research [26861200] Funding Source: KAKEN	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Health and Labour Sciences Research Expenses for Commission; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Cancer Center Research and Development Fund (26-A-4), the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer (H26-084) from the Ministry of Health, Labour and Welfare, and the Grants-in-Aid for Scientific Research (No. 24592250) from Japan Society for the Promotion of Science.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Bai M, 2004, MODERN PATHOL, V17, P1338, DOI 10.1038/modpathol.3800183; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Bui Thi V, 2010, Genes Cancer, V1, P568; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gong JN, 2014, CELL DEATH DIFFER, V21, P100, DOI 10.1038/cdd.2013.133; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ke Y, 2013, FEBS LETT, V587, P3153, DOI 10.1016/j.febslet.2013.08.010; Kenneth NS, 2009, CURR OPIN GENET DEV, V19, P38, DOI 10.1016/j.gde.2008.11.012; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Li YJ, 2013, EXP CELL RES, V319, P1094, DOI 10.1016/j.yexcr.2013.02.002; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu JL, 2012, LIFE SCI, V90, P1020, DOI 10.1016/j.lfs.2012.05.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Rodriguez-Galindo C, 2008, ANN ONCOL, V19, P814, DOI 10.1093/annonc/mdm521; Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x; Sarkar R, 2010, COLORECTAL DIS, V12, P316, DOI 10.1111/j.1463-1318.2009.01829.x; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soria-Valles C, 2014, ONCOGENE, V33, P3054, DOI 10.1038/onc.2013.267; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095249; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594; Zhang P, 2012, MOL BIOL REP, V39, P1471, DOI 10.1007/s11033-011-0884-1; Zhang X, 2012, ONCOGENE, V31, P3002, DOI 10.1038/onc.2011.470; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003	40	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138560	10.1371/journal.pone.0138560	http://dx.doi.org/10.1371/journal.pone.0138560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393798	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100071
J	Takacs, P; Eros, T; Specziar, A; Saly, P; Vital, Z; Ferincz, A; Molnar, T; Szabolcsi, Z; Biro, P; Csoma, E				Takacs, Peter; Eros, Tibor; Specziar, Andras; Saly, Peter; Vital, Zoltan; Ferincz, Arpad; Molnar, Tamas; Szabolcsi, Zoltan; Biro, Peter; Csoma, Eszter			Population Genetic Patterns of Threatened European Mudminnow (Umbra krameri Walbaum, 1792) in a Fragmented Landscape: Implications for Conservation Management	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; MAXIMUM-LIKELIHOOD-ESTIMATION; RIVER SYSTEMS; SOFTWARE; UNITS; IDENTIFICATION; FLOODPLAIN; HISTORY; FLOW; RAT	The European mudminnow (Umbra krameri) is a Middle Danubian endemic fish species, which is characterised by isolated populations living mainly in artificial habitats in the centre of its range, in the Carpathian Basin. For their long term preservation, reliable information is needed about the structure of stocks and the level of isolation. The recent distribution pattern, and the population genetic structure within and among regions were investigated to designate the Evolutionary Significant, Conservation and Management Units (ESUs, CUs, MUs) and to explore the conservation biological value of the shrinking populations. In total, eight microsatellite loci were studied in 404 specimens originating from eight regions. The results revealed a pronounced population structure, where strictly limited gene flow was detected among regions, as well as various strengths of connections within regions. Following the results of hierarchical structure analyses, two ESUs were supposed in the Carpathian Basin, corresponding to the Danube and Tisza catchments. Our results recommend designating the borders of CUs in an 80-90km range and 16 clusters should be set up as MUs for the 33 investigated populations. How these genetic findings can be used to better allocate conservation resources for the long term maintenance of the metapopulation structure of this threathened endemic fish is discussed.	[Takacs, Peter; Eros, Tibor; Specziar, Andras; Saly, Peter; Vital, Zoltan; Biro, Peter] MTA, Ctr Ecol Res, Balaton Limnol Inst, Tihany, Hungary; [Ferincz, Arpad] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary; [Molnar, Tamas] Kaposvar Univ, Nat Conservat Dept, Kaposvar, Hungary; [Szabolcsi, Zoltan] Network Forens Sci Inst, Inst Forens Med, Budapest, Hungary; [Csoma, Eszter] Univ Debrecen, Dept Med Microbiol, Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Kaposvar University; University of Debrecen	Takacs, P (corresponding author), MTA, Ctr Ecol Res, Balaton Limnol Inst, Tihany, Hungary.	takacs.peter@okologia.mta.hu	Takács, Péter/A-8082-2016; Biro, Peter/CAJ-0232-2022; Molnar, Tamas/H-7945-2019; Vitál, Zoltán/M-8322-2019; Specziár, András/N-5656-2019; Vitál, Zoltán/GXF-7227-2022; Eros, Tibor/I-1671-2019; Molnár, Tamás/F-2206-2013	Takács, Péter/0000-0001-5247-7597; Biro, Peter/0000-0002-2855-4991; Specziár, András/0000-0001-6341-636X; VITAL, Zoltan/0000-0001-7832-082X; Ferincz, Arpad/0000-0003-2420-0245; Molnar, Tamas/0000-0003-1752-4268	Hungarian Scientific Research Fund [OTKA CNK 80140]; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0038]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF))	This work was supported by a Grant of the Hungarian Scientific Research Fund, Grant number: OTKA CNK 80140 (Website: http://www.blki.hu/otka_cnk_80140/index.html); a Grant of the European Social Fund, Grant number: TAMOP-4.2.2.A-11/1/KONV-2012-0038 (Website:http://bki.ke.hu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW., 2009, CONSERV GENET; Alves MJ, 2001, HEREDITY, V87, P463, DOI 10.1046/j.1365-2540.2001.00929.x; Ambrus A., 2014, Pisces Hungarici, V8, P97; Anderson W. Gary, 1997, North American Journal of Fisheries Management, V17, P301, DOI 10.1577/1548-8675(1997)017<0301:TUOCOA>2.3.CO;2; Bajomi B, 2013, GLOBAL REINTRODUCTIO, P15; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bij de Vaate A, 2002, GEOGRAPHICAL PATTERN; Brauer CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082953; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Danko I, 1979, HAJDU BIHAR MEGYEI L, V6, P5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diniz JAF, 2002, CONSERV BIOL, V16, P924, DOI 10.1046/j.1523-1739.2002.00295.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eros T., 2008, HAL SZAT, V101, P75; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Freyhof J., 2014, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.1996.RLTS.T19855A9026693.en; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gabris Gy, 2007, FOLDRAJZI ERTESITO, V56, P39; Gabris G, 2007, QUATERNARY SCI REV, V26, P2758, DOI 10.1016/j.quascirev.2007.06.030; Gaudant J, 2012, NEUES JAHRB GEOL P-A, V263, P93, DOI 10.1127/0077-7749/2012/0214; Hajdu Juraj, 2002, Folia Faunistica Slovaca, V7, P75; Haraszty L, 2014, NATURA 2000 FAJOK EL, P955; Harka A, 1999, HALASZAT, V92, P119; Harka A, 2003, PUSZTA, V18, P49; Herman O, 1887, KIRALYI MAGYAR TERME; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hudman SP, 2013, FRESHWATER BIOL, V58, P441, DOI 10.1111/fwb.12079; IUCN, 2003, 2003 IUCN RED LIST T; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karolyi Zs, 1971, SERIES HYDRAULIC ENG, V3, P65; Kondolf GM, 2006, ECOL SOC, V11; Kuehne LM, 2014, FISHERIES, V39, P341, DOI 10.1080/03632415.2014.933318; Laszloffy W, 1982, TISZA, P610; Leel-Ossy S, 1953, FOLDRAJZI ERTESITO, V2, P70; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LELEK A, 1987, FRESHWATER FISHES EU; Lynch M, 1999, GENETICS, V152, P1753; MANTEL N, 1967, CANCER RES, V27, P209; Martonne Erdos K, 2004, MAGYARORSZAG TERMESZ, P245; Meybeck M, 2003, PHILOS T R SOC B, V358, P1935, DOI 10.1098/rstb.2003.1379; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Muller T, 2014, VESZELYEZTETETT LAPI, P11; Muller Tamas, 2011, Pisces Hungarici, V5, P15; NAGABABU E, 1992, BIOCHEM PHARMACOL, V43, P2393, DOI 10.1016/0006-2952(92)90318-D; Nagy L, 2013, 17 MAG HIDR; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pekarik L, 2014, FUND APPL LIMNOL, V184, P151, DOI 10.1127/1863-9135/2014/0477; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reshetnikov A. N., 2010, Russian Journal of Biological Invasions, V1, P119, DOI 10.1134/S2075111710020116; Reshetnikov AN, 2013, AQUAT INVASIONS, V8, P193, DOI 10.3391/ai.2013.8.2.07; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruszkiczay-Rudiger Z., 2007, FOLDRAJZI KOZLEMENYE, V131, P319; Sallai Z., 2005, PUSZTA, V1, P113; Sanderson EW, 2006, BIOSCIENCE, V56, P911, DOI 10.1641/0006-3568(2006)56[911:HMADWW]2.0.CO;2; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Szabo Zs, 2010, AGR INFORM, V1, P40; Takacs P, 2015, HALASZAT IN PRESS, P108; Tatar S, 2015, ORYX IN PRESS; Timar G, 2008, GEOMORPHOLOGY, V98, P250, DOI 10.1016/j.geomorph.2006.12.031; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vital Z, 2012, LOCALITY BESIDE HUNG, V105, P6; Wanzenboeck J., 1995, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V97, P439; Williams JD, 1980, WETLAND FUNCTIONS VA, P565; Winkler KA, 2009, CONSERV GENET, V10, P1155, DOI 10.1007/s10592-008-9731-x	82	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138640	10.1371/journal.pone.0138640	http://dx.doi.org/10.1371/journal.pone.0138640			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393510	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100079
J	Kinyanjui, TM; House, TA; Kiti, MC; Cane, PA; Nokes, DJ; Medley, GF				Kinyanjui, Timothy M.; House, Thomas A.; Kiti, Moses C.; Cane, Patricia A.; Nokes, David J.; Medley, Graham F.			Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; SOCIAL CONTACTS; YOUNG-CHILDREN; BIRTH COHORT; RURAL KENYA; INFECTION; INFANTS; LIVE; IMPACT; AGE	Background Respiratory syncytial virus (RSV) is globally ubiquitous, and infection during the first six months of life is a major risk for severe disease and hospital admission; consequently RSV is the most important viral cause of respiratory morbidity and mortality in young children. Development of vaccines for young infants is complicated by the presence of maternal antibodies and immunological immaturity, but vaccines targeted at older children avoid these problems. Vaccine development for young infants has been unsuccessful, but this is not the case for older children (> 6m). Would vaccinating older children have a significant public health impact? We developed a mathematical model to explore the benefits of a vaccine against RSV. Methods and Findings We have used a deterministic age structured model capturing the key epidemiological characteristics of RSV and performed a statistical maximum-likelihood fit to age-specific hospitalization data from a developing country setting. To explore the effects of vaccination under different mixing assumptions, we included two versions of contact matrices: one from a social contact diary study, and the second a synthesised construction based on demographic data. Vaccination is assumed to elicit an immune response equivalent to primary infection. Our results show that immunisation of young children (5-10m) is likely to be a highly effective method of protection of infants (<6m) against hospitalisation. The majority benefit is derived from indirect protection (herd immunity). A full sensitivity and uncertainty analysis using Latin Hypercube Sampling of the parameter space shows that our results are robust to model structure and model parameters. Conclusions This result suggests that vaccinating older infants and children against RSV can have a major public health benefit.	[Kinyanjui, Timothy M.; House, Thomas A.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [House, Thomas A.] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England; [House, Thomas A.] Univ Warwick, WIDER, Coventry CV4 7AL, W Midlands, England; [Kiti, Moses C.; Nokes, David J.] Kenya Med Res Inst KEMRI Wellcome Trust Res P, KEMRI Ctr Geog Med Res Coast, Kilifi, Kenya; [Cane, Patricia A.] Publ Hlth England, Salisbury, Wilts, England; [Nokes, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Nokes, David J.] Univ Warwick, WIDER, Coventry CV4 7AL, W Midlands, England; [Medley, Graham F.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England	University of Manchester; University of Warwick; University of Warwick; Kenya Medical Research Institute; Public Health England; University of Warwick; University of Warwick; University of London; London School of Hygiene & Tropical Medicine	Kinyanjui, TM (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	timothymuiruri.kinyanjui@manchester.ac.uk	Medley, Graham/B-7289-2008; Kinyanjui, Timothy/S-8489-2019; Kiti, Moses Chapa/ABE-8183-2020; Kiti, Moses Chapa/I-1175-2015	Medley, Graham/0000-0002-0030-7278; Kiti, Moses Chapa/0000-0003-2338-9170; Kiti, Moses Chapa/0000-0003-2338-9170; House, Thomas/0000-0001-5835-8062; Kinyanjui, Timothy/0000-0001-5461-4946	Wellcome Trust, UK [077092, 084633, 098556]; Engineering and Physical Sciences Research Council [EP/J002437/2, EP/K026550/2] Funding Source: researchfish; EPSRC [EP/J002437/2, EP/K026550/2] Funding Source: UKRI	Wellcome Trust, UK(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by The Wellcome Trust, UK [077092], [084633], [098556], TMK MCK DJN, http://www.wellcome.ac.uk/.	Acedo L, 2010, EPIDEMIOL INFECT, V138, P853, DOI 10.1017/S0950268809991373; Agoti CN, 2012, J INFECT DIS, V206, P1532, DOI 10.1093/infdis/jis570; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Anderson R M, 1984, IMA J Math Appl Med Biol, V1, P233; Armstrong GL, 2007, PEDIATRICS, V119, pE22, DOI 10.1542/peds.2006-1572; Bernstein DI, 2012, PEDIATR INFECT DIS J, V31, P109, DOI 10.1097/INF.0b013e31823386f1; Brearey SP, 2007, RESPIRATORY SYNCYTIA, P141; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Collins PL, 2007, RESP SYNCYTIAL VIRUS, P233; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Graham BS, 2014, J INFECT DIS, V209, P1679, DOI 10.1093/infdis/jiu075; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Keeling MJ, 2007, MODELING INFECT DIS, P366; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Malkin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077104; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Morris SE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1245; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; Pitzer VE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004591; Poletti P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0283-x; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Schenzle D., 1985, LECT NOTES BIOMATH, V57, P171; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; WARIS M, 1992, J MED VIROL, V38, P111, DOI 10.1002/jmv.1890380208; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	45	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138018	10.1371/journal.pone.0138018	http://dx.doi.org/10.1371/journal.pone.0138018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390032	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000361791000015
J	Nishikawa, Y; Hosokawa, M; Maruyama, T; Yamagishi, K; Mori, T; Takeyama, H				Nishikawa, Yohei; Hosokawa, Masahito; Maruyama, Toru; Yamagishi, Keisuke; Mori, Tetsushi; Takeyama, Haruko			Monodisperse Picoliter Droplets for Low-Bias and Contamination-Free Reactions in Single-Cell Whole Genome Amplification	PLOS ONE			English	Article							MULTIPLE-DISPLACEMENT AMPLIFICATION; POLYMERASE CLONING; BACTERIAL-CELLS; EMULSION PCR; MICROORGANISMS; INSIGHTS; DEVICE; DNA	Whole genome amplification (WGA) is essential for obtaining genome sequences from single bacterial cells because the quantity of template DNA contained in a single cell is very low. Multiple displacement amplification (MDA), using Phi29 DNA polymerase and random primers, is the most widely used method for single-cell WGA. However, single-cell MDA usually results in uneven genome coverage because of amplification bias, background amplification of contaminating DNA, and formation of chimeras by linking of non-contiguous chromosomal regions. Here, we present a novel MDA method, termed droplet MDA, that minimizes amplification bias and amplification of contaminants by using picoliter-sized droplets for compartmentalized WGA reactions. Extracted DNA fragments from a lysed cell in MDA mixture are divided into 10(5) droplets (67 pL) within minutes via flow through simple microfluidic channels. Compartmentalized genome fragments can be individually amplified in these droplets without the risk of encounter with reagent-borne or environmental contaminants. Following quality assessment of WGA products from single Escherichia coli cells, we showed that droplet MDA minimized unexpected amplification and improved the percentage of genome recovery from 59% to 89%. Our results demonstrate that microfluidic-generated droplets show potential as an efficient tool for effective amplification of low-input DNA for single-cell genomics and greatly reduce the cost and labor investment required for determination of nearly complete genome sequences of uncultured bacteria from environmental samples.	[Nishikawa, Yohei; Hosokawa, Masahito; Maruyama, Toru; Yamagishi, Keisuke; Mori, Tetsushi; Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Hosokawa, Masahito; Takeyama, Haruko] Waseda Univ, Res Org Nano & Life Innovat, Shinjuku Ku, Tokyo 1620041, Japan; [Hosokawa, Masahito; Mori, Tetsushi; Takeyama, Haruko] Japan Sci & Technol Agcy JST, Core Res Evolutionary Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Waseda University; Waseda University; Japan Science & Technology Agency (JST)	Takeyama, H (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	haruko-takeyama@waseda.jp	Mori, Tetsushi/C-1973-2017; Nishikawa, Yohei/ABD-5629-2020; t, lf/AAJ-4924-2020; Mori, Tetsushi/AAN-5656-2020	Mori, Tetsushi/0000-0001-7096-4161; Nishikawa, Yohei/0000-0001-5443-7230; Hosokawa, Masahito/0000-0002-7070-4690	Japan Science and Technology Agency - Core Research for Evolutional Science and Technology (JST-CREST) "Establishment of core technology for the preservation and regeneration of marine biodiversity and ecosystems"; Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [23226010, 26820365]; Council for Science, Technology and Innovation (CSTI); Grants-in-Aid for Scientific Research [26820365] Funding Source: KAKEN	Japan Science and Technology Agency - Core Research for Evolutional Science and Technology (JST-CREST) "Establishment of core technology for the preservation and regeneration of marine biodiversity and ecosystems"; Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science, Technology and Innovation (CSTI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is partly supported by Japan Science and Technology Agency - Core Research for Evolutional Science and Technology (JST-CREST) "Establishment of core technology for the preservation and regeneration of marine biodiversity and ecosystems", Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) Grant-in-Aid for Scientific Basic Research (S) No. 23226010, Grant-in-Aid for Young Scientists (B) No. 26820365 and Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution).	Arakaki A, 2010, APPL ENVIRON MICROB, V76, P1480, DOI 10.1128/AEM.02124-09; Ballantyne KN, 2006, ANAL BIOCHEM, V355, P298, DOI 10.1016/j.ab.2006.04.039; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dichosa AEK, 2014, NAT PROTOC, V9, P608, DOI 10.1038/nprot.2014.034; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Ellegaard KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082319; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hori M, 2007, BIOCHEM BIOPH RES CO, V352, P323, DOI 10.1016/j.bbrc.2006.11.037; Hosokawa M, 2015, BIOSENS BIOELECTRON, V67, P379, DOI 10.1016/j.bios.2014.08.059; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Kintses B, 2010, CURR OPIN CHEM BIOL, V14, P548, DOI 10.1016/j.cbpa.2010.08.013; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; McLean JS, 2013, P NATL ACAD SCI USA, V110, pE2390, DOI 10.1073/pnas.1219809110; Motley ST, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-443; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rinke C, 2014, NAT PROTOC, V9, P1038, DOI 10.1038/nprot.2014.067; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Streets AM, 2014, P NATL ACAD SCI USA, V111, P7048, DOI 10.1073/pnas.1402030111; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yilmaz S, 2012, CURR OPIN BIOTECH, V23, P437, DOI 10.1016/j.copbio.2011.11.018; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x; Yu ZL, 2014, ANAL CHEM, V86, P9386, DOI 10.1021/ac5032176; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	44	33	43	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138733	10.1371/journal.pone.0138733	http://dx.doi.org/10.1371/journal.pone.0138733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389587	Green Submitted, gold, Green Published			2022-12-26	WOS:000361791000053
J	Stefanaki, A; Kantsa, A; Tscheulin, T; Charitonidou, M; Petanidou, T				Stefanaki, Anastasia; Kantsa, Aphrodite; Tscheulin, Thomas; Charitonidou, Martha; Petanidou, Theodora			Lessons from Red Data Books: Plant Vulnerability Increases with Floral Complexity	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; POLLINATION ECOLOGY; CONSERVATION; COMPETITION; FLOWER; BIODIVERSITY; EXTINCTION; COMMUNITY; RARE; TREE	The architectural complexity of flower structures (hereafter referred to as floral complexity) may be linked to pollination by specialized pollinators that can increase the probability of successful seed set. As plant-pollinator systems become fragile, a loss of such specialized pollinators could presumably result in an increased likelihood of pollination failure. This is an issue likely to be particularly evident in plants that are currently rare. Using a novel index describing floral complexity we explored whether this aspect of the structure of flowers could be used to predict vulnerability of plant species to extinction. To do this we defined plant vulnerability using the Red Data Book of Rare and Threatened Plants of Greece, a Mediterranean biodiversity hotspot. We also tested whether other intrinsic (e.g. life form, asexual reproduction) or extrinsic (e.g. habitat, altitude, range-restrictedness) factors could affect plant vulnerability. We found that plants with high floral complexity scores were significantly more likely to be vulnerable to extinction. Among all the floral complexity components only floral symmetry was found to have a significant effect, with radial-flower plants appearing to be less vulnerable. Life form was also a predictor of vulnerability, with woody perennial plants having significantly lower risk of extinction. Among the extrinsic factors, both habitat and maximum range were significantly associated with plant vulnerability (coastal plants and narrow-ranged plants are more likely to face higher risk). Although extrinsic and in particular anthropogenic factors determine plant extinction risk, intrinsic traits can indicate a plant's proneness to vulnerability. This raises the potential threat of declining global pollinator diversity interacting with floral complexity to increase the vulnerability of individual plant species. There is potential scope for using plant-pollinator specializations to identify plant species particularly at risk and so target conservation efforts towards them.	[Stefanaki, Anastasia; Kantsa, Aphrodite; Tscheulin, Thomas; Charitonidou, Martha; Petanidou, Theodora] Univ Aegean, Dept Geog, Lab Biogeog & Ecol, Mitilini, Greece; [Stefanaki, Anastasia] Naturalis Biodivers Ctr, Natl Herbarium Netherlands, Leiden, Netherlands	University of Aegean; Naturalis Biodiversity Center	Stefanaki, A (corresponding author), Univ Aegean, Dept Geog, Lab Biogeog & Ecol, Mitilini, Greece.	anastasia.stefanaki@gmail.com	Kantsa, Aphrodite/C-5956-2009; Petanidou, Theodora/AAU-3212-2020; Tscheulin, T./B-9722-2011; Charitonidou, Martha/ABF-1132-2020; Stefanaki, Anastasia/ABC-9302-2021	Kantsa, Aphrodite/0000-0002-4586-1109; Petanidou, Theodora/0000-0003-1883-0945; Tscheulin, T./0000-0002-9901-1521; Charitonidou, Martha/0000-0002-9657-8362; Stefanaki, Anastasia/0000-0002-6393-9416	European Union (European Social Fund [ESF]); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES - Investing in knowledge society through the European Social Fund; FP7 European project STEP	European Union (European Social Fund [ESF])(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES - Investing in knowledge society through the European Social Fund(Thales Group); FP7 European project STEP	This study was co-financed by the European Union (European Social Fund [ESF]) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES - Investing in knowledge society through the European Social Fund (see ref. 20 in the text). Additional support has been provided to AS by the FP7 European project STEP (see ref. 21 in the text). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN GI, 1980, OIKOS, V35, P161, DOI 10.2307/3544424; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], 1965, FLORA TURKEY E AEGEA; Bacchetta G, 2012, PLANT BIOSYST, V146, P638, DOI 10.1080/11263504.2011.642417; Bandi A., 2012, THESIS ARISTOTLE U T; Barth F. G., 1985, Insects and flowers. The biology of a partnership.; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogacheva-Milkoteva K, 2013, CR ACAD BULG SCI, V66, P1427; BROWN JH, 1979, ECOLOGY, V60, P1022, DOI 10.2307/1936870; Brummitt RK, 2001, WORLD GEOGRAPHICAL S; Campbell DR, 1996, ECOLOGY, V77, P1463, DOI 10.2307/2265543; Carlstru┬m A., 1984, WILLDENOWIA, V14, P15; CHRISTODOULAKIS D, 1994, PHYTON-ANN REI BOT A, V33, P289; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Committee on the Status of Pollinators in North America NRC, 2007, STAT POLL N AM; Constantinidis T., 1995, RED DATA BOOK RARE T, P478; Crawley M. J., 2013, R BOOK; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Pena JCD, 2014, BIOL CONSERV, V170, P130, DOI 10.1016/j.biocon.2013.12.015; De Halacsy E., 1901, LIPSIAE; Dimopoulos P., 2013, Englera, V31; Lozano FD, 2013, BIOL CONSERV, V157, P21, DOI 10.1016/j.biocon.2012.07.008; Egli B. R. P., 1990, WILLD, V19, P389; FAEGRI K, 1979, P244; Fahmy GM, 2013, TURK J BOT, V37, P908, DOI 10.3906/bot-1210-48; Fenu G, 2013, FLORA, V208, P104, DOI 10.1016/j.flora.2013.02.003; Foley M. J. Y., 2008, BOT CHRON, V19, P5; Freville H, 2007, ECOLOGY, V88, P2662, DOI 10.1890/06-1453.1; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gabrielova J, 2013, FOLIA GEOBOT, V48, P449, DOI 10.1007/s12224-012-9145-x; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Godefroid S, 2014, PLANT ECOL EVOL, V147, P154, DOI 10.5091/plecevo.2014.863; GREUTER W, 1979, Willdenowia, V8, P531; Greuter W., 1967, FLORA INSEL KYTHERA, P1, DOI [10.5169/seals-895631, DOI 10.5169/SEALS-895631]; Harper K.T., 1979, GREAT BASIN NAT, V3, P129; Hartvig P., 1998, Willdenowia, V28, P65, DOI 10.3372/wi.28.2806; Hartvig P., 1989, WILLDENOWIA, V19, P75; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kamari Georgia, 2013, Flora Mediterranea, V23, P183, DOI 10.7320/FlMedit23.183; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Karl Rainer, 2009, Phytologia Balcanica, V15, P337; Kasecker TP, 2009, PLANTAS RARAS BRASIL; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Lafranchis T, 2009, FLOWERS OF GREECE; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LINHART YB, 1973, AM NAT, V107, P511, DOI 10.1086/282854; MCCALL C, 1992, AM J BOT, V79, P434, DOI 10.2307/2445156; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MENZEL R, 1985, FORTS ZOOL, V31, P55; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Olesen JN, 2007, TAXON, V56, P729, DOI 10.2307/25065857; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Papanicolaou K, 1982, WILLDENOWIA, V12, P221; PETANIDOU T, 1995, AM J BOT, V82, P607, DOI 10.2307/2445419; Petanidou T, 2005, PLANT BIOSYST, V139, P279, DOI 10.1080/11263500500333941; Petanidou T., 1991, POLLINATION ECOLOGY; Petanidou T, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.20; PHITOS D., 1964, OSTERREICHISCHE BOT Z, V111, P208, DOI 10.1007/BF01373765; Phitos D., 2009, RED DATA BOOK RARE T, VVolume 1; PLEASANTS JM, 1980, ECOLOGY, V61, P1446, DOI 10.2307/1939053; Potts SG, 2011, J APICULT RES, V50, P152, DOI 10.3896/IBRA.1.50.2.07; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rafferty NE, 2013, ECOLOGY, V94, P2321, DOI 10.1890/12-1948.1; Rathcke B., 1983, P305; Rathcke BJ, 2000, ECOLOGY, V81, P1951; Raus T., 1987, WILLDENOWIA, V16, P335; Regan EC, 2015, CONSERV LETT, V8, P397, DOI 10.1111/conl.12162; Snogerup S., 1985, WILLD, V14, P309; Sondergaard Poul, 2006, Willdenowia, V36, P317, DOI 10.3372/wi.36.36126; Spira TP, 2001, NAT AREA J, V21, P78; Steiner KE, 1996, PLANT SYST EVOL, V201, P131, DOI 10.1007/BF00989056; Strid A., 1980, WILD FLOWERS MOUNT O; Strid A, 1991, MOUNTAIN FLORA GREEC, V2; Strid A., 1986, MOUNTAIN FLORA GREEC, V1; Strid A, 1997, FLORA HELLENICA, V1; Strid K., 2002, FLORA HELLENICA, V2; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Tan K., 2001, ENDEMIC PLANTS GREEC; Tan Kit, 2010, Phytologia Balcanica, V16, P237; The University of York, 2011, CHEM DATA BOOK; Turland Nicholas J., 2008, Willdenowia, V38, P61, DOI 10.3372/wi.38.38103; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Tutin TG, 1968, FLORA EUROPAEA, V2- 5; Waser N.M., 1983, P277; WCSP, 2014, WORLD CHECKL SEL PLA; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; West EL, 1998, CAN J ZOOL, V76, P730, DOI 10.1139/cjz-76-4-730; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Zych Marcin, 2008, Acta Agrobotanica, V61, P85; Zych M, 2013, BOT J LINN SOC, V173, P92, DOI 10.1111/boj.12071	103	15	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138414	10.1371/journal.pone.0138414	http://dx.doi.org/10.1371/journal.pone.0138414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390402	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000027
J	Buhtz, A; Witzel, K; Strehmel, N; Ziegler, J; Abel, S; Grosch, R				Buhtz, Anja; Witzel, Katja; Strehmel, Nadine; Ziegler, Joerg; Abel, Steffen; Grosch, Rita			Perturbations in the Primary Metabolism of Tomato and Arabidopsis thaliana Plants Infected with the Soil-Borne Fungus Verticillium dahliae	PLOS ONE			English	Article							AMPLIFIED POLYMORPHIC DNA; PROTEIN-TAGGED ISOLATE; VEGETATIVE COMPATIBILITY; GAS-CHROMATOGRAPHY; GENE-EXPRESSION; BRASSICA-NAPUS; AMINO-ACIDS; DEFENSE; PATHOGEN; LONGISPORUM	The hemibiotrophic soil-borne fungus Verticillium dahliae is a major pathogen of a number of economically important crop species. Here, the metabolic response of both tomato and Arabidopsis thaliana to V. dahliae infection was analysed by first using non-targeted GC-MS profiling. The leaf content of both major cell wall components glucuronic acid and xylose was reduced in the presence of the pathogen in tomato but enhanced in A. thaliana. The leaf content of the two tricarboxylic acid cycle intermediates fumaric acid and succinic acid was increased in the leaf of both species, reflecting a likely higher demand for reducing equivalents required for defence responses. A prominent group of affected compounds was amino acids and based on the targeted analysis in the root, it was shown that the level of 12 and four free amino acids was enhanced by the infection in, respectively, tomato and A. thaliana, with leucine and histidine being represented in both host species. The leaf content of six free amino acids was reduced in the leaf tissue of diseased A. thaliana plants, while that of two free amino acids was raised in the tomato plants. This study emphasizes the role of primary plant metabolites in adaptive responses when the fungus has colonized the plant.	[Buhtz, Anja; Witzel, Katja; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops, D-14979 Grossbeeren, Germany; [Strehmel, Nadine; Ziegler, Joerg; Abel, Steffen] Leibniz Inst Plant Biochem, D-06120 Halle, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Pflanzenbiochemie	Witzel, K (corresponding author), Leibniz Inst Vegetable & Ornamental Crops, Theodor Echtermeyer Weg 1, D-14979 Grossbeeren, Germany.	witzel@igzev.de	Grosch, Rita/HHM-5490-2022; Ziegler, Jörg/W-7645-2019	Grosch, Rita/0000-0002-7179-5715	Leibniz Association [SAW-2011-IPB-3]	Leibniz Association	The work was supported by the Leibniz Association (www.leibniz-gemeinschaft.de/en/home/) under the project 'Chemical Communication in the Rhizosphere' (SAW-2011-IPB-3). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Atallah ZK, 2011, PLANT DIS, V95, P784, DOI 10.1094/PDIS-01-11-0075; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; DAAYF F, 1995, EUR J PLANT PATHOL, V101, P69, DOI 10.1007/BF01876095; Depuydt S, 2009, PLANT PHYSIOL, V149, P1366, DOI 10.1104/pp.108.131805; Dervis S, 2009, PHYTOPARASITICA, V37, P467, DOI 10.1007/s12600-009-0061-4; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUNCAN DR, 1987, CAN J BOT, V65, P1299, DOI 10.1139/b87-182; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Floerl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031435; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; GEBHARDT C, 1989, THEOR APPL GENET, V78, P65, DOI 10.1007/BF00299755; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Heinz R, 1998, PHYSIOL MOL PLANT P, V52, P385, DOI 10.1006/pmpp.1998.0163; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; Hill MK, 1999, PLANT MOL BIOL, V40, P289, DOI 10.1023/A:1006146419544; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Jimenez-Diaz RM, 2012, PLANT DIS, V96, P304, DOI 10.1094/PDIS-06-11-0496; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Li KN, 1999, MYCOL RES, V103, P1361, DOI 10.1017/S0953756299008357; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; McFadden HG, 2001, PHYSIOL MOL PLANT P, V58, P119, DOI 10.1006/pmpp.2001.0320; Parker D, 2009, PLANT J, V59, P723, DOI 10.1111/j.1365-313X.2009.03912.x; Peluffo L, 2010, PHYTOCHEMISTRY, V71, P70, DOI 10.1016/j.phytochem.2009.09.018; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Reusche M, 2014, ENVIRON EXP BOT, V108, P23, DOI 10.1016/j.envexpbot.2013.12.009; Reusche M, 2012, PLANT CELL, V24, P3823, DOI 10.1105/tpc.112.103374; Robb J, 2007, PLANTA, V226, P299, DOI 10.1007/s00425-007-0482-6; Robb J, 2009, BOTANY, V87, P993, DOI 10.1139/B09-056; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Sun C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0268-5; TINKER NA, 1993, THEOR APPL GENET, V85, P976, DOI 10.1007/BF00215037; Tischner R, 2010, PHYSIOL MOL PLANT P, V74, P419, DOI 10.1016/j.pmpp.2010.06.004; Tsror L, 2001, PLANT PATHOL, V50, P477, DOI 10.1046/j.1365-3059.2001.00587.x; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; van Esse HP, 2009, MOL PLANT MICROBE IN, V22, P245, DOI 10.1094/MPMI-22-3-0245; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venugopal SC, 2009, PLANT SIGNAL BEHAV, V4, P746, DOI 10.4161/psb.4.8.9111; Wang FX, 2011, PROTEOMICS, V11, P4296, DOI 10.1002/pmic.201100062; Witzel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071877; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x; Zhang WW, 2013, EUR J PLANT PATHOL, V135, P867, DOI 10.1007/s10658-012-0131-1; Zhao FA, 2012, PLANT SCI, V185, P176, DOI 10.1016/j.plantsci.2011.10.007; Zhao P, 2014, PROTEIN CELL, V5, P94, DOI 10.1007/s13238-013-0009-9; Zhou L, 2006, PLANT PATHOL, V55, P137, DOI 10.1111/j.1365-3059.2005.01311.x; Ziegler J, 2014, AMINO ACIDS, V46, P2799, DOI 10.1007/s00726-014-1837-5	68	17	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138242	10.1371/journal.pone.0138242	http://dx.doi.org/10.1371/journal.pone.0138242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381754	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200076
J	Chanakira, A; Kir, D; Barke, RA; Santilli, SM; Ramakrishnan, S; Roy, S				Chanakira, Alice; Kir, Devika; Barke, Roderick A.; Santilli, Steve M.; Ramakrishnan, Sundaram; Roy, Sabita			Hypoxia Differentially Regulates Arterial and Venous Smooth Muscle Cell Migration	PLOS ONE			English	Article							INTERNAL-THORACIC-ARTERY; CORONARY-BYPASS SURGERY; SAPHENOUS-VEIN; RADIAL ARTERY; INTIMAL HYPERPLASIA; VASA VASORUM; SURVIVAL; PROLIFERATION; PATENCY; GRAFTS	Objective Intimal hyperplasia (IH) is a clinical concern leading to failure of up to 50% of vein grafts and 10% of arterial grafts after 10 years with no known current treatment. Recent studies have shown that hypoxia differentially regulates proliferation of vein derived smooth muscle cells (V-SMC) compared to artery derived smooth muscle cells (A-SMC). The objective of this study is to evaluate the effect of hypoxia on cellular migration and the mechanisms underlying the differential effects of hypoxia on A-SMC and V-SMC migration. Methods and Results Hypoxic treatment (3-5% O2) of Smooth Muscle Cells (SMC) resulted in differential migration in scratch wound and electric cell substrate impedance sensing (ECIS) assays. Hypoxia led to greater migration compared to normoxia with venous derived wound closure (V-SMC 30.8% Normoxia to 67% Hypoxia) greater than arterial wound closure (A-SMC 6.2% Normoxia to 24.7% Hypoxia). Paracrine factors secreted by hypoxic endothelial cells induced more migration in SMC compared to factors secreted by normoxic endothelial cells. Migration of V-SMC was greater than A-SMC in the presence of paracrine factors. Neutralizing antibody to Vascular Endothelial Growth Factor Receptor -1 (VEGFR-1) completely inhibited V-SMC migration while there was only partial inhibition of A-SMC migration. A-SMC migration was completely inhibited by Platelet Derived Growth Factor BB (PDGF-BB) neutralizing antibody. p38 Mitogen Activated Protein kinase (p38 MAPK) inhibitor pre-incubation completely inhibited migration induced by paracrine factors in both ASMC and V-SMC. Conclusion Our study determines that SMC migration under hypoxia occurs via both an autocrine and paracrine mechanism and is dependent on Vascular Endothelial Growth Factor-A (VEGFA) in V-SMC and PDGF-BB in A-SMC. Migration of both A-SMC and V-SMC is inhibited by p38 MAPK inhibitor. These studies suggest that pharmacotherapeutic strategies directed at modulating p38 MAPK activity can be exploited to prevent IH in vascular grafts.	[Chanakira, Alice; Kir, Devika; Santilli, Steve M.; Roy, Sabita] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kir, Devika; Ramakrishnan, Sundaram; Roy, Sabita] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Barke, Roderick A.; Santilli, Steve M.] VA Med Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	royxx002@umn.edu	Kir, Devika/AAA-1255-2021	Kir, Devika/0000-0001-7134-7325	National Institutes for Health (National Institute for Drug Abuse) [RO1 DA 12104, RO1 DA 022935, RO1 DA031202, K05DA033881]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012104, R01DA022935, K05DA033881, R01DA031202] Funding Source: NIH RePORTER	National Institutes for Health (National Institute for Drug Abuse); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was funded by the following grants from the National Institutes for Health (National Institute for Drug Abuse): RO1 DA 12104, RO1 DA 022935, RO1 DA031202, K05DA033881.	Athanasiou T, 2011, EUR J CARDIO-THORAC, V40, P208, DOI 10.1016/j.ejcts.2010.11.012; Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; BARKER SGE, 1993, ARTERIOSCLER THROMB, V13, P70, DOI 10.1161/01.ATV.13.1.70; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402; CAMERON AAC, 1995, J AM COLL CARDIOL, V25, P188, DOI 10.1016/0735-1097(94)00332-K; Cao C, 2013, J THORAC CARDIOV SUR, V146, P255, DOI 10.1016/j.jtcvs.2012.07.014; Chanakira A, 2012, AM J PHYSIOL-HEART C, V302, pH1173, DOI 10.1152/ajpheart.00411.2011; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; CLOWES AW, 1991, J VASC SURG, V13, P885; CORSON JD, 1985, ARCH SURG-CHICAGO, V120, P386; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Deb S, 2012, J AM COLL CARDIOL, V60, P28, DOI 10.1016/j.jacc.2012.03.037; Dimitrova KR, 2012, ANN THORAC SURG, V94, P475, DOI 10.1016/j.athoracsur.2012.04.035; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Lee ES, 2000, J SURG RES, V91, P32, DOI 10.1006/jsre.2000.5891; Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040; Liang M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0431-z; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Wan J, 2014, ANN VASC SURG, V28, P725, DOI 10.1016/j.avsg.2013.10.007; Zacharias A, 2004, CIRCULATION, V109, P1489, DOI 10.1161/01.CIR.0000121743.10146.78	25	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138587	10.1371/journal.pone.0138587	http://dx.doi.org/10.1371/journal.pone.0138587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381529	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200134
J	Duan, XG; Zhang, T; Ding, SQ; Wei, J; Su, CX; Liu, HP; Xu, GX				Duan, Xiangguo; Zhang, Tao; Ding, Shuqin; Wei, Jun; Su, Chunxia; Liu, Hongpeng; Xu, Guangxian			microRNA-17-5p Modulates Bacille Calmette-Guerin Growth in RAW264.7 Cells by Targeting ULK1	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; MYCOBACTERIUM-TUBERCULOSIS; AUTOPHAGY PROCESS; PHAGOLYSOSOME; EXPRESSION; INDUCTION; PATHWAY; CLUSTER; GENES; RNA	To explore the potential roles of miRNAs in controlling the survival of mycobacteria in macrophages, miR-17-5p in the regulation of Bacillus Calmette-Guerin(BCG) growth in the macrophage RAW264.7 cells was interrogated. Our results reveal that an infection of BCG shows a time-dependent up-regulation of miR-17-5p in RAW264.7 cells in early phase; importantly, excessive expression of miR-17-5p in these cells exhibits an increased propagation of intracellular BCG. Mechanistically, the Unc-51 like autophagy activating kinase 1 (ULK1), an initial molecular of autophagy are identified as novel target of miR-17-5p, the miR-17-5p is capable of targeting down-regulating the expression of ULK1 protein. In addition, an overexpression of miR-17-5p in RAW264.7 cells is correlated with repression of ULK1 and the autophagosome related proteins LC3I/II. These results imply that miR-17-5p may be able to arrest the maturation of mycobacterial phagosomes in part by targeting ULK1, subsequently reduces the ability of host cells to kill intracellular BCG.	[Duan, Xiangguo; Zhang, Tao; Ding, Shuqin; Su, Chunxia; Liu, Hongpeng; Xu, Guangxian] Ningxia Med Univ, Sch Lab Med, Yinchuan 750004, Peoples R China; [Duan, Xiangguo; Wei, Jun; Xu, Guangxian] Ningxia Med Univ, Gen Hosp, Yinchuan 750004, Peoples R China; [Duan, Xiangguo; Zhang, Tao; Ding, Shuqin; Wei, Jun; Su, Chunxia; Liu, Hongpeng; Xu, Guangxian] Ningxia Key Lab Clin & Pathogen Microbiol, Yinchuan 750004, Peoples R China; [Zhang, Tao] Taian City Cent Hosp, Tai An 271000, Shandong, Peoples R China	Ningxia Medical University; Ningxia Medical University	Xu, GX (corresponding author), Ningxia Med Univ, Sch Lab Med, Yinchuan 750004, Peoples R China.	xuguangxian@nxmu.edu.cn			National Natural Science Foundation of China [31472168, 31160494]; program for New Century Excellent Talents in University [NCET 11-11023]; Clinical Laboratory Diagnosis Creative Group Open Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Clinical Laboratory Diagnosis Creative Group Open Project	This work was funded by the National Natural Science Foundation of China (No. 31472168, 31160494), the program for New Century Excellent Talents in University (No. NCET 11-11023), and the 2013 Clinical Laboratory Diagnosis Creative Group Open Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Cai YH, 2014, CELL SIGNAL, V26, P1204, DOI 10.1016/j.cellsig.2014.02.013; Cai YH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-356; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Comincini S, 2013, CANCER BIOL THER, V14, P574, DOI 10.4161/cbt.24597; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Foley NH, 2012, J LEUKOCYTE BIOL, V92, P521, DOI 10.1189/jlb.0312160; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lewin A, 2003, J VET MED B, V50, P505, DOI 10.1046/j.1439-0450.2003.00715.x; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Ma CY, 2014, MOL IMMUNOL, V62, P150, DOI 10.1016/j.molimm.2014.06.014; Ma CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092419; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Modlin RL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007402; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Philippe L, 2013, ANN RHEUM DIS, V72, P1071, DOI 10.1136/annrheumdis-2012-201654; Poitz DM, 2013, MOL IMMUNOL, V56, P442, DOI 10.1016/j.molimm.2013.06.014; Seto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086017; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Steinhauser Christine, 2014, Curr Protoc Immunol, V105, DOI 10.1002/0471142735.im1436s105; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Xu GX, 2013, TUBERCULOSIS, V93, P606, DOI 10.1016/j.tube.2013.08.006; XU SM, 1994, J IMMUNOL, V153, P2568; Yang XJ, 2013, BIOCHEM BIOPH RES CO, V431, P617, DOI 10.1016/j.bbrc.2012.12.083; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005	41	37	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138011	10.1371/journal.pone.0138011	http://dx.doi.org/10.1371/journal.pone.0138011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384021	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200047
J	Li, G; He, NN; Jin, HX; Liu, Y; Guo, YH; Su, YC; Sun, YP				Li, Gang; He, Nannan; Jin, Haixia; Liu, Yan; Guo, Yihong; Su, Yingchun; Sun, Yingpu			The Influence of Single Nucleotide Polymorphism Microarray-Based Molecular Karyotype on Preimplantation Embryonic Development Potential	PLOS ONE			English	Article							GENETIC DIAGNOSIS; CHROMOSOMAL-ABNORMALITIES; BLASTOCYST DEVELOPMENT; NUMBER; AGE; ANEUPLOIDY; MOSAICISM; OOCYTES; GROWTH	In order to investigate the influence of the molecular karyotype based on single nucleotide polymorphism (SNP) microarray on embryonic development potential in preimplantation genetic diagnosis (PGD), we retrospectively analyzed the clinical data generated by PGD using embryos retrieved from parents with chromosome rearrangements in our center. In total, 929 embryos from 119 couples had exact diagnosis and development status. The blastocyst formation rate of balanced molecular karyotype embryos was 56.6% (276/488), which was significantly higher than that of genetic imbalanced embryos 24.5% (108/441) (P<0.001). No significant difference was detected in blastocyst formation rates in the groups of maternal age<30, 30-35 and >35 respectively. Blastocyst formation rates of male and female embryos were 44.5% (183/411) and 38.8% (201/518) respectively, with no significant difference between them (P>0.05). The rates of balanced molecular karyotype embryos vary from groups of embryos with different cell numbers at 68 hours after insemination. The blastocyst formation rate of embryos with 6-8 cells (48.1%) was significantly higher than that of embryos with <6 cells (23.9%) and with >8 cells (42.9%) (P<0.05). As for the unbalanced embryos, there was no significant difference of the distribution of abnormal molecular karyotypes in the subgroup of the arrest, morula and blastocyst. Thus, we conclude that embryos with balanced molecular karyotype have significant higher development potential than those with imbalanced molecular karyotype whilst maternal age, embryo gender and types of abnormal molecular karyotype have no significant influence on blastocyst formation. Compared with embryos with <6 and >8 cells, embryos with 6-8 blastomeres have higher rate of balanced molecular karyotype and blastocyst formation.	[Li, Gang; He, Nannan; Jin, Haixia; Liu, Yan; Guo, Yihong; Su, Yingchun; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China	Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China.	syp2008@vip.sina.com	jin, haixia/HGA-9179-2022		National Natural Science Foundation of China [31271605]; key project of Henan Province [112102310103]; medical tackle key problems in science and technology of Henan Province [2011020011, 2011020045]; Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Henan Province; medical tackle key problems in science and technology of Henan Province; Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (Grant No. 31271605), the grants from key project of Henan Province (112102310103), medical tackle key problems in science and technology of Henan Province (2011020011, 2011020045), and Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University.	Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Dumoulin JCM, 2005, HUM REPROD, V20, P484, DOI 10.1093/humrep/deh614; Eaton JL, 2011, FERTIL STERIL, V95, P936, DOI 10.1016/j.fertnstert.2010.06.063; Janny L, 1996, MOL REPROD DEV, V45, P31; Kearns WG, 2007, FERTIL STERIL, V88, pS237; Li G, 2014, SYST BIOL REPROD MED, V60, P119, DOI 10.3109/19396368.2013.875241; Luna M, 2008, FERTIL STERIL, V89, P358, DOI 10.1016/j.fertnstert.2007.03.030; Magli MC, 2000, HUM REPROD, V15, P1781, DOI 10.1093/humrep/15.8.1781; Magli MC, 1998, J ASSIST REPROD GEN, V15, P297, DOI 10.1023/A:1022596528036; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Pantos K, 1999, FERTIL STERIL, V71, P1144, DOI 10.1016/S0015-0282(99)00121-1; Ribeiro CV, 2006, FERTIL STERIL, V86, pS481, DOI 10.1016/j.fertnstert.2006.07.1329; Sandalinas M, 2001, HUM REPROD, V16, P1954, DOI 10.1093/humrep/16.9.1954; Scholtes MCW, 1998, FERTIL STERIL, V69, P78, DOI 10.1016/S0015-0282(97)00450-0; Shapiro BS, 2000, FERTIL STERIL, V73, P582, DOI 10.1016/S0015-0282(99)00586-5; Shapiro BS, 2002, FERTIL STERIL, V77, P700, DOI 10.1016/S0015-0282(01)03251-4; Tan YQ, 2013, HUM REPROD, V28, P2581, DOI 10.1093/humrep/det271; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; van Uum CMJ, 2012, EUR J HUM GENET, V20, P938, DOI 10.1038/ejhg.2012.27; Weston G, 2009, FERTIL STERIL, V92, P1302, DOI 10.1016/j.fertnstert.2008.07.1784; Ziebe S, 2003, HUM REPROD, V18, P2575, DOI 10.1093/humrep/deg489	23	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138234	10.1371/journal.pone.0138234	http://dx.doi.org/10.1371/journal.pone.0138234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381524	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200074
J	Yang, J; Zhang, J; Ou, S; Wang, N; Wang, J				Yang, Juan; Zhang, Jie; Ou, Shu; Wang, Ni; Wang, Jian			Knowledge of Community General Practitioners and Nurses on Pre-Hospital Stroke Prevention and Treatment in Chongqing, China	PLOS ONE			English	Article							INTERVENTION; CARE	Background and Purpose This study aimed to investigate the knowledge of community general practitioners (GPs) and nurses about pre-hospital stroke recognition, treatment and management and secondary stroke prevention; to identify the sociodemographic and educational factors influencing knowledge. Methods A self-designed test questionnaire was applied in a self-administered close-exam setting among 480 GPs and nurses working in community health centers (stations) in eight urban districts of Chongqing. Results A total of 331 (69%) valid test questionnaires were returned. Of the 331 participants, 39% were aware of the clinical guidelines for cerebrovascular diseases, whereas 48% considered themselves to have stroke management capabilities. The correct rate of answering questions of pre-hospital recognition and management knowledge was as low as 24%, the correct rate of secondary stroke prevention knowledge was only 38%. In terms of the total score for stroke prevention and treatment knowledge, there were significant differences between the medical staff with different specialties before engaging in community health services and whether they have received GP training (P < 0.05). Conclusion The community GPs and nurses in the urban districts of Chongqing clearly lack knowledge of stroke, and the levels of stroke prevention and treatment urgently need to be improved.	[Yang, Juan; Wang, Jian] Second Peoples Hosp Chengdu, Dept Neurol, Chengdu, Sichuan, Peoples R China; [Zhang, Jie] Chongqing Emergency Med Ctr, Dept Neurol, Chongqing, Peoples R China; [Ou, Shu; Wang, Ni] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University	Wang, J (corresponding author), Second Peoples Hosp Chengdu, Dept Neurol, Chengdu, Sichuan, Peoples R China.	jian.wx@163.com						Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Bi Q, 2010, OVERVIEW PROGR FIELD; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116; Cheng X, 1992, CHINESE J PREVENTION, V2, P43; Chinese Medical Association Neurology Branch Cerebrovascular Disease Study Group, 2010, CHINESE J NEUROLOGY, V43, P146, DOI DOI 10.3969/J.ISSN.1672-7185.2013.08.004; Deng YZ, 2006, NEUROLOGY, V66, P306, DOI 10.1212/01.wnl.0000196478.77152.fc; Du Shu-chun, 2008, Power System Technology, V32, P1; Fan BL, 2011, MODERN PREVENTIVE ME, V38, P1445; FORTMANN SP, 1995, AM J EPIDEMIOL, V142, P576, DOI 10.1093/oxfordjournals.aje.a117678; Gao FX, 2009, CHINA MODERN DOCTOR, V47, P11; Han J, 2015, INT J ENV RES PUB HE, V12, P4617, DOI 10.3390/ijerph120504617; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jiang B, 2004, STROKE, V35, P1242, DOI 10.1161/01.STR.0000128417.88694.9f; [江滨 JIANG Bin], 2009, [中国全科医学, Chinese General Practice], V12, P1134; Johnson SC, 2005, NEUROLOGY, V64, P654; KJELSBERG MO, 1990, JAMA-J AM MED ASSOC, V263, P1795; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; [孟秀君 MENG Xiu-jun], 2010, [中国全科医学, Chinese General Practice], V13, P399; Meng XJ, 2010, CHINESE COMMUNITY DO, V12, P252; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; The Chinses Society of Neurology, 2010, CHIN J NEUROL CHIN, V43, P154, DOI DOI 10.3760/CMA.J.ISSN.1006-7876.2010.02.023; Wester P, 1999, STROKE, V30, P40, DOI 10.1161/01.STR.30.1.40	24	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138476	10.1371/journal.pone.0138476	http://dx.doi.org/10.1371/journal.pone.0138476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384330	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200109
J	Chang, CH; Yeh, SY; Lee, BH; Chen, CJ; Su, CT; Lin, YT; Liu, CL; Chen, HY				Chang, Chih-Hao; Yeh, Shu-Yun; Lee, Bing-Heng; Chen, Chia-Jie; Su, Chiao-Tzu; Lin, Yen-Ting; Liu, Chien-Lin; Chen, Hsien-Yeh			Osteogenic Surface Modification Based on Functionalized Poly-P-Xylylene Coating	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; CHEMICAL CROSS-LINKING; OSTEOBLAST DIFFERENTIATION; TITANIUM IMPLANTS; IN-VIVO; IMMOBILIZATION; GROWTH; BMP-2; POLYDOPAMINE; BIOMOLECULES	The biotechnology to immobilize biomolecules on material surfaces has been developed vigorously due to its high potentials in medical applications. In this study, a simple and effective method was designed to immobilize biomolecules via amine-N-hydroxysuccinimide (NHS) ester conjugation reaction using functionalized poly-p-xylylene coating on material surfaces. The NHS ester functionalized coating is synthesized via chemical vapor deposition, a facile and solvent-less method, creating a surface which is ready to perform a onestep conjugation reaction. Bone morphogenetic protein 2 (BMP-2) is immobilized onto material surfaces by this coating method, forming an osteogenic environment. The immobilization process is controlled at a low temperature which does not damage proteins. This modified surface induces differentiation of preosteoblast into osteoblast, manifested by alkaline phosphatase (ALP) activity assay, Alizarin Red S (ARS) staining and the expression of osteogenic gene markers, Alp! and Bglap3. With this coating technology, immobilization of growth factors onto material surface can be achieved more simply and more effectively.	[Chang, Chih-Hao; Lee, Bing-Heng; Chen, Chia-Jie] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Chang, Chih-Hao; Lee, Bing-Heng; Chen, Chia-Jie] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yeh, Shu-Yun; Su, Chiao-Tzu; Lin, Yen-Ting; Chen, Hsien-Yeh] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Liu, Chien-Lin] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Liu, Chien-Lin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan.	mike920@gmail.com		CHANG, CHIH-HAO/0000-0001-9794-0610; Lin, Yen-Ting/0000-0002-1332-5475	Ministry of Science and Technology of Taiwan [MOST 103-2633-B-002-014, NSC 102-2320-B-002-002-MY2, NSC 101-2628-E-002-034-MY3, NSC-DAAD 102-2911-I-002-507]; National Taiwan University Hospital-Taipei Veterans General Hospital [NTUH-TVGH VN103-10]; National Taiwan University [102R7745, 103R7745]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital-Taipei Veterans General Hospital; National Taiwan University(National Taiwan University)	CHC gratefully acknowledges support from the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-002-014; NSC 102-2320-B-002-002-MY2) and National Taiwan University Hospital-Taipei Veterans General Hospital Joint Research Program (NTUH-TVGH VN103-10). This work is further supported by the Ministry of Science and Technology of Taiwan (NSC 101-2628-E-002-034-MY3; NSC-DAAD 102-2911-I-002-507), and National Taiwan University (102R7745; 103R7745) for HYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Chang CH, 2014, J MATER CHEM B, V2, P8496, DOI 10.1039/c4tb00992d; Chen HY, 2010, J AM CHEM SOC, V132, P18023, DOI 10.1021/ja108679m; Chen HY, 2011, LANGMUIR, V27, P34, DOI 10.1021/la101623n; Cho HJ, 2014, ACS APPL MATER INTER, V6, P11225, DOI 10.1021/am501391z; Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x; Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x; Hsu JM, 2009, IEEE T BIO-MED ENG, V56, P23, DOI 10.1109/TBME.2008.2002155; Hsu WK, 2007, BONE, V40, P931, DOI 10.1016/j.bone.2006.10.030; Jeffrey B., 2004, CHEM VAPOR DEPOSITIO; Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Klein E, 2008, BIOMATERIALS, V29, P204, DOI 10.1016/j.biomaterials.2007.09.013; Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Leventis R, 2010, BIOPHYS J, V99, P2125, DOI 10.1016/j.bpj.2010.07.047; Liberelle B, 2010, BIOCONJUGATE CHEM, V21, P2257, DOI 10.1021/bc1002604; Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9; Lorenz C, 2011, MACROMOL BIOSCI, V11, P234, DOI 10.1002/mabi.201000342; Luo RF, 2013, COLLOID SURFACE B, V106, P66, DOI 10.1016/j.colsurfb.2013.01.033; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505; Nishii N, 2009, BIOL PHARM BULL, V32, P10, DOI 10.1248/bpb.32.10; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075; Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019; Sask KN, 2010, ACTA BIOMATER, V6, P2911, DOI 10.1016/j.actbio.2010.02.043; Schliephake H, 2005, CLIN ORAL IMPLAN RES, V16, P563, DOI 10.1111/j.1600-0501.2005.01143.x; Schmidmaier G, 2004, J ORTHOP RES, V22, P514, DOI 10.1016/j.orthres.2003.09.009; Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168; Schuessele A, 2009, J BIOMED MATER RES A, V90A, P959, DOI 10.1002/jbm.a.31745; Seymour JP, 2009, BIOMATERIALS, V30, P6158, DOI 10.1016/j.biomaterials.2009.07.061; Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b; Smith DM, 2008, J CRANIOFAC SURG, V19, P1244, DOI 10.1097/SCS.0b013e3181843312; Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001; Sun HY, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400093; TERRELL TG, 1993, INT REV EXP PATHOL, V34, P43; Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wiemann M, 2002, J BIOMED MATER RES, V62, P119, DOI 10.1002/jbm.10251; Wu J-T, 2012, MACROMOLECULAR RAPID, V33, P948, DOI [10.1002/marc.201290033, DOI 10.1002/MARC.201290033]; Xie XZ, 2013, IEEE T BIO-MED ENG, V60, P2943, DOI 10.1109/TBME.2013.2266542; Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2; Yang ZG, 2013, LANGMUIR, V29, P1498, DOI 10.1021/la3041055; Zhang CH, 2011, ACTA BIOMATER, V7, P3746, DOI 10.1016/j.actbio.2011.06.003	63	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137017	10.1371/journal.pone.0137017	http://dx.doi.org/10.1371/journal.pone.0137017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379273	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400012
J	Puig-Ribera, A; Martin-Cantera, C; Puigdomenech, E; Real, J; Romaguera, M; Magdalena-Belio, JF; Recio-Rodriguez, JI; Rodriguez-Martin, B; Arietaleanizbeaskoa, MS; Repiso-Gento, I; Garcia-Ortiz, L				Puig-Ribera, Anna; Martin-Cantera, Carlos; Puigdomenech, Elisa; Real, Jordi; Romaguera, Montserrat; Felix Magdalena-Belio, Jose; Ignacio Recio-Rodriguez, Jose; Rodriguez-Martin, Beatriz; Soledad Arietaleanizbeaskoa, Maria; Repiso-Gento, Irene; Garcia-Ortiz, Luis		EVIDENT Grp	Screening Physical Activity in Family Practice: Validity of the Spanish Version of a Brief Physical Activity Questionnaire	PLOS ONE			English	Article							COMPUTER-SCIENCE; PRIMARY-CARE; RELIABILITY; INACTIVITY; FUTURE; INDEX	Objectives The use of brief screening tools to identify inactive patients is essential to improve the efficiency of primary care-based physical activity (PA) programs. However, the current employment of short PA questionnaires within the Spanish primary care pathway is unclear. This study evaluated the validity of the Spanish version of a Brief Physical Activity Assessment Tool (SBPAAT). Methods A validation study was carried out within the EVIDENT project. A convenience sample of patients (n = 1,184; age 58.9 13.7 years; 60.5% female) completed the SBPAAT and the 7-day Physical Activity Recall (7DPAR) and, in addition, wore an accelerometer (ActiGraph GT3X) for seven consecutive days. Validity was evaluated by measuring agreement, Kappa correlation coefficients, sensitivity and specificity in achieving current PA recommendations with the 7DPAR. Pearson correlation coefficients with the number of daily minutes engaged in moderate and vigorous intensity PA according to the accelerometer were also assessed. Comparison with accelerometer counts, daily minutes engaged in sedentary, light, moderate, and vigorous intensity PA, total daily kilocalories, and total PA and leisure time expenditure (METs-hour-week) between the sufficiently and insufficiently active groups identified by SBPAAT were reported. Results The SBPAAT identified 41.3% sufficiently active (n = 489) and 58.7% insufficiently active (n = 695) patients; it showed moderate validity (k = 0.454, 95% Cl: 0.402-0.505) and a specificity and sensitivity of 74.3% and 74.6%, respectively. Validity was fair for identifying daily minutes engaged in moderate (r = 0.215, 95% CI:0.156 to 0.272) and vigorous PA (r = 0.282, 95% CI:0.165 to 0.391). Insufficiently active patients according to the SBPAAT significantly reported fewer counts/minute (-22%), fewer minutes/day of moderate (-11.38) and vigorous PA (-2.69), spent fewer total kilocalories/day (-753), and reported a lower energy cost (METs-hour-week) of physical activities globally (-26.82) and during leisure time (-19.62). Conclusions The SBPAAT is a valid tool to identify Spanish-speaking patients who are insufficiently active to achieve health benefits.	[Puig-Ribera, Anna] Univ Vic Cent Univ Catalonia UVic UCC, Dept Phys Act Sci, Ctr Hlth & Social Care Res CEES, Sport & Phys Act Res Grp GREAF, Barcelona, Spain; [Martin-Cantera, Carlos] Univ Autonoma Barcelona, Dept Med, Passeig St Joan Hlth Ctr, Catalan Hlth Serv, E-08193 Barcelona, Spain; [Martin-Cantera, Carlos; Puigdomenech, Elisa; Real, Jordi] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Real, Jordi] Univ Int Catalunya, Sch Med & Hlth Sci, Sant Cugat Del Valles, Spain; [Romaguera, Montserrat] Ca NOriac Hlth Ctr, Hlth Serv, Catalan, Spain; [Felix Magdalena-Belio, Jose] Torre Ramona Hlth Ctr, Aragon Hlth Serv, Zaragoza, Spain; [Ignacio Recio-Rodriguez, Jose] Castilla & Leon Hlth Serv SACYL, Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Rodriguez-Martin, Beatriz] Univ Castilla La Mancha, Logopedia & Nursing Fac, Occupat Therapy, E-13071 Ciudad Real, Spain; [Soledad Arietaleanizbeaskoa, Maria] Basque Hlth Care Serv Osakidetza, Primary Care Res Unit Bizkaia, Bilbao, Spain; [Repiso-Gento, Irene] Castilla & Leon Hlth Serv, Primary Care Res Unit Valladolid, Valladolid, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Primary Care Res Unit, Alamedilla Hlth Ctr, Castilla & Leon Hlth Serv SACYL,IBSAL, E-37008 Salamanca, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Universitat Internacional de Catalunya (UIC); Universidad de Castilla-La Mancha; University of Salamanca; University of Salamanca	Puig-Ribera, A (corresponding author), Univ Vic Cent Univ Catalonia UVic UCC, Dept Phys Act Sci, Ctr Hlth & Social Care Res CEES, Sport & Phys Act Res Grp GREAF, Barcelona, Spain.	annam.puig@uvic.cat	Recio-Rodriguez, Jose I/AAA-8588-2020; Martin Cantera, Carlos/D-2693-2011; Rodríguez-Martin, Beatriz/F-5743-2016; Arietaleanizbeaskoa, Maria Soledad/D-9296-2017; Maderuelo-Fernandez, Jose-Angel/R-8868-2018	Martin Cantera, Carlos/0000-0003-0656-8126; Rodríguez-Martin, Beatriz/0000-0003-3939-0299; Arietaleanizbeaskoa, Maria Soledad/0000-0001-8747-6789; Sierra Quintana, Eva/0000-0002-2572-0982; Recio-Rodriguez, Jose I/0000-0002-3772-8746; Real, Jordi/0000-0002-5979-8948; Cabrejas-Sanchez, Alfredo/0000-0001-7049-063X; Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684	Carlos III Health Institute of the Ministry of Health in Spain [FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018]; Autonomous Government of Castile and Leon [SAN/1778/2009]	Carlos III Health Institute of the Ministry of Health in Spain; Autonomous Government of Castile and Leon	This project was financed by the Carlos III Health Institute of the Ministry of Health in Spain (FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018) and the Autonomous Government of Castile and Leon (SAN/1778/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Cordoba Rodrigo, 2014, Aten Primaria, V46 Suppl 4, P16, DOI 10.1016/S0212-6567(14)70048-4; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garcia-Ortiz L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-233; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Huijg JM, 2014, INT J BEHAV MED; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Marshall AL, 2005, BRIT J SPORT MED, V39, P294, DOI 10.1136/bjsm.2004.013771; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; NICE, 2013, PHYS ACT BRIEF ADV A, V44, P44; Orrow G, 2013, BRIT J SPORT MED, V47, P27, DOI 10.1136/bjsports-2012-e1389rep; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Ribera AP, 2012, ATEN PRIM, V44, P485, DOI 10.1016/j.aprim.2012.01.005; Vinas BR, 2013, GAC SANIT, V27, P254, DOI 10.1016/j.gaceta.2012.05.013; Comellas AR, 2012, REV ESP SALUD PUBLIC, V86, P495, DOI 10.4321/S1135-57272012000500004; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sanchez A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-108; Shuval K, 2014, BRIT J SPORT MED, V48, P250, DOI 10.1136/bjsports-2013-092901; Smith BJ, 2005, AM J PREV MED, V29, P256, DOI 10.1016/j.amepre.2005.07.005; Vega-Lopez Sonia, 2014, BMC Res Notes, V7, P29, DOI 10.1186/1756-0500-7-29; Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Zuazagoitia A, 2014, EUR J SPORT SCI, V14, pS361, DOI 10.1080/17461391.2012.705332	29	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136870	10.1371/journal.pone.0136870	http://dx.doi.org/10.1371/journal.pone.0136870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379036	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400009
J	Xiao, F; Deng, JL; Yu, JJ; Guo, YJ; Chen, SH; Guo, FF				Xiao, Fei; Deng, Jiali; Yu, Junjie; Guo, Yajie; Chen, Shanghai; Guo, Feifan			A novel function of B-cell translocation gene 1 (BTG1) in the regulation of hepatic insulin sensitivity in mice via c-Jun	FASEB JOURNAL			English	Article						liver; insulin signaling; high-carbohydrate diet; leucine deprivation	EXPRESSION; PROTEIN; HYPERGLYCEMIA; INDUCTION; INTERACT; GLUCOSE; LIVER	Insulin resistance is one of the major factors contributing to metabolic diseases, but the underlying mechanisms are still poorly understood. As an important cofactor, B-cell translocation gene 1 (BTG1) is involved in many physiologic processes; however, the direct effect of BTG1 on insulin sensitivity has not been described. In our study, BTG1 overexpression or knockdown improved or impaired insulin signaling in vitro, respectively. In addition, adenovirus-mediated BTG1 overexpression improved insulin sensitivity in wild-type (WT) and insulin-resistant leptin-receptor mutated (db/db) mice. In addition, transgenic BTG1-overexpressing mice were resistant to high-carbohydrate diet-induced insulin resistance. Adenovirus-mediated BTG1 knockdown consistently impaired insulin sensitivity in WT and insulin sensitive leucine-deprived mice. Moreover, hepatic BTG1 expression was increased by leucine deprivation via the mammalian target of rapamycin/ribosomal protein S6 kinase 1 pathway. Furthermore, c-Jun expression was up-regulated by BTG1, and adenovirus-mediated c-Jun knockdown blocked BTG1-improved insulin signaling and insulin sensitivity in vitro and in vivo. Finally, BTG1 promoted c-Jun expression via stimulating c-Jun and retinoic acid receptor activities. Taken together, these results identify a novel function for BTG1 in the regulation of hepatic insulin sensitivity and provide important insights into the nutritional regulation of BTG1 expression.	[Xiao, Fei; Deng, Jiali; Yu, Junjie; Guo, Yajie; Chen, Shanghai; Guo, Feifan] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Guo, FF (corresponding author), Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	ffguo@sibs.ac.cn			National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350, 81300659, 81570777]; Shanghai Science and Technology Commission [13JC1409000]; International Science and Technology Cooperation Program of China (Singapore) [2014DFG32470]; the International Partnership Program for Creative Research Teams (CAS/SAFEA); Chinese Academy of Sciences; China Postdoctoral Science Foundation [2012M520950]; Chinese Academy of Sciences [2013T60473, 2013KIP310]; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); International Science and Technology Cooperation Program of China (Singapore); the International Partnership Program for Creative Research Teams (CAS/SAFEA); Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS)	This work was supported by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, 81390350, 81300659, and 81570777; Basic Research Project of the Shanghai Science and Technology Commission Grant 13JC1409000; International Science and Technology Cooperation Program of China (Singapore) Grant 2014DFG32470; the International Partnership Program for Creative Research Teams (CAS/SAFEA); the One Hundred Talents Program of the Chinese Academy of Sciences (F.G.); China Postdoctoral Science Foundation Grant 2012M520950; Chinese Academy of Sciences Grants 2013T60473 and 2013KIP310 (to F.X.); and by the Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program (F.X.). The authors declare no conflicts of interest.	[Anonymous], INT J PHOTOENERGY, DOI DOI 10.1186/1476-511X-13-189; Bessesen DH, 2001, J NUTR, V131, p2782S, DOI 10.1093/jn/131.10.2782S; Busson M, 2005, ONCOGENE, V24, P1698, DOI 10.1038/sj.onc.1208373; Camina-Tato M, 2009, J NEUROIMMUNOL, V213, P142, DOI 10.1016/j.jneuroim.2009.05.010; Cho IJ, 2005, FREE RADICAL BIO MED, V39, P1523, DOI 10.1016/j.freeradbiomed.2005.07.017; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P1585, DOI 10.1093/nar/19.7.1585; Duriez Cyril, 2004, Bull Cancer, V91, pE242; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Kim YD, 2014, DIABETES, V63, P1870, DOI 10.2337/db13-1368; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee AK, 2002, MOL CELL BIOCHEM, V231, P163, DOI 10.1023/A:1014481319278; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Ma XR, 2011, J HEPATOL, V55, P445, DOI 10.1016/j.jhep.2010.11.022; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takahashi A, 2012, MOL CELL BIOL, V32, P5067, DOI 10.1128/MCB.00610-12; Takitani K, 2003, LEUKEMIA, V17, P646, DOI 10.1038/sj.leu.2402818; Ueda H, 2000, DIABETOLOGIA, V43, P932, DOI 10.1007/s001250051472; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246	30	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					348	359		10.1096/fj.15-278689	http://dx.doi.org/10.1096/fj.15-278689			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396236				2022-12-26	WOS:000367621000033
J	Hsu, CH; Nguyen, C; Yan, CH; Ries, RE; Chen, QR; Hu, Y; Ostronoff, F; Stirewalt, DL; Komatsoulis, G; Levy, S; Meerzaman, D; Meshinchi, S				Hsu, Chih-Hao; Cu Nguyen; Yan, Chunhua; Ries, Rhonda E.; Chen, Qing-Rong; Hu, Ying; Ostronoff, Fabiana; Stirewalt, Derek L.; Komatsoulis, George; Levy, Shawn; Meerzaman, Daoud; Meshinchi, Soheil			Transcriptome Profiling of Pediatric Core Binding Factor AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; RNA-SEQ; FUSION GENES; DIFFERENTIAL EXPRESSION; MITOTIC CHROMOSOMES; SEQUENCING DATA; CBF-BETA; HOX; CANCER	The t(8; 21) and Inv(16) translocations disrupt the normal function of core binding factors alpha (CBFA) and beta (CBFB), respectively. These translocations represent two of the most common genomic abnormalities in acute myeloid leukemia (AML) patients, occurring in approximately 25% pediatric and 15% of adult with this malignancy. Both translocations are associated with favorable clinical outcomes after intensive chemotherapy, and given the perceived mechanistic similarities, patients with these translocations are frequently referred to as having CBF-AML. It remains uncertain as to whether, collectively, these translocations are mechanistically the same or impact different pathways in subtle ways that have both biological and clinical significance. Therefore, we used transcriptome sequencing (RNA-seq) to investigate the similarities and differences in genes and pathways between these subtypes of pediatric AMLs. Diagnostic RNA from patients with t(8; 21) (N = 17), Inv(16) (N = 14), and normal karyotype (NK, N = 33) were subjected to RNA-seq. Analyses compared the transcriptomes across these three cytogenetic subtypes, using the NK cohort as the control. A total of 1291 genes in t(8;21) and 474 genes in Inv(16) were differentially expressed relative to the NK controls, with 198 genes differentially expressed in both subtypes. The majority of these genes (175/198; binomial test p-value < 10(-30)) are consistent in expression changes among the two subtypes suggesting the expression profiles are more similar between the CBF cohorts than in the NK cohort. Our analysis also revealed alternative splicing events (ASEs) differentially expressed across subtypes, with 337 t(8;21)-specific and 407 Inv(16)-specific ASEs detected, the majority of which were acetylated proteins (p = 1.5x10(-51) and p = 1.8x10(-54) for the two subsets). In addition to known fusions, we identified and verified 16 de novo fusions in 43 patients, including three fusions involving NUP98 in six patients. Clustering of differentially expressed genes indicated that the homeobox (HOX) gene family, including two transcription factors (MEIS1 and NKX2-3) were down-regulated in CBF compared to NK samples. This finding supports existing data that the dysregulation of HOX genes play a central role in biology CBF-AML hematopoiesis. These data provide comprehensive transcriptome profiling of CBF-AML and delineate genes and pathways that are differentially expressed, providing insights into the shared biology as well as differences in the two CBF subsets.	[Hsu, Chih-Hao; Cu Nguyen; Yan, Chunhua; Chen, Qing-Rong; Hu, Ying; Komatsoulis, George; Meerzaman, Daoud] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA; [Ries, Rhonda E.; Ostronoff, Fabiana; Stirewalt, Derek L.; Meshinchi, Soheil] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Levy, Shawn] Hudson Alpha Inst Biotechnol, Huntsville, AL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center	Meshinchi, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	smeshinc@fredhutch.org		Levy, Shawn/0000-0002-1369-5740; Ries, Rhonda/0000-0002-3702-7923	National Cancer Institute [NCI 5 R01 CA114563-08]; Scientific Leadership NIH National Clinical Trials Network (NCTN) [U10CA180886]; NATIONAL CANCER INSTITUTE [T32CA009515, U10CA180886, R01CA114563] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Scientific Leadership NIH National Clinical Trials Network (NCTN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, NCI 5 R01 CA114563-08 (www.nih.gov) and a Scientific Leadership NIH National Clinical Trials Network (NCTN) Grant (U10CA180886).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; Bakshi R, 2008, J CELL SCI, V121, P3981, DOI 10.1242/jcs.033431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Hollink IHIM, 2012, LEUKEMIA, V26, P371, DOI 10.1038/leu.2011.210; Hollink IHIM, 2011, BLOOD, V118, P3645, DOI 10.1182/blood-2011-04-346643; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa M, 2013, INT J HEMATOL, V97, P726, DOI 10.1007/s12185-013-1347-3; Ito Y, 1996, J CANCER RES CLIN, V122, P266, DOI 10.1007/BF01261402; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lilljebjorn H, 2014, LEUKEMIA, V28, P977, DOI 10.1038/leu.2013.324; LIU PP, 1995, BLOOD, V85, P2289, DOI 10.1182/blood.V85.9.2289.bloodjournal8592289; Lopez-Camacho C, 2014, J CELL BIOCHEM, V115, P2155, DOI 10.1002/jcb.24892; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mandoli A, 2014, LEUKEMIA, V28, P770, DOI 10.1038/leu.2013.257; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mrozek K, 1997, SEMIN ONCOL, V24, P17; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pabst O, 1999, DEVELOPMENT, V126, P2215; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Schuback HL, 2013, SEMIN HEMATOL, V50, P325, DOI 10.1053/j.seminhematol.2013.09.003; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shigesada K, 2004, ONCOGENE, V23, P4297, DOI 10.1038/sj.onc.1207748; Sitwala KV, 2008, INT J CLIN EXP PATHO, V1, P461; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Thanasopoulou A, 2014, HAEMATOLOGICA, V99, P1465, DOI 10.3324/haematol.2013.100917; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108	55	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138782	10.1371/journal.pone.0138782	http://dx.doi.org/10.1371/journal.pone.0138782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397705	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500106
J	Jacome, R; Becerra, A; de Leon, SP; Lazcano, A				Jacome, Rodrigo; Becerra, Arturo; Ponce de Leon, Samuel; Lazcano, Antonio			Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications	PLOS ONE			English	Article							EBOLA-VIRUS INFECTION; AMINO-ACID-SEQUENCE; DOUBLE-STRANDED DNA; IN-VIVO ACTIVITIES; CRYSTAL-STRUCTURE; REVERSE-TRANSCRIPTASE; ACTIVE-SITE; FAVIPIRAVIR T-705; PROTEIN; VITRO	The crystal structures of monomeric RNA-dependent RNA polymerases and reverse transcriptases of more than 20 different viruses are available in the Protein Data Bank. They all share the characteristic right-hand shape of DNA- and RNA polymerases formed by the fingers, palm and thumb subdomains, and, in many cases, "fingertips" that extend from the fingers towards the thumb subdomain, giving the viral enzyme a closed right-hand appearance. Six conserved structural motifs that contain key residues for the proper functioning of the enzyme have been identified in all these RNA-dependent polymerases. These enzymes share a two divalent metal-ion mechanism of polymerization in which two conserved aspartate residues coordinate the interactions with the metal ions to catalyze the nucleotidyl transfer reaction. The recent availability of crystal structures of polymerases of the Orthomyxoviridae and Bunyaviridae families allowed us to make pairwise comparisons of the tertiary structures of polymerases belonging to the four main RNA viral groups, which has led to a phylogenetic tree in which single-stranded negative RNA viral polymerases have been included for the first time. This has also allowed us to use a homology-based structural prediction approach to develop a general three-dimensional model of the Ebola virus RNA-dependent RNA polymerase. Our model includes several of the conserved structural motifs and residues described in other viral RNA-dependent RNA polymerases that define the catalytic and highly conserved palm subdomain, as well as portions of the fingers and thumb subdomains. The results presented here help to understand the current use and apparent success of antivirals, i.e. Brincidofovir, Lamivudine and Favipiravir, originally aimed at other types of polymerases, to counteract the Ebola virus infection.	[Jacome, Rodrigo; Becerra, Arturo; Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Ponce de Leon, Samuel] Univ Nacl Autonoma Mexico, Fac Med, Direcc Gen Invest, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Cd Univ, Mexico City 04510, DF, Mexico.	alar@ciencias.unam.mx	Becerra, Arturo/U-2875-2019; Becerra, Arturo/J-8364-2015	Becerra, Arturo/0000-0002-7076-0342; Lazcano, Antonio/0000-0001-7365-8557; Jacome, Rodrigo/0000-0002-6367-1907	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [263004]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Rodrigo Jacome is supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT), scholarship number 263004.	Alam I, 2012, VIROLOGY, V426, P143, DOI 10.1016/j.virol.2012.01.016; Appleby TC, 2005, J VIROL, V79, P277, DOI 10.1128/JVI.79.1.277-288.2005; Azango M, 2014, LIBERIAN DOCTOR DEFE; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Barr JN, 2001, J VIROL, V75, P6901, DOI 10.1128/JVI.75.15.6901-6913.2001; Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227; Bray M, 2008, ANTIVIR RES, V78, P1, DOI 10.1016/j.antiviral.2007.12.007; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070; Chattopadhyay A, 2004, VIRUS RES, V99, P139, DOI 10.1016/j.virusres.2003.11.003; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; De Clercq E, 2013, MED RES REV, V33, P1249, DOI 10.1002/med.21281; Delaye L, 2001, FIRST STEPS IN THE ORIGIN OF LIFE IN THE UNIVERSE, PROCEEDINGS, P223; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fauci AS, 2014, NIH EBOLA UPDATE WOR; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; GARCIAMEZA V, 1994, NATO ADV SCI INST SE, V446, P231; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gowen BB, 2010, ANTIVIR RES, V86, P121, DOI 10.1016/j.antiviral.2009.10.015; Han ZY, 2003, J VIROL, V77, P1793, DOI 10.1128/JVI.77.3.1793-1800.2003; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HASELOFF J, 1984, P NATL ACAD SCI-BIOL, V81, P4358, DOI 10.1073/pnas.81.14.4358; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang Y, 2002, MOL CELL, V10, P307, DOI 10.1016/S1097-2765(02)00588-9; HUGGINS JW, 1989, REV INFECT DIS, V11, pS750; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Julander JG, 2009, ANTIVIR RES, V82, P169, DOI 10.1016/j.antiviral.2009.02.201; Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Lang DM, 2013, NUCLEIC ACIDS RES, V41, P1464, DOI 10.1093/nar/gks1251; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; LAZCANO A, 1992, J MOL EVOL, V35, P524, DOI 10.1007/BF00160213; LAZCANO A, 1988, J MOL EVOL, V27, P365, DOI 10.1007/BF02101199; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Llaca V, 1990, PREBIOLOGICAL SELF O, P247; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Magee WC, 2005, ANTIMICROB AGENTS CH, V49, P3153, DOI 10.1128/AAC.49.8.3153-3162.2005; Malur AG, 2002, GENE EXPRESSION, V10, P93; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marty FM, 2013, NEW ENGL J MED, V369, P1227, DOI 10.1056/NEJMoa1303688; Mayhoub AS, 2012, BIOORGAN MED CHEM, V20, P3150, DOI 10.1016/j.bmc.2012.03.049; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; Monttinen HAM, 2014, MOL BIOL EVOL, V31, P2741, DOI 10.1093/molbev/msu219; Morin B, 2012, EMBO J, V31, P1320, DOI 10.1038/emboj.2011.483; Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009; Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Noton SL, 2010, P NATL ACAD SCI USA, V107, P10226, DOI 10.1073/pnas.0913065107; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Olson VA, 2014, ANTIMICROB AGENTS CH, V58, P5570, DOI 10.1128/AAC.02814-14; Ortin J, 2006, ANNU REV MICROBIOL, V60, P305, DOI 10.1146/annurev.micro.60.080805.142248; Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11; Pan J, 2007, P NATL ACAD SCI USA, V166, P1; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Pringle CR, 1997, SEMIN VIROL, V8, P49, DOI 10.1006/smvy.1997.0105; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034; Rosenberg R, 2015, CELL MOL LIFE SCI, V72, P1115, DOI 10.1007/s00018-014-1785-y; Sandkovsky U, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0416-y; SANKAR S, 1992, J BIOL CHEM, V267, P10168; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schnell MJ, 1995, VIROLOGY, V214, P522, DOI 10.1006/viro.1995.0063; Sesmero E, 2015, VIRUSES-BASEL, V7, P3974, DOI 10.3390/v7072808; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P1972, DOI 10.1128/AAC.31.12.1972; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000; Vieth S, 2004, VIROLOGY, V318, P153, DOI 10.1016/j.virol.2003.09.009; Vivet-Boudou V, 2015, J BIOL CHEM, V290, P371, DOI 10.1074/jbc.M114.616383; Volchkov VE, 1999, J GEN VIROL, V80, P355, DOI 10.1099/0022-1317-80-2-355; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; Wu Y, 2010, PROTEIN CELL, V1, P491, DOI 10.1007/s13238-010-0061-7; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	110	57	58	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139001	10.1371/journal.pone.0139001	http://dx.doi.org/10.1371/journal.pone.0139001			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397100	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500132
J	Bechelli, J; Smalley, C; Milhano, N; Walker, DH; Fang, R				Bechelli, Jeremy; Smalley, Claire; Milhano, Natacha; Walker, David H.; Fang, Rong			Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain Differentially Regulate Endothelial Cell Responses	PLOS ONE			English	Article							TICK-BITE FEVER; NF-KAPPA-B; VASCULAR ENDOTHELIUM; MOLECULAR-DETECTION; TIGHT JUNCTION; INFECTION; ACTIVATION; INFLAMMATION; EXPRESSION; APOPTOSIS	Rickettsiae primarily target microvascular endothelial cells. However, it remains elusive how endothelial cell responses to rickettsiae play a role in the pathogenesis of rickettsial diseases. In the present study, we employed two rickettsial species with high sequence homology but differing virulence to investigate the pathological endothelial cell responses. Rickettsia massiliae is a newly documented human pathogen that causes a mild spotted fever rickettsiosis. The "Israeli spotted fever" strain of R. conorii (ISF) causes severe disease with a mortality rate up to 30% in hospitalized patients. At 48 hours post infection (HPI), R. conorii (ISF) induced a significant elevation of IL-8 and IL-6 while R. massiliae induced a statistically significant elevated amount of MCP-1 at both transcriptional and protein synthesis levels. Strikingly, R. conorii (ISF), but not R. massiliae, caused a significant level of cell death or injury in HMEC-1 cells at 72 HPI, demonstrated by live-dead cell staining, annexin V staining and lactate dehydrogenase release. Monolayers of endothelial cells infected with R. conorii (ISF) showed a statistically significant decrease in electrical resistance across the monolayer compared to both R. massiliae-infected and uninfected cells at 72 HPI, suggesting increased endothelial permeability. Interestingly, pharmacological inhibitors of caspase-1 significantly reduced the release of lactate dehydrogenase by R. conorii (ISF)-infected HMEC-1 cells, which suggests the role of caspase-1 in mediating the death of endothelial cells. Taken together, our data illustrated that a distinct proinflammatory cytokine profile and endothelial dysfunction, as evidenced by endothelial cell death/injury and increased permeability, are associated with the severity of rickettsial diseases.	[Bechelli, Jeremy; Smalley, Claire; Milhano, Natacha; Walker, David H.; Fang, Rong] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Fang, R (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	rofang@utmb.edu	Fang, Rong/ABD-6123-2020; Bechelli, Jeremy/ABC-6193-2020	Bechelli, Jeremy/0000-0002-8786-7795	Carmage and Martha Walls Distinguished University Chair in Tropical Diseases; UTMB Institute for Human Infections and Immunity Endothelial Biology Pilot Grant; UTMB [T32-AI060549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101413, T32AI060549] Funding Source: NIH RePORTER	Carmage and Martha Walls Distinguished University Chair in Tropical Diseases; UTMB Institute for Human Infections and Immunity Endothelial Biology Pilot Grant; UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Carmage and Martha Walls Distinguished University Chair in Tropical Diseases and the UTMB Institute for Human Infections and Immunity Endothelial Biology Pilot Grant. Jeremy Bechelli is supported by the UTMB T32-AI060549 Biodefense Training Grant.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Bechelli JR, 2009, J INFECT DIS, V199, P1389, DOI 10.1086/597805; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Cascio A, 2013, EMERG INFECT DIS, V19, P836, DOI 10.3201/eid1905.121169; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Clifton DR, 2005, INT J MED MICROBIOL, V295, P267, DOI 10.1016/j.ijmm.2005.05.006; Damas JK, 2009, J INFECTION, V58, P68, DOI 10.1016/j.jinf.2008.11.008; De Sousa R, 2003, ANN NY ACAD SCI, V990, P285; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Elghetany MT, 1999, AM J CLIN PATHOL, V112, P159; Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501; Harrus S, 2011, CLIN MICROBIOL INFEC, V17, P176, DOI 10.1111/j.1469-0691.2010.03224.x; Jensenius M, 2003, J INFECT DIS, V187, P1332, DOI 10.1086/368415; JORIS I, 1990, AM J PATHOL, V137, P1353; Joshi SG, 2004, FEMS MICROBIOL LETT, V234, P333, DOI 10.1016/j.femsle.2004.03.046; Joshi SG, 2003, INFECT IMMUN, V71, P4127, DOI 10.1128/IAI.71.7.4127-4136.2003; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maia C, 2014, TICKS TICK-BORNE DIS, V5, P409, DOI 10.1016/j.ttbdis.2014.01.009; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; McAmis WC, 2003, BBA-MOL CELL RES, V1641, P43, DOI 10.1016/S0167-4889(03)00063-6; Milhano N, 2015, MED VET ENTOMOL; Oristrell J, 2004, EUR J CLIN MICROBIOL, V23, P417, DOI 10.1007/s10096-004-1121-9; Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035; POBER JS, 1988, AM J PATHOL, V133, P426; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021; Rydkina E, 2007, J MED MICROBIOL, V56, P896, DOI 10.1099/jmm.0.47050-0; SILVERMAN DJ, 1984, INFECT IMMUN, V44, P545, DOI 10.1128/IAI.44.3.545-553.1984; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Valbuena G, 2009, THROMB HAEMOSTASIS, V102, P1071, DOI 10.1160/TH09-03-0186; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Walker DH, 2007, CLIN INFECT DIS, V45, pS39, DOI 10.1086/518145; Walker DH, 1994, INVEST, V70, P358; Walker DH., 1996, MED MICROBIOLOGY, V4th; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138830	10.1371/journal.pone.0138830	http://dx.doi.org/10.1371/journal.pone.0138830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394396	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100104
J	Balotra, S; Warden, AC; Newman, J; Briggs, LJ; Scott, C; Peat, TS				Balotra, Sahil; Warden, Andrew C.; Newman, Janet; Briggs, Lyndall J.; Scott, Colin; Peat, Thomas S.			X-Ray Structure and Mutagenesis Studies of the N-Isopropylammelide Isopropylaminohydrolase, AtzC	PLOS ONE			English	Article							SP STRAIN ADP; CYANURIC ACID HYDROLASE; YEAST CYTOSINE DEAMINASE; S-TRIAZINE RING; PSEUDOMONAS SP; ALLOPHANATE HYDROLASE; AMIDOHYDROLASE SUPERFAMILY; ATRAZINE CHLOROHYDROLASE; CARBONIC-ANHYDRASE; CRYSTAL-STRUCTURE	The N-isopropylammelide isopropylaminohydrolase from Pseudomonas sp. strain ADP, AtzC, provides the third hydrolytic step in the mineralization of s-triazine herbicides, such as atrazine. We obtained the X-ray crystal structure of AtzC at 1.84 angstrom with a weak inhibitor bound in the active site and then used a combination of in silico docking and site-directed mutagenesis to understand the interactions between AtzC and its substrate, isopropylammelide. The substitution of an active site histidine residue (His249) for an alanine abolished the enzyme's catalytic activity. We propose a plausible catalytic mechanism, consistent with the biochemical and crystallographic data obtained that is similar to that found in carbonic anhydrase and other members of subtype III of the amidohydrolase family	[Balotra, Sahil; Warden, Andrew C.; Briggs, Lyndall J.; Scott, Colin] CSIRO Land & Water Flagship, Canberra, ACT, Australia; [Balotra, Sahil] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Newman, Janet; Peat, Thomas S.] CSIRO Biomed Mfg, Parkville, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scott, C (corresponding author), CSIRO Land & Water Flagship, Canberra, ACT, Australia.	Colin.scott@csiro.au; Thomas.peat@csiro.au	Peat, Thomas S/F-9817-2010; Newman, Janet M/D-1857-2011; Briggs, Lyndall J/A-7549-2011; Warden, Andrew C/C-1484-2008; Scott, Colin/A-4682-2009	Peat, Thomas S/0000-0002-6488-0831; Newman, Janet M/0000-0003-2666-3219; Warden, Andrew C/0000-0003-2683-9798; Scott, Colin/0000-0001-6110-6982				Balotra S, 2015, APPL ENVIRON MICROB, V81, P470, DOI 10.1128/AEM.02783-14; Balotra S, 2014, ACTA CRYSTALLOGR F, V70, P310, DOI 10.1107/S2053230X13034705; BoundyMills KL, 1997, APPL ENVIRON MICROB, V63, P916, DOI 10.1128/AEM.63.3.916-923.1997; Cheng G, 2005, APPL ENVIRON MICROB, V71, P4437, DOI 10.1128/AEM.71.8.4437-4445.2005; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; EATON RW, 1991, J BACTERIOL, V173, P1363, DOI 10.1128/jb.173.3.1363-1366.1991; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fedorov AA, 2007, CRYSTAL STRUCTURE OF; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Gilmour KM, 2010, COMP BIOCHEM PHYS A, V157, P193, DOI 10.1016/j.cbpa.2010.06.161; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Jackson CJ, 2014, APPL ENVIRON MICROB, V80, P4003, DOI 10.1128/AEM.00916-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; MANDELBAUM RT, 1993, APPL ENVIRON MICROB, V59, P1695, DOI 10.1128/AEM.59.6.1695-1701.1993; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikulski RL, 2010, BBA-PROTEINS PROTEOM, V1804, P422, DOI 10.1016/j.bbapap.2009.08.003; Miller JH., 1972, EXPERIMENTS IN MOLEC; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Sadowsky MJ, 1998, J BACTERIOL, V180, P152, DOI 10.1128/JB.180.1.152-158.1998; Seabrook SA, 2013, ACS COMB SCI, V15, P387, DOI 10.1021/co400013v; Seffernick JL, 2007, J BACTERIOL, V189, P6989, DOI 10.1128/JB.00630-07; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Seffernick JL, 2010, J BIOL CHEM, V285, P30606, DOI 10.1074/jbc.M110.138677; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shapir N, 2002, J BACTERIOL, V184, P5376, DOI 10.1128/JB.184.19.5376-5384.2002; Singh P, 2004, BIOCHEM BIOPH RES CO, V317, P697, DOI 10.1016/j.bbrc.2004.03.112; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; Sugrue E, 2015, APPL ENVIRON MICROB, V81, P2612, DOI 10.1128/AEM.04016-14; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Vargha M, 2005, WATER RES, V39, P1560, DOI 10.1016/j.watres.2004.10.013	46	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137700	10.1371/journal.pone.0137700	http://dx.doi.org/10.1371/journal.pone.0137700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390431	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000012
J	Leleu, A; Demily, C; Franck, N; Durand, K; Schaal, B; Baudouin, JY				Leleu, Arnaud; Demily, Caroline; Franck, Nicolas; Durand, Karine; Schaal, Benoist; Baudouin, Jean-Yves			The Odor Context Facilitates the Perception of Low-Intensity Facial Expressions of Emotion	PLOS ONE			English	Article							CHEMOSENSORY ANXIETY SIGNALS; HUMAN AMYGDALA; MULTISENSORY INTEGRATION; CONFIGURAL INFORMATION; CULTURAL-DIFFERENCES; RECOGNITION; FACES; RESPONSES; LANGUAGE; FEAR	It has been established that the recognition of facial expressions integrates contextual information. In this study, we aimed to clarify the influence of contextual odors. The participants were asked to match a target face varying in expression intensity with non-ambiguous expressive faces. Intensity variations in the target faces were designed by morphing expressive faces with neutral faces. In addition, the influence of verbal information was assessed by providing half the participants with the emotion names. Odor cues were manipulated by placing participants in a pleasant (strawberry), aversive (butyric acid), or no-odor control context. The results showed two main effects of the odor context. First, the minimum amount of visual information required to perceive an expression was lowered when the odor context was emotionally congruent: happiness was correctly perceived at lower intensities in the faces displayed in the pleasant odor context, and the same phenomenon occurred for disgust and anger in the aversive odor context. Second, the odor context influenced the false perception of expressions that were not used in target faces, with distinct patterns according to the presence of emotion names. When emotion names were provided, the aversive odor context decreased intrusions for disgust ambiguous faces but increased them for anger. When the emotion names were not provided, this effect did not occur and the pleasant odor context elicited an overall increase in intrusions for negative expressions. We conclude that olfaction plays a role in the way facial expressions are perceived in interaction with other contextual influences such as verbal information.	[Leleu, Arnaud; Durand, Karine; Schaal, Benoist; Baudouin, Jean-Yves] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, UMR CNRS 6265, Equipe Ethol Dev & Psychol Cognit,UMR INRA 1324, Dijon, France; [Demily, Caroline] Ctr Hosp Vinatier, Ctr Depistage & Prises Charge Troubles Psychiat O, Bron, France; [Demily, Caroline; Franck, Nicolas] Univ Lyon 1, Ctr Neurosci Cognit, Inst Cognit Sci, UMR CNRS 5229, F-69365 Lyon, France; [Franck, Nicolas] Ctr Hosp Vinatier, Serv Univ Rehabil, Bron, France; [Baudouin, Jean-Yves] Inst Univ France, Paris, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut Universitaire de France	Leleu, A (corresponding author), Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, UMR CNRS 6265, Equipe Ethol Dev & Psychol Cognit,UMR INRA 1324, Dijon, France.	arnaud.leleu@u-bourgogne.fr; jean-yves.baudouin@u-bourgogne.fr	Leleu, Arnaud/J-7883-2019; Franck, Nicolas/GWZ-4383-2022	Leleu, Arnaud/0000-0002-2943-8183; Franck, Nicolas/0000-0002-2894-5108; Baudouin, Jean-Yves/0000-0002-4405-7987	French National Agency for Research (project INTERFACE, EMCO), Paris; Scientific Council for Research of Le Vinatier Hospital, Bron; Regional Council of Burgundy (PARI grant), Dijon; European Community (FEDER grant), Brussels; Institut Universitaire de France, Paris	French National Agency for Research (project INTERFACE, EMCO), Paris; Scientific Council for Research of Le Vinatier Hospital, Bron; Regional Council of Burgundy (PARI grant), Dijon(Region Bourgogne-Franche-Comte); European Community (FEDER grant), Brussels; Institut Universitaire de France, Paris	This work was supported by the French National Agency for Research (project INTERFACE, EMCO, 2011), Paris; the Scientific Council for Research of Le Vinatier Hospital, Bron; the Regional Council of Burgundy (PARI grant), Dijon; The European Community (FEDER grant), Brussels; and the Institut Universitaire de France, Paris (to JYB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolph D, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00425, 10.3389/fnhum.2013.00283]; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bijlstra G, 2014, PERS SOC PSYCHOL BUL; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205; Chambon V, 2006, NEUROPSYCHOLOGIA, V44, P2437, DOI 10.1016/j.neuropsychologia.2006.04.008; Dailey MN, 2002, J COGNITIVE NEUROSCI, V14, P1158, DOI 10.1162/089892902760807177; Dalton P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077144; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Durand K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070677; Ekman P., 1978, FACIAL ACTION CODING; Elfenbein HA, 2003, J PERS SOC PSYCHOL, V85, P276, DOI 10.1037/0022-3514.85.2.276; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gauthier L, 1989, J CLIN NEUROPSYCHOL; Gendron M, 2014, EMOTION, V14, P251, DOI 10.1037/a0036052; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; Godard O, 2016, DEVELOPMENTAL SCI, V19, P155, DOI 10.1111/desc.12292; Gosselin P, 2005, PSYCHOLOGY OF MOODS, P29; Hassin RR, 2013, EMOT REV, V5, P60, DOI 10.1177/1754073912451331; Hennenlotter A, 2006, PROG BRAIN RES, V156, P443, DOI 10.1016/S0079-6123(06)56024-8; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JANCKE L, 1994, CHEM SENSES, V19, P99, DOI 10.1093/chemse/19.2.99; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Lindquist KA, 2006, EMOTION, V6, P125, DOI 10.1037/1528-3542.6.1.125; Lindquist KA, 2013, EMOT REV, V5, P66, DOI 10.1177/1754073912451351; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Morris J. S., 1996, DIFFERENTIAL NEURAL; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pye A, 2015, COGNITION, V134, P245, DOI 10.1016/j.cognition.2014.11.001; Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Robinson AK, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00077; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Royet JP, 2000, J NEUROSCI, V20, P7752; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; RUSSELL JA, 1986, SOC COGNITION, V4, P309, DOI 10.1521/soco.1986.4.3.309; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; Schwarz KA, 2013, SOC COGN AFFECT NEUR, V8, P438, DOI 10.1093/scan/nss013; Seigneuric A, 2010, PERCEPTION, V39, P1541, DOI 10.1068/p6740; Semin GR, 2013, TRENDS COGN SCI, V17, P427, DOI 10.1016/j.tics.2013.05.008; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Seubert J, 2010, J PSYCHIATR NEUROSCI, V35, P185, DOI 10.1503/jpn.090094; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Soussignan R, 1996, ETHOLOGY, V102, P1020, DOI 10.1111/j.1439-0310.1996.tb01179.x; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; Zernecke R, 2011, J PSYCHOPHYSIOL, V25, P116, DOI 10.1027/0269-8803/a000047; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	79	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138656	10.1371/journal.pone.0138656	http://dx.doi.org/10.1371/journal.pone.0138656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZM	26390036	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000047
J	Lim, EJ; Chin, R; Nachbur, U; Silke, J; Jia, ZY; Angus, PW; Torresi, J				Lim, Eu Jin; Chin, Ruth; Nachbur, Ueli; Silke, John; Jia, Zhiyuan; Angus, Peter W.; Torresi, Joseph			Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE-A; SIGNAL-TRANSDUCTION; HEPATITIS-C; RAPAMYCIN; CELLS; TACROLIMUS; PROGRESSION; INHIBITION	Introduction Immunosuppressants are used ubiquitously post-liver transplantation to prevent allograft rejection. However their effects on hepatocytes are unknown. Experimental data from nonliver cells indicate that immunosuppressants may promote cell death thereby driving an inflammatory response that promotes fibrosis and raises concerns that a similar effect may occur within the liver. We evaluated apoptosis within the liver tissue of post-liver transplant patients and correlated these findings with in vitro experiments investigating the effects of immunosuppressants on apoptosis in primary hepatocytes. Methods Hepatocyte apoptosis was assessed using immunohistochemistry for M30 CytoDEATH and cleaved PARP in human liver tissue. Primary mouse hepatocytes were treated with various combinations of cyclosporine, tacrolimus, sirolimus, or MMF. Cell viability and apoptosis were evaluated using crystal violet assays and Western immunoblots probed for cleaved PARP and cleaved caspase 3. Results Post-liver transplant patients had a 4.9-fold and 1.7-fold increase in M30 CytoDEATH and cleaved PARP compared to normal subjects. Cyclosporine and tacrolimus at therapeutic concentrations did not affect hepatocyte apoptosis, however when they were combined with MMF, cell death was significantly enhanced. Cell viability was reduced by 46% and 41%, cleaved PARP was increased 2.6-fold and 2.2-fold, and cleaved caspase 3 increased 2.2-fold and 1.8-fold following treatment with Cyclosporine/MMF and Tacrolimus/MMF respectively. By contrast, the sirolimus/MMF combination did not significantly reduce hepatocyte viability or promote apoptosis. Conclusion Commonly used immunosuppressive drug regimens employed after liver transplantation enhance hepatocyte cell death and may thus contribute to the increased liver fibrosis that occurs in a proportion of liver transplant recipients.	[Lim, Eu Jin; Angus, Peter W.] Austin Hosp, Liver Transplant Unit, Heidelberg, Vic 3084, Australia; [Lim, Eu Jin; Chin, Ruth; Jia, Zhiyuan; Angus, Peter W.; Torresi, Joseph] Univ Melbourne, Dept Med, Austin Hosp, Heidelberg, Vic, Australia; [Nachbur, Ueli; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Torresi, Joseph] Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Torresi, Joseph] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Walter & Eliza Hall Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Torresi, J (corresponding author), Austin Hosp, Liver Transplant Unit, Heidelberg, Vic 3084, Australia.	josepht@unimelb.edu.au	Silke, John/B-7622-2008	Silke, John/0000-0002-7611-5774; Torresi, Joseph/0000-0002-8212-0887; Nachbur, Ueli/0000-0001-5968-2235	postgraduate scholarship from the NHMRC; Austin Medical Research Foundation, Austin Hospital	postgraduate scholarship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Austin Medical Research Foundation, Austin Hospital	Dr. Eu Jin Lim was supported by a postgraduate scholarship from the NHMRC. The work was supported by a grant from Austin Medical Research Foundation, Austin Hospital. No grant number. Url: http://austinmrf.org.au/.	Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Balibrea del Castillo JM, 2009, CELL TRANSPLANT, V18, P1237, DOI 10.3727/096368909X12483162197240; Ballardini G, 2002, LIVER TRANSPLANT, V8, P10, DOI 10.1053/jlts.2002.30141; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Bouvier N, 2009, AM J PHYSIOL-RENAL, V296, pF160, DOI 10.1152/ajprenal.90567.2008; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Choi SJN, 2008, TRANSPL P, V40, P2734, DOI 10.1016/j.transproceed.2008.08.028; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Hood KA, 1997, AM J HEALTH-SYST PH, V54, P285, DOI 10.1093/ajhp/54.3.285; Jimenez-Perez M, 2006, TRANSPL P, V38, P2480, DOI 10.1016/j.transproceed.2006.08.039; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Jung JY, 2008, ARCH ORAL BIOL, V53, P1042, DOI 10.1016/j.archoralbio.2008.03.008; KAHN D, 1989, TRANSPLANT P, V21, P2240; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; Neumann UP, 2004, J HEPATOL, V41, P830, DOI 10.1016/j.jhep.2004.06.029; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398; Pardo-Mindan FJ, 1999, NEPHRON, V82, P232, DOI 10.1159/000045407; Sehgal SN, 1998, CLIN BIOCHEM, V31, P335, DOI 10.1016/S0009-9120(98)00045-9; Stegall MD, 1997, TRANSPLANTATION, V64, P1755, DOI 10.1097/00007890-199712270-00023; Sun BK, 2004, J LAB CLIN MED, V143, P175, DOI 10.1016/j.lab.2003.10.014; Tannuri U, 2008, PEDIATR TRANSPLANT, V12, P73, DOI 10.1111/j.1399-3046.2007.00801.x; Tharakan B, 2009, J TRAUMA, V66, P1033, DOI 10.1097/TA.0b013e31816c905f; Thong N, 2009, AM J SURG PATHOL, V33, P1355, DOI 10.1097/PAS.0b013e3181a755bd; Watson CJE, 2007, LIVER TRANSPLANT, V13, P1694, DOI 10.1002/lt.21314	29	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138522	10.1371/journal.pone.0138522	http://dx.doi.org/10.1371/journal.pone.0138522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390404	gold, Green Published			2022-12-26	WOS:000361791000035
J	Wang, JX; Yi, XY; Liu, MX; Zhou, Q; Ren, SP; Wang, Y; Yang, C; Zhou, JW; Han, Y				Wang, Jiexi; Yi, Xiaoyang; Liu, Minxia; Zhou, Qian; Ren, Suping; Wang, Yan; Yang, Chao; Zhou, Jianwei; Han, Ying			Correlation between the In Vitro Functionality of Stored Platelets and the Cytosolic Esterase-Induced Fluorescence Intensity with CMFDA	PLOS ONE			English	Article							FLOW-CYTOMETRY; VIABILITY	It has been hypothesized that the cytosolic esterase-induced fluorescence intensity (CEIFI) from carboxy dimethyl fluorescein diacetate (CMFDA) in platelets may related to platelet functions. In the present study, we measured the change of CEIFI in platelets during storage, and examined the correlations of CEIFI with the in vitro functionality of stored platelets, including the ADP-induced aggregation activity, hypotonic shock response, expression of CD62P as well as platelet apoptosis. The CEIFI of fresh platelets, when tested at 10 mu M CMFDA, the mean fluorescence intensity index (MFI) was 305.9 +/- 49.9 (N = 80). After 1day storage, it was 203.8 +/- 34.4, the CEIFI of the stored platelets started to decline significantly, and reduced to 112.7 +/- 27.7 after 7-day storage. The change in CEIFI is highly correlated to all four functional parameters measured, with the correlation coefficients being 0.9813, 0.9848, -0.9945 and -0.9847 for the ADP-induced aggregation activity, hypotonic shock response (HSR), expression of CD62P and platelet apoptosis respectively. The above results show that the CEIFI measurement of platelets represents well the viability and functional state of in vitro stored platelets. This may be used as a convenient new method for quality evaluation for stored platelets if this result can be further validated by the following clinical trials.	[Wang, Jiexi; Yi, Xiaoyang; Liu, Minxia; Ren, Suping; Wang, Yan; Zhou, Jianwei; Han, Ying] Acad Mil Med Sci, Beijing Inst Blood Transfus, Beijing, Peoples R China; [Zhou, Qian] Beijing Red Cross Blood Ctr, Beijing, Peoples R China; [Yang, Chao] Second Artillery Gen Hosp PLA, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Han, Y (corresponding author), Acad Mil Med Sci, Beijing Inst Blood Transfus, Beijing, Peoples R China.	hanying_1001@126.com	Ren, Suping/AAC-9167-2020		research grant from the National Natural Science Foundation of China [81100333]	research grant from the National Natural Science Foundation of China	The study was supported by the research grant (grant number 81100333) from the National Natural Science Foundation of China. URLs of (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BARHOUMI R, 1993, CYTOMETRY, V14, P747, DOI 10.1002/cyto.990140707; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; BURGHARDT RC, 1992, TOXICOL APPL PHARM, V112, P235, DOI 10.1016/0041-008X(92)90193-V; Cai Ke-jun, 2003, Zoological Research, V24, P311; CUMBERLEDGE S, 1993, NATURE, V363, P549, DOI 10.1038/363549a0; JAROSZESKI MJ, 1994, ANAL BIOCHEM, V216, P271, DOI 10.1006/abio.1994.1041; Kickler TS, 2006, TRANSFUS ALTERN TRAN, V8, P79, DOI [10.1111/j.1778-428X.2006.00013.x, DOI 10.1111/J.1778-428X.2006.00013.X]; KIM BK, 1974, TRANSFUSION, V14, P130, DOI 10.1111/j.1537-2995.1974.tb04504.x; Lindahl TL, 2009, TRANSFUS APHER SCI, V41, P121, DOI 10.1016/j.transci.2009.07.015; Nylander S, 2006, PLATELETS, V17, P49, DOI 10.1080/09537100500197448; Pena A, 1999, THERIOGENOLOGY, V52, P965, DOI 10.1016/S0093-691X(99)00186-7; Pena AI, 1998, THERIOGENOLOGY, V50, P1211, DOI 10.1016/S0093-691X(98)00221-0; Scialla JJ, 2011, AM J NEPHROL, V33, P224, DOI 10.1159/000324517; VALERI CR, 1974, TRANSFUSION, V14, P331, DOI 10.1111/j.1537-2995.1974.tb04541.x; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044	15	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138509	10.1371/journal.pone.0138509	http://dx.doi.org/10.1371/journal.pone.0138509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390135	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000032
J	Wang, ZH; Bhattacharya, A; Ivanov, DN				Wang, Zhonghua; Bhattacharya, Akash; Ivanov, Dmitri N.			Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation	PLOS ONE			English	Article							AU-RICH ELEMENTS; FRAGMENT-BASED APPROACH; MESSENGER-RNA; CYCLIN-A; HUR; BINDING; PROTEIN; EXPRESSION; STABILITY; CELLS	The human antigen R (HuR) stabilizes many mRNAs of proto-oncogene, transcription factors, cytokines and growth factors by recognizing AU-rich elements (AREs) presented in their 3' or 5' untranslated region (UTR). Multiple lines of experimental evidence suggest that this process plays a key role in cancer development. Thus, destabilizing HuR/RNA interaction by small molecules presents an opportunity for cancer treatment/prevention. Here we present an integrated approach to identify inhibitors of HuR/RNA interaction using a combination of fluorescence-based and NMR-based high throughput screening (HTS). The HTS assay with fluorescence polarization readout and Z'-score of 0.8 was used to perform a screen of the NCI diversity set V library in a 384 well plate format. An NMR-based assay with saturation transfer difference (STD) detection was used for hits validation. Protein NMR spectroscopy was used to demonstrate that some hit compounds disrupt formation of HuR oligomer, whereas others block RNA binding. Thus, our integrated high throughput approach provides a new avenue for identification of small molecules targeting HuR/RNA interaction.	[Wang, Zhonghua; Bhattacharya, Akash; Ivanov, Dmitri N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Wang, ZH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	wangz3@uthscsa.edu	Bhattacharya, Akash/G-9154-2016; Ivanov, Dmitri/B-4600-2011	Bhattacharya, Akash/0000-0001-8748-9969; 	NIH [R01 AI104476, P30 CA054174]; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by NIH R01 AI104476 and Scholar Award from the Cancer Prevention and Research Institute of Texas (CPRIT) to D.I. The NMR core facility at the UT Health Science Center at San Antonio (UTHSCSA) was supported in part by the NIH P30 CA054174 to the Cancer Therapy and Research Center.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benie AJ, 2003, J AM CHEM SOC, V125, P14, DOI 10.1021/ja027691e; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; D'Agostino VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072426; Dalvit C, 2002, J AM CHEM SOC, V124, P7702, DOI 10.1021/ja020174b; Derrigo M, 2000, INT J MOL MED, V5, P111; Dong R, 2007, BIOCHEM BIOPH RES CO, V356, P318, DOI 10.1016/j.bbrc.2007.02.145; Engsberg JR, 2003, SPINE, V28, pE483, DOI 10.1097/01.BRS.0000099093.36335.16; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Evenas J, 2014, BIOORG MED CHEM LETT, V24, P1315, DOI 10.1016/j.bmcl.2014.01.050; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Germer A, 2003, CHEM-EUR J, V9, P1964, DOI 10.1002/chem.200204231; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goldflam M, 2012, METHODS MOL BIOL, V831, P233, DOI 10.1007/978-1-61779-480-3_14; Hajduk PJ, 2002, COMB CHEM HIGH T SCR, V5, P613, DOI 10.2174/1386207023329996; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Liang PI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-611; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Nabors LB, 2001, CANCER RES, V61, P2154; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Ronkainen H, 2011, TUMOR BIOL, V32, P481, DOI 10.1007/s13277-010-0141-6; Scheiba RM, 2014, RNA BIOL, V11, P1250, DOI 10.1080/15476286.2014.996069; Scheiba RM, 2012, EUR BIOPHYS J BIOPHY, V41, P597, DOI 10.1007/s00249-012-0827-3; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Winkler C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.279; Wu BN, 2013, CHEM BIOL, V20, P19, DOI 10.1016/j.chembiol.2012.10.015; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Yuan Z, 2011, ONCOL REP, V26, P237, DOI 10.3892/or.2011.1271; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu Z, 2013, TUMOUR BIOL	54	35	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138780	10.1371/journal.pone.0138780	http://dx.doi.org/10.1371/journal.pone.0138780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390015	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000055
J	Atlan, A; Hornoy, B; Delerue, F; Gonzalez, M; Pierre, JS; Tarayre, M				Atlan, Anne; Hornoy, Benjamin; Delerue, Florian; Gonzalez, Maya; Pierre, Jean-Sebastien; Tarayre, Michele			Phenotypic Plasticity in Reproductive Traits of the Perennial Shrub Ulex europaeus in Response to Shading: A Multi-Year Monitoring of Cultivated Clones	PLOS ONE			English	Article							DISPERSAL SEED PREDATION; FLOWERING PHENOLOGY; CLIMATE-CHANGE; TRADE-OFF; EVOLUTION; GROWTH; LIGHT; POPULATIONS; ALLOCATION; SELECTION	Phenotypic plasticity may be advantageous for plants to be able to rapidly cope with new and changing environments associated with climate change or during biological invasions. This is especially true for perennial plants, as they may need a longer period to respond genetically to selective pressures than annuals, and also because they are more likely to experience environmental changes during their lifespan. However, few studies have explored the plasticity of the reproductive life history traits of woody perennial species. This study focuses on a woody shrub, Ulex europaeus (common gorse), and on the response of its reproductive traits to one important environmental factor, shading. The study was performed on clones originating from western France (within the native range of this invasive species) and grown for seven years. We compared traits of plants grown in a shade treatment (with two successive shade levels) vs. full natural light. The traits monitored included flowering onset, pod production and seed predation. All traits studied responded to shading, exhibiting various levels of plasticity. In particular, dense shade induced a radical but reversible decrease in flower and pod production, while moderate shade had little effect on reproductive traits. The magnitude of the response to dense shade depended on the genotype, showing a genetically based polymorphism of plasticity. The level of plasticity also showed substantial variations between years, and the effect of environmental variations was cumulative over time. This suggests that plasticity can influence the lifetime fitness of U. Europaeus and is involved in the capacity of the species to grow under contrasting environmental conditions.	[Atlan, Anne; Pierre, Jean-Sebastien; Tarayre, Michele] Univ Rennes 1, CNRS, UMR ECOBIO 6553, Rennes, France; [Hornoy, Benjamin] Univ Laval, CEF, Montreal, PQ, Canada; [Delerue, Florian] Bordeaux INP, G&E, EA 4592, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Laval University	Atlan, A (corresponding author), Univ Rennes 1, CNRS, UMR ECOBIO 6553, Rennes, France.	anne.atlan@univ-rennes1.fr		Delerue, Florian/0000-0002-9809-5321; Gonzalez, Maya/0000-0002-5589-3227				Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; Atlan A, 2010, J EVOLUTION BIOL, V23, P362, DOI 10.1111/j.1420-9101.2009.01908.x; Augusto L, 2005, CAN J FOREST RES, V35, P1183, DOI 10.1139/X05-054; Baloch JUD, 2009, INT J AGRIC BIOL, V11, P138; Barat M, 2007, ENTOMOL EXP APPL, V124, P167, DOI 10.1111/j.1570-7458.2007.00565.x; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bowman G, 2008, PLANT ECOL, V197, P197, DOI 10.1007/s11258-007-9370-1; Cai ZQ, 2011, IND CROP PROD, V34, P1235, DOI 10.1016/j.indcrop.2011.03.021; Chambel M. R., 2005, Investigacion Agraria, Sistemas y Recursos Forestales, V14, P334; Closset-Kopp D, 2007, FOREST ECOL MANAG, V247, P120, DOI 10.1016/j.foreco.2007.04.023; Colautti RI, 2009, EVOL APPL, V2, P187, DOI 10.1111/j.1752-4571.2008.00053.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Delerue F, 2014, NEW ZEAL J ECOL, V38, P268; Delerue F, 2013, ANN FOREST SCI, V70, P219, DOI 10.1007/s13595-012-0260-x; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Elle E, 1999, AM J BOT, V86, P278, DOI 10.2307/2656944; Feng YH, 2014, ANN BOT-LONDON, V114, P981, DOI 10.1093/aob/mcu163; Fonti P, 2013, PLANT BIOLOGY, V15, P210, DOI 10.1111/j.1438-8677.2012.00599.x; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Gunthardt-Goerg MS, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00698.x; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; HERRERA CM, 1991, ECOLOGY, V72, P1436, DOI 10.2307/1941116; Holm L., 1997, WORLD WEEDS NATURAL; Hornoy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026275; Hough-Goldstein J, 2012, ARTHROPOD-PLANT INTE, V6, P103, DOI 10.1007/s11829-011-9158-z; Jones FA, 2010, OIKOS, V119, P1841, DOI 10.1111/j.1600-0706.2010.18547.x; Kahar S. A., 2009, Journal of Tropical Agriculture and Food Science, V37, P9; Kelly MG, 2000, AM J BOT, V87, P382, DOI 10.2307/2656634; Kilkenny FF, 2008, OECOLOGIA, V155, P247, DOI 10.1007/s00442-007-0903-z; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; LEE WG, 1986, NEW ZEAL J BOT, V24, P279, DOI 10.1080/0028825X.1986.10412678; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Major JE, 2009, CAN J FOREST RES, V39, P12, DOI 10.1139/X08-153; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Meyers LA, 2005, PLOS COMPUT BIOL, V1, P236, DOI 10.1371/journal.pcbi.0010032; Nicotra AB, 2010, FUNCT PLANT BIOL, V37, P117, DOI 10.1071/FP09139; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; PIERRE JS, 1986, ACTA OECOL-OEC GEN, V7, P365; R Core Team, 2014, R FDN STAT COMP; Saifuddin M., 2010, Asian Journal of Plant Sciences, V9, P20; Santos-del-Blanco L, 2013, J EVOLUTION BIOL, V26, P1912, DOI 10.1111/jeb.12187; SAS Institute, 2009, VERS 9 1; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHEMSKE DW, 1995, EVOLUTION, V49, P207, DOI 10.2307/2410306; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Tarayre M, 2007, EVOL ECOL, V21, P395, DOI 10.1007/s10682-006-9109-9; THOMPSON JD, 1991, TRENDS ECOL EVOL, V6, P246, DOI 10.1016/0169-5347(91)90070-E; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; VALLADARES F, 2000, ECOLOGY, V81, P1925; Valluru R, 2012, PLANT BIOLOGY, V14, P641, DOI 10.1111/j.1438-8677.2011.00540.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Velazquez E, 2009, J TROP ECOL, V25, P249, DOI 10.1017/S0266467409006026; Vitasse Y, 2010, FUNCT ECOL, V24, P1211, DOI 10.1111/j.1365-2435.2010.01748.x; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083	62	10	11	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137500	10.1371/journal.pone.0137500	http://dx.doi.org/10.1371/journal.pone.0137500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383627	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200025
J	Dikshit, HK; Singh, A; Singh, D; Aski, MS; Prakash, P; Jain, N; Meena, S; Kumar, S; Sarker, A				Dikshit, Harsh Kumar; Singh, Akanksha; Singh, Dharmendra; Aski, Muraleedhar Sidaram; Prakash, Prapti; Jain, Neelu; Meena, Suresh; Kumar, Shiv; Sarker, Ashutosh			Genetic Diversity in Lens Species Revealed by EST and Genomic Simple Sequence Repeat Analysis	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENOTYPING APPLICATIONS; LINKAGE MAP; SSR-MARKERS; LENTIL; WILD; RAPD; IDENTIFICATION; AFLP; VARIABILITY	Low productivity of pilosae type lentils grown in South Asia is attributed to narrow genetic base of the released cultivars which results in susceptibility to biotic and abiotic stresses. For enhancement of productivity and production, broadening of genetic base is essentially required. The genetic base of released cultivars can be broadened by using diverse types including bold seeded and early maturing lentils from Mediterranean region and related wild species. Genetic diversity in eighty six accessions of three species of genus Lens was assessed based on twelve genomic and thirty one EST-SSR markers. The evaluated set of genotypes included diverse lentil varieties and advanced breeding lines from Indian programme, two early maturing ICARDA lines and five related wild subspecies/species endemic to the Mediterranean region. Genomic SSRs exhibited higher polymorphism in comparison to EST SSRs. GLLC 598 produced 5 alleles with highest gene diversity value of 0.80. Among the studied subspecies/species 43 SSRs detected maximum number of alleles in L. orientalis. Based on Nei's genetic distance cultivated lentil L. culinaris subsp. culinaris was found to be close to its wild progenitor L. culinaris subsp. orientalis. The Prichard's structure of 86 genotypes distinguished different subspecies/species. Higher variability was recorded among individuals within population than among populations.	[Dikshit, Harsh Kumar; Singh, Akanksha; Singh, Dharmendra; Aski, Muraleedhar Sidaram; Prakash, Prapti; Jain, Neelu; Meena, Suresh] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Kumar, Shiv] Rabat Inst, INRA Quich, Expt Stn, ICARDA, Rabat, Morocco; [Sarker, Ashutosh] ICARDA, South Asia & China Reg Program, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Dikshit, HK (corresponding author), Indian Agr Res Inst, Div Genet, New Delhi 110012, India.	harshgeneticsiari@gmail.com		Singh, Akanksha/0000-0001-6480-2641	Harvest Plus Lentil Biofortification project through ICARDA	Harvest Plus Lentil Biofortification project through ICARDA	There was no specific funding for this work. The work was carried out using Institute fund and partial support from Harvest Plus Lentil Biofortification project funded through ICARDA.	ABOELWAFA A, 1995, THEOR APPL GENET, V90, P335, DOI 10.1007/BF00221974; Ahmad M, 1996, THEOR APPL GENET, V93, P788, DOI 10.1007/BF00224077; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asghar MJ, 2010, PAK J BOT, V42, P2681; Barulina E.I., 1930, B APPL BOT GENET PL, V40, P265, DOI DOI 10.1023/A:1018306723777; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bretting PK, 1995, HORTSCIENCE, V30, P1349, DOI 10.21273/HORTSCI.30.7.1349; Choudhary P, 2012, GENET MOL RES, V11, P891, DOI 10.4238/2012.April.10.5; Cubero J. I., 1981, Lentils, P15; Datta S, 2011, CROP SCI, V51, P2412, DOI 10.2135/cropsci2010.12.0743; DELAROSA L, 1992, EUPHYTICA, V59, P181, DOI 10.1007/BF00041271; DELSENY M, 1983, BIOCHEM BIOPH RES CO, V116, P113, DOI 10.1016/0006-291X(83)90388-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; ERSKINE W, 1991, THEOR APPL GENET, V83, P119, DOI 10.1007/BF00229234; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferguson ME, 2000, BOT J LINN SOC, V133, P41, DOI 10.1111/j.1095-8339.2000.tb01536.x; Ferguson ME, 1998, GENET RESOUR CROP EV, V45, P549, DOI 10.1023/A:1008640201896; Ford R, 1997, EUPHYTICA, V96, P247, DOI 10.1023/A:1003097600701; Gupta D, 2006, GENET RESOUR CROP EV, V53, P1233, DOI 10.1007/s10722-005-2932-y; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; Harish Kumar, 2014, Australian Journal of Crop Science, V8, P1005; Harlan JR, 1992, CROPS MAN, V2nd; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Karp A, 1997, NAT BIOTECHNOL, V15, P625, DOI 10.1038/nbt0797-625; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Kumar S., 2006, BOTANICA-VILNIUS, V56, P31; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Ladizinski D, 1984, BOT GAZ, V145, P235; Lin HS, 2011, INT J MOL SCI, V12, P7835, DOI 10.3390/ijms12117835; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Phillips RL, 2014, PLANT GENET RESOUR-C, V12, pS6, DOI 10.1017/S1479262114000240; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V102, P440; Pritchard JK, 2000, GENETICS, V155, P945; Rahman M. M., 2009, The lentil: botany, production and uses, P121, DOI 10.1079/9781845934873.0121; Saha GC, 2010, EUPHYTICA, V175, P261, DOI 10.1007/s10681-010-0187-y; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; SHARMA SK, 1995, THEOR APPL GENET, V91, P647, DOI 10.1007/BF00223292; Sharma SK, 1996, THEOR APPL GENET, V93, P751, DOI 10.1007/BF00224072; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; SINGH BB, 2006, PLANT GENETIC RESOUR, P240; Singh M, 2011, NAT SEM CONT APPR CR, P365; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Tewari K, 2012, J PLANT BIOCHEM BIOT, V21, P198, DOI 10.1007/s13562-011-0087-9; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Van Treuen, 2000, MOL MARKETS; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2014, PLOS ONE; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhao H, 2015, SCI REP, P5	68	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138101	10.1371/journal.pone.0138101	http://dx.doi.org/10.1371/journal.pone.0138101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381889	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200057
J	Ruther, HS; Phillips, K; Ross, D; Crawford, A; Weidner, MP; Sammra, O; Lammler, C; McGee, DJ				Ruther, Haley S.; Phillips, Kalyn; Ross, Dolores; Crawford, Alyssa; Weidner, M. Payton; Sammra, Osama; Laemmler, Christoph; McGee, David J.			Smooth and Rough Biotypes of Arcanobacterium haemolyticum Can Be Genetically Distinguished at the Arcanolysin Locus	PLOS ONE			English	Article							IDENTIFICATION	Arcanobacterium haemolyticum is a Gram-positive, beta-hemolytic emerging human pathogen that is classified into smooth or rough biotypes. This bacterial species is also a rare pathogen of animals. Smooth biotypes possess smooth colony edges, are moderate to strong in beta-hemolysis, and predominately cause wound infections. In contrast, rough biotypes possess rough and irregular colony edges, have weak to no beta-hemolytic activity, and predominately cause pharyngitis. Using horse erythrocytes we confirmed that smooth isolates are generally more hemolytic than rough isolates. A hemolysin from A. haemolyticum, arcanolysin (aln/ALN), was recently discovered and is a member of the cholesterol-dependent cytolysin (CDC) family. PCR amplification of aln from all 36 smooth A. haemolyticum isolates yielded the expected 2.0 kb product. While 21 rough isolates yielded the 2.0 kb product, 16 isolates had a 3.2 kb product. The extra 1.2 kb segment was 99% identical to IS911 (insertion sequence) from Corynebacterium diphtheriae. PCR amplification and sequence analysis of the upstream region of aln revealed similar to 40 nucleotide polymorphisms among 73 clinical isolates from Finland, Denmark, Germany and United States (Nebraska). Remarkably, multi-sequence alignments of the aln upstream region demonstrated that similar to 90% of the isolates phylogenetically clustered as either smooths or roughs. Differential restriction enzyme analysis of the aln upstream region also demonstrated that the aln upstream region of most (similar to 75%) smooth isolates was cleaved with ClaI while this region in most (similar to 86%) rough isolates was cleaved with XcmI. We conclude that the aln upstream region can be used to genetically distinguish between smooth and rough biotypes of this important emerging pathogen.	[Ruther, Haley S.; McGee, David J.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA; [Phillips, Kalyn; Crawford, Alyssa; Weidner, M. Payton] Southwood High Sch, Shreveport, LA USA; [Ross, Dolores] Centenary Coll Louisiana, Dept Chem, Shreveport, LA USA; [Sammra, Osama; Laemmler, Christoph] Univ Giessen, Inst Pharmakol & Toxikol, D-35390 Giessen, Germany	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Justus Liebig University Giessen	McGee, DJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA.	dmcgee@lsuhsc.edu		McGee, David/0000-0003-0592-7836	BioStart Biotechnology Program through National Center for Research Resources of National Institutes of Health [R25RR026019]; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR026019] Funding Source: NIH RePORTER	BioStart Biotechnology Program through National Center for Research Resources of National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	High school students KP and AC were supported by the BioStart Biotechnology Program through the National Center for Research Resources of the National Institutes of Health (R25RR026019). The authors thank the Cellular Program for support of DR and MPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; CARLSON P, 1994, J CLIN MICROBIOL, V32, P1654, DOI 10.1128/JCM.32.7.1654-1657.1994; CARLSON P, 1994, J CLIN MICROBIOL, V32, P854, DOI 10.1128/JCM.32.3.854-855.1994; Carlson P, 1999, EUR J CLIN MICROBIOL, V18, P915, DOI 10.1007/s100960050432; Hijazin M, 2010, FOLIA MICROBIOL, V55, P666, DOI 10.1007/s12223-010-0108-4; Jost BH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-239; MACLEAN PD, 1946, J INFECT DIS, V79, P67, DOI 10.1093/infdis/79.1.69; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PRERE MF, 1990, J BACTERIOL, V172, P4090, DOI 10.1128/jb.172.7.4090-4099.1990; Rousseau P, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-16; Sammra O, 2014, FOLIA MICROBIOL, V59, P369, DOI 10.1007/s12223-014-0308-4; Sammra O, 2014, BERL MUNCH TIERARZTL, V127, P56, DOI 10.2376/0005-9366-127-56; Therriault BL, 2008, ANN PHARMACOTHER, V42, P1697, DOI 10.1345/aph.1L294; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; WAAGNER DC, 1991, PEDIATR INFECT DIS J, V10, P933, DOI 10.1097/00006454-199112000-00011; Wong V, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-17	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137346	10.1371/journal.pone.0137346	http://dx.doi.org/10.1371/journal.pone.0137346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382754	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200021
J	Chen, JC; Liu, JH; Hsu, DW; Shu, JC; Chen, CY; Chen, CC				Chen, Jung-Chi; Liu, Jyung-Hurng; Hsu, Duen-Wei; Shu, Jwu-Ching; Chen, Chien-Yen; Chen, Chien-Cheng			Methylatable Signaling Helix Coordinated Inhibitory Receiver Domain in Sensor Kinase Modulates Environmental Stress Response in Bacillus Cereus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SIGMA(B) TRANSCRIPTION FACTOR; ESCHERICHIA-COLI ASPARTATE; HISTIDINE KINASE; AGROBACTERIUM-TUMEFACIENS; STREPTOMYCES-COELICOLOR; ENERGY STRESS; CHEMOTAXIS RECEPTORS; CONSERVED ASPARTATE; CYTOPLASMIC DOMAIN	sigma(B), an alternative transcription factor, controls the response of the cell to a variety of environmental stresses in Bacillus cereus. Previously, we reported that RsbM negatively regulates al3 through the methylation of RsbK, a hybrid sensor kinase, on a signaling helix (S-helix). However, RsbK comprises a C-terminal receiver (REC) domain whose function remains unclear. In this study, deletion of the C-terminal REC domain of RsbK resulted in high constitutive al3 expression independent of environmental stimuli. Thus, the REC domain may serve as an inhibitory element. Mutagenic substitution was employed to modify the putative phospho-acceptor residue D827 in the REC domain of RsbK. The expression of R5bKD827N and R5bKD827E exhibited high constitutive sigma(B), indicating that D827, if phosphorylatable, possibly participates in sigma(B) regulation. Bacterial two-hybrid analyses demonstrated that RsbK forms a homodimer and the REC domain interacts mainly with the histidine kinase (HK) domain and partly with the S-helix. In particular, co-expression of RsbM strengthens the interaction between the REC domain and the S-helix. Consistently, our structural model predicts a significant interaction between the HK and REC domains of the RsbK intradimer. Here, we demonstrated that coordinated the methylatable S-helix and the REC domain of RsbK is functionally required to modulate sigma(B)-mediated stress response in B. cereus and maybe ubiquitous in microorganisms encoded RsbK-type sensor kinases.	[Chen, Jung-Chi; Hsu, Duen-Wei; Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Shu, Jwu-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chen, Chien-Yen] Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan	National Kaohsiung Normal University; National Chung Hsing University; National Chung Hsing University; Chang Gung University; National Chung Cheng University	Chen, CC (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	cheng@nknu.edu.tw	Liu, Jyung-Hurng/C-1340-2010; chen, chien-yen/E-6101-2013	Liu, Jyung-Hurng/0000-0002-7173-0372; chen, chien-yen/0000-0003-1130-669X	Ministry of Science and Technology of Taiwan [NSC 102-2320-B-017-001-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant of the Ministry of Science and Technology of Taiwan (NSC 102-2320-B-017-001-MY3), (http://www.most.gov.tw/).	Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Brody MS, 2009, MOL MICROBIOL, V72, P1221, DOI 10.1111/j.1365-2958.2009.06722.x; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Casino P, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P21; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; CHANG CH, 1992, J BACTERIOL, V174, P7033, DOI 10.1128/JB.174.21.7033-7039.1992; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Chen LC, 2012, ENVIRON MICROBIOL, V14, P2788, DOI 10.1111/j.1462-2920.2012.02788.x; Cho YH, 2001, MOL MICROBIOL, V42, P205, DOI 10.1046/j.1365-2958.2001.02622.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; de Been M, 2011, MICROBIOL-SGM, V157, P3, DOI 10.1099/mic.0.045740-0; de Been M, 2010, ENVIRON MICROBIOL, V12, P730, DOI 10.1111/j.1462-2920.2009.02116.x; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferris HU, 2014, J STRUCT BIOL, V186, P349, DOI 10.1016/j.jsb.2014.03.015; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Fouet A, 2000, J BACTERIOL, V182, P5036, DOI 10.1128/JB.182.18.5036-5045.2000; Gao R, 2007, J BACTERIOL, V189, P6048, DOI 10.1128/JB.00459-07; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoch A. L., 1995, 2 COMPONENT SIGNAL T; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; HUANG JZ, 1993, J BACTERIOL, V175, P6169, DOI 10.1128/JB.175.19.6169-6178.1993; Inclan YF, 2008, MOL MICROBIOL, V68, P1328, DOI 10.1111/j.1365-2958.2008.06238.x; IUCHI S, 1993, J BIOL CHEM, V268, P23972; KALMAN S, 1990, J BACTERIOL, V172, P5575, DOI 10.1128/jb.172.10.5575-5585.1990; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kanoksilapatham W, 2007, SILPAKORN U SCI TECH, V1; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Keilberg D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002951; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin YH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00195; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Mondejar LG, 2012, J BIOL CHEM, V287, P1022, DOI 10.1074/jbc.M111.284067; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; PAN SQ, 1993, P NATL ACAD SCI USA, V90, P9939, DOI 10.1073/pnas.90.21.9939; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Thomas SA, 2008, MOL MICROBIOL, V69, P453, DOI 10.1111/j.1365-2958.2008.06296.x; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; WISE AA, 1995, J BACTERIOL, V177, P123, DOI 10.1128/jb.177.1.123-133.1995; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265	65	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137952	10.1371/journal.pone.0137952	http://dx.doi.org/10.1371/journal.pone.0137952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379238	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400039
J	Dodge, HH; Zhu, J; Mattek, NC; Austin, D; Kornfeld, J; Kaye, JA				Dodge, Hiroko H.; Zhu, Jian; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.			Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BIOMARKER; VARIABILITY; DECLINE; WALKING	Background Trials in Alzheimer's disease are increasingly focusing on prevention in asymptomatic individuals. This poses a challenge in examining treatment effects since currently available approaches are often unable to detect cognitive and functional changes among asymptomatic individuals. Resultant small effect sizes require large sample sizes using biomarkers or secondary measures for randomized controlled trials (RCTs). Better assessment approaches and outcomes capable of capturing subtle changes during asymptomatic disease stages are needed. Objective We aimed to develop a new approach to track changes in functional outcomes by using individual-specific distributions (as opposed to group-norms) of unobtrusive continuously monitored in-home data. Our objective was to compare sample sizes required to achieve sufficient power to detect prevention trial effects in trajectories of outcomes in two scenarios: (1) annually assessed neuropsychological test scores (a conventional approach), and (2) the likelihood of having subject-specific low performance thresholds, both modeled as a function of time. Methods One hundred nineteen cognitively intact subjects were enrolled and followed over 3 years in the Intelligent Systems for Assessing Aging Change (ISAAC) study. Using the difference in empirically identified time slopes between those who remained cognitively intact during follow- up (normal control, NC) and those who transitioned to mild cognitive impairment (MCI), we estimated comparative sample sizes required to achieve up to 80% statistical power over a range of effect sizes for detecting reductions in the difference in time slopes between NC and MCI incidence before transition. Results Sample size estimates indicated approximately 2000 subjects with a follow-up duration of 4 years would be needed to achieve a 30% effect size when the outcome is an annually assessed memory test score. When the outcome is likelihood of low walking speed defined using the individual-specific distributions of walking speed collected at baseline, 262 subjects are required. Similarly for computer use, 26 subjects are required. Conclusions Individual-specific thresholds of low functional performance based on high-frequency in-home monitoring data distinguish trajectories of MCI from NC and could substantially reduce sample sizes needed in dementia prevention RCTs.	[Dodge, Hiroko H.; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; [Dodge, Hiroko H.; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Oregon Ctr Aging & Technol ORCATECH, Portland, OR 97201 USA; [Dodge, Hiroko H.] Univ Michigan, Dept Neurol, Michigan Alzheimers Dis Ctr, Ann Arbor, MI USA; [Zhu, Jian] Univ Michigan, Grad Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Kaye, Jeffrey A.] Portland Vet Med Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dodge, HH (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA.	hdodge@med.umich.edu			National Institutes of Health, USA [P30-AG024978, R01-AG024059, P30-AG008017, R01-AG033581]; NATIONAL INSTITUTE ON AGING [P30AG008017, R01AG033581, R01AG024059, P30AG024978] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health, USA (P30-AG024978 (JAK), R01-AG024059 (JAK), P30-AG008017 (JAK, HHD), and R01-AG033581 (HHD)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Ard MC, 2011, J ALZHEIMERS DIS, V26, P369, DOI 10.3233/JAD-2011-0062; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Caroli A, 2015, ALZ DIS ASSOC DIS, V29, P101, DOI 10.1097/WAD.0000000000000071; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dodge HH, 2012, NEUROLOGY, V78, P1946, DOI 10.1212/WNL.0b013e318259e1de; Dodge HH, 2015, CURR ALZHEIMER RES, V12, P513, DOI 10.2174/1567205012666150530201917; Dodge HH, 2014, ALZHEIMERS DEMENT, V10, P690, DOI 10.1016/j.jalz.2014.04.513; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Dorsey ER, 2015, JAMA NEUROL, V72, P582, DOI 10.1001/jamaneurol.2014.4524; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H., 1983, BOSTON NAMING TEST; Grill JD, 2013, NEUROBIOL AGING, V34, P62, DOI 10.1016/j.neurobiolaging.2012.03.006; Hagler S, 2010, IEEE T BIO-MED ENG, V57, P813, DOI 10.1109/TBME.2009.2036732; Hayes TL, 2008, ALZHEIMERS DEMENT, V4, P395, DOI 10.1016/j.jalz.2008.07.004; Hayes TL, 2014, ALZ DIS ASSOC DIS, V28, P145, DOI 10.1097/WAD.0000000000000010; Hayes TL, 2009, J AGING HEALTH, V21, P567, DOI 10.1177/0898264309332836; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1602/neurorx.1.2.189; Kaye J, 2014, ALZHEIMERS DEMENT, V10, P10, DOI 10.1016/j.jalz.2013.01.011; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Leoutsakos JMS, 2014, ALZHEIMERS DEMENT, V10, P152, DOI 10.1016/j.jalz.2013.05.1776; Lyons BE, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00102; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Petersen J, 2014, IEEE J BIOMED HEALTH, V18, P1590, DOI 10.1109/JBHI.2013.2294276; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; REITAN RM, 1985, PERCEPT MOTOR SKILL, V60, P271; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schneider LS, 2010, ALZHEIMERS DEMENT, V6, P367, DOI 10.1016/j.jalz.2010.07.004; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Thielke SM, 2014, J AM GERIATR SOC, V62, P685, DOI 10.1111/jgs.12744; Vellas B, 2015, J Prev Alzheimers Dis, V2, P128; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Yi QL, 2002, CONTROL CLIN TRIALS, V23, P481, DOI 10.1016/S0197-2456(02)00223-4	41	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138095	10.1371/journal.pone.0138095	http://dx.doi.org/10.1371/journal.pone.0138095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379170	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400052
J	Eiriksdottir, VH; Valdimarsdottir, UA; Asgeirsdottir, TL; Hauksottir, A; Lund, SH; Bjarnadottir, RI; Cnattingius, S; Zoega, H				Eiriksdottir, Vedis Helga; Valdimarsdottir, Unnur Anna; Asgeirsdottir, Tinna Laufey; Hauksdottir, Arna; Lund, Sigrun Helga; Bjarnadottir, Ragnheidur Ingibjorg; Cnattingius, Sven; Zoega, Helga			Pregnancy-Induced Hypertensive Disorders before and after a National Economic Collapse: A Population Based Cohort Study	PLOS ONE			English	Article							GESTATIONAL HYPERTENSION; PSYCHOSOCIAL STRESS; BUSINESS CYCLES; BIRTH-WEIGHT; RISK-FACTORS; PREECLAMPSIA; MORTALITY; HEALTH; WOMEN; MORBIDITY	Background Data on the potential influence of macroeconomic recessions on maternal diseases during pregnancy are scarce. We aimed to assess potential change in prevalence of pregnancy-induced hypertensive disorders (preeclampsia and gestational hypertension) during the first years of the major national economic recession in Iceland, which started abruptly in October 2008. Methods and Findings Women whose pregnancies resulted in live singleton births in Iceland in 2005-2012 constituted the study population (N = 35,211). Data on pregnancy-induced hypertensive disorders were obtained from the Icelandic Medical Birth Register and use of antihypertensive drugs during pregnancy, including beta-blockers and calcium channel blockers, from the Icelandic Medicines Register. With the pre-collapse period as reference, we used logistic regression analysis to assess change in pregnancy-induced hypertensive disorders and use of antihy-pertensives during the first four years after the economic collapse, adjusting for demographic and pregnancy characteristics, taking aggregate economic indicators into account. Compared with the pre-collapse period, we observed an increased prevalence of gestational hypertension in the first year following the economic collapse (2.4% vs. 3.9%; adjusted odds ratio [aOR] 1.47; 95 percent confidence interval [95% CI] 1.13-1.91) but not in the subsequent years. The association disappeared completely when we adjusted for aggregate unemployment rate (aOR 1.04; 95% CI 0.74-1.47). Similarly, there was an increase in prescription fills of beta-blockers in the first year following the collapse (1.9% vs. 3.1%; aOR 1.43; 95% CI 1.07-1.90), which disappeared after adjusting for aggregate unemployment rate (aOR 1.05; 95% CI 0.72-1.54). No changes were observed for preeclampsia or use of calcium channel blockers between the pre- and post-collapse periods. Conclusions Our data suggest a transient increased risk of gestational hypertension and use of beta-blockers among pregnant women in Iceland in the first and most severe year of the national economic recession.	[Eiriksdottir, Vedis Helga; Valdimarsdottir, Unnur Anna; Hauksdottir, Arna; Lund, Sigrun Helga; Zoega, Helga] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur Anna] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Asgeirsdottir, Tinna Laufey] Univ Iceland, Fac Econ, Reykjavik, Iceland; [Bjarnadottir, Ragnheidur Ingibjorg] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland; Landspitali National University Hospital; Karolinska Institutet	Eiriksdottir, VH (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	vhe2@hi.is	Eiriksdottir, Vedis/M-1964-2015; Lund, Sigrún Helga/AAG-6042-2019; Zoega, Helga/M-1968-2015; Lund, Sigrun Helga/K-9144-2015	Lund, Sigrún Helga/0000-0002-3806-2296; Lund, Sigrun Helga/0000-0002-3806-2296; Valdimarsdottir, Unnur/0000-0001-5382-946X; Hauksdottir, Arna/0000-0002-4253-1059	RANNIS [120452023]	RANNIS	This work was supported by RANNIS grant number: 120452023, http://en.rannis.is/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2014, SEMIN PERINATOL, V38, P151, DOI 10.1053/j.semperi.2014.03.007; Asgeirsdottir TL, 2014, BLOOD PRESSURE, V23, P213, DOI 10.3109/08037051.2013.862913; Asgeirsdottir TL, 2014, ECON HUM BIOL, V13, P1, DOI 10.1016/j.ehb.2013.03.005; Benediktsdottir S, 2011, ECON POLICY, P183, DOI 10.1111/j.1468-0327.2011.00260.x; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Clarke HM, 2013, THESIS U ICELAND; Clausen T, 2006, ACTA OBSTET GYN SCAN, V85, P526, DOI 10.1080/00016340500523644; Cruces G, 2012, WORLD DEV, V40, P303, DOI 10.1016/j.worlddev.2011.07.014; Directorate of Health, 2014, LYFJ; Directorate of Health Icelandic Food and Veterinary Authority Unit for Nutrition Research, 2011, DIET IC RES NAT NUTR; Economou A, 2008, J ECON STUD, V35, P368, DOI 10.1108/01443580810903536; Eiriksdottir VH, 2015, EUR J PUBLIC HEALTH, V25, P638, DOI 10.1093/eurpub/ckv047; Eiriksdottir VH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080499; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Granados JAT, 2011, EUR J POPUL, V27, P157, DOI 10.1007/s10680-011-9231-4; Guojonsdottir GR, 2012, EMERG MED J, V29, P694, DOI 10.1136/emermed-2011-200518; Haelterman E, 2003, EUR J OBSTET GYN R B, V111, P25, DOI 10.1016/S0301-2115(03)00161-1; Hauksdottir A, 2013, AM J EPIDEMIOL, V177, P979, DOI 10.1093/aje/kws347; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; KlonoffCohen HS, 1996, EPIDEMIOLOGY, V7, P245, DOI 10.1097/00001648-199605000-00005; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Landsbergis PA, 1996, EPIDEMIOLOGY, V7, P346, DOI 10.1097/00001648-199607000-00002; Laszlo KD, 2013, HYPERTENSION, V62, P183, DOI 10.1161/HYPERTENSIONAHA.111.00550; Leeners B, 2007, HYPERTENS PREGNANCY, V26, P211, DOI 10.1080/10641950701274870; McClure C, 2014, THESIS U ICELAND REY; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Olafsdottir T, 2015, EUR J HEALTH ECON, V16, P391, DOI 10.1007/s10198-014-0580-x; Park CL, 2014, ANXIETY STRESS COPIN, V27, P123, DOI 10.1080/10615806.2013.860969; Qiu C., 2007, BMC WOMENS HEALTH, V7, DOI [10.1186/1472-6874-7-15, DOI 10.1186/1472-6874-7-15]; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Shamsi U, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-14; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Silva LM, 2008, J HUM HYPERTENS, V22, P483, DOI 10.1038/jhh.2008.22; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Statistic Iceland, NAT ACC PUBL FIN 201; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Tanaka M, 2007, AM J PUBLIC HEALTH, V97, P163, DOI 10.2105/AJPH.2005.068577; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vollebregt KC, 2008, BJOG-INT J OBSTET GY, V115, P607, DOI 10.1111/j.1471-0528.2008.01665.x; World Health Organization, GLOB DAT BOD MASS IN	48	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138534	10.1371/journal.pone.0138534	http://dx.doi.org/10.1371/journal.pone.0138534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379126	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400108
J	Yokdang, N; Hatakeyama, J; Wald, JH; Simion, C; Tellez, JD; Chang, DZ; Swamynathan, MM; Chen, M; Murphy, WJ; Carraway, KL; Sweeney, C				Yokdang, N.; Hatakeyama, J.; Wald, J. H.; Simion, C.; Tellez, J. D.; Chang, D. Z.; Swamynathan, M. M.; Chen, M.; Murphy, W. J.; Carraway, K. L., III; Sweeney, C.			LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASE; HUMAN-PAPILLOMAVIRUS STATUS; NEGATIVE REGULATOR LRIG1; LEUCINE-RICH REPEAT; MET RECEPTOR; C-MET; CLINICAL-IMPLICATIONS; MASTER REGULATORS; TUMOR-SUPPRESSOR; TIGHT JUNCTIONS	LRIG1 (leucine-rich repeat and immunoglobulin-like domain containing), a member of the LRIG family of transmembrane leucine-rich repeat-containing proteins, is a negative regulator of receptor tyrosine kinase signaling and a tumor suppressor. LRIG1 expression is broadly decreased in human cancer and in breast cancer and low expression of LRIG1 has been linked to decreased relapse-free survival. Recently, low expression of LRIG1 was revealed to be an independent risk factor for breast cancer metastasis and death. These findings suggest that LRIG1 may oppose breast cancer cell motility and invasion, cellular processes that are fundamental to metastasis. However, very little is known of LRIG1 function in this regard. In this study, we demonstrate that LRIG1 is downregulated during epithelial-to-mesenchymal transition (EMT) of human mammary epithelial cells, suggesting that LRIG1 expression may represent a barrier to EMT. Indeed, depletion of endogenous LRIG1 in human mammary epithelial cells expands the stem cell population, augments mammosphere formation and accelerates EMT. Conversely, expression of LRIG1 in highly invasive Basal B breast cancer cells provokes a mesenchymal-to-epithelial transition accompanied by a dramatic suppression of tumorsphere formation and a striking loss of invasive growth in three-dimensional culture. LRIG1 expression perturbs multiple signaling pathways and represses markers and effectors of the mesenchymal state. Furthermore, LRIG1 expression in MDA-MB-231 breast cancer cells significantly slows their growth as tumors, providing the first in vivo evidence that LRIG1 functions as a growth suppressor in breast cancer.	[Yokdang, N.; Hatakeyama, J.; Wald, J. H.; Simion, C.; Chang, D. Z.; Swamynathan, M. M.; Carraway, K. L., III; Sweeney, C.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Tellez, J. D.; Chen, M.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Murphy, W. J.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Sweeney, C (corresponding author), Univ Calif, UC Davis Med Ctr, Dept Biochem & Mol Med, Res Bldg 3,4645 2nd Ave, Sacramento, CA 95817 USA.	casweeney@ucdavis.edu		Mosur Swamynathan, Manojit/0000-0003-1156-586X; Hatakeyama, Jason/0000-0001-8690-5107	T32 training grant in Oncogenic Signals and Chromosome Biology [CA108459]; Lawrence Livermore National Labs UC Davis Fitzpatrick Research Fellowship; NIH [CA118384, CA166412]; UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute [NCI P30CA093373]; NATIONAL CANCER INSTITUTE [T32CA108459, R01CA166412, P30CA093373, R01CA118384] Funding Source: NIH RePORTER	T32 training grant in Oncogenic Signals and Chromosome Biology; Lawrence Livermore National Labs UC Davis Fitzpatrick Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Robert Weinberg (Whitehead Institute) for the kind gift of the HMLE and HMLE-Twist-ER cells, Dr Paola Marignani (Dalhousie University) for the kind gift of the 293GPG packaging cell line, and Dr Ashley Hodel and Mr Sina Azadi for technical support and advice. Dr Nucharee Yokdang was a trainee on the T32 training grant in Oncogenic Signals and Chromosome Biology (CA108459). Dr Joseph Tellez was supported by a Lawrence Livermore National Labs UC Davis Fitzpatrick Research Fellowship. This work was supported by NIH grants CA118384 (Sweeney) and CA166412 (Carraway). We acknowledge the UC Davis Comprehensive Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI P30CA093373) for using the flow cytometer.	Accornero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044982; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Bai LC, 2012, CANCER RES, V72, P1229, DOI 10.1158/0008-5472.CAN-11-2428; Chang L, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-101; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chun J, 2013, CHEM-BIOL INTERACT, V205, P212, DOI 10.1016/j.cbi.2013.07.002; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hawkes SP, 2010, METHODS MOL BIOL, V622, P257, DOI 10.1007/978-1-60327-299-5_16; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Ho-Yen CM, 2014, CANCER-AM CANCER SOC, V120, P163, DOI 10.1002/cncr.28386; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Jimenez-Salazar JE, 2014, HORM CANCER-US, V5, P161, DOI 10.1007/s12672-014-0180-3; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Knopfova L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-15; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee JM, 2014, ONCOGENE, V33, P34, DOI 10.1038/onc.2012.551; Leidy J, 2014, ARCH PATHOL LAB MED, V138, P37, DOI 10.5858/arpa.2012-0439-RA; Lim YC, 2012, ORAL ONCOL, V48, P1114, DOI 10.1016/j.oraloncology.2012.05.013; Lindquist D, 2014, BRIT J CANCER, V110, P1793, DOI 10.1038/bjc.2014.87; Liu L, 2011, MOL CANCER THER, V10, P518, DOI 10.1158/1535-7163.MCT-10-0698; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marchini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014131; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Mueller KL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3224; Muller S, 2013, INT J ONCOL, V42, P247, DOI 10.3892/ijo.2012.1702; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nakamura T, 2014, J CLIN INVEST, V124, P385, DOI 10.1172/JCI71488; Nalwoga H, 2010, BRIT J CANCER, V102, P369, DOI 10.1038/sj.bjc.6605488; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nilsson J, 2001, BIOCHEM BIOPH RES CO, V284, P1155, DOI 10.1006/bbrc.2001.5092; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponzo MG, 2010, CELL CYCLE, V9, P1043, DOI 10.4161/cc.9.6.11033; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Rhodes LV, 2014, BREAST CANCER RES TR, V145, P593, DOI 10.1007/s10549-014-2979-6; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rondahl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073635; Rouam S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-150; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sheu JJC, 2014, ONCOGENE, V33, P1375, DOI 10.1038/onc.2013.98; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thompson PA, 2014, CANCER RES, V74, P2928, DOI 10.1158/0008-5472.CAN-13-2112; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsai PC, 2012, TOXICON, V60, P734, DOI 10.1016/j.toxicon.2012.05.019; Valentin MD, 2012, BREAST CANCER RES TR, V134, P21, DOI 10.1007/s10549-011-1934-z; Van Itallie CM, 2014, SEMIN CELL DEV BIOL, V36, P157, DOI 10.1016/j.semcdb.2014.08.011; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041355; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang Y, 2013, BRIT J CANCER, V108, P1765, DOI 10.1038/bjc.2013.138; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xie RF, 2013, ONCOL REP, V29, P177, DOI 10.3892/or.2012.2102; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YOUNG RK, 1974, IN VITRO CELL DEV B, V9, P239	80	29	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2932	2947		10.1038/onc.2015.345	http://dx.doi.org/10.1038/onc.2015.345			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387542	Green Submitted, Green Accepted			2022-12-26	WOS:000377473700013
J	Gardner, PR; Gardner, DP; Gardner, AP				Gardner, Paul R.; Gardner, Daniel P.; Gardner, Alexander P.			Globins Scavenge Sulfur Trioxide Anion Radical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE DIOXYGENASE FUNCTION; OUTER MITOCHONDRIAL-MEMBRANE; ELECTRON-TRANSFER REACTIONS; OM CYTOCHROME-B; NITRIC-OXIDE; REDUCTION POTENTIALS; SACCHAROMYCES-CEREVISIAE; NITROSATIVE STRESS; REDOX POTENTIALS; PULSE-RADIOLYSIS	Background: Sulfite, an intermediate in sulfur metabolism, can be oxidized to the potentially toxic sulfur trioxide anion radical (STAR). Results: Diverse globins efficiently reduced STAR in vitro, and flavohemoglobin protected yeast from STAR toxicity. Conclusion: Globins can function as STAR scavengers. Significance: The data suggest roles for diverse globins in protecting cells against sulfite stress. Ferrous myoglobin was oxidized by sulfur trioxide anion radical (STAR) during the free radical chain oxidation of sulfite. Oxidation was inhibited by the STAR scavenger GSH and by the heme ligand CO. Bimolecular rate constants for the reaction of STAR with several ferrous globins and biomolecules were determined by kinetic competition. Reaction rate constants for myoglobin, hemoglobin, neuroglobin, and flavohemoglobin are large at 38, 120, 2,600, and >= 7,500 x 10(6) m(-1) s(-1), respectively, and correlate with redox potentials. Measured rate constants for O-2, GSH, ascorbate, and NAD(P)H are also large at -100, 10, 130, and 30 x 10(6) M-1 s(-1), respectively, but nevertheless allow for favorable competition by globins and a capacity for STAR scavenging in vivo. Saccharomyces cerevisiae lacking sulfite oxidase and deleted of flavohemoglobin showed an O-2-dependent growth impairment with nonfermentable substrates that was exacerbated by sulfide, a precursor to mitochondrial sulfite formation. Higher O-2 exposures inactivated the superoxide-sensitive mitochondrial aconitase in cells, and hypoxia elicited both aconitase and NADP(+)-isocitrate dehydrogenase activity losses. Roles for STAR-derived peroxysulfate radical, superoxide radical, and sulfo-NAD(P) in the mechanism of STAR toxicity and flavohemoglobin protection in yeast are suggested.	[Gardner, Paul R.; Gardner, Daniel P.; Gardner, Alexander P.] Miami Valley Biotech, Dayton, OH 45402 USA		Gardner, PR (corresponding author), Miami Valley Biotech, Ste 2445,1001 E Second St, Dayton, OH 45402 USA.	paul.gardner@mvbiotech.com	Regan, Clinton/E-6250-2012	Gardner, Paul/0000-0001-8189-0903; Gardner, Alexander/0000-0001-6103-9556; Gardner, Daniel/0000-0002-3520-8202	National Institutes of Health [R01 GM65090, P30 CA016058]; National Science Foundation [CHE-1040302]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by National Institutes of Health Grants R01 GM65090 (to P.R.G.) and P30 CA016058 and National Science Foundation Grant CHE-1040302 to the Mass Spectrometry and Proteomics Facility at the Ohio State University Campus Chemical Instruments Center. The authors declare that they have no conflicts of interest with the contents of this article.	Avram D, 1996, GENETICS, V144, P511; AWTREY AD, 1951, J AM CHEM SOC, V73, P1842, DOI 10.1021/ja01148a504; Backstrom HLJ, 1927, J AM CHEM SOC, V49, P1460, DOI 10.1021/ja01405a011; Ball EG, 1933, J BIOL CHEM, V102, P691; Berges J, 2012, J PHYS CHEM B, V116, P9352, DOI 10.1021/jp304741e; Bigelow Samuel L., 1898, Z PHYS CHEM, V26, P493; Borodulin RR, 2013, NITRIC OXIDE-BIOL CH, V35, P35, DOI 10.1016/j.niox.2013.07.004; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Buisson N, 1998, J BIOL CHEM, V273, P9527, DOI 10.1074/jbc.273.16.9527; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Buxton G. V., 1989, AIR POLLUTION REPORT, P245; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carmona M, 2006, J AGR FOOD CHEM, V54, P973, DOI 10.1021/jf052297w; Cassanova N, 2005, J BIOL CHEM, V280, P7645, DOI 10.1074/jbc.M411478200; CHOU KC, 1982, J AM CHEM SOC, V104, P1409, DOI 10.1021/ja00369a043; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; Das TN, 1999, J PHYS CHEM A, V103, P3581, DOI 10.1021/jp9900234; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dunn CJ, 1999, J INORG BIOCHEM, V75, P241, DOI 10.1016/S0162-0134(99)00093-8; ELVING PJ, 1982, BIOELECTROCH BIOENER, V9, P365, DOI 10.1016/0302-4598(82)80026-3; ERBENRUSS M, 1987, RADIAT ENVIRON BIOPH, V26, P289, DOI 10.1007/BF01221974; ESCHENBRUCH R, 1974, AM J ENOL VITICULT, V25, P157; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; FRIDOVICH I, 1958, J BIOL CHEM, V233, P1581; FRIDOVICH I, 1961, J BIOL CHEM, V236, P1836; FRIDOVICH I, 1960, J BIOL CHEM, V235, P1835; Fuller E. C., 1941, J AM CHEM SOC, V63, P1644; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/683729; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Haynes W. M., 2012, CRC HDB CHEM PHYS; HAYON E, 1972, J AM CHEM SOC, V94, P47, DOI 10.1021/ja00756a009; Heber U, 1998, INT REV CYTOL, V177, P255; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Huie R. E., 1989, RADIAT PHYS CHEM, V33, P293; HUIE RE, 1985, CHEM-BIOL INTERACT, V53, P233, DOI 10.1016/S0009-2797(85)80099-5; HUIE RE, 1984, J PHYS CHEM-US, V88, P5665, DOI 10.1021/j150667a042; ITO A, 1980, J BIOCHEM, V87, P73, DOI 10.1093/oxfordjournals.jbchem.a132754; ITO A, 1980, J BIOCHEM, V87, P63, DOI 10.1093/oxfordjournals.jbchem.a132753; Jorgensen LV, 1997, FREE RADICAL RES, V27, P73, DOI 10.3109/10715769709097840; JOVANOVIC SV, 1986, J PHYS CHEM-US, V90, P1935, DOI 10.1021/j100400a039; JOVANOVIC SV, 1995, J AM CHEM SOC, V117, P9881, DOI 10.1021/ja00144a014; Koppenol W. H., 1985, ADV FREE RADICALS BI, V1, P91, DOI DOI 10.1016/8755-9668(85)90005-5; KUOCHEN C, 1974, SCI SINICA, V17, P664; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu AY, 2015, INT J MOL SCI, V16, P20082, DOI 10.3390/ijms160820082; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; MARGOLIASH E, 1954, BIOCHEM J, V56, P529, DOI 10.1042/bj0560529; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; Navaratnam S, 1998, J CHEM SOC FARADAY T, V94, P2577, DOI 10.1039/a803477j; NETA P, 1985, ENVIRON HEALTH PERSP, V64, P209, DOI 10.2307/3430011; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Ranguelova K, 2013, FREE RADICAL BIO MED, V60, P98, DOI 10.1016/j.freeradbiomed.2013.01.022; Ranguelova K, 2012, FREE RADICAL BIO MED, V52, P1264, DOI 10.1016/j.freeradbiomed.2012.01.016; Ranguelova K, 2010, J BIOL CHEM, V285, P24195, DOI 10.1074/jbc.M109.069054; Ranguelova K, 2010, ENVIRON HEALTH PERSP, V118, P970, DOI 10.1289/ehp.0901533; Ranguelova K, 2009, FREE RADICAL BIO MED, V47, P128, DOI 10.1016/j.freeradbiomed.2009.04.006; ROBINSON HC, 1964, BIOCHEM J, V93, P487, DOI 10.1042/bj0930487; RODKEY FL, 1950, J BIOL CHEM, V182, P17; SADATSHAFAI T, 1981, RADIAT PHYS CHEM, V17, P283, DOI 10.1016/0146-5724(81)90096-0; Sarver A, 2005, MOL BIOL CELL, V16, P4781, DOI 10.1091/mbc.E05-05-0436; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; SMITH L, 1963, BIOCHEMISTRY-US, V2, P1432, DOI 10.1021/bi00906a040; SURDHAR PS, 1986, J PHYS CHEM-US, V90, P5915, DOI 10.1021/j100280a091; Taylor JF, 1942, J BIOL CHEM, V144, P15; Titoff A, 1903, Z PHYS CHEM-STOCH VE, V45, P641; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; VERHAGEN MFJM, 1995, BBA-GEN SUBJECTS, V1244, P99, DOI 10.1016/0304-4165(94)00201-8; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WILLIAMS NH, 1982, AUST J CHEM, V35, P1133, DOI 10.1071/CH9821133; WURFEL M, 1990, FEBS LETT, V268, P146, DOI 10.1016/0014-5793(90)80994-T; Wyman J, 1941, J BIOL CHEM, V139, P877; Young SW, 1902, J AM CHEM SOC, V24, P297, DOI 10.1021/ja02018a001; ZAGORSKI ZP, 1971, J PHYS CHEM-US, V75, P3510, DOI 10.1021/j100692a004; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131	86	14	14	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27204	27214		10.1074/jbc.M115.679621	http://dx.doi.org/10.1074/jbc.M115.679621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381408	hybrid, Green Published			2022-12-26	WOS:000364794000029
J	Lei, J; Osen, W; Gardyan, A; Hotz-Wagenblatt, A; Wei, GC; Gissmann, L; Eichmuller, S; Lochelt, M				Lei, Janet; Osen, Wolfram; Gardyan, Adriane; Hotz-Wagenblatt, Agnes; Wei, Guochao; Gissmann, Lutz; Eichmueller, Stefan; Loechelt, Martin			Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy	PLOS ONE			English	Article							LEUKOCYTE ADHESION DEFICIENCY; BROADLY NEUTRALIZING ANTIBODIES; CROSS-SPECIES TRANSMISSION; T-LYMPHOCYTE EPITOPE; FELINE FOAMY; ANTIGEN PRESENTATION; RETROVIRAL VECTORS; GENE-THERAPY; INNATE IMMUNITY; MHC MOLECULES	The use of whole viruses as antigen scaffolds is a recent development in vaccination that improves immunogenicity without the need for additional adjuvants. Previous studies highlighted the potential of foamy viruses (FVs) in prophylactic vaccination and gene therapy. Replication-competent FVs can trigger immune signaling and integrate into the host genome, resulting in persistent antigen expression and a robust immune response. Here, we explored feline foamy virus (FFV) proteins as scaffolds for therapeutic B and T cell epitope delivery in vitro. Infection-and cancer-related B and T cell epitopes were grafted into FFV Gag, Env, or Bet by residue replacement, either at sites of high local sequence homology between the epitope and the host protein or in regions known to tolerate sequence alterations. Modified proviruses were evaluated in vitro for protein steady state levels, particle release, and virus titer in permissive cells. Modification of Gag and Env was mostly detrimental to their function. As anticipated, modification of Bet had no impact on virion release and affected virus titers of only some recombinants. Further evaluation of Bet as an epitope carrier was performed using T cell epitopes from the model antigen chicken ovalbumin (OVA), human tyrosinase-related protein 2 (TRP-2), and oncoprotein E7 of human papillomavirus type 16 (HPV16E7). Transfection of murine cells with constructs encoding Bet-epitope chimeric proteins led to efficient MHC-I-restricted epitope presentation as confirmed by interferon-gamma enzyme-linked immunospot assays using epitope-specific cytotoxic T lymphocyte (CTL) lines. FFV infection-mediated transduction of cells with epitope-carrying Bet also induced T-cell responses, albeit with reduced efficacy, in a process independent from the presence of free peptides. We show that primate FV Bet is also a promising T cell epitope carrier for clinical translation. The data demonstrate the utility of replication-competent and -attenuated FVs as antigen carriers in immunotherapy.	[Lei, Janet; Wei, Guochao; Gissmann, Lutz; Loechelt, Martin] German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany; [Osen, Wolfram; Gardyan, Adriane; Eichmueller, Stefan] German Canc Res Ctr, Res Program Tumor Immunol, Div Translat Immunol, Heidelberg, Germany; [Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Bioinformat Core Facil, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Lochelt, M (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany.	m.loechelt@dkfz.de	Eichmüller, Stefan B/A-5053-2008	Eichmüller, Stefan B/0000-0002-3497-6904; Lei, Janet/0000-0001-6486-9651; Wei, Guochao/0000-0002-7768-2404	DKFZ Graduate School; Helmholtz Graduate School for Cancer Research	DKFZ Graduate School; Helmholtz Graduate School for Cancer Research	Support was provided by DKFZ Graduate School; JL is supported by a PhD stipend from the Helmholtz Graduate School for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alke A, 2000, VIROLOGY, V275, P170, DOI 10.1006/viro.2000.0537; Alke A, 2001, VIROLOGY, V287, P310, DOI 10.1006/viro.2001.1065; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bastone P, 2007, GENE THER, V14, P613, DOI 10.1038/sj.gt.3302890; Bauer TR, 2011, GENE THER, V18, P553, DOI 10.1038/gt.2010.169; Bauer TR, 2008, NAT MED, V14, P93, DOI 10.1038/nm1695; Bauer TR, 2013, MOL THER, V21, P964, DOI 10.1038/mt.2013.34; Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Bleiholder A, 2012, EVALUATION FELINE FO; Boyer SN, 1996, CANCER RES, V56, P4620; Chareza S, 2012, VIROLOGY, V424, P138, DOI 10.1016/j.virol.2011.12.017; Cohen WM, 2006, J IMMUNOL, V176, P5401, DOI 10.4049/jimmunol.176.9.5401; COLAS S, 1995, J GEN VIROL, V76, P661, DOI 10.1099/0022-1317-76-3-661; Comber JD, 2014, HEPAT RES TREAT, V2014, DOI [DOI 10.1155/2014/860562, 10.1155/2014/860562]; Dalba C, 2007, MOL THER, V15, P457, DOI 10.1038/sj.mt.6300054; Dell K, 2006, INT J CANCER, V118, P364, DOI 10.1002/ijc.21360; Deyle DR, 2013, GENE THER, V20, P868, DOI 10.1038/gt.2013.6; Engel G, 2006, AM J PRIMATOL, V68, P934, DOI 10.1002/ajp.20299; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hsu Jennifer L, 2013, S D Med, VSpec no, P33; Huang F, 2012, AIDS RES HUM RETROV, V28, P591, DOI [10.1089/AID.2011.0305, 10.1089/aid.2011.0305]; Katzourakis A, 2009, SCIENCE, V325, P1512, DOI 10.1126/science.1174149; Kehl T, 2013, VIRUSES-BASEL, V5, P2169, DOI 10.3390/v5092169; Khan AS, 2009, EXPERT REV ANTI-INFE, V7, P569, DOI [10.1586/eri.09.39, 10.1586/ERI.09.39]; Kloetzel PM, 2004, BBA-MOL CELL RES, V1695, P225, DOI 10.1016/j.bbamcr.2004.10.004; Lindemann D, 2011, VIRUSES-BASEL, V3, P561, DOI 10.3390/v3050561; Liu WB, 2013, VIRUSES-BASEL, V5, P1702, DOI 10.3390/v5071702; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Lukic DS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-76; Maier P, 2010, FUTURE MICROBIOL, V5, P1507, DOI 10.2217/FMB.10.100; Materniak M, 2013, J VIROL, V87, P3516, DOI 10.1128/JVI.02447-12; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mergia A, 1996, J MED PRIMATOL, V25, P2, DOI 10.1111/j.1600-0684.1996.tb00185.x; Monath TP, 2011, BIRKHAUSER ADV INFEC, P47, DOI 10.1007/978-3-0346-0277-8_3; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Mouinga-Ondeme A, 2013, VIRUSES-BASEL, V5, P1536, DOI 10.3390/v5061536; Muhle M, 2013, ANTIVIR RES, V100, P314, DOI 10.1016/j.antiviral.2013.09.009; Muhle M, 2013, IMMUNOL RES, V56, P61, DOI 10.1007/s12026-013-8387-x; MUNGER K, 1993, BIOCHIM BIOPHYS ACTA, V1155, P111, DOI 10.1016/0304-419X(93)90025-8; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Neefjes J, 2013, NAT CHEM BIOL, V9, P769, DOI [10.1038/NCHEMBIO.1391, 10.1038/nchembio.1391]; Niedermann G, 1999, IMMUNOL REV, V172, P29, DOI 10.1111/j.1600-065X.1999.tb01354.x; Nowrouzi A, 2006, J GEN VIROL, V87, P1339, DOI 10.1099/vir.0.81554-0; OLD LJ, 1965, CANCER RES, V25, P813; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pascolo S, 2001, CANCER RES, V61, P4072; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Rethwilm A, 2007, CURR GENE THER, V7, P261; Rua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077072; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Samorski R, 2006, IMMUNOL LETT, V107, P41, DOI 10.1016/j.imlet.2006.07.003; Sang MX, 2011, VACCINE, V29, P8496, DOI 10.1016/j.vaccine.2011.09.014; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwantes A, 2003, J VIROL, V77, P7830, DOI 10.1128/JVI.77.14.7830-7842.2003; Schwantes A, 2002, VIROLOGY, V301, P53, DOI 10.1006/viro.2002.1543; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tang Y, 2007, CANCER IMMUNOL IMMUN, V56, P319, DOI 10.1007/s00262-006-0195-x; Tatsumi T, 2003, CLIN CANCER RES, V9, P947; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Trobridge GD, 2009, EXPERT OPIN BIOL TH, V9, P1427, DOI 10.1517/14712590903246388; van Kasteren SI, 2014, CURR OPIN IMMUNOL, V26, P21, DOI 10.1016/j.coi.2013.10.005; Vita R, 2009, NUCL ACIDS RES, P38; Weikel J, 2003, J VET MED A, V50, P415, DOI 10.1046/j.0931-184X.2003.00565.x; Whisnant AW, 2014, J VIROL, V88, P4679, DOI 10.1128/JVI.03587-13; Wuhle M, 2011, VIROLOGY, V412, P333, DOI 10.1016/j.virol.2011.01.023; Zemba M, 2000, VIROLOGY, V266, P150, DOI 10.1006/viro.1999.0037; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	85	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138458	10.1371/journal.pone.0138458	http://dx.doi.org/10.1371/journal.pone.0138458			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397953	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500066
J	Chen, Z; Gao, K; Su, XX; Rao, P; An, XM				Chen, Zhong; Gao, Kai; Su, Xiaoxing; Rao, Pian; An, Xinmin			Genome-Wide Identification of the Invertase Gene Family in Populus	PLOS ONE			English	Article							BETA-FRUCTOSIDASE; DIFFERENTIAL EXPRESSION; SUCROSE; POPLAR; ACCUMULATION; ARABIDOPSIS; EVOLUTION; PLANTS; GROWTH; FRUCTOFURANOSIDASE	Invertase plays a crucial role in carbohydrate partitioning and plant development as it catalyses the irreversible hydrolysis of sucrose into glucose and fructose. The invertase family in plants is composed of two sub-families: acid invertases, which are targeted to the cell wall and vacuole; and neutral/alkaline invertases, which function in the cytosol. In this study, 5 cell wall invertase genes (PtCWINV1-5), 3 vacuolar invertase genes (PtVINV1-3) and 16 neutral/alkaline invertase genes (PtNINV1-16) were identified in the Populus genome and found to be distributed on 14 chromosomes. A comprehensive analysis of poplar invertase genes was performed, including structures, chromosome location, phylogeny, evolutionary pattern and expression profiles. Phylogenetic analysis indicated that the two sub-families were both divided into two clades. Segmental duplication is contributed to neutral/alkaline sub-family expansion. Furthermore, the Populus invertase genes displayed differential expression in roots, stems, leaves, leaf buds and in response to salt/cold stress and pathogen infection. In addition, the analysis of enzyme activity and sugar content revealed that invertase genes play key roles in the sucrose metabolism of various tissues and organs in poplar. This work lays the foundation for future functional analysis of the invertase genes in Populus and other woody perennials.	[Chen, Zhong; Gao, Kai; Rao, Pian; An, Xinmin] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Chen, Zhong; Gao, Kai; Rao, Pian; An, Xinmin] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Su, Xiaoxing] Beijing Berry Genom Co Ltd, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	An, XM (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	anxinmin@bjfu.edu.cn		Chen, Zhong/0000-0003-3196-5238	Major State Basic Research Development Program of China [2012CB114505]; Fundamental Research Funds for the Central Universities [BLYJ201410]; Project of National Natural Science Foundation of China [31170631, J1103516]; National High Technology Research and Development Program of China [2013AA102703, 2011AA100201]; Beijing Berry Genomics Company Limited	Major State Basic Research Development Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Berry Genomics Company Limited	This work was supported by the Major State Basic Research Development Program of China (2012CB114505), the Fundamental Research Funds for the Central Universities (BLYJ201410), the Project of National Natural Science Foundation of China (31170631 and J1103516), and the National High Technology Research and Development Program of China (2013AA102703 and 2011AA100201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. XS is an employee of Beijing Berry Genomics Company Limited. The funder provided support in the form of salary for XS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Balakirev ES, 2003, GENETICS, V164, P533; Balk PA, 1999, PLANTA, V209, P346, DOI 10.1007/s004250050642; Barakat A, 2011, GENE, V479, P37, DOI 10.1016/j.gene.2011.02.008; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; BENHAMOU N, 1991, PLANT PHYSIOL, V97, P739, DOI 10.1104/pp.97.2.739; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Bournay AS, 1996, NUCLEIC ACIDS RES, V24, P2347, DOI 10.1093/nar/24.12.2347; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; Canam T, 2008, PLANTA, V228, P1011, DOI 10.1007/s00425-008-0801-6; Canam T, 2008, TREE PHYSIOL, V28, P1059, DOI 10.1093/treephys/28.7.1059; Chen Z, 2013, INT J MOL SCI, V14, P6187, DOI 10.3390/ijms14036187; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Godt DE, 1997, PLANT PHYSIOL, V115, P273, DOI 10.1104/pp.115.1.273; Goetz M, 1999, PLANT J, V20, P707, DOI 10.1046/j.1365-313X.1999.00628.x; Gonzalez MC, 2005, PLANTA, V222, P386, DOI 10.1007/s00425-005-1542-4; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; HaouazineTakvorian N, 1997, GENE, V197, P239, DOI 10.1016/S0378-1119(97)00268-0; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Liao WH, 2014, FUNCT INTEGR GENOMIC, V14, P517, DOI 10.1007/s10142-014-0379-y; LORENZ K, 1995, PLANT MOL BIOL, V28, P189, DOI 10.1007/BF00042049; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MCCARREY JR, 1986, P NATL ACAD SCI USA, V83, P679, DOI 10.1073/pnas.83.3.679; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nonis A, 2008, PLANTA, V229, P129, DOI 10.1007/s00425-008-0815-0; Nonis A, 2007, PHYSIOL PLANTARUM, V129, P436, DOI 10.1111/j.1399-3054.2006.00832.x; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rossouw D, 2010, FUNCT PLANT BIOL, V37, P22, DOI 10.1071/FP08210; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; STURM A, 1995, PLANTA, V195, P601, DOI 10.1007/BF00195721; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; STURM A, 1990, PLANT CELL, V2, P1107, DOI 10.1105/tpc.2.11.1107; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TROYANOVSKY SM, 1994, EUR J BIOCHEM, V225, P61, DOI 10.1111/j.1432-1033.1994.00061.x; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vargas W, 2003, PLANTA, V216, P951, DOI 10.1007/s00425-002-0943-x; Vizzotto G, 1996, PHYSIOL PLANTARUM, V96, P225, DOI [10.1111/j.1399-3054.1996.tb00206.x, 10.1034/j.1399-3054.1996.960209.x]; Wang YP, 2015, PLANT CELL TISS ORG, V123, P99, DOI 10.1007/s11240-015-0817-0; Welham T, 2009, J EXP BOT, V60, P3353, DOI 10.1093/jxb/erp169; Xie ZS, 2009, SCI HORTIC-AMSTERDAM, V123, P39, DOI 10.1016/j.scienta.2009.07.017; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang ZY, 2013, J PLANT PHYSIOL, V170, P731, DOI 10.1016/j.jplph.2012.12.021; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao Y, 2015, PLANT MOL BIOL REP, V33, P304, DOI 10.1007/s11105-014-0743-z; Ye MX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-475; Zhang HP, 2014, ACTA PHYSIOL PLANT, V36, P71, DOI 10.1007/s11738-013-1387-6; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	57	30	31	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138540	10.1371/journal.pone.0138540	http://dx.doi.org/10.1371/journal.pone.0138540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393355	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100069
J	Natarajan, R; Barber, K; Buckley, A; Cho, P; Egbejimi, A; Wairkar, YP				Natarajan, Rajalaxmi; Barber, Kara; Buckley, Amanda; Cho, Phillip; Egbejimi, Anuoluwapo; Wairkar, Yogesh P.			Tricornered Kinase Regulates Synapse Development by Regulating the Levels of Wiskott-Aldrich Syndrome Protein	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; DROSOPHILA NEUROMUSCULAR-JUNCTION; SUPPRESSOR GENE DLG; FAMILY PROTEINS; ACTIN CYTOSKELETON; SIGNALING PATHWAY; MYOBLAST FUSION; SENSORY NEURONS; CELL-GROWTH; WASP	Precise regulation of synapses during development is essential to ensure accurate neural connectivity and function of nervous system. Many signaling pathways, including the mTOR (mechanical Target of Rapamycin) pathway operate in neurons to maintain genetically determined number of synapses during development. mTOR, a kinase, is shared between two functionally distinct multi-protein complexes-mTORC1 and mTORC2, that act downstream of Tuberous Sclerosis Complex (TSC). We and others have suggested an important role for TSC in synapse development at the Drosophila neuromuscular junction (NMJ) synapses. In addition, our data suggested that the regulation of the NMJ synapse numbers in Drosophila largely depends on signaling via mTORC2. In the present study, we further this observation by identifying Tricornered (Trc) kinase, a serine/threonine kinase as a likely mediator of TSC signaling. trc genetically interacts with Tsc2 to regulate the number of synapses. In addition, Tsc2 and trc mutants exhibit a dramatic reduction in synaptic levels of WASP, an important regulator of actin polymerization. We show that Trc regulates the WASP levels largely, by regulating the transcription of WASP. Finally, we show that overexpression of WASP (Wiskott-Aldrich Syndrome Protein) in trc mutants can suppress the increase in the number of synapses observed in trc mutants, suggesting that WASP regulates synapses downstream of Trc. Thus, our data provide a novel insight into how Trc may regulate the genetic program that controls the number of synapses during development.	[Natarajan, Rajalaxmi; Buckley, Amanda; Egbejimi, Anuoluwapo; Wairkar, Yogesh P.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Natarajan, Rajalaxmi; Buckley, Amanda; Wairkar, Yogesh P.] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Cho, Phillip] Univ Texas Med Branch, Summer Undergrad Res Program, Galveston, TX 77555 USA; [Barber, Kara; Egbejimi, Anuoluwapo] Univ Texas Med Branch, Grad Program Neurosci, Galveston, TX 77555 USA; [Wairkar, Yogesh P.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wairkar, YP (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	yowairka@utmb.edu		Barber, Kara/0000-0002-4042-9886	University of Texas Faculty Development Award, Mitchell Center for Neurodegenerative Diseases; University of Texas System, Stars Award	University of Texas Faculty Development Award, Mitchell Center for Neurodegenerative Diseases; University of Texas System, Stars Award	Funding: This work was supported by the University of Texas Faculty Development Award, Mitchell Center for Neurodegenerative Diseases, and University of Texas System, Stars Award.	Avruch J., 2012, SEMINARS CELL DEV BI; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Campbell M, 2013, GENETICS, V195, P915, DOI 10.1534/genetics.113.156562; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Chang L, 2013, MOL BIOL CELL, V24, P1749, DOI 10.1091/mbc.E12-09-0697; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2011, J BIOCHEM, V150, P133, DOI 10.1093/jb/mvr080; Fang XL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-40; Fang XL, 2010, DEV BIOL, V341, P360, DOI 10.1016/j.ydbio.2010.02.029; Geng W, 2000, GENETICS, V156, P1817; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Haralalka S, 2010, EXP CELL RES, V316, P3007, DOI 10.1016/j.yexcr.2010.05.018; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; He Y, 2005, MOL BIOL CELL, V16, P4139, DOI 10.1091/mbc.e05-01-0018; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2008, BBA-PROTEINS PROTEOM, V1784, P3, DOI 10.1016/j.bbapap.2007.07.017; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; MEINERTZHAGEN IA, 1994, J NEUROGENET, V9, P157, DOI 10.3109/01677069409167277; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Natarajan R, 2013, HUMAN MOLECULAR GENE; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Peca J, 2012, CURR OPIN NEUROBIOL, V22, P866, DOI 10.1016/j.conb.2012.02.015; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang YL, 2007, ANN NEUROL, V61, P139, DOI 10.1002/ana.21058; Weston MC, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00001; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	72	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138188	10.1371/journal.pone.0138188	http://dx.doi.org/10.1371/journal.pone.0138188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393506	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100034
J	Sacco, A; Ruggieri, V; Parisi, M; Festa, G; Rigano, MM; Picarella, ME; Mazzucato, A; Barone, A				Sacco, Adriana; Ruggieri, Valentino; Parisi, Mario; Festa, Giovanna; Rigano, Maria Manuela; Picarella, Maurizio Enea; Mazzucato, Andrea; Barone, Amalia			Exploring a Tomato Landraces Collection for Fruit-Related Traits by the Aid of a High-Throughput Genomic Platform	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; SOLANUM-LYCOPERSICON; WIDE ASSOCIATION; CULTIVATED TOMATO; GENETIC DIVERSITY; CANDIDATE GENES; QUALITY TRAITS; COMPLEX TRAITS; SIZE; REVEALS	During its evolution and domestication Solanum lycopersicum has undergone various genetic 'bottlenecks' and extreme inbreeding of limited genotypes. In Europe the tomato found a secondary centre for diversification, which resulted in a wide array of fruit shape variation given rise to a range of landraces that have been cultivated for centuries. Landraces represent a reservoir of genetic diversity especially for traits such as abiotic stress resistance and high fruit quality. Information about the variation present among tomato landrace populations is still limited. A collection of 123 genotypes from different geographical areas was established with the aim of capturing a wide diversity. Eighteen morphological traits were evaluated, mainly related to the fruit. About 45% of morphological variation was attributed to fruit shape, as estimated by the principal component analysis, and the dendrogram of relatedness divided the population in subgroups mainly on the basis of fruit weight and locule number. Genotyping was carried out using the tomato array platform SolCAP able to interrogate 7,720 SNPs. In the whole collection 87.1% markers were polymorphic but they decreased to 44-54% when considering groups of genotypes with different origin. The neighbour-joining tree analysis clustered the 123 genotypes into two main branches. The STRUCTURE analysis with K = 3 also divided the population on the basis of fruit size. A genomic-wide association strategy revealed 36 novel markers associated to the variation of 15 traits. The markers were mapped on the tomato chromosomes together with 98 candidate genes for the traits analyzed. Six regions were evidenced in which candidate genes co-localized with 19 associated SNPs. In addition, 17 associated SNPs were localized in genomic regions lacking candidate genes. The identification of these markers demonstrated that novel variability was captured in our germoplasm collection. They might also provide a viable indirect selection tool in future practical breeding programs.	[Sacco, Adriana; Ruggieri, Valentino; Rigano, Maria Manuela; Barone, Amalia] Univ Naples Federico II, Dept Agr Sci, Portici, Italy; [Parisi, Mario; Festa, Giovanna] Ctr Ric Orticoltura, Consiglio Ric Agr & Anal Econ Agr, Pontecagnano, Italy; [Picarella, Maurizio Enea; Mazzucato, Andrea] DAFNE Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy, Viterbo, Italy	University of Naples Federico II; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Tuscia University	Barone, A (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	ambarone@unina.it	Picarella, Maurizio/AAQ-4874-2021; parisi, mario/O-8924-2018; Ruggieri, Valentino/H-8041-2019; parisi, mario/N-7573-2019; Mazzucato, Andrea/AEA-1650-2022; Sacco, Adriana/P-3309-2018	parisi, mario/0000-0001-5550-5135; Ruggieri, Valentino/0000-0001-6038-8703; parisi, mario/0000-0001-5550-5135; rigano, maria manuela/0000-0001-7826-9067; Sacco, Adriana/0000-0001-5254-0576	Italian Ministry of Agricultural and Forestry Policy (MiPAF); Italian Ministry of University and Research (MIUR) [MIUR-PON02-GenoPOMpro]	Italian Ministry of Agricultural and Forestry Policy (MiPAF); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funding: This research was supported by the Italian Ministry of Agricultural and Forestry Policy (MiPAF) [grants AGRONANOTECH, ESPLORA] and by the Italian Ministry of University and Research (MIUR) [grant MIUR-PON02-GenoPOMpro]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2004, J AGR FOOD CHEM, V52, P3366, DOI 10.1021/jf049963y; Bailey LH, 1960, STANDARD CYCLOPEDIA, P3353; Barrero LS, 2006, GENOME, V49, P991, DOI 10.1139/G06-059; Bauchet G, 2012, GENETIC DIVERSITY TO; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Blanca J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1444-1; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carbonell-Barrachina AA, 2006, EUR FOOD RES TECHNOL, V222, P536, DOI 10.1007/s00217-005-0131-x; Carelli BP, 2006, GENET RESOUR CROP EV, V53, P395, DOI 10.1007/s10722-004-0578-9; Causse M, 2004, J EXP BOT, V55, P1671, DOI 10.1093/jxb/erh207; Chusreeaeom K, 2014, PLANT BIOTECHNOL-NAR, V31, P149, DOI 10.5511/plantbiotechnology.14.0204a; Corrado G, 2014, SCI HORTIC-AMSTERDAM, V168, P138, DOI 10.1016/j.scienta.2014.01.027; Corrado G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-835; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Futterer J., 1995, P215; Garcia-Martinez S, 2006, GENOME, V49, P648, DOI 10.1139/G06-016; Goncalves LSA, 2009, GENET MOL RES, V8, P364, DOI 10.4238/vol8-1gmr549; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; Jose Diez Maria, 2008, P249, DOI 10.1007/978-0-387-74110-9_7; Labate JA, 2009, HEREDITY, V103, P257, DOI 10.1038/hdy.2009.58; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lippman Z, 2001, GENETICS, V158, P413; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; Mazzucato A, 2010, SCI HORTIC-AMSTERDAM, V125, P55, DOI 10.1016/j.scienta.2010.02.021; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Ranc N, 2012, G3-GENES GENOM GENET, V2, P853, DOI 10.1534/g3.112.002667; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; Rick C. M., 1991, Diversity, V7, P54; RICK CM, 1990, ECON BOT, V44, P69, DOI 10.1007/BF02860476; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Rodriguez GR, 2013, HEREDITY, V111, P256, DOI 10.1038/hdy.2013.45; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Shirasawa K, 2013, DNA RES, V20, P593, DOI 10.1093/dnares/dst033; Shirasawa K, 2010, DNA RES, V17, P381, DOI 10.1093/dnares/dsq024; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Terzopoulos PJ, 2009, EUR J HORTIC SCI, V74, P24; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WILLIAMS CE, 1993, GENOME, V36, P619, DOI 10.1139/g93-083; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xu JX, 2013, THEOR APPL GENET, V126, P567, DOI 10.1007/s00122-012-2002-8; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	57	48	48	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137139	10.1371/journal.pone.0137139	http://dx.doi.org/10.1371/journal.pone.0137139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393929	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100009
J	Jesus, FM; Pereira, MR; Rosa, CS; Moreira, MZ; Sperber, CF				Jesus, Fabiene Maria; Pereira, Marcelo Ribeiro; Rosa, Cassiano Sousa; Moreira, Marcelo Zacharias; Sperber, Carlos Frankl			Preservation Methods Alter Carbon and Nitrogen Stable Isotope Values in Crickets (Orthoptera: Grylloidea)	PLOS ONE			English	Article							TERRESTRIAL FOOD WEBS; PITFALL TRAPS; TISSUE; DELTA-C-13; SIGNATURES; RATIOS; DELTA-N-15; ASSUMPTIONS; EVOLUTION; TERMITES	Stable isotope analysis (SIA) is an important tool for investigation of animal dietary habits for determination of feeding niche. Ideally, fresh samples should be used for isotopic analysis, but logistics frequently demands preservation of organisms for analysis at a later time. The goal of this study was to establish the best methodology for preserving forest litter-dwelling crickets for later SIA analysis without altering results. We collected two cricket species, Phoremia sp. and Mellopsis doucasae, from which we prepared 70 samples per species, divided among seven treatments: (i) freshly processed (control); preserved in fuel ethanol for (ii) 15 and (iii) 60 days; preserved in commercial ethanol for (iv) 15 and (v) 60 days; fresh material frozen for (vi) 15 and (vii) 60 days. After oven drying, samples were analyzed for delta N-15, delta C-13 values, N(%), C(%) and C/N atomic values using continuous flow isotope ratio mass spectrometry. All preservation methods tested, significantly impacted delta C-13 and delta N-15 and C/N atomic values. Chemical preservatives caused delta C-13 enrichment as great as 1.5%, and delta N-15 enrichment as great as 0.9%; the one exception was M. doucasae stored in ethanol for 15 days, which had delta N-15 depletion up to 1.8%. Freezing depleted delta C-13 and delta N-15 by up to 0.7 and 2.2%, respectively. C/N atomic values decreased when stored in ethanol, and increased when frozen for 60 days for both cricket species. Our results indicate that all preservation methods tested in this study altered at least one of the tested isotope values when compared to fresh material (controls). We conclude that only freshly processed material provides adequate SIA results for litter-dwelling crickets.	[Jesus, Fabiene Maria; Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Pereira, Marcelo Ribeiro] Univ Fed Espirito Santo, Ctr Ciencias Agr, Dept Biol, Alegre, ES, Brazil; [Rosa, Cassiano Sousa] Univ Fed Triangulo Mineiro, Curso Ciencias Biol, Iturama, MG, Brazil; [Moreira, Marcelo Zacharias] Univ Sao Paulo, Ctr Energia Nucl Agr, Lab Ecol Isotop, Piracicaba, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal do Espirito Santo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo	Jesus, FM (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil.	fabieneuab@gmail.com	Sperber, Carlos Frankl/F-9298-2012; Moreira, Marcelo Z/D-4622-2013; Pereira, Marcelo/E-8420-2013; Rosa, Cassiano S/A-1780-2011; Sperber, Carlos Frankl/AAH-4443-2021	Sperber, Carlos Frankl/0000-0002-0334-7216; Moreira, Marcelo Z/0000-0001-6769-5570; Rosa, Cassiano S/0000-0003-3294-5677; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [309787/2012-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq; FAPEMIG [563360/2010-0, 47/2010]; Acao Transversal/Fundacoes de Apoio a Pesquisa, Sistema Nacional de Pesquisa em Biodiversidade, SISBIOTA Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Acao Transversal/Fundacoes de Apoio a Pesquisa, Sistema Nacional de Pesquisa em Biodiversidade, SISBIOTA Brazil	FMJ, MRP, CSR, and CFS (309787/2012-2) were supported by research grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) and the Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG, http://www.fapemig.br/), and benefitted from financial support provided by CNPq and FAPEMIG, Process N. 563360/2010-0, Edital N. 47/2010 of the Ministerio de Ciencia e Tecnologia/CNPq/Ministerio de Meio Ambiente/Ministerio da Educacao/CAPES/Fundo Nacional de Desenvolvimento Cientifico e Tecnologico, Acao Transversal/Fundacoes de Apoio a Pesquisa, Sistema Nacional de Pesquisa em Biodiversidade, SISBIOTA Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2002, T AM FISH SOC, V131, P337, DOI 10.1577/1548-8659(2002)131<0337:PEOSIA>2.0.CO;2; Barrow LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P688, DOI 10.1086/588172; Bell WJ, 1984, CHEM ECOLOGY INSECTS; Bugoni L, 2008, RAPID COMMUN MASS SP, V22, P2457, DOI 10.1002/rcm.3633; Carabel S, 2009, ESTUAR COAST SHELF S, V82, P348, DOI 10.1016/j.ecss.2009.01.011; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; Cocco LC, 2005, CHEMOMETR INTELL LAB, V76, P55, DOI 10.1016/j.chemolab.2004.09.004; Collier KJ, 2002, FRESHWATER BIOL, V47, P1651, DOI 10.1046/j.1365-2427.2002.00903.x; Crawley MJ, 2013, R BOOK, P557; Cummings DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040539; Dannheim J, 2007, J EXP MAR BIOL ECOL, V351, P37, DOI 10.1016/j.jembe.2007.06.001; de Lecea AM, 2011, RAPID COMMUN MASS SP, V25, P3640, DOI 10.1002/rcm.5265; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DESUTTER L, 1987, ANN SOC ENTOMOL FR, V23, P213; Desutter-Grandcolas L., 1995, J ORTHOPTERA RES, V1995, P163, DOI DOI 10.2307/3503472; Edwards MS, 2002, COPEIA, P1106; Fanelli E, 2010, J EXP MAR BIOL ECOL, V395, P93, DOI 10.1016/j.jembe.2010.08.020; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; Fleming NEC, 2011, MAR BIOL, V158, P2141, DOI 10.1007/s00227-011-1714-7; Florencio DF, 2011, RAPID COMMUN MASS SP, V25, P243, DOI 10.1002/rcm.4820; Florencio DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066535; Fry B, 2002, B MAR SCI, V70, P871; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GOROCHOV AV, 1986, ZOOL ZH, V65, P516; Gurdebeke S, 2002, J ARACHN, V30; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; Huber F., 1989, CRICKET BEHAV NEUROB; Ji R, 2005, SOIL BIOL BIOCHEM, V37, P1648, DOI 10.1016/j.soilbio.2005.01.026; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kelly B, 2006, J FISH BIOL, V69, P1595, DOI 10.1111/j.1095-8649.2006.01226.x; Krab EJ, 2012, METHODS ECOL EVOL, V3, P138, DOI 10.1111/j.2041-210X.2011.00126.x; Medeiros L, 2015, AQUAT BIOL, V23, P191, DOI 10.3354/ab00628; Nagy ZT, 2010, ORG DIVERS EVOL, V10, P91, DOI 10.1007/s13127-010-0012-4; Nelson P., 2013, BIOL PHYS NEW ART D; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Perkins MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093281; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Ribas CR, 2005, ACTA OECOL, V27, P31, DOI 10.1016/j.actao.2004.08.008; Ruiz-Cooley RI, 2011, J EXP MAR BIOL ECOL, V407, P101, DOI 10.1016/j.jembe.2011.07.002; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Sasakawa K, 2007, ENTOMOL EXP APPL, V125, P321, DOI 10.1111/j.1570-7458.2007.00620.x; Schmidt MH, 2006, J ARACHNOL, V34, P159, DOI 10.1636/T04-95.1; Spain AV, 1996, SOIL BIOL BIOCHEM, V28, P1585, DOI 10.1016/S0038-0717(96)00260-X; Sperber Carlos F., 2003, Neotrop. entomol., V32, P733, DOI 10.1590/S1519-566X2003000400030; Sperber Carlos F., 2007, Journal of Orthoptera Research, V16, P77, DOI 10.1665/1082-6467(2007)16[77:LDATSP]2.0.CO;2; Stallings CD, 2015, PEERJ, V3, DOI 10.7717/peerj.874; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Syvaranta J, 2011, HYDROBIOLOGIA, V658, P383, DOI 10.1007/s10750-010-0512-4; Syvaranta J, 2008, HYDROBIOLOGIA, V600, P121, DOI 10.1007/s10750-007-9181-3; Szinwelski N, 2013, ENVIRON ENTOMOL, V42, P758, DOI 10.1603/EN13030; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; Tayasu I, 1997, ECOL ENTOMOL, V22, P343, DOI 10.1046/j.1365-2311.1997.00070.x; Team RDC, 2014, R LANG ENV STAT COMP; Tillberg CV, 2006, INSECT SOC, V53, P65, DOI 10.1007/s00040-005-0836-7; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Ventura M, 2009, HYDROBIOLOGIA, V632, P297, DOI 10.1007/s10750-009-9852-3; Wessels FJ, 2010, FUNCT ECOL, V24, P1017, DOI 10.1111/j.1365-2435.2010.01716.x; Wolf BO, 2000, OECOLOGIA, V124, P536, DOI 10.1007/s004420000406; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; [No title captured]	69	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137650	10.1371/journal.pone.0137650	http://dx.doi.org/10.1371/journal.pone.0137650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390400	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000011
J	Nijaguna, MB; Patil, V; Hegde, AS; Chandramouli, BA; Arivazhagan, A; Santosh, V; Somasundaram, K				Nijaguna, Mamatha B.; Patil, Vikas; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Santosh, Vani; Somasundaram, Kumaravel			An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; FIBROBLAST GROWTH-FACTORS; MESSENGER-RNA EXPRESSION; MALIGNANT GLIOMA; INTERFERON-GAMMA; GLIOBLASTOMA-MULTIFORME; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; IN-VIVO	Glioblastomas (GBM) are largely incurable as they diffusely infiltrate adjacent brain tissues and are difficult to diagnose at early stages. Biomarkers derived from serum, which can be obtained by minimally invasive procedures, may help in early diagnosis, prognosis and treatment monitoring. To develop a serum cytokine signature, we profiled 48 cytokines in sera derived from normal healthy individuals (n = 26) and different grades of glioma patients (n = 194). We divided the normal and grade IV glioma/GBM serum samples randomly into equal sized training and test sets. In the training set, the Prediction Analysis for Microarrays (PAM) identified a panel of 18 cytokines that could discriminate GBM sera fromnormal sera with maximum accuracy (95.40%) and minimum error (4.60%). The 18-cytokine signature obtained in the training set discriminated GBM sera from normal sera in the test set as well (accuracy 96.55%; error 3.45%). Interestingly, the 18-cytokine signature also differentiated grade II/Diffuse Astrocytoma (DA) and grade III/Anaplastic Astrocytoma (AA) sera from normal sera very efficiently (DA vs. normal-accuracy 96.00%, error 4.00%; AA vs. normal-accuracy 95.83%, error 4.17%). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using 18 cytokines resulted in the enrichment of two pathways, cytokine-cytokine receptor interaction and JAK-STAT pathways with high significance. Thus our study identified an 18-cytokine signature for distinguishing glioma sera fromnormal healthy individual sera and also demonstrated the importance of their differential abundance in glioma biology.	[Nijaguna, Mamatha B.; Patil, Vikas; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Hegde, Alangar S.] Sri Satya Sai Inst Higher Med Sci, Dept Neurosurg, Bangalore 560066, Karnataka, India; [Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			DBT, Government of India; IISc; DBT	DBT, Government of India(Department of Biotechnology (DBT) India); IISc; DBT(Department of Biotechnology (DBT) India)	KS thanks DBT, Government of India for financial support. MBN acknowledges IISc and DBT for the fellowship. KS is a J. C. Bose Fellow of the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albulescu R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/979748; Arimappamagan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062042; Badie B, 2001, MICROSC RES TECHNIQ, V54, P106, DOI 10.1002/jemt.1125; Chen SD, 2014, EUR REV MED PHARMACO, V18, P1904; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cui L, 2012, CANCER BIOL THER, V13, P496, DOI 10.4161/cbt.19592; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Ding YL, 2014, BRAIN BEHAV, V4, P841, DOI 10.1002/brb3.288; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; FARKKILA M, 1994, BRIT J CANCER, V70, P138, DOI 10.1038/bjc.1994.263; George J, 2009, CLIN CANCER RES, V15, P7186, DOI 10.1158/1078-0432.CCR-09-1425; Hao CH, 2002, ACTA NEUROPATHOL, V103, P171; Haque A, 2007, NEUROCHEM RES, V32, P2203, DOI 10.1007/s11064-007-9420-z; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; HISHII M, 1995, NEUROSURGERY, V37, P1160, DOI 10.1227/00006123-199512000-00016; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Huettner C, 1997, ANTICANCER RES, V17, P3217; HUETTNER C, 1995, AM J PATHOL, V146, P317; Iwami K, 2011, NEUROSURG REV, V34, P253, DOI 10.1007/s10143-011-0320-y; Kimura S, 2002, J NEURO-ONCOL, V59, P199, DOI 10.1023/A:1019919019497; Knupfer MM, 2001, ANTICANCER RES, V21, P3989; Knupfer MM, 1997, KLIN PADIATR, V209, P271, DOI 10.1055/s-2008-1043961; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee J, 2014, NMR BIOMED, V27, P1046, DOI 10.1002/nbm.3153; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liang RF, 2014, INT J CLIN EXP MED, V7, P5573; Lichtor T, 2003, J NEURO-ONCOL, V65, P247, DOI 10.1023/B:NEON.0000003654.83272.4a; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MORRISON RS, 1990, CANCER RES, V50, P2524; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nagai M, 1984, Neurosurg Rev, V7, P55, DOI 10.1007/BF01743290; NAKAGAWA Y, 1983, CANCER TREAT REP, V67, P833; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oelmann E, 1997, INT J CANCER, V71, P1066, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1066::AID-IJC25>3.0.CO;2-A; Paradkar PH, 2014, ASIAN PAC J CANCER P, V15, P3851, DOI 10.7314/APJCP.2014.15.9.3851; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rahaman SO, 2005, CANCER RES, V65, P2956, DOI 10.1158/0008-5472.CAN-04-3592; Rao SAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085200; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Sahin N, 2013, NEURORADIOL J, V26, P531, DOI 10.1177/197140091302600506; Shevtsov MA, 2015, NEOPLASIA, V17, P32, DOI 10.1016/j.neo.2014.11.001; Shukla S, 2013, CANCER RES, V73, P6563, DOI 10.1158/0008-5472.CAN-13-0298; SIDKY YA, 1987, CANCER RES, V47, P5155; Sloan A E, 2000, Neurosurg Focus, V9, pe9; Somasundaram K, 2009, EXPERT REV MOL DIAGN, V9, P695, DOI 10.1586/ERM.09.52; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; STEFANIK DF, 1991, CANCER RES, V51, P5760; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; TADA M, 1994, J NEUROIMMUNOL, V50, P187, DOI 10.1016/0165-5728(94)90045-0; TAKAHASHI JA, 1990, P NATL ACAD SCI USA, V87, P5710, DOI 10.1073/pnas.87.15.5710; Tanwar MK, 2002, CANCER RES, V62, P4364; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tietze A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123044; Tu YY, 2011, MED ONCOL, V28, P15, DOI 10.1007/s12032-010-9435-1; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wagner S, 1999, INT J CANCER, V82, P12, DOI 10.1002/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O; Wang XC, 2014, J MAGN RESON IMAGING, V39, P1569, DOI 10.1002/jmri.24312; Weber F, 2003, J NEURO-ONCOL, V64, P125, DOI 10.1023/A:1024901501173; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; YOSHIDA J, 1994, ACTA NEUROCHIR, V127, P55, DOI 10.1007/BF01808547; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001	71	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137524	10.1371/journal.pone.0137524	http://dx.doi.org/10.1371/journal.pone.0137524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390214	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000009
J	Mela, V; Diaz, F; Borcel, E; Argente, J; Chowen, JA; Viveros, MP				Mela, Virginia; Diaz, Francisca; Borcel, Erika; Argente, Jesus; Chowen, Julie A.; Viveros, Maria-Paz			Long Term Hippocampal and Cortical Changes Induced by Maternal Deprivation and Neonatal Leptin Treatment in Male and Female Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; EARLY-LIFE STRESS; HYPOTHALAMIC ASTROCYTES; UNPREDICTABLE STRESS; CHILDHOOD TRAUMA; POSTNATAL LEPTIN; MESSENGER-RNA; ANIMAL-MODEL; ADULT; GLUTAMATE	Maternal deprivation (MD) during neonatal life has diverse long-term behavioral effects and alters the development of the hippocampus and frontal cortex, with several of these effects being sexually dimorphic. MD animals show a marked reduction in their circulating leptin levels, not only during the MD period, but also several days later (PND 13). A neonatal leptin surge occurs in rodents (beginning around PND 5 and peaking between PND 9 and 10) that has an important neurotrophic role. We hypothesized that the deficient neonatal leptin signaling of MD rats could be involved in the altered development of their hippocampus and frontal cortex. Accordingly, a neonatal leptin treatment in MD rats would at least in part counteract their neurobehavioural alterations. MD was carried out in Wistar rats for 24 h on PND 9. Male and female MD and control rats were treated from PND 9 to 13 with rat leptin (3 mg/kg/day sc) or vehicle. In adulthood, the animals were submitted to the open field, novel object memory test and the elevated plus maze test of anxiety. Neuronal and glial population markers, components of the glutamatergic and cannabinoid systems and diverse synaptic plasticity markers were evaluated by PCR and/or western blotting. Main results include: 1) In some of the parameters analyzed, neonatal leptin treatment reversed the effects of MD (eg., mRNA expression of hippocampal IGF1 and protein expression of GFAP and vimentin) partially confirming our hypothesis; 2) The neonatal leptin treatment, per se, exerted a number of behavioral (increased anxiety) and neural effects (eg., expression of the following proteins: NG2, NeuN, PSD95, NCAM, synaptophysin). Most of these effects were sex dependent. An adequate neonatal leptin level (avoiding excess and deficiency) appears to be necessary for its correct neuro-programing effect.	[Mela, Virginia; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Physiol Anim Physiol 2, Madrid, Spain; [Diaz, Francisca; Argente, Jesus; Chowen, Julie A.] Hosp Infantil Univ Nino Jesus, Inst Invest Princesa, Dept Endocrinol, Madrid, Spain; [Diaz, Francisca; Argente, Jesus; Chowen, Julie A.] CIBEROBN Inst Carlos III, Madrid, Spain; [Borcel, Erika] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Borcel, Erika] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Viveros, MP (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Physiol Anim Physiol 2, Madrid, Spain.	pazviver@bio.ucm.es	Viveros, Maria-Paz/S-6855-2016; Argente, Jesús/M-5226-2019; Chowen, Julie/C-8979-2011; Mela, Virginia/N-4664-2017; Mela, Virginia/AIE-5893-2022	Viveros, Maria-Paz/0000-0002-4119-4636; Argente, Jesús/0000-0001-5826-0276; Chowen, Julie/0000-0002-4770-2291; Mela, Virginia/0000-0001-7702-0972; Diaz-Gonzalez, Francisca/0000-0003-1364-7586	Ministerio de Economia y Competitividad [BFU2012-38144, BFU2011-27492]; Fondo de Investigacion Sanitaria [PI13/02195]; European FEDER Program; GRUPOS UCM Universidad Complutense de Madrid (UCM)- Banco de Santander (BSCH) GRUPO UCM [951579]; Redes Tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RTA) [RD2012/0028/0021]; Centro de Investigacion Biomedica en Red Fisiopatologia de Obesidad y Nutricion	Ministerio de Economia y Competitividad(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European FEDER Program(European Commission); GRUPOS UCM Universidad Complutense de Madrid (UCM)- Banco de Santander (BSCH) GRUPO UCM; Redes Tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RTA); Centro de Investigacion Biomedica en Red Fisiopatologia de Obesidad y Nutricion	This study was supported by the Ministerio de Economia y Competitividad, Grants Reference numbers: BFU2012-38144 (to MPV) and BFU2011-27492 (to JAC), Fondo de Investigacion Sanitaria Reference number PI13/02195 co-funded by European FEDER Program (to JAC), GRUPOS UCM Universidad Complutense de Madrid (UCM)-Banco de Santander (BSCH) GRUPO UCM Reference number 951579, (to MPV) and Redes Tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RTA) Reference number: RD2012/0028/0021 (MPV) and Centro de Investigacion Biomedica en Red Fisiopatologia de Obesidad y Nutricion (JAC). Neither of these institutions had any role in the in study design; in the collection, analysis, interpretation of data, writing of the report or in the decision to submit the article for publication.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Alvarez P, 2015, NEUROSCI LETT, V591, P207, DOI 10.1016/j.neulet.2015.01.066; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Bellefontaine N, 2014, J CLIN INVEST, V124, P2550, DOI 10.1172/JCI65928; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bouret SG, 2013, FRONT NEUROENDOCRIN, V34, P18, DOI 10.1016/j.yfrne.2013.01.001; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Burke NN, 2013, J PAIN, V14, P1173, DOI 10.1016/j.jpain.2013.05.003; Caron E, 2010, J COMP NEUROL, V518, P459, DOI 10.1002/cne.22219; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Corvin AP, 2012, NEUROSCI LETT, V520, P51, DOI 10.1016/j.neulet.2012.05.029; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Ellenbroek BA, 2005, STRESS, V8, P247, DOI 10.1080/10253890500404634; Ellenbroek BA, 2003, CLIN NEUROSCI RES, V3, P297, DOI 10.1016/S1566-2772(03)00090-2; Ellenbroek BA, 2002, PHARMACOL BIOCHEM BE, V73, P177, DOI 10.1016/S0091-3057(02)00794-3; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FILE SE, 1992, BIOL COUN S, P25; Folch J, 2012, J MOL ENDOCRINOL, V49, pR149, DOI 10.1530/JME-12-0151; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Garcia-Caceres C, 2013, ENDOCRIN METAB CLIN, V42, P57, DOI 10.1016/j.ecl.2012.11.003; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Granado M, 2014, HORM METAB RES, V46, P462, DOI 10.1055/s-0033-1363226; Granado M, 2012, OBESITY FACTS, V5, P138, DOI 10.1159/000336967; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Harvey J, 2007, CURR OPIN PHARMACOL, V7, P643, DOI 10.1016/j.coph.2007.10.006; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Huang LT, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00008; Hung HC, 2009, PEPTIDES, V30, P2275, DOI 10.1016/j.peptides.2009.08.023; IRVING AJ, 2014, BIOL SCI, V369, DOI DOI 10.1098/RSTB.2013.0155; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; LEVINE S, 1991, DEV PSYCHOBIOL, V24, P547, DOI 10.1002/dev.420240803; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Llorente R, 2007, PSYCHONEUROENDOCRINO, V32, P636, DOI 10.1016/j.psyneuen.2007.04.002; Llorente-Berzal A, 2011, ADDICT BIOL, V16, P624, DOI 10.1111/j.1369-1600.2011.00318.x; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Macri S, 2008, BEHAV BRAIN RES, V191, P227, DOI 10.1016/j.bbr.2008.03.031; Marco EM, 2015, NEUROSCI BIOBEHAV R, V51, P151, DOI 10.1016/j.neubiorev.2015.01.015; Marco EM, 2009, NEUROSCI BIOBEHAV R, V33, P498, DOI 10.1016/j.neubiorev.2008.03.008; Marco EM, 2007, PHARMACOL BIOCHEM BE, V86, P334, DOI 10.1016/j.pbb.2006.10.006; Mateos B, 2011, J PSYCHOPHARMACOL, V25, P1676, DOI 10.1177/0269881110370503; Mela V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048915; Meyer LR, 2014, BEHAV BRAIN RES, V275, P131, DOI 10.1016/j.bbr.2014.08.054; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Moult PR, 2009, J NEUROCHEM, V108, P685, DOI 10.1111/j.1471-4159.2008.05810.x; Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2; Pan WH, 2012, ANN NY ACAD SCI, V1264, P64, DOI 10.1111/j.1749-6632.2012.06472.x; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Rentesi G, 2010, NEUROSCI LETT, V480, P7, DOI 10.1016/j.neulet.2010.04.054; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schmitt A, 1997, J NEUROSCI, V17, P1, DOI 10.1523/jneurosci.17-01-00001.1997; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Stieg MR, 2015, PSYCHONEUROENDOCRINO, V51, P47, DOI 10.1016/j.psyneuen.2014.09.004; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Udagawa J, 2000, BRAIN RES, V868, P251, DOI 10.1016/S0006-8993(00)02334-9; Udagawa Jun, 2006, Congenital Anomalies, V46, P16; Udagawa J, 2006, NEUROENDOCRINOL LETT, V27, P177; VIRGIN CE, 1991, J NEUROCHEM, V57, P1422, DOI 10.1111/j.1471-4159.1991.tb08309.x; Viveros M P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS217, DOI 10.1016/j.psyneuen.2009.05.015; Viveros MP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00084; Viveros MP, 2011, NEUROSCI BIOBEHAV R, V35, P1740, DOI 10.1016/j.neubiorev.2010.09.005; Viveros MP, 2010, HORM BEHAV, V58, P808, DOI 10.1016/j.yhbeh.2010.08.003; Viveros MP, 2010, HORM BEHAV, V57, P405, DOI 10.1016/j.yhbeh.2010.01.009; Xie L, 2013, GROWTH HORM IGF RES, V23, P187, DOI 10.1016/j.ghir.2013.07.003; Yatsushiro S, 2000, J NEUROCHEM, V75, P288, DOI 10.1046/j.1471-4159.2000.0750288.x; Yon MA, 2013, BRIT J NUTR, V109, P1573, DOI 10.1017/S000711451200579X; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; ZIMMERBERG B, 1992, DEV PSYCHOBIOL, V25, P213, DOI 10.1002/dev.420250306	78	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137283	10.1371/journal.pone.0137283	http://dx.doi.org/10.1371/journal.pone.0137283			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382238	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000361790200019
J	Nason, G; Stevens, K				Nason, Guy; Stevens, Kara			Bayesian Wavelet Shrinkage of the Haar-Fisz Transformed Wavelet Periodogram	PLOS ONE			English	Article							ADAPTIVE ESTIMATION; TIME-SERIES	It is increasingly being realised that many real world time series are not stationary and exhibit evolving second-order autocovariance or spectral structure. This article introduces a Bayesian approach for modelling the evolving wavelet spectrum of a locally stationary wavelet time series. Our new method works by combining the advantages of a Haar-Fisz transformed spectrum with a simple, but powerful, Bayesian wavelet shrinkage method. Our new method produces excellent and stable spectral estimates and this is demonstrated via simulated data and on differenced infant electrocardiogram data. A major additional benefit of the Bayesian paradigm is that we obtain rigorous and useful credible intervals of the evolving spectral structure. We show how the Bayesian credible intervals provide extra insight into the infant electrocardiogram data.	[Nason, Guy; Stevens, Kara] Univ Bristol, Sch Math, Bristol, Avon, England	University of Bristol	Nason, G (corresponding author), Univ Bristol, Sch Math, Bristol, Avon, England.	g.p.nason@bristol.ac.uk	Nason, Guy/H-6446-2014	Nason, Guy/0000-0002-4664-3154; Stevens, Kara/0000-0003-4898-1795	SuSTaIn Science and Innovation Award [EP/D063485/1]; EPSRC [EP/I01687X/1]; Engineering and Physical Sciences Research Council [EP/I01697X/1, EP/D063485/1, EP/K020951/1] Funding Source: researchfish; EPSRC [EP/I01697X/1, EP/K020951/1, EP/D063485/1] Funding Source: UKRI	SuSTaIn Science and Innovation Award; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Kara Stevens was supported by a studentship funded by the SuSTaIn Science and Innovation Award grant EP/D063485/1. Guy Nason was partially supported by EPSRC grants from EP/I01687X/1: "The Energy Programme, an RCUK cross-council initiative led by EPSRC and contributed to by ESRC, NERC, BBSRC and STFC" and EP/K02951/1.	Barber S, 2002, J R STAT SOC B, V64, P189, DOI 10.1111/1467-9868.00332; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chipman HA, 1997, J AM STAT ASSOC, V92, P1413, DOI 10.2307/2965411; Clyde M., 1999, BAYESIAN INFERENCE W, V141, P309; Coifman R. R., 1995, TRANSLATION INVARIAN, P125, DOI [10.1007/978-1-4612-2544-7, DOI 10.1007/978-1-4612-2544-7_9, 10.1007/978-1-4612-2544-7_9]; Dahlhaus R, 1997, ANN STAT, V25, P1; Dahlhaus R, 2012, HANDB STAT, V30, P351, DOI 10.1016/B978-0-444-53858-1.00013-2; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Davison AC, 2009, BIOMETRIKA, V96, P479, DOI 10.1093/biomet/asp022; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Eckley IA, 2005, STAT COMPUT, V15, P83, DOI 10.1007/s11222-005-6200-y; Fryzlewicz P, 2003, ANN I STAT MATH, V55, P737, DOI 10.1007/BF02523391; Fryzlewicz P, 2006, J R STAT SOC B, V68, P611, DOI 10.1111/j.1467-9868.2006.00558.x; Johnstone IM, 2005, ANN STAT, V33, P1700, DOI 10.1214/009053605000000345; Muller P, 1998, J COMPUT GRAPH STAT, V7, P456, DOI 10.2307/1390676; Nason G., 1995, SPRINGER LECT NOTES, V103, P281, DOI DOI 10.1007/978-1-4612-2544-7_17; Nason G., 2012, WAVETHRESH WAVELETS; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; Nason GP, 2000, J ROY STAT SOC B, V62, P271, DOI 10.1111/1467-9868.00231; PAGE CH, 1952, J APPL PHYS, V23, P103, DOI 10.1063/1.1701949; Pensky M, 2007, STAT SINICA, V17, P635; PRIESTLEY MB, 1965, J ROY STAT SOC B, V27, P204; R Development Core Team, 2012, R LANG ENV STAT COMP; Ruggeri F, 2005, HANDB STAT, V25, P315, DOI 10.1016/S0169-7161(05)25011-3; Sawczenko A, 1995, PEDIAT PULMONOL, V20, P341; Semadeni C, 2004, BIOMETRIKA, V91, P497, DOI 10.1093/biomet/91.2.497; SILVERMAN RA, 1957, IRE T INFORM THEOR, V3, P182, DOI 10.1109/TIT.1957.1057413; Van Bellegem S, 2008, ANN STAT, V36, P1879, DOI 10.1214/07-AOS524; Vidakovic B., 1999, STAT MODELING WAVELE; Vidakovic B., 1998, LECT NOTES STAT, V133, P133	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137662	10.1371/journal.pone.0137662	http://dx.doi.org/10.1371/journal.pone.0137662			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381141	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200031
J	Tangena, JAA; Thammavong, P; Hiscox, A; Lindsay, SW; Brey, PT				Tangena, Julie-Anne A.; Thammavong, Phoutmany; Hiscox, Alexandra; Lindsay, Steve W.; Brey, Paul T.			The Human-Baited Double Net Trap: An Alternative to Human Landing Catches for Collecting Outdoor Biting Mosquitoes in Lao PDR	PLOS ONE			English	Article							DIPTERA-CULICIDAE; ANOPHELES-GAMBIAE; AEDES-ALBOPICTUS; BG-SENTINEL; MALARIA; SURVEILLANCE	Estimating the exposure of individuals tomosquito-borne diseases is a key measure used to evaluate the success of vector control operations. The gold standard is to use human landing catches wheremosquitoes are collected off the exposed limbs of human collectors. This is however an unsatisfactory method since it potentially exposes individuals to a range of mosquito-borne diseases. In this study several samplingmethods were compared to find amethod that is representative of the human-biting rate outdoors, but which does not expose collectors to mosquito-borne infections. The sampling efficiency of four odour-baited traps were compared outdoors in rural Lao PDR; the human-baited double net (HDN) trap, CDC light trap, BG sentinel trap and Suna trap. Subsequently the HDN, the best performing trap, was compared directly with human landing catches (HLC), the 'gold standard', for estimating human-biting rates. HDNs collected 11-44 times more mosquitoes than the other traps, with the exception of the HLC. The HDN collected similar numbers of Anopheles (Rate Ratio, RR = 1.16, 95% Confidence Intervals, 95% CI = 0.61-2.20) and Culex mosquitoes (RR = 1.26, 95% CI = 0.74-2.17) as HLC, but under-estimated the numbers of Aedes albopictus (RR = 0.45, 95% CI = 0.27-0.77). Simpson's index of diversity was 0.845 (95% CI 0.836-0.854) for the HDN trap and 0.778 (95% CI 0.769-0.787) for HLC, indicating that the HDN collected a greater diversity of mosquito species than HLC. Both HLC and HDN can distinguish between low and high biting rates and are crude ways to measure human-biting rate. The HDN is a simple and cheap method to estimate the human-biting rate outdoors without exposing collectors tomosquito bites.	[Tangena, Julie-Anne A.; Thammavong, Phoutmany; Brey, Paul T.] Inst Pasteur Laos, Dept Entomol, Viangchan, Laos; [Tangena, Julie-Anne A.; Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hiscox, Alexandra] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands	Durham University; Wageningen University & Research	Tangena, JAA (corresponding author), Inst Pasteur Laos, Dept Entomol, Viangchan, Laos.	j.tangena@pasteur.la	Tangena, Julie-Anne/L-1053-2019	Lindsay, Steve/0000-0002-3461-9050; Tangena, Julie-Anne/0000-0002-8188-4498	Agence Francaise de Developpement [CZZ 1809 AA]	Agence Francaise de Developpement	Funding: This work was supported by The Agence Francaise de Developpement; Grant number CZZ 1809 AA; http://www.afd.fr/lang/en/home. This project falls under the project ECOMORE; http://ecomore.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, COMPUTER PROGRAM CAL; [Anonymous], 2012, BG SENT BIOG MOSQ TR; Azil AH, 2011, ASIA-PAC J PUBLIC HE, V23, P827, DOI 10.1177/1010539511426595; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Gater BAR, 1935, AIDS IDENTIFICATION; Gimnig JE, 2013, AM J TROP MED HYG, V88, P301, DOI 10.4269/ajtmh.2012.12-0209; HADDOW AJ, 1945, B ENTOMOL RES, V36, P33, DOI 10.1017/S0007485300023907; HAMON JACQUES, 1964, BULL SOC PATHOL EXOTIQUE, V57, P576; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kim Heung Chul, 2003, Korean Journal of Entomology, V33, P189; Klock J. W., 1953, Mosquito News Albany NY, V13, P157; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Lee RML, 2012, J AM MOSQUITO CONTR, V28, P248, DOI 10.2987/12-6239R.1; LeGoff G, 1997, PARASITE, V4, P75, DOI 10.1051/parasite/1997041075; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; McKenzie FE, 2004, MALARIA J, P3; Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Mweresa C, 2014, MALARIA J, P13; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Rattanarithikul R, 1996, J AM MOSQUITO CONTR, V12, P52; Rattanarithikul R, 2005, SE ASIAN J TROP MED, p[37, 41, 36]; RUBIOPALIS Y, 1992, J AM MOSQUITO CONTR, V8, P261; Schultz George W., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P157; Seng Chang Moh, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P454; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Service MW, 1963, B ENTOMOL RES, V54, P601, DOI DOI 10.1017/S000748530004904X; Silver JB., 2008, FIELD SAMPLING METHO; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh Neeru, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P196; Smallegange RC, 2010, MALARIA J, P9; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; *WHO, 1975, MAN PRACT ENT MAL 2, P191; Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2; World Health Organization (WHO), 2013, GLOB ACT PLAN PREV C, V1; Zahedi M., 1994, Mosquito Borne Diseases Bulletin, V11, P81	41	58	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138735	10.1371/journal.pone.0138735	http://dx.doi.org/10.1371/journal.pone.0138735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381896	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361790200157
J	Xu, Y; Burgess, P; Huang, BR				Xu, Yi; Burgess, Patrick; Huang, Bingru			Root Antioxidant Mechanisms in Relation to Root Thermotolerance in Perennial Grass Species Contrasting in Heat Tolerance	PLOS ONE			English	Article							ALTERNATIVE OXIDASE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; OXIDATIVE STRESS; ASCORBATE PEROXIDASE; PLANT-MITOCHONDRIA; HIGH-TEMPERATURE; ABIOTIC STRESS; EARLY EVENTS; OXYGEN	Mechanisms of plant root tolerance to high temperatures through antioxidant defense are not well understood. The objective of this study was to investigate whether superior root thermotolerance of heat-tolerant Agrostis scabra relative to its congeneric heat-sensitive Agrostis stolonifera was associated with differential accumulation of reactive oxygen species and antioxidant scavenging systems. A. scabra 'NTAS' and A. stolonifera 'Penncross' plants were exposed to heat stress (35/30 degrees C, day/night) in growth chambers for 24 d. Superoxide (O-2(-)) content increased in both A. stolonifera and A. scabra roots under heat stress but to a far lesser extent in A. scabra than in A. stolonifera. Hydrogen peroxide (H2O2) content increased significantly in A. stolonifera roots but not in A. scabra roots responding to heat stress. The content of antioxidant compounds (ascorbate and glutathione) did not differ between A. stolonifera and A. scabra under heat stress. Enzymatic activity of superoxide dismutase was less suppressed in A. scabra than that in A. stolonifera under heat stress, while peroxidase and catalase were more induced in A. scabra than in A. stolonifera. Similarly, their encoded transcript levels were either less suppressed, or more induced in A. scabra roots than those in A. stolonifera during heat stress. Roots of A. scabra exhibited greater alternative respiration rate and lower cytochrome respiration rate under heat stress, which was associated with suppression of O-2(-) and H2O2 production as shown by respiration inhibitors. Superior root thermotolerance of A. scabra was related to decreases in H2O2 and O-2(-) accumulation facilitated by active enzymatic antioxidant defense systems and the maintenance of alternative respiration, alleviating cellular damages by heat-induced oxidative stress.	[Xu, Yi; Burgess, Patrick; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA.	huang@aesop.rutgers.edu						Anderson JA, 2002, SCI HORTIC-AMSTERDAM, V95, P277, DOI 10.1016/S0304-4238(02)00076-6; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Asada K., 1987, PHOTOINHIBITION, P227; Atkin OK, 2000, NEW PHYTOL, V147, P141, DOI 10.1046/j.1469-8137.2000.00683.x; Atkin OK, 2002, PLANT PHYSIOL, V128, P212, DOI 10.1104/pp.010326; Beligni MV, 1999, NITRIC OXIDE-BIOL CH, V3, P199, DOI 10.1006/niox.1999.0222; Bian SM, 2009, SCI HORTIC-AMSTERDAM, V120, P264, DOI 10.1016/j.scienta.2008.10.014; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Chaitanya KV, 2002, PLANT GROWTH REGUL, V36, P175, DOI 10.1023/A:1015092628374; Cvetkovska M, 2012, NEW PHYTOL, V195, P32, DOI 10.1111/j.1469-8137.2012.04166.x; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Ederli L, 2006, PLANT PHYSIOL, V142, P595, DOI 10.1104/pp.106.085472; Fiorani F, 2005, PLANT PHYSIOL, V139, P1795, DOI 10.1104/pp.105.070789; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gupta KJ, 2012, J EXP BOT, V63, P1773, DOI 10.1093/jxb/ers053; GURI A, 1983, CAN J PLANT SCI, V63, P733, DOI 10.4141/cjps83-090; Halliwell B, 1999, FREE RADICAL BIO MED; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; Huang BR, 2012, J EXP BOT, V63, P3455, DOI 10.1093/jxb/ers003; Huang X, 2002, PLANTA, V215, P914, DOI 10.1007/s00425-002-0828-z; Huve K, 2011, PLANT CELL ENVIRON, V34, P113, DOI 10.1111/j.1365-3040.2010.02229.x; Juszczuk I, 2001, J PLANT PHYSIOL, V158, P1299, DOI 10.1078/0176-1617-00541; Konigshofer H, 2008, PLANT CELL ENVIRON, V31, P1771, DOI 10.1111/j.1365-3040.2008.01880.x; Ma YH, 2008, PLANT SCI, V175, P761, DOI 10.1016/j.plantsci.2008.07.010; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Millar AH, 1996, FEBS LETT, V398, P155, DOI 10.1016/S0014-5793(96)01230-6; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Navrot N, 2007, PHYSIOL PLANTARUM, V129, P185, DOI 10.1111/j.1399-3054.2006.00777.x; Naya L, 2007, PLANT PHYSIOL, V144, P1104, DOI 10.1104/pp.107.099648; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; PURVIS AC, 1993, PHYSIOL PLANTARUM, V88, P712, DOI 10.1111/j.1399-3054.1993.tb01393.x; Rachmilevitch S, 2006, J EXP BOT, V57, P623, DOI 10.1093/jxb/erj047; Rachmilevitch S, 2008, J EXP BOT, V59, P3803, DOI 10.1093/jxb/ern233; Rachmilevitch S, 2007, PHYSIOL PLANTARUM, V129, P163, DOI 10.1111/j.1399-3054.2006.00784.x; Redha A, 2012, BIOCHEM SYST ECOL, V43, P80, DOI 10.1016/j.bse.2012.02.026; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Ribas-Carbo M, 2005, PLANT PHYSIOL, V139, P466, DOI 10.1104/pp.105.065565; Rotter D, 2007, MOL GENET GENOMICS, V278, P197, DOI 10.1007/s00438-007-0240-2; Savicka M., 2010, EKOLOGIJA, V56, P26, DOI [10.2478/v10055-010-0004-x, DOI 10.2478/V10055-010-0004-X]; Schwarzlander M, 2009, BBA-BIOENERGETICS, V1787, P468, DOI 10.1016/j.bbabio.2009.01.020; Stout RG, 2002, ANN BOT-LONDON, V90, P259, DOI 10.1093/aob/mcf174; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Vacca RA, 2004, PLANT PHYSIOL, V134, P1100, DOI 10.1104/pp.103.035956; WAGNER AM, 1995, PHYSIOL PLANTARUM, V95, P318, DOI 10.1111/j.1399-3054.1995.tb00844.x; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang HH, 2010, PLANT SIGNAL BEHAV, V5, P1636, DOI 10.4161/psb.5.12.13775; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu CP, 2010, PHYSIOL PLANTARUM, V139, P192, DOI 10.1111/j.1399-3054.2010.01357.x; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu Y, 2013, CROP SCI, V53, P1626, DOI 10.2135/cropsci2013.01.0045; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yannarelli GG, 2007, PHYTOCHEMISTRY, V68, P505, DOI 10.1016/j.phytochem.2006.11.016; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang XZ, 2000, CROP SCI, V40, P1344, DOI 10.2135/cropsci2000.4051344x; Zhou BY, 2006, PLANT GROWTH REGUL, V49, P113, DOI 10.1007/s10725-006-9000-2	65	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138268	10.1371/journal.pone.0138268	http://dx.doi.org/10.1371/journal.pone.0138268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382960	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200082
J	Yang, WP; Yang, JJ; Gao, YL; Tang, XY; Ren, YN; Takahashi, S; Wu, JL				Yang, Weiping; Yang, Jingjing; Gao, Yulin; Tang, Xiaoyu; Ren, Yanna; Takahashi, Satoshi; Wu, Jinglong			Effects of Sound Frequency on Audiovisual Integration: An Event-Related Potential Study	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTIONS; MULTISENSORY INTEGRATION; MULTIMODAL INTEGRATION; SELECTIVE ATTENTION; CORTEX; PITCH; LOUDNESS; TONES; ORGANIZATION; INTENSITY	A combination of signals across modalities can facilitate sensory perception. The audiovisual facilitative effect strongly depends on the features of the stimulus. Here, we investigated how sound frequency, which is one of basic features of an auditory signal, modulates audiovisual integration. In this study, the task of the participant was to respond to a visual target stimulus by pressing a key while ignoring auditory stimuli, comprising of tones of different frequencies (0.5, 1, 2.5 and 5 kHz). A significant facilitation of reaction times was obtained following audiovisual stimulation, irrespective of whether the task-irrelevant sounds were low or high frequency. Using event-related potential (ERP), audiovisual integration was found over the occipital area for 0.5 kHz auditory stimuli from 190-210 ms, for 1 kHz stimuli from 170-200 ms, for 2.5 kHz stimuli from 140-200 ms, 5 kHz stimuli from 100-200 ms. These findings suggest that a higher frequency sound signal paired with visual stimuli might be early processed or integrated despite the auditory stimuli being task-irrelevant information. Furthermore, audiovisual integration in late latency (300-340 ms) ERPs with fronto-central topography was found for auditory stimuli of lower frequencies (0.5, 1 and 2.5 kHz). Our results confirmed that audiovisual integration is affected by the frequency of an auditory stimulus. Taken together, the neurophysiological results provide unique insight into how the brain processes a multisensory visual signal and auditory stimuli of different frequencies.	[Yang, Weiping] Hubei Univ, Fac Educ, Dept Psychol, Enshi, Hubei, Peoples R China; [Yang, Weiping; Tang, Xiaoyu; Ren, Yanna; Takahashi, Satoshi; Wu, Jinglong] Okayama Univ, Grad Sch Nat Sci & Technol, Biomed Engn Lab, Okayama, Japan; [Wu, Jinglong] Beijing Inst Technol, Biorobot & Syst Lab, Beijing 100081, Peoples R China; [Yang, Jingjing] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China; [Gao, Yulin] Jilin Univ, Sch Philosophy & Sociol, Dept Psychol, Changchun 130023, Peoples R China	Hubei University; Okayama University; Beijing Institute of Technology; Changchun University of Science & Technology; Jilin University	Wu, JL (corresponding author), Beijing Inst Technol, Biorobot & Syst Lab, Beijing 100081, Peoples R China.	wu@mech.okayama-u.ac.jp	Takahashi, Satoshi/ABG-8262-2021; Yang, Wei/HIA-0360-2022	Takahashi, Satoshi/0000-0002-3535-1535; Yang, Weiping/0000-0001-8839-2173	JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) KAKENHI [25249026, 25303013]; Okayama University; National Natural Science Foundation of China [NSFC61473043]; Natural Science Foundation of Hubei University [098379]	JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Okayama University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei University	This study was supported in part by JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) KAKENHI, grant numbers: 25249026 and 25303013, and a Grant-in-Aid for Strategic Research Promotion from Okayama University, and National Natural Science Foundation of China (NSFC61473043), and Natural Science Foundation of Hubei University (098379).	Andrew J, 2004, P NATL ACAD SCI USA, V101, P1421; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bernstein JGW, 2005, J ACOUST SOC AM, V117, P3816, DOI 10.1121/1.1904268; Berryhill M, 2007, PERCEPT PSYCHOPHYS, V69, P628, DOI 10.3758/BF03193920; Brandwein AB, 2011, CEREB CORTEX, V21, P1042, DOI 10.1093/cercor/bhq170; BURDA H, 1988, J MORPHOL, V198, P269, DOI 10.1002/jmor.1051980303; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Butler JS, 2012, J NEUROSCI, V32, P15338, DOI 10.1523/JNEUROSCI.1796-12.2012; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Chatterjee M, 1997, HEARING RES, V111, P65, DOI 10.1016/S0378-5955(97)00089-0; Colonius H, 2009, BRAIN TOPOGR, V21, P177, DOI 10.1007/s10548-009-0091-8; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Da Costa S, 2013, J NEUROSCI, V33, P1858, DOI 10.1523/JNEUROSCI.4405-12.2013; Donohue SE, 2011, J NEUROSCI, V31, P7982, DOI 10.1523/JNEUROSCI.5298-10.2011; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Falchier A, 2002, J NEUROSCI, V22, P5749; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; LOEB GE, 1983, BIOL CYBERN, V47, P149, DOI 10.1007/BF00337005; Macaluso E, 2006, NEUROSCIENTIST, V12, P327, DOI 10.1177/1073858406287908; Macmillan N. A., 1993, HDB DATA ANAL BEHAV, P21; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; MOLINO JA, 1973, PERCEPT PSYCHOPHYS, V14, P1, DOI 10.3758/BF03198606; Moore BC, 2012, INTRO PSYCHOL HEARIN; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Perez-Bellido A, 2013, J NEUROPHYSIOL, V109, P1065, DOI 10.1152/jn.00226.2012; Pickles JO, 2012, INTRO PHYSL HEARING; Plack CJ, 2014, HEARING RES, V307, P53, DOI 10.1016/j.heares.2013.07.020; POLICH J, 1985, BIOL PSYCHOL, V21, P309, DOI 10.1016/0301-0511(85)90185-1; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P360, DOI 10.1016/j.clinph.2008.10.158; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Rask-Andersen H, 2012, ANAT REC, V295, P1791, DOI 10.1002/ar.22599; ROBINSON DW, 1957, J ACOUST SOC AM, V29, P1284, DOI 10.1121/1.1908766; Rohl M, 2012, JARO-J ASSOC RES OTO, V13, P369, DOI 10.1007/s10162-012-0315-6; Rohl M, 2011, HUM BRAIN MAPP, V32, P1483, DOI 10.1002/hbm.21123; RUGG MD, 1995, J COGNITIVE NEUROSCI, V7, P209, DOI 10.1162/jocn.1995.7.2.209; Schlauch RS, 2001, J ACOUST SOC AM, V110, P1713; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Uppenkamp S, 2014, HEARING RES, V307, P65, DOI 10.1016/j.heares.2013.08.005; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Weisz N, 2004, HEARING RES, V191, P49, DOI 10.1016/j.heares.2004.01.012; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Wu JL, 2012, NEUROREPORT, V23, P616, DOI [10.1097/00001756-201207110-00008, 10.1097/WNR.0b013e3283552b0f]; Wu JL, 2009, J CLIN NEUROPHYSIOL, V26, P407, DOI 10.1097/WNP.0b013e3181c298b1; Yang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066402	61	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138296	10.1371/journal.pone.0138296	http://dx.doi.org/10.1371/journal.pone.0138296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26384256	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200088
J	Riccomi, A; Palma, C				Riccomi, Antonella; Palma, Carla			B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-gamma Recall Response by Splenic CD4(+) Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B	PLOS ONE			English	Article							IFN-GAMMA; BCG VACCINATION; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; MOUSE MODEL; EXPRESSION; INFECTION; PROTECTION; MHC; EFFECTOR	CD4(+) T cells producing interferon-y are crucial for protection against Mycobacterium tuberculosis infection and are the cornerstone of tuberculosis vaccination and immunological diagnostic assays. Since emerging evidence indicates that B cells can modulate T cell responses to M. tuberculosis infection, we investigated the contribution of B cells in regulating interferon-y recall response by memory Thelper1 cells specific for Ag85B, a leading candidate for tuberculosis sub-unit vaccines. We found that B cells were able to maximize the reactivation of CD4(+) memory T cells and the interferon-y response against ex vivo antigen recall in spleens of mice vaccinated with Ag85B. B cell-mediated increase of interferon-y response was particular evident for high interferon-y producer CD4(+) memory T cells, likely because those T cells were required for triggering and amplification of B cell activation. A positive-feedback loop of mutual activation between B cells, not necessarily antigenexperienced but with integral phosphatidylinosito1-3 kinase (PI3K) pathway and a peculiar interferon-y-producing CD4high1 cell subset was established. Programed death-ligand 2 (PD-L2), expressed both on B and the highly activated 4high T cells, contributed to the increase of interferon-y recall response through a PD1-independent pathway. In B celldeficient mice, interferon-y production and activation of Ag85B-specific CD4(+) T cells were blunted against ex vivo antigen recall but these responses could be restored by adding B cells. On the other hand, B cells appeared to down-regulate interleukin-22 recall response. Our data point out that nature of antigen presenting cells determines quality and size of T cell cytokine recall responses. Thus, antigen presenting cells, including B cells, deserve to be considered for a better prediction of cytokine responses by peripheral memory T cells specific for M. tuberculosis antigens. We also invite to consider B cells, PD-L2 and PI3K as potential targets for therapeutic modulation of T cell cytokine responses for tuberculosis control.	[Riccomi, Antonella; Palma, Carla] Ist Super Sanita, Dept Infect Parasit & Immunemediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Palma, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunemediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	carla.palma@iss.it	PALMA, CARLA/C-8821-2016	PALMA, CARLA/0000-0003-2583-5306	Ministero della Salute (IT) [3H/16]	Ministero della Salute (IT)	This work was supported by the Ministero della Salute (IT) 3H/16.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Badell E, 2009, VACCINE, V27, P28, DOI 10.1016/j.vaccine.2008.10.034; Barr Tom A., 2012, Infectious Disorders - Drug Targets, V12, P222; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Behrends J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057379; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; da Costa AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112848; Dhiman R, 2014, J INFECT DIS, V209, P578, DOI 10.1093/infdis/jit495; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Henao-Tamayo M, 2012, TUBERCULOSIS, V92, P211, DOI 10.1016/j.tube.2012.02.008; Heuts F, 2013, P NATL ACAD SCI USA, V110, P6482, DOI 10.1073/pnas.1219985110; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; Kumararatne DS, 1997, CLIN EXP IMMUNOL, V107, P11, DOI 10.1046/j.1365-2249.1997.d01-910.x; Lange C, 2009, EUR RESPIR J, V33, P1250, DOI 10.1183/09031936.00019709; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Lejon K, 1999, J IMMUNOL, V163, P5708; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Matthews K, 2011, TUBERCULOSIS, V91, P587, DOI 10.1016/j.tube.2011.06.009; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Novak EJ, 2001, INT IMMUNOL, V13, P799, DOI 10.1093/intimm/13.6.799; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Palma C, 2007, CELL MICROBIOL, V9, P1455, DOI 10.1111/j.1462-5822.2007.00884.x; Palma C, 2013, EUR J IMMUNOL, V43, P2386, DOI 10.1002/eji.201243245; Palma C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011019; Qiu YQ, 2013, IMMUNOL LETT, V150, P48, DOI 10.1016/j.imlet.2012.12.008; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Ridgway W, 1998, J IMMUNOL, V161, P714; Rohn WM, 1996, CRIT REV IMMUNOL, V16, P311, DOI 10.1615/CritRevImmunol.v16.i3.40; Rosenits K, 2010, EUR J IMMUNOL, V40, P3450, DOI 10.1002/eji.201040743; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Wyndham-Thomas C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0796-0; Wythe SE, 2012, J IMMUNOL, V188, P1647, DOI 10.4049/jimmunol.1103001; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	68	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137783	10.1371/journal.pone.0137783	http://dx.doi.org/10.1371/journal.pone.0137783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379242	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400025
J	Stanley, FM; Linder, KM; Cardozo, TJ				Stanley, Frederick M.; Linder, Kathryn M.; Cardozo, Timothy J.			Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; THYROID-HORMONE; FARNESYL PYROPHOSPHATE; PAI-1 PROMOTER; DIRECT BINDING; EXPRESSION; CELLS; PXR; ALPHA; INSULIN	Plasminogen activator inhibitor type 1 (PAI-1) is a multifunctional protein that has important roles in inflammation and wound healing. Its aberrant regulation may contribute to many disease processes such as heart disease. The PAI-1 promoter is responsive to multiple inputs including cytokines, growth factors, steroids and oxidative stress. The statin drugs, atorvastatin, mevastatin and rosuvastatin, increased basal and stimulated expression of the PAI-1 promoter 3-fold. A statin-responsive, nuclear hormone response element was previously identified in the PAI-1 promoter, but it was incompletely characterized. We characterized this direct repeat (DR) of AGGTCA with a 3-nucleotide spacer at -269/-255 using deletion and directed mutagenesis. Deletion or mutation of this element increased basal transcription from the promoter suggesting that it repressed PAI-1 transcription in the unliganded state. The half-site spacing and the ligand specificity suggested that this might be a pregnane X receptor (PXR) responsive element. Computational molecular docking showed that atorvastatin, mevastatin and rosuvastatin were structurally compatible with the PXR ligand-binding pocket in its agonist conformation. Experiments with Gal4 DNA binding domain fusion proteins showed that Gal4-PXR was activated by statins while other DR + 3 binding nuclear receptor fusions were not. Overexpression of PXR further enhanced PAI-1 transcription in response to statins. Finally, ChIP experiments using Halo-tagged PXR and RXR demonstrated that both components of the PXR-RXR heterodimer bound to this region of the PAI-1 promoter.	[Stanley, Frederick M.; Linder, Kathryn M.; Cardozo, Timothy J.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Stanley, Frederick M.; Cardozo, Timothy J.] NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA	New York University; NYU Langone Medical Center	Stanley, FM (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	Frederick.stanley@nyumc.org		Stanley, Frederick/0000-0002-3684-2168	NIH [DK067540, DP2 OD004631]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067540] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH DK067540 to FM Stanley and DP2 OD004631 to TJ Cardozo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; BRUZDZINSKI CJ, 1993, MOL ENDOCRINOL, V7, P1169, DOI 10.1210/me.7.9.1169; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Cho KJ, 2011, MOL CELL BIOL, V31, P1110, DOI 10.1128/MCB.00989-10; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Diamond DM, 2015, EXPERT REV CLIN PHAR, V8, P201, DOI 10.1586/17512433.2015.1012494; Dimova EY, 2005, THROMB HAEMOSTASIS, V93, P1176, DOI 10.1160/TH04-11-0761; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Escriva H, 2000, BIOESSAYS, V22, P717; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Goyanka R, 2010, PROTEIN ENG DES SEL, V23, P809, DOI 10.1093/protein/gzq056; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Habeos I, 2005, BIOCHEM BIOPH RES CO, V334, P601, DOI 10.1016/j.bbrc.2005.06.129; Hoffart E, 2012, BRIT J PHARMACOL, V165, P1595, DOI 10.1111/j.1476-5381.2011.01665.x; Howe K, 2011, XENOBIOTICA, V41, P519, DOI 10.3109/00498254.2011.569773; Jag U, 2009, MOL ENDOCRI IN PRESS, V23; Juhan-Vague I, 2000, ANN MED, V32, P78; Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; Li H, 2013, J BIOL CHEM, V288, P13655, DOI 10.1074/jbc.M113.455485; Li JQ, 2006, CLIN CHIM ACTA, V370, P57, DOI 10.1016/j.cca.2006.01.024; Mani S, 2013, DRUG METAB REV, V45, P60, DOI 10.3109/03602532.2012.746363; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Maser RE, 1997, J DIABETES COMPLICAT, V11, P243, DOI 10.1016/S1056-8727(96)00040-2; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Okuyama H, 2015, EXPERT REV CLIN PHAR, V8, P189, DOI 10.1586/17512433.2015.1011125; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; Plee-Gautier E, 2012, BIOCHEM PHARMACOL, V84, P571, DOI 10.1016/j.bcp.2012.05.012; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schaars CF, 2008, CURR OPIN LIPIDOL, V19, P553, DOI 10.1097/MOL.0b013e3283168ecd; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; STANLEY F, 1989, MOL ENDOCRINOL, V3, P1627, DOI 10.1210/mend-3-10-1627; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Vulin AI, 2004, J BIOL CHEM, V279, P25172, DOI 10.1074/jbc.M403184200; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Zaman AKMT, 2007, HISTOCHEM CELL BIOL, V128, P135, DOI 10.1007/s00418-007-0300-z	46	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138097	10.1371/journal.pone.0138097	http://dx.doi.org/10.1371/journal.pone.0138097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379245	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400053
J	Gutka, HJ; Wang, YH; Franzblau, SG; Movahedzadeh, F				Gutka, Hiten J.; Wang, Yuehong; Franzblau, Scott G.; Movahedzadeh, Farahnaz			glpx Gene in Mycobacterium tuberculosis Is Required for In Vitro Gluconeogenic Growth and In Vivo Survival	PLOS ONE			English	Article							INOSITOL MONOPHOSPHATASE; BIOCHEMICAL-CHARACTERIZATION; ISOCITRATE LYASE; MALATE SYNTHASE; FRUCTOSE-1,6-BISPHOSPHATASE; EXPRESSION; VIRULENCE; MICE; PURIFICATION; MACROPHAGES	Several enzymes involved in central carbon metabolism and gluconeogenesisplay a critical role in survival and pathogenesis of Mycobacterium tuberculosis (Mtb). The only known functional fructose 1,6-bisphosphatase (FBPase) in Mtb is encoded by the glpX gene and belongs to the Class II sub-family of FBPase. We describe herein the generation of a Delta glpX strain using homologous recombination. Although the growth profile of Delta glpX is comparable to that of wild type Mtb when grown on the standard enrichment media, its growth is dysgonic with individual gluconeogenic substrates such as oleic acid, glycerol and acetate. In mice lung CFU titers of Delta glpX were 2-3 log(10) lower than the wild-type Mtb strain. The results indicate that glpX gene encodes a functional FBPase and is essential for both in vitro and in vivo growth and survival of Mtb. Loss of glpX results in significant reduction of FBPase activity but not complete abolition. These findings verify that the glpX encoded FBPase II in Mtb can be a potential target for drug discovery.	[Gutka, Hiten J.; Wang, Yuehong; Franzblau, Scott G.; Movahedzadeh, Farahnaz] Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 61801 USA; [Gutka, Hiten J.; Franzblau, Scott G.; Movahedzadeh, Farahnaz] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Movahedzadeh, F (corresponding author), Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 61801 USA.	movahed@uic.edu			American Lung Association [RG-82534-N]; Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust	American Lung Association; Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust	This work was supported by the American Lung Association (Grant No. RG-82534-N), and the Chicago Biomedical Consortium with support from The Searle Funds at the Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthy D, 2010, MICROBIOL-SGM, V156, P2691, DOI 10.1099/mic.0.040717-0; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brown AK, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-55; Chen LJ, 1999, APPL ENVIRON MICROB, V65, P4559; Chen LJ, 1998, APPL ENVIRON MICROB, V64, P2609; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; DUBOS RJ, 1946, AM REV TUBERC PULM, V54, P204; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gutka HJ, 2011, APPL BIOCHEM BIOTECH, V164, P1376, DOI 10.1007/s12010-011-9219-x; Hines JK, 2007, J BIOL CHEM, V282, P36121, DOI 10.1074/jbc.M707302200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Manjunatha UH, 2006, ANTIMICROB AGENTS CH, V50, P3350, DOI 10.1128/AAC.00488-06; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Movahedzadeh F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-50; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nigou J, 2002, BIOCHEMISTRY-US, V41, P4392, DOI 10.1021/bi0160056; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Rittmann D, 2003, ARCH MICROBIOL, V180, P285, DOI 10.1007/s00203-003-0588-6; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; YOUMANS AS, 1953, J BACTERIOL, V65, P96, DOI 10.1128/JB.65.1.96-99.1953; YOUMANS AS, 1954, J BACTERIOL, V67, P731, DOI 10.1128/JB.67.6.731-733.1954; YOUMANS AS, 1953, J BACTERIOL, V65, P100, DOI 10.1128/JB.65.1.100-102.1953; YOUMANS AS, 1954, J BACTERIOL, V67, P734, DOI 10.1128/JB.67.6.734-737.1954; YOUMANS GP, 1953, J BACTERIOL, V65, P92, DOI 10.1128/JB.65.1.92-95.1953	40	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138436	10.1371/journal.pone.0138436	http://dx.doi.org/10.1371/journal.pone.0138436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397812	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500065
J	Hess, MW; de Baaij, JHF; Gommers, LMM; Hoenderop, JGJ; Bindels, RJM				Hess, Mark W.; de Baaij, Jeroen H. F.; Gommers, Lisanne M. M.; Hoenderop, Joost G. J.; Bindels, Rene J. M.			Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL-ABSORPTION; MOLECULAR DETERMINANTS; MAGNESIUM TRANSPORT; MG2+ ABSORPTION; EXPRESSION; OMEPRAZOLE; CALCIUM; HYPOMAGNESEMIA; BIFIDOBACTERIA	Background Proton-pump inhibitor-induced hypomagnesemia (PPIH) is the most recognized side effect of proton-pump inhibitors (PPIs). Additionally, PPIH is associated with hypocalcemia and hypokalemia. It is hypothesized that PPIs reduce epithelial proton secretion and thereby increase the pH in the colon, which may explain the reduced absorption of and Mg2+ and Ca2+. Fermentation of dietary oligofructose-enriched inulin fibers by the microflora leads to acidification of the intestinal lumen and by this enhances mineral uptake. This study aimed, therefore, to improve mineral absorption by application of dietary inulin to counteract PPIH. Methods Here, C57BL/J6 mice were supplemented with omeprazole and/or inulin. Subsequently, Mg2+ and Ca2+ homeostasis was assessed by means of serum, urine and fecal electrolyte measurements. Moreover, the mRNA levels of magnesiotropic and calciotropic genes were examined in the large intestine and kidney by real-time PCR. Results Treatment with omeprazole significantly reduced serum Mg2+ and Ca2+ levels. However, concomitant addition of dietary inulin fibers normalized serum Ca2+ but not serum Mg2+ concentrations. Inulin abolished enhanced expression of Trpv6 and S100g in the colon by omeprazole. Additionally, intestinal and renal mRNA levels of the Trpm6 gene were reduced after inulin intake. Conclusions This study suggests that dietary inulin counteracts reduced intestinal Ca2+ absorption upon PPI treatment. In contrast, inulin did not increase intestinal absorption of Mg2+ sufficiently to recover serum Mg2+. The clinical potential of dietary inulin treatment should be the subject of future studies.	[Hess, Mark W.; de Baaij, Jeroen H. F.; Gommers, Lisanne M. M.; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	de Baaij, Jeroen/P-5704-2015; Gommers, Lisanne/O-8313-2016; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Institute of Genetic Metabolic Diseases of Radboud university medical center Nijmegen; Netherlands Organization for Scientific Research [ZonMw 9120.8026, NWO ALW 818.02.001, VICI 016.130.668, Rubicon 825.14.021]; Dutch Kidney Foundation [Kolff 14OKG17]; EURenOmics project from the European Union seventh Framework Programme (FP7) [305608]	Institute of Genetic Metabolic Diseases of Radboud university medical center Nijmegen; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; EURenOmics project from the European Union seventh Framework Programme (FP7)	This study was funded through a grant of the Institute of Genetic Metabolic Diseases of the Radboud university medical center Nijmegen. This work was supported by grants from the Netherlands Organization for Scientific Research (ZonMw 9120.8026, NWO ALW 818.02.001, VICI 016.130.668, Rubicon 825.14.021), the Dutch Kidney Foundation (Kolff 14OKG17), and the EURenOmics project from the European Union seventh Framework Programme (FP7/2007-2013, agreement no. 305608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JPF, 2012, MOL PHARMACEUT, V9, P3495, DOI 10.1021/mp300323q; Burdsall DP, 2013, J AM MED DIR ASSOC, V14, P429, DOI 10.1016/j.jamda.2013.01.021; Coudray C, 2005, EUR J NUTR, V44, P293, DOI 10.1007/s00394-004-0526-7; Coudray C, 2003, EUR J NUTR, V42, P91, DOI 10.1007/s00394-003-0390-x; Coudray C, 2003, J NUTR, V133, P1; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; Deroux A, 2014, CLIN RES HEPATOL GAS, V38, pE103, DOI 10.1016/j.clinre.2014.03.005; Epstein M, 2006, NEW ENGL J MED, V355, P1834, DOI 10.1056/NEJMc066308; Florentin Matilda, 2012, World J Nephrol, V1, P151, DOI 10.5527/wjn.v1.i6.151; Geeta Shukla AV, 2014, J PROB HEALTH, V2, P121, DOI [10.4172/2329-8901.1000121, DOI 10.4172/2329-8901.1000121]; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Hess MW, 2012, ALIMENT PHARM THER, V36, P405, DOI 10.1111/j.1365-2036.2012.05201.x; Holloway L, 2007, BRIT J NUTR, V97, P365, DOI 10.1017/S000711450733674X; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Huang CL, 2007, J AM SOC NEPHROL, V18, P2649, DOI 10.1681/ASN.2007070792; Jung TH, 2015, J MICROBIOLOGY BIOTE; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Leonhard-Marek S, 1998, EXP PHYSIOL, V83, P155, DOI 10.1113/expphysiol.1998.sp004098; Leontiadis Grigorios I, 2014, Curr Treat Options Gastroenterol, V12, P414, DOI 10.1007/s11938-014-0030-y; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk CP, 2013, ANN PHARMACOTHER, V47, P773, DOI 10.1345/aph.1R556; LUTZ T, 1991, EXP PHYSIOL, V76, P615, DOI 10.1113/expphysiol.1991.sp003530; Mackay JD, 2010, QJM-INT J MED, V103, P387, DOI 10.1093/qjmed/hcq021; Metz DC, 2004, AM J MED, V117, p49S, DOI 10.1016/j.amjmed.2004.07.009; MIZUNASHI K, 1993, CALCIFIED TISSUE INT, V53, P21, DOI 10.1007/BF01352010; Negri AL, 2011, CURR DRUG SAF, V6, P204, DOI 10.2174/157488611797579320; Petry N, 2012, AM J CLIN NUTR, V96, P325, DOI 10.3945/ajcn.112.035717; Regolisti G, 2010, AM J KIDNEY DIS, V56, P168, DOI 10.1053/j.ajkd.2010.03.013; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Rondon LJ, 2008, MAGNESIUM RES, V21, P224; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Sachs G, 1997, PHARMACOTHERAPY, V17, P22; SCHARRER E, 1990, Z ERNAHRUNGSWISS, V29, P162, DOI 10.1007/BF02021554; Thongon N, 2012, EXP MOL MED, V44, P684, DOI 10.3858/emm.2012.44.11.077; Thongon N, 2011, WORLD J GASTROENTERO, V17, P1574, DOI [10.3748/wjg.v17.i12. 1574, 10.3748/wjg.v17.i12.1574]; Tjon JA, 2013, PHARMACOTHERAPY, V33, P956, DOI 10.1002/phar.1299; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200	43	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138881	10.1371/journal.pone.0138881	http://dx.doi.org/10.1371/journal.pone.0138881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397986	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500122
J	Palstra, AP; Fukaya, K; Chiba, H; Dirks, RP; Planas, JV; Ueda, H				Palstra, Arjan P.; Fukaya, Kosuke; Chiba, Hiroaki; Dirks, Ron P.; Planas, Josep V.; Ueda, Hiroshi			The Olfactory Transcriptome and Progression of Sexual Maturation in Homing Chum Salmon Oncorhynchus keta	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GENE-EXPRESSION PROFILES; MATURING SOCKEYE-SALMON; LUTEINIZING-HORMONE; ANALOG IMPLANTATION; LIFE-HISTORIES; PACIFIC SALMON; LAKE SHIKOTSU; IN-VITRO; GNRH	Reproductive homing migration of salmonids requires accurate interaction between the reception of external olfactory cues for navigation to the spawning grounds and the regulation of sexual maturation processes. This study aimed at providing insights into the hypothesized functional link between olfactory sensing of the spawning ground and final sexual maturation. We have therefore assessed the presence and expression levels of olfactory genes by RNA sequencing (RNAseq) of the olfactory rosettes in homing chum salmon Oncorhynchus keta Walbaum from the coastal sea to 75 km upstream the rivers at the pre-spawning ground. The progression of sexual maturation along the brain-pituitary-gonadal axis was assessed through determination of plasma steroid levels by time-resolved fluoro-immunoassays (TR-FIA), pituitary gonadotropin subunit expression and salmon gonadotropin-releasing hormone (sgnrh) expression in the brain by quantitative real-time PCR. RNAseq revealed the expression of 75 known and 27 unknown salmonid olfactory genes of which 13 genes were differentially expressed between fish from the pre-spawning area and from the coastal area, suggesting an important role of these genes in homing. A clear progression towards final maturation was characterised by higher plasma 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one (DHP) levels, increased pituitary luteinizing hormone beta subunit (lh beta) expression and sgnrh expression in the post brain, and lower plasma testosterone (T) and 17 beta-estradiol (E2) levels. Olfactomedins and ependymin are candidates among the differentially expressed genes that may connect olfactory reception to the expression of sgnrh to regulate final maturation.	[Palstra, Arjan P.] Univ Wageningen & Res Ctr, Inst Marine Resources & Ecosyst Studies, NL-4401 NT Yerseke, Netherlands; [Palstra, Arjan P.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, NL-6700 AH Wageningen, Netherlands; [Fukaya, Kosuke; Ueda, Hiroshi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sect Ecosyst Conservat, Lab Aquat Bioresources & Ecosyst, Sapporo, Hokkaido 0600809, Japan; [Chiba, Hiroaki] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Dirks, Ron P.] ZF Screens BV, NL-2333 CH Leiden, Netherlands; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain	Wageningen University & Research; Wageningen University & Research; Hokkaido University; Kitasato University; University of Barcelona; University of Barcelona	Palstra, AP (corresponding author), Univ Wageningen & Res Ctr, Inst Marine Resources & Ecosyst Studies, Korringaweg 5, NL-4401 NT Yerseke, Netherlands.	arjan.palstra@wur.nl	; Ueda, Hiroshi/G-4446-2010	Planas, Josep/0000-0002-6525-9617; Ueda, Hiroshi/0000-0002-4706-8665	ZF-screens B.V	ZF-screens B.V	ZF-screens B.V. provided support in the form of salaries for author RD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Amano M, 1997, ZOOL SCI, V14, P1, DOI 10.2108/zsj.14.1; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Aubin-Horth N, 2009, GEN COMP ENDOCR, V163, P278, DOI 10.1016/j.ygcen.2009.04.021; Bernier JC, 2008, T AM FISH SOC, V137, P1378, DOI 10.1577/T07-222.1; Churcher AM, 2015, MOL ECOL, V24, P822, DOI 10.1111/mec.13065; Connon RE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-608; Crespo D, 2013, GEN COMP ENDOCR, V188, P175, DOI 10.1016/j.ygcen.2013.02.031; Fukaya M, 1998, FISHERIES SCI, V64, P948, DOI 10.2331/fishsci.64.948; Hayashida Kazufumi, 2013, P3; Hino H, 2009, J FISH BIOL, V75, P945, DOI 10.1111/j.1095-8649.2009.02341.x; Johnson MA, 2011, GENE, V485, P16, DOI 10.1016/j.gene.2011.05.029; Johnstone KA, 2012, J FISH BIOL, V81, P559, DOI 10.1111/j.1095-8649.2012.03368.x; Johnstone KA, 2011, MOL ECOL, V20, P4059, DOI 10.1111/j.1365-294X.2011.05251.x; Kim NN, 2013, MAR FRESHW BEHAV PHY, V45, P397, DOI 10.1080/10236244.2013.777215; Kitahashi T, 1998, ZOOL SCI, V15, P761, DOI 10.2108/zsj.15.761; Kitahashi T, 1998, ZOOL SCI, V15, P767, DOI 10.2108/zsj.15.767; Lado WE, 2013, GEN COMP ENDOCR, V192, P204, DOI 10.1016/j.ygcen.2013.06.015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makino K, 2007, GEN COMP ENDOCR, V152, P304, DOI 10.1016/j.ygcen.2007.01.010; Planas Josep V., 2008, P37; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Powell JFF, 1996, J ENDOCRINOL, V150, P17, DOI 10.1677/joe.0.1500017; Sato A, 1997, ZOOL SCI, V14, P1009, DOI 10.2108/zsj.14.1009; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueda H, 2012, J FISH BIOL, V81, P543, DOI 10.1111/j.1095-8649.2012.03354.x; UEDA H, 1995, ENV ECOLOGICAL BIOCH, P265; Ueda H, 1999, B TOHOKU NAT FISH RE, V62, P133; Ueda H, 2000, P 6 INT S REPR PHYS, P95; Ueda H, 2011, GEN COMP ENDOCR, V170, P222, DOI 10.1016/j.ygcen.2010.02.003; Urano A, 1999, RECENT PROGRESS IN MOLECULAR AND COMPARATIVE ENDOCRINOLOGY, P46; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Yamada H, 2002, ZOOL SCI, V19, P891, DOI 10.2108/zsj.19.891; Yamada H, 2002, GEN COMP ENDOCR, V126, P136, DOI 10.1006/gcen.2002.7791; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655; Zhu GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103832; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	43	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137404	10.1371/journal.pone.0137404	http://dx.doi.org/10.1371/journal.pone.0137404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397372	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500035
J	Aguila, RD; Perez, SKL; Catacutan, BJN; Lopez, GV; Barut, NC; Santos, MD				Aguila, Roselyn D.; Perez, Sweedy Kay L.; Catacutan, Billy Joel N.; Lopez, Grace V.; Barut, Noel C.; Santos, Mudjekeewis D.			Distinct Yellowfin Tuna (Thunnus albacares) Stocks Detected in Western and Central Pacific Ocean (WCPO) Using DNA Microsatellites	PLOS ONE			English	Article							GLOBAL POPULATION-STRUCTURE; SKIPJACK TUNA; ATLANTIC; SOFTWARE; PHYLOGEOGRAPHY; ALLOZYME; OBESUS	The yellowfin tuna, Thunnus albacares (Bonnaterre, 1788), covers majority of the Philippines' tuna catch, one of the major fisheries commodities in the country. Due to its high economic importance sustainable management of these tunas has become an imperative measure to prevent stock depletion. Currently, the Philippine yellowfin tuna is believed to be part of a single stock of the greater WCPO though some reports suggest otherwise. This study therefore aims to establish the genetic stock structure of the said species in the Philippines as compared to Bismarck Sea, Papua New Guinea using nine (9) DNA microsatellite markers. DNA microsatellite data revealed significant genetic differentiation between the Philippine and Bismarck Sea, Papua New Guinea yellowfin tuna samples. (FST = 0.034, P = 0.016), which is further supported by multilocus distance matrix testing (PCoA) and model-based clustering (STRUCTURE 2.2). With these findings, this study posits that the yellowfin tuna population in the Philippines is a separate stock from the Bismarck Sea population. These findings add evidence to the alternative hypothesis of having at least 2 subpopulations of yellowfin tuna in the WCPO and calls for additional scientific studies using other parameters to investigate this. Accurate population information is necessary in formulating a more appropriate management strategy for the sustainability of the yellowfin tuna not only in the Philippines but also in the WCPO.	[Aguila, Roselyn D.; Catacutan, Billy Joel N.; Santos, Mudjekeewis D.] Natl Fisheries Res & Dev Inst, Res & Ecol Assessment Div, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines; [Perez, Sweedy Kay L.] Philippine Drug Enforcement Agcy, Lab Serv, Examinat Div, Quezon City, Metro Manila, Philippines; [Lopez, Grace V.] Natl Fisheries Res & Dev Inst, Res & Ecol Assessment Div, Vertebrates Sect, Quezon City, Metro Manila, Philippines; [Barut, Noel C.] Natl Fisheries Res & Dev Inst, Off Interim Deputy Execut Director, Quezon City, Metro Manila, Philippines		Aguila, RD (corresponding author), Natl Fisheries Res & Dev Inst, Res & Ecol Assessment Div, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines.	roselynaguila@yahoo.com; mudjiesantos@yahoo.com		Aguila, Roselyn/0000-0002-3849-7097; Santos, Mudjekeewis/0000-0002-4770-1221	Department of Science and Technology - Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development	Department of Science and Technology - Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development	The Department of Science and Technology - Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development granted funding to MDS, NCB, and GVL for the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard SA, 2001, MAR BIOL, V139, P383; Bureau of Agricultural Statistics, 2010, FISH PROD 1998 2009; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carmen MA, 2006, FISH RES, V78, P158, DOI 10.1016/j.fishres.2006.02.006; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chiang HC, 2006, FISH RES, V79, P219, DOI 10.1016/j.fishres.2005.11.026; Chow S, 2000, MOL ECOL, V9, P221, DOI 10.1046/j.1365-294x.2000.00851.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FUJINO K, 1976, B JPN SOC SCI FISH, V42, P1229; FUJINO K, 1981, B JPN SOC SCI FISH, V47, P215; Garvilles E, 2012, PHILIPPINE TUNA FISH; Grewe P. M., 1998, 9805 SOEST, P98; Itano DG, 2005, HDB IDENTIFICATION Y; Jackson AM, 2014, B MAR SCI, V90, P471, DOI 10.5343/bms.2012.1097; Langley A, 2011, SCI COMM 7 REG SESS; Martinez Pilar, 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V57, P195; Nohara K, 2011, MOL ECOL RESOUR, V11, P418, DOI [10.1111/j.1755-0998.2010.02970.x, DOI 10.1111/J.1755-0998.2010.02970.X]; Park S, 2008, EXCEL MICROSATELLITE; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedicillo G, 2010, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010030; Pedrosa-Gerasmio IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035604; PRIMEX SPC, 1993, PHIL TUN RES PROJ PT; Pritchard JK, 2000, GENETICS, V155, P945; QGIS Development Team, 2012, QGIS 1 8 0 LISB GEOG; Qiu F, 2011, COPEIA, P264, DOI 10.1643/CI-10-112; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Schaefer Kurt M., 2009, Inter-American Tropical Tuna Commission Stock Assessment Report, V9, P203; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; WARD RD, 1994, MAR BIOL, V118, P531, DOI 10.1007/BF00347499; Ward RD, 1997, FISH B-NOAA, V95, P566; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1996, SINAUER ASS SUNDERL; Williams P, 2012, SCI COMM 8 REG SESS; Wright S, 1921, GENETICS, V6, P111; Wu GCC, 2010, FISH RES, V105, P248, DOI 10.1016/j.fishres.2010.03.015	43	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138292	10.1371/journal.pone.0138292	http://dx.doi.org/10.1371/journal.pone.0138292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394234	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100048
J	Moisander, PH; Sexton, AD; Daley, MC				Moisander, Pia H.; Sexton, Andrew D.; Daley, Meaghan C.			Stable Associations Masked by Temporal Variability in the Marine Copepod Microbiome	PLOS ONE			English	Article							VERTICAL TRANSMISSION; VIBRIO-PARAHAEMOLYTICUS; FECAL PELLETS; BACTERIA; ZOOPLANKTON; COMMUNITY; GULF; ECOLOGY; FOOD; BAY	Copepod-bacteria interactions include permanent and transient epi- and endobiotic associations that may play roles in copepod health, transfer of elements in the food web, and bio-geochemical cycling. Microbiomes of three temperate copepod species (Acartia longiremis, Centropages hamatus, and Calanus finmarchicus) from the Gulf of Maine were investigated during the early summer season using high throughput amplicon sequencing. The most prominent stable component of the microbiome included several taxa within Gammaproteobacteria, with Pseudoalteromonas spp. especially abundant across copepod species. These Gammaproteobacteria appear to be promoted by the copepod association, likely benefitting from nutrient enriched microenvironments on copepods, and forming a more important part of the copepod-associated community than Vibrio spp. during the cold-water season in this temperate system. Taxon-specific associations included an elevated relative abundance of Piscirickettsiaceae and Colwelliaceae on Calanus, and Marinomonas sp. in Centropages. The communities in full and voided gut copepods had distinct characteristics, thus the presence of a food-associated microbiome was evident, including higher abundance of Rhodobacteraceae and chloroplast sequences in the transient communities. The observed variability was partially explained by collection date that may be linked to factors such as variable time since molting, gender differences, and changes in food availability and type over the study period. While some taxon-specific and stable associations were identified, temporal changes in environmental conditions, including food type, appear to be key in controlling the composition of bacterial communities associated with copepods in this temperate coastal system during the early summer.	[Moisander, Pia H.; Daley, Meaghan C.] Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA 02747 USA; [Sexton, Andrew D.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University of Massachusetts System; University Massachusetts Dartmouth; University System Of New Hampshire; University of New Hampshire	Moisander, PH (corresponding author), Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA 02747 USA.	pmoisander@umassd.edu		Moisander, Pia/0000-0002-3262-3662	National Science Foundation [OCE 1130495]; University of Massachusetts Dartmouth; Shoals Marine Lab	National Science Foundation(National Science Foundation (NSF)); University of Massachusetts Dartmouth; Shoals Marine Lab	Funding was provided by National Science Foundation (OCE 1130495) and the University of Massachusetts Dartmouth to P.M., and the Shoals Marine Lab for A.S. and P.M. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Shoals Marine Lab personnel provided assistance in sample collection.	Aksoy S, 1997, INSECT MOL BIOL, V6, P183, DOI 10.1111/j.1365-2583.1997.tb00086.x; Arp A, 2014, ENVIRON ENTOMOL, V43, P344, DOI 10.1603/EN13256; Autio R, 1998, ESTUAR COAST SHELF S, V46, P465, DOI 10.1006/ecss.1997.0282; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Calbet A, 2000, MAR ECOL PROG SER, V193, P75, DOI 10.3354/meps193075; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Cnudde C, 2013, MAR BIOL, V160, P327, DOI 10.1007/s00227-012-2091-6; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; De Corte D, 2014, AQUAT MICROB ECOL, V72, P215, DOI 10.3354/ame01696; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukushima H, 2004, FEMS MICROBIOL ECOL, V48, P221, DOI 10.1016/j.femsec.2004.01.009; Gorley R.N., 2006, USER MANUAL TUTORIAL, P190; Gowing MM, 1998, DEEP-SEA RES PT II, V45, P2433, DOI 10.1016/S0967-0645(98)00077-0; Hansen B, 1996, J PLANKTON RES, V18, P257, DOI 10.1093/plankt/18.2.257; Hansen BW, 2000, J PLANKTON RES, V22, P569, DOI 10.1093/plankt/22.3.569; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5488, DOI 10.1128/AEM.68.11.5488-5497.2002; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Hisatugo KF, 2014, LIMNOLOGICA, V44, P98, DOI 10.1016/j.limno.2013.08.002; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Itoh H, 2014, APPL ENVIRON MICROB, V80, P5974, DOI 10.1128/AEM.01087-14; Ji RB, 2009, MAR ECOL PROG SER, V384, P187, DOI 10.3354/meps08032; Kane J, 2009, J PLANKTON RES, V31, P249, DOI 10.1093/plankt/fbn119; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Krueger DM, 1996, BIOL BULL, V190, P195, DOI 10.2307/1542539; Kuczynski J, 2012, CURR PROTOC MICROBIO, V27, p1E; Lawrence D, 2004, ESTUAR COAST SHELF S, V61, P547, DOI 10.1016/j.ecss.2004.06.018; Lizarraga-Partida ML, 2009, ENVIRON MICROBIOL, V11, P201, DOI 10.1111/j.1462-2920.2008.01753.x; Manning CA, 2005, MAR ECOL PROG SER, V292, P233, DOI 10.3354/meps292233; McFall-Ngai M. J., 2005, INFLUENCE COOPERATIV, P35; Montanari MP, 1999, FEMS MICROBIOL ECOL, V29, P241, DOI 10.1111/j.1574-6941.1999.tb00615.x; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Pendleton DE, 2009, MAR ECOL PROG SER, V378, P211, DOI 10.3354/meps07832; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Scavotto RE, 2015, ENVIRON MICROBIOL, V17, P3754, DOI 10.1111/1462-2920.12777; Segata N, 2011, GENOME BIOL, V12; Shoemaker KM, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv064; SOCHARD MR, 1979, APPL ENVIRON MICROB, V37, P750, DOI 10.1128/AEM.37.4.750-759.1979; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Svensen C, 2014, MAR ECOL PROG SER, V516, P61, DOI 10.3354/meps10976; Szabo G, 2013, ISME J, V7, P509, DOI 10.1038/ismej.2012.134; Tang K, 2009, BIOL LETTERS, V5, P549, DOI 10.1098/rsbl.2009.0076; Tang KW, 2011, LIMNOL OCEANOGR, V56, P666, DOI 10.4319/lo.2011.56.2.0666; Tang KW, 2010, AQUAT MICROB ECOL, V61, P261, DOI 10.3354/ame01424; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; Tommasi D, 2013, J MARINE SYST, V115, P10, DOI 10.1016/j.jmarsys.2013.01.005; Urbanczyk H, 2011, FEMS MICROBIOL REV, V35, P324, DOI 10.1111/j.1574-6976.2010.00250.x; White JF, 2009, MYCOL SER, V27, P1, DOI 10.1201/9781420069327; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08	55	36	36	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138967	10.1371/journal.pone.0138967	http://dx.doi.org/10.1371/journal.pone.0138967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393930	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100117
J	Meunier, I; Morisseau, O; Garneau, E; Marois, I; Cloutier, A; Richter, MV				Meunier, Isabelle; Morisseau, Olivier; Garneau, Emilie; Marois, Isabelle; Cloutier, Alexandre; Richter, Martin V.			Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; DENDRITIC CELLS; EPITHELIAL-CELLS; MEMORY RESPONSES; PROINFLAMMATORY CYTOKINES; ANTIVIRAL RESPONSES; RESPIRATORY VIRUS; HUMAN MACROPHAGES; GLOBAL MORTALITY; IMMUNE-RESPONSE	Despite a relatively low fatality rate, the 2009 H1N1 pandemic virus differed from other seasonal viruses in that it caused mortality and severe pneumonia in the young and middle-aged population (18-59 years old). The mechanisms underlying this increased disease severity are still poorly understood. In this study, a human isolate of the 2009 H1N1 pandemic virus was adapted to the mouse (MAp2009). The pathogenicity of the MAp2009 virus and the host immune responses were evaluated in the mouse model and compared to the laboratory H1N1 strain A/Puerto Rico/8/1934 (PR8). The MAp2009 virus reached consistently higher titers in the lungs over 14 days compared to the PR8 virus, and caused severe disease associated with high morbidity and 85% mortality rate, contrasting with the 0% death rate in the PR8 group. During the early phase of infection, both viruses induced similar pathology in the lungs. However, MAp2009-induced lung inflammation was sustained until the end of the study (day 14), while there was no sign of inflammation in the PR8-infected group by day 10. Furthermore, at day 3 post-infection, MAp2009 induced up to 10- to 40-fold more cytokine and chemokine gene expression, respectively. More importantly, the numbers of CD4(+) T cells and virus-specific CD8(+) T cells were significantly lower in the lungs of MAp2009-infected mice compared to PR8-infected mice. Interestingly, there was no difference in the number of dendritic cells in the lung and in the draining lymph node. Moreover, mice infected with PR8 or MAp2009 had similar numbers of CCR5 and CXCR3-expressing T cells, suggesting that the impaired T cell response was not due to a lack of chemokine responsiveness or priming of T cells. This study demonstrates that a mouse-adapted virus from an isolate of the 2009 pandemic virus interferes with the adaptive immune response leading to a more severe disease.	[Richter, Martin V.] Univ Sherbrooke, Div Pulm, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; Ctr Rech CHUS, Sherbrooke, PQ, Canada	University of Sherbrooke	Richter, MV (corresponding author), Univ Sherbrooke, Div Pulm, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Richter@usherbrooke.ca			Canadian Institutes of Health Research [MOP-102670]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) through grant number MOP-102670 to MVR. IM (1) was the recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; ALLAN W, 1990, J IMMUNOL, V144, P3980; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Fleury H, 2009, EUROSURVEILLANCE, V14, P14; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Fujiwara H, 2001, INT IMMUNOPHARMACOL, V1, P613, DOI 10.1016/S1567-5769(00)00049-7; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GARTEN W, 1981, VIROLOGY, V115, P361, DOI 10.1016/0042-6822(81)90117-3; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hillaire MLB, 2013, CURR OPIN VIROL, V3, P430, DOI 10.1016/j.coviro.2013.05.002; Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Kim Tae Hoon, 2014, Immune Netw, V14, P128, DOI 10.4110/in.2014.14.3.128; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; Lafon M, 2008, DEV BIOLOGICALS, V131, P413; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Marois I, 2012, J LEUKOCYTE BIOL, V92, P107, DOI 10.1189/jlb.1011490; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Munster VJ, 2010, J VIROL, V84, P7953, DOI 10.1128/JVI.00449-10; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rosseau S, 2000, J IMMUNOL, V164, P427, DOI 10.4049/jimmunol.164.1.427; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sage LK, 2013, J GEN VIROL, V94, P1701, DOI 10.1099/vir.0.049494-0; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Smirnov YA, 2000, ACTA VIROL, V44, P1; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001; Takahashi Yoshimasa, 2012, Infectious Disorders - Drug Targets, V12, P232; Tiwari N, 2014, J MED VIROL, V86, P1034, DOI 10.1002/jmv.23877; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Topham DJ, 1998, J IMMUNOL, V161, P4530; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; von Messling V, 1999, J CLIN MICROBIOL, V37, P1049, DOI 10.1128/JCM.37.4.1049-1056.1999; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	98	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138055	10.1371/journal.pone.0138055	http://dx.doi.org/10.1371/journal.pone.0138055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381265	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200052
J	Rajput, MS; Iyer, B; Pandya, M; Jog, R; Kumar, GN; Rajkumar, S				Rajput, Mahendrapal Singh; Iyer, Bhagya; Pandya, Maharshi; Jog, Rahul; Kumar, Naresh G.; Rajkumar, Shalini			Derepression of Mineral Phosphate Solubilization Phenotype by Insertional Inactivation of iclR in Klebsiella pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; PLANT-GROWTH; PROTEIN-PHOSPHORYLATION; DENSITY FERMENTATION; ACETATE METABOLISM; GLYOXYLATE CYCLE; BACTERIA; GLUCOSE; ACID	The mode of succinate mediated repression of mineral phosphate solubilization and the role of repressor in suppressing phosphate solubilization phenotype of two free-living nitrogen fixing Klebsiella pneumoniae strains was studied. Organic acid mediated mineral phosphate solubilization phenotype of oxalic acid producing Klebsiella pneumoniae SM6 and SM11 were transcriptionally repressed by IclR in presence of succinate as carbon source. Oxalic acid production and expression of genes of the glyoxylate shunt (aceBAK) was found only in glucose but not in succinate-and glucose+succinate-grown cells. IclR, repressor of aceBAK operon, was inactivated using an allelic exchange system resulting in derepressed mineral phosphate solubilization phenotype through constitutive expression of the glyoxylate shunt. Insertional inactivation of iclR resulted in increased activity of the glyoxylate shunt enzymes even in succinate-grown cells. An augmented phosphate solubilization up to 54 and 59% soluble phosphate release was attained in glucose+succinate-grown SM6 Delta and SM11 Delta strains respectively, compared to glucose-grown cells, whereas phosphate solubilization was absent or negligible in wildtype cells grown in glucose+succinate. Both wildtype and iclR deletion strains showed similar indole-3-acetic acid production. Wheat seeds inoculated with wildtype SM6 and SM11 improved both root and shoot length by 1.2 fold. However, iclR deletion SM6 Delta and SM11 Delta strains increased root and shoot length by 1.5 and 1.4 folds, respectively, compared to uninoculated controls. The repressor inactivated phosphate solubilizers better served the purpose of constitutive phosphate solubilization in pot experiments, where presence of other carbon sources (e.g., succinate) might repress mineral phosphate solubilization phenotype of wildtype strains.	[Rajput, Mahendrapal Singh; Iyer, Bhagya; Pandya, Maharshi; Jog, Rahul; Rajkumar, Shalini] Nirma Univ, Inst Sci, Ahmadabad, Gujarat, India; [Jog, Rahul] Hokkaido Univ, Fac Environm Earth Sci, Div Biosphere, Environm Mol Biol Lab, Sapporo, Hokkaido, Japan; [Kumar, Naresh G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, Gujarat, India	Nirma University; Hokkaido University; Maharaja Sayajirao University Baroda	Rajkumar, S (corresponding author), Nirma Univ, Inst Sci, Ahmadabad, Gujarat, India.	shalini.rjk@nirmauni.ac.in	Gattupalli, Naresh Kumar/AAF-5987-2020	Gattupalli, Nareshkumar/0000-0001-7317-7438	Department of Science and Technology (Ministry of Science, India) [SERB/F/1433/1014-15]; Council of Scientific and Industrial Research (CSIR), Government of India [113827/2K12/1]; Department of Science and Technology (DST), Government of India [IF130895]	Department of Science and Technology (Ministry of Science, India)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	Dr. SR received the financial grant from the Department of Science and Technology (Ministry of Science, India) (Project Sanction number SERB/F/1433/1014-15). The authors would like to acknowledge the Council of Scientific and Industrial Research (CSIR), Government of India, for providing senior research fellowship to Mahendrapal Singh Rajput (Ack No. 113827/2K12/1) and the Department of Science and Technology (DST), Government of India for providing INSPIRE fellowship to Bhagya Iyer (IF130895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahemad M, 2012, J PEST SCI, V85, P29, DOI 10.1007/s10340-011-0402-1; Ahemad M, 2011, PESTIC BIOCHEM PHYS, V100, P51, DOI 10.1016/j.pestbp.2011.02.004; Ahemad M, 2011, CURR MICROBIOL, V62, P532, DOI 10.1007/s00284-010-9740-0; AKAMATSU Y, 1994, PHYTOCHEMISTRY, V37, P649, DOI 10.1016/S0031-9422(00)90332-7; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; An QL, 2001, ACTA BOT SIN, V43, P558; Ando S, 2005, SOIL SCI PLANT NUTR, V51, P303, DOI 10.1111/j.1747-0765.2005.tb00034.x; ARISTIDOU AA, 1995, BIOTECHNOL PROGR, V11, P475, DOI 10.1021/bp00034a019; Brinkrolf K, 2006, GENET MOL RES, V5, P773; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Buch A, 2008, RES MICROBIOL, V159, P635, DOI 10.1016/j.resmic.2008.09.012; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Chen GZ, 2004, MUTAT RES-FUND MOL M, V554, P193, DOI 10.1016/j.mrfmmm.2004.04.013; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; CORTAY JC, 1991, EMBO J, V10, P675, DOI 10.1002/j.1460-2075.1991.tb07996.x; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; DIXON GH, 1959, BIOCHEM J, V72, pP3; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gory L, 2001, FEMS MICROBIOL LETT, V194, P127, DOI 10.1111/j.1574-6968.2001.tb09457.x; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Holms WH, 1989, BIOTECHNOL BIOENG, V35, P732; Iniguez AL, 2004, MOL PLANT MICROBE IN, V17, P1078, DOI 10.1094/MPMI.2004.17.10.1078; Khan MS, 2007, AGRON SUSTAIN DEV, V27, P29, DOI 10.1051/agro:2006011; KLEMAN GL, 1994, APPL ENVIRON MICROB, V60, P3952, DOI 10.1128/AEM.60.11.3952-3958.1994; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Maharjan RP, 2005, RES MICROBIOL, V156, P178, DOI 10.1016/j.resmic.2004.09.004; MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; MANDAL NC, 1993, CURR MICROBIOL, V26, P247, DOI 10.1007/BF01575912; Martinez L, 2003, PLANT SOIL, V257, P35, DOI 10.1023/A:1026283311770; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Mii K., 1996, Wood Research, P23; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rajput MS, 2013, ARCH MICROBIOL, V195, P81, DOI 10.1007/s00203-012-0850-x; Rittinger K, 1996, EUR J BIOCHEM, V237, P247, DOI 10.1111/j.1432-1033.1996.0247n.x; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2; Seth GN, 1990, P NATL ACAD SCI USA, V87, P4645; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; vandeWalle M, 1998, BIOTECHNOL BIOENG, V57, P71, DOI 10.1002/(SICI)1097-0290(19980105)57:1<71::AID-BIT9>3.0.CO;2-S; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699	52	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138235	10.1371/journal.pone.0138235	http://dx.doi.org/10.1371/journal.pone.0138235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381651	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200075
J	Woldring, DR; Holec, PV; Zhou, H; Hackel, BJ				Woldring, Daniel R.; Holec, Patrick V.; Zhou, Hong; Hackel, Benjamin J.			High-Throughput Ligand Discovery Reveals a Sitewise Gradient of Diversity in Broadly Evolved Hydrophilic Fibronectin Domains	PLOS ONE			English	Article							COMBINATORIAL ANTIBODY LIBRARIES; YEAST SURFACE DISPLAY; HOT-SPOTS; SYNTHETIC ANTIBODIES; III DOMAIN; MOLECULAR CONVERGENCE; COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; BINDING-ENERGY; AFFINITY	Discovering new binding function via a combinatorial library in small protein scaffolds requires balance between appropriate mutations to introduce favorable intermolecular interactions while maintaining intramolecular integrity. Sitewise constraints exist in a non-spatial gradient from diverse to conserved in evolved antibody repertoires; yet non-antibody scaffolds generally do not implement this strategy in combinatorial libraries. Despite the fact that biased amino acid distributions, typically elevated in tyrosine, serine, and glycine, have gained wider use in synthetic scaffolds, these distributions are still predominantly applied uniformly to diversified sites. While select sites in fibronectin domains and DARPins have shown benefit from sitewise designs, they have not been deeply evaluated. Inspired by this disparity between diversity distributions in natural libraries and synthetic scaffold libraries, we hypothesized that binders resulting from discovery and evolution would exhibit a non-spatial, sitewise gradient of amino acid diversity. To identify sitewise diversities consistent with efficient evolution in the context of a hydrophilic fibronectin domain, >10(5) binders to six targets were evolved and sequenced. Evolutionarily favorable amino acid distributions at 25 sites reveal Shannon entropies (range: 0.3-3.9; median: 2.1; standard deviation: 1.1) supporting the diversity gradient hypothesis. Sitewise constraints in evolved sequences are consistent with complementarity, stability, and consensus biases. Implementation of sitewise constrained diversity enables direct selection of nanomolar affinity binders validating an efficient strategy to balance inter-and intra-molecular interaction demands at each site.	[Woldring, Daniel R.; Holec, Patrick V.; Zhou, Hong; Hackel, Benjamin J.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hackel, BJ (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	hackel@umn.edu		Woldring, Daniel/0000-0001-8881-9931	Department of Defense [W81XWH-13-1-0471]; University of Minnesota; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019518] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding: This work was funded by the Department of Defense (Grant W81XWH-13-1-0471 to BJH) and the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Arnold FH, 2006, NAT BIOTECHNOL, V24, P328, DOI 10.1038/nbt0306-328; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Correa A, 2014, PLOS ONE, P9, DOI [10.1371/journal.pone.0097438, DOI 10.1371/J0URNAL.P0NE.0097438]; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; Deng ZF, 2012, J MOL BIOL, V424, P150, DOI 10.1016/j.jmb.2012.09.014; Diem MD, 2014, PROTEIN ENG DES SEL, V27, P419, DOI 10.1093/protein/gzu016; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gebauer M, 2013, J MOL BIOL, V425, P780, DOI 10.1016/j.jmb.2012.12.004; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gilbreth RN, 2011, P NATL ACAD SCI USA, V108, P7751, DOI 10.1073/pnas.1102294108; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grimm S, 2011, MOL BIOTECHNOL, V48, P263, DOI 10.1007/s12033-010-9367-1; Gronwall C, 2007, J BIOTECHNOL, V128, P162, DOI 10.1016/j.jbiotec.2006.09.013; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hackel BJ, 2012, PROTEIN ENG DES SEL, V25, P639, DOI 10.1093/protein/gzs036; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Khoury GA, 2014, TRENDS BIOTECHNOL, V32, P99, DOI 10.1016/j.tibtech.2013.10.008; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2001, BIOCHEMISTRY-US, V40, P10326, DOI 10.1021/bi010916y; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide A, 2009, PROTEIN ENG DES SEL, V22, P685, DOI 10.1093/protein/gzp053; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Liao HI, 2009, J BIOL CHEM, V284, P17512, DOI 10.1074/jbc.M901547200; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Ma BY, 2001, CURR OPIN STRUC BIOL, V11, P364, DOI 10.1016/S0959-440X(00)00216-5; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Parker MH, 2005, PROTEIN ENG DES SEL, V18, P435, DOI 10.1093/protein/gzi050; Prassler J, 2011, J MOL BIOL, V413, P261, DOI 10.1016/j.jmb.2011.08.012; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schlatter D, 2012, MABS-AUSTIN, V4, P497, DOI 10.4161/mabs.20452; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seeger MA, 2013, PROTEIN SCI, V22, P1239, DOI 10.1002/pro.2312; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Steemson JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086050; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Stern L, 2013, CURR OPIN CHEM ENG; Sullivan MA, 2013, BIOCHEMISTRY-US, V52, P1802, DOI 10.1021/bi3016668; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhai WW, 2011, J MOL BIOL, V412, P55, DOI 10.1016/j.jmb.2011.07.018	93	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138956	10.1371/journal.pone.0138956	http://dx.doi.org/10.1371/journal.pone.0138956			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383268	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200164
J	Walitt, B; Nahin, RL; Katz, RS; Bergman, MJ; Wolfe, F				Walitt, Brian; Nahin, Richard L.; Katz, Robert S.; Bergman, Martin J.; Wolfe, Frederick			The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; POLYSYMPTOMATIC DISTRESS; RHEUMATOID-ARTHRITIS; PHARMACEUTICAL-INDUSTRY; BODILY DISTRESS; SYMPTOMS; CRITERIA; COMORBIDITIES; CATEGORIES; DISORDERS	Background Most knowledge of fibromyalgia comes from the clinical setting, where healthcare-seeking behavior and selection issues influence study results. The characteristics of fibromyalgia in the general population have not been studied in detail. Methods We developed and tested surrogate study specific criteria for fibromyalgia in rheumatology practices using variables from the US National Health Interview Survey (NHIS) and the modification (for surveys) of the 2010 American College of Rheumatology (ACR) preliminary fibromyalgia criteria. The surrogate criteria were applied to the 2012 NHIS and identified persons who satisfied criteria from symptom data. The NHIS weighted sample of 8446 persons represents 225.7 million US adults. Results Fibromyalgia was identified in 1.75%(95% CI 1.42, 2.07), or 3.94 million persons. However, 73% of identified cases self-reported a physician's diagnosis other than fibromyalgia. Identified cases had high levels of self-reported pain, non-pain symptoms, comorbidity, psychological distress, medical costs, Social Security and work disability. Caseness was associated with gender, education, ethnicity, citizenship and unhealthy behaviors. Demographics, behaviors, and comorbidity were predictive of case status. Examination of the surrogate polysymptomatic distress scale (PSD) of the 2010 ACR criteria found fibromyalgia symptoms extending through the full length of the scale. Conclusions Persons identified with criteria-based fibromyalgia have severe symptoms, butmost (73%) have not received a clinical diagnosis of fibromyalgia. The association of fibromyalgia-like symptoms over the full length of the PSD scale with physiological as well as mental stressors suggests PSD may be a universal response variable rather than one restricted to fibromyalgia.	[Walitt, Brian; Nahin, Richard L.] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Katz, Robert S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Bergman, Martin J.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA	National Institutes of Health (NIH) - USA; Rush University; Drexel University; National Data Bank for Rheumatic Diseases	Walitt, B (corresponding author), NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA.	brian.walitt@nih.gov		Wolfe, Frederick/0000-0002-2801-6413				Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Aceves-Avila FJ, 2004, BEST PRACT RES CL RH, V18, P155, DOI 10.1016/j.berh.2004.02.004; Aronowitz RA, 2001, ANN INTERN MED, V134, P803, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00002; Barker KK, 2011, SOC SCI MED, V73, P833, DOI 10.1016/j.socscimed.2011.05.055; Berger A, 2007, INT J CLIN PRACT, V61, P1498, DOI 10.1111/j.1742-1241.2007.01480.x; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Corporation S., 2013, STAT STAT SOFTW REL; Dumit J, 2006, SOC SCI MED, V62, P577, DOI 10.1016/j.socscimed.2005.06.018; Ehrlich GE, 2003, J RHEUMATOL, V30, P1666; English B, 2014, PAIN MANAG NURS, V15, P530, DOI 10.1016/j.pmn.2012.07.009; Epstein SA, 1999, PSYCHOSOMATICS, V40, P57, DOI 10.1016/S0033-3182(99)71272-7; Fietta Pierluigi, 2007, Acta Biomed, V78, P88; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Hadler NM, 2005, SPINE, V30, P1; Holliday KL, 2010, J PSYCHOSOM RES, V68, P469, DOI 10.1016/j.jpsychores.2010.01.024; Jeffery DD, 2014, MIL MED, V179, P1021, DOI 10.7205/MILMED-D-13-00419; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kendler KS, 2012, MOL PSYCHIATR, V17, P377, DOI 10.1038/mp.2011.182; Kendler KS, 2014, PERSPECTIVES, V171; Kirmayer LJ, 2007, PSYCHOSOM MED, V69, P832, DOI 10.1097/PSY.0b013e31815b002c; Kleinman A., 1988, ILLNESS NARRATIVES; Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P1591, DOI 10.1136/ard.2008.093088; Macfarlane GJ, 1999, J RHEUMATOL, V26, P413; Maeland S, 2012, ISRN PUBLIC HLTH, V2012; McBeth J, 2001, Curr Rheumatol Rep, V3, P157, DOI 10.1007/s11926-001-0011-8; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NAT'L CONF. OF STATE LEGISLATURES, 2013, DAT BOOK HLTH CAR SP, P1; Nicholl BI, 2009, PAIN, V141, P119, DOI 10.1016/j.pain.2008.10.022; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Pollard LC, 2010, RHEUMATOLOGY, V49, P924, DOI 10.1093/rheumatology/kep458; Raphael KG, 2006, PAIN, V124, P117, DOI 10.1016/j.pain.2006.04.004; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sacks JJ, 2005, J RHEUMATOL, V32, P340; Schaefer C, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-71; Segura-Jimenez V, 2014, RHEUMATOLOGY; Walitt B, 2014, 2014 AM COLL RHEUM A; Wessely S, 1999, BEST PRACT RES CL RH, V13, P427, DOI 10.1053/berh.1999.0032; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Wolfe F, 1999, CLIN EXP RHEUMATOL, V17, P297; Wolfe F, 2004, J RHEUMATOL, V31, P695; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2014, ARTHRITIS CARE RES; Wolfe F, 2015, J RHEUMATOL, V42, P1494, DOI 10.3899/jrheum.141519; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1465, DOI 10.1002/acr.22300; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolinsky H, 2005, EMBO REP, V6, P612, DOI 10.1038/sj.embor.7400476; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	59	135	138	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138024	10.1371/journal.pone.0138024	http://dx.doi.org/10.1371/journal.pone.0138024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379048	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400044
J	Wu, J; Li, HH; Sun, XR; Zhang, H; Hao, SY; Ji, MH; Yang, JJ; Li, KY				Wu, Jing; Li, Huihui; Sun, Xiaoru; Zhang, Hui; Hao, Shuangying; Ji, Muhuo; Yang, Jianjun; Li, Kuanyu			A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice	PLOS ONE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; DEVELOPING RAT-BRAIN; NEURODEGENERATIVE DISEASES; ANESTHETIC ISOFLURANE; CELL-DEATH; IMPAIRMENT; DYSFUNCTION; STRATEGIES; MECHANISM; APOPTOSIS	Isoflurane possesses neurotoxicity and can induce cognitive deficits, particularly in aging mammals. Mitochondrial reactive oxygen species (mtROS) have been linked to the early pathogenesis of this disorder. However, the role of mtROS remains to be evaluated due to a lack of targeted method to treat mtROS. Here, we determined in aging mice the effects of the mitochondrion-targeted antioxidant SS-31, on cognitive deficits induced by isoflurane, a general inhalation anesthetic. We further investigated the possible mechanisms underlying the effects of SS-31 on hippocampal neuro-inflammation and apoptosis. The results showed that isoflurane induced hippocampus-dependent memory deficit, which was associated with mitochondrial dysfunction including reduced ATP contents, increased ROS levels, and mitochondrial swelling. Treatment with SS-31 significantly ameliorated isoflurane-induced cognitive deficits through the improvement of mitochondrial integrity and function. Mechanistically, SS-31 treatment suppressed pro-inflammatory responses by decreasing the levels of NF-kappa B, NLRP3, caspase 1, IL-1 beta, and TNF-alpha; and inhibited the apoptotic pathway by decreasing the Bax/Bcl-2 ratio, reducing the release of cytochrome C, and blocking the cleavage of caspase 3. Our results indicate that isoflurane-induced cognitive deficits may be attenuated by mitochondrion-targeted antioxidants, such as SS-31. Therefore, SS-31 may have therapeutic potentials in preventing injuries from oxidative stresses that contribute to anesthetic-induced neurotoxicity.	[Wu, Jing; Li, Huihui; Hao, Shuangying; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Jing; Sun, Xiaoru; Zhang, Hui; Ji, Muhuo; Yang, Jianjun] Nanjing Univ, Dept Anesthesiol, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Yang, JJ (corresponding author), Nanjing Univ, Dept Anesthesiol, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	yjyangjj@126.com; likuanyu@nju.edu.cn	sun, xiaoru/GZL-0771-2022; Yang, Jianjun/AAN-4960-2021; Li, Kuanyu/AAL-2051-2020		National Nature Science foundation of China [31071085, 31371060, 81271216, 81300946]	National Nature Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science foundation of China; grant numbers: 31071085, 31371060, 81271216, and 81300946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mansoori KM, 2013, CURR ALZHEIMER RES, V10, P559; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blum FE, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-16; Boscolo A, 2012, NEUROBIOL DIS, V45, P1031, DOI 10.1016/j.nbd.2011.12.022; Boscolo A, 2013, ANESTHESIOLOGY, V118, P1086, DOI 10.1097/ALN.0b013e318289bc9b; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; Jevtovic-Todorovic V, 2012, FRONTIERS NEUROLOGY, V3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Li XM, 2014, J MOL NEUROSCI, V52, P286, DOI 10.1007/s12031-013-0141-2; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Li ZQ, 2013, BIOCHEM BIOPH RES CO, V438, P628, DOI 10.1016/j.bbrc.2013.08.003; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Petri S, 2006, J NEUROCHEM, V98, P1141, DOI 10.1111/j.1471-4159.2006.04018.x; Popova EN, 2010, ANTIOXID REDOX SIGN, V13, P1297, DOI 10.1089/ars.2009.2949; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sun YX, 2014, BRAIN SCI, V4, P311, DOI 10.3390/brainsci4020311; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Wu X, 2014, MATH PROBL ENG, V2014, P1; Yang LC, 2009, ANTIOXID REDOX SIGN, V11, P2095, DOI [10.1089/ars.2009.2445, 10.1089/ARS.2009.2445]; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	30	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138256	10.1371/journal.pone.0138256	http://dx.doi.org/10.1371/journal.pone.0138256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379247	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400074
J	Perotti, V; Baldassari, P; Molla, A; Vegetti, C; Bersani, I; Maurichi, A; Santinami, M; Anichini, A; Mortarini, R				Perotti, V.; Baldassari, P.; Molla, A.; Vegetti, C.; Bersani, I.; Maurichi, A.; Santinami, M.; Anichini, A.; Mortarini, R.			NFATc2 is an intrinsic regulator of melanoma dedifferentiation	ONCOGENE			English	Article							ACTIVATED T-CELLS; C-MYC EXPRESSION; NUCLEAR FACTOR; METASTATIC MELANOMA; THERAPEUTIC TARGET; MALIGNANT-MELANOMA; SIGNALING PATHWAY; INITIATING CELLS; ONCOGENIC BRAF; DIFFERENTIATION	Melanoma dedifferentiation, characterized by the loss of MITF and MITF regulated genes and by upregulation of stemness markers as CD271, is implicated in resistance to chemotherapy, target therapy and immunotherapy. The identification of intrinsic mechanisms fostering melanoma dedifferentiation may provide actionable therapeutic targets to improve current treatments. Here, we identify NFATc2 transcription factor as an intrinsic regulator of human melanoma dedifferentiation. In panels of melanoma cell lines, NFATc2 expression correlated inversely with MITF at both mRNA and protein levels. NFATc2(+/Hi) melanoma cell lines were CD271(+) and deficient for expression of melanocyte differentiation antigens (MDAs) MART-1, gp100, tyrosinase and of GPNMB, PGC1-alpha and Rab27a, all regulated by MITF. Targeting of NFATc2 by small interfering RNA, short hairpin RNA and by an NFATc2 inhibitor upregulated MITF, MDAs, GPNMB, PGC-1 alpha, tyrosinase activity and pigmentation and suppressed CD271. Mechanistically, we found that NFATc2 controls melanoma dedifferentiation by inducing expression in neoplastic cells of membrane-bound tumor necrosis factor-alpha (mTNF-alpha) and that melanoma-expressed TNF-alpha regulates a c-myc-Brn2 axis. Specifically, NFATc2, mTNF-alpha and expression of TNF receptors were significantly correlated in panels of cell lines. NFATc2 silencing suppressed TNF-alpha expression, and neutralization of melanoma-expressed TNF-alpha promoted melanoma differentiation. Moreover, silencing of NFATc2 and TNF-alpha neutralization downmodulated c-myc and POU3F2/Brn2. Brn2 was strongly expressed in NFATc2(+/Hi) MITFLo cell lines and its silencing upregulated MITF. Targeting of c-myc, by silencing or by a c-myc inhibitor, suppressed Brn2 and upregulated MITF and MART-1 in melanoma cells. The relevance of NFATc2-dependent melanoma dedifferentiation for immune escape was shown by cytolytic T-cell assays. NFATc2(Hi) MITFLo MDA(Lo) HLA-A2.1(+) melanoma cells were poorly recognized by MDA-specific and HLA-A2-restricted CTL lines, but NFATc2 targeting significantly increased CTL-mediated tumor recognition. Taken together, these results suggest that the expression of NFATc2 promotes melanoma dedifferentiation and immune escape.	[Perotti, V.; Baldassari, P.; Molla, A.; Vegetti, C.; Bersani, I.; Anichini, A.; Mortarini, R.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Human Tumors Immunobiol Unit, Via Venezian 1, I-20133 Milan, Italy; [Maurichi, A.; Santinami, M.] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Melanoma & Sarcoma Unit, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Mortarini, R (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Human Tumors Immunobiol Unit, Via Venezian 1, I-20133 Milan, Italy.	roberta.mortarini@istitutotumori.mi.it	Anichini, Andrea/K-1434-2016; Mortarini, Roberta/C-9483-2017; Maurichi, Andrea/AAX-5020-2020; Perotti, Valentina/C-1049-2017; Maurichi, Andrea/E-7030-2017; Santinami, Mario/I-3795-2017	Anichini, Andrea/0000-0001-5096-5538; Mortarini, Roberta/0000-0001-7732-0561; Maurichi, Andrea/0000-0002-6503-5373; Perotti, Valentina/0000-0003-4506-2363; Maurichi, Andrea/0000-0002-6503-5373; Santinami, Mario/0000-0001-8436-4757	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., Milan) [12020, 15860]	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., Milan)(Fondazione AIRC per la ricerca sul cancro)	We thank Dr L. De Cecco and Mr. E. Marchesi of the Functional Genomics Facility of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, for qPCR and gene expression analysis, Ms. G. Nicolini for the skillfull technical work. This investigation was supported by grant #12020 #15860 (to RM) from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., Milan).	Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Barral AM, 2000, MELANOMA RES, V10, P331, DOI 10.1097/00008390-200008000-00004; Bellei B, 2011, PIGM CELL MELANOMA R, V24, P309, DOI 10.1111/j.1755-148X.2010.00800.x; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Caballero FJ, 2007, BIOCHEM PHARMACOL, V73, P1013, DOI 10.1016/j.bcp.2006.12.001; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Cheli Y, 2014, ONCOTARGET, V5, P5272, DOI 10.18632/oncotarget.1967; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Flockhart RJ, 2009, BRIT J CANCER, V101, P1448, DOI 10.1038/sj.bjc.6605277; Furuta J, 2014, J INVEST DERMATOL, V134, P1369, DOI 10.1038/jid.2013.490; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Grazia G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.410; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Menon DR, 2015, ONCOGENE, V34, P4448, DOI 10.1038/onc.2014.372; Minematsu H, 2011, CELL SIGNAL, V23, P1785, DOI 10.1016/j.cellsig.2011.06.013; Mognol GP, 2012, CELL CYCLE, V11, P1014, DOI 10.4161/cc.11.5.19518; Mortarini R, 2005, CANCER RES, V65, P3428, DOI 10.1158/0008-5472.CAN-04-3239; Mortarini R, 2003, CANCER RES, V63, P2535; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; NINOMIYATSUJI J, 1993, P NATL ACAD SCI USA, V90, P9611, DOI 10.1073/pnas.90.20.9611; Oliver JL, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12091; Perotti V, 2012, J INVEST DERMATOL, V132, P2652, DOI 10.1038/jid.2012.179; Pouryazdanparast P, 2012, MODERN PATHOL, V25, P1221, DOI 10.1038/modpathol.2012.75; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shou JW, 2015, CANCER LETT, V361, P174, DOI 10.1016/j.canlet.2015.03.005; Singh G, 2010, J BIOL CHEM, V285, P27241, DOI 10.1074/jbc.M110.100438; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tam TTP, 2013, BIOCHEM BIOPH RES CO, V430, P722, DOI 10.1016/j.bbrc.2012.11.082; Tassi E, 2012, CLIN CANCER RES, V18, P3316, DOI 10.1158/1078-0432.CCR-11-2232; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhou YN, 2014, MOL BIOL CELL, V25, P2882, DOI 10.1091/mbc.E14-05-0998	51	28	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2862	2872		10.1038/onc.2015.355	http://dx.doi.org/10.1038/onc.2015.355			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387540				2022-12-26	WOS:000377473700006
J	Sheikh, BN; Bechtel-Walz, W; Lucci, J; Karpiuk, O; Hild, I; Hartleben, B; Vornweg, J; Helmstadter, M; Sahyoun, AH; Bhardwaj, V; Stehle, T; Diehl, S; Kretz, O; Voss, AK; Thomas, T; Manke, T; Huber, TB; Akhtar, A				Sheikh, B. N.; Bechtel-Walz, W.; Lucci, J.; Karpiuk, O.; Hild, I.; Hartleben, B.; Vornweg, J.; Helmstaedter, M.; Sahyoun, A. H.; Bhardwaj, V.; Stehle, T.; Diehl, S.; Kretz, O.; Voss, A. K.; Thomas, T.; Manke, T.; Huber, T. B.; Akhtar, A.			MOF maintains transcriptional programs regulating cellular stress response	ONCOGENE			English	Article							H4 LYSINE 16; HISTONE ACETYLTRANSFERASE; EMBRYONIC-DEVELOPMENT; DOSAGE COMPENSATION; PODOCYTE; AUTOPHAGY; GENE; ACETYLATION; PROTEIN; SENESCENCE	MOF (MYST1, KAT8) is the major H4K16 lysine acetyltransferase (KAT) in Drosophila and mammals and is essential for embryonic development. However, little is known regarding the role of MOF in specific cell lineages. Here we analyze the differential role of MOF in proliferating and terminally differentiated tissues at steady state and under stress conditions. In proliferating cells, MOF directly binds and maintains the expression of genes required for cell cycle progression. In contrast, MOF is dispensable for terminally differentiated, postmitotic glomerular podocytes under physiological conditions. However, in response to injury, MOF is absolutely critical for podocyte maintenance in vivo. Consistently, we detect defective nuclear, endoplasmic reticulum and Golgi structures, as well as presence of multivesicular bodies in vivo in podocytes lacking Mof following injury. Undertaking genome-wide expression analysis of podocytes, we uncover several MOF-regulated pathways required for stress response. We find that MOF, along with the members of the non-specific lethal but not the male-specific lethal complex, directly binds to genes encoding the lysosome, endocytosis and vacuole pathways, which are known regulators of podocyte maintenance. Thus, our work identifies MOF as a key regulator of cellular stress response in glomerular podocytes.	[Sheikh, B. N.; Lucci, J.; Karpiuk, O.; Sahyoun, A. H.; Bhardwaj, V.; Stehle, T.; Diehl, S.; Manke, T.; Akhtar, A.] Max Planck Inst Immunobiol & Epigenet, Dept Chromatin Regulat, Stubeweg 51, D-79108 Freiburg, Baden Wuertenbe, Germany; [Bechtel-Walz, W.; Hild, I.; Hartleben, B.; Vornweg, J.; Helmstaedter, M.; Kretz, O.; Huber, T. B.] Univ Med Ctr, Renal Div, Freiburg, Germany; [Kretz, O.] Univ Freiburg, Neuroanat, Hugstetter Str 55, D-79106 Freiburg, Germany; [Voss, A. K.; Thomas, T.] Walter & Eliza Hall Inst Med Res, Dev & Canc Div, Melbourne, Vic 3050, Australia; [Voss, A. K.; Thomas, T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Huber, T. B.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg; University of Melbourne; University of Freiburg	Akhtar, A (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Chromatin Regulat, Stubeweg 51, D-79108 Freiburg, Baden Wuertenbe, Germany.	akhtar@ie-freiburg.mpg.de	Voss, Anne K/F-5110-2013; Manke, Thomas/L-9075-2019	Voss, Anne K/0000-0002-3853-9381; Keller, Julia/0000-0001-9808-4983; Manke, Thomas/0000-0003-3702-0868; Bhardwaj, Vivek/0000-0002-5570-9338; Bechtel-Walz, Wibke/0000-0001-6032-3627; Kretz, Oliver/0000-0003-1152-5956; Huber, Tobias B./0000-0001-7175-5062; Sahyoun, Abdullah/0000-0002-3333-8599; Sheikh, Bilal/0000-0002-1970-6236; Thomas, Tim/0000-0002-7623-8344	Humboldt postdoctoral fellowship; Marie Curie Career Integration Grant; Margarete von Wrangell Habilitations-Stipendium; Australian National Health and Medical Research Council; Australian Federal Government (IRISS); Victorian State Government (OIS); DFG (Heisenberg program) [CRC992, CRC1140]; European Research Council (ERC grant); DGF [CRC992, CRC1140, CRC746]	Humboldt postdoctoral fellowship; Marie Curie Career Integration Grant; Margarete von Wrangell Habilitations-Stipendium; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Federal Government (IRISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government (OIS); DFG (Heisenberg program)(German Research Foundation (DFG)); European Research Council (ERC grant)(European Research Council (ERC)); DGF(German Research Foundation (DFG))	We thank K Lam, M Shvedunova and A Chatterjee for helpful discussions. We are grateful for the assistance provided by P Kindle (MPI-IE, Imaging facility) and B Joch (University Freiburg). BNS is supported by a Humboldt postdoctoral fellowship, WBW by a Marie Curie Career Integration Grant and a Margarete von Wrangell Habilitations-Stipendium. AKV and TT were supported by the Australian National Health and Medical Research Council, operational infrastructure grants from the Australian Federal Government (IRISS) and the Victorian State Government (OIS). TBH was supported by the DFG (Heisenberg program and CRC992 and CRC1140) and the European Research Council (ERC grant). AA is supported by the DGF CRC1140, CRC992 and CRC746. AA and TBH are part of the BIOSS II (Freiburg), the Excellence Initiative of the German Federal and State Governments.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bhadra MP, 2012, CHROMOSOMA, V121, P79, DOI 10.1007/s00412-011-0344-7; Blumenthal A, 2015, AM J PHYSIOL-RENAL, V308, pF602, DOI 10.1152/ajprenal.00190.2014; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Chelmicki T, 2014, ELIFE, V3, DOI 10.7554/eLife.02024; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Gupta A, 2014, CELL REP, V8, P177, DOI 10.1016/j.celrep.2014.05.044; Gupta A, 2013, MUTAGENESIS, V28, P263, DOI 10.1093/mutage/ges080; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JY, 2010, TRANSPLANTATION, V89, P215, DOI 10.1097/TP.0b013e3181c353e5; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Kumar R, 2011, P NATL ACAD SCI USA, V108, P3636, DOI 10.1073/pnas.1016524108; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Lenoir O, 2015, AUTOPHAGY, V11, P1130, DOI 10.1080/15548627.2015.1049799; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liapis H, 2013, AM J PATHOL, V183, P1364, DOI 10.1016/j.ajpath.2013.06.033; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Schell C, 2014, SEMIN CELL DEV BIOL, V36, P39, DOI 10.1016/j.semcdb.2014.07.016; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sheikh BN, 2015, ONCOGENE, V34, P5807, DOI 10.1038/onc.2015.33; Sheikh BN, 2015, BLOOD, V125, P1910, DOI 10.1182/blood-2014-08-594655; Sheikh BN, 2014, CELL TISSUE RES, V356, P553, DOI 10.1007/s00441-014-1835-7; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Takabatake Y, 2014, NEPHROL DIAL TRANSPL, V29, P1639, DOI 10.1093/ndt/gft535; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Thomas T, 2000, DEVELOPMENT, V127, P2537; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795	67	36	36	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2698	2710		10.1038/onc.2015.335	http://dx.doi.org/10.1038/onc.2015.335			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26387537	Green Published, hybrid			2022-12-26	WOS:000377472700004
J	von Kanel, R; Fardad, N; Steurer, N; Horak, N; Hindermann, E; Fischer, F; Gessler, K				von Kaenel, Roland; Fardad, Nasser; Steurer, Nadine; Horak, Nicole; Hindermann, Esther; Fischer, Franz; Gessler, Katharina			Vitamin D Deficiency and Depressive Symptomatology in Psychiatric Patients Hospitalized with a Current Depressive Episode: A Factor Analytic Study	PLOS ONE			English	Article							D-RECEPTOR; D SUPPLEMENTATION; HEART-DISEASE; METAANALYSIS; SYMPTOMS; ASSOCIATION; EXPRESSION; DISORDER; KETAMINE; NEURONS	Background Low vitamin D levels have been associated with depressive symptoms in population-based studies and non-clinical samples as well as with clinical depression. This study aimed to examine the association of vitamin D levels with the severity and dimensions of depressive symptoms in hospitalized patients with a current episode of depression taking into account confounding variables. Methods We investigated 380 patients (mean age 47 +/- 12 years, 70% women) who were consecutively hospitalized with a main diagnosis of an ICD-10 depressive episode. All patients self-rated depressive symptom severity with the Hospital Anxiety and Depression Scale (HADS-D), the Beck Depression Inventory-II (BDI-II), and the Brief Symptom Inventory. A principal component analysis was performed with all 34 items of these questionnaires and serum levels of 25-hydroxyvitamin D3 (25-OH D) were measured. Results Vitamin D deficiency (<50 nmol/l), insufficiency (50-75 nmol/l), and sufficiency (>75 nmol/l) were present in 55.5%, 31.8% and 12.6%, respectively, of patients. Patients with vitamin D deficiency scored higher on the HADS-D scale and on an anhedonia symptom factor than those with insufficient (p-values <= 0.023) or sufficient (p-values <= 0.008) vitamin D. Vitamin D deficient patients also scored higher on the BDI-II scale than those with sufficient vitamin D (p = 0.007); BDI-II cognitive/affective symptoms, but not somatic/affective symptoms, were higher in patients with vitamin D deficiency (p = 0.005) and insufficiency (p = 0.041) relative to those with sufficient vitamin D. Effect sizes suggested clinically relevant findings. Conclusions Low vitamin D levels are frequent in hospitalized patients with a current episode of depression. Especially 25-OH D levels <50 nmol/l were associated with cognitive/affective depressive symptoms, and anhedonia symptoms in particular.	[von Kaenel, Roland; Fardad, Nasser; Steurer, Nadine; Horak, Nicole; Hindermann, Esther; Gessler, Katharina] Clin Barmelweid, Dept Psychosomat Med, Barmelweid, Switzerland; [von Kaenel, Roland] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [von Kaenel, Roland] Univ Bern, Bern, Switzerland; [von Kaenel, Roland] Univ Bern, Dept Clin Res, Bern, Switzerland; [Fischer, Franz] Psymeta GmbH, Schafisheim, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	von Kanel, R (corresponding author), Clin Barmelweid, Dept Psychosomat Med, Barmelweid, Switzerland.	roland.vonkaenel@insel.ch	von Känel, Roland/B-1811-2019	von Känel, Roland/0000-0002-8929-5129	Psymeta GmbH	Psymeta GmbH	The authors received no specific funding for this work. Psymeta GmbH provided support in the form of salaries for author F.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Annweiler C, 2013, J CLIN PSYCHIAT, V74, P1121, DOI 10.4088/JCP.13ac08783; Azevedo RD, 2014, PSYCHOL MED, V44, P2689, DOI 10.1017/S0033291714000063; Beck AT, 1996, PSYCHOL ASSESS; Begre S, 2010, SOC PSYCH PSYCH EPID, V45, P17, DOI 10.1007/s00127-009-0036-2; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Cieslak K, 2014, SCHIZOPHR RES, V159, P543, DOI 10.1016/j.schres.2014.08.031; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; Di Stefano C., 2009, PRACT ASSESS RES EVA, V14, P11; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Franke GH., 2000, BRIEF SYMPTOM INVENT; Ganji Vijay, 2010, Int Arch Med, V3, P29, DOI 10.1186/1755-7682-3-29; Gezen-Ak D, 2013, NEUROL SCI, V34, P1453, DOI 10.1007/s10072-012-1268-6; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Hautzinger M., 2006, BECK DEPRESSIONSINVE; Herrmann C., 1995, HADS D HOSP ANXIETY; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Jiang P, 2013, PSYCHONEUROENDOCRINO, V38, P2091, DOI 10.1016/j.psyneuen.2013.03.017; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; KEDDIE KMG, 1987, BRIT J PSYCHIAT, V150, P394, DOI 10.1192/bjp.150.3.394; Khoraminya N, 2013, AUST NZ J PSYCHIAT, V47, P271, DOI 10.1177/0004867412465022; Lally N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.105; Lally N, 2015, J PSYCHOPHARMACOL, V29, P596, DOI 10.1177/0269881114568041; Lux V, 2010, PSYCHOL MED, V40, P1679, DOI 10.1017/S0033291709992157; Maddock J, 2013, CLIN NUTR, V32, P758, DOI 10.1016/j.clnu.2013.01.006; Modan-Moses D, 2015, INT J EAT DISORDER, V48, P607, DOI 10.1002/eat.22347; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; Pramyothin P, 2012, CURR OPIN GASTROEN, V28, P139, DOI 10.1097/MOG.0b013e32835004dc; Shaffer JA, 2014, PSYCHOSOM MED, V76, P190, DOI 10.1097/PSY.0000000000000044; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Spedding S, 2014, NUTRIENTS, V6, P1501, DOI 10.3390/nu6041501; Tang M, 2013, BRAIN RES, V1513, P127, DOI 10.1016/j.brainres.2013.03.042; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; von Kanel R, 2014, PAIN MED, V15, P1609, DOI 10.1111/pme.12454; Zhou CC, 2006, J CLIN INVEST, V116, P1703, DOI 10.1172/JCI27793; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138550	10.1371/journal.pone.0138550	http://dx.doi.org/10.1371/journal.pone.0138550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397113	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500076
J	Gatziolis, D; Lienard, JF; Vogs, A; Strigul, NS				Gatziolis, Demetrios; Lienard, Jean F.; Vogs, Andre; Strigul, Nikolay S.			3D Tree Dimensionality Assessment Using Photogrammetry and Small Unmanned Aerial Vehicles	PLOS ONE			English	Article							CROWN ASYMMETRY; AIRBORNE LIDAR; FOREST INVENTORY; COMPETITION; HEIGHT; RECOGNITION; DISTURBANCE; GENERATION; BIOMASS; VOLUME	Detailed, precise, three-dimensional (3D) representations of individual trees are a prerequisite for an accurate assessment of tree competition, growth, and morphological plasticity. Until recently, our ability to measure the dimensionality, spatial arrangement, shape of trees, and shape of tree components with precision has been constrained by technological and logistical limitations and cost. Traditional methods of forest biometrics provide only partial measurements and are labor intensive. Active remote technologies such as LiDAR operated from airborne platforms provide only partial crown reconstructions. The use of terrestrial LiDAR is laborious, has portability limitations and high cost. In this work we capitalized on recent improvements in the capabilities and availability of small unmanned aerial vehicles (UAVs), light and inexpensive cameras, and developed an affordable method for obtaining precise and comprehensive 3D models of trees and small groups of trees. The method employs slow-moving UAVs that acquire images along predefined trajectories near and around targeted trees, and computer vision-based approaches that process the images to obtain detailed tree reconstructions. After we confirmed the potential of the methodology via simulation we evaluated several UAV platforms, strategies for image acquisition, and image processing algorithms. We present an original, step-by-step workflow which utilizes open source programs and original software. We anticipate that future development and applications of our method will improve our understanding of forest self-organization emerging from the competition among trees, and will lead to a refined generation of individual-tree-based forest models.	[Gatziolis, Demetrios] US Forest Serv, USDA, Pacific NW Res Stn, Portland, OR USA; [Lienard, Jean F.; Vogs, Andre; Strigul, Nikolay S.] Washington State Univ Vancouver, Dept Math, Vancouver, WA 98686 USA; [Vogs, Andre] Intel Inc, Hillsboro, OR USA	United States Department of Agriculture (USDA); United States Forest Service; Washington State University; Intel Corporation	Strigul, NS (corresponding author), Washington State Univ Vancouver, Dept Math, Vancouver, WA 98686 USA.	nick.strigul@vancouver.wsu.edu	Strigul, Nick/C-3987-2016	Lienard, Jean/0000-0003-4279-4980	Simons Foundation [283770]; Washington State University New Faculty SEED grant	Simons Foundation; Washington State University New Faculty SEED grant	Funding: This work was partially supported by a grant from the Simons Foundation, (www.simonsfoundation.org) (#283770 to N.S.), and a Washington State University New Faculty SEED grant, (http://faculty.wsu.edu/career/seed-grants/) (to NS). The funders and any other individuals employed had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HE, 2006, CAN J REMOTE SENS, V32, P355, DOI 10.5589/m06-030; Balletti C, 2014, SENSORS-BASEL, V14, P17471, DOI 10.3390/s140917471; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brisson J, 2001, CAN J FOREST RES, V31, P2151, DOI 10.1139/x01-161; Changchang Wu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3057, DOI 10.1109/CVPR.2011.5995552; Cote JF, 2009, REMOTE SENS ENVIRON, V113, P1067, DOI 10.1016/j.rse.2009.01.017; Coulston JW, 2012, PHOTOGRAMM ENG REM S, V78, P715, DOI 10.14358/PERS.78.7.715; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dandois JP, 2010, REMOTE SENS-BASEL, V2, P1157, DOI 10.3390/rs2041157; de Matias J, 2009, REMOTE SENS-BASEL, V1, P829, DOI 10.3390/rs1040829; Erdody TL, 2010, REMOTE SENS ENVIRON, V114, P725, DOI 10.1016/j.rse.2009.11.002; FRELICH LE, 1988, FOREST SCI, V34, P530; Frew EW, 2006, P IEEE AM CONTR C; Fries J., 1974, RES NOTES, V30; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gatziolis D, 2012, P SILV 2012 12 INT C, P16; Gatziolis D, 2010, P SILVILASER 2010 10, P197; Gatziolis D, 2010, FOREST SCI, V56, P139; GDAL, 2015, GDAL GEOSP DAT ABSTR; Gong P, 2002, PHOTOGRAMM ENG REM S, V68, P1203; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; GYSEL LESLIE W., 1951, JOUR FOREST, V49, P13; Henning JG, 2006, FOREST SCI, V52, P67; Hirschmugl M, 2007, REMOTE SENS ENVIRON, V110, P533, DOI 10.1016/j.rse.2007.02.029; Karaman S, 2012, IEEE INT CONF ROBOT, P2899, DOI 10.1109/ICRA.2012.6225235; Korpela I, 2012, REMOTE SENS ENVIRON, V119, P92, DOI 10.1016/j.rse.2011.12.011; Leckie DG, 2005, REMOTE SENS ENVIRON, V94, P311, DOI 10.1016/j.rse.2004.10.011; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Levin S., 1999, FRAGILE DOMINION; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; LOEHLE C, 1986, AM MIDL NAT, V116, P190, DOI 10.2307/2425951; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo YW, 2015, NEUROCOMPUTING, V156, P105, DOI 10.1016/j.neucom.2014.12.079; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Metz J, 2013, FOREST ECOL MANAG, V310, P275, DOI 10.1016/j.foreco.2013.08.014; Mori T, 2013, IEEE INT CONF ROBOT, P1750, DOI 10.1109/ICRA.2013.6630807; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Popescu SC, 2008, REMOTE SENS ENVIRON, V112, P767, DOI 10.1016/j.rse.2007.06.011; Reda I., 2008, SOLAR POSITION ALGOR; Roberts R, 2012, PROC SPIE, V8387, DOI 10.1117/12.919598; Rosnell T, 2012, SENSORS-BASEL, V12, P453, DOI 10.3390/s120100453; Rothermel M., 2012, P LC3D WORKSH BERL M; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Sheridan RD, 2015, REMOTE SENS-BASEL, V7, P229, DOI 10.3390/rs70100229; Shreiner Dave, 2009, OPENGL PROGRAMMING G; Skurikhin AN, 2013, REMOTE SENS LETT, V4, P465, DOI 10.1080/2150704X.2012.749361; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Song C, 2007, INT J REMOTE SENS, V28, P3305, DOI 10.1080/01431160600993413; Stoll P, 1998, J ECOL, V86, P934, DOI 10.1046/j.1365-2745.1998.00313.x; Strigul, 2012, SUSTAINABLE FOREST M, DOI DOI 10.5772/29590; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Sukthankar Rahul, 2012, IEEE WORKSHOP APPL C, P329; UMEKI K, 1995, CAN J FOREST RES, V25, P1876, DOI 10.1139/x95-202; Webster CR, 2005, ECOL APPL, V15, P1245, DOI 10.1890/04-0763; WOODS FW, 1959, ECOLOGY, V40, P349, DOI 10.2307/1929751; Wu C, 2014, P IEEE C COMP VIS PA; Wu CC, 2013, 2013 INTERNATIONAL CONFERENCE ON 3D VISION (3DV 2013), P127, DOI 10.1109/3DV.2013.25; Wulder M, 2000, REMOTE SENS ENVIRON, V73, P103, DOI 10.1016/S0034-4257(00)00101-2; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119; ZHANG ZY, 1995, ARTIF INTELL, V78, P87, DOI 10.1016/0004-3702(95)00022-4; Zhao KG, 2009, REMOTE SENS ENVIRON, V113, P182, DOI 10.1016/j.rse.2008.09.009	66	64	68	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137765	10.1371/journal.pone.0137765	http://dx.doi.org/10.1371/journal.pone.0137765			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393926	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100018
J	Kang, JH; Kim, SJ; Cho, YS; Kim, SP				Kang, Jae-Hwan; Kim, Su Jin; Cho, Yang Seok; Kim, Sung-Phil			Modulation of Alpha Oscillations in the Human EEG with Facial Preference	PLOS ONE			English	Article							AVERAGE REFERENCE; FACE PERCEPTION; PARIETAL CORTEX; MEMORY; ATTRACTIVENESS; ASYMMETRY; COMPONENT; DYNAMICS; BEAUTY; SPACE	Facial preference that results from the processing of facial information plays an important role in social interactions as well as the selection of a mate, friend, candidate, or favorite actor. However, it still remains elusive which brain regions are implicated in the neural mechanisms underlying facial preference, and how neural activities in these regions are modulated during the formation of facial preference. In the present study, we investigated the modulation of electroencephalography (EEG) oscillatory power with facial preference. For the reliable assessments of facial preference, we designed a series of passive viewing and active choice tasks. In the former task, twenty-four face stimuli were passively viewed by participants for multiple times in random order. In the latter task, the same stimuli were then evaluated by participants for their facial preference judgments. In both tasks, significant differences between the preferred and non-preferred faces groups were found in alpha band power (8-13 Hz) but not in other frequency bands. The preferred faces generated more decreases in alpha power. During the passive viewing task, significant differences in alpha power between the preferred and non-preferred face groups were observed at the left frontal regions in the early (0.15-0.4 s) period during the 1-s presentation. By contrast, during the active choice task when participants consecutively watched the first and second face for 1 s and then selected the preferred one, an alpha power difference was found for the late (0.65-0.8 s) period over the whole brain during the first face presentation and over the posterior regions during the second face presentation. These results demonstrate that the modulation of alpha activity by facial preference is a top-down process, which requires additional cognitive resources to facilitate information processing of the preferred faces that capture more visual attention than the non-preferred faces.	[Kang, Jae-Hwan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Kim, Su Jin; Cho, Yang Seok] Korea Univ, Dept Psychol, Seoul, South Korea; [Kim, Sung-Phil] Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea	Korea University; Korea University; Ulsan National Institute of Science & Technology (UNIST)	Kim, SP (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea.	spkim@unist.ac.kr		Kang, Jae-Hwan/0000-0002-9425-847X	Mid-career Researcher Program through National Research Foundation of Korea - ICT & Future Planning [NRF-2012R1A2A2A04047239]; Brain Research Program through National Research Foundation of Korea - ICT & Future Planning [NRF-2006-2005112]; Components & Materials Technology Development Program - Ministry of Trade, Industry Energy [10043826]	Mid-career Researcher Program through National Research Foundation of Korea - ICT & Future Planning; Brain Research Program through National Research Foundation of Korea - ICT & Future Planning; Components & Materials Technology Development Program - Ministry of Trade, Industry Energy	Funding: This research was supported by the Mid-career Researcher Program (NRF-2012R1A2A2A04047239) and the Brain Research Program (NRF-2006-2005112) through the National Research Foundation of Korea funded by the ICT & Future Planning, and the Components & Materials Technology Development Program (10043826) funded by Ministry of Trade, Industry & Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amishav R, 2010, PSYCHON B REV, V17, P743, DOI 10.3758/PBR.17.5.743; Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P25, DOI 10.1016/j.ijpsycho.2012.07.001; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Bhushan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043351; Breton A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091451; Brown SBRE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00033; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; De Cesarei A, 2011, PSYCHOPHYSIOLOGY, V48, P1397, DOI 10.1111/j.1469-8986.2011.01204.x; De Vos M, 2012, NEUROIMAGE, V63, P1196, DOI 10.1016/j.neuroimage.2012.07.055; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Gao ZF, 2013, HUM BRAIN MAPP, V34, P1783, DOI 10.1002/hbm.22028; Genetti M, 2009, BRAIN COGNITION, V69, P296, DOI 10.1016/j.bandc.2008.08.008; Giardina A, 2012, SOC NEUROSCI-UK, V7, P359, DOI 10.1080/17470919.2011.628410; Girges C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089382; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Heisz JJ, 2006, VISION RES, V46, P4604, DOI 10.1016/j.visres.2006.09.026; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Johnston VS, 2006, TRENDS COGN SCI, V10, P9, DOI 10.1016/j.tics.2005.11.003; Johnston VS, 1997, J SEX RES, V34, P188, DOI 10.1080/00224499709551884; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jung KH, 2012, EVOL HUM BEHAV, V33, P241, DOI 10.1016/j.evolhumbehav.2011.10.001; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Lee N, 2007, INT J PSYCHOPHYSIOL, V63, P199, DOI 10.1016/j.ijpsycho.2006.03.007; Lindsen JP, 2010, NEUROIMAGE, V50, P1626, DOI 10.1016/j.neuroimage.2010.01.079; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Morgan LK, 2014, EVOL HUM BEHAV, V35, P96, DOI 10.1016/j.evolhumbehav.2013.11.002; Neggers SFW, 2006, NEUROIMAGE, V31, P320, DOI 10.1016/j.neuroimage.2005.12.028; OSSELTON JW, 1965, ELECTROEN CLIN NEURO, V19, P527, DOI 10.1016/0013-4694(65)90195-1; Pfurtscheller G, 2005, EURASIP J APPL SIG P, V2005, P3152, DOI 10.1155/ASP.2005.3152; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; Sun DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031250; Sun YT, 2010, BRAIN RES, V1327, P69, DOI 10.1016/j.brainres.2010.02.013; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Trujillo L, 2014, COGN AFFECT BEHAV NE, V14, P1061, DOI 10.3758/s13415-013-0230-2; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Tusche A, 2013, NEUROIMAGE, V72, P174, DOI 10.1016/j.neuroimage.2013.01.020; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; Yamakawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004360; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044; Zeng JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045945; Zion-Golumbic E, 2008, NEUROIMAGE, V39, P1980, DOI 10.1016/j.neuroimage.2007.10.025; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251; Zumer JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001965	63	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138153	10.1371/journal.pone.0138153	http://dx.doi.org/10.1371/journal.pone.0138153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394328	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100031
J	Lindemeyer, J; Oros-Peusquens, AM; Shah, NJ				Lindemeyer, Johannes; Oros-Peusquens, Ana-Maria; Shah, N. Jon			Multistage Background Field Removal (MUBAFIRE)-Compensating for B-0 Distortions at Ultra-High Field	PLOS ONE			English	Article							PHASE-UNWRAPPING ALGORITHM; MAGNETIC-SUSCEPTIBILITY; HUMAN BRAIN; MRI; INHOMOGENEITY; RESONANCE; EXTRACTION; CONTRAST; IMAGES; GRAY	The investigation of tissue magnetic susceptibility and the resultant magnetic field offers a new avenue for quantitative tissue characterisation by MRI. One crucial step in mining the phase and field data for relevant tissue information is the correction of externally induced field shifts. This article outlines a multistep approach comprising several methodologies for background field removal. The virtues of B-0 long-range variation detection and compensation of more localised external disturbances are unified in a sequential filter chain. The algorithm is tested by means of a numerical Monte Carlo simulation model and applied to in vivo measurements at 3T and 9.4T as well as to a fixed brain tissue measurement at 9.4T. Further, a comparison to conventional filter types has been undertaken.	[Lindemeyer, Johannes; Oros-Peusquens, Ana-Maria; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, INM Med Imaging Phys 4, D-52425 Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Fac Med, Dept Neurol, JARA, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med 4, INM Med Imaging Phys 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013; Lindemeyer, Johannes/HGU-3286-2022	Shah, N. Jon/0000-0002-8151-6169; Lindemeyer, Johannes/0000-0003-4756-7947	Bundesministerium fur Bildung und Forschung [13N9121]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	The authors gratefully acknowledge funding from the Bundesministerium fur Bildung und Forschung (Grant No.: 13N9121, http://www.bmbf.de/). This work was further funded in part by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (http://www.helmholtz.de/helmholtz_zentren_netzwerke/helmholtz_allianzen/icemed/). Generous support from Siemens for construction of the 9.4T MR scanner is also gratefully acknowledged (http://www.healthcare.siemens.de/magnetic-resonance-imaging). The authors declare that Siemens (Siemens Healthcare, Erlangen, Germany) was only acknowledged for general support and did not fund any projects, material or positions involved in this research work. Neither has the company had any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bilgic B., 2013, P 21 ANN M ISMRM, P168; Bouwman JG, 2012, MAGN RESON MED, V68, P621, DOI 10.1002/mrm.24343; D'ERRICO J., 2006, POLYFITN; de Rochefort L, 2009, P INT SOC MAGNET RES, V17, P1134; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hirsch S, 2009, HIGH FIELD SYSTEMS A, P31; Hirsch S, 2009, THESIS JOHANNES GUTE; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Koch KM, 2006, PHYS MED BIOL, V51, P6381, DOI 10.1088/0031-9155/51/24/007; Lai S, 1996, MAGNET RESON MED, V36, P781, DOI 10.1002/mrm.1910360518; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Li SZ, 1996, MAGNET RESON MED, V36, P705, DOI 10.1002/mrm.1910360509; Lindemeyer J, 2015, THESIS RWTH AACHEN U; Lindemeyer J, 2012, P INT SOC MAGNET RES, V20, P2329; Lindemeyer J, 2013, P INT SOC MAGNET RES, V21, P2494; Lindemeyer J, 2011, MAGNETIC RESONANCE S, V24, P507; Liu CL, 2010, MAGN RESON MED, V63, P1471, DOI 10.1002/mrm.22482; Liu JM, 2010, MAGN RESON MED, V63, P510, DOI 10.1002/mrm.22198; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Marques JPRF, 2004, THESIS U NOTTINGHAM; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shewchuk J.R., 1994, INTRO CONJUGATE GRAD; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sun H., 2013, MAGN RESON MED, V1157, P1151; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Zhao YS, 2005, J MAGN RESON, V173, P10, DOI 10.1016/j.jmr.2004.11.009	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138325	10.1371/journal.pone.0138325	http://dx.doi.org/10.1371/journal.pone.0138325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393515	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100052
J	Shin, J; Lee, I				Shin, Junha; Lee, Insuk			Co-Inheritance Analysis within the Domains of Life Substantially Improves Network Inference by Phylogenetic Profiling	PLOS ONE			English	Article							FUNCTIONAL LINKAGES; GENOME DATABASE; GENE NETWORK; PROTEIN; INFORMATION; ANNOTATION; DISCOVERY; PATHWAYS; RESOURCE; YEAST	Phylogenetic profiling, a network inference method based on gene inheritance profiles, has been widely used to construct functional gene networks in microbes. However, its utility for network inference in higher eukaryotes has been limited. An improved algorithm with an in-depth understanding of pathway evolution may overcome this limitation. In this study, we investigated the effects of taxonomic structures on co-inheritance analysis using 2,144 reference species in four query species: Escherichia coli, Saccharomyces cerevisiae, Arabidopsis thaliana, and Homo sapiens. We observed three clusters of reference species based on a principal component analysis of the phylogenetic profiles, which correspond to the three domains of life-Archaea, Bacteria, and Eukaryota-suggesting that pathways inherit primarily within specific domains or lower-ranked taxonomic groups during speciation. Hence, the co-inheritance pattern within a taxonomic group may be eroded by confounding inheritance patterns from irrelevant taxonomic groups. We demonstrated that co-inheritance analysis within domains substantially improved network inference not only in microbe species but also in the higher eukaryotes, including humans. Although we observed two sub-domain clusters of reference species within Eukaryota, co-inheritance analysis within these sub-domain taxonomic groups only marginally improved network inference. Therefore, we conclude that co-inheritance analysis within domains is the optimal approach to network inference with the given reference species. The construction of a series of human gene networks with increasing sample sizes of the reference species for each domain revealed that the size of the high-accuracy networks increased as additional reference species genomes were included, suggesting that within-domain co-inheritance analysis will continue to expand human gene networks as genomes of additional species are sequenced. Taken together, we propose that co-inheritance analysis within the domains of life will greatly potentiate the use of the expected onslaught of sequenced genomes in the study of molecular pathways in higher eukaryotes.	[Shin, Junha; Lee, Insuk] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Lee, I (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	insuklee@yonsei.ac.kr			National Research Foundation of Korea [2012M3A9B4028641, 2012M3A9C7050151]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2012M3A9B4028641, 2012M3A9C7050151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Costanzo MC, 2014, NUCLEIC ACIDS RES, V42, pD717, DOI 10.1093/nar/gkt1158; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dey G, 2015, CELL REP, V10, P993, DOI 10.1016/j.celrep.2015.01.025; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Fox J, 2010, NAT BIOTECHNOL, V28, P189, DOI 10.1038/nbt0310-189c; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Oates ME, 2015, NUCLEIC ACIDS RES, V43, pD227, DOI 10.1093/nar/gku1041; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pakseresht N, 2014, NUCLEIC ACIDS RES, V42, pD38, DOI 10.1093/nar/gkt1082; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Sun JC, 2005, BIOINFORMATICS, V21, P3409, DOI 10.1093/bioinformatics/bti532; Tabach Y, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.50	30	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0139006	10.1371/journal.pone.0139006	http://dx.doi.org/10.1371/journal.pone.0139006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394049	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100118
J	Takahashi, A; Sugimoto, H; Kato, S; Shiroishi, T; Koide, T				Takahashi, Aki; Sugimoto, Hiroki; Kato, Shogo; Shiroishi, Toshihiko; Koide, Tsuyoshi			Mapping of Genetic Factors That Elicit Intermale Aggressive Behavior on Mouse Chromosome 15: Intruder Effects and the Complex Genetic Basis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; Y-CHROMOSOME; STRAINS; MICE; QTL; IDENTIFICATION; HERITABILITY; ASSOCIATION; DISSECTION; OFFENSE	Despite high estimates of the heritability of aggressiveness, the genetic basis for individual differences in aggression remains unclear. Previously, we showed that the wild-derived mouse strain MSM/Ms (MSM) exhibits highly aggressive behaviors, and identified chromosome 15 (Chr 15) as the location of one of the genetic factors behind this escalated aggression by using a panel of consomic strains of MSM in a C57BL/6J (B6) background. To understand the genetic effect of Chr 15 derived from MSM in detail, this study examined the aggressive behavior of a Chr 15 consomic strain towards different types of opponent. Our results showed that both resident and intruder animals had to have the same MSM Chr 15 genotype in order for attack bites to increase and attack latency to be reduced, whereas there was an intruder effect of MSM Chr 15 on tail rattle behavior. To narrow down the region that contains the genetic loci involved in the aggression-eliciting effects on Chr 15, we established a panel of subconsomic strains of MSM Chr 15. Analysis of these strains suggested the existence of multiple genes that enhance and suppress aggressive behavior on Chr 15, and these loci interact in a complex way. Regression analysis successfully identified four genetic loci on Chr 15 that influence attack latency, and one genetic locus that partially elicits aggressive behaviors was narrowed down to a 4.1-Mbp region (from 68.40 Mb to 72.50 Mb) on Chr 15.	[Takahashi, Aki; Sugimoto, Hiroki; Koide, Tsuyoshi] Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 411, Japan; [Takahashi, Aki; Shiroishi, Toshihiko; Koide, Tsuyoshi] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Takahashi, Aki] Univ Tsukuba, Lab Behav Neuroendocrinol, Tsukuba, Ibaraki, Japan; [Takahashi, Aki; Kato, Shogo; Shiroishi, Toshihiko; Koide, Tsuyoshi] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Minato Ku, Tokyo 1050001, Japan; [Sugimoto, Hiroki] Jichi Med Univ, Ctr Mol Med, Div Biol, Shimotsuke, Tochigi, Japan; [Kato, Shogo] Inst Stat Math, Tachikawa, Tokyo, Japan; [Shiroishi, Toshihiko] NIG, Mammalian Genet Lab, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Tsukuba; Research Organization of Information & Systems (ROIS); Jichi Medical University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Koide, T (corresponding author), Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 411, Japan.	tkoide@nig.ac.jp	Takahashi, Aki/AAC-9290-2021	Takahashi, Aki/0000-0001-8325-9744	KAKENHI [23683021, 15H01298, 15H04289, 15H05724]; Grants-in-Aid for Scientific Research [15H04289] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Grants-in-Aid for Scientific Research (KAKENHI) (https://www.jsps.go.jp/english/e-grants/) as follows: KAKENHI 23683021 (AT), KAKENHI 15H01298 and 15H04289 (TK), and KAKENHI 15H05724 (AT and TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodkin ES, 2002, J NEUROSCI, V22, P1165, DOI 10.1523/JNEUROSCI.22-03-01165.2002; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Coccaro EF, 1997, BIOL PSYCHIAT, V41, P273, DOI 10.1016/S0006-3223(96)00257-0; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; DIDIERERICKSON A, 1989, BEHAV GENET, V19, P675, DOI 10.1007/BF01066030; Dow HC, 2011, GENES BRAIN BEHAV, V10, P57, DOI 10.1111/j.1601-183X.2010.00640.x; Ghazalpour A, 2006, GENETICS, V173, P943, DOI 10.1534/genetics.106.057455; Guillot PV, 1996, BEHAV GENET, V26, P497, DOI 10.1007/BF02359754; Kato S, 2014, HEREDITY, V113, P416, DOI 10.1038/hdy.2014.42; KING J A, 1957, J Genet Psychol, V90, P151; Konishi S, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-71887-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maxson SC, 2003, HORM BEHAV, V44, P258, DOI 10.1016/S0018-506X(03)00137-5; MAXSON SC, 1989, BEHAV NEURAL BIOL, V52, P251, DOI 10.1016/S0163-1047(89)90369-5; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Monahan EJ, 1998, PHYSIOL BEHAV, V64, P123, DOI 10.1016/S0031-9384(98)00041-9; Nehrenberg DL, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-113; Ogawa S, 2004, ANN NY ACAD SCI, V1036, P257, DOI 10.1196/annals.1330.016; Parker CC, 2013, GENES BRAIN BEHAV, V12, P714, DOI 10.1111/gbb.12064; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; Roubertoux PL, 2005, EUR J PHARMACOL, V526, P172, DOI 10.1016/j.ejphar.2005.09.026; Spiezio SH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-38; Stewart TP, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-81; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Takada T, 2008, GENOME RES, V18, P500, DOI 10.1101/gr.7175308; Takahashi A, 2008, GENES BRAIN BEHAV, V7, P849, DOI 10.1111/j.1601-183X.2008.00419.x; Takahashi A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00156; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Takahashi A, 2010, BEHAV GENET, V40, P366, DOI 10.1007/s10519-009-9312-x; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tordjman S, 2003, BEHAV GENET, V33, P529, DOI 10.1023/A:1025774716976; VANABEELEN JHF, 1963, GENETICA, V34, P79, DOI 10.1007/BF01664181; Vassos E, 2014, MOL PSYCHIATR, V19, P471, DOI 10.1038/mp.2013.31; Wesson DW, 2013, CURR BIOL, V23, P575, DOI 10.1016/j.cub.2013.02.012; Youngren KK, 2003, HUM MOL GENET, V12, P389, DOI 10.1093/hmg/ddg036	36	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137764	10.1371/journal.pone.0137764	http://dx.doi.org/10.1371/journal.pone.0137764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389588	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000013
J	Wennerstrom, ECM; Simonsen, J; Melbye, M				Wennerstrom, E. Christina M.; Simonsen, Jacob; Melbye, Mads			Long-Term Survival of Individuals Born Small and Large for Gestational Age	PLOS ONE			English	Article							CIVIL REGISTRATION SYSTEM; BIRTH-WEIGHT; MORTALITY; ADULTHOOD; INFANTS; DISEASE	Background Little is known on long-term survival and causes of death among individuals born small or large for gestational age. This study investigates birth weight in relation to survival and causes of death over time. Methods A national cohort of 1.7 million live-born singletons in Denmark was followed during 19792011, using the Danish Civil Registration System, the Medical Birth Registry and the Cause of Death Registry. Cox proportional hazards were estimated for the impact of small (SGA) and large (LGA) gestation weight and mortality overall, by age group and birth cohort. Results Compared to normal weight children, SGA children were associated with increased risk of dying over time. Though most of the deaths occurred during the first year of life, the cumulative mortality risk was increased until 30 years of age. The hazard ratios [HR] for dying among SGA children ages < 2 years were: 3.47 (95% CI, 3.30-3.64) and 1.06 (95% CI, 0.60-1.87) in 30 years and older. HR for dying among SGA adults (20-29 years) were: 1.20 (95% CI, 0.99-1.46) in years 1979-1982 and 1.61 (95% CI, 1.04-2.51) in years 19891994. The SGA born had increased risk of dying from infection, heart disease, respiratory disease, digestive disease, congenital malformation, perinatal conditions, and accidents, suicide, and homicide. Individuals born LGA were associated with decreased mortality risk, but with increased risk of dying from malignant neoplasm. Conclusions Survival has improved independently of birth weight the past 30 years. However, children born SGA remain at significantly increased risk of dying up till they turn 30 years of age. Individuals born LGA have lower mortality risk but only in the first two years of life.	[Wennerstrom, E. Christina M.; Simonsen, Jacob; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Melbye, Mads] Univ Copenhagen, Med Clin, Copenhagen, Denmark; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA	Statens Serum Institut; University of Copenhagen; Stanford University	Wennerstrom, ECM (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	ecmp@ssi.dk		melbye, mads/0000-0001-8264-6785; Wennerstrom, E. Christina M./0000-0002-0111-3416; Simonsen, Jacob/0000-0002-8700-4826	Oak Foundation Fellowship [OCAY-12-319]	Oak Foundation Fellowship	Dr. ECM Wennerstrom is supported by an Oak Foundation Fellowship (http://www.oakfnd.org), grant number OCAY-12-319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Costeloe KL, 2012, BMJ-BRIT MED J, V345, pe7976, DOI DOI 10.1136/BMJ.E7976; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; De Jesus LC, 2013, J PEDIATR-US, V163, P55, DOI 10.1016/j.jpeds.2012.12.097; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Knudsen LB, 1998, DAN MED BULL, V45, P320; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Malin G, 2014, BJOG; Ota E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105155; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rogvi RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016668; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Vashevnik S, 2007, AUST NZ J OBSTET GYN, V47, P302, DOI 10.1111/j.1479-828X.2007.00742.x; Xu H, 2010, ACTA PAEDIATR, V99, P550, DOI 10.1111/j.1651-2227.2009.01674.x	20	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138594	10.1371/journal.pone.0138594	http://dx.doi.org/10.1371/journal.pone.0138594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390219	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000041
J	Yao, H; Ferdaus, MZ; Zahid, HM; Ohara, H; Nakahara, T; Nabika, T				Yao, Hiroshi; Ferdaus, Mohammed Zubaerul; Zahid, Hasan Md.; Ohara, Hiroki; Nakahara, Tatsuo; Nabika, Toru			Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases	PLOS ONE			English	Article							INFARCT VOLUME; MICE; OCCLUSION; SIZE	By means of introgressing a loss-of-function mutation in the p22phox gene from the Matsumoto Eosinophilia Shinshu (MES) rat to stroke-prone spontaneously hypertensive rats (SHRSP), we constructed the SHRSP-based congenic strain lacking the P22PHOX expression (i.e., lacking NADPH oxidases [NOX] activities) (SHRSP.MES-Cyba(mes)/Izm; hereafter referred to as SP.MES). To examine the effects of Nox activities on the focal ischemic injury or stroke, we performed middle cerebral artery (MCA) occlusion in this new congenic strain; the distal MCA was occluded by 561-nm laser-driven photothrombosis. Resting mean arterial blood pressure was significantly lower in SP.MES when compared with the control PM0/SHRSP (150 +/- 11 mmHg vs. 166 +/- 11 mmHg). Cerebral blood flow decreased to 37 +/- 13% in SP.MES and 35 +/- 17% in PM0/SHRSP at 10 min after MCA occlusion (not significant). Infarct volume determined at 24 h after MCA occlusion in SP. MES was 89 +/- 39 mm(3), which was not significantly different from 83 +/- 35 mm(3) in PM0/SHRSP. The distal MCA pattern was more complex in SP.MES (median 3, IQR 3-5) than PM0/SHRSP (median 2, IQR 1-3) (p = 0.001). Because more complex distal MCA is known to produce larger infarction after distal MCA occlusion in SHR, we adjusted for the branching pattern in an ANCOVA. The adjusted mean of infarct volume was significantly smaller in SP.MES compared with that in PM0/SHRSP (67 [95% CI 46 to 87] mm3 vs. 100 [95% CI 82 to 118] mm3, p = 0.032). Elimination of the P22PHOX expression induced complex distal MCA, which would suggest the presence of 'loss of complexity' induced by enhanced oxidative stress in SHRSP; infarct size in SP.MES-when adjusted for distal MCA complexity-was significantly attenuated compared with that in PM0/SHRSP. Therefore, the present results suggest that Nox is harmful for ischemic brain tissue.	[Yao, Hiroshi; Nakahara, Tatsuo] Natl Hosp Org, Lab Neurochem, Hizen Psychiat Ctr, Saga, Japan; [Ferdaus, Mohammed Zubaerul; Zahid, Hasan Md.; Ohara, Hiroki; Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan	Shimane University	Yao, H (corresponding author), Natl Hosp Org, Lab Neurochem, Hizen Psychiat Ctr, Saga, Japan.	rinkenyao@abelia.ocn.ne.jp	Yao, Hiroshi/K-1374-2019	Ferdaus, Mohammed/0000-0002-4860-5506	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25461098]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25461098 to HY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanso Angelica M, 2012, Front Biosci (Schol Ed), V4, P1044; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cai H, 1998, STROKE, V29, P1982, DOI 10.1161/01.STR.29.9.1982; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; De Silva TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028393; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; FUJII K, 1992, HYPERTENSION, V19, P713, DOI 10.1161/01.HYP.19.6.713; Gandolgor TA, 2013, HYPERTENSION, V62, P55, DOI 10.1161/HYPERTENSIONAHA.111.00488; Horowitz A, 2009, CIRC RES, V104, pE21, DOI 10.1161/CIRCRESAHA.108.191494; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jackman KA, 2009, BRAIN RES, V1286, P215, DOI 10.1016/j.brainres.2009.06.056; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Kerr S, 1999, HYPERTENSION, V33, P1353, DOI 10.1161/01.HYP.33.6.1353; Kim HA, 2012, BRAIN RES, V1483, P105, DOI 10.1016/j.brainres.2012.09.023; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Miller AA, 2005, CIRC RES, V97, P1055, DOI 10.1161/01.RES.0000189301.10217.87; Mori M, 2009, J LEUKOCYTE BIOL, V86, P473, DOI 10.1189/jlb.1108715; Radermacher Kim A, 2012, Exp Transl Stroke Med, V4, P11, DOI 10.1186/2040-7378-4-11; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Yao H, 2007, PHYSIOL GENOMICS, V30, P69, DOI 10.1152/physiolgenomics.00149.2006; Yao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097109; Yao H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-139	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138551	10.1371/journal.pone.0138551	http://dx.doi.org/10.1371/journal.pone.0138551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389812	gold, Green Submitted, Green Published			2022-12-26	WOS:000361791000038
J	Lu, CS; Chang, PY; Chen, YG; Chen, JH; Wu, YY; Ho, CL				Lu, Chieh-Sheng; Chang, Ping-Ying; Chen, Yu-Guang; Chen, Jia-Hong; Wu, Yi-Ying; Ho, Ching-Liang			Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TEGAFUR PLUS LEUCOVORIN; PHASE-III; INTRAVENOUS FLUOROURACIL; POSTMENOPAUSAL WOMEN; FINAL REPORT; ORAL URACIL; OXALIPLATIN; SURVIVAL; TRIAL	Background The aim of this study was to examine the specific chemoregimens selected for adjuvant therapy in the patients with stage III colon cancer. We investigated the trends in chemotherapeutic prescribing patterns and looked for adequate therapeutic setting for these patients. Methods 288 patients presenting with stage III colon cancer and undergoing adjuvant therapies after curative surgery for more than 3-month were enrolled between January 2006 and December 2011. Demographic characteristics and therapeutic factors were analyzed, including age, gender, histological grade, tumor sizes, tumor location, pathologic stage, performance status, serum carcinoembryonic antigen, regimens selection, interval from the operation to the start of adjuvant therapy and prolonged adjuvant therapy. Kaplan-Meier methods were utilized for drawing survival curves and Cox model was used to analyze survival, prognostic factors. Results The analysis showed that the patients aged under 70 received more intensive therapies than those aged over 70 (P<0.001). Later, advanced analysis in therapeutic factors was conducted between the patients aged under 70 and those over 70. In the patients aged under 70, significant differences in 4-year overall survival (OS) were noted between UFUR (oral tegafur-uracil plus leucovorin) groups and FOLFOX (5-FU plus oxaliplatin) [65.6% versus (vs) 89.8%, relative risk (RR) 3.780, 95% confidence interval (CI) 1.263-11.315, P = 0.017]. There were also differences in 4-year OS between these patients with and without oxaliplatin-contained regimens (92.1% vs 83.4%, respectively, RR 0.385, 95% CI 0.157-0.946, P = 0.037). In addition, the patients who received intravenous or combined therapy also had higher 4-year OS than those only received oral regimens (92.1% vs 76.6%, P = 0.077), though the finding did not reach statistical significance. In contrast to the survival benefits of above therapeutic settings for the patients aged under 70, there was less advantage in the old patients when they received intensive therapies or even oxaliplatin-contained regimens. Prolonged cycles of adjuvant therapy resulted in no significant benefit to survival rates regardless of ages. Conclusions The adequate individualized therapeutic strategy plays an important role for stage III colon cancer. Our findings suggested that benefit of oxaliplatin-contained therapy is limited to patients aged under 70 and oral fluoropyrimidines may be an effective option for old patients. In addition, prolonged adjuvant setting is suggested to be unbeneficial for managing stage III colon cancer.	[Lu, Chieh-Sheng] Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Chieh-Sheng; Chang, Ping-Ying; Chen, Yu-Guang; Chen, Jia-Hong; Wu, Yi-Ying; Ho, Ching-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Lu, CS (corresponding author), Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan.	chengsem@gmail.com; hochingliang@yahoo.com.tw		Lu, Chieh-Sheng/0000-0002-9056-3135; Wu, Yi-Ying/0000-0003-0411-6265				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Andre T, 1999, EUR J CANCER, V35, P1343, DOI 10.1016/S0959-8049(99)00150-1; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Benson AB, 2000, J CLIN ONCOL, V18, P3586, DOI 10.1200/JCO.2000.18.20.3586; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Chan A, 2014, CURR ONCOL, V21, P181, DOI 10.3747/co.21.1963; Cheeseman SL, 2002, BRIT J CANCER, V87, P393, DOI 10.1038/sj.bjc.6600467; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Edge SB, 2010, AJCC CANC STAGING MA; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Health Promotion Administration Ministry of Health and Welfare Taiwan, TAIW CANC REG ANN RE; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Ishihara S, 2014, INT J SURG, V12, P925, DOI 10.1016/j.ijsu.2014.07.270; Kim DJ, 2003, YONSEI MED J, V44, P665, DOI 10.3349/ymj.2003.44.4.665; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Maindrault-Goebel F, 2000, ANN ONCOL, V11, P1477, DOI 10.1023/A:1026520812351; McCleary NAJ, 2009, J CLIN ONCOL, V27; McCleary NJ, 2013, J CLIN ONCOL, V31, P2600, DOI 10.1200/JCO.2013.49.6638; McCleary NJ, 2013, CLIN COLORECTAL CANC, V12, P62, DOI 10.1016/j.clcc.2012.09.001; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Qin Qiong, 2013, Zhonghua Zhong Liu Za Zhi, V35, P212, DOI 10.3760/cma.j.issn.0253-3766.2013.03.011; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Resch A, 2013, WORLD J GASTROENTERO, V19, P8515, DOI 10.3748/wjg.v19.i46.8515; Saha S, 2013, J CLIN ONCOL, V31; Scheer Adena, 2009, Clin Colon Rectal Surg, V22, P242, DOI 10.1055/s-0029-1242464; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Sugimoto K, 2015, ANN SURG ONCOL, V22, P528, DOI 10.1245/s10434-014-4015-9; Taiwan Cancer Registry, AG STAND INC LONG TE; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Wu Xiaocheng, 2004, J La State Med Soc, V156, P255	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138632	10.1371/journal.pone.0138632	http://dx.doi.org/10.1371/journal.pone.0138632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382962	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200142
J	Neth, K; Lucio, M; Walker, A; Zorn, J; Schmitt-Kopplin, P; Michalke, B				Neth, Katharina; Lucio, Marianna; Walker, Alesia; Zorn, Julia; Schmitt-Kopplin, Philippe; Michalke, Bernhard			Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats	PLOS ONE			English	Article							RESOLUTION MASS-SPECTROMETRY; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; PAIRED SERUM; FATTY-ACIDS; EXPOSURE; GLUTAMATE; NEUROTOXICITY; METABOLOMICS; SPECIATION	Exposure to high concentrations of Manganese (Mn) is known to potentially induce an accumulation in the brain, leading to a Parkinson related disease, called manganism. Versatile mechanisms of Mn-induced brain injury are discussed, with inactivation of mitochondrial defense against oxidative stress being a major one. So far, studies indicate that the main Mn-species entering the brain are low molecular mass (LMM) compounds such as Mn-citrate. Applying a single low dose MnCl2 injection in rats, we observed alterations in Mn-species pattern within the brain by analysis of aqueous brain extracts by size-exclusion chromatography-inductively coupled plasma mass spectrometry (SEC-ICP-MS). Additionally, electrospray ionization-ion cyclotron resonance-Fourier transform-mass spectrometry (ESI-ICR/FT-MS) measurement of methanolic brain extracts revealed a comprehensive analysis of changes in brain metabolisms after the single MnCl2 injection. Major alterations were observed for amino acid, fatty acid, glutathione, glucose and purine/pyrimidine metabolism. The power of this metabolomic approach is the broad and detailed overview of affected brain metabolisms. We also correlated results from the metallomic investigations (Mn concentrations and Mn-species in brain) with the findings from metabolomics. This strategy might help to unravel the role of different Mn-species during Mn-induced alterations in brain metabolism.	[Neth, Katharina; Lucio, Marianna; Walker, Alesia; Schmitt-Kopplin, Philippe; Michalke, Bernhard] Helmholtz Zentrum Munchen, German Res Ctr Environm & Hlth GmbH, Res Unit Analyt BioGeoChem, D-85764 Neuherberg, Germany; [Zorn, Julia] Helmholtz Zentrum Munchen, German Res Ctr Environm & Hlth GmbH, Res Unit Comparat Med, D-85764 Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, D-85354 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Neth, K (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm & Hlth GmbH, Res Unit Analyt BioGeoChem, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	katharina.neth@helmholtz-muenchen.de	Schmitt-Kopplin, Philippe/H-6271-2011	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098; Walker, Alesia/0000-0002-1477-2023	German Research Center for Environment and Health (GmbH)	German Research Center for Environment and Health (GmbH)	German Research Center for Environment and Health (GmbH) provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antonini JM, 2006, NEUROTOXICOLOGY, V27, P304, DOI 10.1016/j.neuro.2005.09.001; Aschner M, 2006, NEUROTOXICOLOGY, V27, P733, DOI 10.1016/j.neuro.2005.10.005; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Bonilla E, 1994, Invest Clin, V35, P175; Bornhorst J, 2012, METALLOMICS, V4, P297, DOI 10.1039/c2mt00164k; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Crossgrove JS, 2004, REPORT NO 119; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Deng Y, 2012, BIOL TRACE ELEM RES, V148, P242, DOI 10.1007/s12011-012-9365-1; Diederich J, 2012, MICROCHEM J, V105, P115, DOI 10.1016/j.microc.2012.03.015; Diederich J, 2011, ANAL BIOANAL CHEM, V399, P1799, DOI 10.1007/s00216-010-4162-1; Dorman DC, 2008, TOXICOL SCI, V106, P46, DOI 10.1093/toxsci/kfn159; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Erikson KM, 2008, NEUROTOXICOLOGY, V29, P377, DOI 10.1016/j.neuro.2007.12.007; Erikson KM, 2006, BIOL TRACE ELEM RES, V111, P199, DOI 10.1385/BTER:111:1:199; Erikson KM, 2003, NEUROCHEM INT, V43, P475, DOI 10.1016/S0197-0186(03)00037-8; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fernsebner K, 2014, METALLOMICS, V6, P921, DOI 10.1039/c4mt00022f; FERRAZ HB, 1988, NEUROLOGY, V38, P550, DOI 10.1212/WNL.38.4.550; Fitsanakis VA, 2006, NEUROCHEM INT, V48, P426, DOI 10.1016/j.neuint.2005.10.012; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Frumkin H, 1997, AM J IND MED, V31, P107; Fuxe K, 2010, CNS NEUROSCI THER, V16, pe18, DOI 10.1111/j.1755-5949.2009.00126.x; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gallez B, 1998, MAGN RESON IMAGING, V16, P1211, DOI 10.1016/S0730-725X(98)00082-4; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Kapich AN, 2011, ENZYME MICROB TECH, V49, P25, DOI 10.1016/j.enzmictec.2011.04.009; Karki P, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-4; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Kumar KK, 2015, METALLOMICS, V7, P363, DOI 10.1039/c4mt00223g; Lin SH, 2013, ANAL BIOANAL CHEM, V405, P5105, DOI 10.1007/s00216-013-6825-1; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; Liu XH, 2006, TOXICOL SCI, V91, P521, DOI 10.1093/toxsci/kfj150; Lucchini R, 2009, NEUROTOXICOLOGY, V30, P1144, DOI 10.1016/j.neuro.2009.10.003; Lucchini RG, 2007, AM J IND MED, V50, P788, DOI 10.1002/ajim.20494; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; Maruyama W, 2014, SUBCELL BIOCHEM, V77, P127, DOI 10.1007/978-94-007-7920-4_11; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; Michalke B, 2013, ANAL BIOANAL CHEM, V405, P2301, DOI 10.1007/s00216-012-6662-7; Michalke B, 2007, ELECTROPHORESIS, V28, P1380, DOI 10.1002/elps.200600686; Michalke B, 2014, J TRACE ELEM MED BIO, V28, P106, DOI 10.1016/j.jtemb.2013.08.005; Muller C, 2013, ANAL BIOANAL CHEM, V405, P5119, DOI 10.1007/s00216-013-6732-5; Neth K, 2015, CHEM RES TOXICOL, V28, P1434, DOI 10.1021/acs.chemrestox.5b00104; Nischwitz V, 2008, ANAL CHIM ACTA, V627, P258, DOI 10.1016/j.aca.2008.08.018; Pan DPJ, 2011, WIRES NANOMED NANOBI, V3, P162, DOI 10.1002/wnan.116; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Richardson P J, 1999, Adv Neurol, V80, P111; Schmitt-Kopplin P, 2010, ANAL CHEM, V82, P8017, DOI 10.1021/ac101444r; Sidoryk-Wegrzynowicz M, 2013, J INTERN MED, V273, P466, DOI 10.1111/joim.12040; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Takeda A, 1998, NEUROSCI LETT, V242, P45, DOI 10.1016/S0304-3940(98)00006-8; Taylor MD, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/791431; Villalobos V, 2001, NEUROCHEM RES, V26, P1157, DOI 10.1023/A:1012379024571; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Walker A, 2014, ISME J, V8, P2380, DOI 10.1038/ismej.2014.79; Witting M, 2014, ANAL BIOANAL CHEM, P1; Xu K, 2005, PHARMACOL THERAPEUT, V105, P267, DOI 10.1016/j.pharmthera.2004.10.007; Zayed J, 2001, AM J IND MED, V39, P426, DOI 10.1002/ajim.1034.abs; Zhang DH, 2011, TOXICOL APPL PHARM, V254, P65, DOI 10.1016/j.taap.2010.03.023; Zheng W, 2000, TOXICOL SCI, V54, P295, DOI 10.1093/toxsci/54.2.295; Zwingmann C, 2003, J CEREBR BLOOD F MET, V23, P756, DOI 10.1097/01.WCB.0000056062.25434.4D	69	23	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138270	10.1371/journal.pone.0138270	http://dx.doi.org/10.1371/journal.pone.0138270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383269	Green Published, gold			2022-12-26	WOS:000361790200084
J	Rong, Y; Nakamura, S; Hirata, T; Motooka, D; Liu, YS; He, ZA; Gao, XD; Maeda, Y; Kinoshita, T; Fujita, M				Rong, Yao; Nakamura, Shota; Hirata, Tetsuya; Motooka, Daisuke; Liu, Yi-Shi; He, Zeng-An; Gao, Xiao-Dong; Maeda, Yusuke; Kinoshita, Taroh; Fujita, Morihisa			Genome-Wide Screening of Genes Required for Glycosylphosphatidylinositol Biosynthesis	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; DOLICHOL-PHOSPHATE-MANNOSE; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SOMATIC MUTATION; MAMMALIAN-CELLS; INITIAL ENZYME; VIRUS ENTRY	Glycosylphosphatidylinositol (GPI) is synthesized and transferred to proteins in the endoplasmic reticulum (ER). GPI-anchored proteins are then transported from the ER to the plasma membrane through the Golgi apparatus. To date, at least 17 steps have been identified to be required for the GPI biosynthetic pathway. Here, we aimed to establish a comprehensive screening method to identify genes involved in GPI biosynthesis using mammalian haploid screens. Human haploid cells were mutagenized by the integration of gene trap vectors into the genome. Mutagenized cells were then treated with a bacterial pore-forming toxin, aerolysin, which binds to GPI-anchored proteins for targeting to the cell membrane. Cells that showed low surface expression of CD59, a GPI-anchored protein, were further enriched for. Gene trap insertion sites in the non-selected population and in the enriched population were determined by deep sequencing. This screening enriched 23 gene regions among the 26 known GPI biosynthetic genes, which when mutated are expected to decrease the surface expression of GPI-anchored proteins. Our results indicate that the forward genetic approach using haploid cells is a useful and powerful technique to identify factors involved in phenotypes of interest.	[Rong, Yao; Liu, Yi-Shi; He, Zeng-An; Gao, Xiao-Dong; Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Nakamura, Shota; Hirata, Tetsuya; Motooka, Daisuke; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Hirata, Tetsuya; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Jiangnan University; Osaka University; Osaka University	Gao, XD (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China.	xdgao@jiangnan.edu.cn; fujita@jiangnan.edu.cn	Nakamura, Shota/E-3033-2010; Kinoshita, Taroh/C-7353-2009; Fujita, Morihisa/AAM-4142-2020	Nakamura, Shota/0000-0003-2058-5942; Rong, Yao/0000-0002-1726-2555; Liu, Yi-Shi/0000-0001-5640-1899	National Natural Science Foundation for Young Scientists of China [31400693]; Natural Science Foundation of Jiangsu Province [BK20140141]; Fundamental Research Funds for the Central Universities [JUSRP51508]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS) Research Fellowship; Grants-in-Aid for Scientific Research [14J07702] Funding Source: KAKEN	National Natural Science Foundation for Young Scientists of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant-in-aids from the National Natural Science Foundation for Young Scientists of China (31400693), and the Natural Science Foundation of Jiangsu Province (BK20140141) (to M. Fujita), Fundamental Research Funds for the Central Universities (JUSRP51508) (to X.D. Gao and M. Fujita), and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Kinoshita and M. Fujita). T. Hirata was supported by Japan Society for the Promotion of Science (JSPS) Research Fellowship.	Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; BENGHEZAL M, 1995, J CELL BIOL, V130, P1333, DOI 10.1083/jcb.130.6.1333; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; de la Morena-Barrio ME, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-170; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hirata T, 2013, J BIOCHEM, V154, P257, DOI 10.1093/jb/mvt045; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kawagoe K, 1996, BLOOD, V87, P3600, DOI 10.1182/blood.V87.9.3600.bloodjournal8793600; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Krawitz PM, 2013, BLOOD, V122, P1312, DOI 10.1182/blood-2013-01-481499; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murakami Y, 2005, MOL BIOL CELL, V16, P5236, DOI 10.1091/mbc.E05-08-0743; Ng BG, 2015, J INHERIT METAB DIS, V38, P171, DOI 10.1007/s10545-014-9752-1; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Seong J, 2013, J LIPID RES, V54, P1077, DOI 10.1194/jlr.M034421; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Tokunaga M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1016; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402	54	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138553	10.1371/journal.pone.0138553	http://dx.doi.org/10.1371/journal.pone.0138553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383639	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200125
J	Volpe, G; Clarke, M; Garcia, P; Walton, DS; Vegiopoulos, A; Del Pozzo, W; O'Neill, LP; Frampton, J; Dumon, S				Volpe, Giacomo; Clarke, Mary; Garcia, Paloma; Walton, David Scott; Vegiopoulos, Alexandros; Del Pozzo, Walter; O'Neill, Laura Patricia; Frampton, Jonathan; Dumon, Stephanie			Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells	PLOS ONE			English	Article							C-MYB-KNOCKOUT; LINEAGE COMMITMENT; BONE-MARROW; MULTIPOTENT PROGENITORS; SELF-RENEWAL; C/EBP-ALPHA; MYELOID-LEUKEMIA; CRITICAL ROLES; DIFFERENTIATION; EXPRESSION	The MYB transcription factor plays critical roles in normal and malignant haematopoiesis. We previously showed that MYB was a direct activator of FLT3 expression within the context of acute myeloid leukaemia. During normal haematopoiesis, increasing levels of FLT3 expression determine a strict hierarchy within the haematopoietic stem and early progenitor compartment, which associates with lymphoid and myeloid commitment potential. We use the conditional deletion of the Myb gene to investigate the influence of MYB in Flt3 transcriptional regulation within the haematopoietic stem cell (HSC) hierarchy. In accordance with previous report, in vivo deletion of Myb resulted in rapid biased differentiation of HSC with concomitant loss of proliferation capacity. We find that loss of MYB activity also coincided with decreased FLT3 expression. At the chromatin level, the Flt3 promoter is primed in immature HSC, but occupancy of further intronic elements determines expression. Binding to these locations, MYB and C/EBP alpha need functional cooperation to activate transcription of the locus. This cooperation is cell context dependent and indicates that MYB and C/EBP alpha activities are inter-dependent in controlling Flt3 expression to influence lineage commitment of multipotential progenitors.	[Volpe, Giacomo; Clarke, Mary; Garcia, Paloma; Walton, David Scott; O'Neill, Laura Patricia; Frampton, Jonathan; Dumon, Stephanie] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Vegiopoulos, Alexandros] German Canc Res Ctr, Div Mol Metab Control A170, DKFZ Jr Grp Metab & Stem Cell Plast, Heidelberg, Germany; [Del Pozzo, Walter] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	University of Birmingham; Helmholtz Association; German Cancer Research Center (DKFZ); University of Birmingham	Frampton, J (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	j.frampton@bham.ac.uk; s.dumon@bham.ac.uk	Volpe, Giacomo/AAQ-5235-2021; Volpe, Giacomo/AAT-2783-2020; Volpe, Giacomo/GSI-6601-2022; Garcia, Paloma/AFO-2595-2022	Volpe, Giacomo/0000-0001-5000-6951; Del Pozzo, Walter/0000-0003-3978-2030; Garcia, Paloma/0000-0001-5582-8575	Leukaemia and Lymphoma Research [12030]; Medical Research Council [G0501688, MR/K01076X/1] Funding Source: researchfish; MRC [MR/K01076X/1, G0501688] Funding Source: UKRI	Leukaemia and Lymphoma Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Leukaemia and Lymphoma Research (leukaemialymphomaresearch.org.uk) (grant number 12030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Boiers C, 2010, BLOOD, V115, P5061, DOI 10.1182/blood-2009-12-258756; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Cho S, 2011, J IMMUNOL, V187, P5203, DOI 10.4049/jimmunol.1102119; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Dumon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043300; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Fahl SP, 2009, J IMMUNOL, V183, P5582, DOI 10.4049/jimmunol.0901187; Garcia P, 2009, EMBO J, V28, P1492, DOI 10.1038/emboj.2009.97; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; Gwin K, 2010, J IMMUNOL, V185, P6572, DOI 10.4049/jimmunol.0904203; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Lieu YK, 2012, CELL CYCLE, V11, P3504, DOI 10.4161/cc.21802; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Volpe G, 2013, LEUKEMIA, V27, P1487, DOI 10.1038/leu.2013.23; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yao CJ, 2008, BIOCHEM BIOPH RES CO, V371, P309, DOI 10.1016/j.bbrc.2008.04.065; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	46	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138257	10.1371/journal.pone.0138257	http://dx.doi.org/10.1371/journal.pone.0138257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382271	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200079
J	Watanabe, S; Sueda, R; Fukumori, F; Watanabe, Y				Watanabe, Seiya; Sueda, Rui; Fukumori, Fumiyasu; Watanabe, Yasuo			Characterization of Flavin-Containing Opine Dehydrogenase from Bacteria	PLOS ONE			English	Article							CROWN-GALL TUMORS; L-PROLINE DEHYDROGENASE; AMINO-ACID OXIDASES; PSEUDOMONAS-PUTIDA; AGROBACTERIUM-TUMEFACIENS; OCTOPINE SYNTHASE; L-HYDROXYPROLINE; TI-PLASMID; IDENTIFICATION; NOPALINE	Opines, in particular nopaline and octopine, are specific compounds found in crown gall tumor tissues induced by infections with Agrobacterium species, and are synthesized by well-studied NAD(P)H-dependent dehydrogenases (synthases), which catalyze the reductive condensation of a-ketoglutarate or pyruvate with L-arginine. The corresponding genes are transferred into plant cells via a tumor-inducing (Ti) plasmid. In addition to the reverse oxidative reaction(s), the genes noxB-noxA and ooxB-ooxA are considered to be involved in opine catabolism as (membrane-associated) oxidases; however, their properties have not yet been elucidated in detail due to the difficulties associated with purification (and preservation). We herein successfully expressed Nox/Oox-like genes from Pseudomonas putida in P. putida cells. The purified protein consisted of different alpha-, beta-, and gamma-subunits encoded by the OdhA, OdhB, and OdhC genes, which were arranged in tandem on the chromosome (OdhB-C-A), and exhibited dehydrogenase (but not oxidase) activity toward nopaline in the presence of artificial electron acceptors such as 2,6-dichloroindophenol. The enzyme contained FAD, FMN, and [2Fe-2S]-iron sulfur as prosthetic groups. On the other hand, the gene cluster from Bradyrhizobium japonicum consisted of OdhB(1)-C-A-B-2, from which two proteins, OdhAB(1)C and OdhAB(2)C, appeared through the assembly of each beta-subunit together with common alpha- and gamma-subunits. A poor phylogenetic relationship was detected between OdhB(1) and OdhB(2) in spite of them both functioning as octopine dehydrogenases, which provided clear evidence for the acquisition of novel functions by "subunit-exchange". To the best of our knowledge, this is the first study to have examined flavin-containing opine dehydrogenase.	[Watanabe, Seiya; Sueda, Rui; Watanabe, Yasuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Watanabe, Seiya] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Fukumori, Fumiyasu] Toyo Univ, Fac Food & Nutr Sci, Itakura Machi, Gunma, Japan	Ehime University; Ehime University; Toyo University	Watanabe, S (corresponding author), Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan.	irab@agr.ehime-u.ac.jp			KAKENHI [25440049]; HOKTO Research Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); HOKTO Research Foundation	This work was supported by KAKENHI (25440049) (to S.W.) (http://www.jsps.go.jp/english/e-grants/index.html) and HOKTO Research Foundation (to S.W.) (http://www.hokto-kinoko.co.jp/en/index.php).	ASANO Y, 1989, J BACTERIOL, V171, P4466, DOI 10.1128/JB.171.8.4466-4471.1989; BEVAN MW, 1982, ANNU REV GENET, V16, P357, DOI 10.1146/annurev.ge.16.120182.002041; CHANG CC, 1983, P NATL ACAD SCI-BIOL, V80, P3573, DOI 10.1073/pnas.80.12.3573; CHILTON WS, 1984, J BACTERIOL, V157, P357, DOI 10.1128/JB.157.2.357-362.1984; DAIRI T, 1995, APPL ENVIRON MICROB, V61, P3169, DOI 10.1128/AEM.61.8.3169-3171.1995; FIRMIN JL, 1985, BIOCHEM J, V232, P431, DOI 10.1042/bj2320431; Fischer L, 1996, ANN NY ACAD SCI, V799, P683, DOI 10.1111/j.1749-6632.1996.tb33274.x; Flores-Mireles AL, 2012, MOL MICROBIOL, V84, P845, DOI 10.1111/j.1365-2958.2012.08061.x; Fushiya S, 1996, TETRAHEDRON, V52, P877, DOI 10.1016/0040-4020(95)00929-9; HACK E, 1977, BIOCHEM BIOPH RES CO, V78, P785, DOI 10.1016/0006-291X(77)90248-0; HACK E, 1980, PLANT PHYSIOL, V65, P949, DOI 10.1104/pp.65.5.949; Harcet M, 2013, BIOCHEM GENET, V51, P666, DOI 10.1007/s10528-013-9596-7; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; Kawakami R, 2012, APPL MICROBIOL BIOT, V93, P83, DOI 10.1007/s00253-011-3682-8; KEMP JD, 1979, BIOCHEMISTRY-US, V18, P3755, DOI 10.1021/bi00584a017; Kobayashi Y, 2011, ENVIRON MICROBIOL, V13, P2007, DOI 10.1111/j.1462-2920.2010.02344.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moore LW, 1997, APPL ENVIRON MICROB, V63, P201, DOI 10.1128/AEM.63.1.201-207.1997; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Pollegioni L, 2008, APPL MICROBIOL BIOT, V78, P1, DOI 10.1007/s00253-007-1282-4; RONCHEL MC, 1995, APPL ENVIRON MICROB, V61, P2990, DOI 10.1128/AEM.61.8.2990-2994.1995; Sambrook J., 2001, MOL CLONING LAB MANU; SANS N, 1987, EUR J BIOCHEM, V167, P81, DOI 10.1111/j.1432-1033.1987.tb13306.x; SUTTON DW, 1978, PLANT PHYSIOL, V62, P363, DOI 10.1104/pp.62.3.363; TREMBLAY G, 1987, APPL ENVIRON MICROB, V53, P1519, DOI 10.1128/AEM.53.7.1519-1524.1987; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Watanabe S, 2015, J BIOTECHNOL, V199, P9, DOI 10.1016/j.jbiotec.2015.01.026; Watanabe S, 2014, FEBS OPEN BIO, V4, P240, DOI 10.1016/j.fob.2014.02.010; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; ZANKER H, 1994, J BACTERIOL, V176, P4511, DOI 10.1128/JB.176.15.4511-4517.1994	34	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138434	10.1371/journal.pone.0138434	http://dx.doi.org/10.1371/journal.pone.0138434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382958	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200102
J	Aires, RF; Oliveira, GA; Oliveira, TF; Res, AFH; Oliveira, RF				Aires, Rui F.; Oliveira, Goncalo A.; Oliveira, Tania F.; Res, Albert F. H.; Oliveira, Rui F.			Dear Enemies Elicit Lower Androgen Responses to Territorial Challenges than Unfamiliar Intruders in a Cichlid Fish	PLOS ONE			English	Article							OREOCHROMIS-MOSSAMBICUS; SOCIAL MODULATION; NEIGHBORS; STRANGERS; STEROIDS; RECOGNITION; ATTRITION; BEHAVIOR; PLASMA; PETERS	In many territorial species androgen hormones are known to increase in response to territorial intrusions as a way to adjust the expression of androgen-dependent behaviour to social challenges. The dear enemy effect has also been described in territorial species and posits that resident individuals show a more aggressive response to intrusions by strangers than by other territorial neighbours. Therefore, we hypothesized that the dear enemy effect may also modulate the androgen response to a territorial intrusion. Here we tested this hypothesis in male cichlid fish (Mozambique tilapia, Oreochromis mossambicus) using a paradigm of four repeated territorial intrusions, either by the same neighbour or by four different unfamiliar intruders. Neighbour intruders elicited lower aggression and a weaker androgen response than strangers on the first intrusion of the experiment. With repeated intrusions, the agonistic behaviour of the resident males against familiar intruders was similar to that displayed towards strangers. By the fourth intrusion the androgen response was significantly reduced and there was no longer a difference between the responses to the two types of intruders. These results suggest that the dear enemy effect modulates the androgen response to territorial intrusions and that repeated intrusions lead to a habituation of the androgen response.	[Aires, Rui F.; Oliveira, Goncalo A.; Oliveira, Tania F.; Res, Albert F. H.; Oliveira, Rui F.] ISPA Inst Univ, Lisbon, Portugal; [Oliveira, Goncalo A.; Oliveira, Rui F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Oliveira, Rui F.] Champalimaud Fdn, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Instituto Gulbenkian de Ciencia; Fundacao Champalimaud	Oliveira, RF (corresponding author), ISPA Inst Univ, Lisbon, Portugal.	ruiol@ispa.pt	Oliveira, Rui/A-3581-2013; Ros, Albert FH/I-7726-2015; Oliveira, Tania F./W-1153-2018	Oliveira, Rui/0000-0003-1528-618X; Ros, Albert FH/0000-0003-3241-9722; Oliveira, Tania F./0000-0002-4724-6935; Oliveira, Goncalo/0000-0002-6462-0546	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [SFRH/BD/68528/2010, SFRH/BD/36746/2007]; FCT [EXCL/BIA-ANM/0549/2012]; Fundação para a Ciência e a Tecnologia [EXCL/BIA-ANM/0549/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	GAO and TFO were supported by doctoral fellowships (SFRH/BD/68528/2010 and SFRH/BD/36746/2007, respectively) from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). This research was funded by the FCT grant EXCL/BIA-ANM/0549/2012 awarded to RFO.	Akcay C, 2009, ANIM BEHAV, V78, P97, DOI 10.1016/j.anbehav.2009.03.023; Almeida O, 2014, HORM BEHAV, V66, P369, DOI 10.1016/j.yhbeh.2014.05.007; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Antunes RA, 2009, P NATL ACAD SCI USA, V106, P15985, DOI 10.1073/pnas.0900817106; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; Booksmythe I, 2010, ANIM BEHAV, V79, P419, DOI 10.1016/j.anbehav.2009.11.020; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Brandt Yoni, 1999, Animal Behaviour Forum, V57, pF13, DOI 10.1006/anbe.1998.1073; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; BRONSTEIN PM, 1994, J COMP PSYCHOL, V108, P45, DOI 10.1037/0735-7036.108.1.45; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Frostman P, 2004, ICHTHYOL RES, V51, P283, DOI 10.1007/s10228-004-0223-9; Galhardo L, 2008, ANIM WELFARE, V17, P239; GETTY T, 1989, ANIM BEHAV, V37, P337, DOI 10.1016/0003-3472(89)90125-5; Goncalves DM, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 1: FISHES, P119; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Leiser JK, 1999, BEHAVIOUR, V136, P983, DOI 10.1163/156853999501685; Leiser JK, 2003, ANIM BEHAV, V65, P453, DOI 10.1006/anbe.2003.2087; Monclus R, 2014, BEHAV PROCESS, V106, P17, DOI 10.1016/j.beproc.2014.04.004; Neat FC, 1998, ANIM BEHAV, V55, P883, DOI 10.1006/anbe.1997.0669; NEIL E. H., 1964, UNIV CALIF PUBLICATIONS ZOOL, V75, P1; Nelson CM, 1995, ANIM BEHAV, V50, P1587, DOI 10.1016/0003-3472(95)80013-1; Oliveira GA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00209; Oliveira R. F., 2001, NATURE, V409, P2001, DOI DOI 10.1038/35054128; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Oliveira RF, 1998, J FISH BIOL, V52, P1115, DOI 10.1111/j.1095-8649.1998.tb00959.x; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Oliveira RF, 2009, P ROY SOC B-BIOL SCI, V276, P2249, DOI 10.1098/rspb.2009.0132; Owen PC, 1998, BEHAV ECOL SOCIOBIOL, V44, P209, DOI 10.1007/s002650050533; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Parker G.A., 1984, BEHAVIOURAL ECOLOGY, P30; Rocha MJ, 1996, COMP BIOCHEM PHYS C, V115, P257, DOI 10.1016/S0742-8413(96)00133-8; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1994, GEN COMP ENDOCR, V96, P309, DOI 10.1006/gcen.1994.1186; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; TEMELES EJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P57; TURNER GF, 1986, J FISH BIOL, V29, P573, DOI 10.1111/j.1095-8649.1986.tb04974.x; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6	40	15	15	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137705	10.1371/journal.pone.0137705	http://dx.doi.org/10.1371/journal.pone.0137705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379045	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400023
J	do Amaral, FR; Neves, LG; Resende, MFR; Mobili, F; Miyaki, CY; Pellegrino, KCM; Biondo, C				do Amaral, Fabio Raposo; Neves, Leandro G.; Resende, Marcio F. R., Jr.; Mobili, Flavia; Miyaki, Cristina Y.; Pellegrino, Katia C. M.; Biondo, Cibele			Ultraconserved Elements Sequencing as a Low-Cost Source of Complete Mitochondrial Genomes and Microsatellite Markers in Non-Model Amniotes	PLOS ONE			English	Article							GENETIC-MARKERS; DNA; PHYLOGEOGRAPHY; PERSPECTIVE; ANNOTATION; GENERATION; TIME; HETEROPLASMY; INFORMATION; SYSTEMATICS	Sequence capture of ultraconserved elements (UCEs) associated with massively parallel sequencing has become a common source of nuclear data for studies of animal systematics and phylogeography. However, mitochondrial and microsatellite variation are still commonly used in various kinds of molecular studies, and probably will complement genomic data in years to come. Here we show that besides providing abundant genomic data, UCE sequencing is an excellent source of both sequences for microsatellite loci design and complete mitochondrial genomes with high sequencing depth. Identification of dozens of microsatellite loci and assembly of complete mitogenomes is exemplified here using three species of Poospiza warbling finches from southern and southeastern Brazil. This strategy opens exciting opportunities to simultaneously analyze genome-wide nuclear datasets and traditionally used mtDNA and microsatellite markers in non-model amniotes at no additional cost.	[do Amaral, Fabio Raposo; Mobili, Flavia; Pellegrino, Katia C. M.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Lab Genet Evolut, BR-09972270 Diadema, SP, Brazil; [Neves, Leandro G.; Resende, Marcio F. R., Jr.] RAPiD Genom LLC, Gainesville, FL 32601 USA; [Miyaki, Cristina Y.] Univ Sao Paulo, Dept Genet & Biol Evolut, BR-05508090 Sao Paulo, SP, Brazil; [Biondo, Cibele] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09606070 Sao Bernardo Do Campo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	do Amaral, FR (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Lab Genet Evolut, Rua Prof Artur Riedel 275, BR-09972270 Diadema, SP, Brazil.	fabioraposo@gmail.com	Amaral, Fabio Raposo do/B-9817-2012; Miyaki, Cristina Y/J-2431-2015; Pellegrino, Katia Cristina M/D-7566-2013; Biondo, Cibele/G-3811-2015	Amaral, Fabio Raposo do/0000-0002-1133-3789; Miyaki, Cristina Y/0000-0002-9708-9202; Biondo, Cibele/0000-0003-4020-4246; Resende Jr., Marcio/0000-0002-2367-0766	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011-50143-7, 2011/23155-4, 2013/50297-0]; National Science Foundation [DOB 1343578]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation(National Science Foundation (NSF))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant numbers 2011-50143-7 and 2011/23155-4 to FR, website: http://www.bv.fapesp.br/21144; grant number 2013/50297-0 to CYM, website: http://www.bv.fapesp.br/7387) and National Science Foundation (DOB 1343578 to CYM, http://nsf.gov/awardsearch/showAward?AWD_ID=1343578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RAPiD Genomics provided support in the form of salaries for authors LGN and MFRR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2015, FASTQC QUALITY CONTR; [Anonymous], 2010, P GATEWAY COMPUTING; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bolger AM, BIOINFORMAT IN PRESS; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; do Amaral FR, 2013, MOL ECOL, V22, P3996, DOI 10.1111/mec.12361; do Amaral FR, 2012, J FIELD ORNITHOL, V83, P403, DOI 10.1111/j.1557-9263.2012.00390.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2000, EVOLUTION, V54, P1839; ESTOUP A, 1993, HEREDITY, V71, P488, DOI 10.1038/hdy.1993.167; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Faircloth BC, 2014, PHYLUCE PHYLOGENETIC; Faircloth BC, 2014, ILLUMIPROCESSOR TRIM; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Falk MJ, 2012, DISCOV MED, V14, P389; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrison E, 2014, ARXIV12073907; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66; Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harvey MG, 2013, SEQUENCE CAPTURE VER, P1; Jennings TN, 2011, MOL ECOL RESOUR, V11, P1060, DOI 10.1111/j.1755-0998.2011.03033.x; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Miller MJ, 2014, MITOCHONDR DNA, P1; Nylander J. A. A., 2004, MRMODELTEST V2; Pan T, 2013, MITOCHONDR DNA, V24, P382, DOI 10.3109/19401736.2013.763238; Parrini R., 2007, ARARAJUBA, V15, P103; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	60	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138446	10.1371/journal.pone.0138446	http://dx.doi.org/10.1371/journal.pone.0138446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379155	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400101
J	Zmora, P; Moldenhauer, AS; Hofmann-Winkler, H; Pohlmann, S				Zmora, Pawel; Moldenhauer, Anna-Sophie; Hofmann-Winkler, Heike; Poehlmann, Stefan			TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; INFLUENZA-A VIRUS; SERINE-PROTEASE; PROTEOLYTIC ACTIVATION; TRANSMEMBRANE; ENTRY; CLONING; GENE; H7N9	The cellular protease TMPRSS2 cleaves and activates the influenza virus hemagglutinin (HA) and TMPRSS2 expression is essential for viral spread and pathogenesis in mice. Moreover, severe acute respiratory syndrome coronavirus (SARS-CoV) and other respiratory viruses are activated by TMPRSS2. However, previous studies on viral activation by TMPRSS2 focused on a 492 amino acids comprising form of the protein (isoform 2) while other TMPRSS2 isoforms, generated upon alternative splicing of the tmprss2 mRNA, have not been characterized. Here, we show that the mRNA encoding a TMPRSS2 isoform with an extended N-terminal cytoplasmic domain (isoform 1) is expressed in lung-derived cell lines and tissues. Moreover, we demonstrate that TMPRSS2 isoform 1 colocalizes with HA and cleaves and activates HA. Finally, we show that isoform 1 activates the SARS-CoV spike protein for cathepsin L-independent entry into target cells. Our results indicate that TMPRSS2 isoform 1 is expressed in viral target cells and might contribute to viral activation in the host.	[Zmora, Pawel; Moldenhauer, Anna-Sophie; Hofmann-Winkler, Heike; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	spoehlmann@dpz.eu	Pöhlmann, Stefan/H-2395-2011; Zmora, Pawel/V-3843-2019	Pöhlmann, Stefan/0000-0001-6086-9136; Zmora, Pawel/0000-0002-2012-7223	DFG [PO 716/6-1]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG) [GSC 226/1, GSC 226/2]	DFG(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG)	This work was supported by DFG (PO 716/6-1) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG Grant GSC 226/1 and DFG Grant GSC 226/2).	Abe M, 2013, J VIROL, V87, P11930, DOI 10.1128/JVI.01490-13; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng Z, 2015, J INFECT DIS; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Esumi M, 2015, HEPATOLOGY, V61, P437, DOI 10.1002/hep.27426; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Lapointe J, 2007, MODERN PATHOL, V20, P467, DOI 10.1038/modpathol.3800759; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	32	21	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138380	10.1371/journal.pone.0138380	http://dx.doi.org/10.1371/journal.pone.0138380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379044	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400093
J	Luanpitpong, S; Li, J; Manke, A; Brundage, K; Ellis, E; McLaughlin, SL; Angsutararux, P; Chanthra, N; Voronkova, M; Chen, YC; Wang, L; Chanvorachote, P; Pei, M; Issaragrisil, S; Rojanasakul, Y				Luanpitpong, S.; Li, J.; Manke, A.; Brundage, K.; Ellis, E.; McLaughlin, S. L.; Angsutararux, P.; Chanthra, N.; Voronkova, M.; Chen, Y. C.; Wang, L.; Chanvorachote, P.; Pei, M.; Issaragrisil, S.; Rojanasakul, Y.			SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma	ONCOGENE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; BREAST-CANCER; ALDEHYDE DEHYDROGENASE; DEGRADATION; ADENOCARCINOMA; EXPRESSION; GROWTH; IDENTIFICATION	Cancer stem cells (CSCs) are a promising target for cancer therapy, particularly for metastatic lung cancers, but how CSCs are regulated is largely unknown. We identify two proteins, SLUG (encoded by SNAI2 gene) and SOX9, which are associated with advanced stage lung cancers and are implicated in the regulation of CSCs. Inhibition of either SLUG or SOX9 sufficiently inhibits CSCs in human lung cancer cells and attenuates experimental lung metastasis in a xenograft mouse model. Correlation between SLUG and SOX9 levels was observed remarkably, we therefore sought to explore their mechanistic relationship and regulation. SLUG, beyond its known function as an epithelial-mesenchymal transition transcription factor, was found to regulate SOX9 by controlling its stability via a post-translational modification process. SLUG interacts directly with SOX9 and prevents it from ubiquitin-mediated proteasomal degradation. SLUG expression and binding are necessary for SOX9 promotion of lung CSCs and metastasis in a mouse model. Together, our findings provide a novel mechanistic insight into the regulation of CSCs via SLUG-SOX9 regulatory axis, which represents a potential novel target for CSC therapy that may overcome cancer chemoresistance and relapse.	[Angsutararux, P.; Chanthra, N.; Issaragrisil, S.] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Bangkok 10700, Thailand; [Luanpitpong, S.; Manke, A.; Rojanasakul, Y.] W Virginia Univ, Pharmaceut & Pharmacol Sci Program, Morgantwon, WV 26506 USA; [Luanpitpong, S.; Voronkova, M.; Rojanasakul, Y.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantwon, WV 26506 USA; [Li, J.; Pei, M.] W Virginia Univ, Stem Cell & Tissue Engn Lab, Morgantwon, WV 26506 USA; [Brundage, K.] W Virginia Univ, Flow Cytometry Core Facil, Morgantwon, WV 26506 USA; [Ellis, E.; McLaughlin, S. L.] W Virginia Univ, Anim Models & Imaging Facil, Morgantwon, WV 26506 USA; [Chen, Y. C.] Alderson Broaddus Univ, Div Nat Sci, Philippi, WV USA; [Wang, L.] NIOSH, Allergy & Clin Immunol Branch, Morgantown, WV USA; [Chanvorachote, P.] Chulalongkorn Univ, Prod Dev Res Unit, Cell Based Drug & Hlth, Bangkok, Thailand	Mahidol University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Chulalongkorn University	Luanpitpong, S (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Bangkok 10700, Thailand.; Luanpitpong, S; Rojanasakul, Y (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantwon, WV 26506 USA.	suidjit@gmail.com; yrojan@hsc.wvu.edu	Li, Jingting/AAA-4598-2020; Luanpitpong, Sudjit/ABF-1962-2021; Pei, Ming/N-8175-2017	Li, Jingting/0000-0002-3576-0320; chanvorachote, pithi/0000-0002-3103-3249; McLaughlin, Sarah/0000-0002-8413-3585; Voronkova, Maria/0000-0001-9778-5032; Luanpitpong, Sudjit/0000-0002-1639-4935	National Institutes of Health (NIH) [R01-ES022968]; National Science Foundation [CBET-1434503]; Mary Babb Randolph Cancer Center (MBRCC) Sara C Allen Lung and James F Allen Comp Lung Cancer Research Fund; NIH [P30 GM103488, P20 RR016440, P30 RR032138/GM103488, S10 RR026378]; MBRCC; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026378, P20RR016440, P30RR032138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mary Babb Randolph Cancer Center (MBRCC) Sara C Allen Lung and James F Allen Comp Lung Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MBRCC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH; R01-ES022968), National Science Foundation (CBET-1434503) and Mary Babb Randolph Cancer Center (MBRCC) Sara C Allen Lung and James F Allen Comp Lung Cancer Research Fund. Flow cytometric analysis was performed in the WVU Flow Cytometry Core Facility, which is supported in part by the NIH Grant P30 GM103488. Animal experiments were performed in the WVU Animal Models and Imaging Facility, which is supported in part by the MBRCC and NIH Grants P20 RR016440, P30 RR032138/GM103488 and S10 RR026378. We would like to acknowledge the WVU Pathology Laboratory for Translational Medicine for tissue sectioning and staining services and Drs Davor Solter and Barbara Knowles for their comments on the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chakravarty G, 2011, CANCER BIOL THER, V11, P71, DOI 10.4161/cbt.11.1.13952; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Ding GX, 2012, PANMINERVA MED, V54, P219; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Esposito L, 2010, CURR GENOMICS, V11, P513, DOI 10.2174/138920210793175903; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hasan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082846; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Luanpitpong S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-22; Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; Phillips S, 2014, STEM CELL REP, V2, P633, DOI 10.1016/j.stemcr.2014.03.008; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tan YX, 2014, MOL CLIN ONCOL, V2, P111, DOI 10.3892/mco.2013.195; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Turcatel G, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-117; Xu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034327; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739	49	77	79	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2824	2833		10.1038/onc.2015.351	http://dx.doi.org/10.1038/onc.2015.351			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387547	Green Accepted			2022-12-26	WOS:000377473700002
J	Pecze, L; Blum, W; Schwaller, B				Pecze, Laszlo; Blum, Walter; Schwaller, Beat			Routes of Ca2+ Shuttling during Ca2+ Oscillations FOCUS ON THE ROLE OF MITOCHONDRIAL Ca2+ HANDLING AND CYTOSOLIC Ca2+ BUFFERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE INSP(3); CALCIUM OSCILLATIONS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; LUMINAL CA2+; CALRETININ; CELLS; PROTEIN; RECEPTOR	In some cell types, Ca2+ oscillations are strictly dependent on Ca2+ influx across the plasma membrane, whereas in others, oscillations also persist in the absence of Ca2+ influx. We observed that, in primary mesothelial cells, the plasmalemmal Ca2+ influx played a pivotal role. However, when the Ca' transport across the plasma membrane by the "lanthanum insulation method" was blocked prior to the induction of the serum-induced Ca2+ oscillations, mitochondrial Ca2+ transport was found to be able to substitute for the plasmalernmal Ca2+ exchange function, thus rendering the oscillations independent of extracellular Ca2+. However, in a physiological situation, the Ca2+-buffering capacity of mitochondria was found not to be essential for Ca2+ oscillations. Moreover, brief spontaneous Ca2+ changes were observed in the mitochondrial Ca2+ concentration without apparent changes in the cytosolic Ca2+ concentration, indicating the presence of a mitochondrial autonomous Ca2+ signaling mechanism. In the presence of calretinin, a Ca2+-buffering protein, the amplitude of cytosolic spikes during oscillations was decreased, and the amount of Ca2+ ions taken up by mitochondria was reduced. Thus, the increased calretinin expression observed in mesothelioma cells and in certain colon cancer might be correlated to the increased resistance of these tumor cells to proapoptotic/pronecrotic signals. We identified and characterized (experimentally and by modeling) three Ca2+ shuttling pathways in primary rnesothelial cells during Ca2+ oscillations: Ca2+ shuttled between (i) the endoplasmic reticulum (ER) and mitochondria, (ii) the ER and the extracellular space, and (iii) the ER and cytoplasmic Ca2+ buffers.	[Pecze, Laszlo; Blum, Walter; Schwaller, Beat] Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Pecze, L (corresponding author), Univ Fribourg, Dept Med, Anat, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	laszlo.pecze@unifr.ch	Blum, Walter/A-5996-2016	Blum, Walter/0000-0003-2219-9180; Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 147697]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was partially supported by Swiss National Science Foundation Grants 130680 and 147697 (Sinergia) (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBALDAWI NF, 1995, CELL CALCIUM, V17, P422, DOI 10.1016/0143-4160(95)90088-8; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Blum W, 2015, IN VITRO CELL DEV-AN, V51, P714, DOI 10.1007/s11626-015-9885-z; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; CHAUDRY IH, 1982, YALE J BIOL MED, V55, P1; Christel CJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406363; CLAPHAM DE, 1993, ADV SEC MESS PHOSPH, V28, P161; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; De Marchi U, 2014, J BIOL CHEM, V289, P20377, DOI 10.1074/jbc.M113.540898; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; Ducreux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044837; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Dupont G, 2008, BIOPHYS J, V95, P2193, DOI 10.1529/biophysj.108.133777; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Faas GC, 2007, PLOS BIOL, V5, P2646, DOI 10.1371/journal.pbio.0050311; Fink CC, 2000, BIOPHYS J, V79, P163, DOI 10.1016/S0006-3495(00)76281-3; Foreman MA, 2006, J CELL PHYSIOL, V206, P664, DOI 10.1002/jcp.20521; Frame MK, 1997, EXP CELL RES, V230, P197, DOI 10.1006/excr.1996.3409; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Gander JC, 1996, EXP CELL RES, V225, P399, DOI 10.1006/excr.1996.0191; Gander JC, 1996, CELL CALCIUM, V20, P63, DOI 10.1016/S0143-4160(96)90051-2; Gotzos V, 1999, AM J SURG PATHOL, V23, P701, DOI 10.1097/00000478-199906000-00010; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Haynes CL, 2006, BIOPHYS CHEM, V123, P20, DOI 10.1016/j.bpc.2006.04.005; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HORNE JH, 1995, BIOCHEMISTRY-US, V34, P12738, DOI 10.1021/bi00039a033; HOUAMED K, 2004, DIABETES MELLITUS FU, P51; Hrabakova R, 2013, J PROTEOME RES, V12, P455, DOI 10.1021/pr300819m; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Ivannikov MV, 2013, BIOPHYS J, V104, P2353, DOI 10.1016/j.bpj.2013.03.064; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LICHTSTEIN D, 1979, P NATL ACAD SCI USA, V76, P650, DOI 10.1073/pnas.76.2.650; LUKAS W, 1994, NEUROSCIENCE, V61, P307, DOI 10.1016/0306-4522(94)90233-X; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; MARTIN SC, 1994, FEBS LETT, V352, P32, DOI 10.1016/0014-5793(94)00913-9; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; MISSIAEN L, 1994, J BIOL CHEM, V269, P7238; Pecze L, 2015, BBA-MOL CELL RES, V1853, P632, DOI 10.1016/j.bbamcr.2014.12.025; Pecze L, 2013, BBA-MOL CELL RES, V1833, P1680, DOI 10.1016/j.bbamcr.2012.08.018; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Schwaller B, 2004, ANTICANCER RES, V24, P4003; Schwaller B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00003; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; SOMOGYI R, 1991, J BIOL CHEM, V266, P11068; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Tanimura A, 2009, J BIOL CHEM, V284, P8901, DOI 10.1074/jbc.M805865200; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P26, DOI 10.1134/S199074781106016X; VANBREEMEN C, 1972, CIRC RES, V30, P44, DOI 10.1161/01.RES.30.1.44; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WOOD A, 1993, J NEUROSCI, V13, P3319; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Wu YW, 2014, CELL CALCIUM, V55, P119, DOI 10.1016/j.ceca.2013.12.006; Young RC, 2001, AM J OBSTET GYNECOL, V184, P1228, DOI 10.1067/mob.2001.113872; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; Zimmermann B, 2000, J PHYSIOL-LONDON, V525, P707, DOI 10.1111/j.1469-7793.2000.t01-1-00707.x	87	14	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28214	28230		10.1074/jbc.M115.663179	http://dx.doi.org/10.1074/jbc.M115.663179			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396196	hybrid, Green Published			2022-12-26	WOS:000365761900016
J	Entrekin, SA; Maloney, KO; Kapo, KE; Walters, AW; Evans-White, MA; Klemow, KM				Entrekin, Sally A.; Maloney, Kelly O.; Kapo, Katherine E.; Walters, Annika W.; Evans-White, Michelle A.; Klemow, Kenneth M.			Stream Vulnerability to Widespread and Emergent Stressors: A Focus on Unconventional Oil and Gas	PLOS ONE			English	Article							AQUATIC RESOURCES; WATER; IMPACTS; MANAGEMENT; HABITAT; CONSERVATION; EXTRACTION; CHALLENGES; INTEGRITY; THREAT	Multiple stressors threaten stream physical and biological quality, including elevated nutrients and other contaminants, riparian and in-stream habitat degradation and altered natural flow regime. Unconventional oil and gas (UOG) development is one emerging stressor that spans the U.S. UOG development could alter stream sedimentation, riparian extent and composition, in-stream flow, and water quality. We developed indices to describe the watershed sensitivity and exposure to natural and anthropogenic disturbances and computed a vulnerability index from these two scores across stream catchments in six productive shale plays. We predicted that catchment vulnerability scores would vary across plays due to climatic, geologic and anthropogenic differences. Across-shale averages supported this prediction revealing differences in catchment sensitivity, exposure, and vulnerability scores that resulted from different natural and anthropogenic environmental conditions. For example, semi-arid Western shale play catchments (Mowry, Hilliard, and Bakken) tended to be more sensitive to stressors due to low annual average precipitation and extensive grassland. Catchments in the Barnett and Marcellus-Utica were naturally sensitive from more erosive soils and steeper catchment slopes, but these catchments also experienced areas with greater UOG densities and urbanization. Our analysis suggested Fayetteville and Barnett catchments were vulnerable due to existing anthropogenic exposure. However, all shale plays had catchments that spanned a wide vulnerability gradient. Our results identify vulnerable catchments that can help prioritize stream protection and monitoring efforts. Resource managers can also use these findings to guide local development activities to help reduce possible environmental effects.	[Entrekin, Sally A.] Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA; [Maloney, Kelly O.] US Geol Survey, Northern Appalachian Res Lab, Leetown Sci Ctr, Wellsboro, PA USA; [Kapo, Katherine E.] Waterborne Environm Inc, Leesburg, VA USA; [Walters, Annika W.] Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol, Laramie, WY 82071 USA; [Evans-White, Michelle A.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Klemow, Kenneth M.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	University of Central Arkansas; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Wyoming; University of Arkansas System; University of Arkansas Fayetteville; Wilkes University	Entrekin, SA (corresponding author), Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA.	sentrekin@uca.edu	Klemow, Kenneth M./E-1577-2012	Walters, Annika/0000-0002-8638-6682	Waterborne Environmental Inc.	Waterborne Environmental Inc.	The authors have no support or funding to report. Waterborne Environmental Inc., provided support in the form of salaries for author KEK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 2011, J ENVIRON QUAL, V40, P1340, DOI 10.2134/jeq2010.0504; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Austin BJ, 2015, SCI TOTAL ENVIRON, V529, P54, DOI 10.1016/j.scitotenv.2015.05.030; Bern CR, 2015, J HYDROL, V524, P123, DOI 10.1016/j.jhydrol.2015.02.020; Brittingham MC, 2014, ENVIRON SCI TECHNOL, V48, P11034, DOI 10.1021/es5020482; Bruns DA, 2005, AQUAT SCI, V67, P403, DOI 10.1007/s00027-005-0792-3; Burton GA, 2014, ENVIRON TOXICOL CHEM, V33, P1679, DOI 10.1002/etc.2619; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Carrillo AMR, 2009, ENERG POLICY, V37, P4303, DOI 10.1016/j.enpol.2009.05.074; Davis JB, 2012, ECOL SOC, V17, DOI 10.5751/ES-04822-170225; Davis WN, 2010, FRESHWATER BIOL, V55, P2612, DOI 10.1111/j.1365-2427.2010.02480.x; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dodds WK, 2015, FRESHW SCI, V34, P1, DOI 10.1086/679756; Drohan PJ, 2012, ENVIRON MANAGE, V49, P1061, DOI 10.1007/s00267-012-9841-6; Entrekin S, 2011, FRONT ECOL ENVIRON, V9, P503, DOI 10.1890/110053; Freyman M, 2013, CERES, P1; Gillen JL, 2011, ENV PRACT, V14, P320; Goldstein BD, 2014, TOXICOL SCI, V139, P271, DOI 10.1093/toxsci/kfu061; Griffith MB, 2014, FRESHW SCI, V33, P1, DOI 10.1086/674704; Hart R., 2014, 20145057 US GEOL SUR, P1, DOI DOI 10.3133/SIR20145057; Hennig C, 2014, R PACKAGE FPC FLEXIB; Ingraffea A. R., 2014, P NATL ACAD SCI US; International Energy Agency, 2012, ANN EN OUTL; Jackson RB, 2014, P NATL ACAD SCI USA, V111, P10902, DOI 10.1073/pnas.1410786111; Johnson BR, 2015, ENVIRON TOXICOL CHEM, V34, P167, DOI 10.1002/etc.2777; Johnson E, 2015, SCI TOTAL ENVIRON, V530, P323, DOI 10.1016/j.scitotenv.2015.05.027; Johnson N, 2011, NATURAL GAS PIPELINE, P1; Kargbo DM, 2010, ENVIRON SCI TECHNOL, V44, P5679, DOI 10.1021/es903811p; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Konschnik KE, 2014, ENVIRON SCI TECHNOL, V48, P8404, DOI 10.1021/es405377u; Krupnick AJ, 2013, RESOUR FUTUR, P1; Labbe TR, 2000, ECOL APPL, V10, P1774, DOI 10.1890/1051-0761(2000)010[1774:DOISHR]2.0.CO;2; Maechler M., 2014, CLUSTER ANAL BASICS; Malakoff D, 2014, SCIENCE, V344, P1464, DOI 10.1126/science.344.6191.1464; Maloney KO, 2012, ENVIRON PRAC, V14, P278, DOI 10.1017/S146604661200035X; Master L, 1998, RIVERS LIFE CRITICAL, P1; Mattson KM, 2007, ENVIRON MANAGE, V39, P125, DOI 10.1007/s00267-005-0238-7; Mauter MS, 2014, ENVIRON SCI TECHNOL, V48, P8298, DOI 10.1021/es405432k; McKay L. K., 2011, ENERGY LAW J, V32, P125; MINEAR RA, 1976, J WATER POLLUT CON F, V48, P2549; Moran MD, 2015, ENVIRON MANAGE, V55, P1276, DOI 10.1007/s00267-014-0440-6; Nicot JP, 2014, ENVIRON SCI TECHNOL, V48, P2464, DOI 10.1021/es404050r; Olmstead SM, 2013, P NATL ACAD SCI USA, V110, P4962, DOI 10.1073/pnas.1213871110; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Paukert CP, 2011, ECOL INDIC, V11, P304, DOI 10.1016/j.ecolind.2010.05.008; Paul MJ, 2006, FRESHWATER BIOL, V51, P1684, DOI 10.1111/j.1365-2427.2006.01612.x; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Preston TM, 2014, SCI TOTAL ENVIRON, V472, P1152, DOI 10.1016/j.scitotenv.2013.09.027; Rahm BG, 2014, ENVIRON SCI-PROC IMP, V16, P1400, DOI 10.1039/c4em00018h; Rahm BG, 2012, ENVIRON SCI POLICY, V17, P12, DOI 10.1016/j.envsci.2011.12.004; Rozell DJ, 2012, RISK ANAL, V32, P1382, DOI 10.1111/j.1539-6924.2011.01757.x; Shank M. K., 2014, J FRESHWATER ECOL, V13, P1; Souther S, 2014, FRONT ECOL ENVIRON, V12, P330, DOI 10.1890/130324; Stearman LW, 2015, ENVIRON BIOL FISH, V98, P623, DOI 10.1007/s10641-014-0300-5; Struewing KA, 2014, CHEMOSPHERE; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; US DOE/EIA (US Department of Energy/Energy Information Agency), 2013, ANN EN OUTL; US EPA, 2015, EPA600R14179; US EPA (Environmental Protection Agency), 2004, 841R08001 US EPA; Vengosh A., 2014, ENV SCI TECHNOL; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Wachal DJ, 2008, ENVIRON GEOL, V56, P1615; Weltman-Fahs M, 2013, FISHERIES, V38, P4, DOI 10.1080/03632415.2013.750112; Williams HFL, 2008, ENVIRON GEOL, V55, P1463, DOI 10.1007/s00254-007-1096-9; Wood PJ, 1999, REGUL RIVER, V15, P199, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;199::AID-RRR531&gt;3.0.CO;2-0	67	20	23	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137416	10.1371/journal.pone.0137416	http://dx.doi.org/10.1371/journal.pone.0137416			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397727	Green Published, gold			2022-12-26	WOS:000361797500036
J	Larsson, MH; Hakansson, P; Jansen, FP; Magnell, K; Brodin, P				Larsson, Marie H.; Hakansson, Pernilla; Jansen, Frank P.; Magnell, Kerstin; Brodin, Peter			Ablation of TRPM5 in Mice Results in Reduced Body Weight Gain and Improved Glucose Tolerance and Protects from Excessive Consumption of Sweet Palatable Food when Fed High Caloric Diets	PLOS ONE			English	Article							TASTE RECEPTORS; PANCREATIC-ISLETS; CHANNEL TRPM5; ION-CHANNEL; CELLS; EXPRESSION; OBESITY; BITTER; RISK; T1R3	The calcium activated cation channel transient receptor potential channel type M5 (TRPM5) is part of the downstream machinery of the taste receptors and have been shown to play a central role in taste signalling. In addition it is also found in other types of chemosensory cells in various parts of the body as well as in pancreatic beta-cells. The aim of this study was to investigate the effects of TRPM5 gene ablation on body weight, insulin sensitivity and other metabolic parameters in long-term high caloric diet induced obesity. Trpm5(-/-) mice gained significantly less body weight and fat mass on both palatable carbohydrate and fat rich cafeteria diet and 60% high fat diet (HFD) and developed less insulin resistance compared to wild type mice. A main finding was the clearly improved glucose tolerance in Trpm5(-/-) mice compared to wild type mice on cafeteria diet, which was independent of body weight. In addition, it was shown that Trpm5(-/-) mice consumed the same amount of calories when fed a HFD only or a HFD in combination with a palatable chocolate ball, which is in contrast to wild type mice that increased their caloric intake when fed the combination, mainly due to excessive consumption of the chocolate ball. Thus the palatable sugar containing diet induced overeating was prevented in Trpm5(-/-) mice. This indicates that sweet taste induced overeating may be a cause for the increased energy intake and glucose intolerance development seen for wild type mice on a sugar and high fat rich cafeteria diet compared to when on a high fat diet. This study point to an important role for the taste signalling system and TRPM5 in diet induced glucose intolerance.	[Larsson, Marie H.; Hakansson, Pernilla; Jansen, Frank P.; Brodin, Peter] AstraZeneca R&D, Dept Biosci, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Larsson, Marie H.] AstraZeneca R&D, Dept Discovery Safety Drug Safety & Metab, Molndal, Sweden; [Jansen, Frank P.] AstraZeneca R&D, Dept Screening Sci & Compound Management, Discovery Sci, Molndal, Sweden; [Magnell, Kerstin] AstraZeneca R&D, Dept Reagents & Assay Dev, Transgen, Discovery Sci, Molndal, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Larsson, MH (corresponding author), AstraZeneca R&D, Dept Biosci, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden.	Marie.h.larsson@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	The study was funded by AstraZeneca. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Brixel LR, 2010, PFLUG ARCH EUR J PHY, V460, P69, DOI 10.1007/s00424-010-0835-z; Colsoul B, 2014, PFLUG ARCH EUR J PHY, V466, P611, DOI 10.1007/s00424-013-1389-7; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; de Araujo IE, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00099; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Glendinning JI, 2012, PHYSIOL BEHAV, V107, P50, DOI 10.1016/j.physbeh.2012.05.023; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hayar A, 2006, J NEUROSCI METH, V153, P203, DOI 10.1016/j.jneumeth.2005.10.023; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kokrashvili Z, 2009, GASTROENTEROLOGY, V137, P598, DOI 10.1053/j.gastro.2009.02.070; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu P, 2011, J NEUROSCI, V31, P8634, DOI 10.1523/JNEUROSCI.6273-10.2011; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1504, DOI 10.1152/ajpregu.00364.2007; Sclafani A, 2013, APPETITE, V71, P454, DOI 10.1016/j.appet.2012.05.024; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zukerman S, 2013, CHEM SENSES, V38, P421, DOI 10.1093/chemse/bjt011	40	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138373	10.1371/journal.pone.0138373	http://dx.doi.org/10.1371/journal.pone.0138373			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397098	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500062
J	Obia, A; Cornelissen, G; Mulder, J; Dorsch, P				Obia, Alfred; Cornelissen, Gerard; Mulder, Jan; Dorsch, Peter			Effect of Soil pH Increase by Biochar on NO, N2O and N-2 Production during Denitrification in Acid Soils	PLOS ONE			English	Article							NITROGEN; OXIDE; EMISSIONS; NITRITE; DECOMPOSITION; ACIDIFICATION; AGRICULTURE; TURNOVER; KINETICS; SORPTION	Biochar (BC) application to soil suppresses emission of nitrous-(N2O) and nitric oxide (NO), but the mechanisms are unclear. One of the most prominent features of BC is its alkalizing effect in soils, which may affect denitrification and its product stoichiometry directly or indirectly. We conducted laboratory experiments with anoxic slurries of acid Acrisols from Indonesia and Zambia and two contrasting BCs produced locally from rice husk and cacao shell. Dose-dependent responses of denitrification and gaseous products (NO, N2O and N-2) were assessed by high-resolution gas kinetics and related to the alkalizing effect of the BCs. To delineate the pH effect from other BC effects, we removed part of the alkalinity by leaching the BCs with water and acid prior to incubation. Uncharred cacao shell and sodium hydroxide (NaOH) were also included in the study. The untreated BCs suppressed N2O and NO and increased N-2 production during denitrification, irrespective of the effect on denitrification rate. The extent of N2O and NO suppression was dose-dependent and increased with the alkalizing effect of the two BC types, which was strongest for cacao shell BC. Acid leaching of BC, which decreased its alkalizing effect, reduced or eliminated the ability of BC to suppress N2O and NO net production. Just like untreated BCs, NaOH reduced net production of N2O and NO while increasing that of N-2. This confirms the importance of altered soil pH for denitrification product stoichiometry. Addition of uncharred cacao shell stimulated denitrification strongly due to availability of labile carbon but only minor effects on the product stoichiometry of denitrification were found, in accordance with its modest effect on soil pH. Our study indicates that stimulation of denitrification was mainly due to increases in labile carbon whereas change in product stoichiometry was mainly due to a change in soil pH.	[Obia, Alfred; Cornelissen, Gerard; Mulder, Jan; Dorsch, Peter] Norwegian Univ Life Sci NMBU, Dept Environm Sci IMV, As, Norway; [Cornelissen, Gerard] Norwegian Geotech Inst, Dept Environm Engn, Oslo, Norway; [Cornelissen, Gerard] Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden	Norwegian University of Life Sciences; Norwegian Geotechnical Institute, NGI; Stockholm University	Obia, A (corresponding author), Norwegian Univ Life Sci NMBU, Dept Environm Sci IMV, As, Norway.	alfred.obia@nmbu.no	Dörsch, Peter/U-2572-2018; Obia, Alfred/AAE-7257-2019	Dörsch, Peter/0000-0002-4916-1839; Obia, Alfred/0000-0003-0960-7020	Norwegian Research Council project FRIMUF [204112]; Norwegian University of Life Sciences; Norwegian Research Council FriPro project [217918]	Norwegian Research Council project FRIMUF; Norwegian University of Life Sciences; Norwegian Research Council FriPro project	This work was funded by Norwegian Research Council project FRIMUF No. 204112 awarded to JM and Norwegian University of Life Sciences PhD internal financing to AO, with co-funding from Norwegian Research Council FriPro project No. 217918 awarded to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, AGENDA; Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bergaust L, 2010, APPL ENVIRON MICROB, V76, P6387, DOI 10.1128/AEM.00608-10; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; BOLLAG JM, 1978, SOIL BIOL BIOCHEM, V10, P377, DOI 10.1016/0038-0717(78)90061-5; Braida W, 2000, WATER AIR SOIL POLL, V118, P13, DOI 10.1023/A:1005193313166; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Clough TJ, 2010, SOIL SCI SOC AM J, V74, P852, DOI 10.2136/sssaj2009.0185; Clough TJ, 2013, AGRONOMY-BASEL, V3, P275, DOI 10.3390/agronomy3020275; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Cornelissen G, 2013, ENVIRON SCI TECHNOL, V47, P7704, DOI 10.1021/es400676q; Dail DB, 2001, BIOGEOCHEMISTRY, V54, P131, DOI 10.1023/A:1010627431722; Dorsch P, 2012, FEMS MICROBIOL ECOL, V79, P530, DOI 10.1111/j.1574-6941.2011.01233.x; Hale SE, 2013, CHEMOSPHERE, V91, P1612, DOI 10.1016/j.chemosphere.2012.12.057; Harter J, 2014, ISME J, V8, P660, DOI 10.1038/ismej.2013.160; Holtan-Hartwig L, 2000, SOIL BIOL BIOCHEM, V32, P833, DOI 10.1016/S0038-0717(99)00213-8; Islam A, 2008, SOIL BIOL BIOCHEM, V40, P262, DOI 10.1016/j.soilbio.2007.07.008; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; KIEFT TL, 1987, SOIL BIOL BIOCHEM, V19, P119, DOI 10.1016/0038-0717(87)90070-8; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J., 2007, NATURE, P447; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Liu BB, 2014, MBIO, V5, DOI 10.1128/mBio.01383-14; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Martinsen V, 2015, SOIL SCI PLANT NUTR, V61, P821, DOI 10.1080/00380768.2015.1052985; Molstad L, 2007, J MICROBIOL METH, V71, P202, DOI 10.1016/j.mimet.2007.08.011; Montzka SA, 2011, NATURE, V476, P43, DOI 10.1038/nature10322; Nadeem S, 2013, SOIL BIOL BIOCHEM, V57, P606, DOI 10.1016/j.soilbio.2012.10.007; Nadeem S, 2013, FEMS MICROBIOL ECOL, V83, P672, DOI 10.1111/1574-6941.12024; Nelissen V, 2014, SOIL BIOL BIOCHEM, V70, P244, DOI 10.1016/j.soilbio.2013.12.026; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; R Core Team, 2014, LANG ENV STAT COMP; Raut N, 2012, SOIL BIOL BIOCHEM, V55, P104, DOI 10.1016/j.soilbio.2012.06.011; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; SAAD OALO, 1993, BIOL FERT SOILS, V15, P21, DOI 10.1007/BF00336283; Simek M, 2002, EUR J SOIL SCI, V53, P345, DOI 10.1046/j.1365-2389.2002.00461.x; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; Smebye A., 2014, THESIS U OSLO; Smebye A, 2016, CHEMOSPHERE, V142, P100, DOI 10.1016/j.chemosphere.2015.04.087; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Spokas KA, 2009, CHEMOSPHERE, V77, P574, DOI 10.1016/j.chemosphere.2009.06.053; Spokas KA, 2013, GCB BIOENERGY, V5, P165, DOI 10.1111/gcbb.12005; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Verheijen F, 2009, EUR 24099 EN; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang R, 2013, PLANT SOIL, V363, P175, DOI 10.1007/s11104-012-1264-x; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yuan JH, 2012, SOIL RES, V50, P570, DOI 10.1071/SR12118; Zhang AF, 2010, AGR ECOSYST ENVIRON, V139, P469, DOI 10.1016/j.agee.2010.09.003; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	57	107	113	10	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138781	10.1371/journal.pone.0138781	http://dx.doi.org/10.1371/journal.pone.0138781			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397367	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000361797500105
J	Wang, SJ; Fang, CL; Li, GD				Wang, Shaojian; Fang, Chuanglin; Li, Guangdong			Spatiotemporal Characteristics, Determinants and Scenario Analysis of CO2 Emissions in China Using Provincial Panel Data	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; GREENHOUSE-GAS EMISSIONS; UNIT-ROOT TESTS; ENERGY-CONSUMPTION; ECONOMIC-GROWTH; IMPACT FACTORS; RELATIVE IMPORTANCE; INDUSTRIAL SECTOR; STRUCTURAL-CHANGE; DRIVING FORCES	This paper empirically investigated the spatiotemporal variations, influencing factors and future emission trends of China's CO2 emissions based on a provincial panel data set. A series of panel econometric models were used taking the period 1995-2011 into consideration. The results indicated that CO2 emissions in China increased over time, and were characterized by noticeable regional discrepancies; in addition, CO2 emissions also exhibited properties of spatial dependence and convergence. Factors such as population scale, economic level and urbanization level exerted a positive influence on CO2 emissions. Conversely, energy intensity was identified as having a negative influence on CO2 emissions. In addition, the significance of the relationship between CO2 emissions and the four variables varied across the provinces based on their scale of economic development. Scenario simulations further showed that the scenario of middle economic growth, middle population increase, low urbanization growth, and high technology improvement (here referred to as Scenario BTU), constitutes the best development model for China to realize the future sustainable development. Based on these empirical findings, we also provide a number of policy recommendations with respect to the future mitigation of CO2 emissions.	[Wang, Shaojian] Sun Yat Sen Univ, Sch Geog & Planning, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Chuanglin; Li, Guangdong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Fang, Chuanglin; Li, Guangdong] Chinese Acad Sci, Key Lab Reg Sustainable Dev Modeling, Beijing 100101, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences	Fang, CL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	fangcl@igsnrr.ac.cn; ligd@igsnrr.ac.cn			National Natural Science Foundation of China [71433008, 41501175]; Non-profit Industry Financial Program of Ministry of Land and Resources of China [201411014-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Non-profit Industry Financial Program of Ministry of Land and Resources of China	This study was supported by National Natural Science Foundation of China (Grant No. 71433008 and No. 41501175; http://www.nsfc.gov.cn/) and Non-profit Industry Financial Program of Ministry of Land and Resources of China (Grant No. 201411014-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbostanci E, 2011, APPL ENERG, V88, P2273, DOI 10.1016/j.apenergy.2010.12.076; Al-mulali U, 2012, ENERGY, V44, P564, DOI 10.1016/j.energy.2012.05.045; Ang BW, 1998, ENERGY, V23, P489, DOI 10.1016/S0360-5442(98)00016-4; [Anonymous], 2011, J AUDIT EC; Breitung J, 2000, ADV ECONOMETRICS, V15, P161; Brizga J, 2014, ECOL ECON, V98, P22, DOI 10.1016/j.ecolecon.2013.12.001; Cai WJ, 2008, ENERG POLICY, V36, P1181, DOI 10.1016/j.enpol.2007.11.030; Chen Wenying, 2004, Journal of Tsinghua University (Science and Technology), V44, P342; Dinda S, 2006, ECOL ECON, V57, P167, DOI 10.1016/j.ecolecon.2005.03.028; Du LM, 2012, CHINA ECON REV, V23, P371, DOI 10.1016/j.chieco.2012.02.004; EIA, 2009, INT EN OUTL; ERINDRC (Energy Research Institute National Development and Reform Commission), 2009, CHIN LOW CARB DEV PA; Fan Y, 2007, ECOL ECON, V62, P683, DOI 10.1016/j.ecolecon.2006.08.016; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; Gui SS, 2014, ENERGY, V74, P405, DOI 10.1016/j.energy.2014.06.116; Hamit-Haggar M, 2012, ENERG ECON, V34, P358, DOI 10.1016/j.eneco.2011.06.005; Hawkes AD, 2014, APPL ENERG, V125, P197, DOI 10.1016/j.apenergy.2014.03.060; Hoekstra R, 2003, ENERG ECON, V25, P39, DOI 10.1016/S0140-9883(02)00059-2; IEA, 2008, INT EN AG WORLD EN O; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; International Energy Agency (IEA), 2007, WORLD EN MOD METH AS; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Kum H, 2012, RENEW SUST ENERG REV, V16, P2361, DOI 10.1016/j.rser.2012.01.041; Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7; Li F, 2011, ENERG POLICY, V39, P568, DOI 10.1016/j.enpol.2010.10.025; Li HN, 2012, ENERGY, V39, P319, DOI 10.1016/j.energy.2012.01.008; Li HA, 2011, ENERG POLICY, V39, P6906, DOI 10.1016/j.enpol.2011.08.056; Liang QM, 2007, ENERG POLICY, V35, P1685, DOI 10.1016/j.enpol.2006.04.018; Lin SF, 2009, ENVIRON IMPACT ASSES, V29, P341, DOI 10.1016/j.eiar.2009.01.009; [刘红光 LIU Hongguang], 2009, [地理科学进展, Progress in Geography], V28, P285; Liu YB, 2013, ENERG ECON, V36, P43, DOI 10.1016/j.eneco.2012.12.003; Liu YB, 2009, ENERGY, V34, P1846, DOI 10.1016/j.energy.2009.07.029; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; Ma C, 2008, ENERG POLICY, V36, P2517, DOI 10.1016/j.enpol.2008.03.013; Ma Z, 2013, APPL MECH MATER, V281, P542, DOI 10.4028/www.scientific.net/AMM.281.542; Narayan PK, 2010, ENERG POLICY, V38, P661, DOI 10.1016/j.enpol.2009.09.005; National Coordination Committee Office on Climate Change and Energy Research Institute under the National Development and Reform Commission, 2007, NAT GREENH GAS INV P; Niu SW, 2011, ENERG POLICY, V39, P2121, DOI 10.1016/j.enpol.2011.02.003; Ozcan B, 2013, ENERG POLICY, V62, P1138, DOI 10.1016/j.enpol.2013.07.016; Ozkan F, 2012, ENER EDUC SCI TECH-A, V29, P1233; Pao H, 2011, ENERGY, V36, P1; Pao HT, 2011, ENERGY, V36, P2450, DOI 10.1016/j.energy.2011.01.032; Pao HT, 2010, ENERG POLICY, V38, P7850, DOI 10.1016/j.enpol.2010.08.045; Pedroni P, 2000, ADV ECONOMETRICS, V15, P93; Pedroni P., 1999, WORKING PAPER; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Shao S., 2010, J FINANCE EC, V36, P16; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Shi LY, 2011, ENRGY PROCED, V5, P79, DOI 10.1016/j.egypro.2011.03.015; [宋杰鲲 Song Jiekun], 2012, [资源科学, Resources Science], V34, P35; Soytas U, 2007, ECOL ECON, V62, P482, DOI 10.1016/j.ecolecon.2006.07.009; Wang C, 2005, ENERGY, V30, P73, DOI 10.1016/j.energy.2004.04.002; Wang MW, 2011, ENERG POLICY, V39, P6981, DOI 10.1016/j.enpol.2011.07.041; Wang P, 2013, APPL ENERG, V106, P65, DOI 10.1016/j.apenergy.2013.01.036; Wang SS, 2011, ENERG POLICY, V39, P4870, DOI 10.1016/j.enpol.2011.06.032; Wang SJ, 2015, ECOL INDIC, V49, P121, DOI 10.1016/j.ecolind.2014.10.004; Wang SJ, 2014, APPL ENERG, V136, P738, DOI 10.1016/j.apenergy.2014.09.059; Wang SJ, 2014, ECOL INDIC, V45, P171, DOI 10.1016/j.ecolind.2014.04.006; Wang SJ, 2014, J GEOGR SCI, V24, P612, DOI 10.1007/s11442-014-1109-z; Wang ZH, 2012, APPL ENERG, V100, P277, DOI 10.1016/j.apenergy.2012.05.038; Wu LB, 2005, ENERG POLICY, V33, P319, DOI 10.1016/j.enpol.2003.08.003; [徐国泉 XU Guoquan], 2006, [中国人口·资源与环境, China Population·Resources and Environment], V16, P158; Xu SC, 2014, APPL ENERG, V127, P182, DOI 10.1016/j.apenergy.2014.03.093; [徐中民 Xu Zhongmin], 2005, [冰川冻土, Journal of Glaciology and Geocryology], V27, P767; [燕华 Yan Hua], 2010, [地理学报, Acta Geographica Sinica], V65, P983; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; [查冬兰 ZHA Donglan], 2007, [系统工程, Systems Engineering], V25, P65; Zhang L, 2014, J ARID LAND, V6, P145, DOI 10.1007/s40333-013-0242-3; Zhang M, 2013, ECOL INDIC, V32, P239, DOI 10.1016/j.ecolind.2013.03.033; Zhang ZX, 2003, ENERG ECON, V25, P625, DOI 10.1016/S0140-9883(03)00042-2; Zhao T, 2013, ADV MATER RES-SWITZ, V734-737, P1896, DOI 10.4028/www.scientific.net/AMR.734-737.1896; Zhao YB, 2015, SUSTAINABILITY-BASEL, V7, P5609, DOI 10.3390/su7055609; Zhu HM, 2012, ECON LETT, V117, P848, DOI 10.1016/j.econlet.2012.09.001	73	19	19	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138666	10.1371/journal.pone.0138666	http://dx.doi.org/10.1371/journal.pone.0138666			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397373	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500091
J	Do, Q; Martini, B; Choo, KKR				Do, Quang; Martini, Ben; Choo, Kim-Kwang Raymond			A Forensically Sound Adversary Model for Mobile Devices	PLOS ONE			English	Article							GENERAL COLLECTION METHODOLOGY	In this paper, we propose an adversary model to facilitate forensic investigations of mobile devices (e.g. Android, iOS and Windows smartphones) that can be readily adapted to the latest mobile device technologies. This is essential given the ongoing and rapidly changing nature of mobile device technologies. An integral principle and significant constraint upon forensic practitioners is that of forensic soundness. Our adversary model specifically considers and integrates the constraints of forensic soundness on the adversary, in our case, a forensic practitioner. One construction of the adversary model is an evidence collection and analysis methodology for Android devices. Using the methodology with six popular cloud apps, we were successful in extracting various information of forensic interest in both the external and internal storage of the mobile device.	[Do, Quang; Martini, Ben; Choo, Kim-Kwang Raymond] Univ S Australia, Informat Assurance Res Grp, Adelaide, SA 5001, Australia	University of South Australia	Choo, KKR (corresponding author), Univ S Australia, Informat Assurance Res Grp, Adelaide, SA 5001, Australia.	raymond.choo@unisa.edu.au	Choo, Kim-Kwang Raymond/A-3634-2009	Choo, Kim-Kwang Raymond/0000-0001-9208-5336				Bellare M., 1993, LNCS, V773, P232, DOI [10.1007/3-540-48329-2_21, DOI 10.1007/3-540-48329-2_21]; Bugiel S, 2013, USENIX SECURITY, P131; Casey E, 2007, DIGIT INVEST, V4, P49, DOI 10.1016/j.diin.2007.05.001; Creech G, 2014, IEEE T COMPUT, V63, P807, DOI 10.1109/TC.2013.13; Do Q, 2015, COMPUT SECUR, V48, P74, DOI 10.1016/j.cose.2014.10.016; DOLEV D, 1983, IEEE T INFORM THEORY, V29, P198, DOI 10.1109/TIT.1983.1056650; Glisson WB, 2013, DIGIT INVEST, V10, P44, DOI 10.1016/j.diin.2013.03.004; He D., 2013, P ACM SIGSAC C COMP, P1017; Heiber T, 2005, SPRINGER INT SER ENG, V780, P35; Holt TJ, 2013, J CONTEMP CRIM JUST, V29, P420, DOI 10.1177/1043986213507401; Lessard J., 2010, SMALL SCALE DIGIT DE, P1; Martini B., 2015, CLOUD SECURITY ECOSY, DOI [DOI 10.1016/B9780-12801595-7.00015X, 10.1016/B978-0-12-801595-7.00015-X]; Martini B., 2015, CLOUD SECURITY ECOSY, P285, DOI [10.1016/b978-0- 12-801595-7.00014-8, DOI 10.1016/B978-0-12-801595-7.00014-8]; Martini B, 2014, P 13 INT C TRUST SEC, P935, DOI DOI 10.1109/TRUSTCOM.2014.124; Martini B, 2012, DIGIT INVEST, V9, P71, DOI 10.1016/j.diin.2012.07.001; Mckemmish R., 1999, TRENDS ISSUES CRIME, V118, P1; McKemmish R, 2008, INT FED INFO PROC, V285, P3; Miettinen M, 2006, 20TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 2, PROCEEDINGS, P72; Sheng-Wen Chen, 2011, 2011 Fifth International Conference on Genetic and Evolutionary Computing, P157, DOI 10.1109/ICGEC.2011.46; Son N, 2013, DIGIT INVEST, V10, pS3, DOI 10.1016/j.diin.2013.06.001; Syverson P., 2001, Designing Privacy Enhancing Technologies. International Workshop on Design Issues in Anonymity and Unobservability. Proceedings (Lecture Notes in Computer Science Vol.2009), P96; Tassone C, 2013, TRENDS ISS CRIME CRI, P1; Vidas T, 2011, DIGIT INVEST, V8, pS14, DOI 10.1016/j.diin.2011.05.003; Votipka D, 2013, IEEE T INF FOREN SEC, V8, P1937, DOI 10.1109/TIFS.2013.2285360; Wu Lei, 2013, P 2013 ACM SIGSAC C, P623, DOI DOI 10.1145/2508859.2516728	25	58	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138449	10.1371/journal.pone.0138449	http://dx.doi.org/10.1371/journal.pone.0138449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393812	Green Accepted, Green Published, gold			2022-12-26	WOS:000361792100062
J	dos Santos, O; Rigo, GD; Frasson, AP; Macedo, AJ; Tasca, T				dos Santos, Odelta; Rigo, Graziela de Vargas; Frasson, Amanda Piccoli; Macedo, Alexandre Jose; Tasca, Tiana			Optimal Reference Genes for Gene Expression Normalization in Trichomonas vaginalis	PLOS ONE			English	Article							IDENTIFICATION; PCR; SURFACE; INFECTIONS; VALIDATION; SELECTION; PROTEINS; NTPDASE; CP65	Trichomonas vaginalis is the etiologic agent of trichomonosis, the most common non-viral sexually transmitted disease worldwide. This infection is associated with several health consequences, including cervical and prostate cancers and HIV acquisition. Gene expression analysis has been facilitated because of available genome sequences and large-scale transcriptomes in T. vaginalis, particularly using quantitative real-time polymerase chain reaction (qRT-PCR), one of the most used methods for molecular studies. Reference genes for normalization are crucial to ensure the accuracy of this method. However, to the best of our knowledge, a systematic validation of reference genes has not been performed for T. vaginalis. In this study, the transcripts of nine candidate reference genes were quantified using qRT-PCR under different cultivation conditions, and the stability of these genes was compared using the geNorm and NormFinder algorithms. The most stable reference genes were alpha-tubulin, actin and DNATopII, and, conversely, the widely used T. vaginalis reference genes GAPDH and beta-tubulin were less stable. The PFOR gene was used to validate the reliability of the use of these candidate reference genes. As expected, the PFOR gene was upregulated when the trophozoites were cultivated with ferrous ammonium sulfate when the DNATopII, alpha-tubulin and actin genes were used as normalizing gene. By contrast, the PFOR gene was downregulated when the GAPDH gene was used as an internal control, leading to misinterpretation of the data. These results provide an important starting point for reference gene selection and gene expression analysis with qRT-PCR studies of T. vaginalis.	[dos Santos, Odelta; Rigo, Graziela de Vargas; Frasson, Amanda Piccoli; Macedo, Alexandre Jose; Tasca, Tiana] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Tasca, T (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.	tiana.tasca@ufrgs.br	Tasca, Tiana/AAG-5911-2019; Macedo, Alexandre J/C-5178-2013	Macedo, Alexandre J/0000-0002-8951-4029; Tasca, Tiana/0000-0002-8334-5105	Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [23038.019022/2009-68]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [475315/2011-1, 474930/2012-2]; CAPES/Brazil; CNPq; CAPES	Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (grant 23038.019022/2009-68) to AJM; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (grants 475315/2011-1 and 474930/2012-2) to TT. OS and APF are recipients of scholarships from CAPES/Brazil. TT and AJM thank CNPq for researcher fellowships. CAPES: http://www.capes.gov.br/. CNPq: http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez ME, 2007, MICROBES INFECT, V9, P1597, DOI 10.1016/j.micinf.2007.09.011; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2012, REPROD HEALTH MATTER, V20, P207, DOI 10.1016/S0968-8080(12)40660-7; Becker D, 2015, INFECT GENE IN PRESS; Bradic M, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-12; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Miguel N, 2010, MOL CELL PROTEOMICS, V9, P1554, DOI 10.1074/mcp.M000022-MCP201; Charcas-Lopez MD, 2014, PARASITE, V21, DOI 10.1051/parasite/2014006; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Alvarez-Sanchez ME, 2008, INT J BIOCHEM CELL B, V40, P2442, DOI 10.1016/j.biocel.2008.04.023; Figueroa-Angulo EE, 2012, PARASITOLOGY, V139, P1729, DOI 10.1017/S003118201200114X; Frasson AP, 2012, MEM I OSWALDO CRUZ, V107, P170, DOI 10.1590/S0074-02762012000200004; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; GRODSTEIN F, 1993, AM J EPIDEMIOL, V137, P577, DOI 10.1093/oxfordjournals.aje.a116711; Hernandez-Romano P, 2010, PARASITOLOGY, V137, P1621, DOI 10.1017/S003118201000051X; Horvathova L, 2012, GENOME BIOL EVOL, V4, P1017, DOI 10.1093/gbe/evs078; Huang KY, 2012, INFECT IMMUN, V80, P3900, DOI 10.1128/IAI.00611-12; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Carvajal-Gamez BI, 2011, MOL BIOCHEM PARASIT, V180, P8, DOI 10.1016/j.molbiopara.2011.07.003; Quintas-Granados LI, 2013, MOL CELL PROTEOMICS, V12, P1953, DOI 10.1074/mcp.M112.022012; Kim Yong-Seok, 2006, Korean Journal of Parasitology, V44, P373, DOI 10.3347/kjp.2006.44.4.373; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Kucknoor AS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-58; Lin LY, 2013, MOL GENET GENOMICS, V288, P727, DOI 10.1007/s00438-013-0785-1; Lin WC, 2009, PARASITOL RES, V105, P1683, DOI 10.1007/s00436-009-1616-5; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallo N, 2013, ANTIMICROB AGENTS CH, V57, P2476, DOI 10.1128/AAC.00009-13; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Moreno-Brito V, 2005, CELL MICROBIOL, V7, P245, DOI 10.1111/j.1462-5822.2004.00455.x; Mundodi V, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-6; Napolitano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098669; Nielsen TJ, 2012, J EUKARYOT MICROBIOL, V59, P359, DOI 10.1111/j.1550-7408.2012.00624.x; Quinlivan EB, 2012, SEX TRANSM DIS, V39, P671, DOI 10.1097/OLQ.0b013e3182593839; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Riemer AB, 2012, EXP DERMATOL, V21, P625, DOI 10.1111/j.1600-0625.2012.01537.x; Ruckert C, 2010, EXP PARASITOL, V125, P187, DOI 10.1016/j.exppara.2010.01.029; Calla-Choque JS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/424767; Secor WE, 2014, AM J TROP MED HYG, V90, P800, DOI 10.4269/ajtmh.13-0723; Shen J, 2014, PARASITOL RES, V113, P3073, DOI 10.1007/s00436-014-3973-y; Solano-Gonzalez E, 2007, FEBS LETT, V581, P2919, DOI 10.1016/j.febslet.2007.05.056; Sutcliffe S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002801; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003; Weizenmann M, 2011, FEMS MICROBIOL LETT, V319, P115, DOI 10.1111/j.1574-6968.2011.02283.x; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338	52	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138331	10.1371/journal.pone.0138331	http://dx.doi.org/10.1371/journal.pone.0138331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393928	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100054
J	Houston, DD; Evans, RP; Shiozawa, DK				Houston, Derek D.; Evans, R. Paul; Shiozawa, Dennis K.			Pluvial Drainage Patterns and Holocene Desiccation Influenced the Genetic Architecture of Relict Dace, Relictus solitarius (Teleostei: Cyprinidae)	PLOS ONE			English	Article							GREAT-BASIN; TUI CHUB; HISTORY; DIVERSITY; CLIMATE; LAKES; PHYLOGEOGRAPHY; POPULATIONS; DISPERSAL; LAHONTAN	Changing drainage patterns have played a significant role in the evolution of western North American aquatic taxa. Relict dace, Relictus solitarius, is a Great Basin endemic cyprinid with a native range that is restricted to four valleys in eastern Nevada. Relictus solitarius now occupies spring systems that are the remnants of Pleistocene-era pluvial lakes, although it may have occurred in the area for much longer. Here we use mitochondrial DNA sequence data to assess range-wide genetic diversity of R. solitarius, and to estimate divergence times to determine whether pluvial drainages played an important role in shaping intraspecific genetic diversity. Genetic diversification within R. solitarius began during the early to mid-Pleistocene, separating populations within two sets of valleys (Butte/Ruby and Goshute/Steptoe). Additional diversification in each of the two sets of valleys occurred more recently, in the mid-to late-Pleistocene. Holocene desiccation has further isolated populations, and each population sampled contains unique mtDNA haplotypes. Pluvial drainage patterns did contribute to the genetic structure observed within R. solitarius, but most of the intraspecific diversification does not appear to be associated with the Last Glacial Maximum. Holocene desiccation has also contributed to the observed genetic structure. The relict dace populations we sampled are all unique, and we recommend that future management efforts should strive to preserve as much of the genetic diversity as possible.	[Houston, Derek D.; Shiozawa, Dennis K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Evans, R. Paul] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Houston, DD (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	derek.d.houston@gmail.com	Houston, Derek/ABC-2833-2020		Ruby Lake National Wildlife Refuge; Fish Phylogenetics Program at Brigham Young University	Ruby Lake National Wildlife Refuge; Fish Phylogenetics Program at Brigham Young University	Funding was provided by the Ruby Lake National Wildlife Refuge, and by the Fish Phylogenetics Program at Brigham Young University.	Ardren WR, 2010, CONSERV GENET, V11, P1299, DOI 10.1007/s10592-009-9959-0; Blakney JR, 2014, CONSERV GENET, V15, P757, DOI 10.1007/s10592-014-0576-1; Chen YJ, 2007, CONSERV GENET, V8, P221, DOI 10.1007/s10592-006-9164-3; Chen YJ, 2009, CONSERV GENET, V10, P101, DOI 10.1007/s10592-008-9529-x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dowling TE, 2002, COPEIA, P665, DOI 10.1643/0045-8511(2002)002[0665:EROTPT]2.0.CO;2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLASCHKA I, 1987, WATER RESOUR BULL, V23, P47; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Houston DD, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-111; Houston DD, 2012, CONSERV GENET, V13, P727, DOI 10.1007/s10592-012-0321-6; Houston DD, 2011, BIOL J LINN SOC, V104, P163, DOI 10.1111/j.1095-8312.2011.01723.x; Houston DD, 2010, T AM FISH SOC, V139, P303, DOI 10.1577/T09-075.1; Houston DD, 2010, MOL PHYLOGENET EVOL, V55, P259, DOI 10.1016/j.ympev.2009.10.017; HUBBS C L, 1972, Transactions of the San Diego Society of Natural History, V17, P101; Hubbs C.L., 1974, MEM CALIF ACAD SCI, V7, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G., 2008, TREEFINDER; Johnson JB, 2004, SYST BIOL, V53, P841, DOI 10.1080/10635150490522557; Kohn MJ, 2008, GEOLOGY, V36, P783, DOI 10.1130/G24928A.1; Lillquist KD, 1994, LATE QUATERNARY LAKE; Liu HP, 2003, MOL ECOL, V12, P2771, DOI 10.1046/j.1365-294X.2003.01949.x; May B, 2015, CONSERV GENET; Minckley W.L., 1986, P519; Mock KE, 2006, MOL ECOL, V15, P2223, DOI 10.1111/j.1365-294X.2006.02932.x; Mock KE, 2010, MOL ECOL, V19, P569, DOI 10.1111/j.1365-294X.2009.04468.x; Munroe J.S., 2011, GEOLOGIC FIELD TRIPS, V21, P1; Munroe JS, 2013, GEOL SOC AM BULL, V125, P322, DOI 10.1130/B30696.1; Oakey DD, 2004, COPEIA, P207, DOI 10.1643/CG-02-264R1; Orme AR, 2008, GEOL SOC SPEC PUBL, V301, P51, DOI 10.1144/SP301.4; Oviatt CG, 1997, GEOLOGY, V25, P155, DOI 10.1130/0091-7613(1997)025<0155:LBFAGC>2.3.CO;2; Oviatt CG, 2002, SMITHSON CONTRIB EAR, P121; Rambaut A., 2014, TRACER V1 6; Reheis M, 1999, QUATERNARY RES, V52, P196, DOI 10.1006/qres.1999.2064; Reheis MC, 2014, QUATERNARY SCI REV, V97, P33, DOI 10.1016/j.quascirev.2014.04.012; Reheis MC, 2002, SMITHSON CONTRIB EAR, P53; Schonhuth S, 2015, ZOOL SCR, V44, P11, DOI 10.1111/zsc.12083; Simons AM, 2003, ZOOL J LINN SOC-LOND, V139, P63, DOI 10.1046/j.1096-3642.2003.00076.x; Smith GR, 2010, EVOL ECOL RES, V12, P693; Smith GR, 2008, GEOL SOC AM SPEC PAP, V439, P301, DOI 10.1130/2008.2439(13); Smith GR, 2002, SMITHSON CONTRIB EAR, P175; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Sproul JS, 2014, FRESHWATER BIOL, V59, P2051, DOI 10.1111/fwb.12406; Stokes WL, 1988, GEOLOGY OF UTAH; Stutz HL, 2010, J N AM BENTHOL SOC, V29, P1132, DOI 10.1899/09-157.1; Taylor D.W., 1985, P265; TAYLOR D W, 1981, Contributions from the Museum of Paleontology University of Michigan, V25, P339; Taylor Eric B., 2013, Diversity-Basel, V5, P149; Unmack PJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090061, DOI 10.1371/J0URNAL.P0NE.0090061]; Waples R.S., 1991, MAR FISH REV, V53, P11; [No title captured]	56	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138433	10.1371/journal.pone.0138433	http://dx.doi.org/10.1371/journal.pone.0138433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394395	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100059
J	Wilson, LE; Kim, S; Xu, ZL; Harlid, S; Sandler, DP; Taylor, JA				Wilson, Lauren E.; Kim, Sangmi; Xu, Zongli; Harlid, Sophia; Sandler, Dale P.; Taylor, Jack A.			Non-Steroidal Anti-Inflammatory Drug Use and Genomic DNA Methylation in Blood	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; TISSUES; SISTER; GENES; CELLS	Background Non-steroidal anti-inflammatory drug (NSAID) use is associated with decreased risk of some cancers. NSAID use modulates the epigenetic profile of normal colonic epithelium and may reduce risk of colon cancer through this pathway; however, the effect of NSAID use on the DNA methylation profile of other tissues including whole blood has not yet been examined. Findings Using the Sister Study cohort, we examined the association between NSAID usage and whole genome methylation patterns in blood DNA. Blood DNA methylation status across 27,589 CpG sites was evaluated for 871 women using the Illumina Infinium HumanMethylation27 Beadchip, and in a non-overlapping replication sample of 187 women at 485,512 CpG sites using the Infinium HumanMethylation450 Beadchip. We identified a number of CpG sites that were differentially methylated in regular, long-term users of NSAIDs in the discovery group, but none of these sites were statistically significant in our replication group. Conclusions We found no replicable methylation differences in blood related to NSAID usage. If NSAID use does effect blood DNA methylation patterns, differences are likely small.	[Wilson, Lauren E.; Xu, Zongli; Harlid, Sophia; Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Kim, Sangmi] Georgia Regents Univ, Ctr Canc, Dept Med, Hematol Oncol Sect, Augusta, GA USA; [Kim, Sangmi] Med Coll Georgia, Augusta, GA 30912 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Taylor, JA (corresponding author), NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	taylor@niehs.nih.gov	Harlid, Sophia/AAJ-5809-2021; taylor, jack a/C-7154-2019	Harlid, Sophia/0000-0001-8540-6891; taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; Wilson, Lauren/0000-0002-5953-2293; xu, zongli/0000-0002-9034-8902	National Institute of Environmental Health Sciences, NIH [Z01 ES044005, Z01 ES044032, Z01 ES049033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES044005, Z01ES049033, ZIAES049032, ZIAES044005, ZIAES049033] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Z01 ES044005, Z01 ES044032, and Z01 ES049033).	Accomando WP, 2012, CLIN CANCER RES, V18, P6147, DOI 10.1158/1078-0432.CCR-12-1008; Brasky TM, 2010, CANCER CAUSE CONTROL, V21, P1503, DOI 10.1007/s10552-010-9579-5; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Guay SP, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-14; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Harlid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118757; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang SK, PROSTAGLANDIN E2 INC, P3703; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katsurano M, ONCOGENE, P342, DOI [10.1038/onc.2011.241, DOI 10.1038/0NC.2011.241]; Noreen F, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju161; O'Hagan Heather A M, CANCER CELL, V20, P606, DOI [10.1016/j.ccr.2011.09.012, DOI 10.1016/J.CCR.2011.09.012]; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pan MR, 2008, EXP BIOL MED, V233, P456, DOI 10.3181/0709-RM-257; Siegel EM, 2014, CANCER EPIDEM BIOMAR, V23, P2622, DOI 10.1158/1055-9965.EPI-14-0464; Tahara T, 2009, CANCER SCI, V100, P1192, DOI 10.1111/j.1349-7006.2009.01175.x; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Xu ZL, 2014, CARCINOGENESIS, V35, P356, DOI 10.1093/carcin/bgt391; Xu ZL, 2013, JNCI-J NATL CANCER I, V105, P694, DOI 10.1093/jnci/djt045; Zhao YS, 2009, BREAST CANCER RES TR, V117, P141, DOI 10.1007/s10549-008-0228-6	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138920	10.1371/journal.pone.0138920	http://dx.doi.org/10.1371/journal.pone.0138920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393518	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100115
J	Cortes-Castell, E; Sanchez-Gonzalez, P; Palazon-Bru, A; Bosch-Gimenez, V; Manero-Soler, H; Juste-Ruiz, M; Rizo-Baeza, MM; Gil-Guillen, VF				Cortes-Castell, Ernesto; Sanchez-Gonzalez, Pablo; Palazon-Bru, Antonio; Bosch-Gimenez, Vicente; Manero-Soler, Herminia; Juste-Ruiz, Mercedes; Mercedes Rizo-Baeza, Maria; Francisco Gil-Guillen, Vicente			Highest Plasma Phenylalanine Levels in (Very) Premature Infants on Intravenous Feeding; A Need for Concern	PLOS ONE			English	Article							AMINO-ACIDS; PRETERM INFANTS; PARENTERAL-NUTRITION; PROTEIN; VALUES	Objective To analyse the association in newborns between blood levels of phenylalanine and feeding method and gestational age. Study Design This observational, cross-sectional study included a sample of 11,829 infants between 2008 and 2013 in a Spanish region. Data were recorded on phenylalanine values, feeding method [breast, formula, mixed (breast plus formula), or partial or fully intravenous feeding], gestational age in weeks (<32, 32-37, >= 37), gender and days since birth at the moment of blood collection. Outcomes were [phenylalanine] and [phenylalanine] >= 95th percentile. Associations were analysed using multivariate models [linear (means difference) and logistic regression (adjusted odds ratios)]. Results Higher phenylalanine values were associated with lower gestational age (p<0.001) and with intravenous feeding (p<0.001). Conclusion The degree of prematurity and intravenous feeding influenced the plasma concentration of phenylalanine in the newborn. Caution should be taken in [phenylalanine] for newborns with intravenous feeding, monitoring them carefully. Very preterm infants given the recommended amount of amino acids should also be strictly monitored. These findings should be taken into consideration and call for adapting the amounts to the needs of the infant.	[Cortes-Castell, Ernesto; Juste-Ruiz, Mercedes] Miguel Hernandez Univ, Dept Pharmacol Paediat & Organ Chem, Alacant, Spain; [Sanchez-Gonzalez, Pablo; Manero-Soler, Herminia] Alicante Gen Univ Hosp, Clin Anal Dept, Alicante, Spain; [Palazon-Bru, Antonio; Francisco Gil-Guillen, Vicente] Miguel Hernandez Univ, Dept Clin Med, Alacant, Spain; [Bosch-Gimenez, Vicente] Univ Murcia, Dept Surg Paediat Obstet & Gynaecol, Murcia, Spain; [Mercedes Rizo-Baeza, Maria] Univ Alicante, Dept Nursing, San Vicente Del Raspeig, Spain	Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; University of Murcia; Universitat d'Alacant	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Pharmacol Paediat & Organ Chem, Alacant, Spain.	antonio.pb23@gmail.com	Guillén, Vicente Francisco Gil/AAE-8201-2019; Rizo-Baeza, Mercedes/J-3974-2017; Cortés-Castell, Ernesto/H-8528-2019	Rizo-Baeza, Mercedes/0000-0002-6754-6505; Sanhez, Pablo/0000-0002-2844-6843; Gil-Guillen, Vicente F/0000-0003-3793-9786; CORTES CASTELL, ERNESTO/0000-0002-8079-1695				Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Beath S V, 2003, Semin Neonatol, V8, P337; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Chow S., 2007, CHAPMAN HALL CRC BIO; Conselleria de Sanitat Universal i Salut Publica, 2021, CONS SAN UN SAL PUBL; Corte Z, 2010, CLIN CHEM LAB MED, V48, P99, DOI 10.1515/CCLM.2010.008; Castell EC, 2013, NUTR HOSP, V28, P1536, DOI 10.3305/nh.2013.28.5.6500; Cortes E, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0166-9; Darling PB, 2004, J NUTR, V134, P2540, DOI 10.1093/jn/134.10.2540; Embleton ND, 2014, WORLD REV NUTR DIET, V110, P177, DOI 10.1159/000358466; Espada M, 2001, QUIMICA CLIN, V20, P81; Fingerhut R, 2010, J INHERIT METAB DIS, V33, pS235, DOI 10.1007/s10545-010-9167-6; Hay WW, 2010, PEDIATR NEONATOL, V51, P198, DOI 10.1016/S1875-9572(10)60039-3; Heine WE, 1994, PROTEIN METABOLISM I, P121; Kalhan SC, 2008, ANNU REV NUTR, V28, P389, DOI 10.1146/annurev.nutr.28.061807.155333; Klein CJ, 2002, J NUTR, V132, p1395S, DOI 10.1093/jn/132.6.1395S; Lin HJ, 2011, J PERINATOL, V31, P507, DOI 10.1038/jp.2010.207; Llanos M Adolfo, 2004, Rev. chil. pediatr., V75, P107; Marin Soria JL, 2009, PROGRAMAS DE CRIBADO; Medina JM, 1992, PERINATAL BIOCH, P234; Morisaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088392; Moro G, 1999, ACTA PAEDIATR, V88, P885, DOI 10.1080/08035259950168838; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; Quigley MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub2; RASSIN DK, 1994, NESTLE NUTR WORKS SE, V33, P183; Rellan S, 2008, PROTOCOLOS DIAGNOSTI; SCOTT PH, 1990, CLIN CHEM, V36, P1922; Zaffanello M, 2005, J PERINAT MED, V33, P246, DOI 10.1515/JPM.2005.045; Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138532	10.1371/journal.pone.0138532	http://dx.doi.org/10.1371/journal.pone.0138532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389596	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000037
J	Tanaka, Y; Inoue-Yokoo, T; Kulkeaw, K; Yanagi-Mizuochi, C; Shirasawa, S; Nakanishi, Y; Sugiyama, D				Tanaka, Yuka; Inoue-Yokoo, Tomoko; Kulkeaw, Kasem; Yanagi-Mizuochi, Chiyo; Shirasawa, Senji; Nakanishi, Yoichi; Sugiyama, Daisuke			Embryonic Hematopoietic Progenitor Cells Reside in Muscle before Bone Marrow Hematopoiesis	PLOS ONE			English	Article							STEM-CELLS; MOUSE EMBRYO; DEFINITIVE HEMATOPOIESIS; EXTRACELLULAR-MATRIX; HEPATIC PRIMORDIUM; SELF-RENEWAL; C-MYC; EXPRESSION; DIFFERENTIATION; MIGRATION	In mice, hematopoietic cells home to bone marrow from fetal liver prenatally. To elucidate mechanisms underlying homing, we performed immunohistochemistry with the hematopoietic cell marker c-Kit, and observed c-Kit(+) cells localized inside muscle surrounding bone after 14.5 days post coitum. Flow cytometric analysis showed that CD45(+) c-Kit(+) hematopoietic cells were more abundant in muscle than in bone marrow between 14.5 and 17.5 days post coitum, peaking at 16.5 days post coitum. CD45(+) c-Kit(+) cells in muscle at 16.5 days post coitum exhibited higher expression of Gata2, among several hematopoietic genes, than did fetal liver or bone marrow cells. Colony formation assays revealed that muscle hematopoietic cells possess hematopoietic progenitor activity. Furthermore, exo utero transplantation revealed that fetal liver hematopoietic progenitor cells home to muscle and then to BM. Our findings demonstrate that hematopoietic progenitor cell homing occurs earlier than previously reported and that hematopoietic progenitor cells reside in muscle tissue before bone marrow hematopoiesis occurs during mouse embryogenesis.	[Tanaka, Yuka; Sugiyama, Daisuke] Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan; [Tanaka, Yuka; Yanagi-Mizuochi, Chiyo; Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Fac Med, Fukuoka 81401, Japan; [Inoue-Yokoo, Tomoko; Kulkeaw, Kasem; Sugiyama, Daisuke] Kyushu Univ, Fac Med Sci, Dept Res & Dev Next Generat Med, Fukuoka 812, Japan; [Nakanishi, Yoichi; Sugiyama, Daisuke] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan	Kyushu University; Fukuoka University; Kyushu University; Kyushu University	Sugiyama, D (corresponding author), Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan.	ds-mons@yb3.so-net.ne.jp	, Kasem/AAH-6083-2020	, Kasem/0000-0002-6652-9244				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bertrand JY, 2006, DEVELOPMENT, V133, P3619, DOI 10.1242/dev.02510; BRAUN N, 1988, VIRCHOWS ARCH B, V56, P25, DOI 10.1007/BF02889998; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Coskun S, 2014, CELL REP, V9, P581, DOI 10.1016/j.celrep.2014.09.013; CUDENNEC CA, 1981, J EMBRYOL EXP MORPH, V61, P51; Cumano A, 2000, VACCINE, V18, P1621, DOI 10.1016/S0264-410X(99)00496-X; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; JOHNSON GR, 1973, J EMBRYOL EXP MORPH, V30, P83; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mizuochi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035763; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MUNEOKA K, 1986, J EXP ZOOL, V239, P289, DOI 10.1002/jez.1402390216; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; ROBINSON S, 1991, J ANAT, V174, P153; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schuhmacher M., 2013, TRANSCRIPTION, V4; Strobel ES, 1997, BLOOD, V90, P3524, DOI 10.1182/blood.V90.9.3524; Sugiyama D, 2005, STEM CELLS DEV, V14, P687, DOI 10.1089/scd.2005.14.687; Sugiyama D, 2013, MECH DEVELOP, V130, P195, DOI 10.1016/j.mod.2012.09.003; Sugiyama D, 2011, THESCIENTIFICWORLDJO, V11, P1770, DOI 10.1100/2011/598097; Sugiyama D, 2011, BIOCHEM BIOPH RES CO, V410, P301, DOI 10.1016/j.bbrc.2011.05.137; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zorn A.M., 2008, LIVER DEV	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138621	10.1371/journal.pone.0138621	http://dx.doi.org/10.1371/journal.pone.0138621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389592	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000045
J	Izumi, K; Ohkado, A; Uchimura, K; Murase, Y; Tatsumi, Y; Kayebeta, A; Watanabe, Y; Ishikawa, N				Izumi, Kiyohiko; Ohkado, Akihiro; Uchimura, Kazuhiro; Murase, Yoshiro; Tatsumi, Yuriko; Kayebeta, Aya; Watanabe, Yu; Ishikawa, Nobukatsu			Detection of Tuberculosis Infection Hotspots Using Activity Spaces Based Spatial Approach in an Urban Tokyo, from 2003 to 2011	PLOS ONE			English	Article							HIGH-INCIDENCE AREA; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; PATTERNS; STATISTICS; CONTACT; JAPAN	Background Identifying ongoing tuberculosis infection sites is crucial for breaking chains of transmission in tuberculosis-prevalent urban areas. Previous studies have pointed out that detection of local accumulation of tuberculosis patients based on their residential addresses may be limited by a lack of matching between residences and tuberculosis infection sites. This study aimed to identify possible tuberculosis hotspots using TB genotype clustering statuses and a concept of "activity space", a place where patients spend most of their waking hours. We further compared the spatial distribution by different residential statuses and describe urban environmental features of the detected hotspots. Methods Culture-positive tuberculosis patients notified to Shinjuku city from 2003 to 2011 were enrolled in this case-based cross-sectional study, and their demographic and clinical information, TB genotype clustering statuses, and activity space were collected. Spatial statistics (Global Moran's I and Getis-Ord Gi* statistics) identified significant hotspots in 152 census tracts, and urban environmental features and tuberculosis patients' characteristics in these hotspots were assessed. Results Of the enrolled 643 culture-positive tuberculosis patients, 416 (64.2%) were general inhabitants, 42 (6.5%) were foreign-born people, and 184 were homeless people (28.6%). The percentage of overall genotype clustering was 43.7%. Genotype-clustered general inhabitants and homeless people formed significant hotspots around a major railway station, whereas the non-clustered general inhabitants formed no hotspots. This suggested the detected hotspots of activity spaces may reflect ongoing tuberculosis transmission sites and were characterized by smaller residential floor size and a higher proportion of non-working households. Conclusions Activity space-based spatial analysis suggested possible TB transmission sites around the major railway station and it can assist in further comprehension of TB transmission dynamics in an urban setting in Japan.	[Izumi, Kiyohiko; Ohkado, Akihiro; Uchimura, Kazuhiro; Tatsumi, Yuriko] Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, Kiyose, Tokyo, Japan; [Izumi, Kiyohiko; Ohkado, Akihiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Nagasaki 852, Japan; [Murase, Yoshiro] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo, Japan; [Kayebeta, Aya; Watanabe, Yu] Shinjuku City Publ Hlth Ctr, Shinjuku City, Tokyo, Japan; [Ishikawa, Nobukatsu] Japan AntiTB Assoc, Res Inst TB, Kiyose, Tokyo, Japan	Nagasaki University	Izumi, K (corresponding author), Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, Kiyose, Tokyo, Japan.	kizumi@jata.or.jp	Ohkado, Akihiro/HGF-2977-2022		Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED, Government of Japan; double-barred cross seal donation fund, Japan Anti-Tuberculosis Association	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED, Government of Japan(Japan Agency for Medical Research and Development (AMED)); double-barred cross seal donation fund, Japan Anti-Tuberculosis Association	Funding: This research was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED, Government of Japan, and double-barred cross seal donation fund, Japan Anti-Tuberculosis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hernandez G, 2010, INT J TUBERC LUNG D, V14, P708; Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; [Anonymous], 2014, STAT TB 2014; Barr RG, 2001, AM J PUBLIC HEALTH, V91, P1487, DOI 10.2105/AJPH.91.9.1487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Bureau of Social Welfare and Public Health Tokyo Metropolitan Government, 2005, TUB CONTR PREV PLAN; Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320; Feske ML, 2011, TUBERCULOSIS, V91, pS24, DOI 10.1016/j.tube.2011.10.006; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Golub JE, 2001, ARCH INTERN MED, V161, P2254, DOI 10.1001/archinte.161.18.2254; Haase I, 2007, INT J TUBERC LUNG D, V11, P632; Kinoshita Setsuko, 2007, Kekkaku, V82, P749; Lloyd C. D., 2010, LOCAL MODELS SPATIAL; Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Moonan Patrick K, 2004, Int J Health Geogr, V3, P23, DOI 10.1186/1476-072X-3-23; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Murray M, 2002, B WORLD HEALTH ORGAN, V80, P477; Nagamine Michiko, 2008, Kekkaku, V83, P379; Ng IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050740; Ohkado A, 2008, INT J TUBERC LUNG D, V12, P548; Ohmori M, 2002, INT J TUBERC LUNG D, V6, P415; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Research Institute of Shinjuku Autonomy, 2013, RES REP FEAT SHINJ C; Shinjuku City, 2015, STAT SHINJUKU; Souza WV, 2007, TROP MED INT HEALTH, V12, P323, DOI 10.1111/j.1365-3156.2006.01797.x; Tamaru A, 2004, JAPAN PUBLIC HLTH PR, V68, P186; The Ministry of Internal Affairs and Communications the Bureau of the Statistics, 2005, JAP CENS 2005; Tsai P-J, 2011, OPEN J PREV MED, V01, P125, DOI [10.4236/ojpm.2011.13017, DOI 10.4236/OJPM.2011.13017]; Uchimura K, 2013, WEST PAC SURVEILL RE, V4, P11, DOI [10.5365/wpsar.2012.3.4.016, 10.5365/WPSAR.2012.3.4.016]; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Watase Hirotoshi, 2006, Kekkaku, V81, P481; World Health Organization, 2012, WHOHTMTB20129; World Health Organization, 2014, WHOHTMTB201408	38	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138831	10.1371/journal.pone.0138831	http://dx.doi.org/10.1371/journal.pone.0138831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382251	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200159
J	King, R; Min, J; Birungi, J; Nyonyintono, M; Muldoon, KA; Khanakwa, S; Kaleebu, P; Moore, DM				King, Rachel; Min, Jeong; Birungi, Josephine; Nyonyintono, Maureen; Muldoon, Katherine A.; Khanakwa, Sarah; Kaleebu, Pontiano; Moore, David M.			Effect of Couples Counselling on Reported HIV Risk Behaviour among HIV Serodiscordant Couples by ART Use, HIV Status and Gender in Rural Uganda	PLOS ONE			English	Article							SERO-DISCORDANT COUPLES; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; CONDOM USE; TRANSMISSION RISK; INFECTED ADULTS; SOUTH-AFRICA; PREVENTION	Background We examined several measures of self-reported HIV risk behaviour in mutually disclosed sero-discordant couples over time to see if a couples counselling intervention was associated with changes in these behaviors. Methods We analysed data from a prospective cohort study of HIV sero-discordant couples in Jinja, Uganda collected between June 2009 and December 2011. Participants received couples counselling, at 3-monthly intervals. We examined trends in reported condom-use, number of concurrent sexual partners, knowledge of HIV serostatus of concurrent partners and condom use of concurrent partners using Generalized Estimating Equation models, comparing responses at study enrollment with responses at six, 12 18 and 24 months of follow-up. Results A total of 586 couples were enrolled and the female member was HIV positive in 255 (44%) of them. The median age for female participants was 35 years and 42 years for men. Reported condom use at last sex with spouse increased over time (p<0.001) with the largest increases found among couples where the positive participant never received ART during the study(an increase from 68.8% at enrollment to 97.1% at 24 months). Male participants reported reductions in the number of concurrent sexual partners (p<0.001), increase in the knowledge of the HIV serostatus of these partners (p = 0.001) and a trend towards improved condom-use among non-primary partners (p = 0.070). Reported reduced risky behaviors did not wane over the study period. Conclusion Couples counselling resulted in increased condom use among all participants and among men the intervention resulted in reductions in risk behaviour with concurrent sexual partners. Routine counselling for serodiscordant couples should be integrated in routine ART care programs.	[King, Rachel] Univ Calif San Francisco, Kampala, Uganda; [Min, Jeong; Moore, David M.] British Colombia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Birungi, Josephine; Nyonyintono, Maureen; Khanakwa, Sarah] AIDS Support Org, Jinja, Uganda; [Muldoon, Katherine A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, AIDS Res Unit, Entebbe, Uganda; [Moore, David M.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Uganda Virus Research Institute; University of British Columbia	King, R (corresponding author), Univ Calif San Francisco, Kampala, Uganda.	rachel.king@ucsf.edu	Muldoon, Katherine/AAC-4703-2021	Muldoon, Katherine/0000-0002-0766-4294	Canadian Institutes of Health Research (CIHR) [MOP-8970, HBF-112308, MHI-I26391]; Michael Smith Foundation for Health Research; CIHR Doctoral Award - Canadian Association for HIV/AIDS Research (CAHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Doctoral Award - Canadian Association for HIV/AIDS Research (CAHR)	DMM was supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR) and a Scholar Award from the Michael Smith Foundation for Health Research. KAM is supported by a CIHR Doctoral Award funded by the Canadian Association for HIV/AIDS Research (CAHR). The study was funded by CIHR (Grant numbers MOP-8970, HBF-112308 and MHI-I26391).	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Allen S, 2014, AIDS RESEARCH AND HU, P30; Allen S, 2014, AIDS RES HUM RETROV, V30, pA285, DOI 10.1089/aid.2014.5646.abstract; Anglemyer A, 2014, AIDS, V28, pS105, DOI 10.1097/QAD.0000000000000232; Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Apondi R, 2011, AIDS, V25, P1317, DOI 10.1097/QAD.0b013e328347f775; Birungi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132182; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kilembe W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124548; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Muldoon KA, 2014, SEX TRANSM INFECT, V90, P408, DOI 10.1136/sextrans-2013-051326; Muldoon KA, 2011, CULT HEALTH SEX, V13, P933, DOI 10.1080/13691058.2011.590901; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Rugpao S, 2008, AIDS BEHAV, V12, P419, DOI 10.1007/s10461-007-9283-y; Senkoro KP, 2000, J ACQ IMMUN DEF SYND, V23, P194; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; Uganda Ministry of Gender Labour and Social Development/Ministry of Local Govern-ment, 2005, GEND BUDG GUID AN TO; World Health Organization, 2012, GUID OR PREEXP PROPH	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136531	10.1371/journal.pone.0136531	http://dx.doi.org/10.1371/journal.pone.0136531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26384103	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200008
J	Koshimori, Y; Ko, JH; Mizrahi, R; Rusjan, P; Mabrouk, R; Jacobs, MF; Christopher, L; Hamani, C; Lang, AE; Wilson, AA; Houle, S; Strafella, AP				Koshimori, Yuko; Ko, Ji-Hyun; Mizrahi, Romina; Rusjan, Pablo; Mabrouk, Rostom; Jacobs, Mark F.; Christopher, Leigh; Hamani, Clement; Lang, Anthony E.; Wilson, Alan A.; Houle, Sylvain; Strafella, Antonio P.			Imaging Striatal Microglial Activation in Patients with Parkinson's Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRANSLOCATOR PROTEIN TSPO; HUMAN BRAIN; BINDING-AFFINITY; PET RADIOLIGAND; FACTOR-ALPHA; POLYMORPHISM; ALZHEIMERS; INTERLEUKIN-1-BETA; NEUROINFLAMMATION	This study investigated whether the second-generation translocator protein 18kDa (TSPO) radioligand, [F-18]-FEPPA, could be used in neurodegenerative parkinsonian disorders as a biomarker for detecting neuroinflammation in the striatum. Neuroinflammation has been implicated as a potential mechanism for the progression of Parkinson's disease (PD). Positron Emission Tomography (PET) radioligand targeting for TSPO allows for the quantification of neuroinflammation in vivo. Based on genotype of the rs6791 polymorphism in the TSPO gene, 16 mixed-affinity binders (MABs) (8 PD and age-matched 8 healthy controls (HCs)), 16 high-affinity binders (HABs) (8 PD and age-matched 8 HCs) and 4 low-affinity binders (LABs) (3 PD and 1 HCs) were identified. Total distribution volume (V-T) values in the striatum were derived from a two-tissue compartment model with arterial plasma as an input function. There was a significant main effect of genotype on [F-18]-FEPPA VT values in the caudate nucleus (p = 0.001) and putamen (p < 0.001), but no main effect of disease or disease x genotype interaction in either ROI. In the HAB group, the percentage difference between PD and HC was 16% in both caudate nucleus and putamen; in the MAB group, it was -8% and 3%, respectively. While this PET study showed no evidence of increased striatal TSPO expression in PD patients, the current findings provide some insights on the possible interactions between rs6791 polymorphism and neuroinflammation in PD.	[Koshimori, Yuko; Christopher, Leigh; Strafella, Antonio P.] Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hosp Network, Toronto, ON, Canada; [Koshimori, Yuko; Mizrahi, Romina; Rusjan, Pablo; Mabrouk, Rostom; Jacobs, Mark F.; Christopher, Leigh; Wilson, Alan A.; Houle, Sylvain; Strafella, Antonio P.] Univ Toronto, Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Ko, Ji-Hyun] Univ Manitoba, Dept Human Anat & Cell Sci, Fac Hlth Sci, Winnipeg, MB, Canada; [Hamani, Clement] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Univ Hosp Network, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorder Unit, Univ Hosp Network, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinson Dis, Univ Hosp Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Strafella, AP (corresponding author), Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hosp Network, Toronto, ON, Canada.	antonio.strafella@uhn.ca	Lang, Anthony/ABF-8114-2021; Ko, Ji Hyun/E-5150-2011; Mabrouk, Rostom/M-1674-2019	Ko, Ji Hyun/0000-0002-9700-7692; Mizrahi, Romina/0000-0001-6667-7928; Houle, Sylvain/0000-0002-4231-6316; Lang, Anthony/0000-0003-1229-3667; Rusjan, Pablo/0000-0003-0075-2918	Canadian Institutes of Health Research [INE 117891]; Weston Brain Institute; Canada Research Chair program from Canadian Institutes of Health Research; Doctoral Research Award from Canadian Institutes of Health Research [GDS-D 128684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Weston Brain Institute; Canada Research Chair program from Canadian Institutes of Health Research; Doctoral Research Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (INE 117891) and Weston Brain Institute (http://westonbraininstitute.ca). AS is supported by the Canada Research Chair program from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). YK is supported by a Doctoral Research Award from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (GDS-D 128684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencherif B, 2004, J NUCL MED, V45, P402; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; Costa B, 2009, ENDOCRINOLOGY, V150, P5438, DOI 10.1210/en.2009-0752; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Hatano K, 2010, NEUROIMAGE, V52, pS138, DOI 10.1016/j.neuroimage.2010.04.112; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Ko JH, 2013, J CEREBR BLOOD F MET, V33, P348, DOI 10.1038/jcbfm.2012.203; Kobylecki C, 2013, PARKINSONISM RELAT D, V19, P527, DOI 10.1016/j.parkreldis.2013.01.017; Kreisl WC, 2013, J CEREBR BLOOD F MET, V33, P53, DOI 10.1038/jcbfm.2012.131; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Narendran R, 2014, J NEUROSCI, V34, P9945, DOI 10.1523/JNEUROSCI.0928-14.2014; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2014, J CEREBR BLOOD F MET, V34, P883, DOI 10.1038/jcbfm.2014.34; Rusjan PM, 2011, J CEREBR BLOOD F MET, V31, P1807, DOI 10.1038/jcbfm.2011.55; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Suridjan I., 2015, MOL PSYCHIAT; Varrone A, 2015, EUR J NUCL MED MOL I, V42, P438, DOI 10.1007/s00259-014-2955-8; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009	30	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138721	10.1371/journal.pone.0138721	http://dx.doi.org/10.1371/journal.pone.0138721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381267	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200152
J	Ge, Z; Guo, XL; Chen, XR; Zhang, JY; Yan, LX; Tang, JL; Cai, XN; Xu, AQ; Ma, JX				Ge, Zeng; Guo, Xiaolei; Chen, Xiaorong; Zhang, Jiyu; Yan, Liuxia; Tang, Junli; Cai, Xiaoning; Xu, Aiqiang; Ma, Jixiang			Are Microalbuminuria and Elevated 24 H Urinary Microalbumin Excretion within Normal Range Associated with Metabolic Syndrome in Chinese Adults?	PLOS ONE			English	Article							HYPERTENSION; ALBUMINURIA; RISKS	The association of microalbuminuria and elevated 24 h urinary microalbumin excretion (UAE) with metabolic syndrome (MetS) has not been well examined in Chinese Adults. In the present study, a population-based cross-sectional study was conducted among Chinese adults aged 18-69 years in Shandong province in 2011 to determine the relationship between them. Data on 24 h UAE and other variables were obtained and components of MetS were examined. The prevalence of MetS and mean 24 h UAE was 24.7% and 6.7 mg, respectively. Compared with participants with normoalbuminuria, the odds of MetS and its components including central obesity, elevated blood pressure and elevated fasting glucose, but not the odds of low HDL cholesterol and elevated triglycerides, significantly increased in those with microalbuminuria. Additionally, the odds of MetS and its three components significantly increased across increasing quartiles of 24 h UAE within normal range (1.00, 1.11, 1.02 and 1.58, respectively, for MetS; 1.00, 1.14, 1.21, and 1.68, respectively, for central obesity; 1.00, 1.35, 1.26 and 1.68, respectively, for elevated blood pressure; and 1.00, 1.32, 1.06 and 1.47, respectively, for elevated triglycerides; p for linear trend <= 0.05 for all). Furthermore, for each increment of 10 mg 24 h UAE within normal range, the odds of MetS and its components including central obesity, elevated blood pressure, and elevated triglycerides significantly increased by 53%, 65%, 55%, and 41%, respectively. These findings suggest that both microalbuminuria and elevated 24 h UAE within normal range might be important risk factors for MetS in Chinese adults.	[Ge, Zeng; Chen, Xiaorong; Yan, Liuxia; Cai, Xiaoning; Ma, Jixiang] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Guo, Xiaolei; Zhang, Jiyu; Tang, Junli; Xu, Aiqiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, AQ (corresponding author), Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China.	aqxuepi@163.com; majix@163.com	zhang, jiyu/W-9297-2018; Stefanadis, Christodoulos/ABH-2232-2020	zhang, jiyu/0000-0001-6236-8781; Stefanadis, Christodoulos/0000-0001-5974-6454	Chinese Center for Disease Control and Prevention, Beijing, China; People's Government of Shandong Province, Jinan, China [2012GSF11828]	Chinese Center for Disease Control and Prevention, Beijing, China; People's Government of Shandong Province, Jinan, China	The present study was supported by a grant from the Chinese Center for Disease Control and Prevention, Beijing, China, and a provincial technical development plan grant (2012GSF11828) from the People's Government of Shandong Province, Jinan, China. The sponsors had no role in the design and conduct of the study; in the collection, management, analysis, or interpretation of the data; or in the preparation of the manuscript.	Choi HS, 2006, NEPHRON CLIN PRACT, V104, pC85, DOI 10.1159/000093995; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Ge Z, 2015, BRIT J NUTR, V113, P996, DOI 10.1017/S0007114514003833; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Li MF, 2015, J DIABETES INVEST, V6, P354, DOI 10.1111/jdi.12307; Meng De-jing, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P312; Oh CM, 2014, MATURITAS, V77, P149, DOI 10.1016/j.maturitas.2013.10.013; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Park SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125615; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-6; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Vyssoulis G, 2010, J CLIN HYPERTENS, V12, P597, DOI 10.1111/j.1751-7176.2010.00306.x; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065597	15	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138410	10.1371/journal.pone.0138410	http://dx.doi.org/10.1371/journal.pone.0138410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379278	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400096
J	Smith, GT; Rahman, AR; Li, M; Moore, B; Gietema, H; Veronesi, G; Massion, PP; Walker, RC				Smith, Gary T.; Rahman, Ahmad R.; Li, Ming; Moore, Brandon; Gietema, Hester; Veronesi, Giulia; Massion, Pierre P.; Walker, Ronald C.			Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval	PLOS ONE			English	Article							LUNG-CANCER; FLEISCHNER-SOCIETY; DOUBLING TIMES; CT; MANAGEMENT; PERFORMANCE; STATEMENT; LEVEL	Purpose To use clinically measured reproducibility of volumetric CT (vCT) of lung nodules to estimate error in nodule growth rate in order to determine optimal scan interval for patient follow-up. Methods We performed quantitative vCT on 89 stable non-calcified nodules and 49 calcified nodules measuring 3-13 mm diameter in 71 patients who underwent 3-9 repeat vCT studies for clinical evaluation of pulmonary nodules. Calculated volume standard deviation as a function of mean nodule volume was used to compute error in estimated growth rate. This error was then used to determine the optimal patient follow-up scan interval while fixing the false positive rate at 5%. Results Linear regression of nodule volume standard deviation versus the mean nodule volume for stable non-calcified nodules yielded a slope of 0.057 +/- 0.002 (r(2) = 0.79, p<0.001). For calcified stable nodules, the regression slope was 0.052 +/- 0.005 (r(2) = 0.65, p = 0.03). Using this with the error propagation formula, the optimal patient follow-up scan interval was calculated to be 81 days, independent of initial nodule volume. Conclusions Reproducibility of vCT is excellent, and the standard error is proportional to the mean calculated nodule volume for the range of nodules examined. This relationship constrains statistical certainty of vCT calculated doubling times and results in an optimal scan interval that is independent of the initial nodule volume.	[Smith, Gary T.; Rahman, Ahmad R.; Moore, Brandon; Walker, Ronald C.] Tennessee Valley Healthcare Syst, Dept Med Imaging, Dept Vet Affairs, Nashville, TN 37212 USA; [Li, Ming] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA; [Gietema, Hester] Med Spectrum Twente, Enschede, Netherlands; [Veronesi, Giulia] European Inst Oncol, Milan, Italy; [Massion, Pierre P.] Tennessee Valley Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Nashville, TN USA; [Massion, Pierre P.] Thorac Program Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA; [Massion, Pierre P.] Thorac Program Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN USA; [Smith, Gary T.; Walker, Ronald C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Medical Spectrum Twente; IRCCS European Institute of Oncology (IEO); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Smith, GT (corresponding author), Tennessee Valley Healthcare Syst, Dept Med Imaging, Dept Vet Affairs, Nashville, TN 37212 USA.	gary.t.smith@vanderbilt.edu	Li, Ming/P-9514-2019; Veronesi, Giulia/AAA-6327-2021	Li, Ming/0000-0001-8270-2070; Veronesi, Giulia/0000-0001-9032-1278	National Cancer Institute [U01CA152662]; NATIONAL CANCER INSTITUTE [U01CA152662] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by National Cancer Institute U01CA152662 awarded to PPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ashraf H, 2011, THORAX, V66, P315, DOI 10.1136/thx.2010.136747; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gavrielides MA, 2009, RADIOLOGY, V251, P26, DOI 10.1148/radiol.2511071897; Gietema HA, 2007, RADIOLOGY, V245, P888, DOI 10.1148/radiol.2452061054; Grogan EL, 2011, J THORAC ONCOL, V6, P1720, DOI 10.1097/JTO.0b013e318226b48a; Henschke CI, 2012, RADIOLOGY, V263, P578, DOI 10.1148/radiol.12102489; Horeweg N, 2014, LANCET ONCOL, V15, P1342, DOI 10.1016/S1470-2045(14)70387-0; Kostis WJ, 2004, RADIOLOGY, V231, P446, DOI 10.1148/radiol.2312030553; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Marchiano A, 2009, RADIOLOGY, V251, P919, DOI 10.1148/radiol.2513081313; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nietert PJ, 2009, CHEST, V135, P1580, DOI 10.1378/chest.08-2040; Pecot CV, 2012, CANCER EPIDEM BIOMAR, V21, P786, DOI 10.1158/1055-9965.EPI-11-0932; Revel MP, 2006, AM J ROENTGENOL, V187, P135, DOI 10.2214/AJR.05.1228; Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241; Revel MP, 2004, RADIOLOGY, V231, P453, DOI 10.1148/radiol.2312030167; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Wang JB, 2012, LUNG CANCER, V78, P51, DOI 10.1016/j.lungcan.2012.06.010; Xie X, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130160; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251	23	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138144	10.1371/journal.pone.0138144	http://dx.doi.org/10.1371/journal.pone.0138144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379272	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400061
J	Kulikova, V; Shabalin, K; Nerinovski, K; Dolle, C; Niere, M; Yakimov, A; Redpath, P; Khodorkovskiy, M; Migaud, ME; Ziegler, M; Nikiforov, A				Kulikova, Veronika; Shabalin, Konstantin; Nerinovski, Kirill; Dolle, Christian; Niere, Marc; Yakimov, Alexander; Redpath, Philip; Khodorkovskiy, Mikhail; Migaud, Marie E.; Ziegler, Mathias; Nikiforov, Andrey			Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLISM; DISEASE; 5'-NUCLEOTIDASE; BIOSYNTHESIS; PHOSPHORIBOSYLTRANSFERASE; ACTIVATION; PATHWAYS; PROTECTS; ENZYMES; HEALTH	NAD is essential for cellular metabolism and has a key role in various signaling pathways in human cells. To ensure proper control of vital reactions, NAD must be permanently resynthesized. Nicotinamide and nicotinic acid as well as nicotinamide riboside (NR) and nicotinic acid riboside (NAR) are the major precursors for NAD biosynthesis in humans. In this study, we explored whether the ribosides NR and NAR can be generated in human cells. We demonstrate that purified, recombinant human cytosolic 5'-nucleotidases (5-NTs) CN-II and CN-III, but not CN-IA, can dephosphorylate the mononucleotides nicotinamide mononucleotide and nicotinic acid mononucleotide (NAMN) and thus catalyze NR and NAR formation in vitro. Similar to their counterpart from yeast, Sdt1, the human 5-NTs require high (millimolar) concentrations of nicotinamide mononucleotide or NAMN for efficient catalysis. Overexpression of FLAG-tagged CN-II and CN-III in HEK293 and HepG2 cells resulted in the formation and release of NAR. However, NAR accumulation in the culture medium of these cells was only detectable under conditions that led to increased NAMN production from nicotinic acid. The amount of NAR released from cells engineered for increased NAMN production was sufficient to maintain viability of surrounding cells unable to use any other NAD precursor. Moreover, we found that untransfected HeLa cells produce and release sufficient amounts of NAR and NR under normal culture conditions. Collectively, our results indicate that cytosolic 5-NTs participate in the conversion of NAD precursors and establish NR and NAR as integral constituents of human NAD metabolism. In addition, they point to the possibility that different cell types might facilitate each other's NAD supply by providing alternative precursors.	[Kulikova, Veronika; Shabalin, Konstantin; Nerinovski, Kirill; Yakimov, Alexander; Khodorkovskiy, Mikhail; Nikiforov, Andrey] Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia; [Shabalin, Konstantin; Yakimov, Alexander] Natl Res Ctr, Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina 188300, Russia; [Nerinovski, Kirill] St Petersburg State Univ, St Petersburg 199034, Russia; [Dolle, Christian; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Redpath, Philip; Migaud, Marie E.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Nikiforov, Andrey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Peter the Great St. Petersburg Polytechnic University; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Saint Petersburg State University; University of Bergen; Queens University Belfast; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	mathias.ziegler@mbi.uib.no; andrey.nikiforov@gmail.com	Khodorkovskiy, Mikhail/G-2793-2011; Nerinovski, Kirill/P-4607-2016; Shabalin, Konstantin A/G-1821-2015; Yakimov, Alexander/J-3336-2013; Nikiforov, Andrey A/B-6643-2012; migaud, marie/C-9026-2015; Kulikova, Veronika/AAE-9110-2021; Yakimov, Alexander/I-4731-2019	Nerinovski, Kirill/0000-0002-7517-9784; Shabalin, Konstantin A/0000-0002-4590-2011; Yakimov, Alexander/0000-0003-0462-1157; Nikiforov, Andrey A/0000-0002-5009-6130; Yakimov, Alexander/0000-0003-0462-1157; Ziegler, Mathias/0000-0001-6961-2396; Khodorkovskii, Mikhail/0000-0003-0562-0156	Russian Foundation for Basic Research [14-04-01765 a, 14-04-32117 mol_a]; Norwegian Research Council	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Russian Foundation for Basic Research Grants 14-04-01765 a and 14-04-32117 mol_a and by the Norwegian Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Amici A, 2002, ARCH BIOCHEM BIOPHYS, V397, P184, DOI 10.1006/abbi.2001.2676; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Ipata PL, 2013, CURR MED CHEM, V20, P4205; Ipata Piero Luigi, 2006, Purinergic Signal, V2, P669, DOI 10.1007/s11302-006-9009-z; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Koch-Nolte F, 2008, FRONT BIOSCI-LANDMRK, V13, P6716, DOI 10.2741/3184; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012	30	53	60	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27124	27137		10.1074/jbc.M115.664458	http://dx.doi.org/10.1074/jbc.M115.664458			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26385918	Green Published, hybrid			2022-12-26	WOS:000364794000022
J	Chang, YQ; Li, CX; Gan, L; Li, H; Guo, ZK				Chang, Yuqiao; Li, Cixia; Gan, Li; Li, He; Guo, Zhikun			Telocytes in the Spleen	PLOS ONE			English	Article							SKELETAL-MUSCLE INTERSTITIUM; PUTATIVE STEM-CELLS; HUMAN HEART; PLURIPOTENCY; REGENERATION; NANOG; ICLC; SKIN	Telocytes, a novel type of interstitial cells with very long and thin prolongations, have been identified in many organs in mammals. At present, the ultrastructural, immunocytochemical and electrophysiological properties of telocytes in multiple organs have been understood. However, telocytes in spleen, especially their roles in spleen have not been reported. The aim of this study was to investigate the ultrastructure, distribution and immunophenotypes of splenic telocytes. Rat spleen was harvested for the ultrastructure analysis by transmission electron microscopy (TEM). The primary culture of telocytes was performed after combined enzymatic digestion. The characteristic morphology was analyzed by a scanning electron microscopy (SEM). It was shown that telocytes displayed a piriform/spindle/triangular shape with long and slender telopods and extremely long prolongation contracting with surrounding cells in the spleen. Their dynamic profiles of cytoplasmic separation were recorded by the Live Cell Imaging System. The length of telopods was mostly distributing in 20-30 mu m, in accordance with normal distribution. Most telocytes had three or two telopods (28.71% and 22.58% respectively). Immunostaining indicated that these cells were positive for vimentin, CD34, nanog and sca-1, but negative for c-kit. These data prove the existence of telocytes in the spleen, which may serve as the experimental base for exploring their roles in the spleen.	[Chang, Yuqiao; Li, Cixia; Gan, Li; Guo, Zhikun] Xinxiang Med Univ, Henan Key Lab Med Tissue Regenerat, Xinxiang 453003, Peoples R China; [Chang, Yuqiao; Li, He] Huazhong Univ Sci & Technol, Dept Human Anat & Embryol, Tongji Med Coll, Wuhan 430030, Peoples R China	Xinxiang Medical University; Huazhong University of Science & Technology	Guo, ZK (corresponding author), Xinxiang Med Univ, Henan Key Lab Med Tissue Regenerat, Xinxiang 453003, Peoples R China.	gzk@xxmu.edu.cn			National Natural Science Foundation of China [81570268]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81570268).	Bojin FM, 2011, J CELL MOL MED, V15, P2269, DOI 10.1111/j.1582-4934.2011.01386.x; Ceafalan L, 2012, J CELL MOL MED, V16, P1405, DOI 10.1111/j.1582-4934.2012.01580.x; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cismasiu VB, 2015, J CELL MOL MED, V19, P351, DOI 10.1111/jcmm.12529; Cretoiu Sanda M, 2014, Biomol Concepts, V5, P353, DOI 10.1515/bmc-2014-0029; Cretoiu SM, 2013, REPRODUCTION, V145, P357, DOI 10.1530/REP-12-0369; du Pre BC, 2013, J GERIATR CARDIOL, V10, P186, DOI 10.3969/j.issn.1671-5411.2013.02.003; Gevaert T, 2012, J CELL MOL MED, V16, P2085, DOI 10.1111/j.1582-4934.2011.01504.x; Gherghiceanu M, 2012, CELL TISSUE RES, V348, P265, DOI 10.1007/s00441-012-1333-8; Gherghiceanu M, 2010, J CELL MOL MED, V14, P871, DOI 10.1111/j.1582-4934.2010.01060.x; Hinescu M E, 2005, J Cell Mol Med, V9, P972, DOI 10.1111/j.1582-4934.2005.tb00394.x; Hinescu ME, 2006, J CELL MOL MED, V10, P243, DOI 10.1111/j.1582-4934.2006.tb00306.x; Luesma MJ, 2013, J CELL MOL MED, V17, P1016, DOI 10.1111/jcmm.12111; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Popescu BO, 2012, NEUROSCI LETT, V516, P265, DOI 10.1016/j.neulet.2012.04.006; Popescu LM, 2013, RESIDENT STEM CELLS AND REGENERATIVE THERAPY, P205, DOI 10.1016/B978-0-12-416012-5.00011-6; Popescu LM, 2011, J CELL MOL MED, V15, P1379, DOI 10.1111/j.1582-4934.2011.01330.x; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2009, J CELL MOL MED, V13, P866, DOI 10.1111/j.1582-4934.2009.00758.x; Popescu LM, 2015, J CELL MOL MED, V19, P31, DOI 10.1111/jcmm.12509; Popescu LM, 2011, CELL TISSUE RES, V345, P391, DOI 10.1007/s00441-011-1229-z; Robinson S, 2000, J HEMATOTH STEM CELL, V9, P711, DOI 10.1089/15258160050196759; Rusu MC, 2012, ANN ANAT, V194, P359, DOI 10.1016/j.aanat.2011.11.007; Rusu MC, 2012, J CELL MOL MED, V16, P401, DOI 10.1111/j.1582-4934.2011.01465.x; Suciu L, 2010, CELLS TISSUES ORGANS, V192, P325, DOI 10.1159/000319467; Suciu LC, 2012, J CELL MOL MED, V16, P701, DOI 10.1111/j.1582-4934.2011.01505.x; Wagner-Souza K, 2008, INT J MOL MED, V22, P237, DOI 10.3892/ijmm_00000014; Xiao JJ, 2013, J CELL MOL MED, V17, P1537, DOI 10.1111/jcmm.12195; Yang Y, 2014, J CELL MOL MED, V18, P759, DOI 10.1111/jcmm.12285; Zhao BY, 2014, J CELL MOL MED, V18, P780, DOI 10.1111/jcmm.12259; Zheng YH, 2012, J CELL PHYSIOL, V227, P2311, DOI 10.1002/jcp.23022; Zheng YH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-188	32	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138851	10.1371/journal.pone.0138851	http://dx.doi.org/10.1371/journal.pone.0138851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397114	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500118
J	Garcia, NA; Ontoria-Oviedo, I; Gonzalez-King, H; Diez-Juan, A; Sepulveda, P				Garcia, Nahuel A.; Ontoria-Oviedo, Imelda; Gonzalez-King, Hernan; Diez-Juan, Antonio; Sepulveda, Pilar			Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells	PLOS ONE			English	Article							COMMUNICATION; MICROVESICLES; INVASION; PATHWAY; MEDIATE; MIRNAS; GROWTH; DEATH	Cardiomyocytes (CMs) and endothelial cells (ECs) have an intimate anatomical relationship that is essential for maintaining normal development and function in the heart. Little is known about the mechanisms that regulate cardiac and endothelial crosstalk, particularly in situations of acute stress when local active processes are required to regulate endothelial function. We examined whether CM-derived exosomes could modulate endothelial function. Under conditions of glucose deprivation, immortalized H9C2 cardiomyocytes increase their secretion of exosomes. CM-derived exosomes are loaded with a broad repertoire of miRNA and proteins in a glucose availability-dependent manner. Gene Ontology (GO) analysis of exosome cargo molecules identified an enrichment of biological process that could alter EC activity. We observed that addition of CM-derived exosomes to ECs induced changes in transcriptional activity of pro-angiogenic genes. Finally, we demonstrated that incubation of H9C2-derived exosomes with ECs induced proliferation and angiogenesis in the latter. Thus, exosome-mediated communication between CM and EC establishes a functional relationship that could have potential implications for the induction of local neo-vascularization during acute situations such as cardiac injury.	[Garcia, Nahuel A.; Ontoria-Oviedo, Imelda; Gonzalez-King, Hernan; Sepulveda, Pilar] Inst Invest Sanitaria La Fe, Ctr Invest Principe Felipe, Mixed Unit Cardiovasc Repair, Valencia, Spain; [Diez-Juan, Antonio] Fdn IVI INCLIVA, Valencia, Spain; [Diez-Juan, Antonio] IGENOMIX, Valencia, Spain	Prince Felipe Research Center	Diez-Juan, A (corresponding author), Fdn IVI INCLIVA, Valencia, Spain.	antonio.diez@igenomix.com; pilar.sepulveda.sanchis@gmail.com	Sepulveda, Pilar/AAA-6636-2022; Ontoria-Oviedo, Imelda/W-1069-2018; Diez Juan, Antonio/D-3695-2018; Sepúlveda, Pilar/GWN-0626-2022	Sepulveda, Pilar/0000-0001-6071-7431; Ontoria-Oviedo, Imelda/0000-0002-2497-1325; Garcia, Nahuel/0000-0001-6903-9972	Erasmus Mundus Eurotango Program; Instituto de Investigacion Sanitaria La Fe; Ramon y Cajal Program [RYC-2008-02378]; RETICS; Miguel Servet I3SNS Program (ISCIII); IGENOMIX;  [PI10/743];  [PI13/414]	Erasmus Mundus Eurotango Program; Instituto de Investigacion Sanitaria La Fe; Ramon y Cajal Program(Spanish Government); RETICS; Miguel Servet I3SNS Program (ISCIII); IGENOMIX; ; 	N.A.G. acknowledges a fellowship from Erasmus Mundus Eurotango Program. I.O-O acknowledges Instituto de Investigacion Sanitaria La Fe for a postdoctoral fellowship. A.D.J. acknowledges support from Ramon y Cajal Program (RYC-2008-02378). P.S. acknowledges support from PI10/743, PI13/414 grants, RETICS and Miguel Servet I3SNS Program (ISCIII). IGENOMIX provided support in the form of salaries for authors A D-J, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Brutsaert DL, 1998, CARDIOVASC RES, V38, P281, DOI 10.1016/S0008-6363(98)00044-3; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Brzezinska AK, 2005, AM J PHYSIOL-HEART C, V288, pH2232, DOI 10.1152/ajpheart.00202.2004; Buschow SI, 2005, BLOOD CELL MOL DIS, V35, P398, DOI 10.1016/j.bcmd.2005.08.005; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; Embrey RP, 1997, CARDIOVASC RES, V35, P148, DOI 10.1016/S0008-6363(97)00096-5; Goncalves LM, 2000, CARDIOVASC RES, V45, P294, DOI 10.1016/S0008-6363(99)00358-2; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jaffer FA, 2006, J MOL CELL CARDIOL, V41, P921, DOI 10.1016/j.yjmcc.2006.09.008; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kelly T, 2003, CANCER RES, V63, P8749; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Lancaster GI, 2005, EXERC IMMUNOL REV, V11, P46; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Lu A, 2014, TRENDS CELL BIOL, V24, P389, DOI 10.1016/j.tcb.2014.02.001; Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; REIMER KA, 1979, LAB INVEST, V40, P633; RONQUIST G, 1977, BIOCHIM BIOPHYS ACTA, V483, P483, DOI 10.1016/0005-2744(77)90078-X; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Savina A, 2002, J CELL SCI, V115, P2505; Schuldt A, 2013, NAT REV MOL CELL BIO, V14, P263, DOI 10.1038/nrm3569; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Su SC, 2008, AM J PHYSIOL-CELL PH, V295, pC1215, DOI 10.1152/ajpcell.00336.2008; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032765	50	125	132	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138849	10.1371/journal.pone.0138849	http://dx.doi.org/10.1371/journal.pone.0138849			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393803	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100107
J	Gebremikael, MT; Steel, H; Bert, W; Maenhout, P; Sleutel, S; De Neve, S				Gebremikael, Mesfin Tsegaye; Steel, Hanne; Bert, Wim; Maenhout, Peter; Sleutel, Steven; De Neve, Stefaan			Quantifying the Contribution of Entire Free-Living Nematode Communities to Carbon Mineralization under Contrasting C and N Availability	PLOS ONE			English	Article							BACTERIAL-FEEDING NEMATODES; SOIL MICROBIAL COMMUNITIES; NITROGEN MINERALIZATION; TERRESTRIAL ECOSYSTEMS; POPULATION ENERGETICS; DYNAMICS; BIOMASS; PROTOZOA; ENERGY; DECOMPOSITION	To understand the roles of nematodes in organic matter (OM) decomposition, experimental setups should include the entire nematode community, the native soil microflora, and their food sources. Yet, published studies are often based on either simplified experimental setups, using only a few selected species of nematode and their respective prey, despite the multitude of species present in natural soil, or on indirect estimation of the mineralization process using O-2 consumption and the fresh weight of nematodes. We set up a six-month incubation experiment to quantify the contribution of the entire free living nematode community to carbon (C) mineralization under realistic conditions. The following treatments were compared with and without grass-clover amendment: defaunated soil reinoculated with the entire free living nematode communities (+Nem) and defaunated soil that was not reinoculated (-Nem). We also included untreated fresh soil as a control (CTR). Nematode abundances and diversity in +Nem was comparable to the CTR showing the success of the reinoculation. No significant differences in C mineralization were found between + Nem and -Nem treatments of the amended and unamended samples at the end of incubation. Other related parameters such as microbial biomass C and enzymatic activities did not show significant differences between + Nem and -Nem treatments in both amended and unamended samples. These findings show that the collective contribution of the entire nematode community to C mineralization is small. Previous reports in literature based on simplified experimental setups and indirect estimations are contrasting with the findings of the current study and further investigations are needed to elucidate the extent and the mechanisms of nematode involvement in C mineralization.	[Gebremikael, Mesfin Tsegaye; Maenhout, Peter; Sleutel, Steven; De Neve, Stefaan] Univ Ghent, Dept Soil Management, B-9000 Ghent, Belgium; [Steel, Hanne; Bert, Wim] Univ Ghent, Dept Biol, Nematol Res Unit, B-9000 Ghent, Belgium	Ghent University; Ghent University	Gebremikael, MT (corresponding author), Univ Ghent, Dept Soil Management, B-9000 Ghent, Belgium.	mesfintsegaye.gebremikael@ugent.be	Bert, Wim/D-4511-2013; Gebremikael, Mesfin/AHE-1590-2022	Bert, Wim/0000-0002-5864-412X; Gebremikael, Mesfin Tsegaye/0000-0001-8696-9960; Sleutel, Steven/0000-0002-4557-0598	Research Foundation-Flanders (FWO) [G.0426.13N]; Special Research Fund-Ghent University (BOF) [BOF10/2JO/227]; Special Research Fund-Ghent University (BOF)	Research Foundation-Flanders (FWO)(FWO); Special Research Fund-Ghent University (BOF)(Ghent University); Special Research Fund-Ghent University (BOF)(Ghent University)	Funding: Funding was provided by The Research Foundation-Flanders (FWO): research grant G.0426.13N. http://www.fwo.be/; Special Research Fund-Ghent University (BOF): grant number BOF10/2JO/227. http://www.ugent.be/nl/onderzoek/financiering/bof; Special Research Fund-Ghent University (BOF): (HS). http://www.ugent.be/nl/onderzoek/financiering/bof. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef K., 1995, METHODS APPL SOIL MI, P350, DOI 10.1016/B978-012513840-6/50022-7; ANDERSON RV, 1981, ECOLOGY, V62, P549, DOI 10.2307/1937720; Beare MH, 1997, SOIL ECOLOGY SUSTAIN, P37; Benitez E, 2006, APPL SOIL ECOL, V32, P221, DOI 10.1016/j.apsoil.2005.06.002; Bjornlund L, 2012, EUR J SOIL BIOL, V50, P28, DOI 10.1016/j.ejsobi.2011.11.012; Bongers T, 1999, PLANT SOIL, V212, P13, DOI 10.1023/A:1004571900425; Bongers T., 1994, IDENTIFICATION KEY N, V46; Buchan D., 2013, INFLUENCES FREE LIVI; Buchan D, 2013, SOIL BIOL BIOCHEM, V60, P142, DOI 10.1016/j.soilbio.2013.01.022; Buchan D, 2012, SOIL BIOL BIOCHEM, V47, P10, DOI 10.1016/j.soilbio.2011.12.014; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Chen J, 1999, SOIL BIOL BIOCHEM, V31, P1265, DOI 10.1016/S0038-0717(99)00042-5; Coleman D. C., 1977, Ecology Bulletin - NFR (Statens Naturvetensk Forskningsrad), Stockholm, P299; COLEMAN DC, 1978, MICROBIAL ECOL, V4, P373, DOI 10.1007/BF02013280; DERUITER PC, 1994, AGR ECOSYST ENVIRON, V51, P199, DOI 10.1016/0167-8809(94)90044-2; Djigal D, 2010, EUR J SOIL BIOL, V46, P112, DOI 10.1016/j.ejsobi.2009.12.001; FERRIS H, 1995, SOIL BIOL BIOCHEM, V27, P319, DOI 10.1016/0038-0717(94)00186-5; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Ferris H, 2006, J NEMATOL, V38, P3; Ferris H, 2012, J NEMATOL, V44, P115; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Freckman D, 1988, ECOSYSTEMS ENV, V24, P195; Frostegard A, 1996, SOIL BIOL BIOCHEM, V28, P55, DOI 10.1016/0038-0717(95)00100-X; Fu SL, 2005, SOIL BIOL BIOCHEM, V37, P1979, DOI 10.1016/j.soilbio.2005.01.018; Gebremikael MT, 2015, APPL SOIL ECOL, V92, P1, DOI 10.1016/j.apsoil.2015.03.003; Gebremikael MT, 2014, SOIL BIOL BIOCHEM, V70, P131, DOI 10.1016/j.soilbio.2013.12.006; Gebremikael MT, 2014, 18 NITR WORKSH NITR; GRIFFITHS BS, 1993, BIOL FERT SOILS, V15, P201, DOI 10.1007/BF00361612; GRIFFITHS BS, 1994, PLANT SOIL, V164, P25, DOI 10.1007/BF00010107; Hendrickx G., 1995, NEMATOLOGICA, V41, P308; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; Kitazawa Y, 1977, ECOSYSTEM ANAL SUNAL, P181; KLEKOWSKI RZ, 1972, NEMATOLOGICA, V18, P391, DOI 10.1163/187529272X00665; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Okada H, 2005, SOIL BIOL BIOCHEM, V37, P1113, DOI 10.1016/j.soilbio.2004.11.010; Osler GHR, 2007, ECOLOGY, V88, P1611, DOI 10.1890/06-1357.1; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; Reichle D. E., 1977, Ecological Bulletins (Stockholm), P145; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Sleutel S, 2005, EUR J SOIL SCI, V56, P505, DOI 10.1111/j.1365-2389.2004.00685.x; SOHLENIUS B, 1980, OIKOS, V34, P186, DOI 10.2307/3544181; SOHLENIUS B, 1979, Holarctic Ecology, V2, P30; Standing D, 2006, MICROB ECOL, V52, P444, DOI 10.1007/s00248-006-9119-8; van Bezooijen J., 2006, METHODS TECHNIQUES N; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; WOODS LE, 1982, SOIL BIOL BIOCHEM, V14, P93, DOI 10.1016/0038-0717(82)90050-5; Xiao HF, 2010, APPL SOIL ECOL, V45, P131, DOI 10.1016/j.apsoil.2010.03.011; YEATES GW, 1979, J NEMATOL, V11, P213; YEATES GW, 1993, J NEMATOL, V25, P315; YEATES GW, 1973, OIKOS, V24, P179, DOI 10.2307/3543873; Zhao J, 2014, NEMATOLOGY, V16, P379, DOI 10.1163/15685411-00002771	54	10	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0136244	10.1371/journal.pone.0136244	http://dx.doi.org/10.1371/journal.pone.0136244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393517	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100007
J	Hallmann, K; Griebeler, EM				Hallmann, Konstantin; Griebeler, Eva Maria			Eggshell Types and Their Evolutionary Correlation with Life-History Strategies in Squamates	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; METABOLIC-RATES; LIZARDS; VIVIPARITY; TRAITS; MODEL; REPTILES; TEMPERATURE; PROVISION; OVIPARITY	The eggshell is an important physiological structure for the embryo. It enables gas exchange, physical protection and is a calcium reserve. Most squamates (lizards, snakes, worm lizards) lay parchment-shelled eggs, whereas only some gekkotan species, a subgroup of lizards, have strongly calcified eggshells. In viviparous (live-bearing) squamates the eggshell is reduced or completely missing (hereafter "shell-less"). Recent studies showed that life-history strategies of gekkotan species differ between species with parchment- and rigid-shelled eggshells. Here we test if the three different eggshell types found in the squamates are also associated with different life-history strategies. We first investigated the influence of the phylogeny on the trait "eggshell type" and on six life-history traits of 32 squamate species. Phylogenetic principal component analysis (pPCA) was then conducted to identify an association between life-history strategies and eggshell types. Finally, we also considered adult weight in the pPCA to examine its potential effect on this association. Eggshell types in squamates show a strong phylogenetic signal at a low taxonomical level. Four out of the six life-history traits showed also a phylogenetic signal (birth size, clutch size, clutches per year and age at female maturity), while two had none (incubation time, maximum longevity). The pPCA suggested an association of life-history strategies and eggshell types, which disappeared when adult weight was included in the analysis. We conclude that the variability seen in eggshell types of squamates is weakly influenced by phylogeny. Eggshell types correlate with different life-history strategies, and mainly reflect differences in adult weights of species.	[Hallmann, Konstantin; Griebeler, Eva Maria] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Ecol, Rhineland Palatinate, Germany	Johannes Gutenberg University of Mainz	Hallmann, K (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Ecol, Rhineland Palatinate, Germany.	hallmank@uni-mainz.de						Abouheif E, 1999, EVOL ECOL RES, V1, P895; ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Agasyan A, 2009, IUCN RED LIST THREAT; Agasyan A, 2010, IUCN RED LIST THREAT; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Bartlett RD, 2006, BARRONS ED SERIES; Bauwens D, 1997, AM NAT, V149, P91, DOI 10.1086/285980; Bischoff W., 1998, HDB REPTILIEN AMPHIB; BLACKBURN D G, 1985, Amphibia-Reptilia, V6, P259, DOI 10.1163/156853885X00290; BLACKBURN D G, 1982, Amphibia-Reptilia, V3, P185, DOI 10.1163/156853882X00419; Blackburn DG, 2006, HERPETOL MONOGR, V20, P131, DOI 10.1655/0733-1347(2007)20[131:SRAMOF]2.0.CO;2; Blackburn DG, 2009, J EXP ZOOL PART B, V312B, P579, DOI 10.1002/jez.b.21234; BLACKBURN DG, 1993, HERPETOLOGICA, V49, P118; Blackburn DG, 1999, HERPETOLOGICA, V55, P556; Blackburn DG, 1998, J EXP ZOOL, V282, P560; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bohme W, 1999, HDB REPTILIEN AMPHIB; Bohme W., 1993, HDB REPTILIEN AMPHIB, V3; Bohme W, 1981, HDB REPTILIEN AMPHIB; Bohme W., 1986, HDB REPTILIEN AMPHIB, V2/II; Bonine KE, 2001, J MORPHOL, V250, P265; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CHAPPELL MA, 1987, J COMP PHYSIOL B, V157, P227, DOI 10.1007/BF00692367; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; deFraipont M, 1996, EVOLUTION, V50, P391, DOI 10.1111/j.1558-5646.1996.tb04501.x; Delaugerre Michel, 2011, Herpetology Notes, V4, P127; Dunham A.E., 1988, Biology of Reptilia, V16, P441; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitch HS, 1970, MUSEUM NATURAL HIST; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Gasso VY, 2003, SOME ECOLOGICAL PARA; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GOWER JC, 1969, ROY STAT SOC C-APP, V18, P54; Guillaume Cl. P., 2006, Russian Journal of Herpetology, V13, P1; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heibl C., 2008, PHYLOCH R LANGUAGE T; Henkel FW, 1991, GECKOS BIOL HALTUNG; HEULIN B, 1989, CR ACAD SCI III-VIE, V308, P341; hme W, 1984, HDB REPTILIEN AMPHIB; Hodges WL, 2004, J EVOLUTION BIOL, V17, P1230, DOI 10.1111/j.1420-9101.2004.00770.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Joger U., 2005, HDB REPTILIEN AMPHIB, V3; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Jombart T, 2010, J THEOR BIOL, V264, P693, DOI 10.1016/j.jtbi.2010.03.038; Kabisch K, 1990, WORTERBUCH HERPETOLO; Lode T, 2012, REPROD BIOL, V12, P259, DOI 10.1016/j.repbio.2012.09.001; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MATHIES T, 1995, OECOLOGIA, V104, P101, DOI 10.1007/BF00365568; Meiri S, 2012, GLOBAL ECOL BIOGEOGR, V21, P592, DOI 10.1111/j.1466-8238.2011.00700.x; Mendez-de la Cruz FR, 1998, HERPETOLOGICA, V54, P521; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Osborne L, 2005, COPEIA, P683, DOI 10.1643/CH-04-280R1; PACKARD MJ, 1982, J MORPHOL, V174, P197, DOI 10.1002/jmor.1051740208; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Pike DA, 2012, EVOL ECOL, V26, P847, DOI 10.1007/s10682-011-9527-1; Pinheiro J, 2020, R PACKAGE VERSION 31; Pough FH, 2001, HERPETOLOGY; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; R Core Team, 2021, R LANGUAGE ENV STAT; R_osler H., 1995, GECKOS WELT GATTUNGE; Raxworthy CJ, 2011, IUCN RED LIST THREAT; Rogner M, 1992, ECHSEN; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Scharf I, 2015, GLOBAL ECOL BIOGEOGR, V24, P396, DOI 10.1111/geb.12244; Schleich H.H., 1988, REPTILE EGG SHELLS S; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; STEARNS SC, 1984, AM NAT, V123, P56, DOI 10.1086/284186; Stewart JR, 2013, J MORPHOL, V274, P824, DOI 10.1002/jmor.20141; Stewart JR, 2010, HERPETOL CONSERV BIO, V5, P341; Stewart JR, 2009, J EXP BIOL, V212, P2520, DOI 10.1242/jeb.030643; STEWART JR, 1992, AM ZOOL, V32, P303; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Thompson GG, 1997, PHYSIOL ZOOL, V70, P307, DOI 10.1086/639605; Thompson MB, 2006, J COMP PHYSIOL B, V176, P179, DOI 10.1007/s00360-005-0048-5; Tinkle D.W, 1977, Miscellaneous Publs Mus Zool Univ Michigan, VNo. 154, P1; TINKLE DW, 1970, EVOLUTION, V24, P55, DOI 10.1111/j.1558-5646.1970.tb01740.x; TINKLE DW, 1969, AM NAT, V103, P501, DOI 10.1086/282617; Uetz P., REPTILE DATABASE; Van Heygen Emmanuel, 2004, Phelsuma, V12, P99; Vences M, 2011, IUCN RED LIST THREAT; VIETS BE, 1994, J EXP ZOOL, V270, P45, DOI 10.1002/jez.1402700106; Wiens JJ, 2001, EVOLUTION, V55, P2303; Wise PAD, 2009, ANAT REC, V292, P1198, DOI 10.1002/ar.20945; Yu YG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0178-z	96	15	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138785	10.1371/journal.pone.0138785	http://dx.doi.org/10.1371/journal.pone.0138785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393343	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100096
J	Hovick, TJ; Allred, BW; Elmore, RD; Fuhlendorf, SD; Hamilton, RG; Breland, A				Hovick, Torre J.; Allred, Brady W.; Elmore, R. Dwayne; Fuhlendorf, Samuel D.; Hamilton, Robert G.; Breland, Amber			Dynamic Disturbance Processes Create Dynamic Lek Site Selection in a Prairie Grouse	PLOS ONE			English	Article							FIRE-GRAZING INTERACTION; GREATER SAGE-GROUSE; TALLGRASS PRAIRIE; SPATIAL HETEROGENEITY; RESTORING HETEROGENEITY; LANDSCAPE ECOLOGY; PYRIC-HERBIVORY; CHICKEN LEKS; LAND-USE; CONSERVATION	It is well understood that landscape processes can affect habitat selection patterns, movements, and species persistence. These selection patterns may be altered or even eliminated as a result of changes in disturbance regimes and a concomitant management focus on uniform, moderate disturbance across landscapes. To assess how restored landscape heterogeneity influences habitat selection patterns, we examined 21 years (1991, 19932012) of Greater Prairie-Chicken (Tympanuchus cupido) lek location data in tallgrass prairie with restored fire and grazing processes. Our study took place at The Nature Conservancy's Tallgrass Prairie Preserve located at the southern extent of Flint Hills in northeastern Oklahoma. We specifically addressed stability of lek locations in the context of the fire-grazing interaction, and the environmental factors influencing lek locations. We found that lek locations were dynamic in a landscape with interacting fire and grazing. While previous conservation efforts have treated leks as stable with high site fidelity in static landscapes, a majority of lek locations in our study (i.e., 65%) moved by nearly one kilometer on an annual basis in this dynamic setting. Lek sites were in elevated areas with low tree cover and low road density. Additionally, lek site selection was influenced by an interaction of fire and patch edge, indicating that in recently burned patches, leks were located near patch edges. These results suggest that dynamic and interactive processes such as fire and grazing that restore heterogeneity to grasslands do influence habitat selection patterns in prairie grouse, a phenomenon that is likely to apply throughout the Greater Prairie-Chicken's distribution when dynamic processes are restored. As conservation moves toward restoring dynamic historic disturbance patterns, it will be important that siting and planning of anthropogenic structures (e.g., wind energy, oil and gas) and management plans not view lek locations as static points, but rather as sites that shift around the landscape in response to shifting vegetation structure. Acknowledging shifting lek locations in these landscapes will help ensure conservation efforts are successful by targeting the appropriate areas for protection and management.	[Hovick, Torre J.] N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA; [Allred, Brady W.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Elmore, R. Dwayne; Fuhlendorf, Samuel D.] Oklahoma State Univ, Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Hamilton, Robert G.] Nature Conservancy, Tallgrass Prairie Preserve, Pawhuska, OK USA; [Breland, Amber] US Fish & Wildlife Serv, Dahomey Natl Wildlife Refuge, Boyle, MS USA	North Dakota State University Fargo; University of Montana System; University of Montana; Oklahoma State University System; Oklahoma State University - Stillwater; Nature Conservancy; United States Department of the Interior; US Fish & Wildlife Service	Hovick, TJ (corresponding author), N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA.	torre.hovick@ndsu.edu	Fuhlendorf, Samuel/A-2931-2011	Fuhlendorf, Samuel/0000-0002-8726-9402	U.S. Department of Agriculture-Agriculture and Food Research Initiative (USDA-AFRI) [2010-85101-20457]; Oklahoma Agricultural Experiment Station	U.S. Department of Agriculture-Agriculture and Food Research Initiative (USDA-AFRI)(United States Department of Agriculture (USDA)); Oklahoma Agricultural Experiment Station	Funding: This work was supported by funding from the U.S. Department of Agriculture-Agriculture and Food Research Initiative (USDA-AFRI) Managed Ecosystems grant #2010-85101-20457 and by the Oklahoma Agricultural Experiment Station.	Allred BW, 2014, AGR ECOSYST ENVIRON, V193, P37, DOI 10.1016/j.agee.2014.04.020; Allred BW, 2011, ECOL EVOL, V1, P132, DOI 10.1002/ece3.12; Anderson RC, 2006, J TORREY BOT SOC, V133, P626, DOI 10.3159/1095-5674(2006)133[626:EAOOTC]2.0.CO;2; [Anonymous], 2014, LANG ENV STAT COMP; Askins R. A., 2000, RESTORING N AM BIRDS, DOI [10.12987/9780300127119, DOI 10.12987/9780300127119]; Aspbury A, 2004, ANIM BEHAV, V67, P1127, DOI 10.1016/j.anbehav.2003.06.021; Augustine JK, 2011, AVIAN CONSERV ECOL, V6, DOI 10.5751/ACE-00429-060102; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Churchwell RT, 2008, J WILDLIFE MANAGE, V72, P1596, DOI 10.2193/2007-365; Collins S.L., 1990, FIRE N AM TALLGRASS; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2012, RANGELAND ECOL MANAG, V65, P579, DOI 10.2111/REM-D-11-00109.1; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Gregory AJ, 2011, STUD AVIAN BIOL, P21; Hamerstrom FN, 1973, WISCONSIN DEP NATURA, P64; Hamilton RG, 2007, TALL TIMB FIRE ECOL, P163; Hovick TJ, 2015, RANGELAND ECOL MANAG, V68, P186, DOI 10.1016/j.rama.2015.01.009; Hovick TJ, 2015, ECOL APPL, V25, P662, DOI 10.1890/14-1067.1; Hovick TJ, 2014, J APPL ECOL, V51, P1680, DOI 10.1111/1365-2664.12331; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00062.1; Hovick TJ, 2012, J WILDLIFE MANAGE, V76, P19, DOI 10.1002/jwmg.243; Johnsgard P. A., 1983, GROUSE WORLD; Johnsgard P. A., 2002, GRASSLAND GROUSE THE; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Knopf Fritz L., 1994, Studies in Avian Biology, V15, P247; Lautenbach J.M., 2015, THESIS KANSAS STATE; McGranahan DA, 2012, J APPL ECOL, V49, P903, DOI 10.1111/j.1365-2664.2012.02168.x; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Mcnew LB, 2012, J WILDLIFE MANAGE, V76, P38, DOI 10.1002/jwmg.237; Merrill MD, 1999, J WILDLIFE MANAGE, V63, P189, DOI 10.2307/3802500; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Niemuth ND, 2000, J WILDLIFE MANAGE, V64, P278, DOI 10.2307/3803000; Patten M. A., 2007, P TALL TIMB FIR EC C, V23, P149; Poiani KA, 2001, CONSERV BIOL, V15, P513, DOI 10.1046/j.1523-1739.2001.015002513.x; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Robbins M.B., 2002, N AM BIRDS, V56, P239; Schroeder M. A., 1993, BIRDS N AM; SCHROEDER MA, 1992, WILSON BULL, V104, P273; SCHROEDER MA, 1993, BEHAV ECOL, V4, P266, DOI 10.1093/beheco/4.3.266; Slater SJ, 2010, J WILDLIFE MANAGE, V74, P1080, DOI 10.2193/2008-525; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Walsh DP, 2010, J WILDLIFE MANAGE, V74, P1607, DOI 10.2193/2009-353; Wiens J. A., 1997, ECOLOGICAL BASIS CON, P167; Winder VL, 2015, CONDOR, V117, P284, DOI 10.1650/CONDOR-14-98.1; Woinarski JC, 1999, 1 ENV AUSTR, P56	54	14	14	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137882	10.1371/journal.pone.0137882	http://dx.doi.org/10.1371/journal.pone.0137882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394226	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100021
J	Pedrera-Canal, M; Moran, JM; Vera, V; Roncero-Martin, R; Lavado-Garcia, JM; Aliaga, I; Pedrera-Zamorano, JD				Pedrera-Canal, Maria; Moran, Jose M.; Vera, Vicente; Roncero-Martin, Raul; Lavado-Garcia, Jesus M.; Aliaga, Ignacio; Pedrera-Zamorano, Juan D.			Lack of Influence of Vitamin D Receptor BsmI (rs1544410) Polymorphism on the Rate of Bone Loss in a Cohort of Postmenopausal Spanish Women Affected by Osteoporosis and Followed for Five Years	PLOS ONE			English	Article							MINERAL DENSITY; GENE POLYMORPHISMS; ASSOCIATION; MASS; DETERMINANTS; METAANALYSIS; ULTRASOUND; GENOTYPE; THERAPY; RISK	A longitudinal study was conducted to investigate the relation between a polymorphism in the vitamin D receptor (VDR) gene and changes in bone mineral density (BMD) and quantitative ultrasound of the phalanges (QUS) over a five-year period. The subjects were 456 postmenopausal women with osteoporosis undergoing treatment, aged 59.95 +/- 7.97 years (mean +/- standard deviation [SD]) at baseline. BMD was measured at the hips and lumbar spine by dual-energy X-ray absorptiometry, and QUS was measured by means of amplitude-dependent speed of sound (Ad-SoS) at the phalanges. Lifestyle information was obtained via a questionnaire. The genotype frequencies of the BsmI (rs1544410) gene polymorphism were 29.4%, 47.1%, and 23.5% for bb, Bb, and BB, respectively. After five years, BMD (annual change in %/year) at the femoral neck (FN) showed a significant modification based on the rs1544410 genotype (BB vs Bb); there was an overall decrease in bone mass (-0.70 +/- 2.79%/year; P = 0.025). An analysis of covariance with adjustments for age, weight, height, percentage of weight change per year, baseline BMD and calcium intake showed that the observed associations were no longer significant (P = 0.429). No significant associations were found between the QUS measurements and the rs1544410 genotype after the five-year period. Our study limitations includes lack of information about type and length of duration of the osteoporosis treatment. Our results indicate that rs1544410 polymorphisms do not account significantly for the changes in bone mass in Spanish women with osteoporosis undergoing treatment.	[Pedrera-Canal, Maria; Moran, Jose M.; Vera, Vicente; Roncero-Martin, Raul; Lavado-Garcia, Jesus M.; Aliaga, Ignacio; Pedrera-Zamorano, Juan D.] Univ Extremadura, Metab Bone Dis Res Grp, Dept Nursing, Caceres, Spain	Universidad de Extremadura	Pedrera-Zamorano, JD (corresponding author), Univ Extremadura, Metab Bone Dis Res Grp, Dept Nursing, Caceres, Spain.	jpedrera@unex.es	Moran, Jose M./N-9636-2013; Lavado-Garcia, Jesus/J-6937-2014	Moran, Jose M./0000-0002-5538-182X; Lavado-Garcia, Jesus/0000-0001-5861-3908; VERA GONZALEZ, VICENTE/0000-0001-9456-9203				Bjornerem A, 2015, J BONE MINER RES, V30, P516, DOI 10.1002/jbmr.2365; Calderon-Garcia JF, 2013, BIOL RES NURS, V15, P416, DOI 10.1177/1099800412459800; Cooper GS, 1996, J BONE MINER RES, V11, P1841; Creatsa M, 2011, J OBSTET GYNAECOL RE, V37, P1415, DOI 10.1111/j.1447-0756.2011.01557.x; Gennari L, 2010, CLIN REV BONE MINER, V8, P77, DOI 10.1007/s12018-010-9071-5; Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116; Hunter DJ, 2001, OSTEOPOROSIS INT, V12, P406, DOI 10.1007/s001980170110; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jia F, 2013, GENET TEST MOL BIOMA, V17, P30, DOI 10.1089/gtmb.2012.0267; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KRALL EA, 1993, J BONE MINER RES, V8, P1; Marc J, 1999, OSTEOPOROSIS INT, V10, P303, DOI 10.1007/s001980050231; Marini F, 2009, CALCIFIED TISSUE INT, V84, P337, DOI 10.1007/s00223-009-9226-x; Mohammadi Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0098-x; Moran JM, 2015, PEERJ, V3, DOI 10.7717/peerj.953; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Nguyen T. V., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P62; Palomba S, 2005, OSTEOPOROSIS INT, V16, P943, DOI 10.1007/s00198-004-1800-5; Palomba S, 2003, CLIN ENDOCRINOL, V58, P365, DOI 10.1046/j.1365-2265.2003.01724.x; Palomba S, 2003, HUM REPROD, V18, P192, DOI 10.1093/humrep/deg031; Pedrera-Zamorano JD, 2009, NUTRITION, V25, P1057, DOI 10.1016/j.nut.2009.02.007; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Ralston SH, 2010, ANN NY ACAD SCI, V1192, P181, DOI 10.1111/j.1749-6632.2009.05317.x; Rapuri PB, 2004, J STEROID BIOCHEM, V89-90, P503, DOI 10.1016/j.jsbmb.2004.03.060; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; Tofteng CL, 2002, J BONE MINER RES, V17, P1535, DOI 10.1359/jbmr.2002.17.8.1535; Tranah GJ, 2008, CALCIFIED TISSUE INT, V83, P155, DOI 10.1007/s00223-008-9165-y; TYLAVSKY FA, 1989, CALCIFIED TISSUE INT, V45, P265, DOI 10.1007/BF02556017; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; Urano T, 2014, BIOCHEM BIOPH RES CO, V452, P287, DOI 10.1016/j.bbrc.2014.07.141; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032	32	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138606	10.1371/journal.pone.0138606	http://dx.doi.org/10.1371/journal.pone.0138606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393357	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100078
J	Zhang, BW; Xu, M; Bian, SQ; Hou, LL; Tang, D; Li, YF; Gu, MH; Cheng, ZK; Yu, HX				Zhang, Bingwei; Xu, Meng; Bian, Shiquan; Hou, Lili; Tang, Ding; Li, Yafei; Gu, Minghong; Cheng, Zhukuan; Yu, Hengxiu			Global Identification of Genes Specific for Rice Meiosis	PLOS ONE			English	Article							HOMOLOGOUS CHROMOSOME SYNAPSIS; LEPTOTENE-ZYGOTENE TRANSITION; CONTROLS MEIOTIC CHROMOSOME; ORIGIN RECOGNITION COMPLEX; ARABIDOPSIS MALE MEIOCYTES; CROSSOVER FORMATION; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; MAIZE AMEIOTIC1; FISSION YEAST	The leptotene-zygotene transition is a major step in meiotic progression during which pairing between homologous chromosomes is initiated and double strand breaks occur. OsAM1, a homologue of maize AM1 and Arabidopsis SWI1, encodes a protein with a coiled-coil domain in its central region that is required for the leptotene-zygotene transition during rice meiosis. To gain more insight into the role of OsAM1 in rice meiosis and identify additional meiosis-specific genes, we characterized the transcriptomes of young panicles of Osam1 mutant and wild-type rice plants using RNA-Seq combined with bioinformatic and statistical analyses. As a result, a total of 25,750 and 28,455 genes were expressed in young panicles of wild-type and Osam1 mutant plants, respectively, and 4,400 differentially expressed genes (DEGs; log(2) Ratio >= 1, FDR <= 0.05) were identified. Of these DEGs, four known rice meiosis-specific genes were detected, and 22 new putative meiosis-related genes were found by mapping these DEGs to reference biological pathways in the KEGG database. We identified eight additional well-conserved OsAM1-responsive rice meiotic genes by comparing our RNA-Seq data with known meiotic genes in Arabidopsis and fission yeast.	[Zhang, Bingwei; Xu, Meng; Bian, Shiquan; Hou, Lili; Gu, Minghong; Yu, Hengxiu] Yangzhou Univ, Key Lab Plant Funct Genom, Minist Educ, Jiangsu Key Lab Crop Genet & Physiol,Coinnovat Ct, Yangzhou 225009, Peoples R China; [Tang, Ding; Li, Yafei; Cheng, Zhukuan] Chinese Acad Sci, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Tang, Ding; Li, Yafei; Cheng, Zhukuan] Chinese Acad Sci, Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Yangzhou University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yu, HX (corresponding author), Yangzhou Univ, Key Lab Plant Funct Genom, Minist Educ, Jiangsu Key Lab Crop Genet & Physiol,Coinnovat Ct, Yangzhou 225009, Peoples R China.	hxyu@yzu.edu.cn			Ministry of Sciences and Technology of China [2011CB944602]; National Natural Science Foundation of China [31170288, 31230038]; Jiangsu Education Department of China [15KJA180010]; Six Big Talent Peak of Jiangsu Province [NY018]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Education Department of China; Six Big Talent Peak of Jiangsu Province	Funding: This work was supported by grants from the Ministry of Sciences and Technology of China (2011CB944602), the National Natural Science Foundation of China (31170288 and 31230038), Key Project of Jiangsu Education Department of China (15KJA180010) and Six Big Talent Peak of Jiangsu Province (NY018).	Abdu U, 2003, GENETICS, V165, P197; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bhatt AM, 2001, TRENDS PLANT SCI, V6, P114, DOI 10.1016/S1360-1385(00)01861-6; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boateng KA, 2008, MOL PLANT, V1, P620, DOI 10.1093/mp/ssn030; Bogdanov YF, 2007, INT REV CYTOL, V257, P83, DOI 10.1016/S0074-7696(07)57003-8; Bonnet S, 2013, NUCLEIC ACIDS RES, V41, P9349, DOI 10.1093/nar/gkt730; Caryl AP, 2003, J EXP BOT, V54, P25, DOI 10.1093/jxb/erg041; Che LX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004405; Che LX, 2011, CELL RES, V21, P654, DOI 10.1038/cr.2011.7; Chen CB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-280; Cheng Zhukuan, 2013, Methods Mol Biol, V990, P125, DOI 10.1007/978-1-62703-333-6_13; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Garcia V, 2000, NUCLEIC ACIDS RES, V28, P1692, DOI 10.1093/nar/28.8.1692; Goldman ASH, 2000, P NATL ACAD SCI USA, V97, P9537, DOI 10.1073/pnas.97.17.9537; Golubovskaya I, 1997, GENETICS, V147, P1339; GOLUBOVSKAYA I, 1993, GENETICS, V135, P1151; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hong LL, 2012, PLANT CELL, V24, P577, DOI 10.1105/tpc.111.093740; Jenkins G, 2008, CYTOGENET GENOME RES, V120, P291, DOI 10.1159/000121078; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Lam WS, 2005, J CELL SCI, V118, P3037, DOI 10.1242/jcs.02443; Libeau P, 2011, PLANT BIOLOGY, V13, P784, DOI 10.1111/j.1438-8677.2010.00435.x; LOIDL J, 1990, GENOME, V33, P759, DOI 10.1139/g90-115; Luo Q, 2014, J GENET GENOMICS, V41, P125, DOI 10.1016/j.jgg.2014.02.002; Luo Q, 2013, MOL PLANT, V6, P729, DOI 10.1093/mp/sss145; Maeda Y, 2009, BIOSCI BIOTECH BIOCH, V73, P339, DOI 10.1271/bbb.80575; Manheim EA, 2003, CURR BIOL, V13, P276, DOI 10.1016/S0960-9822(03)00050-2; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mercier R, 2008, CYTOGENET GENOME RES, V120, P281, DOI 10.1159/000121077; Morozumi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075451; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nan GL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-120; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nonomura KI, 2007, PLANT CELL, V19, P2583, DOI 10.1105/tpc.107.053199; Nonomura KI, 2006, J CELL SCI, V119, P217, DOI 10.1242/jcs.02736; Nonomura KL, 2004, PLANT CELL, V16, P1008, DOI 10.1105/tpc.020701; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; Pawlowski WP, 2009, P NATL ACAD SCI USA, V106, P3603, DOI 10.1073/pnas.0810115106; Pawlowski WP, 2004, SCIENCE, V303, P89, DOI 10.1126/science.1091110; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Shao T, 2011, PLANT PHYSIOL, V156, P1386, DOI 10.1104/pp.111.177428; Shen Y, 2012, J CELL SCI, V125, P2581, DOI 10.1242/jcs.090993; Sheridan WF, 1996, GENETICS, V142, P1009; STAIGER CJ, 1992, DEV BIOL, V154, P226, DOI 10.1016/0012-1606(92)90063-M; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Wang KJ, 2009, J CELL SCI, V122, P2055, DOI 10.1242/jcs.049080; Wang M, 2010, PLANT CELL, V22, P417, DOI 10.1105/tpc.109.070789; Wang YX, 2006, PLANTA, V223, P613, DOI 10.1007/s00425-005-0154-3; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Yang XH, 2006, J CELL SCI, V119, P3754, DOI 10.1242/jcs.03155; Yu HX, 2010, CHROMOSOMA, V119, P625, DOI 10.1007/s00412-010-0284-7; Zhang BW, 2015, J EXP BOT, V66, P5713, DOI 10.1093/jxb/erv253; Zhang L, 2014, GENETICS, V198, P1447, DOI 10.1534/genetics.114.168732; Zhou SR, 2011, PLANT CELL, V23, P111, DOI 10.1105/tpc.109.073692; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	69	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137399	10.1371/journal.pone.0137399	http://dx.doi.org/10.1371/journal.pone.0137399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394329	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100013
J	Bader, AM; Klose, K; Bieback, K; Korinth, D; Schneider, M; Seifert, M; Choi, YH; Kurtz, A; Falk, V; Stamm, C				Bader, Andreas Matthaeus; Klose, Kristin; Bieback, Karen; Korinth, Dirk; Schneider, Maria; Seifert, Martina; Choi, Yeong-Hoon; Kurtz, Andreas; Falk, Volkmar; Stamm, Christof			Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro	PLOS ONE			English	Article							PROTECTS ENDOTHELIAL-CELLS; INFARCTED HEART FUNCTION; STEM-CELLS; BONE-MARROW; ISCHEMIC CARDIOMYOPATHY; RANDOMIZED-TRIAL; LIMB ISCHEMIA; APOPTOSIS; TRANSPLANTATION; EXPRESSION	Hypoxic preconditioning was shown to improve the therapeutic efficacy of bone marrow-derived multipotent mesenchymal stromal cells (MSCs) upon transplantation in ischemic tissue. Given the interest in clinical applications of umbilical cord blood-derived MSCs, we developed a specific hypoxic preconditioning protocol and investigated its anti-apoptotic and pro-angiogenic effects on cord blood MSCs undergoing simulated ischemia in vitro by subjecting them to hypoxia and nutrient deprivation with or without preceding hypoxic preconditioning. Cell number, metabolic activity, surface marker expression, chromosomal stability, apoptosis (caspases-3/7 activity) and necrosis were determined, and phosphorylation, mRNA expression and protein secretion of selected apoptosis and angiogenesis-regulating factors were quantified. Then, human umbilical vein endothelial cells (HUVEC) were subjected to simulated ischemia in co-culture with hypoxically preconditioned or naive cord blood MSCs, and HUVEC proliferation was measured. Migration, proliferation and nitric oxide production of HUVECs were determined in presence of cord blood MSC-conditioned medium. Cord blood MSCs proved least sensitive to simulated ischemia when they were preconditioned for 24 h, while their basic behavior, immunophenotype and karyotype in culture remained unchanged. Here, "post-ischemic" cell number and metabolic activity were enhanced and caspase-3/7 activity and lactate dehydrogenase release were reduced as compared to non-preconditioned cells. Phosphorylation of AKT and BAD, mRNA expression of BCL-XL, BAG1 and VEGF, and VEGF protein secretion were higher in preconditioned cells. Hypoxically preconditioned cord blood MSCs enhanced HUVEC proliferation and migration, while nitric oxide production remained unchanged. We conclude that hypoxic preconditioning protects cord blood MSCs by activation of anti-apoptotic signaling mechanisms and enhances their angiogenic potential. Hence, hypoxic preconditioning might be a translationally relevant strategy to increase the tolerance of cord blood MSCs to ischemia and improve their therapeutic efficacy in clinical applications.	[Bader, Andreas Matthaeus; Klose, Kristin; Schneider, Maria; Seifert, Martina; Kurtz, Andreas; Stamm, Christof] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Bieback, Karen] Heidelberg Univ, Inst Transfus Med & Immunol, Mannheim, Germany; [Korinth, Dirk] Labor Berlin GmbH, Berlin, Germany; [Choi, Yeong-Hoon] Univ Cologne, Ctr Heart, D-50931 Cologne, Germany; [Bader, Andreas Matthaeus; Falk, Volkmar; Stamm, Christof] Deutsch Herzzentrum Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Heart Center Berlin	Stamm, C (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.	stamm@dhzb.de		Kurtz, Andreas/0000-0003-3301-6546; , Martina/0000-0002-6372-9769; Falk, Volkmar/0000-0002-7911-8620	Federal Ministry of Education and Research; federal state of Berlin [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B]; federal state of Brandenburg [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); federal state of Berlin; federal state of Brandenburg	This study was jointly funded by the Federal Ministry of Education and Research and the federal states of Berlin and Brandenburg [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B] (http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AM, 2014, CELL PHYSIOL BIOCHEM, V34, P646, DOI 10.1159/000363030; Bader AM, 2014, EUR J CARDIO-THORAC, V45, P983, DOI 10.1093/ejcts/ezt576; Beegle J, 2015, STEM CELLS, V33, P1818, DOI 10.1002/stem.1976; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chen PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103587; De Barros S, 2013, MOL THER, V21, P399, DOI 10.1038/mt.2012.213; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; He AN, 2009, CAN J CARDIOL, V25, P353, DOI 10.1016/S0828-282X(09)70094-7; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Heldring N, 2015, HUM GENE THER, V26, P506, DOI 10.1089/hum.2015.072; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Hu XY, 2014, STEM CELLS, V32, P2702, DOI 10.1002/stem.1784; Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Jaussaud J, 2013, EUR J CARDIO-THORAC, V43, P1050, DOI 10.1093/ejcts/ezs549; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim HW, 2012, ANTIOXID REDOX SIGN, V17, P1053, DOI 10.1089/ars.2012.4518; Kim HW, 2012, J MOL MED, V90, P997, DOI 10.1007/s00109-012-0920-1; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kim YS, 2015, MOL NEUROBIOL, V52, P792, DOI 10.1007/s12035-014-8912-5; Klose K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-236; Lee MW, 2005, INT J HEMATOL, V81, P126, DOI 10.1532/IJH97.A10404; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Luetzkendorf J, 2015, CYTOTHERAPY, V17, P186, DOI 10.1016/j.jcyt.2014.10.018; Pan YX, 2007, LIFE SCI, V81, P1042, DOI 10.1016/j.lfs.2007.08.015; Peterson KM, 2011, LIFE SCI, V88, P65, DOI 10.1016/j.lfs.2010.10.023; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Wang JA, 2009, INT J CARDIOL, V133, P410, DOI 10.1016/j.ijcard.2007.11.096; Wang LH, 2014, SCI CHINA LIFE SCI, V57, P171, DOI 10.1007/s11427-014-4607-4; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang Shin-Seok, 2013, International Journal of Stem Cells, V6, P37; Zhang WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/462472; Zhu HM, 2014, ARTERIOSCL THROM VAS, V34, P870, DOI 10.1161/ATVBAHA.114.303194	48	71	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138477	10.1371/journal.pone.0138477	http://dx.doi.org/10.1371/journal.pone.0138477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380983	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200110
J	Rawat, V; Abdelsamad, A; Pietzenuk, B; Seymour, DK; Koenig, D; Weigel, D; Pecinka, A; Schneeberger, K				Rawat, Vimal; Abdelsamad, Ahmed; Pietzenuk, Bjoern; Seymour, Danelle K.; Koenig, Daniel; Weigel, Detlef; Pecinka, Ales; Schneeberger, Korbinian			Improving the Annotation of Arabidopsis lyrata Using RNA-Seq Data	PLOS ONE			English	Article							GENOME SIZE; PROVIDES INSIGHT; EVOLUTION; THALIANA; ALIGNMENT; SEQUENCE; GENE; TOOL; BRASSICACEAE; RESOURCE	Gene model annotations are important community resources that ensure comparability and reproducibility of analyses and are typically the first step for functional annotation of genomic regions. Without up-to-date genome annotations, genome sequences cannot be used to maximum advantage. It is therefore essential to regularly update gene annotations by integrating the latest information to guarantee that reference annotations can remain a common basis for various types of analyses. Here, we report an improvement of the Arabidopsis lyrata gene annotation using extensive RNA-seq data. This new annotation consists of 31,132 protein coding gene models in addition to 2,089 genes with high similarity to transposable elements. Overall, similar to 87% of the gene models are corroborated by evidence of expression and 2,235 of these models feature multiple transcripts. Our updated gene annotation corrects hundreds of incorrectly split or merged gene models in the original annotation, and as a result the identification of alternative splicing events and differential isoform usage are vastly improved.	[Rawat, Vimal; Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, D-50829 Cologne, Germany; [Abdelsamad, Ahmed; Pietzenuk, Bjoern; Pecinka, Ales] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, D-50829 Cologne, Germany; [Abdelsamad, Ahmed] Cairo Univ, Dept Genet, Giza 12613, Egypt; [Seymour, Danelle K.; Koenig, Daniel; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society; Egyptian Knowledge Bank (EKB); Cairo University; Max Planck Society	Pecinka, A (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Carl von Linne Weg 10, D-50829 Cologne, Germany.	pecinka@mpipz.mpg.de; schneeberger@mpipz.mpg.de	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Schneeberger, Korbinian/U-6329-2019	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Pietzenuk, Bjorn/0000-0002-2688-3783; rawat, vimal/0000-0002-6566-9253	German Research Foundation (dfg.de) [AP1829-2]	German Research Foundation (dfg.de)	This work was funded by German Research Foundation (dfg.de) grant AP1829-2 to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cheng SF, 2013, PLANT CELL, V25, P2813, DOI 10.1105/tpc.113.113480; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lobreaux S, 2014, MOL ECOL RESOUR, V14, P411, DOI 10.1111/1755-0998.12189; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Oh DH, 2014, PLANT PHYSIOL, V164, P2123, DOI 10.1104/pp.113.233551; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Szarzynska B, 2015, NATURE PLANTS, V1; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu HJ, 2012, P NATL ACAD SCI USA, V109, P12219, DOI 10.1073/pnas.1209954109; Yang RL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00046	36	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137391	10.1371/journal.pone.0137391	http://dx.doi.org/10.1371/journal.pone.0137391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382944	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200022
J	Kellett-Clarke, H; Stegmann, M; Barclay, AN; Metcalfe, C				Kellett-Clarke, Helena; Stegmann, Monika; Barclay, A. Neil; Metcalfe, Clive			CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site	PLOS ONE			English	Article							IN-VIVO; RHEUMATOID-ARTHRITIS; PROTEIN FUNCTION; DISEASE-ACTIVITY; T-CELLS; RECEPTOR; ACTIVATION; MODULATION; ADHESION; ANTIBODY	CD44 is the primary leukocyte cell surface receptor for hyaluronic acid (HA), a component of the extracellular matrix. Enzymatic post translational cleavage of labile disulfide bonds is a mechanism by which proteins are structurally regulated by imparting an allosteric change and altering activity. We have identified one such disulfide bond in CD44 formed by Cys77 and Cys97 that stabilises the HA binding groove. This bond is labile on the surface of leukocytes treated with chemical and enzymatic reducing agents. Analysis of CD44 crystal structures reveal the disulfide bond to be solvent accessible and in the-LH hook configuration characteristic of labile disulfide bonds. Kinetic trapping and binding experiments on CD44-Fc chimeric proteins show the bond is preferentially reduced over the other disulfide bonds in CD44 and reduction inhibits the CD44-HA interaction. Furthermore cells transfected with CD44 no longer adhere to HA coated surfaces after pre-treatment with reducing agents. The implications of CD44 redox regulation are discussed in the context of immune function, disease and therapeutic strategies.	[Kellett-Clarke, Helena; Stegmann, Monika; Barclay, A. Neil; Metcalfe, Clive] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Metcalfe, C (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	clive.metcalfe@path.ox.ac.uk		Metcalfe, Clive/0000-0002-7856-8574	Medical Research Council [G9826026]; MRC [G9826026] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant No. G9826026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Castellani P, 2008, EUR J IMMUNOL, V38, P2419, DOI 10.1002/eji.200838439; Consortium U., 2014, NUCL ACIDS RES; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; English NM, 1998, CANCER RES, V58, P3736; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Faller CE, 2014, PROTEINS, V82, P3079, DOI 10.1002/prot.24668; HAYNES BF, 1991, ARTHRITIS RHEUM, V34, P1434; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Matthias LJ, 2010, J BIOL CHEM, V285, P40793, DOI 10.1074/jbc.M110.190579; Metcalfe C, 2012, OPEN BIOL, P2, DOI DOI 10.1098/RSOB.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pellom ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081134; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yung S, 2012, AUTOIMMUNE DIS, V2012; Zhang SP, 2013, P NATL ACAD SCI USA, V110, P6127, DOI 10.1073/pnas.1221841110; Zhou BF, 2014, BIOPHYS J, V107, P672, DOI 10.1016/j.bpj.2014.06.025	38	19	20	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138137	10.1371/journal.pone.0138137	http://dx.doi.org/10.1371/journal.pone.0138137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379032	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400058
J	Ferrer, I; Verdugo-Sivianes, EM; Castilla, MA; Melendez, R; Marin, JJ; Munoz-Galvan, S; Lopez-Guerra, JL; Vieites, B; Ortiz-Gordillo, MJ; De Leon, JM; Praena-Fernandez, JM; Perez, M; Palacios, J; Carnero, A				Ferrer, I.; Verdugo-Sivianes, E. M.; Castilla, M. A.; Melendez, R.; Marin, J. J.; Munoz-Galvan, S.; Lopez-Guerra, J. L.; Vieites, B.; Ortiz-Gordillo, M. J.; De Leon, J. M.; Praena-Fernandez, J. M.; Perez, M.; Palacios, J.; Carnero, A.			Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors	ONCOGENE			English	Article							GENETIC-LINKAGE ANALYSIS; IN-VITRO PROPAGATION; BINDING-PROTEIN; CHROMOSOME 17Q12-21; DENDRITIC SPINES; FAMILIAL BREAST; POOR-PROGNOSIS; OVARIAN-CANCER; HETEROGENEITY; CARCINOMA	The spinophilin (Spn, PPP1R9B) gene is located at 17q21.33, a region frequently associated with microsatellite instability and loss of heterozygosity, especially in breast tumors. Spn is a regulatory subunit of phosphatase1a (PP1), which targets the catalytic subunit to distinct subcellular locations. Spn downregulation reduces PPP1CA activity against the retinoblastoma protein, pRb, thereby maintaining higher levels of phosphorylated pRb. This effect contributes to an increase in the tumorigenic properties of cells in certain contexts. Here, we explored the mechanism of how Spn downregulation contributes to the malignant phenotype and poor prognosis in breast tumors and found an increase in the stemness phenotype. Analysis of human breast tumors showed that Spn mRNA and protein are reduced or lost in 15% of carcinomas, correlating with a worse prognosis, a more aggressive tumor phenotype and triple-negative tumors, whereas luminal tumors showed high Spn levels. Downregulation of Spn by shRNA increased the stemness properties along with the expression of stem-related genes (Sox2, KLF4, Nanog and OCT4), whereas ectopic overexpression of Spn cDNA reduced these properties. Breast tumor stem cells appeared to have low levels of Spn mRNA, and Spn loss correlated with increased stem-like cell appearance in breast tumors as indicated by an increase in CD44+/CD24- cells. A reduction of the levels of PPP1CA mimicked the cancer stem-like cell phenotype of Spn downregulation, suggesting that the mechanism of Spn involves PP1a. These increased cancer stem cell-like properties with reduced Spn might account for the malignant phenotype observed in Spn-loss tumors and may contribute to a worse patient prognosis.	[Ferrer, I.; Verdugo-Sivianes, E. M.; Castilla, M. A.; Melendez, R.; Marin, J. J.; Munoz-Galvan, S.; Perez, M.; Carnero, A.] Univ Seville, CSIC, HUVR, Inst Biomed Sevilla,IBIS, Campus HUVR,Edificio IBIS,Avda Manuel Siurot S-N, Seville 41013, Spain; [Marin, J. J.] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain; [Lopez-Guerra, J. L.; Ortiz-Gordillo, M. J.] Univ Hosp Virgen Del Rocio, Dept Radiat Oncol, Seville, Spain; [Vieites, B.] Univ Hosp Virgen Del Rocio, Dept Pathol, Seville, Spain; [De Leon, J. M.] Univ Hosp Virgen Del Rocio, Unidad Func Patol Mamaria, Seville, Spain; [Praena-Fernandez, J. M.] Virgen del Rocio Univ Hosp, Methodol Unit, Fdn Publ Andaluza Gest Invest Salud Sevilla, Seville, Spain; [Palacios, J.] Univ Hosp Ramon y Cajal, Dept Pathol, Madrid, Spain; [Carnero, A.] CSIC, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla; Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC)	Carnero, A (corresponding author), Univ Seville, CSIC, HUVR, Inst Biomed Sevilla,IBIS, Campus HUVR,Edificio IBIS,Avda Manuel Siurot S-N, Seville 41013, Spain.	acarnero-ibis@us.es	IBIS, RADIOBIOLOGIA/H-7452-2016; Muñoz-Galván, Sandra/K-5827-2015; IBIS, CANCER/P-3323-2015; Ferrer, Irene/C-9418-2015; IBIS, BIOMARCADORES/P-3515-2015; PRAENA-FERNANDEZ, J M/GON-7040-2022; Palacios, Jose/AAV-3765-2020; Marin-Lopez, Juan J./G-7123-2012	Ferrer, Irene/0000-0002-2748-2607; PRAENA-FERNANDEZ, J M/0000-0001-5728-1024; Marin-Lopez, Juan J./0000-0001-6072-739X; Carnero, Amancio/0000-0003-4357-3979; VERDUGO SIVIANES, EVA MARIA/0000-0002-0922-0371; Perez, Marco/0000-0001-6997-9593	Spanish Ministry of Economy and Competitivity; Consejeria de Ciencia e Innovacion [CTS-6844, CTS-1848]; Consejeria de Salud of the Junta de Andalucia [PI-0135-2010, PI-0306-2012]; ISCIII [PIE13/0004]; FEDER funds; Sara Borrel Fellowship [CD12/00596]; ISCIII (Fis) - FEDER from Regional Development European Funds (European Union) [PI12/00137, PI15/00045]; ISCIII (RTICC) - FEDER from Regional Development European Funds (European Union) [RD12/0036/0028]	Spanish Ministry of Economy and Competitivity(Spanish Government); Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); ISCIII(Instituto de Salud Carlos III); FEDER funds(European Commission); Sara Borrel Fellowship; ISCIII (Fis) - FEDER from Regional Development European Funds (European Union); ISCIII (RTICC) - FEDER from Regional Development European Funds (European Union)	AC lab was supported by grants from the Spanish Ministry of Economy and Competitivity, Plan Nacional de I+D+I 2008-2011, Plan Estatal de I+D+I 2013-2016, ISCIII (Fis: PI12/00137, PI15/00045, RTICC: RD12/0036/0028) co-funded by FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion (CTS-6844 and CTS-1848) and Consejeria de Salud of the Junta de Andalucia (PI-0135-2010 and PI-0306-2012). This work has been also possible with the help of the Plan Estatal de I+D+i 2013-2016, Grant PIE13/0004 co-funded by the ISCIII and FEDER funds. We thank the donors and the CNIO tumor bank and HUVR-IBiS Biobank (Andalusian Public Health System Biobank and ISCIII-Red de Biobancos PT13/0010/0056) for the human specimens used in this study. IF was funded by a Sara Borrel Fellowship (CD12/00596).	Abujiang P, 1998, ONCOGENE, V17, P3029, DOI 10.1038/sj.onc.1202230; Aigelsreiter A, 2013, BRIT J CANCER, V108, P1830, DOI 10.1038/bjc.2013.165; Aigelsreiter MM, 2014, HUM PATHOL, V45, P683, DOI 10.1016/j.humpath.2013.11.014; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Berndt Norbert, 1999, Frontiers in Bioscience, V4, pD22, DOI 10.2741/Berndt; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Carnero A, 2012, CURR MOL MED, V12, P528, DOI 10.2174/156652412800619987; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chang CC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1385; COHEN BB, 1993, AM J HUM GENET, V52, P723; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; EASTON DF, 1993, AM J HUM GENET, V52, P678; Estevez-Garcia P, 2013, CLIN CANCER RES, V19, P3925, DOI 10.1158/1078-0432.CCR-13-0057; Ferrer I, 2011, CELL CYCLE, V10, P2751, DOI 10.4161/cc.10.16.16422; Ferrer I, 2011, CELL CYCLE, V10, P1948, DOI 10.4161/cc.10.12.15798; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Ghebeh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-289; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Kuntziger T, 2011, CELL CYCLE, V10, P1356, DOI 10.4161/cc.10.9.15442; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Mannello F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-169; Mannello F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-344; Molina-Pinelo S, 2011, J PATHOL, V225, P73, DOI 10.1002/path.2905; Ouimet CC, 2004, J COMP NEUROL, V479, P374, DOI 10.1002/cne.20313; Pinto CA, 2013, CANCER LETT, V341, P56, DOI 10.1016/j.canlet.2013.06.003; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; PORTER DE, 1993, BRIT J SURG, V80, P1381, DOI 10.1002/bjs.1800801108; PORTER DE, 1994, BRIT J SURG, V81, P1512, DOI 10.1002/bjs.1800811038; Querzoli P, 2001, BREAST CANCER RES TR, V66, P135, DOI 10.1023/A:1010643515095; RESNICOFF M, 1987, P NATL ACAD SCI USA, V84, P7295, DOI 10.1073/pnas.84.20.7295; Ress AL, 2014, ONCOTARGET, V5, P8492; Santamaria D, 2011, CELL CYCLE, V10, P2831, DOI 10.4161/cc.10.17.16528; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Santra M, 2011, CANCER SCI, V102, P1350, DOI 10.1111/j.1349-7006.2011.01952.x; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Setoguchi T, 2004, CELL CYCLE, V3, P414; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; SMITH SA, 1993, AM J HUM GENET, V52, P767; Tseng SL, 1997, GENE CHROMOSOME CANC, V20, P377; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Vivo M, 2001, J BIOL CHEM, V276, P14161, DOI 10.1074/jbc.M006845200; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274	52	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2777	2788		10.1038/onc.2015.341	http://dx.doi.org/10.1038/onc.2015.341			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26387546				2022-12-26	WOS:000377472700011
J	Liu, Y; Wang, G; Yang, Y; Mei, Z; Liang, Z; Cui, A; Wu, T; Liu, CY; Cui, L				Liu, Y.; Wang, G.; Yang, Y.; Mei, Z.; Liang, Z.; Cui, A.; Wu, T.; Liu, C-Y; Cui, L.			Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; GASTRIC-CANCER; HIPPO PATHWAY; BETA-CATENIN; E-CADHERIN; ENHANCER; GROWTH; DISRUPTION; COMPLEX; LINEAGE	Dysregulation of the Hippo pathway occurs in a variety of cancers and often correlates with a poor prognosis. To further explore the potential role of Hippo pathway dysregulation in tumor development and progression, we investigated its downstream transcription factor TEAD4 in colorectal cancer (CRC). Increased expression and nuclear localization of TEAD4 were found in a significant portion of CRC tissues, in association with metastasis and a poor prognosis. In CRC cells, TEAD4 knockdown induced the mesenchymal-epithelial transition and decreased cell mobility in vitro and metastasis in vivo. Microarray analysis revealed that TEAD4 promoted cell adhesion and upregulated the epithelial-mesenchymal transition-related transcriptome in CRC cells. Vimentin was identified as a new direct target gene mediating TEAD4 function in CRC cells, whereby forced vimentin expression markedly reversed TEAD4-knockdown-induced cell morphological changes and decreased mobility. Interestingly, rescued expression of both WT TEAD4 and a Y429H mutant can reverse the mesenchymal-epithelial transition and increase vimentin expression, cell mobility and metastatic potential in TEAD4-knockdown CRC cells. The discrepant expression of YAP and TEAD4 in CRC tissues, the rescue ability of TEAD4 mutant defect in YAP binding and no effect on vimentin expression by YAP knockdown in CRC cells, all implicated a YAP-independent manner of TEAD4 function in CRC. Furthermore, vimentin positively correlated and CDH1 reversely correlated with the level of TEAD4 in CRC tissues and xenograft tumors. Our results suggest that TEAD4 nuclear expression can serve as a biomarker for CRC progression and poor prognosis. The transcription factor TEAD4 regulates a pro-metastasis transcription program in a YAP-independent manner in CRC, thus providing a novel mechanism of TEAD4 transcriptional regulation and its oncogenic role in CRC, independently of the Hippo pathway.	[Liu, Y.; Wang, G.; Yang, Y.; Mei, Z.; Liang, Z.; Cui, A.; Wu, T.; Liu, C-Y; Cui, L.] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Kongjiang Rd 1665, Shanghai 200092, Peoples R China; [Liu, Y.; Wang, G.; Yang, Y.; Mei, Z.; Liang, Z.; Cui, A.; Wu, T.; Liu, C-Y; Cui, L.] Shanghai Colorectal Canc Res Ctr, Shanghai, Peoples R China; [Yang, Y.] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Ctr Med Res, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, CY; Cui, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Kongjiang Rd 1665, Shanghai 200092, Peoples R China.	cyliu_eric@126.com; longcuidr@126.com	Mei, Zubing/H-7879-2019	cui, long/0000-0003-1838-4471; Liu, Chen-Ying/0000-0002-8930-6182	National Natural Science Foundation of China [81372636, 81302089]; National High Technology Research and Development Program of China (863 Program) [SQ2014SFOZD00314]; Shanghai Excellent Young Teachers Program [ZZjdyx13074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Shanghai Excellent Young Teachers Program	This work was supported by National Natural Science Foundation of China (grant no. 81372636 and No. 81302089), the National High Technology Research and Development Program of China (863 Program) (grant no. SQ2014SFOZD00314), the Shanghai Excellent Young Teachers Program (grant no. ZZjdyx13074).	Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gilles C, 2003, CANCER RES, V63, P2658; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kaneko KJ, 2007, GENESIS, V45, P577, DOI 10.1002/dvg.20330; Kaneko KJ, 2013, DEVELOPMENT, V140, P3680, DOI 10.1242/dev.093799; Kobayashi H, 2004, CLIN CANCER RES, V10, P572, DOI 10.1158/1078-0432.CCR-1323-03; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang W, 2014, BRIT J CANCER, V110, P450, DOI 10.1038/bjc.2013.724; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhong XY, 2008, HISTOPATHOLOGY, V52, P560, DOI 10.1111/j.1365-2559.2008.02971.x	36	93	95	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2789	2800		10.1038/onc.2015.342	http://dx.doi.org/10.1038/onc.2015.342			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26387538				2022-12-26	WOS:000377472700012
J	Yamaguchi, S; Kitamura, M; Ushikubo, T; Murata, A; Akagi, R; Sasho, T				Yamaguchi, Satoshi; Kitamura, Masako; Ushikubo, Tomohiro; Murata, Atsushi; Akagi, Ryuichiro; Sasho, Takahisa			Effect of Laterally Wedged Insoles on the External Knee Adduction Moment across Different Reference Frames	PLOS ONE			English	Article							MEDIAL CONTACT FORCE; JOINT MOMENTS; OSTEOARTHRITIS; GAIT; REPEATABILITY; PROGRESSION; MECHANICS; ROTATION; PREDICT; MODEL	Objective Biomechanical effects of laterally wedged insoles are assessed by reduction in the knee adduction moment. However, the degree of reduction may vary depending on the reference frame with which it is calculated. The purpose of this study was to clarify the effect of reference frame on the reduction in the knee adduction moment by laterally wedged insoles. Methods Twenty-nine healthy participants performed gait trials with a laterally wedged insole and with a flat insole as a control. The knee adduction moment, including the first and second peaks and the angular impulse, were calculated using four different reference frames: the femoral frame, tibial frame, laboratory frame and the Joint Coordinate System. Results There were significant effects of reference frame on the knee adduction moment first and second peaks (P < 0.001 for both variables), while the effect was not significant for the angular impulse (P = 0.84). No significant interaction between the gait condition and reference frame was found in either of the knee adduction moment variables (P = 0.99 for all variables), indicating that the effects of laterally wedged insole on the knee adduction moments were similar across the four reference frames. On the other hand, the average percent changes ranged from 9% to 16% for the first peak, from 16% to 18% for the second peak and from 17% to 21% for the angular impulse when using the different reference frames. Conclusion The effects of laterally wedged insole on the reduction in the knee adduction moment were similar across the reference frames. On the other hand, Researchers need to recognize that when the percent change was used as the parameter of the efficacy of laterally wedged insole, the choice of reference frame may influence the interpretation of how laterally wedged insoles affect the knee adduction moment.	[Yamaguchi, Satoshi; Akagi, Ryuichiro; Sasho, Takahisa] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba, Japan; [Kitamura, Masako; Murata, Atsushi] Chiba Univ Hosp, Div Rehabil Med, Chuo Ku, Chiba, Japan; [Ushikubo, Tomohiro] Anima Corp, Div Syst Dev, Chofu, Tokyo, Japan	Chiba University	Yamaguchi, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba, Japan.	y-satoshi@mvb.biglobe.ne.jp		Akagi, Ryuichiro/0000-0002-7057-0936	manufacturer of the three-dimensional motion analysis system and force plate	manufacturer of the three-dimensional motion analysis system and force plate	One of the authors was employed by a manufacturer of the three-dimensional motion analysis system and force plate used in this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; Birmingham TB, 2007, ARTHRIT RHEUM-ARTHR, V57, P1012, DOI 10.1002/art.22899; Block JA, 2010, CURR OPIN RHEUMATOL, V22, P544, DOI 10.1097/BOR.0b013e32833bd81f; Brandon SCE, 2011, CLIN BIOMECH, V26, P65, DOI 10.1016/j.clinbiomech.2010.08.010; BRYANT JT, 1984, MED BIOL ENG COMPUT, V22, P597, DOI 10.1007/BF02443876; Butler RJ, 2007, J ORTHOP RES, V25, P1121, DOI 10.1002/jor.20423; Hinman RS, 2008, ARTHRIT RHEUM-ARTHR, V59, P408, DOI 10.1002/art.23326; Hinman RS, 2008, ARTHRIT RHEUM-ARTHR, V59, P144, DOI 10.1002/art.23249; Hinman RS, 2012, CLIN BIOMECH, V27, P27, DOI 10.1016/j.clinbiomech.2011.07.010; Hurwitz DE, 2000, J ORTHOPAED RES, V18, P572, DOI 10.1002/jor.1100180409; Ingham SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-57; Kakihana W, 2004, AM J PHYS MED REHAB, V83, P273, DOI 10.1097/01.PHM.0000118035.71195.DE; Kakihana W, 2007, AM J PHYS MED REHAB, V86, P446, DOI 10.1097/PHM.0b013e31805bfff5; Kean CO, 2012, CLIN BIOMECH, V27, P520, DOI 10.1016/j.clinbiomech.2011.12.007; Lewinson RT, 2015, KNEE, V22, P292, DOI 10.1016/j.knee.2015.04.003; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Nakajima K, 2009, GAIT POSTURE, V29, P208, DOI 10.1016/j.gaitpost.2008.08.007; Newell RS, 2008, GAIT POSTURE, V27, P485, DOI 10.1016/j.gaitpost.2007.06.004; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; O'Reilly OM, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025327; Radzimski AO, 2012, KNEE, V19, P163, DOI 10.1016/j.knee.2011.05.013; Schache AG, 2008, CLIN BIOMECH, V23, P601, DOI 10.1016/j.clinbiomech.2007.12.008; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Stebbins J, 2006, GAIT POSTURE, V23, P401, DOI 10.1016/j.gaitpost.2005.03.002; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Tomatsuri K, 1975, CENTRAL JPN J ORTHOP, V18, P398; van Raaij TM, 2010, CLIN ORTHOP RELAT R, V468, P1926, DOI 10.1007/s11999-010-1274-z; Wada M, 1998, CLIN ORTHOP RELAT R, P180; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Winter David A., 1994, Journal of Biomechanics, V27, P818; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138554	10.1371/journal.pone.0138554	http://dx.doi.org/10.1371/journal.pone.0138554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397375	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500077
J	Shoda, H; Yanai, R; Yoshimura, T; Nagai, T; Kimura, K; Sobrin, L; Connor, KM; Sakoda, Y; Tamada, K; Ikeda, T; Sonoda, KH				Shoda, Hiromi; Yanai, Ryoji; Yoshimura, Takeru; Nagai, Tomohiko; Kimura, Kazuhiro; Sobrin, Lucia; Connor, Kip M.; Sakoda, Yukimi; Tamada, Koji; Ikeda, Tsunehiko; Sonoda, Koh-Hei			Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function	PLOS ONE			English	Article							KOYANAGI-HARADA-DISEASE; FATTY-ACIDS; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; N-3 PUFA; MICE; UVEORETINITIS; NEOVASCULARIZATION; INFLAMMATION; MACROPHAGES	Omega (omega)-3 long-chain polyunsaturated fatty acids (LCPUFAs) inhibit the production of inflammatory mediators and thereby contribute to the regulation of inflammation. Experimental autoimmune uveitis (EAU) is a well-established animal model of autoimmune retinal inflammation. To investigate the potential effects of dietary intake of omega-3 LCPUFAs on uveitis, we examined the anti-inflammatory properties of these molecules in comparison with omega-6 LCPUFAs in a mouse EAU model. C57BL/6 mice were fed a diet containing omega-3 LCPU-FAs or omega-6 LCPUFAs for 2 weeks before as well as after the induction of EAU by subcutaneous injection of a fragment of human interphotoreceptor retinoid-binding protein emulsified with complete Freund's adjuvant. Both clinical and histological scores for uveitis were smaller for mice fed omega-3 LCPUFAs than for those fed omega-6 LCPUFAs. The concentrations of the T helper 1 (Th1) cytokine interferon-gamma and the Th17 cytokine interleukin-17 in intraocular fluid as well as the production of these cytokines by lymph node cells were reduced for mice fed omega-3 LCPUFAs. Furthermore, the amounts of mRNAs for the Th1- and Th17-related transcription factors T-bet and ROR gamma t, respectively, were reduced both in the retina and in lymph node cells of mice fed omega-3 LCPUFAs. Our results thus show that a diet enriched in omega-3 LCPUFAs suppressed uveitis in mice in association with inhibition of Th1 and Th17 cell function.	[Shoda, Hiromi; Yanai, Ryoji; Nagai, Tomohiko; Kimura, Kazuhiro; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan; [Yoshimura, Takeru; Sobrin, Lucia; Connor, Kip M.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Angiogenesis Lab,Dept Ophthalmol, Cambridge, MA 02138 USA; [Sakoda, Yukimi; Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol, Ube, Yamaguchi 755, Japan; [Shoda, Hiromi; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan	Yamaguchi University; Harvard University; Massachusetts Eye & Ear Infirmary; Yamaguchi University; Osaka Medical College	Yanai, R (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan.	yanai@yamaguchi-u.ac.jp		Yoshimura, Takeru/0000-0002-5983-7193; Connor, Kip/0000-0002-2048-9080; Sobrin, Lucia/0000-0003-1575-0819	Grants-in-Aid for Scientific Research [26462663] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agarwal Rajeev K, 2012, Methods Mol Biol, V900, P443, DOI 10.1007/978-1-60761-720-4_22; Al-Kharashi Abdullah S., 2007, International Ophthalmology, V27, P201, DOI 10.1007/s10792-007-9062-9; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Babcock Tricia A, 2002, Surg Infect (Larchmt), V3, P145, DOI 10.1089/109629602760105817; Bhargava R, 2013, INT J OPHTHALMOL-CHI, V6, P811, DOI 10.3980/j.issn.2222-3959.2013.06.13; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Caspi R. R., 2006, DRUG DISCOV TODAY, V3, P3; Caspi RR, 1997, EYE, V11, P209, DOI 10.1038/eye.1997.53; Chong WP, 2014, J AUTOIMMUN, V50, P12, DOI 10.1016/j.jaut.2013.08.003; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P2568, DOI 10.1167/iovs.09-4769; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Din JN, 2004, BMJ-BRIT MED J, V328, P30, DOI 10.1136/bmj.328.7430.30; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; Ferrante A, 2011, POLYUNSATURATED FATT, P159; Gasparin F, 2012, ARQ BRAS OFTALMOL, V75, P143, DOI 10.1590/S0004-27492012000200016; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Huang H, 2013, INT J MOL SCI, V14, P21463, DOI 10.3390/ijms141121463; Jiang HR, 1999, INVEST OPHTH VIS SCI, V40, P3177; Katakura M, 2014, MOLECULES, V19, P3247, DOI 10.3390/molecules19033247; Khawaja OA, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0450-0; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Kris-Etherton PM, 2009, PROSTAG LEUKOTR ESS, V81, P99, DOI 10.1016/j.plefa.2009.05.011; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Liu A, 2013, CANC METASTAS REV, V32, P201; Lobo A, 2003, CLIN EXP OPHTHALMOL, V31, P310, DOI 10.1046/j.1442-9071.2003.00666.x; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Monk JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049739; Monk JM, 2012, J NUTR, V142, P117, DOI 10.3945/jn.111.147058; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Sonoda KH, 2003, J IMMUNOL, V171, P2652, DOI 10.4049/jimmunol.171.5.2652; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Suzuki M, 2010, MOL VIS, V16, P1382; Szostak-Wegierek Dorota, 2013, Rocz Panstw Zakl Hig, V64, P263; Takeda A., 2013, INFLAMM REGEN, V33, P261, DOI [10.2492/inflammregen.33.261, DOI 10.2492/INFLAMMREGEN.33.261]; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Wang CK, 2012, INVEST OPHTH VIS SCI, V53, P4668, DOI 10.1167/iovs.12-9863; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096286; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Yanai R, 2014, P NATL ACAD SCI USA, V111, P9603, DOI 10.1073/pnas.1401191111; Yang PZ, 2008, AM J OPHTHALMOL, V146, P767, DOI 10.1016/j.ajo.2008.05.044; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135	43	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138241	10.1371/journal.pone.0138241	http://dx.doi.org/10.1371/journal.pone.0138241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393358	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100042
J	Szpunar, KK; Jing, HG; Benoit, RG; Schacter, DL				Szpunar, Karl K.; Jing, Helen G.; Benoit, Roland G.; Schacter, Daniel L.			Repetition-Related Reductions in Neural Activity during Emotional Simulations of Future Events	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; MAJOR DEPRESSIVE DISORDER; CINGULATE CORTEX; PULVINAR; ACTIVATION; AMYGDALA; MEMORY; NEUROANATOMY; ORGANIZATION; PREDICTORS	Simulations of future experiences are often emotionally arousing, and the tendency to repeatedly simulate negative future outcomes has been identified as a predictor of the onset of symptoms of anxiety. Nonetheless, next to nothing is known about how the healthy human brain processes repeated simulations of emotional future events. In this study, we present a paradigm that can be used to study repeated simulations of the emotional future in a manner that overcomes phenomenological confounds between positive and negative events. The results show that pulvinar nucleus and orbitofrontal cortex respectively demonstrate selective reductions in neural activity in response to frequently as compared to infrequently repeated simulations of negative and positive future events. Implications for research on repeated simulations of the emotional future in both non-clinical and clinical populations are discussed.	[Szpunar, Karl K.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Jing, Helen G.; Benoit, Roland G.; Schacter, Daniel L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Jing, Helen G.; Benoit, Roland G.; Schacter, Daniel L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Harvard University	Szpunar, KK (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	szpunar@uic.edu	Szpunar, Karl/AAF-6600-2019		National Institute of Mental Health [5R01MH60941-13]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health Grant 5R01MH60941-13, awarded to Daniel L. Schacter.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; BALEYDIER C, 1985, J COMP NEUROL, V232, P219, DOI 10.1002/cne.902320207; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Benoit RG, 2015, NEUROPSYCHOLOGIA, V75, P450, DOI 10.1016/j.neuropsychologia.2015.06.034; Benoit RG, 2014, P NATL ACAD SCI USA, V111, P16550, DOI 10.1073/pnas.1419274111; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Calmes CA, 2007, COGNITIVE THER RES, V31, P343, DOI 10.1007/s10608-006-9026-9; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; D'Argembeau A, 2011, APPL COGNITIVE PSYCH, V25, P96, DOI 10.1002/acp.1647; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Gaesser B, 2013, HIPPOCAMPUS, V23, P1150, DOI 10.1002/hipo.22152; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; HIRAI T, 1989, BRAIN RES REV, V14, P1, DOI 10.1016/0165-0173(89)90007-6; Klein SB, 2013, J APPL RES MEM COGN, V2, P222, DOI 10.1016/j.jarmac.2013.08.001; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Morina N, 2011, J ANXIETY DISORD, V25, P1032, DOI 10.1016/j.janxdis.2011.06.012; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Padmala S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00064; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rubin DC, JOURNAL OF EXPERIMEN; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter DL, 2012, AM PSYCHOL, V67, P603, DOI 10.1037/a0029869; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2014, SOC COGN AFFECT NEUR, V9, P712, DOI 10.1093/scan/nst035; Szpunar KK, 2013, J EXP PSYCHOL GEN, V142, P323, DOI 10.1037/a0028877; Szpunar KK, 2012, PSYCHOL SCI, V23, P24, DOI 10.1177/0956797611422237; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Todd RM, 2012, TRENDS COGN SCI, V16, P365, DOI 10.1016/j.tics.2012.06.003; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; van Mulukom V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069596; Ward R, 2005, CURR BIOL, V15, P571, DOI 10.1016/j.cub.2005.01.056; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138354	10.1371/journal.pone.0138354	http://dx.doi.org/10.1371/journal.pone.0138354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390294	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000026
J	Das, S; Rundell, MS; Mirza, AH; Pingle, MR; Shigyo, K; Garrison, AR; Paragas, J; Smith, SK; Olson, VA; Larone, DH; Spitzer, ED; Barany, F; Golightly, LM				Das, Sanchita; Rundell, Mark S.; Mirza, Aashiq H.; Pingle, Maneesh R.; Shigyo, Kristi; Garrison, Aura R.; Paragas, Jason; Smith, Scott K.; Olson, Victoria A.; Larone, Davise H.; Spitzer, Eric D.; Barany, Francis; Golightly, Linnie M.			A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus	PLOS ONE			English	Article							LIGASE DETECTION REACTION; REVERSE-TRANSCRIPTASE PCR; POLYMERASE-CHAIN-REACTION; EBOLA-VIRUS; BIOTERRORISM AGENTS; SMALLPOX-VIRUS; DIAGNOSIS; DISEASE; DNA; OUTBREAK	CDC designated category A infectious agents pose a major risk to national security and require special action for public health preparedness. They include viruses that cause viral hemorrhagic fever (VHF) syndrome as well as variola virus, the agent of smallpox. VHF is characterized by hemorrhage and fever with multi-organ failure leading to high morbidity and mortality. Smallpox, a prior scourge, has been eradicated for decades, making it a particularly serious threat if released nefariously in the essentially non-immune world population. Early detection of the causative agents, and the ability to distinguish them from other pathogens, is essential to contain outbreaks, implement proper control measures, and prevent morbidity and mortality. We have developed a multiplex detection assay that uses several species-specific PCR primers to generate amplicons from multiple pathogens; these are then targeted in a ligase detection reaction (LDR). The resultant fluorescently-labeled ligation products are detected on a universal array enabling simultaneous identification of the pathogens. The assay was evaluated on 32 different isolates associated with VHF (ebolavirus, marburgvirus, Crimean Congo hemorrhagic fever virus, Lassa fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia virus (the agent of smallpox and its vaccine strain, respectively). The assay was able to detect all viruses tested, including 8 sequences representative of different variola virus strains from the CDC repository. It does not cross react with other emerging zoonoses such as monkeypox virus or cowpox virus, or six flaviviruses tested (St. Louis encephalitis virus, Murray Valley encephalitis virus, Powassan virus, Tick-borne encephalitis virus, West Nile virus and Japanese encephalitis virus).	[Das, Sanchita; Shigyo, Kristi; Golightly, Linnie M.] Cornell Univ, Dept Med, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA; [Rundell, Mark S.; Mirza, Aashiq H.; Pingle, Maneesh R.; Larone, Davise H.; Barany, Francis; Golightly, Linnie M.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Garrison, Aura R.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Paragas, Jason] NIAID, Integrated Res Facil, Div Clin Res, NIH, Ft Detrick, MD USA; [Smith, Scott K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Poxvirus Team, Poxvirus & Rabies Branch,Natl Ctr Emerging Zoonot, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Larone, Davise H.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Spitzer, Eric D.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA	Cornell University; Cornell University; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Golightly, LM (corresponding author), Cornell Univ, Dept Med, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA.	lgolight@med.cornell.edu	Spitzer, Eric/T-7455-2019; Garrison, Aura/O-4123-2019	Garrison, Aura/0000-0003-3034-6400; Spitzer, Eric/0000-0002-8794-2441	National Institute of Allergy and Infectious Diseases of the National Institute of Health [UC1-AI062579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI110732, UC1AI062579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract UC1-AI062579 awarded to FB by the National Institute of Allergy and Infectious Diseases of the National Institute of Health (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At no time during the study did they receive salary support, other funds, or research materials from Beckman Coulter or Coferon Inc. to support the study, nor do either of these entities have any commercial rights or interest in developing a product from the current study.	[Anonymous], 2009, WHO AD COMM VAR VIR; [Anonymous], 2014, FILMARRAY BIOTHREAT; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Barany F, 1991, PCR Methods Appl, V1, P5, DOI 10.1101/gr.1.1.5; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bowick GC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/236528; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Burt FJ, 2005, EPIDEMIOL INFECT, V133, P659, DOI 10.1017/S0950268805003730; Busti E, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-27; Castiglioni B, 2004, APPL ENVIRON MICROB, V70, P7161, DOI 10.1128/AEM.70.12.7161-7172.2004; Cosgrove SE, 2005, ARCH INTERN MED, V165, P2002, DOI 10.1001/archinte.165.17.2002; Damon I.K., 2007, POXVIRUSES BIRKHAUSE, P47; Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Essbauer S., 2007, POXVIRUSES, P65; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Garrison AR, 2007, AM J TROP MED HYG, V77, P514, DOI 10.4269/ajtmh.2007.77.514; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817; Green A, 2014, LANCET, V384, P118, DOI 10.1016/S0140-6736(14)61147-8; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Hasib L, 2011, MOL BIOTECHNOL, V49, P176, DOI 10.1007/s12033-011-9389-3; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Maltezou HC, EURO SURVEILL, V15, P19504; Mardani M, 2009, AM J TROP MED HYG, V81, P675, DOI 10.4269/ajtmh.2009.09-0051; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Narayanan A, 2011, EXPERT OPIN INV DRUG, V20, P239, DOI 10.1517/13543784.2011.547852; Nisii C, 2009, CLIN MICROBIOL INFEC, V15, P720, DOI 10.1111/j.1469-0691.2009.02946.x; Olson VA, 2004, J CLIN MICROBIOL, V42, P1940, DOI 10.1128/JCM.42.5.1940-1946.2004; Outbreak news, 2009, WKLY EPIDEMIOL REC, V84, P49; Palacios G, 2006, EMERG INFECT DIS, V12, P692, DOI 10.3201/eid1204.051515; Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; Pingle M, 2010, METHODS MOL BIOL, V632, P141, DOI 10.1007/978-1-60761-663-4_9; Pingle MR, 2007, J CLIN MICROBIOL, V45, P1927, DOI 10.1128/JCM.00226-07; Riemann K, 2007, J CLIN LAB ANAL, V21, P244, DOI 10.1002/jcla.20174; Rondini S, 2008, J CLIN MICROBIOL, V46, P2269, DOI 10.1128/JCM.02335-07; Rundell MS, 2014, DIAGN MICR INFEC DIS, V79, P135, DOI 10.1016/j.diagmicrobio.2014.02.022; Sall AA, 2002, CLIN DIAGN LAB IMMUN, V9, P713, DOI 10.1128/CDLI.9.3.713-715.2002; Schlaurman T, 2007, J MICROBIOL METH, V71, P238, DOI 10.1016/j.mimet.2007.09.003; SMITH DH, 1982, LANCET, V1, P816; Teets Frank D, 2014, Virol Rep, V1-2, P2; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14; Weidmann M, 2008, J CLIN VIROL, V42, P326, DOI 10.1016/j.jcv.2008.03.005; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	57	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138484	10.1371/journal.pone.0138484	http://dx.doi.org/10.1371/journal.pone.0138484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381398	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200113
J	Jindra, C; Huber, B; Shafti-Keramat, S; Wolschek, M; Ferko, B; Muster, T; Brandt, S; Kirnbauer, R				Jindra, Christoph; Huber, Bettina; Shafti-Keramat, Saeed; Wolschek, Markus; Ferko, Boris; Muster, Thomas; Brandt, Sabine; Kirnbauer, Reinhard			Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; IMMUNE-RESPONSES; TRUNCATED NS1; PROTEIN; CELLS; REPLICATION; PARTICLES; EPITOPES; GENE; ONCOPROTEIN	Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, causes all cervical and most anal cancers, and a subset of vulvar, vaginal, penile and oropharyngeal carcinomas. Two prophylactic virus-like particle (VLPs)-based vaccines, are available that protect against vaccine type-associated persistent infection and associated disease, yet have no therapeutic effect on existing lesions or infections. We have generated recombinant live-attenuated influenza A viruses expressing the HPV16 oncogenes E6 and E7 as experimental immunotherapeutic vaccine candidates. The influenza A virus life cycle lacks DNA intermediates as important safety feature. Different serotypes were generated to ensure efficient prime and boost immunizations. The immune response to vaccination in C57BL/6 mice was characterized by peptide ELISA and IFN-gamma ELISpot, demonstrating induction of cell-mediated immunity to HPV16 E6 and E7 oncoproteins. Prophylactic and therapeutic vaccine efficacy was analyzed in the murine HPV16-positive TC-1 tumor challenge model. Subcutaneous (s.c.) prime and boost vaccinations of mice with recombinant influenza A serotypes H1N1 and H3N2, followed by challenge with TC-1 cells resulted in complete protection or significantly reduced tumor growth as compared to control animals. In a therapeutic setting, s.c. vaccination of mice with established TC-1 tumors decelerated tumor growth and significantly prolonged survival. Importantly, intralesional vaccine administration induced complete tumor regression in 25% of animals, and significantly reduced tumor growth in 50% of mice. These results suggest recombinant E6E7 influenza viruses as a promising new approach for the development of a therapeutic vaccine against HPV-induced disease.	[Jindra, Christoph; Huber, Bettina; Shafti-Keramat, Saeed; Kirnbauer, Reinhard] Med Univ Vienna, Lab Viral Oncol, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Wolschek, Markus; Brandt, Sabine] Vet Univ Vienna, Res Grp Oncol, Equine Clin, A-1030 Vienna, Austria; [Wolschek, Markus; Ferko, Boris; Muster, Thomas] Bluesky Vaccines, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Kirnbauer, R (corresponding author), Med Univ Vienna, Lab Viral Oncol, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria.	reinhard.kirnbauer@meduniwien.ac.at		Brandt, Sabine/0000-0002-3837-3422; FERKO, Boris/0000-0001-5340-4437; Shafti-Keramat, Saeed/0000-0002-4180-8853; Huber, Bettina/0000-0002-8086-7848	Austrian Science Fund; Translational Research Project Vienna Science and Technology Fund [L545]; Life Science Call [LS11-006]; BlueSky Vaccines	Austrian Science Fund(Austrian Science Fund (FWF)); Translational Research Project Vienna Science and Technology Fund; Life Science Call; BlueSky Vaccines	Funded by Austrian Science Fund (www.fwf.ac.at) Translational Research Project L545 Vienna Science and Technology Fund (www.wwtf.at) Life Science Call 2011 LS11-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BlueSky Vaccines provided support in the form of salaries for authors [MW, BF, TM], research materials and technical know how, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Azoury-Ziadeh R, 1999, VIRAL IMMUNOL, V12, P297, DOI 10.1089/vim.1999.12.297; Bergot Anne-Sophie, 2011, Cancers (Basel), V3, P3461, DOI 10.3390/cancers3033461; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Carter JR, 2011, AUST NZ J OBSTET GYN, V51, P103, DOI 10.1111/j.1479-828X.2010.01269.x; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; Ferko B, 2001, J VIROL, V75, P8899, DOI 10.1128/JVI.75.19.8899-8908.2001; Ferko B, 2006, J VIROL, V80, P11621, DOI 10.1128/JVI.01645-06; Forcier M, 2010, DERMATOL THER, V23, P458, DOI 10.1111/j.1529-8019.2010.01350.x; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; GAO L, 1994, J GEN VIROL, V75, P157, DOI 10.1099/0022-1317-75-1-157; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; James MA, 2006, INT J CANCER, V119, P1878, DOI 10.1002/ijc.22064; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; Kwak K, 2011, CURR OPIN IMMUNOL, V23, P244, DOI 10.1016/j.coi.2010.11.009; Lin KY, 1996, CANCER RES, V56, P21; Louie JK, 2010, ARCH PEDIAT ADOL MED, V164, P1023, DOI 10.1001/archpediatrics.2010.203; Maamary J, 2012, J VIROL, V86, P5782, DOI 10.1128/JVI.00190-12; Monie A, 2009, EXPERT REV VACCINES, V8, P1221, DOI 10.1586/ERV.09.76; Monroy-Garcia A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-59; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Palese Peter, 1997, Journal of Infectious Diseases, V176, pS45, DOI 10.1086/514175; Peng SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116389; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Roethl E, 2011, J VIROL, V85, P11139, DOI 10.1128/JVI.00169-11; Romanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005984; Samuel CE, 2010, J BIOL CHEM, V285, P28399, DOI 10.1074/jbc.R110.149625; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stukova MA, 2006, TUBERCULOSIS, V86, P236, DOI 10.1016/j.tube.2006.01.010; Sturlan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004122; TINDLE RW, 1990, J GEN VIROL, V71, P1347, DOI 10.1099/0022-1317-71-6-1347; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; van Rikxoort M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036506; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Wlazlo AP, 2001, HYBRIDOMA, V20, P257, DOI 10.1089/027245701753179848; Wolschek M, 2011, J VIROL, V85, P2469, DOI 10.1128/JVI.01650-10	48	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138722	10.1371/journal.pone.0138722	http://dx.doi.org/10.1371/journal.pone.0138722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381401	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200153
J	Urrestarazu, J; Royo, JB; Santesteban, LG; Miranda, C				Urrestarazu, Jorge; Royo, Jose B.; Santesteban, Luis G.; Miranda, Carlos			Evaluating the Influence of the Microsatellite Marker Set on the Genetic Structure Inferred in Pyrus communis L.	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MULTILOCUS GENOTYPE DATA; LOCAL APPLE CULTIVARS; POPULATION-STRUCTURE; MOLECULAR CHARACTERIZATION; GERMPLASM COLLECTIONS; PEAR CULTIVARS; LINKAGE MAPS; DIVERSITY; MALUS	Fingerprinting information can be used to elucidate in a robust manner the genetic structure of germplasm collections, allowing a more rational and fine assessment of genetic resources. Bayesian model-based approaches are nowadays majorly preferred to infer genetic structure, but it is still largely unresolved how marker sets should be built in order to obtain a robust inference. The objective was to evaluate, in Pyrus germplasm collections, the influence of the SSR marker set size on the genetic structure inferred, also evaluating the influence of the criterion used to select those markers. Inferences were performed considering an increasing number of SSR markers that ranged from just two up to 25, incorporated one at a time into the analysis. The influence of the number of SSR markers used was evaluated comparing the number of populations and the strength of the signal detected, and also the similarity of the genotype assignments to populations between analyses. In order to test if those results were influenced by the criterion used to select the SSRs, several choosing scenarios based on the discrimination power or the fixation index values of the SSRs were tested. Our results indicate that population structure could be inferred accurately once a certain SSR number threshold was reached, which depended on the underlying structure within the genotypes, but the method used to select the markers included on each set appeared not to be very relevant. The minimum number of SSRs required to provide robust structure inferences and adequate measurements of the differentiation, even when low differentiation levels exist within populations, was proved similar to that of the complete list of recommended markers for fingerprinting. When a SSR set size similar to the minimum marker sets recommended for fingerprinting it is used, only major divisions or moderate (F-ST>0.05) differentiation of the germplasm are detected.	[Urrestarazu, Jorge; Royo, Jose B.; Santesteban, Luis G.; Miranda, Carlos] Univ Publ Navarra, Dept Agr Prod, Navarra, Spain	Universidad Publica de Navarra	Miranda, C (corresponding author), Univ Publ Navarra, Dept Agr Prod, Navarra, Spain.	carlos.miranda@unavarra.es	Miranda, Carlos/B-4293-2010; Royo, Jose B/L-4875-2016; Santesteban, Luis Gonzaga/B-2408-2009	Miranda, Carlos/0000-0001-7217-0859; Royo, Jose B/0000-0003-1146-4989; Santesteban, Luis Gonzaga/0000-0001-6924-6744	INIA, Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria [RF2004-008-C03-00]	INIA, Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA))	This study was funded by INIA, Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (Project grant number RF2004-008-C03-00) www.inia.es (JBR), for the consumables and SSR analyses, and internal University funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Blasco M, 2014, TREE GENET GENOMES, V10, P1387, DOI 10.1007/s11295-014-0768-3; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Clarke JB, 2009, ACTA HORTIC, V814, P615, DOI 10.17660/ActaHortic.2009.814.104; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Easteal S, 2003, HUM HERED, V55, P505; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans KM, 2009, ACTA HORTIC, V814, P103; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez-Fernandez F, 2006, MOL ECOL NOTES, V6, P1039, DOI 10.1111/j.1471-8286.2006.01422.x; dos Santos ARF, 2011, TREE GENET GENOMES, V7, P1041, DOI 10.1007/s11295-011-0393-3; Garkava-Gustavsson L, 2008, HEREDITAS, V145, P99, DOI 10.1111/j.0018-0661.2008.02042.x; Garkava-Gustavsson L, 2013, SCI HORTIC-AMSTERDAM, V162, P43, DOI 10.1016/j.scienta.2013.07.040; Gasi F, 2013, SCI HORTIC-AMSTERDAM, V157, P74, DOI 10.1016/j.scienta.2013.04.017; Gharghani A, 2010, ACTA HORTIC, V859, P229; GHARGHANI A, 2009, GENET RESOUR CROP EV, V56, P829, DOI [10.1007/s10722-008-9404-0, DOI 10.1007/S10722-008-9404-0]; Gianfranceschi L, 1998, THEOR APPL GENET, V96, P1069, DOI 10.1007/s001220050841; Guilford P, 1997, THEOR APPL GENET, V94, P249, DOI 10.1007/s001220050407; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hokanson SC, 1998, THEOR APPL GENET, V97, P671, DOI 10.1007/s001220050943; Iketani H, 2012, PLANT SYST EVOL, V298, P1689, DOI 10.1007/s00606-012-0670-0; Iketani H, 2010, CONSERV GENET, V11, P115, DOI 10.1007/s10592-009-0009-8; Jacobs MMJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-42; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kato S, 2013, CONSERV GENET, V14, P983, DOI 10.1007/s10592-013-0489-4; Latch EK, 2001, CONSERV GENET, V7, P295; Lateur M, 2013, WORK GROUP MAL PYR 4; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Li XW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-84; Liang W, 2015, PLANT MOL BIOL REP, V33, P458, DOI 10.1007/s11105-014-0754-9; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Mariette S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-77; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; MONTANARI S, 2013, PLOS ONE, V14, P8, DOI DOI 10.1371/J0URNAL.P0NE.0077022; Montilla-Bascon G, 2013, PLANT MOL BIOL REP, V31, P1305, DOI 10.1007/s11105-013-0598-8; Neophytou C, 2014, TREE GENET GENOMES, V10, P273, DOI 10.1007/s11295-013-0680-2; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Patzak J, 2012, GENOME, V55, P647, DOI [10.1139/g2012-054, 10.1139/G2012-054]; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pereira-Lorenzo S, 2008, SCI HORTIC-AMSTERDAM, V117, P160, DOI 10.1016/j.scienta.2008.03.033; Pierantoni L, 2004, THEOR APPL GENET, V109, P1519, DOI 10.1007/s00122-004-1775-9; Pikunova A, 2014, TREE GENET GENOMES, V10, P261, DOI 10.1007/s11295-013-0679-8; Pina A, 2014, SCI HORTIC-AMSTERDAM, V174, P1, DOI 10.1016/j.scienta.2014.04.037; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Potts SM, 2012, PLANT MOL BIOL REP, V30, P827, DOI 10.1007/s11105-011-0399-x; Pritchard JK, 2000, GENETICS, V155, P945; Reim S, 2013, GENET RESOUR CROP EV, V60, P879, DOI 10.1007/s10722-012-9885-8; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Stock M, 2010, EVOLUTION, V64, P944, DOI 10.1111/j.1558-5646.2009.00876.x; Tessier C, 1999, THEOR APPL GENET, V98, P171, DOI 10.1007/s001220051054; Urrestarazu J, 2015, SCI HORTIC-AMSTERDAM, V191, P65, DOI 10.1016/j.scienta.2015.04.029; Urrestarazu J, 2012, TREE GENET GENOMES, V8, P1163, DOI 10.1007/s11295-012-0502-y; van Hintum TLJ, 2010, GENET RESOUR CROP EV, V47, P507; van Treuren R, 2010, GENET RESOUR CROP EV, V57, P853, DOI 10.1007/s10722-009-9525-0; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vinatzer BA, 2004, PLANT BREEDING, V123, P321, DOI 10.1111/j.1439-0523.2004.00973.x; Volk GM, 2009, J AM SOC HORTIC SCI, V134, P453, DOI 10.21273/JASHS.134.4.453; Yamamoto T, 2013, ACTA HORTIC, V976, P477, DOI 10.17660/ActaHortic.2013.976.67; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; Zong Y, 2014, PLANT MOL BIOL REP, V32, P644, DOI 10.1007/s11105-013-0680-2	76	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138417	10.1371/journal.pone.0138417	http://dx.doi.org/10.1371/journal.pone.0138417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382618	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200100
J	Valdivia, N; Diaz, MJ; Garrido, I; Gomez, I				Valdivia, Nelson; Jose Diaz, Maria; Garrido, Ignacio; Gomez, Ivan			Consistent Richness-Biomass Relationship across Environmental Gradients in a Marine Macroalgal-Dominated Subtidal Community on the Western Antarctic Peninsula	PLOS ONE			English	Article							KING-GEORGE ISLAND; ECOSYSTEM PRODUCTIVITY; FUNCTIONAL DIVERSITY; BIODIVERSITY LOSS; CURRENT KNOWLEDGE; SPECIES RICHNESS; ICE SCOUR; PERFORMANCE; HYPOTHESIS; INSURANCE	Biodiversity loss has spurred the biodiversity-ecosystem functioning research over a range of ecosystems. In Antarctica, however, the relationship of taxonomic and functional diversity with ecosystem properties (e.g., community biomass) has received less attention, despite the presence of sharp and dynamic environmental stress gradients that might modulate these properties. Here, we investigated whether the richness-biomass relationship in macrobenthic subtidal communities is still apparent after accounting for environmental stress gradients in Fildes Bay, King George Island, Antarctica. Measurements of biomass of mobile and sessile macrobenthic taxa were conducted in the austral summer 2013/4 across two environmental stress gradients: distance from nearest glaciers and subtidal depth (from 5 to 30 m). In general, community biomass increased with distance from glaciers and water depth. However, generalised additive models showed that distance from glaciers and depth accounted for negligible proportions of variation in the number of functional groups (i.e., functional richness) and community biomass when compared to taxonomic richness. Functional richness and community biomass were positive and saturating functions of taxonomic richness. Large endemic, canopy-forming brown algae of the order Desmarestiales dominated the community biomass across both gradients. Accordingly, differences in the composition of taxa accounted for a significant and large proportion (51%) of variation in community biomass in comparison with functional richness (10%). Our results suggest that the environmental factors here analysed may be less important than biodiversity in shaping mesoscale (several km) biomass patterns in this Antarctic system. We suggest that further manipulative, hypothesis-driven research should address the role of biodiversity and species' functional traits in the responses of Antarctic subtidal communities to environmental variation.	[Valdivia, Nelson; Jose Diaz, Maria; Garrido, Ignacio; Gomez, Ivan] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson/C-3613-2009	Valdivia, Nelson/0000-0002-5394-2072; Gomez, Ivan/0000-0001-8381-3792	Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica [ART1101]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior [AUS0805]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1141037]	Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was financially supported by the Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica (www.conicyt.cl) grant # ART1101 to IG and NV. While writing, NV was supported by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (www.mecesup.cl), grant # AUS0805, and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.conicyt.cl/fondecyt), grant # 1141037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; Amsler CD, 2014, J PHYCOL, V50, P1, DOI 10.1111/jpy.12137; Amsler MO, 2015, POLAR BIOL, V38, P1171, DOI 10.1007/s00300-015-1681-4; [Anonymous], 2014, R LANG ENV STAT COMP; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Barnes DKA, 2007, RINGBINDUNG BRIT ANT; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bremner J, 2006, J MARINE SYST, V60, P302, DOI 10.1016/j.jmarsys.2006.02.004; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clarke Andrew, 1996, Antarctic Research Series, V70, P373; Deregibus D, 2015, PHOTOSYNTHETIC LIGHT; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Gomez I, 1997, MAR ECOL PROG SER, V148, P281, DOI 10.3354/meps148281; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Hastie T., 1986, STAT SCI, V1, P297; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kim D., 2001, SEASONALITY MARINE A; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Konar B, 2014, HYDROBIOLOGIA, V724, P91, DOI 10.1007/s10750-013-1727-y; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Molina-Montenegro MA, 2005, MAR ECOL PROG SER, V292, P173, DOI 10.3354/meps292173; Nonato EF, 2000, POLAR BIOL, V23, P580, DOI 10.1007/s003000000129; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Perez-Matus A, 2010, J EXP MAR BIOL ECOL, V388, P1, DOI 10.1016/j.jembe.2010.03.013; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Quartino ML, 2013, PLOS ONE, V8; Sakurai Hiroshi, 1996, Proceedings of the NIPR Symposium on Polar Biology, V9, P231; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smale DA, 2007, AUSTRAL ECOL, V32, P878, DOI 10.1111/j.1442-9993.2007.01776.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Tegner M.J., 1987, Advances in Ecological Research, V17, P243, DOI 10.1016/S0065-2504(08)60247-0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valdivia N, 2009, J SEA RES, V61, P216, DOI 10.1016/j.seares.2008.12.001; Wahl M, 2013, BIOGEOSCIENCES, V10, P5227, DOI 10.5194/bg-10-5227-2013; WIENCKE C, 2002, SYNOPSES ANTARCTIC B, P239; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Wu X, 2014, ECOGRAPHY, P602; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082	62	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138582	10.1371/journal.pone.0138582	http://dx.doi.org/10.1371/journal.pone.0138582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381149	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200131
J	He, XM; Lv, GH; Qin, L; Chang, SL; Yang, M; Yang, JJ; Yang, XD				He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun; Yang, Xiaodong			Effects of Simulated Nitrogen Deposition on Soil Respiration in a Populus euphratica Community in the Ebinur Lake Area, a Desert Ecosystem of Northwestern China	PLOS ONE			English	Article							RAINY AREA; MICROBIAL COMMUNITY; TROPICAL FOREST; CARBON STORAGE; N DEPOSITION; LIMITATION; RESPONSES; ADDITIONS; IMPACT; PRECIPITATION	One of the primary limiting factors for biological activities in desert ecosystems is nitrogen (N). This study therefore examined the effects of N and investigated the responses of an arid ecosystem to global change. We selected the typical desert plant Populus euphratica in a desert ecosystem in the Ebinur Lake area to evaluate the effects of N deposition on desert soil respiration. Three levels of N deposition (0, 37.5 and 112.5 kg-NI-ha-11(1) were randomly artificially provided to simulate natural N deposition. Changes in the soil respiration rates were measured from July to September in both 2010 and 2013, after N deposition in April 2010. The different levels of N deposition affected the total soil N, soil organic matter, soil C/N ratio, microorganism number, and microbial community structure and function. However, variable effects were observed over time in relation to changes in the magnitude of N deposition. Simulated high N deposition significantly reduced the soil respiration rate by approximately 23.6 2.5% (P<0.05), whereas low N deposition significantly increased the soil respiration rate by approximately 66.7 2.7% (P<0.05). These differences were clearer in the final growth stage (September). The different levels of N deposition had little effect on soil moisture, whereas N deposition significantly increased the soil temperature in the 0-5 cm layer (P<0.05). These results suggest that in the desert ecosystem of the Ebinur Lake area, N deposition indirectly changes the soil respiration rate by altering soil properties.	[He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun] Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun; Yang, Xiaodong] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Qin, Lu] Xinjiang Acad Environm Protect Sci, Xinjiang Dept Environm Protect, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Xinjiang University	Lv, GH (corresponding author), Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	ler@xju.edu.cn	yang, jian/HIK-0188-2022		International Science & Technology Cooperation Program of China [2010DFA92720]; Key Laboratory of the Xinjiang Uygur Autonomous Region [2015KL004]; National Natural Science Foundation of China [41571034]; State Key Program of National Natural Science of China [41130531]; Ministry of Education [IRT1180]	International Science & Technology Cooperation Program of China; Key Laboratory of the Xinjiang Uygur Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	This work was supported by grants from the International Science & Technology Cooperation Program of China (2010DFA92720), the Open Project from Key Laboratory of the Xinjiang Uygur Autonomous Region (2015KL004), the National Natural Science Foundation of China (41571034), the State Key Program of National Natural Science of China (41130531), and the Ministry of Education Innovation Team Project (IRT1180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2004, SOIL BIOL BIOCHEM, V36, P581, DOI 10.1016/j.soilbio.2003.12.002; Baez S, 2007, J ARID ENVIRON, V68, P640, DOI 10.1016/j.jaridenv.2006.06.011; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Cao YuSong, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P101; Chen WW, 2013, GEODERMA, V192, P335, DOI 10.1016/j.geoderma.2012.08.018; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Deng Qi, 2009, Chinese Journal of Plant Ecology, V33, P1023, DOI 10.3773/j.issn.1005-264x.2009.06.002; Deng Xiao-wen, 2007, Shengtaixue Zazhi, V26, P1622; Di CH, 2010, J AGROENVIRONMENT SC, V29, P1601; Du ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087975; Fan HB, 2014, PLANT SOIL, V379, P361, DOI 10.1007/s11104-014-2076-y; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Giasson MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13.00183.1; Gundale MJ, 2014, GLOBAL CHANGE BIOL, V20, P276, DOI 10.1111/gcb.12422; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Huang YZ, 2009, IMPACTS SIMULATED NI; Institute of Soil Science in Chinese Academy of Sciences, 1978, AN SOIL PHYS CHEM; Kamble PN, 2014, SOIL BIOL BIOCHEM, V74, P11, DOI 10.1016/j.soilbio.2014.02.015; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Lemanski K, 2014, SOIL BIOL BIOCHEM, V69, P38, DOI 10.1016/j.soilbio.2013.10.034; Li HM, 2010, IMPACTS SIMULATED NI; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Li Ren-hong, 2010, Yingyong Shengtai Xuebao, V21, P1649; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Liu XJ, 2010, J ARID LAND, V2, P137, DOI 10.3724/SP.J.1227.2010.00137; Lu Chao-Qun, 2007, Zhiwu Shengtai Xuebao, V31, P205; [雒守华 Luo Shouhua], 2010, [农业环境科学学报, Journal of Agro-Environment Science], V29, P1834; Luo Yand, 2006, SOIL RESP ENV; Ma Xu, 2006, Arid Land Geography, V29, P439; Maestrini B, 2014, BIOGEOSCIENCES DISCU, V11, P1, DOI DOI 10.5194/BGD-11-1-2014; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Midgley MG, 2014, BIOGEOCHEMISTRY, V117, P241, DOI 10.1007/s10533-013-9931-4; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2007, PLANT SOIL, V296, P125, DOI 10.1007/s11104-007-9303-8; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Pinder RW, 2013, BIOGEOCHEMISTRY, V114, P25, DOI 10.1007/s10533-012-9787-z; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Schaeffer SM, 2005, OECOLOGIA, V145, P425, DOI 10.1007/s00442-005-0140-2; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Schrumpf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089364; Shen Ping, 1978, MICROBIOLOGY EXPT; Tietema A, 1998, FOREST ECOL MANAG, V101, P29, DOI 10.1016/S0378-1127(97)00122-9; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Tu Li-hua, 2011, Yingyong Shengtai Xuebao, V22, P829; Tu Li-Hua, 2009, Chinese Journal of Plant Ecology, V33, P728, DOI 10.3773/j.issn.1005-264x.2009.04.011; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; [魏书精 Wei Shujing], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P689; Wright RF, 1998, FOREST ECOL MANAG, V101, P1, DOI 10.1016/S0378-1127(97)00120-5; Xu Guoliang, 2005, Yingyong Shengtai Xuebao, V16, P1235; Yan CongWei, 2012, Research of Environmental Sciences, V25, P678; Yan LM, 2011, PLANT SOIL, V349, P227, DOI 10.1007/s11104-011-0864-1; Yu E. T., 2008, STUDY VAPOR TRANSFER; Zhang NY, 2013, SOIL BIOL BIOCHEM, V65, P96, DOI 10.1016/j.soilbio.2013.05.015; Zhang QM, 2012, J INEQUAL APPL, DOI 10.1186/1029-242X-2012-5; Zhou Xiao-Bing, 2010, Chinese Journal of Plant Ecology, V34, P1394, DOI 10.3773/j.issn.1005-264x.2010.12.005; [周晓兵 ZHOU Xiao-Bing], 2009, [生态学报, Acta Ecologica Sinica], V29, P3835	60	16	16	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137827	10.1371/journal.pone.0137827	http://dx.doi.org/10.1371/journal.pone.0137827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379186	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400031
J	Maggio, S; Takeda, K; Stark, F; Meierovics, AI; Yabe, I; Cowley, SC				Maggio, Savannah; Takeda, Kazuyo; Stark, Felicity; Meierovics, Anda I.; Yabe, Idalia; Cowley, Siobhan C.			Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells	PLOS ONE			English	Article							SYNTHASE GENE-EXPRESSION; NITRIC-OXIDE; REACTIVE NITROGEN; IFN-GAMMA; II CELLS; MURINE MACROPHAGES; IN-VITRO; SCHU S4; LUNG; ACTIVATION	The virulence of F. tularensis is often associated with its ability to grow in macrophages, although recent studies show that Francisella proliferates in multiple host cell types, including pulmonary epithelial cells. Thus far little is known about the requirements for killing of F. tularensis in the non-macrophage host cell types that support replication of this organism. Here we sought to address this question through the use of a murine lung epithelial cell line (TC-1 cells). Our data show that combinations of the cytokines IFN-gamma, TNF, and IL-17A activated murine pulmonary epithelial cells to inhibit the intracellular growth of the F. tularensis Live Vaccine Strain (LVS) and the highly virulent F. tularensis Schu S4 strain. Although paired combinations of IFN-gamma, TNF, and IL-17A all significantly controlled LVS growth, simultaneous treatment with all three cytokines had the greatest effect on LVS growth inhibition. In contrast, Schu S4 was more resistant to cytokine-induced growth effects, exhibiting significant growth inhibition only in response to all three cytokines. Since one of the main antimicrobial mechanisms of activated macrophages is the release of reactive nitrogen intermediates (RNI) via the activity of iNOS, we investigated the role of RNI and iNOS in Francisella growth control by pulmonary epithelial cells. NOS2 gene expression was significantly up-regulated in infected, cytokine-treated pulmonary epithelial cells in a manner that correlated with LVS and Schu S4 growth control. Treatment of LVS-infected cells with an iNOS inhibitor significantly reversed LVS killing in cytokine-treated cultures. Further, we found that mouse pulmonary epithelial cells produced iNOS during in vivo respiratory LVS infection. Overall, these data demonstrate that lung epithelial cells produce iNOS both in vitro and in vivo, and can inhibit Francisella intracellular growth via reactive nitrogen intermediates.	[Maggio, Savannah; Meierovics, Anda I.; Cowley, Siobhan C.] US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Stark, Felicity] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Yabe, Idalia] NHLBI, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Research Council Canada; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cowley, SC (corresponding author), US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	siobhan.cowley@fda.hhs.gov	Stark, Felicity/AAT-2342-2021	Stark, Felicity/0000-0002-7547-8493; Cowley, Siobhan/0000-0003-3073-0269	FDA Medical Countermeasures Initiative	FDA Medical Countermeasures Initiative	This work was supported by the FDA Medical Countermeasures Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer LS, 2010, BIOCHEM BIOPH RES CO, V396, P246, DOI 10.1016/j.bbrc.2010.04.073; ANTHONY LSD, 1992, J IMMUNOL, V148, P1829; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Binesse J, 2015, INFECT IMMUN, V83, P2255, DOI 10.1128/IAI.02488-14; Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; LIEW FY, 1990, J IMMUNOL, V145, P4306; Lin KY, 1996, CANCER RES, V56, P21; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; POLSINELLI T, 1994, J IMMUNOL, V153, P1238; Prolo C, 2014, BIOFACTORS, V40, P215, DOI 10.1002/biof.1150; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Toga H, 2001, EXP LUNG RES, V27, P485, DOI 10.1080/019021401750414029; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138565	10.1371/journal.pone.0138565	http://dx.doi.org/10.1371/journal.pone.0138565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379269	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400110
J	Saigusa, T; Dang, YJ; Mullick, AE; Yeh, ST; Zile, MR; Baicu, CF; Bell, PD				Saigusa, Takamitsu; Dang, Yujing; Mullick, Adam E.; Yeh, Steve T.; Zile, Michael R.; Baicu, Catalin F.; Bell, P. Darwin			Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model	FASEB JOURNAL			English	Article						renin angiotensin system; antisense oligonucleotide; polycystic kidney disease; hypertension	BLOOD-PRESSURE; ANTISENSE OLIGODEOXYNUCLEOTIDES; IN-VIVO; DISEASE; RENIN; SYSTEM; INHIBITOR; CELL; HYPERTENSION; RATS	Activation of the intrarenal renin angiotensin system(RAS) is believed to play an important role in the development of hypertension and cystogenesis in autosomal dominant polycystic kidney disease (ADPKD). Results of clinical studies testing RAS inhibitors in slowing the progression of cystic disease in ADPKD are inconclusive, and we hypothesized that current RAS inhibitors do not adequately suppress intrarenal RAS. For this study, we compared a novel Gen 2 antisense oligonucleotide (ASO) that inhibits angiotensinogen (Agt) synthesis to lisinopril in adult conditional Pkd1 systemic-knockout mice, a model of ADPKD. Six weeks after Pkd1 global gene knockout, the mice were treated with Agt-ASO (66 mg/kg/wk), lisinopril (100 mg/kg/d), PBS (control), or scrambled ASO (66 mg/kg/wk) for 10 wk, followed by tissue collection. Agt ASO resulted in significant reduction in plasma, liver, and kidney Agt, and increased kidney renin compared with control treatments. Kidneys from Agt-ASO-treated mice were not as enlarged and showed reduced cystic volume compared with lisinopril or control treatments. Blood pressure was better controlled with lisinopril than with Agt-ASO. Agt-ASO suppressed cell proliferation in both cystic and noncystic cells compared with lisinopril and control treatments. However, Agt-ASO did not reduce cell proliferation in liver, which indicates that Agt-ASO targets cell signaling pathways that specifically suppresses cystogenesis in the kidney. These data suggest that Agt-ASO effectively attenuates intrarenal RAS and therefore can be a novel and effective agent for treating ADPKD.	[Saigusa, Takamitsu; Dang, Yujing; Bell, P. Darwin] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA; [Zile, Michael R.; Baicu, Catalin F.] Med Univ S Carolina, Div Cardiol, Charleston, SC 29425 USA; [Saigusa, Takamitsu; Dang, Yujing; Zile, Michael R.; Baicu, Catalin F.; Bell, P. Darwin] Ralph Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Mullick, Adam E.; Yeh, Steve T.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Isis Pharmaceuticals Inc	Saigusa, T (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	saigusa@musc.edu; bellpd@musc.edu		Mullick, Adam/0000-0003-4600-961X; Zile, Michael/0000-0001-7076-221X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K08DK106465, P30 DK074038]; U.S. Department of Veterans Affairs Merit Award; Dialysis Clinic, Inc. (Nashville, TN, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, K08DK106465] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Dialysis Clinic, Inc. (Nashville, TN, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants K08DK106465 (to T.S.) and P30 DK074038 (to P.D.B.); U.S. Department of Veterans Affairs Merit Award (to P.D.B.); and a Dialysis Clinic, Inc. (Nashville, TN, USA) grant (to T.S. and P.D.B.). The authors declare no conflicts of interest.	Ahmad S, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0429-9; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Cao ZM, 2001, SEMIN NEPHROL, V21, P554, DOI 10.1053/snep.2001.26794; Celerier J, 2002, HYPERTENSION, V39, P224, DOI 10.1161/hy0202.103441; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; Chapman AB, 2010, ADV CHRONIC KIDNEY D, V17, P153, DOI 10.1053/j.ackd.2010.01.001; GRAHAM PC, 1988, KIDNEY INT, V33, P1084, DOI 10.1038/ki.1988.115; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jafar TH, 2005, KIDNEY INT, V67, P265, DOI 10.1111/j.1523-1755.2005.00077.x; Kamiyama M, 2012, J HYPERTENS, V30, P2365, DOI 10.1097/HJH.0b013e3283598eed; KEITH DS, 1994, AM J KIDNEY DIS, V24, P491, DOI 10.1016/S0272-6386(12)80907-3; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Loghman-Adham M, 2004, AM J PHYSIOL-RENAL, V287, pF775, DOI 10.1152/ajprenal.00370.2003; Makino N, 1998, HYPERTENSION, V31, P1166, DOI 10.1161/01.HYP.31.5.1166; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; McPherson EA, 2004, J AM SOC NEPHROL, V15, P493, DOI 10.1097/01.ASN.0000109782.28991.26; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Pohl M, 2010, J BIOL CHEM, V285, P41935, DOI 10.1074/jbc.M110.150284; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Ravichandran K, 2015, AM J PHYSIOL-RENAL, V308, pF349, DOI 10.1152/ajprenal.00478.2014; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Saigusa T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12405; Saigusa T, 2015, PHYSIOLOGY, V30, P195, DOI 10.1152/physiol.00032.2014; Sas KM, 2015, AM J PHYSIOL-RENAL, V309, pF79, DOI 10.1152/ajprenal.00652.2014; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; TOMITA N, 1995, HYPERTENSION, V26, P131, DOI 10.1161/01.HYP.26.1.131; TORRES VE, 1992, KIDNEY INT, V42, P364, DOI 10.1038/ki.1992.297; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Torres VE, 2010, CLIN J AM SOC NEPHRO, V5, P1312, DOI 10.2215/CJN.01360210; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Wu Congqing, 2011, N Am J Med Sci (Boston), V4, P183; Zafar I, 2007, AM J PHYSIOL-RENAL, V293, pF854, DOI 10.1152/ajprenal.00059.2007	42	23	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					370	379		10.1096/fj.15-279299	http://dx.doi.org/10.1096/fj.15-279299			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26391272	Green Published			2022-12-26	WOS:000367621000035
J	Polettini, J; Behnia, F; Taylor, BD; Saade, GR; Taylor, RN; Menon, R				Polettini, Jossimara; Behnia, Faranak; Taylor, Brandie D.; Saade, George R.; Taylor, Robert N.; Menon, Ramkumar			Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DNA-DAMAGE RESPONSES; OXIDATIVE STRESS; PRETERM BIRTH; T-OLIGO; PREMATURE RUPTURE; FETAL MEMBRANES; GENE-EXPRESSION; PREGNANCY; OVERHANG	Oxidative stress (OS)-induced senescence of the amniochorion has been associated with parturition at term. We investigated whether telomere fragments shed into the amniotic fluid (AF) correlated with labor status and tested if exogenous telomere fragments (T-oligos) could induce human and murine amnion cell senescence. In a cross-sectional clinical study, AF telomere fragment concentrations quantitated by a validated real-time PCR assay were higher in women in labor at term compared to those not in labor. In vitro treatment of primary human amnion epithelial cells with 40 mu MT-oligos ([TTAGGG](2)) that mimic telomere fragments, activated p38MAPK, produced senescence-associated (SA) beta-gal staining and increased interleukin (IL)-6 and IL-8 production compared to cells treated with complementary DNA sequences (Cont-oligos, [AATCCC](2)). T-oligos injected into the uteri of pregnant CD1 mice on day 14 of gestation, led to increased p38MAPK, SA-beta-gal (SA beta-gal) staining in murine amniotic sacs and higher AF IL-8 levels on day 18, compared to saline treated controls. In summary, term labor AF samples had higher telomere fragments than term not in labor AF. In vitro and in situ telomere fragments increased human and murine amnion p38MAPK, senescence and inflammatory cytokines. We propose that telomere fragments released from senescent fetal cells are indicative of fetal cell aging. Based on our data, these telomere fragments cause oxidative stress associated damages to the term amniotic sac and force them to release other DAMPS, which, in turn, provide a sterile immune response that may be one of the many inflammatory signals required to initiate parturition at term.	[Polettini, Jossimara; Behnia, Faranak; Saade, George R.; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Polettini, Jossimara] Univ Estadual Paulista, Dept Pathol, Botucatu Med Sch, UNESP, Botucatu, SP, Brazil; [Taylor, Brandie D.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Epidemiol & Biostat, College Stn, TX USA; [Taylor, Robert N.] Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA	University of Texas System; University of Texas Medical Branch Galveston; Universidade Estadual Paulista; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wake Forest University	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.	ram.menon@utmb.edu	Taylor, Brandie/GRR-3837-2022; Polettini, Jossimara/C-5814-2012; Taylor, Brandie DePaoli/Q-4949-2019; Polettini, Jossimara/M-8562-2019; Polettini, Jossimara/K-9437-2014	Polettini, Jossimara/0000-0002-6719-8715; Taylor, Brandie DePaoli/0000-0002-8234-1815; Polettini, Jossimara/0000-0002-6719-8715; Polettini, Jossimara/0000-0002-6719-8715	Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, TX, USA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES, Brazil [CAPES/PGCI 12415-12-0]	Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, TX, USA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study is supported by development funds to Dr. R Menon by the Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, TX, USA. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES, Brazil supported the primary author JP, CAPES/PGCI 12415-12-0.	Aoshiba K, 2013, EXP TOXICOL PATHOL, V65, P1053, DOI 10.1016/j.etp.2013.04.001; Behnia F, 2015, AJOG IN PRESSS, DOI [10.1016/j.ajog.2015.05.041, DOI 10.1016/J.AJOG.2015.05.041.[]; Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brandl A, 2011, EXP CELL RES, V317, P1541, DOI 10.1016/j.yexcr.2011.02.015; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2009, J GERONTOL A-BIOL, V64, P175, DOI 10.1093/gerona/gln065; Cao ZH, 2006, ANAL CHEM, V78, P1478, DOI 10.1021/ac0517601; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cha J, 2012, CELL CYCLE, V11, P205, DOI 10.4161/cc.11.2.18781; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Erkhembaatar LO, 2013, PLACENTA, V34, P353, DOI 10.1016/j.placenta.2013.01.014; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Fortunato SJ, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.02.003; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Ganu RS, 2013, AM J PERINAT, V30, P613, DOI 10.1055/s-0032-1329693; Gnanasekar M, 2009, OLIGONUCLEOTIDES, V19, P287, DOI 10.1089/oli.2009.0179; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hahn S, 2014, J REPROD IMMUNOL, V104, P26, DOI 10.1016/j.jri.2014.03.007; Hallows SE, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/638476; Harbo M, 2012, DNA REPAIR, V11, P774, DOI 10.1016/j.dnarep.2012.06.003; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Kagan VE, 2001, CANCER RES, V61, P7777; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Kostjuk S, 2012, EXPERT OPIN BIOL TH, V12, pS99, DOI 10.1517/14712598.2012.690028; Kusanovic JP, 2007, ULTRASOUND OBST GYN, V30, P706, DOI 10.1002/uog.4081; Lamy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053240; Lappas M, 2011, PLACENTA, V32, P1016, DOI 10.1016/j.placenta.2011.09.011; Lee MS, 2009, J DERMATOL SCI, V56, P154, DOI 10.1016/j.jdermsci.2009.08.008; Li GZ, 2004, EXP CELL RES, V301, P189, DOI 10.1016/j.yexcr.2004.08.019; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Longe HO, 2009, INT J CANCER, V124, P473, DOI 10.1002/ijc.23946; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marwaha V, 2005, J BIOL CHEM, V280, P32379, DOI 10.1074/jbc.M503245200; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Menon R, 2008, HUM GENET, V124, P243, DOI 10.1007/s00439-008-0547-z; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2006, AM J OBSTET GYNECOL, V194, P1616, DOI 10.1016/j.ajog.2006.03.059; Menon R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00567; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Menon R, 2010, ANN HUM GENET, V74, P165, DOI 10.1111/j.1469-1809.2010.00562.x; Moore RM, 2003, PLACENTA, V24, P173, DOI 10.1053/plac.2002.0886; Morgan CC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-251; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; Ohtani N, 2013, CANCER SCI, V104, P525, DOI 10.1111/cas.12118; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054006; Pawelec M, 2013, ADV CLIN EXP MED, V22, P283; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Pereira AC, 2014, CELL BIOL TOXICOL, V30, P301, DOI 10.1007/s10565-014-9285-2; Phillippe M, 2014, NEW ENGL J MED, V370, P2534, DOI 10.1056/NEJMcibr1404324; Pitman RT, 2013, ONCOTARGET, V4, P761, DOI 10.18632/oncotarget.1047; Puri N, 2014, CANCER LETT, V343, P14, DOI 10.1016/j.canlet.2013.09.010; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Rankin AM, 2008, ANTI-CANCER DRUG, V19, P329, DOI 10.1097/CAD.0b013e3282f5d4c2; Rankin AM, 2012, J CELL PHYSIOL, V227, P2586, DOI 10.1002/jcp.22997; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sarkar S, 2013, NUCLEIC ACID THER, V23, P167, DOI 10.1089/nat.2012.0401; Seol HJ, 2008, YONSEI MED J, V49, P366, DOI 10.3349/ymj.2008.49.3.366; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Tyurina YY, 2004, J BIOL CHEM, V279, P6056, DOI 10.1074/jbc.M309929200; Uchida K, 2013, J REPROD IMMUNOL, V100, P118, DOI 10.1016/j.jri.2013.10.001; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Watanabe K, 2013, HYPERTENS RES, V36, P356, DOI 10.1038/hr.2012.208; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yaar M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1646; Yu AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048501	86	70	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137188	10.1371/journal.pone.0137188	http://dx.doi.org/10.1371/journal.pone.0137188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397719	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500022
J	Amosova, AV; Bolsheva, NL; Samatadze, TE; Twardovska, MO; Zoshchuk, SA; Andreev, IO; Badaeva, ED; Kunakh, VA; Muravenko, OV				Amosova, Alexandra V.; Bolsheva, Nadezhda L.; Samatadze, Tatiana E.; Twardovska, Maryana O.; Zoshchuk, Svyatoslav A.; Andreev, Igor O.; Badaeva, Ekaterina D.; Kunakh, Viktor A.; Muravenko, Olga V.			Molecular Cytogenetic Analysis of Deschampsia antarctica Desv. (Poaceae), Maritime Antarctic	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FREEZE TOLERANCE; REPEATED DNA; DAPI BANDS; GENOME; CHROMOSOMES; WHEAT; POPULATIONS; EVOLUTION; SEQUENCE	Deschampsia antarctica Desv. (Poaceae) (2n = 26) is one of the two vascular plants adapted to the harshest environment of the Antarctic. Although the species is a valuable model for study of environmental stress tolerance in plants, its karyotype is still poorly investigated. We firstly conducted a comprehensive molecular cytogenetic analysis of D. antarctica collected on four islands of the Maritime Antarctic. D. antarctica karyotypes were studied by Giemsa C-and DAPI/C-banding, Ag-NOR staining, multicolour fluorescence in situ hybridization with repeated DNA probes (pTa71, pTa794, telomere repeats, pSc119.2, pAs1) and the GAA simple sequence repeat probe. We also performed sequential rapid in situ hybridization with genomic DNA of D. caespitosa. Two chromosome pairs bearing transcriptionally active 45S rDNA loci and five pairs with 5S rDNA sites were detected. A weak intercalary site of telomere repeats was revealed on the largest chromosome in addition to telomere hybridization signals at terminal positions. This fact confirms indirectly the hypothesis that chromosome fusion might have been the cause of the unusual for cereals chromosome number in this species. Based on patterns of distribution of the examined molecular cytogenetic markers, all chromosomes in karyotypes were identified, and chromosome idiograms of D. antarctica were constructed. B chromosomes were found in most karyotypes of plants from Darboux Island. A mixoploid plant with mainly triploid cells bearing a Robertsonian rearrangement was detected among typical diploid specimens from Great Jalour Island. The karyotype variability found in D. antarctica is probably an expression of genome instability induced by environmental stress factors. The differences in C-banding patterns and in chromosome distribution of rDNA loci as well as homologous highly repeated DNA sequences detected between genomes of D. antarctica and its related species D. caespitosa indicate that genome reorganization involving coding and noncoding repeated DNA sequences had occurred during the divergence of these species.	[Amosova, Alexandra V.; Bolsheva, Nadezhda L.; Samatadze, Tatiana E.; Zoshchuk, Svyatoslav A.; Badaeva, Ekaterina D.; Muravenko, Olga V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Twardovska, Maryana O.; Andreev, Igor O.; Kunakh, Viktor A.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Amosova, AV (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia.	amomar@mail.ru	Tatiana, Samatadze/AAD-4816-2019; Andreev, Igor/G-6194-2016; Badaeva, Ekaterina D./N-4368-2017; Muravenko, Olga/A-3889-2017	Tatiana, Samatadze/0000-0002-1012-3560; Andreev, Igor/0000-0002-3706-8514; Badaeva, Ekaterina D./0000-0001-7101-9639; Twardovska, Maryana/0000-0002-9132-1330; Kunakh, Viktor/0000-0002-9418-3172; Muravenko, Olga/0000-0003-3150-8598	Russian Foundation of Basic Research [15-04-05574, 14-08-01167]; Russian Academy of Sciences [0103-2015-0117]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Foundation of Basic Research [grants no. 15-04-05574; 14-08-01167] and Fundamental Research Program of the Russian Academy of Sciences "Dynamics of Plant, Animal and Human Genofonds" [grant no. 0103-2015-0117]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M, 2002, PHYSIOL PLANTARUM, V115, P479, DOI 10.1034/j.1399-3054.2002.1150401.x; Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Badaeva ED, 2010, GENOME, V53, P125, DOI [10.1139/G09-089, 10.1139/g09-089]; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Belyayev A, 2013, ANN BOT-LONDON, V111, P531, DOI 10.1093/aob/mct023; Bennett MD, 1998, P NATL ACAD SCI USA, V95, P2011, DOI 10.1073/pnas.95.5.2011; Bolsheva NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122015; Bravo LA, 2005, J EXP BOT, V56, P1189, DOI 10.1093/jxb/eri112; Bravo LA, 2001, PHYSIOL PLANTARUM, V111, P55, DOI 10.1034/j.1399-3054.2001.1110108.x; Butorina A K, 2001, Tsitologiia, V43, P809; Cabral AL, 2013, GENET RESOUR CROP EV, V60, P1153, DOI 10.1007/s10722-012-9911-x; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Cardone S, 2009, POLAR BIOL, V32, P427, DOI 10.1007/s00300-008-0535-8; Chew O, 2012, PLANT CELL ENVIRON, V35, P829, DOI 10.1111/j.1365-3040.2011.02456.x; Chiapella J, 2007, TAXON, V56, P55, DOI 10.2307/25065735; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chwedorzewska KJ, 2008, POL J ECOL, V56, P209; Chwedorzewska KJ, 2004, ACTA SOC BOT POL, V73, P23, DOI 10.5586/asbp.2004.004; Contento A, 2005, CYTOGENET GENOME RES, V109, P34, DOI 10.1159/000082379; COX AV, 1993, ANN BOT-LONDON, V72, P239, DOI 10.1006/anbo.1993.1104; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Dobrochaeva DN, 1999, MANUAL VASCULAR PLAN; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Souto DPF, 2006, PLANT SYST EVOL, V261, P1, DOI 10.1007/s00606-006-0425-x; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; FLAVELL RB, 1980, COLD SPRING HARB SYM, V45, P501, DOI 10.1101/SQB.1981.045.01.066; FRIEBE B, 1995, PLANT SYST EVOL, V196, P131, DOI 10.1007/BF00982954; Gaiero P, 2012, AUST J BOT, V60, P378, DOI 10.1071/BT12029; GAMBORG OL, 1968, CAN J BIOCHEM CELL B, V46, P417, DOI 10.1139/o68-063; GarciaSuarez R, 1997, PLANT SYST EVOL, V205, P99, DOI 10.1007/BF00982800; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Greene DM., 1971, BRIT ANTARCT SURV B, V26, P1; Henry RJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00068; Holderegger R, 2003, ARCT ANTARCT ALP RES, V35, P214, DOI 10.1657/1523-0430(2003)035[0214:POAHDA]2.0.CO;2; Houben A, 2013, PLANT GENOME DIVERSI, V2, P149, DOI DOI 10.1007/978-3-7091-1160-4_10; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; John UP, 2009, PLANT CELL ENVIRON, V32, P336, DOI [10.1111/j.1365-3040.2009.01925.x, 10.1111/j.1365-3040.2008.01925.x]; John UP, 2005, COMP FUNCT GENOM, V6, P230, DOI 10.1002/cfg.475; Kashin A S, 2012, Ontogenez, V43, P121; Katsiotis A, 1997, ANN BOT-LONDON, V79, P103, DOI 10.1006/anbo.1996.0312; KAWANO SHOICHI, 1963, CANADIAN JOUR BOT, V41, P719, DOI 10.1139/b63-059; Kozyrenko MM, 2002, BIOTEKHNOLOGIYA, V4, P38; Kravets AA, 2011, UAJ, V10-11, P302; Lavania UC, 2010, J GENET, V89, P493, DOI 10.1007/s12041-010-0071-5; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; MILLER DA, 1977, AM J HUM GENET, V29, P490; MILLER DA, 1976, EXP CELL RES, V101, P235, DOI 10.1016/0014-4827(76)90373-6; Moore DM, 1970, BRIT ANTARCTIC SURVE, V23, P633; Moore DM, 1967, BRIT ANTARCTIC SURVE, V14, P69; Muravenko O. V., 2001, Genetika, V37, P332; Muravenko O V, 2010, Genetika, V46, P1339; Muravenko OV, 2009, GENETICA, V135, P245, DOI 10.1007/s10709-008-9273-7; Nagaki K, 1998, J MOL EVOL, V47, P183, DOI 10.1007/PL00006375; Nkongolo KK, 2001, GENOME, V44, P818, DOI 10.1139/gen-44-5-818; Parnikoza I., 2011, American Journal of Plant Sciences, V2, P381, DOI 10.4236/ajps.2011.23044; Pedersen C, 1996, GENOME, V39, P93, DOI 10.1139/g96-013; Pereira BK, 2009, J PHOTOCH PHOTOBIO B, V96, P117, DOI 10.1016/j.jphotobiol.2009.04.011; Rabert C, 2014, INT J MOL SCI, V15, P2359, DOI 10.3390/ijms15022359; RAYBURN AL, 1986, J HERED, V77, P253, DOI 10.1093/oxfordjournals.jhered.a110231; Rodionov A V, 2013, Tsitologiia, V55, P225; Ruban A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090214; Ruhland CT, 2005, PHOTOCHEM PHOTOBIOL, V81, P1086, DOI 10.1562/2004-09-18-RA-321; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Saarela Jeffeg M., 2010, P557; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; van De Wouw M, 2008, J BIOGEOGR, V35, P365, DOI 10.1111/j.1365-2699.2007.01784.x; Volkov RA, 2010, POLAR SCI, V4, P469, DOI 10.1016/j.polar.2010.04.011; White MJD, 1973, THE CHROMOSOMES; Winterfeld G, 2007, BOT J LINN SOC, V155, P193, DOI 10.1111/j.1095-8339.2007.00690.x; Xiong FS, 1999, PHYSIOL PLANTARUM, V106, P276, DOI 10.1034/j.1399-3054.1999.106304.x; Yudanova S. S., 2003, Sugar Tech, V5, P173, DOI 10.1007/BF02943630; Yurkevich OY, 2013, GENET RESOUR CROP EV, V60, P661, DOI 10.1007/s10722-012-9865-z; Zagrichuk OM, 2011, UKR ANTARKT ZH, V10-11, P289	80	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138878	10.1371/journal.pone.0138878	http://dx.doi.org/10.1371/journal.pone.0138878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394331	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100112
J	Shao, J; Yang, LN; Peng, L; Chi, TH; Wang, XM				Shao, Jing; Yang, Lina; Peng, Ling; Chi, Tianhe; Wang, Xiaomeng			An Improved Artificial Bee Colony-Based Approach for Zoning Protected Ecological Areas	PLOS ONE			English	Article							LAND-USE ALLOCATION; CELLULAR-AUTOMATA; SUSTAINABLE DEVELOPMENT; GENETIC ALGORITHM; SUPPORT-SYSTEM; ABC ALGORITHM; OPTIMIZATION; CHINA; GIS; CONSERVATION	China is facing ecological and environmental challenges as its urban growth rate continues to rise, and zoning protected ecological areas is recognized as an effective response measure. Zoning inherently involves both site attributes and aggregation attributes, and the combination of mathematical models and heuristic algorithms have proven advantageous. In this article, an improved artificial bee colony (IABC)-based approach is proposed for zoning protected ecological areas at a regional scale. Three main improvements were made: the first is the use of multiple strategies to generate the initial bee population of a specific quality and diversity, the second is an exploitation search procedure to generate neighbor solutions combining "replace" and "alter" operations, and the third is a "swap" strategy to enable a local search for the iterative optimal solution. The IABC algorithm was verified using simulated data. Then it was applied to define an optimum scheme of protected ecological areas of Sanya (in the Hainan province of China), and a reasonable solution was obtained. Finally, a comparison experiment with other methods (agent-based land allocation model, ant colony optimization, and density slicing) was conducted and demonstrated that the IABC algorithm was more effective and efficient than the other methods. Through this study, we aimed to provide a scientifically sound, practical approach for zoning procedures.	[Shao, Jing; Yang, Lina; Peng, Ling; Chi, Tianhe; Wang, Xiaomeng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Shao, Jing; Wang, Xiaomeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, LN (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	yangln@radi.ac.cn			National Natural Science Youth Foundation of China [41201397]	National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by the National Natural Science Youth Foundation of China (Grant No. 41201397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 2003, GEOGR ANAL, V35, P148, DOI 10.1353/geo.2003.0001; Aerts JCJH, 2002, INT J GEOGR INF SCI, V16, P571, DOI 10.1080/13658810210138751; Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Brabec E, 2002, LANDSCAPE URBAN PLAN, V58, P255, DOI 10.1016/S0169-2046(01)00225-0; Brookes CJ, 2001, INT J GEOGR INF SCI, V15, P539, DOI 10.1080/136588101316907227; Cao K, 2012, COMPUT ENVIRON URBAN, V36, P257, DOI 10.1016/j.compenvurbsys.2011.08.001; CARVER SJ, 1991, INT J GEOGR INF SYST, V5, P321, DOI 10.1080/02693799108927858; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Chen YM, 2010, INT J GEOGR INF SCI, V24, P1269, DOI 10.1080/13658810903401024; China NBoSo, POP DAT ANN DAT NAT; COCKS KD, 1989, BIOL CONSERV, V49, P113, DOI 10.1016/0006-3207(89)90083-9; Cova T. J., 2000, Computers, Environment and Urban Systems, V24, P401, DOI 10.1016/S0198-9715(00)00015-6; Eastman WJl, 1995, PHOTOGRAMMETRIC ENG, V61, P539; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; FAQ, 1976, FRAM LAND EV; Geneletti D, 2004, LAND USE POLICY, V21, P149, DOI 10.1016/j.landusepol.2003.09.005; Geneletti D, 2008, LANDSCAPE URBAN PLAN, V85, P97, DOI 10.1016/j.landurbplan.2007.10.004; HOF JG, 1993, FOREST SCI, V39, P816; Huang KN, 2013, INT J GEOGR INF SCI, V27, P922, DOI 10.1080/13658816.2012.730147; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Karaboga D., 2005, TR06 ERC U, V10; Karaboga D, LECT NOTES ARTIFICIA, P318; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga D, 2009, APPL MATH COMPUT, V214, P108, DOI 10.1016/j.amc.2009.03.090; Li X, 2005, INT J GEOGR INF SCI, V19, P581, DOI 10.1080/13658810500032388; Li X, 2001, PHOTOGRAMM ENG REM S, V67, P471; Li X, 2008, INT J GEOGR INF SCI, V22, P21, DOI 10.1080/13658810701228686; Li X, 2011, INT J GEOGR INF SCI, V25, P575, DOI 10.1080/13658816.2010.481262; Liu XP, 2013, ECOL MODEL, V257, P11, DOI 10.1016/j.ecolmodel.2013.02.027; Liu XP, 2012, LANDSCAPE ECOL, V27, P447, DOI 10.1007/s10980-011-9684-1; Liu XP, 2011, INT J GEOGR INF SCI, V25, P1829, DOI 10.1080/13658816.2011.557380; Liu XH, 2008, ECOL MODEL, V215, P237, DOI 10.1016/j.ecolmodel.2008.02.015; Matisziw TC, 2006, J GEOGR SYST, V8, P289, DOI 10.1007/s10109-006-0020-2; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sante-Riveira I, 2008, COMPUT ELECTRON AGR, V63, P257, DOI 10.1016/j.compag.2008.03.007; Sante-Riveira I, 2008, COMPUT GEOSCI-UK, V34, P259, DOI 10.1016/j.cageo.2007.03.014; Seto KC, 2002, INT J REMOTE SENS, V23, P1985, DOI 10.1080/01431160110075532; Steiner F, 2000, LANDSCAPE URBAN PLAN, V50, P199, DOI 10.1016/S0169-2046(00)00093-1; Stewart TJ, 2004, COMPUT OPER RES, V31, P2293, DOI 10.1016/S0305-0548(03)00188-6; Strager MP, 2006, ECOL ECON, V57, P627, DOI 10.1016/j.ecolecon.2005.05.015; STRASSMANN WP, 1967, B ATOM SCI, V23, P52, DOI 10.1080/00963402.1967.11455096; Thomas S, 1980, ANAL HIERARCHY PROCE; Tpsgo Dongguan, REG BAS EC CONTR LIN; Tpsgo Shenzhen, REG BAS EC CONTR LIN; Udgata SK, 2009, WOR CONG NAT BIOL, P1308; Urban planning LRCoSM, ADJ OPT SCHEM BAS EC; Verdiell A., 2005, International Transactions in Operational Research, V12, P203, DOI 10.1111/j.1475-3995.2005.00498.x; WALTHER P, 1986, J ENVIRON MANAGE, V22, P331; Yang JY, 2013, INT J GEOGR INF SCI, V27, P1849, DOI 10.1080/13658816.2013.823498; Zhang KM, 2008, J ENVIRON MANAGE, V88, P1249, DOI 10.1016/j.jenvman.2007.06.019; Zhao SQ, 2006, FRONT ECOL ENVIRON, V4, P341, DOI 10.1890/1540-9295(2006)004[0341:ECORUE]2.0.CO;2	52	6	6	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137880	10.1371/journal.pone.0137880	http://dx.doi.org/10.1371/journal.pone.0137880			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26394148	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100020
J	Shibata, S; Nishijima, T; Aoki, T; Tanabe, Y; Teruya, K; Kikuchi, Y; Kikuchi, T; Oka, S; Gatanaga, H				Shibata, Satoshi; Nishijima, Takeshi; Aoki, Takahiro; Tanabe, Yoshinari; Teruya, Katsuji; Kikuchi, Yoshimi; Kikuchi, Toshiaki; Oka, Shinichi; Gatanaga, Hiroyuki			A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CARINII-PNEUMONIA; CONTROLLED TRIAL; THERAPY; AIDS; INFECTIONS; RISK	Background The current guidelines recommend 21-day adjunctive corticosteroid therapy for HIV-1-infected pneumocystis pneumonia patients (HIV-PCP) with moderate-to-severe disease. Whether shorter adjunctive corticosteroid therapy is feasible in such patients is unknown. Methods We conducted a retrospective study to elucidate the proportion of patients with moderate and severe HIV-PCP who required adjunctive corticosteroid therapy for 21 days. The enrollment criteria included HIV-PCP that fulfilled the current criteria for 21-day corticosteroid therapy; PaO2 on room air of <70mmHg or A-aDO(2) >= 35 mmHg. Results The median duration of corticosteroid therapy in the 73 study patients was 13 days (IQR 9-21). Adjunctive corticosteroid therapy was effective and discontinued within 10 and 14 days in 30% and 60% of the patients, respectively. Only 9% of the patients with moderate HIV-PCP (n = 22, A-aDO(2) 35-45 mmHg) received steroids for > 14 days, whereas 35% of the patients with severe HIV-PCP (n = 51, A-aDO(2) >= 45 mmHg) required corticosteroid therapy for >= 21 days. Four (13%) of the severe cases died, whereas no patient with moderate disease died. Among patients with severe HIV-PCP, discontinuation of corticosteroid therapy within 14 days correlated significantly with higher baseline CD4 (p = 0.049). Conclusion Shorter adjunctive corticosteroid therapy was clinically effective and adjunctive corticosteroid could be discontinued within 14 days in 60% of moderate-to-severe HIV-PCP and 90% of moderate cases.	[Shibata, Satoshi; Nishijima, Takeshi; Aoki, Takahiro; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Shibata, Satoshi; Tanabe, Yoshinari; Kikuchi, Toshiaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan; [Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Niigata University; Kumamoto University	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in Aids for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID PREV TREATM OPP; Bonnet F, 2005, SCAND J INFECT DIS, V37, P482, DOI 10.1080/00365540510035328; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; Buchman AL, 2001, J CLIN GASTROENTEROL, V33, P289, DOI 10.1097/00004836-200110000-00006; GAGNON S, 1990, NEW ENGL J MED, V323, P1444, DOI 10.1056/NEJM199011223232103; GINZLER E, 1978, ARTHRITIS RHEUM, V21, P37, DOI 10.1002/art.1780210107; Ko JH, 2015, CLIN INFECT DIS, V60, pE20, DOI 10.1093/cid/ciu969; MASUR H, 1990, NEW ENGL J MED, V323, P1500, DOI 10.1056/NEJM199011223232131; MONTANER JSG, 1990, ANN INTERN MED, V113, P14, DOI 10.7326/0003-4819-113-1-14; NIELSEN TL, 1992, J ACQ IMMUN DEF SYND, V5, P726; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; STUCK AE, 1989, REV INFECT DIS, V11, P954; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Watanabe T, 2009, CLIN INFECT DIS, V49, P1128, DOI 10.1086/605579; Wolfe F, 2006, ARTHRITIS RHEUM-US, V54, P628, DOI 10.1002/art.21568; Wolff AJ, 2003, CURR OPIN PULM MED, V9, P210, DOI 10.1097/00063198-200305000-00009	17	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138926	10.1371/journal.pone.0138926	http://dx.doi.org/10.1371/journal.pone.0138926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393804	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100116
J	de Oliveira, LMF; Morale, MG; Chaves, AAM; Cavalher, AM; Lopes, AS; Diniz, MDO; Schanoski, AS; de Melo, RL; Ferreira, LCD; de Oliveira, MLS; Demasi, M; Ho, PL				Fernandes de Oliveira, Liliane Maria; Morale, Mirian Galliote; Chaves, Agatha A. Muniz; Cavalher, Aline Marques; Lopes, Aline Soriano; Diniz, Mariana de Oliveira; Schanoski, Alessandra Soares; de Melo, Robson Lopes; de Souza Ferreira, Luis Carlos; de Oliveira, Maria Leonor S.; Demasi, Marilene; Ho, Paulo Lee			Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; T-LYMPHOCYTE EPITOPE; CERVICAL-CANCER; CELL EPITOPES; INTRAEPITHELIAL NEOPLASIA; HEALTHY-VOLUNTEERS; CTL EPITOPES; IN-VITRO; IDENTIFICATION; PROTEIN	Cervical cancer is a common type of cancer among women worldwide and infection with high-risk human papillomavirus (HPVs) types represents the major risk factor for the etiopathogenesis of the disease. HPV-16 is the most frequently identified HPV type in cervical lesions and expression of E6 and E7 oncoproteins is required for the uncontrolled cellular proliferation. In the present study we report the design and experimental testing of a recombinant multi-epitope protein containing immunogenic epitopes of HPV-16 E6 and E7. Tumor preventive assays, based on the engraftment of TC-1 cells in mice, showed that the E6E7 multi-epitope protein induced a full preventive anti-tumor protection in wild-type mice, as well as in mice deficient in expression of CD4(+) T cells and TLR4 receptor. Nonetheless, no anti-tumor protection was observed in mice deficient in CD8(+) T cells. Also, the vaccine promoted high activation of E6/E7-specific T cells and in a therapeutic-approach, E6E7 protein conferred full anti-tumor protection in mice. These results show a potential use of this E6E7 multi-epitope antigen as a new and promising antigen for the development of a therapeutic vaccine against tumors induced by HPV.	[Fernandes de Oliveira, Liliane Maria; Morale, Mirian Galliote; Chaves, Agatha A. Muniz; Cavalher, Aline Marques; Schanoski, Alessandra Soares; de Oliveira, Maria Leonor S.; Ho, Paulo Lee] Inst Butantan, Lab Biotecnol Mol 1, Sao Paulo, SP, Brazil; [Lopes, Aline Soriano; de Melo, Robson Lopes] Inst Butantan, Lab Especial Toxinol Aplicada, CeTICS, Sao Paulo, SP, Brazil; [Diniz, Mariana de Oliveira; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, SP, Brazil; [Demasi, Marilene] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan	Ho, PL (corresponding author), Inst Butantan, Lab Biotecnol Mol 1, Av Vital Brasil 1500, Sao Paulo, SP, Brazil.	paulo.ho@butantan.gov.br	Galliote Morale, Mirian/CAF-4263-2022; Oliveira, Maria Leonor S/F-4988-2012; Ho, Paulo/P-8267-2015; Demasi, Marilene/E-5873-2012; Soares Schanoski, Alessandra/H-8144-2014; Ferreira, Luis/M-3954-2014	Galliote Morale, Mirian/0000-0002-2778-7697; Ho, Paulo/0000-0003-3652-241X; Demasi, Marilene/0000-0002-3749-1160; Fernandes de Oliveira, Liliane Maria/0000-0003-3696-9414; Oliveira, Maria Leonor/0000-0003-4849-3062; Soares Schanoski, Alessandra/0000-0002-6514-8458; Ferreira, Luis/0000-0002-4883-1693	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2010/04490-4, 2007/51698-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPQ [304467/2010-3, 306992/2014-0]; Fundacao Butantan	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (2010/04490-4 and 2007/51698-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPQ (304467/2010-3 and 306992/2014-0) and Fundacao Butantan.	Bergmann CC, 1996, J IMMUNOL, V157, P3242; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Chen CH, 2000, CANCER RES, V60, P1035; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; COMERFORD SA, 1991, J VIROL, V65, P4681, DOI 10.1128/JVI.65.9.4681-4690.1991; de Jong A, 2002, VACCINE, V20, P3456, DOI 10.1016/S0264-410X(02)00350-X; Diniz MO, 2013, HUM GENE THER, V24, P861, DOI 10.1089/hum.2013.102; Diniz MO, 2010, CLIN VACCINE IMMUNOL, V17, P1576, DOI 10.1128/CVI.00264-10; Einstein MH, 2007, GYNECOL ONCOL, V106, P453, DOI 10.1016/j.ygyno.2007.04.038; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Freyschmidt EJ, 2004, ANTIVIR THER, V9, P479; Gallagher KME, 2007, J GEN VIROL, V88, P1470, DOI 10.1099/vir.0.82558-0; Gambhira R, 2006, CANCER RES, V66, P11120, DOI 10.1158/0008-5472.CAN-06-2560; Granadillo M, 2011, VACCINE, V29, P920, DOI 10.1016/j.vaccine.2010.11.083; Hohn H, 1999, J IMMUNOL, V163, P5715; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; KAST WM, 1994, J IMMUNOL, V152, P3904; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Liu TY, 2012, CURR TOP MED CHEM, V12, P1581, DOI 10.2174/156802612802652402; Monroy-Garcia A, 2014, ARCH VIROL, V159, P291, DOI 10.1007/s00705-013-1819-z; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Nakagawa M, 2004, CLIN DIAGN LAB IMMUN, V11, P889, DOI 10.1128/CDLI.11.5.889-896.2004; Nakagawa M, 2007, J VIROL, V81, P1412, DOI 10.1128/JVI.01768-06; Naylor Paul H, 2011, Cancers (Basel), V3, P3991, DOI 10.3390/cancers3043991; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Peng S, 2006, GENE THER, V13, P257, DOI 10.1038/sj.gt.3302646; Piersma SJ, 2008, INT J CANCER, V122, P486, DOI 10.1002/ijc.23162; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; RESSING ME, 1995, J IMMUNOL, V154, P5934; Ressing ME, 1999, EUR J IMMUNOL, V29, P1292, DOI 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6; Robinson W, 2001, CANC TREAT, V104, P287; Schreurs MWJ, 2005, VACCINE, V23, P4005, DOI 10.1016/j.vaccine.2005.03.014; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Smith KL, 2005, INT IMMUNOL, V17, P167, DOI 10.1093/intimm/dxh197; STAUSS HJ, 1992, P NATL ACAD SCI USA, V89, P7871, DOI 10.1073/pnas.89.17.7871; Su JH, 2010, BIODRUGS, V24, P109, DOI 10.2165/11532810-000000000-00000; Thomas KJ, 2008, INT J CANCER, V122, P2791, DOI 10.1002/ijc.23475; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Burg SH, 2001, VACCINE, V19, P3652, DOI 10.1016/S0264-410X(01)00086-X; van der Burg SH, 2001, INT J CANCER, V91, P612, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C; van der Burg SH, 2008, EXPERT REV VACCINES, V7, P1, DOI 10.1586/14760584.7.1.1; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	46	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							0138686	10.1371/journal.pone.0138686	http://dx.doi.org/10.1371/journal.pone.0138686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390407	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000051
J	Lebherz-Eichinger, D; Tudor, B; Ankersmit, HJ; Reiter, T; Haas, M; Roth-Walter, F; Krenn, CG; Roth, GA				Lebherz-Eichinger, Diana; Tudor, Bianca; Ankersmit, Hendrik J.; Reiter, Thomas; Haas, Martin; Roth-Walter, Franziska; Krenn, Claus G.; Roth, Georg A.			Trefoil Factor 1 Excretion Is Increased in Early Stages of Chronic Kidney Disease	PLOS ONE			English	Article							EXPRESSION; PEPTIDES; HSP27; RISK; TFF3	Chronic kidney disease (CKD) is associated with high morbidity and mortality. In many patients CKD is diagnosed late during disease progression. Therefore, the implementation of potential biomarkers may facilitate the early identification of individuals at risk. Trefoil factor family (TFF) peptides promote restitution processes of mucous epithelia and are abundant in the urinary tract. We therefore sought to investigate the TFF peptide levels in patients suffering from CKD and their potential as biomarkers for CKD. We analysed TFF1 and TFF3 in serum and urine of 115 patients with CKD stages 1-5 without dialysis by ELISA. 20 healthy volunteers served as controls. Our results showed, that urinary TFF1 levels were significantly increased with the onset of CKD in stages 1-4 as compared to controls and declined during disease progression (p = 0.003, < 0.001, 0.005, and 0.007. median concentrations: 3.5 pg/mL in controls vs 165.2, 61.1, 17.2, and 15.8 pg/mL in CKD 1-4). TFF1 and TFF3 serum levels were significantly elevated in stages 3-5 as compared to controls (TFF1: p < 0.01; median concentrations: 12.1, 39.7, and 34.5 pg/mL in CKD 3-5. TFF3: p < 0.001; median concentrations: 7.1 ng/mL in controls vs 26.1, 52.8, and 78.8 ng/mL in CKD 3-5). TFF3 excretion was increased in stages 4 and 5 (p < 0.001; median urinary levels: 65.2 ng/mL in controls vs 231.5 and 382.6 ng/mL in CKD 4/5; fractional TFF3 excretion: 6.4 in controls vs 19.6 and 44.1 in CKD 4/5). ROC curve analyses showed, that monitoring TFF peptide levels can predict various CKD stages (AUC urinary/serum TFF > 0.8). In conclusion our results show increased levels of TFF1 and TFF3 in CKD patients with a pronounced elevation of urinary TFF1 in lower CKD stages. Furthermore, TFF1 and TFF3 seems to be differently regulated and show potential to predict various CKD stages, as shown by ROC curve analysis.	[Lebherz-Eichinger, Diana; Tudor, Bianca; Krenn, Claus G.; Roth, Georg A.] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Med, Vienna, Austria; [Ankersmit, Hendrik J.] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Lebherz-Eichinger, Diana; Ankersmit, Hendrik J.] Med Univ Vienna, Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Reiter, Thomas; Haas, Martin] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Haas, Martin] Univ Hosp St Polten, Dept Cardiol, St Polten, Austria; [Roth-Walter, Franziska] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Med, Vienna, Austria; [Roth-Walter, Franziska] Univ Vienna, Vienna, Austria; [Lebherz-Eichinger, Diana; Tudor, Bianca; Krenn, Claus G.; Roth, Georg A.] Med Univ Vienna, RAIC Lab 13C1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Medical University of Vienna	Roth, GA (corresponding author), Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Med, Vienna, Austria.	georg.roth@meduniwien.ac.at	Reiter, Thomas J/Q-2660-2015; Roth-Walter, Franziska/V-4651-2017	Reiter, Thomas J/0000-0002-4607-5329; Roth-Walter, Franziska/0000-0001-5005-9228; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Roth, Georg/0000-0002-3984-3107				Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Astor BC, 2011, AM J NEPHROL, V34, P291, DOI 10.1159/000330699; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; Coons SJ, 2009, CLIN THER, V31, P2572, DOI 10.1016/j.clinthera.2009.11.035; Du TY, 2014, PLOS ONE, V8; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Itoh H, 1996, BIOCHEM J, V318, P939, DOI 10.1042/bj3180939; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lebherz-Eichinger D, 2014, TRANSL RES; Lebherz-Eichinger D, 2012, CLIN CHIM ACTA, V413, P282, DOI 10.1016/j.cca.2011.10.010; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Moser B, 2003, BIOCHEM BIOPH RES CO, V308, P581, DOI 10.1016/S0006-291X(03)01389-5; Musial K, 2013, KIDNEY INT, V83, P971, DOI 10.1038/ki.2013.33; Musial K, 2010, PERITON DIALYSIS INT, V30, P227, DOI 10.3747/pdi.2008.00153; Rinnert M, 2010, CELL TISSUE RES, V339, P639, DOI 10.1007/s00441-009-0913-8; Roth GA, 2011, CLIN CHIM ACTA, V412, P713, DOI 10.1016/j.cca.2010.12.030; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; System USRD, 2014, 2014 ANN DAT REP OV; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Xian CJ, 1999, AM J PHYSIOL-GASTR L, V277, pG785, DOI 10.1152/ajpgi.1999.277.4.G785; Zoccali C, 2006, KIDNEY INT, V70, P26, DOI 10.1038/sj.ki.5000417	25	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138312	10.1371/journal.pone.0138312	http://dx.doi.org/10.1371/journal.pone.0138312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390128	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000024
J	Miller, CN; Yang, JY; England, E; Yin, A; Baile, CA; Rayalam, S				Miller, Colette N.; Yang, Jeong-Yeh; England, Emily; Yin, Amelia; Baile, Clifton A.; Rayalam, Srujana			Isoproterenol Increases Uncoupling, Glycolysis, and Markers of Beiging in Mature 3T3-L1 Adipocytes	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUES; BROWN FAT; ADRENERGIC-STIMULATION; PROTEIN-KINASE; SMOOTH-MUSCLE; IN-VIVO; EXPRESSION; LIPOLYSIS; CELLS; PREADIPOCYTES	Beta-adrenergic activation stimulates uncoupling protein 1 (UCP1), enhancing metabolic rate. In vitro, most work has studied brown adipocytes, however, few have investigated more established adipocyte lines such as the murine 3T3-L1 line. To assess the effect of beta-adrenergic activation, mature 3T3-L1s were treated for 6 or 48 hours with or without isoproterenol (10 and 100 mu M) following standard differentiation supplemented with thyroid hormone (T3; 1 nM). The highest dose of isoproterenol increased lipid content following 48 hours of treatment. This concentration enhanced UCP1 mRNA and protein expression. The increase in UCP1 following 48 hours of isoproterenol increased oxygen consumption rate. Further, coupling efficiency of the electron transport chain was disturbed and an enhancement of glycolytic rate was measured alongside this, indicating an attempt to meet the energy demands of the cell. Lastly, markers of beige adipocytes (protein content of CD137 and gene transcript of CITED1) were also found to be upregulated at 48 hours of isoproterenol treatment. This data indicates that mature 3T3-L1 adipocytes are responsive to isoproterenol and induce UCP1 expression and activity. Further, this finding provides a model for further pharmaceutical and nutraceutical investigation of UCP1 in 3T3-L1s.	[Miller, Colette N.; Baile, Clifton A.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Miller, Colette N.; Baile, Clifton A.] Univ Georgia, Dept Foods & Nutr, Athens, GA 30602 USA; [Yang, Jeong-Yeh; Yin, Amelia] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [England, Emily] Univ Georgia, Biomed & Hlth Sci Inst, Div Neurosci, Athens, GA 30602 USA; [Rayalam, Srujana] Philadelphia Coll Osteopath Med, Pharmaceut Sci, Philadelphia, PA 19131 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Rayalam, S (corresponding author), Philadelphia Coll Osteopath Med, Pharmaceut Sci, GA Campus, Philadelphia, PA 19131 USA.	srujanara@pcom.edu		Rayalam, Srujana/0000-0003-3550-6741; Miller, Colette/0000-0001-7599-7886; Trunnell, Emily/0000-0001-6320-1289	University of Georgia Research Foundation; Atlanta Chapter of the Achievement Rewards for College Scientists; CSO Intramural Funds from the Philadelphia College of Medicine, School of Pharmacy	University of Georgia Research Foundation; Atlanta Chapter of the Achievement Rewards for College Scientists; CSO Intramural Funds from the Philadelphia College of Medicine, School of Pharmacy	This work was supported in part by the University of Georgia Research Foundation and the Georgia Research Alliance Eminent Scholar Endowment held by the late Dr. Clifton A. Baile, the Atlanta Chapter of the Achievement Rewards for College Scientists (CNM), and CSO Intramural Funds from the Philadelphia College of Medicine, School of Pharmacy (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein N, 2014, ADIPOCYTE, V3, P121, DOI 10.4161/adip.27936; Asano H, 2014, J VET MED SCI, V76, P57, DOI 10.1292/jvms.13-0359; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Beattie JH, 2000, AM J PHYSIOL-REG I, V278, pR1082; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Dorsa KK, 2010, ARQ BRAS ENDOCRINOL, V54, P381, DOI 10.1590/S0004-27302010000400007; Erlanson-Albertsson C, 2003, ACTA PHYSIOL SCAND, V178, P405, DOI 10.1046/j.1365-201X.2003.01159.x; Fasshauer M, 2002, J ENDOCRINOL, V175, P727, DOI 10.1677/joe.0.1750727; Fogli S, 2011, BRIT J PHARMACOL, V162, P378, DOI 10.1111/j.1476-5381.2010.01021.x; Grimpo K, 2014, J LIPID RES, V55, P398, DOI 10.1194/jlr.M042895; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hernandez A, 2000, AM J PHYSIOL-ENDOC M, V278, pE769, DOI 10.1152/ajpendo.2000.278.5.E769; Kimura K, 2000, HORM METAB RES, V32, P91, DOI 10.1055/s-2007-978597; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; LAI E, 1982, J BIOL CHEM, V257, P6691; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Li YG, 2014, BBA-MOL CELL BIOL L, V1841, P1345, DOI 10.1016/j.bbalip.2014.06.003; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Nibbelink M, 2001, J BIOL CHEM, V276, P47291, DOI 10.1074/jbc.M105658200; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Thonberg H, 2002, BIOCHEM J, V364, P73, DOI 10.1042/bj3640073; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200	33	31	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138344	10.1371/journal.pone.0138344	http://dx.doi.org/10.1371/journal.pone.0138344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390217	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000025
J	Zhang, JG; Tan, LJ; Xu, C; He, H; Tian, Q; Zhou, Y; Qiu, C; Chen, XD; Deng, HW				Zhang, Ji-Gang; Tan, Li-Jun; Xu, Chao; He, Hao; Tian, Qing; Zhou, Yu; Qiu, Chuan; Chen, Xiang-Ding; Deng, Hong-Wen			Integrative Analysis of Transcriptomic and Epigenomic Data to Reveal Regulation Patterns for BMD Variation	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAY; BONE-RESORPTION; WIDE ASSOCIATION; GENE-EXPRESSION; OSTEOPOROSIS; BLOOD; RISK; OSTEOCLASTOGENESIS; METHYLATION	Integration of multiple profiling data and construction of functional gene networks may provide additional insights into the molecular mechanisms of complex diseases. Osteoporosis is a worldwide public health problem, but the complex gene-gene interactions, post-transcriptional modifications and regulation of functional networks are still unclear. To gain a comprehensive understanding of osteoporosis etiology, transcriptome gene expression microarray, epigenomic miRNA microarray and methylome sequencing were performed simultaneously in 5 high hip BMD (Bone Mineral Density) subjects and 5 low hip BMD subjects. SPIA (Signaling Pathway Impact Analysis) and PCST (Prize Collecting Steiner Tree) algorithm were used to perform pathway-enrichment analysis and construct the interaction networks. Through integrating the transcriptomic and epigenomic data, firstly we identified 3 genes (FAM50A, ZNF473 and TMEM55B) and one miRNA (hsa-mir-4291) which showed the consistent association evidence from both gene expression and methylation data; secondly in network analysis we identified an interaction network module with 12 genes and 11 miRNAs including AKT1, STAT3, STAT5A, FLT3, hsa-mir-141 and hsa-mir-34a which have been associated with BMD in previous studies. This module revealed the crosstalk among miRNAs, mRNAs and DNA methylation and showed four potential regulatory patterns of gene expression to influence the BMD status. In conclusion, the integration of multiple layers of omics can yield in-depth results than analysis of individual omics data respectively. Integrative analysis from transcriptomics and epigenomic data improves our ability to identify causal genetic factors, and more importantly uncover functional regulation pattern of multi-omics for osteoporosis etiology.	[Zhang, Ji-Gang; Xu, Chao; He, Hao; Tian, Qing; Zhou, Yu; Qiu, Chuan; Deng, Hong-Wen] Tulane Univ, Ctr Genom & Bioinformat, New Orleans, LA 70112 USA; [Zhang, Ji-Gang; Xu, Chao; He, Hao; Tian, Qing; Zhou, Yu; Qiu, Chuan; Deng, Hong-Wen] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70112 USA; [Tan, Li-Jun; Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Lab Mol & Stat Genet, Changsha 410081, Hunan, Peoples R China	Tulane University; Tulane University; Hunan Normal University	Tan, LJ (corresponding author), Hunan Normal Univ, Lab Mol & Stat Genet, Changsha 410081, Hunan, Peoples R China.	ljtan@hunnu.edu.cn; hdeng2@tulane.edu	Qiu, Chuan/AAN-3319-2021; Xu, Chao/AAN-6427-2020; Tan, Li-Jun/AAO-1130-2020	Qiu, Chuan/0000-0001-6202-9229; Xu, Chao/0000-0002-3821-6187; Deng, Hong-Wen/0000-0002-0387-8818	Natural Science Foundation of China (NSFC) [81570807, 31271344]; Hunan Provincial Construct Program of the Key Discipline in Ecology [0713]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Franklin D Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR059781, R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hunan Provincial Construct Program of the Key Discipline in Ecology; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the Natural Science Foundation of China (NSFC; 81570807 and 31271344), Hunan Provincial Construct Program of the Key Discipline in Ecology (0713) and the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486). HWD was supported in part by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221) and the Franklin D Dickson/Missouri Endowment.	Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; Coli G, 2013, CLIN CASES MINER BON, V10, P83, DOI 10.11138/ccmbm/2013.10.2.083; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Deng Fei-Yan, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M111.011700; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Farber CR, 2009, J BONE MINER RES, V24, P1937, DOI [10.1359/jbmr.091101, 10.1359/JBMR.091101]; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; Harvey N, 2014, J BONE MINER RES, V29, P1917, DOI 10.1002/jbmr.2286; Higuchi S, 1998, J BONE MINER RES, V13, P44, DOI 10.1359/jbmr.1998.13.1.44; Hirose J, 2014, J EXP MED, V211, P153, DOI 10.1084/jem.20130538; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; JAK-STAT Li J., 2013, JAK STAT, V2; Jevon M, 2003, SCAND J RHEUMATOL, V32, P95, DOI 10.1080/03009740310000102; Juran BD, 2011, SEMIN LIVER DIS, V31, P215, DOI 10.1055/s-0031-1276641; Kanno H, 2012, CELL CYCLE, V11, P3175, DOI 10.4161/cc.21262; Koh JM, 2007, J BONE MINER RES, V22, P1752, DOI 10.1359/JBMR.070705; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Laulederkind SJF, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat015; Leung R, 2011, BLOOD, V117, P2044, DOI 10.1182/blood-2010-05-282574; Li BX, 2013, ENDOCRINE, V43, P136, DOI 10.1007/s12020-012-9757-1; Li CH, 2013, BIOCHEM BIOPH RES CO, V435, P533, DOI 10.1016/j.bbrc.2013.04.084; Li CH, 2012, BIOCHEM BIOPH RES CO, V429, P156, DOI 10.1016/j.bbrc.2012.10.122; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Mukherjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093040; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Recker RR, 2002, ENDOCRINE, V17, P55, DOI 10.1385/ENDO:17:1:55; Reddy SV, 1999, J BONE MINER RES, V14, P3, DOI 10.1002/jbmr.5650140203; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Shinohara M, 2012, J BONE MINER RES, V27, P2464, DOI 10.1002/jbmr.1703; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S15; Sun GJ, 2013, EUR REV MED PHARMACO, V17, P1; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tyekucheva S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r105; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019; Zhou Y, 2015, CIRCULATING MONOCYTE, DOI [10.1007/s00198-015-3250-7, DOI 10.1007/S00198-015-3250-7]	53	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138524	10.1371/journal.pone.0138524	http://dx.doi.org/10.1371/journal.pone.0138524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390436	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000036
J	Zhang, YY; Li, G; Che, H; Sun, HY; Xiao, GS; Wang, Y; Li, GR				Zhang, Ying-Ying; Li, Gang; Che, Hui; Sun, Hai-Ying; Xiao, Guo-Sheng; Wang, Yan; Li, Gui-Rong			Effects of BKCa and Kir2.1 Channels on Cell Cycling Progression and Migration in Human Cardiac c-kit(+) Progenitor Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CA2+-ACTIVATED K+ CHANNELS; FUNCTIONAL ION CHANNELS; VASCULAR SMOOTH-MUSCLE; POTASSIUM CHANNELS; K(CA)3.1 CHANNELS; BONE-MARROW; MYOCARDIAL-INFARCTION; UP-REGULATION; PROLIFERATION	Our previous study demonstrated that a large-conductance Ca2+-activated K+ current (BKCa), a voltage-gated TTX-sensitive sodium current (I-Na.(TTX)), and an inward rectifier K+ current (I-Kir) were heterogeneously present in most of human cardiac c-kit(+) progenitor cells. The present study was designed to investigate the effects of these ion channels on cell cycling progression and migration of human cardiac c-kit(+) progenitor cells with approaches of cell proliferation and mobility assays, siRNA, RT-PCR, Western blots, flow cytometry analysis, etc. It was found that inhibition of BKCa with paxilline, but not I-Na.TTX with tetrodotoxin, decreased both cell proliferation and migration. Inhibition of I-Kir with Ba2+ had no effect on cell proliferation, while enhanced cell mobility. Silencing KCa.1.1 reduced cell proliferation by accumulating the cells at G0/G1 phase and decreased cell mobility. Interestingly, silencing Kir2.1 increased the cell migration without affecting cell cycling progression. These results demonstrate the novel information that blockade or silence of BKCa channels, but not I-Na.TTX channels, decreases cell cycling progression and mobility, whereas inhibition of Kir2.1 channels increases cell mobility without affecting cell cycling progression in human cardiac c-kit(+) progenitor cells.	[Zhang, Ying-Ying; Li, Gang; Che, Hui; Sun, Hai-Ying; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Li, Gang; Xiao, Guo-Sheng; Wang, Yan; Li, Gui-Rong] Xiamen Univ, Xiamen Cardiovasc Hosp, Sch Med, Xiamen 361004, Fujian, Peoples R China	University of Hong Kong; Xiamen University	Wang, Y (corresponding author), Xiamen Univ, Xiamen Cardiovasc Hosp, Sch Med, Xiamen 361004, Fujian, Peoples R China.	wy@medmail.com.cn; grli8@outlook.com	Li, Gang/GWM-7351-2022; , 李贵荣（沧海一粟）/AAZ-4335-2020	, 李贵荣（沧海一粟）/0000-0002-9437-2280; Li, Gang/0000-0003-3875-2112	Research Grant Council of Hong Kong [771712M]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by a General Research Fund (771712M) from the Research Grant Council of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghouth PG, 2015, BBA-BIOMEMBRANES, V1848, P2629, DOI 10.1016/j.bbamem.2015.02.024; Barile Lucio, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS9, DOI 10.1038/ncpcardio0738; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Chen JB, 2012, BRIT J PHARMACOL, V166, P1140, DOI 10.1111/j.1476-5381.2012.01831.x; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Deng XL, 2007, CELL PROLIFERAT, V40, P656, DOI 10.1111/j.1365-2184.2007.00458.x; Ding FF, 2012, TISSUE CELL, V44, P358, DOI 10.1016/j.tice.2012.06.001; Donaldson MR, 2004, ANN MED, V36, P92, DOI 10.1080/17431380410032490; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Han Y, 2010, AM J PHYSIOL-CELL PH, V298, pC1109, DOI 10.1152/ajpcell.00207.2009; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; He ML, 2011, J MOL CELL CARDIOL, V51, P198, DOI 10.1016/j.yjmcc.2011.05.008; Hu H, 2009, J CELL PHYSIOL, V218, P427, DOI 10.1002/jcp.21617; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Kuhlmann CRW, 2005, ACTA PHYSIOL SCAND, V183, P161, DOI 10.1111/j.1365-201X.2004.01378.x; Kuhn EN, 2010, J CELL PHYSIOL, V225, P321, DOI 10.1002/jcp.22281; Lam D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00185; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Li JD, 2004, AM J PHYSIOL-HEART C, V287, pH2790, DOI 10.1152/ajpheart.00114.2004; Lotz MM, 2004, WOUND REPAIR REGEN, V12, P565, DOI 10.1111/j.1067-1927.2004.012509.x; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rooj AK, 2012, J BIOL CHEM, V287, P4053, DOI 10.1074/jbc.M111.311688; Rybarczyk P, 2012, INT J CANCER, V131, pE851, DOI 10.1002/ijc.27487; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Su XL, 2011, J MOL CELL CARDIOL, V51, P51, DOI 10.1016/j.yjmcc.2011.03.014; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Wang LP, 2013, BIOCHEM PHARMACOL, V85, P1486, DOI 10.1016/j.bcp.2013.02.032; Wang P, 2012, MOL CELL BIOCHEM, V365, P313, DOI 10.1007/s11010-012-1271-5; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Wu WKK, 2008, MOL CELL BIOCHEM, V308, P219, DOI 10.1007/s11010-007-9631-2; Wu WKK, 2006, J CELL PHYSIOL, V207, P437, DOI 10.1002/jcp.20576; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Yaniz-Galende E, 2012, CIRC RES, V111, P1434, DOI 10.1161/CIRCRESAHA.111.263830; Zhang YY, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0407-z; Zhang YY, 2014, J CELL PHYSIOL, V229, P202, DOI 10.1002/jcp.24435; Zhang Y, 2012, BRIT J PHARMACOL, V166, P1247, DOI 10.1111/j.1476-5381.2012.01852.x; Zhao LM, 2013, LAB INVEST, V93, P159, DOI 10.1038/labinvest.2012.163; Zhao ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032628	58	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138581	10.1371/journal.pone.0138581	http://dx.doi.org/10.1371/journal.pone.0138581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390131	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000040
J	Calderon, CP; Bloom, K				Calderon, Christopher P.; Bloom, Kerry			Inferring Latent States and Refining Force Estimates via Hierarchical Dirichlet Process Modeling in Single Particle Tracking Experiments	PLOS ONE			English	Article							MESSENGER-RNA PARTICLES; MOLECULE TRACKING; PERICENTRIC CHROMATIN; DENDRITIC SPINES; DYNAMICS; RECEPTORS; DIFFUSION; TRAJECTORIES; MICROSCOPY; REVEALS	Understanding the basis for intracellular motion is critical as the field moves toward a deeper understanding of the relation between Brownian forces, molecular crowding, and anisotropic (or isotropic) energetic forcing. Effective forces and other parameters used to summarize molecular motion change over time in live cells due to latent state changes, e.g., changes induced by dynamic micro-environments, photobleaching, and other heterogeneity inherent in biological processes. This study discusses limitations in currently popular analysis methods (e.g., mean square displacement-based analyses) and how new techniques can be used to systematically analyze Single Particle Tracking (SPT) data experiencing abrupt state changes in time or space. The approach is to track GFP tagged chromatids in metaphase in live yeast cells and quantitatively probe the effective forces resulting from dynamic interactions that reflect the sum of a number of physical phenomena. State changes can be induced by various sources including: microtubule dynamics exerting force through the centromere, thermal polymer fluctuations, and DNA-based molecular machines including polymerases and protein exchange complexes such as chaperones and chromatin remodeling complexes. Simulations aiming to show the relevance of the approach to more general SPT data analyses are also studied. Refined force estimates are obtained by adopting and modifying a nonparametric Bayesian modeling technique, the Hierarchical Dirichlet Process Switching Linear Dynamical System (HDP-SLDS), for SPT applications. The HDP-SLDS method shows promise in systematically identifying dynamical regime changes induced by unobserved state changes when the number of underlying states is unknown in advance (a common problem in SPT applications). We expand on the relevance of the HDP-SLDS approach, review the relevant background of Hierarchical Dirichlet Processes, show how to map discrete time HDP-SLDS models to classic SPT models, and discuss limitations of the approach. In addition, we demonstrate new computational techniques for tuning hyperparameters and for checking the statistical consistency of model assumptions directly against individual experimental trajectories; the techniques circumvent the need for "ground-truth" and/or subjective information.	[Calderon, Christopher P.] Ursa Analyt, Denver, CO 80212 USA; [Bloom, Kerry] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Calderon, CP (corresponding author), Ursa Analyt, Denver, CO 80212 USA.	Chris.Calderon@UrsaAnalytics.com	Bloom, Kerry/AAE-5336-2019	Bloom, Kerry/0000-0002-3457-004X	Ursa Analytics internal RD; National Institutes of Health [GM32238]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032238] Funding Source: NIH RePORTER	Ursa Analytics internal RD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CPC was supported by Ursa Analytics internal R&D. KB was supported by National Institutes of Health R37 grant GM32238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; [Anonymous], 2008, MODEL SELECTION MODE; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Berglund AJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011917; Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Calderon CP, 2007, MULTISCALE MODEL SIM, V6, P656, DOI 10.1137/050643647; Calderon CP, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2567098; Calderon CP, 2014, MOLECULES, V19, P18381, DOI 10.3390/molecules191118381; Calderon CP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052705; Calderon CP, 2013, J PHYS CHEM B, V117, P15701, DOI 10.1021/jp4064214; Calderon CP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012707; Calderon CP, 2010, J PHYS CHEM B, V114, P3242, DOI 10.1021/jp911124z; Calderon CP, 2009, J PHYS CHEM B, V113, P138, DOI 10.1021/jp807908c; Calderon CP, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034114; Calderon CR, 2009, J MOL RECOGNIT, V22, P356, DOI 10.1002/jmr.959; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen KJ, 2013, ACS NANO, V7, P8634, DOI 10.1021/nn402787a; Chenouard N, 2014, NAT METHODS, V11, P281, DOI 10.1038/nmeth.2808; Enderlein J, 2006, OPT EXPRESS, V14, P8111, DOI 10.1364/OE.14.008111; Ensign DL, 2010, J PHYS CHEM B, V114, P280, DOI 10.1021/jp906786b; Fisher JK, 2009, P NATL ACAD SCI USA, V106, P9250, DOI 10.1073/pnas.0812723106; Fox EB, 2011, ANN APPL STAT, V5, P1020, DOI 10.1214/10-AOAS395; Fox EB, 2010, IEEE SIGNAL PROC MAG, V27, P43, DOI 10.1109/MSP.2010.937999; Gahlmann A, 2014, NAT REV MICROBIOL, V12, P9, DOI 10.1038/nrmicro3154; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Gardiner C. W., 1985, HDB STOCHASTIC MODEL; Ghosh Ramamoorthi RV, 2010, BAYESIAN NONPARAMETR; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hajjoul H, 2013, GENOME RES, V23, P1829, DOI 10.1101/gr.157008.113; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hines KE, 2015, BIOPHYS J, V108, P540, DOI 10.1016/j.bpj.2014.12.016; Holcman D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021906; Hong YM, 2005, REV FINANC STUD, V18, P37, DOI 10.1093/rfs/hhh006; Hoze N, 2014, BIOPHYS J, V107, P2999, DOI 10.1016/j.bpj.2014.10.018; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jaqaman K, 2006, BIOPHYS J, V91, P2312, DOI 10.1529/biophysj.106.080333; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lessard GA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2819074; Lubelski A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.250602; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; Masson JB, 2014, BIOPHYS J, V106, P74, DOI 10.1016/j.bpj.2013.10.027; Montiel D, 2006, J PHYS CHEM B, V110, P19763, DOI 10.1021/jp062024j; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Park HY, 2010, METHOD ENZYMOL, V472, P387, DOI 10.1016/S0076-6879(10)72003-6; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Pokern Y, 2009, J R STAT SOC B, V71, P49, DOI 10.1111/j.1467-9868.2008.00689.x; Presse S, 2013, J PHYS CHEM B, V117, P495, DOI 10.1021/jp309420u; Ram S, 2012, BIOPHYS J, V103, P1594, DOI 10.1016/j.bpj.2012.08.054; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schwantes CR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895044; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Stephens AD, 2013, MOL BIOL CELL, V24, P3909, DOI 10.1091/mbc.E13-06-0325; Stephens AD, 2013, J CELL BIOL, V200, P757, DOI 10.1083/jcb.201208163; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; Thompson MA, 2010, P NATL ACAD SCI USA, V107, P17864, DOI 10.1073/pnas.1012868107; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Meent JW, 2014, BIOPHYS J, V106, P1327, DOI 10.1016/j.bpj.2013.12.055; Verdaasdonk JS, 2013, MOL CELL, V52, P819, DOI 10.1016/j.molcel.2013.10.021; Weber SC, 2012, BIOPHYS J, V102, P2443, DOI 10.1016/j.bpj.2012.03.062; Weigel AV, 2013, P NATL ACAD SCI USA, V110, pE4591, DOI 10.1073/pnas.1315202110; Welsher K, 2014, NAT NANOTECHNOL, V9, P198, DOI [10.1038/NNANO.2014.12, 10.1038/nnano.2014.12]	71	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137633	10.1371/journal.pone.0137633	http://dx.doi.org/10.1371/journal.pone.0137633			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384324	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200029
J	Li, XR; Zhao, XP; Duan, XB; Wang, XL				Li, Xiangrong; Zhao, Xupei; Duan, Xiabin; Wang, Xiaoliang			A Conjugate Gradient Algorithm with Function Value Information and N-Step Quadratic Convergence for Unconstrained Optimization	PLOS ONE			English	Article							QUASI-NEWTON METHODS; GLOBAL CONVERGENCE; SUPERLINEAR CONVERGENCE; BFGS METHOD; DESCENT; SEGMENTATION; MINIMIZATION	It is generally acknowledged that the conjugate gradient (CG) method achieves global convergence-with at most a linear convergence rate-because CG formulas are generated by linear approximations of the objective functions. The quadratically convergent results are very limited. We introduce a new PRP method in which the restart strategy is also used. Moreover, the method we developed includes not only n-step quadratic convergence but also both the function value information and gradient value information. In this paper, we will show that the new PRP method (with either the Armijo line search or the Wolfe line search) is both linearly and quadratically convergent. The numerical experiments demonstrate that the new PRP algorithm is competitive with the normal CG method.	[Li, Xiangrong; Duan, Xiabin; Wang, Xiaoliang] Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China; [Zhao, Xupei] Henan Univ Urban Construct, Math & Phys Inst, Pingdingshan, Henan, Peoples R China	Guangxi University; Henan University of Urban Construction	Wang, XL (corresponding author), Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China.	xliangwang@126.com		Wang, XiaoLiang/0000-0002-6926-1765	Guangxi NSF [2012GXNSFAA053002]; China NSF [11261006, 11161003]; Fund of Henan University of Urban Construction [2014JBS003]	Guangxi NSF; China NSF(National Natural Science Foundation of China (NSFC)); Fund of Henan University of Urban Construction	Mrs. Li and Dr. Zhao are the members of the Guangxi NSF (Grant No. 2012GXNSFAA053002) and the China NSF (Grant No. 11261006 and 11161003). Moreover Dr. Zhao is one member of the Fund of Henan University of Urban Construction (Grant No. 2014JBS003).	Broyden C. G., 1973, Journal of the Institute of Mathematics and Its Applications, V12, P223; BURMEISTER W, 1973, Z ANGEW MATH MECH, V53, P693, DOI 10.1002/zamm.19730531007; BYRD RH, 1987, SIAM J NUMER ANAL, V24, P1171, DOI 10.1137/0724077; BYRD RH, 1989, SIAM J NUMER ANAL, V26, P727, DOI 10.1137/0726042; COHEN AI, 1972, SIAM J NUMER ANAL, V9, P248, DOI 10.1137/0709024; Dai Y., 1997, THESIS CHESE ACAD SC; Dai Y., 1998, NONLINEAR CONJUGATE; Dai YH, 2003, SIAM J OPTIMIZ, V13, P693; Dai YH, 1999, SIAM J OPTIMIZ, V10, P177, DOI 10.1137/S1052623497318992; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Fletcher R., 1997, PRACTICAL METHODS OP, V1; Fu ZJ, 2015, IEICE T COMMUN, VE98B, P190, DOI 10.1587/transcom.E98.B.190; Gilbert JC, 1992, SIAM J OPTIMIZ, V2, P21, DOI 10.1137/0802003; Gu B, 2013, IEEE T NEUR NET LEAR, V24, P1304, DOI 10.1109/TNNLS.2013.2250300; Hager WW, 2006, ACM T MATH SOFTWARE, V32, P113, DOI 10.1145/1132973.1132979; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Li DH, 2001, SIAM J OPTIMIZ, V11, P1054, DOI 10.1137/S1052623499354242; Li DH, 2001, J COMPUT APPL MATH, V129, P15, DOI 10.1016/S0377-0427(00)00540-9; Li DH, 2011, J COMPUT APPL MATH, V235, P4978, DOI 10.1016/j.cam.2011.04.026; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; Liu G., 1995, Optimization, V34, P147, DOI 10.1080/02331939508844101; Nicholas I, 2003, ACM T MATH SOFTWARE, V29, P373; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Polyak BT., 1969, USSR COMP MATH MATH, V9, P94, DOI [10.1016/0041-5553(69)90035-4, DOI 10.1016/0041-5553(69)90035-4]; POWELL MJD, 1984, LECT NOTES MATH, V1066, P122; POWELL MJD, 1986, SIAM REV, V28, P487, DOI 10.1137/1028154; RITTER K, 1980, NUMER MATH, V35, P293, DOI 10.1007/BF01396414; Storey C, 1992, J APPL MATH COMPUT, V69, P17; Tian BS, GLOBAL CONVERGENCE S; Wei ZX, 2006, APPL MATH COMPUT, V183, P1341, DOI 10.1016/j.amc.2006.05.150; Wei ZX, 2006, APPL MATH COMPUT, V175, P1156, DOI 10.1016/j.amc.2005.08.027; Wei ZX, 2004, COMPUT OPTIM APPL, V29, P315, DOI 10.1023/B:COAP.0000044184.25410.39; Wen XZ, 2015, IEEE T CIRC SYST VID, V25, P508, DOI 10.1109/TCSVT.2014.2358031; Yu GH, 2007, THESIS SUN YAT SEN U; Yuan GL, 2014, IIE TRANS, V46, P397, DOI 10.1080/0740817X.2012.726757; Yuan GL, 2014, J COMPUT APPL MATH, V255, P86, DOI 10.1016/j.cam.2013.04.032; Yuan GL, 2013, NUMER FUNC ANAL OPT, V34, P914, DOI 10.1080/01630563.2013.777350; Yuan GL, 2009, OPTIM LETT, V3, P11, DOI 10.1007/s11590-008-0086-5; Yuan GL, 2010, COMPUT OPTIM APPL, V47, P237, DOI 10.1007/s10589-008-9219-0; Yuan GL, 2009, J COMPUT APPL MATH, V233, P519, DOI 10.1016/j.cam.2009.08.001; Yuan GL, 2009, ANN OPER RES, V166, P73, DOI 10.1007/s10479-008-0420-4; Yuan Y., 1993, OPTIM METHOD SOFTW, V2, P19, DOI [DOI 10.1080/10556789308805532, 10.1080/10556789308805532]; Zhang H, 2014, IEEE T GEOSCI REMOTE, V52, P4391, DOI 10.1109/TGRS.2013.2281854; Zhang L, 2006, IMA J NUMER ANAL, V26, P629, DOI 10.1093/imanum/dr1016	46	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137166	10.1371/journal.pone.0137166	http://dx.doi.org/10.1371/journal.pone.0137166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381742	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200016
J	Saito, T; Kasamatsu, A; Ogawara, K; Miyamoto, I; Saito, K; Lyoda, M; Suzuki, T; Endo-Sakamoto, Y; Shiiba, M; Tanzawa, H; Uzawa, K				Saito, Tomoaki; Kasamatsu, Atsushi; Ogawara, Katsunori; Miyamoto, Isao; Saito, Kengo; Lyoda, Manabu; Suzuki, Takane; Endo-Sakamoto, Yosuke; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis	PLOS ONE			English	Article							PROGNOSTIC MARKER; EXPRESSION; 7A; PROGRESSION; D1; INHIBITION; SUPPRESSOR; INDUCTION; INTEGRINS; CARCINOMA	Background Semaphorins (SEMAs) consist of a large family of secreted and membrane-anchored proteins that are important in neuronal pathfinding and axon guidance in selected areas of the developing nervous system. Of them, SEMA7A has been reported to have a chemotactic activity in neurogenesis and to be an immunomodulator; however, little is known about the relevance of SEMA7A in the behaviors of oral squamous cell carcinoma (OSCC). Methods We evaluated SEMA7A expression in OSCC-derived cell lines and primary OSCC samples using quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and semiquantitative immunohistochemistry (sq-IHC). In addition, SEMA7A knockdown cells (5hSEMA7A cells) were used for functional experiments, including cellular proliferation, invasiveness, and migration assays. We also analyzed the clinical correlation between SEMA7A status and clinical behaviors in patients with OSCC. Results SEMA7A mRNA and protein were up-regulated significantly (P<0.05) in OSCC-derived cell lines compared with human normal oral keratinocytes. The shSEMA7A cells showed decreased cellular growth by cell-cycle arrest at the G1 phase, resulting from up-regulation of cyclin-dependent kinase inhibitors (p21c1P1 and p27KiP1) and down-regulation of cyclins (cyclin Dl, cyclin E) and cyclin-dependent kinases (CDK2, CDK4, and CDK6); and decreased invasiveness and migration activities by reduced secretion of matrix metalloproteases (MMPs) (MMP-2, proMMP-2, pro-MMP-9), and expression of membrane type 1MMP (MT1-MMP). We also found inactivation of the extracellular regulated kinase 1/2 and AKT pathways, an upstream molecule of cell-cycle arrest at the G1 phase, and reduced secretion of MMPs in shSEMA7A cells. sq-IHC showed that SEMA7A expression in the primary OSCCs was significantly (P = 0.001) greater than that in normal counterparts and was correlated with primary tumoral size (P = 0.0254) and regional lymph node metastasis (P = 0.0002). Conclusion Our data provide evidence for an essential role of SEMA7A in tumoral growth and metastasis in OSCC and indicated that SEMA7A may play a potential diagnostic/therapeutic target for use in patients with OSCC.	[Saito, Tomoaki; Miyamoto, Isao; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba 2608670, Japan; [Kasamatsu, Atsushi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba 2608670, Japan; [Ogawara, Katsunori] Funabashi Cent Hosp, Div Oral Surg, Funabashi, Chiba 2738556, Japan; [Ogawara, Katsunori] Funabashi Cent Hosp, Oral Implant Ctr, Funabashi, Chiba 2738556, Japan; [Saito, Kengo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chuo Ku, Chiba 2608670, Japan; [Lyoda, Manabu] Chiba Rosai Hosp, Div Oral Surg, Ichihara, Chiba 2900003, Japan; [Suzuki, Takane] Chiba Univ, Grad Sch Med, Dept Environm Hlth Sci, Chuo Ku, Chiba 2608670, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University; Chiba University	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	uzawak@faculty.chibau.jp		Suzuki, Takane/0000-0002-0365-2544; Uzawa, Katsuhiro/0000-0002-7036-0859				Baba T, 2013, MOL CARCINOG; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; De Minicis S, 2013, AM J PATHOL, V183, P820, DOI 10.1016/j.ajpath.2013.05.030; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Epstein JA, 2015, CELL METAB, V21, P163, DOI 10.1016/j.cmet.2014.12.015; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Garcia-Areas R, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-346; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kim S, 2010, BBA-MOL CELL RES, V1803, P1287, DOI 10.1016/j.bbamcr.2010.06.011; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Lombardi DP, 1999, CANCER RES, V59, P5724; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Minakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085951; Moller MN, 2010, LARYNGOSCOPE, V120, P657, DOI 10.1002/lary.20834; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Norii T, 2012, BIOL TRACE ELEM RES, V146, P207, DOI 10.1007/s12011-011-9236-1; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pindborg JJ, 1997, HISTOLOGICAL TYPING; Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003; Rajashekhar G, 2014, EXP EYE RES, V122, P77, DOI 10.1016/j.exer.2014.03.004; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Sauter ER, 2002, CANCER RES, V62, P3200; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Serini G, 2008, CARDIOVASC RES, V78, P213, DOI 10.1093/cvr/cvn045; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Sounni NE, 2005, BIOCHIMIE, V87, P329, DOI 10.1016/j.biochi.2004.07.012; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; TAM SW, 1994, ONCOGENE, V9, P2663; Tseng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019396; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Wilson MJ, 2002, J CELL PHYSIOL, V191, P208, DOI 10.1002/jcp.10092; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yamatoji M, 2010, ONCOL REP, V23, P61, DOI 10.3892/or_00000606; Yue H, 2005, WORLD J GASTROENTERO, V11, P5057, DOI 10.3748/wjg.v11.i32.5057; Zhang SJ, 2014, MOL BIOL REP, V41, P2101, DOI 10.1007/s11033-014-3059-z; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	51	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137923	10.1371/journal.pone.0137923	http://dx.doi.org/10.1371/journal.pone.0137923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378920	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400036
J	Spielman, SJ; Wilke, CO				Spielman, Stephanie J.; Wilke, Claus O.			Pyvolve: A Flexible Python Module for Simulating Sequences along Phylogenies	PLOS ONE			English	Article							AMINO-ACID SITES; NUCLEOTIDE SUBSTITUTION; PROTEIN EVOLUTION; MODEL	We introduce Pyvolve, a flexible Python module for simulating genetic data along a phylogeny using continuous-time Markov models of sequence evolution. Easily incorporated into Python bioinformatics pipelines, Pyvolve can simulate sequences according to most standard models of nucleotide, amino-acid, and codon sequence evolution. All model parameters are fully customizable. Users can additionally specify custom evolutionary models, with custom rate matrices and/or states to evolve. This flexibility makes Pyvolve a convenient framework not only for simulating sequences under a wide variety of conditions, but also for developing and testing new evolutionary models. Pyvolve is an open-source project under a FreeBSD license, and it is available for download, along with a detailed user-manual and example scripts, from http://github.com/sjspielman/pyvolve.	[Spielman, Stephanie J.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Dept Integrat Biol, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Spielman, SJ (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Dept Integrat Biol, Austin, TX 78712 USA.	stephanie.spielman@gmail.com		Spielman, Stephanie/0000-0002-9090-4788	National Institutes of Health [F31GM113622]; Army Research Office [W911NF-12-1-0390]; Defense Threat Reduction Agency [HDTRA1-12-C-0007]; National Science Foundation, BEACON Center [DBI-0939454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM113622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation, BEACON Center(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.nih.gov/), Grant No. F31GM113622 to SJS; Army Research Office (www.aro.army.mil/), Grant No. W911NF-12-1-0390 to COW; Defense Threat Reduction Agency (www.dtra.mil/), Grant No. HDTRA1-12-C-0007 to COW; and National Science Foundation (www.nsf.gov/), Cooperative Agreement No. DBI-0939454, BEACON Center, to COW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, COMPUT SCI MONOGR, V28, P1; Arenas M, 2015, J MOL EVOL, V80, P189, DOI 10.1007/s00239-015-9673-0; Arenas M, 2013, BIOINFORMATICS, V29, P3020, DOI 10.1093/bioinformatics/btt530; Beiko RG, 2007, BIOINFORMATICS, V23, P825, DOI 10.1093/bioinformatics/btm024; Bielejec F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-133; Cartwright RA, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bti1200; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Jukes T.H., 1969, MAMMALIAN PROTEIN ME; Koestler T, 2012, MOL BIOL EVOL, V29, P2133, DOI 10.1093/molbev/mss078; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liberles, 2012, TRENDS EVOLUTIONARY, V4, pe9, DOI [10.4081/eb.2012.e9, DOI 10.4081/EB.2012.E9]; Mirsky A, 2015, MOL BIOL EVOL, V32, P806, DOI 10.1093/molbev/msu340; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Sipos B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-104; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	24	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139047	10.1371/journal.pone.0139047	http://dx.doi.org/10.1371/journal.pone.0139047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397960	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500136
J	Heinzel, S; Metzger, FG; Ehlis, AC; Korell, R; Alboji, A; Haeussinger, FB; Wurster, I; Brockmann, K; Suenkel, U; Eschweiler, GW; Maetzler, W; Berg, D; Fallgatter, AJ				Heinzel, Sebastian; Metzger, Florian G.; Ehlis, Ann-Christine; Korell, Robert; Alboji, Ahmed; Haeussinger, Florian B.; Wurster, Isabel; Brockmann, Kathrin; Suenkel, Ulrike; Eschweiler, Gerhard W.; Maetzler, Walter; Berg, Daniela; Fallgatter, Andreas J.			Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; RISK-FACTORS; HEMISPHERIC-ASYMMETRY; BLOOD-FLOW; DEMENTIA; MODEL; CONVERSION; SIGNALS	Background Aging processes and several vascular burden factors have been shown to increase the risk of dementia including Alzheimer's disease. While pathological alterations in dementia precede diagnosis by many years, reorganization of brain processing might temporarily delay cognitive decline. We hypothesized that in healthy elderly individuals both age-related neural and vascular factors known to be related to the development of dementia impact functional cortical hemodynamics during increased cognitive demands. Methods Vascular burden factors and cortical functional hemodynamics during verbal fluency were assessed in 1052 non-demented elderly individuals (51 to 83 years; cross-sectional data of the longitudinal TREND study) using functional near-infrared spectroscopy (fNIRS). The prediction of functional hemodynamic responses by age in multiple regressions and the impact of single and cumulative vascular burden factors including hypertension, diabetes, obesity, smoking and atherosclerosis were investigated. Results Replicating and extending previous findings we could show that increasing age predicted functional hemodynamics to be increased in right prefrontal and bilateral parietal cortex, and decreased in bilateral inferior frontal junction during phonological fluency. Cumulative vascular burden factors, with hypertension in particular, decreased left inferior frontal junction hemodynamic responses during phonological fluency. However, age and vascular burden factors showed no statistical interaction on functional hemodynamics. Conclusion Based on these findings, one might hypothesize that increased fronto-parietal processing may represent age-related compensatory reorganization during increased cognitive demands. Vascular burden factors, such as hypertension, may contribute to regional cerebral hypoperfusion. These neural and vascular hemodynamic determinants should be investigated longitudinally and combined with other markers to advance the prediction of future cognitive decline and dementia.	[Heinzel, Sebastian; Wurster, Isabel; Brockmann, Kathrin; Suenkel, Ulrike; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany; [Heinzel, Sebastian; Metzger, Florian G.; Ehlis, Ann-Christine; Korell, Robert; Alboji, Ahmed; Haeussinger, Florian B.; Eschweiler, Gerhard W.; Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Heinzel, Sebastian; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Metzger, Florian G.; Eschweiler, Gerhard W.] Univ Tubingen Hosp, Geriatr Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heinzel, S (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany.	Sebastian.Heinzel@med.uni-tuebingen.de	Suenkel, Ulrike/ABE-3111-2020; Heinzel, Sebastian/AFK-4188-2022; Suenkel, Ulrike/AAN-3845-2021; Maetzler, Walter/AAE-5831-2020; Berg, Daniela/A-8728-2019; Maetzler, Walter/A-6796-2011	Suenkel, Ulrike/0000-0002-5348-3996; Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Ehlis, Ann-Christine/0000-0002-8142-9743; Heinzel, Sebastian/0000-0003-4516-0529	University Hospital of Tubingen; Hertie-Institute for Clinical Brain Research; German Center for Neurodegenerative Diseases (DZNE); Center for integrative Neurosciences (CIN); Parkinson Fonds; Teva Pharmaceutical Industries; ucb; Janssen Pharmaceutical Inc.	University Hospital of Tubingen; Hertie-Institute for Clinical Brain Research; German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); Center for integrative Neurosciences (CIN); Parkinson Fonds; Teva Pharmaceutical Industries(Teva Pharmaceutical Industries); ucb(UCB Pharma SA); Janssen Pharmaceutical Inc.	This work was supported by mixed financing with institutional support by the University Hospital of Tubingen, Hertie-Institute for Clinical Brain Research, German Center for Neurodegenerative Diseases (DZNE), Center for integrative Neurosciences (CIN), Parkinson Fonds and Industry (Teva Pharmaceutical Industries, ucb, Janssen Pharmaceutical Inc.), http://www.trend-studie.de/english/funding/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Bauernfeind G, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4430; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg Daniela, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS195, DOI 10.1016/S1353-8020(11)70061-X; Bonnery C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056002; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chetelat G, 2013, NEUROIMAGE, V76, P167, DOI 10.1016/j.neuroimage.2013.03.009; de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fallgatter AJ, 1997, COGNITIVE BRAIN RES, V6, P67, DOI 10.1016/S0926-6410(97)00016-5; Gaenslen A, 2014, EUR J NEUROL, V21, P766, DOI 10.1111/ene.12382; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Heinzel S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00161; Heinzel S, 2013, NEUROIMAGE, V71, P125, DOI 10.1016/j.neuroimage.2012.12.074; Heinzel S, 2013, NEUROBIOL AGING, V34, P439, DOI 10.1016/j.neurobiolaging.2012.05.021; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Herrmann MJ, 2008, AM J GERIAT PSYCHIAT, V16, P125, DOI 10.1097/JGP.0b013e3180cc1fbc; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Huang CM, 2012, NEUROPSYCHOLOGIA, V50, P55, DOI 10.1016/j.neuropsychologia.2011.10.022; Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kitabayashi Y, 2001, PSYCHIAT CLIN NEUROS, V55, P459, DOI 10.1046/j.1440-1819.2001.00890.x; Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Maetzler W, 2012, J ALZHEIMERS DIS, V32, P95, DOI 10.3233/JAD-2012-120625; Moghekar A, 2013, NEUROLOGY, V81, P1753, DOI 10.1212/01.wnl.0000435558.98447.17; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Purnell C, 2009, ALZ DIS ASSOC DIS, V23, P1, DOI 10.1097/WAD.0b013e318187541c; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Song XW, 2013, J NEUROL NEUROSUR PS, V84, P71, DOI 10.1136/jnnp-2012-303579; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Yamamoto T, 2002, PHYS MED BIOL, V47, P1121, DOI 10.1088/0031-9155/47/7/309; Zimmerman B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00059; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	51	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138863	10.1371/journal.pone.0138863	http://dx.doi.org/10.1371/journal.pone.0138863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394050	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100109
J	Lo, LY; Wong, ML; Lee, KH; Leung, KS				Lo, Leung-Yau; Wong, Man-Leung; Lee, Kin-Hong; Leung, Kwong-Sak			Time Delayed Causal Gene Regulatory Network Inference with Hidden Common Causes	PLOS ONE			English	Article							EXPRESSION; LATENT; RECONSTRUCTION; IDENTIFICATION; ALGORITHM; MODELS; ARACNE	Inferring the gene regulatory network (GRN) is crucial to understanding the working of the cell. Many computational methods attempt to infer the GRN from time series expression data, instead of through expensive and time-consuming experiments. However, existing methods make the convenient but unrealistic assumption of causal sufficiency, i.e. all the relevant factors in the causal network have been observed and there are no unobserved common cause. In principle, in the real world, it is impossible to be certain that all relevant factors or common causes have been observed, because some factors may not have been conceived of, and therefore are impossible to measure. In view of this, we have developed a novel algorithm named HCC-CLINDE to infer an GRN from time series data allowing the presence of hidden common cause(s). We assume there is a sparse causal graph (possibly with cycles) of interest, where the variables are continuous and each causal link has a delay (possibly more than one time step). A small but unknown number of variables are not observed. Each unobserved variable has only observed variables as children and parents, with at least two children, and the children are not linked to each other. Since it is difficult to obtain very long time series, our algorithm is also capable of utilizing multiple short time series, which is more realistic. To our knowledge, our algorithm is far less restrictive than previous works. We have performed extensive experiments using synthetic data on GRNs of size up to 100, with up to 10 hidden nodes. The results show that our algorithm can adequately recover the true causal GRN and is robust to slight deviation from Gaussian distribution in the error terms. We have also demonstrated the potential of our algorithm on small YEASTRACT subnetworks using limited real data.	[Lo, Leung-Yau; Lee, Kin-Hong; Leung, Kwong-Sak] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Wong, Man-Leung] Lingnan Univ, Dept Comp & Decis Sci, Tuen Mun, Hong Kong, Peoples R China	Chinese University of Hong Kong; Lingnan University	Lo, LY (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China.	lylo@cse.cuhk.edu.hk			Research Grants Council of the Hong Kong Special Administrative Region [414413, LU310111]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This work was supported by The Research Grants Council of the Hong Kong Special Administrative Region (http://www.ugc.edu.hk/eng/rgc/index.htm), Project References 414413: KSL and LU310111: MLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Anandkumar A., 2013, P INT C MACH LEARN, V28, P249; Anchang B, 2009, P NATL ACAD SCI USA, V106, P6447, DOI 10.1073/pnas.0809822106; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Boyen X, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P91; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Colombo D, 2012, ANN STAT, V40, P294, DOI 10.1214/11-AOS940; Dumcke S, 2013, BIOINFORMATICS; Eichler M., 2005, TECHNICAL REPORT; ElBakry O, 2013, IEEE ACM T COMPUT BI, V10, P671, DOI 10.1109/TCBB.2013.73; Elidan G., 2000, P ANN C NEUR INF PRO, P479; Elidan G, 2001, P 17 C UNC ART INT, P144; GLYMOUR C, 1988, J ECONOMETRICS, V39, P175, DOI 10.1016/0304-4076(88)90044-9; Gregoretti F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010179; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hyttinen A, 2013, P 29 C UNC ART INT B; Hyvarinen A., 2008, PROC INT C MACH LEAR, P424; Itani S., 2010, J MACHINE LEARNING R, P165; Jalali A., 2012, P 29 INT C MACH LEAR, P473; Julius A, 2009, IET SYST BIOL, V3, P155, DOI 10.1049/iet-syb.2008.0130; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kuo HC, 2009, HIS 2009: 2009 NINTH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS, VOL 1, PROCEEDINGS, P117, DOI 10.1109/HIS.2009.31; Lacerda G, 2008, P 24 C UNC ART INT U; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Lo LY, 2015, IEEE ACM T COMPUT BI, V12, P1169, DOI 10.1109/TCBB.2015.2394442; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Pellet Jean-Philippe, 2009, ADV NEURAL INFORM PR, P1249; Ram R., 2006, COMP INT BIOINF COMP, P1, DOI [10.1109/CIBCB.2006.330982, DOI 10.1109/CIBCB.2006.330982]; Richardson T, 1996, TECHNICAL REPORT; Sadeh MJ, 2013, J COMPUT BIOL, V20, P920, DOI 10.1089/cmb.2013.0119; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Silva R, 2005, THESIS U W FLORIDA; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spirtes P, 2001, CAUSATION PREDICTION; Swinburne IA, 2008, DEV CELL, V14, P324, DOI 10.1016/j.devcel.2008.02.002; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Teran-Romero L. Mier-y, 2010, PLOS COMPUT BIOL, V6, DOI DOI 10.1371/J0URNAL.PCBI.1000726; Tienda-Luna I., 2007, EURASIP J BIOINFORMA; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Xing ZZ, 2006, ICDM 2006: SIXTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, WORKSHOPS, P190; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang X, 2005, LECT NOTES ARTIF INT, V3581, P524; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	55	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138596	10.1371/journal.pone.0138596	http://dx.doi.org/10.1371/journal.pone.0138596			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394325	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100076
J	Xiong, JH; Piemontese, M; Onal, M; Campbell, J; Goellner, JJ; Dusevich, V; Bonewald, L; Manolagas, SC; O'Brien, CA				Xiong, Jinhu; Piemontese, Marilina; Onal, Melda; Campbell, Josh; Goellner, Joseph J.; Dusevich, Vladimir; Bonewald, Lynda; Manolagas, Stavros C.; O'Brien, Charles A.			Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone	PLOS ONE			English	Article							LIGAND GENE-EXPRESSION; OSTEOPROTEGERIN-LIGAND; RECEPTOR ACTIVATOR; T-CELLS; RESORPTION; ENHANCERS; DIFFERENTIATION; HOMEOSTASIS; REGULATOR; LINEAGE	The cytokine receptor activator of nuclear factor kappa B ligand (RANKL), encoded by the Tnfsf11 gene, is essential for osteoclastogenesis and previous studies have shown that deletion of the Tnfsf11 gene using a Dmp1-Cre transgene reduces osteoclast formation in cancellous bone by more than 70%. However, the Dmp1-Cre transgene used in those studies leads to recombination in osteocytes, osteoblasts, and lining cells making it unclear whether one or more of these cell types produce the RANKL required for osteoclast formation in cancellous bone. Because osteoblasts, osteocytes, and lining cells have distinct locations and functions, distinguishing which of these cell types are sources of RANKL is essential for understanding the orchestration of bone remodeling. To distinguish between these possibilities, we have now created transgenic mice expressing the Cre recombinase under the control of regulatory elements of the Sost gene, which is expressed in osteocytes but not osteoblasts or lining cells in murine bone. Activity of the Sost-Cre transgene in osteocytes, but not osteoblast or lining cells, was confirmed by crossing Sost-Cre transgenic mice with tdTomato and R26R Cre-reporter mice, which express tdTomato fluorescent protein or LacZ, respectively, only in cells expressing the Cre recombinase or their descendants. Deletion of the Tnfsf11 gene in Sost-Cre mice led to a threefold decrease in osteoclast number in cancellous bone and increased cancellous bone mass, mimicking the skeletal phenotype of mice in which the Tnfsf11 gene was deleted using the Dmp1-Cre transgene. These results demonstrate that osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling cancellous bone.	[Xiong, Jinhu; Piemontese, Marilina; Onal, Melda; Campbell, Josh; Goellner, Joseph J.; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Xiong, Jinhu; Piemontese, Marilina; Onal, Melda; Campbell, Josh; Goellner, Joseph J.; Manolagas, Stavros C.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Dusevich, Vladimir; Bonewald, Lynda] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Missouri System; University of Missouri Kansas City	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; xiong, jinhu/E-1849-2011; Bonewald, Lynda/Q-3638-2019	Piemontese, Marilina/0000-0002-9296-1348	National Institutes of Health [AR049794, AG13918]; Central Arkansas Veteran's Healthcare System [1I01BX000294]; UAMS Translational Research Institute [UL1 RR029884]; UAMS; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute; UAMS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	Funding: This work was supported by grants from the National Institutes of Health (AR049794 to C.A.O. and AG13918 to S.C.M.) and the Central Arkansas Veteran's Healthcare System (Merit Review 1I01BX000294 to C.A.O.). Additional support was provided by the UAMS Translational Research Institute (UL1 RR029884) and by UAMS tobacco settlement funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Bishop KA, 2015, J CELL BIOCHEM, V116, P320, DOI 10.1002/jcb.24974; Bishop KA, 2011, J BIOL CHEM, V286, P20880, DOI 10.1074/jbc.M111.231548; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Chia LY, 2015, BONE, V72, P34, DOI 10.1016/j.bone.2014.11.005; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Fumoto T, 2014, J BONE MINER RES, V29, P830, DOI 10.1002/jbmr.2096; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Obr AE, 2013, MOL ENDOCRINOL, V27, P1808, DOI 10.1210/me.2013-1077; Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steenhard BA, 2007, DEV DYNAM, V236, P1115, DOI 10.1002/dvdy.21106; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Weinstein RS, 2011, ENDOCRINOLOGY, V152, P3323, DOI 10.1210/en.2011-0170; WEIS J, 1991, J CELL BIOL, V113, P1385, DOI 10.1083/jcb.113.6.1385; Xiong JH, 2014, BONE, V66, P146, DOI 10.1016/j.bone.2014.06.006; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	37	158	164	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138189	10.1371/journal.pone.0138189	http://dx.doi.org/10.1371/journal.pone.0138189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393791	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100035
J	Guruge, KS; Yamanaka, N; Sonobe, M; Fujizono, W; Yoshioka, M; Akiba, M; Yamamoto, T; Joshua, DI; Balakrishna, K; Yamashita, N; Kannan, K; Tsutsui, T				Guruge, Keerthi S.; Yamanaka, Noriko; Sonobe, Miyuki; Fujizono, Wataru; Yoshioka, Miyako; Akiba, Masato; Yamamoto, Takehisa; Joshua, Derrick I.; Balakrishna, Keshava; Yamashita, Nobuyoshi; Kannan, Kurunthachalam; Tsutsui, Toshiyuki			Source-Related Effects of Wastewater on Transcription Factor (AhR, CAR and PXR)-Mediated Induction of Gene Expression in Cultured Rat Hepatocytes and Their Association with the Prevalence of Antimicrobial-Resistant Escherichia coli	PLOS ONE			English	Article							TREATMENT-PLANT EFFLUENTS; SEWAGE-TREATMENT PLANTS; IN-VITRO ASSESSMENT; MUNICIPAL WASTE; ORGANIC MICROPOLLUTANTS; ANTIBIOTIC-RESISTANCE; DRINKING-WATER; PHARMACEUTICALS; SURFACE; IDENTIFICATION	Extracts of wastewater collected from 4 sewage treatment plants (STPs) receiving effluents from different sources in South India were investigated for their levels of transcription factor-mediated gene induction in primary cultured rat hepatocytes. In addition, the relation between gene induction levels and the prevalence of antimicrobial-resistant Escherichia coli (E. coli) in wastewater was examined. STP-3, which treats only hospital wastewater, exhibited significantly greater induction potency of all 6 drug metabolizing cytochrome P450 (CYP) genes examined, CYP1A1, 1A2, 1B1, 2B15, 3A1, and 3A2, whereas the wastewater at STP-1, which exclusively receives domestic sewage, showed significantly diminished levels of induction of 3 CYP genes when compared to the levels of CYP induction at STP-2, which receives mixed wastewater. Samples collected during the monsoon season showed a significantly altered gene induction capacity compared to that of samples from the pre-monsoon period. The data suggest that the toxicity of wastewater in STPs was not significantly diminished during the treatment process. The chemical-gene interaction data predicted that a vast number of chemicals present in the wastewater would stimulate the genes studied in the rat hepatocytes. The multivariable logistic regression analysis demonstrated that the prevalence of isolates resistant to cefotaxime, imipenem and streptomycin was significantly correlated with the levels of induction of at least three CYP-isozymes in STP wastewater. In addition, the resistance of isolates in treatment plants was not altered by the treatment steps, whereas the sampling season did have an impact on the resistance to specific antimicrobials. The identification of receptor-mediated gene regulation capacities offers important data not limited to the (synergistic) physiological role of chemicals in biological systems but may provide new insight into the link between the effects of known/unknown drugs and prevalence of antimicrobial-resistant bacteria in wastewater.	[Guruge, Keerthi S.; Yamanaka, Noriko; Sonobe, Miyuki; Fujizono, Wataru; Yoshioka, Miyako] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki, Japan; [Sonobe, Miyuki] Cent Livestock Hyg Serv Ctr, Wakakusu, Japan; [Fujizono, Wataru] Cent Livestock Hyg Serv Ctr, Minami Ku, Kumamoto, Japan; [Akiba, Masato] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Yamamoto, Takehisa; Tsutsui, Toshiyuki] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki, Japan; [Joshua, Derrick I.; Balakrishna, Keshava] Manipal Univ, Manipal Inst Technol, Dept Civil Engn, Manipal, Karnataka, India; [Yamashita, Nobuyoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Kannan, Kurunthachalam] SUNY Albany, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12222 USA; [Kannan, Kurunthachalam] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Manipal Academy of Higher Education (MAHE); National Institute of Advanced Industrial Science & Technology (AIST); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Guruge, KS (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki, Japan.	guruge@affrc.go.jp	Guruge, Keerthi/AAW-4155-2021; Balakrishna, K/H-4796-2019; Yamashita, Nobuyoshi/L-3290-2018	Balakrishna, K/0000-0002-5399-0808; Yamashita, Nobuyoshi/0000-0003-3448-8713; Kannan, Kurunthachalam/0000-0002-1926-7456	Japan Society for the Promotion of Science [24256004]; Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University	This work was supported by the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (A), 2012 to 2015 (24256004). Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University, is thanked for supporting this study at Manipal, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens L, 2009, MAR POLLUT BULL, V58, P1326, DOI 10.1016/j.marpolbul.2009.04.028; Akiba M, 2015, ECOTOX ENVIRON SAFE, V115, P203, DOI 10.1016/j.ecoenv.2015.02.018; Amos GCA, 2015, ISME J, V9, P1467, DOI 10.1038/ismej.2014.237; Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Budinsky RA, 2010, TOXICOL SCI, V118, P224, DOI 10.1093/toxsci/kfq238; Clarke BO, 2011, ENVIRON INT, V37, P226, DOI 10.1016/j.envint.2010.06.004; Escher BI, 2008, J ENVIRON MONITOR, V10, P622, DOI 10.1039/b800951a; Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t; Escher BI, 2011, WATER RES, V45, P75, DOI 10.1016/j.watres.2010.08.019; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1; Guruge KS, 2009, TOXICOL LETT, V185, P193, DOI 10.1016/j.toxlet.2009.01.002; Hasegawa J, 2007, CHEMOSPHERE, V69, P1188, DOI 10.1016/j.chemosphere.2007.06.021; Hilscherova K, 2000, ENVIRON SCI POLLUT R, V7, P159, DOI 10.1065/espr2000.02.017; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jacobs JM, 1999, TOXICOL APPL PHARM, V157, P51, DOI 10.1006/taap.1999.8659; Jalova V, 2013, ENVIRON INT, V59, P372, DOI 10.1016/j.envint.2013.06.024; Jarosova B, 2014, ENVIRON SCI POLLUT R, V21, P10970, DOI 10.1007/s11356-014-3056-8; Kido T, 2013, ENVIRON TOXICOL, V28, P21, DOI 10.1002/tox.20693; Kitani H., 2011, J VISUAL EXP JVE, V51, P2757; Kostich MS, 2014, ENVIRON POLLUT, V184, P354, DOI 10.1016/j.envpol.2013.09.013; Kumar V, 2008, TOXICOL APPL PHARM, V226, P60, DOI 10.1016/j.taap.2007.08.023; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kumari Ranjeeta, 2012, J Family Med Prim Care, V1, P86, DOI 10.4103/2249-4863.104943; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; McClellan K, 2010, WATER RES, V44, P658, DOI 10.1016/j.watres.2009.12.032; Morisseau C, 2009, ENVIRON HEALTH PERSP, V117, P1867, DOI 10.1289/ehp.0900834; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Pustylnyak VO, 2007, LIFE SCI, V80, P324, DOI 10.1016/j.lfs.2006.09.015; R Core Team, 2013, R LANG ENV STAT COMP; Ratola N, 2012, J HAZARD MATER, V239, P1, DOI 10.1016/j.jhazmat.2012.05.040; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Schriks M, 2010, ENVIRON SCI TECHNOL, V44, P4766, DOI 10.1021/es100013x; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Smital T, 2011, ECOTOX ENVIRON SAFE, V74, P844, DOI 10.1016/j.ecoenv.2010.11.010; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; Subedi B, 2014, ENVIRON SCI TECHNOL, V48, P6661, DOI 10.1021/es501709a; Suzuki G, 2010, ENVIRON SCI TECHNOL, V44, P8330, DOI 10.1021/es102021c; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060368; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang J G, 2010, Drug Metab Lett, V4, P185; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	54	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138391	10.1371/journal.pone.0138391	http://dx.doi.org/10.1371/journal.pone.0138391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381891	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200097
J	Kramer, BH; Schrempf, A; Scheuerlein, A; Heinze, J				Kramer, Boris H.; Schrempf, Alexandra; Scheuerlein, Alexander; Heinze, Juergen			Ant Colonies Do Not Trade-Off Reproduction against Maintenance	PLOS ONE			English	Article							BODY-SIZE; LIFE-SPAN; EVOLUTION; FECUNDITY; QUEENS; LONGEVITY; AGE; PRODUCTIVITY; POPULATIONS; SENESCENCE	The question on how individuals allocate resources into maintenance and reproduction is one of the central questions in life history theory. Yet, resource allocation into maintenance on the organismic level can only be measured indirectly. This is different in a social insect colony, a "superorganism" where workers represent the soma and the queen the germ line of the colony. Here, we investigate whether trade-offs exist between maintenance and reproduction on two levels of biological organization, queens and colonies, by following single-queen colonies of the ant Cardiocondyla obscurior throughout the entire lifespan of the queen. Our results show that maintenance and reproduction are positively correlated on the colony level, and we confirm results of an earlier study that found no trade-off on the individual (queen) level. We attribute this unexpected outcome to the existence of a positive feedback loop where investment into maintenance (workers) increases the rate of resource acquisition under laboratory conditions. Even though food was provided ad libitum, variation in productivity among the colonies suggests that resources can only be utilized and invested into additional maintenance and reproduction by the colony if enough workers are available. The resulting relationship between per-capita and colony productivity in our study fits well with other studies conducted in the field, where decreasing per-capita productivity and the leveling off of colony productivity have been linked to density dependent effects due to competition among colonies. This suggests that the absence of trade-offs in our laboratory study might also be prevalent under natural conditions, leading to a positive association of maintenance, (=growth) and reproduction. In this respect, insect colonies resemble indeterminate growing organisms.	[Kramer, Boris H.; Scheuerlein, Alexander] Max Planck Inst Demog Res, Konrad Zuse Str 1, D-18055 Rostock, Germany; [Schrempf, Alexandra; Heinze, Juergen] Univ Regensburg, Zool Evolutionary Biol Lab, D-93040 Regensburg, Germany	Max Planck Society; University of Regensburg	Kramer, BH (corresponding author), Max Planck Inst Demog Res, Konrad Zuse Str 1, D-18055 Rostock, Germany.	Kramer@demogr.mpg.de	Kramer, Boris/AAO-3183-2021; Scheuerlein, Alexander/AAK-1111-2021					Brian A, 2013, CLASSIFICATION REGRE; Charnov Eric L., 1993, P1; Crawley M.J., 2007, R BOOK; Cremer S, 2002, P ROY SOC B-BIOL SCI, V269, P417, DOI 10.1098/rspb.2001.1892; Cremer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017323; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; French BW, 2011, ANN ENTOMOL SOC AM, V104, P834, DOI 10.1603/AN11003; Giraldo YM, 2014, BEHAV ECOL SOCIOBIOL, V68, P1901, DOI 10.1007/s00265-014-1826-4; Heinze J, 2006, INSECT SOC, V53, P1, DOI 10.1007/s00040-005-0847-4; Heinze J, 2008, GERONTOLOGY, V54, P160, DOI 10.1159/000122472; Heinze J, 2013, BEHAV ECOL SOCIOBIOL, V67, P1555, DOI 10.1007/s00265-013-1567-9; Heinze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035201; Heyland A, 2011, MECH LIFE HIST EVOLU, DOI [10.1111/j.1558-5646.2011.01337.x, DOI 10.1111/J.1558-5646.2011.01337.X]; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holldobler B., 1990, pi; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; KASPARI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P255, DOI 10.1007/s002650050189; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kramer BH, 2014, BEHAV ECOL SOCIOBIOL, V68, P41, DOI 10.1007/s00265-013-1620-8; Kramer BH, 2013, BIOL J LINN SOC, V109, P710, DOI 10.1111/bij.12072; Kramer BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061813; Lopez VM, 2014, ANN ENTOMOL SOC AM, V107, P539, DOI 10.1603/AN13158; Lopez-Vaamonde C, 2009, J EVOLUTION BIOL, V22, P983, DOI 10.1111/j.1420-9101.2009.01706.x; Lumley T, 2011, R PACKAGE VERSION, V2, P36, DOI DOI 10.HTTP://CRAN.R-PR0JECT.0RG/PACKAGE; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; Medeiros RS, 2000, J APPL ENTOMOL, V124, P319, DOI 10.1046/j.1439-0418.2000.00482.x; Michener C. D., 1964, Insectes Sociaux Paris, V11, P317, DOI 10.1007/BF02227433; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Naug D, 2006, BEHAV ECOL SOCIOBIOL, V60, P62, DOI 10.1007/s00265-005-0141-5; Polanco Andrea M., 2011, Insects, V2, P326, DOI 10.3390/insects2030326; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; [R Development Core Team Team R], 2013, R LANG ENV STAT COM; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 2003, EXP GERONTOL, V38, P741, DOI 10.1016/S0531-5565(03)00101-3; Ricklefs RE, 2007, ECOL LETT, V10, P867, DOI 10.1111/j.1461-0248.2007.01085.x; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI [10.1111/j.1558-5646.1999.tb03796.x, 10.2307/2640797]; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Schrempf A, 2011, J EVOLUTION BIOL, V24, P1455, DOI 10.1111/j.1420-9101.2011.02278.x; Seifert B., 2003, ANN NATURHISTORISC B, V104 B, P203; Stearns S.C., 1992, pi; Stevens MI, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-153; Tsuji K, 1996, OIKOS, V76, P83, DOI 10.2307/3545750; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Wheller WM, 1911, J MORPHOL, V22, P307; Wilson DS, 1997, AM NAT, V150, pS122, DOI 10.1086/286053	50	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137969	10.1371/journal.pone.0137969	http://dx.doi.org/10.1371/journal.pone.0137969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383861	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200046
J	Wang, Y; Dong, WZ; Mauk, K; Li, PY; Wan, J; Yang, G; Fang, LY; Huan, W; Chen, C; Hao, M				Wang, Ying; Dong, Weizhen; Mauk, Kristen; Li, Peiying; Wan, Jin; Yang, Guang; Fang, Lyuying; Huan, Wan; Chen, Chun; Hao, Mo			Nurses' Practice Environment and Their Job Satisfaction: A Study on Nurses Caring for Older Adults in Shanghai	PLOS ONE			English	Article							LONG-TERM-CARE; REGISTERED NURSES; HEALTH-SERVICE; WORK; LEAVE; INTENTIONS; PREDICTORS; CHINA; QUIT	Aim To examine the job satisfaction of nurses who are caring for older adults in healthcare settings in Shanghai, and to explore the underlying factors in order to explain and predict nurses' job satisfaction. Background China has the largest elderly population in the world, and its population is aging rapidly. Studies on job satisfaction of nurses providing care for the elderly in China can help to identify problem areas and develop strategies for the improvement of nurses' working conditions. However, to date, this subject matter has not been thoroughly studied in the Chinese context. Previous studies in other countries show that many factors impact nurses' job satisfaction, with the practice environment being a critical factor. There is a serious nursing shortage in China, especially in the big cities such as Shanghai. Given the increasing care demand of the aging population, learning about the job satisfaction level among nurses who are caring for older adults can provide essential information to help attract and retain nurses in this specialty area. Methods A cross-sectional survey was conducted among 444 nurses in 22 elderly care institutions in Shanghai. The Chinese version of the Index of Work Satisfaction (IWS) and the Nursing Practice Environment Scale were instruments used. Inferential statistical tests used to analyze the data included Spearman correlation analysis, one-way analysis of variance, and hierarchical regression tests. Results The average overall IWS (part B) score was 135.21 +/- 19.34. Personality, job and organizational characteristics were found to be the most influential factors, and the practice environment was identified as having the strongest impact on job satisfaction (Beta = 0.494). Conclusion Job satisfaction level among nurses who are caring for older adults in Shanghai is moderate, but the data suggest that this could be greatly increased if the nursing practice environment was improved.	[Wang, Ying; Wan, Jin; Yang, Guang; Fang, Lyuying; Huan, Wan; Hao, Mo] Fudan Univ, Res Inst Hlth Dev Strategies, Shanghai 200433, Peoples R China; [Dong, Weizhen] Univ Toronto, Munk Sch Global Affairs, Toronto, ON M5S 0A7, Canada; [Mauk, Kristen] Valparaiso Univ, Coll Nursing & Hlth Profess, Valparaiso, IN 46383 USA; [Li, Peiying] Hangzhou Vocat & Tech Coll, Sch Nursing, Hangzhou, Zhejiang, Peoples R China; [Chen, Chun] Wenzhou Med Coll, Coll Humanities & Management, Hangzhou, Zhejiang, Peoples R China	Fudan University; University of Toronto; Valparaiso University; Hangzhou Vocational & Technical College; Wenzhou Medical University	Chen, C (corresponding author), Wenzhou Med Coll, Coll Humanities & Management, Hangzhou, Zhejiang, Peoples R China.	chenchun408@126.com; haomo03@fudan.edu.cn	Chen, Chun/E-9759-2011; Hao, Mo/GRR-6669-2022		National Natural Science Foundation of China [70733002, 70703005]; Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT) [IRT_13R11]; Humanities and Social Sciences Research from the Ministry of Education of China [12YJCZH100]; National Social Science Fund of China [13AZD081]; Collaborative Innovation Center of Social Risks Governance in Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Humanities and Social Sciences Research from the Ministry of Education of China(Ministry of Education, China); National Social Science Fund of China; Collaborative Innovation Center of Social Risks Governance in Health	The project team is grateful to all of the participants in the study. This project was supported by the National Natural Science Foundation of China (grant number 70733002, 70703005), the Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT) (NO. IRT_13R11); the Humanities and Social Sciences Research (12YJCZH100) from the Ministry of Education of China; Program of National Social Science Fund of China [13AZD081]; and Collaborative Innovation Center of Social Risks Governance in Health also provided funding for the original research project. Mo Hao contributed in the study design, data collection.	Altier ME, 2006, J NURSES PROF DEV, V22, P70, DOI 10.1097/00124645-200603000-00006; Andrews Diane Randall, 2005, J Nurs Manag, V13, P286, DOI 10.1111/j.1365-2934.2005.00567.x; [Anonymous], 2011, CHINAS MAIN DEMOGRAP; Asadi A., 2008, J SOCIAL SCI, V4, P246; Burke Ronald J, 2003, Health Care Manag (Frederick), V22, P99; Caers R, 2008, J ADV NURS, V62, P521, DOI 10.1111/j.1365-2648.2008.04620.x; CARR KK, 1994, J ADV NURS, V19, P878, DOI 10.1111/j.1365-2648.1994.tb01164.x; Chan MF, 2009, J CLIN NURS, V18, P893, DOI 10.1111/j.1365-2702.2008.02463.x; China MoHo, 2013, CHIN HLTH STAT YB 20; Choi SPP, 2013, J NURS MANAGE, V21, P429, DOI 10.1111/j.1365-2834.2012.01415.x; Cimete G, 2003, J NURS CARE QUAL, V18, P151, DOI 10.1097/00001786-200304000-00009; Cohen JD, 2006, J HEALTHC MANAG, V51, P233, DOI 10.1097/00115514-200607000-00006; Curtis EA, 2007, INT NURS REV, V54, P92, DOI 10.1111/j.1466-7657.2007.00507.x; Evans MG, 1995, NURSING RES; Feng ZL, 2012, HEALTH AFFAIR, V31, P2764, DOI 10.1377/hlthaff.2012.0535; Fillion Lise, 2006, Palliat Support Care, V4, P333; Flanagan NA, 2002, RES NURS HEALTH, V25, P282, DOI 10.1002/nur.10042; Friese CR, 2005, ONCOLOGY NURSING FOR; Gardner Jane K, 2007, Nephrol Nurs J, V34, P271; Government SMPs, 2012, 5 YEAR PLAN 2011 201; Grant D, 2009, J HEALTH ECON, V28, P244, DOI 10.1016/j.jhealeco.2008.09.005; Hall Debra S, 2007, Nurs Adm Q, V31, P68; Happell B, 2003, INT J MENT HEALTH NU, V12, P39, DOI 10.1046/j.1440-0979.2003.00267.x; Hong T, 2010, CHINESE PRIMARY HLTH, V24, P17; IskraGolec I, 1996, WORK STRESS, V10, P251; Kacel Barbara, 2005, J Am Acad Nurse Pract, V17, P27, DOI 10.1111/j.1041-2972.2005.00007.x; Karanikola Maria N, 2007, J Nurs Manag, V15, P78, DOI 10.1111/j.1365-2934.2006.00673.x; Kash BA, 2010, HEALTH CARE MANAGE R, V35, P246, DOI 10.1097/HMR.0b013e3181dc826d; Lake ET, 2002, RES NURS HEALTH, V25, P176, DOI 10.1002/nur.10032; Larrabee JH, 2003, J NURS ADMIN, V33, P271, DOI 10.1097/00005110-200305000-00003; Ma CC, 2003, J NURS ADMIN, V33, P293, DOI 10.1097/00005110-200305000-00005; Manojlovich M, 2005, J NURS SCHOLARSHIP, V37, P367, DOI 10.1111/j.1547-5069.2005.00063.x; Manojlovich M, 2002, J NURS ADMIN, V32, P586, DOI 10.1097/00005110-200211000-00006; March JG., 1958, ORGANIZATIONS; Microbell, 2012, SER POP AG CHIN INL; Ministry of Health of the Peoples Republic of China, 2006, NOT WEB CTR PEOPL GO; Mittra R, 2010, DIMENTION ED, P137; Patrician PA, 2010, RES NURS HEALTH, V33, P99, DOI 10.1002/nur.20370; PETTERSON IL, 1995, PSYCHOTHER PSYCHOSOM, V64, P9, DOI 10.1159/000288986; Ruggiero JS, 2005, J NURS ADMIN, V35, P254; Sheng z, 2012, CHINESE J NURSING ED, V9, P319; Shields MA, 2002, ECONOMICA, V69, P295, DOI 10.1111/1468-0335.00284; Shields MA, 2001, J HEALTH ECON, V20, P677, DOI 10.1016/S0167-6296(01)00092-3; Stamps P.L., 1997, NURSES WORK SATISFAC, V2nd ed.; Upenieks VV, 2002, J NURS ADMIN, V32, P564, DOI 10.1097/00005110-200211000-00004; Wu B, 2008, J AGING SOC POLICY, V20, P218, DOI 10.1080/08959420801977632; Wu L, 2007, STUDY WORK SATISFACT; Xinhua, CHIN POP AG HIGHL SH; Yang Y., 2011, RES STATUS POLICIES; Zangaro GA, 2005, J NURS MEAS, V13, P7, DOI 10.1891/jnum.2005.13.1.7; Zangaro GA, 2007, RES NURS HEALTH, V30, P445, DOI 10.1002/nur.20202; Zeng Q, 2008, STUDY WORK SATISFACT; Zheng X, 2009, NURSE JOB SATISFACTI	53	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138035	10.1371/journal.pone.0138035	http://dx.doi.org/10.1371/journal.pone.0138035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26380980	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200050
J	Daniels, CML; Paffenrothl, E; Austin, EV; Glebov, K; Lewis, D; Walter, J; Messing, A				Daniels, Christine M. LaPash; Paffenrothl, Elizabeth; Austin, Elizabeth V.; Glebov, Konstantin; Lewis, Diana; Walter, Jochen; Messing, Albee			Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; AGGREGATE-PRONE PROTEINS; ALPHA-B-CRYSTALLIN; SIGNALING PATHWAY; GFAP ACCUMULATION; STRESS-RESPONSE; IN-VIVO; AUTOPHAGY; BRAIN; INHIBITION	Alexander disease is a fatal neurodegenerative disease caused by mutations in the astrocyte intermediate filament glial fibrillary acidic protein (GFAP). The disease is characterized by elevated levels of GFAP and the formation of protein aggregates, known as Rosenthal fibers, within astrocytes. Lithium has previously been shown to decrease protein aggregates by increasing the autophagy pathway for protein degradation. In addition, lithium has also been reported to decrease activation of the transcription factor STAT3, which is a regulator of GFAP transcription and astrogliogenesis. Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. Mice with the Gfap-R236H point mutation were fed lithium food pellets for 4 to 8 weeks. Four weeks of treatment with LiCl at 0.5% in food pellets decreased GFAP protein and transcripts in several brain regions, although with mild side effects and some mortality. Extending the duration of treatment to 8 weeks resulted in higher mortality, and again with a decrease in GFAP in the surviving animals. Indicators of autophagy, such as LC3, were not increased, suggesting that lithium may decrease levels of GFAP through other pathways. Lithium reduced the levels of phosphorylated STAT3, suggesting this as one pathway mediating the effects on GFAP. In conclusion, lithium has the potential to decrease GFAP levels in Alexander disease, but with a narrow therapeutic window separating efficacy and toxicity.	[Daniels, Christine M. LaPash; Paffenrothl, Elizabeth; Austin, Elizabeth V.; Lewis, Diana; Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Glebov, Konstantin; Walter, Jochen] Univ Bonn, Dept Neurol, Bonn, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Bonn	Messing, A (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	amessing@wisc.edu	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	National Institute of Neurological Disorders and Stroke [NS060120, NS042803]; National Institute of Child Health and Human Development [P30 HD003352]; Juanma Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060120, P01NS042803] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juanma Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (ninds.nih.gov; NS060120 and NS042803 to AM), the National Institute of Child Health and Human Development (nichd.nih.gov; P30 HD003352 to the Waisman Center), and the Juanma Fund (AM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi M, 2010, EUR J PAEDIATR NEURO, V14, P354, DOI 10.1016/j.ejpn.2009.11.006; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bersudsky Y, 2007, BEHAV PHARMACOL, V18, P77, DOI 10.1097/FBP.0b013e32801416ed; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chandana R, 2009, INDIAN J MED RES, V129, P189; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; Festing MFW, 2003, TRENDS PHARMACOL SCI, V24, P341, DOI 10.1016/S0165-6147(03)00159-7; Festing Michael F W, 2002, ILAR J, V43, P244; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P443, DOI 10.1021/cn5000309; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gao M, 2013, NEUROSCIENCE, V254, P301, DOI 10.1016/j.neuroscience.2013.09.033; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P1321, DOI 10.1038/sj.npp.1301254; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirschfeld R., 2002, PRACTICE GUIDELINE T; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kyllerman M, 2005, NEUROPEDIATRICS, V36, P319, DOI 10.1055/s-2005-872876; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MARTIN PM, 1995, J NEUROSCI METH, V58, P181, DOI 10.1016/0165-0270(94)00175-G; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; ROIZIN L, 1970, Diseases of the Nervous System, V31, P38; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; SCHOU M, 1958, ACTA PHARMACOL TOX, V15, P70; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Tajes M, 2008, J NEUROPATH EXP NEUR, V67, P612, DOI 10.1097/NEN.0b013e3181776293; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; THELLIER M, 1980, BRAIN RES, V199, P175, DOI 10.1016/0006-8993(80)90239-5; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8; Yoshida T, 2011, J NEUROL, V258, P1998, DOI 10.1007/s00415-011-6056-3; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020; Zhu ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023341	56	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138132	10.1371/journal.pone.0138132	http://dx.doi.org/10.1371/journal.pone.0138132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378915	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400057
J	Montoya, V; Fan, HL; Bryar, PJ; Weinstein, JL; Mets, MB; Feng, G; Martin, J; Martin, A; Jiang, HM; Laurie, NA				Montoya, Vanessa; Fan, Hanli; Bryar, Paul J.; Weinstein, Joanna L.; Mets, Marilyn B.; Feng, Gang; Martin, Joshua; Martin, Alissa; Jiang, Hongmei; Laurie, Nikia A.			Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation	PLOS ONE			English	Article							CELL-LINE; SERINE/THREONINE KINASE; ILLUMINA MICROARRAY; GENE; EXPRESSION; INVASION; MICRORNA-31; MIGRATION; INACTIVATION; CHEMOTHERAPY	Retinoblastoma is the most common intraocular tumor in children. Current management includes broad-based treatments such as chemotherapy, enucleation, laser therapy, or cryotherapy. However, therapies that target specific pathways important for retinoblastoma progression could provide valuable alternatives for treatment. MicroRNAs are short, noncoding RNA transcripts that can regulate the expression of target genes, and their aberrant expression often facilitates disease. The identification of post-transcriptional events that occur after the initiating genetic lesions could further define the rapidly aggressive growth displayed by retinoblastoma tumors. In this study, we used two phenotypically different retinoblastoma cell lines to elucidate the roles of miRNA-31 and miRNA-200a in tumor proliferation. Our approach confirmed thatmiRNAs-31 and -200a expression is significantly reduced in human retinoblastomas. Moreover, overexpression of these two miRNAs restricts the expansion of a highly proliferative cell line (Y79), but does not restrict the growth rate of a less aggressive cell line (Weri1). Gene expression profiling of miRNA-31 and/or miRNA-200a-overexpressing cells identified differentially expressed mRNAs associated with the divergent response of the two cell lines. This work has the potential to enhance the development of targeted therapeutic approaches for retinoblastoma and improve the efficacy of treatment.	[Montoya, Vanessa; Fan, Hanli; Martin, Joshua; Laurie, Nikia A.] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA; [Montoya, Vanessa; Weinstein, Joanna L.; Laurie, Nikia A.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Bryar, Paul J.; Mets, Marilyn B.] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Bryar, Paul J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Weinstein, Joanna L.; Martin, Alissa; Laurie, Nikia A.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60611 USA; [Mets, Marilyn B.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Ophthalmol, Chicago, IL 60611 USA; [Feng, Gang] Northwestern Univ, Feinberg Sch Med, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Jiang, Hongmei] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Stat, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University	Laurie, NA (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA.	n-laurie@northwestern.edu	Jiang, Hongmei/AAU-2911-2021	Bryar, Paul/0000-0001-8494-3089	Illinois Department of Public Health - Excellence in Academic Medicine Award; National Institutes of Health/National Cancer Institute grant [R21 CA167225]; National Institute of General Medical Sciences grant [R25 GM079300]; Research to Prevent Blindness Inc. NY, NY; NATIONAL CANCER INSTITUTE [R21CA167225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	Illinois Department of Public Health - Excellence in Academic Medicine Award; National Institutes of Health/National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness Inc. NY, NY(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Illinois Department of Public Health - Excellence in Academic Medicine Award (to NAL); National Institutes of Health/National Cancer Institute grant R21 CA167225, (www.nih.gov) (to NAL); National Institute of General Medical Sciences grant R25 GM079300, (www.nih.gov) (to VM); and the Research to Prevent Blindness Inc. NY, NY, (http://www.rpbusa.org) (to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adithi M, 2006, EXP EYE RES, V83, P1446, DOI 10.1016/j.exer.2006.08.003; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; FRANCOIS J, 1975, OPHTHALMOLOGICA, V170, P405, DOI 10.1159/000307248; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hua DS, 2012, ONCOL REP, V27, P700, DOI 10.3892/or.2011.1555; Huang J, 2003, BIOCHEM BIOPH RES CO, V309, P774, DOI 10.1016/j.bbrc.2003.08.069; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Jo DH, 2011, J PEDIAT HEMATOL ONC, V33, P529, DOI 10.1097/MPH.0b013e318228280a; Kaliki S, 2013, OPHTHALMOLOGY, V120, P997, DOI 10.1016/j.ophtha.2012.10.044; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Laurie N, 2009, MOL CELL BIOL, V29, P6268, DOI 10.1128/MCB.00374-09; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Laurila EM, 2012, GENE CHROMOSOME CANC, V51, P557, DOI 10.1002/gcc.21941; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martin A, 2013, BIOCHEM BIOPH RES CO, V440, P599, DOI 10.1016/j.bbrc.2013.09.117; Martin J, 2013, GENE, V512, P294, DOI 10.1016/j.gene.2012.09.129; MCFALL RC, 1977, CANCER RES, V37, P1003; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; SHIELDS CL, 1994, CANCER, V73, P692, DOI 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8; Silva AK, 2010, MOL VIS, V16, P36; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu N, 2013, J IMMUNOL, V190, P678, DOI 10.4049/jimmunol.1202695; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	44	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138366	10.1371/journal.pone.0138366	http://dx.doi.org/10.1371/journal.pone.0138366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379276	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400089
J	Pires, BM; Silva, DM; Visentin, LC; Rodrigues, BL; Carvalho, NMF; Faria, RB				Pires, Bianca M.; Silva, Daniel M.; Visentin, Lorenzo C.; Rodrigues, Bernardo L.; Carvalho, Nakedia M. F.; Faria, Roberto B.			Synthesis and Characterization of Cobalt(III), Nickel(II) and Copper(II) Mononuclear Complexes with the Ligand 1,3-bis[(2-aminoethypamino]-2-propanol and Their Catalase-Like Activity	PLOS ONE			English	Article							ABSORPTION-SPECTROSCOPY; CRYSTAL-STRUCTURE; EXCITED-STATES; BASE COMPLEXES; COORDINATION; PEROXIDE; ACID; OXIDATION; ALCOHOL; MIMICS	In this work, we present the synthesis and characterization of two new mononuclear complexes with the ligand 1,3-bis[(2-aminoethypamino]-2-propanol (HL), [Co(L)(H2O)](CIO4)(2) (1), [Ni(HL)](CIO4)2 (2), as well as the known complex [Cu(HL)](CIO4)2 (3) for comparison. Their abilities to catalyze the dismutation of H2O2 and the oxidation of cyclohexane were investigated. The complexes were characterized by X-ray diffraction, elemental analysis, electronic and infrared spectroscopy, cyclic voltammetry, electrospray ionization mass spectrometry (ESI-MS) and conductivity measurements. The X-ray structures showed that the nickel (2) and copper (3) complexes are tetracoordinated, with the metal ion bound to the nitrogen atoms of the ligand. On the other hand, the cobalt complex (1) is hexacoordinated, possessing additional bonds to the alkoxo group of the ligand and to a water molecule. Neither of the complexes was able to catalyze the oxidation of cyclohexane, but all of them exhibited catalase-like activity, following Michaelis-Menten kinetics, which suggest resemblance with the catalase natural enzymes. The catalytic activity followed the order: > [Cu(HIA(CIOO2 (3) [Ni(HLTCIO4)2 (2) > [Co(L)(H2O)](CIO2 (1). As far as we know, this is the first description of a nickel complex presenting a significant catalase-like activity.	[Pires, Bianca M.; Silva, Daniel M.; Carvalho, Nakedia M. F.; Faria, Roberto B.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil; [Visentin, Lorenzo C.] NanoBusiness Informacao & Inovacao Ltda, Rio De Janeiro, RJ, Brazil; [Rodrigues, Bernardo L.] Univ Fed Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais	Faria, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	faria@iq.ufrj.br	Faria, Roberto B./B-5455-2013; Visentin, Lorenzo C/L-4657-2016; Carvalho, Nakédia M F/G-8260-2012; Rodrigues, Bernardo Lages/U-1471-2019	Visentin, Lorenzo C/0000-0003-0727-2108; Carvalho, Nakédia M F/0000-0001-5229-5689; FARIA, ROBERTO/0000-0001-9337-4324	Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ) [308.497/2013-9, 132.749/2010-6, 140.797/2012-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/200.171/2015]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01778-12]; NanoBusiness Informacao e Inovacao Ltda	Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NanoBusiness Informacao e Inovacao Ltda	This work was supported by Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ), Grants 308.497/2013-9, 132.749/2010-6, 140.797/2012-2; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Grant E-26/200.171/2015; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant APQ-01778-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that NanoBusiness Informacao e Inovacao Ltda provided support in the form of salaries for the author LCV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Allen F.H., 1995, INT TABLES CRYSTALLO, VC, P685; Bernhardt PV, 1998, J CHEM SOC DALTON, P1087, DOI 10.1039/a800297e; Bussiere G, 1998, J AM CHEM SOC, V120, P6306, DOI 10.1021/ja9740733; Carvalho NMF, 2006, APPL CATAL A-GEN, V305, P140, DOI 10.1016/j.apcata.2006.02.053; Choua S, 1997, J INORG BIOCHEM, V65, P79, DOI 10.1016/S0162-0134(96)00091-8; Dede B, 2009, APPL ORGANOMET CHEM, V23, P512, DOI 10.1002/aoc.1557; Dede B, 2009, J HAZARD MATER, V163, P1148, DOI 10.1016/j.jhazmat.2008.07.070; Demetgul C, 2012, CARBOHYD POLYM, V89, P354, DOI 10.1016/j.carbpol.2012.03.013; Duisenberg AJM, 2003, J APPL CRYSTALLOGR, V36, P220, DOI 10.1107/S0021889802022628; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Duisenberg AJM, 2000, J APPL CRYSTALLOGR, V33, P893, DOI 10.1107/S0021889800002363; Espenson J.H., 2002, CHEM KINETICS REACTI; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Gao J, 2003, INORG CHIM ACTA, V346, P32, DOI 10.1016/S0020-1693(02)01393-2; Gao J, 2002, INORG CHEM COMMUN, V5, P1095; GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0; Gonzalez E, 2007, COORDIN CHEM REV, V251, P351, DOI 10.1016/j.ccr.2006.08.011; Griesser R., 1974, J COORD CHEM, V3, P235; Hadadzadeh H, 2011, POLYHEDRON, V30, P2535, DOI 10.1016/j.poly.2011.06.037; Harrowfield JM, 2004, INORG CHEM, V43, P1689, DOI 10.1021/ic034912o; Heineman W.R., 1996, LAB TECHNIQUES ELECT; Johansson FB, 2008, INORG CHEM, V47, P5079, DOI 10.1021/ic7020534; Kaizer J, 2005, J MOL CATAL A-CHEM, V236, P12, DOI 10.1016/j.molcata.2005.04.006; Kaizer J, 2006, INORG CHEM COMMUN, V9, P1037, DOI 10.1016/j.inoche.2006.06.005; Karipcin F, 2012, HELV CHIM ACTA, V95, P647, DOI 10.1002/hlca.201100314; Krabbe JG, 2007, J AM SOC MASS SPECTR, V18, P707, DOI 10.1016/j.jasms.2006.12.006; LEKCHIRI A, 1991, EUR POLYM J, V27, P1271, DOI 10.1016/0014-3057(91)90065-V; Lever A.B.P., 1985, INORGANIC ELECT SPEC, V2nd; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; NISHIDA Y, 1989, INORG CHIM ACTA, V163, P9, DOI 10.1016/S0020-1693(00)87136-4; NISHIDA Y, 1994, POLYHEDRON, V13, P1539, DOI 10.1016/S0277-5387(00)83448-8; Oliveira M.C.B., 2005, INORG CHEM, V44, P921; Padhi SK, 2011, INORG CHIM ACTA, V367, P57, DOI 10.1016/j.ica.2010.11.035; Pires BM, 2013, INORG CHIM ACTA, V407, P69, DOI 10.1016/j.ica.2013.07.034; Ray A, 2011, INORG CHIM ACTA, V375, P20, DOI 10.1016/j.ica.2011.04.008; Senaratne C, 1996, J PHYS CHEM-US, V100, P5849, DOI 10.1021/jp951923x; SHANK M, 1994, BIOCHEMISTRY-US, V33, P15433, DOI 10.1021/bi00255a025; Sheldrick G.M., 1996, PROGRAM EMPIRICAL AB; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIGEL H, 1979, INORG CHEM, V18, P1354, DOI 10.1021/ic50195a040; Signorella S, 2007, INORG CHEM, V46, P10864, DOI 10.1021/ic070180e; Taran MN, 2008, PHYS CHEM MINER, V35, P117, DOI 10.1007/s00269-007-0202-6; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Xie YS, 2005, POLYHEDRON, V24, P165, DOI 10.1016/j.poly.2004.11.009; Yamami M, 1997, J CHEM SOC DALTON, P4595, DOI 10.1039/a703842i; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	46	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137926	10.1371/journal.pone.0137926	http://dx.doi.org/10.1371/journal.pone.0137926			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379038	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400037
J	Zhang, XL; Li, DF; Fleming, J; Wang, LW; Zhou, Y; Wang, DC; Zhang, XE; Bi, LJ				Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun			Core component EccB1 of the Mycobacterium tuberculosis type VII secretion system is a periplasmic ATPase	FASEB JOURNAL			English	Article						virulence; ESX-1; crystal structure	PROTEIN; VIRULENCE; MEMBRANE; COMPLEX; ESX-1; IMMUNOGENICITY; PATHOGENICITY; MECHANISM; APPARATUS; DOCKING	Pathogenic mycobacteria transport virulence factors across their complex cell wall via a type VII secretion system (T7SS)/early secreted antigenic target-6 of kDa secretion system (ESX). ESX conserved component (Ecc) B, a core component of the T7SS architecture, is predicted to be a membrane bound protein, but little is known about its structure and function. Here, we characterize EccB1, showing that it is an ATPase with no sequence or structural homology to other ATPases located in the cell envelope of Mycobacterium tuberculosis H37Rv. We obtained the crystal structure of an EccB1-DN72 truncated transmembrane helix and performed modeling and ATP docking studies, showing that EccB1 likely exists as a hexamer. Sequence alignment and ATPase activity determination of EccB1 homologues indicated the presence of 3 conserved motifs in the N- and C-terminals of EccB1-DN72 that assemble together between 2 membrane proximal domains of the EccB1-DN72 monomer. Models of the EccB1 hexamer show that 2 of the conserved motifs are involved in ATPase activity and form an ATP binding pocket located on the surface of 2 adjacent molecules. Our results suggest that EccB may act as the energy provider in the transport of T7SS virulence factors and may be involved in the formation of a channel across the mycomembrane.	[Zhang, Xiao-Li; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li] Chinese Acad Sci, Grad Sch, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Zhang, XE (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	zhangxe@sun5.ibp.ac.cn; blj@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021	Zhang, Xian-En/0000-0003-1347-3168	National Basic Research Program of China [2011CB910300, 2012CB518700, 2013CB911500]; Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health [2013ZX10003006, 2012ZX10003002]; Chinese Academy of Sciences [KJZD-EW-L02, XDB08020200]; National Natural Science Foundation of China [31170132, 31270792]	National Basic Research Program of China(National Basic Research Program of China); Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors express their appreciation to the staff at the Shanghai Synchrotron Radiation Facility of China for assistance with collecting protein diffraction data, and thank Yi Han and Sheng-Quan Liu from the Institute of Biophysics, Chinese Academy of Sciences, for their assistance in data collection, Xiao-Xia Yu and Xiao-Qian Xie for assistance with protein purification, Hong-Jie Zhang and Wen-Jing Wei for help with the ATPase activity assay, and Hong-Tai Zhang for helpful discussions on the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB910300, 2012CB518700, 2013CB911500), the Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health (2013ZX10003006 and 2012ZX10003002), the Chinese Academy of Sciences (KJZD-EW-L02, XDB08020200), and the National Natural Science Foundation of China (31170132, 31270792).	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bitter W, 2014, CELL HOST MICROBE, V16, P430, DOI 10.1016/j.chom.2014.09.010; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bitter W, 2009, TRENDS MICROBIOL, V17, P337, DOI 10.1016/j.tim.2009.05.007; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Das C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027980; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P39; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gey Van Pittius N. C., 2001, GENOME BIOL, V2; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEUPOLD CM, 1983, EUR J BIOCHEM, V135, P237, DOI 10.1111/j.1432-1033.1983.tb07643.x; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026743; Luthra A, 2008, J BIOL CHEM, V283, P36532, DOI 10.1074/jbc.M807144200; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Ramsdell TL, 2015, J MOL BIOL, V427, P1119, DOI 10.1016/j.jmb.2014.06.013; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Solomonson M, 2013, J BIOL CHEM, V288, P17782, DOI 10.1074/jbc.M113.462036; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Tao J, 2013, NUCLEIC ACIDS RES, V41, P2370, DOI 10.1093/nar/gks1351; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van der Woude AD, 2014, CURR TOP MICROBIOL, V374, P109, DOI 10.1007/82_2012_298; WINANS SC, 1989, J BACTERIOL, V171, P1616, DOI 10.1128/jb.171.3.1616-1622.1989	45	19	19	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4804	4814		10.1096/fj.15-270843	http://dx.doi.org/10.1096/fj.15-270843			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26396239				2022-12-26	WOS:000365523600008
J	Lagousi, T; Routsias, J; Piperi, C; Tsakris, A; Chrousos, G; Theodoridou, M; Spoulou, V				Lagousi, Theano; Routsias, John; Piperi, Christina; Tsakris, Athanassios; Chrousos, George; Theodoridou, Maria; Spoulou, Vana			Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN YOUNGER; EPITHELIAL-CELLS; TRIAD PROTEINS; OTITIS-MEDIA; PHT PROTEINS; ANTIBODIES; ANTIGENS; CARRIAGE	The identification of immunodominant B cell epitopes within surface pneumococcal virulence proteins in pediatric patients with invasive pneumococcal disease (IPD) is a valuable approach to define novel vaccine candidates. To this aim, we evaluated sera from children with IPD and age-matched controls against 141 20-mer synthetic peptides covering the entire sequence of major antigenic fragments within pneumococcal virulence proteins; namely, choline-binding protein D (CbpD), pneumococcal histidine triad proteins (PhtD and PhtE), pneumococcal surface protein A (PspA), plasminogen and fibronectin binding protein B (PfbB), and zinc metalloproteinase B (ZmpB). Ten immunodominant B cell epitopes were identified: CbpD-pep4 (amino acids (aa) 291-310), PhtD-pep11 (aa 88-107), PhtD-pep17 (aa 172-191), PhtD-pep19 (aa 200-219), PhtE-pep32 (aa 300-319), PhtE-pep40 (aa 79-98), PfbB-pep76 (aa 180-199), PfbB-pep79 (aa 222-241), PfbB-pep90 (aa 484-503), and ZmpB-pep125 (aa 431-450). All epitopes were highly conserved among different pneumococcal serotypes, and four of them were located within the functional zinc-binding domain of the histidine triad proteins PhtD and PhtE. Peptides CbpD-pep4, PhtD-pep19, and PhtE-pep40 were broadly recognized by IPD patient sera with prevalences of 96.4%, 92.9%, and 71.4%, respectively, whereas control sera exhibited only minor reactivities (< 10.7%). Their specificities for IPD were 93.3%, 95%, and 96.7%; their sensitivities were 96.4%, 92.9%, and 71.4% and their positivity likelihood ratios for IPD were 14.5, 18.6, and 21.4, respectively. Furthermore, purified antibodies against CbpD-pep4, PhtD-pep19, and PhtE-pep40 readily bound on the surfaces of different pneumococcal serotypes, as assessed by FACS and immunofluorescence analysis. The identified immunodominant B cell epitopes provide a better understanding of immune response in IPD and are worth evaluation in additional studies as potential vaccine candidates.	[Lagousi, Theano; Chrousos, George; Theodoridou, Maria; Spoulou, Vana] Aghia Sophia Childrens Hosp, Immunobiol Res Lab, Dept Pediat 1, Athens 11527, Greece; [Lagousi, Theano; Chrousos, George; Theodoridou, Maria; Spoulou, Vana] Sch Med, Infect Dis Dept MAKKA, Athens 11527, Greece; [Lagousi, Theano; Routsias, John; Tsakris, Athanassios] Sch Med, Dept Microbiol, Athens 11527, Greece; [Piperi, Christina] Sch Med, Dept Biol Chem, Athens 11527, Greece	The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Lagousi, T (corresponding author), Aghia Sophia Childrens Hosp, Immunobiol Res Lab, Dept Pediat 1, Thivon & Papadiamantopoulou Str, Athens 11527, Greece.	theanolagousi@hotmail.com	Piperi, Christina/AAF-2009-2020	Piperi, Christina/0000-0002-2701-0618; Routsias, John/0000-0002-5819-021X	Special Account for Research Funds (ELKE) [70/3/9687, 70/3/9473]	Special Account for Research Funds (ELKE)	This work was supported by Special Account for Research Funds (ELKE) Grants 70/3/9687 and 70/3/9473. The authors declare that they have no conflicts of interest with the contents of this article.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Adrian PV, 2004, VACCINE, V22, P2737, DOI 10.1016/j.vaccine.2004.01.042; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Cao J, 2007, VACCINE, V25, P4996, DOI 10.1016/j.vaccine.2007.04.069; Chibuk TK, 2010, EUR J PEDIATR, V169, P1123, DOI 10.1007/s00431-010-1195-6; Ciapponi A, 2014, PEDIATR INFECT DIS J, V33, P971, DOI 10.1097/INF.0000000000000363; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Fried AJ, 2013, J CLIN IMMUNOL, V33, P847, DOI 10.1007/s10875-013-9870-9; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Gong Y, 2011, INFECT IMMUN, V79, P867, DOI 10.1128/IAI.00717-10; Gor DO, 2005, INFECT IMMUN, V73, P1304, DOI 10.1128/IAI.73.3.1304-1312.2005; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; IVANOV VS, 1992, J IMMUNOL METHODS, V153, P229, DOI 10.1016/0022-1759(92)90326-O; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kausmally L, 2005, J BACTERIOL, V187, P4338, DOI 10.1128/JB.187.13.4338-4345.2005; Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Papastamatiou T., 2015, 33 ANN M EUR SOC PAE, P80; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Posfay-Barbe KM, 2011, CLIN MICROBIOL INFEC, V17, P1232, DOI 10.1111/j.1469-0691.2010.03389.x; Riboldi-Tunnicliffe A, 2005, FEBS LETT, V579, P5353, DOI 10.1016/j.febslet.2005.08.066; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Routsias JG, 2004, J MED CHEM, V47, P4327, DOI 10.1021/jm049844+; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2009, VACCINE, V27, P4615, DOI 10.1016/j.vaccine.2009.05.071; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Zhou JH, 2004, INFECT IMMUN, V72, P3505, DOI 10.1128/IAI.72.6.3505-3514.2004	40	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27500	27510		10.1074/jbc.M115.666818	http://dx.doi.org/10.1074/jbc.M115.666818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396191	hybrid, Green Published			2022-12-26	WOS:000365757500006
J	Kazmierczak, PM; Burian, E; Eschbach, R; Hirner-Eppeneder, H; Moser, M; Havla, L; Eisenblatter, M; Reiser, MF; Nikolaou, K; Cyran, CC				Kazmierczak, Philipp M.; Burian, Egon; Eschbach, Ralf; Hirner-Eppeneder, Heidrun; Moser, Matthias; Havla, Lukas; Eisenblaetter, Michel; Reiser, Maximilian F.; Nikolaou, Konstantin; Cyran, Clemens C.			Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CONTRAST-ENHANCED MR; APOPTOSIS; NECROSIS; GROWTH; DISCRIMINATION; BIOMARKERS; SORAFENIB; MODELS; TUMORS	Objective To investigate annexin-based optical fluorescence imaging (OI) for monitoring regorafenib-induced early cell death in experimental colon carcinomas in rats, validated by perfusion MRI and multiparametric immunohistochemistry. Materials and Methods Subcutaneous human colon carcinomas (HT-29) in athymic rats (n = 16) were imaged before and after a one-week therapy with regorafenib (n = 8) or placebo (n = 8) using annexin-based OI and perfusion MRI at 3 Tesla. Optical signal-to-noise ratio (SNR) and MRI tumor perfusion parameters (plasma flow PF, mL/100mL/min; plasma volume PV, %) were assessed. On day 7, tumors underwent immunohistochemical analysis for tumor cell apoptosis (TUNEL), proliferation (Ki-67), and microvascular density (CD31). Results Apoptosis-targeted OI demonstrated a tumor-specific probe accumulation with a significant increase of tumor SNR under therapy (mean Delta +7.78 +/- 2.95, control: -0.80 +/- 2.48, p = 0.021). MRI detected a significant reduction of tumor perfusion in the therapy group (mean Delta PF -8.17 +/- 2.32 mL/100 mL/min, control -0.11 +/- 3.36 mL/100 mL/min, p = 0.036). Immunohistochemistry showed significantly more apoptosis (TUNEL; 11392 +/- 1486 vs. 2921 +/- 334, p = 0.001), significantly less proliferation (Ki-67; 1754 +/- 184 vs. 2883 +/- 323, p = 0.012), and significantly lower microvascular density (CD31; 107 +/- 10 vs. 182 +/- 22, p = 0.006) in the therapy group. Conclusions Annexin-based OI allowed for the non-invasive monitoring of regorafenib-induced early cell death in experimental colon carcinomas, validated by perfusion MRI and multiparametric immunohistochemistry.	[Kazmierczak, Philipp M.; Burian, Egon; Eschbach, Ralf; Hirner-Eppeneder, Heidrun; Moser, Matthias; Reiser, Maximilian F.; Nikolaou, Konstantin; Cyran, Clemens C.] Ludwig Maximilians Univ Hosp Munich, Expt Radiol Lab, Inst Clin Radiol, Munich, Germany; [Havla, Lukas] Ludwig Maximilians Univ Hosp Munich, Josef Lissner Lab Biomed Imaging, Inst Clin Radiol, Munich, Germany; [Eisenblaetter, Michel] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Eisenblaetter, Michel] Kings Coll London, Div Imaging Sci & Biomed Engn, Comprehens Canc Imaging Ctr, London WC2R 2LS, England; [Nikolaou, Konstantin] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, Tubingen, Germany	University of Munich; University of Munich; University of Munster; University of London; King's College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kazmierczak, PM (corresponding author), Ludwig Maximilians Univ Hosp Munich, Expt Radiol Lab, Inst Clin Radiol, Munich, Germany.	philipp.kazmierczak@med.lmu.de			German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 [01EX1021X]; Bayer HealthCare	German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4(Federal Ministry of Education & Research (BMBF)); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This study was supported by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) Excellence Cluster M4 (www.m4.de, 01EX1021X) and a research grant from Bayer HealthCare (healthcare.bayer.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Behbahaninia M, 2013, CLIN NEUROL NEUROSUR, V115, P517, DOI 10.1016/j.clineuro.2013.02.019; Carter NJ, 2014, DRUG AGING, V31, P67, DOI 10.1007/s40266-013-0140-6; Chen DS, 2014, CLIN CANCER RES, V20, P3472, DOI 10.1158/1078-0432.CCR-13-2944; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Cyran CC, 2012, AM J ROENTGENOL, V198, P384, DOI 10.2214/AJR.11.6951; Cyran CC, 2012, INVEST RADIOL, V47, P49, DOI 10.1097/RLI.0b013e3182300fe4; Desar IME, 2009, CANCER TREAT REV, V35, P309, DOI 10.1016/j.ctrv.2008.12.001; Eisenblatter M, 2010, EUR J NUCL MED MOL I, V37, pS127, DOI 10.1007/s00259-010-1514-1; Eisenblatter M, 2009, J NUCL MED, V50, P1676, DOI 10.2967/jnumed.108.060707; Fan LC, 2014, ONCOTARGET, V5, P6243, DOI 10.18632/oncotarget.2191; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Jung KH, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00002; Keereweer S, 2014, MOL IMAGING BIOL, V16, P1, DOI 10.1007/s11307-013-0688-x; Koch M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046012; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lederle W, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-26; Lehner S, 2014, MOL IMAGING, P13; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Messiou C, 2012, RADIOLOGY, V265, P426, DOI 10.1148/radiol.12112565; Metildi CA, 2014, J AM COLL SURGEONS, V219, P132, DOI 10.1016/j.jamcollsurg.2014.02.021; Neves AA, 2014, J NUCL MED, V55, P1, DOI 10.2967/jnumed.112.114264; Qin HD, 2015, AM J NUCL MED MOLEC, V5, P27; Nguyen QD, 2012, EUR J CANCER, V48, P432, DOI 10.1016/j.ejca.2011.11.033; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Reshef A, 2010, J NUCL MED, V51, P837, DOI 10.2967/jnumed.109.063917; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Schellenberger EA, 2003, NEOPLASIA, V5, P187, DOI 10.1016/S1476-5586(03)80050-7; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Sheth RA, 2014, RADIOLOGY, V271, P770, DOI 10.1148/radiol.14131880; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Witjes JA, 2014, EUR UROL; Zhang CC, 2014, CANCER MED-US, V3, P462, DOI 10.1002/cam4.215	35	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138452	10.1371/journal.pone.0138452	http://dx.doi.org/10.1371/journal.pone.0138452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393949	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100063
J	Garvin, P; Jonasson, L; Nilsson, L; Falk, M; Kristenson, M				Garvin, Peter; Jonasson, Lena; Nilsson, Lennart; Falk, Magnus; Kristenson, Margareta			Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CARDIOVASCULAR RISK; OXIDATIVE STRESS; TISSUE INHIBITOR; 92-KD GELATINASE; ARTERY-DISEASE; TNF-ALPHA; INFLAMMATION; ASSOCIATION; EXPRESSION	Background The enzyme in matrix metalloproteinase (MMP)-9 has been suggested to be an important determinant of plaque degradation. While several studies have shown elevated levels in patients with coronary heart disease, results in prospective population based studies evaluating MMP-9 in relation to first time coronary events have been inconclusive. As of today, there are four published studies which have measured MMP-9 in serum and none using plasma. Measures of MMP-9 in serum have been suggested to have more flaws than measures in plasma. Aim To investigate the independent association between plasma levels of MMP-9 and first-time incidence of coronary events in an 8-year follow-up. Material and Methods 428 men and 438 women, aged 45-69 years, free of previous coronary events and stroke at baseline, were followed-up. Adjustments were made for sex, age, socioeconomic position, behavioral and cardiovascular risk factors, chronic disease at baseline, depressive symptoms, interleukin-6 and C-reactive protein. Results 53 events were identified during a risk-time of 6 607 person years. Hazard ratio (HR) for MMP-9 after adjustment for all covariates were HR = 1.44 (1.03 to 2.02, p = 0.033). Overall, the effect of adjustments for other cardiovascular risk factors was low. Conclusion Levels of plasma MMP-9 are independently associated with risk of first-time CHD events, regardless of adjustments. These results are in contrast to previous prospective population-based studies based on MMP-9 in serum. It is essential that more studies look at MMP-9 levels in plasma to further evaluate the association with first coronary events.	[Garvin, Peter; Falk, Magnus; Kristenson, Margareta] Cty Ostergotland, Unit Res & Dev Local Hlth Care, Linkoping, Sweden; [Garvin, Peter; Falk, Magnus] Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden; [Jonasson, Lena; Nilsson, Lennart] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	City Council Ostergotland; Linkoping University; Linkoping University	Garvin, P (corresponding author), Cty Ostergotland, Unit Res & Dev Local Hlth Care, Linkoping, Sweden.	peter.garvin@regionostergotland.se		Garvin, Peter/0000-0001-7429-0889	Swedish Research Council [2004-1881]; Swedish Heart and Lung Foundation [2004053]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The study was funded by the Swedish Research Council (2004-1881) and the Swedish Heart and Lung Foundation (2004053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Britton A, 2004, ADDICTION, V99, P109, DOI 10.1111/j.1360-0443.2004.00530.x; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; Derosa G, 2007, HEART VESSELS, V22, P361, DOI 10.1007/s00380-007-0989-6; Eriksson JS, 2020, SCAND J MED SCI SPOR, V30, P370, DOI 10.1111/sms.13581; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Garvin P, 2009, PSYCHOSOM MED, V71, P292, DOI 10.1097/PSY.0b013e3181960e7f; Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P557, DOI 10.1016/j.atherosclerosis.2009.08.018; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Jung K, 1998, CLIN CHEM, V44, P1060; Jung K, 2002, MATRIX BIOL, V21, P381, DOI 10.1016/S0945-053X(02)00029-X; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Kameda K, 2006, CIRC J, V70, P673, DOI 10.1253/circj.70.673; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Mannello F, 2003, CLIN CHEM, V49, P339, DOI 10.1373/49.2.339; Newby AC, 2006, CURR OPIN LIPIDOL, V17, P556, DOI 10.1097/01.mol.0000245262.48258.b4; Nikkari ST, 1996, AM J PATHOL, V149, P1427; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Saren P, 1996, J IMMUNOL, V157, P4159; Sillanaukee P, 2002, EUR J CLIN INVEST, V32, P225, DOI 10.1046/j.1365-2362.2002.00975.x; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Tayebjee MH, 2005, CURR MED CHEM, V12, P917, DOI 10.2174/0929867053507270; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Wagner DR, 2006, J CARD FAIL, V12, P66, DOI 10.1016/j.cardfail.2005.08.002; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41	39	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138290	10.1371/journal.pone.0138290	http://dx.doi.org/10.1371/journal.pone.0138290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389803	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000022
J	Nguyen, HT; Nguyen, TD; van den Heuvel, ER; Haaijer-Ruskamp, FM; Taxis, K				Huong-Thao Nguyen; Tuan-Dung Nguyen; van den Heuvel, Edwin R.; Haaijer-Ruskamp, Flora M.; Taxis, Katja			Medication Errors in Vietnamese Hospitals: Prevalence, Potential Outcome and Associated Factors	PLOS ONE			English	Article							DRUG ADMINISTRATION ERRORS; PATIENT SAFETY; INTENSIVE-CARE; INTERVENTIONS; SEVERITY; INTERRUPTIONS; EXPERIENCE; PROGRAM; IMPACT; SCALE	Background Evidence from developed countries showed that medication errors are common and harmful. Little is known about medication errors in resource-restricted settings, including Vietnam. Objectives To determine the prevalence and potential clinical outcome of medication preparation and administration errors, and to identify factors associated with errors. Methods This was a prospective study conducted on six wards in two urban public hospitals in Vietnam. Data of preparation and administration errors of oral and intravenous medications was collected by direct observation, 12 hours per day on 7 consecutive days, on each ward. Multivariable logistic regression was applied to identify factors contributing to errors. Results In total, 2060 out of 5271 doses had at least one error. The error rate was 39.1%(95% confidence interval 37.8%-40.4%). Experts judged potential clinical outcomes as minor, moderate, and severe in 72 (1.4%), 1806 (34.2%) and 182 (3.5%) doses. Factors associated with errors were drug characteristics (administration route, complexity of preparation, drug class; all p values < 0.001), and administration time (drug round, p = 0.023; day of the week, p = 0.024). Several interactions between these factors were also significant. Nurse experience was not significant. Higher error rates were observed for intravenous medications involving complex preparation procedures and for anti-infective drugs. Slightly lower medication error rates were observed during afternoon rounds compared to other rounds. Conclusions Potentially clinically relevant errors occurred in more than a third of all medications in this large study conducted in a resource-restricted setting. Educational interventions, focusing on intravenous medications with complex preparation procedure, particularly antibiotics, are likely to improve patient safety.	[Huong-Thao Nguyen; Tuan-Dung Nguyen] Univ Med & Pharm Ho Chi Minh City, Sch Pharm, Dept Clin Pharm, Ho Chi Minh, Vietnam; [van den Heuvel, Edwin R.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van den Heuvel, Edwin R.] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Haaijer-Ruskamp, Flora M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Huong-Thao Nguyen; Taxis, Katja] Univ Groningen, Dept Pharm, Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands	Hochiminh City University of Medicine & Pharmacy; University of Groningen; Eindhoven University of Technology; University of Groningen; University of Groningen	Taxis, K (corresponding author), Univ Groningen, Dept Pharm, Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands.	k.taxis@rug.nl	Taxis, Katja/ABE-2637-2021	Taxis, Katja/0000-0001-8539-2004	NUFFIC (the Netherlands Organisation for International Cooperation in Higher Education)	NUFFIC (the Netherlands Organisation for International Cooperation in Higher Education)	This study was supported by NUFFIC (the Netherlands Organisation for International Cooperation in Higher Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN EL, 1990, AM J HOSP PHARM, V47, P555, DOI 10.1093/ajhp/47.3.555; American Society of Health-System Pharmacists, 2009, AHFS DRUG INFORM; Barber N, 2003, QUAL SAF HEALTH CARE, V12, pI29, DOI 10.1136/qhc.12.suppl_1.i29; Berdot S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-60; Berdot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068856; Chua SS, 2009, J CLIN PHARM THER, V34, P215, DOI 10.1111/j.1365-2710.2008.00997.x; Chua SS, 2010, EUR J PEDIATR, V169, P603, DOI 10.1007/s00431-009-1084-z; Dean B, 2001, AM J HEALTH-SYST PH, V58, P54, DOI 10.1093/ajhp/58.1.54; Dean BS, 1999, AM J HEALTH-SYST PH, V56, P57, DOI 10.1093/ajhp/56.1.57; Duckers M, 2009, MED CARE RES REV, V66, p90S, DOI 10.1177/1077558709345870; Flynn EA, 2002, AM J HEALTH-SYST PH, V59, P436, DOI 10.1093/ajhp/59.5.436; Freeman R, 2013, J NURS CARE QUAL, V28, P176, DOI 10.1097/NCQ.0b013e318275ac3e; Greengold NL, 2003, ARCH INTERN MED, V163, P2359, DOI 10.1001/archinte.163.19.2359; Nguyen HT, 2014, BMJ QUAL SAF, V23, P319, DOI 10.1136/bmjqs-2013-002357; Nguyen HT, 2014, NURS RES, V63, P68, DOI 10.1097/NNR.0000000000000010; Jha AK, 2010, QUAL SAF HEALTH CARE, V19, P42, DOI 10.1136/qshc.2008.029165; Keers RN, 2014, DRUG SAFETY, V37, P317, DOI 10.1007/s40264-014-0152-0; Keers RN, 2013, ANN PHARMACOTHER, V47, P237, DOI 10.1345/aph.1R147; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Lemoine Jennifer B, 2012, Nurs Womens Health, V16, P151, DOI 10.1111/j.1751-486X.2012.01721.x; Manias E, 2012, BRIT J CLIN PHARMACO, V74, P411, DOI 10.1111/j.1365-2125.2012.04220.x; McDowell SE, 2010, QUAL SAF HEALTH CARE, V19, P341, DOI 10.1136/qshc.2008.029785; Pierson S, 2007, QUAL SAF HEALTH CARE, V16, P297, DOI 10.1136/qshc.2007.022483; Prakash V, 2014, BMJ QUAL SAF, V23, P884, DOI 10.1136/bmjqs-2013-002484; Romero CM, 2013, J CRIT CARE, V28, P451, DOI 10.1016/j.jcrc.2012.11.011; Ross LM, 2000, ARCH DIS CHILD, V83, P492, DOI 10.1136/adc.83.6.492; Taxis K, 2004, EUR J CLIN PHARMACOL, V59, P815, DOI 10.1007/s00228-003-0689-9; Taxis K, 2003, BMJ-BRIT MED J, V326, P684, DOI 10.1136/bmj.326.7391.684; Tissot E, 2003, PHARM WORLD SCI, V25, P264, DOI 10.1023/B:PHAR.0000006519.44483.a0; Trissel L., 2009, HDB INJECTABLE DRUGS; Trossman Susan, 2010, Am Nurse, V42, P6; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; Vietnam Ministry of Health, 2009, VIETN NAT DRUG FORM; Vietnam Ministry of Health, 2008, 072008TTBYT VIETN MI; Westbrook JI, 2011, BMJ QUAL SAF, V20, P1027, DOI 10.1136/bmjqs-2011-000089; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65; Williams T, 2014, AM J NURS, V114, P53, DOI 10.1097/01.NAJ.0000456433.07343.7f; Wilson RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e832; Wirtz V, 2003, PHARM WORLD SCI, V25, P104, DOI 10.1023/A:1024009000113	39	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138284	10.1371/journal.pone.0138284	http://dx.doi.org/10.1371/journal.pone.0138284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383873	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200086
J	Kim, IY; Kim, BR; Kim, YW				Kim, Ik Yong; Kim, Bo Ra; Kim, Young Wan			Factors Affecting Use and Delay (>= 8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes	PLOS ONE			English	Article							III COLON-CANCER; STAGE-II; SURVIVAL; THERAPY; FLUOROURACIL; INITIATION; COMPLICATIONS; LEUCOVORIN; RESECTION	Purpose To evaluate factors affecting the use and delay >= 8 weeks of adjuvant chemotherapy and the impact of chemotherapy use and delay on survival. Methods Between 2005 and 2012, consecutive patients with stage II and III colorectal cancer who were treated with major curative resection were enrolled. Results Among 750 patients with stage II (n = 318) and III (n = 432) disease, 153 (20.4%) did not receive chemotherapy. Among 597 patients with adjuvant chemotherapy, 31 (5.2%) began chemotherapy 8 weeks or more after surgery. Factors associated with not receiving chemotherapy were: age >= 80 years (hazard ratio [HR] = 5.2), American Society of Anesthesiologists score >= 3 (HR = 1.9), underlying cerebrovascular disease (HR = 1.7), stage II disease (HR = 2.0), presence of postoperative complications (HR = 2.2), or intensive care unit admission (HR = 2.4). Factors associated with chemotherapy delay >= 8 weeks were: male sex (HR = 4.2), rectal primary cancer (HR = 5.4), or presence of postoperative complications (HR = 2.5). Independent prognostic factors for overall survival included TNM III stage (HR = 2.04) and chemotherapy delay >= 8 weeks (HR = 0.39) or <8 weeks (HR = 0.22). Independent prognostic factors for recurrence-free survival were TNM III stage (HR = 2.26) and chemotherapy delay <8 weeks (HR = 0.35). Conclusions Postoperative complications were associated with both lack of and delayed chemotherapy. Timely initiation of chemotherapy, defined as <8 weeks, was a favorable prognostic factor for overall and recurrence-free survival. To increase the proportion of patients receiving chemotherapy and timely initiation of chemotherapy, surgical complications should be minimized after curative resection.	[Kim, Ik Yong; Kim, Young Wan] Yonsei Univ, Wonju Coll Med, Dept Surg, Div Colorectal Surg, Wonju, South Korea; [Kim, Bo Ra] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol, Wonju, South Korea	Yonsei University; Yonsei University	Kim, YW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Surg, Div Colorectal Surg, Wonju, South Korea.	youngwkim@yonsei.ac.kr						Ahmed S, 2010, DIS COLON RECTUM, V53, P1432, DOI 10.1007/DCR.0b013e3181e78815; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Baldwin LM, 2005, J NATL CANCER I, V97, P1211, DOI 10.1093/jnci/dji241; Bayraktar UD, 2011, CANCER-AM CANCER SOC, V117, P2364, DOI 10.1002/cncr.25720; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Chau I, 2005, ANN ONCOL, V16, P549, DOI 10.1093/annonc/mdi116; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Czaykowski PM, 2011, DIS COLON RECTUM, V54, P1082, DOI 10.1097/DCR.0b013e318223c3d6; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dobie SA, 2006, JNCI-J NATL CANCER I, V98, P610, DOI 10.1093/jnci/djj159; Dube S, 1997, DIS COLON RECTUM, V40, P35, DOI 10.1007/BF02055679; Etzioni DA, 2008, CANCER-AM CANCER SOC, V113, P3279, DOI 10.1002/cncr.23958; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Gross CP, 2007, CANCER-AM CANCER SOC, V109, P2410, DOI 10.1002/cncr.22726; Hendren S, 2010, DIS COLON RECTUM, V53, P1587, DOI 10.1007/DCR.0b013e3181f2f202; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Kim YW, 2013, ANN COLOPROCTOL, V29, P44, DOI 10.3393/ac.2013.29.2.44; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Law WL, 2000, AM J SURG, V179, P92, DOI 10.1016/S0002-9610(00)00252-X; Luo RL, 2006, ONCOLOGIST, V11, P1025, DOI 10.1634/theoncologist.11-9-1025; McGory ML, 2006, DIS COLON RECTUM, V49, P319, DOI 10.1007/s10350-005-0283-6; National Comprehensive Cancer Network, RECT CANC VERS 1 201; National Comprehensive Cancer Network, COL CANC VERS 2 2015; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Zeig-Owens Rachel, 2009, J Registry Manag, V36, P30	30	44	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138720	10.1371/journal.pone.0138720	http://dx.doi.org/10.1371/journal.pone.0138720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381146	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200151
J	Lee, YE; Yun, JEE; Kim, EY; Song, HJ				Lee, Young-eun; Yun, Jung-eun Ellie; Kim, Eun Young; Song, Hyun-Joo			The Development of Infants' Sensitivity to Behavioral Intentions when Inferring Others' Social Preferences	PLOS ONE			English	Article							PREVERBAL INFANTS; MORAL JUDGMENT	The present study investigated whether infants reason about others' social preferences based on the intentions of others' interactive actions. In Experiment 1, 12-month-old infants were familiarized with an event in which an agent either successfully helped a circle to climb up a hill (successful-helping condition) or failed to help the circle to achieve its goal (failed-helping condition). During the test, the infants saw the circle approach either the helper (approach-helper event) or the hinderer (approach-hinderer event). In the successful-helping condition, the 12-month-old infants looked for longer at the approach-hinderer event than at the approach-helper event, but in the failed-helping condition, looking times were about equal for the two test events. These results suggest that 12-month-old infants could not infer the circle's preference when the helper's action did not lead to its intended outcome. In Experiment 2, 16-month-olds were tested in the failed-helping condition; they looked longer at the approach-hinderer event than at the approach-helper event, which suggests that they could reason about the third party's social preferences based on the exhibited intentions. In Experiment 3, 12-month-olds were familiarized with events in which the final outcomes of helping and hindering actions were ambiguous. The results revealed that 12-month-old infants are also sensitive to intentions when inferring other's social preferences. The results suggest that by 12-months of age, infants expect an agent to prefer and approach another who intends to help the circle to achieve its goal, regardless of the outcome. The current research has implications for moral reasoning and social evaluation in infancy.	[Lee, Young-eun; Song, Hyun-Joo] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Yun, Jung-eun Ellie] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA USA; [Kim, Eun Young] Soonchunhyang Univ, Coll Med Sci, Dept Occupat Therapy, Asan, South Korea	Yonsei University; University of California System; University of California Los Angeles; Soonchunhyang University	Song, HJ (corresponding author), Yonsei Univ, Dept Psychol, Seoul 120749, South Korea.	hsong@yonsei.ac.kr	Song, hyunjoo/GWC-1292-2022		National Research Foundation of Korea - Korean Government [NRF-2012-S1A3-A2033375]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2012-S1A3-A2033375) to HjS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillargeon R., 2015, APA HDB PERSONALITY, V1, P79, DOI DOI 10.1037/14341-003; Baird JA, 2004, NEW DIR CHILD ADOLES, V103, P37, DOI 10.1002/cd.96; Bloom P., 2012, SOCIAL PSYCHOL MORAL, P71, DOI DOI 10.1037/13091-004; Brandone AC, 2009, PSYCHOL SCI, V20, P85, DOI 10.1111/j.1467-9280.2008.02246.x; Brownell C. A., 2007, SOCIOEMOTIONAL DEV T, P1; Carpenter M, 1998, INFANT BEHAV DEV, V21, P315, DOI 10.1016/S0163-6383(98)90009-1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cushman F, 2013, COGNITION, V127, P6, DOI 10.1016/j.cognition.2012.11.008; ECKERMAN CO, 1977, CHILD DEV, V48, P1645, DOI 10.2307/1128529; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fawcett C, 2012, INFANT CHILD DEV, V21, P239, DOI 10.1002/icd.739; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Killen M., 2006, HDB MORAL DEV; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Kuhlmeier V, 2003, BIENN M SOC RES CHIL; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Natale E, 2014, DEV COGN NEUROS-NETH, V7, P23, DOI 10.1016/j.dcn.2013.10.004; NELSON SA, 1980, CHILD DEV, V51, P823, DOI 10.1111/j.1467-8624.1980.tb02619.x; Piaget, 1932, MORAL JUDGEMENT CHIL; Scott RM, 2009, CHILD DEV, V80, P1172, DOI 10.1111/j.1467-8624.2009.01324.x; Vandell D. L., 2006, HDB EARLY CHILDHOOD, P455, DOI DOI 10.1002/9780470757703.CH22; Williams ST, 2010, EARLY CHILD RES Q, V25, P251, DOI 10.1016/j.ecresq.2009.11.004	27	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0135588	10.1371/journal.pone.0135588	http://dx.doi.org/10.1371/journal.pone.0135588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26383160	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200004
J	Swier, VJ; Tang, L; Krueger, KD; Radwan, MM; Del Core, MG; Agrawal, DK				Swier, Vicki J.; Tang, Lin; Krueger, Kristopher D.; Radwan, Mohamed M.; Del Core, Michael G.; Agrawal, Devendra K.			Coronary Injury Score Correlates with Proliferating Cells and Alpha-Smooth Muscle Actin Expression in Stented Porcine Coronary Arteries	PLOS ONE			English	Article							NEOINTIMAL HYPERPLASIA; RESTENOSIS; MODEL; HMGB1; INHIBITOR; PHENOTYPE; APOPTOSIS; RELEASE; PROTEIN	Neointimal formation and cell proliferation resulting into in-stent restenosis is a major pathophysiological event following the deployment of stents in the coronary arteries. In this study, we assessed the degree of injury, based on damage to internal elastic lamina, media, external elastic lamina, and adventitia following the intravascular stenting, and its relationship with the degree of smooth muscle cell proliferation. We examined the smooth muscle cell proliferation and their phenotype at different levels of stent injury in the coronary arteries of domestic swine fed a normal swine diet. Five weeks after stent implantation, swine with and without stents were euthanized and coronaries were excised. Arteries were embedded in methyl methacrylate and sections were stained with H&E, trichrome, and Movat's pentachrome. The expression of Ki67, a-smooth muscle actin (SMA), vimentin, and HMGB1 was evaluated by immunofluorescence. There was a positive correlation between percent area stenosis and injury score. The distribution of SMA and vimentin was correlated with the degree of arterial injury such that arteries that had an injury score > 2 did not have immunoreactivity to SMA in the neointimal cells near the stent struts, but these neointimal cells were positive for vimentin, suggesting a change in the smooth muscle cell phenotype. The Ki67 and HMGB1 immunoreactivity was highly correlated with the fragmentation of the IEL and injury in the tunica media. Thus, the extent of coronary arterial injury during interventional procedure will dictate the degree of neointimal hyperplasia, in-stent restenosis, and smooth muscle cell phenotype.	[Swier, Vicki J.; Tang, Lin; Krueger, Kristopher D.; Radwan, Mohamed M.; Del Core, Michael G.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Ctr Clin & Translat Sci, Omaha, NE 68102 USA	Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Ctr Clin & Translat Sci, Omaha, NE 68102 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013; Swier, Vicki/0000-0001-7509-9920; Radwan Ahmed, Mohamed/0000-0002-8074-2535	NIH-NHLBI [R01HL104516, R01HL112597, R01HL116042, R01HL128063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104516, R01HL116042, R01HL128063, R01HL112597] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH-NHLBI R01HL104516, NIH-NHLBI R01HL112597, NIH-NHLBI R01HL116042, and NIH-NHLBI R01HL128063.	Bascands JL, 2001, HYPERTENSION, V38, P1294, DOI 10.1161/hy1201.096540; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Chieffo A, 2009, AM J CARDIOL, V104, P1660, DOI 10.1016/j.amjcard.2009.07.041; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; GRINSTEAD WC, 1994, CORONARY ARTERY DIS, V5, P425, DOI 10.1097/00019501-199405000-00009; Indolfi C, 2002, AM J PHYSIOL-HEART C, V283, pH760, DOI 10.1152/ajpheart.00613.2001; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Krueger KD, 2006, J CLIN PATHOL, V59, P575, DOI 10.1136/jcp.2004.025643; Meiners S, 2002, CIRCULATION, V105, P483, DOI 10.1161/hc0402.102951; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4; Schwartz RS, 1996, CIRCULATION, V93, P1542, DOI 10.1161/01.CIR.93.8.1542; SIMS FH, 1989, PATHOLOGY, V21, P115, DOI 10.3109/00313028909059547; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Wang ZB, 2005, AM J PHYSIOL-HEART C, V288, pH293, DOI 10.1152/ajpheart.00165.2004	19	9	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138539	10.1371/journal.pone.0138539	http://dx.doi.org/10.1371/journal.pone.0138539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382957	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200122
J	Swanson, DK				Swanson, David K.			Environmental Limits of Tall Shrubs in Alaska's Arctic National Parks	PLOS ONE			English	Article							KUPARUK RIVER-BASIN; VEGETATION CHANGE; TUNDRA; TEMPERATURE; EXPANSION; THAW; PRECIPITATION; FIRE; PERMAFROST; ECOSYSTEMS	We sampled shrub canopy volume (height times area) and environmental factors (soil wetness, soil depth of thaw, soil pH, mean July air temperature, and typical date of spring snow loss) on 471 plots across five National Park Service units in northern Alaska. Our goal was to determine the environments where tall shrubs thrive and use this information to predict the location of future shrub expansion. The study area covers over 80,000 km(2) and has mostly tundra vegetation. Large canopy volumes were uncommon, with volumes over 0.5 m(3)/m(2) present on just 8% of plots. Shrub canopy volumes were highest where mean July temperatures were above 10.5 degrees C and on weakly acid to neutral soils (pH of 6 to 7) with deep summer thaw (>80 cm) and good drainage. On many sites, flooding helped maintain favorable soil conditions for shrub growth. Canopy volumes were highest where the typical snow loss date was near 20 May; these represent sites that are neither strongly wind-scoured in the winter nor late to melt from deep snowdrifts. Individual species varied widely in the canopy volumes they attained and their response to the environmental factors. Betula sp. shrubs were the most common and quite tolerant of soil acidity, cold July temperatures, and shallow thaw depths, but they did not form high-volume canopies under these conditions. Alnus viridis formed the largest canopies and was tolerant of soil acidity down to about pH 5, but required more summer warmth (over 12 degrees C) than the other species. The Salix species varied widely from S. pulchra, tolerant of wet and moderately acid soils, to S. alaxensis, requiring well-drained soils with near neutral pH. Nearly half of the land area in ARCN has mean July temperatures of 10.5 to 12.5 degrees C, where 2 degrees C of warming would bring temperatures into the range needed for all of the potential tall shrub species to form large canopies. However, limitations in the other environmental factors would probably prevent the formation of large shrub canopies on at least half of the land area with newly favorable temperatures after 2 degrees C of warming.	Natl Pk Serv, Arctic Inventory & Monitoring Network, Fairbanks, AK 99709 USA	United States Department of the Interior	Swanson, DK (corresponding author), Natl Pk Serv, Arctic Inventory & Monitoring Network, Fairbanks, AK 99709 USA.	david_k_swanson@nps.gov			U.S. Department of Interior, National Park Service, Inventory and Monitoring program	U.S. Department of Interior, National Park Service, Inventory and Monitoring program	This study was funded entirely by base funding from the U.S. Department of Interior, National Park Service, Inventory and Monitoring program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Fire Service, 2014, FIR HIST AL; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], USDA HDB; Bartleman AP, 2001, ARCTIC, V54, P149; Benham E. C, 2012, SOIL SURVEY STAFF FI; Bockheim JG, 1998, ARCTIC ALPINE RES, V30, P166, DOI 10.2307/1552131; Bryant JP, 2014, ECOGRAPHY, V37, P204, DOI 10.1111/j.1600-0587.2013.00436.x; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Burn CR, 1998, CAN J EARTH SCI, V35, P184, DOI 10.1139/e97-105; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Cornelissen JHC, 2001, J ECOL, V89, P984, DOI 10.1111/j.1365-2745.2001.00625.x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DYRNESS CT, 1983, CAN J FOREST RES, V13, P879, DOI 10.1139/x83-118; DYRNESS CT, 1979, CAN J BOT, V57, P2644, DOI 10.1139/b79-314; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Frost GV, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015035; FS-R10-FHP, 2022, USDA SERV PUBL; Harden JW, 2001, SOIL DRAINAGE ITS PO, P139; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; HINKEL KM, 1995, ARCTIC ALPINE RES, V27, P72, DOI 10.2307/1552069; Joly Kyle, 2007, Rangifer, P199; Jones BM, 2013, J GEOPHYS RES-BIOGEO, V118, P1334, DOI 10.1002/jgrg.20113; Jorgenson M. T., 2008, P 9 INT C PERM, V29, P869; Jorgenson MT, 2015, CLIMATIC CHANGE, V130, P131, DOI 10.1007/s10584-014-1302-1; Jorgenson MT, 2009, ARCNNRTR2009270; Kaplan JO, 2006, CLIMATIC CHANGE, V79, P213, DOI 10.1007/s10584-006-9113-7; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; LaMotte, 2014, MORGAN SOIL PH TEST; Lantz TC, 2013, ECOSYSTEMS, V16, P47, DOI 10.1007/s10021-012-9595-2; Lantz TC, 2010, J BIOGEOGR, V37, P1597, DOI 10.1111/j.1365-2699.2010.02317.x; Lantz TC, 2009, GLOBAL CHANGE BIOL, V15, P1664, DOI 10.1111/j.1365-2486.2009.01917.x; Liang E, 2014, ECOLOGY, V95, P2453, DOI 10.1890/13-1904.1; Liang EY, 2009, ANN BOT-LONDON, V104, P665, DOI 10.1093/aob/mcp158; Macander MJ, NPSARCNNRTR2012643; Mack MC, 2011, NATURE, V475, P489, DOI 10.1038/nature10283; Marchenko S., 2008, P 9 INT C PERM I NO, V2, P1125, DOI DOI 10.5194/TC-6-613-2012; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Naito AT, 2015, ECOL EVOL, V5, P87, DOI 10.1002/ece3.1341; Nelson FE, 1997, ARCTIC ALPINE RES, V29, P367, DOI 10.2307/1551985; Parker CL., 2006, VASCULAR PLANT INVEN; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; PRISM Climate Group, 2009, JULY MEAN AV TEMP AL; Racine C, 2004, ARCT ANTARCT ALP RES, V36, P1, DOI 10.1657/1523-0430(2004)036[0001:TFAVCA]2.0.CO;2; Simpson JJ, 2005, ARCTIC, V58, P137; SONESSON M, 1991, ARCTIC, V44, P95; Stafford JM, 2000, THEOR APPL CLIMATOL, V67, P33, DOI 10.1007/s007040070014; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; Swanson D.K., 2014, NATURAL RESOURCE DAT, P122; Swanson D.K, 2013, NPSARCNNRTR2013668; Swanson DK, 1996, ARCTIC ALPINE RES, V28, P217, DOI 10.2307/1551763; Swanson DK, 2014, NPSARCNNRDS2014634; Swanson DK., NPSARCNNRDS2013580; Swanson DK, 2012, VEGETATON SAMPLING A; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Tape KD, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001795; Tape KD, 2010, ECOSCIENCE, V17, P186, DOI 10.2980/17-2-3323; van Oldenborgh GJ, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1311; VANCLEVE K, 1983, BIOSCIENCE, V33, P39, DOI 10.2307/1309243; Viereck L. A., 2007, ALASKA TREES SHRUBS, V2nd; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wang YF, 2015, GLOBAL PLANET CHANGE, V132, P20, DOI 10.1016/j.gloplacha.2015.06.007; Western Regional Climate Center (WRCC), 2015, W US CLIM HIST SUMM	66	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138387	10.1371/journal.pone.0138387	http://dx.doi.org/10.1371/journal.pone.0138387			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379243	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400095
J	Vohra, R; Accorsi, A; Kumar, A; Walter, G; Girgenrath, M				Vohra, Ravneet; Accorsi, Anthony; Kumar, Ajay; Walter, Glenn; Girgenrath, Mahasweta			Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)	PLOS ONE			English	Article							SKELETAL-MUSCLE; MOUSE MODEL; T2; MICE; REGENERATION; LOSARTAN; FIBROSIS; DAMAGE	Purpose To elucidate the reliability of MRI as a non-invasive tool for assessing in vivo muscle health and pathological amelioration in response to Losartan (Angiotensin II Type 1 receptor blocker) in DyW mice (mouse model for Laminin-deficient Congenital Muscular Dystrophy Type 1A). Methods Multiparametric MR quantifications along with histological/biochemical analyses were utilized to measure muscle volume and composition in untreated and Losartan-treated 7-week old DyW mice. Results MRI shows that DyW mice have significantly less hind limb muscle volume and areas of hyperintensity that are absent in WT muscle. DyW mice also have significantly elevated muscle levels (suggestive of inflammation and edema). Muscle T-2 returned to WT levels in response to Losartan treatment. When considering only muscle pixels without T-2 elevation, DyW T-2 levels are significantly lower than WT (suggestive of fibrosis) whereas Losartan-treated animals do not demonstrate this decrease in muscle T-2. MRI measurements suggestive of elevated inflammation and fibrosis corroborate with increased Mac-1 positive cells as well as increased Picrosirius red staining/COL1a gene expression that is returned to WT levels in response to Losartan. Conclusions MRI is sensitive to and tightly corresponds with pathological changes in DyW mice and thus is a viable and effective non-invasive tool for assessing pathological changes.	[Accorsi, Anthony; Kumar, Ajay; Girgenrath, Mahasweta] Boston Univ, Dept Hlth Sci, Sargent Coll, Boston, MA 02215 USA; [Vohra, Ravneet; Walter, Glenn] Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL USA	Boston University; State University System of Florida; University of Florida	Girgenrath, M (corresponding author), Boston Univ, Dept Hlth Sci, Sargent Coll, Boston, MA 02215 USA.	swetag@bu.edu	Vohra, Ravneet/AAD-5864-2019	Vohra, Ravneet/0000-0001-6258-2710	Cure CMD; Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association [218938]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [U54AR052646]; National High Magnetic Field Laboratory - NSF [DMR-1157490]; State of Florida; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	Cure CMD; Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association(Muscular Dystrophy Association); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; National High Magnetic Field Laboratory - NSF; State of Florida; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported with the research grants awarded to M.G. from Cure CMD, Struggle Against Muscular Dystrophy (SAM), Muscular Dystrophy Association (218938), the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (U54AR052646) and the National High Magnetic Field Laboratory, which is supported by NSF DMR-1157490 and the State of Florida.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856; Bryant ND, 2014, NMR BIOMED, V27, P716, DOI 10.1002/nbm.3113; Bun SS, 2012, INVEST RADIOL, V47, P319, DOI 10.1097/RLI.0b013e318243e062; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Connolly AM, 2001, NEUROMUSCULAR DISORD, V11, P703, DOI 10.1016/S0960-8966(01)00232-2; Elbaz M, 2012, ANN NEUROL, V71, P699, DOI 10.1002/ana.22694; Elliott MA, 1999, MAGN RESON MED, V41, P450, DOI 10.1002/(SICI)1522-2594(199903)41:3<450::AID-MRM4>3.0.CO;2-9; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Kumar A, 2011, HUM MOL GENET, V20, P2333, DOI 10.1093/hmg/ddr126; Loganathan R, 2006, INT J CARDIOVAS IMAG, V22, P81, DOI 10.1007/s10554-005-5386-6; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Mavrogeni S, 2005, CHEST, V127, P143, DOI 10.1378/chest.127.1.143; Mavrogeni S, 2009, EUR J PAEDIATR NEURO, V13, P34, DOI 10.1016/j.ejpn.2008.02.006; Mehuron T, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-14; Meinen S, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-18; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Philpot J, 1999, ARCH DIS CHILD, V80, P542, DOI 10.1136/adc.80.6.542; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; van Nierop BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129899; Vohra RS, 2016, MUSCLE NERVE, V53, P84, DOI 10.1002/mus.24675; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0096463; Wansapura JP, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-14; Ye F, 2013, EXP PHYSIOL, V98, P1038, DOI 10.1113/expphysiol.2012.070722	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138254	10.1371/journal.pone.0138254	http://dx.doi.org/10.1371/journal.pone.0138254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379183	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400073
J	Schuler, MH; Di Bartolomeo, F; Bottinger, L; Horvath, SE; Wenz, LS; Daum, G; Becker, T				Schuler, Max-Hinderk; Di Bartolomeo, Francesca; Boettinger, Lena; Horvath, Susanne E.; Wenz, Lena-Sophie; Daum, Guenther; Becker, Thomas			Phosphatidylcholine Affects the Role of the Sorting and Assembly Machinery in the Biogenesis of Mitochondrial beta-Barrel Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; RESPIRATORY-CHAIN SUPERCOMPLEXES; SYNTHETIC LETHAL INTERACTION; OUTER-MEMBRANE BIOGENESIS; GENERAL IMPORT PORE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; INTERMEMBRANE SPACE; EVOLUTIONARY CONSERVATION; PREPROTEIN TRANSLOCASE	Two protein translocases drive the import of beta-barrel precursor proteins into the mitochondrial outer membrane: The translocase of the outer membrane (TOM complex) promotes transport of the precursor to the intermembrane space, whereas the sorting and assembly machinery (SAM complex) mediates subsequent folding of the beta-barrel and its integration into the target membrane. The non-bilayer-forming phospholipids phosphatidylethanolamine (PE) and cardiolipin (CL) are required for the biogenesis of beta-barrel proteins. Whether bilayer-forming phospholipids such as phosphatidylcholine (PC), the most abundant phospholipid of the mitochondrial outer membrane, play a role in the import of beta-barrel precursors is unclear. In this study, we show that PC is required for stability and function of the SAM complex during the biogenesis of beta-barrel proteins. PC further promotes the SAM-dependent assembly of the TOM complex, indicating a general role of PC for the function of the SAM complex. In contrast to PE-deficient mitochondria precursor accumulation at the TOM complex is not affected by depletion of PC. We conclude that PC and PE affect the function of distinct protein translocases in mitochondrial beta-barrel biogenesis.	[Schuler, Max-Hinderk; Boettinger, Lena; Horvath, Susanne E.; Wenz, Lena-Sophie; Becker, Thomas] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Di Bartolomeo, Francesca; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Becker, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Graz University of Technology; University of Freiburg	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at; thomas.becker@biochemie.uni-freiburg.de	Schuler, Max-Hinderk/AAZ-8376-2021; Schuler, Max-Hinderk/AAZ-8388-2021; Becker, Thomas/AAS-9404-2020	Schuler, Max-Hinderk/0000-0002-6734-8250; Di Bartolomeo, Francesca/0000-0002-4302-0701	Deutsche Forschungsgemeinschaft [BE4679/2-1, Sonderforschungsbereich 746]; Excellence Initiative of the German Federal & State Governments [EXC 294 BIOSS]; German Academy of Sciences Leopoldina [LPDS 2013-08]; Austrian Science Fund [P-26133]; Austrian Science Fund (FWF) [P 26133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments; German Academy of Sciences Leopoldina; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Deutsche Forschungsgemeinschaft (BE4679/2-1), the Sonderforschungsbereich 746, the Excellence Initiative of the German Federal & State Governments (EXC 294 BIOSS), the German Academy of Sciences Leopoldina (LPDS 2013-08, to S. E. H.) and by the Austrian Science Fund (to F. W. F.), Project P-26133 (to G. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; GREENBERG ML, 1983, J BACTERIOL, V153, P791, DOI 10.1128/JB.153.2.791-799.1983; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Klein A, 2012, J CELL BIOL, V199, P599, DOI 10.1083/jcb.201207161; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lackey SWK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025650; Lang A, 2015, CURR OPIN CELL BIOL, V35, P7, DOI 10.1016/j.ceb.2015.03.002; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PREITSCHOPF W, 1993, CURR GENET, V23, P95, DOI 10.1007/BF00352006; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Song JY, 2014, EMBO REP, V15, P670, DOI 10.1002/embr.201338142; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; SUMMERS EF, 1988, GENETICS, V120, P909; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	86	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26523	26532		10.1074/jbc.M115.687921	http://dx.doi.org/10.1074/jbc.M115.687921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26385920	hybrid, Green Published			2022-12-26	WOS:000364793600020
J	Banowary, B; Dang, V; Sarker, S; Connolly, JH; Chenu, J; Groves, P; Ayton, M; Raidal, S; Devi, A; Vanniasinkam, T; Ghorashi, SA				Banowary, Banya; Dang, Van Tuan; Sarker, Subir; Connolly, Joanne H.; Chenu, Jeremy; Groves, Peter; Ayton, Michelle; Raidal, Shane; Devi, Aruna; Vanniasinkam, Thiru; Ghorashi, Seyed A.			Differentiation of Campylobacter jejuni and Campylobacter coli Using Multiplex-PCR and High Resolution Melt Curve Analysis	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISMS; FIELD GEL-ELECTROPHORESIS; REAL-TIME PCR; FECAL SAMPLES; GENE; IDENTIFICATION; ASSAY; STRAINS; REGION	Campylobacter spp. are important causes of bacterial gastroenteritis in humans in developed countries. Among Campylobacter spp. Campylobacter jejuni (C. jejuni) and C. coli are the most common causes of human infection. In this study, a multiplex PCR (mPCR) and high resolution melt (HRM) curve analysis were optimized for simultaneous detection and differentiation of C. jejuni and C. coli isolates. A segment of the hippuricase gene (hipO) of C. jejuni and putative aspartokinase (asp) gene of C. coli were amplified from 26 Campylobacter isolates and amplicons were subjected to HRM curve analysis. The mPCR-HRM was able to differentiate between C. jejuni and C. coli species. All DNA amplicons generated by mPCR were sequenced. Analysis of the nucleotide sequences from each isolate revealed that the HRM curves were correlated with the nucleotide sequences of the amplicons. Minor variation in melting point temperatures of C. coli or C. jejuni isolates was also observed and enabled some intraspecies differentiation between C. coli and/or C. jejuni isolates. The potential of PCR-HRM curve analysis for the detection and speciation of Campylobacter in additional human clinical specimens and chicken swab samples was also confirmed. The sensitivity and specificity of the test were found to be 100% and 92%, respectively. The results indicated that mPCR followed by HRM curve analysis provides a rapid (8 hours) technique for differentiation between C. jejuni and C. coli isolates.	[Banowary, Banya; Dang, Van Tuan; Sarker, Subir; Connolly, Joanne H.; Ayton, Michelle; Raidal, Shane; Ghorashi, Seyed A.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Banowary, Banya; Dang, Van Tuan; Sarker, Subir; Connolly, Joanne H.; Ayton, Michelle; Raidal, Shane; Vanniasinkam, Thiru; Ghorashi, Seyed A.] Graham Ctr Agr Innovat, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Banowary, Banya; Dang, Van Tuan; Sarker, Subir; Connolly, Joanne H.; Ayton, Michelle; Raidal, Shane; Vanniasinkam, Thiru; Ghorashi, Seyed A.] Charles Sturt Univ, Wagga Wagga, NSW, Australia; [Chenu, Jeremy] Birling Avian Labs, Bringelly, NSW, Australia; [Groves, Peter] Univ Sydney, Sydney, NSW 2006, Australia; [Devi, Aruna; Vanniasinkam, Thiru] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; University of Sydney; Charles Sturt University	Ghorashi, SA (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.	aghorashi@csu.edu.au	Devi, Aruna/I-3775-2019; Raidal, Shane/C-4632-2008; Sarker, Subir/U-8444-2019; Vanniasinkam, Thiru/W-2137-2018; Ghorashi, Seyed A/C-1529-2016; Connolly, Joanne/O-6730-2018	Raidal, Shane/0000-0001-7917-8976; Sarker, Subir/0000-0002-2685-8377; Vanniasinkam, Thiru/0000-0001-9318-3982; Ghorashi, Seyed A/0000-0002-9820-5308; Groves, Peter/0000-0002-8984-3156; Connolly, Joanne/0000-0002-8797-1007	School of Animal and Veterinary Science [40702]; Graham Centre for Agricultural Innovation [40830]; Faculty of Science at Charles Sturt University [40797]; Birling Avian Laboratories	School of Animal and Veterinary Science; Graham Centre for Agricultural Innovation; Faculty of Science at Charles Sturt University; Birling Avian Laboratories	Funded by School of Animal and Veterinary Science under Grant number 40702, the Graham Centre for Agricultural Innovation under Grant number 40830, and Faculty of Science under Grant number 40797 at Charles Sturt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Birling Avian Laboratories provided support in the form of a salary for JC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; CDC, 2013, PULS FIELD GEL EL PF; Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Debruyne L, 2008, RES MICROBIOL, V159, P88, DOI 10.1016/j.resmic.2007.11.020; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Eurosurveillance editorial team, 2013, Euro Surveill, V18, P20449; Fussing V, 2007, CLIN MICROBIOL INFEC, V13, P635, DOI 10.1111/j.1469-0691.2007.01689.x; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Ghorashi SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126824; Ghorashi SA, 2013, VET MICROBIOL, V167, P440, DOI 10.1016/j.vetmic.2013.09.032; Ghorashi SA, 2011, J VIROL METHODS, V171, P264, DOI 10.1016/j.jviromet.2010.11.013; Gilpin B, 2012, J CLIN MICROBIOL, V50, P457, DOI 10.1128/JCM.05928-11; Goldschmidt P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037660; Gray J, 2014, EPIDEMIOL INFECT, V142, P1, DOI 10.1017/S0950268813002367; Havelaar AH, 2007, ZOONOSES PUBLIC HLTH, V54, P103, DOI 10.1111/j.1863-2378.2007.01036.x; Hedberg CW, 2001, J INFECT DIS, V184, P242, DOI 10.1086/322005; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Khan IUH, 2007, J APPL MICROBIOL, V103, P2561, DOI 10.1111/j.1365-2672.2007.03511.x; Kramer JM, 2000, J FOOD PROTECT, V63, P1654, DOI 10.4315/0362-028X-63.12.1654; Lawson AJ, 1999, J CLIN MICROBIOL, V37, P3860, DOI 10.1128/JCM.37.12.3860-3864.1999; Lawson AJ, 1998, EPIDEMIOL INFECT, V121, P547, DOI 10.1017/S0950268898001630; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Li BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028078; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Merchant-Patel S, 2008, INT J FOOD MICROBIOL, V128, P304, DOI 10.1016/j.ijfoodmicro.2008.09.002; Merchant-Patel S, 2010, APPL ENVIRON MICROB, V76, P493, DOI 10.1128/AEM.01164-09; NACHAMKIN I, 1993, J CLIN MICROBIOL, V31, P1531, DOI 10.1128/JCM.31.6.1531-1536.1993; Noormohamed A, 2013, INT J ENV RES PUB HE, V10, P2058, DOI 10.3390/ijerph10052058; OWEN RJ, 1993, MOL CELL PROBE, V7, P471, DOI 10.1006/mcpr.1993.1070; Poly F, 2011, J CLIN MICROBIOL, V49, P1750, DOI 10.1128/JCM.02348-10; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Quinn T. C., 1995, Annals Academy of Medicine Singapore, V24, P627; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ridley AM, 2008, APPL ENVIRON MICROB, V74, P2492, DOI 10.1128/AEM.01242-07; Rosenquist H, 2013, INT J FOOD MICROBIOL, V162, P226, DOI 10.1016/j.ijfoodmicro.2013.01.022; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Steer PA, 2011, AUST VET J, V89, P184, DOI 10.1111/j.1751-0813.2011.00695.x; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Strachan NJC, 2012, INT J FOOD MICROBIOL, V153, P234, DOI 10.1016/j.ijfoodmicro.2011.10.033; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toi CS, 2008, J CLIN VIROL, V43, P18, DOI 10.1016/j.jcv.2008.03.027; Tsai HJ, 2006, J VET MED SCI, V68, P815, DOI 10.1292/jvms.68.815; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Whiley H, 2013, INT J ENV RES PUB HE, V10, P5886, DOI 10.3390/ijerph10115886; Wiemer D, 2011, INT J MED MICROBIOL, V301, P577, DOI 10.1016/j.ijmm.2011.06.001; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Yamazaki-Matsune W, 2007, J MED MICROBIOL, V56, P1467, DOI 10.1099/jmm.0.47363-0; Yang CB, 2003, FEMS IMMUNOL MED MIC, V38, P265, DOI 10.1016/S0928-8244(03)00168-8; Zhao S., 2010, APPL ENVIRON MICROB, V76, P7949, DOI DOI 10.1128/AEM.01297-10	56	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138808	10.1371/journal.pone.0138808	http://dx.doi.org/10.1371/journal.pone.0138808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394042	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100100
J	Demos, TC; Peterhans, JCK; Joseph, TA; Robinson, JD; Agwanda, B; Hickerson, MJ				Demos, Terrence C.; Peterhans, Julian C. Kerbis; Joseph, Tyler A.; Robinson, John D.; Agwanda, Bernard; Hickerson, Michael J.			Comparative Population Genomics of African Montane Forest Mammals Support Population Persistence across a Climatic Gradient and Quaternary Climatic Cycles	PLOS ONE			English	Article							ALBERTINE RIFT; SPECIES DELIMITATION; EASTERN-AFRICA; PHYLOGENETIC NETWORKS; BIODIVERSITY HOTSPOT; CONGO; DIVERSITY; SORICIDAE; PHYLOGEOGRAPHY; CONSERVATION	The Eastern Afromontane biodiversity hotspot (EABH) has the highest concentration of biodiversity in tropical Africa, yet few studies have investigated recent historical diversification processes in EABH lineages. Herein, we analyze restriction-site associated DNA-sequences (RAD-Seq) to study recent historical processes in co-distributed mouse (Hylomyscus) and shrew (Sylvisorex) species complexes, with an aim to better determine how historical paleoenvironmental processes might have contributed to the EABH's high diversity. We analyzed complete SNP matrices of >50,000 RAD loci to delineate populations, reconstruct the history of isolation and admixture, and discover geographic patterns of genetic partitioning. These analyses demonstrate that persistently unsuitable habitat may have isolated multiple populations distributed across montane habitat islands in the Itombwe Massif and Albertine Rift to the west as well as Mt Elgon and Kenyan Highlands to the east. We detected low genetic diversity in Kenyan Highland populations of both genera, consistent with smaller historical population sizes in this region. We additionally tested predictions that Albertine Rift populations are older and more persistently isolated compared to the Kenyan Highlands. Phylogenetic analyses support greater historical isolation among Albertine Rift populations of both shrews and mice compared to the Kenyan Highlands and suggest that there are genetically isolated populations from both focal genera in the Itombwe Massif, Democratic Republic of Congo. The Albertine Rift ecoregion has the highest mammalian tropical forest species richness per unit area on earth. Our results clearly support accelerating efforts to conserve this diversity.	[Demos, Terrence C.; Joseph, Tyler A.; Robinson, John D.; Hickerson, Michael J.] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Demos, Terrence C.; Hickerson, Michael J.] CUNY Grad Sch & Univ Ctr, Biol Doctoral Program, New York, NY 10036 USA; [Demos, Terrence C.; Peterhans, Julian C. Kerbis] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Peterhans, Julian C. Kerbis] Roosevelt Univ, Coll Profess Studies, Chicago, IL 60605 USA; [Robinson, John D.] South Carolina Dept Nat Resources, Charleston, SC 29412 USA; [Agwanda, Bernard] Natl Museums Kenya, Mammal Sect, Nairobi 00100, Kenya; [Hickerson, Michael J.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Field Museum of Natural History (Chicago); American Museum of Natural History (AMNH)	Demos, TC (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	terrencedemos@gmail.com	Demos, Terrence C/J-9169-2013	Demos, Terrence C/0000-0003-0522-3708; Robinson, John/0000-0002-9782-1598	NSF [DEB-1110682, DEB-1253710, DOB 1343578, CNS-0958379, CNS-0855217]; FMNH Council on Africa; American Philosophical Society Lewis and Clark Fund; Queens College Graduate Advisory Council; PSC CUNY Research Award; FAPESP (BIOTA) [2013/50297-0]; NASA through Dimensions of Biodiversity Program; Div Of Biological Infrastructure [1156512] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); FMNH Council on Africa; American Philosophical Society Lewis and Clark Fund; Queens College Graduate Advisory Council; PSC CUNY Research Award; FAPESP (BIOTA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NASA through Dimensions of Biodiversity Program; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This research was supported by the following sources: NSF Doctoral Dissertation Improvement Grant (DEB-1110682 to TCD and MJH), FMNH Council on Africa (to TCD), the American Philosophical Society Lewis and Clark Fund (to TCD), the Queens College Graduate Advisory Council (to TCD), PSC CUNY Research Award (to TCD and MJH), NSF (DEB-1253710 to MJH), FAPESP (BIOTA, 2013/50297-0), NSF (DOB 1343578) and NASA through the Dimensions of Biodiversity Program. Molecular analyses were carried out on the CUNY HPCC operated by the College of Staten Island and funded in part by NSF Grants CNS-0958379 and CNS-0855217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; [Anonymous], 2014, LANG ENV STAT COMP; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brooks T., 2004, HOTSPOTS REVISITED E, V2, P241; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Carleton MD, 2006, P BIOL SOC WASH, V119, P293, DOI 10.2988/0006-324X(2006)119[293:ROTHDG]2.0.CO;2; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Demos TC, 2014, J MAMMAL, V95, P1, DOI DOI 10.1644/13-MAMM-A-268; Demos TC, 2014, MOL PHYLOGENET EVOL, V71, P41, DOI 10.1016/j.ympev.2013.10.014; DIAMOND AW, 1980, J ZOOL, V191, P379; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Esselstyn JA, 2013, MOL ECOL, V22, P4972, DOI 10.1111/mec.12450; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Hearn J, 2014, MOL ECOL, V23, P198, DOI 10.1111/mec.12578; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Huhndorf MH, 2007, MOL ECOL, V16, P663, DOI 10.1111/j.1365-294X.2007.03153.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KINGDON J, 1981, AFR J ECOL, V19, P115, DOI 10.1111/j.1365-2028.1981.tb00656.x; Kingdon J., 2013, MAMMALS AFRICA, V1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Lohse K, 2011, GENETICS, V189, P977, DOI 10.1534/genetics.111.129569; Lohse K, 2014, GENETICS, V196, P1241, DOI 10.1534/genetics.114.162396; Mazel F, 2014, GLOBAL ECOL BIOGEOGR, V23, P836, DOI 10.1111/geb.12158; Moreau R. E., 1966, BIRD FAUNA AFRICA IT; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Omari I, 1999, ORYX, V33, P301, DOI 10.1017/S0030605300030714; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Peterhans Julian C. Kerbis, 2013, Bonn Zoological Bulletin, V62, P203; Peterhans Julian C. Kerbis, 2013, Bonn Zoological Bulletin, V62, P186; Peterhans Julian C. Kerbis, 2010, Journal of East African Natural History, V99, P103; Peterhans Julian Kerbis, 2009, Bonner Zoologische Beitraege, V56, P175; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; PRIGOGINE A, 1987, Bonner Zoologische Beitraege, V38, P195; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roux C, 2013, MOL BIOL EVOL, V30, P1574, DOI 10.1093/molbev/mst066; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wichura H, 2010, GEOLOGY, V38, P543, DOI 10.1130/G31022.1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	59	22	23	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0131800	10.1371/journal.pone.0131800	http://dx.doi.org/10.1371/journal.pone.0131800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394036	Green Published, gold			2022-12-26	WOS:000361792100001
J	McWilliams-Koeppen, HP; Foster, JS; Hackenbrack, N; Ramirez-Alvarado, M; Donohoe, D; Williams, A; Macy, S; Wooliver, C; Wortham, D; Morrell-Falvey, J; Foster, CM; Kennel, SJ; Wall, JS				McWilliams-Koeppen, Helen P.; Foster, James S.; Hackenbrack, Nicole; Ramirez-Alvarado, Marina; Donohoe, Dallas; Williams, Angela; Macy, Sallie; Wooliver, Craig; Wortham, Dale; Morrell-Falvey, Jennifer; Foster, Carmen M.; Kennel, Stephen J.; Wall, Jonathan S.			Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING AGENT; CARDIAC AMYLOIDOSIS; ALZHEIMERS-DISEASE; AL AMYLOIDOSIS; IN-VITRO; CELL-CULTURE; SPINAL-CORD; DIAGNOSIS; 2,4-DINITROPHENOL; TRANSTHYRETIN	Light chain (AL) amyloidosis is the most common form of systemic amyloid disease, and cardiomyopathy is a dire consequence, resulting in an extremely poor prognosis. AL is characterized by the production of monoclonal free light chains that deposit as amyloid fibrils principally in the heart, liver, and kidneys causing organ dysfunction. We have studied the effects of amyloid fibrils, produced from recombinant lambda 6 light chain variable domains, on metabolic activity of human cardiomyocytes. The data indicate that fibrils at 0.1 mu M, but not monomer, significantly decrease the enzymatic activity of cellular NAD(P) H-dependent oxidoreductase, without causing significant cell death. The presence of amyloid fibrils did not affect ATP levels; however, oxygen consumption was increased and reactive oxygen species were detected. Confocal fluorescence microscopy showed that fibrils bound to and remained at the cell surface with little fibril internalization. These data indicate that AL amyloid fibrils severely impair cardiomyocyte metabolism in a dose dependent manner. These data suggest that effective therapeutic intervention for these patients should include methods for removing potentially toxic amyloid fibrils.	[McWilliams-Koeppen, Helen P.; Foster, James S.; Hackenbrack, Nicole; Williams, Angela; Macy, Sallie; Wooliver, Craig; Wortham, Dale; Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Radiol, Knoxville, TN USA; [Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem Mol Biol & Immunol, Rochester, MN USA; [Donohoe, Dallas] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Morrell-Falvey, Jennifer; Foster, Carmen M.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Mayo Clinic; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Wall, JS (corresponding author), Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA.	jwall@utmck.edu	Morrell-Falvey, Jennifer L/A-6615-2011	Morrell-Falvey, Jennifer L/0000-0002-9362-7528; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Wall, Jonathan/0000-0002-5516-8578; Hackenbrack, Nicky/0000-0002-2344-1533; Hackenbrack, Nicole/0000-0001-9155-5711	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [R01DK079984]; Molecular Imaging and Translational Research Program; Department of Medicine at The University of Tennessee Graduate School of Medicine; US Department of Energy [DE-AC05-00OR22725]; Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular Imaging and Translational Research Program; Department of Medicine at The University of Tennessee Graduate School of Medicine; US Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported in part by grant number R01DK079984 from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), as well as The Molecular Imaging and Translational Research Program and Department of Medicine at The University of Tennessee Graduate School of Medicine. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the US Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bourgault S, 2011, BIOCHEM BIOPH RES CO, V410, P707, DOI 10.1016/j.bbrc.2011.04.133; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dubrey SW, 2011, HEART, V97, P75, DOI 10.1136/hrt.2009.190405; Dubrey SW, 2010, BRIT J HOSP MED, V71, P76, DOI 10.12968/hmed.2010.71.2.46484; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Gonzalez-Andrade M, 2013, FEBS J, V280, P6173, DOI 10.1111/febs.12538; Guan J, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0378-5; Guan J, 2012, AM J PHYSIOL-HEART C, V302, pH544, DOI 10.1152/ajpheart.00815.2011; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Keeling J, 2009, KIDNEY INT, V75, P634, DOI 10.1038/ki.2008.504; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Migrino RQ, 2011, AM J PHYSIOL-HEART C, V301, pH2305, DOI 10.1152/ajpheart.00503.2011; Migrino RQ, 2010, INT J CARDIOL, V145, P67, DOI 10.1016/j.ijcard.2009.04.044; O'Hara C, 2003, AMYLOID, V10, P127, DOI 10.3109/13506120309041735; OKUDA M, 1992, ACTA PHYSIOL SCAND, V145, P159, DOI 10.1111/j.1748-1716.1992.tb09351.x; Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Quarta CC, 2012, CIRCULATION, V126, pE178, DOI 10.1161/CIRCULATIONAHA.111.069195; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sikkink LA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.75; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Teng JM, 2004, LAB INVEST, V84, P440, DOI 10.1038/labinvest.3700069; Voigt S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-74; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wang G, 2008, FREE RADICAL RES, V42, P435, DOI 10.1080/10715760802074462; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	52	42	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137716	10.1371/journal.pone.0137716	http://dx.doi.org/10.1371/journal.pone.0137716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393799	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100017
J	Morris, JK; Wald, NJ; Springett, AL				Morris, Joan K.; Wald, Nicholas J.; Springett, Anna L.			Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up	PLOS ONE			English	Article							MORTALITY; COHORT	Purpose Hydrazine is carcinogenic in animals, but there is inadequate evidence to determine if it is carcinogenic in humans. This study aimed to evaluate the association between hydrazine exposure and the risk of lung cancer. Methods The cause specific mortality rates of a cohort of 427 men who were employed at an English factory that produced hydrazine between 1945 and 1971 were compared with national mortality rates. Results By the end of December 2012 205 deaths had occurred. For men in the highest exposure category with greater than two years exposure and after more than ten years since first exposure the relative risks compared with national rates were: 0.85 (95% CI: 0.18-2.48) for lung cancer, 0.61 (95% CI: 0.07-2.21) for cancers of the digestive system, and 0.44 (95% CI: 0.05-1.57) for other cancers. Conclusions After 50 years of follow up, the results provide no evidence of an increased risk of death from lung cancer or death from any other cause.	[Morris, Joan K.; Wald, Nicholas J.; Springett, Anna L.] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London, England	University of London; Queen Mary University London	Morris, JK (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, Charterhouse Sq, London, England.	j.k.morris@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-2814-2021	Morris, Joan/0000-0002-7164-612X; 				[Anonymous], 1999, IARC Monogr Eval Carcinog Risks Hum, V71 Pt 3, P991; [Anonymous], 1974, IARC MON EV CARC RIS, V4, P127; [Anonymous], 1987, IARC MONOGR EVAL CAR, V7, P223; Boice JD, 2006, J OCCUP ENVIRON MED, V48, P1070, DOI 10.1097/01.jom.0000240661.33413.b5; MORRIS J, 1995, OCCUP ENVIRON MED, V52, P43, DOI 10.1136/oem.52.1.43; Ritz B, 2006, EPIDEMIOLOGY, V17, P154, DOI 10.1097/01.ede.0000199323.55534.fb; Ritz B, 1999, J OCCUP ENVIRON MED, V41, P903, DOI 10.1097/00043764-199910000-00011; Zhivin S, 2013, AM J IND MED, V56, P1262, DOI 10.1002/ajim.22231	9	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138884	10.1371/journal.pone.0138884	http://dx.doi.org/10.1371/journal.pone.0138884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394402	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100113
J	Song, B; Pei, LL; Fang, H; Zhao, L; Gao, Y; Wang, YY; Tan, S; Xu, YM				Song, Bo; Pei, Lulu; Fang, Hui; Zhao, Lu; Gao, Yuan; Wang, Yuanyuan; Tan, Song; Xu, Yuming			Validation of the RRE-90 Scale to Predict Stroke Risk after Transient Symptoms with Infarction: A Prospective Cohort Study	PLOS ONE			English	Article							ISCHEMIC ATTACK; ABCD(2) SCORE; MINOR STROKE; RECURRENCE; TIA; PERFORMANCE; DEFINITION; DIAGNOSIS; DISEASE	Background and Purpose The risk of stroke after a transient ischemic attack (TIA) for patients with a positive diffusion-weighted image (DWI), i.e., transient symptoms with infarction (TSI), is much higher than for those with a negative DWI. The aim of this study was to validate the predictive value of a web-based recurrence risk estimator (RRE; http://www.nmr.mgh.harvard.edu/RRE/) of TSI. Methods Data from the prospective hospital-based TIA database of the First Affiliated Hospital of Zhengzhou University were analyzed. The RRE and ABCD(2) scores were calculated within 7 days of symptom onset. The predictive outcome was ischemic stroke occurrence at 90 days. The receiver-operating characteristics curves were plotted, and the predictive value of the two models was assessed by computing the C statistics. Results A total of 221 eligible patients were prospectively enrolled, of whom 46 (20.81%) experienced a stroke within 90 days. The 90-day stroke risk in high-risk TSI patients (RRE >= 4) was 3.406-fold greater than in those at low risk (P < 0.001). The C statistic of RRE (0.681; 95% confidence interval [CI], 0.592-0.771) was statistically higher than that of ABCD2 score (0.546; 95% CI, 0.454-0.638; Z = 2.115; P = 0.0344) at 90 days. Conclusion The RRE score had a higher predictive value than the ABCD2 score for assessing the 90-day risk of stroke after TSI.	[Song, Bo; Pei, Lulu; Fang, Hui; Zhao, Lu; Gao, Yuan; Wang, Yuanyuan; Xu, Yuming] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China; [Tan, Song] Sichuan Prov Peoples Hosp, Dept Neurol, Chengdu, Sichuan Provinc, Peoples R China	Zhengzhou University; Sichuan Provincial People's Hospital	Xu, YM (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China.	xuyuming@zzu.edu.cn			Health Department of Henan Province [201202005]; Education Department of Henan Province [12A320046]	Health Department of Henan Province; Education Department of Henan Province	Funding: This study was funded by the Health Department of Henan Province (201202005) and the Education Department of Henan Province (12A320046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaled M, 2013, NEUROLOGY, V80, P1920, DOI 10.1212/WNL.0b013e318293e15f; Amarenco P, 2012, STROKE, V43, P863, DOI 10.1161/STROKEAHA.111.636506; Arsava EM, 2011, STROKE, V42, P2186, DOI 10.1161/STROKEAHA.110.604280; Ay H, 2005, ANN NEUROL, V57, P679, DOI 10.1002/ana.20465; Ay H, 2010, NEUROLOGY, V74, P128, DOI 10.1212/WNL.0b013e3181ca9cff; Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; Brazzelli M, 2014, ANN NEUROL, V75, P67, DOI 10.1002/ana.24026; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Dai Q, 2015, NEUROLOGY; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Forster A, 2012, EUR NEUROL, V67, P136, DOI 10.1159/000333286; Galvin R, 2011, FAM PRACT, V28, P366, DOI 10.1093/fampra/cmr008; Giles MF, 2011, NEUROLOGY, V77, P1222, DOI 10.1212/WNL.0b013e3182309f91; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Gupta HV, 2014, THER CLIN RISK MANAG, V10, P27, DOI 10.2147/TCRM.S54810; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kokubo Y, 2014, FRONT NEUROL NEUROSC, V33, P69, DOI 10.1159/000351892; Maier IL, 2013, EUR J NEUROL, V20, P599, DOI 10.1111/ene.12037; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Prabhakaran S, 2007, ARCH NEUROL-CHICAGO, V64, P1105, DOI 10.1001/archneur.64.8.1105; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Purroy F, 2007, STROKE, V38, P3225, DOI 10.1161/STROKEAHA.107.488833; Sanders LM, 2012, NEUROLOGY, V79, P971, DOI 10.1212/WNL.0b013e31825f9d02; Sheehan OC, 2010, STROKE, V41, P844, DOI 10.1161/STROKEAHA.109.571844; Song B, 2013, STROKE, V44, P1244, DOI 10.1161/STROKEAHA.113.000969; Sorensen AG, 2011, NEUROIMAG CLIN N AM, V21, P303, DOI 10.1016/j.nic.2011.01.013; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; von Weitzel-Mudersbach P, 2013, NEUROEPIDEMIOLOGY, V40, P50, DOI 10.1159/000341696; Wang Yuan-yuan, 2013, Zhonghua Yi Xue Za Zhi, V93, P3424	31	7	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137425	10.1371/journal.pone.0137425	http://dx.doi.org/10.1371/journal.pone.0137425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394400	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100014
J	Kojima, Y; Yoneyama, T; Hatakeyama, S; Mikami, J; Sato, T; Mori, K; Hashimoto, Y; Koie, T; Ohyama, C; Fukuda, M; Tobisawa, Y				Kojima, Yuta; Yoneyama, Tohru; Hatakeyama, Shingo; Mikami, Jotaro; Sato, Tendo; Mori, Kazuyuki; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara; Fukuda, Minoru; Tobisawa, Yuki			Detection of Core2 beta-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer	PLOS ONE			English	Article							ABERRANT GLYCOSYLATION; RADICAL PROSTATECTOMY; INCREASED EXPRESSION; GENE-TRANSFER; CELLS; CARCINOMA; ADHESION; ANTIGEN; METASTASIS; MORTALITY	To identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 beta-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-branched O-glycans. Its expression is associated with the progression of several cancers. We established a mouse IgG monoclonal antibody (mAb) against GCNT1 and examined the relationship of GCNT1 expression to the clinicopathological status of PCa. Paraffin-embedded PCa specimens were analyzed by immunohistochemistry for GCNT1 expression using a newly established mouse anti-GCNT1 mAb by ourselves. GCNT1-positive tumor showed significantly higher Gleason score and larger tumor volume. The number of GCNT1-positive cases was significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors were associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis revealed that detection of GCNT1 expression was an independent risk factor for PSA recurrence. We established new methods for GCNT1 detection from PCa specimens. Immunoblotting was used to examine post-digital rectal examination (DRE) urine from PCa patients. Over 90% of GCNT1-positive PCa patients with high concentrations of PSA showed extracapsular extension. In conclusion, GCNT1 expression closely associates with the aggressive potential of PCa. Further research aims to develop GCNT1 detection in post-DRE urine as a marker for PCa aggressiveness.	[Kojima, Yuta; Hatakeyama, Shingo; Mikami, Jotaro; Sato, Tendo; Mori, Kazuyuki; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara; Tobisawa, Yuki] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori, Japan; [Yoneyama, Tohru; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori, Japan; [Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, Ctr Canc, La Jolla, CA 92037 USA	Hirosaki University; Hirosaki University; Sanford Burnham Prebys Medical Discovery Institute	Tobisawa, Y (corresponding author), Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori, Japan.	tobisawa@hirosaki-u.ac.jp	Hatakeyama, Shingo/E-9234-2013; Yoneyama, Tohru/P-7820-2016; Hatakeyama, Shingo/AAQ-2583-2020; Yoneyama, Tohru/ABG-2670-2020; Tobisawa, Yuki/G-3802-2014	Yoneyama, Tohru/0000-0002-1098-407X; Hatakeyama, Shingo/0000-0002-0026-4079; Hashimoto, Yasuhiro/0000-0003-0967-6835; Tobisawa, Yuki/0000-0001-8026-9541	Japan Society for the Promotion of Science [24791631, 15K10569, 22390301, 15H02563, 24659708]; National Institutes Health [UO1 CA168924]; Suzuki Urological Research Foundation, research grant [2014]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Suzuki Urological Research Foundation, research grant	Japan Society for the Promotion of Science (https://www.jsps.go.jp/), Grant-in-Aid for Young Scientists (B) 24791631 and Grant-in-Aid for Scientific Research (C) 15K10569 (YT); Japan Society for the Promotion of Science (https://www.jsps.go.jp/), Grant-in-Aid for Scientific Research (B) 22390301, Grant-in-Aid for Scientific Research (A) 15H02563 and Grant-in-Aid for Challenging Exploratory Research 24659708 (CO); National Institutes Health Grants UO1 CA168924 (MF); The Suzuki Urological Research Foundation, research grant 2014 (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baade PD, 2013, PROSTATE INT, V1, P47, DOI 10.12954/PI.12014; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Chen ZX, 2014, PROSTATE, V74, P1059, DOI 10.1002/pros.22826; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fukuda M, 1996, CANCER RES, V56, P2237; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Hakomori S, 1996, CANCER RES, V56, P5309; Hatakeyama S, 2014, J UROLOGY, V191, P805, DOI 10.1016/j.juro.2013.10.052; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; Inaba Y, 2003, INT J CANCER, V107, P949, DOI 10.1002/ijc.11513; Ishikawa D, 1998, FEBS LETT, V441, P20, DOI 10.1016/S0014-5793(98)01511-7; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Machida E, 2001, CANCER RES, V61, P2226; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; Muramatsu H, 2008, GLYCOBIOLOGY, V18, P242, DOI 10.1093/glycob/cwm138; NAKAMORI S, 1993, CANCER RES, V53, P3632; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Ramsay CR, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19490; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shimodaira K, 1997, CANCER RES, V57, P5201; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Tallon L, 2014, INT J MOL SCI, V15, P13299, DOI 10.3390/ijms150813299; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Tsui KH, 2008, ANTICANCER RES, V28, P1993; Yoneyama T, 2014, BIOCHEM BIOPH RES CO, V448, P390, DOI 10.1016/j.bbrc.2014.04.107	40	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138520	10.1371/journal.pone.0138520	http://dx.doi.org/10.1371/journal.pone.0138520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390303	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000034
J	Liao, AH; Ho, HC; Lin, YC; Chen, HK; Wang, CH				Liao, Ai-Ho; Ho, Hsin-Chiao; Lin, Yi-Chun; Chen, Hang-Kang; Wang, Chih-Hung			Effects of Microbubble Size on Ultrasound-Induced Transdermal Delivery of High-Molecular-Weight Drugs	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; LOW-FREQUENCY SONOPHORESIS; IN-VIVO; FOCUSED ULTRASOUND; ENHANCEMENT; PERMEATION; VITRO	The transdermal delivery of a wide range of high-molecular-weight drugs is limited by the stratum corneum layer of the epidermis representing a significant barrier to penetration across the skin. This study first determined the different effects of different-size ultrasound (US) contrast agents and microbubbles (MBs) for enhancing the transdermal delivery of high-molecular-weight drugs. The effects of US-mediated different-size (1.4, 2.1, and 3.5 mu m) MBs (as a contrast agent) and ascorbyl tetraisopalmitate (VC-IP) on enhancing skin transdermal delivery were demonstrated both in vitro and in vivo. The results indicated that at a power density of 3 W/cm(2) the penetration depth in group US combined with 3.5-mu m MBs and penetrating VC-IP (U+3.5) was 34% and 14% higher than those in groups US combined with 1.4-mu m MBs and penetrating VC-IP (U+1.4) and US combined with 2.1-mu m MBs and penetrating VC-IP (U+2.1), respectively, for the agarose phantoms, while the corresponding increases for pigskin were 37% and 19%. In terms of the skin permeation of VC-IP, the VC-IP concentration in group U+3.5 was 23% and 10% higher in than those in groups U+1.4 and U+2.1, respectively. The whitening effect (luminosity index) of mice skin in group U+3.5 had increased (significantly) by 28% after 1 week, by 34% after 2 weeks, and tended to stabilize after 3 weeks (45%) in C57BL/6J mice over a 4-week experimental period. The results obtained in this study indicate that combining US with MBs of different sizes can produce different degrees of skin permeability so as to enhance the delivery of VC-IP to inhibit melanogenesis, without damaging the skin in mice.	[Liao, Ai-Ho; Ho, Hsin-Chiao] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan; [Liao, Ai-Ho] Natl Def Med Ctr, Dept Med Engn, Taipei 11490, Taiwan; [Lin, Yi-Chun; Chen, Hang-Kang; Wang, Chih-Hung] Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Triserv Gen Hosp, Taipei 11490, Taiwan; [Wang, Chih-Hung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 11490, Taiwan; [Wang, Chih-Hung] Hualien Armed Forces Gen Hosp, Xincheng Township 97144, Hualien County, Taiwan	National Taiwan University of Science & Technology; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Liao, AH (corresponding author), Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan.	aiho@mail.ntust.edu.tw; chw@ms3.hinet.net	hangkang, chen/ABD-7516-2021	hangkang, chen/0000-0002-5344-2019	Ministry of Science and Technology, Taiwan [MOST103-2221-E-011-004-MY3, MOST101-2314-B-016-012-MY3]; Tri-Service General Hospital [TSGH-NTUST-104-02, TSGH-C102-011]; National Defense Medical Research grant [MAB102-40]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Defense Medical Research grant	This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST103-2221-E-011-004-MY3 to AH Liao and MOST101-2314-B-016-012-MY3 to CH Wang), Tri-Service General Hospital (TSGH-NTUST-104-02 to AH Liao and TSGH-C102-011 to CH Wang), and a National Defense Medical Research grant (MAB102-40 to CH Wang).	Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Browning RJ, 2012, ULTRASOUND MED BIOL, V38, P1067, DOI 10.1016/j.ultrasmedbio.2012.02.020; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; Han T, 2013, J PHARM SCI-US, V102, P3614, DOI 10.1002/jps.23662; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Ishikawa M, 2007, BIOL PHARM BULL, V30, P2031, DOI 10.1248/bpb.30.2031; Kanikkannan N, 2002, INT J PHARM, V248, P219, DOI 10.1016/S0378-5173(02)00454-4; Liao A, 2014, DRUG DELIV, V22, P1; Liao AH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840852; Lopez RFV, 2011, BIOMATERIALS, V32, P933, DOI 10.1016/j.biomaterials.2010.09.060; Marepally S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082581; Ochiai Y, 2006, J DERMATOL SCI, V44, P37, DOI 10.1016/j.jdermsci.2006.07.001; Pandey Suneel, 2015, Recent Pat Drug Deliv Formul, V9, P88; Park D, 2014, ULTRASONICS, V54, P56, DOI 10.1016/j.ultras.2013.07.007; Park D, 2012, ULTRASOUND MED BIOL, V38, P642, DOI 10.1016/j.ultrasmedbio.2011.12.015; Park Donghee, 2010, Open Biomed Eng J, V4, P56, DOI 10.2174/1874120701004010056; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shih CP, 2013, J CONTROL RELEASE, V167, P167, DOI 10.1016/j.jconrel.2013.01.028; Tezel A, 2003, BIOPHYS J, V85, P3502, DOI 10.1016/S0006-3495(03)74770-5; Tsai YH, 2010, INT J PHARMACEUT, V388, P257, DOI 10.1016/j.ijpharm.2009.12.051; Tung YS, 2011, J ACOUST SOC AM, V130, P3059, DOI 10.1121/1.3646905; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Wu D, 2015, BIOL PHARM BULL, V38, P365, DOI 10.1248/bpb.b14-00502; Yang Ye, 2011, Pharmaceutics, V3, P474, DOI 10.3390/pharmaceutics3030474	26	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138500	10.1371/journal.pone.0138500	http://dx.doi.org/10.1371/journal.pone.0138500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390051	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000031
J	Perquin, M; Diederich, N; Pastore, J; Lair, ML; Stranges, S; Vaillant, M				Perquin, Magali; Diederich, Nico; Pastore, Jessica; Lair, Marie-Lise; Stranges, Saverio; Vaillant, Michel		MemoVie Grp	Prevalence of Dementia and Cognitive Complaints in the Context of High Cognitive Reserve: A Population-Based Study	PLOS ONE			English	Article							SUBJECTIVE MEMORY COMPLAINTS; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; OLDER-ADULTS; SOCIOECONOMIC-STATUS; IMPAIRMENT; SUBTYPES; PARTICIPATION; METAANALYSIS; DEPRESSION	Objectives This study aimed to assess the prevalence of dementia and cognitive complaints in a cross-sectional sample of Luxembourg seniors, and to discuss the results in the societal context of high cognitive reserve resulting from multilingualism. Methods A population sample of 1,377 people representative of Luxembourg residents aged over 64 years was initially identified via the national social insurance register. There were three different levels of contribution: full participation in the study, partial participation, and non-participation. We examined the profiles of these three different samples so that we could infer the prevalence estimates in the Luxembourgish senior population as a whole using the prevalence estimates obtained in this study. Results After careful attention to the potential bias and of the possibility of underestimation, we considered the obtained prevalence estimates of 3.8% for dementia (with corresponding 95% confidence limits (CL) of 2.8% and 4.8%) and 26.1% for cognitive complaints (CL = [17.8-34.3]) as trustworthy. Conclusion Based on these findings, we postulate that high cognitive reserve may result in surprisingly low prevalence estimates of cognitive complaints and dementia in adults over the age of 64 years, which thereby corroborates the longer disability-free life expectancy observed in the Luxembourg population. To the best of our knowledge, this study is the first to report such Luxembourgish public health data.	[Perquin, Magali; Pastore, Jessica; Lair, Marie-Lise; Stranges, Saverio] Luxembourg Inst Hlth, Dept Populat Hlth, Strassen, Luxembourg; [Diederich, Nico] Ctr Hosp Luxembourg, Dept Neurol, Luxembourg, Luxembourg; [Vaillant, Michel] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center; Luxembourg Institute of Health	Perquin, M (corresponding author), Luxembourg Inst Hlth, Dept Populat Hlth, Strassen, Luxembourg.	magali.perquin@lih.lu	vaillant, michel/H-5635-2019; Diederich, Nico J/AAX-4467-2020	vaillant, michel/0000-0003-4714-8128; Perquin, Magali/0000-0002-0386-0212; Stranges, Saverio/0000-0001-5226-8373	Fonds National de la Recherche (FNR) of Luxembourg [FNR/15/06/10c]	Fonds National de la Recherche (FNR) of Luxembourg(Luxembourg National Research Fund)	This work was supported by Fonds National de la Recherche (FNR) of Luxembourg, Grant no FNR/15/06/10c (http://www.fnr.lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034580; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; Balash Y, 2013, ACTA NEUROL SCAND, V127, P344, DOI 10.1111/ane.12038; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Busija L, 2013, CEREBROVASC DIS, V35, P483, DOI 10.1159/000350724; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; Dance A, 2013, ALZHEIMERS ASS INT C; de Pedro-Cuesta J, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-55; Eurostat, 2014, EUROSTAT; Fargo KN, 2014, ALZHEIMERS DEMENT, V10, pS430, DOI 10.1016/j.jalz.2014.08.103; Foubert-Samier A, 2010, NEUROBIOL AGING; Freedman M, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/808137; Garibotto V, 2008, NEUROLOGY, V71, P1342, DOI 10.1212/01.wnl.0000327670.62378.c0; Garibotto V, 2012, NEUROL SCI, V33, P1037, DOI 10.1007/s10072-011-0889-5; Gross CP, 2005, CANCER, V103, P483, DOI 10.1002/cncr.20792; Hurt CS, 2012, INT J GERIATR PSYCH, V27, P394, DOI 10.1002/gps.2731; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Lamb F, 2013, ARCH PHYS MED REHAB, V94, P1747, DOI 10.1016/j.apmr.2013.02.026; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lobo A, 2000, NEUROLOGY, V54, pS4; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Mazloum M, 2012, PAEDIATR PERINAT EP, V26, P276, DOI 10.1111/j.1365-3016.2011.01253.x; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; Mewton L, 2014, AM J GERIAT PSYCHIAT, V22, P1222, DOI 10.1016/j.jagp.2013.04.004; Montejo P, 2012, ARCH GERONTOL GERIAT, V54, P298, DOI 10.1016/j.archger.2011.05.021; Montejo P, 2011, AGING MENT HEALTH, V15, P85, DOI 10.1080/13607863.2010.501062; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430; Perquin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062030; Perquin M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-519; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ramaroson H, 2003, REV NEUROL-FRANCE, V159, P405; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; SAS Institute Inc, 2009, PROC SURV PPS SAMPL; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Sharp ES, 2011, ALZHEIMER DIS ASS DI; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Snitz BE, 2012, ALZ DIS ASSOC DIS, V26, P344, DOI 10.1097/WAD.0b013e3182420bdf; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tang Jennifer, 2014, Nurs Older People, V26, P10, DOI 10.7748/nop.26.5.10.s12; Thomas-Anterion C., 2003, LANNEE GERONTOLOGIQU, V17, P56; Turvey CL, 2000, J AM GERIATR SOC, V48, P1435, DOI 10.1111/j.1532-5415.2000.tb02634.x; Unverzagt FW, 2001, NEUROLOGY, V57, P1655, DOI 10.1212/WNL.57.9.1655; Wada-Isoe K, 2012, DEMENT GERIATR COGN, V2, P190; Waldorff FB, 2012, INT J GERIATR PSYCH, V27, P1180, DOI 10.1002/gps.3765; Westoby CJ, 2009, EUR J PAIN, V13, P970, DOI 10.1016/j.ejpain.2008.11.011; Wilkins CH, 2007, J AM GERIATR SOC, V55, P1771, DOI 10.1111/j.1532-5415.2007.01417.x; Zhang YD, 2012, J CLIN NEUROSCI, V19, P1333, DOI 10.1016/j.jocn.2012.01.029	52	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138818	10.1371/journal.pone.0138818	http://dx.doi.org/10.1371/journal.pone.0138818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZM	26390288	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000058
J	Chan, YB; Alekseyenko, OV; Kravitz, EA				Chan, Yick-Bun; Alekseyenko, Olga V.; Kravitz, Edward A.			Optogenetic Control of Gene Expression in Drosophila	PLOS ONE			English	Article							SPATIOTEMPORAL CONTROL; TRANSCRIPTION; ACTIVATION; NEURONS; SYSTEM; TOOLS; CELLS	To study the molecular mechanism of complex biological systems, it is important to be able to artificially manipulate gene expression in desired target sites with high precision. Based on the light dependent binding of cryptochrome 2 and a cryptochrome interacting bHLH protein, we developed a split lexA transcriptional activation system for use in Drosophila that allows regulation of gene expression in vivo using blue light or two-photon excitation. We show that this system offers high spatiotemporal resolution by inducing gene expression in tissues at various developmental stages. In combination with two-photon excitation, gene expression can be manipulated at precise sites in embryos, potentially offering an important tool with which to examine developmental processes.	[Chan, Yick-Bun; Alekseyenko, Olga V.; Kravitz, Edward A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chan, YB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	ybchan@hms.harvard.edu			National Institute of General Medical Sciences [GM0099883, GM074675]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074675, R01GM099883] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences [GM0099883 to E.A.K., GM074675 to E.A.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2013, P NATL ACAD SCI USA, V110, P6151, DOI 10.1073/pnas.1303446110; Bashaw GJ, 2010, COLD SPRING HARB PRO, V10; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cambridge SB, 2009, NAT METHODS, V6, P527, DOI 10.1038/nmeth.1340; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lelito KR, 2012, J NEUROPHYSIOL, V107, P2096, DOI 10.1152/jn.00931.2011; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050738; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021144; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ting CY, 2011, GENETICS, V188, P229, DOI 10.1534/genetics.110.126193; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	31	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138181	10.1371/journal.pone.0138181	http://dx.doi.org/10.1371/journal.pone.0138181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383635	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200065
J	Drakeley, M; Lapiedra, O; Kolbe, JJ				Drakeley, Maximilian; Lapiedra, Oriol; Kolbe, Jason J.			Predation Risk Perception, Food Density and Conspecific Cues Shape Foraging Decisions in a Tropical Lizard	PLOS ONE			English	Article							TRADE-OFF; ANOLIS LIZARDS; ESCAPE BEHAVIOR; RESPONSES; COMPETITION; ALLOCATION; DYNAMICS; STRENGTH; ECOLOGY; CYCLES	When foraging, animals can maximize their fitness if they are able to tailor their foraging decisions to current environmental conditions. When making foraging decisions, individuals need to assess the benefits of foraging while accounting for the potential risks of being captured by a predator. However, whether and how different factors interact to shape these decisions is not yet well understood, especially in individual foragers. Here we present a standardized set of manipulative field experiments in the form of foraging assays in the tropical lizard Anolis cristatellus in Puerto Rico. We presented male lizards with foraging opportunities to test how the presence of conspecifics, predation-risk perception, the abundance of food, and interactions among these factors determines the outcome of foraging decisions. In Experiment 1, anoles foraged faster when food was scarce and other conspecifics were present near the feeding tray, while they took longer to feed when food was abundant and when no conspecifics were present. These results suggest that foraging decisions in anoles are the result of a complex process in which individuals assess predation risk by using information from conspecific individuals while taking into account food abundance. In Experiment 2, a simulated increase in predation risk (i.e., distance to the feeding tray) confirmed the relevance of risk perception by showing that the use of available perches is strongly correlated with the latency to feed. We found Puerto Rican crested anoles integrate instantaneous ecological information about food abundance, conspecific activity and predation risk, and adjust their foraging behavior accordingly.	[Drakeley, Maximilian] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Drakeley, Maximilian; Lapiedra, Oriol; Kolbe, Jason J.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	University of Manchester; University of Rhode Island	Kolbe, JJ (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	jjkolbe@uri.edu		Lapiedra, Oriol/0000-0003-0383-0061	University of Manchester Zochonis Travel Award; National Science Foundation (NSF) [DEB-1354897]; Direct For Biological Sciences [1354897] Funding Source: National Science Foundation	University of Manchester Zochonis Travel Award; National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a University of Manchester Zochonis Travel Award to MD and a National Science Foundation (NSF) grant (DEB-1354897) to JJK, which supported OL during the preparation of this manuscript.	ABRAMS PA, 1993, BEHAV ECOL, V4, P246, DOI 10.1093/beheco/4.3.246; Amo L, 2007, PHYSIOL BEHAV, V90, P334, DOI 10.1016/j.physbeh.2006.09.035; Beauchamp G, 2003, BEHAV PROCESS, V63, P141, DOI 10.1016/S0376-6357(03)00011-1; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Bednekoff Peter A., 2007, P305; Blomberg SP, 2000, BEHAV ECOL SOCIOBIOL, V48, P484, DOI 10.1007/s002650000260; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Brock KM, 2015, EVOLUTION, V69, P216, DOI 10.1111/evo.12555; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Cantwell LR, 2013, J HERPETOL, V47, P293, DOI 10.1670/11-184; Cooper WE, 2006, BEHAV ECOL, V17, P554, DOI 10.1093/beheco/arj066; Cooper WE, 2005, J ZOOL, V265, P133, DOI 10.1017/S0952836904006065; Cooper WE, 2004, HERPETOLOGICA, V60, P321, DOI 10.1655/04-20; Dall Sasha R.X., 2010, P194; Farallo Vincent R., 2010, PHYLLOMEDUSA, V9, P109; FITCH H S, 1989, Amphibia-Reptilia, V10, P307, DOI 10.1163/156853889X00458; Foster KL, 2015, ESCAPING FROM PREDAT, P287; GARBER S D, 1978, Transactions of the Kansas Academy of Science, V81, P79, DOI 10.2307/3627360; Giraldeau Luc-Alain, 1997, P42; GORMAN GC, 1974, ECOLOGY, V55, P360, DOI 10.2307/1935223; Gunderson AR, 2012, FUNCT ECOL, V26, P783, DOI 10.1111/j.1365-2435.2012.01987.x; Hamilton Ian M., 2010, P177; Hamilton IM, 2004, BEHAV ECOL SOCIOBIOL, V56, P530, DOI 10.1007/s00265-004-0822-5; Henderson R, 1991, AMPHIBIANS AND REPTI; Hertz BYPE, 1982, ANIM BEHAV; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; HUEY RB, 1976, ECOLOGY, V57, P985, DOI 10.2307/1941063; Kolbe JJ, 2008, COPEIA, P261, DOI 10.1643/CE-07-011; LEAL M, 1995, COPEIA, P155; Leal M, 1999, ANIM BEHAV, V58, P521, DOI 10.1006/anbe.1999.1181; LICHT P, 1975, COPEIA, P496; LICHT P, 1974, COPEIA, P215, DOI 10.2307/1443026; Licht P, 1970, U CALIF PUBL ZOOL, V95, P1; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1985, ANIM BEHAV, V33, P155, DOI 10.1016/S0003-3472(85)80129-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez-Darias M, 2012, ECOLOGY, V93, P2512, DOI 10.1890/12-0483.1; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Losos JB, 2009, LIZARDS IN AN EVOLUT; Martin J, 2003, ETHOLOGY, V109, P77, DOI 10.1046/j.1439-0310.2003.00855.x; MARTIN J, 1995, CAN J ZOOL, V73, P129, DOI 10.1139/z95-014; Mathot KJ, 2009, ANIM BEHAV, V77, P1179, DOI 10.1016/j.anbehav.2009.01.024; METCALFE NB, 1984, BEHAV ECOL SOCIOBIOL, V15, P203, DOI 10.1007/BF00292976; Nonacs Peter, 2010, P207; Perez-Tris J, 2004, ANIM BEHAV, V67, P511, DOI 10.1016/j.anbehav.2003.06.008; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preisser EL, 2009, ECOL LETT, V12, P315, DOI 10.1111/j.1461-0248.2009.01290.x; [R Core Team Team C], 2015, R FOUNDATION FOR STA; Rand AS, 1967, THE ECOLOGICAL DISTR; Rodriguez-Prieto I, 2011, P ROY SOC B-BIOL SCI, V278, P266, DOI 10.1098/rspb.2010.1194; Roughgarden J, 1995, ANOLIS LIZARDS OF TH; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Shafir S, 1998, BEHAV ECOL, V9, P74, DOI 10.1093/beheco/9.1.74; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; STAMPS JA, 1977, COPEIA, P756; Stephens D. W., 2007, FORAGING BEHAVIOR AN; Stephens DW, 2008, COGN AFFECT BEHAV NE, V8, P475, DOI 10.3758/CABN.8.4.475; Stephens David WKJR, 1986, FORAGING THEORY; Torchiano M., 2015, CRAN REPOSITORY; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; Yee J, 2013, ETHOLOGY, V119, P480, DOI 10.1111/eth.12085	66	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138016	10.1371/journal.pone.0138016	http://dx.doi.org/10.1371/journal.pone.0138016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384236	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200048
J	Yun, HM; Lee, ES; Kim, MJ; Kim, JJ; Lee, JH; Lee, HH; Park, KR; Yi, JK; Kim, HW; Kim, EC				Yun, Hyung-Mun; Lee, Eui-Suk; Kim, Mi-joo; Kim, Jung-Ju; Lee, Jung-Hwan; Lee, Hae-Hyoung; Park, Kyung-Ran; Yi, Jin-Kyu; Kim, Hae-Won; Kim, Eun-cheol			Magnetic Nanocomposite Scaffold-Induced Stimulation of Migration and Odontogenesis of Human Dental Pulp Cells through Integrin Signaling Pathways	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ODONTOBLASTIC DIFFERENTIATION; STEM-CELLS; NANOPARTICLES; PROLIFERATION; POLYCAPROLACTONE	Magnetism is an intriguing physical cue that can alter the behaviors of a broad range of cells. Nanocomposite scaffolds that exhibit magnetic properties are thus considered useful 3D matrix for culture of cells and their fate control in repair and regeneration processes. Here we produced magnetic nanocomposite scaffolds made of magnetite nanoparticles (MNPs) and polycaprolactone (PCL), and the effects of the scaffolds on the adhesion, growth, migration and odontogenic differentiation of human dental pulp cells (HDPCs) were investigated. Furthermore, the associated signaling pathways were examined in order to elucidate the molecular mechanisms in the cellular events. The magnetic scaffolds incorporated with MNPs at varying concentrations (up to 10% wt) supported cellular adhesion and multiplication over 2 weeks, showing good viability. The cellular constructs in the nanocomposite scaffolds played significant roles in the stimulation of adhesion, migration and odontogenesis of HDPCs. Cells were shown to adhere to substantially higher number when affected by the magnetic scaffolds. Cell migration tested by in vitro wound closure model was significantly enhanced by the magnetic scaffolds. Furthermore, odontogenic differentiation of HDPCs, as assessed by the alkaline phosphatase activity, mRNA expressions of odontogenic markers (DMP-1, DSPP, osteocalcin, and ostepontin), and alizarin red staining, was significantly stimulated by the magnetic scaffolds. Signal transduction was analyzed by RT-PCR, Western blotting, and confocal microscopy. The magnetic scaffolds upregulated the integrin subunits (alpha 1, alpha 2, beta 1 and beta 3) and activated downstream pathways, such as FAK, paxillin, p38, ERK MAPK, and NF-kappa B. The current study reports for the first time the significant impact of magnetic scaffolds in stimulating HDPC behaviors, including cell migration and odontogenesis, implying the potential usefulness of the magnetic scaffolds for dentin-pulp tissue engineering.	[Yun, Hyung-Mun; Kim, Mi-joo; Park, Kyung-Ran; Kim, Eun-cheol] Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea; [Yun, Hyung-Mun; Kim, Mi-joo; Park, Kyung-Ran; Kim, Eun-cheol] Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Tissue Regenerat MRC, Seoul, South Korea; [Lee, Eui-Suk] Korea Univ, Guro Hosp, Dept Oral & Maxillofacial Surg, Seoul, South Korea; [Kim, Jung-Ju; Lee, Jung-Hwan; Lee, Hae-Hyoung; Yi, Jin-Kyu; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Kim, Jung-Ju; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Kim, Jung-Ju; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Lee, Jung-Hwan; Lee, Hae-Hyoung; Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea	Kyung Hee University; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine); Dankook University; Dankook University; Dankook University; Dankook University	Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.	kimhw@dku.edu; eckim@khu.ac.kr	Lee, Jung-Hwan/AFK-0831-2022; aksel, hacer/H-1572-2015	Lee, Jung-Hwan/0000-0001-8678-5459; Kim, Mijoo/0000-0003-0445-9567; Lee, Eui Seok/0000-0002-1818-1140	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2012R1A5A2051384, 2009-0093829]; Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A111412]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (no. 2012R1A5A2051384, No. 2009-0093829) and by a grant of the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A111412).	Alexandrina N, 2009, J POLYM SCI A, V47, P5397; Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084; Baranov P, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414554139; BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402; CHAN PY, 1994, J BIOL CHEM, V269, P20567; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Cormier Catherine, 1995, Current Opinion in Rheumatology, V7, P243, DOI 10.1097/00002281-199505000-00016; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326; HARRIS H, 1990, CLIN CHIM ACTA, V186, P133, DOI 10.1016/0009-8981(90)90031-M; Hong DW, 2011, J APPL POLYM SCI, V122, P898, DOI 10.1002/app.34191; Hsu SH, 2010, CYTOTECHNOLOGY, V62, P143, DOI 10.1007/s10616-010-9271-3; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jegal SH, 2011, ACTA BIOMATER, V7, P1609, DOI 10.1016/j.actbio.2010.12.003; JORDAN A, 1993, INT J HYPERTHER, V9, P51, DOI 10.3109/02656739309061478; Khanna-Jain R, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412467998; Kim DS, 2014, J ENDODONT, V40, P1087, DOI 10.1016/j.joen.2013.11.023; Kim EC, 2012, J ENDODONT, V38, P769, DOI 10.1016/j.joen.2012.03.014; Kim JJ, 2014, J BIOMATER APPL, V28, P1069, DOI 10.1177/0885328213495903; Kim JJ, 2012, J ENDODONT, V38, P899, DOI 10.1016/j.joen.2012.04.006; Kim JJ, 2014, RSC ADV, V4, P17325, DOI 10.1039/c4ra00040d; Kim SJ, 2010, J ENDODONT, V36, P1326, DOI 10.1016/j.joen.2010.04.011; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Kitagawa M, 2007, ARCH ORAL BIOL, V52, P727, DOI 10.1016/j.archoralbio.2007.02.006; Kular JK, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414557112; Lee SY, 2012, J DENT RES, V91, P407, DOI 10.1177/0022034511436113; McNamara LE, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414536177; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Perez RA, 2015, RSC ADV, V5, P13411, DOI 10.1039/c4ra12640h; Sharma S, 2010, ANN NEUROSCI, V17, P31, DOI 10.5214/ans.0972.7531.2010.170109; Singh RK, 2012, J BIOMED MATER RES A, V100A, P1734, DOI 10.1002/jbm.a.34140; Sniadecki NJ, 2010, ENDOCRINOLOGY, V151, P451, DOI 10.1210/en.2009-0932; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009; Wu Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/1/015001; Yuan WZ, 2010, POLYMER, V51, P2540, DOI 10.1016/j.polymer.2010.04.016; Zhang BL, 2013, APPL SURF SCI, V266, P375, DOI 10.1016/j.apsusc.2012.12.032	40	35	36	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138614	10.1371/journal.pone.0138614	http://dx.doi.org/10.1371/journal.pone.0138614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382272	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200139
J	Zhao, HP; Zhang, XY; Xue, M; Zhang, X				Zhao, Haipeng; Zhang, Xiaoying; Xue, Ming; Zhang, Xiao			Feeding of Whitefly on Tobacco Decreases Aphid Performance via Increased Salicylate Signaling	PLOS ONE			English	Article							TABACI BIOTYPE-B; PATHOGENESIS-RELATED PROTEINS; SYSTEMIC ACQUIRED-RESISTANCE; INTERSPECIFIC INTERACTIONS; TRIALEURODES-VAPORARIORUM; GENE-EXPRESSION; PLANT DEFENSE; HEMIPTERA ALEYRODIDAE; MYZUS-PERSICAE; RESPONSES	Background The feeding of Bemisia tabaci nymphs trigger the SA pathway in some plant species. A previous study showed that B. tabaci nymphs induced defense against aphids (Myzus persicae) in tobacco. However, the mechanism underlying this defense response is not well understood. Methodology/Principal Findings Here, the effect of activating the SA signaling pathway in tobacco plants through B. tabaci nymph infestation on subsequent M. persicae colonization is investigated. Performance assays showed that B. tabaci nymphs pre-infestation significantly reduced M. persicae survival and fecundity systemically in wild-type (WT) but not salicylate-deficient (NahG) plants compared with respective control. However, pre-infestation had no obvious local effects on subsequent M. persicae in eitherWT or NahG tobacco. SA quantification results indicated that the highest accumulation of SA was induced by B. tabaci nymphs in WT plants after 15 days of infestation. These levels were 8.45-and 6.14-fold higher in the local and systemic leaves, respectively, than in controls. Meanwhile, no significant changes of SA levels were detected in NahG plants. Further, biochemical analysis of defense enzymes polyphenol oxidase (PPO), peroxidase (POD), beta-1,3-glucanase, and chitinase demonstrated that B. tabaci nymph infestation increased these enzymes' activity locally and systemically in WT plants, and there was more chitinase and beta-1, 3-glucanase activity systemically than locally, which was opposite to the changing trends of PPO. However, B. tabaci nymph infestation caused no obvious increase in enzyme activity in any NahG plants except POD. Conclusions/Significance In conclusion, these results underscore the important role that induction of the SA signaling pathway by B. tabaci nymphs plays in defeating aphids. It also indicates that the activity of beta-1, 3-glucanase and chitinase may be positively correlated with resistance to aphids.	[Zhao, Haipeng; Zhang, Xiaoying; Xue, Ming; Zhang, Xiao] Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An, Shandong, Peoples R China; [Zhang, Xiaoying] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Xue, M (corresponding author), Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An, Shandong, Peoples R China.	xueming@sdau.edu.cn			Nature Science Foundation of China [30971906]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Nature Science Foundation of China (30971906) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076619; Alvarez ME, 2000, PROGRAMMED CELL DEAT, P185; Antony B, 2006, INDIAN J BIOCHEM BIO, V43, P182; Bergey DR, 1999, P NATL ACAD SCI USA, V96, P1756, DOI 10.1073/pnas.96.4.1756; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Cooper WC, 2004, J CHEM ECOL, V30, P2527, DOI 10.1007/s10886-004-7948-9; Cui XH, 2008, J INSECT SCI, V8; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Duan CX, 2014, CROP J, V2, P55, DOI 10.1016/j.cj.2013.12.001; Dugravot S, 2007, ENTOMOL EXP APPL, V123, P271, DOI 10.1111/j.1570-7458.2007.00542.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elsayed G., 2011, Archives of Phytopathology and Plant Protection, V44, P1534, DOI 10.1080/03235408.2010.507957; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Estrada-Hernandez MG, 2009, PHYSIOL PLANTARUM, V137, P44, DOI 10.1111/j.1399-3054.2009.01260.x; Hebert SL, 2007, ENVIRON ENTOMOL, V36, P458, DOI 10.1603/0046-225X(2007)36[458:QDIAVA]2.0.CO;2; Inbar M, 1999, J CHEM ECOL, V25, P1961, DOI 10.1023/A:1020998219928; Inbar M, 1999, ENVIRON ENTOMOL, V28, P353, DOI 10.1093/ee/28.3.353; JIMENEZ DR, 1995, PHYSIOL MOL PLANT P, V46, P227, DOI 10.1006/pmpp.1995.1018; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kant R., 2008, New Zealand Plant Protection, V61, P355; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P1; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kerchev PI, 2013, ANTIOXID REDOX SIGN, V18, P2091, DOI 10.1089/ars.2012.5097; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mayer RT, 1996, BEMISIA 1995 TAXONOM; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SABOROWSKI R, 1993, COMP BIOCHEM PHYS B, V105, P673, DOI 10.1016/0305-0491(93)90104-D; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Schaller A., 2008, INDUCED PLANT RESIST; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Stout MJ, 1998, ENTOMOL EXP APPL, V86, P267, DOI 10.1023/A:1003199023355; Tarchevsky IA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P590, DOI 10.1134/S0006297910050081; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; van de Ven WTG, 2000, PLANT CELL, V12, P1409, DOI 10.1105/tpc.12.8.1409; van der Westhuizen AJ, 1998, PLANT CELL REP, V18, P132, DOI 10.1007/s002990050545; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang CX, 2010, ACTA ENTOMOL SINICA, V3; Wang XR, 1996, INSECT BIOCHEM MOLEC, V26, P1055, DOI 10.1016/S0965-1748(96)00056-2; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Xue M, 2010, ENVIRON ENTOMOL, V39, P883, DOI 10.1603/EN09307; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang CL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-11; Zhang GF, 2014, PEST MANAG SCI, V70, P1797, DOI 10.1002/ps.3713; Zhang LP, 2005, J APPL ENTOMOL, V129, P443, DOI 10.1111/j.1439-0418.2005.00991.x; Zhang PJ, 2013, J CHEM ECOL, V39, P612, DOI 10.1007/s10886-013-0283-2; Zhang SZ, 2013, ENTOMOL EXP APPL, V147, P293, DOI 10.1111/eea.12067; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x; Zhu F, 2014, NEW PHYTOL, P1	67	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138584	10.1371/journal.pone.0138584	http://dx.doi.org/10.1371/journal.pone.0138584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381273	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200132
J	Coady, A; Xu, M; Phung, Q; Cheung, TK; Bakalarski, C; Alexander, MK; Lehar, SM; Kim, J; Park, S; Tan, MW; Nishiyama, M				Coady, Alison; Xu, Min; Phung, Qui; Cheung, Tommy K.; Bakalarski, Corey; Alexander, Mary Kate; Lehar, Sophie M.; Kim, Janice; Park, Summer; Tan, Man-Wah; Nishiyama, Mireille			The Staphylococcus aureus ABC-Type Manganese Transporter MntABC Is Critical for Reinitiation of Bacterial Replication Following Exposure to Phagocytic Oxidative Burst	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; STRESS RESISTANCE; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; SUPEROXIDE DISMUTASES; EPITHELIAL-CELLS; REACTIVE OXYGEN; NADPH-OXIDASE; HOST-DEFENSE; AMINO-ACIDS	Manganese plays a central role in cellular detoxification of reactive oxygen species (ROS). Therefore, manganese acquisition is considered to be important for bacterial pathogenesis by counteracting the oxidative burst of phagocytic cells during host infection. However, detailed analysis of the interplay between bacterial manganese acquisition and phagocytic cells and its impact on bacterial pathogenesis has remained elusive for Staphylococcus aureus, a major human pathogen. Here, we show that a mntC mutant, which lacks the functional manganese transporter MntABC, was more sensitive to killing by human neutrophils but not murine macrophages, unless the mntC mutant was pre-exposed to oxidative stress. Notably, the mntC mutant formed strikingly small colonies when recovered from both type of phagocytic cells. We show that this phenotype is a direct consequence of the inability of the mntC mutant to reinitiate growth after exposure to phagocytic oxidative burst. Transcript and quantitative proteomics analyses revealed that the manganese-dependent ribonucleotide reductase complex NrdEF, which is essential for DNA synthesis and repair, was highly induced in the mntC mutant under oxidative stress conditions including after phagocytosis. Since NrdEF proteins are essential for S. aureus viability we hypothesize that cells lacking MntABC might attempt to compensate for the impaired function of NrdEF by increasing their expression. Our data suggest that besides ROS detoxification, functional manganese acquisition is likely crucial for S. aureus pathogenesis by repairing oxidative damages, thereby ensuring efficient bacterial growth after phagocytic oxidative burst, which is an attribute critical for disseminating and establishing infection in the host.	[Coady, Alison; Alexander, Mary Kate; Lehar, Sophie M.; Tan, Man-Wah; Nishiyama, Mireille] Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA; [Xu, Min; Kim, Janice; Park, Summer] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Phung, Qui; Cheung, Tommy K.; Bakalarski, Corey] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Bakalarski, Corey] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Nishiyama, M (corresponding author), Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA.	nishiyama.mireille@gene.com		Bakalarski, Corey/0000-0003-1085-7828; Coady, Alison/0000-0003-1871-5576	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	All work was supported by internal funds at Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funder provided support in the form of salaries for authors CA, MX, QP, TKC, CB, MKA, SML, JK, SP, MWT, MN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja S, 2015, STRUCTURE, V23, P713, DOI 10.1016/j.str.2015.01.020; Badwey JA, 1980, ANNU REV BIOCHEM, V49, P16366; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI [10.1097/INF.0b013e3181ef2477, DOI 10.1097/INF.0B013E3181EF2477]; BAYLES KW, 1994, GENE, V147, P13, DOI 10.1016/0378-1119(94)90033-7; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Christiansen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089018; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; DuMont AL, 2013, INFECT IMMUN, V81, P1830, DOI 10.1128/IAI.00095-13; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Freltas M, 2008, CLIN BIOCHEM, V41, P570, DOI 10.1016/j.clinbiochem.2007.12.021; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Govoni G, 1997, J LEUKOCYTE BIOL, V62, P277, DOI 10.1002/jlb.62.2.277; Gray JP, 2007, J BIOL CHEM, V282, P7939, DOI 10.1074/jbc.M611817200; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Masalha M, 2001, J BACTERIOL, V183, P7260, DOI 10.1128/JB.183.24.7260-7272.2001; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McAllister LJ, 2012, MOL MICROBIOL, V53, P215; Mohanty K., 2012, OXIDANTS ANTIOXIDANT, V1, P21; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pham VC, 2012, J PROTEOME RES, V11, P2947, DOI 10.1021/pr300035k; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Silva MT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00174; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; STANLEY PE, 1989, J BIOLUM CHEMILUM, V4, P375, DOI 10.1002/bio.1170040151; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Yui S, 2003, BIOL PHARM BULL, V26, P753	72	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138350	10.1371/journal.pone.0138350	http://dx.doi.org/10.1371/journal.pone.0138350			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379037	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400086
J	Nagayama, K; Kyotani, Y; Zhao, J; Ito, S; Ozawa, K; Bolstad, FA; Yoshizumi, M				Nagayama, Kosuke; Kyotani, Yoji; Zhao, Jing; Ito, Satoyasu; Ozawa, Kentaro; Bolstad, Francesco A.; Yoshizumi, Masanori			Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ACTIVATED PROTEIN-KINASE; GLP-1 RECEPTOR AGONISTS; ENDOTHELIAL-CELLS; BETA-CELLS; SRC; ATHEROSCLEROSIS; TRANSDUCTION; REGENERATION; MECHANISMS	Angiotensin 11 (Ang II) is a main pathophysiological culprit peptide for hypertension and atherosclerosis by causing vascular smooth muscle cell (VSMC) proliferation and migration. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, is currently used for the treatment of type-2 diabetes, and is believed to have beneficial effects for cardiovascular diseases. However, the vascular protective mechanisms of GLP-1 receptor agonists remain largely unexplained. In the present study, we examined the effect of exendin-4 on Ang IIinduced proliferation and migration of cultured rat aortic smooth muscle cells (RASMC). The major findings of the present study are as follows: (1) Angllcaused a phenotypic switch of RASMC from contractile type to synthetic proliferative type cells; (2) Ang II caused concentration-dependent RASMC proliferation, which was significantly inhibited by the pretreatment with exendin-4; (3) Ang II caused concentration-dependent RASMC migration, which was effectively inhibited by the pretreatment with exendin-4; (4) exendin-4 inhibited Ang IIinduced phosphorylation of ERK1/2 and JNK in a pre-incubation time-dependent manner; and (5) U0126 (an ERK1/2 kinase inhibitor) and SP600125 (a JNK inhibitor) also inhibited both RASMC proliferation and migration induced by Ang II stimulation. These results suggest that exendin-4 prevented Ang II-induced VSMC proliferation and migration through the inhibition of ERK1/2 and JNK phosphorylation caused by Ang II stimulation. This indicates that GLP-1 receptor agonists should be considered for use in the treatment of cardiovascular diseases in addition to their current use in the treatment of diabetes mellitus.	[Nagayama, Kosuke; Kyotani, Yoji; Zhao, Jing; Ito, Satoyasu; Ozawa, Kentaro; Yoshizumi, Masanori] Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan; [Bolstad, Francesco A.] Nara Med Univ, Dept Clin English, Sch Med, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Yoshizumi, M (corresponding author), Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan.	yoshizu@naramed-u.ac.jp	Kyotani, Yoji/AAR-3830-2020	Kyotani, Yoji/0000-0002-7771-6889	JPJS KAKENHI [23590306, 26460345]	JPJS KAKENHI	The study was supported by JPJS KAKENHI Grants, number 23590306 and 26460345, to M.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Berk BC, 2000, J CLIN INVEST, V105, P1525, DOI 10.1172/JCI9820; Bojanowska E, 2000, REGUL PEPTIDES, V91, P75, DOI 10.1016/S0167-0115(00)00119-1; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; ENG J, 1992, J BIOL CHEM, V267, P7402; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gardiner SM, 2006, J PHARMACOL EXP THER, V316, P852, DOI 10.1124/jpet.105.093104; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8; Hirata Y, 2013, EUR J PHARMACOL, V699, P106, DOI 10.1016/j.ejphar.2012.11.057; Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Kyotani Y, 2010, J PHARMACOL SCI, V113, P161, DOI 10.1254/jphs.09332FP; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Schmitz U, 1997, TRENDS ENDOCRIN MET, V8, P261, DOI 10.1016/S1043-2760(97)00101-X; Touyz RM, 2000, PHARMACOL REV, V52, P639; TSUDA T, 1992, CIRC RES, V71, P620, DOI 10.1161/01.RES.71.3.620; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Yao HL, 2012, MOL CELL BIOCHEM, V366, P355, DOI 10.1007/s11010-012-1315-x; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Zhao L, 2014, AM J PHYSIOL-CELL PH, V307, pC1130, DOI 10.1152/ajpcell.00151.2014	34	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137960	10.1371/journal.pone.0137960	http://dx.doi.org/10.1371/journal.pone.0137960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379274	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400040
J	Pook, M; Teino, I; Kailas, A; Maimets, T; Ingerpuu, S; Jaks, V				Pook, Martin; Teino, Indrek; Kailas, Ade; Maimets, Toivo; Ingerpuu, Sulev; Jaks, Viljar			Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							BASEMENT-MEMBRANES; RETINOIC ACID; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; EMBRYOGENESIS; ISOFORMS; NANOG	Laminin isoforms laminin-511 and -521 are expressed by human embryonic stem cells (hESC) and can be used as a growth matrix to culture these cells under pluripotent conditions. However, the expression of these laminins during the induction of hESC differentiation has not been studied in detail. Furthermore, the data regarding the expression pattern of laminin chains in differentiating hESC is scarce. In the current study we aimed to fill this gap and investigated the potential changes in laminin expression during early hESC differentiation induced by retinoic acid (RA). We found that laminin-511 but not -521 accumulates in the committed cells during early steps of hESC differentiation. We also performed a comprehensive analysis of the laminin chain repertoire and found that pluripotent hESC express a more diverse range of laminin chains than shown previously. In particular, we provide the evidence that in addition to alpha 1, alpha 5, beta 1, beta 2 and gamma 1 chains, hESC express alpha 2, alpha 3, beta 3, gamma 2 and gamma 3 chain proteins and mRNA. Additionally, we found that a variant of laminin alpha 3 chain-145 kDa-accumulated in RA-treated hESC showing that these cells produce prevalently specifically modified version of alpha 3 chain in early phase of differentiation.	[Pook, Martin; Teino, Indrek; Kailas, Ade; Maimets, Toivo; Ingerpuu, Sulev; Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, EE-51010 Tartu, Estonia; [Jaks, Viljar] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden	University of Tartu; Karolinska Institutet	Pook, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	pookm@ut.ee	Kallas-Kivi, Ade/F-2411-2017; Maimets, Toivo/E-9268-2017; Pook, Martin/G-3467-2017; Pook, Martin/Q-9707-2019; Jaks, Viljar/H-2467-2012; Teino, Indrek/AAJ-1106-2021	Kallas-Kivi, Ade/0000-0002-0536-5020; Maimets, Toivo/0000-0001-6461-3365; Pook, Martin/0000-0002-8386-0203; Jaks, Viljar/0000-0002-2221-6262; Teino, Indrek/0000-0002-2381-4715	EMBO Installation Grant [1819]; Estonian Research Council [PUT4, ETF8932, PUT374]; Estonian Ministry of Higher Education and Research [SF0180100s08]	EMBO Installation Grant; Estonian Research Council; Estonian Ministry of Higher Education and Research	This work was supported by the EMBO Installation Grant No1819 and grants no. ETF8932 and PUT4 from the Estonian Research Council (to V. J.), and research grants PUT374 from Estonian Research Council and SF0180100s08 from Estonian Ministry of Higher Education and Research (to T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Church HJ, 1997, PLACENTA, V18, P143, DOI [DOI 10.1016/S0143-4004(97)80085-9, DOI 10.1016/S0143-4004(97)80085-9)]; COOPER AR, 1983, DEV BIOL, V96, P467, DOI 10.1016/0012-1606(83)90183-5; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; ENGVALL E, 1993, KIDNEY INT, V43, P2, DOI 10.1038/ki.1993.2; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Geberhiwot T, 1999, EXP CELL RES, V253, P723, DOI 10.1006/excr.1999.4653; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Inanc B, 2008, TISSUE ENG PT A, V14, P955, DOI [10.1089/ten.tea.2007.0213, 10.1089/tea.2007.0213]; Jagtap S, 2013, STEM CELL RES, V10, P228, DOI 10.1016/j.scr.2012.12.002; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Laperle A, 2015, STEM CELL REP, V5, P195, DOI 10.1016/j.stemcr.2015.06.009; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rodriguez RT, 2007, EXP BIOL MED, V232, P1368, DOI 10.3181/0703-RM-63; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shiraki N, 2011, PLOS ONE, V6, P1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Wondimu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053648; Yamashita H, 2010, J ONCOL, V2010, DOI 10.1155/2010/107075; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	41	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138346	10.1371/journal.pone.0138346	http://dx.doi.org/10.1371/journal.pone.0138346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378917	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400085
J	Rehan, M; Ahmad, E; Sheikh, IA; Abuzenadah, AM; Damanhouri, GA; Bajouh, OS; AlBasri, SF; Assiri, MM; Beg, MA				Rehan, Mohd; Ahmad, Ejaz; Sheikh, Ishfaq A.; Abuzenadah, Adel M.; Damanhouri, Ghazi A.; Bajouh, Osama S.; AlBasri, Samera F.; Assiri, Mansour M.; Beg, Mohd A.			Androgen and Progesterone Receptors Are Targets for Bisphenol A (BPA), 4-Methyl-2,4-bis-(P-Hydroxyphenyl)Pent-1-Ene-A Potent Metabolite of BPA, and 4-Tert-Octylphenol: A Computational Insight	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; REPRODUCTIVE FUNCTION; WIDESPREAD EXPOSURE; SCORING FUNCTIONS; URINARY; INFERTILITY; CHEMICALS; WOMEN; NONYLPHENOL; POPULATION	Exposure to toxic industrial chemicals that have capacity to disrupt the endocrine system, also known as endocrine disrupting chemicals (EDCs), has been increasingly associated with reproductive problems in human population. Bisphenol A (BPA; 4,4'-(propane-2,2-diyl)diphenol) and 4-tert-octylphenol (OP; 4-(1,1,3,3-tetramethylbutyl)phenol) are among the most common environmental contaminants possessing endocrine disruption properties and are present in plastics, epoxy resins, detergents and other commercial products of common personal and industrial use. A metabolite of BPA, 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) is about 1000 times more biologically active compared to BPA. Epidemiological, clinical, and experimental studies have shown association of BPA and OP with adverse effects on male and female reproductive system in human and animals. The endocrine disruption activity can occur through multiple pathways including binding to steroid receptors. Androgen receptor (AR) and progesterone receptor (PR) are critical for reproductive tract growth and function. Structural binding characterization of BPA, MBP, and OP with AR and PR using molecular docking simulation approaches revealed novel interactions of BPA with PR, and MBP and OP with AR and PR. For BPA, MBP, and OP, five AR interacting residues Leu-701, Leu-704, Asn-705, Met-742, and Phe-764 overlapped with those of native AR ligand testosterone, and four PR interacting residues Leu-715, Leu-718, Met-756, and Met-759 overlapped with those of PR co-complex ligand, norethindrone. For both the receptors the binding strength of MBP was maximum among the three compounds. Thus, these compounds have the potential to block or interfere in the binding of the endogenous native AR and PR ligands and, hence, resulting in dysfunction. The knowledge of the key interactions and the important amino-acid residues also allows better prediction of potential of xenobiotic molecules for disrupting AR- and PR-mediated pathways, thus, helping in design of less potent alternatives for commercial use.	[Rehan, Mohd; Ahmad, Ejaz; Sheikh, Ishfaq A.; Damanhouri, Ghazi A.; Beg, Mohd A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Abuzenadah, Adel M.] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia; [Bajouh, Osama S.; AlBasri, Samera F.; Assiri, Mansour M.] King Abdulaziz Univ, Fac Med, Dept Obstet & Gynecol, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Beg, MA (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mabeg51@gmail.com	Ahmad, Ejaz/P-2730-2015; Rehan, Mohd/H-9835-2012; Sheikh, Ishfaq A/H-9611-2012; Damanhouri, Ghazi/Q-7901-2019; Beg, Mohd A/K-3366-2013	Beg, Mohd A/0000-0002-8495-4738; Rehan, Mohd/0000-0003-4898-6043	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [434/019-T]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 434/019-T. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; Baker ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046078; Ben Maamar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117226; Bergman A., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1016/J; Bian Q, 2006, FOOD CHEM TOXICOL, V44, P1355, DOI 10.1016/j.fct.2006.02.014; Blake CA, 1997, BIOL REPROD, V57, P255, DOI 10.1095/biolreprod57.2.255; Bloom MS, 2011, FERTIL STERIL, V96, P672, DOI 10.1016/j.fertnstert.2011.06.063; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Caserta D, 2013, GYNECOL ENDOCRINOL, V29, P444, DOI 10.3109/09513590.2012.758702; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cobellis L, 2009, BIOMED CHROMATOGR, V23, P1186, DOI 10.1002/bmc.1241; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich S, 2012, ENVIRON HEALTH PERSP, V120, P978, DOI 10.1289/ehp.1104307; Ellmann S, 2009, CELL MOL LIFE SCI, V66, P2405, DOI 10.1007/s00018-009-0017-3; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Forti G, 1998, J CLIN ENDOCR METAB, V83, P4177, DOI 10.1210/jc.83.12.4177; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Gurunath S, 2011, HUM REPROD UPDATE, V17, P575, DOI 10.1093/humupd/dmr015; Hao Junxia, 2011, Wei Sheng Yan Jiu, V40, P312; Hubbard S. J., 1993, TECHNICAL REPORT; Jung YW, 2005, TOXICOL SCI, V83, P78, DOI 10.1093/toxsci/kfi015; Kamel RM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-21; Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Kolsek K, 2015, TOXICOL IN VITRO, V29, P8, DOI 10.1016/j.tiv.2014.08.009; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Luccio-Camelo DC, 2011, J STEROID BIOCHEM, V127, P74, DOI 10.1016/j.jsbmb.2011.04.004; Manfo FPT, 2014, REV ENVIRON CONTAM T, V228, P57, DOI 10.1007/978-3-319-01619-1_3; Marques-Pinto A, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0036; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Mendiola J, 2010, ENVIRON HEALTH PERSP, V118, P1286, DOI 10.1289/ehp.1002037; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Mok-Lin E, 2010, INT J ANDROL, V33, P385, DOI 10.1111/j.1365-2605.2009.01014.x; Mueller S.O., 2001, HDB ENV CHEM, P3; Myllymaki SA, 2005, TOXICOL APPL PHARM, V207, P59, DOI 10.1016/j.taap.2004.12.001; Oberpenning R, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P521, DOI 10.1007/978-3-540-78355-8_25; Okuda K, 2010, TOXICOL LETT, V197, P7, DOI 10.1016/j.toxlet.2010.04.017; Patel S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130336; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pihlajamaa P., 2015, ENDOCR REV, V2015; Qiao Lili, 2010, Wei Sheng Yan Jiu, V39, P9; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Tang CY, 2012, BIOMED ENVIRON SCI, V25, P291, DOI 10.3967/0895-3988.2012.03.006; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang H, 2010, ASIAN J ANDROL, V12, P535, DOI 10.1038/aja.2010.14; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang XX, 2013, ECOTOX ENVIRON SAFE, V89, P143, DOI 10.1016/j.ecoenv.2012.11.020; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YI BY, 2013, MATH PROBL ENG, DOI DOI 10.1155/2013/; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047; Zheng Yan-min, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P841; Zhuang WL, 2015, ARCH ENVIRON CON TOX, V68, P38, DOI 10.1007/s00244-014-0078-7	67	39	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138438	10.1371/journal.pone.0138438	http://dx.doi.org/10.1371/journal.pone.0138438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379041	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400100
J	Shukla, S; Shankar, E; Fu, PF; MacLennan, GT; Gupta, S				Shukla, Sanjeev; Shankar, Eswar; Fu, Pingfu; MacLennan, Gregory T.; Gupta, Sanjay			Suppression of NF-kappa B and NF-kappa B-Regulated Gene Expression by Apigenin through I kappa B alpha and IKK Pathway in TRAMP Mice	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; CONSTITUTIVE ACTIVATION; DIETARY FLAVONOIDS; INDUCED APOPTOSIS; PROGNOSTIC-SIGNIFICANCE; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; DOWN-REGULATION; ANGIOGENESIS; BLOCKADE	Aberrant Nuclear Factor-kappa appaB (NF-kappa B) activation due to rapid I kappa B alpha turnover and high basal I kappa B alpha kinase (IKK) activity has been frequently observed in prostate cancer. Apigenin, a naturally occurring plant flavone, exhibits anti-proliferative, anti-inflammatory and anti-carcinogenic activities by inhibiting NF-kappa B pathway, through a mechanism not fully understood. We found that apigenin feeding in microgram doses (bioavailable in humans) inhibited prostate tumorigenesis in TRAMP mice by interfering with NF-kappa B signaling. Apigenin feeding to TRAMP mice (20 and 50 mu g/mouse/day, 6 days/week for 20 weeks) exhibited significant decrease in tumor volumes of the prostate and completely abolished metastasis, which correlated with inhibition of NF-kappa B activation and binding to the DNA. Apigenin intake blocked phosphorylation and degradation of I kappa B alpha by inhibiting IKK activation, which in turn led to suppression of NF-kappa B activation. The expression of NF-kappa B-regulated gene products involved in proliferation (cyclin D1, and COX-2), anti-apoptosis (Bcl-2 and Bcl-xL), and angiogenesis (vascular endothelial growth factor) were also downregulated after apigenin feeding. These events correlated with the induction of apoptosis in tumor cells, as evident by increased cleaved caspase-3 labeling index in the dorsolateral prostate. Our results provide convincing evidence that apigenin inhibits IKK activation and restores the expression of I kappa B alpha, preventing it's phosphorylation in a fashion similar to that elicited by IKK and proteasomal inhibitors through suppression of NF-kappa B signaling pathway.	[Shukla, Sanjeev; Shankar, Eswar; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Shukla, Sanjeev; Shankar, Eswar; Gupta, Sanjay] Univ Hosp Case Med Ctr, Inst Urol, Cleveland, OH USA; [Fu, Pingfu] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [MacLennan, Gregory T.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Gupta, Sanjay] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Fu, Pingfu; Gupta, Sanjay] Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH USA; [Gupta, Sanjay] Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Urol, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Shankar, Eswar/E-5139-2015; Fu, Pingfu/O-5415-2019	Shankar, Eswar/0000-0001-8968-838X; Fu, Pingfu/0000-0002-2334-5218; MacLennan, Gregory T./0000-0003-0089-449X; Gupta, Sanjay/0000-0002-9492-3249	NATIONAL CANCER INSTITUTE [R01CA108512] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002494] Funding Source: NIH RePORTER; VA [5I01BX002494-03] Funding Source: Federal RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs)		Abu-Yousif AO, 2008, CANCER RES, V68, P3057, DOI 10.1158/0008-5472.CAN-07-2763; American Cancer Society, 2015, CANC FACTS FIG 2015; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Chang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054318; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Das S, 2012, EXP BIOL MED, V237, P1433, DOI 10.1258/ebm.2012.012148; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Fang J, 2007, CARCINOGENESIS, V28, P858, DOI 10.1093/carcin/bgl205; Fonseca Gilvan Neiva, 2004, Sao Paulo Med. J., V122, P124, DOI 10.1590/S1516-31802004000300009; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Gasparian AV, 2002, J CELL SCI, V115, P141; Gates MA, 2009, INT J CANCER, V124, P1918, DOI 10.1002/ijc.24151; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Hu M, 2003, J PHARMACOL EXP THER, V307, P314, DOI 10.1124/jpet.103.053496; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hussain AR, 2010, CELL PROLIFERAT, V43, P170, DOI 10.1111/j.1365-2184.2009.00662.x; Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Kallakury BVS, 1997, CANCER-AM CANCER SOC, V80, P753, DOI 10.1002/(SICI)1097-0142(19970815)80:4<753::AID-CNCR15>3.0.CO;2-S; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim BR, 2011, FOOD CHEM TOXICOL, V49, P1626, DOI 10.1016/j.fct.2011.04.015; Kim SH, 2013, MOL CELL ENDOCRINOL, V369, P130, DOI 10.1016/j.mce.2013.01.012; Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Kuo SH, 2012, GYNECOL ONCOL, V126, P245, DOI 10.1016/j.ygyno.2012.04.047; Kyle JAA, 2010, BRIT J NUTR, V103, P429, DOI 10.1017/S0007114509991784; Leclercq G, 2014, J STEROID BIOCHEM, V139, P237, DOI 10.1016/j.jsbmb.2012.12.010; Lee BH, 2015, EUR UROL, V67, P204, DOI 10.1016/j.eururo.2014.09.017; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Meyer H, 2006, ANN NUTR METAB, V50, P167, DOI 10.1159/000090736; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X; Pomerantz MM, 2011, CANCER PREV RES, V4, P719, DOI 10.1158/1940-6207.CAPR-10-0292; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Seo HS, 2012, MOL CELL BIOCHEM, V366, P319, DOI 10.1007/s11010-012-1310-2; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Shukla S, 2008, FREE RADICAL BIO MED, V44, P1833, DOI 10.1016/j.freeradbiomed.2008.02.007; Shukla S, 2007, CANCER RES, V67, P6925, DOI 10.1158/0008-5472.CAN-07-0717; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Shukla S, 2014, APOPTOSIS, V19, P883, DOI 10.1007/s10495-014-0971-6; Shukla S, 2014, CARCINOGENESIS, V35, P452, DOI 10.1093/carcin/bgt316; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Tong X, 2013, ANTI-CANCER AGENT ME, V13, P971, DOI 10.2174/18715206113139990119; Vinall Ruth L., 2011, Hormones & Cancer, V2, P224, DOI 10.1007/s12672-011-0076-4; Yang SH, 2013, ONCOLOGY-BASEL, V85, P86, DOI 10.1159/000353452; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	67	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138710	10.1371/journal.pone.0138710	http://dx.doi.org/10.1371/journal.pone.0138710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379052	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400114
J	Smit, IPJ; Prins, HHT				Smit, Izak P. J.; Prins, Herbert H. T.			Predicting the Effects of Woody Encroachment on Mammal Communities, Grazing Biomass and Fire Frequency in African Savannas	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; IRREVERSIBLE VEGETATION CHANGE; DISTRIBUTION PATTERNS; PLANT ENCROACHMENT; BUSH ENCROACHMENT; SOUTH-AFRICA; LANDSCAPE; HETEROGENEITY; GRAZERS; TREES	With grasslands and savannas covering 20% of the world's land surface, accounting for 30-35% of worldwide Net Primary Productivity and supporting hundreds of millions of people, predicting changes in tree/grass systems is priority. Inappropriate land management and rising atmospheric CO2 levels result in increased woody cover in savannas. Although woody encroachment occurs world-wide, Africa's tourism and livestock grazing industries may be particularly vulnerable. Forecasts of responses of African wildlife and available grazing biomass to increases in woody cover are thus urgently needed. These predictions are hard to make due to non-linear responses and poorly understood feedback mechanisms between woody cover and other ecological responders, problems further amplified by the lack of long-term and large-scale datasets. We propose that a space-for-time analysis along an existing woody cover gradient overcomes some of these forecasting problems. Here we show, using an existing woody cover gradient (0-65%) across the Kruger National Park, South Africa, that increased woody cover is associated with (i) changed herbivore assemblage composition, (ii) reduced grass biomass, and (iii) reduced fire frequency. Furthermore, although increased woody cover is associated with reduced livestock production, we found indigenous herbivore biomass (excluding elephants) remains unchanged between 20-65% woody cover. This is due to a significant reorganization in the herbivore assemblage composition, mostly as a result of meso-grazers being substituted by browsers at increasing woody cover. Our results suggest that woody encroachment will have cascading consequences for Africa's grazing systems, fire regimes and iconic wildlife. These effects will pose challenges and require adaptation of livelihoods and industries dependent on conditions currently prevailing.	[Smit, Izak P. J.] Sci Serv, Skukuza, South Africa; [Smit, Izak P. J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Prins, Herbert H. T.] Wageningen UR, Resource Ecol Grp, Wageningen, Netherlands	University of Witwatersrand; Wageningen University & Research	Smit, IPJ (corresponding author), Sci Serv, South African Natl Parks, Skukuza, South Africa.	izak.smit@sanparks.org		Prins, Herbert/0000-0003-1131-5107				Anadon JD, 2014, P NATL ACAD SCI USA, V111, P12948, DOI 10.1073/pnas.1320585111; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; BENSHAHAR R, 1992, ECOL APPL, V2, P95, DOI 10.2307/1941892; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bothma JDP, 2004, WILDLIFE SOC B, V32, P840, DOI 10.2193/0091-7648(2004)032[0840:UDAPRT]2.0.CO;2; Browne C., 2011, VELD FLORA, V97, P62; Bucini G., 2011, ECOSYSTEM FUNCTION S, P219; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; CACHIER H, 1995, J ATMOS CHEM, V22, P123, DOI 10.1007/BF00708185; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; du Toit J.T., 2003, KRUGER EXPERIENCE EC; du Toit JT, 2014, CONSERV SC PR SER, V14, P30; Edenhofer O., 2014, CONTRIBUTION WORKING; Eldridge DJ, 2006, ECOL LETT, V14, P709; Gillson L, 2015, ECOL COMPLEX, V21, P78, DOI 10.1016/j.ecocom.2014.12.005; Gordon Iain J., 2008, V195, P309, DOI 10.1007/978-3-540-72422-3_12; Govender N, 2012, AFR J RANGE FOR SCI, V29, P63, DOI 10.2989/10220119.2012.697918; Gray EF, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1106; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Kulmatiski Andrew, 2013, Oecologia, V171, P25, DOI 10.1007/s00442-012-2390-0; Loarie SR, 2013, ANIM BEHAV, V85, P899, DOI 10.1016/j.anbehav.2013.01.018; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Mills MGL, WILDLIFE RES, V195, P75; Moleele NM, 2002, J ENVIRON MANAGE, V64, P3, DOI 10.1006/jema.2001.0486; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Owen-Smith N, 2008, ECOLOGY, V89, P1120, DOI 10.1890/07-0970.1; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; PRINS HHT, 1990, OECOLOGIA, V83, P392, DOI 10.1007/BF00317566; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Redfern JV, 2002, S AFR J SCI, V98, P455; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Seydack A. H., 2012, Koedoe, V54, P1047; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Skinner JD, 2000, THE MAMMALS OF THE S; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Smit IPJ, 2013, ECOGRAPHY, V36, P447, DOI 10.1111/j.1600-0587.2012.07555.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Trollope W. S. W., 1986, Journal of the Grassland Society of Southern Africa, V3, P148; van de Koppel J, 2002, AM NAT, V159, P209, DOI 10.1086/324791; van de Koppel J, 2000, OIKOS, V90, P253, DOI 10.1034/j.1600-0706.2000.900205.x; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Wessels KJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014007; Whyte Ian J., 2003, P332; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x	57	53	54	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137857	10.1371/journal.pone.0137857	http://dx.doi.org/10.1371/journal.pone.0137857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379249	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400032
J	Wang, WJ; Mandel, J; Bouaziz, J; Commenges, D; Nabirotchkine, S; Chumakov, I; Cohen, D; Guedj, M				Wang, Wenjia; Mandel, Jonas; Bouaziz, Jan; Commenges, Daniel; Nabirotchkine, Serguei; Chumakov, Ilya; Cohen, Daniel; Guedj, Mickael		Alzheimer's Dis Neuroimaging Initi	A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; PATHWAY ANALYSIS; GLUCOSE-METABOLISM; MAMMALIAN TARGET; WIDE ASSOCIATION; SUSCEPTIBILITY; SET; CHOLESTEROL; REGULATOR; MIGRATION	Results from Genome-Wide Association Studies (GWAS) have shown that the genetic basis of complex traits often include many genetic variants with small to moderate effects whose identification remains a challenging problem. In this context multi-marker analysis at the gene and pathway level can complement traditional point-wise approaches that treat the genetic markers individually. In this paper we propose a novel statistical approach for multi-marker analysis based on the Rasch model. The method summarizes the categorical genotypes of SNPs by a generalized logistic function into a genetic score that can be used for association analysis. Through different sets of simulations, the false-positive rate and power of the proposed approach are compared to a set of existing methods, and shows good performances. The application of the Rasch model on Alzheimer's Disease (AD) ADNI GWAS dataset also allows a coherent interpretation of the results. Our analysis supports the idea that APOE is a major susceptibility gene for AD. In the top genes selected by proposed method, several could be functionally linked to AD. In particular, a pathway analysis of these genes also highlights the metabolism of cholesterol, that is known to play a key role in AD pathogenesis. Interestingly, many of these top genes can be integrated in a hypothetic signalling network.	[Wang, Wenjia; Mandel, Jonas; Bouaziz, Jan; Nabirotchkine, Serguei; Chumakov, Ilya; Cohen, Daniel; Guedj, Mickael] Pharnext, Issy Les Moulineaux, Ile De France, France; [Wang, Wenjia; Commenges, Daniel] Univ Bordeaux, INSERM, U897, Bordeaux, Aquitaine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Wang, WJ (corresponding author), Pharnext, Issy Les Moulineaux, Ile De France, France.	wenjia.wang@pharnext.com	Commenges, Daniel/T-6536-2019		Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). Pharnext provided support in the form of salaries for authors WW, MG, JM, JB, D. Cohen, SN, and IC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Allison AC, 2001, MED HYPOTHESES, V57, P151, DOI 10.1054/mehy.2001.1307; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrich D, 2000, RUMM A WINDOWS BASED; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Bouaziz Matthieu, 2012, Methods Mol Biol, V888, P213, DOI 10.1007/978-1-61779-870-2_13; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Chumakov I, 2015, SCI REP-UK, V5, DOI 10.1038/srep07608; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUMAN MOLECULAR GENE; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Evangelou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041018; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gil OD, 1998, J NEUROSCI, V18, P9312; Gomes CM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/487534; Guedj M, 2006, STATISTICAL APPLICAT, V5, DOI [10.2202/1544-6115.1192, DOI 10.2202/1544-6115.1192]; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang GR, 2011, J CLIN INVEST, V121, P769, DOI 10.1172/JCI45096; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maiese K, 2014, ANN MED, V46, P587, DOI 10.3109/07853890.2014.941921; Mason BJ, 2001, J CLIN PSYCHIAT, V62, P42; Moncada-Pazos A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408625; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Olah J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/jbc.M111.243907; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Huy PDQ, 2013, BBA-GEN SUBJECTS, V1830, P2960, DOI 10.1016/j.bbagen.2012.12.026; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasch G, 1960, STUDIES IN MATHEMATI; Rogaeva E, 2002, NEUROMOL MED, V2, P1, DOI 10.1385/NMM:2:1:01; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Scart-Gres C, 2014, THE JOURNAL OF PREVE, V1, P232; Schwender H, 2012, J TOXICOL ENV HEAL A, V75, P438, DOI 10.1080/15287394.2012.674910; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shiba S, 2014, BIOCHEM BIOPH RES CO, V453, P350, DOI 10.1016/j.bbrc.2014.09.091; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh JM, 2007, CELL METAB, V6, P195, DOI 10.1016/j.cmet.2007.08.001; Sun JP, 2014, ELECTRON J DIFFER EQ, P1; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Van Gassen G, 1999, NEUROBIOL DIS, V6, P376, DOI 10.1006/nbdi.1999.0265; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Woods A., 1985, LANG TEST, V2, P117, DOI [10.1177/ 026553228500200202, DOI 10.1177/026553228500200202, 10.1177/026553228500200202]; Wright B. D., 1982, RATING SCALE ANALYSI; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu YL, 2015, NEUROBIOL AGING, V36, P169, DOI 10.1016/j.neurobiolaging.2014.07.029	82	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138223	10.1371/journal.pone.0138223	http://dx.doi.org/10.1371/journal.pone.0138223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379234	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400067
J	Liu, ZY; Zou, MH				Liu, Zhaoyu; Zou, Ming-hui			Macrophage Liver Kinase B-1 Interacts with IKK beta and Inhibits Inflammatory Signaling in Response to LPS	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology Meeting	MAR 28-APR 01, 2015	Boston, MA	Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, ASIP, ASN, ASPET					[Liu, Zhaoyu; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Biochem & Mol Biol, Norman, OK 73019 USA; [Liu, Zhaoyu; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Mol Med, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman			Kahn, Richard/ABD-2666-2020; liu, zhao/GXV-6141-2022	Kahn, Richard/0000-0002-0259-0601; West, Andrew/0000-0002-3034-4061	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148, P30 CA013148] Funding Source: Medline; NINDS NIH HHS [R01 NS064934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	39	39	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29			1		718.8				10.1096/fj.15-277095	http://dx.doi.org/10.1096/fj.15-277095			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CS0BT	26396237	Green Published			2022-12-26	WOS:000361722701183
J	Carpenter, BL; Chen, M; Knifley, T; Davis, KA; Harrison, SMW; Stewart, RL; O'Connor, KL				Carpenter, Brittany L.; Chen, Min; Knifley, Teresa; Davis, Kelley A.; Harrison, Susan M. W.; Stewart, Rachel L.; O'Connor, Kathleen L.			Integrin alpha 6 beta 4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC-CANCER; BREAST-CARCINOMA CELLS; EPITHELIAL-CELLS; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; UP-REGULATION; AMPHIREGULIN; EXPRESSION; ADENOCARCINOMA; ACTIVATION	Background: Integrin alpha 6 beta 4 is overexpressed in pancreatic cancer and enhances invasion. Results: Integrin alpha 6 beta 4 coordinately up-regulates AREG, EREG, and MMP1 through DNA demethylation and NFAT5 that in turn enhances HGF-mediated invasion. Conclusion: Integrin alpha 6 beta 4 stimulates HGF-dependent invasion through autocrine EGFR signaling. Significance: HGF-stimulated invasion is dependent on autocrine EGFR signaling, thus implicating why EGFR inhibitors are effective in a complex tumor microenvironment. Integrin alpha 6 beta 4 is up-regulated in pancreatic adenocarcinomas where it contributes to carcinoma cell invasion by altering the transcriptome. In this study, we found that integrin alpha 6 beta 4 up-regulates several genes in the epidermal growth factor receptor ( EGFR) pathway, including amphiregulin (AREG), epiregulin (EREG), and ectodomain cleavage protease MMP1, which is mediated by promoter demethylation and NFAT5. The correlation of these genes with integrin alpha 6 beta 4 was confirmed in The Cancer Genome Atlas Pancreatic Cancer Database. Based on previous observations that integrin alpha 6 beta 4 cooperates with c-Met in pancreatic cancers, we examined the impact of EGFR signaling on hepatocyte growth factor (HGF)-stimulated migration and invasion. We found that AREG and EREG were required for autocrine EGFR signaling, as knocking down either ligand inhibited HGF-mediated migration and invasion. We further determined that HGF induced secretion of AREG, which is dependent on integrin-growth factor signaling pathways, including MAPK, PI3K, and PKC. Moreover, matrix metalloproteinase activity and integrin alpha 6 beta 4 signaling were required for AREG secretion. Blocking EGFR signaling with EGFR-specific antibodies or an EGFR tyrosine kinase inhibitor hindered HGF-stimulated pancreatic carcinoma cell chemotaxis and invasive growth in three-dimensional culture. Finally, we found that EGFR was phosphorylated in response to HGF stimulation that isdependenton EGF Rkinase activity; however, c-Metphosphorylation in response to HGF was unaffected by EGFR signaling. Taken together, these data illustrate that integrin alpha 6 beta 4 stimulates invasion by promoting autocrine EGFR signaling through transcriptional up-regulation of key EGFR family members and by facilitating HGF-stimulated EGFR ligand secretion. These signaling events, in turn, promote pancreatic carcinoma migration and invasion.	[Carpenter, Brittany L.; Chen, Min; Knifley, Teresa; Davis, Kelley A.; Harrison, Susan M. W.; Stewart, Rachel L.; O'Connor, Kathleen L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Carpenter, Brittany L.; O'Connor, Kathleen L.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Chen, Min] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA; [Stewart, Rachel L.] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	O'Connor, KL (corresponding author), Univ Kentucky, Markey Canc Ctr, 741 S Limestone St, Lexington, KY 40506 USA.	kloconnor@uky.edu	Regan, Clinton/E-6250-2012; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734; Stewart, Rachel/0000-0001-8031-5720; Carpenter, Brittany/0000-0002-0372-5811	National Institutes of Health [T32 CA165990, T32 CA160003, IRG-85-001-25, R01 CA109136]; NATIONAL CANCER INSTITUTE [R01CA109136, T32CA160003, T32CA165990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants T32 CA165990 (to B.L.C.), T32 CA160003 (to R.L.S.), IRG-85-001-25 (to M.C.), and R01 CA109136 (to K.L.O. and M.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Cruz-Monserrate Z, 2008, NEOPLASIA, V10, P408, DOI 10.1593/neo.07868; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; de Melker AA, 2001, J CELL SCI, V114, P2167; DIRENZO MF, 1995, CANCER RES, V55, P1129; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; EBERT M, 1994, CANCER RES, V54, P3959; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gilcrease MZ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-67; Gleason B, 2005, J HISTOCHEM CYTOCHEM, V53, P799, DOI 10.1369/jhc.4B6522.2005; Gschwind A, 2002, CANCER RES, V62, P6329; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Liu W, 2007, CLIN CANCER RES, V13, P6788, DOI 10.1158/1078-0432.CCR-07-0547; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nanjo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084700; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Park S, 2011, BIOCHEM BIOPH RES CO, V407, P680, DOI 10.1016/j.bbrc.2011.03.075; Plopper George E., 2000, Molecular Cell Biology Research Communications, V4, P129, DOI 10.1006/mcbr.2001.0267; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; So WK, 2014, FEBS LETT, V588, P3998, DOI 10.1016/j.febslet.2014.09.017; Stabile L. P., 2010, CANCERS BASEL, V1, P2153; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tun MT, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-15; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; YOKOYAMA M, 1995, INT J ONCOL, V6, P625; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zhu ZW, 2000, BIOCHEM BIOPH RES CO, V273, P1019, DOI 10.1006/bbrc.2000.3033	62	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27228	27238		10.1074/jbc.M115.686873	http://dx.doi.org/10.1074/jbc.M115.686873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381405	Green Published, hybrid			2022-12-26	WOS:000364794000031
J	Broeckhoven, C; Mouton, PLN				Broeckhoven, Chris; Mouton, Pieter le Fras Nortier			Some Like It Hot: Camera Traps Unravel the Effects of Weather Conditions and Predator Presence on the Activity Levels of Two Lizards	PLOS ONE			English	Article							GROUP-LIVING LIZARD; GUT-PASSAGE TIME; THERMAL-DEPENDENCE; BEHAVIOR; RISK; TEMPERATURE; SEASONALITY; EVOLUTION; FREQUENCY; FOOD	It is generally assumed that favourable weather conditions determine the activity levels of lizards, because of their temperature-dependent behavioural performance. Inactivity, however, might have a selective advantage over activity, as it could increase survival by reducing exposure to predators. Consequently, the effects of weather conditions on the activity patterns of lizards should be strongly influenced by the presence of predators. Using remote camera traps, we test the hypothesis that predator presence and weather conditions interact to modulate daily activity levels in two sedentary cordylid lizards, Karusasaurus polyzonus and Ouroborus cataphractus. While both species are closely related and have a fully overlapping distribution, the former is a fast-moving lightly armoured lizard, whereas the latter is a slow-moving heavily armoured lizard. The significant interspecific difference in anti-predator morphology and consequently differential vulnerability to aerial and terrestrial predators, allowed us to unravel the effects of predation risk and weather conditions on activity levels. Our results demonstrate that K. polyzonus is predominantly active during summer, when ambient temperatures are favourable enough to permit activity. In contrast, a peak in activity during spring was observed in O. cataphractus, with individuals being inactive during most of summer. While favourable weather conditions had a strong effect on the activity levels of K. polyzonus, no such relationship was present in O. cataphractus. Contrary to our hypothesis, the presence of terrestrial predators does not seem to affect daily activity levels or alter the influence of weather conditions on activity levels. We conclude that inactivity in O. cataphractus appears to be related to seasonal differences in vulnerability to predators, rather than the presence of predators, and highlight the importance of additional selective pressures, such as food abundance, in determining the species' activity levels.	[Broeckhoven, Chris; Mouton, Pieter le Fras Nortier] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Broeckhoven, C (corresponding author), Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa.	cbroeck@sun.ac.za	Van Broeckhoven, Christine/G-8362-2017	Van Broeckhoven, Christine/0000-0003-0183-7665	National Research Foundation (NRF); National Geographic Young Explorers Grant [9090-12]	National Research Foundation (NRF); National Geographic Young Explorers Grant(National Geographic Society)	This research was supported by incentive funding from the National Research Foundation (NRF) to PFNM and a National Geographic Young Explorers Grant (#9090-12) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Andrews RM, 1979, BIOTROPICA; Anholt BR, 2000, ECOLOGY, V81, P3509, DOI 10.2307/177510; Ariefiandy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058800; BALLINGER R E, 1979, Southwestern Naturalist, V24, P347, DOI 10.2307/3670932; Bates M.F., 2014, ATLAS RED LIST REPTI; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Bennett Daniel, 2014, Biawak, V8, P19; BEUCHAT CA, 1989, J HERPETOL, V23, P152, DOI 10.2307/1564021; Bridges AS, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P57, DOI 10.1007/978-4-431-99495-4_5; Broeckhoven C, 2015, J ANIM ECOL, V84, P1213, DOI 10.1111/1365-2656.12414; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Desmet PG, 2007, J ARID ENVIRON, V70, P570, DOI 10.1016/j.jaridenv.2006.11.019; Desmet PG, 2004, KAROO ECOLOGICAL PAT, P3; DIAZ JA, 1993, CAN J ZOOL, V71, P1104, DOI 10.1139/z93-150; DURBIN J, 1970, ECONOMETRICA, V38, P410, DOI 10.2307/1909547; Flemming AF, 2002, J HERPETOL, V36, P691; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; GRANT BW, 1988, ECOLOGY, V69, P167, DOI 10.2307/1943171; Greene H.W., 1988, Biology of Reptilia, V16, P1; Hayward J, 2008, THESIS STELLENBOSCH; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Huey R.B., 1982, Biology of Reptilia, V12, P25; Johnston L, 2014, THESIS U OTAGO; Keogh JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038856; Kerr GD, 2004, J HERPETOL, V38, P519, DOI 10.1670/13-04A; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LISTER BC, 1992, J ANIM ECOL, V61, P717, DOI 10.2307/5626; Lopez-Darias M, 2012, ECOLOGY, V93, P2512, DOI 10.1890/12-0483.1; Losos JB, 2002, ANIM BEHAV, V64, P313, DOI 10.1006/anbe.2002.3051; MARSH RL, 1986, J EXP BIOL, V126, P79; McConnachie S, 2004, J COMP PHYSIOL B, V174, P99, DOI 10.1007/s00360-003-0393-1; Mouton P. le F.N., 1997, African Journal of Herpetology, V46, P78, DOI 10.1080/21564574.1997.9649981; MOUTON P.le F.N., 2001, J MORPHOL, V248, P264; Mouton PLN, 2011, AFR J HERPETOL, V60, P155, DOI 10.1080/21564574.2011.562926; Mouton PL, 2000, AFR ZOOL, V35, P1; Mucina L., 2006, VEGETATION S AFRICA; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Pitt WC, 1999, EVOL ECOL, V13, P499, DOI 10.1023/A:1006792726166; REDDY MV, 1990, INT J BIOMETEOROL, V34, P49, DOI 10.1007/BF01045820; ROSE B, 1981, ECOLOGY, V62, P706, DOI 10.2307/1937739; Rowcliffe JM, 2014, METHODS ECOL EVOL, V5, P1170, DOI 10.1111/2041-210X.12278; Shuttleworth C, 2013, AFR ZOOL, V48, P367, DOI 10.3377/004.048.0219; Stanley EL, 2011, MOL PHYLOGENET EVOL, V58, P53, DOI 10.1016/j.ympev.2010.08.024; SUGERMAN RA, 1980, J HERPETOL, V14, P188, DOI 10.2307/1563855; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Truter JC, 2011, THESIS STELLENBOSCH; Truter JC, 2014, AMPHIBIA-REPTILIA, V35, P391, DOI 10.1163/15685381-00002965; VANDAMME R, 1991, FUNCT ECOL, V5, P507; Vasconcellos A, 2010, REV BRAS ENTOMOL, V54, P471, DOI 10.1590/S0085-56262010000300019; Visagie L, 2001, THESIS STELLENBOSCH; WHITFORD WG, 1975, ENVIRON ENTOMOL, V4, P689, DOI 10.1093/ee/4.5.689; Whiting Martin J., 2007, P405, DOI 10.1017/CBO9780511752438.015	54	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137428	10.1371/journal.pone.0137428	http://dx.doi.org/10.1371/journal.pone.0137428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397831	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500037
J	Li, X; Li, Y; Gong, W; Yang, MY; Yang, Y; Li, ZP; Wang, YL; Zhang, ZQ				Li, Xin; Li, Ying; Gong, Wei; Yang, Mei Yan; Yang, Yang; Li, Zhi Ping; Wang, Yu Li; Zhang, Zhen Qing			Auto-Induction Effect of Chloroxoquinoline on the Cytochrome P450 Enzymes of Rats Associated with CYP 3A and 1A	PLOS ONE			English	Article							IN-VIVO; DRUG-INTERACTIONS; HUMAN HEPATOCYTES; INDUCTION; METABOLISM; COCKTAIL; VITRO	To investigate the auto-induction of cytochrome P450 (CYP450) by Chloroxoquinoline (CXL), a novel anticancer drug. Three experiments related to the induction of CYP450 were performed: a) In vitro use of the rat fresh hepatocytes model; b) In vivo 'cocktail' of CYP450 probe model; c) Pharmacokinetic (PK) study of the single and multiple doses. Some typical CYP enzyme probes and inducers were used in these experiments and were all determined by HPLC-MS/MS. The expression levels of CYP3A and CYP1A mRNA were analyzed by the real time polymerase chain reaction (RT-PCR) technique. The PK studies showed that the area under the curve (AUC(0-t)) and the peak concentration (C-max) of the multiple doses were approximately 2.4-fold and 1.9-fold lower than those of the single dose, respectively (p<0.05). Subsequent studies were conducted to study the possible induction of CXL on CYP 450. The in vivo 'cocktail' administration of CYP450 probe model indicated that 5 d pretreatment with CXL resulted in a mean 4.6 times increase in the metabolites/probe plasma ratios for CYP 3A and a 336% increase for CYP 1A than those of the negative control (p<0.05). The induction effect of CXL on CYP450 was further evaluated on rat hepatocytes with four concentrations (1, 10, 50 and 100 mu mol/L). Compared with the negative control, the mRNA levels of CYP 1A2 increased significantly in rat hepatocytes after treatment with 10, 50 and 100 mu mol/L CXL (p<0.05). While significant inductions of CYP 3A1 were observed in the entire treated groups. The results of the present study demonstrate enhanced and induced expression of CYP 3A and CYP 1A in response to CXL exposure in rats, suggesting that CXL is an auto-inducer of CYP 3A and CYP 1A.	[Li, Xin; Li, Ying; Gong, Wei; Yang, Mei Yan; Yang, Yang; Li, Zhi Ping; Wang, Yu Li; Zhang, Zhen Qing] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Li, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Pharm, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital	Li, Y (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.	liying.sky@126.com			National Science Foundation of China [81102498]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Foundation of China (No. 81102498), (http://www.nsfc.gov.cn), and Ying Li received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; Chainuvati S, 2003, CLIN PHARMACOL THER, V74, P437, DOI 10.1016/S0009-9236(03)00229-7; [陈志明 Chen Zhiming], 2011, [中华放射医学与防护杂志, Chinese Journal of Radiological Medicine and Protection], V31, P33; Chiang TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094885; FRENCH SW, 1993, EXP MOL PATHOL, V58, P61, DOI 10.1006/exmp.1993.1006; Gordon GJ, 2000, EXP MOL PATHOL, V69, P17, DOI 10.1006/exmp.2000.2308; Kot M, 2008, BIOCHEM PHARMACOL, V75, P1538, DOI 10.1016/j.bcp.2007.12.017; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; Madan A, 1999, DRUG METAB DISPOS, V27, P327; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Palmer JL, 2001, BRIT J CLIN PHARMACO, V52, P555, DOI 10.1046/j.0306-5251.2001.01479.x; Ripp SL, 2006, DRUG METAB DISPOS, V34, P1742, DOI 10.1124/dmd.106.010132; Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007; Silva JM, 1999, CHEM-BIOL INTERACT, V121, P49, DOI 10.1016/S0009-2797(99)00090-3; Tanaka E, 2003, J CLIN PHARM THER, V28, P157, DOI 10.1046/j.1365-2710.2003.00486.x; Zhu XD, 2009, HEPATO-GASTROENTEROL, V56, P555	17	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138875	10.1371/journal.pone.0138875	http://dx.doi.org/10.1371/journal.pone.0138875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397835	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500121
J	de Back, TR; Bodewes, AJ; Brewster, LM; Kunst, AE				de Back, Tim R.; Bodewes, Adee J.; Brewster, Lizzy M.; Kunst, Anton E.			Cardiovascular Health and Related Health Care Use of Moluccan-Dutch Immigrants	PLOS ONE			English	Article							ETHNIC DISPARITIES; RISK-FACTORS; NATIVE DUTCH; NETHERLANDS; HYPERTENSION; DISEASE; PREVALENCE; STROKE; POPULATION; AMSTERDAM	Objective Studies regularly show a higher incidence, prevalence and mortality of cardiovascular disease among immigrant groups from low-income countries. Despite residing in the Netherlands for over 60 years, the Moluccan-Dutch cardiovascular disease profile and health care use are still unknown. We aimed to compare (a) the clinical prevalence of cardiovascular diseases and (b) the use of health care services by cardiovascular disease patients of 5,532 Moluccan-Dutch to an age-sex matched control group of 55,320 native Dutch. Methods We performed a cross-sectional analysis of data of the Achmea health insurance company for the period of 1 January 2009 to 31 December 2010. We collected information on health care use, including diagnostic information. Linear and logistic regression models were used for comparison. Results Moluccans had a higher clinical prevalence of ischemic heart diseases (odds ratio 1.26; 95% confidence interval 1.03-1.56), but tended to have a lower prevalence of cerebrovascular accidents (0.79; 0.56-1.11) and cardiac failure (0.67; 0.44-1.03). The clinical prevalence of cardiovascular diseases together tended to be lower among Moluccans (0.90; 0.80-1.00). Consultation of medical specialists did not differ. Angiotensin II inhibitors (1.42; 1.09-1.84), antiplatelet agents (1.27; 1.01-1.59) and statins (1.27; 1.00-1.60) were prescribedmore frequently to Moluccans, as were cardiovascular agents in general (1.27; 0.94-1.71). Conclusion The experience of Moluccans in the Netherlands suggests that, in the long run, cardiovascular risk and related health care use of ethnic minority groups may converge towards that of the majority population.	[de Back, Tim R.; Bodewes, Adee J.; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Brewster, Lizzy M.] Univ Amsterdam, Acad Med Ctr, Dept Internal & Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bodewes, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.j.bodewes@amc.uva.nl	Brewster, Lizzy M/K-7675-2019	Kunst, Anton/0000-0002-3313-5273; Brewster, Lizzy M/0000-0002-7434-0038	BUAT Foundation - platform for Moluccans in the Netherlands [cj.201.008]	BUAT Foundation - platform for Moluccans in the Netherlands	This work was supported by BUAT Foundation - platform for Moluccans in the Netherlands. BUAT stands for Betrokken (Involved) Uitnodigend (Inviting) Actief (Active) and Transparant (Transparent). Website: http://www.minderheden.org/samenwerkingsverbanden/BUAT. Grant number: cj.201.008. Grant recipient: AJB.	Agyemang C, 2006, J HYPERTENS, V24, P2169, DOI 10.1097/01.hjh.0000249693.73618.c9; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Agyemang C, 2013, EUR J PREV CARDIOL, V20, P938, DOI 10.1177/2047487312451540; AHA. Cardiac medications at a glance ( American Heart Association), 2014, CARD MED GLANC; Avendano M, 2006, J CLIN EPIDEMIOL, V59, P1285, DOI 10.1016/j.jclinepi.2006.03.010; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Corlin L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-603; Denktas S, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-35; El Fakiri F, 2008, J IMMIGR MINOR HEALT, V10, P559, DOI 10.1007/s10903-008-9144-4; Gishti O, 2015, PREV MED, V76, P84, DOI 10.1016/j.ypmed.2015.03.027; Head J., 2000, BBC NEWS; Hill LK, 2015, PSYCHOSOM MED, V77, P16, DOI 10.1097/PSY.0000000000000133; Jatrana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105141; Jayaweera H, 2010, SOC SCI MED, V71, P1002, DOI 10.1016/j.socscimed.2010.05.039; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Kalchiem-Dekel O, 2014, JOURNAL OF DIABETES; Kusuma Y, 2009, INT J STROKE, V4, P379, DOI 10.1111/j.1747-4949.2009.00326.x; Malik MO, 2015, DIABETOLOGIA, V58, P716, DOI 10.1007/s00125-015-3492-0; Misbach J, 2001, J CLIN NEUROSCI, V8, P245, DOI 10.1054/jocn.1999.0667; Rodgers A, 1998, LANCET, V352, P1801; Schellingerhout R., 2004, GEZONDHEID WELZIJN A; Schneiderman N, 2014, PROG CARDIOVASC DIS, V57, P253, DOI 10.1016/j.pcad.2014.08.004; Setiati Siti, 2005, Acta Med Indones, V37, P20; Stronks K, 2001, J EPIDEMIOL COMMUN H, V55, P701, DOI 10.1136/jech.55.10.701; Uiters E, 2006, EUR J PUBLIC HEALTH, V16, P388, DOI 10.1093/eurpub/ckl040; Ujcic-Voortman JK, 2012, OBES REV, V13, P2, DOI 10.1111/j.1467-789X.2011.00932.x; van den Born BJH, 2006, J HYPERTENS, V24, P2299, DOI 10.1097/01.hjh.0000249710.21146.38; van der Wal JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1273; van Lieshout T, 2007, GEZONDHEIDSSITUATIE; Verhagen I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0125-z; Yancy CW, 2011, J AM COLL CARDIOL, V57, P245, DOI 10.1016/j.jacc.2010.09.027	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138644	10.1371/journal.pone.0138644	http://dx.doi.org/10.1371/journal.pone.0138644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26393795	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100080
J	Francois, A; Julian, A; Ragot, S; Dugast, E; Blanchard, L; Brishoual, S; Chassaing, D; Page, G; Paccalin, M				Francois, Arnaud; Julian, Adrien; Ragot, Stephanie; Dugast, Emilie; Blanchard, Ludovic; Brishoual, Sonia; Chassaing, Damien; Page, Guylene; Paccalin, Marc			Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STARVATION-INDUCED AUTOPHAGY; BETA-AMYLOID PEPTIDE; BECLIN 1; NEURODEGENERATIVE DISEASE; REDUCED EXPRESSION; IMMUNE-RESPONSES; T-CELLS; MICROGLIA; CYTOKINES	Recent findings indicate that microglia in Alzheimer's disease (AD) is senescent whereas peripheral blood mononuclear cells (PBMCs) could infiltrate the brain to phagocyte amyloid deposits. However, the molecular mechanisms involved in the amyloid peptide clearance remain unknown. Autophagy is a physiological degradation of proteins and organelles and can be controlled by pro-inflammatory cytokines. The purpose of this study was to evaluate the impact of inflammation on autophagy in PBMCs from AD patients at baseline, 12 and 24 months of follow-up. Furthermore, PBMCs from healthy patients were also included and treated with 20 mu M amyloid peptide 1-42 to mimic AD environment. For each patient, PBMCs were stimulated with the mitogenic factor, phytohaemagglutin (PHA), and treated with either 1 mu M C16 as an anti-inflammatory drug or its vehicle. Autophagic markers (Beclin-1, p62/sequestosome 1 and microtubule-associated protein-light chain 3: LC3) were quantified by western blot and cytokines (Interleukin (IL)-1 beta, Tumor necrosis Factor (TNF)-alpha and IL-6) by Luminex X-MAP (R) technology. Beclin-1 and TNF-alpha levels were inversely correlated in AD PBMCs at 12 months post-inclusion. In addition, Beclin-1 and p62 increased in the low inflammatory environment induced by C16. Only LC3-I levels were inversely correlated with cognitive decline at baseline. For the first time, this study describes longitudinal changes in autophagic markers in PBMCs of AD patients under an inflammatory environment. Inflammation would induce autophagy in the PBMCs of AD patients while an anti-inflammatory environment could inhibit their autophagic response. However, this positive response could be altered in a highly aggressive environment.	[Francois, Arnaud; Julian, Adrien; Dugast, Emilie; Chassaing, Damien; Page, Guylene; Paccalin, Marc] Univ Poitiers, Mol Targets & Therapeut Alzheimers Dis EA3808, Poitiers, France; [Julian, Adrien] Univ Poitiers Hosp, Dept Neurol, Poitiers, France; [Julian, Adrien; Paccalin, Marc] Univ Poitiers Hosp, Ctr Memoire Ressources & Rech, Poitiers, France; [Julian, Adrien; Blanchard, Ludovic; Paccalin, Marc] Univ Poitiers Hosp, Dept Geriatr, Poitiers, France; [Ragot, Stephanie; Dugast, Emilie; Blanchard, Ludovic; Brishoual, Sonia; Paccalin, Marc] Univ Poitiers Hosp, CIC P 1402, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Francois, A (corresponding author), CHU Quebec, Ctr Rech, Neurosci Axis, Quebec City, PQ G1V 4G2, Canada.	arnaudfrancois85@gmail.com			Poitiers University Hospital; French Ministry of Social Affairs and Health (PHRC CYTOCOGMA); "Ligue Europeenne Contre la Maladie d'Alzheimer" (LECMA) [10704]	Poitiers University Hospital; French Ministry of Social Affairs and Health (PHRC CYTOCOGMA); "Ligue Europeenne Contre la Maladie d'Alzheimer" (LECMA)	This study was supported by Poitiers University Hospital with a grant from the French Ministry of Social Affairs and Health (PHRC CYTOCOGMA) and by a grant (10704 number) from the "Ligue Europeenne Contre la Maladie d'Alzheimer" (LECMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2014, ACTA NEUROPATHOL, V128, P705, DOI 10.1007/s00401-014-1289-8; Angelopoulos P, 2008, INT J NEUROSCI, V118, P1659, DOI 10.1080/00207450701392068; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Butchart J, 2015, NEUROLOGY, V84, P2161, DOI 10.1212/WNL.0000000000001617; Butovsky O, 2007, EUR J NEUROSCI, V26, P413, DOI 10.1111/j.1460-9568.2007.05652.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Couturier J, 2010, J ALZHEIMERS DIS, V21, P1217, DOI 10.3233/JAD-2010-100258; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fisher Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010830; Floden AM, 2011, J ALZHEIMERS DIS, V25, P279, DOI 10.3233/JAD-2011-101014; Francois A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0139-x; Francois A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-151; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Majumdar A, 2008, NEUROBIOL AGING, V29, P707, DOI 10.1016/j.neurobiolaging.2006.12.001; Marselli L, 2013, DIABETES OBES METAB, V15, P130, DOI 10.1111/dom.12152; Mohan N, 2011, NEUROSCI LETT, V502, P24, DOI 10.1016/j.neulet.2011.07.016; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; O'Brien CE, 2014, J NEUROIMMUNE PHARM, V9, P285, DOI 10.1007/s11481-013-9519-8; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Randall-Demllo S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00301; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reale M, 2004, J NEUROIMMUNOL, V148, P162, DOI 10.1016/j.jneuroim.2003.11.003; Reale MA, 2013, CURR ALZHEIMER RES; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Richardson C, 2013, INT J GERIATR PSYCH, V28, P1312, DOI 10.1002/gps.3966; Rocha NP, 2012, MOL CELL NEUROSCI, V49, P77, DOI 10.1016/j.mcn.2011.09.005; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Sala G, 2014, BRAIN RES, V1546, P46, DOI 10.1016/j.brainres.2013.12.017; Sala G, 2012, AMYOTROPH LATERAL SC, V13, P119, DOI 10.3109/17482968.2011.611139; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shi CH, 2014, BIOCHEM BIOPH RES CO, V452, P308, DOI 10.1016/j.bbrc.2014.08.017; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Sulkowski G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186068; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Vedin I, 2008, AM J CLIN NUTR, V87, P1616, DOI 10.1093/ajcn/87.6.1616; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xue ZF, 2013, J MOL NEUROSCI, V51, P180, DOI 10.1007/s12031-013-9974-y; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0	70	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138326	10.1371/journal.pone.0138326	http://dx.doi.org/10.1371/journal.pone.0138326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393801	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100053
J	Liu, YY; Li, FN; Kong, XF; Tan, B; Li, YH; Duan, YH; Blachier, F; Hu, CAA; Yin, YL				Liu, Yingying; Li, Fengna; Kong, Xiangfeng; Tan, Bie; Li, Yinghui; Duan, Yehui; Blachier, Francois; Hu, Chien-An A.; Yin, Yulong			Signaling Pathways Related to Protein Synthesis and Amino Acid Concentration in Pig Skeletal Muscles Depend on the Dietary Protein Level, Genotype and Developmental Stages	PLOS ONE			English	Article							L-ARGININE; CROSS-TALK; EXPRESSION; MTOR; GROWTH; SUPPLEMENTATION; METABOLISM; MYOSTATIN; GENES; MYOD	Muscle growth is regulated by the homeostatic balance of the biosynthesis and degradation of muscle proteins. To elucidate the molecular interactions among diet, pig genotype, and physiological stage, we examined the effect of dietary protein concentration, pig genotype, and physiological stages on amino acid (AA) pools, protein deposition, and related signaling pathways in different types of skeletal muscles. The study used 48 Landrace pigs and 48 pure-bred Bama mini-pigs assigned to each of 2 dietary treatments: lower/GB (Chinese conventional diet)- or higher/NRC (National Research Council)-protein diet. Diets were fed from 5 weeks of age to respective market weights of each genotype. Samples of biceps femoris muscle (BFM, type I) and longissimus dorsi muscle (LDM, type II) were collected at nursery, growing, and finishing phases according to the physiological stage of each genotype, to determine the AA concentrations, mRNA levels for growth-related genes in muscles, and protein abundances of mechanistic target of rapamycin (mTOR) signaling pathway. Our data showed that the concentrations of most AAs in LDM and BFM of pigs increased (P< 0.05) gradually with increasing age. Bama mini-pigs had generally higher (P< 0.05) muscle concentrations of flavor-related AA, including Met, Phe, Tyr, Pro, and Ser, compared with Landrace pigs. The mRNA levels for myogenic determining factor, myogenin, myocyte-specific enhancer binding factor 2 A, and myostatin of Bama mini-pigs were higher (P< 0.05) than those of Landrace pigs, while total and phosphorylated protein levels for protein kinase B, mTOR, and p70 ribosomal protein S6 kinases (p70S6K), and ratios of p-mTOR/mTOR, p-AKT/AKT, and p-p70S6K/p70S6K were lower (P< 0.05). There was a significant pig genotype-dependent effect of dietary protein on the levels for mTOR and p70S6K. When compared with the higher protein-NRC diet, the lower protein-GB diet increased (P< 0.05) the levels for mTOR and p70S6K in Bama mini-pigs, but repressed (P< 0.05) the level for p70S6K in Landrace pigs. The higher protein-NRC diet increased ratio of p-mTOR/mTOR in Landrace pigs. These findings indicated that the dynamic consequences of AA profile and protein deposition in muscle tissues are the concerted effort of distinctive genotype, nutrient status, age, and muscle type. Our results provide valuable information for animal feeding strategy.	[Liu, Yingying; Li, Fengna; Kong, Xiangfeng; Tan, Bie; Li, Yinghui; Duan, Yehui; Yin, Yulong] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Liu, Yingying] Hunan Anim Sci & Vet Med Res Inst, Changsha, Hunan, Peoples R China; [Blachier, Francois] INRA, CNRH IdF, AgroParisTech, UMR Nutr Physiol & Ingest Behav 914, Paris, France; [Hu, Chien-An A.] Univ New Mexico, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Liu, Yingying; Li, Yinghui; Duan, Yehui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yin, Yulong] Hunan Normal Univ, Sch Biol, Changsha 410018, Hunan, Peoples R China; [Yin, Yulong] Changsha Lvye Biotechnol Ltd Co, Guangdong Hinapharm Grp, Changsha 41019, Hunan, Peoples R China; [Yin, Yulong] Changsha Lvye Biotechnol Ltd Co, WangDa Acad Workstn, Changsha 41019, Hunan, Peoples R China	Chinese Academy of Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of New Mexico; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan Normal University	Kong, XF (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022		National Nature Science Foundation of China [31330075, 31110103909, 31270044, 31372325]; National Basic Research Program of China [2012CB124704, 2013CB127305]; K. C. Wong Education Foundation(Hong Kong); Changsha Lvye Biotechnology Limited Company; Guangdong Hinapharm Group; WangDa Academician Workstation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); K. C. Wong Education Foundation(Hong Kong); Changsha Lvye Biotechnology Limited Company; Guangdong Hinapharm Group; WangDa Academician Workstation	The present work was jointly supported by grants from National Nature Science Foundation of China (31330075, 31110103909,31270044 and 31372325), the National Basic Research Program of China (No. 2012CB124704 and 2013CB127305), K. C. Wong Education Foundation(Hong Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Changsha Lvye Biotechnology Limited Company, Guangdong Hinapharm Group and WangDa Academician Workstation provided support in the form of a salary for YY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizen N, 2010, DIFFERENTIATION, V80, pS8, DOI 10.1016/j.diff.2010.09.152; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Cho OH, 2015, DEV DYNAM, V244, P43, DOI 10.1002/dvdy.24217; Davis TA, 2009, CURR OPIN CLIN NUTR, V12, P78, DOI 10.1097/MCO.0b013e32831cef9f; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Deng HL, 2014, POULTRY SCI, V93, P114, DOI 10.3382/ps.2013-03287; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Dickinson JM, 2013, CURR OPIN CLIN NUTR, V16, P638, DOI 10.1097/MCO.0b013e3283653ec5; Dierks C, 2015, ANIM GENET, V46, P91, DOI 10.1111/age.12242; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; Duan YH, 2015, AMINO ACIDS, V47, P857, DOI 10.1007/s00726-015-1937-x; Feidt C, 1996, MEAT SCI, V44, P19, DOI 10.1016/S0309-1740(96)00088-5; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hou YQ, 2015, EXP BIOL MED, V240, P997, DOI 10.1177/1535370215587913; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Imamura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0511; Jayasena DD, 2013, ASIAN AUSTRAL J ANIM, V26, P732, DOI 10.5713/ajas.2012.12619; KATO H, 1989, ACS SYM SER, V388, P158; Kim NK, 2010, MAMM GENOME, V21, P307, DOI 10.1007/s00335-010-9264-8; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kimball SR, 2002, AM J PHYSIOL-ENDOC M, V282, pE585, DOI 10.1152/ajpendo.00269.2001; Kong XF, 2009, LIVEST SCI, V123, P261, DOI 10.1016/j.livsci.2008.11.015; Kong XF, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.113977; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liu YY, 2015, BRIT J NUTR, V113, P1069, DOI 10.1017/S0007114514004310; Matsakas A, 2009, HISTOL HISTOPATHOL, V24, P611, DOI 10.14670/HH-24.611; Maughan C, 2012, MEAT SCI, V90, P116, DOI 10.1016/j.meatsci.2011.06.006; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Ministry of Agriculture of the People's Republic of China, 2004, 652004 GB NYT MIN AG; Miretti S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-194; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Murgiano L, 2010, J PROTEOME RES, V9, P6450, DOI 10.1021/pr100693h; Newton AE, 2012, FOOD FUNCT, V3, P1231, DOI 10.1039/c2fo30089c; NRC, 2012, NUTRIENT REQUIREMENT; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Phang JM, 2013, EPIGENETICS-US, V8, P231, DOI 10.4161/epi.24042; Sato T, 2013, J NUTR SCI VITAMINOL, V59, P412, DOI 10.3177/jnsv.59.412; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Suryawan A, 2011, FRONT BIOSCI-LANDMRK, V16, P1445, DOI 10.2741/3798; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Wang J, 2015, J ANIM SCI; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032537; Wood WM, 2013, DEV BIOL, V384, P114, DOI 10.1016/j.ydbio.2013.09.012; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Wu X, 2012, J ANIM SCI, V90, P337, DOI 10.2527/jas.53752; Wu X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-63; Xin W, 2013, BIOL TRACE ELEM RES, V153, P191, DOI 10.1007/s12011-013-9668-x; Xu YJ, 2009, J ANIM SCI, V87, P2519, DOI 10.2527/jas.2008-1708; Yang CB, 2005, J SCI FOOD AGR, V85, P1947, DOI 10.1002/jsfa.2123; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Yi D, 2015, AMINO ACIDS, V47, P65, DOI 10.1007/s00726-014-1842-8; Yin FG, 2009, AMINO ACIDS, V37, P263, DOI 10.1007/s00726-008-0142-6; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2010, J FOOD AGRIC ENVIRON, V8, P447; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yu AN, 2012, FOOD CHEM, V132, P1316, DOI 10.1016/j.foodchem.2011.11.111; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhang SH, 2014, AMINO ACIDS, V46, P2633, DOI 10.1007/s00726-014-1809-9; Zhao X, 2011, PLOS ONE, V6, P18; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	72	21	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138277	10.1371/journal.pone.0138277	http://dx.doi.org/10.1371/journal.pone.0138277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394157	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100047
J	Stratilo, CW; Crichton, MKF; Sawyer, TW				Stratilo, Chad W.; Crichton, Melissa K. F.; Sawyer, Thomas W.			Decontamination Efficacy and Skin Toxicity of Two Decontaminants against Bacillus anthracis	PLOS ONE			English	Article							CHLORINE DIOXIDE; BACTERIAL-SPORES; HYPOCHLORITE; SURROGATE; MECHANISMS; SUBTILIS; SURFACE; CEREUS; ACID	Decontamination of bacterial endospores such as Bacillus anthracis has traditionally required the use of harsh or caustic chemicals. The aim of this study was to evaluate the efficacy of a chlorine dioxide decontaminant in killing Bacillus anthracis spores in solution and on a human skin simulant (porcine cadaver skin), compared to that of commonly used sodium hypochlorite or soapy water decontamination procedures. In addition, the relative toxicities of these decontaminants were compared in human skin keratinocyte primary cultures. The chlorine dioxide decontaminant was similarly effective to sodium hypochlorite in reducing spore numbers of Bacillus anthracis Ames in liquid suspension after a 10 minute exposure. After five minutes, the chlorine dioxide product was significantly more efficacious. Decontamination of isolated swine skin contaminated with Bacillus anthracis Sterne with the chlorine dioxide product resulted in no viable spores sampled. The toxicity of the chlorine dioxide decontaminant was up to two orders of magnitude less than that of sodium hypochlorite in human skin keratinocyte cultures. In summary, the chlorine dioxide based decontaminant efficiently killed Bacillus anthracis spores in liquid suspension, as well as on isolated swine skin, and was less toxic than sodium hypochlorite in cultures of human skin keratinocytes.	[Stratilo, Chad W.; Crichton, Melissa K. F.] Def Res & Dev Canada, Suffield Res Ctr, Biol Threat Def Sect, Medicine Hat, AB, Canada; [Sawyer, Thomas W.] Def Res & Dev Canada, Suffield Res Ctr, Casualty Management Sect, Medicine Hat, AB, Canada	Defence Research & Development Canada; Defence Research & Development Canada	Stratilo, CW (corresponding author), Def Res & Dev Canada, Suffield Res Ctr, Biol Threat Def Sect, Medicine Hat, AB, Canada.	chad.stratilo@drdc-rddc.gc.ca						Amlot R, 2010, PREHOSP DISASTER MED, V25, P435, DOI 10.1017/S1049023X00008529; BENARDE MA, 1965, APPL MICROBIOL, V13, P776, DOI 10.1128/AEM.13.5.776-780.1965; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Cha C-N, 2012, J FD HYG SAFETY, V27, P50; Coleman WH, 2007, J BACTERIOL, V189, P8458, DOI 10.1128/JB.01242-07; Greenberg David L, 2010, Investig Genet, V1, P4, DOI 10.1186/2041-2223-1-4; Guan JW, 2013, CAN J VET RES, V77, P100; HEGGERS J P, 1991, Journal of Burn Care and Rehabilitation, V12, P420, DOI 10.1097/00004630-199109000-00005; Hemmer JD, 2007, J BIOMED MATER RES B, V80B, P511, DOI 10.1002/jbm.b.30625; Heninger Sara J, 2009, Appl Biosaf, V14, P7; Hidalgo E, 2002, CHEM-BIOL INTERACT, V139, P265, DOI 10.1016/S0009-2797(02)00003-0; Hurst C.G., 1997, MED ASPECTS CHEM BIO, P351; Kim H, 2008, FOOD MICROBIOL, V25, P964, DOI 10.1016/j.fm.2008.05.008; Kreske AC, 2006, J FOOD PROTECT, V69, P1892, DOI 10.4315/0362-028X-69.8.1892; Lake W, 2013, 210105424 APG MD US, VI; Lake W, 2013, 210105424 APG MD US, VII; Levitin Howard W, 2003, Prehosp Disaster Med, V18, P200; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Maillard JY, 2011, J HOSP INFECT, V77, P204, DOI 10.1016/j.jhin.2010.06.028; Majcher MR, 2008, APPL ENVIRON MICROB, V74, P676, DOI 10.1128/AEM.01715-07; March JK, 2012, MICROBIOLOGYOPEN, V1, P407, DOI 10.1002/mbo3.45; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Nelson P, 2006, TOXICOLOGY, V222, P8, DOI 10.1016/j.tox.2005.12.026; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Noszticzius Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079157; OSUNA DJ, 1990, VET SURG, V19, P20, DOI 10.1111/j.1532-950X.1990.tb01137.x; Perez J, 2005, AM J INFECT CONTROL, V33, P320, DOI 10.1016/j.ajic.2005.04.240; Rose LJ, 2005, APPL ENVIRON MICROB, V71, P566, DOI 10.1128/AEM.71.1.566-568.2005; RUSSELL AD, 1990, CLIN MICROBIOL REV, V3, P99, DOI 10.1128/CMR.3.2.99-119.1990; Rutala WA, 1997, CLIN MICROBIOL REV, V10, P597, DOI 10.1128/CMR.10.4.597; Schmitt K, 2012, BIOSECUR BIOTERROR, V10, P98, DOI 10.1089/bsp.2010.0053; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tanner RS, 1989, J IN DMICROBIOL, V4; Tomasino SF, 2008, J AOAC INT, V91, P833; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274; Whitney EAS, 2003, EMERG INFECT DIS, V9, P623; YANG YC, 1992, CHEM REV, V92, P1729, DOI 10.1021/cr00016a003; Young SB, 2003, J APPL MICROBIOL, V95, P54, DOI 10.1046/j.1365-2672.2003.01960.x	38	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138491	10.1371/journal.pone.0138491	http://dx.doi.org/10.1371/journal.pone.0138491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394165	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100065
J	Antony, P; Vijayan, R				Antony, Priya; Vijayan, Ranjit			Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study	PLOS ONE			English	Article							OXIDATIVE STRESS; POLYOL PATHWAY; DRUG DISCOVERY; ABNORMALITIES; COMPLEX; DESIGN; TARGET; GLIDE	Hyperglycemia in diabetic patients results in a diverse range of complications such as diabetic retinopathy, neuropathy, nephropathy and cardiovascular diseases. The role of aldose reductase (AR), the key enzyme in the polyol pathway, in these complications is well established. Due to notable side-effects of several drugs, phytochemicals as an alternative has gained considerable importance for the treatment of several ailments. In order to evaluate the inhibitory effects of dietary spices on AR, a collection of phytochemicals were identified from Zingiber officinale (ginger), Curcuma longa (turmeric) Allium sativum (garlic) and Trigonella foenum graecum (fenugreek). Molecular docking was performed for lead identification and molecular dynamics simulations were performed to study the dynamic behaviour of these protein-ligand interactions. Gingerenones A, B and C, lariciresinol, quercetin and calebin A from these spices exhibited high docking score, binding affinity and sustained protein-ligand interactions. Rescoring of protein ligand interactions at the end of MD simulations produced binding scores that were better than the initially docked conformations. Docking results, ligand interactions and ADMET properties of these molecules were significantly better than commercially available AR inhibitors like epalrestat, sorbinil and ranirestat. Thus, these natural molecules could be potent AR inhibitors.	[Antony, Priya; Vijayan, Ranjit] United Arab Emirates Univ, Coll Sci, Dept Biol, Abu Dhabi, U Arab Emirates	United Arab Emirates University	Vijayan, R (corresponding author), United Arab Emirates Univ, Coll Sci, Dept Biol, POB 15551, Abu Dhabi, U Arab Emirates.	ranjit.v@uaeu.ac.ae	Vijayan, Ranjit/GXF-4345-2022; Vijayan, Ranjit/AAH-6015-2019	Vijayan, Ranjit/0000-0002-3830-7409; Vijayan, Ranjit/0000-0002-3830-7409	United Arab Emirates University-National Research Foundation grant	United Arab Emirates University-National Research Foundation grant	This study was funded by a United Arab Emirates University-National Research Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari AT, 2007, FOOD CHEM, V101, P148, DOI 10.1016/j.foodchem.2006.01.013; Al-Qattan K, 2008, E SPEN, V3, P62; [Anonymous], 2014, J COMPUT AIDED MOL D; [Anonymous], 2014, PRIM VERS 3 8; [Anonymous], 2014, DESM MOL DYN SYST VE; [Anonymous], 2014, QIKPROP VERS 4 3; [Anonymous], 2014, LIGPREP VERS 3 2; [Anonymous], 2014, GLID VERS 6 5; Arun N, 2002, PLANT FOOD HUM NUTR, V57, P41, DOI 10.1023/A:1013106527829; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; El-Kabbani O, 2003, PROTEINS, V50, P230, DOI 10.1002/prot.10278; ENDO K, 1990, PHYTOCHEMISTRY, V29, P797, DOI 10.1016/0031-9422(90)80021-8; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fanfrlik J, 2013, ACS CHEM BIOL, V8, P2484, DOI 10.1021/cb400526n; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; HAMADA Y, 1991, DIABETES, V40, P1233, DOI 10.2337/diabetes.40.10.1233; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; International Diabetes Federation, 2014, IDF DIABETES ATLAS; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; KINOSHITA JH, 1981, JAMA-J AM MED ASSOC, V246, P257, DOI 10.1001/jama.246.3.257; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kochhar K P, 2008, Indian J Physiol Pharmacol, V52, P106; Koukoulitsa C, 2006, BIOORGAN MED CHEM, V14, P1653, DOI 10.1016/j.bmc.2005.10.013; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Naeem S., 2013, J APPL PHARM SCI, V3, P13; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Padiya R, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-53; Patel DK, 2012, CHIN J NAT MEDICINES, V10, P388, DOI 10.1016/S1875-5364(12)60078-8; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Podjarny AD, COMPLEX ALDOSE REDUC, DOI [http://dx.doi.org/10.2210/pdb4gca/pdb, DOI 10.2210/PDB4GCA/PDB]; Preet A, 2006, MOL CELL BIOCHEM, V289, P137, DOI 10.1007/s11010-006-9156-0; Rahmani Arshad H, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P125; Ramirez MA, 2008, PHARMACOTHERAPY, V28, P646, DOI 10.1592/phco.28.5.646; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; Samir Malhotra, 2003, Natural Product Radiance, V2, P296; Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Stefek M, 2015, J MED CHEM, V58, P2649, DOI 10.1021/jm5015814; Sun W, 2006, DIABETES, V55, P2757, DOI 10.2337/db06-0138; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; TARLE I, 1993, J BIOL CHEM, V268, P25687; Tavafi Majid, 2013, J Nephropathol, V2, P20, DOI 10.5812/nephropathol.9093; Thomson M., 2007, INT J DIABETES METAB, V15, P108, DOI DOI 10.1186/S12906-016-0992-5; Trueblood N, 1998, AM J PHYSIOL-HEART C, V275, pH75, DOI 10.1152/ajpheart.1998.275.1.H75; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Vasudevan Dinakaran, 2012, Journal of Medicinal Plants Research, V6, P5119; Wang L, 2013, J CHEM INF MODEL, V53, P2409, DOI 10.1021/ci400322j; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Yabe-Nishimura C, 1998, PHARMACOL REV, V50, P21; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077; Zhang LM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623753; Zhu C., 2013, ALDOSE REDUCTASE INH	67	28	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138186	10.1371/journal.pone.0138186	http://dx.doi.org/10.1371/journal.pone.0138186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384019	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200067
J	Cabral, KMS; Raymundo, DP; Silva, VS; Sampaio, LAG; Johanson, L; Hill, LF; Almeida, FCL; Cordeiro, Y; Almeida, MS				Cabral, Katia M. S.; Raymundo, Diana P.; Silva, Viviane S.; Sampaio, Laura A. G.; Johanson, Laizes; Hill, Luis Fernando; Almeida, Fabio C. L.; Cordeiro, Yraima; Almeida, Marcius S.			Biophysical Studies on BEX3, the p75(NTR)-Associated Cell Death Executor, Reveal a High-Order Oligomer with Partially Folded Regions	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; P75 NEUROTROPHIN RECEPTOR; MODEL-FREE APPROACH; SECONDARY STRUCTURE; BACKBONE DYNAMICS; ALPHA-SYNUCLEIN; PROTEIN; NMR; NADE; N-15	BEX3 (Brain Expressed X-linked protein 3) is a member of a mammal-specific placental protein family. Several studies have found the BEX proteins to be associated with neurodegeneration, the cell cycle and cancer. BEX3 has been predicted to be intrinsically disordered and also to represent an intracellular hub for cell signaling. The pro-apoptotic activity of BEX3 in association with a number of additional proteins has been widely supported; however, to the best of our knowledge, very limited data are available on the conformation of any of the members of the BEX family. In this study, we structurally characterized BEX3 using biophysical experimental data. Small angle X-ray scattering and atomic force microscopy revealed that BEX3 forms a specific higher-order oligomer that is consistent with a globular molecule. Solution nuclear magnetic resonance, partial proteinase K digestion, circular dichroism spectroscopy, and fluorescence techniques that were performed on the recombinant protein indicated that the structure of BEX3 is composed of approximately 31% a-helix and 20% beta-strand, contains partially folded regions near the N- and C-termini, and a core which is proteolysis-resistant around residues 55-120. The self-oligomerization of BEX3 has been previously reported in cell culture and is consistent with our in vitro data.	[Cabral, Katia M. S.; Raymundo, Diana P.; Silva, Viviane S.; Sampaio, Laura A. G.; Johanson, Laizes; Almeida, Fabio C. L.; Almeida, Marcius S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil; [Hill, Luis Fernando] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil; [Almeida, Fabio C. L.; Almeida, Marcius S.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Almeida, MS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.	msalmeida@bioqmed.ufrj.br	Cordeiro, Yraima/J-7619-2012; Almeida, Fabio/O-4989-2018	Cordeiro, Yraima/0000-0003-4278-212X; Almeida, Fabio/0000-0001-6046-7006; almeida, marcius/0000-0003-4921-8185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Universal CNPq 470349/2012-3]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [APQ1/E-26/111.771/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal CNPq 470349/2012-3, http://www.cnpq.br); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (APQ1/E-26/111.771/2012, www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; BOYD J, 1990, CHEM PHYS LETT, V175, P477, DOI 10.1016/0009-2614(90)85567-V; Canaves JM, 1998, J BIOL CHEM, V273, P34214, DOI 10.1074/jbc.273.51.34214; Chen Y, 2009, J INT MED RES, V37, P281, DOI 10.1177/147323000903700201; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; Erickson HP, 2000, BIOL PROCEDURES ONLI, V11, P32; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117206; Gaczynska M, 2008, CURR OPIN COLLOID IN, V13, P351, DOI 10.1016/j.cocis.2008.01.004; Glatter O., 1982, SMALL ANGLE X RAY SC; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guinier A., 1955, SMALL ANGLE SCATTERI, P268; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031; Kimura MT, 2001, J BIOL CHEM, V276, P17291, DOI 10.1074/jbc.M005453200; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MCDONALD CC, 1967, J AM CHEM SOC, V89, P6332, DOI 10.1021/ja01000a061; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Muka J, 2003, VITAM HORM, V66, P385, DOI 10.1016/S0083-6729(03)01011-2; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Park JA, 2000, J NEUROSCI, V20, P9096; Parkhurst CN, 2010, J BIOL CHEM, V285, P5361, DOI 10.1074/jbc.M109.045054; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; Snyder DA, 2005, J AM CHEM SOC, V127, P16505, DOI 10.1021/ja053564h; Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Themistou E, 2009, BIOPHYS J, V97, P2567, DOI 10.1016/j.bpj.2009.08.023; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tong XJ, 2003, INT J ONCOL, V22, P1357; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wall J, 1999, METHOD ENZYMOL, V309, P204; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yasui S, 2007, MOL CELL NEUROSCI, V35, P100, DOI 10.1016/j.mcn.2007.02.007; Yi JS, 2003, NEUROSCI LETT, V347, P126, DOI 10.1016/S0304-3940(03)00656-6; Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043; Yu Y, 2006, BRAIN RES, V1100, P13, DOI 10.1016/j.brainres.2006.05.010; Zhang MJ, 1998, BIOCHEM BIOPH RES CO, V243, P113, DOI 10.1006/bbrc.1997.8070; Zhang Y.Z., 1995, THESIS U PENNSYLVANI; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137916	10.1371/journal.pone.0137916	http://dx.doi.org/10.1371/journal.pone.0137916			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383250	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200044
J	Camhi, SM; Crouter, SE; Hayman, LL; Must, A; Lichtenstein, AH				Camhi, Sarah M.; Crouter, Scott E.; Hayman, Laura L.; Must, Aviva; Lichtenstein, Alice H.			Lifestyle Behaviors in Metabolically Healthy and Unhealthy Overweight and Obese Women: A Preliminary Study	PLOS ONE			English	Article							INTENSITY PHYSICAL-ACTIVITY; 2-REGRESSION MODEL; NORMAL-WEIGHT; RISK-FACTORS; PHENOTYPES; QUESTIONNAIRE; VALIDITY; PROFILE; RECALL; LEVEL	Background Few studies have examined dietary data or objective measures of physical activity (PA) and sedentary behavior among metabolically healthy overweight/obese (MHO) and metabolically unhealthy overweight/obese (MUO). Thus, the purpose is to determine whether PA, sedentary behavior and/or diet differ between MHO and MUO in a sample of young women. Methods Forty-six overweight/obese (BMI >= 25 kg/m(2)) African American and Caucasian women 1935 years were classified by cardiometabolic risk factors, including elevated blood pressure, triglyceride, glucose and C-reactive protein, low high density lipoprotein, and insulin resistance (MUO >= 2; MHO, < 2). Time (mins/day) in light, moderate, vigorous PA, and sedentary behavior were estimated using an accelerometer (>= 3 days; >= 8 hrs wear time). Questionnaires were used to quantify sitting time, TV/computer use and usual daily activity. The Block Food Frequency Questionnaire assessed dietary food intake. Differences between MHO and MUO for lifestyle behaviors were tested with linear regression (continuous data) or logistic regression (categorical data) after adjusting for age, race, BMI, smoking and accelerometer wear and/or total kilocalories, as appropriate. Results Women were 26.7+/-4.7 years, with a mean BMI of 31.1+/-3.7 kg/m(2), and 61% were African American. Compared to MUO (n = 9), MHO (n = 37; 80%) spent less mins/day in sedentary behavior (difference: -58.1+/-25.5, p = 0.02), more mins/day in light PA (difference: 38.2+/-16.1, p = 0.02), and had higher daily METs (difference: 0.21+/-0.09, p = 0.03). MHO had higher fiber intakes (g/day of total fiber, soluble fiber, fruit/vegetable fiber, bean fiber) and daily servings of vegetables; but lower daily dairy servings, saturated fat, monounsaturated fat and trans fats (g/day) compared to MUO. Conclusion Compared to MUO, MHO young women demonstrate healthier lifestyle habits with less sedentary behavior, more time in light PA, and healthier dietary quality for fat type and fiber. Future studies are needed to replicate findings with larger samples that include men and women of diverse race/ethnic groups.	[Camhi, Sarah M.] Univ Massachusetts, Exercise & Hlth Sci Dept, Boston, MA 02125 USA; [Crouter, Scott E.] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Hayman, Laura L.] Univ Massachusetts, Off Vice Provost Res, Boston, MA 02125 USA; [Must, Aviva] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Lichtenstein, Alice H.] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	University of Massachusetts System; University of Massachusetts Boston; University of Tennessee System; University of Tennessee Knoxville; University of Massachusetts System; University of Massachusetts Boston; Massachusetts Department of Public Health; Tufts University; Tufts University; United States Department of Agriculture (USDA)	Camhi, SM (corresponding author), Univ Massachusetts, Exercise & Hlth Sci Dept, Harbor Campus, Boston, MA 02125 USA.	sarah.camhi@umb.edu	Crouter, Scott/H-4852-2011	Crouter, Scott/0000-0003-1297-9538	University of Massachusetts Boston Proposal Development Grant; Boston Nutrition Obesity Research Center [DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	University of Massachusetts Boston Proposal Development Grant; Boston Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support was provided by the University of Massachusetts Boston Proposal Development Grant (no grant number available) and the Boston Nutrition Obesity Research Center DK46200.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; [Anonymous], 2012, NHANES QUEST DAT REL; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Bailey RK, 2013, J NATL MED ASSOC, V105, P112, DOI 10.1016/S0027-9684(15)30113-9; Bell JA, 2014, PREV MED, V62, P35, DOI 10.1016/j.ypmed.2014.01.028; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Camhi SM, 2015, PREV MED, V77, P23, DOI 10.1016/j.ypmed.2015.04.023; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crouter SE, 2013, J PHYS ACT HEALTH, V10, P504, DOI 10.1123/jpah.10.4.504; Crouter SE, 2010, MED SCI SPORT EXER, V42, P1029, DOI 10.1249/MSS.0b013e3181c37458; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Hankinson AL, 2013, OBESITY, V21, P637, DOI 10.1002/oby.20257; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kumanyika S K, 1994, Obes Res, V2, P166; KUMANYIKA SK, 1993, ANN INTERN MED, V119, P650, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00005; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Leenders M, 2014, EUR J EPIDEMIOL, V29, P639, DOI 10.1007/s10654-014-9945-9; Li SX, 2012, AM J EPIDEMIOL, V176, pS142, DOI 10.1093/aje/kws236; Matthews CE, 2005, MED SCI SPORTS EXERC, V37; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Sarvottam K, 2013, J ALTERN COMPLEM MED, V19, P397, DOI 10.1089/acm.2012.0086; Sarwer DB, 2009, CURR OPIN ENDOCRINOL, V16, P347, DOI 10.1097/MED.0b013e32832f5a79; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; van der A DL, 2014, OBESITY, V22, P557, DOI 10.1002/oby.20480; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Washburn RA, 2003, MED SCI SPORT EXER, V35, P1374, DOI 10.1249/01.MSS.0000079081.08476.EA; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wolff DL, 2014, J PHYS ACT HLTH	42	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138548	10.1371/journal.pone.0138548	http://dx.doi.org/10.1371/journal.pone.0138548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383251	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200124
J	Cao, HH; Ke, T; Liu, RH; Yu, JY; Dong, CH; Cheng, MX; Huang, JY; Liu, SY				Cao, Huihui; Ke, Tao; Liu, Renhu; Yu, Jingyin; Dong, Caihua; Cheng, Mingxing; Huang, Junyan; Liu, Shengyi			Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDES; DATABASE; MECHANISMS; EXPRESSION; PROTEINS; RANGE	Proline-rich antimicrobial peptides (PR-AMPs) are a group of cationic host defense peptides that are characterized by a high content of proline residues. Up to now, they have been reported in some insects, vertebrate and invertebrate animals, but are not found in plants. In this study, we performed an in silico screening of antimicrobial peptides, which led to discovery of a Brassica napus gene encoding a novel PR-AMP. This gene encodes a 35-amino acid peptide with 13 proline residues, designated BnPRP1. BnPRP1 has 40.5% identity with a known proline-rich antimicrobial peptide SP-B from the pig. BnPRP1 was artificially synthetized and cloned into the prokaryotic expression vector pET30a/His-EDDIE-GFP. Recombinant BnPRP1 was produced in Escherichia coli and has a predicted molecular mass of 3.8 kDa. Analysis of its activity demonstrated that BnPRP1 exhibited strong antimicrobial activity against Gram-positive bacterium, Gram-negative bacterium, yeast and also had strong antifungal activity against several pathogenic fungi, such as Sclerotinia sclerotiorum, Mucor sp., Magnaporthe oryzae and Botrytis cinerea. Circular dichroism (CD) revealed the main secondary structure of BnPRP1 was the random coil. BnPRP1 gene expression detected by qRT-PCR is responsive to pathogen inoculation. At 48 hours after S. sclerotiorum inoculation, the expression of BnPRP1 increased significantly in the susceptible lines while slight decrease occurred in resistant lines. These suggested that BnPRP1 might play a role in the plant defense response against S. sclerotiorum. BnPRP1 isolated from B. napus was the first PR-AMP member that was characterized in plants, and its homology sequences were found in some other Brassicaceae plants by the genome sequences analysis. Compared with the known PR-AMPs, BnPRP1 has the different primary sequences and antimicrobial activity. Above all, this study gives a chance to cast a new light on further understanding about the AMPs' mechanism and application.	[Cao, Huihui; Yu, Jingyin; Dong, Caihua; Cheng, Mingxing; Huang, Junyan; Liu, Shengyi] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China; [Ke, Tao] Nanyang Normal Univ, Dept Life Sci & Technol, Nanyang 473061, Peoples R China; [Dong, Caihua; Huang, Junyan; Liu, Shengyi] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Peoples R China; [Liu, Renhu] Zhejiang Acad Agr Sci, Hangzhou 310021, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanyang Normal College; Hubei University; Zhejiang Academy of Agricultural Sciences	Huang, JY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China.	huangjy@oilcrops.cn	Liu, Renhu/H-5168-2019; Liu, Shengyi/S-6772-2016	Liu, Shengyi/0000-0002-4955-4763	National Basic Research Program of China [2011CB109300]; National High Technology Research and Development Program of China [2013AA102602]; Special Fund for Agro-Scientific Research in Public Interest of China [201103016]; National Natural Science Foundation of China [31471536]; China Agriculture Research System [CARS-13]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-Scientific Research in Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This research was supported by National Basic Research Program of China (2011CB109300) to SL, National High Technology Research and Development Program of China (2013AA102602) to CD, Special Fund for Agro-Scientific Research in the Public Interest of China (201103016) to SL, National Natural Science Foundation of China (31471536) to SL and China Agriculture Research System (CARS-13) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodkin MJ, 1996, BIOPOLYMERS, V39, P43, DOI 10.1002/(SICI)1097-0282(199607)39:1<43::AID-BIP5>3.0.CO;2-V; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Brahmachary M, 2004, NUCLEIC ACIDS RES, V32, pD586, DOI 10.1093/nar/gkh032; Bulet P, 1999, M S-MED SCI, V15, P23, DOI 10.4267/10608/1192; Cabras T, 2008, J PEPT SCI, V14, P251, DOI 10.1002/psc.914; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; Chakchouk-Mtibaa A, 2014, ANAEROBE, V27, P1, DOI 10.1016/j.anaerobe.2014.02.002; Chamorro C, 2012, BBA-BIOMEMBRANES, V1818, P2171, DOI 10.1016/j.bbamem.2012.04.004; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Destoumieux D, 1999, EUR J BIOCHEM, V266, P335, DOI 10.1046/j.1432-1327.1999.00855.x; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Gennaro R, 2002, CURR PHARM DESIGN, V8, P763, DOI 10.2174/1381612023395394; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235; Ke T, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-10; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li JX, 2006, LIFE SCI, V78, P1953, DOI 10.1016/j.lfs.2005.08.034; Liu Ying, 1999, Weishengwu Xuebao, V39, P441; Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026; Nawrot R, 2014, FOLIA MICROBIOL, V59, P181, DOI 10.1007/s12223-013-0280-4; Otvos L, 2000, J PEPT SCI, V6, P497; Otvos L, 2002, CELL MOL LIFE SCI, V59, P1138, DOI 10.1007/s00018-002-8493-8; Padovan L, 2010, CURR PROTEIN PEPT SC, V11, P210, DOI 10.2174/138920310791112093; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Rees JA, 1997, INSECT BIOCHEM MOLEC, V27, P413, DOI 10.1016/S0965-1748(97)00013-1; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wessely-Szponder J, 2010, J MICROBIOL METH, V83, P8, DOI 10.1016/j.mimet.2010.07.010; Wu GQ, 2011, PEPTIDES, V32, P1139, DOI 10.1016/j.peptides.2011.03.019	36	21	22	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137414	10.1371/journal.pone.0137414	http://dx.doi.org/10.1371/journal.pone.0137414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383098	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200023
J	Li, P; Wu, YH; Li, MX; Qiu, XJ; Bai, XY; Zhao, XJ				Li, Ping; Wu, Yonghong; Li, Manxiang; Qiu, Xiaojuan; Bai, Xiaoyan; Zhao, Xiaojing			AS-703026 Inhibits LPS-Induced TNFa Production through MEK/ERK Dependent and Independent Mechanisms	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR (TNF)-ALPHA PRODUCTION; COPD PATIENTS; IN-VIVO; IMMUNOLOGICAL ASPECTS; MEK1/2 INHIBITOR; ALPHA; LIPOPOLYSACCHARIDE; AS703026; PROTEIN	Chronic obstructive pulmonary disease (COPD) is characterized by intense lung infiltrations of immune cells (macrophages and monocytes). Lipopolysaccharide (LPS) activates macrophages/monocytes, leading to production of tumor necrosis factor a (TNF alpha) and other cytokines, which cause subsequent lung damages. In the current study, our results demonstrated that AS-703026, a novel MEK/ERK inhibitor, suppressed LPS-induced TNF alpha mRNA expression and protein secretion in RAW 264.7 murine macrophages, and in murine bone marrow-derived macrophages (BMDMs). Meanwhile, TNF alpha production in LPS-stimulated COPD patents' peripheral blood mononuclear cells (PBMCs) was also repressed by AS-703026. At the molecular level, we showed that AS-703026 blocked LPS-induced MEK/ERK activation in above macrophages/monocytes. However, restoring ERK activation in AS-703026-treated RAW 264.7 cells by introducing a constitutive-actively (CA)-ERK1 only partially reinstated LPS-mediated TNF alpha production. Meanwhile, AS-703026 could still inhibit TNF alpha response in ERK1/2-depleted (by shRNA) RAW 264.7 cells. Significantly, we found that AS-703026 inhibited LPS-induced nuclear factor kappa B (NF kappa B) activation in above macrophages and COPD patients' PBMCs. In vivo, oral administration of AS-703026 inhibited LPS-induced TNF alpha production and endotoxin shock in BALB/c mice. Together, we show that AS-703026 in vitro inhibits LPS-induced TNF alpha production in macrophages/monocytes, and in vivo protects mice from LPS-induced endotoxin shock. Thus, it could be further studied as a useful anti-inflammatory therapy for COPD patients.	[Li, Ping; Qiu, Xiaojuan; Bai, Xiaoyan; Zhao, Xiaojing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Emergency, Xian 710049, Peoples R China; [Wu, Yonghong] Xian Med Univ, Dept Clin Immunol & Pathogen Examinat, Xian, Peoples R China; [Li, Manxiang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Zhao, XJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Emergency, Xian 710049, Peoples R China.	Zhao_xiandr@163.com			Natural Science Foundation of Xian	Natural Science Foundation of Xian	This study is supported by the Natural Science Foundation of Xian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Brusasco V, 2014, COMPR PHYSIOL, V4, P1, DOI 10.1002/cphy.c110037; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Du SL, 2015, BIOCHEM BIOPH RES CO, V458, P667, DOI 10.1016/j.bbrc.2015.01.160; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; Lamela J, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc091370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Ouagued M, 2005, PULM PHARMACOL THER, V18, P49, DOI 10.1016/j.pupt.2004.09.031; Park SJ, 2013, AM J MED SCI, V346, P494, DOI 10.1097/MAJ.0b013e318298a185; Profita M, 2003, THORAX, V58, P573, DOI 10.1136/thorax.58.7.573; Rabinovich RA, 2003, EUR RESPIR J, V21, P789, DOI 10.1183/09031936.03.00042702; Roversi S, 2014, EUR J CLIN INVEST, V44, P93, DOI 10.1111/eci.12181; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Zhang JL, 2014, INT J MOL SCI, V15, P12119, DOI 10.3390/ijms150712119	22	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137107	10.1371/journal.pone.0137107	http://dx.doi.org/10.1371/journal.pone.0137107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381508	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200014
J	Polla, DL; Cardoso, MTO; Silva, MCB; Cardoso, ICC; Medina, CTN; Araujo, R; Fernandes, CC; Reis, AMM; de Andrade, RV; Pereira, RW; Pogue, R				Polla, Daniel L.; Cardoso, Maria T. O.; Silva, Mayara C. B.; Cardoso, Isabela C. C.; Medina, Cristina T. N.; Araujo, Rosenelle; Fernandes, Camila C.; Reis, Alessandra M. M.; de Andrade, Rosangela V.; Pereira, Rinaldo W.; Pogue, Robert			Use of Targeted Exome Sequencing for Molecular Diagnosis of Skeletal Disorders	PLOS ONE			English	Article							IMPERFECTA TYPE-V; PHENOTYPIC VARIABILITY; CAMPOMELIC DYSPLASIA; GENETIC-VARIATIONS; MUTATIONS; DELETION; CAPTURE; MICRODELETION; LIBRARY; DISEASE	Genetic disorders of the skeleton comprise a large group of more than 450 clinically distinct and genetically heterogeneous diseases associated with mutations in more than 300 genes. Achieving a definitive diagnosis is complicated due to the genetic heterogeneity of these disorders, their individual rarity and their diverse radiographic presentations. We used targeted exome sequencing and designed a 1.4Mb panel for simultaneous testing of more than 4,800 exons in 309 genes involved in skeletal disorders. DNA from 69 individuals from 66 families with a known or suspected clinical diagnosis of a skeletal disorder was analyzed. Of 36 cases with a specific clinical hypothesis with a known genetic basis, mutations were identified for eight cases (22%). Of 20 cases with a suspected skeletal disorder but without a specific diagnosis, four causative mutations were identified. Also included were 11 cases with a specific skeletal disorder but for which there was at the time no known associated gene. For these cases, one mutation was identified in a known skeletal disease genes, and re-evaluation of the clinical phenotype in this case changed the diagnoses from osteodys-plasia syndrome to Apert syndrome. These results suggest that the NGS panel provides a fast, accurate and cost-effective molecular diagnostic tool for identifying mutations in a highly genetically heterogeneous set of disorders such as genetic skeletal disorders. The data also stress the importance of a thorough clinical evaluation before DNA sequencing. The strategy should be applicable to other groups of disorders in which the molecular basis is largely known.	[Polla, Daniel L.; Silva, Mayara C. B.; Cardoso, Isabela C. C.; Reis, Alessandra M. M.; de Andrade, Rosangela V.; Pereira, Rinaldo W.; Pogue, Robert] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Cardoso, Maria T. O.; Medina, Cristina T. N.; Araujo, Rosenelle] Nucleo Genet Secretaria Saude Dist Fed, Brasilia, DF, Brazil; [Cardoso, Maria T. O.] Univ Catolica Brasilia, Curso Med, Taguatinga, DF, Brazil; [Fernandes, Camila C.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Lab Multiusuario Centralizado Sequenciamento DNA, Jaboticabal, SP, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Universidade Estadual Paulista	Pogue, R (corresponding author), Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil.	redward@ucb.br	Polla, Daniel L./B-3887-2015; Pogue, Robert/C-3860-2016; Pereira, Rinaldo W/B-9255-2011	Polla, Daniel L./0000-0002-5552-3488; Pogue, Robert/0000-0002-8789-3512; Pereira, Rinaldo W/0000-0003-3704-2848; Cardoso, Isabela/0000-0003-4494-5287; Batista da Silva, Mayara Cristina/0000-0002-0192-6767	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [564537/2010-1]; Fundacao de Apoio a Pesquisa do Distrito Federal [19300 487/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RP-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-564537/2010-1-http://www.cnpq.br/. RP-Fundacao de Apoio a Pesquisa do Distrito Federal-19300 487/2011-http://www.fap.df.gov.br/. RP DLP-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2003, AM J MED GENET A, V117A, P295, DOI 10.1002/ajmg.a.10915; Alanay Y, 2011, J CLIN RES PEDIATR E, V3, P163, DOI 10.4274/jcrpe.463; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarado DM, 2010, AM J HUM GENET, V87, P154, DOI 10.1016/j.ajhg.2010.06.010; Balemans W, 2005, BONE, V36, P943, DOI 10.1016/j.bone.2005.02.019; Barroso E, 2010, EUR J MED GENET, V53, P204, DOI 10.1016/j.ejmg.2010.04.003; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bedoyan JK, 2011, AM J MED GENET A, V155A, P154, DOI 10.1002/ajmg.a.33751; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Bleyl SB, 2007, AM J MED GENET A, V143A, P2785, DOI 10.1002/ajmg.a.32036; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Brett M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093409; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Carmichael H, 2013, CLIN GENET, V84, P213, DOI 10.1111/cge.12064; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Eggermann T, 2012, CLIN GENET, V81, P298, DOI 10.1111/j.1399-0004.2011.01719.x; Fattahi Z, 2014, J HUM GENET, V59, P368, DOI 10.1038/jhg.2014.28; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Grover CE, 2012, AM J BOT, V99, P312, DOI 10.3732/ajb.1100323; Hannes F, 2012, AM J MED GENET A, V158A, P996, DOI 10.1002/ajmg.a.35299; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hilton MJ, 2002, J HUM GENET, V47, P103, DOI 10.1007/s100380200010; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Isidor B, 2010, AM J HUM GENET, V87, P95, DOI 10.1016/j.ajhg.2010.05.012; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kannu P, 2006, AM J MED GENET A, V140A, P1955, DOI 10.1002/ajmg.a.31411; Kinning E, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033829; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Klopocki E, 2010, AM J HUM GENET, V86, P434, DOI 10.1016/j.ajhg.2010.01.023; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Laurell T, 2012, HUM MUTAT, V33, P1063, DOI 10.1002/humu.22097; Lecointre C, 2009, AM J MED GENET A, V149A, P1183, DOI 10.1002/ajmg.a.32830; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Linden H, 2009, AM J MED GENET A, V149A, P2809, DOI 10.1002/ajmg.a.33096; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lynch SA, 2011, EUR J HUM GENET, V19, P534, DOI 10.1038/ejhg.2010.215; Makitie O, 2011, ENDOCR DEV, V21, P78, DOI 10.1159/000328131; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Millat G, 2014, MOL DIAGN THER, V18, P533, DOI 10.1007/s40291-014-0099-y; Millat G, 2014, CLIN CHIM ACTA, V433, P266, DOI 10.1016/j.cca.2014.03.032; Mook ORF, 2013, J MED GENET, V50, P614, DOI 10.1136/jmedgenet-2012-101231; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nigro Vincenzo, 2012, Acta Myol, V31, P196; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pauli RM, 1993, ACHONDROPLASIA; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qi XP, 2013, GENE, V516, P93, DOI 10.1016/j.gene.2012.12.060; Rauch F, 2013, J MED GENET, V50, P21, DOI 10.1136/jmedgenet-2012-101307; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimoin DL, 2007, ANN NY ACAD SCI, V1117, P302, DOI 10.1196/annals.1402.072; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; Sanlaville D, 2005, EUR J HUM GENET, V13, P690, DOI 10.1038/sj.ejhg.5201383; Sarig O, 2012, AM J HUM GENET, V91, P337, DOI 10.1016/j.ajhg.2012.06.003; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schwartz CE, 2000, EUR J HUM GENET, V8, P869, DOI 10.1038/sj.ejhg.5200553; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shaheen R, 2012, AM J HUM GENET, V91, P330, DOI 10.1016/j.ajhg.2012.05.025; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Skuse GR, 1997, HUM MOL GENET, V6, P1707, DOI 10.1093/hmg/6.10.1707; Smyk M, 2007, AM J MED GENET A, V143A, P866, DOI 10.1002/ajmg.a.31631; South ST, 2008, AM J MED GENET A, V146A, P2691, DOI 10.1002/ajmg.a.32516; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Steichen-Gersdorf E, 2008, CLIN GENET, V74, P560, DOI 10.1111/j.1399-0004.2008.01050.x; Stevenson RE, 2006, HUMAN MALFORMATIONS, pxiv; Sule G, 2013, OSTEOPOROSIS INT, V24, P2253, DOI 10.1007/s00198-013-2290-0; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Wooderchak-Donahue WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	107	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138314	10.1371/journal.pone.0138314	http://dx.doi.org/10.1371/journal.pone.0138314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380986	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200090
J	Tako, E; Reed, S; Anandaraman, A; Beebe, SE; Hart, JJ; Glahn, RP				Tako, Elad; Reed, Spenser; Anandaraman, Amrutha; Beebe, Steve E.; Hart, Jonathan J.; Glahn, Raymond P.			Studies of Cream Seeded Carioca Beans (Phaseolus vulgaris L.) from a Rwandan Efficacy Trial: In Vitro and In Vivo Screening Tools Reflect Human Studies and Predict Beneficial Results from Iron Biofortified Beans	PLOS ONE			English	Article							DIETARY POLYPHENOLIC COMPOUNDS; BIOAVAILABLE IRON; ASCORBIC-ACID; GALLUS-GALLUS; COMMON BEANS; ABSORPTION; RED; DEFICIENCY; PHYTATE; WOMEN	Iron (Fe) deficiency is a highly prevalent micronutrient insufficiency predominantly caused by a lack of bioavailable Fe from the diet. The consumption of beans as a major food crop in some populations suffering from Fe deficiency is relatively high. Therefore, our objective was to determine whether a biofortified variety of cream seeded carioca bean (Phaseolus vulgaris L.) could provide more bioavailable-Fe than a standard variety using in-vivo (broiler chicken, Gallus gallus) and in-vitro (Caco-2 cell) models. Studies were conducted under conditions designed to mimic the actual human feeding protocol. Two carioca-beans, a standard (G4825; 58 mu g Fe/g) and a biofortified (SMC; 106 mu g Fe/g), were utilized. Diets were formulated to meet the nutrient requirements of Gallus gallus except for Fe (33.7 and 48.7 mu g Fe/g, standard and biofortified diets, respectively). In-vitro observations indicated that more bioavailable- Fe was present in the biofortified beans and diet (P<0.05). In-vivo, improvements in Fe-status were observed in the biofortified bean treatment, as indicated by the increased total-body-Hemoglobin-Fe, and hepatic Fe-concentration (P<0.05). Also, DMT-1 mRNA-expression was increased in the standard bean treatment (P< 0.05), indicating an upregulation of absorption to compensate for less bioavailable-Fe. These results demonstrate that the biofortified beans provided more bioavailable Fe; however, the in vitro results revealed that ferritin formation values were relatively low. Such observations are indicative of the presence of high levels of polyphenols and phytate that inhibit Fe absorption. Indeed, we identified higher levels of phytate and quercetin 3-glucoside in the Fe biofortified bean variety. Our results indicate that the biofortified bean line was able to moderately improve Fe-status, and that concurrent increase in the concentration of phytate and polyphenols in beans may limit the benefit of increased Fe-concentration. Therefore, specific targeting of such compounds during the breeding process may yield improved dietary Fe-bioavailability. Our findings are in agreement with the human efficacy trial that demonstrated that the biofortified carioca beans improved the Fe-status of Rwandan women. We suggest the utilization of these in vitro and in vivo screening tools to guide studies aimed to develop and evaluate biofortified staple food crops. This approach has the potential to more effectively utilize research funds and provides a means to monitor the nutritional quality of the Fe-biofortified crops once released to farmers.	[Tako, Elad; Reed, Spenser; Hart, Jonathan J.; Glahn, Raymond P.] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Anandaraman, Amrutha] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Beebe, Steve E.] CIAT Int Ctr Trop Agr, Cali 6713, Colombia	Cornell University; United States Department of Agriculture (USDA); Cornell University; Alliance; International Center for Tropical Agriculture - CIAT	Tako, E (corresponding author), Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	et79@cornell.edu			ARS [ARS-0426380] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Beebe Stephen, 2000, Food and Nutrition Bulletin, V21, P387; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Blair MW, 2013, J AGR FOOD CHEM, V61, P8287, DOI 10.1021/jf400774y; Blair MW, 2012, THEOR APPL GENET, V125, P1015, DOI 10.1007/s00122-012-1891-x; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2010, J PLANT REGIST, V4, P55, DOI 10.3198/jpr2008.09.0562crg; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; BRUNE M, 1989, EUR J CLIN NUTR, V43, P547; BRUNE M, 1989, AM J CLIN NUTR, V49, P542, DOI 10.1093/ajcn/49.3.542; Cercamondi CI, 2014, BRIT J NUTR, V111, P481, DOI 10.1017/S0007114513002705; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Danquah I, 2014, TROP MED INT HEALTH, V19, P117, DOI 10.1111/tmi.12216; De Moura FF, 2014, ADV NUTR, V5, P568, DOI 10.3945/an.114.006627; Della Valle DM, 2014, FOOD NUTR BULL, V35, P431, DOI 10.1177/156482651403500405; DellaValle DM, 2013, J AGR FOOD CHEM, V61, P8084, DOI 10.1021/jf4022916; Fanzo J, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P76, DOI 10.1079/9781845937140.0076; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Glahn RP, 2002, J AGR FOOD CHEM, V50, P3586, DOI 10.1021/jf0116496; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haas J, 2014, FASEB J, V28; Hart J. J., 2013, FASEB J, V634, P13; Hart JJ, 2015, J AGR FOOD CHEM, V63, P5950, DOI 10.1021/acs.jafc.5b00531; Hu Y, 2006, J AGR FOOD CHEM, V54, P9254, DOI 10.1021/jf0612981; HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573; Kim EY, 2008, J NUTR, V138, P1647, DOI 10.1093/jn/138.9.1647; Kim E, 2011, J NUTR, V141, P828, DOI 10.3945/jn.110.134031; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Lesjak R, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102900, DOI 10.1371/J0URNAL.P0NE.0102900]; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Ma XY, 2014, POULTRY SCI, V93, P556, DOI 10.3382/ps.2013-03296; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Murgia I, 2012, TRENDS PLANT SCI, V17, P47, DOI 10.1016/j.tplants.2011.10.003; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989; Petry N, 2012, J NUTR, V142, P492, DOI 10.3945/jn.111.149286; Petry N, 2010, J NUTR, V140, P1977, DOI 10.3945/jn.110.125369; Reed S, 2014, NUTRIENTS, V6, P1164, DOI 10.3390/nu6031164; Ryan P, 2008, J INORG BIOCHEM, V102, P127, DOI 10.1016/j.jinorgbio.2007.07.041; Samman S, 2001, AM J CLIN NUTR, V73, P607; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Sharp PA, 2010, INT J VITAM NUTR RES, V80, P231, DOI 10.1024/0300-9831/a000029; Tako E., 2011, International Journal of Poultry Science, V10, P42; Tako E, 2010, POULTRY SCI, V89, P514, DOI 10.3382/ps.2009-00326; Tako E, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-11; Tako E, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-28; Tako E, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-113; Tako E, 2010, INT J VITAM NUTR RES, V80, P416, DOI 10.1024/0300-9831/a000028; Tako E, 2009, J AGR FOOD CHEM, V57, P3134, DOI 10.1021/jf803647m; Welch RM, 2000, J AGR FOOD CHEM, V48, P3576, DOI 10.1021/jf0000981; WHO, 2001, GUIDE PROGRAM MANAGE, P15; Wortmann C.S., 1998, ATLAS COMMON BEAN PH; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115	56	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138479	10.1371/journal.pone.0138479	http://dx.doi.org/10.1371/journal.pone.0138479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381264	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200112
J	Tsai, FM; Chen, ML; Wang, LK; Lee, MC				Tsai, Fu-Ming; Chen, Mao-Liang; Wang, Lu-Kai; Lee, Ming-Cheng			H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; FUNCTIONAL-CHARACTERIZATION; DOWN-REGULATION; GENE; CLONING; ACTIVATION; P450; METABOLISM; APOPTOSIS; ENZYMES	H-rev107 is a member of the HREV107 type II tumor suppressor gene family and acts as a phospholipase to catalyze the release of fatty acids from glycerophospholipid. H-rev107 has been shown to play an important role in fat metabolism in adipocytes through the PGE2/cAMP pathway, but the detailed molecular mechanism underlying H-rev107-mediated lipid degradation has not been studied. In this study, the interaction between H-rev107 and cytochrome P450 reductase (POR), which is involved in hepatic lipid content regulation, was determined by yeast two-hybrid screen and confirmed by using in vitro pull down assays and immunofluorescent staining. The expression of POR in H-rev107-expressing cells enhanced the H-rev107-mediated release of arachidonic acid. However, H-rev107 inhibited POR activity and relieved POR-mediated decreased triglyceride content in HtTA and HeLa cervical cells. The inhibitory effect of H-rev107 will be abolished when POR-expressing cells transfected with PLA(2)-lacking pH-rev107 or treated with PLA(2) inhibitor. Silencing of H-rev107 using siRNA resulted in increased glycerol production and reversion of free fatty acid-mediated growth suppression in Huh7 hepatic cells. In summary, our results revealed that H-rev107 is also involved in lipid accumulation in liver cells through the POR pathway via its PLA(2) activity.	[Tsai, Fu-Ming; Chen, Mao-Liang; Lee, Ming-Cheng] Buddhist Tzuchi Med Fdn, Taipei Tzuchi Hosp, Dept Res, New Taipei City, Taiwan; [Wang, Lu-Kai] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan University	Tsai, FM (corresponding author), Buddhist Tzuchi Med Fdn, Taipei Tzuchi Hosp, Dept Res, New Taipei City, Taiwan.	afu2215@gmail.com	Chen, Mao-Liang/AAH-1283-2019	Tsai, Fu-Ming/0000-0002-4563-0458				Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Baer-Dubowska W, 2013, EXPERT OPIN DRUG MET, V9, P927, DOI 10.1517/17425255.2013.795219; Cao RS, 2014, CELL PHYSIOL BIOCHEM, V34, P1427, DOI 10.1159/000366348; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Dai ZY, 2013, INT J BIOCHEM CELL B, V45, P2076, DOI 10.1016/j.biocel.2013.07.008; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Deucher A, 2000, INT J ONCOL, V17, P1195; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Furge LL, 2006, BIOCHEM MOL BIOL EDU, V34, P66, DOI 10.1002/bmb.2006.49403402066; GELB MH, 1994, FASEB J, V8, P916, DOI 10.1096/fasebj.8.12.8088457; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; HAJNAL A, 1994, ONCOGENE, V9, P479; Huang SL, 2002, ANTICANCER RES, V22, P799; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Ito H, 2001, CYTOGENET CELL GENET, V93, P36, DOI 10.1159/000056944; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; LIU J, 1995, J PHARMACOL EXP THER, V275, P768; LU AYH, 1969, J BIOL CHEM, V244, P3714; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mutch DM, 2007, J PROTEOME RES, V6, P3976, DOI 10.1021/pr0700448; Nazarenko I, 2007, J CELL SCI, V120, P1393, DOI 10.1242/jcs.000018; Pikuleva I, 1999, Mol Aspects Med, V20, P33; Porter TD, 2011, DRUG METAB DISPOS, V39, P966, DOI 10.1124/dmd.111.038562; Ren XB, 2010, BIOMOL NMR ASSIGN, V4, P175, DOI 10.1007/s12104-010-9238-5; Scharadin TM, 2012, J CELL SCI, V125, P2604, DOI 10.1242/jcs.096495; Scharadin TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023230; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; Shyu RY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-30; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; Tsai FM, 2006, CELL SIGNAL, V18, P349, DOI 10.1016/j.cellsig.2005.05.005; Tsai FM, 2007, CELL SIGNAL, V19, P989, DOI 10.1016/j.cellsig.2006.11.005; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Uyama T, 2015, J BIOL CHEM, V290, P17520, DOI 10.1074/jbc.M114.635433; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Wang CH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-36; WAXMAN DJ, 1992, J STEROID BIOCHEM, V43, P1055, DOI 10.1016/0960-0760(92)90333-E; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Wu CC, 2012, BBA-MOL CELL RES, V1823, P2227, DOI 10.1016/j.bbamcr.2012.08.013	52	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138586	10.1371/journal.pone.0138586	http://dx.doi.org/10.1371/journal.pone.0138586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381418	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200133
J	Wang, HF; Jacobs, DR; Gaffo, AL; Gross, MD; Goff, DC; Carr, JJ				Wang, Huifen; Jacobs, David R., Jr.; Gaffo, Angelo L.; Gross, Myron D.; Goff, David C., Jr.; Carr, J. Jeffrey			Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study	PLOS ONE			English	Article							URIC-ACID LEVELS; HEART-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; BLOOD-PRESSURE; HYPERURICEMIA; ASSOCIATION; MORTALITY; PLASMA; STROKE	Objective There is controversy about whether serum urate (sUA) predicts future cardiovascular disease (CVD) independently of classical risk factors, and the age at which any prediction starts. We studied the sUA-CVD association among generally healthy adults. Methods CARDIA recruited 5115 black and white individuals aged 18-30 years in 1985-1986 (year-). Fatal and nonfatal CVD events by year 27 (n = 164) were ascertained during annual contacts and classified using medical records. The association with sUA (year-0, 10, 15 and 20) was modeled using Cox proportional hazards regression, pooling over gender-specific quartiles. Results Mean sUA concentration was higher in men than women, but increased over time in both genders. Those with elevated sUA had worse metabolic profiles that substantially deteriorated over time. Adjusting for demographic and lifestyle factors (the minimal model), baseline sUA concentration was positively associated with incident CVD (hazard ratio (HR) per mg/dL = 1.21; 95% confidence interval: 1.05, 1.39; P = 0.005). This positive association attenuated to nonsignificance in the full model accounting simultaneously for classical CVD risk factors (HR = 1.09; 0.94, 1.27; P = 0.24). Both the minimal and full models appeared to show stronger associations (than year-0 sUA) between year-10 sUA and incident CVD (HR = 1.27 and 1.12, respectively), but sUA was not statistically significant in the full model. Despite fewer events, year-15 sUA showed a significant sUA-CVD association pattern, with minimal model association magnitude comparable to year-10, and remained significant in the full model (HR = 1.19; 1.02, 1.40; P = 0.03). Hyperuricemia at year-15 strongly predicted CVD risk (HR = 2.11; 1.34, 3.33; P = 0.001), with some attenuation in the full model (HR = 1.68; P = 0.04). Conclusions sUA may be an early biomarker for CVD in adults entering middle age. The prediction of CVD by sUA appeared to strengthen with aging. The potential complex relation of sUA with deterioration of a cluster of metabolic abnormalities warrants future exploration.	[Wang, Huifen] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Epidemiol Lab, Boston, MA 02111 USA; [Jacobs, David R., Jr.] Univ Minnesota Twin Cities, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Gaffo, Angelo L.] Univ Alabama Birmingham, Div Rheumatol, Birmingham, AL USA; [Gross, Myron D.] Univ Minnesota Twin Cities, Lab Med & Pathol, Minneapolis, MN USA; [Goff, David C., Jr.] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA; [Carr, J. Jeffrey] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA	Tufts University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University	Jacobs, DR (corresponding author), Univ Minnesota Twin Cities, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	jacob004@umn.edu	Gaffo, Angelo/ABD-1653-2021; Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Gaffo, Angelo/0000-0001-7365-7212; Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Jacobs, David/0000-0002-7232-0543	National Heart, Lung, and Blood Institute [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C, RO1- HL53560]; Cymabay, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cymabay, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CARDIA is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute. DRJ and MDG are the joint principal investigators for YALTA supported by RO1- HL53560 from the National Heart, Lung, and Blood Institute. The funding organization participated in the design of study, choice of enrolled patients, and review and interpretation of data. The CARDIA Publications and Presentations Committee, in which National Heart, Lung, and Blood Institute and academic members participate as equal partners, reviewed and approved the manuscript. Cymabay, Inc provided support in the form of consulting fees for activities unrelated to this paper or its general topic for one author (ALG), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	ADAMOPOULOS D, 1977, ACTA ENDOCRINOL-COP, V85, P198; Archer SL, 1998, ARTERIOSCL THROM VAS, V18, P1119, DOI 10.1161/01.ATV.18.7.1119; Baena CP, 2015, AM J HYPERTENS; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Dutta A, 2013, J AM GERIATR SOC, V61, P319, DOI 10.1111/jgs.12149; DYER AR, 1990, J CLIN EPIDEMIOL, V43, P1, DOI 10.1016/0895-4356(90)90050-Y; Elsurer R, 2014, BLOOD PRESS MONIT, V19, P271, DOI 10.1097/MBP.0000000000000056; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2012, J CLIN HYPERTENS, V14, P346, DOI 10.1111/j.1751-7176.2012.00662.x; FOSSATI P, 1980, CLIN CHEM, V26, P227; Gaffo AL, 2012, ANN RHEUM DIS; Gaffo AL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3552; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kleber ME, 2015, J AM SOC NEPHROL; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Mehta T, 2014, AM J HYPERTENS; Mercuro G, 2010, J CARDIOVASC MED, V11, P207, DOI 10.2459/JCM.0b013e32833178ed; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Musser A W, 1966, Tech Bull Regist Med Technol, V36, P21; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Oikonen M, 2012, ATHEROSCLEROSIS, V223, P497, DOI 10.1016/j.atherosclerosis.2012.05.036; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Reaven G, 2014, J INTERN MED; Sattui SE, 2014, RHEUM DIS CLIN N AM, V40, P251, DOI 10.1016/j.rdc.2014.01.005; The CARDIA Endpoints Surveillance and Adjudication Committee (ESAS), 2012, CARDIA ENDP EV MAN O; Thornley S, 2013, RHEUMATOLOGY, V52, P135, DOI 10.1093/rheumatology/kes269; Wang H, 2013, J INTERN MED; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; ZAVARONI I, 1993, J INTERN MED, V234, P25, DOI 10.1111/j.1365-2796.1993.tb00700.x	43	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138067	10.1371/journal.pone.0138067	http://dx.doi.org/10.1371/journal.pone.0138067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381512	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200054
J	Yang, YH; Teng, HW; Lai, YT; Li, SY; Lin, CC; Yang, AC; Chan, HL; Hsieh, YH; Lin, CF; Hsu, FY; Liu, CK; Liu, WS				Yang, Ya-Hsu; Teng, Hao-Wei; Lai, Yen-Ting; Li, Szu-Yuan; Lin, Chih-Ching; Yang, Albert C.; Chan, Hsiang-Lin; Hsieh, Yi-Hsuan; Lin, Chiao-Fan; Hsu, Fu-Ying; Liu, Chih-Kuang; Liu, Wen-Sheng			Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COLLABORATIVE REANALYSIS; COGNITIVE IMPAIRMENT; REDUCTASE INHIBITORS; ELDERLY-PEOPLE; OLDER-ADULTS; PREVALENCE; ATORVASTATIN; ASSOCIATION; CHOLESTEROL	Objective Patients with late-onset depression (LOD) have been reported to run a higher risk of subsequent dementia. The present study was conducted to assess whether statins can reduce the risk of dementia in these patients. Methods We used the data from National Health Insurance of Taiwan during 1996-2009. Standardized Incidence Ratios (SIRs) were calculated for LOD and subsequent dementia. The criteria for LOD diagnoses included age >= 65 years, diagnosis of depression after 65 years of age, at least three service claims, and treatment with antidepressants. The time-dependent Cox proportional hazards model was applied for multivariate analyses. Propensity scores with the one-to-one nearest-neighbor matching model were used to select matching patients for validation studies. Kaplan-Meier curve estimate was used to measure the group of patients with dementia living after diagnosis of LOD. Results Totally 45,973 patients aged >= 65 years were enrolled. The prevalence of LOD was 12.9% (5,952/45,973). Patients with LOD showed to have a higher incidence of subsequent dementia compared with those without LOD (Odds Ratio: 2.785; 95% CI 2.619-2.958). Among patients with LOD, lipid lowering agent (LLA) users (for at least 3 months) had lower incidence of subsequent dementia than non-users (Hazard Ratio = 0.781, 95% CI 0.685-0.891). Nevertheless, only statins users showed to have reduced risk of dementia (Hazard Ratio = 0.674, 95% CI 0.547-0.832) while other LLAs did not, which was further validated by Kaplan-Meier estimates after we used the propensity scores with the one-to-one nearest-neighbor matching model to control the confounding factors. Conclusions Statins may reduce the risk of subsequent dementia in patients with LOD.	[Yang, Ya-Hsu] Taipei City Hosp, Renai Branch, Dept Psychiat, Taipei, Taiwan; [Yang, Ya-Hsu; Teng, Hao-Wei; Li, Szu-Yuan; Lin, Chih-Ching; Yang, Albert C.; Liu, Wen-Sheng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Teng, Hao-Wei] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Lai, Yen-Ting] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Phys Med & Rehabil, Hsinchu, Taiwan; [Lai, Yen-Ting] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan; [Li, Szu-Yuan; Lin, Chih-Ching] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chan, Hsiang-Lin; Hsieh, Yi-Hsuan; Lin, Chiao-Fan] Chang Gung Mem Hosp & Univ, Dept Child Psychiat, Taoyuan, Taiwan; [Hsu, Fu-Ying; Liu, Wen-Sheng] Taipei City Hosp, Zhong Xing Branch, Dept Med, Div Nephrol, Taipei, Taiwan; [Liu, Chih-Kuang; Liu, Wen-Sheng] Fu Jen Catholic Univ, Coll Med, New Taipei City, Taiwan; [Liu, Chih-Kuang; Liu, Wen-Sheng] Fu Jen Catholic Univ, Grad Inst Business Adm, New Taipei City, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Taipei City Hospital; Fu Jen Catholic University; Fu Jen Catholic University	Liu, WS (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	robertliu2001@yahoo.com	liu, wen/HGE-3071-2022	Lai, Yen-Ting/0000-0001-8043-5183; Yang, Albert Chih-Chieh/0000-0003-2794-9649	Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital; Taipei Veterans General Hospital, Taiwan Clinical Oncology Research Foundation, Department of Health, Taiwan (Center of Excellence for Cancer Research at Taipei Veterans General Hospital)	Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taipei Veterans General Hospital, Taiwan Clinical Oncology Research Foundation, Department of Health, Taiwan (Center of Excellence for Cancer Research at Taipei Veterans General Hospital)	This work was supported in part by the Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital, and by the Taipei Veterans General Hospital, Taiwan Clinical Oncology Research Foundation, Department of Health, Taiwan (Center of Excellence for Cancer Research at Taipei Veterans General Hospital).	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Arvanitakis Z, 2008, NEUROLOGY, V70, P1795, DOI 10.1212/01.wnl.0000288181.00826.63; Baldwin RC, 2005, INT J GERIATR PSYCH, V20, P1, DOI 10.1002/gps.1255; Baldwin RC, 2002, BRIT J PSYCHIAT, V180, P157, DOI 10.1192/bjp.180.2.157; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Brodaty H, 2001, J AFFECT DISORDERS, V66, P225, DOI 10.1016/S0165-0327(00)00317-7; Buee L, 1997, ANN NY ACAD SCI, V826, P7, DOI 10.1111/j.1749-6632.1997.tb48457.x; Buntinx F, 1996, AGE AGEING, V25, P231, DOI 10.1093/ageing/25.3.231; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; CLAYTON D, 1991, INT J EPIDEMIOL, V20, pS62, DOI 10.1093/ije/20.Supplement_2.S62; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dahiyat M, 1999, ANN NEUROL, V46, P664, DOI 10.1002/1531-8249(199910)46:4<664::AID-ANA18>3.0.CO;2-J; EMERY VO, 1992, AM J PSYCHIAT, V149, P305; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Ganguli M, 2006, ARCH GEN PSYCHIAT, V63, P153, DOI 10.1001/archpsyc.63.2.153; Hajjar L, 2002, J GERONTOL A-BIOL, V57, pM414, DOI 10.1093/gerona/57.7.M414; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329; Jagust WJ, 1997, ANN NY ACAD SCI, V826, P254, DOI 10.1111/j.1749-6632.1997.tb48477.x; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; JORM AF, 1991, INT J EPIDEMIOL, V20, pS43, DOI 10.1093/ije/20.Supplement_2.S43; Kessing LV, 2006, INT J GERIATR PSYCH, V21, P1127, DOI 10.1002/gps.1617; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; KRAL VA, 1989, CAN J PSYCHIAT, V34, P445, DOI 10.1177/070674378903400515; KRISHNAN KRR, 1995, AM J PSYCHIAT, V152, P785; LARSON EB, 1993, NEW ENGL J MED, V328, P203, DOI 10.1056/NEJM199301213280308; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Liu WS, 2012, SCI WORLD J, P1, DOI 10.1100/2012/157437; Lockwood KA, 2000, AM J GERIAT PSYCHIAT, V8, P201, DOI 10.1176/appi.ajgp.8.3.201; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub2; Rea TD, 2005, ARCH NEUROL-CHICAGO, V62, P1047, DOI 10.1001/archneur.62.7.1047; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Zamrini E, 2004, NEUROEPIDEMIOLOGY, V23, P94, DOI 10.1159/000073981	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137914	10.1371/journal.pone.0137914	http://dx.doi.org/10.1371/journal.pone.0137914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383103	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200043
J	Yang, HB; Palmbos, PL; Wang, LD; Kim, EH; Ney, GM; Liu, C; Prasad, J; Misek, DE; Yu, XC; Ljungman, M; Simeone, DM				Yang, Huibin; Palmbos, Phillip L.; Wang, Lidong; Kim, Evelyn H.; Ney, Gina M.; Liu, Chao; Prasad, Jayendra; Misek, David E.; Yu, Xiaochun; Ljungman, Mats; Simeone, Diane M.			ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-PROLIFERATION; C-KINASE SUBSTRATE; PANCREATIC-CANCER; UP-REGULATION; GENE; TRIM29; REPAIR; PHOSPHORYLATION; INHIBITION; ACTIVATION	Background: ATDC/TRIM29 promotes resistance to ionizing radiation, but the factor(s) that mediate this effect are incompletely understood. Results: ATDC/TRIM29 binds to RNF8, promoting DNA repair and resistance to IR. Conclusion: Following DNA damage, ATDC/TRIM29 is phosphorylated and interacts with RNF8, promoting DNA repair and cell survival. Significance: The interaction between ATDC/TRIM29 and RNF8 is novel and is important for the DNA damage response. Induction of DNA damage by ionizing radiation (IR) and/or cytotoxic chemotherapy is an essential component of cancer therapy. The ataxia telangiectasia group D complementing gene (ATDC, also called TRIM29) is highly expressed in many malignancies. It participates in the DNA damage response downstream of ataxia telangiectasia-mutated (ATM) and p38/MK2 and promotes cell survival after IR. To elucidate the downstream mechanisms of ATDC-induced IR protection, we performed a mass spectrometry screen to identify ATDC binding partners. We identified a direct physical interaction between ATDC and the E3 ubiquitin ligase and DNA damage response protein, RNF8, which is required for ATDC-induced radioresistance. This interaction was refined to the C-terminal portion (amino acids 348-588) of ATDC and the RING domain of RNF8 and was disrupted by mutation of ATDC Ser-550 to alanine. Mutations disrupting this interaction abrogated ATDC-induced radioresistance. The interaction between RNF8 and ATDC, which was increased by IR, also promoted downstream DNA damage responses such as IR-induced gamma-H2AX ubiquitination, 53BP1 phosphorylation, and subsequent resolution of the DNA damage foci. These studies define a novel function for ATDC in the RNF8-mediated DNA damage response and implicate RNF8 binding as a key determinant of the radioprotective function of ATDC.	[Yang, Huibin; Wang, Lidong; Kim, Evelyn H.; Misek, David E.; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Palmbos, Phillip L.; Liu, Chao; Yu, Xiaochun] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ney, Gina M.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Prasad, Jayendra; Ljungman, Mats] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Yang, Huibin; Palmbos, Phillip L.; Wang, Lidong; Ney, Gina M.; Prasad, Jayendra; Ljungman, Mats; Simeone, Diane M.] Univ Michigan, Translat Oncol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Sch Med, Translat Oncol Program, Dept Surg, TC 2922D,Box 0331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	simeone@med.umich.edu	Regan, Clinton/E-6250-2012		Pardee Foundation; National Institutes of Health [T32 CA009357, R01 CA13104505A1, CA17483601A1]; American Society of Clinical Oncology (ASCO) Young Investigator Award; Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award; NATIONAL CANCER INSTITUTE [R01CA130899, T32CA009357, R01CA132755, R01CA174836, R01CA187209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	Pardee Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology (ASCO) Young Investigator Award; Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Pardee Foundation (to D. M. S.), National Institutes of Health Grants R01 CA13104505A1 and CA17483601A1 (to D. M. S.), National Institutes of Health Grant T32 CA009357 (to P. L. P.), American Society of Clinical Oncology (ASCO) Young Investigator Award (to P. L. P.), and the Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award (to P. L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartocci Cristina, 2013, Frontiers in Genetics, V4, P128, DOI 10.3389/fgene.2013.00128; Bertrand-Vallery V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010462; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Chen CH, 2014, AM J RESP CRIT CARE, V189, P1002, DOI 10.1164/rccm.201401-0053LE; Chiong E, 2009, J UROLOGY, V181, P2737, DOI 10.1016/j.juro.2009.01.108; Fu P, 2013, J BIOL CHEM, V288, P29890, DOI 10.1074/jbc.M113.510826; Hanada S, 2013, CANCER BIOMARK, V13, P289, DOI 10.3233/CBM-130354; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0715-4; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Laderoute KR, 1996, INT J CANCER, V66, P772, DOI 10.1002/(SICI)1097-0215(19960611)66:6<772::AID-IJC11>3.0.CO;2-5; Lai W, 2013, DIS ESOPHAGUS, V26, P817, DOI 10.1111/j.1442-2050.2012.01400.x; LEONHARDT EA, 1994, GENOMICS, V19, P130, DOI 10.1006/geno.1994.1022; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masuda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8299; Meroni G, 2012, ADV EXP MED BIOL, V770, P1; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Sho T, 2011, BBA-MOL CELL RES, V1813, P1245, DOI 10.1016/j.bbamcr.2011.03.018; Tang ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063676; Wang LD, 2014, CANCER RES, V74, P1778, DOI 10.1158/0008-5472.CAN-13-2289; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Yang HB, 2006, MOL BIOL CELL, V17, P2177, DOI 10.1091/mbc.E05-10-0913; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09	31	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27146	27157		10.1074/jbc.M115.665489	http://dx.doi.org/10.1074/jbc.M115.665489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381412	Green Published, hybrid			2022-12-26	WOS:000364794000024
J	Rosenberg, J; Reske, M; Warbrick, T; Shah, NJ				Rosenberg, Jessica; Reske, Martina; Warbrick, Tracy; Shah, N. J.			Chronotype Modulates Language Processing-Related Cerebral Activity during Functional MRI (fMRI)	PLOS ONE			English	Article							THEMATIC CATEGORIES; DISPLACED SLEEP; BRAIN IMAGES; TASK; OPTIMIZATION; REGISTRATION; ACTIVATION; REGIONS; CORTEX; MEMORY	Objective Based on individual daily physiological cycles, humans can be classified as early (EC), late (LC) and intermediate (IC) chronotypes. Recent studies have verified that chronotype-specificity relates to performance on cognitive tasks: participants perform more efficiently when tested in the chronotype-specific optimal time of day than when tested in their non-optimal time. Surprisingly, imaging studies focussing on the underlying neural mechanisms of potential chronotype-specificities are sparse. Moreover, chronotype-specific alterations of language-related semantic processing have been neglected so far. Methods 16 male, healthy ECs, 16 ICs and 16 LCs participated in a fast event-related functional Magnetic Resonance Imaging (fMRI) paradigm probing semantic priming. Subjects read two subsequently presented words (prime, target) and were requested to determine whether the target word was an existing word or a non-word. Subjects were tested during their individual evening hours when homeostatic sleep pressure and circadian alertness levels are high to ensure equal entrainment. Results Chronotype-specificity is associated with task-performance and brain activation. First, ECs exhibited slower reaction times than LCs. Second, ECs showed attenuated BOLD responses in several language-related brain areas, e.g. in the left postcentral gyrus, left and right precentral gyrus and in the right superior frontal gyrus. Additionally, increased BOLD responses were revealed for LCs as compared to ICs in task-related areas, e.g. in the right inferior parietal lobule and in the right postcentral gyrus. Conclusions These findings reveal that even basic language processes are associated with chronotype-specific neuronal mechanisms. Consequently, results might change the way we schedule patient evaluations and/or healthy subjects in e.g. experimental research and adding "chronotype" as a statistical covariate.	[Rosenberg, Jessica; Reske, Martina; Warbrick, Tracy; Shah, N. J.] Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med INM 4, D-52425 Julich, Germany; [Rosenberg, Jessica; Shah, N. J.] Rhein Westfal TH Aachen, JARA, Translat Brain Med, D-52074 Aachen, Germany; [Rosenberg, Jessica; Shah, N. J.] Univ Clin Aachen, Dept Neurol, D-52074 Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Rosenberg, J (corresponding author), Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med INM 4, D-52425 Julich, Germany.	j.rosenberg@fz-juelich.de	Rosenberg, Jessica/P-1868-2016; Shah, N. Jon/H-5849-2013; Reske, Martina/M-6083-2013	Rosenberg, Jessica/0000-0003-2688-9410; Shah, N. Jon/0000-0002-8151-6169; Reske, Martina/0000-0001-5754-4795	JARA; RWTH; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; Forschungszentrum Julich GmbH	JARA; RWTH; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; Forschungszentrum Julich GmbH(Helmholtz Association)	This research was supported by grants from JARA and RWTH. NJS is funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. Forschungszentrum Julich GmbH provided support in the form of salaries for authors Jessica Rosenberg, Martina Reske, Tracy Warbrick and N. J. Shah. These funders did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; AKERSTEDT T, 1982, ELECTROEN CLIN NEURO, V54, P220, DOI 10.1016/0013-4694(82)90163-8; AKERSTEDT T, 1982, SLEEP, V5, pS95, DOI 10.1093/sleep/5.S2.S95; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Baayen R. H, 1995, CELEX LEXICAL DATABA; Babkoff H, 2005, J SLEEP RES, V14, P7, DOI 10.1111/j.1365-2869.2004.00423.x; Beyersmann E, 2014, BRAIN RES, V1579, P45, DOI 10.1016/j.brainres.2014.07.010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Chervin RD, 2003, SLEEP MED, V4, P175, DOI 10.1016/S1389-9457(03)00030-3; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; De Carli D, 2007, MAGN RESON IMAGING, V25, P933, DOI 10.1016/j.mri.2007.03.031; GILLBERG M, 1994, SLEEP, V17, P236, DOI 10.1093/sleep/17.3.236; GILLBERG M, 1994, J SLEEP RES, V3, P144, DOI 10.1111/j.1365-2869.1994.tb00121.x; GILLBERG M, 1980, CHRONOBIOLOGIA, V7, P390; Gillberg M, 1996, SLEEP, V19, P570, DOI 10.1093/sleep/19.7.570; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hautzinger M., 2006, BDI 2 BECK DEPRESSIO; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joanisse MF, 2003, NEUROIMAGE, V19, P64, DOI 10.1016/S1053-8119(03)00046-6; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Ken S, 2007, MAGN RESON IMAGING, V25, P883, DOI 10.1016/j.mri.2007.02.003; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; Kircher T, 2009, HUM BRAIN MAPP, V30, P4116, DOI 10.1002/hbm.20833; MAY CP, 1993, PSYCHOL SCI, V4, P326, DOI 10.1111/j.1467-9280.1993.tb00573.x; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; Mecacci L, 1998, PERS INDIV DIFFER, V25, P537, DOI 10.1016/S0191-8869(98)00087-7; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Reske M, 2015, NEUROIMAGE, DOI [10.1016/j.neuroimage.2015.02.013, DOI 10.1016/J.NEUR0IMAGE.2015.02.013]; Reske M, 2007, J PSYCHIATR RES, V41, P918, DOI 10.1016/j.jpsychires.2007.02.009; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sachs O, 2008, BRAIN RES, V1218, P194, DOI 10.1016/j.brainres.2008.03.045; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Sass K, 2009, NEUROIMAGE, V45, P224, DOI 10.1016/j.neuroimage.2008.10.014; Schmidt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029658; Sommerhoff G., 2000, UNDERSTANDING CONSCI, P135; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taillard C, 2003, J CLIN MICROBIOL, V41, P1240, DOI 10.1128/JCM.41.3.1240-1244.2003; Taillard J, 2003, J SLEEP RES, V12, P275, DOI 10.1046/j.0962-1105.2003.00369.x; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Van Dongen HPA, 2004, SLEEP, V27, P423; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zilles K., 1990, HUMAN NERVOUS SYSTEM	53	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137197	10.1371/journal.pone.0137197	http://dx.doi.org/10.1371/journal.pone.0137197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397824	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500023
J	Gestal, MC; Holban, AM; Escalante, S; Cevallos, M				Cartelle Gestal, Monica; Holban, Alina Maria; Escalante, Santiago; Cevallos, Marcelo			Epidemiology of Tropical Neglected Diseases in Ecuador in the Last 20 Years	PLOS ONE			English	Article							LONG-TERM TREATMENT; VOLVULUS TRANSMISSION; ONCHOCERCA-VOLVULUS; ECHINOCOCCOSIS; ELIMINATION; IVERMECTIN; AMERICA; IMPACT; BRUCELLOSIS; PREVALENCE	Background Tropical and zoonotic diseases are major problems in developing countries like Ecuador. Poorly designed houses, the high proportion of isolated indigenous population and under developed infrastructure represent a fertile environment for vectors to proliferate. Control campaigns in Ecuador over the years have had varying success, depending on the disease and vectors targeted. Aims In our study we analyse the current situation of some neglected diseases in Ecuador and the efficiency of the control campaigns (by measuring changes in numbers of cases reported) that the Ecuadorian government has been running to limit the spread of these infectious and parasitic diseases. Results Our study reveals that Brucellosis, Chagas Disease, Rabies and Onchocerciasis have been controlled, but small outbreaks are still detected in endemic areas. Leptospirosis and Echinococcosis have been increasing steadily in recent years in Ecuador since the first records. The same increase has been reported world-wide also. Better diagnosis has resulted in a higher number of cases being identified, particularly with regard to the linking of outdoor activities and contact with farm animals as contributing vectors. Improvements in diagnosis are due to regular professional training, implementation of automatized systems, establishing diagnosis protocols and the creation of an epidemiological vigilance network that acts as soon as a case is reported. Conclusion Control campaigns performed in Ecuador have been successful in recent years, although natural phenomena limit their efficiency. Leptospirosis and Echinococcosis infections remain a growing problem in Ecuador as it is worldwide.	[Cartelle Gestal, Monica] Secretary Higher Educ Sci Technol & Innovat Ecuad, Dept Microbiol, Quito, Ecuador; [Holban, Alina Maria] Univ Bucharest, Fac Biol, Dept Microbiol Immunol, Bucharest, Romania; [Escalante, Santiago] Minist Publ Hlth, Dept Intelligence, Quito, Ecuador; [Cevallos, Marcelo] Minist Publ Hlth, Dept Econ Hlth, Quito, Ecuador	University of Bucharest	Gestal, MC (corresponding author), Secretary Higher Educ Sci Technol & Innovat Ecuad, Dept Microbiol, Quito, Ecuador.	mcarges@gmail.com	Gestal, Monica Cartelle/I-3195-2015	Gestal, Monica Cartelle/0000-0001-7417-2460; Holban, Alina/0000-0002-1257-5042				Abad-Franch F, 2003, CONTROL ENFERMEDAD C; Atkinson JAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002386; Barragan VA, 2011, CURR MICROBIOL, V62, P1802, DOI 10.1007/s00284-011-9931-3; Ben Shimol S, 2012, ISR MED ASSOC J, V14, P475; BERAN GW, 1988, REV INFECT DIS, V10, pS672; Bruno Moggia J, 1966, Rev Ecuat Hig Med Trop, V23, P259; Bruno Moggia J, 1965, Rev Ecuat Hig Med Trop, V22, P189; Cabanel N, 2013, EMERG INFECT DIS, V19, P230, DOI 10.3201/eid1902.121031; Castilho JG, 2010, VIRUS RES, V153, P100, DOI 10.1016/j.virusres.2010.07.012; Costa F, 2012, REV PANAMERICANCA SA, V32; CRUZORTIZ N, 2012, J PARASITOL RES, V2012, DOI DOI 10.1155/2012/638429; Cupp EW, 2004, AM J TROP MED HYG, V71, P602; DALESSANDRO A, 1979, AM J TROP MED HYG, V28, P303, DOI 10.4269/ajtmh.1979.28.303; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Ecuador MoPHo, 2013, MANUAL PROCEDIMIENTO; Elizabeth M, 2010, DETERMINACION INCIDE; Guevara AG, 2003, AM J TROP MED HYG, V68, P222, DOI 10.4269/ajtmh.2003.68.222; Gustavsen K, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-205; Herrick JA, 2014, LANCET INFECT DIS, V14, P520, DOI 10.1016/S1473-3099(13)70270-6; Hotez PJ, 2014, INT J PARASITOL, V44, P597, DOI 10.1016/j.ijpara.2014.04.001; Kenyon Aulta S, 2014, REV PERU MED EXP SAL, V31, P319; Lazo R F, 1977, Rev Ecuat Hig Med Trop, V30, P305; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; Moncayo AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000293; Luo J, 2012, EMERG INFECT DIS, V18, P1527, DOI 10.3201/eid1809.120069; Manias V, 2013, REV ARGENT MICROBIOL, V45, P50; Pereira PCM, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-34; Monroy J, 2013, ONCCOCERCOSIS ECUADO; Najar Hagit, 2012, Germs, V2, P95, DOI 10.11599/germs.2012.1019; Otero-Abad B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002249; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Patricio Jimenez C, 2010, DETERMINACION HIDATI; Paulina S, 2011, ESTUDIO SANITARIO PR; Perez-Morales D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/902803; Petrone L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/978146; Poeppl W, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.25.20509; Radl C, 2011, WIEN KLIN WOCHENSCHR, V123, P751, DOI 10.1007/s00508-011-0100-2; Ron-Roman J, 2014, VECTOR-BORNE ZOONOT, V14, P124, DOI 10.1089/vbz.2012.1191; Ron-Roman J, 2012, AM J TROP MED HYG, V87, P524, DOI 10.4269/ajtmh.2012.11-0341; Sadkowska-Todys M, 2013, PRZEGL EPIDEMIOL, V67, P473; Sadkowska- Todys M, 2013, PRZEGL EPIDEMIOL, V67, P571; Seetahal JFR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002365; Stoianov G, 2007, Khirurgiia (Sofiia), P53; Torres Andrade FA, 2012, IDENTIFICACION PRESE; Usubalieva J, 2013, EMERG INFECT DIS, V19, P1095, DOI 10.3201/eid1907.121405; Valarezo-Sevilla D., 2014, Rev. esp. sanid. penit., V16, P20, DOI [10.4321/S1575-06202014000100004, 10.4321/s1575-06202014000100004]; Vieira JC, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-9; Willingham AL, 2004, VET PARASITOL, V125, P183, DOI 10.1016/j.vetpar.2004.05.013	49	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138311	10.1371/journal.pone.0138311	http://dx.doi.org/10.1371/journal.pone.0138311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394405	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100050
J	Jones-Lopez, EC; White, LF; Kirenga, B; Mumbowa, F; Ssebidandi, M; Moine, S; Mbabazi, O; Mboowa, G; Ayakaka, I; Kim, S; Thornton, CS; Okwera, A; Joloba, M; Fennelly, KP				Jones-Lopez, Edward C.; White, Laura F.; Kirenga, Bruce; Mumbowa, Francis; Ssebidandi, Martin; Moine, Stephanie; Mbabazi, Olive; Mboowa, Gerald; Ayakaka, Irene; Kim, Soyeon; Thornton, Christina S.; Okwera, Alphonse; Joloba, Moses; Fennelly, Kevin P.			Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST/IGRA Discordance and Transmission Dynamics	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; QUANTIFERON-TB-GOLD; WITHIN-SUBJECT VARIABILITY; LATENT TUBERCULOSIS; SKIN-TEST; HOUSEHOLD CONTACTS; TUBE ASSAY; INFECTION; DIAGNOSIS; RESPONSES	Rationale The diagnosis of latent tuberculosis (TB) infection (LTBI) is complicated by the absence of a gold standard. Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRA) occurs in 10-20% of individuals, but the underlying mechanisms are poorly understood. Methods We analyzed data from a prospective household contact study that included cough aerosol culture results from index cases, environmental and contact factors. We assessed contacts for LTBI using TST and IGRA at baseline and six weeks. We examined TST/IGRA discordance in qualitative and quantitative analyses, and used multivariable logistic regression analysis with generalized estimating equations to analyze predictors of discordance. Measurements and Results We included 96 TB patients and 384 contacts. Discordance decreased from 15% at baseline to 8% by six weeks. In adjusted analyses, discordance was related to less crowding (p = 0.004), non-cavitary disease (OR 1.41, 95% CI: 1.02-1.96; p = 0.03), and marginally with BCG vaccination in contacts (OR 1.40, 95% CI: 0.99-1.98, p = 0.06). Conclusions We observed significant individual variability and temporal dynamism in TST and IGRA results in household contacts of pulmonary TB cases. Discordance was associated with a less intense infectious exposure, and marginally associated with a BCG-mediated delay in IGRA conversion. Cough aerosols provide an additional dimension to the assessment of infectiousness and risk of infection in contacts.	[Jones-Lopez, Edward C.; Moine, Stephanie] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Jones-Lopez, Edward C.; Moine, Stephanie] Boston Univ, Sch Med, Boston, MA 02118 USA; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kirenga, Bruce; Mboowa, Gerald] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mumbowa, Francis; Mboowa, Gerald; Okwera, Alphonse; Joloba, Moses] Makerere Univ, Coll Hlth Sci, Dept Microbiol, Kampala, Uganda; [Ssebidandi, Martin; Ayakaka, Irene] Makerere Univ, Boston Med Ctr Res Collaborat, Kampala, Uganda; [Mbabazi, Olive] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Kim, Soyeon] Rutgers State Univ, Dept Prevent Med & Community Hlth, Newark, NJ 07102 USA; [Thornton, Christina S.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Okwera, Alphonse] Mulago Hosp, Mulago Hosp TB Clin, Kampala, Uganda; [Fennelly, Kevin P.] Univ Florida, Div Infect Dis & Global Med, Dept Med & Emerging Pathogens Inst, Gainesville, FL USA	Boston Medical Center; Boston University; Boston University; Makerere University; Makerere University; Makerere University; Makerere University; Rutgers State University Newark; Rutgers State University New Brunswick; University of Calgary; Mulago National Referral Hospital; State University System of Florida; University of Florida	Jones-Lopez, EC (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.	edward.jones@bmc.org	Mboowa, Gerald/K-9976-2018	Mboowa, Gerald/0000-0001-8445-9414; Joloba, Moses/0000-0002-0334-9983; Kirenga, Bruce/0000-0002-2023-2840; White, Laura F/0000-0002-0588-8235; Jones Lopez, Edward/0000-0001-6323-286X	Rutgers University; Division of Infectious Diseases at New Jersey Medical School; Section of Infectious Diseases at Boston Medical Center/Boston University School of Medicine	Rutgers University; Division of Infectious Diseases at New Jersey Medical School; Section of Infectious Diseases at Boston Medical Center/Boston University School of Medicine	This study was supported by a University of Medicine and Dentistry of New Jersey (now Rutgers University) Foundation award with matching funds from the Division of Infectious Diseases at New Jersey Medical School, and funds from the Section of Infectious Diseases at Boston Medical Center/Boston University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anibarro L, 2011, EUR RESPIR J, V37, P215, DOI 10.1183/09031936.00030610; Anibarro L, 2011, SCAND J INFECT DIS, V43, P424, DOI 10.3109/00365548.2011.558912; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bradshaw L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020770; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Falk A OCJ, 1969, DIAGNOSTIC STANDARDS; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Higuchi K, 2008, TUBERCULOSIS, V88, P244, DOI 10.1016/j.tube.2007.11.009; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Johnson JL, 1998, AM J RESP CRIT CARE, V158, P1790, DOI 10.1164/ajrccm.158.6.9803104; Jones-Lopez EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100984; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Kampmann B, 2006, LANCET, V368, P282, DOI 10.1016/S0140-6736(06)69064-8; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Kunimoto D, 2009, INT J TUBERC LUNG D, V13, P726; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; Mancuso JD, 2013, AM J RESP CRIT CARE, V187, P122, DOI 10.1164/rccm.201211-2033ED; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Metcalfe JZ, 2010, AM J RESP CRIT CARE, V181, P87, DOI 10.1164/rccm.200906-0981OC; Ministry of Health U, 2010, MAN NAT TUB LEPR PRO; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Powell RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020061; Raj AA, 2007, PULM PHARMACOL THER, V20, P334, DOI 10.1016/j.pupt.2006.10.002; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Ribeiro-Rodrigues R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096564; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Schwartz IS, 2014, INT J TUBERC LUNG D, V18, P787, DOI 10.5588/ijtld.13.0816; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026787; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; Whalen CC, 2005, JAMA-J AM MED ASSOC, V293, P2785, DOI 10.1001/jama.293.22.2785; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; WHO, 1998, WHO TB 98 258; Zwerling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054748	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138358	10.1371/journal.pone.0138358	http://dx.doi.org/10.1371/journal.pone.0138358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394149	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100056
J	Besse, L; Sedlarikova, L; Kryukov, F; Nekvindova, J; Radova, L; Slaby, O; Kuglik, P; Almasi, M; Penka, M; Krejci, M; Adam, Z; Pour, L; Sevcikova, S; Hajek, R				Besse, Lenka; Sedlarikova, Lenka; Kryukov, Fedor; Nekvindova, Jana; Radova, Lenka; Slaby, Ondrej; Kuglik, Petr; Almasi, Martina; Penka, Miroslav; Krejci, Marta; Adam, Zdenek; Pour, Ludek; Sevcikova, Sabina; Hajek, Roman			Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma	PLOS ONE			English	Article							MULTIPLE-MYELOMA	Poor outcome of extramedullary disease in multiple myeloma patients and lack of outcome predictors prompt continued search for new markers of the disease. In this report, we show circulating microRNA distinguishing multiple myeloma patients with extramedullary disease from myeloma patients without such manifestation and from healthy donors. MicroRNA-130a was identified by TaqMan Low Density Arrays and verified by quantitative PCR on 144 serum samples (59 multiple myeloma, 55 myeloma with extramedullary disease, 30 healthy donors) in test and validation cohorts as being down-regulated in myeloma patients with extramedullary disease. Circulating microRNA-130a distinguished myeloma patients with extramedullary disease from healthy donors with specificity of 90.0% and sensitivity of 77.1%, patients with extramedullary disease from newly diagnosed multiple myeloma patients with specificity of 77.1% and sensitivity of 34.3% in the test cohort and with specificity of 91.7% and sensitivity of 30.0% in the validation cohort of patients. Circulating microRNA-130a in patients with extramedullary myeloma was associated with bone marrow plasma cells infiltration. Further, microRNA-130a was decreased in bone marrow plasma cells obtained from patients with extramedullary myeloma in comparison to bone marrow plasma cells of myeloma patients without such manifestation, but it was increased in tumor site plasma cells of patients with extramedullary disease compared to bone marrow plasma cells of such patients (p<0.0001). Together, our data suggest connection between lower level of microRNA-130a and extramedullary disease and prompt further work to evaluate this miRNA as a marker of extramedullary disease in multiple myeloma.	[Besse, Lenka; Sedlarikova, Lenka; Kryukov, Fedor; Kuglik, Petr; Almasi, Martina; Sevcikova, Sabina; Hajek, Roman] Masaryk Univ, Babak Myeloma Grp, Dept Pathol Physiol, Fac Med, Brno, Czech Republic; [Besse, Lenka; Sedlarikova, Lenka; Almasi, Martina; Penka, Miroslav; Sevcikova, Sabina; Hajek, Roman] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic; [Kryukov, Fedor; Hajek, Roman] Univ Ostrava, Dept Hematooncol, Fac Med, CZ-70103 Ostrava, Czech Republic; [Kryukov, Fedor; Hajek, Roman] Univ Hosp Ostrava, Ostrava, Czech Republic; [Nekvindova, Jana] Charles Univ Prague, Inst Clin Biochem & Diagnost, Fac Med, Hradec Kralove, Czech Republic; [Nekvindova, Jana] Charles Univ Prague, Fac Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Radova, Lenka; Slaby, Ondrej] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Krejci, Marta; Adam, Zdenek; Pour, Ludek] Univ Hosp Brno, Dept Internal Med Hematooncol, Brno, Czech Republic	Masaryk University Brno; University Hospital Brno; University of Ostrava; University Hospital Ostrava; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Masaryk University Brno; University Hospital Brno	Sevcikova, S (corresponding author), Masaryk Univ, Babak Myeloma Grp, Dept Pathol Physiol, Fac Med, Brno, Czech Republic.	sevcik@med.muni.cz	Krejci, Marta/ABE-2414-2020; Sevcikova, Sabina/AAB-4267-2021; Hajek, Roman/I-6639-2017	Krejci, Marta/0000-0001-5216-8778; Hajek, Roman/0000-0001-6955-6267; Nekvindova, Jana/0000-0002-2861-5483; Radova, Lenka/0000-0001-8103-148X; Sedlarikova, Lenka/0000-0002-9752-0824	Czech Ministry of Health [NT14575]; Ministry of Health, Czech Republic - conceptual development of research organization (FNBr) [65269705];  [MUNI/11/InGA17/2012]	Czech Ministry of Health(Ministry of Health, Czech Republic); Ministry of Health, Czech Republic - conceptual development of research organization (FNBr); 	This work was supported by grants of the Czech Ministry of Health NT14575, Internal Grant INGA (MUNI/11/InGA17/2012), grant of the Ministry of Health, Czech Republic - conceptual development of research organization (FNBr, 65269705).	Anderson KC, 2011, ANNU REV PATHOL-MECH, P6; Chen Y, 2008, BLOOD, V111; Corsini LR, 2012, EXPERT OPIN THER S2, V16; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Hao M, 2015, INT J CANC, V136; Jones CI, 2012, BR J CANC, V107; Katodritou E, 2009, LEUK RES, V33; Kovaleva V, 2012, CANC RES, V72; Kubiczkova L, 2014, HAEMATOLOGICA, V99, P511, DOI 10.3324/haematol.2013.093500; Larsen MT, 2014, BLOOD, V123, P1079, DOI 10.1182/blood-2013-08-523233; Lionetti M, 2009, BLOOD, V114; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Navarro A, 2015, ONCOTARGET, V6; Nemec P, 2012, LEUK LYMPHOMA, V53; Oriol A, 2011, ADV THER S7, V28; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pour L, 2014, HAEMATOLOGICA, V99, P360, DOI 10.3324/haematol.2013.094409; Rajkumar SV, 2005, MAYO CLIN P, V80; Reimers M, 2006, METHOD ENZYMOL, P411; Rocci A, 2014, LEUKEMIA, V28, P1922, DOI 10.1038/leu.2014.155; Sevcikova S, 2013, LEUK LYMPHOMA, V54; Short KD, 2011, LEUKEMIA, V25, P906, DOI 10.1038/leu.2011.29; Smith GK, 2005, BIOINFORMATICS COMPU; Turchinovich A, 2011, NUCL ACIDS RES, V39; Turchinovich A, 2012, TRENDS BIOCH SCI, V37; Usmani SZ, 2012, HAEMATOLOGICA, V97; Vandesompele J, 2014, HAEMATOLOGICA, V99, P401, DOI 10.3324/haematol.2013.103127; Varettoni M, 2010, ANN ONCOL, V21, P325, DOI 10.1093/annonc/mdp329; Wu P, 2009, LEUK LYMPHOMA, V50; Zamagni E, 2014, CLIN LYMPHOMA MYELOM, V14	32	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137294	10.1371/journal.pone.0137294	http://dx.doi.org/10.1371/journal.pone.0137294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389804	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000006
J	Ogawa, Y; Eto, A; Miyake, C; Tsuchida, N; Miyake, H; Takaku, Y; Hagiwara, H; Oishi, K				Ogawa, Yasuhiro; Eto, Akira; Miyake, Chisato; Tsuchida, Nana; Miyake, Haruka; Takaku, Yasuhiro; Hagiwara, Hiroaki; Oishi, Kazuhiko			Induced Pluripotent Stem Cells Generated from P0-Cre; Z/EG Transgenic Mice	PLOS ONE			English	Article							NEURAL CREST CELLS; RETINOIC-ACID; MOUSE; DIFFERENTIATION; SYSTEM; INHIBITION; EXPRESSION; INDUCTION; PAX3; WNT	Neural crest (NC) cells are a migratory, multipotent cell population that arises at the neural plate border, and migrate from the dorsal neural tube to their target tissues, where they differentiate into various cell types. Abnormal development of NC cells can result in severe congenital birth defects. Because only a limited number of cells can be obtained from an embryo, mechanistic studies are difficult to perform with directly isolated NC cells. Protein zero (P0) is expressed by migrating NC cells during the early embryonic period. In the P0-Cre; Z/EG transgenic mouse, transient activation of the P0 promoter induces Cre-mediated recombination, indelibly tagging NC-derived cells with enhanced green fluorescent protein (EGFP). Induced pluripotent stem cell (iPSC) technology offers new opportunities for both mechanistic studies and development of stem cell-based therapies. Here, we report the generation of iPSCs from the P0-Cre; Z/EG mouse. P0-Cre; Z/EG mouse-derived iPSCs (P/ G-iPSCs) exhibited pluripotent stem cell properties. In lineage-directed differentiation studies, P/G-iPSCs were efficiently differentiated along the neural lineage while expressing EGFP. These results suggest that P/G-iPSCs are useful to study NC development and NC-associated diseases.	[Ogawa, Yasuhiro; Eto, Akira; Miyake, Chisato; Tsuchida, Nana; Miyake, Haruka; Takaku, Yasuhiro; Hagiwara, Hiroaki; Oishi, Kazuhiko] Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo 2048588, Japan	Meiji Pharmaceutical University	Oishi, K (corresponding author), Meiji Pharmaceut Univ, Dept Pharmacol, 2-522-1 Noshio, Tokyo 2048588, Japan.	oishikz@my-pharm.ac.jp		Ogawa, Yasuhiro/0000-0003-3306-277X				Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; FUKIISHI Y, 1992, CELL TISSUE RES, V268, P1, DOI 10.1007/BF00338048; Giovannini M, 2000, GENE DEV, V14, P1617; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Jacob C, 2014, J NEUROSCI, V34, P6112, DOI 10.1523/JNEUROSCI.5212-13.2014; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Katoh H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-34; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Le Douarin NM, 1999, NEURAL CREST, V2; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nagoshi N, 2011, GLIA, V59, P771, DOI 10.1002/glia.21150; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055856; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Poelmann RE, 1999, DEV BIOL, V207, P271, DOI 10.1006/dbio.1998.9166; Raible DW, 2005, SEMIN CELL DEV BIOL, V16, P673, DOI 10.1016/j.semcdb.2005.06.008; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Villanueva S, 2002, DEV BIOL, V241, P289, DOI 10.1006/dbio.2001.0485; Waldo KL, 1999, DEV BIOL, V208, P307, DOI 10.1006/dbio.1999.9219; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhou Y, 2008, BIOCHEM BIOPH RES CO, V376, P542, DOI 10.1016/j.bbrc.2008.09.032	46	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138620	10.1371/journal.pone.0138620	http://dx.doi.org/10.1371/journal.pone.0138620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382630	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200140
J	Visvabharathy, L; Xayarath, B; Weinberg, G; Shilling, RA; Freitag, NE				Visvabharathy, Lavanya; Xayarath, Bobbi; Weinberg, Guy; Shilling, Rebecca A.; Freitag, Nancy E.			Propofol Increases Host Susceptibility to Microbial Infection by Reducing Subpopulations of Mature Immune Effector Cells at Sites of Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTION; PROCEDURAL SEDATION; DENDRITIC CELLS; DEFENSE; MACROPHAGE; EXPRESSION; RESPONSES; PHOSPHORYLATION	Anesthetics are known to modulate host immune responses, but separating the variables of surgery from anesthesia when analyzing hospital acquired infections is often difficult. Here, the bacterial pathogen Listeria monocytogenes (Lm) was used to assess the impact of the common anesthetic propofol on host susceptibility to infection. Brief sedation of mice with physiologically relevant concentrations of propofol increased bacterial burdens in target organs by more than 10,000-fold relative to infected control animals. The adverse effects of propofol sedation on immune clearance of Lm persisted after recovery from sedation, as animals given the drug remained susceptible to infection for days following anesthesia. In contrast to propofol, sedation with alternative anesthetics such as ketamine/xylazine or pentobarbital did not increase susceptibility to systemic Lm infection. Propofol altered systemic cytokine and chemokine expression during infection, and prevented effective bacterial clearance by inhibiting the recruitment and/or activity of immune effector cells at sites of infection. Propofol exposure induced a marked reduction in marginal zone macrophages in the spleens of Lm infected mice, resulting in bacterial dissemination into deep tissue. Propofol also significantly increased mouse kidney abscess formation following infection with the common nosocomial pathogen Staphylococcus aureus. Taken together, these data indicate that even brief exposure to propofol severely compromises host resistance to microbial infection for days after recovery from sedation.	[Visvabharathy, Lavanya; Xayarath, Bobbi; Shilling, Rebecca A.; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Weinberg, Guy] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Shilling, Rebecca A.] Univ Illinois, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Freitag, NE (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	nfreitag@uic.edu		Visvabharathy, Lavanya/0000-0002-8157-4385	Public Health Service [AI097160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097160] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI097160 (N. E. F). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources.	Alonzo F, 2011, INFECT IMMUN, V79, P1458, DOI 10.1128/IAI.01140-10; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Carrero JA, 2012, ADV IMMUNOL, V113, P157, DOI 10.1016/B978-0-12-394590-7.00001-4; Chen RM, 2003, ANESTHESIOLOGY, V98, P1178, DOI 10.1097/00000542-200305000-00021; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Chong SZ, 2011, EUR J IMMUNOL, V41, P1639, DOI 10.1002/eji.201041022; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cox CE, 2008, CRIT CARE MED, V36, P706, DOI 10.1097/CCM.0B013E3181544248; Di YM, 2009, CURR DRUG METAB, V10, P754, DOI 10.2174/138920009789895507; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Favetta P, 2002, BRIT J ANAESTH, V88, P653, DOI 10.1093/bja/88.5.653; FDA, 2005, EST MAX SAF START DO; Green SM, 2007, ANN EMERG MED, V49, P454, DOI 10.1016/j.annemergmed.2006.08.017; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Heuss LT, 2004, AM J GASTROENTEROL, V99, P511, DOI 10.1111/j.1572-0241.2004.04088.x; Heuss LT, 2004, DIGESTION, V69, P20, DOI 10.1159/000076543; Hong DM, 2011, ANESTH ANALG, V112, P1096, DOI 10.1213/ANE.0b013e31820fcc3e; Kambara Tomoko, 2009, Immunopharmacol Immunotoxicol, V31, P117, DOI 10.1080/08923970802452046; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Lara-Tejero M, 2004, CURR OPIN MICROBIOL, V7, P45, DOI 10.1016/j.mib.2003.12.002; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liu Y, 2012, EFFICACY NMDA RECEPT; MCLEISH KR, 1987, FREE RADICAL BIO MED, V3, P15, DOI 10.1016/0891-5849(87)90034-7; McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; Miner JR, 2007, ACAD EMERG MED, V14, P170, DOI 10.1197/j.aem.2006.10.101; Nigam R, 2010, ARCH DERMATOL RES, V302, P507, DOI 10.1007/s00403-010-1052-5; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Qiu J, 2011, CLIN VACCINE IMMUNOL, V18, P640, DOI 10.1128/CVI.00254-10; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Schlapfer M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0751-x; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002	50	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138043	10.1371/journal.pone.0138043	http://dx.doi.org/10.1371/journal.pone.0138043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381144	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200051
J	McManus, BA; Coleman, DC; Deasy, EC; Brennan, GI; Connell, BO; Monecke, S; Ehricht, R; Leggett, B; Leonard, N; Shore, AC				McManus, Brenda A.; Coleman, David C.; Deasy, Emily C.; Brennan, Grainne I.; Connell, Brian O.; Monecke, Stefan; Ehricht, Ralf; Leggett, Bernadette; Leonard, Nola; Shore, Anna C.			Comparative Genotypes, Staphylococcal Cassette Chromosome mec (SCCmec) Genes and Antimicrobial Resistance amongst Staphylococcus epidermidis and Staphylococcus haemolyticus Isolates from Infections in Humans and Companion Animals	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; POPULATION-STRUCTURE; ANTIBIOTIC-RESISTANCE; RAPID IDENTIFICATION; AUREUS STRAINS; PCR STRATEGY; PIG FARMS; DIVERSITY; MULTIPLEX	This study compares the characteristics of Staphylococcus epidermidis (SE) and Staphylococcus haemolyticus (SH) isolates from epidemiologically unrelated infections in humans (Hu) (28 SE-Hu; 8 SH-Hu) and companion animals (CpA) (12 SE-CpA; 13 SH-CpA). All isolates underwent antimicrobial susceptibility testing, multilocus sequence typing and DNA microarray profiling to detect antimicrobial resistance and SCCmec-associated genes. All methicillin-resistant (MR) isolates (33/40 SE, 20/21 SH) underwent dru and mecA allele typing. Isolates were predominantly assigned to sequence types (STs) within a single clonal complex (CC2, SE, 84.8%; CC1, SH, 95.2%). SCCmec IV predominated among MRSE with ST2-MRSE-IVc common to both Hu (40.9%) and CpA (54.5%). Identical mecA alleles and nontypeable dru types (dts) were identified in one ST2-MRSE-IVc Hu and CpA isolate, however, all mecA alleles and 2/4 dts detected among 18 ST2-MRSE-IVc isolates were closely related, sharing >96.5% DNA sequence homology. Although only one ST-SCCmec type combination (ST1 with a non-typeable [NT] SCCmec NT9 [class C mec and ccrB4]) was common to four MRSH-Hu and one MRSH-CpA, all MRSH isolates were closely related based on similar STs, SCCmec genes (V/V-T or components thereof), mecA alleles and dts. Overall, 39.6% of MR isolates harbored NT SCCmec elements, and ACME was more common amongst MRSE and CpA isolates. Multidrug resistance (MDR) was detected among 96.7% of isolates but they differed in the prevalence of specific macrolide, aminoglycoside and trimethoprim resistance genes amongst SE and SH isolates. Ciprofloxacin, rifampicin, chloramphenicol [fexA, cat-pC221], tetracycline [tet(K)], aminoglycosides [aadD, aphA3] and fusidic acid [fusB] resistance was significantly more common amongst CpA isolates. SE and SH isolates causing infections in Hu and CpA hosts belong predominantly to STs within a single lineage, harboring similar but variable SCCmec genes, mecA alleles and dts. Host and staphylococcal species-specific characteristics were identified in relation to antimicrobial resistance genes and phenotypes, SCCmec and ACME.	[McManus, Brenda A.; Coleman, David C.; Deasy, Emily C.; Brennan, Grainne I.; Shore, Anna C.] Univ Dublin, Trinity Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 9, Ireland; [Brennan, Grainne I.; Connell, Brian O.; Shore, Anna C.] St James Hosp, Natl MRSA Reference Lab, Dublin 8, Ireland; [Connell, Brian O.] St James Hosp, Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin 8, Ireland; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Monecke, Stefan; Ehricht, Ralf] InfectoGnost Res Campus, Jena, Germany; [Leggett, Bernadette; Leonard, Nola] Univ Coll Dublin, Sch Vet Med, Pathobiol, Dublin 4, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Alere; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University College Dublin	Shore, AC (corresponding author), Univ Dublin, Trinity Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 9, Ireland.	anna.shore@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Mircobiology Research unit, Dublin Dental University Hospital; Alere Technologies GmbH	Mircobiology Research unit, Dublin Dental University Hospital; Alere Technologies GmbH	The Mircobiology Research unit, Dublin Dental University Hospital provided all funding for staff, materials and DNA sequencing for this study apart from the mecA allele typing. The mecA Allele typing was undertaken and funded by S. Monecke and R. Ehricht at Alere Technologies GmbH. There was no external funding for this project.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Argudin MA, 2014, MICROB PATHOGENESIS, V74, P8, DOI 10.1016/j.micpath.2014.06.005; Argudin MA, 2015, VET J, V203, P302, DOI 10.1016/j.tvjl.2015.01.008; Bagcigil FA, 2007, VET MICROBIOL, V121, P307, DOI 10.1016/j.vetmic.2006.12.007; Bartels MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061860; Bouchami O, 2011, FOLIA MICROBIOL, V56, P122, DOI 10.1007/s12223-011-0017-1; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Brzychczy-Wloch M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-41; Burns K, 2012, POINT PREVALENCE SUR; Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028; Cavanagh JP, 2014, J ANTIMICROB CHEMOTH, V69, P2920, DOI 10.1093/jac/dku271; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKPOINT TABLES FO; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kern A, 2013, J ANTIMICROB CHEMOTH, V68, P1256, DOI 10.1093/jac/dkt020; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kristof K, 2011, EUR J CLIN MICROBIOL, V30, P691, DOI 10.1007/s10096-010-1142-5; Le Bouter A, 2011, INT J ANTIMICROB AG, V37, P118, DOI 10.1016/j.ijantimicag.2010.10.008; Leonard FC, 2006, VET REC, V158, P155, DOI 10.1136/vr.158.5.155; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Lindgren JK, 2014, J BACTERIOL, V196, P2277, DOI 10.1128/JB.00051-14; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; May L, 2014, ANTIMICROB AGENTS CH, V58, P1404, DOI 10.1128/AAC.01908-13; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Moodley A, 2009, VET MICROBIOL, V137, P397, DOI 10.1016/j.vetmic.2009.01.034; Nahvi MD, 2001, MICROB DRUG RESIST, V7, P1, DOI 10.1089/107662901750152684; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Singh R, 2003, APPL ENVIRON MICROB, V69, P3412, DOI 10.1128/AEM.69.6.3412-3420.2003; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Stevens NT, 2008, CLIN MICROBIOL INFEC, V14, P719, DOI 10.1111/j.1469-0691.2008.02012.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Tulinski P, 2012, APPL ENVIRON MICROB, V78, P299, DOI 10.1128/AEM.05594-11; Urushibara N, 2011, MICROB DRUG RESIST, V17, P291, DOI 10.1089/mdr.2010.0144; Veterinary Ireland-AMR Working Group, 2014, POLICY DOCUMENT ON A; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Yu DL, 2014, GENOMICS, V104, P8, DOI 10.1016/j.ygeno.2014.04.003; Zhang M, 2012, EPIDEMIOL INFECT, V140, P1366, DOI 10.1017/S095026881100207X; Zhang YF, 2011, RES VET SCI, V90, P23, DOI 10.1016/j.rvsc.2010.05.018; Zong ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020191	68	40	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138079	10.1371/journal.pone.0138079	http://dx.doi.org/10.1371/journal.pone.0138079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379051	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400051
J	Nitzki, F; Cuvelier, N; Drager, J; Schneider, A; Braun, T; Hahn, H				Nitzki, F.; Cuvelier, N.; Draeger, J.; Schneider, A.; Braun, T.; Hahn, H.			Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells	ONCOGENE			English	Article							WNT INHIBITORY FACTOR-1; EMBRYONAL RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; SKELETAL MYOGENESIS; MOUSE MODEL; GENE; EXPRESSION; PATHWAY; GLI; PROTEINS	Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. In children, the 2 major RMS subtypes are alveolar and embryonal RMS. Aberrant Hedgehog/Patched1 (Hh/Ptch) signaling is a hallmark of embryonal RMS. We demonstrate that mice carrying a Ptch mutation in mesodermal Delta1-expressing cells develop embryonal-like RMS at a similar rate as mice harboring a Ptch mutation in the germline or the brachury-expressing mesoderm. The tumor incidence decreases dramatically when Ptch is mutated in Myf5- or Pax3-expressing cells. No RMS develop from Myogenin/Mef2c-expressing cells. This suggests that Hh/Ptch-associated RMS are derived from Delta1-positive, Myf5-negative, Myogenin-negative and Pax3-negative mesodermal progenitors that can undergo myogenic differentiation but lack stable lineage commitment. Additional preliminary genetic data and data on mesodermal progenitors further imply an interplay of Hh/Ptch and Delta/Notch signaling activity during RMS initiation. In contrast, Wnt signals supposedly suppress RMS formation because RMS multiplicity decreases after inactivation of the Wnt-inhibitor Wif1. Finally, our results strongly suggest that the tumor-initiating event determines the lineage of RMS origin.	[Nitzki, F.; Cuvelier, N.; Draeger, J.; Hahn, H.] Univ Med Ctr Goettingen, Dept Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Germany; [Schneider, A.; Braun, T.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany	University of Gottingen; Max Planck Society	Hahn, H (corresponding author), Univ Med Ctr Goettingen, Dept Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Germany.	hhahn@gwdg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804	DFG [HA2197/7-1]	DFG(German Research Foundation (DFG))	We thank Lars Wittler and Ludger Hartmann for Wnt<SUP>vt/vt</SUP> mice, Walter Birchmeier and Felix Brembeck for beta-cat<SUP>flox/flox</SUP> mice and Christoph Englert and David Thomas for Wif1<SUP>-/-</SUP> mice. We are grateful to Susan Peter and Stefan Wolf for excellent animal care. We thank Anke Frommhold, Ina Hess and Tobias Goldak for technical assistance and Walter Schulz-Schaeffer (Institute of Neuropathology, University Medical Center Gottingen) and Ilona Skerjanc for useful advice. This work was supported by the DFG Grant HA2197/7-1 to HH.	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Belyea Brian, 2012, Sarcoma, V2012, P406239, DOI 10.1155/2012/406239; Benito-Gonzalez A, 2014, J NEUROSCI, V34, P12865, DOI 10.1523/JNEUROSCI.1494-14.2014; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Diaconescu S, 2013, ROM J MORPHOL EMBRYO, V54, P531; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Feller J, 2008, GENE DEV, V22, P2166, DOI 10.1101/gad.480408; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Gurney JG, 1999, CANC INCIDENCE SURVI, P111; Hahn H, 2004, GENOMICS, V84, P853, DOI 10.1016/j.ygeno.2004.07.002; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Ji SJ, 2006, DEV BIOL, V297, P249, DOI 10.1016/j.ydbio.2006.05.015; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Nitzki F, 2011, ONCOGENE, V30, P4428, DOI 10.1038/onc.2011.157; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pressey JG, 2011, PEDIATR BLOOD CANCER, V57, P930, DOI 10.1002/pbc.23174; Rajurkar M, 2014, ONCOGENE, V33, P5370, DOI 10.1038/onc.2013.480; Roma J, 2011, CLIN CANCER RES, V17, P505, DOI 10.1158/1078-0432.CCR-10-0166; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sebire NJ, 2003, J CLIN PATHOL, V56, P412, DOI 10.1136/jcp.56.6.412; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stock M, 2013, ARTHRITIS RHEUM-US, V65, P2310, DOI 10.1002/art.38054; Surmann-Schmitt C, 2009, J CELL SCI, V122, P3627, DOI 10.1242/jcs.048926; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Tews D, 2011, HORM RES PAEDIAT, V75, P231, DOI 10.1159/000324806; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Zibat A, 2010, ONCOGENE, V29, P6323, DOI 10.1038/onc.2010.368; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	57	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2923	2931		10.1038/onc.2015.346	http://dx.doi.org/10.1038/onc.2015.346			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387541				2022-12-26	WOS:000377473700012
J	Delmar, JA; Chou, TH; Wright, CC; Licon, MH; Doh, JK; Radhakrishnan, A; Kumar, N; Lei, HT; Bolla, JR; Rajashankar, KR; Su, CC; Purdy, GE; Yu, EW				Delmar, Jared A.; Chou, Tsung-Han; Wright, Catherine C.; Licon, Meredith H.; Doh, Julia K.; Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Bolla, Jani Reddy; Rajashankar, Kanagalaghatta R.; Su, Chih-Chia; Purdy, Georgiana E.; Yu, Edward W.			Structural Basis for the Regulation of the MmpL Transporters of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; CRYSTAL-STRUCTURE; CELL-WALL; DNA-BINDING; REPRESSOR; BIOSYNTHESIS; FAMILY; INHIBITION; EVOLUTION; SOFTWARE	The mycobacterial cell wall is critical to the virulence of these pathogens. Recent work shows that the MmpL (mycobacterial membrane protein large) family of transporters contributes to cell wall biosynthesis by exporting fatty acids and lipidic elements of the cell wall. The expression of the Mycobacterium tuberculosis MmpL proteins is controlled by a complex regulatory network, including the TetR family transcriptional regulators Rv3249c and Rv1816. Here we report the crystal structures of these two regulators, revealing dimeric, two-domain molecules with architecture consistent with the TetR family of regulators. Buried extensively within the C-terminal regulatory domains of Rv3249c and Rv1816, we found fortuitous bound ligands, which were identified as palmitic acid (a fatty acid) and isopropyl laurate (a fatty acid ester), respectively. Our results suggest that fatty acids may be the natural ligands of these regulatory proteins. Using fluorescence polarization and electrophoretic mobility shift assays, we demonstrate the recognition of promoter and intragenic regions of multiple mmpL genes by these proteins. Binding of palmitic acid renders these regulators incapable of interacting with their respective operator DNAs, which will result in derepression of the corresponding mmpL genes. Taken together, these experiments provide new perspectives on the regulation of the MmpL family of transporters.	[Delmar, Jared A.; Chou, Tsung-Han; Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Bolla, Jani Reddy; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Wright, Catherine C.; Licon, Meredith H.; Doh, Julia K.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Iowa State University; Iowa State University; Oregon Health & Science University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Dept Phys & Astron, Ames, IA 50011 USA.	ewyu@iastate.edu	Radhakrishnan, Abhijith/V-6182-2019; Regan, Clinton/E-6250-2012; , Nitin/J-8078-2019; Bolla, Jani Reddy/AAT-1370-2020	Radhakrishnan, Abhijith/0000-0001-8107-3487; Bolla, Jani Reddy/0000-0003-4346-182X	National Institutes of Health [R56AI114664]; NIGMS, National Institutes of Health [P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; U.S. Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R56AI114664 (to G. E. P. and E. W. Y.); by NIGMS, National Institutes of Health Grant P41 GM103403 (to the Northeastern Collaborative Access Team beamlines); by NIH-ORIP HEI Grant S10 RR029205 (to the Pilatus 6M detector on 24-ID-C Beamline); and by U.S. Department of Energy Office of Science User Facility Contract DE-AC02-06CH11357 (to Advanced Photon Source, Argonne National Laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chou TH, 2015, PROTEIN SCI, V24, P1942, DOI 10.1002/pro.2802; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kumar N, 2014, PROTEIN SCI, V23, P423, DOI 10.1002/pro.2424; Lei HT, 2011, PROTEIN SCI, V20, P712, DOI 10.1002/pro.602; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Natsume R., 2004, J MOL BIOL, V336, P409; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ML PHARE CCP4 P 80, P80; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wells R. M., 2013, PLOS PATHOG, V9, P1; WINDER F G, 1970, Journal of General Microbiology, V63, P41	56	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28559	28574		10.1074/jbc.M115.683797	http://dx.doi.org/10.1074/jbc.M115.683797			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396194	Green Published, hybrid			2022-12-26	WOS:000365761900047
J	Kassa, T; Jana, S; Strader, MB; Meng, FT; Jia, YP; Wilson, MT; Alayash, AI				Kassa, Tigist; Jana, Sirsendu; Strader, Michael Brad; Meng, Fantao; Jia, Yiping; Wilson, Michael T.; Alayash, Abdu I.			Sickle Cell Hemoglobin in the Ferryl State Promotes beta Cys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE CHEST SYNDROME; HEME OXYGENASE-1; HYDROGEN-PEROXIDE; MASS-SPECTROMETRY; CROSS-LINKING; STRESS; MYOGLOBIN; MECHANISM; RADICALS; COMPLEX	Polymerization of intraerythrocytic deoxyhemoglobin S (HbS) is the primary molecular event that leads to hemolytic anemia in sickle cell disease (SCD). We reasoned that HbS may contribute to the complex pathophysiology of SCD in part due to its pseudoperoxidase activity. We compared oxidation reactions and the turnover of oxidation intermediates of purified human HbS and HbA. Hydrogen peroxide (H2O2) drives a catalytic cycle that includes the following three distinct steps: 1) initial oxidation of ferrous (oxy) to ferryl Hb; 2) autoreduction of the ferryl intermediate to ferric (metHb); and 3) reaction of metHb with an additional H2O2 molecule to regenerate the ferryl intermediate. Ferrous and ferric forms of both proteins underwent initial oxidation to the ferryl heme in the presence of H2O2 at equal rates. However, the rate of autoreduction of ferryl to the ferric form was slower in the HbS solutions. Using quantitative mass spectrometry and the spin trap, 5,5-dimethyl-1pyrroline-N-oxide, we found more irreversibly oxidized beta Cys-93 in HbS than in HbA. Incubation of the ferric or ferryl HbS with cultured lung epithelial cells (E10) induced a drop in mitochondrial oxygen consumption rate and impairment of cellular bioenergetics that was related to the redox state of the iron. Ferryl HbS induced a substantial drop in the mitochondrial transmembrane potential and increases in cytosolic heme oxygenase (HO-1) expression and mitochondrial colocalization in E10 cells. Thus, highly oxidizing ferryl Hb and heme, the product of oxidation, may be central to the evolution of vasculopathy in SCD and may suggest therapeutic modalities that interrupt heme-mediated inflammation.	[Kassa, Tigist; Jana, Sirsendu; Strader, Michael Brad; Meng, Fantao; Jia, Yiping; Alayash, Abdu I.] Food & Drug Adm, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	US Food & Drug Administration (FDA); University of Essex	Alayash, AI (corresponding author), Food & Drug Adm, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	abdu.alayash@fda.hhs.gov			National Institutes of Health NHLBI [P01-HL110900]; United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health NHLBI Grant P01-HL110900 (to A. I. A.) and grants from the United States Food and Drug Administration (MODSCI) (to A. I. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham B, 2011, BIOCHEMISTRY-US, V50, P9752, DOI 10.1021/bi200876e; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ASAKURA T, 1974, P NATL ACAD SCI USA, V71, P1594, DOI 10.1073/pnas.71.5.1594; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; Bansal S, 2014, REDOX BIOL, V2, P273, DOI 10.1016/j.redox.2013.07.004; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; CASHON RE, 1995, ARCH BIOCHEM BIOPHYS, V316, P461, DOI 10.1006/abbi.1995.1061; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; Chintagari NR, 2015, BLOOD CELL MOL DIS, V54, P302, DOI 10.1016/j.bcmd.2014.12.001; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; GAREL MC, 1990, BIOCHIM BIOPHYS ACTA, V1041, P133, DOI 10.1016/0167-4838(90)90056-L; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gladwin MT, 2014, BLOOD, V123, P3689, DOI 10.1182/blood-2014-03-563874; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; Gunther MR, 1998, BIOCHEM J, V330, P1293; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HEBBEL RP, 1989, AM J PHYSIOL, V256, pC579, DOI 10.1152/ajpcell.1989.256.3.C579; Herold S, 2003, FREE RADICAL BIO MED, V34, P531, DOI 10.1016/S0891-5849(02)01355-2; Higdon AN, 2012, AM J PHYSIOL-HEART C, V302, pH1394, DOI 10.1152/ajpheart.00584.2011; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jana S, 2011, BBA-MOL BASIS DIS, V1812, P663, DOI 10.1016/j.bbadis.2011.02.013; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; MAPLES KR, 1990, ARCH BIOCHEM BIOPHYS, V277, P402, DOI 10.1016/0003-9861(90)90596-Q; MARVA E, 1994, BLOOD, V83, P242; MCARTHUR KM, 1993, BIOCHIM BIOPHYS ACTA, V1202, P173, DOI 10.1016/0167-4838(93)90002-9; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; OSAWA Y, 1993, BIOCHEM PHARMACOL, V46, P2299, DOI 10.1016/0006-2952(93)90621-3; PAULING L, 1964, Bull N Y Acad Med, V40, P334; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; Potoka KP, 2015, AM J PHYSIOL-LUNG C, V308, pL314, DOI 10.1152/ajplung.00252.2014; Reeder BJ, 2001, FREE RADICAL BIO MED, V30, P1311, DOI 10.1016/S0891-5849(01)00534-2; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Safo MK, 2013, ACTA CRYSTALLOGR D, V69, P2061, DOI 10.1107/S0907444913019197; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tam MF, 2015, J BIOL CHEM, V290, P21762, DOI 10.1074/jbc.M115.658054; TEW D, 1988, J BIOL CHEM, V263, P17880; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; Wright PJ, 2003, J AM CHEM SOC, V125, P8655, DOI 10.1021/ja0291888	70	36	36	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27939	27958		10.1074/jbc.M115.651257	http://dx.doi.org/10.1074/jbc.M115.651257			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396189	hybrid, Green Published			2022-12-26	WOS:000365757500042
J	Feng, YQ; Love, RP; Ara, A; Baig, TT; Adolph, MB; Chelico, L				Feng, Yuqing; Love, Robin P.; Ara, Anjuman; Baig, Tayyba T.; Adolph, Madison B.; Chelico, Linda			Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTIDINE DEAMINASE APOBEC3H; AMINO-ACID DIFFERENCE; HIV-1 VIF-BINDING; CRYSTAL-STRUCTURE; RESTRICTION FACTORS; STRUCTURAL DETERMINANTS; ANTIVIRAL ACTIVITY; IN-VIVO; FUNCTIONAL IMPLICATIONS	APOBEC3H is a deoxycytidine deaminase that can restrict the replication of HIV-1 in the absence of the viral protein Vif that induces APOBEC3H degradation in cells. APOBEC3H exists in humans as seven haplotypes (I-VII) with different cellular stabilities. Of the three stable APOBEC3H haplotypes (II, V, and VII), haplotypes II and V occur most frequently in the population. Despite APOBEC3H being a bona fide restriction factor, there has been no comparative biochemical characterization of APOBEC3H haplotypes. We characterized the ssDNA scanning mechanisms that haplotypes II and V use to search their ssDNA substrate for cytosine-containing deamination motifs. APOBEC3H haplotype II was able to processively deaminate multiple cytosines in a single enzyme-substrate encounter by using sliding, jumping, and intersegmental transfer movements. In contrast, APOBEC3H haplotype V exhibited diminished sliding and intersegmental transfer abilities but was able to jump along ssDNA. Due to an Asp or Glu at amino acid 178 differentiating these APOBEC3H haplotypes, the data indicated that this amino acid on helix 6 contributes to processivity. The diminished processivity of APOBEC3H haplotype V did not result in a reduced efficiency to restrict HIV-1 replication in single-cycle infectivity assays, suggesting a redundancy in the contributions of jumping and intersegmental transfer to mutagenic efficiency. Optimal processivity on ssDNA also required dimerization of APOBEC3H through the 2 strands. The findings support a model in which jumping can compensate for deficiencies in intersegmental transfer and suggest that APOBEC3H haplotypes II and V induce HIV-1 mutagenesis efficiently but by different mechanisms.	[Feng, Yuqing; Love, Robin P.; Ara, Anjuman; Baig, Tayyba T.; Adolph, Madison B.; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Ara, Anjuman/0000-0002-6302-4849; Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978; Love, Robin/0000-0002-2509-706X	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research [MOP-37090]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and Canadian Institutes for Health Research Grant MOP-37090. The authors declare that they have no conflicts of interest with the contents of this article.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Baig TT, 2014, J VIROL, V88, P14380, DOI 10.1128/JVI.02484-14; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Feng YQ, 2013, J BIOL CHEM, V288, P6083, DOI 10.1074/jbc.M112.421875; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; King JJ, 2015, STRUCTURE, V23, P615, DOI 10.1016/j.str.2015.01.016; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li MMH, 2011, J VIROL, V85, P8197, DOI 10.1128/JVI.00624-11; Li MMH, 2010, J VIROL, V84, P88, DOI 10.1128/JVI.01344-09; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mitra M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0130-8; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Ooms M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057744; Ooms M, 2010, J VIROL, V84, P7961, DOI 10.1128/JVI.00754-10; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Sakurai D, 2015, IMMUNOGENETICS, V67, P253, DOI 10.1007/s00251-015-0829-2; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shandilya SMD, 2014, VIROLOGY, V471, P105, DOI 10.1016/j.virol.2014.09.023; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Song CS, 2012, J BIOL CHEM, V287, P16965, DOI 10.1074/jbc.M111.310839; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	88	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27188	27203		10.1074/jbc.M115.666065	http://dx.doi.org/10.1074/jbc.M115.666065			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396192	Green Published, hybrid			2022-12-26	WOS:000364794000028
J	Sahu, B; Sun, WY; Perusek, L; Parmar, V; Le, YZ; Griswold, MD; Palczewski, K; Maeda, A				Sahu, Bhubanananda; Sun, Wenyu; Perusek, Lindsay; Parmar, Vipulkumar; Le, Yun-Zheng; Griswold, Michael D.; Palczewski, Krzysztof; Maeda, Akiko			Conditional Ablation of Retinol Dehydrogenase 10 in the Retinal Pigmented Epithelium Causes Delayed Dark Adaption in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE; ALL-TRANS-RETINOL; VISUAL CYCLE; ALCOHOL-DEHYDROGENASE; RETINITIS-PIGMENTOSA; VERTEBRATE RETINA; BINDING PROTEIN; IN-VIVO; FUNDUS-ALBIPUNCTATUS; MOLECULAR-MECHANISMS	Background: RDH10 is a candidate 11-cis-retinol dehydrogenase in the retinal pigmented epithelium (RPE) capable of regenerating the visual chromophore, 11-cis-retinal. Results: Loss of Rdh10 in RPE cells caused delayed regeneration of 11-cis-retinal. Conclusion: Rdh10 is an NAD(+)-dependent 11-cis-retinol dehydrogenase localized to RPE cells. Significance: This study provides evidence that RDH10 plays a complimentary role in producing 11-cis-retinal in the RPE. Regeneration of the visual chromophore, 11-cis-retinal, is a crucial step in the visual cycle required to sustain vision. This cycle consists of sequential biochemical reactions that occur in photoreceptor cells and the retinal pigmented epithelium (RPE). Oxidation of 11-cis-retinol to 11-cis-retinal is accomplished by a family of enzymes termed 11-cis-retinol dehydrogenases, including RDH5 and RDH11. Double deletion of Rdh5 and Rdh11 does not limit the production of 11-cis-retinal in mice. Here we describe a third retinol dehydrogenase in the RPE, RDH10, which can produce 11-cis-retinal. Mice with a conditional knock-out of Rdh10 in RPE cells (Rdh10 cKO) displayed delayed 11-cis-retinal regeneration and dark adaption after bright light illumination. Retinal function measured by electroretinogram after light exposure was also delayed in Rdh10 cKO mice as compared with controls. Double deletion of Rdh5 and Rdh10 (cDKO) in mice caused elevated 11/13-cis-retinyl ester content also seen in Rdh5(-/-)Rdh11(-/-) mice as compared with Rdh5(-/-) mice. Normal retinal morphology was observed in 6-month-old Rdh10 cKO and cDKO mice, suggesting that loss of Rdh10 in the RPE does not negatively affect the health of the retina. Compensatory expression of other retinol dehydrogenases was observed in both Rdh5(-/-) and Rdh10 cKO mice. These results indicate that RDH10 acts in cooperation with other RDH isoforms to produce the 11-cis-retinal chromophore needed for vision.	[Sahu, Bhubanananda; Perusek, Lindsay; Parmar, Vipulkumar; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Sun, Wenyu] Polgenix Inc, Cleveland, OH 44106 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Washington State University	Maeda, A (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01EY022658, R24EY021126, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Midwest Eye Banks; Ohio Lions Eye Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022658, R24EY021126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Midwest Eye Banks; Ohio Lions Eye Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01EY022658 (to A.M.), R24EY021126 (to K.P.), and P30EY011373, Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Midwest Eye Banks, and Ohio Lions Eye Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; BLISS AF, 1951, ARCH BIOCHEM BIOPHYS, V31, P197, DOI 10.1016/0003-9861(51)90206-8; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Driessen C, 2003, VISION RES, V43, P3075, DOI 10.1016/S0042-6989(03)00483-8; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Martras S, 2004, EUR J BIOCHEM, V271, P1660, DOI 10.1111/j.1432-1033.2004.04058.x; Mata NL, 1998, BBA-LIPID LIPID MET, V1394, P16, DOI 10.1016/S0005-2760(98)00078-2; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Svensson S, 1999, J BIOL CHEM, V274, P29712, DOI 10.1074/jbc.274.42.29712; Takahashi Y, 2009, BIOCHEM J, V419, P113, DOI 10.1042/BJ20080812; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Xie YJ, 2014, HUM MOL GENET, V23, P5774, DOI 10.1093/hmg/ddu291; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Yesim F, 2004, AM J OPHTHALMOL, V138, P171, DOI 10.1016/j.ajo.2004.02.060; ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P10868, DOI 10.1074/jbc.270.18.10868; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhuang R, 2002, BIOCHEMISTRY-US, V41, P3477, DOI 10.1021/bi0119316	53	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27239	27247		10.1074/jbc.M115.682096	http://dx.doi.org/10.1074/jbc.M115.682096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391396	hybrid, Green Published			2022-12-26	WOS:000364794000032
J	Staniec, D; Ksiazek, M; Thogersen, IB; Enghild, JJ; Sroka, A; Bryzek, D; Bogyo, M; Abrahamson, M; Potempa, J				Staniec, Dominika; Ksiazek, Miroslaw; Thogersen, Ida B.; Enghild, Jan J.; Sroka, Aneta; Bryzek, Danuta; Bogyo, Matthew; Abrahamson, Magnus; Potempa, Jan			Calcium Regulates the Activity and Structural Stability of Tpr, a Bacterial Calpain-like Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS W83; VIRULENCE FACTORS; PROTEASE GENE; PERIODONTITIS; EXPRESSION; GINGIPAINS; PROTEINASES; MECHANISM; DISEASE	Background: Calcium-activated, family C2 cysteine peptidases (calpains) are rare among prokaryotes, and none have been characterized. Results: Tpr peptidase from Porphyromonas gingivalis requires calcium for stability, autoprocessing, and activity. Conclusion: Tpr is the calcium-regulated peptidase well adapted to function on the P. gingivalis cell surface. Significance: Tpr is the first characterized bacteria-derived calpain-like peptidase. Porphyromonas gingivalis is a peptide-fermenting asaccharolytic periodontal pathogen. Its genome contains several genes encoding cysteine peptidases other than gingipains. One of these genes (PG1055) encodes a protein called Tpr (thiol protease) that has sequence similarity to cysteine peptidases of the papain and calpain families. In this study we biochemically characterize Tpr. We found that the 55-kDa Tpr inactive zymogen proteolytically processes itself into active forms of 48, 37, and 33 kDa via sequential truncations at the N terminus. These processed molecular forms of Tpr are associated with the bacterial outer membrane where they are likely responsible for the generation of metabolic peptides required for survival of the pathogen. Both autoprocessing and activity were dependent on calcium concentrations >1 mM, consistent with the protein's activity within the intestinal and inflammatory milieus. Calcium also stabilized the Tpr structure and rendered the protein fully resistant to proteolytic degradation by gingipains. Together, our findings suggest that Tpr is an example of a bacterial calpain, a calcium-responsive peptidase that may generate substrates required for the peptide-fermenting metabolism of P. gingivalis. Aside from nutrient generation, Tpr may also be involved in evasion of host immune response through degradation of the antimicrobial peptide LL-37 and complement proteins C3, C4, and C5. Taken together, these results indicate that Tpr likely represents an important pathogenesis factor for P. gingivalis.	[Staniec, Dominika; Ksiazek, Miroslaw; Sroka, Aneta; Bryzek, Danuta; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus, Denmark; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Staniec, Dominika; Abrahamson, Magnus] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22100 Lund, Sweden; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Ksiazek, Miroslaw; Potempa, Jan] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University; Aarhus University; Aarhus University; Stanford University; Lund University; University of Louisville; Jagiellonian University	Staniec, D (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Gronostajowa 7, PL-30387 Krakow, Poland.	dominika.staniec@uj.edu.pl	Potempa, Jan/AAA-6850-2021; Abrahamson, Magnus/CAG-9507-2022	Sroka, Aneta/0000-0002-3386-5364; Potempa, Jan/0000-0002-3600-7461; Enghild, Jan Johannes/0000-0001-9292-9172; Bogyo, Matthew/0000-0003-3753-4412	Ministry of Science and Higher Education; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to Anna-Cathrine Carlberg-Lofstrom for technical assistance. The Faculty of Biochemistry, Biophysics, and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; BOURGEAU G, 1992, INFECT IMMUN, V60, P3186, DOI 10.1128/IAI.60.8.3186-3192.1992; Chee B, 2013, INT J EVID-BASED HEA, V11, P317, DOI 10.1111/1744-1609.12038; Cobb CM, 2009, PERIODONTOL 2000, V50, P13, DOI 10.1111/j.1600-0757.2008.00284.x; Darby I, 2001, PERIODONTOL 2000, V26, P33, DOI 10.1034/j.1600-0757.2001.2260103.x; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Fitzpatrick RE, 2009, J INNATE IMMUN, V1, P109, DOI 10.1159/000181145; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Lu BQ, 1998, INFECT IMMUN, V66, P5147, DOI 10.1128/IAI.66.11.5147-5156.1998; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park Y, 1997, INFECT IMMUN, V65, P1101, DOI 10.1128/IAI.65.3.1101-1104.1997; PARK Y, 1993, INFECT IMMUN, V61, P4139, DOI 10.1128/IAI.61.10.4139-4146.1993; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; POTEMPA J, 1995, TRENDS MICROBIOL, V3, P430, DOI 10.1016/S0966-842X(00)88996-9; Potempa M, 2012, BIOL CHEM, V393, P873, DOI 10.1515/hsz-2012-0174; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tokuda M, 1998, INFECT IMMUN, V66, P5232, DOI 10.1128/IAI.66.11.5232-5237.1998; Travis J, 1997, J PERIODONTAL RES, V32, P120, DOI 10.1111/j.1600-0765.1997.tb01392.x; Veillard F, 2012, BIOL CHEM, V393, P1471, DOI 10.1515/hsz-2012-0222; Walker CB, 1997, CLIN INFECT DIS, V25, pS281, DOI 10.1086/516222; Wegner N, 2009, INT J BIOCHEM CELL B, V41, P390, DOI 10.1016/j.biocel.2008.09.012; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992	32	11	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27248	27260		10.1074/jbc.M115.648782	http://dx.doi.org/10.1074/jbc.M115.648782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26385924	Green Published, hybrid			2022-12-26	WOS:000364794000033
J	Dahl, V; Tegnell, A; Wallensten, A				Dahl, Viktor; Tegnell, Anders; Wallensten, Anders			Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013	PLOS ONE			English	Article							SETTING PRIORITIES; SUCCESS	To establish strategic priorities for the Public Health Agency of Sweden we prioritized pathogens according to their public health relevance in Sweden in order to guide resource allocation. We then compared the outcome to ongoing surveillance. We used a modified prioritization method developed at the Robert Koch Institute in Germany. In a Delphi process experts scored pathogens according to ten variables. We ranked the pathogens according to the total score and divided them into four priority groups. We then compared the priority groups to self-reported time spent on surveillance by epidemiologists and ongoing programmes for surveillance through mandatory and/or voluntary notifications and for surveillance of typing results. 106 pathogens were scored. The result of the prioritization process was similar to the outcome of the prioritization in Germany. Common pathogens such as calicivirus and Influenza virus as well as blood-borne pathogens such as human immunodeficiency virus, hepatitis B and C virus, gastro-intestinal infections such as Campylobacter and Salmonella and vector-borne pathogens such as Borrelia were all in the highest priority group. 63% of time spent by epidemiologists on surveillance was spent on pathogens in the highest priority group and all pathogens in the highest priority group, except for Borrelia and varicella-zoster virus, were under surveillance through notifications. Ten pathogens in the highest priority group (Borrelia, calicivirus, Campylobacter, Echinococcus multilocularis, hepatitis C virus, HIV, respiratory syncytial virus, SARS- and MERS coronavirus, tick-borne encephalitis virus and varicella-zoster virus) did not have any surveillance of typing results. We will evaluate the possibilities of surveillance for the pathogens in the highest priority group where we currently do not have any ongoing surveillance and evaluate the need of surveillance for the pathogens from the low priority group where there is ongoing surveillance in order to focus our work on the pathogens with the highest relevance.	[Dahl, Viktor; Tegnell, Anders; Wallensten, Anders] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Dahl, Viktor] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Wallensten, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control; Uppsala University	Dahl, V (corresponding author), Publ Hlth Agcy Sweden, Stockholm, Sweden.	viktor.dahl@folkhalsomyndigheten.se		Dahl, Viktor/0000-0001-9921-5172	Public Health Agency of Sweden	Public Health Agency of Sweden	The work was funded by The Public Health Agency of Sweden.	Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Doherty J A, 2000, Can J Infect Dis, V11, P21; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Heymann David L., 2008, CONTROL COMMUNICABLE; Krause G., 2008, EURO SURVEILLANCE B, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; Pavlin BI, 2010, ASIA-PAC J PUBLIC HE, V22, P279, DOI 10.1177/1010539509342748; Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5; Sibbald SL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-131; Sibbald SL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-43; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36	12	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136353	10.1371/journal.pone.0136353	http://dx.doi.org/10.1371/journal.pone.0136353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397699	Green Published, gold			2022-12-26	WOS:000361797500008
J	Alvarez, JV; Chung, JS				Alvarez, Javier V.; Chung, J. Sook			The Involvement of Hemocyte Prophenoloxidase in the Shell-Hardening Process of the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; MOLT-INHIBITING HORMONE; MOLECULAR-CLONING; CUTICLE SCLEROTIZATION; HYPERGLYCEMIC HORMONE; PRO-PHENOLOXIDASE; ACTIVATING SYSTEM; PHENOL OXIDASE; FIDDLER-CRAB; H+ EXCRETION	Cuticular structures of arthropods undergo dramatic molt-related changes frombeing soft to becoming hard. The shell-hardening process of decapod crustaceans includes sclerotization and mineralization. Hemocyte PPO plays a central role in melanization and sclerotization particularly in wound healing in crustaceans. However, little is known about its role in the crustacean initial shell-hardening process. The earlier findings of the aggregation of heavily granulated hemocytes beneath the hypodermis during ecdysis imply that the hemocytes may be involved in the shell-hardening process. In order to determine if hemocytes and hemocyte PPO have a role in the shell-hardening of crustaceans, a knockdown study using specific CasPPO-hemo-dsRNA was carried out with juvenile blue crabs, Callinectes sapidus. Multiple injections of CasPPO-hemo-dsRNA reduce specifically the levels of CasPPO-hemo expression by 57% and PO activity by 54% in hemocyte lysate at the postmolt, while they have no effect on the total hemocyte numbers. Immunocytochemistry and flow cytometry analysis using a specific antiserum generated against CasPPO show granulocytes, semigranulocytes and hyaline cells as the cellular sources for PPO at the postmolt. Interestingly, the type of hemocytes, as the cellular sources of PPO, varies by molt stage. The granulocytes always contain PPO throughout the molt cycle. However, semigranulocytes and hyaline cells become CasPPO immune-positive only at early premolt and postmolt, indicating that PPO expression in these cells may be involved in the shell-hardening process of C. sapidus.	[Alvarez, Javier V.; Chung, J. Sook] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Chung, JS (corresponding author), Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, 701 E Pratt St, Baltimore, MD 21201 USA.	chung@umces.edu	Chung, J.Sook/D-3832-2012	Chung, J.Sook/0000-0002-9318-304X	Fulbright program; Chilean government through educational exchange program	Fulbright program; Chilean government through educational exchange program	We are grateful to the staff of the blue crab hatchery for young juvenile crabs, Aquaculture Research center (ARC, Institute of Marine and Environmental Technology, Baltimore, MD) for maintaining the re-circulated artificial seawater system in the experimental tanks and the Laboratory Service, Biological Program Department in National Aquarium (Baltimore) for testing water quality daily. J. V. Alvarez was supported by the Fulbright program and the Chilean government through educational exchange program between Chile and USA. This article is contribution no. 5078 of the University of Maryland Center for Environmental Science and contribution no. 15-163 of the Institute of Marine and Environmental Technology.	Ai HS, 2009, DEV COMP IMMUNOL, V33, P59, DOI 10.1016/j.dci.2008.07.017; Alvarez JV, 2013, FISH SHELLFISH IMMUN, V35, P1349, DOI 10.1016/j.fsi.2013.07.041; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; Andersen SO, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P167, DOI 10.1016/B978-0-12-384747-8.10006-6; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; [Anonymous], 1995, ANIM BIOL; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Arockiaraj J, 2013, GENE, V524, P139, DOI 10.1016/j.gene.2013.04.044; Asada N, 2003, BIOCHEM GENET, V41, P151, DOI 10.1023/A:1023325610300; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; Asano T, 2001, J BIOL CHEM, V276, P11113, DOI 10.1074/jbc.M008425200; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; BODAMMER JE, 1978, CELL TISSUE RES, V187, P79; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P85, DOI 10.1007/978-1-59745-324-0_12; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P75, DOI 10.1007/978-1-59745-324-0_11; BRODY MD, 1989, INVERTEBR REPROD DEV, V16, P141, DOI 10.1080/07924259.1989.9672070; Buda ES, 2005, COMP BIOCHEM PHYS B, V140, P521, DOI 10.1016/j.cbpc.2004.11.017; Buda ES., 2004, THESIS U N CAROLINA, P28; CAMERON JN, 1985, J EXP BIOL, V119, P275; CAMERON JN, 1985, J EXP BIOL, V114, P181; CAMERON JN, 1989, J EXP BIOL, V143, P285; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; CHANG ES, 1993, AM ZOOL, V33, P324; Chang ES, 2001, AM ZOOL, V41, P1090, DOI 10.1668/0003-1569(2001)041[1090:HITLOC]2.0.CO;2; Chen P, 2010, FISH SHELLFISH IMMUN, V28, P106, DOI 10.1016/j.fsi.2009.10.002; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 2014, GEN COMP ENDOCR, V199, P56, DOI 10.1016/j.ygcen.2014.01.012; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; Chung JS, 2012, FISH SHELLFISH IMMUN, V32, P16, DOI 10.1016/j.fsi.2011.08.023; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cunningham RE, 2010, METHODS MOL BIOL, V588, P335, DOI 10.1007/978-1-59745-324-0_34; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dillaman R, 2005, J MORPHOL, V263, P356, DOI 10.1002/jmor.10311; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Grigorian M, 2013, DEV GENES EVOL, V223, P103, DOI 10.1007/s00427-012-0428-2; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P237, DOI 10.1016/S0022-0981(03)00236-3; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; HOSE JE, 1992, BIOL BULL-US, V183, P185, DOI 10.2307/1542206; HOSE JE, 1987, BIOL BULL, V173, P178, DOI 10.2307/1541871; HOSE JE, 1990, BIOL BULL, V178, P33, DOI 10.2307/1541535; Itou K, 2009, FISHERIES SCI, V75, P91, DOI 10.1007/s12562-008-0003-y; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; KATO Y, 1987, DEVELOPMENT, V100, P227; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Ko CF, 2007, DEV COMP IMMUNOL, V31, P12, DOI 10.1016/j.dci.2006.05.002; LANZ H, 1993, DEV COMP IMMUNOL, V17, P389, DOI 10.1016/0145-305X(93)90030-T; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P60, DOI 10.1016/j.fsi.2005.10.004; LORET SM, 1993, J EXP ZOOL, V267, P548, DOI 10.1002/jez.1402670510; Masuda T, 2012, FISH SHELLFISH IMMUN, V32, P61, DOI 10.1016/j.fsi.2011.10.020; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; NEUFELD DS, 1994, J EXP BIOL, V188, P11; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Paria A, 2013, APPL BIOCHEM BIOTECH, V169, P281, DOI 10.1007/s12010-012-9964-5; Passano L., 1960, PHYSIOL CRUSTACEA, P473, DOI DOI 10.1016/B978-0-12-395628-6.50021-X; ROER R, 1984, AM ZOOL, V24, P893; Sequeira T, 1995, BIOL BULL, V189, P376, DOI 10.2307/1542156; SHAFER TH, 1995, J EXP ZOOL, V271, P171, DOI 10.1002/jez.1402710303; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; SKOWSKY WR, 1972, J LAB CLIN MED, V80, P134; Smith SG., 2007, BLUE CRAB CALLINECTE, P197; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Soderhall K, 2011, DESEASES ASIAN AQUAC, P177; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Stevens BG, 2009, J CRUSTACEAN BIOL, V29, P157, DOI 10.1651/08-3039R.1; SUGUMARAN M, 1992, J BIOL CHEM, V267, P10355; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; SUMMERS NM, 1967, COMP BIOCHEM PHYSIOL, V23, P129, DOI 10.1016/0010-406X(67)90480-X; SZOPA TM, 1985, DEV BIOL, V107, P325, DOI 10.1016/0012-1606(85)90315-X; Techa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117278; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; Wang YC, 2006, FISH SHELLFISH IMMUN, V20, P414, DOI 10.1016/j.fsi.2005.05.003; Wang YC, 2007, FISH SHELLFISH IMMUN, V23, P1161, DOI 10.1016/j.fsi.2007.04.004; Wenli C., 2007, T CHINESE CRUSTACEAN, V5, P25; Williams DL, 2009, J CRUSTACEAN BIOL, V29, P550, DOI 10.1651/08-3053.1; Zmora N, 2014, ENDOCRINOLOGY, V155, P230, DOI 10.1210/en.2013-1603	90	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0136916	10.1371/journal.pone.0136916	http://dx.doi.org/10.1371/journal.pone.0136916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393802	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100008
J	Horscroft, JA; Burgess, SL; Hu, YQ; Murray, AJ				Horscroft, James A.; Burgess, Sarah L.; Hu, Yaqi; Murray, Andrew J.			Altered Oxygen Utilisation in Rat Left Ventricle and Soleus after 14 Days, but Not 2 Days, of Environmental Hypoxia	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; HYPOBARIC HYPOXIA; OXIDATIVE STRESS; GENE-EXPRESSION; ALTITUDE; HEART; ACCLIMATIZATION; ADAPTATIONS; METABOLISM; ENERGETICS	The effects of environmental hypoxia on cardiac and skeletal muscle metabolism are dependent on the duration and severity of hypoxic exposure, though factors which dictate the nature of the metabolic response to hypoxia are poorly understood. We therefore set out to investigate the time-dependence of metabolic acclimatisation to hypoxia in rat cardiac and skeletal muscle. Rats were housed under normoxic conditions, or exposed to short-term (2 d) or sustained (14 d) hypoxia (10% O-2), after which samples were obtained from the left ventricle of the heart and the soleus for assessment of metabolic regulation and mitochondrial function. Mass-corrected maximal oxidative phosphorylation was 20% lower in the left ventricle following sustained but not short-term hypoxia, though no change was observed in the soleus. After sustained hypoxia, the ratio of octanoyl carnitine-to pyruvate-supported respiration was 11% and 12% lower in the left ventricle and soleus, respectively, whilst hexokinase activity increased by 33% and 2.1-fold in these tissues. mRNA levels of PPAR alpha targets fell after sustained hypoxia in both tissues, but those of PPAR alpha remained unchanged. Despite decreased Ucp3 expression after short-term hypoxia, UCP3 protein levels and mitochondrial coupling remained unchanged. Protein carbonylation was 40% higher after short-term but not sustained hypoxic exposure in the left ventricle, but was unchanged in the soleus at both timepoints. Our findings therefore demonstrate that 14 days, but not 2 days, of hypoxia induces a loss of oxidative capacity in the left ventricle but not the soleus, and a substrate switch away from fatty acid oxidation in both tissues.	[Horscroft, James A.; Burgess, Sarah L.; Hu, Yaqi; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of Cambridge	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk		Murray, Andrew/0000-0002-0929-9315	Biotechnology and Biological Sciences Research Council [BB/F016581/1]; Imperial College, London; Resarch Council UK; Biotechnology and Biological Sciences Research Council [1103090] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College, London; Resarch Council UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JAH received a PhD Studentship from the Biotechnology and Biological Sciences Research Council (Grant number: BB/F016581/1, www.bbsrc.ac.uk). SLB received no specific funding for this work. HY received a Departmental Summer Studentship Bursary from Imperial College, London (www.imperial.ac.uk). AJM received an academic fellowship from the Resarch Council UK (www.rcuk.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalki A, 1996, PFLUG ARCH EUR J PHY, V431, P671, DOI 10.1007/BF02253829; Adrogue JV, 2005, MOL CELL BIOCHEM, V278, P71, DOI 10.1007/s11010-005-6629-5; Anedda A, 2013, FREE RADICAL BIO MED, V61, P395, DOI 10.1016/j.freeradbiomed.2013.04.007; Ashmore T, 2014, J PHYSIOL-LONDON, V592, P4715, DOI 10.1113/jphysiol.2014.275263; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Essop MF, 2004, BIOCHEM BIOPH RES CO, V314, P561, DOI 10.1016/j.bbrc.2003.12.121; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Holloway C, 2011, FASEB J, V25, P3130, DOI 10.1096/fj.11-183426; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Houle-Leroy P, 2000, J APPL PHYSIOL, V89, P1608, DOI 10.1152/jappl.2000.89.4.1608; Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206; Jacobs RA, 2013, EXP PHYSIOL, V98, P245, DOI 10.1113/expphysiol.2012.066092; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Magalhaes J, 2007, CLIN SCI, V113, P459, DOI 10.1042/CS20070075; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mason SD, 2007, AM J PHYSIOL-REG I, V293, pR2059, DOI 10.1152/ajpregu.00335.2007; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; McClelland GB, 2002, J APPL PHYSIOL, V92, P1573, DOI 10.1152/japplphysiol.01069.2001; Morash AJ, 2013, AM J PHYSIOL-REG I, V305, pR534, DOI 10.1152/ajpregu.00510.2012; Murray AJ, 2015, J PHYSL; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; O'Brien KA, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-015-0026-9; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Roberts AC, 1996, J APPL PHYSIOL, V80, P605, DOI 10.1152/jappl.1996.80.2.605; Roberts AC, 1996, J APPL PHYSIOL, V81, P1762, DOI 10.1152/jappl.1996.81.4.1762; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tsutsui H, 2006, INTERNAL MED, V45, P809, DOI 10.2169/internalmedicine.45.1765; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138564	10.1371/journal.pone.0138564	http://dx.doi.org/10.1371/journal.pone.0138564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390043	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000039
J	Lee, Z; Nishikawa, S; Gao, S; Eksteen, JB; Czub, M; Gill, MJ; Osiowy, C; van der Meer, F; van Marle, G; Coffin, CS				Lee, Z.; Nishikawa, S.; Gao, S.; Eksteen, J. B.; Czub, M.; Gill, M. J.; Osiowy, C.; van der Meer, F.; van Marle, G.; Coffin, C. S.			Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; NORTH-AMERICAN COHORT; NON-HODGKIN-LYMPHOMA; PERIPHERAL-BLOOD; TRANSPLANT RECIPIENTS; LIVER-TRANSPLANTATION; ANTIVIRAL THERAPY; VIRAL-HEPATITIS; DNA; PERSISTENCE	The hepatitis B virus (HBV) and the human immunodeficiency virus type 1 (HIV-1) can infect cells of the lymphatic system. It is unknown whether HIV-1 co-infection impacts infection of peripheral blood mononuclear cell (PBMC) subsets by the HBV. Aims To compare the detection of HBV genomes and HBV sequences in unsorted PBMCs and subsets (i.e., CD4 + T, CD8+ T, CD14+ monocytes, CD19+ B, CD56+ NK cells) in HBV mono-infected vs. HBV/HIV-1 co-infected individuals. Methods Total PBMC and subsets isolated from 14 HBV mono-infected (4/14 before and after anti-HBV therapy) and 6 HBV/HIV-1 co-infected individuals (5/6 consistently on dual active anti-HBV/HIV therapy) were tested for HBV genomes, including replication indicative HBV covalently closed circular (ccc)-DNA, by nested PCR/nucleic hybridization and/or quantitative PCR. In CD4+, and/or CD56+ subsets from two HBV monoinfected cases, the HBV polymerase/overlapping surface region was analyzed by next generation sequencing. Results All analyzed whole PBMC from HBV monoinfected and HBV/HIV coinfected individuals were HBV genome positive. Similarly, HBV DNA was detected in all target PBMC subsets regardless of antiviral therapy, but was absent from the CD4+ T cell subset from all HBV/HIV-1 positive cases (P<0.04). In the CD4 + and CD56+ subset of 2 HBV monoinfected cases on tenofovir therapy, mutations at residues associated with drug resistance and/or immune escape (i.e., G145R) were detected in a minor percentage of the population. Summary HBV genomes and drug resistant variants were detectable in PBMC subsets from HBV mono-infected individuals. The HBV replicates in PBMC subsets of HBV/HIV-1 patients except the CD4+ T cell subpopulation.	[Lee, Z.; Nishikawa, S.; Gao, S.; Eksteen, J. B.; Coffin, C. S.] Univ Calgary, Div Gastroenterol & Hepatol, Cumming Sch Med, Liver Unit, Calgary, AB, Canada; [Lee, Z.; Nishikawa, S.; Gao, S.; Gill, M. J.; van Marle, G.; Coffin, C. S.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, Calgary, AB, Canada; [Czub, M.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Osiowy, C.] Natl Microbiol Lab, Bloodborne Pathogens & Hepatitis Lab, Winnipeg, MB, Canada; [van der Meer, F.] Univ Calgary, Fac Vet Med, Ecosyst & Publ Hlth, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Coffin, CS (corresponding author), Univ Calgary, Div Gastroenterol & Hepatol, Cumming Sch Med, Liver Unit, Calgary, AB, Canada.	cscoffin@ucalgary.ca	Dodsley, Maria/G-7083-2016; Osiowy, Carla/L-5692-2019; van der Meer, Frank JUM/F-5011-2012; van der Meer, Frank/T-3497-2019; van der Meer, Frank/AAX-3784-2020; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Osiowy, Carla/0000-0002-5429-7220; van der Meer, Frank JUM/0000-0003-3785-9639; van der Meer, Frank/0000-0003-3785-9639; Gill, Michael John/0000-0002-8546-8790	Canadian Institutes of Health Research [CIHR-III HIV-1/AIDS BF-200630]; Canadian Liver Foundation Graduate Studentship Award; Queen Elizabeth II Award; CIHR New Investigator Award (CIHR Priority Announcement HIV/AIDS Biomedical/Clinical Research) [122776]; American Gastroenterology Research Scholar Award; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Liver Foundation Graduate Studentship Award; Queen Elizabeth II Award; CIHR New Investigator Award (CIHR Priority Announcement HIV/AIDS Biomedical/Clinical Research); American Gastroenterology Research Scholar Award; Alberta Innovates	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR-III HIV-1/AIDS BF-200630, www.cihr-irsc.gc.ca). ZL was supported by the 2013 Canadian Liver Foundation Graduate Studentship Award (www.liver.ca) and the 2012 Queen Elizabeth II Award. CSC is supported by the 2012 CIHR New Investigator Award (CIHR Priority Announcement HIV/AIDS Biomedical/Clinical Research 122776) and the 2011-2013 American Gastroenterology Research Scholar Award (www.aga.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLOME FJ, 1990, J HEPATOL, V10, P186, DOI 10.1016/0168-8278(90)90050-2; Becker N, 2012, J CANCER RES CLIN, V138, P1993, DOI 10.1007/s00432-012-1279-y; BOUFFARD P, 1992, J MED VIROL, V37, P255, DOI 10.1002/jmv.1890370404; BOUFFARD P, 1990, J MED VIROL, V31, P312, DOI 10.1002/jmv.1890310413; Brind A, 1997, J HEPATOL, V26, P228, DOI 10.1016/S0168-8278(97)80035-9; Cabrerizo M, 2000, HEPATOLOGY, V32, P116, DOI 10.1053/jhep.2000.8541; Chakravarty R, 2002, VIRUS RES, V90, P133, DOI 10.1016/S0168-1702(02)00147-8; Chemin I, 1994, J Viral Hepat, V1, P39, DOI 10.1111/j.1365-2893.1994.tb00060.x; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Coffin CS, 2015, J VIRAL HEPATITIS, V22, P416, DOI 10.1111/jvh.12308; Coffin CS, 2013, J CLIN VIROL, V57, P103, DOI 10.1016/j.jcv.2013.02.004; Coffin CS, 2011, J VIRAL HEPATITIS, V18, P415, DOI 10.1111/j.1365-2893.2010.01321.x; Coffin CS, 2010, AM J TRANSPLANT, V10, P1268, DOI 10.1111/j.1600-6143.2010.03070.x; Coffin CS, 2007, LIVER INT, V27, P722, DOI 10.1111/j.1478-3231.2007.01477.x; Coffin CS, 2014, J CLIN VIROL, V60, P347, DOI 10.1016/j.jcv.2014.04.021; Coffin CS, 2011, LIVER TRANSPLANT, V17, P955, DOI 10.1002/lt.22312; Coffin CS, 1999, J CLIN INVEST, V104, P203, DOI 10.1172/JCI5048; Datta S, 2009, J VIROL, V83, P9983, DOI 10.1128/JVI.01905-08; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; FERAY C, 1990, TRANSPLANTATION, V49, P1155, DOI 10.1097/00007890-199006000-00025; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; LAURE F, 1985, SCIENCE, V229, P561, DOI 10.1126/science.2410981; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Loustaud-Ratti V, 2013, CLIN RES HEPATOL GAS, V37, P373, DOI 10.1016/j.clinre.2012.11.002; MASON A, 1993, HEPATOLOGY, V18, P781, DOI 10.1002/hep.1840180406; Michalak TI, 2004, J VIROL, V78, P1730, DOI 10.1128/JVI.78.4.1730-1738.2004; MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Nath A, 2010, INTERN MED J, V40, P633, DOI 10.1111/j.1445-5994.2009.02060.x; NOONAN CA, 1986, P NATL ACAD SCI USA, V83, P5698, DOI 10.1073/pnas.83.15.5698; PASQUINELLI C, 1986, J HEPATOL, V3, P95, DOI 10.1016/S0168-8278(86)80152-0; Pontisso P, 2008, AUTOIMMUN REV, V8, P13, DOI 10.1016/j.autrev.2008.07.016; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Shao QL, 2013, ARCH GYNECOL OBSTET, V288, P1257, DOI 10.1007/s00404-013-2893-x; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; StollBecker S, 1997, J VIROL, V71, P5399, DOI 10.1128/JVI.71.7.5399-5407.1997; Trippler M, 1999, J VIROL METHODS, V78, P129, DOI 10.1016/S0166-0934(98)00172-4; Wang F, 2007, CANCER-AM CANCER SOC, V109, P1360, DOI 10.1002/cncr.22549; YOFFE B, 1986, J INFECT DIS, V153, P471, DOI 10.1093/infdis/153.3.471; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	41	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137568	10.1371/journal.pone.0137568	http://dx.doi.org/10.1371/journal.pone.0137568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390290	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000010
J	Vicente-Steijn, R; Scherptong, RWC; Kruithof, BPT; Duim, SN; Goumans, MJTH; Wisse, LJ; Zhou, B; Pu, WT; Poelmann, RE; Schalij, MJ; Tallquist, MD; Gittenberger-de Groot, AC; Jongbloed, MRM				Vicente-Steijn, Rebecca; Scherptong, Roderick W. C.; Kruithof, Boudewijn P. T.; Duim, Sjoerd N.; Goumans, Marie Jose T. H.; Wisse, Lambertus J.; Zhou, Bin; Pu, William T.; Poelmann, Robert E.; Schalij, Martin J.; Tallquist, Michelle D.; Gittenberger-de Groot, Adriana C.; Jongbloed, Monique R. M.			Regional differences in WT-1 and Tcf21 expression during ventricular development: implications for myocardial compaction	PLOS ONE			English	Article							EPICARDIUM-DERIVED CELLS; TO-MESENCHYMAL TRANSITION; CARDIAC-MALFORMATIONS; WT1; FATE; POPULATION; RECEPTOR; LINEAGE; DIFFERENTIATION; ACTIVATION	Background Morphological and functional differences of the right and left ventricle are apparent in the adult human heart. A differential contribution of cardiac fibroblasts and smooth muscle cells (populations of epicardium-derived cells) to each ventricle may account for part of the morphological-functional disparity. Here we studied the relation between epicardial derivatives and the development of compact ventricular myocardium. Results Wildtype and Wt1(CreERT2/+) reporter mice were used to study WT-1 expressing cells, and Tcf21(lacZ/+) reporter mice and PDGFR alpha(-/-); Tcf21(LacZ/+) mice to study the formation of the cardiac fibroblast population. After covering the heart, intramyocardial WT-1+ cells were first observed at the inner curvature, the right ventricular postero-lateral wall and left ventricular apical wall. Later, WT-1+ cells were present in the walls of both ventricles, but significantly more pronounced in the left ventricle. Tcf21-(LacZ) + cells followed the same distribution pattern as WT-1+ cells but at later stages, indicating a timing difference between these cell populations. Within the right ventricle, WT-1+ and Tcf21-lacZ+ cell distribution was more pronounced in the posterior inlet part. A gradual increase in myocardial wall thickness was observed early in the left ventricle and at later stages in the right ventricle. PDGFR alpha(-/-); Tcf21(LacZ/+) mice showed deficient epicardium, diminished number of Tcf21-(LacZ) + cells and reduced ventricular compaction. Conclusions During normal heart development, spatio-temporal differences in contribution of WT-1 and Tcf21-(LacZ) + cells to right versus left ventricular myocardium occur parallel to myocardial thickening. These findings may relate to lateralized differences in ventricular (patho) morphology in humans.	[Vicente-Steijn, Rebecca; Scherptong, Roderick W. C.; Schalij, Martin J.; Gittenberger-de Groot, Adriana C.; Jongbloed, Monique R. M.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Vicente-Steijn, Rebecca; Wisse, Lambertus J.; Poelmann, Robert E.; Gittenberger-de Groot, Adriana C.; Jongbloed, Monique R. M.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Kruithof, Boudewijn P. T.; Duim, Sjoerd N.; Goumans, Marie Jose T. H.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Tallquist, Michelle D.] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA; [Zhou, Bin] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutrit Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Zhou, Bin] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Zhou, Bin; Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hawaii System; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard University; Boston Children's Hospital	Jongbloed, MRM (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	m.r.m.jongbloed@lumc.nl	Kruithof, Boudewijn/C-1718-2014; Pu, William/AAJ-8301-2020; Goumans, Marie-José/AAG-4994-2021; Tallquist, Michelle/AAU-5277-2021; Goumans, Marie Jose/U-1455-2019; Jongbloed, Monique/AAA-4239-2022	Kruithof, Boudewijn/0000-0002-9604-4563; Pu, William/0000-0002-4551-8079; Tallquist, Michelle/0000-0002-1383-144X; Goumans, Marie Jose/0000-0001-9344-6746; Jongbloed, Monique/0000-0002-9132-0418; Zhou, Bin/0000-0001-5278-5522	Netherlands Heart Foundation [2012T7.1]; Actelion Pharmaceuticals Nederland BV; Netherlands Institute for Regenerative Medicine [FES0908]; ZonMw/NWO [90700368]; NIH, National Heart, Lung, and Blood Institute [HL074257]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074257] Funding Source: NIH RePORTER	Netherlands Heart Foundation(Netherlands Heart Foundation); Actelion Pharmaceuticals Nederland BV; Netherlands Institute for Regenerative Medicine; ZonMw/NWO(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NIH, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Netherlands Heart Foundation (2012T7.1 to RVS); an unrestricted educational grant of Actelion Pharmaceuticals Nederland BV(to RWCS); by the Netherlands Institute for Regenerative Medicine (grant No. FES0908 to BPTK, SND, MJTHG) by ZonMw/NWO (90700368 to MRMJ); and by NIH, National Heart, Lung, and Blood Institute (HL074257 to MDT).	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Anderson RH, 2011, CARDIOL YOUNG, V21, P14, DOI 10.1017/S1047951111001387; Bax NAM, 2010, DEV DYNAM, V239, P2307, DOI 10.1002/dvdy.22363; Bleasdale RA, 2002, HEART, V88, P323, DOI 10.1136/heart.88.4.323; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Borgdorff MA, 2013, INT J CARDIOL, V169, P183, DOI 10.1016/j.ijcard.2013.08.102; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Combs MD, 2011, DEVELOPMENT, V138, P1747, DOI 10.1242/dev.060996; Daubeney PEF, 2002, J AM COLL CARDIOL, V39, P1670, DOI 10.1016/S0735-1097(02)01832-6; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470; Duim SN, 2015, J MOL CELL CARDIOL, V81, P127, DOI 10.1016/j.yjmcc.2015.02.007; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Gittenberger-de Groot AC, 2010, J CELL MOL MED, V14, P1056, DOI 10.1111/j.1582-4934.2010.01077.x; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jongbloed MRM, 2011, DEV DYNAM, V240, P2561, DOI 10.1002/dvdy.22762; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Kelly RG, 2007, CIRC RES, V100, P943, DOI 10.1161/01.RES.0000265523.36667.18; Kirschner KM, 2006, J BIOL CHEM, V281, P31930, DOI 10.1074/jbc.M602668200; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lescroart F, 2012, CIRC RES, V111, P1313, DOI 10.1161/CIRCRESAHA.112.271064; Lie-Venema H, 2005, ANAT REC PART A, V282A, P120, DOI 10.1002/ar.a.20154; Lie-Venema H, 2007, THESCIENTIFICWORLDJO, V7, P1777, DOI 10.1100/tsw.2007.294; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Loukas M, 2013, CARDIOVASC PATHOL, V22, P417, DOI 10.1016/j.carpath.2013.03.004; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Perez-Pomares JM, 2003, DEV DYNAM, V227, P56, DOI 10.1002/dvdy.10284; Poelmann RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106569; Romero J, 2013, CLIN MED INSIGHTS-CA, V7, P97, DOI 10.4137/CMC.S10940; Rudat C, 2013, CARDIOVASC RES, V100, P411, DOI 10.1093/cvr/cvt210; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Smart N, 2012, FUTUR CARDIOL, V8, P53, DOI [10.2217/fca.11.87, 10.2217/FCA.11.87]; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Thavendiranathan P, 2013, HEART, V99, P681, DOI 10.1136/heartjnl-2012-302816; Umar S, 2009, AM J PHYSIOL-HEART C, V297, pH1606, DOI 10.1152/ajpheart.00590.2009; van der Bom T, 2013, CIRCULATION, V127, P322, DOI 10.1161/CIRCULATIONAHA.112.135392; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, CIRC RES, V111, pE276, DOI 10.1161/CIRCRESAHA.112.275784; Zhou B, 2011, J CELL MOL MED, V15, P2781, DOI 10.1111/j.1582-4934.2011.01450.x; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007	51	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0136025	10.1371/journal.pone.0136025	http://dx.doi.org/10.1371/journal.pone.0136025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390289	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000003
J	Koo, T; Song, C; Kim, JS; Kim, K; Chie, EK; Kang, SB; Lee, KW; Kim, JH; Jeong, SY; Kim, TY				Koo, Taeryool; Song, Changhoon; Kim, Jae-Sung; Kim, Kyubo; Chie, Eui Kyu; Kang, Sung-Bum; Lee, Keun-Wook; Kim, Jee Hyun; Jeong, Seung-Yong; Kim, Tae-You			Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; CURATIVE RESECTION; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; TUMOR RESPONSE; CHEMORADIATION; TRIAL; RADIOCHEMOTHERAPY; OXALIPLATIN; RETRIEVAL	Purpose To evaluate the prognostic impact of the lymph node ratio (LNR) in ypStage III rectal cancer patients who were treated with neoadjuvant chemoradiotherapy (NCRT). Materials and Methods We retrospectively reviewed the data of 638 consecutive patients who underwent NCRT followed by total mesorectal excision, and postoperative adjuvant chemotherapy for rectal cancer from 2004 to 2011. Of these, 125 patients were positive for lymph node (LN) metastasis and were analyzed in this study. Results The median numbers of examined and metastatic LNs were 17 and 2, respectively, and the median LNR was 0.143 (range, 0.02-1). Median follow-up time was 55 months. In multivariate analyses, LNR was an independent prognostic factor for overall survival (OS) (hazard ratio [HR] 2.17, p = 0.041), disease-free survival (DFS) (HR 2.28, p = 0.005), and distant metastasis-free survival (DMFS) (HR 2.30, p = 0.010). When ypN1 patients were divided into low (low LNR ypN1 group) and high LNR (high LNR ypN1 group) according to a cut-off value of 0.152, the high LNR ypN1 group had poorer OS (p = 0.043) and DFS (p = 0.056) compared with the low LNR ypN1 group. And there were no differences between the high LNR ypN1 group and the ypN2 group in terms of the OS (p = 0.703) and DFS (p = 0.831). Conclusions For ypN-positive rectal cancer patients, the LNR was a more effective prognostic marker than the ypN stage, circumferential resection margin, or tumor regression grade after NCRT, and could be used to discern the high-risk group among ypN1 patients.	[Koo, Taeryool; Kim, Kyubo; Chie, Eui Kyu] Seoul Natl Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Song, Changhoon; Kim, Jae-Sung] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea; [Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea; [Lee, Keun-Wook; Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Jeong, Seung-Yong] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea.	jskim@snubh.org	Kim, Kyubo/R-8061-2019	Kim, Jae-Sung/0000-0001-5348-9178; Song, Changhoon/0000-0002-0714-8775; Chie, Eui Kyu/0000-0003-2027-7472				Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Bhatti I, 2010, WORLD J SURG, V34, P768, DOI 10.1007/s00268-009-0336-4; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chang GJ, 2009, CANCER, V115, P5432, DOI 10.1002/cncr.24622; de la Fuente SG, 2009, J GASTROINTEST SURG, V13, P269, DOI 10.1007/s11605-008-0717-2; Fokas E, 2014, J CLIN ONCOL, V32, P1554, DOI 10.1200/JCO.2013.54.3769; Frederique P, 2008, ANN SURG, V248, P1067, DOI 10.1097/SLA.0b013e31818842ec; Glynne-Jones R, 2006, ANN ONCOL, V17, P1239, DOI 10.1093/annonc/mdl173; Hong YS, 2014, LANCET ONCOL, V15, P1245, DOI 10.1016/S1470-2045(14)70377-8; Jang NY, 2011, DIS COLON RECTUM, V54, P245, DOI 10.1007/DCR.0b013e3181fcee68; Kang J, 2011, J SURG ONCOL, V104, P53, DOI 10.1002/jso.21913; Kim H, 2014, CANCER RES TREAT, V46, P148, DOI 10.4143/crt.2014.46.2.148; Kim TH, 2010, INT J RADIAT ONCOL, V77, P1158, DOI 10.1016/j.ijrobp.2009.06.019; Kim YS, 2009, INT J RADIAT ONCOL, V74, P796, DOI 10.1016/j.ijrobp.2008.08.065; Klos CL, 2011, DIS COLON RECTUM, V54, P171, DOI 10.1007/DCR.0b013e3181fd677d; Laska E, 2012, STAT MED, V31, P3178, DOI 10.1002/sim.5384; Lee JH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-576; Lee SD, 2012, EJSO-EUR J SURG ONC, V38, P478, DOI 10.1016/j.ejso.2012.03.002; Lim SB, 2012, J SURG ONCOL, V106, P667, DOI 10.1002/jso.23198; Madbouly KM, 2014, AM J SURG, V207, P824, DOI 10.1016/j.amjsurg.2013.07.022; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; Nadoshan JJ, 2013, ASIAN PAC J CANCER P, V14, P3769, DOI 10.7314/APJCP.2013.14.6.3769; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Sun Z, 2009, ANN ONCOL, V20, P897, DOI 10.1093/annonc/mdn707; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Wichmann MW, 2002, ARCH SURG-CHICAGO, V137, P206, DOI 10.1001/archsurg.137.2.206; Wu SG, 2014, CANC RES TREAT	29	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138728	10.1371/journal.pone.0138728	http://dx.doi.org/10.1371/journal.pone.0138728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381522	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200154
J	Gamez-Mendez, AM; Vargas-Robles, H; Rios, A; Escalante, B				Maria Gamez-Mendez, Ana; Vargas-Robles, Hilda; Rios, Amelia; Escalante, Bruno			Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice	PLOS ONE			English	Article							NITRIC-OXIDE; HIGH-FAT; SUPEROXIDE ANION; ACETYLCHOLINE; PROSTACYCLIN; LEPTIN; NO; CONTRACTIONS; RESTORES; APOCYNIN	Obesity is involved in several cardiovascular diseases including coronary artery disease and endothelial dysfunction. Endothelial Endothelium vasodilator and vasoconstrictor agonists play a key role in regulation of vascular tone. In this study, we evaluated coronary vascular response in an 8 weeks diet-induced obese C57BL/6 mice model. Coronary perfusion pressure in response to acetylcholine in isolated hearts from obese mice showed increased vasoconstriction and reduced vasodilation responses compared with control mice. Vascular nitric oxide assessed in situ with DAF-2 DA showed diminished levels in coronary arteries from obese mice in both basal and acetylcholine-stimulated conditions. Also, released prostacyclin was decreased in heart perfusates from obese mice, along with plasma tetrahydrobiopterin level and endothelium nitric oxide synthase dimer/monomer ratio. Obesity increased thromboxane A(2) synthesis and oxidative stress evaluated by superoxide and peroxynitrite levels, compared with control mice. Obese mice treated with apocynin, a NADPH oxidase inhibitor, reversed all parameters to normal levels. These results suggest that after 8 weeks on a high-fat diet, the increase in oxidative stress lead to imbalance in vasoactive substances and consequently to endothelial dysfunction in coronary arteries.	[Maria Gamez-Mendez, Ana; Vargas-Robles, Hilda] Inst Politecn Nacl, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Rios, Amelia; Escalante, Bruno] Cinvestav Monterrey, Apodaca, NL, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Escalante, B (corresponding author), Cinvestav Monterrey, Apodaca, NL, Mexico.	bescalan@cinvestav.mx		Gamez-Mendez, Ana Maria/0000-0003-0638-9988	Mexico National Council of Science and technology [81359]	Mexico National Council of Science and technology	The present study was supported by Mexico National Council of Science and technology grant number 81359 to BE, and graduate scholarship to AMG.	Al Suwaidi J, 2001, AM J CARDIOL, V88, P1300, DOI 10.1016/S0002-9149(01)02093-8; ALTIERE RJ, 1986, J PHARMACOL EXP THER, V236, P535; Arellano-Mendoza MG, 2011, RENAL FAILURE, V33, P47, DOI 10.3109/0886022X.2010.541583; Bagi Z, 2003, AM J PHYSIOL-HEART C, V285, pH1404, DOI 10.1152/ajpheart.00235.2003; Bagi Z, 2012, BRIT J PHARMACOL, V165, P544, DOI 10.1111/j.1476-5381.2011.01606.x; BANK N, 1992, J CLIN INVEST, V89, P1636, DOI 10.1172/JCI115760; Barton M, 2012, BRIT J PHARMACOL, V165, P591, DOI 10.1111/j.1476-5381.2011.01472.x; Bell RM, 2011, J MOL CELL CARDIOL, V50, P940, DOI 10.1016/j.yjmcc.2011.02.018; Beltowski J, 2004, LIFE SCI, V74, P2987, DOI 10.1016/j.lfs.2003.10.029; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Bender SB, 2007, DIABETES OBES METAB, V9, P688, DOI 10.1111/j.1463-1326.2006.00650.x; Boa BCS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102554; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Cediel E, 2002, KIDNEY INT, V62, pS2, DOI 10.1046/j.1523-1755.62.s82.2.x; Codoner-Franch P, 2011, TRANSL RES, V158, P369, DOI 10.1016/j.trsl.2011.08.004; Coronel I, 2010, J RENAL NUTR, V20, P158, DOI 10.1053/j.jrn.2009.10.008; d'Uscio LV, 2003, CIRC RES, V92, P88, DOI 10.1161/01.RES.0000049166.33035.62; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Du JJ, 2013, BRIT J PHARMACOL, V170, P1064, DOI 10.1111/bph.12336; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fukuda Y, 2002, HEART, V87, P264, DOI 10.1136/heart.87.3.264; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gangula PRR, 2010, AM J PHYSIOL-GASTR L, V298, pG692, DOI 10.1152/ajpgi.00450.2009; Gao YJ, 2005, BRIT J PHARMACOL, V146, P1061, DOI 10.1038/sj.bjp.0706423; Godecke A, 2002, CARDIOVASC RES, V53, P253, DOI 10.1016/S0008-6363(01)00432-1; Gwozdz P, 2007, PHARMACOL REP, V59, P545; Han KA, 2011, DIABETES-METAB RES, V27, P354, DOI 10.1002/dmrr.1183; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hayashi T, 2005, DIABETES OBES METAB, V7, P334, DOI 10.1111/j.1463-1326.2004.00393.x; Hodnett BL, 2009, AM J PHYSIOL-REG I, V296, pR715, DOI 10.1152/ajpregu.90330.2008; KATUSIC ZS, 1989, AM J PHYSIOL, V257, pH33, DOI 10.1152/ajpheart.1989.257.1.H33; Ketonen J, 2010, HEART VESSELS, V25, P254, DOI 10.1007/s00380-009-1182-x; Knudson JD, 2008, CURR HYPERTENS REP, V10, P434, DOI 10.1007/s11906-008-0082-2; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; LAMONTAGNE D, 1992, J CARDIOVASC PHARM, V20, P652, DOI 10.1097/00005344-199210000-00020; Laursen JB, 2001, CIRCULATION, P1282; Littlejohns B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100579; Gamez-Mendez AM, 2014, J NEPHROL, V27, P281, DOI 10.1007/s40620-013-0029-9; Meng R, 2011, ANN CLIN LAB SCI, V41, P236; Naderali EK, 2001, CLIN SCI, V100, P635, DOI 10.1042/cs1000635; Noll G, 1998, EUR HEART J, V19, pC30; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Park S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/984643; Roberts CK, 2000, HYPERTENSION, V36, P423, DOI 10.1161/01.HYP.36.3.423; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Stunkard AJ, 1993, OBESITY THEORY THERA; Sturm W, 2009, OBESITY, V17, P1783, DOI 10.1038/oby.2009.81; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	57	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138609	10.1371/journal.pone.0138609	http://dx.doi.org/10.1371/journal.pone.0138609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381906	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200137
J	Matthews, L; Kolind, S; Brazier, A; Leite, MI; Brooks, J; Traboulsee, A; Jenkinson, M; Johansen-Berg, H; Palace, J				Matthews, Lucy; Kolind, Shannon; Brazier, Alix; Leite, Maria Isabel; Brooks, Jonathan; Traboulsee, Anthony; Jenkinson, Mark; Johansen-Berg, Heidi; Palace, Jacqueline			Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; BRAIN ATROPHY; SPECTRUM DISORDER; SPINAL-CORD; DIFFUSION; MRI; DAMAGE; PATHOGENESIS; DISABILITY; ASTROCYTOPATHY	Inflammatory demyelinating lesions of the central nervous system are a common feature of both neuromyelitis optica and multiple sclerosis. Despite this similarity, it is evident clinically that the accumulation of disability in patients with neuromyelitis optica is relapse related and that a progressive phase is very uncommon. This poses the question whether there is any pathological evidence of disease activity or neurodegeneration in neuromyelitis optica between relapses. To investigate this we conducted a longitudinal advanced MRI study of the brain and spinal cord in neuromyelitis optica patients, comparing to patients with multiple sclerosis and controls. We found both cross-sectional and longitudinal evidence of diffusely distributed neurodegenerative surrogates in the multiple sclerosis group (including thalamic atrophy, cervical cord atrophy and progressive widespread diffusion and myelin water imaging abnormalities in the normal appearing white matter) but not in those with neuromyelitis optica, where localised abnormalities in the optic radiations of those with severe visual impairment were noted. In addition, between relapses, there were no new silent brain lesions in the neuromyelitis optica group. These findings indicate that global central nervous system neurodegeneration is not a feature of neuromyelitis optica. The work also questions the theory that neurodegeneration in multiple sclerosis is a chronic sequela to prior inflammatory and demyelinating pathology, as this has not been found to be the case in neuromyelitis optica where the lesions are often more destructive.	[Matthews, Lucy; Brazier, Alix; Leite, Maria Isabel; Jenkinson, Mark; Johansen-Berg, Heidi; Palace, Jacqueline] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Matthews, Lucy; Leite, Maria Isabel; Palace, Jacqueline] Oxford Univ Hosp NHS Trust, Dept Neurol, Oxford, England; [Kolind, Shannon; Traboulsee, Anthony] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada; [Brooks, Jonathan] Univ Bristol, Clin Res & Imaging Ctr CRiCBristol, Bristol, Avon, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of British Columbia; University of Bristol	Palace, J (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	jacqueline.palace@ndcn.ox.ac.uk	Jenkinson, Mark/AAC-8861-2019; Traboulsee, Anthony L/AAB-2051-2020	Jenkinson, Mark/0000-0001-6043-0166; Brooks, Jonathan/0000-0003-3335-6209; Johansen-Berg, Heidi/0000-0002-4134-9730	Medical Research Council UK [G0901996]; MS Society of Canada; NHS National Specialised Commissioning Group for Neuromyelitis optica; NIHR Oxford Biomedical Research Centre; Wellcome Trust; NIHR; MRC [G0901996, G0700238] Funding Source: UKRI; Medical Research Council [G0700238, G0901996] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MS Society of Canada; NHS National Specialised Commissioning Group for Neuromyelitis optica; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Lucy Matthews was funded by a research training fellowship from the Medical Research Council UK whilst conducting this research (G0901996). Shannon Kolind was funded by a postgraduate fellowship from the MS Society of Canada during this research. Maria Isabel Leite is is supported by NHS National Specialised Commissioning Group for Neuromyelitis optica and by NIHR Oxford Biomedical Research Centre. Heidi Johansen-Berg is funded by a fellowship from the Wellcome Trust and is also supported by a grant from the NIHR.	Alonso-Ortiz E, 2015, MAGN RESON MED, V73, P70, DOI 10.1002/mrm.25198; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Chanson JB, 2013, EUR J NEUROL, V20, P361, DOI 10.1111/j.1468-1331.2012.03867.x; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Confavreux C, 2006, CLIN NEUROL NEUROSUR, V108, P327, DOI 10.1016/j.clineuro.2005.11.018; de Seze J, 2010, J NEUROL NEUROSUR PS, V81, P409, DOI 10.1136/jnnp.2008.168070; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; De Stefano N, 2007, J NEUROIMAGING, V17, p10S, DOI 10.1111/j.1552-6569.2007.00130.x; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Filippi M, 2004, NEUROL SCI, V25, pS371, DOI 10.1007/s10072-004-0344-y; Filippi M, 1999, NEUROLOGY, V53, P1705, DOI 10.1212/WNL.53.8.1705; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fujihara K, 2011, J NEUROL SCI, V306, P183, DOI 10.1016/j.jns.2011.02.018; Gelineau-Morel R, 2012, HUM BRAIN MAPP, V33, P2802, DOI 10.1002/hbm.21402; Harrison DM, 2011, NEUROLOGY, V76, P179, DOI 10.1212/WNL.0b013e318206ca61; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kremer S, 2015, JAMA NEUROL, V72, P815, DOI 10.1001/jamaneurol.2015.0248; Lassmann H, 2013, J NEUROL SCI, V333, P1, DOI 10.1016/j.jns.2013.05.010; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Liu Y, 2012, MULT SCLER J, V18, P1013, DOI 10.1177/1352458511431731; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lucchinetti CF, 2014, BRAIN PATHOL, V24, P83, DOI 10.1111/bpa.12099; Maggs FG, 2004, MULT SCLER J, V10, P326, DOI 10.1191/1352458504ms1019rr; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; Matthews LA, 2014, MULT SCLER RELAT DIS, V3, P284, DOI 10.1016/j.msard.2013.11.003; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pichiecchio A, 2012, MULT SCLER J, V18, P817, DOI 10.1177/1352458511431072; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Simon JH, 1999, NEUROLOGY, V53, P139, DOI 10.1212/WNL.53.1.139; Smith SA, 2005, MAGN RESON MED, V54, P201, DOI 10.1002/mrm.20553; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2007, RADIOLOGY, V244, P249, DOI 10.1148/radiol.2441060930; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075	57	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137715	10.1371/journal.pone.0137715	http://dx.doi.org/10.1371/journal.pone.0137715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381510	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200034
J	Zhao, J; Yang, ZY; Luo, BN; Yang, JY; Chu, JP				Zhao, Jing; Yang, Zhi-yun; Luo, Bo-ning; Yang, Jian-yong; Chu, Jian-ping			Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; MAGNETIC-RESONANCE-SPECTROSCOPY; SOLITARY METASTATIC LESIONS; INTRACRANIAL MASS LESIONS; PRIMARY CNS LYMPHOMA; GLIOBLASTOMA-MULTIFORME; MICROVASCULAR PERMEABILITY; PERFUSION MRI; DIFFERENTIATION; COEFFICIENT	Purpose To quantitatively evaluate the diagnostic efficiency of parameters from diffusion and dynamic contrast-enhanced MR which based on tumor parenchyma (TP) and peritumoral (PT) area in classification of brain tumors. Methods 45 patients (male: 23, female: 22; mean age: 46 y) were prospectively recruited and they underwent conventional, DCE-MR and DWI examination. With each tumor, 10-15 regions of interest (ROIs) were manually placed on TP and PT area. ADC and permeability parameters (K-trans, Ve, Kep and iAUC) were calculated and their diagnostic efficiency was assessed. Results In TP, all permeability parameters and ADC value could significantly discriminate Low-from High grade gliomas (HGG) (p<0.001); among theses parameters, Ve demonstrated the highest diagnostic power (iAUC: 0.79, cut-off point: 0.15); the most sensitive and specific index for gliomas grading were K-trans (84%) and Kep (89%). While, in PT area, only K-trans could help in gliomas grading (P = 0.009, cut-off point: 0.03 min(-1)). Moreover, in TP, mean Ve and iAUC of primary central nervous system lymphoma (PCNSL) and metastases were significantly higher than that in HGG (p<0.003). Further, in PT area, mean K-trans (p <= 0.004) could discriminate PCNSL from HGG and ADC (p <= 0.003) could differentiate metastases with HGG. Conclusions Quantitative ADC and permeability parameters from Diffusion and DCE-MR in TP and PT area, especially DCE-MR, can aid in gliomas grading and brain tumors discrimination.	[Zhao, Jing; Yang, Zhi-yun; Luo, Bo-ning; Yang, Jian-yong; Chu, Jian-ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Yang, JY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, 58th Second Zhongshan Rd, Guangzhou 510080, Guangdong, Peoples R China.	cjr.yangjianyong@vip.163.com; truechu@hotmail.com			National Natural Science Foundation of China [81201074]; Fundamental Research Funds for the Central Universities [13ykpy14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China, 81201074; http://www.nsfc.gov.cn/ (JPC) Fundamental Research Funds for the Central Universities, 13ykpy14 (http://www.sysu.edu.cn/2012/cn/index.htm) (JPC).	Apuzzo ML, 1990, NEUROSURGICAL TOPICS, P3; Awasthi R, 2012, NEURORADIOLOGY, V54, P205, DOI 10.1007/s00234-011-0874-y; Blasel S, 2013, J NEURO-ONCOL, V114, P127, DOI 10.1007/s11060-013-1161-z; Blasel S, 2011, J NEURO-ONCOL, V103, P575, DOI 10.1007/s11060-010-0421-4; Blasel S, 2010, ACTA NEUROCHIR, V152, P1893, DOI 10.1007/s00701-010-0774-7; Buhring U, 2001, NEUROLOGY, V57, P393, DOI 10.1212/WNL.57.3.393; BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2; Cao Y, 2006, CANCER RES, V66, P8912, DOI 10.1158/0008-5472.CAN-05-4328; Cha S, 2006, AM J NEURORADIOL, V27, P409; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Choi HS, 2013, KOREAN J RADIOL, V14, P487, DOI 10.3348/kjr.2013.14.3.487; DICHIRO G, 1989, RADIOLOGY, V172, P578; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Jia ZZ, 2012, J CLIN NEUROSCI, V19, P820, DOI 10.1016/j.jocn.2011.08.030; JIDDANE M, 1986, J NEUROSURG, V65, P592, DOI 10.3171/jns.1986.65.5.0592; Kitis O, 2005, EUR J RADIOL, V55, P393, DOI 10.1016/j.ejrad.2005.02.004; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Lacerda S, 2009, NEUROIMAG CLIN N AM, V19, P527, DOI 10.1016/j.nic.2009.08.007; Lam WWM, 2002, CLIN RADIOL, V57, P219, DOI 10.1053/crad.2001.0741; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021; Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752; Mills SJ, 2010, AM J NEURORADIOL, V31, P549, DOI 10.3174/ajnr.A1844; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Roberts HC, 2000, AM J NEURORADIOL, V21, P891; Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897; SCATLIFF JH, 1971, SEMIN ROENTGENOL, V6, P59, DOI 10.1016/0037-198X(71)90019-8; SCATLIFF JH, 1969, AMER J ROENTGENOL RA, V105, P795, DOI 10.2214/ajr.105.4.795; Schafer ML, 2013, EUR RADIOL, V23, P2846, DOI 10.1007/s00330-013-2886-y; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schlegel U, 2000, J NEUROL SCI, V181, P1, DOI 10.1016/S0022-510X(00)00385-3; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Svolos P, 2013, MAGN RESON IMAGING, V31, P1567, DOI 10.1016/j.mri.2013.06.010; Thompson G, 2010, NEUROIMAG CLIN N AM, V20, P337, DOI 10.1016/j.nic.2010.04.008; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1989, J NEUROL NEUROSUR PS, V52, P1019, DOI 10.1136/jnnp.52.8.1019; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Weber MA, 2006, NEUROLOGY, V66, P1899, DOI 10.1212/01.wnl.0000219767.49705.9c; Weber MA, 2004, INVEST RADIOL, V39, P277, DOI 10.1097/01.rli.0000119195.50515.04; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Zhang N, 2012, J MAGN RESON IMAGING, V36, P355, DOI 10.1002/jmri.23675	46	16	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138573	10.1371/journal.pone.0138573	http://dx.doi.org/10.1371/journal.pone.0138573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384329	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200129
J	Chiu, CH; Siow, TY; Weng, SJ; Hsu, YH; Huang, YS; Chang, KW; Cheng, CY; Ma, KH				Chiu, Chuang-Hsin; Siow, Tiing-Yee; Weng, Shao-Ju; Hsu, Yi-Hua; Huang, Yuahn-Sieh; Chang, Kang-Wei; Cheng, Cheng-Yi; Ma, Kuo-Hsing			Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; EXHIBIT DIFFERENTIAL VULNERABILITY; AXON TERMINALS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SUBSTITUTED AMPHETAMINES; ASCENDING PROJECTIONS; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; BRAIN ACTIVATION; CAUDATE-PUTAMEN	3,4-Methylenedioxymethamphetamine (MDMA), also known as "Ecstasy", is a common recreational drug of abuse. Several previous studies have attributed the central serotonergic neurotoxicity of MDMA to distal axotomy, since only fine serotonergic axons ascending from the raphe nucleus are lost without apparent damage to their cell bodies. However, this axotomy has never been visualized directly in vivo. The present study examined the axonal integrity of the efferent projections from the midbrain raphe nucleus after MDMA exposure using in vivo manganese-enhanced magnetic resonance imaging (MEMRI). Rats were injected subcutaneously six times with MDMA (5 mg/kg) or saline once daily. Eight days after the last injection, manganese ions (Mn2+) were injected stereotactically into the raphe nucleus, and a series of MEMRI images was acquired over a period of 38 h to monitor the evolution of Mn2+-induced signal enhancement across the ventral tegmental area, the medial forebrain bundle (MFB), and the striatum. The MDMA-induced loss of serotonin transporters was clearly evidenced by immunohistological staining consistent with the Mn2+-induced signal enhancement observed across the MFB and striatum. MEMRI successfully revealed the disruption of the serotonergic raphe-striatal projections and the variable effect of MDMA on the kinetics of Mn2+ accumulation in the MFB and striatum.	[Chiu, Chuang-Hsin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chiu, Chuang-Hsin; Cheng, Cheng-Yi] Triserv Gen Hosp, Natl Def Med Ctr, Dept Nucl Med, Taipei, Taiwan; [Siow, Tiing-Yee] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Weng, Shao-Ju; Huang, Yuahn-Sieh; Ma, Kuo-Hsing] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Hsu, Yi-Hua] Acad Sinica, Inst Biomed Sci, Funct Micromagnet Resonance Imaging Ctr, Taipei, Taiwan; [Hsu, Yi-Hua] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Kang-Wei] Inst Nucl Energy Res, Taoyaun, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Institute of Nuclear Energy Research - Taiwan	Cheng, CY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Nucl Med, Taipei, Taiwan.	kuohsing91@yahoo.com.tw; steveccy60@gmail.com		Chang, Kang-Wei/0000-0002-4476-3603	Ministry of Science and Technology of Taiwan [99-2314-B-016-030-MY3]; Tri-Service General Hospital, National Defense Medical Center [TSGH-C104-179]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, National Defense Medical Center	This work was supported by the Ministry of Science and Technology of Taiwan (Grant: 99-2314-B-016-030-MY3) (http://www.most.gov.tw/) and Tri-Service General Hospital, National Defense Medical Center (Grant: TSGH-C104-179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adori C, 2011, PSYCHOPHARMACOLOGY, V213, P377, DOI 10.1007/s00213-010-2041-2; AXEL L, 1987, AM J ROENTGENOL, V148, P418, DOI 10.2214/ajr.148.2.418; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Bankson MG, 2004, J NEUROCHEM, V91, P852, DOI 10.1111/j.1471-4159.2004.02763.x; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Baumann MH, 2009, DRUG METAB DISPOS, V37, P2163, DOI 10.1124/dmd.109.028506; BERGER UV, 1992, EUR J PHARMACOL, V215, P153, DOI 10.1016/0014-2999(92)90023-W; CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456; Concheiro M, 2014, DRUG METAB DISPOS, V42, P119, DOI 10.1124/dmd.113.053678; de la Torre R, 2004, TRENDS PHARMACOL SCI, V25, P505, DOI 10.1016/j.tips.2004.08.001; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; GOLD LH, 1988, J PHARMACOL EXP THER, V247, P547; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; Hrometz SL, 2004, NEUROSCI LETT, V367, P56, DOI 10.1016/j.neulet.2004.05.075; Hsu YH, 2008, PSYCHOPHARMACOLOGY, V196, P543, DOI 10.1007/s00213-007-0990-x; IMAI H, 1986, J COMP NEUROL, V243, P363, DOI 10.1002/cne.902430307; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; Koch S, 1997, J NEURAL TRANSM, V104, P135, DOI 10.1007/BF01273176; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Lehallier B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048491; Li IH, 2010, NEUROIMAGE, V49, P1259, DOI 10.1016/j.neuroimage.2009.07.072; Li YX, 2009, MAGN RESON IMAGING, V27, P293, DOI 10.1016/j.mri.2008.07.011; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; MAMOUNAS LA, 1991, J COMP NEUROL, V314, P558, DOI 10.1002/cne.903140312; Molliver M.E., 1990, ANN NY ACAD SCI, V600, P661; Nixdorf WL, 2001, J NEUROCHEM, V77, P647, DOI 10.1046/j.1471-4159.2001.00262.x; OHEARN E, 1988, J NEUROSCI, V8, P2788; Pardo-Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047599; Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rietjens SJ, 2012, CRIT REV TOXICOL, V42, P854, DOI 10.3109/10408444.2012.725029; Sarkar S, 2010, CURR PHARM BIOTECHNO, V11, P460, DOI 10.2174/138920110791591490; Schenk S, 2011, NEUROSCI BIOBEHAV R, V35, P1203, DOI 10.1016/j.neubiorev.2010.12.010; Schindler CW, 2014, BRIT J PHARMACOL, V171, P83, DOI 10.1111/bph.12423; SCHMIDT CJ, 1986, EUR J PHARMACOL, V124, P175, DOI 10.1016/0014-2999(86)90140-8; Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008; Sprague JE, 1998, NEUROTOXICOLOGY, V19, P427; STEINBUSCH HWM, 1980, NEUROSCI LETT, V19, P137, DOI 10.1016/0304-3940(80)90184-6; Takeda A, 1998, BRAIN RES, V811, P147, DOI 10.1016/S0006-8993(98)00881-6; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; Van der Linden A, 2004, NMR BIOMED, V17, P602, DOI 10.1002/nbm.936; VANDERKOOY D, 1980, BRAIN RES, V186, P1, DOI 10.1016/0006-8993(80)90250-4; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Weng SJ, 2013, CELL TRANSPLANT, V22, P1295, DOI 10.3727/096368912X658683; WIKLUND L, 1981, J COMP NEUROL, V203, P613, DOI 10.1002/cne.902030405; WILSON MA, 1989, NEUROSCIENCE, V28, P121, DOI 10.1016/0306-4522(89)90237-6; Xie T, 2006, NEUROPSYCHOPHARMACOL, V31, P2639, DOI 10.1038/sj.npp.1301031	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138431	10.1371/journal.pone.0138431	http://dx.doi.org/10.1371/journal.pone.0138431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378923	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400099
J	Moreira, F; Calado, G; Dias, S				Moreira, Francisco; Calado, Goncalo; Dias, Susana			Conservation Status of a Recently Described Endemic Land Snail, Candidula coudensis, from the Iberian Peninsula	PLOS ONE			English	Article							FIRE; PROJECTIONS; COMMUNITIES; GASTROPODA; DISPERSAL; PORTUGAL; CLIMATE	We assessed the distribution, population size and conservation status of Candidula coudensis, a recently described endemic land snail from Portugal. From March 2013 to April 2014, surveys were carried out in the region where the species was described. We found an extent of occurrence larger than originally described, but still quite small (13.5 km(2)). The species was found mainly in olive groves, although it occurred in a variety of other habitats with limestone soils, including grasslands, scrublands and stone walls. Minimum population estimate ranged from 110,000-311,000 individuals. The main identified potential threats to the species include wildfires, pesticides and quarrying. Following the application of IUCN criteria, we advise a conservation status of either "Least Concern" or "Near-threatened" under criterion D (restricted population).	[Moreira, Francisco; Calado, Goncalo; Dias, Susana] Lusofona Univ, Dept Life Sci, Lisbon, Portugal; [Moreira, Francisco] Univ Porto, CIBIO InBIO Associate Lab, REN Biodivers Chair, Vairao, Portugal; [Moreira, Francisco; Dias, Susana] Univ Lisbon, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves, InBIO Associate Lab, P-1699 Lisbon, Portugal	Lusofona University; Universidade do Porto; Universidade de Lisboa	Moreira, F (corresponding author), Lusofona Univ, Dept Life Sci, Lisbon, Portugal.	fmoreira@isa.ulisboa.pt	Moreira, Francisco/B-2873-2008; Dias, Susana/ABG-6916-2020; Dias, Susana/L-7156-2013; Calado, Goncalo/F-5368-2011	Moreira, Francisco/0000-0003-4393-8018; Dias, Susana/0000-0002-5600-4444; Dias, Susana/0000-0002-5600-4444; Calado, Goncalo/0000-0001-9727-6051				Amatulli G, 2013, SCI TOTAL ENVIRON, V450, P209, DOI 10.1016/j.scitotenv.2013.02.014; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Aubry S, 2006, J ANIM ECOL, V75, P802, DOI 10.1111/j.1365-2656.2006.01100.x; Bahl A., 1996, P329; BAUR B, 1995, ECOGRAPHY, V18, P123, DOI 10.1111/j.1600-0587.1995.tb00332.x; Bros V, 2011, FOREST ECOL MANAG, V261, P611, DOI 10.1016/j.foreco.2010.11.014; Buttner G., 2007, CLC2006 TECHNICAL GU; Cardoso P, 2011, BIOL CONSERV, V144, P2432, DOI 10.1016/j.biocon.2011.06.020; Cuttelod A, 2011, EUROPEAN RED LIST NO, DOI 10.2779/84538; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Holyoak G, 2014, J CONCHOL, V41, P1; Holyoak Geraldine A., 2010, Iberus, V28, P67; Hylander K, 2011, FOREST ECOL MANAG, V261, P1811, DOI 10.1016/j.foreco.2011.02.003; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Kiss L, 2003, J MOLLUS STUD, V69, P43, DOI 10.1093/mollus/69.1.43; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Limondin-Lozouet N, 2011, J MOLLUS STUD, V80, P224; Martinez-Orti A, 2011, ANIM BIODIV CONSERV, V34, P1; Oliveira SLJ, 2012, INT J WILDLAND FIRE, V21, P48, DOI 10.1071/WF10131; Orlowsky B, 2013, HYDROL EARTH SYST SC, V17, P1765, DOI 10.5194/hess-17-1765-2013; POLLARD E, 1975, J ANIM ECOL, V44, P305, DOI 10.2307/3865; Santos X, 2012, CONTRIB ZOOL, V81, P167, DOI 10.1163/18759866-08103004; Santos X, 2009, BIODIVERS CONSERV, V18, P3153, DOI 10.1007/s10531-009-9634-2; Watters GT, 2005, BIOL CONSERV, V126, P166, DOI 10.1016/j.biocon.2005.05.005	24	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138464	10.1371/journal.pone.0138464	http://dx.doi.org/10.1371/journal.pone.0138464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379241	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400102
J	Shi, ZB; Zhang, Z; Zhang, ZZ; Wang, YY; Li, CC; Wang, X; He, F; Sun, LN; Jiao, S; Shi, WY; Zhou, ZC				Shi, Zhubing; Zhang, Zhen; Zhang, Zhenzhen; Wang, Yanyan; Li, Chuanchuan; Wang, Xin; He, Feng; Sun, Lina; Jiao, Shi; Shi, Weiyang; Zhou, Zhaocai			Structural Insights into Mitochondrial Antiviral Signaling Protein (MAVS)-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; ADAPTER PROTEIN; CD40 RECOGNITION; RNA RECOGNITION; IMMUNE; ACTIVATION; LGP2; REGULATOR; MECHANISM; SEQUENCE	In response to viral infection, cytosolic retinoic acid-inducible gene I-like receptors sense viral RNA and promote oligomerization of mitochondrial antiviral signaling protein (MAVS), which then recruits tumor necrosis factor receptor-associated factor (TRAF) family proteins, including TRAF6, to activate an antiviral response. Currently, the interaction between MAVS and TRAF6 is only partially understood, and atomic details are lacking. Here, we demonstrated that MAVS directly interacts with TRAF6 through its potential TRAF6-binding motif 2 (T6BM2; amino acids 455-460). Further, we solved the crystal structure of MAVS T6BM2 in complex with the TRAF6 TRAF_C domain at 2.95 angstrom resolution. T6BM2 of MAVS binds to the canonical adaptor-binding groove of the TRAF_C domain. Structure-directed mutational analyses in vitro and in cells revealed that MAVS binding to TRAF6 via T6BM2 instead of T6BM1 is essential but not sufficient for an optimal antiviral response. Particularly, a MAVS mutant Y460E retained its TRAF6-binding ability as predicted but showed significantly impaired signaling activity, highlighting the functional importance of this tyrosine. Moreover, these observations were further confirmed in MAVS(-/-) mouse embryonic fibroblast cells. Collectively, our work provides a structural basis for understanding the MAVS-TRAF6 antiviral response.	[Shi, Zhubing; Shi, Weiyang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Shi, Zhubing; Zhang, Zhen; Zhang, Zhenzhen; Wang, Yanyan; Li, Chuanchuan; Wang, Xin; He, Feng; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Sun, Lina] Qingdao Binhai Univ, Qingdao 266555, Shandong, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, WY (corresponding author), Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	wshi@tongji.edu.cn; zczhou@sibcb.ac.cn	wang, yan/GSE-6489-2022; Shi, Zhubing/F-9490-2010; Wang, Yanbo/HFZ-8018-2022	Shi, Zhubing/0000-0002-9624-4960; He, Feng/0000-0002-6286-8134	973 program of the Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868, 41476120, 91442125, 91542125]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP202]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by the 973 program of the Ministry of Science and Technology of China (Grant 2012CB910204); National Natural Science Foundation of China Grants 31270808, 31300734, 31470736, 31470868, 41476120, 91442125, and 91542125; Science and Technology Commission of Shanghai Municipality Grants 11JC14140000 and 13ZR1446400; the "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grant 2014KIP202. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CL, 2002, STRUCTURE, V10, P403, DOI 10.1016/S0969-2126(02)00733-5; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wang YY, 2010, SCI CHINA LIFE SCI, V53, P159, DOI 10.1007/s11427-010-0050-3; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003152	48	26	26	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26811	26820		10.1074/jbc.M115.666578	http://dx.doi.org/10.1074/jbc.M115.666578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26385923	hybrid, Green Published			2022-12-26	WOS:000364793600043
J	Pinna, A; Pezzolesi, L; Pistocchi, R; Vanucci, S; Ciavatta, S; Polimene, L				Pinna, Adriano; Pezzolesi, Laura; Pistocchi, Rossella; Vanucci, Silvana; Ciavatta, Stefano; Polimene, Luca			Modelling the Stoichiometric Regulation of C-Rich Toxins in Marine Dinoflagellates	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; P SUPPLY RATIOS; N-P; ALEXANDRIUM-FUNDYENSE; KARLODINIUM-VENEFICUM; PHYTOPLANKTON GROWTH; COASTAL WATERS; CELL-GROWTH; BACTERIA; TEMPERATURE	Toxin production in marine microalgae was previously shown to be tightly coupled with cellular stoichiometry. The highest values of cellular toxin are in fact mainly associated with a high carbon to nutrient cellular ratio. In particular, the cellular accumulation of C-rich toxins (i.e., with C:N > 6.6) can be stimulated by both N and P deficiency. Dinoflagellates are the main producers of C-rich toxins and may represent a serious threat for human health and the marine ecosystem. As such, the development of a numerical model able to predict how toxin production is stimulated by nutrient supply/deficiency is of primary utility for both scientific and management purposes. In this work we have developed a mechanistic model describing the stoichiometric regulation of C-rich toxins in marine dinoflagellates. To this purpose, a new formulation describing toxin production and fate was embedded in the European Regional Seas Ecosystem Model (ERSEM), here simplified to describe a monospecific batch culture. Toxin production was assumed to be composed by two distinct additive terms; the first is a constant fraction of algal production and is assumed to take place at any physiological conditions. The second term is assumed to be dependent on algal biomass and to be stimulated by internal nutrient deficiency. By using these assumptions, the model reproduced the concentrations and temporal evolution of toxins observed in cultures of Ostreopsis cf. ovata, a benthic/epiphytic dinoflagellate producing C-rich toxins named ovatoxins. The analysis of simulations and their comparison with experimental data provided a conceptual model linking toxin production and nutritional status in this species. The model was also qualitatively validated by using independent literature data, and the results indicate that our formulation can be also used to simulate toxin dynamics in other dinoflagellates. Our model represents an important step towards the simulation and prediction of marine algal toxicity.	[Pinna, Adriano; Pezzolesi, Laura; Pistocchi, Rossella] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, I-48123 Ravenna, Italy; [Ciavatta, Stefano; Polimene, Luca] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; [Vanucci, Silvana] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy; [Ciavatta, Stefano] Plymouth Marine Lab, Natl Ctr Earth Observat, Plymouth PL1 3DH, Devon, England	University of Bologna; Plymouth Marine Laboratory; University of Messina; Plymouth Marine Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation	Polimene, L (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth PL1 3DH, Devon, England.	luca@pml.ac.uk	Ciavatta, Stefano/AAL-1381-2020; Pezzolesi, Laura/ABD-7677-2020	Ciavatta, Stefano/0000-0001-7165-2805; PEZZOLESI, LAURA/0000-0002-6260-2715; PISTOCCHI, ROSSELLA/0000-0003-1304-6270	UK Natural Environment Research Council (NERC); UK Natural Environment Research Council (NERC) National centre for Earth Observation (NCEO); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through "Progetti di Ricerca di Interesse nazionale (PRIN)", Rome, Italy; NERC [nceo020004, NE/K001876/1, pml010010, pml010006] Funding Source: UKRI; Natural Environment Research Council [pml010010, pml010006, NE/K001876/1, nceo020004] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council (NERC) National centre for Earth Observation (NCEO)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through "Progetti di Ricerca di Interesse nazionale (PRIN)", Rome, Italy; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Luca Polimene was funded through the UK Natural Environment Research Council (NERC, www.nerc.ac.uk) National Capability in sustained observations and marine modelling. Stefano Ciavatta was partly funded through the UK Natural Environment Research Council (NERC) National centre for Earth Observation (NCEO). Laura Pezzolesi, Rossella Pistocchi and Adriano Pinna were funded by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR, www.istruzione.it), through the "Progetti di Ricerca di Interesse nazionale (PRIN)" 2009, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoroni S, 2014, HARMFUL ALGAE, V34, P7, DOI 10.1016/j.hal.2014.02.003; Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; Aligizaki K, 2008, TOXICON, V51, P418, DOI 10.1016/j.toxicon.2007.10.016; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Bagoien E, 1996, MAR BIOL, V126, P361, DOI 10.1007/BF00354618; Barone Rossella, 2006, Naturalista Siciliano, V30, P401; Blackford JC, 2004, J MARINE SYST, V52, P191, DOI 10.1016/j.jmarsys.2004.02.004; Bravo I, 2012, HARMFUL ALGAE, V18, P24, DOI 10.1016/j.hal.2012.04.001; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Ciavatta S, 2009, ENVIRON TOXICOL CHEM, V28, P718, DOI 10.1897/08-102R.1; Ciminiello P, 2014, ENVIRON SCI TECHNOL, V48, P3532, DOI 10.1021/es405617d; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Ciminiello P, 2012, J AM CHEM SOC, V134, P1869, DOI 10.1021/ja210784u; Ciminiello P, 2011, TOXICON, V57, P376, DOI 10.1016/j.toxicon.2010.11.002; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Davidson K, 2014, J ENVIRON MANAGE, V146, P206, DOI 10.1016/j.jenvman.2014.07.002; Di Turi L., 2003, Biologia Marina Mediterranea, V10, P675; DROOP MR, 1974, J MAR BIOL ASSOC UK, V54, P825, DOI 10.1017/S002531540005760X; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Faimali M, 2012, MAR ENVIRON RES, V76, P97, DOI 10.1016/j.marenvres.2011.09.010; Falkowski G., 1985, LIMNOL OCEANOGR, V30, P311; FAUST MA, 1998, HARMFUL ALGAE, P390; Fiori E, 2013, AQUAT TOXICOL, V128, P79, DOI 10.1016/j.aquatox.2012.12.001; FLYNN K, 1994, MAR ECOL PROG SER, V111, P99, DOI 10.3354/meps111099; Flynn KJ, 2010, J MARINE SYST, V83, P170, DOI 10.1016/j.jmarsys.2010.04.007; Garcia-Altares M, 2015, ANAL BIOANAL CHEM, V407, P1191, DOI 10.1007/s00216-014-8338-y; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; GOLDMAN JC, 1986, LIMNOL OCEANOGR, V31, P1358, DOI 10.4319/lo.1986.31.6.1358; GOLDMAN JC, 1987, LIMNOL OCEANOGR, V32, P1239, DOI 10.4319/lo.1987.32.6.1239; Grzebyk D, 2003, J PLANKTON RES, V25, P1185, DOI 10.1093/plankt/fbg088; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; Hardison DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058545; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Honsell G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057291; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; Johansson N, 1996, HARMFUL TOXIC ALGAL, P277; John EH, 2000, EUR J PHYCOL, V35, P11, DOI 10.1080/09670260010001735581; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; MENZEL DAVID W., 1965, LIMNOL OCEANOGR, V10, P280; Pastres R, 2005, ENVIRON MODELL SOFTW, V20, P981, DOI 10.1016/j.envsoft.2004.09.010; Pezzolesi L, 2014, HARMFUL ALGAE, V36, P1, DOI 10.1016/j.hal.2014.03.006; Pfiester L. A., 1987, BIOL DINOFLAGELLATES, P611; Pistocchi R., 2014, P 16 ICHA C IN NUTR, P104; Pistocchi R, 2014, TOXINS AND BIOLOGICALLY ACTIVE COMPOUNDS FROM MICROALGAE, VOL 1: ORIGIN, CHEMISTRY AND DETECTION, P75; Polimene L, 2006, AQUAT MICROB ECOL, V43, P127, DOI 10.3354/ame043127; Polimene L, 2015, PROG OCEANOGR; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Redfield A. C., 1934, P176; REDFIELD AC, 1958, AM SCI, V46, P205; Saltelli A., 2000, WILEY SERIES PROBABI; Saltelli A., 2008, GLOBAL SENSITIVITY A; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Senft-Batoh CD, 2015, HARMFUL ALGAE, V44, P20, DOI 10.1016/j.hal.2015.02.008; Shibata A, 2006, AQUAT MICROB ECOL, V43, P223, DOI 10.3354/ame043223; Steenbergh AK, 2013, ENVIRON MICROBIOL, V15, P1572, DOI 10.1111/1462-2920.12042; Thessen AE, 2009, HARMFUL ALGAE, V8, P792, DOI 10.1016/j.hal.2009.01.003; Tillmann U, 2009, HARMFUL ALGAE, V8, P759, DOI 10.1016/j.hal.2009.03.005; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; Vale C, 2007, PHYCOTOXINS CHEM BIO, P95, DOI DOI 10.1002/9780470277874.CH6; Van de Waal DB, 2014, ECOL LETT, V17, P736, DOI 10.1111/ele.12280; Vanucci S, 2012, CRYPTOGAMIE ALGOL, V33, P105, DOI 10.7872/crya.v33.iss2.2011.105; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vidyarathna NK, 2013, HARMFUL ALGAE, V21-22, P54, DOI 10.1016/j.hal.2012.11.006; Vidyarathna NK, 2012, AQUAT MICROB ECOL, V65, P261, DOI 10.3354/ame01555; Waggett RJ, 2008, MAR ECOL PROG SER, V366, P31, DOI 10.3354/meps07518; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94	74	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139046	10.1371/journal.pone.0139046	http://dx.doi.org/10.1371/journal.pone.0139046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397815	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000361797500135
J	Cui, YM; Sun, B; Wang, HF; Ferguson, DK; Wang, YF; Li, CS; Yang, J; Ma, QW				Cui, Yi-Ming; Sun, Bin; Wang, Hai-Feng; Ferguson, David Kay; Wang, Yu-Fei; Li, Cheng-Sen; Yang, Jian; Ma, Qing-Wen			Exploring the Formation of a Disjunctive Pattern between Eastern Asia and North America Based on Fossil Evidence from Thuja (Cupressaceae)	PLOS ONE			English	Article							EVOLUTION; HISTORY; CHINA; DIVERSIFICATION; BIOGEOGRAPHY; VICARIANCE; PHYLOGENY; DISPERSAL	Thuja, a genus of Cupressaceae comprising five extant species, presently occurs in both East Asia (3 species) and North America (2 species) and has a long fossil record from Paleocene to Pleistocene in the Northern Hemisphere. Two distinct hypotheses have been proposed to account for the origin and present distribution of this genus. Here we recognize and describe T. sutchuenensis Franch., a new fossil Thuja from the late Pliocene sediments of Zhangcun, Shanxi, North China, based on detailed comparisons with all living species and other fossil ones, integrate the global fossil records of this genus plotted in a set of paleomaps from different time intervals, which show that Thuja probably first appeared at high latitudes of North America in or before the Paleocene. This genus reached Greenland in the Paleocene, then arrived in eastern Asia in the Miocene via the land connection between East Asia and western North America. In the late Pliocene, it migrated into the interior of China. With the Quaternary cooling and drying, Thuja gradually retreated southwards to form today's disjunctive distribution between East Asia and North America.	[Cui, Yi-Ming; Sun, Bin; Wang, Hai-Feng; Wang, Yu-Fei; Li, Cheng-Sen; Yang, Jian] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Ferguson, David Kay] Univ Vienna, Dept Paleontol, A-1090 Vienna, Austria; [Ma, Qing-Wen] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Cui, Yi-Ming; Sun, Bin] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; University of Vienna; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, 20 Nan Xin Cun, Beijing 100093, Peoples R China.	wangyf@ibcas.ac.cn; yangjian@ibcas.ac.cn	Cui, Yiming/AAZ-1438-2021		China National Key Basic Research Program [2014CB954201]; National Natural Science Foundation of China [30990241, 41072022, 41210001, 31370254, 31300186]; Chinese Academy of Sciences [90004F1005]	China National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the China National Key Basic Research Program (2014CB954201), and the National Natural Science Foundation of China (Nos. 30990241; 41072022, 41210001, 31370254, 31300186). Prof. David K. Ferguson was supported by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists at the Institute of Botany (Nos. 90004F1005).	Akhmetiev M.A., 1973, SIKHOTE ALIN MIOCENE; Bai YJ, 2015, GLOBAL CHANGE BIOL, V21, P874, DOI 10.1111/gcb.12670; Bell WA, 1965, UPPER CRETACEOUS PAL, V65, P1; Bell WA, 1957, MEM GEOL SURV CAN, V293, P1; Bennike O., 1990, Meddelelser om Gronland Geoscience, V23, P1; BOUFFORD DE, 1983, ANN MO BOT GARD, V70, P423, DOI 10.2307/2992081; Brown R. W., 1962, US GEOLOGICAL SURVEY, V375, P1; Brown RW, 1939, US GEOLOGICAL SURVEY, P189; CHANEY RALPH W., 1959, CARNEGIE INST WASHINGTON PUBL, V617, P1; DILCHER DL, 1974, BOT REV, V40, P1, DOI 10.1007/BF02860067; Farjon A, 2005, MONOGRAPH CUPRESSACE; Fu L., 1999, FLORA CHINA, P62; GRAHAM A, 1966, BRITTONIA, V18, P131, DOI 10.2307/2805196; Graham A., 1972, FLORISTICS PALEOFLOR, P1; Gray A, 1878, AM J SCI, V16, P85; Gray A, 1857, AM J SCI ARTS, V23, P62; Gray A, 1857, AM J SCI ARTS, V23, P369; Gray A., 1846, AM J SCI ARTS SERII, V2, P135; Gray A., 1856, AM J SCI ARTS, V22, P204; Gray A., 1859, MEM AM ACAD ARTS, V6, P377, DOI DOI 10.2307/25057953; Gray A., 1840, AM J SCI ARTS, V39, P175; Heer O, 1882, FOSSILE FLORA GRON 1, V6; Heer O., 1870, KONGLIGA SVENSKA VET, V8, P1; Hollick A., 1936, GEOL SURV PROF PAPER, V182, P1; HSU J, 1983, ANN MO BOT GARD, V70, P490, DOI 10.2307/2992084; Huzioka K., 1973, B NATL SCI MUSEUM TO, V78, P661; Knowlton F.H., 1905, GEOL SURV BULL, V257, P129; LePage BA, 2003, AM J BOT, V90, P167, DOI 10.3732/ajb.90.2.167; LePage BA, 2005, TOP GEOBIOL, V22, P3; Li JH, 2005, J INTEGR PLANT BIOL, V47, P651, DOI 10.1111/j.1744-7909.2005.00087.x; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 2001, INT J PLANT SCI, V162, pS19, DOI 10.1086/323657; MCIVER EE, 1989, CAN J BOT, V67, P1903, DOI 10.1139/b89-242; NEWBERRY JS, 1868, ANN LYCEUM NATURAL H, V9, P1, DOI DOI 10.1111/J.1749-6632.1870.TB00175.X; Nie ZL, 2006, AM J BOT, V93, P1343, DOI 10.3732/ajb.93.9.1343; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 1993, ACTA PHYTOTAX SINICA, V31, P1; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schweitzer H. J., 1974, PALAEONTOGRAPHICA AB, V149, P1; Scotese C. R, 1997, 900497 PALEOMAP U TE; Sun B, 2015, PHYTOTAXA, V219, P101, DOI 10.11646/phytotaxa.219.2.1; Sveshnikova I. N., 1967, PALAEOBOTANICA, V6, P178; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Wang XQ, 2014, MOL PHYLOGENET EVOL, V75, P24, DOI 10.1016/j.ympev.2014.02.005; Wang YF, 2006, TAXON, V55, P165, DOI 10.2307/25065538; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2002, ANN MO BOT GARD, V89, P414, DOI 10.2307/3298601; WHITE PS, 1983, ANN MO BOT GARD, V70, P734, DOI 10.2307/2398988; WU ZY, 1983, ANN MO BOT GARD, V70, P577; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Xiang QYJ, 2001, INT J PLANT SCI, V162, pS29, DOI 10.1086/323332	54	12	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138544	10.1371/journal.pone.0138544	http://dx.doi.org/10.1371/journal.pone.0138544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393513	Green Submitted, gold, Green Published			2022-12-26	WOS:000361792100070
J	Hromadnikova, I; Kotlabova, K; Hympanova, L; Krofta, L				Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie; Krofta, Ladislav			Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; PLASMA MICRORNA; CARDIAC-HYPERTROPHY; EXPRESSION PROFILE; HOUSEKEEPING GENES; TROPHOBLAST CELLS; MIRNA EXPRESSION; DOWN-REGULATION	Aims To demonstrate that pregnancy-related complications are associated with alterations in cardiovascular and cerebrovascular microRNA expression. Gene expression of 32 microRNAs (miR-1-3p, miR-16-5p, miR-17-5p, miR-20a-5p, miR-20b-5p, miR-21-5p, miR-23a-3p, miR-24-3p, miR-26a-5p, miR-29a-3p, miR-33a-5p, miR-92a-3p, miR-100-5p, miR-103a-3p, miR-122-5p, miR-125b-5p, miR-126-3p, miR-130b-3p, miR-133a-3p, miR-143-3p, miR-145-5p, miR-146a-5p, miR-155-5p, miR-181a-5p, miR-195-5p, miR-199a-5p, miR-208a-3p, miR-210-3p, miR-221-3p, miR-342-3p, miR-499a-5p, and miR-574-3p) was assessed in placental tissues, compared between groups (35 gestational hypertension, 80 preeclampsia, 35 intrauterine growth restriction and 20 normal pregnancies) and correlated with the severity of the disease with respect to clinical signs, delivery date, and Doppler ultrasound parameters. Initially, selection and validation of endogenous controls for microRNA expression studies in placental tissues affected by pregnancy-related complications have been carried out. Results The expression profile of microRNAs was different between pregnancy-related complications and controls. The up-regulation of miR-499a-5p was a common phenomenon shared between gestational hypertension, preeclampsia, and intrauterine growth restriction. Preeclamptic pregnancies delivering after 34 weeks of gestation and IUGR with abnormal values of flow rate in the umbilical artery demonstrated up-regulation of miR-1-3b. Preeclampsia and IUGR requiring termination of gestation before 34 weeks of gestation were associated with down-regulation of miR-26a-5p, miR-103a-3p and miR-145-5p. On the other hand, some of microRNAs (miR-16-5p, miR-100-5p, miR-122-5p, miR-125b-5p, miR126- 3p, miR-143-3p, miR-195-5p, miR-199a-5p, miR-221-3p, miR-342-3p, and miR-5743p) were only down-regulated or showed a trend to down-regulation just in intrauterine growth restriction pregnancies requiring the delivery before 34 weeks of gestation. Conclusion Epigenetic changes induced by pregnancy-related complications in placental tissue may cause later onset of cardiovascular and cerebrovascular diseases in offspring.	[Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie] Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic; [Hympanova, Lucie; Krofta, Ladislav] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague, Czech Republic	Charles University Prague; Charles University Prague	Hromadnikova, I (corresponding author), Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic.	Ilona.Hromadnikova@lf3.cuni.cz	Hromadnikova, Ilona/E-1957-2017; Hympanova, Lucie/GRJ-1255-2022; Hympanova, Lucie/AAS-7474-2020	Hromadnikova, Ilona/0000-0002-4396-3304; Hympanova, Lucie/0000-0002-9002-9231; Hympanova, Lucie/0000-0002-9002-9231; Kotlabova, Katerina/0000-0002-8824-4653	Charles University [PRVOUK P32]	Charles University	The work was exclusively supported by the Charles University research program PRVOUK P32.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson CM, 2007, JOGNN-J OBST GYN NEO, V36, P3, DOI [10.1111/j.1552-6909.2006.00115.x, 10.1111/J.1552-6909.2006.00115.x]; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Bamfo JEAK, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/640715; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Beaumont J, 2014, CLIN SCI, V126, P497, DOI 10.1042/CS20130538; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bergkvist A, 2008, GENET ENG BIOTECHN N, V28, P26; Berks D, 2013, BJOG-INT J OBSTET GY, V120, P924, DOI 10.1111/1471-0528.12191; Borna S, 2012, J MATERN-FETAL NEO M, V25, P1114, DOI 10.3109/14767058.2011.624218; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi SY, 2013, PLACENTA, V34, P799, DOI 10.1016/j.placenta.2013.06.006; COHN HE, 1974, AM J OBSTET GYNECOL, V120, P817, DOI 10.1016/0002-9378(74)90587-0; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Craici IM, 2008, WOMENS HEALTH, V4, P133, DOI 10.2217/17455057.4.2.133; Croce CM, 2005, ONCOGENE; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hakim J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953150; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Haukkamaa L, 2009, CEREBROVASC DIS, V27, P599, DOI 10.1159/000216834; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Hong FZ, 2014, J INT MED RES, V42, P1243, DOI 10.1177/0300060514540627; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kida K, 2011, PHARM RES-DORDR, V28, P2467, DOI 10.1007/s11095-011-0473-y; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Li XL, 2014, MOL MED REP, V10, P550, DOI 10.3892/mmr.2014.2214; Libby G, 2007, DIABETOLOGIA, V50, P523, DOI 10.1007/s00125-006-0558-z; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Luo RC, 2014, HYPERTENSION, V64, P839, DOI 10.1161/HYPERTENSIONAHA.114.03530; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McDonald SD, 2013, ATHEROSCLEROSIS, V229, P234, DOI 10.1016/j.atherosclerosis.2013.04.020; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Miko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071811; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Noack F, 2011, J PERINAT MED, V39, P267, DOI [10.1515/JPM.2011.012, 10.1515/jpm.2011.012]; Norata GD, 2012, INT J IMMUNOPATH PH, V25, P467, DOI 10.1177/039463201202500216; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rane S, 2010, CELL SIGNAL, V22, P1054, DOI 10.1016/j.cellsig.2010.02.008; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rayner KJ, 2012, CURR ATHEROSCLER REP, V14, P413, DOI 10.1007/s11883-012-0272-x; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; Tappia Paramjit S, 2006, Expert Rev Cardiovasc Ther, V4, P211, DOI 10.1586/14779072.4.2.211; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voellenkle C, 2010, PHYSIOL GENOMICS, V42, P420, DOI 10.1152/physiolgenomics.00211.2009; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Wang Y, 2014, INT J BIOL SCI, V10, P973, DOI 10.7150/ijbs.9088; Wang YS, 2012, CARDIOVASC RES, V95, P517, DOI 10.1093/cvr/cvs223; Wei CY, 2013, J CELL PHYSIOL, V228, P1433, DOI 10.1002/jcp.24296; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yan T, 2013, J CELL BIOCHEM, V114, P2148, DOI 10.1002/jcb.24563; Yang K, 2011, FEBS LETT, V585, P854, DOI 10.1016/j.febslet.2011.02.009; Yang S, 2015, MOL MED REP, V12, P527, DOI 10.3892/mmr.2015.3414; Yhu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046551, DOI 10.1371/J0URNAL.P0NE.0046551]; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao HL, 2010, PANCREAS, V39, P843, DOI 10.1097/MPA.0b013e3181d12613; Zhong D, 2013, CELL SIGNAL, V25, P1429, DOI 10.1016/j.cellsig.2013.03.003; Zhong D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-32; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045; Zile MR, 2011, CIRC-CARDIOVASC GENE, V4, P614, DOI 10.1161/CIRCGENETICS.111.959841	140	89	95	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138383	10.1371/journal.pone.0138383	http://dx.doi.org/10.1371/journal.pone.0138383			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394310	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100058
J	Lamy, T; Legendre, P; Chancerelle, Y; Siu, G; Claudet, J				Lamy, Thomas; Legendre, Pierre; Chancerelle, Yannick; Siu, Gilles; Claudet, Joachim			Understanding the Spatio-Temporal Response of Coral Reef Fish Communities to Natural Disturbances: Insights from Beta-Diversity Decomposition	PLOS ONE			English	Article							OF-THORNS STARFISH; ECOSYSTEM STABILITY; ACANTHASTER-PLANCI; FRENCH-POLYNESIA; CLIMATE-CHANGE; MOOREA-ISLAND; PHASE-SHIFTS; RESILIENCE; RESISTANCE; BIODIVERSITY	Understanding how communities respond to natural disturbances is fundamental to assess the mechanisms of ecosystem resistance and resilience. However, ecosystem responses to natural disturbances are rarely monitored both through space and time, while the factors promoting ecosystem stability act at various temporal and spatial scales. Hence, assessing both the spatial and temporal variations in species composition is important to comprehensively explore the effects of natural disturbances. Here, we suggest a framework to better scrutinize the mechanisms underlying community responses to disturbances through both time and space. Our analytical approach is based on beta diversity decomposition into two components, replacement and biomass difference. We illustrate this approach using a 9-year monitoring of coral reef fish communities off Moorea Island (French Polynesia), which encompassed two severe natural disturbances: a crown-of-thorns starfish outbreak and a hurricane. These disturbances triggered a fast logistic decline in coral cover, which suffered a 90% decrease on all reefs. However, we found that the coral reef fish composition remained largely stable through time and space whereas compensatory changes in biomass among species were responsible for most of the temporal fluctuations, as outlined by the overall high contribution of the replacement component to total beta diversity. This suggests that, despite the severity of the two disturbances, fish communities exhibited high resistance and the ability to reorganize their compositions to maintain the same level of total community biomass as before the disturbances. We further investigated the spatial congruence of this pattern and showed that temporal dynamics involved different species across sites; yet, herbivores controlling the proliferation of algae that compete with coral communities were consistently favored. These results suggest that compensatory changes in biomass among species and spatial heterogeneity in species responses can provide further insurance against natural disturbances in coral reef ecosystems by promoting high levels of key species (herbivores). They can also allow the ecosystem to recover more quickly.	[Lamy, Thomas; Claudet, Joachim] CNRS, CRIOBE USR CNRS EPHE UPVD 3278, 58 Ave Paul Alduy, F-66860 Perpignan, France; [Lamy, Thomas; Chancerelle, Yannick; Siu, Gilles; Claudet, Joachim] Lab Excellence CORAIL, F-66860 Perpignan, France; [Lamy, Thomas; Legendre, Pierre] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Chancerelle, Yannick; Siu, Gilles] Ecole Prat Hautes Etud, CRIOBE USR CNRS EPHE UPVD 3278, Papetoai, Moorea, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montreal	Lamy, T (corresponding author), CNRS, CRIOBE USR CNRS EPHE UPVD 3278, 58 Ave Paul Alduy, F-66860 Perpignan, France.	thomas.lamy27@gmail.com	Legendre, Pierre/C-8279-2013; Legendre, Pierre/U-9266-2019; Lamy, Thomas/K-9430-2015; Claudet, Joachim/C-6335-2008; Lamy, Thomas/H-4340-2019	Legendre, Pierre/0000-0002-3838-3305; Legendre, Pierre/0000-0002-3838-3305; Lamy, Thomas/0000-0002-7881-0578; Claudet, Joachim/0000-0001-6295-1061; Lamy, Thomas/0000-0002-7881-0578	Laboratoire d'Excellence CORAIL; NSERC [7738]; Fondation de France-INTHENSE; ANR-LIVE AND LET DIE; ANR-ACRoSS; Direction des Ressources Marines et Minieres (DDRM) of French Polynesia	Laboratoire d'Excellence CORAIL; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fondation de France-INTHENSE; ANR-LIVE AND LET DIE(French National Research Agency (ANR)); ANR-ACRoSS(French National Research Agency (ANR)); Direction des Ressources Marines et Minieres (DDRM) of French Polynesia	T. Lamy was supported by a post-doctoral fellowship from Laboratoire d'Excellence CORAIL to J. Claudet and by a postdoctoral scholarship from NSERC grant no. 7738 to P. Legendre. J. Claudet thanks Fondation de France-INTHENSE, ANR-LIVE AND LET DIE and ANR-ACRoSS for financial support. The authors also thank the Direction des Ressources Marines et Minieres (DDRM) of French Polynesia for the financial support they provided for field surveys.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Adjeroud M, 2002, MAR ECOL PROG SER, V237, P121, DOI 10.3354/meps237121; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2014, R LANG ENV STAT COMP; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bouchon C., 1985, P 5 COR REEF C, V6, P279; BRADBURY RH, 1985, J THEOR BIOL, V113, P69, DOI 10.1016/S0022-5193(85)80076-X; Bruelheide H, 2009, ECOLOGY, V90, P1314, DOI 10.1890/07-2148.1; CADORET L, 1995, ECOSCIENCE, V2, P129, DOI 10.1080/11956860.1995.11682277; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Collin A, 2014, UNDERWATER SEASCAPES, P245; de Loma TL, 2008, PAC SCI, V62, P431, DOI 10.2984/1534-6188(2008)62[431:AFFAIO]2.0.CO;2; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; FAURE G, 1989, J COASTAL RES, V5, P295; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Feary DA, 2007, MAR ECOL PROG SER, V333, P243, DOI 10.3354/meps333243; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; GALZIN R, 1987, Pacific Science, V41, P158; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kulbicki M, 2005, CYBIUM, V29, P235; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; MMS, 2021, CLIMATE RODRIGUES IS; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Palumbi SR, 2008, BIOSCIENCE, V58, P33, DOI 10.1641/B580108; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Podani J, 2013, ECOL COMPLEX, V15, P52, DOI 10.1016/j.ecocom.2013.03.002; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; PORTER JW, 1972, AM NAT, V106, P487, DOI 10.1086/282789; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Ripa J, 2003, THEOR POPUL BIOL, V64, P369, DOI 10.1016/S0040-5809(03)00089-3; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Steiner CF, 2011, AM NAT, V178, P159, DOI 10.1086/660835; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Thorson JT, 2014, J ANIM ECOL, V83, P157, DOI 10.1111/1365-2656.12117; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; Vogler C, 2013, CORAL REEFS, V32, P515, DOI 10.1007/s00338-012-1003-z; WALBRAN PD, 1989, SCIENCE, V245, P847, DOI 10.1126/science.245.4920.847; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wang SP, 2014, ECOL LETT, V17, P891, DOI 10.1111/ele.12292; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wolkovich EM, 2014, ECOL LETT, V17, P1365, DOI 10.1111/ele.12353	75	43	44	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138696	10.1371/journal.pone.0138696	http://dx.doi.org/10.1371/journal.pone.0138696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393511	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100088
J	Soares, DJ; Pignitter, M; Ehrnhofer-Ressler, MM; Walker, J; Brasil, IM; Somoza, V				Soares, Denise Josino; Pignitter, Marc; Ehrnhofer-Ressler, Miriam Margit; Walker, Jessica; Brasil, Isabella Montenegro; Somoza, Veronika			Identification and Quantification of Oxidoselina-1,3,7(11)-Trien-8-One and Cyanidin-3-Glucoside as One of the Major Volatile and Non-Volatile Low-Molecular-Weight Constituents in Pitanga Pulp	PLOS ONE			English	Article							EUGENIA-UNIFLORA L.; ESSENTIAL OILS; FRUITS; CAROTENOIDS; EXTRACTS; LEAVES	The pulp of pitanga (Eugenia uniflora L.) is used to prepare pitanga juice. However, there are no reports on the identification and quantification of the main constituents in pitanga pulp. The aim of this study was to identify and quantify the major volatile and non-volatile low-molecular-weight constituents of the pulp. Isolation of volatile compounds was performed by solvent-assisted flavor evaporation technique. Characterization of the main volatile and non-volatile constituents was performed by GC-MS, LC-MS and NMR spectroscopy. For quantitative measurements, the main volatile compound needed to be isolated from pitanga pulp to obtain a commercially not available reference standard. Cyanidin-3-glucoside was determined as one of the most abundant non-volatile pulp compound yielding 53.8% of the sum of the intensities of all ions detected by LC-MS. Quantification of cyanidin-3-glucoside in pitanga pulp resulted in a concentration of 344 +/- 66.4 mu g/mL corresponding to 688 +/- 133 mu g/g dried pulp and 530 +/- 102 mu g/g fruit. For the volatile fraction, oxidoselina-1,3,7(11)-trien-8-one was identified as the main volatile pulp constituent (27.7% of the sum of the intensities of all ions detected by GC-MS), reaching a concentration of 89.0 +/- 16.9 mu g/mL corresponding to 1.34 +/- 0.25 mu g/g fresh pulp and 1.03 +/- 0.19 mu g/g fruit. The results provide quantitative evidence for the occurrence of an anthocyanin and an oxygenated sesquiterpene as one of the major volatile and non-volatile low-molecular-weight compounds in pitanga pulp.	[Soares, Denise Josino] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Pignitter, Marc; Ehrnhofer-Ressler, Miriam Margit; Walker, Jessica; Somoza, Veronika] Univ Vienna, Dept Nutr & Physiol Chem, Fac Chem, Vienna, Austria; [Brasil, Isabella Montenegro] Univ Fed Ceara, Dept Food Technol, Fortaleza, Ceara, Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Vienna; Universidade Federal do Ceara	Pignitter, M (corresponding author), Univ Vienna, Dept Nutr & Physiol Chem, Fac Chem, Vienna, Austria.	marc.pignitter@univie.ac.at	Somoza, Veronika/D-4141-2013; Pignitter, Marc/AAL-2976-2021	Somoza, Veronika/0000-0003-2456-9245; Pignitter, Marc/0000-0002-5793-8572	CAPES Foundation, Ministry of Education of Brazil	CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the CAPES Foundation, Ministry of Education of Brazil, for providing a doctoral sandwich fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; ADEBAJO AC, 1989, PHYTOTHER RES, V3, P258, DOI 10.1002/ptr.2650030608; Arai I, 1999, J ETHNOPHARMACOL, V68, P307, DOI 10.1016/S0378-8741(99)00066-5; Azevedo-Meleiro CH, 2004, J FOOD COMPOS ANAL, V17, P385, DOI 10.1016/j.jfca.2004.02.004; Bagetti M, 2011, CIENCIA TECNOL ALIME, V31, P147, DOI 10.1590/S0101-20612011000100021; Celli GB, 2011, FOOD RES INT, V44, P2442, DOI 10.1016/j.foodres.2010.12.036; Consolini AE, 1999, J ETHNOPHARMACOL, V66, P33, DOI 10.1016/S0378-8741(98)00194-9; Correia RTP, 2012, FOOD SCI TECHNOL INT, V18, P539, DOI 10.1177/1082013211433077; Costa DP, 2010, J BRAZIL CHEM SOC, V21, P851, DOI 10.1590/S0103-50532010000500012; Costa DP, 2009, J BRAZIL CHEM SOC, V20, P1287, DOI 10.1590/S0103-50532009000700013; Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486; Filho GL, 2008, J SUPERCRIT FLUID, V46, P33, DOI 10.1016/j.supflu.2008.02.014; Gbolade AA, 1996, PHYTOTHER RES, V10, P613, DOI 10.1002/(SICI)1099-1573(199611)10:7&lt;613::AID-PTR880&gt;3.0.CO;2-H; Hoffmann-Ribani R, 2009, J FOOD COMPOS ANAL, V22, P263, DOI 10.1016/j.jfca.2008.12.004; Mity Thambi, 2013, International Journal of Pharmacy and Biomedical Sciences, V4, P46; Morais S. M. de, 1996, Journal of Essential Oil Research, V8, P449; MORTON J., 1987, FRUITS WARM CLIMATES, P386; Ogunwande I. A., 2005, International Journal of Aromatherapy, V15, P147, DOI 10.1016/j.ijat.2005.07.004; Oliveira AL, 2006, FOOD CHEM, V99, P1, DOI 10.1016/j.foodchem.2005.07.012; SCHAPOVAL EES, 1994, J ETHNOPHARMACOL, V44, P137, DOI 10.1016/0378-8741(94)01178-8; Serra FCO, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.0063915, 10.1371/journal.pone.0073001]; Silva S. M., 2006, REV BRAS FRUTIC, V28, P1; Soares DJ, 2014, FOOD FUNCT, V5, P2981, DOI [10.1039/c4fo00509k, 10.1039/C4FO00509K]; Souza LKHE, 2002, BRAZ J MICROBIOL, V33, P247, DOI 10.1590/S1517-83822002000300012; Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036; WEYERSTAHL P, 1988, PLANTA MED, P546, DOI 10.1055/s-2006-962544	26	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138809	10.1371/journal.pone.0138809	http://dx.doi.org/10.1371/journal.pone.0138809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394146	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100101
J	Stalnov, O; Ben-Gida, H; Kirchhefer, AJ; Guglielmo, CG; Kopp, GA; Liberzon, A; Gurka, R				Stalnov, Oksana; Ben-Gida, Hadar; Kirchhefer, Adam J.; Guglielmo, Christopher G.; Kopp, Gregory A.; Liberzon, Alexander; Gurka, Roi			On the Estimation of Time Dependent Lift of a European Starling (Sturnus vulgaris) during Flapping Flight	PLOS ONE			English	Article							FLOW-FIELD; WAKE; KINEMATICS; PERFORMANCE; MECHANICS; VORTICES; AIRFOIL	We study the role of unsteady lift in the context of flapping wing bird flight. Both aerodynamicists and biologists have attempted to address this subject, yet it seems that the contribution of unsteady lift still holds many open questions. The current study deals with the estimation of unsteady aerodynamic forces on a freely flying bird through analysis of wingbeat kinematics and near wake flow measurements using time resolved particle image velocimetry. The aerodynamic forces are obtained through two approaches, the unsteady thin airfoil theory and using the momentum equation for viscous flows. The unsteady lift is comprised of circulatory and non-circulatory components. Both approaches are presented over the duration of wingbeat cycles. Using long-time sampling data, several wingbeat cycles have been analyzed in order to cover both the downstroke and upstroke phases. It appears that the unsteady lift varies over the wingbeat cycle emphasizing its contribution to the total lift and its role in power estimations. It is suggested that the circulatory lift component cannot assumed to be negligible and should be considered when estimating lift or power of birds in flapping motion.	[Stalnov, Oksana] Univ Southampton, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England; [Ben-Gida, Hadar] Technion Israel Inst Technol, Fac Aerosp Engn, IL-32000 Haifa, Israel; [Kirchhefer, Adam J.; Kopp, Gregory A.] Boundary Layer Wind Tunnel Lab, London, ON N6A 3K7, Canada; [Guglielmo, Christopher G.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON N6A 5B7, Canada; [Liberzon, Alexander] Tel Aviv Univ, Sch Mech Engn, IL-69978 Tel Aviv, Israel; [Gurka, Roi] Coastal Carolina Univ, Sch Coastal & Marine Syst Sci, Conway, SC 29528 USA	University of Southampton; Technion Israel Institute of Technology; Western University (University of Western Ontario); Western University (University of Western Ontario); Tel Aviv University	Gurka, R (corresponding author), Coastal Carolina Univ, Sch Coastal & Marine Syst Sci, Conway, SC 29528 USA.	rgurka@coastal.edu	Ben-Gida, Hadar/GLU-4962-2022; Liberzon, Alex/A-8596-2008	Ben-Gida, Hadar/0000-0003-2488-3234; Liberzon, Alex/0000-0002-6882-4191; Kopp, Gregory/0000-0002-0784-3014; Gurka, Roi/0000-0002-8907-6663				Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; Anderson Jr JD, 1985, FUNDAMENTALS OF AERO; [Anonymous], STUDIES PORTABLE AIR; Bai P, 2007, ACTA MECH SINICA, V23, P485, DOI 10.1007/s10409-007-0102-5; Ben-Gida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080086; BROWN RHJ, 1963, BIOL REV, V38, P460, DOI 10.1111/j.1469-185X.1963.tb00790.x; DeVoria AC, 2014, J FLUID MECH, V749, P297, DOI 10.1017/jfm.2014.237; Dong H, 2006, J FLUID MECH, V566, P309, DOI 10.1017/S002211200600190X; Ford CWP, 2013, J FLUID MECH, V720, P280, DOI 10.1017/jfm.2013.28; Glauert H., 1930, FORCE MOMENT OSCILLA; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; Hedenstrom A, 2008, J R SOC INTERFACE, V5, P595, DOI 10.1098/rsif.2008.0027; Henningsson P, 2008, J EXP BIOL, V211, P717, DOI 10.1242/jeb.012146; Henningsson P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090170; Hubel TY, 2009, EXP FLUIDS, V46, P933, DOI 10.1007/s00348-009-0624-7; Johnson W., 2012, HELICOPTER THEORY; Katz J., 2001, LOW SPEED AERODYNAMI, V13; Kirchhefer AJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4807064; Lamb H., 1945, HYDRODYNAMICS; Leishman JG, 2006, PRINCIPLES HELICOPTE; Liberzon A, 2001, P 4 INT S PIV GOTT G; LIGHTHILL J, 1986, J FLUID MECH, V173, P667, DOI 10.1017/S0022112086001313; Muijres FT, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025006; Muijres FT, 2011, J R SOC INTERFACE, V8, P1418, DOI 10.1098/rsif.2011.0015; PANDA J, 1994, J FLUID MECH, V265, P65, DOI 10.1017/S0022112094000765; PENNYCUICK CJ, 1969, IBIS, V111, P525, DOI 10.1111/j.1474-919X.1969.tb02566.x; Poelma C, 2006, EXP FLUIDS, V41, P213, DOI 10.1007/s00348-006-0172-3; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; RAYNER JMV, 1979, J FLUID MECH, V91, P731, DOI 10.1017/S0022112079000422; Rayner JMV, 2001, MATH METHOD APPL SCI, V24, P1485, DOI 10.1002/mma.196; Rival D, 2009, EXP FLUIDS, V46, P823, DOI 10.1007/s00348-008-0586-1; Rozhdestvensky KV, 2003, PROG AEROSP SCI, V39, P585, DOI 10.1016/S0376-0421(03)00077-0; Saffman P.G., 1993, VORTEX DYNAMICS; Shyy W, 2008, CAMB AERO SER, P1; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Taylor GI, 1938, PROC R SOC LON SER-A, V164, P0476, DOI 10.1098/rspa.1938.0032; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Taylor ZJ, 2010, IEEE T INSTRUM MEAS, V59, P3262, DOI 10.1109/TIM.2010.2047149; Theodorsen T, 1935, NACA REPT, V496, P291; TUCKER VA, 1973, J EXP BIOL, V58, P689; von Ellenrieder KD, 2008, EXP THERM FLUID SCI, V32, P1578, DOI 10.1016/j.expthermflusci.2008.05.003; von Karman T., 1938, J AERONAUT SCI, V5, P379, DOI [10.2514/8.674, DOI 10.2514/8.674]; Waldman RM, 2012, EXP FLUIDS, V53, P1487, DOI 10.1007/s00348-012-1368-3; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; WU JC, 1981, AIAA J, V19, P432, DOI 10.2514/3.50966; Zdunich P, 2007, J AIRCRAFT, V44, P1701, DOI 10.2514/1.28463	48	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0134582	10.1371/journal.pone.0134582	http://dx.doi.org/10.1371/journal.pone.0134582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394213	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100003
J	Reed, BK; Chopp, LB; Malo, CS; Renner, DN; Van Keulen, VS; Girtman, MA; Nevala, WN; Pavelko, KD; Gil, D; Schrum, AG; Johnson, AJ; Pease, LR				Reed, Brendan K.; Chopp, Laura B.; Malo, Courtney S.; Renner, Danielle N.; Van Keulen, Virginia S.; Girtman, Megan A.; Nevala, Wendy N.; Pavelko, Kevin D.; Gil, Diana; Schrum, Adam G.; Johnson, Aaron J.; Pease, Larry R.			A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCLONAL-ANTIBODIES; T-LYMPHOCYTES; ANTIGENS; LOCALIZATION; MICE; SPECIFICITY; EPITOPE; HLA-A2; VIRUS	Antigen-specific T cell responses can be visualized using MHC:peptide multimers. In cases where robust T cell controls are not readily available to assess the integrity of multimer reagents prior to analyzing limited sample, the ability to assess the structural integrity of MHC multimers before their use in critical experiments would be useful. We present a method to probe the structural integrity of MHC multimers using antibodies specific for conformational determinants. Beads coated with anti-mouse Ig are incubated with conformation-specific mouse monoclonal antibody and then with fluorescently tagged MHC multimer. The ability of the bead to capture the labeled multimer can be measured semi-quantitatively by flow cytometry. In this manner, the correct folding of MHC multimers can be visualized and batches of multimer can be compared for quality control. Because there are multiple conformational epitopes formed by various molecular interactions among heavy chain, peptide, and beta M-2, this capture assay can assess the fidelity of each aspect of multimer structure, depending on the availability of antibodies. The described approach could be particularly useful for studies using irreplaceable samples, including patient samples collected in clinical trials.	[Reed, Brendan K.; Chopp, Laura B.; Malo, Courtney S.; Renner, Danielle N.; Van Keulen, Virginia S.; Girtman, Megan A.; Pavelko, Kevin D.; Gil, Diana; Schrum, Adam G.; Johnson, Aaron J.; Pease, Larry R.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Nevala, Wendy N.] Mayo Clin, Div Hematol, Coll Med, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Pease, LR (corresponding author), Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA.	pease.larry@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Schrum, Adam/0000-0001-9276-1859; Chopp, Laura/0000-0001-6494-4439	National Institutes of Health [R21 AI097337-01A1, T32 AI07425]; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R21 AI097337-01A1 and T32 AI07425 (BKR and MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Dethlefs S, 1997, J VIROL, V71, P5361, DOI 10.1128/JVI.71.7.5361-5365.1997; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HOGAN KT, 1992, HUM IMMUNOL, V33, P185, DOI 10.1016/0198-8859(92)90070-4; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Kohler G., 1981, IMMUNE SYSTEM, V2, P202; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Messaoudi I, 1999, J IMMUNOL, V163, P3286; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1980, J IMMUNOL, V125, P2473; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PARHAM P, 1981, IMMUNOGENETICS, V13, P509, DOI 10.1007/BF00343719; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Schrum A. G., 2007, SCI STKE, pl2; Schrum Adam G, 2009, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0509s87; Smith SEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045722	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137984	10.1371/journal.pone.0137984	http://dx.doi.org/10.1371/journal.pone.0137984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389800	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000014
J	Chen, H; Liang, JY; Liu, HT				Chen, Heng; Liang, Junying; Liu, Haitao			How Does Word Length Evolve in Written Chinese?	PLOS ONE			English	Article							LANGUAGE EVOLUTION	We demonstrate a substantial evidence that the word length can be an essential lexical structural feature for word evolution in written Chinese. The data used in this study are diachronic Chinese short narrative texts with a time span of over 2000-years. We show that the increase of word length is an essential regularity in word evolution. On the one hand, word frequency is found to depend on word length, and their relation is in line with the Power law function y = ax(-b). On the other hand, our deeper analyses show that the increase of word length results in the simplification in characters for balance in written Chinese. Moreover, the correspondence between written and spoken Chinese is discussed. We conclude that the disyllabic trend may account for the increase of word length, and its impacts can be explained in "the principle of least effort".	[Chen, Heng] Zhejiang Univ, Ctr Study Language & Cognit, CN-310028 Hangzhou, Zhejiang, Peoples R China; [Liang, Junying; Liu, Haitao] Zhejiang Univ, Dept Linguist, CN-310058 Hangzhou, Zhejiang, Peoples R China; [Liu, Haitao] Zhejiang Univ, Ningbo Inst Technol, CN-315100 Ningbo, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Liu, HT (corresponding author), Zhejiang Univ, Dept Linguist, CN-310058 Hangzhou, Zhejiang, Peoples R China.	lhtzju@yeah.net	Liu, Haitao/HIR-1601-2022; Chen, Heng/GOJ-8064-2022; Chen, Heng/Q-3590-2017; Chen, Heng/AAB-1784-2019; Liu, Haitao/A-6053-2011	Chen, Heng/0000-0003-3678-9827; Chen, Heng/0000-0003-3678-9827; Liu, Haitao/0000-0003-1724-4418; Liang, Junying/0000-0002-3603-294X	National Social Science Foundation of China [11, ZD 188]	National Social Science Foundation of China	This work is supported by the National Social Science Foundation of China (Grant number: 11 & ZD 188). URL: http://www.npopss-cn.gov.cn/. Haitao Liu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann G., 2013, ISSUES QUANTITATIVE, V3, P23; Baixeries J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053227; Baldauf R, 2007, PLANNING CHINESE CHA; Ball P, 2014, NATURE NEWS, DOI [10.1038/news.2011.40, DOI 10.1038/NEWS.2011.40]; Baxter William H.III, 2014, OLD CHINESE NEW RECO; Best KH, 2011, GLOTTOMETRICS, V22, P57; Bickerton D, 2007, LINGUA, V117, P510, DOI 10.1016/j.lingua.2005.02.006; Bochkarev V, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0841; Bochkarev V, 2012, CORR; Boltz W.G, 1994, ORIGIN EARLY DEV CHI; Chao YR, 1946, LANGUAGE, V22, P4, DOI 10.2307/410329; Chen Matthew, 2000, TONE SANDHI; De Francis J., 1984, CHINESE LANGUAGE FAC; Ge L, 2001, OUT MARGINS RISE CHI, P4; Gong T, 2014, PHYS LIFE REV, V11, P280, DOI 10.1016/j.plrev.2013.11.009; Grzybek P., 2013, ISSUES QUANTITATIVE, P66; Grzybek P, 2006, CONTRIBUTIONS SCI TE, V31, P15; Hsu DB, 2009, J EAST ASIAN LINGUIS, V18, P361, DOI 10.1007/s10831-009-9050-3; Kohler R, 2005, SYNERGETIC LINGUISTI, P760; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Miller G. A., 1981, LANGUAGE SPEECH; Nowak MA, 1999, P ROY SOC B-BIOL SCI, V266, P2131, DOI 10.1098/rspb.1999.0898; Nowak MA, 1999, J THEOR BIOL, V200, P147, DOI 10.1006/jtbi.1999.0981; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; Packard Jerome L., 2011, NEW APPROACHES CHINE, P1; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pastreich Emanuel, 2001, COLUMBIA HIST CHINES, P1067; Peng Z, 2006, CONT LINGUISTICS, V8, P97; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Plotkin JB, 2000, J THEOR BIOL, V205, P147, DOI 10.1006/jtbi.2000.2053; Pulleyblank Edwin G., 1995, OUTLINE CLASSICAL CH; Sihih Chi-lin, 1986, THESIS U CALIFORNIA; Smith R, 2012, GLOTTOMETRICS, V23, P7; Stekauer P, 2012, WORD-FORMATION IN THE WORLD'S LANGUAGES: A TYPOLOGICAL SURVEY, P1, DOI 10.1017/CBO9780511895005; Strauss U., 2007, CONTRIBUTIONS SCI TE, V31, P277, DOI DOI 10.1007/978-1-4020-4068-9_13; Wang L, 2004, CHINESE LANGUA UNPUB; Wittgenstein L., 1965, PHILOS INVESTIGATION; Xu S, 2007, HIST CHINESE DIALECT; Zhang Z.-s., 1988, THESIS OHIO STATE U; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; Zipf GeorgeKingsley., 1936, PSYCHOBIOLOGY LANGUA	43	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138567	10.1371/journal.pone.0138567	http://dx.doi.org/10.1371/journal.pone.0138567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CS0ZE	26384237	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200128
J	Espie, E; Sarr, FD; Diop, F; Faye, J; Richard, V; Tall, A; Balde, AT				Espie, Emmanuelle; Sarr, Fatoumata Diene; Diop, Fode; Faye, Joseph; Richard, Vincent; Tall, Adama; Balde, Aissatou Toure			Spatio-Temporal Variations in Malaria Incidence in Children Less than 10 Years Old, Health District of Sokone, Senegal, 2010-2013	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; CONTROLLED-TRIAL; VILLAGE LEVEL; TRANSMISSION; AREA; DISEASE	Introduction Malaria is a leading cause of morbidity and mortality in sub-Saharan Africa. Detailed characterization of the risks for malaria, among populations living in areas where the disease is endemic, is an important priority, especially for planning and evaluating future malaria-control tools. A prospective cohort study was implemented in children under ten years living in rural areas with high Plasmodium falciparum transmission in Senegal. Methods Malaria incidence was prospectively evaluated over three year follow-up among a cohort of children aged less than 10 years old living in eight villages of the Sokone health district. The parents of 1316 children comprising a passive case detection cohort were encouraged to seek care from the study health centers at any time their child felt sick. In the event of reported history of fever within 24 hours or measured axillary temperature >= 37.5 degrees C, a Rapid Diagnostic Test (RDT) was performed. Results From November 2010 to October 2013, among the 1468 reported febrile episodes, 264 were confirmed malaria episodes. Over the 3 years, 218 (16.9%) children experienced at least one clinical malaria episode. Cumulative malaria incidence was 7.3 episodes per 100 children-year at risk, with remarkably heterogeneous rates from 2.5 to 10.5 episodes per 100 children-year at risk. Clinical malaria prevalence ranged from 11.5 to 28.4% in the high transmission season versus from 9.6 to 21.2% in the low transmission season. Conclusion This longitudinal community-based study shows that occurrence of clinical malaria was not evenly distributed among all the cohort children in the eight villages. It demonstrates the complexity of spatial distribution of malaria incidence at a local level, even in a region of vegetation and altitudinal homogeneity.	[Espie, Emmanuelle; Sarr, Fatoumata Diene; Faye, Joseph; Richard, Vincent; Tall, Adama] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal; [Diop, Fode; Balde, Aissatou Toure] Pasteur Inst Dakar, Immunol Unit, Dakar, Senegal; [Diop, Fode] Univ Cheikh Anta Diop, Fac Sci & Technol, Lab Parasitol Biol, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Espie, E (corresponding author), Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal.	emmanuelle.espie@gmail.com		Vincent, RICHARD/0000-0002-6961-1753	European and Developing Countries Clinical Trials Partnership (EDCTP) [CB.2007.41700.007]	European and Developing Countries Clinical Trials Partnership (EDCTP)	This work was supported by grant No CB.2007.41700.007 (Capacity building to prepare West African sites for clinical trials on HIV, TB and malaria) from European and Developing Countries Clinical Trials Partnership (EDCTP, http://www.edctp.org/) in the framework of West African Network of Excellence for TB, AIDS, and Malaria (WANETAM) awarded to ATB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; LINDSAY SW, 1990, ANN TROP MED PARASIT, V84, P553, DOI 10.1080/00034983.1990.11812510; Miiro GM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-258; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Ndiaye S., 2009, ENQUETE NATL PALUDIS; Niang el HA, 2013, J TROP MED, V2013, DOI [10.1155/2013/907375, DOI 10.1155/2013/907375]; Roucher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087169; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI DOI 10.1016/S1473-3099(14)70712-1; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; WHO, 2013, WHO GLOB MAL PROGR W; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137737	10.1371/journal.pone.0137737	http://dx.doi.org/10.1371/journal.pone.0137737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381623	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200035
J	Mamdani, M; Williamson, V; McMichael, GO; Blevins, T; Aliev, F; Adkins, A; Hack, L; Bigdeli, T; van der Vaart, AD; Web, BT; Bacanu, SA; Kalsi, G; Kendler, KS; Miles, MF; Dick, D; Riley, BP; Dumur, C; Vladimirov, VI				Mamdani, Mohammed; Williamson, Vernell; McMichael, Gowon O.; Blevins, Tana; Aliev, Fazil; Adkins, Amy; Hack, Laura; Bigdeli, Tim; van der Vaart, Andrew D.; Web, Bradley Todd; Bacanu, Silviu-Alin; Kalsi, Gursharan; Kendler, Kenneth S.; Miles, Michael F.; Dick, Danielle; Riley, Brien P.; Dumur, Catherine; Vladimirov, Vladimir I.		COGA Consortium	Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SET ENRICHMENT ANALYSIS; PREFRONTAL CORTEX; EPIGENETIC REGULATION; FRONTAL-CORTEX; ACUTE ETHANOL; USE DISORDERS; EXPRESSION; BRAIN; MICRORNAS	Alcohol consumption is known to lead to gene expression changes in the brain. After performing weighted gene co-expression network analyses (WGCNA) on genome-wide mRNA and microRNA (miRNA) expression in Nucleus Accumbens (NAc) of subjects with alcohol dependence (AD; N = 18) and of matched controls (N = 18), six mRNA and three miRNA modules significantly correlated with AD were identified (Bonferoni-adj. p <= 0.05). Cell-type-specific transcriptome analyses revealed two of the mRNA modules to be enriched for neuronal specific marker genes and downregulated in AD, whereas the remaining four mRNA modules were enriched for astrocyte and microglial specific marker genes and upregulated in AD. Gene set enrichment analysis demonstrated that neuronal specific modules were enriched for genes involved in oxidative phosphorylation, mitochondrial dysfunction and MAPK signaling. Glial-specific modules were predominantly enriched for genes involved in processes related to immune functions, i.e. cytokine signaling (all adj. p <= 0.05). In mRNA and miRNA modules, 461 and 25 candidate hub genes were identified, respectively. In contrast to the expected biological functions of miRNAs, correlation analyses between mRNA and miRNA hub genes revealed a higher number of positive than negative correlations (chi(2) test p <= 0.0001). Integration of hub gene expression with genome-wide genotypic data resulted in 591 mRNA cis-eQTLs and 62 miRNA cis-eQTLs. mRNA cis-eQTLs were significantly enriched for AD diagnosis and AD symptom counts (adj. p=0.014 and p=0.024, respectively) in AD GWAS signals in a large, independent genetic sample from the Collaborative Study on Genetics of Alcohol (COGA). In conclusion, our study identified putative gene network hubs coordinating mRNA and miRNA co-expression changes in the NAc of AD subjects, and our genetic (cis-eQTL) analysis provides novel insights into the etiological mechanisms of AD.	[Mamdani, Mohammed; Williamson, Vernell; McMichael, Gowon O.; Aliev, Fazil; Adkins, Amy; Hack, Laura; Bigdeli, Tim; Web, Bradley Todd; Bacanu, Silviu-Alin; Kendler, Kenneth S.; Miles, Michael F.; Dick, Danielle; Riley, Brien P.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Blevins, Tana; Dumur, Catherine] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Aliev, Fazil; Kendler, Kenneth S.; Dick, Danielle; Riley, Brien P.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Kendler, Kenneth S.; Dick, Danielle; Riley, Brien P.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [van der Vaart, Andrew D.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Dick, Danielle] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; [Kalsi, Gursharan] Inst Psychiat, Dept Social Genet & Dev Psychiat, London SE5 8AF, England; [Vladimirov, Vladimir I.] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of London; King's College London; Johns Hopkins University	Mamdani, M (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	mamdanim@vcu.edu; vivladimirov@vcu.edu	Dumur, Catherine/AAH-9489-2020; Bigdeli, Tim B./AAX-7761-2020; Aliev, Fazil/D-7172-2013; Kendler, Kenneth/AAF-2876-2019; Webb, Bradley T/B-1459-2009; Rangaswamy, Madhavi/W-3197-2019	Bigdeli, Tim B./0000-0003-2215-5946; Aliev, Fazil/0000-0001-8357-4699; Webb, Bradley T/0000-0002-0576-5366; Rangaswamy, Madhavi/0000-0002-6140-889X; Reilly, Muredach/0000-0002-3035-9386; Nurnberger, John/0000-0002-7674-1767; Bacanu, Silviu-Alin/0000-0002-4364-1583; Kuperman, Samuel/0000-0002-5995-1981; Tischfield, Jay/0000-0003-3217-8287; Edenberg, Howard/0000-0003-0344-9690	NIH from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [P50AA022537, P20AA017828, K02AA018755, 1R21AA022717, VIVU10AA008401]; National Institute on Drug Abuse (NIDA); National Institutes of Mental Health [5T32MH020030]; National Institute on Alcohol Abuse and Alcoholism; NIH GEI [U01HG004438]; NIH [HHSN268200782096C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020634, K02AA018755, P50AA022537, P20AA017828, R21AA022717, U10AA008401, R21AA022749, R28AA012725] Funding Source: NIH RePORTER	NIH from the National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH GEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This national collaborative study is supported by NIH Grants P50AA022537 to KSK, MFM, BPR; P20AA017828 to KSK, MFM, BPR, VIV; K02AA018755 to DD; 1R21AA022717 to SAB, and VIVU10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and by grant 5T32MH020030 from the National Institutes of Mental Health to MM. Funding support for GWAS genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the National Institute on Alcohol Abuse and Alcoholism, the NIH GEI (U01HG004438), and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho L, 2009, J NEUROSCI RES, V87, P2786, DOI 10.1002/jnr.22091; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Buckley ST, 2000, ANN NY ACAD SCI, V914, P58, DOI 10.1111/j.1749-6632.2000.tb05183.x; Chen C, 2013, MOL PSYCHIATR, V18, P1308, DOI 10.1038/mp.2012.146; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Clarke C, 2011, J BIOTECHNOL, V155, P350, DOI 10.1016/j.jbiotec.2011.07.011; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Darcq E, 2015, MOL PSYCHIATR, V20, P1240, DOI 10.1038/mp.2014.120; Dumur CI, 2009, LARYNGOSCOPE, V119, P91, DOI 10.1002/lary.20005; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Enoch M A, 2001, Curr Psychiatry Rep, V3, P144, DOI 10.1007/s11920-001-0012-3; Enright AJ, 2004, GENOME BIOL, V5; Eriksson AK, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-190; Fan L, 1999, ALCOHOL CLIN EXP RES, V23, P408, DOI 10.1111/j.1530-0277.1999.tb04130.x; Fan LI, 2004, ADDICT BIOL, V9, P11, DOI 10.1080/13556210410001674040; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Flatscher-Bader T, 2006, GENES BRAIN BEHAV, V5, P78, DOI 10.1111/j.1601-183X.2006.00197.x; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Flatscher-Bader T, 2010, ALCOHOL CLIN EXP RES, V34, P1291, DOI 10.1111/j.1530-0277.2010.01207.x; Friedman Y, 2013, ADV EXP MED BIOL, V774, P317, DOI 10.1007/978-94-007-5590-1_16; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907420; Himes BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056179; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodgkinson CA, 2010, P NATL ACAD SCI USA, V107, P8695, DOI 10.1073/pnas.0908134107; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Iwamoto K, 2004, NEUROSCI RES, V49, P379, DOI 10.1016/j.neures.2004.04.002; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jung ME, 2008, J APPL PHYSIOL, V105, P510, DOI 10.1152/japplphysiol.90317.2008; Jung ME, 2007, NEUROSCI LETT, V416, P160, DOI 10.1016/j.neulet.2007.01.065; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim SR, 2011, BMB REP, V44, P135, DOI 10.5483/BMBRep.2011.44.2.135; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Kuo PH, 2009, DRUG ALCOHOL DEPEN, V101, P80, DOI 10.1016/j.drugalcdep.2008.11.009; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee DY, 2008, FEBS LETT, V582, P4185, DOI 10.1016/j.febslet.2008.11.007; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li H, 2013, THEOR BIOSCI, V132, P1, DOI 10.1007/s12064-012-0168-x; Li JY, 2013, EMBO MOL MED, V5, P1402, DOI 10.1002/emmm.201201900; Liu CY, 2011, NEUROSCI BULL, V27, P123, DOI 10.1007/s12264-011-1203-5; Loh EW, 2006, ALCOHOL CLIN EXP RES, V30, P1817, DOI 10.1111/j.1530-0277.2006.00218.x; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Manzardo AM, 2013, GENE, V526, P356, DOI 10.1016/j.gene.2013.05.052; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martinelli D, 2013, BRAIN, V136, P872, DOI 10.1093/brain/awt012; Marty VN, 2012, ALCOHOL, V46, P317, DOI 10.1016/j.alcohol.2011.12.002; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Mizuo Keisuke, 2012, Japanese Journal of Alcohol Studies & Drug Dependence, V47, P155; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nowak JS, 2013, BIOCHEM SOC T, V41, P815, DOI 10.1042/BST20130044; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Ron D, 2013, CURR TOP BEHAV NEURO, V13, P87, DOI 10.1007/7854_2011_161; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P194, DOI 10.3389/fgene.2012.00194; Schmitz U, 2014, NUCLEIC ACIDS RES, V42, P7539, DOI 10.1093/nar/gku465; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Sheedy D, 2012, ALCOHOL CLIN EXP RES, V36, P55, DOI 10.1111/j.1530-0277.2011.01580.x; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P994, DOI 10.1111/acer.12341; Tabakoff B, 2013, PHARMACOL BIOCHEM BE, V113, P20, DOI 10.1016/j.pbb.2013.10.009; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tapocik JD, 2014, J NEUROSCI, V34, P4581, DOI 10.1523/JNEUROSCI.0445-14.2014; Tardito D, 2013, EXPERT OPIN INV DRUG, V22, P217, DOI 10.1517/13543784.2013.749237; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Tu K, 2009, NUCLEIC ACIDS RES, V37, P5969, DOI 10.1093/nar/gkp638; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Wang ZF, 2013, CANCER LETT, V331, P1, DOI 10.1016/j.canlet.2012.12.006; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Yan J, 2014, ADDICT BIOL, V19, P708, DOI 10.1111/adb.12035; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HP, 2014, HUM GENET, V133, P1383, DOI 10.1007/s00439-014-1473-x	108	59	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137671	10.1371/journal.pone.0137671	http://dx.doi.org/10.1371/journal.pone.0137671			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381263	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200032
J	Grandez-Rios, JM; Bergamini, LL; de Araujo, WS; Villalobos, F; Almeida-Neto, M				Grandez-Rios, Julio Miguel; Bergamini, Leonardo Lima; de Araujo, Walter Santos; Villalobos, Fabricio; Almeida-Neto, Mario			The Effect of Host-Plant Phylogenetic Isolation on Species Richness, Composition and Specialization of Insect Herbivores: A Comparison between Native and Exotic Hosts	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; EVOLUTION; FAUNA; TREES; CONSERVATISM; RELATEDNESS; ASSEMBLAGES; SPECIFICITY; TOOLS	Understanding the drivers of plant-insect interactions is still a key issue in terrestrial ecology. Here, we used 30 well-defined plant-herbivore assemblages to assess the effects of host plant phylogenetic isolation and origin (native vs. exotic) on the species richness, composition and specialization of the insect herbivore fauna on co-occurring plant species. We also tested for differences in such effects between assemblages composed exclusively of exophagous and endophagous herbivores. We found a consistent negative effect of the phylogenetic isolation of host plants on the richness, similarity and specialization of their insect herbivore faunas. Notably, except for Jaccard dissimilarity, the effect of phylogenetic isolation on the insect herbivore faunas did not vary between native and exotic plants. Our findings show that the phylogenetic isolation of host plants is a key factor that influences the richness, composition and specialization of their local herbivore faunas, regardless of the host plant origin.	[Grandez-Rios, Julio Miguel; Bergamini, Leonardo Lima] Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [de Araujo, Walter Santos; Villalobos, Fabricio; Almeida-Neto, Mario] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Grandez-Rios, JM (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	jgrandezrios@yahoo.com	Bergamini, Leonardo Lima/H-4932-2019; Villalobos, Fabricio/J-6246-2012; de Araújo, Walter Santos/AAA-4606-2020; Bergamini, Leonardo L/D-1036-2019; Almeida-Neto, M./A-6389-2009; de Araújo, Walter S/C-8546-2013	Bergamini, Leonardo Lima/0000-0001-8505-5059; Villalobos, Fabricio/0000-0002-5230-2217; de Araújo, Walter Santos/0000-0003-0157-6151; Bergamini, Leonardo L/0000-0001-8505-5059; Almeida-Neto, M./0000-0002-2161-2968; 	Organization of American States (OAS); Brazilian Universities Coimbra Group (GCUB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Research Council (CNPq)	Organization of American States (OAS); Brazilian Universities Coimbra Group (GCUB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JMGR wishes to thank the Organization of American States (OAS) and the Brazilian Universities Coimbra Group (GCUB) for a scholarship permitting post-graduate studies in Brazil. The authors are also grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a grant to WSdA and LLB, and to the Brazilian Research Council (CNPq) for a BJT-"Science without Borders" fellowship to FV and productivity grant to MAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; Basset Y, 1999, BIOL J LINN SOC, V67, P477, DOI 10.1111/j.1095-8312.1999.tb01943.x; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Becerra JX, 2015, P NATL ACAD SCI USA, V112, P6098, DOI 10.1073/pnas.1418643112; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bezemer TM, 2014, ANNU REV ENTOMOL, V59, P119, DOI 10.1146/annurev-ento-011613-162104; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brandle M, 2008, DIVERS DISTRIB, V14, P905, DOI 10.1111/j.1472-4642.2008.00511.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; CONNOR EF, 1980, ECOL ENTOMOL, V5, P205, DOI 10.1111/j.1365-2311.1980.tb01143.x; Cripps MG, 2006, J BIOGEOGR, V33, P2107, DOI 10.1111/j.1365-2699.2006.01560.x; DALIN P, 2006, INVASIVE FOREST INSE, P63; de Araujo WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115606; de Araujo WS, 2013, ARTHROPOD-PLANT INTE, V7, P373, DOI 10.1007/s11829-013-9259-y; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Fine PVA, 2013, ECOLOGY, V94, P1764, DOI 10.1890/12-1920.1; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Futuyma D.J., 1983, P227; GASTON KJ, 1992, ECOL ENTOMOL, V17, P86, DOI 10.1111/j.1365-2311.1992.tb01044.x; Gontijo L, 2014, ECOL ENTOMOL, V39, P716, DOI 10.1111/een.12152; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; Hackathon R, 2015, PHYLOBASE BASE PACKA; Hansen SO, 2006, EUR J ENTOMOL, V103, P387, DOI 10.14411/eje.2006.052; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Helden AJ, 2012, URBAN ECOSYST, V15, P611, DOI 10.1007/s11252-012-0231-x; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535, DOI 10.1146/annurev.en.36.010191.002535; Hill SB, 2010, BIOL INVASIONS, V12, P3333, DOI 10.1007/s10530-010-9726-7; Hill SB, 2009, OECOLOGIA, V161, P581, DOI 10.1007/s00442-009-1403-0; JANZEN DH, 1968, AM NAT, V102, P592, DOI 10.1086/282574; Jobin A, 1996, ENTOMOL EXP APPL, V79, P33, DOI 10.1007/BF00333819; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Leffler AJ, 2014, ECOLOGY, V95, P298, DOI 10.1890/13-0102.1; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Memmott J, 2000, ACTA OECOL, V21, P213, DOI 10.1016/S1146-609X(00)00124-7; Morais HC, 2011, BIOTROPICA, V43, P467, DOI 10.1111/j.1744-7429.2010.00736.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Proches S, 2008, AUSTRAL ECOL, V33, P691, DOI 10.1111/j.1442-9993.2008.01836.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roques A, 2006, CAN J FOREST RES, V36, P299, DOI 10.1139/x05-277; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Spafford Ryan D., 2013, NeoBiota, V16, P81; Vialatte A, 2010, P ROY SOC B-BIOL SCI, V277, P2227, DOI 10.1098/rspb.2010.0365; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Yguel B, 2014, OECOLOGIA, V176, P521, DOI 10.1007/s00442-014-3026-3; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	63	14	14	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138031	10.1371/journal.pone.0138031	http://dx.doi.org/10.1371/journal.pone.0138031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379159	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400045
J	McMorrow, ML; Emukule, GO; Njuguna, HN; Bigogo, G; Montgomeryz, JM; Nyawanda, B; Audi, A; Breiman, RF; Katz, MA; Cosmas, L; Waiboci, LW; Duque, J; Widdowson, MA; Mott, JA				McMorrow, Meredith L.; Emukule, Gideon O.; Njuguna, Henry N.; Bigogo, Godfrey; Montgomeryz, Joel M.; Nyawanda, Bryan; Audi, Allan; Breiman, Robert F.; Katz, Mark A.; Cosmas, Leonard; Waiboci, Lilian W.; Duque, Jazmin; Widdowson, Marc-Alain; Mott, Joshua A.			The Unrecognized Burden of Influenza in Young Kenyan Children, 2008-2012	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; WESTERN KENYA; RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; SEASONAL INFLUENZA; EPIDEMIOLOGY; AFRICA; SURVEILLANCE; PNEUMONIA; ETIOLOGY	Influenza-associated disease burden among children in tropical sub-Saharan Africa is not well established, particularly outside of the 2009 pandemic period. We estimated the burden of influenza in children aged 0-4 years through population-based surveillance for influenza-like illness (ILI) and acute lower respiratory tract illness (ALRI). Household members meeting ILI or ALRI case definitions were referred to health facilities for evaluation and collection of nasopharyngeal and oropharyngeal swabs for influenza testing by real-time reverse transcription polymerase chain reaction. Estimates were adjusted for health-seeking behavior and those with ILI and ALRI who were not tested. During 2008-2012, there were 9,652 person-years of surveillance among children aged 0-4 years. The average adjusted rate of influenza-associated hospitalization was 4.3 (95% Cl 3.0-6.0) per 1,000 person-years in children aged 0-4 years. Hospitalization rates were highest in the 0-5 month and 6-23 month age groups, at 7.6 (95% Cl 3.2-18.2) and 8.4 (95% Cl 5.4-13.0) per 1,000 personyears, respectively. The average adjusted rate of influenza-associated medically attended (inpatient or outpatient) ALRI in children aged 0-4 years was 17.4 (95% Cl 14.2-19.7) per 1,000 person-years. Few children who had severe laboratory-confirmed influenza were clinically diagnosed with influenza by the treating clinician in the inpatient (0/33, 0%) or outpatient (1/109, 0.9%) settings. Influenza-associated hospitalization rates from 2008-2012 were 5-10 times higher than contemporaneous U.S. estimates. Many children with danger signs were not hospitalized; thus, influenza-associated severe disease rates in Kenyan children are likely higher than hospital-based estimates suggest.	[McMorrow, Meredith L.; Widdowson, Marc-Alain; Mott, Joshua A.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [McMorrow, Meredith L.; Montgomeryz, Joel M.; Mott, Joshua A.] US PHS, Rockville, MD USA; [Emukule, Gideon O.; Njuguna, Henry N.; Montgomeryz, Joel M.; Breiman, Robert F.; Katz, Mark A.; Cosmas, Leonard; Waiboci, Lilian W.; Mott, Joshua A.] Kenya Country Off, Ctr Dis Control & Prevent, Nairobi, Kenya; [Bigogo, Godfrey; Nyawanda, Bryan; Audi, Allan] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Bigogo, Godfrey; Nyawanda, Bryan; Audi, Allan] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Montgomeryz, Joel M.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Duque, Jazmin] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Emory University	McMorrow, ML (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	mmcmorrow@cdc.gov	McMorrow, Meredith/M-1274-2019; Bigogo, Godfrey/W-3591-2019	Duque, Jazmin/0000-0003-3484-276X; Audi, Allan/0000-0003-1683-554X; McMorrow, Meredith/0000-0001-6363-4033	Centers for Disease Control and Prevention (CDC) Cooperative Agreement; Kenya Medical Research Institute (KEMRI) [1U01 GH000048]	Centers for Disease Control and Prevention (CDC) Cooperative Agreement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Kenya Medical Research Institute (KEMRI)	The work was supported by Centers for Disease Control and Prevention (CDC) Cooperative Agreement with Kenya Medical Research Institute (KEMRI) 1U01 GH000048.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P94; CDC, 2013, FLUVIEW INT LAB CONF; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1016; Chaves SS, 2014, PEDIAT INFECT DIS J; Cohen C, 2013, EMERGING INFECT DIS, V19; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Gentile A, 2011, ARCH ARGENT PEDIATR, V109, P198, DOI 10.1590/S0325-00752011000300003; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Miranda-Choque Edwin, 2011, Rev. perú. med. exp. salud publica, V28, P610; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Opwora AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-272; Ortiz JR, 2012, INFLUENZA OTHER RESP, V6, P11, DOI 10.1111/j.1750-2659.2011.00257.x; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; ROOTH IB, 1992, AM J TROP MED HYG, V47, P675, DOI 10.4269/ajtmh.1992.47.675; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Silvennoinen H, 2012, EUR J CLIN MICROBIOL, V31, P225, DOI 10.1007/s10096-011-1297-8; Silvennoinen H, 2011, PEDIATR INFECT DIS J, V30, pE24, DOI 10.1097/INF.0b013e3181fe37c8; Thompson MG, 2012, J INFECT DIS, V206, P1674, DOI 10.1093/infdis/jis591; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Walaza S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129173; Walaza S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0746-x; World Health Organization (WHO), WHO INF MOL DIAGN IN; World Health Organization (WHO), 2002, WHO WKLY EPIDEMIOL R	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138272	10.1371/journal.pone.0138272	http://dx.doi.org/10.1371/journal.pone.0138272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379030	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400079
J	Meads, MB; Fang, B; Mathews, L; Gemmer, J; Nong, L; Rosado-Lopez, I; Nguyen, T; Ring, JE; Matsui, W; MacLeod, AR; Pachter, JA; Hazlehurst, LA; Koomen, JM; Shain, KH				Meads, M. B.; Fang, B.; Mathews, L.; Gemmer, J.; Nong, L.; Rosado-Lopez, I.; Nguyen, T.; Ring, J. E.; Matsui, W.; MacLeod, A. R.; Pachter, J. A.; Hazlehurst, L. A.; Koomen, J. M.; Shain, K. H.			Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma	ONCOGENE			English	Article							BONE-MARROW MICROENVIRONMENT; NOVO DRUG-RESISTANCE; TYROSINE KINASE PYK2; KAPPA-B; GROWTH-FACTOR; CANCER-CELLS; LUNG-CANCER; ACTIVATION; THERAPY; INHIBITION	Multiple myeloma (MM) remains an incurable malignancy due, in part, to the influence of the bone marrow microenvironment on survival and drug response. Identification of microenvironment-specific survival signaling determinants is critical for the rational design of therapy and elimination of MM. Previously, we have shown that collaborative signaling between beta(1) integrin-mediated adhesion to fibronectin and interleukin-6 confers a more malignant phenotype via amplification of signal transducer and activator of transcription 3 (STAT3) activation. Further characterization of the events modulated under these conditions with quantitative phosphotyrosine profiling identified 193 differentially phosphorylated peptides. Seventy-seven phosphorylations were upregulated upon adhesion, including PYK2/FAK2, Paxillin, CASL and p130CAS consistent with focal adhesion (FA) formation. We hypothesized that the collaborative signaling between beta(1) integrin and gp130 (IL-6 beta receptor, IL-6 signal transducer) was mediated by FA formation and proline-rich tyrosine kinase 2 (PYK2) activity. Both pharmacological and molecular targeting of PYK2 attenuated the amplification of STAT3 phosphorylation under co-stimulatory conditions. Co-culture of MM cells with patient bone marrow stromal cells (BMSC) showed similar beta(1) integrin-specific enhancement of PYK2 and STAT3 signaling. Molecular and pharmacological targeting of PYK2 specifically induced cell death and reduced clonogenic growth in BMSC-adherent myeloma cell lines, aldehyde dehydrogenase-positive MM cancer stem cells and patient specimens. Finally, PYK2 inhibition similarly attenuated MM progression in vivo. These data identify a novel PYK2-mediated survival pathway in MM cells and MM cancer stem cells within the context of microenvironmental cues, providing preclinical support for the use of the clinical stage FAK/PYK2 inhibitors for treatment of MM, especially in a minimal residual disease setting.	[Meads, M. B.; Mathews, L.; Gemmer, J.; Nong, L.; Rosado-Lopez, I.; Nguyen, T.; Shain, K. H.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA; [Meads, M. B.; Mathews, L.; Gemmer, J.; Nong, L.; Rosado-Lopez, I.; Nguyen, T.; Shain, K. H.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, 12902 Magnolia Dr SRB2, Tampa, FL 33612 USA; [Fang, B.; Koomen, J. M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote Core Facil, Tampa, FL 33612 USA; [Ring, J. E.; Pachter, J. A.] Verastem Inc, Needham, MA USA; [Matsui, W.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [MacLeod, A. R.] ISIS Pharmaceut, Carlsbad, CA USA; [Hazlehurst, L. A.; Koomen, J. M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins Medicine; Isis Pharmaceuticals Inc; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Shain, KH (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, 12902 Magnolia Dr SRB2, Tampa, FL 33612 USA.	ken.shain@moffitt.org			Florida Department of Health Bankhead-Coley Team Science Program grant [2BT03]; US Army Medical Research and Materiel Command for a National Functional Genomics Center [W81XWH-08-2-0101]; National Cancer Institute as a Cancer Center Support Grant [P30-CA076292]; Moffitt Foundation; NATIONAL CANCER INSTITUTE [P30CA076292, K24CA198315, R01CA174951, P30CA006973, R01CA193887] Funding Source: NIH RePORTER	Florida Department of Health Bankhead-Coley Team Science Program grant; US Army Medical Research and Materiel Command for a National Functional Genomics Center; National Cancer Institute as a Cancer Center Support Grant; Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jianguo Tao and William S Dalton for helpful discussions and critical reading of the manuscript. This work was supported by Florida Department of Health Bankhead-Coley Team Science Program grant 2BT03 (to KSH and LHA). The Moffitt Proteomics Facility is supported by the US Army Medical Research and Materiel Command under Award W81XWH-08-2-0101 for a National Functional Genomics Center, the National Cancer Institute under Award P30-CA076292 as a Cancer Center Support Grant and the Moffitt Foundation. Patient specimens were obtained from the Total Cancer Care program at Moffitt Cancer Center. Patient specimen collection, phosphoproteome mapping and flow cytometry were performed by the Translational Research, Proteomics and Flow Cytometry Core facilities at Moffitt Cancer Center. Antisense oligonucleotides were provided by Isis Pharmaceuticals (Carlsbad, CA, USA). The focal adhesion kinase inhibitors VS-6062, VS-6063 (defactinib), and VS-4718 were provided by Verastem, Inc. (Needham, MA, USA).	[Anonymous], 2012, AUTHENTICATION HUMAN; Ara T, 2013, CANCER RES, V73, P3852, DOI 10.1158/0008-5472.CAN-12-2353; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Benbernou N, 2000, J BIOL CHEM, V275, P7060, DOI 10.1074/jbc.275.10.7060; Boucher K, 2012, CLIN CANCER RES, V18, P6155, DOI 10.1158/1078-0432.CCR-12-0531; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Burel SA, 2013, NUCLEIC ACID THER, V23, P213, DOI 10.1089/nat.2013.0422; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; Chauhan D, 2000, J BIOL CHEM, V275, P27845; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; Fuhler GM, 2012, MOL MED, V18, P65, DOI 10.2119/molmed.2011.00178; Golubovskaya V, 2010, ANTI-CANCER AGENT ME, V10, P713, DOI 10.2174/187152010794728693; Guessous F, 2012, MOL CANCER THER, V11, P288, DOI 10.1158/1535-7163.MCT-11-0490; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Kesanakurti D, 2013, ONCOGENE, V32, P327, DOI 10.1038/onc.2012.52; Kim SM, 2012, MOL CANCER THER, V11, P2254, DOI 10.1158/1535-7163.MCT-12-0311; Kingsley LA, 2007, P NATL ACAD SCI USA, V104, P10753, DOI 10.1073/pnas.0704357104; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin HY, 2012, J AGR FOOD CHEM, V60, P2480, DOI 10.1021/jf204362n; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Meads MB, 2010, J IMMUNOL, V185, P1606, DOI 10.4049/jimmunol.0902026; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shain KH, 2009, EXPERT REV HEMATOL, V2, P649, DOI [10.1586/ehm.09.55, 10.1586/EHM.09.55]; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Shi Z, 2012, BREAST CANCER RES TR, V135, P737, DOI 10.1007/s10549-012-2196-0; St-Germain JR, 2009, P NATL ACAD SCI USA, V106, P20127, DOI 10.1073/pnas.0910957106; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Voorhees PM, 2009, BRIT J HAEMATOL, V145, P481, DOI 10.1111/j.1365-2141.2009.07647.x; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Yang Y, 2015, CANCER RES, V75, P594, DOI 10.1158/0008-5472.CAN-14-2362; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhang GL, 2011, J PROTEOME RES, V10, P305, DOI 10.1021/pr1006203; Zhang Y, 2014, BLOOD, V124, P2675, DOI 10.1182/blood-2014-03-563981	51	25	26	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2723	2734		10.1038/onc.2015.334	http://dx.doi.org/10.1038/onc.2015.334			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26387544	Green Accepted			2022-12-26	WOS:000377472700006
J	Maeda, M; Hasegawa, H; Sugiyama, M; Hyodo, T; Ito, S; Chen, D; Asano, E; Masuda, A; Hasegawa, Y; Hamaguchi, M; Senga, T				Maeda, Masao; Hasegawa, Hitoki; Sugiyama, Mai; Hyodo, Toshinori; Ito, Satoko; Chen, Dan; Asano, Eri; Masuda, Akio; Hasegawa, Yoshinori; Hamaguchi, Michinari; Senga, Takeshi			Arginine methylation of ubiquitin-associated protein 2-like is required for the accurate distribution of chromosomes	FASEB JOURNAL			English	Article						PRMT1; mitosis; kinetochore; UBAP2L	SPINDLE-ASSEMBLY CHECKPOINT; KINETOCHORE-MICROTUBULE INTERFACE; REGULATE MITOTIC PROGRESSION; METHYLTRANSFERASE 7 PRMT7; CELL-DIVISION; CANCER-CELLS; AURORA-B; CENP-E; MITOSIS; BUBR1	Proper bioriented attachment of microtubules and kinetochores is essential for the precise distribution of duplicated chromosomes to each daughter cell. An aberrant kinetochore-microtubule attachment results in chromosome instability, which leads to cellular transformation or apoptosis. In this article, we show that ubiquitin-associated protein 2-like (UBAP2L) is necessary for correct kinetochore-microtubule attachment. Depletion of UBAP2L inhibited chromosome alignment in metaphase and delayed progression to anaphase by activating spindle assembly checkpoint signaling. In addition, UBAP2L knockdown increased side-on attachment of kinetochores along the microtubules and suppressed stable kinetochore fiber formation. A proteomics analysis identified protein arginine methyltransferase (PRMT) 1 as a direct interaction partner of UBAP2L. UBAP2L has an arginine-and glycine-rich motif called the RGG/RG or GAR motif in the N terminus. Biochemical analysis confirmed that arginine residues in the RGG/RG motif of UBAP2L were directly methylated by PRMT1. Finally, we demonstrated that the RGG/RG motif of UBAP2L is essential for the proper alignment of chromosomes in metaphase for the accurate distribution of chromosomes. Our results show a possible role for arginine methylation in UBAP2L for the progression of mitosis.	[Maeda, Masao; Hasegawa, Hitoki; Sugiyama, Mai; Hyodo, Toshinori; Ito, Satoko; Chen, Dan; Asano, Eri; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan; [Masuda, Akio] Nagoya Univ, Grad Sch Med, Div Neurogenet, Nagoya, Aichi 4668550, Japan; [Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University	Senga, T (corresponding author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp	Hasegawa, Yoshinori/I-1277-2012	Hyodo, Toshinori/0000-0003-3046-5338; Maeda, Masao/0000-0001-5936-5790	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25650063, 2306]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank the members of the Division of Cancer Biology for technical assistance and helpful discussions. This research was funded by Grants 25650063 and 2306 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.S.).	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Baumgartner R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003598; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Bordeleau ME, 2014, BLOOD, V124, P2362, DOI 10.1182/blood-2014-01-548651; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Davidovic L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003367; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Feng Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609271; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Hasegawa H, 2013, J CELL SCI, V126, P3627, DOI 10.1242/jcs.124818; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kahyo T, 2011, ONCOGENE, V30, P4453, DOI 10.1038/onc.2011.152; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kruse T, 2013, J CELL SCI, V126, P1086, DOI 10.1242/jcs.122481; Kuniyoshi H, 2002, GENETICS, V162, P1775; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li D, 2014, ONCOL REP, V32, P1578, DOI 10.3892/or.2014.3360; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Park I, 2013, J CELL BIOL, V202, P295, DOI 10.1083/jcb.201210099; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Shrestha RL, 2013, CURR BIOL, V23, P2440, DOI 10.1016/j.cub.2013.11.015; Shrestha RL, 2013, CURR BIOL, V23, P1514, DOI 10.1016/j.cub.2013.06.040; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Sze KMF, 2008, CANCER RES, V68, P9194, DOI 10.1158/0008-5472.CAN-08-2600; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Varma D, 2012, J CELL SCI, V125, P5927, DOI 10.1242/jcs.093724; Wang YC, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29027; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	51	17	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					312	323		10.1096/fj.14-268987	http://dx.doi.org/10.1096/fj.14-268987			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26381755				2022-12-26	WOS:000367621000030
J	Nakadai, T; Fukuda, A; Shimada, M; Nishimura, K; Hisatake, K				Nakadai, Tomoyoshi; Fukuda, Aya; Shimada, Miho; Nishimura, Ken; Hisatake, Koji			The RNA Binding Complexes NF45-NF90 and NF45-NF110 Associate Dynamically with the c-fos Gene and Function as Transcriptional Coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; PRE-MESSENGER-RNA; ACTIVATED T-CELLS; PROMOTER IN-VITRO; NUCLEAR FACTOR-90; RESPONSE ELEMENT; HISTONE H3; INTRACELLULAR-DISTRIBUTION; POLYMERASE-II	The c-fos gene is rapidly induced to high levels by various extracellular stimuli. We used a defined in vitro transcription system that utilizes the c-fos promoter to purify a coactivator activity in an unbiased manner. We report here that NF45-NF90 and NF45-NF110, which possess archetypical double-stranded RNA binding motifs, have a direct function as transcriptional coactivators. The transcriptional activities of the nuclear factor (NF) complexes (NF45-NF90 and NF45-NF110) are mediated by both the upstream enhancer and core promoter regions of the c-fos gene and do not require their double-stranded RNA binding activities. The NF complexes cooperate with general coactivators, PC4 and Mediator, to elicit a high level of transcription and display multiple interactions with activators and the components of the general transcriptional machinery. Knockdown of the endogenous NF90/NF110 in mouse cells shows an important role for the NF complexes in inducing c-fos transcription. Chromatin immunoprecipitation assays demonstrate that the NF complexes occupy the c-fos enhancer/promoter region before and after serum induction and that their occupancies within the coding region of the c-fos gene increase in parallel to that of RNAPII upon serum induction. In light of their dynamic occupancy on the c-fos gene as well as direct functions in both transcription and posttranscriptional processes, the NF complexes appear to serve as multifunctional coactivators that coordinate different steps of gene expression to facilitate rapid response of inducible genes.	[Nakadai, Tomoyoshi; Shimada, Miho] Saitama Med Univ, Fac Med, Dept Mol Biol, Moroyama, Saitama 3500495, Japan; [Fukuda, Aya; Nishimura, Ken; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; University of Tsukuba	Hisatake, K (corresponding author), Univ Tsukuba, Dept Biochem, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp	Nishimura, KEN/HGC-6147-2022	Nishimura, Ken/0000-0002-0716-4142; Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25460354] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research (to T. N., A. F., M. S., K. N., and K. H.) and Special Coordination Funds for Promoting Science and Technology (to A. F. and K. N.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Barber GN, 2009, RNA BIOL, V6, P35, DOI 10.4161/rna.6.1.7565; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Bunimov N, 2010, CELL MOL BIOL LETT, V15, P196, DOI 10.2478/s11658-010-0005-5; Chan HM, 2001, J CELL SCI, V114, P2363; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Coolidge CJ, 2000, NUCLEIC ACIDS RES, V28, P1407, DOI 10.1093/nar/28.6.1407; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2001, GENES CELLS, V6, P707, DOI 10.1046/j.1365-2443.2001.00456.x; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; KAO PN, 1994, J BIOL CHEM, V269, P20691; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934; Xu YH, 2003, MOL GENET METAB, V80, P426, DOI 10.1016/j.ymgme.2003.09.006; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	68	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26832	26845		10.1074/jbc.M115.688317	http://dx.doi.org/10.1074/jbc.M115.688317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26381409	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000364793600045
J	Kouba, Y; Martinez-Garcia, F; de Frutos, A; Alados, CL				Kouba, Yacine; Martinez-Garcia, Felipe; de Frutos, Angel; Alados, Concepcion L.			Effects of Previous Land-Use on Plant Species Composition and Diversity in Mediterranean Forests	PLOS ONE			English	Article							UNDERSTORY VEGETATION; MANAGEMENT; DYNAMICS; BIODIVERSITY; PLANTATIONS; RICHNESS; ANCIENT; CONIFER; DISTURBANCES; METAANALYSIS	At some point in their history, most forests in the Mediterranean Basin have been subjected to intensive management or converted to agriculture land. Knowing how forest plant communities recovered after the abandonment of forest- management or agricultural practices (including livestock grazing) provides a basis for investigating how previous land management have affected plant species diversity and composition in forest ecosystems. Our study investigated the consequences of historical "land management" practices on present-day Mediterranean forests by comparing species assemblages and the diversity of (i) all plant species and (ii) each ecological group defined by species' habitat preferences and successional status (i.e., early-, mid-, and late-successional species). We compared forest stands that differed both in land-use history and in successional stage. In addition, we evaluated the value of those stands for biodiversity conservation. The study revealed significant compositional differentiation among stands that was due to among-stand variations in the diversity (namely, species richness and evenness) of early-, intermediate-, and late-successional species. Historical land management has led to an increase in compositional divergences among forest stands and the loss of late- successional forest species.	[Kouba, Yacine; Alados, Concepcion L.] CSIC, Inst Pirenaico Ecol, Zaragoza, Spain; [Martinez-Garcia, Felipe] Univ Politecn Madrid, Escuela Ingn Montes Forestal & Medio Nat, Dept Sistemas & Recursos Nat, Madrid, Spain; [de Frutos, Angel] CSIC, Inst Pirenaico Ecol, Jaca, Huesca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Kouba, Y (corresponding author), CSIC, Inst Pirenaico Ecol, Zaragoza, Spain.	kouba_yacine@yahoo.fr	Kouba, Yacine/G-1804-2012; Alados, Concepción L/K-8085-2014	Kouba, Yacine/0000-0002-2089-5337; Alados, Concepción L/0000-0002-6227-861X; de Frutos, Angel/0000-0002-5250-9488; MARTINEZ GARCIA, FELIPE/0000-0001-9062-7277	MAEC-AECID grant from Spanish Agency for International Cooperation; JAE-DOC postdoctoral contract from Spanish Research Council (CSIC); Fondo Social Europeo; Spanish Ministry of Economy and Competitiveness and Innovation [CGL2011-27259]	MAEC-AECID grant from Spanish Agency for International Cooperation; JAE-DOC postdoctoral contract from Spanish Research Council (CSIC); Fondo Social Europeo(European Social Fund (ESF)European Commission); Spanish Ministry of Economy and Competitiveness and Innovation	YK was funded by a MAEC-AECID grant from the Spanish Agency for International Cooperation (http://www.aecid.es/EN/aecid). AF was financed by a JAE-DOC postdoctoral contract from the Spanish Research Council (CSIC) (http://www.csic.es/web/guest/home) and Fondo Social Europeo (http://ec.europa.eu/esf/home.jsp?langld=en). The authors acknowledge financial support from the Spanish Ministry of Economy and Competitiveness and Innovation (research project: CGL2011-27259). This funder had no role in study design, data collection and analysis.	Alados CL, 2009, ECOL COMPLEX, V6, P197, DOI 10.1016/j.ecocom.2008.10.015; [Anonymous], 2012, FLORA IBERICA PLANTA; [Anonymous], 2012, FLORA IBERICA PLANTA; [Anonymous], 2012, FLORA IBERICA PLANTA; [Anonymous], 2015, R LANG ENV STAT COMP; [Anonymous], 2012, FLORA IBERICA PLANTA; Baeten L, 2010, J ECOL, V98, P1447, DOI 10.1111/j.1365-2745.2010.01711.x; BARBERO M, 1990, VEGETATIO, V87, P151, DOI 10.1007/BF00042952; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bartels SF, 2010, ECOLOGY, V91, P1931, DOI 10.1890/09-1376.1; Bartemucci P, 2006, CAN J FOREST RES, V36, P2065, DOI 10.1139/X06-088; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Battles JJ, 2001, FOREST ECOL MANAG, V146, P211, DOI 10.1016/S0378-1127(00)00463-1; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Berhane A, 2013, BIODIVERS CONSERV, V22, P2519, DOI 10.1007/s10531-013-0534-0; Calvino-Cancela M, 2012, FOREST ECOL MANAG, V270, P153, DOI 10.1016/j.foreco.2012.01.019; CARSON WP, 2008, TROPICAL FOREST COMM; De Caceres M, 2012, METHODS ECOL EVOL, V3, P973, DOI 10.1111/j.2041-210X.2012.00246.x; De Caceres M, 2009, J VEG SCI, V20, P620, DOI 10.1111/j.1654-1103.2009.01081.x; De Frenne P, 2011, J ECOL, V99, P600, DOI 10.1111/j.1365-2745.2010.01768.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Fahey RT, 2007, J ECOL, V95, P1098, DOI 10.1111/j.1365-2745.2007.01283.x; Farwig N, 2009, FOREST ECOL MANAG, V257, P143, DOI 10.1016/j.foreco.2008.08.022; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Gehring C, 2005, J TROP ECOL, V21, P519, DOI 10.1017/S0266467405002543; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; HALPERN CB, 1995, ECOL APPL, V5, P913, DOI 10.2307/2269343; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Kouba Y, 2014, EUR J FOREST RES, V133, P1057, DOI 10.1007/s10342-014-0822-6; Kouba Y, 2012, FOREST ECOL MANAG, V274, P143, DOI 10.1016/j.foreco.2012.02.033; Kouba Y, 2012, EUR J FOREST RES, V131, P369, DOI 10.1007/s10342-011-0509-1; Lasanta T, 2009, APPL GEOGR, V29, P308, DOI 10.1016/j.apgeog.2008.09.006; Lasanta T, 2000, CATENA, V38, P265, DOI 10.1016/S0341-8162(99)00079-X; Mather AS, 1999, J RURAL STUD, V15, P65, DOI 10.1016/S0743-0167(98)00023-0; Matuszkiewicz JM, 2013, FOREST ECOL MANAG, V310, P567, DOI 10.1016/j.foreco.2013.08.060; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Montserrat M, 1986, FLORA VEGETACION SIE; Okland T, 2003, FOREST ECOL MANAG, V177, P17, DOI 10.1016/S0378-1127(02)00331-6; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Oliver C.D., 1996, FOREST STAND DYNAMIC; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Peinado M, 1987, VEGETACION ESPANA CO; PETERKEN G F, 1974, Biological Conservation, V6, P239, DOI 10.1016/0006-3207(74)90001-9; Pinheiro J, 2020, R PACKAGE VERSION 31; Ramovs BV, 2005, CAN J FOREST RES, V35, P1261, DOI 10.1139/X05-049; Sainz H, 1997, BOSQUES IBERICOS INT; Schmiedinger A, 2012, CAN J FOREST RES, V42, P1239, DOI [10.1139/X2012-052, 10.1139/x2012-052]; Sciama D, 2009, FOREST ECOL MANAG, V258, P600, DOI 10.1016/j.foreco.2009.04.027; Seiwa K, 2012, FOREST ECOL MANAG, V269, P177, DOI 10.1016/j.foreco.2011.12.014; Smith KJ, 2008, CAN J FOREST RES, V38, P1303, DOI 10.1139/X07-236; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; SZEICZ JM, 1995, J ECOL, V83, P873, DOI 10.2307/2261424; van Breugel M, 2007, BIOTROPICA, V39, P610, DOI 10.1111/j.1744-7429.2007.00316.x; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; Verheyen K, 1999, J BIOGEOGR, V26, P1115, DOI 10.1046/j.1365-2699.1999.00340.x; Villar L, 2001, FLORA PIRINEO ARAGON, VI; Villar L, 2003, FLORA PIRINEO ARAGON, VII; Vockenhuber EA, 2011, PERSPECT PLANT ECOL, V13, P111, DOI 10.1016/j.ppees.2011.02.004	60	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139031	10.1371/journal.pone.0139031	http://dx.doi.org/10.1371/journal.pone.0139031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397707	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361797500134
J	Li, SF; Su, JR; Liu, WD; Lang, XD; Huang, XB; Jia, C; Zhang, ZJ; Tong, Q				Li, Shuaifeng; Su, Jianrong; Liu, Wande; Lang, Xuedong; Huang, Xiaobo; Jia, Chengxinzhuo; Zhang, Zhijun; Tong, Qing			Changes in Biomass Carbon and Soil Organic Carbon Stocks following the Conversion from a Secondary Coniferous Forest to a Pine Plantation	PLOS ONE			English	Article							LAND-USE; YUNNAN PROVINCE; GREEN PROGRAM; AFFORESTATION; NITROGEN; STORAGE; CHINA; MANAGEMENT; DYNAMICS; STANDS	The objectives of this study were to estimate changes of tree carbon (C) and soil organic carbon (SOC) stock following a conversion in land use, an issue that has been only insufficiently addressed. For this study, we examined a chronosequence of 2 to 54-year-old Pinus kesiya var. langbianensis plantations that replaced the original secondary coniferous forest (SCF) in Southwest China due to clearing. C stocks considered here consisted of tree, understory, litter, and SOC (0-1 m). The results showed that tree C stocks ranged from 0.02 +/- 0.001 Mg C ha(-1) to 141.43 +/- 5.29 Mg C ha(-1), and increased gradually with the stand age. Accumulation of tree C stocks occurred in 20 years after reforestaion and C stock level recoverd to SCF. The maximum of understory C stock was found in a 5-year-old stand (6.74 +/- 0.7 Mg C ha(-1)) with 5.8 times that of SCF, thereafter, understory C stock decreased with the growth of plantation. Litter C stock had no difference excluding effects of prescribed burning. Tree C stock exhibited a significant decline in the 2, 5-year-old stand following the conversion to plantation, but later, increased until a steady state-level in the 20, 26-year-old stand. The SOC stocks ranged from 81.08 +/- 10.13 Mg C ha(-1) to 160.38 +/- 17.96 Mg C ha(-1). Reforestation significantly decreased SOC stocks of plantation in the 2-year-old stand which lost 42.29 Mg C ha(-1) in the 1 m soil depth compared with SCF by reason of soil disturbance from sites preparation, but then subsequently recovered to SCF level. SOC stocks of SCF had no significant difference with other plantation. The surface profile (0-0.1 m) contained s higher SOC stocks than deeper soil depth. C stock associated with tree biomass represented a higher proportion than SOC stocks as stand development proceeded.	[Li, Shuaifeng; Su, Jianrong; Liu, Wande; Lang, Xuedong; Huang, Xiaobo; Jia, Chengxinzhuo; Zhang, Zhijun] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China; [Li, Shuaifeng; Su, Jianrong; Liu, Wande; Lang, Xuedong; Zhang, Zhijun] State Forestry Bur, Puer Forest Ecosyst Res Stn, Kunming, Peoples R China; [Tong, Qing] Forestry Res Inst Puer Municipal, Puer, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF	Su, JR (corresponding author), Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China.	jianrongsu@vip.sina.com			Research Institute of Resources Insects, Chinese Academy of Forestry [CAFYBB2014QA014, riricaf2012001Z]; Yunnan Provincial Science and Technology Department [2013RA004]	Research Institute of Resources Insects, Chinese Academy of Forestry; Yunnan Provincial Science and Technology Department	The study was funded by the Research Institute of Resources Insects, Chinese Academy of Forestry (CAFYBB2014QA014 and riricaf2012001Z) and Yunnan Provincial Science and Technology Department (2013RA004).	Bashkin MA, 1998, ECOLOGY, V79, P828, DOI 10.1890/0012-9658(1998)079[0828:CISCFA]2.0.CO;2; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bini D, 2013, EUR J SOIL BIOL, V55, P117, DOI 10.1016/j.ejsobi.2012.12.010; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Dang CL, 1992, J YUNNAN U, V14, P95; DAS AK, 1987, FOREST ECOL MANAG, V18, P61, DOI 10.1016/0378-1127(87)90125-3; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Garcia-Franco N, 2014, FOREST ECOL MANAG, V319, P107, DOI 10.1016/j.foreco.2014.01.043; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Li J, 2009, J FUJIAN FORESTRY SC, V36, P12; [李江 Li Jiang], 2011, [中国水土保持科学, Science of Soil and Water Conservation], V9, P106; Li Shuai-Feng, 2013, Chinese Journal of Plant Ecology, V37, P998, DOI 10.3724/SP.J.1258.2013.00103; Mao R, 2010, PLANT SOIL, V332, P277, DOI 10.1007/s11104-010-0292-7; Martens DA, 2004, GLOBAL CHANGE BIOL, V10, P65, DOI 10.1046/j.1529-8817.2003.00722.x; Miao Juan, 2014, Yingyong Shengtai Xuebao, V25, P625; Nave LE, 2013, SOIL SCI SOC AM J, V77, P1035, DOI 10.2136/sssaj2012.0236; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peng SS, 2014, P NATL ACAD SCI USA, V111, P2915, DOI 10.1073/pnas.1315126111; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Sierra CA, 2007, FOREST ECOL MANAG, V243, P299, DOI 10.1016/j.foreco.2007.03.026; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; [温庆忠 Wen Qingzhong], 2010, [资源科学, Resources Science], V32, P1621; Wisniewski J, 1993, TERRESTRIAL BIOSPHER; Yanai RD, 2003, ECOSYSTEMS, V6, P197, DOI 10.1007/s10021-002-0206-5; Yuan ZQ, 2013, GEODERMA, V195, P48, DOI 10.1016/j.geoderma.2012.11.008; Zeng XH, 2014, CATENA, V118, P186, DOI 10.1016/j.catena.2014.01.005; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518; Zinn YL, 2014, FOREST ECOL MANAG, V318, P261, DOI 10.1016/j.foreco.2014.01.034	38	18	24	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0135946	10.1371/journal.pone.0135946	http://dx.doi.org/10.1371/journal.pone.0135946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397366	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500007
J	Sehl, ME; Shimada, M; Landeros, A; Lange, K; Wicha, MS				Sehl, Mary E.; Shimada, Miki; Landeros, Alfonso; Lange, Kenneth; Wicha, Max S.			Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response	PLOS ONE			English	Article							DIVISIONS	Cancer stem cells (CSCs) possess capacity to both self-renew and generate all cells within a tumor, and are thought to drive tumor recurrence. Targeting the stem cell niche to eradicate CSCs represents an important area of therapeutic development. The complex nature of many interacting elements of the stem cell niche, including both intracellular signals and microenvironmental growth factors and cytokines, creates a challenge in choosing which elements to target, alone or in combination. Stochastic stimulation techniques allow for the careful study of complex systems in biology and medicine and are ideal for the investigation of strategies aimed at CSC eradication. We present a mathematical model of the breast cancer stem cell (BCSC) niche to predict population dynamics during carcinogenesis and in response to treatment. Using data from cell line and mouse xenograft experiments, we estimate rates of interconversion between mesenchymal and epithelial states in BCSCs and find that EMT/MET transitions occur frequently. We examine bulk tumor growth dynamics in response to alterations in the rate of symmetric self-renewal of BCSCs and find that small changes in BCSC behavior can give rise to the Gompertzian growth pattern observed in breast tumors. Finally, we examine stochastic reaction kinetic simulations in which elements of the breast cancer stem cell niche are inhibited individually and in combination. We find that slowing self-renewal and disrupting the positive feedback loop between IL-6, Stat3 activation, and NF-kappa B signaling by simultaneous inhibition of IL-6 and HER2 is the most effective combination to eliminate both mesenchymal and epithelial populations of BCSCs. Predictions from our model and simulations show excellent agreement with experimental data showing the efficacy of combined HER2 and Il-6 blockade in reducing BCSC populations. Our findings will be directly examined in a planned clinical trial of combined HER2 and IL-6 targeted therapy in HER2-positive breast cancer.	[Sehl, Mary E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Sehl, Mary E.; Landeros, Alfonso; Lange, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Shimada, Miki] Waseda Univ, Tokyo, Japan; [Lange, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lange, Kenneth] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Wicha, Max S.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Waseda University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan	Sehl, ME (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	msehl@mednet.ucla.edu	Wicha, Max/AAE-7268-2019		NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute [KL2TR000122]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000122] Funding Source: NIH RePORTER	NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute Grant Number KL2TR000122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; American Cancer Society, 2013, BREAST CANC FACTS FI; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Bussard KM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2754; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chevalier MW, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664126; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; El Samad H, 2002, INT J ROBUST NONLIN, V00, P1; Gillespie DT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4801941; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Korkaya H, 2013, CLIN CANCER RES, V19, P511, DOI 10.1158/1078-0432.CCR-12-3450; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lange K., 2010, APPL PROBABILITY; Leder K, 2014, CELL, V156, P603, DOI 10.1016/j.cell.2013.12.029; Liu SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002751; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Liu WY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-139; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; Malik F, 2012, CELL CYCLE, V11, P2780, DOI 10.4161/cc.21395; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; NORTON L, 1988, CANCER RES, V48, P7067; Patel SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00906; Resat Haluk, 2009, V541, P311, DOI 10.1007/978-1-59745-243-4_14; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sehl M, 2009, J COMPUT BIOL, V16, P1195, DOI 10.1089/cmb.2008.0249; Sehl ME, 2009, CANCER RES, V69, P9481, DOI 10.1158/0008-5472.CAN-09-2070; SPEER JF, 1984, CANCER RES, V44, P4124; Stewart-Ornstein J, 2012, METHOD CELL BIOL, V110, P111, DOI 10.1016/B978-0-12-388403-9.00005-9; Wilkinson D. J., 2012, STOCHASTIC MODELING; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	42	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0135797	10.1371/journal.pone.0135797	http://dx.doi.org/10.1371/journal.pone.0135797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397099	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500006
J	Doritchamou, J; Sabbagh, A; Jespersen, JS; Renard, E; Salanti, A; Nielsen, MA; Deloron, P; Ndam, NT				Doritchamou, Justin; Sabbagh, Audrey; Jespersen, Jakob S.; Renard, Emmanuelle; Salanti, Ali; Nielsen, Morten A.; Deloron, Philippe; Ndam, Nicaise Tuikue			Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; MALARIA TRANSMISSION; VACCINE CANDIDATE; PLACENTAL MALARIA; GENETIC DIVERSITY; NTS-DBL2X REGION; PREGNANT-WOMEN; ANTIBODIES	The VAR2CSA protein of Plasmodium falciparum is transported to and expressed on the infected erythrocyte surface where it plays a key role in placental malaria (PM). It is the current leading candidate for a vaccine to prevent PM. However, the antigenic polymorphism integral to VAR2CSA poses a challenge for vaccine development. Based on detailed analysis of polymorphisms in the sequence of its ligand-binding N-terminal region, currently the main focus for vaccine development, we assessed var2csa from parasite isolates infecting pregnant women. The results reveal for the first time the presence of a major dimorphic region in the functionally critical N-terminal ID1 domain. Parasite isolates expressing VAR2CSA with particular motifs present within this domain are associated with gravidity-and parasite density-related effects. These observations are of particular interest in guiding efforts with respect to optimization of the VAR2CSA-based vaccines currently under development.	[Doritchamou, Justin; Sabbagh, Audrey; Renard, Emmanuelle; Deloron, Philippe; Ndam, Nicaise Tuikue] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Doritchamou, Justin; Deloron, Philippe; Ndam, Nicaise Tuikue] Inst Rech Dev, MERIT, UMR216, Paris, France; [Jespersen, Jakob S.; Salanti, Ali; Nielsen, Morten A.] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen	Ndam, NT (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France.	nicaise.ndam@ird.fr	Deloron, Philippe/G-6305-2010; Doritchamou, Justin/T-5671-2017	Deloron, Philippe/0000-0003-4705-2484; Doritchamou, Justin/0000-0002-4589-7216; Schmidt Jespersen, Jakob/0000-0002-4930-5900; Salanti, Ali/0000-0003-2207-5575; Tuikue Ndam, Nicaise/0000-0003-2646-2513; SABBAGH, Audrey/0000-0003-0283-8803; Nielsen, Morten Agertoug/0000-0003-2668-4992	DVS-Maturation-IRD grant DVS; Agence Interetablissements de Recherche pour le Developpement (AIRD); Universite Paris Descartes	DVS-Maturation-IRD grant DVS; Agence Interetablissements de Recherche pour le Developpement (AIRD); Universite Paris Descartes	Funding: This work received funding from DVS-Maturation-IRD grant DVS-2011 and JD was supported by PhD studentships from Agence Interetablissements de Recherche pour le Developpement (AIRD) and mobility grant (BDMU 2013) from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Beeson JG, 2013, EXPERT REV VACCINES, V12, P105, DOI [10.1586/ERV.12.144, 10.1586/erv.12.144]; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2014, INFECT GENET EVOL, V25, P81, DOI 10.1016/j.meegid.2014.04.010; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; Brabin BJ, 2004, ANN TROP PAEDIATR, V24, P311, DOI 10.1179/027249304225019136; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pW242, DOI 10.1093/nar/gks559; Chan JA, 2014, CELL MOL LIFE SCI, V71, P3633, DOI 10.1007/s00018-014-1614-3; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002; Doritchamou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098577; Doritchamou J, 2013, VACCINE, V31, P4516, DOI 10.1016/j.vaccine.2013.07.072; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Guitard J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-165; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Jessen LE, 2013, NUCLEIC ACIDS RES, V41, pW286, DOI 10.1093/nar/gkt497; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam Nicaise T, 2015, EMERG INFECT DIS, V21; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rovira-Vallbona E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069753; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Talundzic E, 2012, PLOS ONE, V7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Wort UU, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-89; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Zhou JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-343	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137695	10.1371/journal.pone.0137695	http://dx.doi.org/10.1371/journal.pone.0137695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393516	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100016
J	Macri, S; Pavesi, E; Crescitelli, R; Aspesi, A; Vizziello, C; Botto, C; Corti, P; Quarello, P; Notari, P; Ramenghi, U; Ellis, SR; Dianzani, I				Macri, Serena; Pavesi, Elisa; Crescitelli, Rossella; Aspesi, Anna; Vizziello, Claudia; Botto, Carlotta; Corti, Paola; Quarello, Paola; Notari, Patrizia; Ramenghi, Ugo; Ellis, Steven Robert; Dianzani, Irma			Immunophenotypic Profiling of Erythroid Progenitor-Derived Extracellular Vesicles in Diamond-Blackfan Anaemia: A New Diagnostic Strategy	PLOS ONE			English	Article							BONE-MARROW; MUTATIONS; PHENOTYPE	Diamond-Blackfan Anaemia (DBA) is a rare inherited anaemia caused by heterozygous mutations in one of 13 ribosomal protein genes. Erythroid progenitors (BFU-E and CFU-E) in bone marrow (BM) show a proapoptotic phenotype. Suspicion of DBA is reached after exclusion of other forms of BM failure syndromes. To improve DBA diagnosis, which is confirmed by mutation analysis, we tested a new approach based on the study of extracellular vesicles (EVs) isolated from plasma by differential centrifugations and analysed by flow cytometry. We chose CD34, CD71 and CD235a markers to study erythroid EVs. We characterised the EVs immunophentoypic profiles of 13 DBA patients, 22 healthy controls and 16 patients with other haematological diseases. Among the three EVs clusters we found, only the CD34+/CD71(low) population showed statistically significant differences between DBA patients and controls (p<0.05). The absence of this cluster is in agreement with the low levels of BFU-E found in DBA patients. The assessment of ROC curves demonstrated the potential diagnostic value of this population. We suggest that this assay may be useful to improve DBA diagnosis as a quicker and less invasive alternative to BM BFU-E culture analysis.	[Macri, Serena; Pavesi, Elisa; Crescitelli, Rossella; Aspesi, Anna; Dianzani, Irma] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Vizziello, Claudia; Notari, Patrizia] Azienda Univ Osped Maggiore Carita, SCDU, Chem Clin Anal Lab, Novara, Italy; [Botto, Carlotta; Ramenghi, Ugo] Univ Turin, Dept Publ Hlth & Pediat Sci, Turin, Italy; [Corti, Paola] San Gerardos Hosp, Dept Pediat Hematol, Monza, Italy; [Quarello, Paola] Regina Margherita Childrens Hosp, Pediat Oncohematol, Turin, Italy; [Ellis, Steven Robert] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Eastern Piedmont Amedeo Avogadro; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Louisville	Dianzani, I (corresponding author), Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy.	irma.dianzani@med.uniupo.it	Aspesi, Anna/ABG-7740-2020; Quarello, Paola/AAD-2731-2020; Crescitelli, Rossella/AAC-8461-2022	Aspesi, Anna/0000-0003-4944-0990; Crescitelli, Rossella/0000-0002-1714-3169	Istituto Piemontese per la ricerca sulla Anemia di Diamond-Blackfan; PRIN [2010 4 AE23N_005, Cariplo 2011-0554]; Diamond-Blackfan Anaemia Foundation; Telethon onlus [GGP13177]; Banca del Piemonte [prot. 14.4.05/03]	Istituto Piemontese per la ricerca sulla Anemia di Diamond-Blackfan; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Diamond-Blackfan Anaemia Foundation; Telethon onlus(Fondazione Telethon); Banca del Piemonte	Funding: The work was supported by Istituto Piemontese per la ricerca sulla Anemia di Diamond-Blackfan and PRIN 2010 4 AE23N_005 (ID and UR), Cariplo 2011-0554 (ID), Diamond-Blackfan Anaemia Foundation (ID), Telethon onlus GGP13177 (ID), and Banca del Piemonte prot. 14.4.05/03 (UR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspesi A, 2014, GENE, V545, P282, DOI 10.1016/j.gene.2014.04.077; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Campagnoli MF, 2008, HUM MUTAT, V29, P911, DOI 10.1002/humu.20752; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Crescitelli R, J EXTRACELL VESICLES; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Fajtova M, 2013, LEUKEMIA LYMPHOMA, V54, P2523, DOI 10.3109/10428194.2013.781167; Farrar JE, 2014, AM J HEMATOL, V89, P985, DOI 10.1002/ajh.23807; Ghashghaeinia M, 2012, BRIT J HAEMATOL, V157, P606, DOI 10.1111/j.1365-2141.2012.09100.x; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Loreni F, 2008, HAEMATOLOGICA, V93, P1; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Parrella S, 2014, PEDIATR BLOOD CANCER, V61, P1319, DOI 10.1002/pbc.24944; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Willig TN, 2000, CURR OPIN HEMATOL, V7, P85, DOI 10.1097/00062752-200003000-00003; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	20	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138200	10.1371/journal.pone.0138200	http://dx.doi.org/10.1371/journal.pone.0138200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394034	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100037
J	Tyagi, K; Gupta, D; Saini, E; Choudhary, S; Jamwal, A; Alam, MS; Zeeshan, M; Tyagi, RK; Sharma, YD				Tyagi, Kriti; Gupta, Deepali; Saini, Ekta; Choudhary, Shilpa; Jamwal, Abhishek; Alam, Mohd. Shoeb; Zeeshan, Mohammad; Tyagi, Rupesh K.; Sharma, Yagya D.			Recognition of Human Erythrocyte Receptors by the Tryptophan-Rich Antigens of Monkey Malaria Parasite Plasmodium knowlesi	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; VIVAX; FALCIPARUM; IDENTIFICATION; EXPRESSION; INVASION; PROTEINS; LIGANDS; YOELII; GENOME	Background The monkey malaria parasite Plasmodium knowlesi also infect humans. There is a lack of information on the molecular mechanisms that take place between this simian parasite and its heterologous human host erythrocytes leading to this zoonotic disease. Therefore, we investigated here the binding ability of P. knowlesi tryptophan-rich antigens (PkTRAgs) to the human erythrocytes and sharing of the erythrocyte receptors between them as well as with other commonly occurring human malaria parasites. Methods Six PkTRAgs were cloned and expressed in E.coli as well as in mammalian CHO-K1 cell to determine their human erythrocyte binding activity by cell-ELISA, and in-vitro rosetting assay, respectively. Results Three of six PkTRAgs (PkTRAg38.3, PkTRAg40.1, and PkTRAg67.1) showed binding to human erythrocytes. Two of them(PkTRAg40.1 and PkTRAg38.3) showed cross-competition with each other as well as with the previously described P. vivax tryptophan-rich antigens (PvTRAgs) for human erythrocyte receptors. However, the third protein (PkTRAg67.1) utilized the additional but different human erythrocyte receptor(s) as it did not cross-compete for erythrocyte binding with either of these two PkTRAgs as well as with any of the PvTRAgs. These three PkTRAgs also inhibited the P. falciparum parasite growth in in-vitro culture, further indicating the sharing of human erythrocyte receptors by these parasite species and the biological significance of this receptor-ligand interaction between heterologous host and simian parasite. Conclusions Recognition and sharing of human erythrocyte receptor(s) by PkTRAgs with human parasite ligands could be part of the strategy adopted by the monkey malaria parasite to establish inside the heterologous human host.	[Tyagi, Kriti; Gupta, Deepali; Saini, Ekta; Choudhary, Shilpa; Jamwal, Abhishek; Alam, Mohd. Shoeb; Zeeshan, Mohammad; Tyagi, Rupesh K.; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma_aiims@yahoo.com	Singh, Balbir/A-3610-2009	Tyagi, Rupesh/0000-0002-5095-8976; Saini, Ekta/0000-0001-5701-6108	Indian Council of Medical Research [61/4/2012-BMS]; Council of Scientific and Industrial Research; Department of Biotechnology, Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funding was provided by Indian Council of Medical Research [Grant No. 61/4/2012-BMS]; Council of Scientific and Industrial Research (Senior Research Fellowships to KT and MSA); and Department of Biotechnology, Government of India (Senior Research Fellowships to MZ and RKT). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam MS, 2015, J BIOL CHEM, V290, P20257, DOI 10.1074/jbc.M115.644906; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Deplaine G, 2011, ANTIMICROB AGENTS CH, V55, P2576, DOI 10.1128/AAC.01409-10; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Koganei A, 2007, J IMMUNOTOXICOL, V4, P77, DOI 10.1080/15476910601161691; Lapp SA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0612-8; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Moyes CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002780; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Semenya AA, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-228, 10.1186/1475-2875-11-355]; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Tyagi RK, 2013, J ANTIMICROB CHEMOTH, V68, P1081, DOI 10.1093/jac/dks508; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138691	10.1371/journal.pone.0138691	http://dx.doi.org/10.1371/journal.pone.0138691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393350	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100087
J	Martinez, T; Texier, H; Nahoum, V; Lafitte, C; Cioci, G; Heux, L; Dumas, B; O'Donohue, M; Gaulin, E; Dumon, C				Martinez, Thomas; Texier, Helene; Nahoum, Virginie; Lafitte, Claude; Cioci, Gianluca; Heux, Laurent; Dumas, Bernard; O'Donohue, Michael; Gaulin, Elodie; Dumon, Claire			Probing the Functions of Carbohydrate Binding Modules in the CBEL Protein from the Oomycete Phytophthora parasitica	PLOS ONE			English	Article							REESEI CELLOBIOHYDROLASE-I; TRICHODERMA-REESEI; APPLE DOMAINS; POLYSACCHARIDE RECOGNITION; AMINO-ACIDS; PAN MODULE; CELLULOSE; HYDROLYSIS; FAMILY; IDENTIFICATION	Oomycetes are microorganisms that are distantly related to true fungi and many members of this phylum are major plant pathogens. Oomycetes express proteins that are able to interact with plant cell wall polysaccharides, such as cellulose. This interaction is thought to be mediated by carbohydrate-binding modules that are classified into CBM family 1 in the CAZy database. In this study, the two CBMs (1-1 and 1-2) that form part of the cell wall glycoprotein, CBEL, from Phytophthora parasitica have been submitted to detailed characterization, first to better quantify their interaction with cellulose and second to determine whether these CBMs can be useful for biotechnological applications, such as biomass hydrolysis. A variety of biophysical techniques were used to study the interaction of the CBMs with various substrates and the data obtained indicate that CBEL's CBM1-1 exhibits much greater cellulose binding ability than CBM1-2. Engineering of the family 11 xylanase from Talaromyces versatilis (TvXynB), an enzyme that naturally bears a fungal family 1 CBM, has produced two variants. The first one lacks its native CBM, whereas the second contains the CBEL CBM1-1. The study of these enzymes has revealed that wild type TvXynB binds to cellulose, via its CBM1, and that the substitution of its CBM by oomycetal CBM1-1 does not affect its activity on wheat straw. However, intriguingly the addition of CBEL during the hydrolysis of wheat straw actually potentiates the action of TvXynB variant lacking a CBM1. This suggests that the potentiating effect of CBM1-1 might not require the formation of a covalent linkage to TvXynB.	[Martinez, Thomas; Lafitte, Claude; Dumas, Bernard; Gaulin, Elodie] Univ Toulouse 3, Lab Rech Sci Vegetales, UPS, F-31326 Castanet Tolosan, France; [Martinez, Thomas; Lafitte, Claude; Dumas, Bernard; Gaulin, Elodie] CNRS, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Martinez, Thomas; Texier, Helene; Cioci, Gianluca; O'Donohue, Michael; Dumon, Claire] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Martinez, Thomas; Texier, Helene; Cioci, Gianluca; O'Donohue, Michael; Dumon, Claire] CNRS, UMR5504, F-31400 Toulouse, France; [Martinez, Thomas; Texier, Helene; Cioci, Gianluca; O'Donohue, Michael; Dumon, Claire] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Texier, Helene] Cinabio ADISSEO France SAS, F-31077 Toulouse, France; [Nahoum, Virginie] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Nahoum, Virginie] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Heux, Laurent] CNRS, CERMAV, Grenoble, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Adisseo France S.A.S.; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Dumon, C (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	claire.dumon@insa-toulouse.fr	O'Donohue, Michael J/E-9183-2013; Claire, Dumon/AAI-2553-2021; Dumas, Bernard/D-1751-2009; O'Donohue, Michael/ABD-9239-2021	O'Donohue, Michael J/0000-0003-4246-3938; Claire, Dumon/0000-0003-4925-7336; Dumas, Bernard/0000-0002-4138-3533; O'Donohue, Michael/0000-0003-4246-3938; Gaulin, Elodie/0000-0003-0572-8749; Nahoum, Virginie/0000-0003-3125-6618				Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; Carrard G, 1999, EUR J BIOCHEM, V262, P637, DOI 10.1046/j.1432-1327.1999.00455.x; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; De La Mare M, 2013, ENZYME MICROB TECH, V53, P351, DOI 10.1016/j.enzmictec.2013.07.008; Dumas B, 2008, TRENDS PLANT SCI, V13, P160, DOI 10.1016/j.tplants.2008.02.004; Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p; Fumagalli M, 2013, BIOMACROMOLECULES, V14, P3246, DOI 10.1021/bm400864z; Gao PJ, 2001, ACTA BIOCH BIOPH SIN, V33, P13; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, P1; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P457, DOI 10.1002/bit.22068; Lafond M, 2014, APPL MICROBIOL BIOT, V98, P6339, DOI 10.1007/s00253-014-5606-x; Lakey JH, 1991, FEBS J, P599; Larroque M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-605; Larroque M, 2011, PROTEIN EXPRES PURIF, V80, P217, DOI 10.1016/j.pep.2011.07.007; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Makela MR, 2014, FUNGAL GENET BIOL, V72, P2, DOI 10.1016/j.fgb.2014.08.010; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Song LT, 2010, BIORESOURCE TECHNOL, V101, P8237, DOI 10.1016/j.biortech.2010.05.097; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; van Gool MP, 2012, BIORESOURCE TECHNOL, V119, P123, DOI 10.1016/j.biortech.2012.05.117; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Xiao ZZ, 2001, BIOTECHNOL LETT, V23, P711, DOI 10.1023/A:1010325122851	44	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137481	10.1371/journal.pone.0137481	http://dx.doi.org/10.1371/journal.pone.0137481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390127	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000008
J	Pereira, RC; Valta, H; Tumber, N; Salusky, IB; Jalanko, H; Makitie, O; Perry, KW				Pereira, Renata C.; Valta, Helena; Tumber, Navdeep; Salusky, Isidro B.; Jalanko, Hannu; Makitie, Outi; Perry, Katherine Wesseling			Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation	PLOS ONE			English	Article							GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; SERUM-LEVELS; CHILDREN; CLASSIFICATION; ADOLESCENTS; PROGRESSION; ALPHA; FGF23	Background Bone fragility is common post solid organ transplantation but little is known about bone pathology on a tissue level. Abnormal osteocytic protein expression has been linked to compromised bone health in chronic kidney disease (CKD) and immunosuppressant medications may impact osteocyte function. Methods Transiliac bone biopsies were obtained from 22 pediatric solid organ allograft recipients (average age 15.6 years) an average of 6.3 +/- 1.2 years after transplantation and from 12 pediatric pre-dialysis CKD patients (average age 13.2 years). Histomorphometry and immunohistochemistry for FGF23, DMP1, sclerostin, and osteopontin were performed on all biopsies. Results FGF23 and sclerostin were increased in transplant recipients relative to non-transplant CKD, regardless of the type of allograft received and despite, in the case of liver and heart recipients, a higher GFR. Bone DMP1 expression was higher in liver or heart than in kidney recipients, concomitant with higher serum phosphate values. Osteopontin expression was higher in CKD than in transplant recipients (p<0.01). Bone FGF23 and sclerostin correlated directly (r = 0.38, p<0.05); bone FGF23 expression and osteoid thickness correlated inversely (r = -0.46, p<0.01). Conclusions Solid-organ transplantation is associated with increased FGF23 and sclerostin expression. The contribution of these findings to compromised bone health post transplantation warrants further evaluation.	[Pereira, Renata C.; Tumber, Navdeep; Salusky, Isidro B.; Perry, Katherine Wesseling] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Valta, Helena; Jalanko, Hannu; Makitie, Outi] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland; [Makitie, Outi] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Makitie, Outi] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Karolinska Institutet; Karolinska Institutet	Perry, KW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	kwesseling@mednet.ucla.edu			USPHS grants [R03DK098627, K23DK080984]; UCLA Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Normal Siegel Research Scholar Award; Casey Lee Ball Foundation; Academy of Finland; Folkhalsan Research Foundation; Finnish Pediatric Research Foundation; Sigrid Juselius Foundation; Helsinki University Hospital Research Funds; Swedish Research Council [2013-2603]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK098627, K23DK080984] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0009813, NNF13OC0004915] Funding Source: researchfish	USPHS grants; UCLA Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Normal Siegel Research Scholar Award; Casey Lee Ball Foundation; Academy of Finland(Academy of Finland); Folkhalsan Research Foundation; Finnish Pediatric Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital Research Funds; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by USPHS grants R03DK098627, K23DK080984, the UCLA Children's Discovery and Innovation Institute, the American Society of Nephrology Foundation's Normal Siegel Research Scholar Award, the Casey Lee Ball Foundation, the Academy of Finland, the Folkhalsan Research Foundation, the Finnish Pediatric Research Foundation, the Sigrid Juselius Foundation, the Helsinki University Hospital Research Funds, and the Swedish Research Council (grant 2013-2603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 2008 ANNUAL REPORT; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Bakkaloglu SA, 2010, CLIN J AM SOC NEPHRO, V5, P1860, DOI 10.2215/CJN.01330210; Berendsen AD, 2010, CELLS TISSUES ORGANS, V192, P116, DOI 10.1159/000289585; Bonewald L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P331; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gokhale S, 2007, APPL IMMUNOHISTO M M, V15, P451, DOI 10.1097/PAI.0b013e31802ee998; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Helenius I, 2006, J BONE MINER RES, V21, P380, DOI 10.1359/JBMR.051107; Hollis BW, 1996, CLIN CHEM, V42, P586; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jiang Z, 2004, HISTOPATHOLOGY, V45, P218, DOI 10.1111/j.1365-2559.2004.01930.x; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Lima F, 2014, CLIN NEPHROL, V82, P287, DOI 10.5414/CN108407; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Pereira RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120856; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Portale AA, 2014, CLIN J AM SOC NEPHRO, V9, P344, DOI 10.2215/CJN.05840513; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Sanchez CP, 1998, KIDNEY INT, V53, P1358, DOI 10.1046/j.1523-1755.1998.00866.x; Schwartz GJ, 2010, KIDNEY INT, V77, P65, DOI 10.1038/ki.2009.398; Tamminen IS, 2014, PEDIATR NEPHROL, V29, P1431, DOI 10.1007/s00467-014-2771-1; Turbin DA, 2008, BREAST CANCER RES TR, V110, P417, DOI 10.1007/s10549-007-9736-z; Valta H, 2008, AM J TRANSPLANT, V8, P150, DOI 10.1111/j.1600-6143.2007.02015.x; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326	28	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138156	10.1371/journal.pone.0138156	http://dx.doi.org/10.1371/journal.pone.0138156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390291	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000018
J	Yang, B; Rajput, PS; Kumar, U; Sastry, BR				Yang, Bo; Rajput, Padmesh S.; Kumar, Ujendra; Sastry, Bhagavatula R.			Regulation of GABA Equilibrium Potential by mGluRs in Rat Hippocampal CA1 Neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; K-CL COTRANSPORTER; GROUP-I MGLURS; NA-K-2CL COTRANSPORTER; PYRAMIDAL NEURONS; CHLORIDE CONCENTRATION; PERFORATED-PATCH; DOWN-REGULATION; KCC2; INHIBITION	The equilibrium potential for GABA-A receptor mediated currents (E-GABA) in neonatal central neurons is set at a relatively depolarized level, which is suggested to be caused by a low expression of K+/Cl(-)co-transporter (KCC2) but a relatively high expression of Na+-K+-Clcotransporter (NKCC1). Theta-burst stimulation (TBS) in stratum radiatum induces a negative shift in E-GABA in juvenile hippocampal CA1 pyramidal neurons. In the current study, the effects of TBS on E-GABA in neonatal and juvenile hippocampal CA1 neurons and the underlying mechanisms were examined. Metabotropic glutamate receptors (mGluRs) are suggested to modulate KCC2 and NKCC1 levels in cortical neurons. Therefore, the involvement of mGluRs in the regulation of KCC2 or NKCC1 activity, and thus E-GABA, following TBS was also investigated. Whole-cell patch recordings were made from Wistar rat hippocampal CA1 pyramidal neurons, in a slice preparation. In neonates, TBS induces a positive shift in E-GABA, which was prevented by NKCC1 antisense but not NKCC1 sense mRNA. (RS)-a-Methyl-4-carboxyphenylglycine (MCPG), a group I and II mGluR antagonist, blocked TBS-induced shifts in both juvenile and neonatal hippocampal neurons. While blockade of mGluR1 or mGluR5 alone could interfere with TBS-induced shifts in E-GABA in neonates, only a combined blockade could do the same in juveniles. These results indicate that TBS induces a negative shift in E-GABA in juvenile hippocampal neurons but a positive shift in neonatal hippocampal neurons via corresponding changes in KCC2 and NKCC1 expressions, respectively. mGluR activation seems to be necessary for both shifts to occur while the specific receptor subtype involved seems to vary.	[Yang, Bo; Sastry, Bhagavatula R.] Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada; [Rajput, Padmesh S.; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Sastry, BR (corresponding author), Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada.	sastry@mail.ubc.ca			Canadian Institute for Health Research [TGS-109219, MOP-744]; Faculty of Medicine at The University of British Columbia	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine at The University of British Columbia	This work was supported by Canadian Institute for Health Research (TGS-109219 to BRS and MOP-74465 to UK). B. Yang is a University Graduate Fellowship at the University of British Columbia, and is supported by a Medicine Graduate award from Faculty of Medicine at The University of British Columbia.	ABE T, 1992, J BIOL CHEM, V267, P13361; Banke TG, 2008, J PHYSIOL-LONDON, V586, P4925, DOI 10.1113/jphysiol.2008.157024; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bianchi R, 1999, J NEUROPHYSIOL, V81, P2903, DOI 10.1152/jn.1999.81.6.2903; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nishimaki T, 2007, EUR J NEUROSCI, V26, P323, DOI 10.1111/j.1460-9568.2007.05656.x; Ouardouz M, 2006, BRAIN RES, V1068, P65, DOI 10.1016/j.brainres.2005.10.089; Ouardouz M, 2005, DEV BRAIN RES, V160, P78, DOI 10.1016/j.devbrainres.2005.09.001; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Schomberg SL, 2001, J NEUROPHYSIOL, V85, P2563, DOI 10.1152/jn.2001.85.6.2563; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Sung KW, 2000, J NEUROSCI, V20, P7531; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Xu JY, 2007, EXP NEUROL, V204, P836, DOI 10.1016/j.expneurol.2007.01.004; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yang B, 2010, EXP NEUROL, V221, P157, DOI 10.1016/j.expneurol.2009.10.017; Yip S, 1996, BRAIN RES, V713, P134, DOI 10.1016/0006-8993(95)01499-3; ZHANG L, 1991, J PHYSIOL-LONDON, V444, P25, DOI 10.1113/jphysiol.1991.sp018864	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138215	10.1371/journal.pone.0138215	http://dx.doi.org/10.1371/journal.pone.0138215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389591	Green Submitted, Green Published, gold			2022-12-26	WOS:000361791000021
J	Abbes, K; Biondi, A; Kurtulus, A; Ricupero, M; Russo, A; Siscaro, G; Chermiti, B; Zappala, L				Abbes, Khaled; Biondi, Antonio; Kurtulus, Alican; Ricupero, Michele; Russo, Agatino; Siscaro, Gaetano; Chermiti, Brahim; Zappala, Lucia			Combined Non-Target Effects of Insecticide and High Temperature on the Parasitoid Bracon nigricans	PLOS ONE			English	Article							ABSOLUTA LEPIDOPTERA-GELECHIIDAE; TUTA-ABSOLUTA; BIOLOGICAL-CONTROL; DEPENDENT DEVELOPMENT; CHRYSOPERLA-CARNEA; NATURAL STRESSORS; RISK-ASSESSMENT; TOXICITY; PEST; PESTICIDES	We studied the acute toxicity and the sublethal effects, on reproduction and host-killing activity, of four widely used insecticides on the generalist parasitoid Bracon nigricans (Hymenoptera: Braconidae), a natural enemy of the invasive tomato pest, Tuta absoluta (Lepidoptera: Gelechiidae). Laboratory bioassays were conducted applying maximum insecticide label rates at three constant temperatures, 25, 35 and 40 degrees C, considered as regular, high and very high, respectively. Data on female survival and offspring production were used to calculate population growth indexes as a measure of population recovery after pesticide exposure. Spinetoram caused 80% mortality at 25 degrees C and 100% at higher temperatures, while spinosad caused 100% mortality under all temperature regimes. Cyantraniliprole was slightly toxic to B. nigricans adults in terms of acute toxicity at the three temperatures, while it did not cause any sublethal effects in egg-laying and host-killing activities. The interaction between the two tested factors (insecticide and temperature) significantly influenced the number of eggs laid by the parasitoid, which was the lowest in the case of females exposed to chlorantraniliprole at 35 degrees C. Furthermore, significantly lower B. nigricans demographic growth indexes were estimated for all the insecticides under all temperature conditions, with the exception of chlorantraniliprole at 25 degrees C. Our findings highlight an interaction between high temperatures and insecticide exposure, which suggests a need for including natural stressors, such as temperature, in pesticide risk assessments procedures.	[Abbes, Khaled; Chermiti, Brahim] Univ Sousse, High Agron Inst Chott Mariem, Chott Mariem 4042, Sousse, Tunisia; [Biondi, Antonio; Ricupero, Michele; Russo, Agatino; Siscaro, Gaetano; Zappala, Lucia] Univ Catania, Dipartimento Agr, Alimentaz & Ambiente, Catania, Italy; [Biondi, Antonio] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kurtulus, Alican] Cukurova Univ, Fac Agr, Dept Plant Protect, Adana, Turkey	Universite de Sousse; University of Catania; University of California System; University of California Berkeley; Cukurova University	Zappala, L (corresponding author), Univ Catania, Dipartimento Agr, Alimentaz & Ambiente, Via Santa Sofia 100, Catania, Italy.	lzappala@unict.it	Abbes, Khaled/ABF-8105-2020; Ricupero, Michele/G-9936-2017; Russo, Agatino/E-6062-2012; kurtuluş, Alican/AAA-5718-2019; BIONDI, Antonio/I-6381-2012; ZAPPALA', Lucia/B-9740-2014	Abbes, Khaled/0000-0001-5592-1892; Ricupero, Michele/0000-0001-5392-7553; Russo, Agatino/0000-0002-6949-397X; BIONDI, Antonio/0000-0002-1982-7716; ZAPPALA', Lucia/0000-0002-2804-3980; SISCARO, Gaetano/0000-0001-6802-1949	Italian Ministry of Education, University and Research [2010CXXHJE_004]; European Union [318246]; University of Catania [FIR n.ABAA52]; Tunisian Ministry of High Education and Scientific Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); University of Catania; Tunisian Ministry of High Education and Scientific Research	This research was partially funded by the Italian Ministry of Education, University and Research (PRIN project GEISCA, 2010CXXHJE_004), the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant agreement no 318246 and the project FIR n.ABAA52 of the University of Catania. KA was the recipient of a grant from the Tunisian Ministry of High Education and Scientific Research and AK received an ERASMUS EU grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbes K, 2014, PHYTOPARASITICA, V42, P85, DOI 10.1007/s12600-013-0341-x; Amarasekare KG, 2013, J ECON ENTOMOL, V106, P1126, DOI 10.1603/EC12483; Amarasekare KG, 2004, J ECON ENTOMOL, V97, P1595, DOI 10.1603/0022-0493-97.5.1595; Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Andreadis SS, 2013, J PEST SCI, V86, P409, DOI 10.1007/s10340-013-0490-1; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Baek S, 2014, J PEST SCI, V87, P331, DOI 10.1007/s10340-013-0546-2; Bednarska AJ, 2009, ENVIRON POLLUT, V157, P1597, DOI 10.1016/j.envpol.2008.12.027; Benelli M, 2015, B INSECTOL, V68, P23; Bengochea P, 2014, J PEST SCI, V87, P351, DOI 10.1007/s10340-013-0543-5; Biondi A, 2015, J ECON ENTOMOL, V108, P1191, DOI 10.1093/jee/tov045; Biondi A, 2013, EGYPT J BIOL PEST CO, V23, P117; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2013, J ECON ENTOMOL, V106, P1638, DOI 10.1603/EC12518; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Boina DR, 2009, J ECON ENTOMOL, V102, P685, DOI 10.1603/029.102.0229; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Campos MR, 2015, J PEST SCI, V88, P405, DOI 10.1007/s10340-014-0618-y; Campos MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103235; Chailleux A, 2014, J PEST SCI, V87, P441, DOI 10.1007/s10340-014-0557-7; Chailleux A, 2013, J PEST SCI, V86, P533, DOI 10.1007/s10340-013-0498-6; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; FAO, 2013, FAOSTAT; Fatnassi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126655; Funderburk J, 2013, FLA ENTOMOL, V96, P229, DOI 10.1653/024.096.0131; Gao Yan, 2006, Acta Entomologica Sinica, V49, P636; Gergs A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02036; Gontijo PC, 2014, J PEST SCI, V87, P711, DOI 10.1007/s10340-014-0611-5; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Haye T, 2014, J PEST SCI, V87, P407, DOI 10.1007/s10340-014-0560-z; Hernandez R, 2011, INSECT SCI, V18, P512, DOI 10.1111/j.1744-7917.2010.01391.x; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kress A, 2014, J PEST SCI, V87, P739, DOI 10.1007/s10340-014-0620-4; Larrain P, 2014, CHIL J AGR RES, V74, P178, DOI 10.4067/S0718-58392014000200008; Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043; Liu TX, 2012, J ECON ENTOMOL, V105, P490, DOI 10.1603/EC11295; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Manoukis NC, 2014, J PEST SCI, V87, P39, DOI 10.1007/s10340-013-0513-y; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Medrzycki P, 2010, J APICULT RES, V49, P52, DOI 10.3896/IBRA.1.49.1.07; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Pozidi-Metaxa E, 2013, J PEST SCI, V86, P203, DOI 10.1007/s10340-012-0445-y; Reis P. R., 2014, Agricultural Sciences, V5, P298, DOI 10.4236/as.2014.54032; Roditakis E, 2015, J PEST SCI, V88, P9, DOI 10.1007/s10340-015-0643-5; Saber M, 2013, J PEST SCI, V86, P685, DOI 10.1007/s10340-013-0528-4; Satpute NS, 2007, J ECON ENTOMOL, V100, P357, DOI 10.1603/0022-0493(2007)100[357:TVITOI]2.0.CO;2; SCOTT JG, 1984, PESTIC BIOCHEM PHYS, V21, P53, DOI 10.1016/0048-3575(84)90073-7; Smagghe G, 2013, PEST MANAG SCI, V69, P787, DOI 10.1002/ps.3504; Smith S. C., 1994, Tropical Science, V34, P391; Stark JD, 2004, P NATL ACAD SCI USA, V101, P732, DOI 10.1073/pnas.0304903101; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; TROPEA GG, 2012, BULL OEPP, V42, P205, DOI DOI 10.1111/EPP.2556; Zappala L, 2012, J APPL ENTOMOL, V136, P401, DOI 10.1111/j.1439-0418.2011.01662.x; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zappala L, 2012, B INSECTOL, V65, P51; Zhang X, 2015, J PEST SCI, V88, P383, DOI 10.1007/s10340-014-0606-2; Zhu YJ, 2006, J PEST SCI, V79, P89, DOI 10.1007/s10340-005-0118-1	64	60	65	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138411	10.1371/journal.pone.0138411	http://dx.doi.org/10.1371/journal.pone.0138411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382245	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200099
J	Brenk-Franz, K; Strauss, B; Tiesler, F; Fleischhauer, C; Ciechanowski, P; Schneider, N; Gensichen, J				Brenk-Franz, Katja; Strauss, Bernhard; Tiesler, Fabian; Fleischhauer, Christian; Ciechanowski, Paul; Schneider, Nico; Gensichen, Jochen			The Influence of Adult Attachment on Patient Self-Management in Primary Care The Need for a Personalized Approach and Patient-Centred Care	PLOS ONE			English	Article							ILLNESS RATING-SCALE; CHRONIC DISEASE; HEALTH-CARE; PATTERNS; STYLES; MODEL	Objective Self-management strategies are essential elements of evidence-based treatment in patients with chronic conditions in primary care. Our objective was to analyse different self-management skills and behaviours and their association to adult attachment in primary care patients with multiple chronic conditions. Methods In the apricare study (Adult Attachment in Primary Care) we used a prospective longitudinal design to examine the association between adult attachment and self-management in primary care patients with multimorbidity. The attachment dimensions avoidance and anxiety were measured using the ECR-RD. Self-management skills were measured by the FERUS (motivation to change, coping, self-efficacy, hope, social support) and self-management-behaviour by the DSMQ (glucose management, dietary control, physical activity, health-care use). Clinical diagnosis and severity of disease were assessed by the patients' GPs. Multivariate analyses (GLM) were used to assess the relationship between the dimensions of adult attachment and patient self-management. Results 219 patients in primary care with multiple chronic conditions (type II diabetes, hypertension and at least one other chronic condition) between the ages of 50 and 85 were included in the study. The attachment dimension anxiety was positively associated with motivation to change and negatively associated with coping, self-efficacy and hope, dietary control and physical activity. Avoidance was negatively associated with coping, self-efficacy, social support and health care use. Conclusion The two attachment dimensions anxiety and avoidance are associated with different components of self-management. A personalized, attachment-based view on patients with chronic diseases could be the key to effective, individual self-management approaches in primary care.	[Brenk-Franz, Katja; Tiesler, Fabian; Fleischhauer, Christian; Schneider, Nico; Gensichen, Jochen] Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Brenk-Franz, Katja; Strauss, Bernhard] Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Ciechanowski, Paul] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Washington; University of Washington Seattle	Brenk-Franz, K (corresponding author), Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany.	katja.brenk-franz@med.uni-jena.de			German Research Foundation (DFG) [FZ GE 2073/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support (about 100.000 Euro) was provided by the German Research Foundation, (http://www.dfg.de/en/index.jsp) DFG: FZ GE 2073/5-1.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, PSYCHOL REV, V12, P8; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Berman WH, 1994, ATTACHEMENT ADULTS T; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Bowlby J, 1988, SECURE BASE CLIN APP; Campbell L, 2005, J PERS SOC PSYCHOL, V88, P510, DOI 10.1037/0022-3514.88.3.510; Ciechanowski P, 1999, PSYCHOSOM MED, V61, P110, DOI 10.1097/00006842-199901000-00145; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; Ciechanowski PS, 2002, DIABETES CARE, V25, P731, DOI 10.2337/diacare.25.4.731; Consedine NS, 2013, J BEHAV HLTH, V2, P308; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gensichen Jochen, 2006, Z Arztl Fortbild Qualitatssich, V100, P365; Gilks WR, 1996, MARKOV CHAIN MONTE C; Henderson SJ, 2009, ATTACHMENT SECURITY; Hudon C, 2007, J CLIN EPIDEMIOL, V60, P212, DOI 10.1016/j.jclinepi.2005.12.021; Jack M., 2007, FERUS QUESTIONNAIRE; Ju┬ckel KH., 1998, MESSUNG SOZIODEMOGRA, P7; Kanfer FH., 2006, SELBSTMANAGEMENT THE; Konig CJ, 2006, LEHRBUCH PERSONALPSY; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; MIKULINCER M, 1991, J PERS SOC PSYCHOL, V61, P321, DOI 10.1037/0022-3514.61.2.321; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Rholes W.S., 1998, ATTACHMENT THEORY CL, P166; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-145; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schmidt S, 2002, J PSYCHOSOM RES, V53, P763, DOI 10.1016/S0022-3999(02)00335-5; Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138; Schwarzer R, 2002, HLTH PSYCHOL A Z; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	37	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136723	10.1371/journal.pone.0136723	http://dx.doi.org/10.1371/journal.pone.0136723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381140	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200011
J	Gizzi, L; Muceli, S; Petzke, F; Falla, D				Gizzi, Leonardo; Muceli, Silvia; Petzke, Frank; Falla, Deborah			Experimental Muscle Pain Impairs the Synergistic Modular Control of Neck Muscles	PLOS ONE			English	Article							LOW-BACK-PAIN; MOTOR MODULES; ACTIVATION PATTERNS; HUMAN LOCOMOTION; HORIZONTAL PLANE; PREMOTOR DRIVES; COORDINATION; MOVEMENT; REORGANIZATION; PRIMITIVES	A motor task can be performed via different patterns of muscle activation that show regularities that can be factorized in combinations of a reduced number of muscle groupings (also referred to as motor modules, or muscle synergies). In this study we evaluate whether an acute noxious stimulus induces a change in the way motor modules are combined to generate movement by neck muscles. The neck region was selected as it is a region with potentially high muscular redundancy. We used the motor modules framework to assess the redistribution of muscular activity of 12 muscles (6 per side) in the neck region of 8 healthy individuals engaged in a head and neck aiming task, in non-painful conditions (baseline, isotonic saline injection, post pain) and after the injection of hypertonic saline into the right splenius capitis muscle. The kinematics of the task was similar in the painful and control conditions. A general decrease of activity was noted for the injected muscle during the painful condition together with an increase or decrease of the activity of the other muscles. Subjects did not adopt shared control strategies (motor modules inter subject similarity at baseline 0.73 +/- 0.14); the motor modules recorded during the painful condition could not be used to reconstruct the activation patterns of the control conditions, and the painful stimulus triggered a subject-specific redistribution of muscular activation (i.e., in some subjects the activity of a given muscle increased, whereas in other subjects it decreased with pain). Alterations of afferent input (i.e., painful stimulus) influenced motor control at a multi muscular level, but not kinematic output. These findings provide new insights into the motor adaptation to pain.	[Gizzi, Leonardo; Petzke, Frank; Falla, Deborah] Univ Hosp Gottingen, Ctr Anesthesiol Emergency & Intens Care Med, Pain Clin, Gottingen, Germany; [Gizzi, Leonardo; Muceli, Silvia; Falla, Deborah] Univ Gottingen, Univ Med Ctr Gottingen, Bernstein Ctr Computat Neurosci, Dept Neurorehabil Engn, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Falla, D (corresponding author), Univ Hosp Gottingen, Ctr Anesthesiol Emergency & Intens Care Med, Pain Clin, Gottingen, Germany.	deborah.falla@bccn.uni-goettingen.de	Gizzi, Leonardo/B-5691-2013; Muceli, Silvia/AAC-9127-2021; Falla, Deborah/ABA-7734-2021	Gizzi, Leonardo/0000-0003-3009-6261; Muceli, Silvia/0000-0002-0310-1021; Falla, Deborah/0000-0003-1689-6190	project DEMOVE - European Research Council (ERC) via ERC [267888]	project DEMOVE - European Research Council (ERC) via ERC	SM is supported by the project DEMOVE financed by the European Research Council (ERC) via the ERC Advanced Grant no. 267888. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandholm T, 2008, EUR J APPL PHYSIOL, V102, P643, DOI 10.1007/s00421-007-0642-1; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bernstein N, 1967, COORDINATION REGULAT; Bizzi E, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00051; Cagnie B, 2011, MANUAL THER, V16, P470, DOI 10.1016/j.math.2011.02.013; Cagnie B, 2011, CLIN J PAIN, V27, P392, DOI 10.1097/AJP.0b013e31820e11a2; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Dideriksen JL, 2014, CLIN NEUROPHYSIOL, V125, P1663, DOI 10.1016/j.clinph.2013.11.037; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Falla D, 2007, J APPL PHYSIOL, V102, P601, DOI 10.1152/japplphysiol.00602.2006; Falla D, 2013, EUR J PAIN, V17, P1517, DOI 10.1002/j.1532-2149.2013.00321.x; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Falla D, 2008, J ELECTROMYOGR KINES, V18, P255, DOI 10.1016/j.jelekin.2006.11.001; Falla D, 2008, PAIN, V138, P217, DOI 10.1016/j.pain.2008.04.004; Falla D, 2007, EXP BRAIN RES, V178, P385, DOI 10.1007/s00221-006-0746-6; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Falla Deborah, 2007, Curr Rheumatol Rep, V9, P497, DOI 10.1007/s11926-007-0080-4; Falla D, 2010, CLIN NEUROPHYSIOL, V121, P744, DOI 10.1016/j.clinph.2009.12.029; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Giszter S, 2007, PROG BRAIN RES, V165, P323, DOI 10.1016/S0079-6123(06)65020-6; Gizzi L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-76; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; GravenNielsen T, 1997, ELECTROMYOGR MOTOR C, V105, P156, DOI 10.1016/S0924-980X(96)96554-6; Hart CB, 2004, J NEUROSCI, V24, P5269, DOI 10.1523/JNEUROSCI.5626-03.2004; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hodges PW, 2013, EUR J PAIN, V17, P1138, DOI 10.1002/j.1532-2149.2013.00286.x; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hodges PW, 2014, CLIN J PAIN; Hug F, 2011, J NEUROPHYSIOL, V106, P91, DOI 10.1152/jn.01096.2010; Ivanenko YP, 2011, HUM MOVEMENT SCI, V30, P341, DOI 10.1016/j.humov.2010.04.001; Ivanenko YP, 2009, BRAIN RES BULL, V78, P13, DOI 10.1016/j.brainresbull.2008.03.018; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2013, J NEUROSCI, V33, P3025, DOI 10.1523/JNEUROSCI.2722-12.2013; KESHNER EA, 1989, EXP BRAIN RES, V75, P335; Kutch JJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002434; Lee D., 2001, ADV NEURAL INFORM PR, V13, P1; Lindstroem R, 2012, ARCH PHYS MED REHAB, V93, P2042, DOI 10.1016/j.apmr.2012.04.014; Lindstrom R, 2011, MANUAL THER, V16, P80, DOI 10.1016/j.math.2010.07.006; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Madeleine P, 1998, EUR J PAIN, V2, P251, DOI 10.1016/S1090-3801(98)90021-0; Moreno JC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-79; Muceli S, 2014, J NEUROPHYSIOL, V111, P1615, DOI 10.1152/jn.00147.2013; Muceli S, 2011, J ELECTROMYOGR KINES, V21, P283, DOI 10.1016/j.jelekin.2010.11.011; Muceli S, 2010, J NEUROPHYSIOL, V103, P1532, DOI 10.1152/jn.00559.2009; Oliveira AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00335; Oliveira AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059029; ROLAND MO, 1986, CLIN BIOMECH, V1, P102, DOI 10.1016/0268-0033(86)90085-9; Svensson P, 2004, PAIN, V109, P225, DOI 10.1016/j.pain.2003.12.031; Ting LH, 2007, CURR OPIN NEUROBIOL, V17, P622, DOI 10.1016/j.conb.2008.01.002; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Tresch MC, 2002, BRAIN RES REV, V40, P66, DOI 10.1016/S0165-0173(02)00189-3; Tsang SMH, 2014, J ELECTROMYOGR KINES, V24, P104, DOI 10.1016/j.jelekin.2013.10.011; Tucker K, 2009, J NEUROSCI, V29, P10820, DOI 10.1523/JNEUROSCI.5211-08.2009; Turpin NA, 2011, EUR J APPL PHYSIOL, V111, P3017, DOI 10.1007/s00421-011-1928-x; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Van den Hoorn W, 2014, J NEUROPHYSIOL; Vasavada AN, 2002, EXP BRAIN RES, V147, P437, DOI 10.1007/s00221-002-1275-6; Wiesinger B, 2013, EUR J PAIN, V17, P995, DOI 10.1002/j.1532-2149.2012.00263.x	64	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137844	10.1371/journal.pone.0137844	http://dx.doi.org/10.1371/journal.pone.0137844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382606	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200040
J	Kreel, NE; Tabita, R				Kreel, Nathan E.; Tabita, Robert			Serine 363 of a Hydrophobic Region of Archaeal Ribulose 1,5-Bisphosphate Carboxylase/Oxygenase from Archaeoglobus fulgidus and Thermococcus kodakaraensis Affects CO2/O-2 Substrate Specificity and Oxygen Sensitivity	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; HYPERTHERMOPHILIC ARCHAEON; BISPHOSPHATE CARBOXYLASE/OXYGENASE; CRYSTAL-STRUCTURE; III RUBISCO; FORM-III; MECHANISM; PROTEINS; SUBSTITUTIONS; TEMPERATURE	Archaeal ribulose 1,5-bisphospate carboxylase/oxygenase (RubisCO) is differentiated from other RubisCO enzymes and is classified as a form III enzyme, as opposed to the form I and form II RubisCOs typical of chemoautotrophic bacteria and prokaryotic and eukaryotic phototrophs. The form III enzyme from archaea is particularly interesting as several of these proteins exhibit unusual and reversible sensitivity to molecular oxygen, including the enzyme from Archaeoglobus fulgidus. Previous studies with A. fulgidus RbcL2 had shown the importance of Met-295 in oxygen sensitivity and pointed towards the potential significance of another residue (Ser-363) found in a hydrophobic pocket that is conserved in all RubisCO proteins. In the current study, further structure/function studies have been performed focusing on Ser-363 of A. fulgidus RbcL2; various changes in this and other residues of the hydrophobic pocket point to and definitively establish the importance of Ser-363 with respect to interactions with oxygen. In addition, previous findings had indicated discrepant CO2/O-2 specificity determinations of the Thermococcus kodakaraensis RubisCO, a close homolog of A. fulgidus RbcL2. It is shown here that the T. kodakaraensis enzyme exhibits a similar substrate specificity as the A. fulgidus enzyme and is also oxygen sensitive, with equivalent residues involved in oxygen interactions.	[Kreel, Nathan E.; Tabita, Robert] Ohio State Univ, Ohio State Univ Biochem Program, Columbus, OH 43210 USA; [Tabita, Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tabita, R (corresponding author), Ohio State Univ, Ohio State Univ Biochem Program, 484 West 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu			Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy [DE-FG02-08ER15976]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy(United States Department of Energy (DOE))	This study was supported by grant DE-FG02-08ER15976 from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy.	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Aono A, 2015, NATURE CHEM BIOL, DOI [10.1038/nchembio.1786, DOI 10.1038/NCHEMBI0.1786]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Estelmann S, 2011, FEMS MICROBIOL LETT, V319, P65, DOI 10.1111/j.1574-6968.2011.02268.x; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HARPEL MR, 1993, ANAL BIOCHEM, V209, P367, DOI 10.1006/abio.1993.1136; HARPEL MR, 1992, J BIOL CHEM, V267, P6475; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Kreel NE, 2007, J BIOL CHEM, V282, P1341, DOI 10.1074/jbc.M609399200; KUNG SD, 1976, SCIENCE, V191, P429; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE GJ, 1992, BIOCHEMISTRY-US, V31, P2304, DOI 10.1021/bi00123a014; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Nishitani Y, 2010, J BIOL CHEM, V285, P39339, DOI 10.1074/jbc.M110.147587; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Satagopan S, 2014, J BIOL CHEM, V289, P21433, DOI 10.1074/jbc.M114.578625; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Stec B, 2012, P NATL ACAD SCI USA, V109, P18785, DOI 10.1073/pnas.1210754109; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tabita FR, 2008, PHILOS T R SOC B, V363, P563; Tcherkez G, 2016, PLANT CELL ENVIRON, V39, P983, DOI 10.1111/pce.12629; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; ZHANG KYJ, 1994, PROTEIN SCI, V3, P64; ZHU GH, 1994, J BIOL CHEM, V269, P3952	45	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138351	10.1371/journal.pone.0138351	http://dx.doi.org/10.1371/journal.pone.0138351			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381513	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200094
J	Park, KW; Lin, CY; Li, K; Lee, YS				Park, Keun Woo; Lin, Ching-Yi; Li, Kevin; Lee, Yu-Shang			Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury	PLOS ONE			English	Article							AXON REGENERATION; GENE-EXPRESSION; GROWTH-FACTOR; ACTIVATION; SURVIVAL; CAT; INTERLEUKIN-6; APOPTOSIS; NEURONS; DEATH	Suppressors of cytokine signaling-3 (SOCS3) is associated with limitations of nerve growth capacity after injury to the central nervous system. Although genetic manipulations of SOCS3 can enhance axonal regeneration after optic injury, the role of SOCS3 in dendritic outgrowth after spinal cord injury (SCI) is still unclear. The present study investigated the endogenous expression of SOCS3 and its role in regulating neurite outgrowth in vitro. Interleukin-6 (IL-6) induces SOCS3 expression at the mRNA and protein levels in neuroscreen-1 (NS-1) cells. In parallel to SOCS3 expression, IL-6 induced tyrosine phosphorylation of signal transducer and activator of transcription 3 (STAT3) in NS-1 cells. Lentiviral delivery of short hairpin RNA (shSOCS3) (Lenti-shSOCS3) to decrease SOCS3 expression into NS-1 cells enhanced IL-6-induced tyrosine phosphorylation of STAT3 (P-STAT3 Tyr705) and promoted neurite outgrowth. In addition, we determined if reduction of SOCS3 expression by microinjection of Lenti-shSOCS3 into spinal cord enhances dendrite outgrowth in spinal cord neurons after SCI. Knocking down of SOCS3 in spinal cord neurons with LentishSOCS3 increased complete SCI-induced P-STAT3 Tyr705. Immunohistochemical analysis showed that complete SCI induced a significant reduction of microtubule association protein 2-positive (MAP-2+) dendrites in the gray and white matter at 1 and 4 weeks after injury. The SCI-induced reduction of MAP-2+ dendrites was inhibited by infection with LentishSOCS3 in areas both rostral and caudal to the lesion at 1 and 4 weeks after complete SCI. Furthermore, shSOCS3 treatment enhanced up-regulation of growth associated protein-43 (GAP-43) expression, which co-localized with MAP-2+ dendrites in white matter and with MAP-2+ cell bodies in gray matter, indicating Lenti-shSOCS3 may induce dendritic regeneration after SCI. Moreover, we demonstrated that Lenti-shSOCS3 decreased SCI-induced demyelination in white matter of spinal cord both rostral and caudal to the injury site 1 week post-injury, but not rostral to the injury at 4 weeks post-injury. Importantly, similar effects as Lenti-shSOCS3 on increasing MAP-2+ intensity and dendrite length, and preventing demyelination were observed when a second shSOCS3 (Lenti-shSOCS3 #2) was applied to rule out the possibilities of off target effects of shRNA. Collectively, these results suggest that knocking down of SOCS3 enhances dendritic regeneration and prevents demyelination after SCI.	[Park, Keun Woo; Lin, Ching-Yi; Li, Kevin; Lee, Yu-Shang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Lee, YS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA.	leey2@ccf.org			National Institute of Health [NS069765]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069765] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (http://nih.gov) grant number NS069765 to YSL.	Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; IWAHORI N, 1978, J COMP NEUROL, V182, P383, DOI 10.1002/cne.901820303; Iwata M, 2006, NEUROSCIENCE, V141, P1301, DOI 10.1016/j.neuroscience.2006.04.060; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Lang B.T., 2014, NATURE; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Li GL, 2000, APMIS, V108, P98; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; MAYER M, 1994, DEVELOPMENT, V120, P143; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Miao T, 2011, EXP NEUROL, V228, P165, DOI 10.1016/j.expneurol.2010.08.021; Miao TZ, 2008, MOL CELL NEUROSCI, V37, P367, DOI 10.1016/j.mcn.2007.10.010; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Park KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050874; Park KW, 2014, EXP NEUROL, V261, P65, DOI 10.1016/j.expneurol.2014.06.013; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9; ROSE PK, 1981, J COMP NEUROL, V199, P191, DOI 10.1002/cne.901990204; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Smith RP, 2011, MOL CELL NEUROSCI, V46, P32, DOI 10.1016/j.mcn.2010.07.015; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; VALVERDE F, 1962, J COMP NEUROL, V119, P25, DOI 10.1002/cne.901190105; VANNER SJ, 1984, J COMP NEUROL, V226, P96, DOI 10.1002/cne.902260108; Wada Y, 2010, J VET MED SCI, V72, P1093, DOI 10.1292/jvms.10-0021; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	50	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138301	10.1371/journal.pone.0138301	http://dx.doi.org/10.1371/journal.pone.0138301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384335	Green Submitted, gold, Green Published			2022-12-26	WOS:000361790200089
J	Saito, Y; Nakamura, K; Yoshida, M; Sugiyama, H; Ohe, T; Kurokawa, J; Furukawa, T; Takano, M; Nagase, S; Morita, H; Kusano, KF; Ito, H				Saito, Yukihiro; Nakamura, Kazufumi; Yoshida, Masashi; Sugiyama, Hiroki; Ohe, Tohru; Kurokawa, Junko; Furukawa, Tetsushi; Takano, Makoto; Nagase, Satoshi; Morita, Hiroshi; Kusano, Kengo F.; Ito, Hiroshi			Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker	PLOS ONE			English	Article							SICK-SINUS SYNDROME; SINOATRIAL NODE; GENE-TRANSFER; CARDIAC PACEMAKING; PLURIPOTENT; CHANNELS; CURRENTS; MODULATION; RABBIT; HEART	Background Establishment of a biological pacemaker is expected to solve the persisting problems of a mechanical pacemaker including the problems of battery life and electromagnetic interference. Enhancement of the funny current (If) flowing through hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and attenuation of the inward rectifier K+ current (I-K1) flowing through inward rectifier potassium (K-ir) channels are essential for generation of a biological pacemaker. Therefore, we generated HCN4-overexpressing mouse embryonic stem cells (mESCs) and induced cardiomyocytes that originally show poor I-K1 currents, and we investigated whether the HCN4-overexpressing mESC-derived cardiomyocytes (mESC-CMs) function as a biological pacemaker in vitro. Methods and Results The rabbit Hcn4 gene was transfected into mESCs, and stable clones were selected. mESC-CMs were generated via embryoid bodies and purified under serum/glucose-free and lactate-supplemented conditions. Approximately 90% of the purified cells were troponin I-positive by immunostaining. In mESC-CMs, expression level of the Kcnj2 gene encoding K(ir)2.1, which is essential for generation of I-K1 currents that are responsible for stabilizing the resting membrane potential, was lower than that in an adult mouse ventricle. HCN4-overexpressing mESC-CMs expressed about a 3-times higher level of the Hcn4 gene than did non-overexpressing mESC-CMs. Expression of the Cacna1h gene, which encodes T-type calcium channel and generates diastolic depolarization in the sinoatrial node, was also confirmed. Additionally, genes required for impulse conduction including Connexin40, Connexin43, and Connexin45 genes, which encode connexins forming gap junctions, and the Scn5a gene, which encodes sodium channels, are expressed in the cells. HCN4-overexpressing mESC-CMs showed significantly larger I-f currents and more rapid spontaneous beating than did non-overexpressing mESC-CMs. The beating rate of HCN4-overexpressing mESC-CMs responded to ivabradine, an I-f inhibitor, and to isoproterenol, a beta-adrenergic receptor agonist. Co-culture of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) with aggregates composed of mESC-CMs resulted in synchronized contraction of the cells. The beating rate of hiPSC-CMs co-cultured with aggregates of HCN4-overexpressing mESC-CMs was significantly higher than that of nontreated hiPSC-CMs and that of hiPSC-CMs co-cultured with aggregates of non-overexpressing mESC-CMs. Conclusions We generated HCN4-overexpresssing mESC-CMs expressing genes required for impulse conduction, showing rapid spontaneous beating, responding to an I-f inhibitor and beta-adrenergic receptor agonist, and having pacing ability in an in vitro co-culture system with other excitable cells. The results indicated that these cells could be applied to a biological pacemaker.	[Saito, Yukihiro; Nakamura, Kazufumi; Yoshida, Masashi; Sugiyama, Hiroki; Nagase, Satoshi; Morita, Hiroshi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Ohe, Tohru] Sakakibara Heart Inst Okayama, Okayama, Japan; [Kurokawa, Junko; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan; [Takano, Makoto] Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 830, Japan; [Morita, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Therapeut, Okayama, Japan; [Kusano, Kengo F.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan	Okayama University; Tokyo Medical & Dental University (TMDU); Kurume University; Okayama University; National Cerebral & Cardiovascular Center - Japan	Nakamura, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	ichibun@cc.okayama-u.ac.jp	Kurokawa, Junko/Q-6287-2017; furukawa, tetsushi/ABD-3178-2020; Kurokawa, Junko/ABF-7557-2021	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908; Saito, Yukihiro/0000-0001-7454-3102	Japan Cardiovascular Research Foundation	Japan Cardiovascular Research Foundation	Dr. Nakamura was supported by a grant from the Japan Cardiovascular Research Foundation, 2003 (http://www.jcvrf.jp/research/index.html).	Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Barbuti A, 2009, J MOL CELL CARDIOL, V46, P343, DOI 10.1016/j.yjmcc.2008.12.001; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Boink GJJ, 2013, J AM COLL CARDIOL, V61, P1192, DOI 10.1016/j.jacc.2012.12.031; Bucchi A, 2006, CIRCULATION, V114, P992, DOI 10.1161/CIRCULATIONAHA.106.617613; Butters TD, 2010, CIRC RES, V107, P126, DOI 10.1161/CIRCRESAHA.110.219949; Cai J, 2007, LIFE SCI, V80, P1746, DOI 10.1016/j.lfs.2007.02.006; Chan YC, 2009, J CARDIOVASC ELECTR, V20, P1048, DOI 10.1111/j.1540-8167.2009.01475.x; Cho HS, 2003, J PHYSIOL-LONDON, V550, P169, DOI 10.1113/jphysiol.2003.040501; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hashem SI, 2013, MOL CELL BIOCHEM, V383, P161, DOI 10.1007/s11010-013-1764-x; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Inada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094565; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kodama I, 1997, AM J PHYSIOL-HEART C, V272, pH2793, DOI 10.1152/ajpheart.1997.272.6.H2793; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Lieu DK, 2008, HEART RHYTHM, V5, P1310, DOI 10.1016/j.hrthm.2008.05.010; Ling-Ling E, 2006, J HEART LUNG TRANSPL, V25, P664, DOI 10.1016/j.healun.2006.12.007; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nikmaram MR, 1997, AM J PHYSIOL-HEART C, V272, pH2782, DOI 10.1152/ajpheart.1997.272.6.H2782; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Plotnikov AN, 2004, CIRCULATION, V109, P506, DOI 10.1161/01.CIR.0000114527.10764.CC; Rigg L, 1996, EXP PHYSIOL, V81, P877, DOI 10.1113/expphysiol.1996.sp003983; Scavone A, 2013, CIRC RES, V113, P389, DOI 10.1161/CIRCRESAHA.113.301283; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Shinagawa Y, 2000, J PHYSIOL-LONDON, V523, P593, DOI 10.1111/j.1469-7793.2000.t01-2-00593.x; Suenari K, 2012, J CARDIOVASC ELECTR, V23, P200, DOI 10.1111/j.1540-8167.2011.02173.x; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOLLON C, 1994, BRIT J PHARMACOL, V112, P37, DOI 10.1111/j.1476-5381.1994.tb13025.x; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wei L, 2013, PACE, V36, P1138, DOI 10.1111/pace.12154; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388	45	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138193	10.1371/journal.pone.0138193	http://dx.doi.org/10.1371/journal.pone.0138193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384234	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200068
J	Su, LQ; Gao, SJ; Unverzagt, FW; Cheng, YB; Hake, AM; Xin, PJ; Chen, C; Liu, JY; Ma, F; Bian, JC; Li, P; Jin, YL				Su, Liqin; Gao, Sujuan; Unverzagt, Frederick W.; Cheng, Yibin; Hake, Ann M.; Xin, Pengju; Chen, Chen; Liu, Jingyi; Ma, Feng; Bian, Jianchao; Li, Ping; Jin, Yinlong			Selenium Level and Dyslipidemia in Rural Elderly Chinese	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E GENOTYPES; SERUM SELENIUM; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; METABOLIC SYNDROME; PLASMA SELENIUM; PROSTATE-CANCER; RISK-FACTORS; VITAMIN-E	Objective Higher selenium level has been hypothesized to have the potential to reduce the risk of cardiovascular diseases including dyslipidemia. However, results from previous studies are inconsistent. This study aims to determine the association between selenium level and dyslipidemia in elderly Chinese with relatively low selenium status. Methods A cross-sectional study of 1859 participants aged 65 or older from four rural counties in China was conducted. Serum total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDLC) and low-density lipoprotein-cholesterol (LDLC), nail selenium concentration and APOE genotype were measured in all subjects. The four types of dyslipidemia were defined as > 5.17mmol/L for High-TC, > 1.69 mmol/L for High-TG, > 3.36 mmol/L for High-LDLC, and < 1.04 mmol/L for Low-HDLC according to Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Logistic models adjusting for age, gender, APOE genotype, body mass index, alcohol consumption, smoking, physical activity, medication use for cardiovascular diseases were used to examine the relationship between selenium levels and the risk of dyslipidemia. Results Mean nail selenium concentration was 0.465 mu g/gin this sample. Rates for High-TC, High-LDLC, High-TG, Low-HDLC were 18.13%, 13.23%, 12.21% and 32.76% respectively. Results from logistic models indicated that higher selenium levels were significantly associated with higher risk of High-TC, High-LDLC and lower risk of Low-HDLC adjusting for covariates (p < 0.0001). Compared with the lowest selenium quartile group, participants in selenium quartile groups 2, 3 and 4 had significantly higher rates of High-TC, High-LDLC, High-TG, and lower rate of Low-HDLC adjusting for covariates. No significant association was observed between selenium level and the risk of High-TG. APOE epsilon 4 carriers had higher rates of High-TC and High-LDLC. There was no interaction between selenium level and APOE with the rates of dyslipidemia. Conclusions Our results suggest long-term selenium exposure level may be associated with the risk of dyslipidemia in elderly population. Future studies are needed to examine the underlying mechanism of the association.	[Su, Liqin] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Impact Assessment, Beijing, Peoples R China; [Gao, Sujuan] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Unverzagt, Frederick W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Cheng, Yibin; Xin, Pengju; Chen, Chen; Liu, Jingyi; Ma, Feng; Jin, Yinlong] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China; [Hake, Ann M.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Bian, Jianchao] Shandong Inst Prevent & Treatment Endem Dis China, Jinan, Peoples R China; [Li, Ping] Sichuan Prov Ctr Dis Control & Prevent China, Chengdu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University Bloomington	Jin, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China.	jinyinlong1951@sina.com	Li, Ping/GYV-4914-2022		National Institutes of Health [2R01 AG019181]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institutes of Health, with grant number 2R01 AG019181, URL: http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alissa EM, 2003, MED SCI MONITOR, V9, pRA9; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Arnaud J, 2009, J TRACE ELEM MED BIO, V23, P21, DOI 10.1016/j.jtemb.2008.08.001; Ayaz M, 2004, ARCH BIOCHEM BIOPHYS, V426, P83, DOI 10.1016/j.abb.2004.03.030; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P145, DOI 10.1081/CLT-100102417; Bates CJ, 2002, J TRACE ELEM MED BIO, V16, P1, DOI 10.1016/S0946-672X(02)80002-5; Bleys J, 2008, AM J CLIN NUTR, V88, P416; Bleys J, 2006, AM J CLIN NUTR, V84, P880, DOI 10.1093/ajcn/84.4.880; Brown K M, 2001, Public Health Nutr, V4, P593; Coudray C, 1997, J AM COLL NUTR, V16, P584; Dhingra S, 2006, MOL CELL BIOCHEM, V282, P75, DOI 10.1007/s11010-006-1266-1; Dhingra S, 2006, BIOMETALS, V19, P493, DOI 10.1007/s10534-005-5393-z; Dhingra S, 2006, CHEM-BIOL INTERACT, V161, P49, DOI 10.1016/j.cbi.2006.02.008; Djeffal A, 2012, TOXICOL IND HLTH; Ducros V, 2000, J INORG BIOCHEM, V81, P105, DOI 10.1016/S0162-0134(00)00071-4; El-Demerdash FM, 2014, J TRACE ELEM MED BIO, V28, P89, DOI 10.1016/j.jtemb.2013.10.001; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Fulop P, 2013, J CELL MOL MED, V17, P350, DOI 10.1111/jcmm.12013; Galan-Chilet I, 2014, FREE RADICAL BIO MED, V74, P229, DOI 10.1016/j.freeradbiomed.2014.07.005; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Gao SJ, 2009, PUBLIC HEALTH NUTR, V12, P2371, DOI 10.1017/S1368980009005102; He K, 2011, EUR J CLIN INVEST, V41, P98, DOI 10.1111/j.1365-2362.2010.02373.x; Henriques AD, 2014, GENE, V539, P275, DOI 10.1016/j.gene.2014.01.077; Hu M, 2012, J CLIN LIPIDOL, V6, P585, DOI 10.1016/j.jacl.2012.02.005; Huang KX, 2002, ATHEROSCLEROSIS, V162, P137, DOI 10.1016/S0021-9150(01)00707-9; Hubacek Jaroslav A., 2011, Drug Metabolism and Drug Interactions, V26, P13, DOI 10.1515/DMDI.2011.107; IPAQ group, 2005, GUIDELINES FOR DATA; Ji A, 1991, CHINESE JOURNAL OF C, V6, P327; 曹静祥, 2007, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V41, P419; JOSSA F, 1991, ATHEROSCLEROSIS, V87, P129, DOI 10.1016/0021-9150(91)90015-U; Karita K, 2008, MENOPAUSE, V15, P119, DOI 10.1097/gme.0b013e31806bf32c; Kim SW, 2010, J TOXICOL ENV HEAL A, V73, P1502, DOI 10.1080/15287394.2010.511573; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kotaska K, 2012, GENET TEST MOL BIOMA, V16, P210, DOI 10.1089/gtmb.2011.0129; Krogh Vittorio, 2003, Journal of Trace Elements in Medicine and Biology, V17, P31; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Navas-Acien A, 2008, CURR OPIN LIPIDOL, V19, P43, DOI 10.1097/MOL.0b013e3282f2b261; Obeid O, 2008, BIOL TRACE ELEM RES, V123, P58, DOI 10.1007/s12011-008-8112-0; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; OVASKAINEN ML, 1993, AM J CLIN NUTR, V57, P662, DOI 10.1093/ajcn/57.5.662; Petkeviciene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041525; Rayman MP, 2011, ANN INTERN MED, V154, P656, DOI 10.7326/0003-4819-154-10-201105170-00005; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SALONEN JT, 1988, ATHEROSCLEROSIS, V70, P155, DOI 10.1016/0021-9150(88)90109-8; Seale LA, 2012, MOL CELL BIOL, V32, P4141, DOI 10.1128/MCB.00293-12; Sengupta A, 2008, BIOCHEM BIOPH RES CO, V365, P446, DOI 10.1016/j.bbrc.2007.10.189; Slotnick MJ, 2006, ENVIRON RES, V102, P125, DOI 10.1016/j.envres.2005.12.001; Smalinskiene A, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-120; Stranges S, 2011, J INTERN MED, V270, P469, DOI 10.1111/j.1365-2796.2011.02398.x; Stranges S, 2010, NUTR METAB CARDIOVAS, V20, P754, DOI 10.1016/j.numecd.2010.10.001; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2010, J NUTR, V140, P81, DOI 10.3945/jn.109.111252; Su L, 2013, HYGIENE, V3, P84; SUADICANI P, 1992, ATHEROSCLEROSIS, V96, P33, DOI 10.1016/0021-9150(92)90035-F; Tanguy S, 2004, ANTIOXID REDOX SIGN, V6, P792, DOI 10.1089/1523086041361631; Tanguy S, 2003, AGE AGEING, V32, P273, DOI 10.1093/ageing/32.3.273; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vegh Csaba, 2012, Orvosi Hetilap, V153, P2070, DOI 10.1556/OH.2012.29508; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; World Health Organization, 1987, ENV HLTH; Yilmaz-Aydogan H, 2013, GENE, V523, P20, DOI 10.1016/j.gene.2013.03.136; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	67	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136706	10.1371/journal.pone.0136706	http://dx.doi.org/10.1371/journal.pone.0136706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380972	gold, Green Published			2022-12-26	WOS:000361790200010
J	Martinez-Briseno, D; Fernandez-Plata, R; Gochicoa-Rangel, L; Torre-Bouscoulet, L; Rojas-Martinez, R; Mendoza-Alvarado, L; Garcia-Sancho, C; Perez-Padilla, R				Martinez-Briseno, David; Fernandez-Plata, Rosario; Gochicoa-Rangel, Laura; Torre-Bouscoulet, Luis; Rojas-Martinez, Rosalba; Mendoza-Alvarado, Laura; Garcia-Sancho, Cecilia; Perez-Padilla, Rogelio			Socioeconomic Status and Longitudinal Lung Function of Healthy Mexican Children	PLOS ONE			English	Article							SCHOOL-CHILDREN; RESPIRATORY HEALTH; GROWTH STATUS; LEG LENGTH; PROPORTION; EXPOSURE; DISEASE; COHORT; BEAUTY; OAXACA	Introduction Our aim was to estimate the longitudinal effect of Socioeconomic status (SES) on lung function growth of Mexican children and adolescents. Materials and Methods A cohort of Mexican children in third grade of primary school was followed with spirometry twice a year for 6 years through secondary school. Multilevel mixed-effects lineal models were fitted for the spirometric variables of 2,641 respiratory-healthy Mexican children. Monthly family income (in 2002 U.S. dollars [USD]) and parents' years completed at school were used as proxies of SES. Results Individuals with higher SES tended to have greater height for age, and smaller sitting height/standing height and crude lung function. For each 1-year increase of parents' schooling, Forced expiratory volume in 1 sec (FEV1) and Forced vital capacity (FVC) increased 8.5 (0.4%) and 10.6 mL (0.4%), respectively (p <0.05) when models were adjusted for gender. Impact of education on lung function was reduced drastically or abolished on adjusting by anthropometric variables and ozone. Conclusions Higher parental schooling and higher monthly family income were associated with higher lung function in healthy Mexican children, with the majority of the effect likely due to the increase in height-for-age.	[Martinez-Briseno, David; Fernandez-Plata, Rosario; Gochicoa-Rangel, Laura; Torre-Bouscoulet, Luis; Garcia-Sancho, Cecilia; Perez-Padilla, Rogelio] Natl Inst Resp Dis INER, Epidemiol & Social Sci Hlth, Mexico City, DF, Mexico; [Rojas-Martinez, Rosalba; Mendoza-Alvarado, Laura] Natl Inst Publ Hlth INSP, Populat Hlth Res Ctr, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis INER, Epidemiol & Social Sci Hlth, Mexico City, DF, Mexico.	perezpad@gmail.com	Rojas, Rosalba/C-8714-2014; Gochicoa, Laura/O-6810-2019	Gochicoa-Rangel, Laura/0000-0003-3009-5867	National Council for Science and Technology (CONACyT)-Mexico; National Institute of Respiratory Diseases (INER)	National Council for Science and Technology (CONACyT)-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Respiratory Diseases (INER)	Funding provided by National Council for Science and Technology (CONACyT)-Mexico, http://www.conacyt.mx/ and National Institute of Respiratory Diseases (INER), http://www.iner.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogin B, 2009, ANTHROPOL ANZ, V67, P439, DOI 10.1127/0003-5548/2009/0036; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; Demissie K, 1996, AM J RESP CRIT CARE, V153, P719, DOI 10.1164/ajrccm.153.2.8564123; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Lebowitz MD, 1996, AM J RESP CRIT CARE, V154, pS273, DOI 10.1164/ajrccm/154.6_Pt_2.S273; Lum S, 2010, EUR RESPIR MONOGR, P46, DOI 10.1183/1025448x.00020909; MALINA RM, 1980, ANN HUM BIOL, V7, P367, DOI 10.1080/03014468000004441; Malina RM, 2009, AM J HUM BIOL, V21, P805, DOI 10.1002/ajhb.20897; Martinez-Briseno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077403; Menezes AMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-596; Perez-Padilla R, 2003, CHEST, V123, P1090, DOI 10.1378/chest.123.4.1090; Perez-Padilla R, 2003, PEDIATR PULM, V35, P177, DOI 10.1002/ppul.10232; Raju PS, 2005, PEDIATR PULM, V39, P528, DOI 10.1002/ppul.20206; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Standardization of Spirometry, 1994, AM J RESP CRIT CARE, V152, P1107; STEINBERG M, 1986, S AFR MED J, V70, P270; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Stocks J, 2013, THER ADV RESPIR DIS, V7, P161, DOI 10.1177/1753465813479428; Ware JH, 1996, AM J RESP CRIT CARE, V154, pS212, DOI 10.1164/ajrccm/154.6_Pt_2.S212	23	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136935	10.1371/journal.pone.0136935	http://dx.doi.org/10.1371/journal.pone.0136935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379144	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400010
J	Xu, DD; Wang, C; Jiang, F; Wei, LL; Shi, LY; Yu, XM; Liu, CM; Liu, XH; Feng, XM; Ping, ZP; Jiang, TT; Chen, ZL; Li, ZJ; Li, JC				Xu, Dan-Dan; Wang, Chong; Jiang, Feng; Wei, Li-Liang; Shi, Li-Ying; Yu, Xiao-Mei; Liu, Chang-Ming; Liu, Xue-Hong; Feng, Xian-Min; Ping, Ze-Peng; Jiang, Ting-Ting; Chen, Zhong-Liang; Li, Zhong-Jie; Li, Ji-Cheng			Association of the FCN2 Gene Single Nucleotide Polymorphisms with Susceptibility to Pulmonary Tuberculosis	PLOS ONE			English	Article							MANNOSE-BINDING-LECTIN; L-FICOLIN; CHINESE-HAN; FUNCTIONAL POLYMORPHISMS; NRAMP1 GENE; COMPLEMENT; VARIANTS; RISK; SARCOIDOSIS; PATHWAY	Ficolin-2 (FCN2) is an innate immune pattern recognition molecule that can activate the complement pathway, opsonophagocytosis, and elimination of the pathogens. The present study aimed to investigate the association of the FCN2 gene single nucleotide polymorphisms (SNPs) with susceptibility to pulmonary tuberculosis (TB). A total of seven SNPs in exon 8 (+6359 C>T and +6424 G>T) and in the promoter region (-986 G>A, -602 G>A, -557 A>G, -64 A>C and -4 A>G) of the FCN2 gene were genotyped using the PCR amplification and DNA sequencing methods in the healthy controls group (n = 254) and the pulmonary TB group (n = 282). The correlation between SNPs and pulmonary TB was analyzed using the logistic regression method. The results showed that there were no significant differences in the distribution of allelic frequencies of seven SNPs between the pulmonary TB group and the healthy controls group. However, the frequency of the variant homozygous genotype (P = 0.037, -557 A>G; P = 0.038, -64 A>C; P = 0.024, +6424 G>T) in the TB group was significantly lower than the control group. After adjustment for age and gender, these variant homozygous genotypes were found to be recessive models in association with pulmonary TB. In addition, -64 A>C (P = 0.047) and +6424 G>T (P = 0.03) were found to be codominant models in association with pulmonary TB. There was strong linkage disequilibrium (r(2) > 0.80, P < 0.0001) between 7 SNPs except the -602 G>A site. Therefore, -557 A>G, -64 A>C and +6424 G>T SNPs of the FCN2 gene were correlated with pulmonary TB, and may be protective factors for TB. This study provides a novel idea for the prevention and control of TB transmission from a genetics perspective.	[Xu, Dan-Dan; Wang, Chong; Liu, Chang-Ming; Ping, Ze-Peng; Jiang, Ting-Ting; Chen, Zhong-Liang; Li, Zhong-Jie; Li, Ji-Cheng] Zhejiang Univ, Inst Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, Feng] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100700, Peoples R China; [Wei, Li-Liang] Sixth Hosp Shaoxing, Dept Resp Med, Shaoxing 312000, Peoples R China; [Shi, Li-Ying; Yu, Xiao-Mei] Zhejiang Hosp, Dept Clin Lab, Hangzhou 310013, Zhejiang, Peoples R China; [Liu, Xue-Hong] Shaoxing Univ, Sch Med, Shaoxing 312000, Peoples R China; [Feng, Xian-Min] Jilin Med Coll, Sch Lab Med, Jilin 132013, Peoples R China	Zhejiang University; Beijing University of Chinese Medicine; Shaoxing University; Jilin Medical University	Li, JC (corresponding author), Zhejiang Univ, Inst Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China.	lijichen@zju.edu.cn	Liu, Xuehong/GVS-4500-2022		National Special Sci-Tech Projects [2012ZX10005001-006]; National Basic Research Program of China [2014CB543002]; National Natural Science Foundation of China [81273882]; Medical & hygienic Foundation of Zhejiang Province [2013KYA209]; Education Department of Jilin Province [2014367]	National Special Sci-Tech Projects; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical & hygienic Foundation of Zhejiang Province; Education Department of Jilin Province	This work was supported by the following sources of funding: 1. National Special Sci-Tech Projects (No. 2012ZX10005001-006; http://www.most.gov.cn/; LJC); 2. National Basic Research Program of China (No. 2014CB543002; http://www.most.gov.cn/; LJC); 3. National Natural Science Foundation of China (No. 81273882; http://www.nsfc.gov.cn/; LJC); 4. Medical & hygienic Foundation of Zhejiang Province (No. 2013KYA209; http://www.zjwst.gov.cn/; WLL); and 5. Education Department of Jilin Province (No. 2014367; http://www.jledu.gov.cn/jyt/; FXM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Alavi-Naini R, 2012, INT J TUBERC LUNG D, V16, P1383, DOI 10.5588/ijtld.11.0827; Amirzargar AA, 2006, EUR CYTOKINE NETW, V17, P84; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015; Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x; Cedzynski M, 2009, MOL IMMUNOL, V47, P415, DOI 10.1016/j.molimm.2009.08.028; Chalmers JD, 2015, INFLAMMATION, V38, P1731, DOI 10.1007/s10753-015-0150-0; Chen X, 2006, J DERMATOL SCI, V43, P201, DOI 10.1016/j.jdermsci.2006.05.010; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; Dubaniewicz A, 2005, EUR J HUM GENET, V13, P829, DOI 10.1038/sj.ejhg.5201370; Dubaniewicz A, 2006, SARCOIDOSIS VASC DIF, V23, P180; Dubaniewicz A, 2013, EXPERT REV CLIN IMMU, V9, P349, DOI [10.1586/eci.13.8, 10.1586/ECI.13.8]; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Gomez LM, 2007, TUBERCULOSIS, V87, P288, DOI 10.1016/j.tube.2007.03.002; Herpers BL, 2006, MOL IMMUNOL, V43, P851, DOI 10.1016/j.molimm.2005.06.035; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Luo FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073859; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Malik S, 2006, HUM GENET, V118, P752, DOI 10.1007/s00439-005-0092-y; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Metzger ML, 2015, CLIN EXP IMMUNOL, V179, P256, DOI 10.1111/cei.12459; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Mosaad YM, 2010, SCAND J IMMUNOL, V72, P358, DOI 10.1111/j.1365-3083.2010.02426.x; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Ojurongbe O, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-37; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Wang C, 2012, INT J BIOL SCI, V8, P945, DOI 10.7150/ijbs.4390; Xue Y, 2010, GENET MOL RES, V9, P1584, DOI 10.4238/vol9-3gmr771; Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x; Xue Y, 2010, CLIN CHEM LAB MED, V48, P785, DOI 10.1515/CCLM.2010.154; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zhang DF, 2013, HUM GENET, V132, P629, DOI 10.1007/s00439-013-1273-8; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282; Zhang X, 2012, INT J BIOL SCI, V8, P375, DOI 10.7150/ijbs.4047; Zhang YX, 2011, GENET MOL RES, V10, P7, DOI 10.4238/vol10-1gmr980; Zhao MY, 2012, GENET MOL RES, V11, P3425, DOI 10.4238/2012.September.25.11; Zhao MY, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-91; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	63	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138356	10.1371/journal.pone.0138356	http://dx.doi.org/10.1371/journal.pone.0138356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379154	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400087
J	Nakayama, T; Mikoshiba, K; Akagawa, K				Nakayama, Takahiro; Mikoshiba, Katsuhiko; Akagawa, Kimio			The cell- and tissue-specific transcription mechanism of the TATA-less syntaxin 1A gene	FASEB JOURNAL			English	Article						histone H3 acetylation; class I HDAC; epigenetic regulation; neuronal disorder; SP1	NF-KAPPA-B; HPC-1/SYNTAXIN 1A; NEURONAL EXPRESSION; BINDING-PROTEIN; RECEPTOR GENE; SP1; PROMOTER; SEQUENCE; ACTIVATION; REQUIRES	Syntaxin 1A (Stx1a) plays an important role in regulation of neuronal synaptic function. To clarify the mechanism of basic transcriptional regulation and neuron-specific transcription of Stx1a we cloned the Stx1a gene from rat, in which knowledge of the expression profile was accumulated, and elucidated that Stx1a consisting of 10 exons, possesses multiple transcription initiation sites and a 204-bp core promoter region (CPR) essential for transcription inPC12 cells. TheTATA-less, conserved, GC-rich CPR has 2 specific protein (SP) sites that bind SP1 and are responsible for 65% of promoter activity. The endogenous CPR, including 23 CpG sites, is not methylated in PC12 cells, which express Stx1a and fetal rat skin keratinocyte (FRSK) cells, which do not, although an exogenous methylated CPR suppresses reporter activity in both lines. TrichostatinA(TSA) and class I histone deacetylase (HDAC) inhibitors, but not 5-azacytidine, induce Stx1a in FRSK cells. Acetylated histone H3 only associates to the CPR in FRSK cells after TSAaddition, whereas the high acetylated histone H3-CPR association in PC12 cells was unchanged following treatment. HDAC inhibitor induction of Stx1a was negated by mithramycin A and deletion/mutation of 2 SP sites. HDAC1, HDAC2, and HDAC8 detach from the CPR when treated with TSA in FRSK cells and are associated with the CPR in lungs, and acetylated histone H3 associates to this region in the brain. In the first study characterizing a syntaxin promoter, we show that association of SP1 and acetylated histone H3 toCPR is important for Stx1a transcription and that HDAC1, HDAC2, and HDAC8 decide cell/tissue specificity in a suppressive manner.	[Nakayama, Takahiro; Akagawa, Kimio] Kyorin Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Neurodev Disorder Res Grp, Dev Neurobiol Lab, Saitama, Japan	Kyorin University; RIKEN	Nakayama, T (corresponding author), Kyorin Univ, Dept Cell Physiol, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	nakayama@ks.kyorin-u.ac.jp	Nakayama, Takahiro/AAE-8953-2019	Nakayama, Takahiro/0000-0003-3064-3536	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan [19300133]; Promotion and Mutual Aid Corporation for Private Schools of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	The authors are grateful to Ms. Masumi Sanada for practical assistance with cell culture and molecular biology techniques and are greatly indebted to Dr. Guntram Suske for providing the plasmids pPac-vector and pPac-Sp1. This study was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science for Japanese Junior Scientists (to T.N.), a grant-in-aid for scientific research (B) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (19300133), and a grant-in-aid from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to K.A.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bedford FK, 1998, J NEUROSCI, V18, P6186; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Brasse-Lagnel C, 2003, J BIOL CHEM, V278, P52504, DOI 10.1074/jbc.M306752200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Fujino I, 1997, NEUROSCI RES, V28, P243, DOI 10.1016/S0168-0102(97)00050-3; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Fujiwara T, 2010, EUR J NEUROSCI, V32, P99, DOI 10.1111/j.1460-9568.2010.07269.x; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hermon P, 2007, PLANT MOL BIOL, V64, P387, DOI 10.1007/s11103-007-9160-0; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; INOUE A, 1992, J BIOL CHEM, V267, P10613; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jin HJ, 2014, J BIOL CHEM, V289, P34743, DOI 10.1074/jbc.M114.576702; Johnson AA, 2013, J NEUROSCI, V33, P7535, DOI 10.1523/JNEUROSCI.3739-12.2013; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Kushima Y, 1997, J MOL NEUROSCI, V8, P19, DOI 10.1007/BF02736860; LATCHMAN DS, 1998, EUKARYOTIC TRANSCRIP; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094523; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; MARUYAMA K, 1994, GENE, V138, P171; Matlhagela K, 2005, J BIOL CHEM, V280, P334, DOI 10.1074/jbc.M411415200; Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nakayama T, 1998, CYTOGENET CELL GENET, V82, P49, DOI 10.1159/000015063; Nakayama T, 1997, GENOMICS, V42, P173, DOI 10.1006/geno.1997.4650; Nguyen HN, 2005, NEUROREPORT, V16, P731, DOI 10.1097/00001756-200505120-00015; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Sambrook J., 2001, MOL CLONING; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; TAGAYA M, 1995, J BIOL CHEM, V270, P15930, DOI 10.1074/jbc.270.27.15930; Teng FYH, 2001, GENOME BIOL, V2; Watanabe T, 1999, J BIOCHEM-TOKYO, V125, P685, DOI 10.1093/oxfordjournals.jbchem.a022337; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Wong CYA, 2011, J BIOL CHEM, V286, P25813, DOI 10.1074/jbc.M110.211292; Wood IC, 1999, BIOCHEM J, V340, P475, DOI 10.1042/0264-6021:3400475; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x	59	5	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					525	543		10.1096/fj.15-275529	http://dx.doi.org/10.1096/fj.15-275529			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26391271				2022-12-26	WOS:000369391900007
J	Tatavosian, R; Zhen, CY; Duc, HN; Balas, MM; Johnson, AM; Ren, XJ				Tatavosian, Roubina; Zhen, Chao Yu; Huy Nguyen Duc; Balas, Maggie M.; Johnson, Aaron M.; Ren, Xiaojun			Distinct Cellular Assembly Stoichiometry of Polycomb Complexes on Chromatin Revealed by Single-molecule Chromatin Immunoprecipitation Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HISTONE H3; NUCLEOSOME DYNAMICS; GENE-EXPRESSION; CBX PROTEINS; SAM DOMAIN; PRC1; METHYLATION; BINDING; HETEROCHROMATIN	Epigenetic complexes play an essential role in regulating chromatin structure, but information about their assembly stoichiometry on chromatin within cells is poorly understood. The cellular assembly stoichiometry is critical for appreciating the initiation, propagation, and maintenance of epigenetic inheritance during normal development and in cancer. By combining genetic engineering, chromatin biochemistry, and single-molecule fluorescence imaging, we developed a novel and sensitive approach termed single-molecule chromatin immunoprecipitation imaging (Sm-ChIPi) to enable investigation of the cellular assembly stoichiometry of epigenetic complexes on chromatin. Sm-ChIPi was validated by using chromatin complexes with known stoichiometry. The stoichiometry of subunits within a polycomb complex and the assembly stoichiometry of polycomb complexes on chromatin have been extensively studied but reached divergent views. Moreover, the cellular assembly stoichiometry of polycomb complexes on chromatin remains unexplored. Using Sm-ChIPi, we demonstrated that within mouse embryonic stem cells, one polycomb repressive complex (PRC) 1 associates with multiple nucleosomes, whereas two PRC2s can bind to a single nucleosome. Furthermore, we obtained direct physical evidence that the nucleoplasmic PRC1 is monomeric, whereas PRC2 can dimerize in the nucleoplasm. We showed that ES cell differentiation induces selective alteration of the assembly stoichiometry of Cbx2 on chromatin but not other PRC1 components. We additionally showed that the PRC2-mediated trimethylation of H3K27 is not required for the assembly stoichiometry of PRC1 on chromatin. Thus, these findings uncover that PRC1 and PRC2 employ distinct mechanisms to assemble on chromatin, and the novel Sm-ChIPi technique could provide single-molecule insight into other epigenetic complexes.	[Tatavosian, Roubina; Zhen, Chao Yu; Huy Nguyen Duc; Ren, Xiaojun] Univ Colorado, Dept Chem, Denver, CO 80217 USA; [Balas, Maggie M.; Johnson, Aaron M.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Ren, XJ (corresponding author), Univ Colorado, Dept Chem, Denver, CO 80217 USA.	xiaojun.ren@ucdenver.edu		Ren, Xiaojun/0000-0002-3931-7625; Balas, Maggie/0000-0002-0701-1787	National Institutes of Health Pathway to Independence Award [K99/R00 GM094291]; University of Colorado Denver; CU-Denver Office Research Service; American Cancer Society [IRG 57-001-53]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM094291, K99GM094291] Funding Source: NIH RePORTER	National Institutes of Health Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Denver; CU-Denver Office Research Service; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pathway to Independence Award K99/R00 GM094291 (to A.J.). This work was also supported by grants from the University of Colorado Denver (to X. R.), the CU-Denver Office Research Service (to X. R.), and American Cancer Society Grant IRG 57-001-53 subaward (to X. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alves D, 2008, NAT CHEM BIOL, V4, P287, DOI 10.1038/nchembio.82; An WJ, 2004, METHOD ENZYMOL, V377, P460; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Cheng B, 2014, MOL CELL BIOL, V34, P2075, DOI 10.1128/MCB.01729-13; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Cowell IG, 1997, BBA-PROTEIN STRUCT M, V1337, P198, DOI 10.1016/S0167-4838(96)00165-3; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Davidovich C, 2014, NUCLEIC ACIDS RES, V42, P9236, DOI 10.1093/nar/gku540; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Johnson A, 2013, J BIOL CHEM, V288, P28771, DOI 10.1074/jbc.M113.460071; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee JY, 2015, J BIOL CHEM, V290, P4291, DOI 10.1074/jbc.M114.619213; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li M, 2015, ELIFE, V4, DOI 10.7554/eLife.06249; Lo SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047162; Lo SM, 2010, BIOCHEMISTRY-US, V49, P9438, DOI 10.1021/bi100532a; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Luo Y, 2014, NUCLEIC ACIDS RES, V42, P3017, DOI 10.1093/nar/gkt1319; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Ren XJ, 2006, J AM CHEM SOC, V128, P4992, DOI 10.1021/ja056613z; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Swygert SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5751; Tardat M, 2015, MOL CELL, V58, P157, DOI 10.1016/j.molcel.2015.02.013; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu L, 2013, BIOCHEMISTRY-US, V52, P9519, DOI 10.1021/bi401085h; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhen CY, 2014, MOL BIOL CELL, V25, P3726, DOI 10.1091/mbc.E14-06-1109; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	77	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28038	28054		10.1074/jbc.M115.671115	http://dx.doi.org/10.1074/jbc.M115.671115			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26381410	Green Published, hybrid			2022-12-26	WOS:000365761900002
J	Chen, L; Xiao, L; Auger, N; Torrie, J; McHugh, NGL; Zoungrana, H; Luo, ZC				Chen, Lu; Xiao, Lin; Auger, Nathalie; Torrie, Jill; McHugh, Nancy Gros-Louis; Zoungrana, Hamado; Luo, Zhong-Cheng			Disparities and Trends in Birth Outcomes, Perinatal and Infant Mortality in Aboriginal vs. Non-Aboriginal Populations: A Population-Based Study in Quebec, Canada 1996-2010	PLOS ONE			English	Article							1ST NATIONS; INDIGENOUS HEALTH; WESTERN-AUSTRALIA; INUIT; NUNAVUT; NATIVES; WEIGHT; DEATH; WOMEN; BORN	Background Aboriginal populations are at substantially higher risks of adverse birth outcomes, perinatal and infant mortality than their non-Aboriginal counterparts even in developed countries including Australia, U.S. and Canada. There is a lack of data on recent trends in Canada. Methods We conducted a population-based retrospective cohort study (n = 254,410) using the linked vital events registry databases for singleton births in Quebec 1996-2010. Aboriginal (First Nations, Inuit) births were identified by mother tongue, place of residence and Indian Registration System membership. Outcomes included preterm birth, small-for-gestational-age, large-for-gestational-age, low birth weight, high birth weight, stillbirth, neonatal death, post-neonatal death, perinatal death and infant death. Results Perinatal and infant mortality rates were 1.47 and 1.80 times higher in First Nations (10.1 and 7.3 per 1000, respectively), and 2.37 and 4.46 times higher in Inuit (16.3 and 18.1 per 1000, respectively) relative to non-Aboriginal (6.9 and 4.1 per 1000, respectively) births (all p<0.001). Compared to non-Aboriginal births, preterm birth rates were persistently (1.7-1.8 times) higher in Inuit, large-for-gestational-age birth rates were persistently (2.7-3.0 times) higher in First Nations births over the study period. Between 1996-2000 and 2006-2010, as compared to non-Aboriginal infants, the relative risk disparities increased for infant mortality (from 4.10 to 5.19 times) in Inuit, and for postneonatal mortality in Inuit (from 6.97 to 12.33 times) or First Nations (from 3.76 to 4.25 times) infants. Adjusting for maternal characteristics (age, marital status, parity, education and rural vs. urban residence) attenuated the risk differences, but significantly elevated risks remained in both Inuit and First Nations births for the risks of perinatal mortality (1.70 and 1.28 times, respectively), infant mortality (3.66 and 1.47 times, respectively) and postneonatal mortality (6.01 and 2.28 times, respectively) in Inuit and First Nations infants (all p<0.001). Conclusions Aboriginal vs. non-Aboriginal disparities in adverse birth outcomes, perinatal and infant mortality are persistent or worsening over the recent decade in Quebec, strongly suggesting the needs for interventions to improve perinatal and infant health in Aboriginal populations, and for monitoring the trends in other regions in Canada.	[Chen, Lu; Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Minist Educ,Xinhua Hosp, Shanghai 200092, Peoples R China; [Chen, Lu; Xiao, Lin; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, St Justine Hosp Res Ctr, Montreal, PQ H3T 1C5, Canada; [Auger, Nathalie] Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada; [Torrie, Jill] Cree Board Hlth & Social Serv James Bay, Mistissini, PQ G0W 1C0, Canada; [McHugh, Nancy Gros-Louis] First Nations Quebec & Labrador Hlth & Social Ser, Wendake, PQ G0A 4V0, Canada; [Zoungrana, Hamado] Nunavik Reg Board Hlth & Social Serv, Kuujjuaq, PQ J0M 1C0, Canada; [Auger, Nathalie] Inst Natl Sante Publ Quebec, Montreal, PQ H2P 1E2, Canada	Shanghai Jiao Tong University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ)	Luo, ZC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Minist Educ,Xinhua Hosp, Shanghai 200092, Peoples R China.	zc_luo@yahoo.com	Auger, Nathalie/E-3736-2016; Luo, Zhong-Cheng/T-3882-2017	Auger, Nathalie/0000-0002-2412-0459; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR grant) [MOP 106521]; National Natural Science Foundation of China (NSFC grant) [81370742]; Cree Board of Health and Social Services of James Bay	Canadian Institutes of Health Research (CIHR grant)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC grant)(National Natural Science Foundation of China (NSFC)); Cree Board of Health and Social Services of James Bay	This work was supported by a research grant from the Canadian Institutes of Health Research (CIHR grant number MOP 106521). LC was partly supported by a research grant from the National Natural Science Foundation of China (NSFC grant number 81370742). LX was partly supported by the Cree Board of Health and Social Services of James Bay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri LM, 2001, MED J AUSTRALIA, V175, P185, DOI 10.5694/j.1326-5377.2001.tb143092.x; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Baldwin LM, 2002, AM J PUBLIC HEALTH, V92, P1491, DOI 10.2105/AJPH.92.9.1491; Castor ML, 2006, AM J PUBLIC HEALTH, V96, P1478, DOI 10.2105/AJPH.2004.053942; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; Collins SA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-190; Elias B, 2014, SOC SCI MED, V123, P125, DOI 10.1016/j.socscimed.2014.10.056; Fair M, 2000, Chronic Dis Can, V21, P8; First Nations of Quebec and Labrador Health and Social Service Commission, 2007, BLUEPR QUEB 1 NAT HL; Freemantle CJ, 2006, LANCET, V367, P1758, DOI 10.1016/S0140-6736(06)68771-0; Gilbert NL, 2015, HEALTH REP, V26, P3; Hauck FR, 2008, PEDIATRICS, V122, pS113, DOI 10.1542/peds.2008-1315o; Healey GK, 2007, INT J CIRCUMPOL HEAL, V66, P199, DOI 10.3402/ijch.v66i3.18256; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kirby R S, 1993, J Perinatol, V13, P433; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Luo ZC, 2004, INT J EPIDEMIOL, V33, P1252, DOI 10.1093/ije/dyh290; Luo ZC, 2004, PAEDIATR PERINAT EP, V18, P40, DOI 10.1111/j.1365-3016.2003.00529.x; Luo ZC, 2012, J EPIDEMIOL COMMUN H, V66, P328, DOI 10.1136/jech.2009.092619; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; Mackerras D, 2000, AUST NZ J PUBL HEAL, V24, P287, DOI 10.1111/j.1467-842X.2000.tb01570.x; NAKAMURA RM, 1991, JAMA-J AM MED ASSOC, V266, P2244, DOI 10.1001/jama.266.16.2244; Plessis V, 2001, RURAL SMALL TOWN CAN, V3; Quamrul HC., 2010, J BIOL SCI, V2, P132; Reading J, 1999, 1 NATIONS INUIT REGI, P87; Simonet F, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18791; Smylie J, 2010, CAN J PUBLIC HEALTH, V101, P143, DOI 10.1007/BF03404361; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Tomashek KM, 2006, AM J PUBLIC HEALTH, V96, P2222, DOI 10.2105/AJPH.2004.053744; Wilkins R, 2012, PCCF VERSION 5F USER	30	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138562	10.1371/journal.pone.0138562	http://dx.doi.org/10.1371/journal.pone.0138562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26397838	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500079
J	Li, F; Zeng, J; Gao, Y; Guan, ZF; Ma, ZK; Shi, Q; Du, C; Jia, J; Xu, S; Wang, XY; Chang, LK; He, DL; Guo, P				Li, Feng; Zeng, Jin; Gao, Yang; Guan, Zhenfeng; Ma, Zhenkun; Shi, Qi; Du, Chong; Jia, Jing; Xu, Shan; Wang, Xinyang; Chang, Luke; He, Dalin; Guo, Peng			G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; AMPK; PHOSPHORYLATION; ACTIVATION; EXPRESSION; APOPTOSIS; PROTEIN; SIRT1; EHMT2; MTOR	G9a has been reported to highly express in bladder transitional cell carcinoma (TCC) and G9a inhibition significantly attenuates cell proliferation, but the underlying mechanism is not fully understood. The present study aimed at examining the potential role of autophagy in the anti-proliferation effect of G9a inhibition on TCC T24 and UMUC-3 cell lines in vitro. We found that both pharmaceutical and genetical G9a inhibition significantly attenuated cell proliferation by MTT assay, Brdu incorporation assay and colony formation assay. G9a inhibition induced autophagy like morphology as determined by transmission electron microscope and LC-3 fluorescence assay. In addition, autophagy flux was induced by G9a inhibition in TCC cells, as determined by p62 turnover assay and LC-3 turnover assay. The autophagy induced positively contributed to the inhibition of cell proliferation because the growth attenuation capacity of G9a inhibition was reversed by autophagy inhibitors 3-MA. Mechanically, AMPK/mTOR pathway was identified to be involved in the regulation of G9a inhibition induced autophagy. Intensively activating mTOR by Rheb overexpression attenuated autophagy and autophagic cell death induced by G9a inhibition. In addition, pre-inhibiting AMPK by Compound C attenuated autophagy together with the anti-proliferation effect induced by G9a inhibition while pre-activating AMPK by AICAR enhanced them. In conclusion, our results indicate that G9a inhibition induces autophagy through activating AMPK/mTOR pathway and the autophagy induced positively contributes to the inhibition of cell proliferation in TCC cells. These findings shed some light on the functional role of G9a in cell metabolism and suggest that G9a might be a therapeutic target in bladder TCC in the future.	[Li, Feng; Zeng, Jin; Gao, Yang; Guan, Zhenfeng; Ma, Zhenkun; Shi, Qi; Du, Chong; Jia, Jing; Xu, Shan; Wang, Xinyang; Chang, Luke; He, Dalin; Guo, Peng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	He, DL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian 710049, Shaanxi, Peoples R China.	dalinhexjtu@163.com; guopeng661@mail.xjtu.edu.cn	Xu, Shan/X-5227-2019; Wang, Xin/GYU-1129-2022; Guo, Peng/GWC-0572-2022; Gao, Yang/AAV-3459-2020; guo, peng/AAG-4052-2019	Gao, Yang/0000-0002-0518-5249; Du, Chong/0000-0002-2105-3078; Shi, Qi/0000-0001-6530-0264; Guo, Peng/0000-0002-4575-8443	National Natural Science Foundation of China [81372279, 81171953, 81101936]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China No. 81372279 and 81171953 to PG supports study design, materials preparation, data collection and analysis, decision to publish, and preparation of the manuscript. The National Natural Science Foundation of China No. 81101936 to JZ supports materials preparation.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Arcaro A, 2013, AUTOPHAGY, V9, P607, DOI 10.4161/auto.23461; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Clarke PGH, 2012, AUTOPHAGY, V8, P867, DOI 10.4161/auto.20380; Cui J, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-014-0149-x; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Di Pierro GB, 2012, CURR GENOMICS, V13, P395, DOI 10.2174/138920212801619232; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Ke XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106962; Kim SY, 2015, BIOMOL THER, V23, P99, DOI 10.4062/biomolther.2015.013; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kou B, 2014, UROL ONCOL-SEMIN ORI, V32, P846, DOI 10.1016/j.urolonc.2014.01.003; Lebrun-Julien F, 2015, ASN NEURO, V7, DOI 10.1177/1759091415593066; Li F, 2015, INT J MOL SCI, V16, P8415, DOI 10.3390/ijms16048415; Li KC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-172; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Oh ST, 2014, FEBS LETT, V588, P685, DOI 10.1016/j.febslet.2014.01.039; Parmar N, 2010, ENZYMES, V27, P39, DOI 10.1016/S1874-6047(10)27003-8; Rah B, 2015, AUTOPHAGY, V11, P314, DOI 10.1080/15548627.2015.1017182; Ren A, 2015, BIOCH BIOPHYS RES CO; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sui XB, 2015, CANCER LETT, V360, P106, DOI 10.1016/j.canlet.2015.02.009; Sui XB, 2011, AUTOPHAGY, V7, P565, DOI 10.4161/auto.7.6.14073; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Xiong YY, 2014, AUTOPHAGY, V10, P2223, DOI 10.4161/15548627.2014.981789; Yuan Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.191; Zhang J, 2015, ONCOTARGET, V6, P2917, DOI 10.18632/oncotarget.2784	50	45	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138390	10.1371/journal.pone.0138390	http://dx.doi.org/10.1371/journal.pone.0138390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397365	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500063
J	Marlet, J; Ankri, A; Charuel, JL; Ghillani-Dalbin, P; Perret, A; Martin-Toutain, I; Haroche, J; Amoura, Z; Musset, L; Miyara, M				Marlet, Julien; Ankri, Annick; Charuel, Jean-Luc; Ghillani-Dalbin, Pascale; Perret, Amelie; Martin-Toutain, Isabelle; Haroche, Julien; Amoura, Zahir; Musset, Lucile; Miyara, Makoto			Thrombophilia Associated with Anti-DFS70 Autoantibodies	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; AUTOIMMUNE RHEUMATIC-DISEASES; VENOUS THROMBOSIS; GROWTH-FACTOR; ANTIPHOSPHOLIPID SYNDROME; ANTINUCLEAR ANTIBODIES; HEALTHY-INDIVIDUALS; RISK-FACTOR; FETAL LOSS; FACTOR-V	Context Anti-DFS70 antibodies are the most frequent antinuclear antibodies (ANA) found in healthy individuals. We assessed the clinical significance of the presence of anti-DFS70 antibodies. Methods We defined a group of patients (n = 421) with anti-DFS70 antibodies and a group of patients (n = 63) with a history of idiopathic arterial and/or venous thrombotic disease and/or obstetric complication (i.e. >= 3 miscarriages, fetal death or premature birth with eclampsia). Anti-DFS70 antibodies prevalence was also assessed in a cohort of 300 healthy blood donors. Results The prevalence of thrombotic disease and/or obstetric complication in the 421 patients with anti-DFS70 antibodies was 13.1%(n = 55) and the prevalence of connective tissue disease was 19% (n = 80). Among the 63 patients with a history of thrombosis and/or obstetric complications, 7 (11.1%) had anti-DFS70 antibodies and among the latter, 5 had no common thrombophilic factor. In contrast, the prevalence of anti-DFS70 antibodies was of 3.0% (9 out of 300) in healthy donors. Finally, the Activated Partial Thromboplastin Time (aPTT) ratio of patients with a history of thrombosis and anti-DFS70 antibodies was lower than the aPTT ratio of other patients, suggesting that thrombotic patients with anti-DFS70 antibodies may have a hypercoagulable state. Conclusion We described here for the first time an immune procoagulant state involving anti-DFS70 antibodies.	[Marlet, Julien; Charuel, Jean-Luc; Ghillani-Dalbin, Pascale; Perret, Amelie; Musset, Lucile; Miyara, Makoto] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Ankri, Annick; Martin-Toutain, Isabelle] Hop La Pitie Salpetriere, AP HP, Hematol Lab, Paris, France; [Haroche, Julien; Amoura, Zahir; Miyara, Makoto] INSERM, Ctr Immunol & Malad Infect, U1135, Paris, France; [Haroche, Julien; Amoura, Zahir] Hop La Pitie Salpetriere, AP HP, Ctr Reference Natl Lupus & Syndrome Antiphospholi, Serv Med Interne 2,Inst E3M, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Miyara, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France.	makoto.miyara@psl.aphp.fr	AMOURA, Zahir/P-5324-2017; Marlet, Julien/ABF-1619-2020; Miyara, Makoto/P-4491-2017; Amoura, Zahir/P-5325-2017; Marlet, Julien/GZG-4349-2022	AMOURA, Zahir/0000-0003-0292-9043; Marlet, Julien/0000-0002-8645-8703; Miyara, Makoto/0000-0001-8743-8846; 				Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Agmon-Levin N, 2010, J AUTOIMMUN, V34, P55, DOI 10.1016/j.jaut.2009.08.009; [Anonymous], 2012, NAT I HLTH CLIN EXC; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818; Biino G, 2012, THROMB RES, V129, pE8, DOI 10.1016/j.thromres.2011.11.018; Chen FF, 2012, GLYCOBIOLOGY, V22, P649, DOI 10.1093/glycob/cwr191; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Goldblatt F, 2013, LANCET, V382, P797, DOI 10.1016/S0140-6736(13)61499-3; Kelton JG, 2008, BLOOD, V112, P2607, DOI 10.1182/blood-2008-02-078014; Kujovich JL, 2004, AM J OBSTET GYNECOL, V191, P412, DOI 10.1016/j.ajog.2004.03.001; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Mariz HA, 2011, ARTHRITIS RHEUM-US, V63, P191, DOI 10.1002/art.30084; Martinelli I, 2000, NEW ENGL J MED, V343, P1015, DOI 10.1056/NEJM200010053431405; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Miyara M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/703759; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; OCHS RL, 1994, J UROLOGY, V151, P587, DOI 10.1016/S0022-5347(17)35023-1; Ogawa Y, 2004, J AUTOIMMUN, V23, P221, DOI 10.1016/j.jaut.2004.07.003; Okamoto M, 2004, J AUTOIMMUN, V23, P257, DOI 10.1016/j.jaut.2004.07.004; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Shinohara T, 2000, J OCUL PHARMACOL TH, V16, P181, DOI 10.1089/jop.2000.16.181; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Stinton LM, 2007, AUTOIMMUN REV, V7, P77, DOI 10.1016/j.autrev.2007.08.003; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tripodi A, 2004, BLOOD, V104, P3631, DOI 10.1182/blood-2004-03-1042; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096; Yamada K, 2001, IMMUNOL LETT, V78, P161, DOI 10.1016/S0165-2478(01)00243-7; Yoon JH, 2011, CARDIOL REV, V19, P143, DOI 10.1097/CRD.0b013e318211f7c0; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	39	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138671	10.1371/journal.pone.0138671	http://dx.doi.org/10.1371/journal.pone.0138671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397729	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500092
J	Duinhouwer, LE; van Rossum, BJM; van Tiel, ST; van der Werf, RM; Doeswijk, GN; Haeck, JC; Rombouts, EWJC; ter Borg, MND; Kotek, G; Braakman, E; Cornelissen, JJ; Bernsen, MR				Duinhouwer, Lucia E.; van Rossum, Bernard J. M.; van Tiel, Sandra T.; van der Werf, Ramon M.; Doeswijk, Gabriela N.; Haeck, Joost C.; Rombouts, Elwin W. J. C.; ter Borg, Marlette N. D.; Kotek, Gyula; Braakman, Eric; Cornelissen, Jan J.; Bernsen, Monique R.			Magnetic Resonance Detection of CD34(+) Cells from Umbilical Cord Blood Using a F-19 Label	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; POLYVINYL-ALCOHOL; BONE-MARROW; PLGA NANOPARTICLES; UNRELATED DONORS; MR TRACKING; POLY(D,L-LACTIDE-CO-GLYCOLIDE); TRANSPLANTATION; MECHANISMS; LEUKEMIA	Impaired homing and delayed recovery upon hematopoietic stem cell transplantation (HSCT) with hematopoietic stem cells (HSC) derived from umbilical cord blood (UCB) is a major problem. Tracking transplanted cells in vivo will be helpful to detect impaired homing at an early stage and allows early interventions to improve engraftment and outcome after transplantation. In this study, we show sufficient intracellular labeling of UCB-derived CD34(+) cells, with F-19-containing PLGA nanoparticles which were detectable with both flow cytometry and magnetic resonance spectroscopy (MRS). In addition, labeled CD34(+) cells maintain their capacity to proliferate and differentiate, which is pivotal for successful engraftment after transplantation in vivo. These results set the stage for in vivo tracking experiments, through which the homing efficiency of transplanted cells can be studied.	[Duinhouwer, Lucia E.; Rombouts, Elwin W. J. C.; ter Borg, Marlette N. D.; Braakman, Eric; Cornelissen, Jan J.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [van Rossum, Bernard J. M.; van Tiel, Sandra T.; van der Werf, Ramon M.; Doeswijk, Gabriela N.; Haeck, Joost C.; Kotek, Gyula; Bernsen, Monique R.] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Bernsen, Monique R.] Erasmus Univ, Dept Nucl Med, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Duinhouwer, LE (corresponding author), Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands.	l.duinhouwer@erasmusmc.nl		van Tiel, Sandra/0000-0002-3057-3032; Bernsen, Monique/0000-0002-5203-5083	TI Pharma [D5-402]	TI Pharma	This work was supported by a grant from TI Pharma and performed within the framework of the TIPharma Project D5-402: 'The Prograft Study: optimizing the applicability of stem cell therapy.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2014, MAGN RESON MED, V72, P1696, DOI 10.1002/mrm.25454; Amiri H, 2015, EUR RADIOL, V25, P726, DOI 10.1007/s00330-014-3474-5; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Avery S, 2011, BLOOD, V117, P3277, DOI 10.1182/blood-2010-08-300491; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Bernsen MR, 2010, EUR RADIOL, V20, P255, DOI 10.1007/s00330-009-1540-1; Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2; FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801; Guenoun J, 2012, CELL TRANSPLANT, V21, P191, DOI 10.3727/096368911X593118; Helfer BM, 2013, CELL TRANSPLANT, V22, P87, DOI 10.3727/096368912X653174; Hidalgo A, 2002, J CLIN INVEST, V110, P559, DOI 10.1172/JCI200214047; Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Maki J, 2007, BIOMATERIALS, V28, P434, DOI 10.1016/j.biomaterials.2006.08.050; Malaisse WJ, 2012, ARCH BIOCHEM BIOPHYS, V517, P138, DOI 10.1016/j.abb.2011.11.014; Masuda C, 2006, NEUROSCI RES, V56, P224, DOI 10.1016/j.neures.2006.06.011; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Panyam J, 2003, PHARM RES-DORDR, V20, P212, DOI 10.1023/A:1022219003551; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Qaddoumi MG, 2004, PHARM RES-DORDR, V21, P641, DOI 10.1023/B:PHAM.0000022411.47059.76; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Willenbrock S, 2012, IN VIVO, V26, P31; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	33	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138572	10.1371/journal.pone.0138572	http://dx.doi.org/10.1371/journal.pone.0138572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394043	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100073
J	Iwakura, T; Ohashi, N; Kato, A; Baba, S; Yasuda, H				Iwakura, Takamasa; Ohashi, Naro; Kato, Akihiko; Baba, Satoshi; Yasuda, Hideo			Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							PHOSPHOLIPASE-A2 RECEPTOR; IGG SUBCLASSES; ANTIBODIES; GLOMERULONEPHRITIS; AUTOANTIBODIES; DEPOSITS; NEPHRITIS; ANTIGEN	Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults. Autoantibodies against M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A), which mainly belong to the IgG4 subclass, were reported as associated antibodies for the development of MN. Although PLA2R is a major target antigen for idiopathic MN, the prevalence of MN patients seropositive for PLA2R in Japan is lower than that in other countries. In this study, we conducted immunohistochemical analysis of the presence of THSD7A and PLA2R in renal specimens of MN patients to estimate the prevalence of THSD7A/PLA2R-related idiopathic MN in Japan. Enhanced granular expression of THSD7A and PLA2R was detected in 9.1% and 52.7%, respectively, of the patients with idiopathic MN. Although none of patients with secondary MN displayed enhanced granular expression of THSD7A, 5.4% of them had enhanced granular expression of PLA2R. In conclusion, the prevalence of enhanced granular expression of THSD7A in the glomeruli of Japanese patients with idiopathic MN was higher than the prevalence of MN patients seropositive for THSD7A in USA and Europe.	[Iwakura, Takamasa; Ohashi, Naro; Yasuda, Hideo] Hamamatsu Univ Sch Med, Div Nephrol, Internal Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Kato, Akihiko] Hamamatsu Univ Sch Med, Blood Purificat Unit, Hamamatsu, Shizuoka 4313192, Japan; [Baba, Satoshi] Hamamatsu Univ Sch Med, Div Pathol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Iwakura, T (corresponding author), Hamamatsu Univ Sch Med, Div Nephrol, Internal Med 1, Hamamatsu, Shizuoka 4313192, Japan.	tkms0421@hama-med.ac.jp						Akiyama S, CLIN EXP NEPHROL; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Dai HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08803; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; NOEL LH, 1988, CLIN IMMUNOL IMMUNOP, V46, P186, DOI 10.1016/0090-1229(88)90181-X; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Segarra-Medrano A, 2014, NEFROLOGIA, V34, P353, DOI 10.3265/Nefrologia.pre2013.Dec.12291; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354	22	47	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138841	10.1371/journal.pone.0138841	http://dx.doi.org/10.1371/journal.pone.0138841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393352	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100105
J	Nakagawa, G; Kouzuma, A; Hirose, A; Kasai, T; Yoshida, G; Watanabe, K				Nakagawa, Gen; Kouzuma, Atsushi; Hirose, Atsumi; Kasai, Takuya; Yoshida, Gen; Watanabe, Kazuya			Metabolic Characteristics of a Glucose-Utilizing Shewanella oneidensis Strain Grown under Electrode-Respiring Conditions	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; ESCHERICHIA-COLI; LACTATE METABOLISM; CURRENT GENERATION; CARBON METABOLISM; GENE-EXPRESSION; MR-1; PATHWAY; OXYGEN; IDENTIFICATION	In bioelectrochemical systems, the electrode potential is an important parameter affecting the electron flow between electrodes and microbes and microbial metabolic activities. Here, we investigated the metabolic characteristics of a glucose-utilizing strain of engineered Shewanella oneidensis under electrode-respiring conditions in electrochemical reactors for gaining insight into how metabolic pathways in electrochemically active bacteria are affected by the electrode potential. When an electrochemical reactor was operated with its working electrode poised at +0.4 V (vs. an Ag/AgCl reference electrode), the engineered S. oneidensis strain, carrying a plasmid encoding a sugar permease and glucose kinase of Escherichia coli, generated current by oxidizing glucose to acetate and produced D-lactate as an intermediate metabolite. However, D-lactate accumulation was not observed when the engineered strain was grown with a working electrode poised at 0 V. We also found that transcription of genes involved in pyruvate and D-lactate metabolisms was upregulated at a high electrode potential compared with their transcription at a low electrode potential. These results suggest that the carbon catabolic pathway of S. oneidensis can be modified by controlling the potential of a working electrode in an electrochemical bioreactor.	[Nakagawa, Gen; Kouzuma, Atsushi; Hirose, Atsumi; Kasai, Takuya; Yoshida, Gen; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Kouzuma, A (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan.	akouzuma@toyaku.ac.jp	Kouzuma, Atsushi/M-4559-2019	Kouzuma, Atsushi/0000-0002-5076-3810	JSPS KAKENHI [24880030, 26850056]; Noguchi Institute; Grants-in-Aid for Scientific Research [26850056] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Noguchi Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by JSPS KAKENHI Grant Numbers 24880030 and 26850056 (http://www.jsps.go.jp/english/index.html) and partly supported by the Noguchi Institute (http://www.noguchi.or.jp/index.php?lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; Brutinel ED, 2012, APPL ENVIRON MICROB, V78, P8474, DOI 10.1128/AEM.02183-12; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; Choi D, 2014, BIORESOURCE TECHNOL, V154, P59, DOI 10.1016/j.biortech.2013.12.025; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Flores S, 2002, METAB ENG, V4, P124, DOI 10.1006/mben.2001.0209; Flynn JM, 2010, MBIO, V1, DOI 10.1128/mBio.00190-10; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hernandez-Montalvo V, 2003, BIOTECHNOL BIOENG, V83, P687, DOI 10.1002/bit.10702; Howard EC, 2012, FEMS MICROBIOL LETT, V327, P9, DOI 10.1111/j.1574-6968.2011.02450.x; Ishii S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2615; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; Kim BH, 1999, J MICROBIOL BIOTECHN, V9, P127; Kouzuma A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-190; Kouzuma A, 2012, BIOSCI BIOTECH BIOCH, V76, P270, DOI 10.1271/bbb.110633; Kouzuma A, 2012, FEMS MICROBIOL LETT, V326, P91, DOI 10.1111/j.1574-6968.2011.02444.x; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lanthier M, 2008, FEMS MICROBIOL LETT, V278, P29, DOI 10.1111/j.1574-6968.2007.00964.x; Liu CG, 2013, BIOTECHNOL ADV, V31, P257, DOI 10.1016/j.biotechadv.2012.11.005; Matsuda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072901; Matsuda S, 2011, ENVIRON SCI TECHNOL, V45, P10163, DOI 10.1021/es200834b; Newton GJ, 2009, APPL ENVIRON MICROB, V75, P7674, DOI 10.1128/AEM.01142-09; Pinchuk GE, 2011, APPL ENVIRON MICROB, V77, P8234, DOI 10.1128/AEM.05382-11; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; Romine MF, 2008, APPL ENVIRON MICROB, V74, P3257, DOI 10.1128/AEM.02720-07; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; Sydow A, 2014, APPL MICROBIOL BIOT, V98, P8481, DOI 10.1007/s00253-014-6005-z; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJ, 2007, J BACTERIOL, V189, P894, DOI 10.1128/JB.00926-06; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Watanabe K, 2008, J BIOSCI BIOENG, V106, P528, DOI 10.1263/jbb.106.528; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200	39	26	25	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138813	10.1371/journal.pone.0138813	http://dx.doi.org/10.1371/journal.pone.0138813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394222	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100102
J	Pedersen, JM; Rod, NH; Andersen, I; Lange, T; Poulsen, G; Prescott, E; Lund, R				Pedersen, Jolene Masters; Rod, Naja Hulvej; Andersen, Ingelise; Lange, Theis; Poulsen, Gry; Prescott, Eva; Lund, Rikke			Accumulation of Major Life Events in Childhood and Adult Life and Risk of Type 2 Diabetes Mellitus	PLOS ONE			English	Article							STRESS; EPIDEMIOLOGY; ASSOCIATION; EXPERIENCES; DISEASE; HEALTH; HEART	Background The aim of the study was to estimate the effect of the accumulation of major life events (MLE) in childhood and adulthood, in both the private and working domains, on risk of type 2 diabetes mellitus (T2DM). Furthermore, we aimed to test the possible interaction between childhood and adult MLE and to investigate modification of these associations by educational attainment. Methods The study was based on 4,761 participants from the Copenhagen City Heart Study free of diabetes at baseline and followed for 10 years. MLE were categorized as 0, 1, 2, 3 or more events. Multivariate logistic regression models adjusted for age, sex, education and family history of diabetes were used to estimate the association between MLE and T2DM. Results In childhood, experiencing 3 or more MLE was associated with a 69% higher risk of developing T2DM (Odds Ratio (OR) 1.69; 95% Confidence Interval (CI) 1.60, 3.27). The accumulation of MLE in adult private (p-trend = 0.016) and work life (p-trend = 0.049) was associated with risk of T2DM in a dose response manner. There was no evidence that experiencing MLE in both childhood and adult life was more strongly associated with T2DM than experiencing events at only one time point. There was some evidence that being simultaneously exposed to childhood MLE and short education (OR 2.28; 95% C.I. 1.45, 3.59) and work MLE and short education (OR 2.86; 95% C.I. 1.62, 5.03) was associated with higher risk of T2DM, as the joint effects were greater than the sum of their individual effects. Conclusions Findings from this study suggest that the accumulation of MLE in childhood, private adult life and work life, respectively, are risk factors for developing T2DM.	[Pedersen, Jolene Masters; Rod, Naja Hulvej; Andersen, Ingelise; Poulsen, Gry; Lund, Rikke] Univ Copenhagen, Inst Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Pedersen, Jolene Masters; Lund, Rikke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Pedersen, Jolene Masters; Rod, Naja Hulvej; Lund, Rikke] Copenhagen Stress Res Ctr, Copenhagen, Denmark; [Lange, Theis] Univ Copenhagen, Biostat Sect, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Pedersen, JM (corresponding author), Univ Copenhagen, Inst Publ Hlth, Sect Social Med, Copenhagen, Denmark.	jope@sund.ku.dk	Rod, Naja/B-9411-2015; Prescott, Eva/AAJ-7441-2020	Rod, Naja/0000-0002-6400-5105; Lange, Theis/0000-0001-6807-8347; Lund, Rikke/0000-0002-0381-4291; Prescott, Eva/0000-0002-4134-0349; Andersen, Ingelise/0000-0002-0076-265X; PEdersen, Jolene MAsters/0000-0002-7592-422X	Center for Healthy Aging, University of Copenhagen [100-33-91001]	Center for Healthy Aging, University of Copenhagen	This work was supported by the Center for Healthy Aging, University of Copenhagen grant number: 100-33-91001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; American Diabetes Association, 2014, DIAGN DIAB LEARN PRE, P22311; Andersen I, 2011, INT J EPIDEMIOL, V40, P904, DOI 10.1093/ije/dyr052; Bjorntorp P, 2001, SCAND CARDIOVASC J, V35, P172, DOI 10.1080/140174301750305045; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Derogatis LR, 1993, HDB STRESS, V200, P206; Diderichsen F., 2001, SOCIAL BASIS DISPARI; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Goodwin RD, 2004, PSYCHOL MED, V34, P509, DOI 10.1017/S003329170300134X; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Husarewycz MN, 2014, GEN HOSP PSYCHIAT, V36, P26, DOI 10.1016/j.genhosppsych.2013.06.003; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; MAES S, 1987, SOC SCI MED, V25, P567, DOI 10.1016/0277-9536(87)90081-5; MCLEOD JD, 1990, J HEALTH SOC BEHAV, V31, P162, DOI 10.2307/2137170; Miller T, 1993, HDB STRESS THEORETIC, P161; Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197; Paykel ES, 2003, ACTA PSYCHIAT SCAND, V108, P61, DOI 10.1034/j.1600-0447.108.s418.13.x; Pouwer F, 2010, DISCOV MED, V9, P112; Renzaho AMN, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/ckt007; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Shaw BA, 2002, J AGING HEALTH, V14, P467, DOI 10.1177/089826402237179; Silva N, 2012, CURR PSYCHIAT REP, V14, P8, DOI 10.1007/s11920-011-0245-8; Tafet GE, 2004, ANN NY ACAD SCI, V1032, P276, DOI 10.1196/annals.1314.037; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138654	10.1371/journal.pone.0138654	http://dx.doi.org/10.1371/journal.pone.0138654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZW	26394040	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100082
J	Li, J; Overall, CC; Johnson, RC; Jones, MB; McDermott, JE; Heffron, F; Adkins, JN; Cambronne, ED				Li, Jie; Overall, Christopher C.; Johnson, Rudd C.; Jones, Marcus B.; McDermott, Jason E.; Heffron, Fred; Adkins, Joshua N.; Cambronne, Eric D.			ChIP-Seq Analysis of the sigma(E) Regulon of Salmonella enterica Serovar Typhimurium Reveals New Genes Implicated in Heat Shock and Oxidative Stress Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIRULENCE FACTORS; PROTEIN; TRANSCRIPTION; BIOSYNTHESIS; METABOLISM; EXPRESSION; NETWORK; SYSTEM; RPOS	The alternative sigma factor sigma(E) functions to maintain bacterial homeostasis and membrane integrity in response to extracytoplasmic stress by regulating thousands of genes both directly and indirectly. The transcriptional regulatory network governed by sigma(E) in Salmonella and E. coli has been examined using microarray, however a genome-wide analysis of sigma(E)-binding sites in Salmonella has not yet been reported. We infected macrophages with Salmonella Typhimurium over a select time course. Using chromatin immunoprecipitation followed by high-throughput DNA sequencing (ChIP-seq), 31 sigma(E)-binding sites were identified. Seventeen sites were new, which included outer membrane proteins, a quorum-sensing protein, a cell division factor, and a signal transduction modulator. The consensus sequence identified for sigma(E) in vivo binding was similar to the one previously reported, except for a conserved G and A between the -35 and -10 regions. One third of the sigma(E)-binding sites did not contain the consensus sequence, suggesting there may be alternative mechanisms by which sigma(E) modulates transcription. By dissecting direct and indirect modes of sigma(E)-mediated regulation, we found that sigma(E) activates gene expression through recognition of both canonical and reversed consensus sequence. New sigma(E) regulated genes (greA, luxS, ompA and ompX) are shown to be involved in heat shock and oxidative stress responses.	[Li, Jie; Johnson, Rudd C.; Heffron, Fred; Cambronne, Eric D.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Overall, Christopher C.; McDermott, Jason E.; Adkins, Joshua N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Jones, Marcus B.] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA	Oregon Health & Science University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; J. Craig Venter Institute	Cambronne, ED (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	cambronn@ohsu.edu		McDermott, Jason/0000-0003-2961-2572; Cambronne, Eric/0000-0003-3958-0463	National Institutes of Health [GM094623, Y1-AI-8401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part by a grant from the National Institutes of Health GM094623 and Y1-AI-8401.	Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00856-13; Brown Roslyn N, 2012, Int J Proteomics, V2012, P123076, DOI 10.1155/2012/123076; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; Dong TG, 2012, NUCLEIC ACIDS RES, V40, P7766, DOI 10.1093/nar/gks567; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gruzdev N, 2012, APPL ENVIRON MICROB, V78, P7866, DOI 10.1128/AEM.01822-12; Harvey PC, 2011, INFECT IMMUN, V79, P4105, DOI 10.1128/IAI.01390-10; JOHNSON K, 1991, MOL MICROBIOL, V5, P401, DOI 10.1111/j.1365-2958.1991.tb02122.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Li J, 2015, J PROTEOME RES, V14, P1716, DOI 10.1021/pr5010423; Li J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00027; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047521; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Marolda CL, 1996, MOL MICROBIOL, V22, P827, DOI 10.1046/j.1365-2958.1996.01531.x; Matsubara M, 2000, FEBS LETT, V470, P118, DOI 10.1016/S0014-5793(00)01303-X; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Perkins TT, 2013, MOL MICROBIOL, V87, P526, DOI 10.1111/mmi.12111; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Skovierova H, 2006, MICROBIOL-SGM, V152, P1347, DOI 10.1099/mic.0.28744-0; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Yoon H, 2011, INFECT IMMUN, V79, P360, DOI 10.1128/IAI.00873-10; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	38	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138466	10.1371/journal.pone.0138466	http://dx.doi.org/10.1371/journal.pone.0138466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389830	Green Published, gold, Green Submitted			2022-12-26	WOS:000361791000030
J	Lin, GH; Chen, HP; Shu, HY				Lin, Guang-Huey; Chen, Hao-Ping; Shu, Hung-Yu			Detoxification of Indole by an Indole-Induced Flavoprotein Oxygenase from Acinetobacter baumannii	PLOS ONE			English	Article							INDIGO-PRODUCING OXYGENASE; ESCHERICHIA-COLI; STYRENE MONOOXYGENASE; FUNCTIONAL-ANALYSIS; EXPRESSION; GENE; IDENTIFICATION; CLONING; TRYPTOPHANASE; DEGRADATION	Indole, a derivative of the amino acid tryptophan, is a toxic signaling molecule, which can inhibit bacterial growth. To overcome indole-induced toxicity, many bacteria have developed enzymatic defense systems to convert indole to non-toxic, water-insoluble indigo. We previously demonstrated that, like other aromatic compound-degrading bacteria, Acinetobacter baumannii can also convert indole to indigo. However, no work has been published investigating this mechanism. Here, we have shown that the growth of wild-type A. baumannii is severely inhibited in the presence of 3.5 mM indole. However, at lower concentrations, growth is stable, implying that the bacteria may be utilizing a survival mechanism to oxidize indole. To this end, we have identified a flavoprotein oxygenase encoded by the iifC gene of A. baumannii. Further, our results suggest that expressing this recombinant oxygenase protein in Escherichia coli can drive indole oxidation to indigo in vitro. Genome analysis shows that the iif operon is exclusively present in the genomes of A. baumannii and Pseudomonas syringae pv. actinidiae. Quantitative PCR and Western blot analysis also indicate that the iif operon is activated by indole through the AraC-like transcriptional regulator IifR. Taken together, these data suggest that this species of bacteria utilizes a novel indole-detoxification mechanism that is modulated by IifC, a protein that appears to be, at least to some extent, regulated by IifR.	[Lin, Guang-Huey] Tzu Chi Univ, Dept Microbiol, Microbial Genet Lab, Hualien, Taiwan; [Chen, Hao-Ping] Tzu Chi Univ, Sch Med, Dept Biochem, Hualien, Taiwan; [Shu, Hung-Yu] Chang Jung Christian Univ, Dept Biosci Technol, Tainan, Taiwan	Tzu Chi University; Tzu Chi University; Chang Jung Christian University	Shu, HY (corresponding author), Chang Jung Christian Univ, Dept Biosci Technol, Tainan, Taiwan.	hyshu@mail.cjcu.edu.tw	Chen, Hao-Ping/Q-3283-2019	Chen, Hao-Ping/0000-0002-6491-2178; Shu, Hung-Yu/0000-0002-2213-9324; Lin, Guang-Huey/0000-0002-5218-9322	496 Ministry of Science and Technology, Taiwan [NSC 102-2320-B-309 -003, MOST 103-2320-B-309- 001-]	496 Ministry of Science and Technology, Taiwan	Work was supported by grants from the 496 Ministry of Science and Technology, Taiwan (grant NSC 102-2320-B-309 -003 and MOST 103-2320-B-309- 001-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu D, 2004, FEMS MICROBIOL LETT, V239, P285, DOI 10.1016/j.femsle.2004.08.046; BAK F, 1986, ARCH MICROBIOL, V146, P170, DOI 10.1007/BF00402346; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beltrametti F, 1997, APPL ENVIRON MICROB, V63, P2232, DOI 10.1128/AEM.63.6.2232-2239.1997; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; Celik A, 2005, CHEM COMMUN, P3652, DOI 10.1039/b506156c; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Choi HS, 2003, BIOCHEM BIOPH RES CO, V306, P930, DOI 10.1016/S0006-291X(03)01087-8; CLAUS G, 1983, SYST APPL MICROBIOL, V4, P169, DOI 10.1016/S0723-2020(83)80046-0; Dijkshoorn L, 2005, CLIN MICROBIOL INFEC, V11, P329, DOI 10.1111/j.1469-0691.2005.01093.x; Doukyu N, 2003, APPL MICROBIOL BIOT, V60, P720, DOI 10.1007/s00253-002-1187-1; Doukyu N, 1997, EXTREMOPHILES, V1, P100, DOI 10.1007/s007920050021; Doukyu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1075, DOI 10.1271/bbb.62.1075; Drewlo S, 2001, APPL ENVIRON MICROB, V67, P1964, DOI 10.1128/AEM.67.4.1964-1969.2001; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Furuya T, 2004, BIOCHEM BIOPH RES CO, V313, P570, DOI 10.1016/j.bbrc.2003.11.157; Gaimster H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093168; Gallegos MT, 1996, J BACTERIOL, V178, P2356, DOI 10.1128/jb.178.8.2356-2361.1996; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Garbe TR, 2000, ARCH MICROBIOL, V173, P78, DOI 10.1007/s002030050012; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Gillam EMJ, 1997, ARCH BIOCHEM BIOPHYS, V346, P81, DOI 10.1006/abbi.1997.0286; HART S, 1992, J GEN MICROBIOL, V138, P211, DOI 10.1099/00221287-138-1-211; Hu MX, 2010, INDIAN J MICROBIOL, V50, P362, DOI 10.1007/s12088-011-0142-1; ISAACS H, 1994, MICROBIOL-UK, V140, P2125, DOI 10.1099/13500872-140-8-2125; KAMATH AV, 1990, APPL ENVIRON MICROB, V56, P275, DOI 10.1128/AEM.56.1.275-280.1990; KUMAR A, 2014, INT J ENG RES APPL, V4, P4, DOI DOI 10.3109/1040841X.2014.917068; Kwon NR, 2008, APPL MICROBIOL BIOT, V79, P417, DOI 10.1007/s00253-008-1445-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Leveau JHJ, 2008, FEMS MICROBIOL ECOL, V65, P238, DOI 10.1111/j.1574-6941.2008.00436.x; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; Li QS, 2000, CHEM-EUR J, V6, P1531, DOI 10.1002/(SICI)1521-3765(20000502)6:9<1531::AID-CHEM1531>3.3.CO;2-4; Lim HK, 2005, APPL ENVIRON MICROB, V71, P7768, DOI 10.1128/AEM.71.12.7768-7777.2005; Lin GH, 2012, ANTON LEEUW INT J G, V101, P881, DOI 10.1007/s10482-012-9704-4; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J IND MICROBIOL BIOT, V34, P247, DOI 10.1007/s10295-006-0193-1; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; Nowak A, 2006, ANAEROBE, V12, P80, DOI 10.1016/j.anaerobe.2005.10.003; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Olson S A, 1994, Methods Mol Biol, V25, P195; OSHIMA T, 1965, J BIOCHEM-TOKYO, V58, P259, DOI 10.1093/oxfordjournals.jbchem.a128196; Park SH, 2006, J MICROBIOL, V44, P632; Pathak H, 2010, APPL BIOCHEM BIOTECH, V160, P1616, DOI 10.1007/s12010-009-8638-4; Qu YY, 2012, J BASIC MICROB, V52, P687, DOI 10.1002/jobm.201100516; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Rosic NN, 2007, GENE, V395, P40, DOI 10.1016/j.gene.2007.01.031; Rosic NN, 2009, APPL MICROBIOL BIOT, V82, P203, DOI 10.1007/s00253-008-1812-8; Rui LY, 2005, APPL MICROBIOL BIOT, V66, P422, DOI 10.1007/s00253-004-1698-z; Sachdev D, 2010, MICROBIOL RES, V165, P627, DOI 10.1016/j.micres.2009.12.002; Singh A, 2010, BIORESOURCE TECHNOL, V101, P8481, DOI 10.1016/j.biortech.2010.06.025; SNELL EE, 1975, ADV ENZYMOL RAMB, V42, P287; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams Peter A., 2008, P99; YANOFSKY C, 1981, J BACTERIOL, V145, P1334, DOI 10.1128/JB.145.3.1334-1341.1981; Yanofsky C, 1996, J BACTERIOL, V178, P3755, DOI 10.1128/jb.178.13.3755-3762.1996; Yin B, 2005, INT BIODETER BIODEGR, V56, P243, DOI 10.1016/j.ibiod.2005.10.001; Zhang M, 2002, ARCH BIOCHEM BIOPHYS, V403, P277, DOI 10.1016/S0003-9861(02)00237-0; Zhang ZG, 2009, J BIOTECHNOL, V139, P12, DOI 10.1016/j.jbiotec.2008.09.010	72	28	31	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138798	10.1371/journal.pone.0138798	http://dx.doi.org/10.1371/journal.pone.0138798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390211	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000057
J	Zafar, S; Jean-Baptiste, R; Rahman, A; Neilson, JP; van den Broek, NR				Zafar, Shamsa; Jean-Baptiste, Rachel; Rahman, Atif; Neilson, James P.; van den Broek, Nynke R.			Non-Life Threatening Maternal Morbidity: Cross Sectional Surveys from Malawi and Pakistan	PLOS ONE			English	Article							POSTNATAL-DEPRESSION-SCALE; RURAL EGYPT; NEAR-MISS; CHILDBIRTH; QUESTIONNAIRE; DISORDERS; PREGNANCY; MORTALITY; HEALTH; DEATH	Background For more accurate estimation of the global burden of pregnancy associated disease, clarity is needed on definition and assessment of non-severe maternal morbidity. Our study aimed to define maternal morbidity with clear criteria for identification at primary care level and estimate the distribution of and evaluate associations between physical (infective and noninfective) and psychological morbidities in two different low-income countries. Methods Cross sectional study with assessment of morbidity in early pregnancy (34%), late pregnancy (35%) and the postnatal period (31%) among 3459 women from two rural communities in Pakistan (1727) and Malawi (1732). Trained health care providers at primary care level used semi-structured questionnaires documenting signs and symptoms, clinical examination and laboratory tests which were bundled to reflect infectious, non-infectious and psychological morbidity. Results One in 10 women in Malawi and 1 in 5 in Pakistan reported a previous pregnancy complication with 1 in 10 overall reporting a previous neonatal death or stillbirth. In the index pregnancy, 50.1% of women in Malawi and 53% in Pakistan were assessed to have at least one morbidity (infective or non-infective). Both infective (Pakistan) and non-infective morbidity (Pakistan and Malawi) was lower in the postnatal period than during pregnancy. Multiple morbidities were uncommon (<10%). There were marked differences in psychological morbidity: 26.9% of women in Pakistan 2.6% in Malawi had an Edinburgh Postnatal Depression Score (EPDS) > 9. Complications during a previous pregnancy, infective morbidity (p < 0.001), intra or postpartum haemorrhage (p < 0.02) were associated with psychological morbidity in both settings. Conclusions Our findings highlight the need to strengthen the availability and quality of antenatal and postnatal care packages. We propose to adapt and improve the framework and criteria used in this study, ensuring a basic set of diagnostic tests is available, to ensure more robust assessment of non-severe maternal morbidity.	[Zafar, Shamsa] Hlth Serv Acad, Islamabad, Pakistan; [Jean-Baptiste, Rachel] Oxford Epidemiol Serv, Oxford, England; [Rahman, Atif] Univ Liverpool, Dept Mental Hlth & Well Being, Liverpool L69 3BX, Merseyside, England; [Neilson, James P.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [van den Broek, Nynke R.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England	Health Services Academy; University of Liverpool; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	van den Broek, NR (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England.	Nynke.VanDenBroek@lstmed.ac.uk		van den Broek, Nynke/0000-0001-8523-2684	Wellcome Trust, UK [065810/Z/01/Z]	Wellcome Trust, UK(Wellcome Trust)	This study was funded by The Wellcome Trust, UK (project grant 065810/Z/01/Z).	AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Ashford L., 2002, HIDDEN SUFFERING DIS; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Bathia JC, 1996, SOC SCI MED, V43, P1507; Bhatia J, 1995, INT J GYNECOL OBSTET, V50, pS153; Chersich MF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-51; COX JL, 1983, J AFFECT DISORDERS, V5, P1, DOI 10.1016/0165-0327(83)90030-7; Danel I, 2003, AM J PUBLIC HEALTH, V93, P631, DOI 10.2105/AJPH.93.4.631; Datta KK, 1980, MORB PATTERN RURAL W, V3, P282; Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564; Fortney J.A., 1997, BASE ICEBERG PREVALE; Geller SE, 2006, WOMEN HEALTH ISS, V16, P176, DOI 10.1016/j.whi.2006.06.003; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Husain N, 2006, ARCH WOMEN MENT HLTH, V9, P197, DOI 10.1007/s00737-006-0129-9; KOBLINSKY MA, 1993, HLTH WOMEN GLOBAL PE; LISKIN LS, 1992, INT J GYNECOL OBSTET, V37, P77, DOI 10.1016/0020-7292(92)90486-3; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; Mathai M, 2010, WHO TECHNICAL CONSUL; NSO and ICF Macro, 2011, MAL DEM HLTH SURV 20; Osman-Hassan E., 1995, STUDY PREVALENCE PER; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Prual A, 1998, Afr J Reprod Health, V2, P10; Rahman A, 2005, J PAK PSYCHIAT SOC, V2, P69; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Ugandan Maternal Child/Family Planning Division, 1994, EV MAT MORB MORT 12; Ukachukwu V E, 2009, East Afr J Public Health, V6, P112; van den Broek NR, 1999, B WORLD HEALTH ORGAN, V77, P15; van den Broek NR, 2003, BJOG-INT J OBSTET GY, V110, P902, DOI 10.1111/j.1471-0528.2003.02402.x; Villar J, 2002, WHO ANTENATAL CARE R; Wall LL, 1998, STUD FAMILY PLANN, V29, P341, DOI 10.2307/172248; Waterstone M, 2003, BJOG-INT J OBSTET GY, V110, P128, DOI 10.1046/j.1471-0528.2003.02151.x; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 1998, DALYS REPR HLTH REP; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047	41	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138026	10.1371/journal.pone.0138026	http://dx.doi.org/10.1371/journal.pone.0138026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZM	26390124	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000361791000016
J	Bhayal, AC; Krishnaveni, D; Rao, KPR; Kumar, AR; Jyothy, A; Nallari, P; Venkateshwari, A				Bhayal, Amar Chand; Krishnaveni, Devulapalli; Rao, Kondadasula Pandu Ranga; Kumar, Adi Rakesh; Jyothy, Akka; Nallari, Pratibha; Venkateshwari, Ananthapur			Significant Association of Interleukin4 Intron 3 VNTR Polymorphism with Susceptibility to Gastric Cancer in a South Indian Population from Telangana	PLOS ONE			English	Article							HELICOBACTER-PYLORI; GENE POLYMORPHISM; IL-4 PRODUCTION; GROWTH; RISK; CARCINOMAS; INFECTION; BLADDER; CELLS	Background Gastric cancer (GC) is the fifth most common malignancy and remains a considerable public health burden worldwide. Genetic variations in genes encoding cytokines and their receptors influence the intensity of the Helicobacter pylori associated inflammatory response, which may contribute to individual differences in the outcome and severity of the disease. Interleukin4 is a typical pleiotropic T helper 2 (Th2) cytokine and is a critical mediator of Th1/Th2 balance. It is involved in the regulation of inflammation-mediated carcinogenesis in human organs, including gastric cancer. Objective The present retrospective case control study was undertaken to evaluate the association of IL4 intron 3 VNTR polymorphism with the susceptibility to GC in a south Indian population from Telangana state. Materials and Methods A total of 182 patients with diagnosed GC and 326 randomly selected healthy controls were enrolled in the present study. Genomic DNA was extracted from peripheral leukocytes and genotyping was determined by PCR-based assay. Association between genotypes and gastric cancer was examined by unconditional logistic regression analysis. Result The variant 3R/2R and 2R/2R genotypes of IL4 exon3 VNTR polymorphism had about 1.9 fold and 3fold increased GC risk, respectively, when compared with 3R/3R genotype [3R/2R vs. 3R/3R: adjusted odds ratio (AOR) = 1.90, 95% confidence interval (CI) = 1.23-2.95 P = 0.004 and 2R/2R vs. 3R/3R: AOR (95% CI) = 2.96 (1.29-6.82), P = 0.011]. Furthermore, a significant increased risk of GC was found for the 2R allele carriers (3R/2R + 2R/2R) compared with the 3R/3R genotype (AOR (95% CI) = 2.04 (1.35-3.10), P = <0.000). The IL4 2R allele frequency was 0.28 among the GC group and 0.18 among the controls, and the difference was statistically significant (P = <0.000). Conclusion The present study revealed an association of 2R allele and 2R carrier genotypes in the etiopathogenesis of GC in south Indian population.	[Bhayal, Amar Chand; Krishnaveni, Devulapalli; Jyothy, Akka; Venkateshwari, Ananthapur] Osmania Univ, Inst Genet, Hyderabad 500007, Andhra Pradesh, India; [Bhayal, Amar Chand; Krishnaveni, Devulapalli; Jyothy, Akka; Venkateshwari, Ananthapur] Osmania Univ, Hosp Genet Dis, Hyderabad 500007, Andhra Pradesh, India; [Rao, Kondadasula Pandu Ranga; Kumar, Adi Rakesh] Osmania Gen Hosp, Dept Gastroenterol, Hyderabad, Andhra Pradesh, India; [Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India	Osmania University; Osmania University; Osmania University	Venkateshwari, A (corresponding author), Osmania Univ, Inst Genet, Hyderabad 500007, Andhra Pradesh, India.	venkateshwari@yahoo.com						Ahirwar D, 2008, CANCER GENET CYTOGEN, V184, P1, DOI 10.1016/j.cancergencyto.2008.02.015; [Anonymous], 2014, R LANG ENV STAT COMP; BECKMANN MP, 1992, CHEM IMMUNOL, V51, P107; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Gonzalez JR, 2014, SNPASSOC SNPS BASED; HOON DSB, 1991, CANCER RES, V51, P5687; Howell WM, 2002, P NUTR SOC, V61, P447, DOI 10.1079/PNS2002186; Kesarwani P, 2008, DNA CELL BIOL, V27, P505, DOI 10.1089/dna.2008.0742; Konwar R, 2009, ONCOL RES, V17, P367, DOI 10.3727/096504009788428442; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LAHM H, 1994, INT J CANCER, V59, P440, DOI 10.1002/ijc.2910590325; Lai KC, 2005, EJSO-EUR J SURG ONC, V31, P1135, DOI 10.1016/j.ejso.2005.07.005; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; MOUT R, 1991, NUCLEIC ACIDS RES, V19, P3763, DOI 10.1093/nar/19.13.3763; Nakashima H, 2002, GENES IMMUN, V3, P107, DOI 10.1038/sj.gene.6363830; Olver S, 2007, TISSUE ANTIGENS, V69, P293, DOI 10.1111/j.1399-0039.2007.00831.x; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Shekari M, 2012, AM J CLIN ONCOL-CANC, V35, P514, DOI 10.1097/COC.0b013e31822d9c12; Singh K, 2006, WORLD J GASTROENTERO, V12, P1346, DOI 10.3748/wjg.v12.i9.1346; Sugimoto M, 2010, WORLD J GASTROENTERO, V16, P1188, DOI 10.3748/wjg.v16.i10.1188; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Tsai FJ, 2005, BJU INT, V95, P432, DOI 10.1111/j.1464-410X.2005.05315.x; Tsai MH, 2005, J CLIN LAB ANAL, V19, P93, DOI 10.1002/jcla.20060; Uchiyama A, 1996, J CELL BIOCHEM, V62, P443, DOI 10.1002/(SICI)1097-4644(19960915)62:4<443::AID-JCB2>3.3.CO;2-H; Yang CM, 2014, ARCH ORAL BIOL, V59, P35, DOI 10.1016/j.archoralbio.2013.09.010	29	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138442	10.1371/journal.pone.0138442	http://dx.doi.org/10.1371/journal.pone.0138442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383107	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200103
J	Vodonos, A; Friger, M; Katra, I; Krasnov, H; Zahger, D; Schwartz, J; Novack, V				Vodonos, Alina; Friger, Michael; Katra, Itzhak; Krasnov, Helena; Zahger, Doron; Schwartz, Joel; Novack, Victor			Individual Effect Modifiers of Dust Exposure Effect on Cardiovascular Morbidity	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CASE-CROSSOVER DESIGN; SAHARAN DUST; HOSPITAL ADMISSIONS; MEASUREMENT ERROR; DESERT DUST; DISEASE; MORTALITY; RISK; ASSOCIATION	Background High concentrations of particulate matter (PM) air pollution have been associated with death and hospital admissions due to cardiovascular morbidity. However, it is not clear a) whether high levels of non-anthropogenic PM from dust storms constitute a health risk; and b) whether these health risks are exacerbated in a particular demographic. Methods This study comprised all patients above 18 years old admitted to Soroka University Medical Center (1000 bed tertiary hospital, Be'er-Sheva, Israel, 2001-2010) with a primary diagnosis of acute coronary syndrome (ACS). Data on meteorological parameters and PM10 (particulate matter < 10 mu m in aerodiameter) were obtained from monitoring stations in the city of Be'er-Sheva. Data were analyzed using a case crossover analysis to examine the effect of dust exposure on hospitalization due to ACS and the interaction with co-morbidities and demographic factors. Results There were 16,734 hospitalizations due to ACS during the study period. The estimated odds of hospitalization due to ACS was significantly associated with PM10 during non dust storm days at the same day of the exposure (lag0); OR = 1.014 (95% CI 1.001-1.027) for a 10 mu g/m(3) increase, while a delayed response (lag1) was found during the dust storm days; OR = 1.007 (95% CI 1.002-1.012). The effect size for the dust exposure association was larger for older (above the age of 65), female or Bedouin patients. Conclusions Exposure to non-anthropogenic PM is associated with cardiovascular morbidity. Health risk associated dust exposure is gender and age specific with older women and Bedouin patients being the most vulnerable groups.	[Vodonos, Alina; Friger, Michael] Ben Gurion Univ Negev, Dept Publ Hlth, IL-84105 Beer Sheva, Israel; [Vodonos, Alina; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Katra, Itzhak; Krasnov, Helena] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Zahger, Doron] Soroka Univ, Med Ctr, Dept Cardiol, Intens Cardiac Care Unit, Beer Sheva, Israel; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Novack, V (corresponding author), Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel.	victorno@clalit.org.il	KATRA, ITZHAK/F-1547-2012		Israeli Environment and Health Fund (EHF) [RGA 1004]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Israeli Environment and Health Fund (EHF); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Israeli Environment and Health Fund (EHF) Grant # RGA 1004. IK received the funding (http://www.ehf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Alpert P, 2004, INT J CLIMATOL, V24, P1013, DOI 10.1002/joc.1037; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540; Cadelis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091136; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ganor E, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012638; Ganor E, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012500; Goldberg MS, 2001, ENVIRON HEALTH PERSP, V109, P487, DOI 10.2307/3454658; Jimenez E, 2010, SCIENCE OF THE TOTAL; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Krasnov H, 2015, BUILD ENVIRON, V87, P169, DOI 10.1016/j.buildenv.2015.01.035; Krasnov H, 2014, J AIR WASTE MANAGE, V64, P89, DOI 10.1080/10962247.2013.841599; Kwan M.-P., 2004, SPAT INTEGR SOC SCI, V27, P721; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Middleton N, 2008, ENV HLTH, V22, P7; Novack V, 2007, ETHNIC DIS, V17, P441; Perez L, 2008, EPIDEMIOLOGY, V19, P800, DOI 10.1097/EDE.0b013e31818131cf; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Reyes M, 2014, INT J ENVIRON HEAL R, V24, P63, DOI 10.1080/09603123.2013.782604; Sajani SZ, 2011, OCCUP ENVIRON MED, V68, P446, DOI 10.1136/oem.2010.058156; Samoli E, 2011, SCI TOTAL ENVIRON, V409, P2049, DOI 10.1016/j.scitotenv.2011.02.031; Sandstrom T, 2008, EPIDEMIOLOGY, V19, P808, DOI 10.1097/EDE.0b013e31818809e0; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Shao YP, 2011, AEOLIAN RES, V2, P181, DOI 10.1016/j.aeolia.2011.02.001; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Vodonos A, 2014, AIR QUAL ATMOS HLTH, V7, P433, DOI 10.1007/s11869-014-0253-z; WHO, 2006, INDIAN J MED RES; Yitshak-Sade M, 2015, EUR RESPIR J, V45, P652, DOI 10.1183/09031936.00078614; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2000, J OCCUP ENVIRON MED, V42, P469, DOI 10.1097/00043764-200005000-00002; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	43	41	41	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137714	10.1371/journal.pone.0137714	http://dx.doi.org/10.1371/journal.pone.0137714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381397	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200033
J	Wu, WJ; Lin, DG; Shen, XT; Li, FF; Fang, YX; Li, KQ; Xun, TR; Yang, G; Yang, J; Liu, SW; He, J				Wu, Wenjiao; Lin, Dongguo; Shen, Xintian; Li, Fangfang; Fang, Yuxin; Li, Kaiqun; Xun, Tianrong; Yang, Guang; Yang, Jie; Liu, Shuwen; He, Jian			New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides	PLOS ONE			English	Article							HEMAGGLUTININ; NEURAMINIDASE; REPLICATION; INFECTION	Influenza A viral (IAV) fusion peptides are known for their important role in viral-cell fusion process and membrane destabilization potential which are compatible with those of antimicrobial peptides. Thus, by replacing the negatively or neutrally charged residues of FPs with positively charged lysines, we synthesized several potent antimicrobial peptides derived from the fusogenic peptides (FPs) of hemagglutinin glycoproteins (HAs) of IAV. The biological screening identified that in addition to the potent antibacterial activities, these positively charged fusion peptides (pFPs) effectively inhibited the replication of influenza A viruses including oseltamivir-resistant strain. By employing pseudovirus-based entry inhibition assays including H5N1 influenza A virus (IAV), and VSV-G, the mechanism study indicated that the antiviral activity may be associated with the interactions between the HA2 subunit and pFP, of which, the nascent pFP exerted a strong effect to interrupt the conformational changes of HA2, thereby blocking the entry of viruses into host cells. In addition to providing new peptide "entry blockers", these data also demonstrate a useful strategy in designing potent antibacterial agents, as well as effective viral entry inhibitors. It would be meaningful in treatment of bacterial co-infection during influenza pandemic periods, as well as in our current war against those emerging pathogenic microorganisms such as IAV and HIV.	[Wu, Wenjiao; Lin, Dongguo; Shen, Xintian; Li, Fangfang; Fang, Yuxin; Li, Kaiqun; Xun, Tianrong; Yang, Guang; Yang, Jie; Liu, Shuwen; He, Jian] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China.	liusw@smu.edu.cn; jianhe@smu.edu.cn		Shen, Xintian/0000-0003-0626-4317; Liu, Shuwen/0000-0001-6346-5006	National Nature Science Foundation of China [U1301224, 81102792]; Guangdong International Cooperation Creative S T platform project [gjhz1105]; Southern Medical University [B1040903]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong International Cooperation Creative S T platform project; Southern Medical University	This work was financially supported by the National Nature Science Foundation of China (No. U1301224, 81102792), Guangdong International Cooperation Creative S T platform project (gjhz1105) to Dr. Shuwen Liu, and startup funding to Dr. Jian He from Southern Medical University (No. B1040903).	Aoki W, 2012, J BIOSCI BIOENG, V114, P365, DOI 10.1016/j.jbiosc.2012.05.001; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Fang YX, 2014, EUR J MED CHEM, V83, P36, DOI 10.1016/j.ejmech.2014.06.003; Francis JN, 2015, VACCINE, V33, P396, DOI 10.1016/j.vaccine.2014.06.006; Gratton JP, 2003, NAT MED, V9, P357, DOI 10.1038/nm835; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Gunther-Ausborn S, 2000, J VIROL, V74, P2714, DOI 10.1128/JVI.74.6.2714-2720.2000; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hoffmann J, 2014, ANTIVIR RES, V104, P23, DOI 10.1016/j.antiviral.2014.01.015; Huang Q, 2009, PROTEINS, V74, P291, DOI 10.1002/prot.22157; Ilic N, 2013, BBA-BIOMEMBRANES, V1828, P1004, DOI 10.1016/j.bbamem.2012.11.017; Kawai N, 2009, J INFECTION, V59, P207, DOI 10.1016/j.jinf.2009.07.002; Khare D, 2013, EUR J NUTR, V52, P1405, DOI 10.1007/s00394-012-0449-7; Lee KK, 2011, J BIOL CHEM, V286, P42141, DOI 10.1074/jbc.M111.254243; Li R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041956, DOI 10.1371/J0URNAL.P0NE.0041956]; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Mair CM, 2014, J VIROL, V88, P13189, DOI 10.1128/JVI.01704-14; Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Siegel DP, 2000, BBA-BIOMEMBRANES, V1468, P87, DOI 10.1016/S0005-2736(00)00246-7; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Vaccaro L, 2005, BIOPHYS J, V88, P25, DOI 10.1529/biophysj.104.044537; Wang JY, 2015, CHEM BIOL DRUG DES, V86, P487, DOI 10.1111/cbdd.12511; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Yang J, 2013, VIRUSES-BASEL, V5, P352, DOI 10.3390/v5010352; Zhu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029120; Zhu ZB, 2012, EUR J MED CHEM, V57, P211, DOI 10.1016/j.ejmech.2012.08.041	31	15	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138426	10.1371/journal.pone.0138426	http://dx.doi.org/10.1371/journal.pone.0138426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382764	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200101
J	Zhou, ZX; Liu, YH; Duan, FK; Qin, MN; Wu, FC; Sheng, W; Yang, LX; Liu, JG; He, KB				Zhou, Zhixiang; Liu, Yanghua; Duan, Fengkui; Qin, Mengnan; Wu, Fengchang; Sheng, Wang; Yang, Lixin; Liu, Jianguo; He, Kebin			Transcriptomic Analyses of the Biological Effects of Airborne PM2.5 Exposure on Human Bronchial Epithelial Cells	PLOS ONE			English	Article							PARTICULATE MATTER PM2.5; DIESEL EXHAUST PARTICLES; AIR-POLLUTION; OXIDATIVE STRESS; CHEMICAL-COMPOSITION; ORGANIC EXTRACTS; INDUCTION; URBAN; FINE; ACTIVATION	Epidemiological studies have associated high levels of airborne particulate matter (PM) with increased respiratory diseases. In order to investigate the mechanisms of air pollution-induced lung toxicity in humans, human bronchial epithelial cells (16HBE) were exposed to various concentrations of particles smaller than 2.5 mu m (PM2.5) collected from Beijing, China. After observing that PM2.5 decreased cell viability in a dose-dependent manner, we first used Illumina RNA-seq to identify genes and pathways that may contribute to PM2.5-induced toxicity to 16HBE cells. A total of 539 genes, 283 up-regulated and 256 down-regulated, were identified to be significantly differentially expressed after exposure to 25 mu g/cm(2) PM2.5. PM2.5 induced a large number of genes involved in responses to xenobtiotic stimuli, metabolic response, and inflammatory and immune response pathways such as MAPK signaling and cytokine-cytokine receptor interaction, which might contribute to PM2.5-related pulmonary diseases. We then confirmed our RNA-seq results by qPCR and by analysis of IL-6, CYP1A1, and IL-8 protein expression. Finally, ELISA assay demonstrated a significant association between exposure to PM2.5 and secretion of IL-6. This research provides a new insight into the mechanisms underlying PM2.5-induced respiratory diseases in Beijing.	[Zhou, Zhixiang; Liu, Yanghua; Qin, Mengnan; Sheng, Wang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China; [Duan, Fengkui; He, Kebin] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China; [Wu, Fengchang; Yang, Lixin] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China; [Liu, Jianguo] Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab Environm Opt & Technol, Hefei 230031, Peoples R China	Beijing University of Technology; Tsinghua University; Chinese Research Academy of Environmental Sciences; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhou, ZX (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China.	zhouzhixiang@bjut.edu.cn; hekb@tsinghua.edu.cn	yang, lixin/AAW-5386-2021; yang, lixin/GSO-1670-2022; He, Kebin/ABF-5224-2020	yang, lixin/0000-0003-3377-1998; yang, lixin/0000-0003-3377-1998; 	Key Laboratory in Environmental Optics & Technology of Chinese Academy of Sciences [2005DP173065-2013-06]; State Key Laboratory project of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences [SKLECRA2014OFP13]; Consulting research project of Chinese Academy of Engineering [2013-ZP-2-1]	Key Laboratory in Environmental Optics & Technology of Chinese Academy of Sciences; State Key Laboratory project of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences; Consulting research project of Chinese Academy of Engineering	This work was supported by Project of Key Laboratory in Environmental Optics & Technology of Chinese Academy of Sciences (2005DP173065-2013-06); State Key Laboratory project of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences (SKLECRA2014OFP13); and Consulting research project of Chinese Academy of Engineering (2013-ZP-2-1).	Alfaro-Moreno E, 2009, ENVIRON RES, V109, P528, DOI 10.1016/j.envres.2009.02.010; Aparicio G, 2006, STUD HEALTH TECHNOL, V120, P194; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baulig A, 2009, TOXICOLOGY, V261, P126, DOI 10.1016/j.tox.2009.05.007; Benjamini Y, 2001, ANN STAT, V29, P1165; Bruggemann E, 2009, ATMOS ENVIRON, V43, P2456, DOI 10.1016/j.atmosenv.2009.01.054; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cachon BF, 2014, ENVIRON POLLUT, V185, P340, DOI 10.1016/j.envpol.2013.10.026; Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Chan JKW, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-34; Chen Z, 2013, LANCET, V382, P1959, DOI 10.1016/S0140-6736(13)62064-4; Cheng Z, 2013, ATMOS ENVIRON, V65, P186, DOI 10.1016/j.atmosenv.2012.10.022; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Dagher Z, 2007, J APPL TOXICOL, V27, P284, DOI 10.1002/jat.1211; de Kok TM, 2005, ENVIRON MOL MUTAGEN, V46, P71, DOI 10.1002/em.20133; Dergham M, 2012, CHEM RES TOXICOL, V25, P904, DOI 10.1021/tx200529v; Dockery DW, 2009, ANN EPIDEMIOL, V19, P257, DOI 10.1016/j.annepidem.2009.01.018; Furuyama A, 2006, ARCH TOXICOL, V80, P154, DOI 10.1007/s00204-005-0020-x; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Gutierrez-Castillo ME, 2006, ENVIRON MOL MUTAGEN, V47, P199, DOI 10.1002/em.20186; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lee JS, 2012, RESP CARE, V57, P758, DOI 10.4187/respcare.01480; Leung PY, 2014, ENVIRON POLLUT, V194, P188, DOI 10.1016/j.envpol.2014.07.032; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Ying-Ji, 2010, Inflammation & Allergy Drug Targets, V9, P300; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; Longhin E, 2013, TOXICOL IN VITRO, V27, P551, DOI 10.1016/j.tiv.2012.10.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazariah S S N, 2013, Glob J Health Sci, V5, P93, DOI 10.5539/gjhs.v5n4p93; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Pozzi R, 2003, TOXICOLOGY, V183, P243, DOI 10.1016/S0300-483X(02)00545-0; Reed MD, 2003, J TOXICOL ENV HEAL A, V66, P1189, DOI 10.1080/15287390306409; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Ro M, 2012, SCAND J IMMUNOL, V76, P151, DOI 10.1111/j.1365-3083.2012.02712.x; Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010; Shang Y, 2013, TOXICOL IN VITRO, V27, P922, DOI 10.1016/j.tiv.2013.01.008; Stephanie V, 2011, INHAL TOXICOL, V23, P627, DOI 10.3109/08958378.2011.599445; Wang S, 2010, J IMMUNOTOXICOL, V7, P298, DOI 10.3109/1547691X.2010.509289; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Q, 2012, NATURE, V484, P161, DOI 10.1038/484161a	42	65	73	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138267	10.1371/journal.pone.0138267	http://dx.doi.org/10.1371/journal.pone.0138267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382838	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200081
J	Fong, MY; Ahmed, MA; Wong, SS; Lau, YL; Sitam, F				Fong, Mun Yik; Ahmed, Md Atique; Wong, Shen Siang; Lau, Yee Ling; Sitam, Frankie			Genetic Diversity and Natural Selection of the Plasmodium knowlesi Circumsporozoite Protein Nonrepeat Regions	PLOS ONE			English	Article							CELL EPITOPE POLYMORPHISMS; P. FALCIPARUM; MALARIA; INFECTION; HUMANS; VIVAX; TRANSMISSION; SPOROZOITE; PARASITES; INVASION	Background Plasmodium knowlesi is a simian malaria parasite that has been identified to cause malaria in humans. To date, several thousand cases of human knowlesi malaria have been reported around Southeast Asia. Thus far, there is no detailed study on genetic diversity and natural selection of P. knowlesi circumsporozoite protein (CSP), a prominent surface antigen on the sporozoite of the parasite. In the present study, the genetic diversity and natural selection acting on the nonrepeat regions of the gene encoding P. knowlesi CSP were investigated, focusing on the T-cell epitope regions at the C-terminal of the protein. Methods Blood samples from 32 knowlesi malaria patients and 2 wild monkeys (Macaca fascicularis) were used. The CSP of the P. knowlesi isolates was amplified by PCR, cloned into Escherichia coil, and sequenced. The nonrepeat regions of the CSP gene were analysed for genetic diversity, natural selection and haplotypic grouping using MEGA5 and DnaSP version 5.10.00 programmes. A haplotype network was constructed based on the C-terminal (Th2R/Th3R) T-cell epitope regions using the Median-Joining method in the NETVVORK version 4.6.1.2 programme. Previously published sequences from other regions (Malaysia Borneo, Singapore) were also included in the analysis. Results A total of 123 P. knowlesi CSP sequences were analysed. Multiple sequence alignment revealed 58 amino acid changes, and 42 novel amino acid haplotypes were identified. Polymorphism was higher in the C-terminal Th2R/Th3R epitope (ii = 0.0293, n = 123) region compared to the overall combined nonrepeat regions (ii = 0.0120, n = 123). Negative natural selection was observed within the nonrepeat regions of the CSP gene. Within the C-terminal Th2R/Th3R epitope regions, there was evidence of slight positive selection. Based on haplotype network analysis of the Th2R/Th3R regions, five abundant haplotypes were identified. Sharing of haplotypes between humans and macaques were observed. Conclusion This study contributes to the understanding of the type and distribution of naturally occurring polymorphism in the P. knowlesi CSP gene. This study also provides a measurement of the genetic diversity of P. knowlesi and identifies the predominant haplotypes within Malaysia based on the C-terminal Th2R/Th3R regions.	[Fong, Mun Yik; Ahmed, Md Atique; Wong, Shen Siang; Lau, Yee Ling] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Sitam, Frankie] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia	Universiti Malaya	Fong, MY (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fongmy@um.edu.my	Sitam, Frankie Thomas/AAF-6279-2021; Ahmed, Atique/L-7820-2015; Singh, Balbir/A-3610-2009; FONG, MUN YIK/B-5443-2010; Lau, Yee Ling/C-6996-2009	Sitam, Frankie Thomas/0000-0001-7160-6243; Lau, Yee Ling/0000-0002-2037-2165; Ahmed, Md Atique/0000-0002-3407-7220	University of Malaya [UM-MOHE UM.C/625/1/HIR/MOHE/MED/09]	University of Malaya(Universiti Malaya)	This study was funded by the University of Malaya High Impact Research Fund, UM-MOHE UM.C/625/1/HIR/MOHE/MED/09). MYF is the recipient of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003086; Ahmed MA, 2015, ISBT SCI SER, V10, P134, DOI 10.1111/voxs.12115; Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; de Brito CFA, 2011, MEM I OSWALDO CRUZ, V106, P12, DOI 10.1590/S0074-02762011000900003; ARNOT DE, 1985, SCIENCE, V230, P815, DOI 10.1126/science.2414847; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baum J, 2003, GENETICS, V163, P1327; Bowman NM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01990; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Dias S, 2013, GENE, V518, P381, DOI 10.1016/j.gene.2013.01.003; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; HUGHES AL, 1991, GENETICS, V127, P345; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Kumkhaek Chutima, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P281; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOCKYER MJ, 1989, MOL BIOCHEM PARASIT, V37, P275, DOI 10.1016/0166-6851(89)90159-X; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; MCCONKEY GA, 1990, ANNU REV MICROBIOL, V44, P479, DOI 10.1146/annurev.mi.44.100190.002403; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; Nardin EH, 1998, MALARIA PARASITE BIO, P495; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; OZAKI LS, 1983, CELL, V34, P815, DOI 10.1016/0092-8674(83)90538-X; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Sermwittayawong N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-36; SHI YP, 1992, AM J TROP MED HYG, V47, P844, DOI 10.4269/ajtmh.1992.47.844; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyagi RK, 2013, J ANTIMICROB CHEMOTH, V68, P1081, DOI 10.1093/jac/dks508; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026; Willmann M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-363; Zakeri S, 2007, AM J TROP MED HYG, V76, P1046, DOI 10.4269/ajtmh.2007.76.1046; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137734	10.1371/journal.pone.0137734	http://dx.doi.org/10.1371/journal.pone.0137734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379157	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400024
J	Agarwal, S; Bell, CM; Rothbart, SB; Moran, RG				Agarwal, Stuti; Bell, Catherine M.; Rothbart, Scott B.; Moran, Richard G.			AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53-and TSC2-independent in Pemetrexed-treated Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAMMALIAN TARGET; METABOLIC CHECKPOINT; RAPAMYCIN INHIBITION; TUBEROUS-SCLEROSIS; PURINE SYNTHESIS; TOS MOTIF; PATHWAY; P53; PHOSPHORYLATION	The key sensor of energy status in mammalian cells, AMP-activated protein kinase (AMPK), can also be activated by the AMP analog aminoimidazolecarboxamide nucleoside monophosphate (ZMP) generated directly from aminoimidazolecarboxamide ribonucleoside (AICAR) or from inhibition of purine synthesis by the antifolate pemetrexed (PTX), a drug used extensively in the treatment of lung cancers. Despite this common mechanism, signaling downstream of AMPK activated by PTX or AICAR differed. AICAR-activated AMPK inhibited mTORC1 both directly by phosphorylation of the mTORC1 subunit Raptor and indirectly by phosphorylation of the regulator TSC2. In contrast, PTX-activated AMPK inhibited mTORC1 solely through Raptor phosphorylation. This dichotomy was due to p53 function. Transcription of p53 target genes, including TSC2, was activated by AICAR but not by PTX. Although both PTX and AICAR stabilized p53, only AICAR activated Chk2 phosphorylation, stimulating p53-dependent transcription. However, Raptor phosphorylation by AMPK was independent of p53 and was sufficient, after PTX treatment, to inhibit mTORC1. We concluded that PTX effects on mTORC1 were independent of TSC2 and p53 and that the activation of a p53 transcriptional response by AICAR was due to an activation of Chk2 that was not elicited by PTX.	[Agarwal, Stuti; Bell, Catherine M.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Agarwal, Stuti; Bell, Catherine M.; Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA	Virginia Commonwealth University; Virginia Commonwealth University; Van Andel Institute	Moran, RG (corresponding author), Massey Canc Ctr, 401 Coll St, Richmond, VA 23298 USA.	rmoran@vcu.edu			National Institutes of Health Cancer Center from NCI [P30-CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA140416] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Andrei Budanov and Bert Vogelstein for essential cell lines and Dr. Reuben Shaw for generous deposition of Raptor vectors in Addgene. We also are grateful to Drs. Shirley Taylor and Andrei Budanov for helpful discussions. The Macromolecular Core Laboratory of the Massey Cancer Center helped support these experiments through National Institutes of Health Cancer Center Support Grant P30-CA016059 from NCI.	Agarwal S., 2015, MOL CANC RES; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; MORAN RG, 1989, J BIOL CHEM, V264, P21047; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rothbart S. B., 2010, THESIS; Rothbart SB, 2010, CANCER RES, V70, P10299, DOI 10.1158/0008-5472.CAN-10-1873; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shieh SY, 2000, GENE DEV, V14, P289; Shih C, 1997, CANCER RES, V57, P1116; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; TAYLOR EC, 1992, J MED CHEM, V35, P4450, DOI 10.1021/jm00101a023; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Vecchio D, 2014, INT J CANCER, V135, P479, DOI 10.1002/ijc.28680; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355	65	42	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27473	27486		10.1074/jbc.M115.665133	http://dx.doi.org/10.1074/jbc.M115.665133			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26391395	Green Published, hybrid			2022-12-26	WOS:000365757500004
J	Robinson, AM; Miller, S; Payne, N; Boyd, R; Sakkal, S; Nurgali, K				Robinson, Ainsley M.; Miller, Sarah; Payne, Natalie; Boyd, Richard; Sakkal, Samy; Nurgali, Kulmira			Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; MYENTERIC AH NEURONS; FUNCTIONAL RECOVERY; STROMAL CELLS; GLUTAMATE EXCITOTOXICITY; ENHANCED EXCITABILITY; CONDITIONED MEDIUM; GROWTH-FACTOR; DISEASE; TRANSPLANTATION	Background & Aims The therapeutic benefits of mesenchymal stem cells (MSCs), such as homing ability, multi-potent differentiation capacity and secretion of soluble bioactive factors which exert neuroprotective, anti-inflammatory and immunomodulatory properties, have been attributed to attenuation of autoimmune, inflammatory and neurodegenerative disorders. In this study, we aimed to determine the earliest time point at which locally administered MSC-based therapies avert enteric neuronal loss and damage associated with intestinal inflammation in the guinea-pig model of colitis. Methods At 3 hours after induction of colitis by 2,4,6-trinitrobenzene-sulfonate (TNBS), guinea-pigs received either human bone marrow-derived MSCs, conditioned medium (CM), or unconditioned medium by enema into the colon. Colon tissues were collected 6, 24 and 72 hours after administration of TNBS. Effects on body weight, gross morphological damage, immune cell infiltration and myenteric neurons were evaluated. RT-PCR, flow cytometry and antibody array kit were used to identify neurotrophic and neuroprotective factors released by MSCs. Results MSC and CM treatments prevented body weight loss, reduced infiltration of leukocytes into the colon wall and the myenteric plexus, facilitated repair of damaged tissue and nerve fibers, averted myenteric neuronal loss, as well as changes in neuronal subpopulations. The neuroprotective effects of MSC and CM treatments were observed as early as 24 hours after induction of inflammation even though the inflammatory reaction at the level of the myenteric ganglia had not completely subsided. Substantial number of neurotrophic and neuroprotective factors released by MSCs was identified in their secretome. Conclusion MSC-based therapies applied at the acute stages of TNBS-induced colitis start exerting their neuroprotective effects towards enteric neurons by 24 hours post treatment. The neuroprotective efficacy of MSC-based therapies can be exerted independently to their anti-inflammatory effects.	[Robinson, Ainsley M.; Miller, Sarah; Sakkal, Samy; Nurgali, Kulmira] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia; [Payne, Natalie; Boyd, Richard] Monash Univ, Dept Anat & Neurosci, Melbourne, Vic 3004, Australia; [Payne, Natalie] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia	Victoria University; Monash University; Australian Regenerative Medicine Institute; Monash University	Nurgali, K (corresponding author), Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia.	kulmira.nurgali@vu.edu.au		Robinson, Ainsley M/0000-0003-3364-506X; Nurgali, Kulmira/0000-0002-2597-6929; Sakkal, Samy/0000-0003-0430-4012	Victoria University Research Development Grant	Victoria University Research Development Grant	This study is supported by a Victoria University Research Development Grant.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alexanian AR, 2010, RESTOR NEUROL NEUROS, V28, P761, DOI 10.3233/RNN-2010-0547; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bassotti G, 2006, GUT, V55, P41, DOI 10.1136/gut.2005.073197; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Belai A, 1997, GUT, V40, P767, DOI 10.1136/gut.40.6.767; Bernado ME, 2011, CELL STEM CELL, V13, P392; Bernstein CN, 2010, INFLAMM BOWEL DIS, V16, P112, DOI 10.1002/ibd.21048; Boyer L, 2005, AUTON NEUROSCI-BASIC, V117, P41, DOI 10.1016/j.autneu.2004.10.006; Boyer L, 2007, AUTON NEUROSCI-BASIC, V134, P106, DOI 10.1016/j.autneu.2007.03.001; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chaudhari S, 2014, INT J PHARM RES REV, V3, P106; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen QQ, 2013, WORLD J GASTROENTERO, V19, P4702, DOI 10.3748/wjg.v19.i29.4702; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Cohen JA, 2013, J NEUROL SCI, V333, P43, DOI 10.1016/j.jns.2012.12.009; Crop MJ, 2010, CLIN EXP IMMUNOL, V162, P474, DOI 10.1111/j.1365-2249.2010.04256.x; De Winter BY, 2005, NEUROGASTROENT MOTIL, V17, P251, DOI 10.1111/j.1365-2982.2004.00618.x; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Everaert BR, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-93; Farrell D, 2012, INT J NURS PRACT, V18, P497, DOI 10.1111/j.1440-172X.2012.02063.x; Ferrante M, 2006, GASTROENTEROLOGY, V130, P1595, DOI 10.1053/j.gastro.2006.02.025; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hayashi Y, 2008, J PHARMACOL EXP THER, V326, P523, DOI 10.1124/jpet.108.137083; He XW, 2012, DIGEST DIS SCI, V57, P3136, DOI 10.1007/s10620-012-2290-5; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jiang WH, 2006, PFLUG ARCH EUR J PHY, V453, P43, DOI 10.1007/s00424-006-0117-y; Jin D. P., 2014, Journal of Clinical and Cellular Immunology, V5, P234; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Krauter EM, 2007, NEUROGASTROENT MOTIL, V19, P990, DOI 10.1111/j.1365-2982.2007.00986.x; Laroni A, 2013, J NEUROIMMUNE PHARM, V8, P1062, DOI 10.1007/s11481-013-9456-6; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lepore AC, 2007, NEUROCHEM INT, V50, P966, DOI 10.1016/j.neuint.2006.09.005; Li J, 2012, XENOTRANSPLANTATION, V19, P273, DOI 10.1111/xen.12000; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; Linden DR, 2004, J PHYSIOL-LONDON, V557, P191, DOI 10.1113/jphysiol.2004.062174; Linden DR, 2003, J PHYSIOL-LONDON, V547, P589, DOI 10.1113/jphysiol.2002.035147; Lomax AE, 2007, AM J PHYSIOL-GASTR L, V292, pG482, DOI 10.1152/ajpgi.00355.2006; Lukas M, 2008, INFLAMM BOWEL DIS, V14, pS271, DOI 10.1002/ibd.20704; Mawe GM, 2009, NEUROGASTROENT MOTIL, V21, P481, DOI 10.1111/j.1365-2982.2009.01291.x; Mirsaidi A, 2012, J TISSUE ENG REGEN M, V6, P378, DOI 10.1002/term.440; Neunlist M, 2003, GUT, V52, P84, DOI 10.1136/gut.52.1.84; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Nurgali K, 2007, J PHYSIOL-LONDON, V583, P593, DOI 10.1113/jphysiol.2007.135947; Nurgali Kulmira, 2011, J Physiol, V589, P325, DOI 10.1113/jphysiol.2010.197707; Nurgali K, 2009, AM J PHYSIOL-GASTR L, V297, pG582, DOI 10.1152/ajpgi.00026.2009; Ohlsson B, 2007, INFLAMM BOWEL DIS, V13, P721, DOI 10.1002/ibd.20095; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontell L, 2009, VIRCHOWS ARCH, V455, P55, DOI 10.1007/s00428-009-0795-x; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Robinson AM, 2014, AM J PHYSIOL-GASTR L, V307, pG1115, DOI 10.1152/ajpgi.00174.2014; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; Sharkey KA, 2014, AUTON NEUROSCI-BASIC, V181, P94, DOI 10.1016/j.autneu.2013.12.006; Shepela Chris, 2008, Minn Med, V91, P42; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sokol H, 2009, GUT, V58, P1218, DOI 10.1136/gut.2009.177782; Stavely R, 2014, INFLAMM REGEN, V34, P184; Steinkamp M, 2012, BMC GASTROENTEROL, V12, DOI [10.1186/1471-230X-12-6, 10.1186/1471-2458-12-870]; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Torres-Espin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076141; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P1009, DOI 10.1111/j.1365-2982.2008.01146.x; von Boyen GBT, 2006, INFLAMM BOWEL DIS, V12, P346, DOI 10.1097/01.MIB.0000219350.72483.44; von Boyen GBT, 2002, J GASTROENTEROL, V37, P583, DOI 10.1007/s005350200093; Voulgari-Kokota A, 2012, EXP NEUROL, V236, P161, DOI 10.1016/j.expneurol.2012.04.011; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Winston JH, 2013, AM J PHYSIOL-GASTR L, V305, pG295, DOI 10.1152/ajpgi.00052.2013; Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535; Zeng R, 2011, SPINE, V36, P997, DOI 10.1097/BRS.0b013e3181eab764; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhao JJ, 2012, NEURAL REGEN RES, V7, P741, DOI 10.3969/j.issn.1673-5374.2012.10.004; Zheng ZH, 2008, RHEUMATOLOGY, V47, P22, DOI 10.1093/rheumatology/kem284; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f	97	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139023	10.1371/journal.pone.0139023	http://dx.doi.org/10.1371/journal.pone.0139023			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397368	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000361797500133
J	Martins, CDS; Pedrosa, AM; Du, DL; Goncalves, LP; Yu, Q; Gmitter, FG; Costa, MGC				Santos Martins, Cristina de Paula; Pedrosa, Andresa Muniz; Du, Dongliang; Goncalves, Luana Pereira; Yu, Qibin; Gmitter, Frederick G., Jr.; Costa, Marcio Gilberto Cardoso			Genome-Wide Characterization and Expression Analysis of Major Intrinsic Proteins during Abiotic and Biotic Stresses in Sweet Orange (Citrus sinensis L. Osb.)	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; WATER TRANSPORT; GENE FAMILY; DROUGHT STRESS; ER MEMBRANE; PLANT AQUAPORINS; HIGHLY DIVERGENT; H+-PUMPS; ARABIDOPSIS; IDENTIFICATION	The family of aquaporins (AQPs), or major intrinsic proteins (MIPs), includes integral membrane proteins that function as transmembrane channels for water and other small molecules of physiological significance. MIPs are classified into five subfamilies in higher plants, including plasma membrane (PIPs), tonoplast (TIPs), NOD26-like (NIPs), small basic (SIPs) and unclassified X (XIPs) intrinsic proteins. This study reports a genome-wide survey of MIP encoding genes in sweet orange (Citrus sinensis L. Osb.), the most widely cultivated Citrus spp. A total of 34 different genes encoding C. sinensis MIPs (CsMIPs) were identified and assigned into five subfamilies (CsPIPs, CsTIPs, CsNIPs, CsSIPs and CsXIPs) based on sequence analysis and also on their phylogenetic relationships with clearly classified MIPs of Arabidopsis thaliana. Analysis of key amino acid residues allowed the assessment of the substrate specificity of each CsMIP. Gene structure analysis revealed that the CsMIPs possess an exon-intron organization that is highly conserved within each subfamily. CsMIP loci were precisely mapped on every sweet orange chromosome, indicating a wide distribution of the gene family in the sweet orange genome. Investigation of their expression patterns in different tissues and upon drought and salt stress treatments, as well as with 'Candidatus Liberibacter asiaticus' infection, revealed a tissue-specific and coordinated regulation of the different CsMIP isoforms, consistent with the organization of the stress-responsive cis-acting regulatory elements observed in their promoter regions. A special role in regulating the flow of water and nutrients is proposed for CsTIPs and CsXIPs during drought stress, and for most CsMIPs during salt stress and the development of HLB disease. These results provide a valuable reference for further exploration of the CsMIPs functions and applications to the genetic improvement of both abiotic and biotic stress tolerance in citrus.	[Santos Martins, Cristina de Paula; Pedrosa, Andresa Muniz; Goncalves, Luana Pereira; Costa, Marcio Gilberto Cardoso] Univ Estadual Santa Cruz, Dept Biol Sci, Ctr Biotechnol & Genet, Ilheus, BA, Brazil; [Santos Martins, Cristina de Paula; Du, Dongliang; Yu, Qibin; Gmitter, Frederick G., Jr.] Univ Florida, Dept Hort Sci, Citrus Res & Educ Ctr, Lake Alfred, FL USA	Universidade Estadual de Santa Cruz; State University System of Florida; University of Florida	Costa, MGC (corresponding author), Univ Estadual Santa Cruz, Dept Biol Sci, Ctr Biotechnol & Genet, Ilheus, BA, Brazil.	marciogc.costa@gmail.com	Costa, Marcio/AAG-3285-2020; martins, cristina/AFV-5571-2022; du, dongliang/N-4308-2015	Costa, Marcio/0000-0002-4358-5489; 	CNPq (Brasilia, Brazil); CAPES (Brasilia, Brazil); FAPESP (Sao Paulo, Brazil); Florida Citrus Research and Development Foundation (USA)	CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Florida Citrus Research and Development Foundation (USA)	This work was supported in part by research grants from CNPq (Brasilia, Brazil), CAPES (Brasilia, Brazil), FAPESP (Sao Paulo, Brazil) and Florida Citrus Research and Development Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achor D. S., 2010, Plant Pathology Journal (Faisalabad), V9, P56; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Aritua V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073742; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; de Oliveira TM, 2011, TREE GENET GENOMES, V7, P1123, DOI 10.1007/s11295-011-0400-8; Deng Z, 2000, THEOR APPL GENET, V101, P814, DOI 10.1007/s001220051548; Deng Z, 2001, THEOR APPL GENET, V102, P1177, DOI 10.1007/s001220000527; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Gustavsson S, 2005, PLANT PHYSIOL, V139, P287, DOI 10.1104/pp.105.063198; Hachez C, 2008, PLANT MOL BIOL, V68, P337, DOI 10.1007/s11103-008-9373-x; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Hachez C, 2012, PLANT CELL ENVIRON, V35, P185, DOI 10.1111/j.1365-3040.2011.02429.x; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jauh GY, 1998, P NATL ACAD SCI USA, V95, P12995, DOI 10.1073/pnas.95.22.12995; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lienard D, 2008, PLANT PHYSIOL, V146, P1207, DOI 10.1104/pp.107.111351; Maeshima M, 2008, PFLUG ARCH EUR J PHY, V456, P709, DOI 10.1007/s00424-007-0363-7; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Mizutani M, 2006, PLANT CELL PHYSIOL, V47, P1420, DOI 10.1093/pcp/pcl004; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Postaire L, 2008, ADV BOT RES, V46, P75; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Rodriguez-Gamir J, 2012, ENVIRON EXP BOT, V78, P163, DOI 10.1016/j.envexpbot.2011.12.027; Rodriguez-Gamir J, 2011, PLANT SOIL, V347, P91, DOI 10.1007/s11104-011-0826-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schaffner AR, 1998, PLANTA, V204, P131, DOI 10.1007/s004250050239; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Shiratake K, 2001, J JPN SOC HORTIC SCI, V70, P287, DOI 10.2503/jjshs.70.287; Shiratake K, 1997, PLANT CELL PHYSIOL, V38, P1039, DOI 10.1093/oxfordjournals.pcp.a029269; Shiratake K, 2007, PLANT BIOTECHNOL-NAR, V24, P127, DOI 10.5511/plantbiotechnology.24.127; Suga S, 2003, PLANT CELL PHYSIOL, V44, P277, DOI 10.1093/pcp/pcg032; Sutka M, 2011, PLANT PHYSIOL, V155, P1264, DOI 10.1104/pp.110.163113; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang ZN, 2003, PLANT PHYSIOL, V131, P482, DOI 10.1104/pp.011262; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]	74	51	55	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138786	10.1371/journal.pone.0138786	http://dx.doi.org/10.1371/journal.pone.0138786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397813	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500107
J	Xu, L; Mao, XY; Imrali, A; Syed, F; Mutsvangwa, K; Berney, D; Cathcart, P; Hines, J; Shamash, J; Lu, YJ				Xu, Lei; Mao, Xueying; Imrali, Ahmet; Syed, Ferrial; Mutsvangwa, Katherine; Berney, Daniel; Cathcart, Paul; Hines, John; Shamash, Jonathan; Lu, Yong-Jie			Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; TECHNOLOGY; METASTASIS; DEVICE	Isolation of circulating tumor cells (CTCs) from peripheral blood has the potential to provide a far easier "liquid biopsy" than tumor tissue biopsies, to monitor tumor cell populations during disease progression and in response to therapies. Many CTC isolation technologies have been developed. We optimized the Parsortix system, an epitope independent, size and compressibility-based platform for CTCs isolation, making it possible to harvest CTCs at the speed and sample volume comparable to standard CellSearch system. We captured more than half of cancer cells from different cancer cell lines spiked in blood samples from healthy donors using this system. Cell loss during immunostaining of cells transferred and fixed on the slides is a major problem for analyzing rare cell samples. We developed a novel cell transfer and fixation method to retain >90% of cells on the slide after the immunofluorescence process without affecting signal strength and specificity. Using this optimized method, we evaluated the Parsortix system for CTC harvest in prostate cancer patients in comparison to immunobead based CTC isolation systems IsoFlux and CellSearch. We harvested a similar number (p = 0.33) of cytokeratin (CK) positive CTCs using Parsortix and IsoFlux from 7.5 mL blood samples of 10 prostate cancer patients (an average of 33.8 and 37.6 respectively). The purity of the CTCs harvested by Parsortix at 3.1% was significantly higher than IsoFlux at 1.0% (p = 0.02). Parsortix harvested significantly more CK positive CTCs than CellSearch (p = 0.04) in seven prostate cancer patient samples, where both systems were utilized (an average of 32.1 and 10.1 respectively). We also captured CTC clusters using Parsortix. Using four-color immunofluorescence we found that 85.8% of PC3 cells expressed EpCAM, 91.7% expressed CK and 2.5% cells lacked both epithelial markers. Interestingly, 95.6% of PC3 cells expressed Vimentin, including those cells that lacked both epithelial marker expression, indicating epithelial-to-mesenchymal transition. CK-positive/Vimentin-positive/CD45-negative, and CK-negative/Vimentin-positive/CD45-negative cells were also observed in four of five prostate cancer patients but rarely in three healthy controls, indicating that Parsortix harvests CTCs with both epithelial and mesenchymal features. We also demonstrated using PC3 and DU145 spiking experiment that Parsortix harvested cells were viable for cell culture.	[Xu, Lei; Mao, Xueying; Imrali, Ahmet; Berney, Daniel; Lu, Yong-Jie] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London, England; [Xu, Lei] Fudan Univ, Dept Urol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Syed, Ferrial; Mutsvangwa, Katherine; Shamash, Jonathan] Barts Hlth NHS, Dept Med Oncol, London, England; [Mutsvangwa, Katherine; Cathcart, Paul; Shamash, Jonathan] Queen Mary Univ London, Ctr Med Expt, Barts Canc Inst, London, England; [Cathcart, Paul] Univ Coll Hosp NHS, Dept Urol, London, England; [Hines, John] Barts Hlth NHS, Dept Urol, London, England	University of London; Queen Mary University London; Fudan University; Barts Health NHS Trust; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; Barts Health NHS Trust	Lu, YJ (corresponding author), Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London, England.	y.j.lu@qmul.ac.uk		Berney, Daniel/0000-0001-5474-8696	Orchid; ANGLE PLC; Chinese Scholarship Council	Orchid; ANGLE PLC; Chinese Scholarship Council(China Scholarship Council)	This work was supported by Orchid and ANGLE PLC. LX also thanks the Chinese Scholarship Council for funding support of his PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; Bussemakers MJG, 1999, CANCER RES, V59, P5975; de Kok JB, 2002, CANCER RES, V62, P2695; Deng G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2131; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; GADEBERG OV, 1982, ACTA HAEMATOL-BASEL, V68, P313, DOI 10.1159/000206999; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Hanenberg J, 2014, BLOOD, V123, P3541, DOI 10.1182/blood-2013-12-541011; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Joosse SA, 2014, EMBO MOL MED, DOI 10.15252/emmm.201303698; Kawasaki M, 2012, NATURE, V489, P510, DOI 10.1038/489510a; Kolostova K, 2014, ANTICANCER RES, V34, P3641; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; PAPILLO JL, 1994, ACTA CYTOL, V38, P33; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Rack B, 2014, JNCI-J NATL CANCER I, V106, P106, DOI 10.1093/jnci/dju066; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ruban GI, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753466; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; SHAPIRO HM, 1976, J HISTOCHEM CYTOCHEM, V24, P396, DOI 10.1177/24.1.56391; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Xu L, 2015, J CANC RES UPDATES, V4, P13, DOI DOI 10.6000/1929-2279.2015.04.01.2; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yusa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088821	39	116	121	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138032	10.1371/journal.pone.0138032	http://dx.doi.org/10.1371/journal.pone.0138032			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397728	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500050
J	de Boer, W; Hundscheid, MPJ; Gunnewiek, PJAK; de Ridder-Duine, AS; Thion, C; van Veen, JA; van der Wal, A				de Boer, Wietse; Hundscheid, Maria P. J.; Gunnewiek, Paulien J. A. Klein; de Ridder-Duine, Annelies S.; Thion, Cecile; van Veen, Johannes A.; van der Wal, Annemieke			Antifungal Rhizosphere Bacteria Can increase as Response to the Presence of Saprotrophic Fungi	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; MICROBIAL COMMUNITIES; RHIZOCTONIA-SOLANI; CAREX-ARENARIA; PLANT-GROWTH; SOIL; IMPACT; MICROORGANISMS; AGRICULTURE	Knowledge on the factors that determine the composition of bacterial communities in the vicinity of roots (rhizosphere) is essential to understand plant-soil interactions. Plant species identity, plant growth stage and soil properties have been indicated as major determinants of rhizosphere bacterial community composition. Here we show that the presence of saprotrophic fungi can be an additional factor steering rhizosphere bacterial community composition and functioning. We studied the impact of presence of two common fungal rhizosphere inhabitants (Mucor hiemalis and Trichoderma harzianum) on the composition of cultivable bacterial communities developing in the rhizosphere of Carex arenaria (sand sedge) in sand microcosms. Identification and phenotypic characterization of bacterial isolates revealed clear shifts in the rhizosphere bacterial community composition by the presence of two fungal strains (M. hiemalis BHB1 and T. harzianum PvdG2), whereas another M. hiemalis strain did not show this effect. Presence of both M. hiemalis BHB1 and T. harzianum PvdG2 resulted in a significant increase of chitinolytic and (in vitro) antifungal bacteria. The latter was most pronounced for M. hiemalis BHB1, an isolate from Carex roots, which stimulated the development of the bacterial genera Achromobacter and Stenotrophomonas. In vitro tests showed that these genera were strongly antagonistic against M. hiemalis but also against the plant-pathogenic fungus Rhizoctonia solani. The most likely explanation for fungal-induced shifts in the composition of rhizosphere bacteria is that bacteria are being selected which are successful in competing with fungi for root exudates. Based on the results we propose that measures increasing saprotrophic fungi in agricultural soils should be explored as an alternative approach to enhance natural biocontrol against soil-borne plant-pathogenic fungi, namely by stimulating indigenous antifungal rhizosphere bacteria.	[de Boer, Wietse; Hundscheid, Maria P. J.; Gunnewiek, Paulien J. A. Klein; de Ridder-Duine, Annelies S.; van Veen, Johannes A.; van der Wal, Annemieke] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, NL-6708 PB Wageningen, Netherlands; [Thion, Cecile] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; [van Veen, Johannes A.] Leiden Univ, Inst Biol, NL-2333 BE Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; University of Aberdeen; Leiden University; Leiden University - Excl LUMC	van der Wal, A (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands.	a.vanderwal@nioo.knaw.nl	van der Wal, Annemieke/F-7411-2012; de Boer, Wietse/C-2737-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Wal, Annemieke/0000-0003-0261-1203; de Boer, Wietse/0000-0002-5380-2993; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding: Funding was provided by the Netherlands Organisation for Scientific Research (NWO) in the form of a personal Veni grant to AvdW. This is publication number 5923 of the NIOO-KNAW Netherlands Institute of Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina MF, 2007, SOIL BIOL BIOCHEM, V39, P2818, DOI 10.1016/j.soilbio.2007.06.004; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bai YN, 2016, ENVIRON MICROBIOL, V18, P38, DOI 10.1111/1462-2920.12545; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Cummings S., 2009, ENV BIOTECHNOL, V5, P43; de Boer W, 2003, APPL ENVIRON MICROB, V69, P835, DOI 10.1128/AEM.69.2.835-844.2003; De Boer W, 2001, APPL ENVIRON MICROB, V67, P3358, DOI 10.1128/AEM.67.8.3358-3362.2001; de Boer W, 2008, SOIL BIOL BIOCHEM, V40, P1542, DOI 10.1016/j.soilbio.2007.12.030; de Ridder-Duine AS, 2006, PEDOBIOLOGIA, V50, P293, DOI 10.1016/j.pedobi.2006.03.004; de Ridder-Duine AS, 2005, SOIL BIOL BIOCHEM, V37, P349, DOI 10.1016/j.soilbio.2004.08.005; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Doornbos RF, 2012, AGRON SUSTAIN DEV, V32, P227, DOI 10.1007/s13593-011-0028-y; Drigo B, 2007, GLOBAL CHANGE BIOL, V13, P2396, DOI 10.1111/j.1365-2486.2007.01445.x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hjort K, 2007, MICROB ECOL, V53, P399, DOI 10.1007/s00248-006-9120-2; Izumi H, 2011, ENVIRON MICROBIOL, V13, P819, DOI 10.1111/j.1462-2920.2010.02393.x; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; Marschner P, 2005, APPL SOIL ECOL, V28, P23, DOI 10.1016/j.apsoil.2004.06.007; Minkwitz A, 2001, J CLIN MICROBIOL, V39, P139, DOI 10.1128/JCM.39.1.139-145.2001; Nehl DB, 1997, APPL SOIL ECOL, V5, P1, DOI 10.1016/S0929-1393(96)00124-2; Nguyen NH, 2015, MICROB ECOL, V69, P914, DOI 10.1007/s00248-015-0574-y; Offre P, 2008, FEMS MICROBIOL ECOL, V65, P180, DOI 10.1111/j.1574-6941.2008.00504.x; Palumbo JD, 2005, PHYTOPATHOLOGY, V95, P701, DOI 10.1094/PHYTO-95-0701; Rillig MC, 2006, FEMS MICROBIOL ECOL, V57, P389, DOI 10.1111/j.1574-6941.2006.00129.x; Rosenberg K, 2009, ISME J, V3, P675, DOI 10.1038/ismej.2009.11; Timonen S, 2006, SOIL BIOL, V7, P155; Troelstra SR, 2001, NEW PHYTOL, V150, P697, DOI 10.1046/j.1469-8137.2001.00133.x; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Wichmann G, 2008, MOL MICROBIOL, V68, P672, DOI 10.1111/j.1365-2958.2008.06175.x; Wilson DH, 1990, J CLIN MICROBIOL, V28, P1942; Zachow C, 2011, APPL SOIL ECOL, V48, P193, DOI 10.1016/j.apsoil.2011.03.006	41	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137988	10.1371/journal.pone.0137988	http://dx.doi.org/10.1371/journal.pone.0137988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393509	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100025
J	Stirnemann, I; Mortelliti, A; Gibbons, P; Lindenmayer, DB				Stirnemann, Ingrid; Mortelliti, Alessio; Gibbons, Philip; Lindenmayer, David B.			Fine-Scale Habitat Heterogeneity Influences Occupancy in Terrestrial Mammals in a Temperate Region of Australia	PLOS ONE			English	Article							GROUND-DWELLING MAMMALS; LONG-NOSED POTOROO; SPECIES-DIVERSITY; EUCALYPT FORESTS; WALLABIA-BICOLOR; SWAMP WALLABY; LANDSCAPE; BIODIVERSITY; VEGETATION; FIRE	Vegetation heterogeneity is an inherent feature of most ecosystems, characterises the structure of habitat, and is considered an important driver of species distribution patterns. However, quantifying fine-scale heterogeneity of vegetation cover can be time consuming, and therefore it is seldom measured. Here, we determine if heterogeneity is worthwhile measuring, in addition to the amount of cover, when examining species distribution patterns. Further, we investigated the effect of the surrounding landscape heterogeneity on species occupancy. We tested the effect of cover and heterogeneity of trees and shrubs, and the context of the surrounding landscape (number of habitats and distance to an ecotone) on site occupancy of three mammal species (the black wallaby [Wallabia bicolor], the long-nosed bandicoot [Perameles nasuta], and the bush rat [Rattus fuscipes]) within a naturally heterogeneous landscape in a temperate region of Australia. We found that fine-scale heterogeneity of vegetation attributes is an important driver of mammal occurrence of two of these species. Further, we found that, although all three species responded positively to vegetation heterogeneity, different mammals vary in their response to different types of vegetation heterogeneity measurement. For example, the black wallaby responded to the proximity of an ecotone, and the bush rat and the long-nosed bandicoot responded to fine-scale heterogeneity of small tree cover, whereas none of the mammals responded to broad scale heterogeneity (i.e., the number of habitat types). Our results highlight the influence of methodological decisions, such as how heterogeneity vegetation is measured, in quantifying species responses to habitat structures. The findings confirm the importance of choosing meaningful heterogeneity measures when modelling the factors influencing occupancy of the species of interest.	[Stirnemann, Ingrid; Mortelliti, Alessio; Gibbons, Philip; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 260, Australia	Australian National University	Stirnemann, I (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 260, Australia.	i.stirnemann@gmail.com	Lindenmayer, David B/P-7183-2017; Gibbons, Philip/I-8248-2012	Lindenmayer, David B/0000-0002-4766-4088; 	Australian Postgraduate Award; Environment Decisions Hub of the Australian Government's National Environmental Research Program; ARC	Australian Postgraduate Award(Australian Government); Environment Decisions Hub of the Australian Government's National Environmental Research Program; ARC(Australian Research Council)	IS was funded by an Australian Postgraduate Award. PG was partly funded by the Environment Decisions Hub of the Australian Government's National Environmental Research Program. DBL is funded by an ARC Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JD, 2006, INT J WILDLAND FIRE, V15, P237, DOI 10.1071/WF05053; Andersen AN, 2014, J APPL ECOL, V51, P1406, DOI 10.1111/1365-2664.12307; Baker LR, 2011, POPUL ECOL, V53, P549, DOI 10.1007/s10144-011-0274-5; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; BENNETT AF, 1993, WILDLIFE RES, V20, P267, DOI 10.1071/WR9930267; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; BOWERS MA, 1993, OECOLOGIA, V94, P247, DOI 10.1007/BF00341324; Burnham K.P., 2003, MODEL SELECTION MULT; Carey AB, 2001, J WILDLIFE MANAGE, V65, P1014, DOI 10.2307/3803050; CATLING PC, 1995, WILDLIFE RES, V22, P271, DOI 10.1071/WR9950271; Claridge AW, 2000, AUSTRAL ECOL, V25, P676, DOI 10.1111/j.1442-9993.2000.tb00074.x; Cliff A.D., 1981, SPATIAL PROCESSES; Crawley M. J, 2002, STAT COMPUTING INTRO; Di Stefano J, 2009, AUSTRAL ECOL, V34, P143, DOI 10.1111/j.1442-9993.2008.01890.x; DSEWPaC, 2013, 1 HIST BOOD NAT PARK; Elzinga C.L., 1998, 17301 BUR LAND MAN; ENOKSSON B, 1995, LANDSCAPE ECOL, V10, P267, DOI 10.1007/BF00128994; ESRI, 2006, ARCMAP VERS 9 2; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fisher DO, 2000, J APPL ECOL, V37, P660, DOI 10.1046/j.1365-2664.2000.00518.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Forman RTT, 1995, LAND MOSAICS ECOLOGY; Fuller RJ, 1997, ECOGRAPHY, V20, P295, DOI 10.1111/j.1600-0587.1997.tb00374.x; Gandiwa E., 2011, International Journal of Environmental Sciences, V2, P458; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Gould WA, 2006, J VEG SCI, V17, P653, DOI 10.1111/j.1654-1103.2006.tb02489.x; Hamer TL, 2006, LANDSCAPE ECOL, V21, P569, DOI 10.1007/s10980-005-2167-5; Haslem A, 2008, AGR ECOSYST ENVIRON, V125, P191, DOI 10.1016/j.agee.2008.01.001; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Holland MM., 1991, ECOTONES ROLE LANDSC, V1st ed; HOLLIS CJ, 1986, AUST WILDLIFE RES, V13, P355, DOI 10.1071/WR9860355; Hutchings M. J., 2000, ECOLOGICAL CONSEQUEN; INGWERSEN F, 1977, THESIS AUSTR NATL U; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jeanneret P, 2003, AGR ECOSYST ENVIRON, V98, P311, DOI 10.1016/S0167-8809(03)00091-4; Jin X., 2008, INT ARCH PHOTOGRAMM, V37, P1385; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Kageyama SA, 2008, CAN J FOREST RES, V38, P1053, DOI 10.1139/X07-221; KIRCHHOFF MD, 1983, J WILDLIFE MANAGE, V47, P497, DOI 10.2307/3808522; Kushla JD, 1997, FOREST ECOL MANAG, V95, P97, DOI 10.1016/S0378-1127(97)82929-5; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer D. B., 2014, BOODEREE NATL PARK J; Lindenmayer DB, 1999, BIOL CONSERV, V88, P387, DOI 10.1016/S0006-3207(98)00111-6; Lindenmayer DB, 2014, ECOGRAPHY, DOI [10.1111/ecog.00939, DOI 10.1111/EC0G.00939]; Louys J, 2011, GLOBAL ECOL BIOGEOGR, V20, P717, DOI 10.1111/j.1466-8238.2010.00643.x; LUNNEY D, 1988, AUST WILDLIFE RES, V15, P695; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manson RH, 1999, LANDSCAPE ECOL, V14, P355, DOI 10.1023/A:1008093823391; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; McElhinny C., 2006, Pacific Conservation Biology, V12, P89; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Morrison ML., 2006, WILDLIFE HABITAT REL; Mortelliti A, 2009, CAN J ZOOL, V87, P662, DOI 10.1139/Z09-054; MOYLE DI, 1995, J COMP PHYSIOL B, V164, P552; Paull DJ, 2011, WILDLIFE RES, V38, P188, DOI 10.1071/WR10203; PIANKA ER, 1972, AM NAT, V106, P581, DOI 10.1086/282798; Price B, 2010, BIOL CONSERV, V143, P2504, DOI 10.1016/j.biocon.2010.06.017; R Core Team, 2012, R LANG ENV STAT COMP; Recher HF, 2009, WILDLIFE RES, V36, P143, DOI 10.1071/WR08086; Ritchie M.E., 2010, SCALE HETEROGENEITY; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Senft AR, 2009, SPECIES DIVERSITY PA; Spencer RJ, 2005, AUSTRAL ECOL, V30, P876; Stein A, 2015, BIOL REV, V90, P815, DOI 10.1111/brv.12135; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Stirnemann IA, 2015, OECOLOGIA, V177, P733, DOI 10.1007/s00442-014-3134-0; Strahan R, 1995, MAMMALS AUSTR NATL P; Taws N, 1997, CANBERRA TAWS BOT RE; Taylor G, 1995, GEOLOGY GEOMORPHOLOG; Taylor J.M., 1988, Mammalian Species, P1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tory MK, 1997, AUST J ECOL, V22, P460, DOI 10.1111/j.1442-9993.1997.tb00697.x; Villasenor NR, 2015, LANDSCAPE ECOL, V30, P229, DOI 10.1007/s10980-014-0117-9; While GM, 2006, WILDLIFE RES, V33, P565, DOI 10.1071/WR05063; Zuur Alain F., 2009, P1; [No title captured]	86	11	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138681	10.1371/journal.pone.0138681	http://dx.doi.org/10.1371/journal.pone.0138681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394327	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100085
J	Teixeira, GM; Bittencourt, H; de Macedo, AV; Martinho, GH; Colosimo, EA; Rezende, SM				Teixeira, Gustavo Machado; Bittencourt, Henrique; de Macedo, Antonio Vaz; Martinho, Glaucia Helena; Colosimo, Enrico Antonio; Rezende, Suely Meireles			Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; NON-RELAPSE MORTALITY; HCT-CI; GRAFT; VALIDATION; PREDICTOR; LEUKEMIA; ALEMTUZUMAB; MORBIDITY	Although the application of Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) has enabled better prediction of transplant-related mortality (TRM) in allogeneic hematopoietic stem cell transplants (AHSCT), data from developing countries are scarce. This study prospectively evaluated the HCT-CI and the Adult Comorbidity Evaluation (ACE-27), in its original and in a modified version, as predictors of post-transplant complications in adults undergoing a first related or unrelated AHSCT in Brazil. Both bone marrow (BM) and peripheral blood stem cells (PBSC) as graft sources were included. We analyzed the cumulative incidence of granulocyte and platelet recovery, sinusoidal obstructive syndrome, acute and chronic graft-versus-host disease, relapse and transplant-related mortality, and rates of event-free survival and overall survival. Ninety-nine patients were assessed. Median age was 38 years (18-65 years); HCT-CI >= 3 accounted for only 8% of cases; hematologic malignancies comprised 75.8% of the indications for AHSCT. There was no association between the HCT-CI or the original or modified ACE-27 with TRM or any other studied outcomes after AHSCT. These results show that, in the population studied, none of the comorbidity indexes seem to be associated with AHSCT outcomes. A significantly low frequency of high-risk (HCT-CI >= 3) in this Brazilian population might justify these results.	[Teixeira, Gustavo Machado; Rezende, Suely Meireles] Univ Fed Minas Gerais, Sch Med, Post Graduat Program Adult Hlth, Belo Horizonte, MG, Brazil; [Teixeira, Gustavo Machado; de Macedo, Antonio Vaz; Martinho, Glaucia Helena] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Bittencourt, Henrique] Univ Montreal, Div Hematol Oncol, CHU St Justine, Montreal, PQ, Canada; [Bittencourt, Henrique] Univ Montreal, Sch Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Colosimo, Enrico Antonio] Univ Fed Minas Gerais, Dept Stat, Inst Exact Sci, Belo Horizonte, MG, Brazil; [Rezende, Suely Meireles] Univ Fed Minas Gerais, Dept Internal Med, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Teixeira, GM (corresponding author), Univ Fed Minas Gerais, Sch Med, Post Graduat Program Adult Hlth, Belo Horizonte, MG, Brazil.	gustmteixeira@yahoo.com.br	Rezende, Suely/AAL-8006-2021	Rezende, Suely/0000-0002-3083-7093				Armand P, 2012, BLOOD, V120, P905, DOI 10.1182/blood-2012-03-418202; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Barba P, 2010, BIOL BLOOD MARROW TR, V16, P413, DOI 10.1016/j.bbmt.2009.11.008; Birninger N, 2011, BIOL BLOOD MARROW TR, V17, P1822, DOI 10.1016/j.bbmt.2011.06.009; Bokhari SW, 2012, BONE MARROW TRANSPL, V47, P528, DOI 10.1038/bmt.2011.138; Chang YJ, 2012, ANN HEMATOL, V91, P427, DOI 10.1007/s00277-011-1299-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colella MP, 2011, REV BRAS HEMATOL S1, V33, pS84; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Guilfoyle R, 2009, BONE MARROW TRANSPL, V43, P133, DOI 10.1038/bmt.2008.300; HOROWITZ MM, 2009, THOMAS HEMATOPOIETIC, P15; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lim ZY, 2010, BONE MARROW TRANSPL, V45, P633, DOI 10.1038/bmt.2009.236; Macedo AV, 2009, REV BRAS HEMATOL S3, V31, pS87; Marsh JC, 2011, BLOOD, V118, P2351, DOI 10.1182/blood-2010-12-327536; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Mo XD, 2013, AM J HEMATOL, V88, P497, DOI 10.1002/ajh.23443; Piccirillo JF, 2004, MED CARE, V42, P482, DOI 10.1097/01.mlr.0000124254.88292.al; Potter VT, 2014, BIOL BLOOD MARROW TR, V20, P111, DOI 10.1016/j.bbmt.2013.10.021; Raimondi R, 2012, BLOOD, V120, P1327, DOI 10.1182/blood-2012-03-414573; Smith AR, 2011, BLOOD, V117, P2728, DOI 10.1182/blood-2010-08-303263; Sorror ML, 2004, BLOOD, V104, P961, DOI 10.1182/blood-2004-02-0545; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; Sorror ML, 2014, BLOOD, V124, P287, DOI 10.1182/blood-2014-01-550566; Wood W, 2011, PEDIATR BLOOD CANCER, V57, P499, DOI 10.1002/pbc.23057; Xhaard A, 2008, LEUKEMIA, V22, P2062, DOI 10.1038/leu.2008.197; Zhang HR, 2012, LEUKEMIA RES, V36, P431, DOI 10.1016/j.leukres.2011.10.016	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0137390	10.1371/journal.pone.0137390	http://dx.doi.org/10.1371/journal.pone.0137390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394228	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100012
J	Vrijkotte, TGM; van den Born, BJH; Hoekstra, CMCA; Gademan, MGJ; van Eijsden, M; de Rooij, SR; Twickler, MTB				Vrijkotte, Tanja G. M.; van den Born, Bert-Jan H.; Hoekstra, Christine M. C. A.; Gademan, Maaike G. J.; van Eijsden, Manon; de Rooij, Susanne R.; Twickler, Marcel T. B.			Cardiac Autonomic Nervous System Activation and Metabolic Profile in Young Children: The ABCD Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; VAGAL TONE; OBESITY; CHILDHOOD; ADOLESCENTS; PREDICTS	Background In adults, increased sympathetic and decreased parasympathetic nervous system activity are associated with a less favorable metabolic profile. Whether this is already determined at early age is unknown. Therefore, we aimed to assess the association between autonomic nervous system activation and metabolic profile and its components in children at age of 5-6 years. Methods Cross-sectional data from an apparently healthy population (within the ABCD study) were collected at age 5-6 years in 1540 children. Heart rate (HR), respiratory sinus arrhythmia (RSA; parasympathetic activity) and pre-ejection period (PEP; sympathetic activity) were assessed during rest. Metabolic components were waist-height ratio (WHtR), systolic blood pressure (SBP), fasting triglycerides, glucose and HDL-cholesterol. Individual components, as well as a cumulative metabolic score, were analyzed. Results In analysis adjusted for child's physical activity, sleep, anxiety score and other potential confounders, increased HR and decreased RSA were associated with higher WHtR (P< 0.01), higher SBP (p< 0.001) and a higher cumulative metabolic score (HR: p < 0.001; RSA: p < 0.01). Lower PEP was only associated with higher SBP (p < 0.05). Of all children, 5.6% had 3 or more (out of 5) adverse metabolic components; only higher HR was associated with this risk (per 10 bpm increase: OR = 1.56; p < 0.001). Conclusions This study shows that decreased parasympathetic activity is associated with central adiposity and higher SBP, indicative of increased metabolic risk, already at age 5-6 years.	[Vrijkotte, Tanja G. M.; Hoekstra, Christine M. C. A.; Gademan, Maaike G. J.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van den Born, Bert-Jan H.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol & Hlth Promot, Amsterdam, Netherlands; [de Rooij, Susanne R.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Twickler, Marcel T. B.] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab Dis, Antwerp, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Antwerp	Vrijkotte, TGM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.vrijkotte@amc.uva.nl	Ghiami, Zeinab/G-5492-2016; van den Born, Bert-Jan/E-4263-2017	de Rooij, Susanne Rosalie/0000-0001-7382-5749; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research and Development (ZonMw) [40-00812-98-11010]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This research was funded by Netherlands Organization for Health Research and Development (ZonMw, http://www.zonmw.nl/en/) Grant (TOP, 40-00812-98-11010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Altuncu ME, 2012, CARDIOL J, V19, P501, DOI 10.5603/CJ.2012.0091; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Berenson GS, 2011, J AM SOC HYPERTENS, V5, P230, DOI 10.1016/j.jash.2011.02.006; Berntson GG, 2008, PSYCHOPHYSIOLOGY, V45, P643, DOI 10.1111/j.1469-8986.2008.00652.x; Berntson GG, 2004, PSYCHOPHYSIOLOGY, V41, P333, DOI 10.1111/j.1469-8986.2004.00156.x; Bodenlos JS, 2007, APPETITE, V48, P145, DOI 10.1016/j.appet.2006.07.080; Camm AJ, 1996, CIRCULATION, V93, P1043; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Beer M, 2011, E SPEN EUR E J CLIN, V6, pe223, DOI DOI 10.1016/J.ECLNM.2011.09.001; El-Sheikh M, 2013, J SLEEP RES, V22, P282, DOI 10.1111/jsr.12019; Emdin M, 2001, CIRCULATION, V103, P513, DOI 10.1161/01.CIR.103.4.513; Goedhart AD, 2007, PSYCHOPHYSIOLOGY, V44, P203, DOI 10.1111/j.1469-8986.2006.00490.x; Gootjes J, 2009, CLIN CHIM ACTA, V401, P152, DOI 10.1016/j.cca.2008.12.016; Graziano PA, 2011, OBESITY, V19, P1818, DOI 10.1038/oby.2011.98; GROSSMAN P, 1993, PSYCHOPHYSIOLOGY, V30, P486, DOI 10.1111/j.1469-8986.1993.tb02072.x; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Jarczok MN, 2013, INT J CARDIOL, V168, P3025, DOI 10.1016/j.ijcard.2013.04.147; Joyner MJ, 2010, HYPERTENSION, V56, P10, DOI 10.1161/HYPERTENSIONAHA.109.140186; Kaufman CL, 2007, OBESITY, V15, P1164, DOI 10.1038/oby.2007.619; Koskinen T, 2009, DIABETIC MED, V26, P354, DOI 10.1111/j.1464-5491.2009.02686.x; Latchman PL, 2011, CLIN AUTON RES, V21, P319, DOI 10.1007/s10286-011-0116-8; Licht CMM, 2013, J CLIN ENDOCR METAB, V98, P2484, DOI 10.1210/jc.2012-3104; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nyberg G, 2011, INT J PEDIATR OBES, V6, P244, DOI 10.3109/17477166.2011.575226; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Quigley KS, 2006, PSYCHOPHYSIOLOGY, V43, P357, DOI 10.1111/j.1469-8986.2006.00405.x; Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176; Rodriguez-Colon SM, 2011, INT J PEDIATR OBES, V6, P128, DOI 10.3109/17477166.2010.490265; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Straznicky NE, 2008, CURR HYPERTENS REP, V10, P440, DOI 10.1007/s11906-008-0083-1; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van Dijk AE, 2013, JOVE-J VIS EXP, DOI 10.3791/50073; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Yakinci C, 2000, BRAIN DEV-JPN, V22, P151, DOI 10.1016/S0387-7604(00)00094-2; Zhou Y, 2012, CAN J CARDIOL, V28, P477, DOI 10.1016/j.cjca.2012.02.003	44	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138302	10.1371/journal.pone.0138302	http://dx.doi.org/10.1371/journal.pone.0138302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394362	Green Published, gold			2022-12-26	WOS:000361792100049
J	Abraham, MK; Nolte, A; Reus, R; Behring, A; Zengerle, D; Avci-Adali, M; Hohmann, JD; Peter, K; Schlensak, C; Wendel, HP; Krajewski, S				Abraham, Meike-Kristin; Nolte, Andrea; Reus, Rebekka; Behring, Andreas; Zengerle, Diane; Avci-Adali, Meltem; Hohmann, Jan David; Peter, Karlheinz; Schlensak, Christian; Wendel, Hans Peter; Krajewski, Stefanie			In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications	PLOS ONE			English	Article							TRIPHOSPHATE DIPHOSPHOHYDROLASE-1; CELL-PROLIFERATION; ATHEROSCLEROSIS; TRANSFECTION; EXPRESSION; PROTEINS; DELIVERY; MICE; ATP	Background Stent angioplasty provides a minimally invasive treatment for atherosclerotic vessels. However, no treatment option for atherosclerosis-associated endothelial dysfunction, which is accompanied by a loss of CD39, is available, and hence, adverse effects like thromboembolism and restenosis may occur. Messenger RNA (mRNA)-based therapy represents a novel strategy, whereby de novo synthesis of a desired protein is achieved after delivery of a modified mRNA to the target cells. Methods and Findings Our study aimed to develop an innovative bioactive stent coating that induces overexpression of CD39 in the atherosclerotic vessel. Therefore, a modified CD39-encodingmRNA was produced by in vitro transcription. Different endothelial cells (ECs) were transfected with the mRNA, and CD39 expression and functionality were analyzed using various assays. Furthermore, CD39 mRNA was immobilized using poly(lactic-co-glycolic-acid) (PLGA), and the transfection efficiency in ECs was analyzed. Our data show that ECs successfully translate in vitro-generated CD39 mRNA after transfection. The overexpressed CD39 protein is highly functional in hydrolyzing ADP and in preventing platelet activation. Furthermore, PLGA-immobilized CD39mRNA can be delivered to ECs without losing its functionality. Summary In summary, we present a novel and promising concept for a stent coating for the treatment of atherosclerotic blood vessels, whereby patients could be protected against angioplasty-associated complications.	[Abraham, Meike-Kristin; Nolte, Andrea; Reus, Rebekka; Behring, Andreas; Zengerle, Diane; Avci-Adali, Meltem; Schlensak, Christian; Wendel, Hans Peter; Krajewski, Stefanie] Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Teubingen, Germany; [Hohmann, Jan David; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Nolte, A (corresponding author), Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Teubingen, Germany.	andrea.nolte@thg-lab.de	/S-2765-2019; Krajewski, Stefanie/AAF-1877-2019	/0000-0002-8040-2258; Avci-Adali, Meltem/0000-0003-4008-4272	German research association (Deutsche Forschungsgemeinschaft) [KR 4296/1-1]	German research association (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by the German research association (Deutsche Forschungsgemeinschaft, grant number KR 4296/1-1).	Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Avci-Adali M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-8; Avci-Adali M, 2013, J BIOMED MATER RES B, V101B, P1061, DOI 10.1002/jbm.b.32916; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Cui S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/428619; Drosopoulos JHF, 2010, THROMB HAEMOSTASIS, V103, P426, DOI 10.1160/TH09-05-0305; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Erlinge D, 1998, GEN PHARMACOL-VASC S, V31, P1, DOI 10.1016/S0306-3623(97)00420-5; Fortier A, 2014, IJC HEART VESSELS; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Koziak K, 2008, J THROMB HAEMOST, V6, P1191, DOI 10.1111/j.1538-7836.2008.03019.x; Krajewski S, 2014, ANAL BIOANAL CHEM, V406, P3395, DOI 10.1007/s00216-014-7769-9; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; McLean Dougal R, 2002, Rev Cardiovasc Med, V3 Suppl 5, pS16; Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040; Patrono C, 2011, EUR HEART J, V32, P2922, DOI 10.1093/eurheartj/ehr373; Rha SW, 2014, WORLD J CARDIOL, V6, P148, DOI 10.4330/wjc.v6.i4.148; Rodriguez-Granillo A, 2011, WORLD J CARDIOL, V3, P84, DOI 10.4330/wjc.v3.i3.84; Sampram ESK, 2004, J VASC INTERV RADIOL, V15, P379, DOI 10.1097/01.RVI.0000121409.46920.B8; Simard T, 2014, CAN J CARDIOL, V30, P35, DOI 10.1016/j.cjca.2013.09.012; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zohra FT, 2007, BIOCHEM BIOPH RES CO, V358, P373, DOI 10.1016/j.bbrc.2007.04.059; Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050	28	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138375	10.1371/journal.pone.0138375	http://dx.doi.org/10.1371/journal.pone.0138375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381750	Green Published, gold			2022-12-26	WOS:000361790200096
J	Krishna, VD; Roach, E; Zaidman, NA; Panoskaltsis-Mortari, A; Rotschafer, JH; O'Grady, SM; Cheeran, MCJ				Krishna, Venkatramana D.; Roach, Erin; Zaidman, Nathan A.; Panoskaltsis-Mortari, Angela; Rotschafer, Jessica H.; O'Grady, Scott M.; Cheeran, Maxim C-J.			Differential Induction of Type I and Type III Interferons by Swine and Human Origin H1N1 Influenza A Viruses in Porcine Airway Epithelial Cells	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; NS1 PROTEIN; AVIAN INFLUENZA; IFN-LAMBDA; RIG-I; INHIBITION; PIGS; RNA; TRANSMISSION; PATHOGENESIS	Interferons (IFNs) have been shown to inhibit influenza A virus (IAV) replication and play an essential role in controlling viral infection. Here we studied the kinetics and magnitude of induction of type I and type III IFN transcripts by primary porcine airway epithelial cells (pAECs) in response to swine and human origin IAV. We observed that swine influenza viruses (SIV) replicate more efficiently than the human pandemic influenza A/California/ 2009 (pH1N1 CA/09) in pAECs. Interestingly, we also found significant difference in kinetics of IFN-beta, IFN-lambda 1 and IFN-lambda 3 gene expression by these viruses. While there was delay of up to 12 hours post infection (hp.i.)in induction of IFN genes in pAECs infected with swine IAV A/Sw/Illinois/2008 (H1N1 IL/08), human pH1N1 CA/09 rapidly induced IFN-beta, IFN-lambda 1 and IFN-lambda 3 gene expression as early as 4 h p. i. However, the magnitude of IFN-beta and IFN-lambda 3 induction at 24 h p. i. was not significantly different between the viral strains tested. Additionally, we found that swine H1N1 IL/08 was less sensitive to dsRNA induced antiviral response compared to human pH1N1 CA/09. Our data suggest that the human and swine IAVs differ in their ability to induce and respond to type I and type III interferons in swine cells. Swine origin IAV may have adapted to the pig host by subverting innate antiviral responses to viral infection.	[Krishna, Venkatramana D.; Roach, Erin; Rotschafer, Jessica H.; Cheeran, Maxim C-J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Zaidman, Nathan A.; O'Grady, Scott M.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Panoskaltsis-Mortari, Angela] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cheeran, MCJ (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	cheeran@umn.edu	Cheeran, Maxim C-J/C-2135-2009; Krishna, Venkatramana/AAB-1227-2021	Cheeran, Maxim C-J/0000-0002-5331-4746; 	Academic Health Center Seed Grant; University of Minnesota; US Department of Agriculture State Agriculture experimentation station; NIFA at the University of Minnesota [MN62-030, MINV-62-035]; Minnesota Agriculture Experiment Station project [MIN-16-096]; National Institutes of Health [HL108627]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108627] Funding Source: NIH RePORTER	Academic Health Center Seed Grant; University of Minnesota(University of Minnesota System); US Department of Agriculture State Agriculture experimentation station; NIFA at the University of Minnesota; Minnesota Agriculture Experiment Station project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the Academic Health Center Seed Grant and the OVPR Grant-in-Aid program at the University of Minnesota to MCJC; Animal Health projects funds from US Department of Agriculture State Agriculture experimentation station and NIFA (MN62-030 and MINV-62-035) at the University of Minnesota to MCJC; Minnesota Agriculture Experiment Station project: MIN-16-096 to SMO; and National Institutes of Health, HL108627 to SMO and AMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bateman AC, 2012, INFLUENZA OTHER RESP, V6, P424, DOI 10.1111/j.1750-2659.2012.00333.x; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Busch MG, 2008, VIRUS RES, V133, P269, DOI 10.1016/j.virusres.2008.01.014; Byrd-Leotis L, 2014, P NATL ACAD SCI USA, V111, pE2241, DOI 10.1073/pnas.1323162111; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; Dobrescu I, 2014, VET MICROBIOL, V169, P18, DOI 10.1016/j.vetmic.2013.11.037; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; HATADA E, 1992, J GEN VIROL, V73, P17, DOI 10.1099/0022-1317-73-1-17; HATADA E, 1992, J GEN VIROL, V73, P3325, DOI 10.1099/0022-1317-73-12-3325; Hauser MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070251; Hsu ACY, 2011, AM J RESP CELL MOL, V44, P906, DOI 10.1165/rcmb.2010-0157OC; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Landolt GA, 2003, J CLIN MICROBIOL, V41, P1936, DOI 10.1128/JCM.41.5.1936-1941.2003; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138704	10.1371/journal.pone.0138704	http://dx.doi.org/10.1371/journal.pone.0138704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384331	gold, Green Published, Green Submitted			2022-12-26	WOS:000361790200149
J	Matsuoka, H; Shima, A; Kuramoto, D; Kikumoto, D; Matsui, T; Michihara, A				Matsuoka, Hiroshi; Shima, Akiho; Kuramoto, Daisuke; Kikumoto, Daisuke; Matsui, Takashi; Michihara, Akihiro			Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor a	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ROR-ALPHA; GENE-TRANSCRIPTION; REV-ERB; CIRCADIAN TRANSCRIPTION; HORMONAL-REGULATION; STAGGERER MOUSE; REGULATORY ROLE; IDENTIFICATION; EXPRESSION	Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes a committed and rate-limiting step in hepatic gluconeogenesis, and its activity is tightly regulated to maintain blood glucose levels within normal limits. PEPCK activity is primarily regulated through hormonal control of gene transcription. Transcription is additionally regulated via a cAMP response unit, which includes a cAMP response element and four binding sites for CCAAT/enhancer-binding protein (C/EBP). Notably, the cAMP response unit also contains a putative response element for retinoic acid receptor-related orphan receptor a (RORa). In this paper, we characterize the effect of the RORa response element on cAMP-induced transcription. Electrophoresis mobility shift assay indicates that RORa binds this response element in a sequence-specific manner. Furthermore, luciferase reporter assays indicate that RORa interacts with C/EBP at the PEPCK promoter to synergistically enhance transcription. We also found that cAMP-induced transcription depends in part on RORa and its response element. In addition, we show that suppression of RORa by siRNA significantly decreased PEPCK transcription. Finally, we found that a RORa antagonist inhibits hepatic gluconeogenesis in an in vitro glucose production assay. Taken together, the data strongly suggest that PEPCK is a direct RORa target. These results define possible new roles for RORa in hepatic gluconeogenesis.	[Matsuoka, Hiroshi; Shima, Akiho; Kuramoto, Daisuke; Kikumoto, Daisuke; Matsui, Takashi; Michihara, Akihiro] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Lab Genome Funct & Pathophysiol, Fukuyama, Hiroshima, Japan	Fukuyama University	Matsuoka, H (corresponding author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Lab Genome Funct & Pathophysiol, Fukuyama, Hiroshima, Japan.	matsuoka@fupharm.fukuyama-u.ac.jp	Matsuoka, Hiroshi/AAI-8629-2020	Matsuoka, Hiroshi/0000-0001-9423-5473	Fukuyama University Grant for Academic Research Projects (GARP)	Fukuyama University Grant for Academic Research Projects (GARP)	This work was supported by Fukuyama University Grant for Academic Research Projects (GARP).	Acquaah-Mensah GK, 2015, J ALZHEIMERS DIS, V44, P827, DOI 10.3233/JAD-141731; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chen YP, 2009, J PHARMACOL EXP THER, V329, P192, DOI 10.1124/jpet.108.148916; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Choudhury M, 2011, MOL CELL ENDOCRINOL, V331, P102, DOI 10.1016/j.mce.2010.08.014; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Devanna P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03994; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Harding HP, 1997, MOL ENDOCRINOL, V11, P1737, DOI 10.1210/me.11.11.1737; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; IMAI E, 1993, J BIOL CHEM, V268, P5353; Jarvis CI, 2002, MOL CELL ENDOCRINOL, V186, P1, DOI 10.1016/S0303-7207(01)00668-2; Kadiri S, 2015, AM J PHYSIOL-ENDOC M, V309, pE105, DOI 10.1152/ajpendo.00518.2014; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kojima H, 2015, TOXICOLOGY, V329, P32, DOI 10.1016/j.tox.2015.01.007; Kuang JY, 2014, FEBS LETT, V588, P1071, DOI 10.1016/j.febslet.2014.02.029; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Lau P, 2011, DIABETOLOGIA, V54, P1169, DOI 10.1007/s00125-011-2046-3; LIU J, 1991, MOL CELL BIOCHEM, V104, P89; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; MUSTERS W, 1989, NUCLEIC ACIDS RES, V17, P9661, DOI 10.1093/nar/17.23.9661; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; PARK EA, 1993, J BIOL CHEM, V268, P613; ROESLER WJ, 1995, J BIOL CHEM, V270, P8225, DOI 10.1074/jbc.270.14.8225; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Solt LA, 2015, ENDOCRINOLOGY, V156, P869, DOI 10.1210/en.2014-1677; Tuong ZK, 2013, ENDOCRINOLOGY, V154, P140, DOI 10.1210/en.2012-1889; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wilson HL, 2002, J BIOL CHEM, V277, P43895, DOI 10.1074/jbc.M203169200; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yeagley D, 2005, MOL ENDOCRINOL, V19, P913, DOI 10.1210/me.2004-0281; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137955	10.1371/journal.pone.0137955	http://dx.doi.org/10.1371/journal.pone.0137955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383638	gold, Green Submitted, Green Published			2022-12-26	WOS:000361790200045
J	Shi, JD; Sun, J; Wu, MN; Hu, NZ; Li, JF; Li, YH; Wang, HX; Hu, YZ				Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang			Inferring Protective CD8(+) T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; HEMORRHAGIC-FEVER; RESPONSES; IDENTIFICATION; FLAVIVIRUS; PREDICTION; INFECTION; REVEALS; CD4(+); ORGANIZATION	Dengue is one of the most globally serious vector-borne infectious diseases in tropical and subtropical areas for which there are currently no effective vaccines. The most highly conserved flavivirus protein, NS5, is an indispensable target of CD8(+) T-cells, making it an ideal vaccine design target. Using the Immune Epitope Database (IEDB), CD8(+) T-cell epitopes of the dengue virus (DENV) NS5 protein were predicted by genotypic frequency of the HLA-A,-B, and-C alleles in Chinese population. Antigenicity scores of all predicted epitopes were analyzed using VaxiJen v2.0. The IEDB analysis revealed that 116 antigenic epitopes for HLA-A (21),-B (53), and-C (42) had high affinity for HLA molecules. Of them, 14 had 90.97-99.35% conversancy among the four serotypes. Moreover, five candidate epitopes, including (200)NS5(210) (94.84%, A*11:01), (515)NS5(525) (98.71%, A*24:02), (225)NS5(232) (99.35%, A*33:03), (516)NS5(523) (98.71%, A*33:03), and (284)NS5(291) (98.06%, A*33:03), were presented by HLA-A. Four candidate epitopes, including (234)NS5(241) (96.77%, B*13:01), (92)NS5(99) (98.06%, B*15:01, B*15:02, and B*46:01), (262)NS5(269) (92.90%, B*38:02), and (538)NS5(547) (90.97%, B*51:01), were presented by HLA-B. Another 9 candidate epitopes, including (514)NS5(522) (98.71%, C*01:02), (514)NS5(524) (98.71%, C*01:02 and C*14:02), (92)NS5(99) (98.06%, C*03:02 and C*15:02), (362)NS5(369) (44.84%, C*03:04 and C*08:01), (225)NS5(232) (99.35%, C*04:01), (234)NS5(241)(96.77%, C*04:01), (361)NS5(369) (94.84%, C*04:01), (515)NS5(522) (98.71%, C*14:02), (515)NS5(524) (98.71%, C*14:02), were presented by HLA-C. Further data showed that the four-epitope combination of (92)NS5(99) (B*15:01, B*15:02, B*46:01, C*03:02 and C*15:02), (200)NS5(210) (A*11:01), (362)NS5(369) (C*03:04, C*08:01), and (514)NS5(524) (C*01:02, C*14:02) could vaccinate >90% of individuals in China. Further in vivo study of our inferred novel epitopes will be needed for a T-cell epitope-based universal vaccine development that may prevent all four China-endemic DENV serotypes.	[Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; [Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Peking Union Med Coll, Kunming 650118, Peoples R China; [Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Yunnan Prov Key Lab Arbo Infect Dis Control Res P, Kunming 650118, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS	Hu, YZ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.	huyunzhangym@126.com			Applied and Fundamental Research program of Yunnan Province [2013FA025]	Applied and Fundamental Research program of Yunnan Province	This research was supported by a grant from the Applied and Fundamental Research program of Yunnan Province (Grant No. 2013FA025), which was received by YZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chang CXL, 2013, EUR J IMMUNOL, V43, P1109, DOI 10.1002/eji.201243088; Duan ZL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-259; Duan ZL, 2015, J MED VIROL, V87, P1077, DOI 10.1002/jmv.24167; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Gededzha MP, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-187; Ghosh A, 2015, INDIAN J MED MICROBI, V33, P3, DOI 10.4103/0255-0857.148369; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; Molero-Abraham Magdalena, 2014, Methods Mol Biol, V1184, P319, DOI 10.1007/978-1-4939-1115-8_18; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; National Health and Family Planning Commission of the Peoples Republic of China, REP PROGR DENG FEV C; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; QIU FX, 1991, AM J TROP MED HYG, V44, P364, DOI 10.4269/ajtmh.1991.44.364; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Tian J, 2012, INT IMMUNOL, V24, P207, DOI 10.1093/intimm/dxr115; Townsley E, 2014, IMMUNOLOGY, V141, P27, DOI 10.1111/imm.12161; Wang BH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0908-x; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Xu G, 2007, AM J TROP MED HYG, V76, P1182; Yao YF, 2013, VACCINE, V31, P2289, DOI 10.1016/j.vaccine.2013.02.065; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959; Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124	43	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138729	10.1371/journal.pone.0138729	http://dx.doi.org/10.1371/journal.pone.0138729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381649	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200155
J	Baez-Saldana, R; Villafuerte-Garcia, A; Cruz-Hervert, P; Delgado-Sanchez, G; Ferreyra-Reyes, L; Ferreira-Guerrero, E; Mongua-Rodriguez, N; Montero-Campos, R; Melchor-Romero, A; Garcia-Garcia, L				Baez-Saldana, Renata; Villafuerte-Garcia, Adriana; Cruz-Hervert, Pablo; Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodriguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; Garcia-Garcia, Lourdes			Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MIDDLE-INCOME COUNTRIES; BACTERIAL PNEUMONIA; HIV-INFECTION; ERA; OUTCOMES; ADULTS; AIDS; EPIDEMIOLOGY; PREVENTION	Background Respiratory manifestations of HIV disease differ globally due to differences in current availability of effective highly active antiretroviral therapy (HAART) programs and epidemiology of infectious diseases. Objective To describe the association between HAART and discharge diagnosis and all-cause in-hospital mortality among hospitalized patients with infectious respiratory disease and HIV/AIDS. Material and Methods We retrospectively reviewed the records of patients hospitalized at a specialty hospital for respiratory diseases in Mexico City between January 1st, 2010 and December 31st, 2011. We included patients whose discharge diagnosis included HIV or AIDS and at least one infectious respiratory diagnosis. The information source was the clinical chart. We analyzed the association between HAART for 180 days or more and type of respiratory disease using polytomous logistic regression and all-cause hospital mortality by multiple logistic regressions. Results We studied 308 patients, of whom 206 (66.9%) had been diagnosed with HIV infection before admission to the hospital. The CD4+ lymphocyte median count was 68 cells/mm(3) [interquartile range (IQR): 30-150]. Seventy-five (24.4%) cases had received HAART for more than 180 days. Pneumocystis jirovecii pneumonia (PJP) (n = 142), tuberculosis (n = 63), and bacterial community-acquired pneumonia (n = 60) were the most frequent discharge diagnoses. Receiving HAART for more than 180 days was associated with a lower probability of PJP [Adjusted odd ratio (aOR): 0.245, 95% Confidence Interval (CI): 0.08-0.8, p = 0.02], adjusted for sociodemographic and clinical covariates. HAART was independently associated with reduced odds (aOR 0.214, 95% CI 0.06-0.75) of all-cause in-hospital mortality, adjusting for HIV diagnosis previous to hospitalization, age, access to social security, low socioeconomic level, CD4 cell count, viral load, and discharge diagnoses. Conclusions HAART for 180 days or more was associated with 79% decrease in all-cause in-hospital mortality and lower frequency of PJP as discharge diagnosis. The prevalence of poorly controlled HIV was high, regardless of whether HIV was diagnosed before or during admission. HIV diagnosis and treatment resources should be improved, and strengthening of HAART program needs to be promoted.	[Baez-Saldana, Renata; Villafuerte-Garcia, Adriana; Cruz-Hervert, Pablo; Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodriguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; Garcia-Garcia, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Baez-Saldana, Renata] Inst Nacl Enfermedades Resp, Serv Clin Neumol Oncol, Mexico City, DF, Mexico; [Baez-Saldana, Renata; Mongua-Rodriguez, Norma] Univ Nacl Autonoma Mexico, Fac Med, Div Posgrad, Mexico City 04510, DF, Mexico; [Cruz-Hervert, Pablo] Univ Nacl Autonoma Mexico, Fac Odontol, Div Posgrad, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	García, Maria de Lourdes/I-2724-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022	García, Maria de Lourdes/0000-0001-5262-1157; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X	National Council of Science and Technology (CONACyT)	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	AVG received a scholarship from the National Council of Science and Technology (CONACyT).	Adebamowo CA, 2014, JAIDS-J ACQ IMM DEF, V67, pS17, DOI 10.1097/QAI.0000000000000255; Baez SR, 2013, NEUMOL CIR TORAX S1, V72, P6; Bartlett J, 2004, DEP HLTH HUMAN SERVI, P13; Bower M, 2003, AIDS, V17, P371, DOI 10.1097/00002030-200302140-00011; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Fink VI, 2011, JAIDS-J ACQ IMM DEF, V56, P467, DOI 10.1097/QAI.0b013e31820bb1c3; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; Hassani AS, 2015, JAIDS-J ACQ IMM DEF, V68, pS257, DOI 10.1097/QAI.0000000000000486; Hull MW, 2008, CHEST, V134, P1287, DOI 10.1378/chest.08-0364; Iglesias Chiesa M, 2011, 30 ANOS VIH SIDA PER, P61; Jiang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083078; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Madeddu G, 2008, INFECTION, V36, P231, DOI 10.1007/s15010-007-7162-0; Madeddu G, 2010, CURR OPIN PULM MED, V16, P201, DOI 10.1097/MCP.0b013e3283375825; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Secretaria de Salud, GUIA MAN ANT PERS CO; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shorr AF, 2004, CHEST, V125, P260, DOI 10.1378/chest.125.1.260; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sullivan JH, 2000, AM J RESP CRIT CARE, V162, P64, DOI 10.1164/ajrccm.162.1.9904101; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, INT STAT CLASS DIS R, V10th	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138115	10.1371/journal.pone.0138115	http://dx.doi.org/10.1371/journal.pone.0138115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379281	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400054
J	Duru, AD; Sutlu, T; Wallblom, A; Uttervall, K; Lund, J; Stellan, B; Gahrton, G; Nahi, H; Alici, E				Duru, Adil Doganay; Sutlu, Tolga; Wallblom, Ann; Uttervall, Katarina; Lund, Johan; Stellan, Birgitta; Gahrton, Gosta; Nahi, Hareth; Alici, Evren			Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; PROTEASOME INHIBITOR BORTEZOMIB; NATURAL-KILLER-CELL; SURVIVIN EXPRESSION; GENE-EXPRESSION; C-MYC; DEATH; DR5; P53	Loss of the chromosomal region 8p21 negatively effects survival in patients with multiple myeloma (MM) that undergo autologous stem cell transplantation (ASCT). In this study, we aimed to identify the immunological and molecular consequences of del(8)(p21) with regards to treatment response and bortezomib resistance. In patients receiving bortezomib as a single first line agent without any high-dose therapy, we have observed that patients with del(8)(p21) responded poorly to bortezomib with 50% showing no response while patients without the deletion had a response rate of 90%. In vitro analysis revealed a higher resistance to bortezomib possibly due to an altered gene expression profile caused by del(8)(p21) including genes such as TRAIL-R4, CCDC25, RHOBTB2, PTK2B, SCARA3, MYC, BCL2 and TP53. Furthermore, while bortezomib sensitized MM cells without del(8)(p21) to TRAIL/APO2L mediated apoptosis, in cells with del (8)(p21) bortezomib failed to upregulate the pro-apoptotic death receptors TRAIL-R1 and TRAIL-R2 which are located on the 8p21 region. Also expressing higher levels of the decoy death receptor TRAIL-R4, these cells were largely resistant to TRAIL/APO2L mediated apoptosis. Corroborating the clinical outcome of the patients, our data provides a potential explanation regarding the poor response of MM patients with del(8)(p21) to bortezomib treatment. Furthermore, our clinical analysis suggests that including immunomodulatory agents such as Lenalidomide in the treatment regimen may help to overcome this negative effect, providing an alternative consideration in treatment planning of MM patients with del(8)(p21).	[Duru, Adil Doganay; Sutlu, Tolga; Wallblom, Ann; Uttervall, Katarina; Lund, Johan; Stellan, Birgitta; Gahrton, Gosta; Nahi, Hareth; Alici, Evren] Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Duru, Adil Doganay; Alici, Evren] Inst Florida, Ctr Dis Aging Vaccine & Gene Therapy, Port St Lucie, FL USA; [Sutlu, Tolga] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey; [Uttervall, Katarina; Lund, Johan; Gahrton, Gosta; Nahi, Hareth; Alici, Evren] Karolinska Univ Hosp, Haematol Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Sabanci University; Karolinska Institutet; Karolinska University Hospital	Alici, E (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Hematol & Regenerat Med, Stockholm, Sweden.	evren.alici@ki.se	Sutlu, Tolga/E-1190-2012; nahi, hareth/AAA-3445-2020; Alici, Evren/A-4696-2010	Sutlu, Tolga/0000-0002-7813-8734; Alici, Evren/0000-0001-5307-6648; Duru, Adil/0000-0002-5844-913X; nahi, hareth/0000-0003-4711-5094	Swedish Cancer Fund (Cancerfonden) [CAN 2013/487]; Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder) [141022]; Swedish Research Council [2011-2784]; VINNOVA [2010-00501]; Karolinska Institutet Foundation [2014fobi41694]; State of Florida [COHH6]	Swedish Cancer Fund (Cancerfonden); Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Karolinska Institutet Foundation(Karolinska Institutet); State of Florida	Swedish Cancer Fund (Cancerfonden): HN, CAN 2013/487, (www.cancerfonden.sse), Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder): EA, 141022 (http://www.rahfo.se/; Om-oss/Cancerforeningen-i-Stockholmli), Swedish Research Council: EA, 2011-2784 (www.vr.se), VINNOVA: EA FH Dnr 2010-00501 (www.vinnova.se), Karolinska Institutet Foundation: HN 2014fobi41694 (https://fonder.ki.se/), State of Florida: COHH6 (http://www.floridahealth.gov/).	Ailawadhi S, 2012, LEUKEMIA LYMPHOMA, V53, P1174, DOI 10.3109/10428194.2011.637212; An JB, 2004, MOL CANCER THER, V3, P727; Anderson KC, 2011, HEMATOL-AM SOC HEMAT, P184, DOI 10.1182/asheducation-2011.1.184; Balsas P, 2009, BIOCHEM PHARMACOL, V77, P804, DOI 10.1016/j.bcp.2008.11.024; Berges C, 2008, IMMUNOLOGY, V124, P234, DOI 10.1111/j.1365-2567.2007.02761.x; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Brown CO, 2013, LEUKEMIA RES, V37, P963, DOI 10.1016/j.leukres.2013.03.004; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Feng XL, 2010, MOL IMMUNOL, V47, P2388, DOI 10.1016/j.molimm.2010.05.003; Fulda S, 2011, ONCOTARGET, V2, P418; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Gmidene A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0489-8; Harousseau Jean-Luc, 2004, Hematology Am Soc Hematol Educ Program, P237; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Holien T, 2012, ONCOTARGET, V3, P739; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jungkunz-Stier I, 2014, LEUKEMIA LYMPHOMA, V55, P168, DOI 10.3109/10428194.2013.794270; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Morales JC, 2007, MOL IMMUNOL, V44, P2587, DOI 10.1016/j.molimm.2006.12.015; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Neben K, 2010, HAEMATOL-HEMATOL J, V95, P1150, DOI 10.3324/haematol.2009.016436; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Surget S, 2012, CANCER RES, V72, P4562, DOI 10.1158/0008-5472.CAN-12-0487; Sutlu T, 2009, BRIT J HAEMATOL, V144, P266, DOI 10.1111/j.1365-2141.2008.07454.x; Sutlu T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0569-9; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Teoh PJ, 2014, LEUKEMIA, V28, P2066, DOI 10.1038/leu.2014.102; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhang Y, 2014, BLOOD, V124, P2675, DOI 10.1182/blood-2014-03-563981; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138248	10.1371/journal.pone.0138248	http://dx.doi.org/10.1371/journal.pone.0138248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378933	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400071
J	Stahl, J; Bergmann, H; Gottig, S; Ebersberger, I; Averhoff, B				Stahl, Julia; Bergmann, Holger; Goettig, Stephan; Ebersberger, Ingo; Averhoff, Beate			Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D	PLOS ONE			English	Article							GALLERIA-MELLONELLA; EPITHELIAL-CELLS; GENETIC-ANALYSIS; PHOSPHATIDYLCHOLINE; IDENTIFICATION; PATHOGENESIS; MUTAGENESIS; INFECTIONS; EXPRESSION; EMERGENCE	Acinetobacter baumannii causes a broad range of opportunistic infections in humans. Its success as an emerging pathogen is due to a combination of increasing antibiotic resistance, environmental persistence and adaptation to the human host. To date very little is known about the molecular basis of the latter. Here we demonstrate that A. baumannii can use phosphatidylcholine, an integral part of human cell membranes, as sole carbon and energy source. We report on the identification of three phospholipases belonging to the PLD superfamily. PLD1 and PLD2 appear restricted to the bacteria and display the general features of bacterial phospholipases D. They possess two PLDc_2 PFAM domains each encompassing the HxKx(4)Dx(6)GS/GGxN (HKD) motif necessary for forming the catalytic core. The third candidate, PLD3, is found in bacteria as well as in eukaryotes and harbours only one PLDc_2 PFAM domain and one conserved HKD motif, which however do not overlap. Employing a markerless mutagenesis system for A. baumannii ATCC 19606(T), we generated a full set of PLD knock-out mutants. Galleria mellonella infection studies as well as invasion experiments using A549 human lung epithelial cells revealed that the three PLDs act in a concerted manner as virulence factors and are playing an important role in host cell invasion.	[Stahl, Julia; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany; [Bergmann, Holger; Ebersberger, Ingo] Goethe Univ Frankfurt, Dept Appl Bioinformat, Inst Cell Biol & Neurosci, D-60054 Frankfurt, Germany; [Goettig, Stephan] Goethe Univ Frankfurt, Inst Med Microbiol & Infect Control, Univ Hosp Frankfurt, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany.	averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649	German Research Council (DFG) [FOR2251]	German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by a grant by the German Research Council (DFG) - FOR2251 (www.acinetobacter.de).	Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berendes F, 1998, APPL ENVIRON MICROB, V64, P2454; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Boeris PS, 2012, MICROBIOL-SGM, V158, P1249, DOI 10.1099/mic.0.054072-0; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Carruthers MD, 2013, GENOME ANNOUNC, P1; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Edwards JL, 2003, INFECT IMMUN, V71, P6381, DOI 10.1128/IAI.71.11.6381-6391.2003; Falagas ME, 2006, CRIT CARE, V10, DOI [10.1186/cc4910, 10.1186/cc4869]; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Mahankali M, 2015, CELL SIGNAL, V27, P69, DOI 10.1016/j.cellsig.2014.09.008; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Moore AD, 2014, BIOINFORMATICS, V30, P282, DOI 10.1093/bioinformatics/btt640; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponting CP, 1996, PROTEIN SCI, V5, P914; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; Sand M, 2014, ENVIRON MICROBIOL, V16, P1490, DOI 10.1111/1462-2920.12188; Sand M, 2011, ARCH MICROBIOL, V193, P723, DOI 10.1007/s00203-011-0713-x; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sun ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103778; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Titball RW, 1998, J APPL MICROBIOL, V84, p127S; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van Dijk MCM, 1998, CURR BIOL, V8, P386, DOI 10.1016/S0960-9822(98)70157-5; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935	59	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138360	10.1371/journal.pone.0138360	http://dx.doi.org/10.1371/journal.pone.0138360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379240	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400088
J	Agamasu, C; Ghanam, RH; Saad, JS				Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.			Structural and Biophysical Characterization of the Interactions between Calmodulin and the Pleckstrin Homology Domain of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; TARGET RECOGNITION; ANALYTICAL ULTRACENTRIFUGATION; NMR-SPECTROSCOPY; BINDING DOMAIN; KINASE; CANCER; ACTIVATION; DIVERSITY; PROTEINS	The translocation of Akt, a serine/threonine kinase, to the plasma membrane is a critical step in the Akt activation pathway. It is established that membrane binding of Akt is mediated by direct interactions between its pleckstrin homology domain (PHD) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3). There is now evidence that Akt activation in many breast cancer cells is also modulated by the calcium-binding protein, calmodulin (CaM). Upon EGF stimulation of breast cancer cells, CaM co-localizes with Akt at the plasma membrane to enhance activation. However, the molecular details of Akt(PHD) interaction with CaM are not known. In this study, we employed NMR, biochemical, and biophysical techniques to characterize CaM binding to Akt(PHD). Our data show that CaM forms a tight complex with the PHD of Akt (dissociation constant = 100 nm). The interaction between CaM and Akt(PHD) is enthalpically driven, and the affinity is greatly dependent on salt concentration, indicating that electrostatic interactions are important for binding. The CaM-binding interface in Akt(PHD) was mapped to two loops adjacent to the PI(3,4,5)P-3 binding site, which represents a rare CaM-binding motif and suggests a synergistic relationship between CaM and PI(3,4,5)P-3 upon Akt activation. Elucidation of the mechanism by which Akt interacts with CaM will help in understanding the activation mechanism, which may provide insights for new potential targets to control the pathophysiological processes of cell survival.	[Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	comprehensive cancer center at the University of Alabama at Birmingham (National Institutes of Health (NIH), NCI) [P30 CA013148]; comprehensive cancer center at the University of Alabama at Birmingham [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER	comprehensive cancer center at the University of Alabama at Birmingham (National Institutes of Health (NIH), NCI); comprehensive cancer center at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a pilot grant (to J. S. S.) from the comprehensive cancer center at the University of Alabama at Birmingham (supported by National Institutes of Health (NIH), NCI, Grant P30 CA013148). The highfield NMR facility and the x-ray core facility that houses the Auto-ITC<INF>200</INF> (acquired through NIH Grant 1S10RR026478) are supported by the comprehensive cancer center at the University of Alabama at Birmingham. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Boyken SE, 2012, PROTEIN SCI, V21, P1288, DOI 10.1002/pro.2114; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; KRISHNARAJU K, 1991, BRIT J CANCER, V63, P346, DOI 10.1038/bjc.1991.82; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Miao BC, 2011, AUTOPHAGY, V7, P650, DOI 10.4161/auto.7.6.15248; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Villarroel A, 2014, J MOL BIOL, V426, P2717, DOI 10.1016/j.jmb.2014.05.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005	62	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27403	27413		10.1074/jbc.M115.673939	http://dx.doi.org/10.1074/jbc.M115.673939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391397	hybrid, Green Published			2022-12-26	WOS:000364794000046
J	Prakhar, P; Holla, S; Ghorpade, DS; Gilleron, M; Puzo, G; Udupa, V; Balaji, KN				Prakhar, Praveen; Holla, Sahana; Ghorpade, Devram Sampat; Gilleron, Martine; Puzo, Germain; Udupa, Vibha; Balaji, Kithiganahalli Narayanaswamy			Ac2PIM-responsive miR-150 and miR-143 Target Receptor-interacting Protein Kinase 2 and Transforming Growth Factor Beta-activated Kinase 1 to Suppress NOD2-induced Immunomodulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL MANNOSIDES; ACYLATION STATE; INNATE IMMUNITY; IN-VIVO; MURAMYL DIPEPTIDE; SOCS3 EXPRESSION; DENDRITIC CELLS	Specific and coordinated regulation of innate immune receptor-driven signaling networks often determines the net outcome of the immune responses. Here, we investigated the cross-regulation of toll-like receptor (TLR)2 and nucleotide-binding oligomerization domain (NOD)2 pathways mediated by Ac2PIM, a tetra-acylated form of mycobacterial cell wall component and muramyl dipeptide (MDP), a peptidoglycan derivative respectively. While Ac2PIM treatment of macrophages compromised their ability to induce NOD2-dependent immunomodulators like cyclooxygenase (COX)-2, suppressor of cytokine signaling (SOCS)-3, and matrix metalloproteinase (MMP)-9, no change in the NOD2-responsive NO, TNF-alpha, VEGF-A, and IL-12 levels was observed. Further, genome-wide microRNA expression profiling identified Ac2PIM-responsive miR-150 and miR-143 to target NOD2 signaling adaptors, RIP2 and TAK1, respectively. Interestingly, Ac2PIM was found to activate the SRC-FAK-PYK2-CREB cascade via TLR2 to recruit CBP/P300 at the promoters of miR-150 and miR-143 and epigenetically induce their expression. Loss-of-function studies utilizing specific miRNA inhibitors establish that Ac2PIM, via the miRNAs, abrogate NOD2-induced PI3K-PKC delta-MAPK pathway to suppress beta-catenin-mediated expression of COX-2, SOCS-3, and MMP-9. Our investigation has thus underscored the negative regulatory role of Ac2PIM-TLR2 signaling on NOD2 pathway which could broaden our understanding on vaccine potential or adjuvant utilities of Ac2PIM and/or MDP.	[Prakhar, Praveen; Holla, Sahana; Ghorpade, Devram Sampat; Udupa, Vibha; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Gilleron, Martine; Puzo, Germain] CNRS, IPBS, F-31077 Toulouse, France; [Gilleron, Martine; Puzo, Germain] Univ Toulouse, F-31077 Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in		Holla, Sahana/0000-0001-5186-0180; Prakhar, Praveen/0000-0001-8726-7397	Dept. of Biotechnology (DBT); Dept. of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); IISc; CSIR	Dept. of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Dept. of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); IISc; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study is supported by funds from the Dept. of Biotechnology (DBT), Dept. of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), and Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA). Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) (to K. N. B.) and fellowship from IISc (to P. P. and S. H.) and CSIR (to D. S. G.) are acknowledged. The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah Z, 2014, EMBO J, V33, P2283, DOI 10.15252/embj.201489055; Juarez-Verdayes MA, 2013, GRAEF ARCH CLIN EXP, V251, P53, DOI 10.1007/s00417-012-2130-5; Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beynon V, 2008, INFLAMM BOWEL DIS, V14, P1033, DOI 10.1002/ibd.20441; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chen KQ, 2008, J LEUKOCYTE BIOL, V83, P1467, DOI 10.1189/jlb.0907607; Cho MK, 2004, BIOCHEM PHARMACOL, V67, P2239, DOI 10.1016/j.bcp.2004.02.024; Court N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024631; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Faisal SM, 2011, VACCINE, V29, P2381, DOI 10.1016/j.vaccine.2011.01.110; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Ghorpade DS, 2013, J BIOL CHEM, V288, P33037, DOI 10.1074/jbc.M113.492496; Ghorpade DS, 2013, J BIOL CHEM, V288, P20592, DOI 10.1074/jbc.M113.472183; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Goodman RH, 2000, GENE DEV, V14, P1553; He ZY, 2013, BIOTECHNOL LETT, V35, P499, DOI 10.1007/s10529-012-1112-3; Holla S, 2014, AUTOPHAGY, V10, P311, DOI 10.4161/auto.27225; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Koslowski MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002523; Landes M. B., 2015, J LEUKOC BIOL; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Nag K, 2009, CURR SIGNAL TRANSD T, V4, P76, DOI 10.2174/157436209788167501; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Singh V, 2015, J IMMUNOL, V194, P3351, DOI 10.4049/jimmunol.1402498; Sprott GD, 2004, INFECT IMMUN, V72, P5235, DOI 10.1128/IAI.72.9.5235-5246.2004; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tan RST, 2014, INT REV IMMUNOL, V33, P443, DOI 10.3109/08830185.2014.921164; Toubiana J, 2015, INNATE IMMUN-LONDON, V21, P685, DOI 10.1177/1753425915586075; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trinath J, 2014, MOL CELL BIOL, V34, P4301, DOI 10.1128/MCB.00641-14; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Vergne I, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00187; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wu JY, 2015, MOL IMMUNOL, V64, P235, DOI 10.1016/j.molimm.2014.11.021; Yang YC, 2003, J NEUROSCI, V23, P4072; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543; Zheng SS, 2015, J IMMUNOL, V194, P1928, DOI 10.4049/jimmunol.1401933; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	70	10	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26576	26586		10.1074/jbc.M115.662817	http://dx.doi.org/10.1074/jbc.M115.662817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26391398	Green Published, hybrid			2022-12-26	WOS:000364793600024
J	Bourgault, D; Cyr, F				Bourgault, Daniel; Cyr, Frederic			Hypoxia in the St. Lawrence Estuary: How a Coding Error Led to the Belief that "Physics Controls Spatial Patterns"	PLOS ONE			English	Article							OXYGEN	Two fundamental sign errors were found in a computer code used for studying the oxygen minimum zone (OMZ) and hypoxia in the Estuary and Gulf of St. Lawrence. These errors invalidate the conclusions drawn from the model, and call into question a proposed mechanism for generating OMZ that challenges classical understanding. The study in question is being cited frequently, leading the discipline in the wrong direction.	[Bourgault, Daniel] Inst Sci Mer Rimouski, Rimouski, PQ, Canada; [Cyr, Frederic] Royal Netherlands Inst Sea Res NIOZ, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Bourgault, D (corresponding author), Inst Sci Mer Rimouski, Rimouski, PQ, Canada.	daniel_bourgault@uqar.ca		Cyr, Frederic/0000-0002-1581-7502				Bearman G, 1989, OCEAN CHEM SEEP SEA; Bourgault D, 2004, J ATMOS OCEAN TECH, V21, P1910, DOI 10.1175/JTECH-1674.1; Cho CW, 2014, J COASTAL RES; Gilbert D., 2009, CROSSING GULF STREAM; Iriarte A, 2015, ESTUAR COAST, V38, P1000, DOI 10.1007/s12237-014-9870-x; Jilbert T, 2015, GEOLOGY, V43, P427, DOI 10.1130/G36454.1; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Lefort S, 2012, J GEOPHYS RES; Lefort S., 2011, THESIS MCGILL U; Li Y, 2015, NANOSCI TECHNOL, P1, DOI 10.1007/978-3-319-14406-1_1; Regnier P, 2013, AQUAT GEOCHEM, V19, P591, DOI 10.1007/s10498-013-9218-3; Silva N, 2014, PROG OCEANOGR, V129, P62, DOI 10.1016/j.pocean.2014.05.016; Villate F, 2013, MAR POLLUT BULL, V70, P234, DOI 10.1016/j.marpolbul.2013.03.010; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7	14	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138858	10.1371/journal.pone.0138858	http://dx.doi.org/10.1371/journal.pone.0138858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397371	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500119
J	Hu, KZ; Tang, XL; Tang, GH; Yao, SB; Yao, BG; Wang, HL; Nie, DH; Liang, X; Tang, CH; He, SZ				Hu, Kongzhen; Tang, Xiaolan; Tang, Ganghua; Yao, Shaobo; Yao, Baoguo; Wang, Hongliang; Nie, Dahong; Liang, Xiang; Tang, Caihua; He, Shanzhen			F-18-FP-PEG(2)-beta-Glu-RGD(2): A Symmetric Integrin alpha(v)beta(3)-Targeting Radiotracer for Tumor PET Imaging	PLOS ONE			English	Article							RGD PEPTIDES; RADIOSYNTHESIS; ANGIOGENESIS	Radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin alpha(v)beta(3) expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new F-18-labeled RGD homodimeric peptide with one 8-amino- 3,6-dioxaoctanoic acid (PEG(2)) linker on the glutamate beta-amino group(F-18-FP-PEG(2)-beta-Glu-RGD(2)) as a symmetric PET tracer for tumor imaging. Biodistribution studies showed that radioactivity of F-18-FP-PEG(2)-beta-Glu-RGD(2) was rapidly cleared from blood by predominately renal excretion. MicroPET-CT imaging with F-18-FP-PEG(2)-beta-Glu-RGD(2) revealed high tumor contrast and low background in A549 human lung adenocarcinoma-bearing mouse models, PC-3 prostate cancer-bearing mouse models, and orthotopic transplanted C6 brain glioma models. F-18-FP-PEG(2)-beta-Glu-RGD(2) exhibited good stability in vitro and in vivo. The results suggest that this tracer is a potential PET tracer for tumor imaging.	[Hu, Kongzhen; Tang, Ganghua; Yao, Shaobo; Yao, Baoguo; Wang, Hongliang; Nie, Dahong; Liang, Xiang; Tang, Caihua; He, Shanzhen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510080, Guangdong, Peoples R China; [Tang, Xiaolan] Southern China Agr Univ, Coll Mat & Energy, Guangzhou 510642, Guangdong, Peoples R China	Sun Yat Sen University; South China Agricultural University	Tang, GH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510080, Guangdong, Peoples R China.	gtang0224@126.com; niedahong@126.com	Yao, Shaobo/AAR-3740-2021	Yao, Shaobo/0000-0003-2245-871X	National Natural Science Foundation [81571704, 81371584, 81201116]; Science Technology Foundation of Guangdong Province [2014A020210008, 2013B021800264]; Science and Technology Planning Project of Guangzhou [2011J5200025, 201510010145]; Wu Jieping Medical Foundation [320675013203]; Sun Yat-Sen University [80000-3126132]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science Technology Foundation of Guangdong Province; Science and Technology Planning Project of Guangzhou; Wu Jieping Medical Foundation; Sun Yat-Sen University	This work was funded by the National Natural Science Foundation (No. 81571704, No. 81371584, No. 81201116), the Science Technology Foundation of Guangdong Province (No. 2014A020210008, No. 2013B021800264), Science and Technology Planning Project of Guangzhou (No. 2011J5200025, No. 201510010145), the Wu Jieping Medical Foundation (320675013203), and Sun Yat-Sen University (No. 80000-3126132).	ALLISON RD, 1977, J BIOL CHEM, V252, P6046; Bandello F, 2013, ACTA DIABETOL, V50, P1, DOI 10.1007/s00592-012-0449-3; Chin FT, 2012, MOL IMAGING BIOL, V14, P88, DOI 10.1007/s11307-011-0477-3; Clementi C, 2011, MOL PHARMACEUT, V8, P1063, DOI 10.1021/mp2001445; Glaser M, 2008, BIOCONJUGATE CHEM, V19, P951, DOI 10.1021/bc700472w; Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; Hu KZ, 2014, J RADIOANAL NUCL CH, V299, P271, DOI 10.1007/s10967-013-2736-z; Hu KZ, 2013, NUCL MED BIOL, V40, P926, DOI 10.1016/j.nucmedbio.2013.06.006; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Langer HF, 2008, J AM COLL CARDIOL, V52, P1, DOI 10.1016/j.jacc.2008.03.036; Li ZB, 2008, EUR J NUCL MED MOL I, V35, P1100, DOI 10.1007/s00259-007-0692-y; Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x; Liu SL, 2010, MOL IMAGING BIOL, V12, P530, DOI 10.1007/s11307-009-0284-2; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1296, DOI 10.1007/s00259-009-1112-2; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robinson P, 2011, APPL ENVIRON MICROB, V67, P4458; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Szekanecz Z, 2010, CURR OPIN RHEUMATOL, V22, P299, DOI 10.1097/BOR.0b013e328337c95a; Tang G, 2013, Chinese Patent, Patent No. [ZL201110275437.2, 201110275437]; Tang GH, 2009, J NUCL MED, V50; Tucker Gordon C, 2003, Curr Opin Investig Drugs, V4, P722; Wu Y, 2005, J NUCL MED, V46, P1707; Wu ZH, 2007, EUR J NUCL MED MOL I, V34, P1823, DOI 10.1007/s00259-007-0427-0; Yan YJ, 2011, AMINO ACIDS, V41, P439, DOI 10.1007/s00726-010-0762-5	25	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138675	10.1371/journal.pone.0138675	http://dx.doi.org/10.1371/journal.pone.0138675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397833	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500093
J	Liu, B; Wu, HY; Wang, YD; Liu, WM				Liu, Bo; Wu, Huayi; Wang, Yandong; Liu, Wenming			Main Road Extraction from ZY-3 Grayscale Imagery Based on Directional Mathematical Morphology and VGI Prior Knowledge in Urban Areas	PLOS ONE			English	Article							RESOLUTION SATELLITE IMAGES; CENTERLINE EXTRACTION; LINEAR FEATURES; SHAPE-FEATURES; AERIAL IMAGES; PATH OPENINGS; NETWORK	Main road features extracted from remotely sensed imagery play an important role in many civilian and military applications, such as updating Geographic Information System (GIS) databases, urban structure analysis, spatial data matching and road navigation. Current methods for road feature extraction from high-resolution imagery are typically based on threshold value segmentation. It is difficult however, to completely separate road features from the background. We present a new method for extracting main roads from high-resolution grayscale imagery based on directional mathematical morphology and prior knowledge obtained from the Volunteered Geographic Information found in the OpenStreetMap. The two salient steps in this strategy are: (1) using directional mathematical morphology to enhance the contrast between roads and non-roads; (2) using OpenStreetMap roads as prior knowledge to segment the remotely sensed imagery. Experiments were conducted on two ZiYuan-3 images and one QuickBird high-resolution grayscale image to compare our proposed method to other commonly used techniques for road feature extraction. The results demonstrated the validity and better performance of the proposed method for urban main road feature extraction.	[Liu, Bo; Wu, Huayi; Wang, Yandong; Liu, Wenming] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Liu, Bo] E China Inst Technol, Fac Geomat, Nanchang City, Peoples R China; [Liu, Bo] E China Inst Technol, Natl Adm Surveying Mapping & Geoinformat, Key Lab Watershed Ecol & Geog Environm Monitoring, Nanchang City, Peoples R China	Wuhan University; East China University of Technology; East China University of Technology	Wang, YD (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China.	ydwang@whu.edu.cn	liu, wen/HGE-3071-2022		National Natural Science Foundation of China [41201395, 41161069, 41271399]; Specialized Research Fund for the Doctoral Program of Higher Education [20120141110036]; Science and Technology Project of Jiangxi Provincial Education Department [GJJ14479]; Key Laboratory of Watershed Ecology and Geographical Environment Monitoring, NASG [WE2015011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Project of Jiangxi Provincial Education Department; Key Laboratory of Watershed Ecology and Geographical Environment Monitoring, NASG	This work was supported by the National Natural Science Foundation of China (No. 41201395, 41161069,41271399), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120141110036), Science and Technology Project of Jiangxi Provincial Education Department (No. GJJ14479), and the Key Laboratory of Watershed Ecology and Geographical Environment Monitoring, NASG (WE2015011).	Amo M, 2006, IEEE T IMAGE PROCESS, V15, P1192, DOI 10.1109/TIP.2005.864232; Barzohar M, 1996, IEEE T PATTERN ANAL, V18, P707, DOI 10.1109/34.506793; Bentabet L, 2003, IEEE T GEOSCI REMOTE, V41, P1785, DOI 10.1109/TGRS.2003.813850; Chanussot J, 1999, IEEE T GEOSCI REMOTE, V37, P1292, DOI 10.1109/36.763290; Chaudhuri D, 2012, IEEE J-STARS, V5, P1538, DOI 10.1109/JSTARS.2012.2199085; Das S, 2011, IEEE T GEOSCI REMOTE, V49, P3906, DOI 10.1109/TGRS.2011.2136381; Gamba P, 2006, IEEE GEOSCI REMOTE S, V3, P387, DOI 10.1109/LGRS.2006.873875; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Grote A, 2012, PHOTOGRAMM REC, V26, P8, DOI 10.1111/j.1477-9730.2011.00670.x; Heijmans H, 2005, J MATH IMAGING VIS, V22, P107, DOI 10.1007/s10851-005-4885-3; Hu XY, 2004, GEOMATICA, V58, P41; Miao ZL, 2013, IEEE GEOSCI REMOTE S, V10, P583, DOI 10.1109/LGRS.2012.2214761; Mokhtarzade M, 2007, INT J APPL EARTH OBS, V9, P32, DOI 10.1016/j.jag.2006.05.001; OReilly Tim, 2005, WHAT IS WEB 2 0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Quackenbush LJ, 2004, PHOTOGRAMM ENG REM S, V70, P1383, DOI 10.14358/PERS.70.12.1383; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shi WZ, 2014, IEEE T GEOSCI REMOTE, V52, P3359, DOI 10.1109/TGRS.2013.2272593; Shi WZ, 2014, IEEE GEOSCI REMOTE S, V11, P788, DOI 10.1109/LGRS.2013.2279034; Shi WZ, 2002, IEEE T GEOSCI REMOTE, V40, P511, DOI 10.1109/36.992826; Soille P, 2001, IEEE T PATTERN ANAL, V23, P1313, DOI 10.1109/34.969120; Song MJ, 2004, PHOTOGRAMM ENG REM S, V70, P1365, DOI 10.14358/PERS.70.12.1365; Talbot H, 2007, IMAGE VISION COMPUT, V25, P416, DOI 10.1016/j.imavis.2006.07.021; Tarabalka Y, 2009, IEEE T GEOSCI REMOTE, V47, P2973, DOI 10.1109/TGRS.2009.2016214; Tuia D, 2009, IEEE T GEOSCI REMOTE, V47, P3866, DOI 10.1109/TGRS.2009.2027895; Valero S, 2010, PATTERN RECOGN LETT, V31, P1120, DOI 10.1016/j.patrec.2009.12.018; Zhu C, 2005, INT J REMOTE SENS, V26, P5493, DOI 10.1080/01431160500300354	27	7	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138071	10.1371/journal.pone.0138071	http://dx.doi.org/10.1371/journal.pone.0138071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397832	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500051
J	Ahmad, F; Hanafi, MM; Hakim, MA; Rafii, MY; Arolu, IW; Abdullah, SNA				Ahmad, Faiz; Hanafi, Mohamed Musa; Hakim, Md Abdul; Rafii, Mohd Y.; Arolu, Ibrahim Wasiu; Abdullah, Siti Nor Akmar			Genetic Divergence and Heritability of 42 Coloured Upland Rice Genotypes (Oryzasativa) as Revealed by Microsatellites Marker and Agro-Morphological Traits	PLOS ONE			English	Article							DIVERSITY; MAP	Coloured rice genotypes have greater nutritious value and consumer demand for these varieties is now greater than ever. The documentation of these genotypes is important for the improvement of the rice plant. In this study, 42 coloured rice genotypes were selected for determination of their genetic divergence using 25 simple sequence repeat (SSR) primers and 15 agro-morphological traits. Twenty-one out of the 25 SSR primers showed distinct, reproducible polymorphism. A dendrogram constructed using the SSR primers clustered the 42 coloured rice genotypes into 7 groups. Further, principle component analysis showed 75.28% of total variations were explained by the first-three components. All agro-morphological traits showed significant difference at the (p <= 0.05) and (p <= 0.01) levels. From the dendrogram constructed using the agro-morphological traits, all the genotypes were clustered into four distinct groups. Pearson's correlation coefficient showed that among the 15 agro-morphological traits, the yield contributing factor had positive correlation with the number of tillers, number of panicles, and panicle length. The heritability of the 15 traits ranged from 17.68 to 99.69%. Yield per plant and harvest index showed the highest value for both heritability and genetic advance. The information on the molecular and agro-morphological traits can be used in rice breeding programmes to improve nutritional value and produce higher yields.	[Ahmad, Faiz; Hakim, Md Abdul; Rafii, Mohd Y.; Arolu, Ibrahim Wasiu] Univ Putra Malaysia, Inst Trop Agr, Lab Food Crops, Serdang 43400, Selangor, Malaysia; [Hanafi, Mohamed Musa; Abdullah, Siti Nor Akmar] Univ Putra Malaysia, Inst Trop Agr, Lab Plantat Crops, Serdang 43400, Selangor, Malaysia; [Hanafi, Mohamed Musa] Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang 43400, Selangor, Malaysia; [Ahmad, Faiz] Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia; [Hakim, Md Abdul] Hajee Mohammad Danesh Sci & Technol Univ, Dept Agr Chem, Dinajpur, Bangladesh	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Agensi Nuklear Malaysia	Hanafi, MM (corresponding author), Univ Putra Malaysia, Inst Trop Agr, Lab Plantat Crops, Serdang 43400, Selangor, Malaysia.	mmhanafi@agri.upm.edu.my; ahakimupm@gmail.com	ahmad, faiz/AAW-2593-2020; Rafii, M.Y./G-9925-2015	Rafii, M.Y./0000-0003-4763-6367; Abdullah, Siti Nor Akmar/0000-0002-3611-6094	Food Security Project, under the Ministry of Education Malaysia (MOE) [LRGS 5525001]	Food Security Project, under the Ministry of Education Malaysia (MOE)	This research was financially supported by the Long-term Research Grant Scheme (LRGS 5525001), Food Security Project, under the Ministry of Education Malaysia (MOE).	Ali S. S., 2000, Pakistan Journal of Agricultural Research, V16, P89; Allard R.W., 1960, S REPORT; Bisne R., 2009, BANGLADESH J AGR RES, V34, P175; Burton G. W., 1952, Proceedings of the Sixth International Grassland Congress 1952, Pennsylvania 1952., V1; 2, P277; CAUSSE MA, 1994, GENETICS, V138, P1251; DEWOODY JA, 1995, J HERED, V86, P317, DOI 10.1093/oxfordjournals.jhered.a111593; DiMichele M, 2009, PLANT BIOSYST, P1; Hanafi M. M., 2009, Pertanika Journal of Tropical Agricultural Science, V32, P225; Harushima Y, 1998, GENETICS, V148, P479; Hu XY, 2009, J GENET GENOMICS, V36, P491, DOI 10.1016/S1673-8527(08)60139-3; IRRI, 2000, BIGG HARV CLEAN PLAN; Jhang T, 2010, J AGR SCI-CAMBRIDGE, V148, P171, DOI 10.1017/S0021859609990591; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P314; Kanagarasu S., 2013, African Journal of Biotechnology, V12, P5723; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Kita T, 1984, HOTSUKAIDO U AGR FAC, P11; Kubo M., 2004, Journal of Food Distribution Research, V35, P128; Laslita-Zapico FC., 2010, PHILIPP J SCI, V139, P177; MESSMER MM, 1992, CROP SCI, V32, P1301, DOI 10.2135/cropsci1992.0011183X003200060001x; Mohanty S., 2013, RICE TODAY; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ramaiah Rao MVBN, 1953, ICAR SCI MONOGRAPH, V19; Ravi M, 2003, EUPHYTICA, V133, P243, DOI 10.1023/A:1025513111279; ROSTA K, 1975, Seed Science and Technology, V3, P161; Seedek SEM, 2009, J AGR RES, V35, P858; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Surek H., 2003, Philippine Journal of Crop Science, V28, P3; Suzuki M, 2004, J JPN SOC FOOD SCI, V51, P424, DOI 10.3136/nskkk.51.424	28	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138246	10.1371/journal.pone.0138246	http://dx.doi.org/10.1371/journal.pone.0138246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393807	Green Published, gold, Green Accepted			2022-12-26	WOS:000361792100044
J	Horschig, JM; Smolders, R; Bonnefond, M; Schoffelen, JM; van den Munckhof, P; Schuurman, PR; Cools, R; Denys, D; Jensen, O				Horschig, Jorn M.; Smolders, Ruud; Bonnefond, Mathilde; Schoffelen, Jan-Mathijs; van den Munckhof, Pepijn; Schuurman, P. Richard; Cools, Roshan; Denys, Damiaan; Jensen, Ole			Directed Communication between Nucleus Accumbens and Neocortex in Humans Is Differentially Supported by Synchronization in the Theta and Alpha Band	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; TREATMENT-RESISTANT DEPRESSION; FIELD POTENTIAL OSCILLATIONS; BASAL GANGLIA; PREFRONTAL CORTEX; WORKING-MEMORY; EEG ALPHA; HIPPOCAMPUS; NETWORK; ATTENTION	Here, we report evidence for oscillatory bi-directional interactions between the nucleus accumbens and the neocortex in humans. Six patients performed a demanding covert visual attention task while we simultaneously recorded brain activity from deep-brain electrodes implanted in the nucleus accumbens and the surface electroencephalogram (EEG). Both theta and alpha oscillations were strongly coherent with the frontal and parietal EEG during the task. Theta-band coherence increased during processing of the visual stimuli. Granger causality analysis revealed that the nucleus accumbens was communicating with the neocortex primarily in the theta-band, while the cortex was communicating the nucleus accumbens in the alpha-band. These data are consistent with a model, in which theta-and alpha-band oscillations serve dissociable roles: Prior to stimulus processing, the cortex might suppress ongoing processing in the nucleus accumbens by modulating alpha-band activity. Subsequently, upon stimulus presentation, theta oscillations might facilitate the active exchange of stimulus information from the nucleus accumbens to the cortex.	[Horschig, Jorn M.; Bonnefond, Mathilde; Schoffelen, Jan-Mathijs; Cools, Roshan; Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Smolders, Ruud; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Schoffelen, Jan-Mathijs] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [van den Munckhof, Pepijn; Schuurman, P. Richard] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands; [Cools, Roshan] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Horschig, JM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	jhorschig@gmail.com; ddenys@gmail.com; ole.jensen@donders.ru.nl	Cools, Roshan/D-1905-2010; Schoffelen, Jan-Mathijs/D-3716-2009; van den Munckhof, Pepijn/AAY-9259-2020; Jensenq, Ole/D-2120-2010; Horschig, Jörn/I-6047-2014; Schuurman, Rick/ABE-9100-2021; Bonnefond, Mathilde/J-7572-2012	Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Jensenq, Ole/0000-0001-8193-8348; Horschig, Jörn/0000-0002-0159-431X; Cools, Roshan/0000-0001-8994-5534	research program "The healthy brain" - Netherlands Initiative Brain and Cognition (NIHC), a part of the Organization for Scientific Research (NWO) [056-14-011, 056-14-012]; VICI [453-09-002]; James McDonnell Scholar Award; Medtronic Inc.	research program "The healthy brain" - Netherlands Initiative Brain and Cognition (NIHC), a part of the Organization for Scientific Research (NWO); VICI(Netherlands Organization for Scientific Research (NWO)); James McDonnell Scholar Award; Medtronic Inc.(Medtronic)	This work is supported by the research program "The healthy brain" funded by the Netherlands Initiative Brain and Cognition (NIHC), a part of the Organization for Scientific Research (NWO) under grant numbers 056-14-011 (O.J.) and 056-14-012 (D.D.), a VICI grant under number 453-09-002 (O.J.). R.C. is supported by a James McDonnell Scholar Award. The DBS intervention was supported by an unrestricted investigator-initiated research grant by Medtronic Inc., which provided the devices used.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antzoulatos EG, 2014, NEURON, V83, P216, DOI 10.1016/j.neuron.2014.05.005; Axmacher N, 2010, NEURON, V65, P541, DOI 10.1016/j.neuron.2010.02.006; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Blomstedt P, 2011, ACTA PSYCHIAT SCAND, V123, P4, DOI 10.1111/j.1600-0447.2010.01625.x; Calhoon GG, 2013, NEURON, V78, P181, DOI 10.1016/j.neuron.2013.01.032; Cohen MX, 2012, HUM BRAIN MAPP, V33, P246, DOI 10.1002/hbm.21195; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P875, DOI 10.1162/jocn.2009.21062; Cohen MX, 2009, J NEUROSCI, V29, P7591, DOI 10.1523/JNEUROSCI.5335-08.2009; Cohen MX, 2009, NEUROPSYCHOPHARMACOL, V34, P1649, DOI 10.1038/npp.2008.222; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Giacobbe P, 2009, EXP NEUROL, V219, P44, DOI 10.1016/j.expneurol.2009.04.028; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940; HABER SN, 1995, J NEUROSCI, V15, P4851; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Horschig JM, 2014, NEUROIMAGE, V89, P235, DOI 10.1016/j.neuroimage.2013.12.018; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Ketz NA, 2015, TRENDS NEUROSCI, V38, P3, DOI 10.1016/j.tins.2014.09.007; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Lega BC, 2011, NEUROREPORT, V22, P795, DOI 10.1097/WNR.0b013e32834b2975; Luigjes J, 2012, MOL PSYCHIATR, V17, P572, DOI 10.1038/mp.2011.114; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Nauczyciel Cecilia, 2013, J Mol Psychiatry, V1, P17, DOI 10.1186/2049-9256-1-17; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pierce RC, 2013, PSYCHOPHARMACOLOGY, V229, P487, DOI 10.1007/s00213-013-3214-6; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Ruzon M, 1999, COMP VIS PATT REC 19, V2, P166, DOI [10.1109/CVPR.1999.784624, DOI 10.1109/CVPR.1999.784624]; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Schlaepfer T E, 2013, Handb Clin Neurol, V116, P235, DOI 10.1016/B978-0-444-53497-2.00018-8; Smolders R, 2013, BIOL PSYCHIAT, V74, pE27, DOI 10.1016/j.biopsych.2013.03.012; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; van den Munckhof Pepijn, 2013, Acta Neurochir Suppl, V117, P53, DOI 10.1007/978-3-7091-1482-7_9; van Schouwenburg MR, 2010, J NEUROSCI, V30, P9910, DOI 10.1523/JNEUROSCI.1111-10.2010; van Schouwenburg MR, 2013, CEREB CORTEX N Y N 1, V1991, DOI [10.1093/cercor/bht345, DOI 10.1093/CERC0R/BHT345]; Wiener N, 1956, THEORY PREDICTION MO; WILSON GT, 1972, SIAM J APPL MATH, V23, P420, DOI 10.1137/0123044	64	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138685	10.1371/journal.pone.0138685	http://dx.doi.org/10.1371/journal.pone.0138685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394404	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100086
J	Shamai, S; Nabiochtchikov, I; Kraus, S; Zigdon, S; Kazanov, D; Itzhak-Klutch, M; Eizner, C; Arber, N; Geva, R				Shamai, Sivan; Nabiochtchikov, Ilana; Kraus, Sarah; Zigdon, Sally; Kazanov, Dina; Itzhak-Klutch, Michal; Eizner, Carmit; Arber, Nadir; Geva, Ravit			CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC MARKER; HUMAN B-CELLS; COLORECTAL-CANCER; TUMOR-GROWTH; EXPRESSION; APOPTOSIS; MOLECULE	Background There are no validated biomarkers that correlate with the prognosis of pancreatic ductal adenocarcinoma (PDA). The CD24 and adenomatous polyposis coli (APC) genes are important in the malignant transformation of gastrointestinal cells. This study examined APC and CD24 genetic polymorphisms and their possible impact on survival of patients with PDA. Methods Clinical and pathological data as well as blood samples for extracting DNA were obtained for 73 patients with PDA. Real-time PCR assessed genetic variants of APC (I1307K and E1317Q), and four different single nucleotide polymorphisms (SNPs) in the CD24 gene: C170T (rs52812045), TG1527del (rs3838646), A1626G (rs1058881) and A1056G (rs1058818). Results The median age at diagnosis was 64 (41-90) years. Thirty-one patients (42.5%) were operable, 16 (22%) had locally advanced disease and 26 (35.5%) had disseminated metastatic cancer. The malignancy-related mortality rate was 84%. Median survival was 14 months (11.25-16.74). Survival was similar for wild-type (WT), heterozygous and homozygous variants of the APC or CD24 genes. The three most frequent CD24 SNP combinations were: heterozygote for A1626G and WT for the rest of the alleles (14% of patients), heterozygote for C170T, A1626G, A1056G and WT for the rest (14% of patients), and heterozygote for C170T, A1056G and WT for the rest (10% of patients). All patients were APC WT. The first two groups were significantly younger at diagnosis than the third group. Conclusions Specific polymorphisms in the APC and CD24 genes may play a role in pancreatic cancer development. Correlation with survival requires a larger cohort.	[Shamai, Sivan; Geva, Ravit] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel; [Nabiochtchikov, Ilana; Kraus, Sarah; Zigdon, Sally; Kazanov, Dina; Itzhak-Klutch, Michal; Eizner, Carmit; Arber, Nadir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel; [Nabiochtchikov, Ilana; Kraus, Sarah; Arber, Nadir] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Arber, N (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel.	nadira@tlvmc.gov.il		Arber, Nadir/0000-0001-5283-6991				Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bretz NP, 2012, CELL MOL LIFE SCI, V69, P3863, DOI 10.1007/s00018-012-1055-9; Choi YL, 2005, GYNECOL ONCOL, V97, P379, DOI 10.1016/j.ygyno.2005.01.018; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Grant RC, 2014, GASTROENTEROLOGY, P01479, DOI [10.1053/j.gastro.2014.11.042, DOI 10.1053/J.GASTR0.2014.11.042]; JACKSON D, 1992, CANCER RES, V52, P5264; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jung KC, 2004, J IMMUNOL, V172, P795, DOI 10.4049/jimmunol.172.2.795; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Liberman E, 2007, BIOMED PHARMACOTHER, V61, P566, DOI 10.1016/j.biopha.2007.08.016; Lisiansky V, 2014, INT J BIOL MARKER, V29, pE62, DOI 10.5301/jbm.5000072; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Poncet C, 1996, ACTA NEUROPATHOL, V91, P400, DOI 10.1007/s004010050442; Sadot E, 2014, INT J BIOL MARKER, V29, pE49, DOI 10.5301/jbm.5000071; Sagiv E, 2006, BIOMED PHARMACOTHER, V60, P280, DOI 10.1016/j.biopha.2006.06.006; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sano A, 2009, ANN SURG ONCOL, V16, P506, DOI 10.1245/s10434-008-0252-0; Sella T, 2013, EUR J INTERN MED, V24, P245, DOI 10.1016/j.ejim.2012.12.012; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spirio LN, 1998, NAT GENET, V20, P385, DOI 10.1038/3865; Strom A, 2007, DEVELOPMENT, V134, P2719, DOI 10.1242/dev.02875; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang LZ, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030049; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Woodward WA, 2008, CANCER METAST REV, V27, P459, DOI 10.1007/s10555-008-9130-2	34	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0134469	10.1371/journal.pone.0134469	http://dx.doi.org/10.1371/journal.pone.0134469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394139	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100002
J	Kekalainen, J; Soler, C; Veentaus, S; Huuskonen, H				Kekalainen, Jukka; Soler, Carles; Veentaus, Sami; Huuskonen, Hannu			Male Investments in High Quality Sperm Improve Fertilization Success, but May Have Negative Impact on Offspring Fitness in Whitefish	PLOS ONE			English	Article							PARENTAL IDENTITY; ALPINE WHITEFISH; LIFE-HISTORY; SELECTION; PERFORMANCE; COMPETITION; TRAITS; GROWTH	Many ejaculate traits show remarkable variation in relation to male social status. Males in disfavoured (subordinate) mating positions often invest heavily on sperm motility but may have less available resources on traits (e.g., secondary sexual ornaments) that improve the probability of gaining matings. Although higher investments in sperm motility can increase the relative fertilization success of subordinate males, it is unclear whether status-dependent differences in sperm traits could have any consequences for offspring fitness. We tested this possibility in whitefish (Coregonus lavaretus L.) by experimentally fertilizing the eggs of 24 females with the sperm of either highly-ornamented (large breeding tubercles, dominant) or less-ornamented (small tubercles, subordinate) males (split-clutch breeding design). In comparison to highly-ornamented individuals, less-ornamented males had higher sperm motility, which fertilized the eggs more efficiently, but produced embryos with impaired hatching success. Also offspring size and body condition were lower among less-ornamented males. Furthermore, sperm motility was positively associated with the fertilization success and offspring size, but only in highly-ornamented males. Together our results indicate that male investments on highly motile (fertile) sperm is not necessarily advantageous during later offspring ontogeny and that male status-dependent differences in sperm phenotype may have important effects on offspring fitness in different life-history stages.	[Kekalainen, Jukka; Veentaus, Sami; Huuskonen, Hannu] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Kekalainen, Jukka] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Soler, Carles] Univ Valencia, Dept Biol Func & Antropol Fis, E-46100 Burjassot, Spain	University of Eastern Finland; University of Western Australia; University of Valencia	Kekalainen, J (corresponding author), Univ Eastern Finland, Dept Biol, Joensuu, Finland.	jukka.kekalainen@uwa.edu.au	Soler, Carles/AAB-2305-2019	Huuskonen, Hannu/0000-0001-5609-768X	Kone Foundation; European Union [PIOF-GA-2013-629472]	Kone Foundation; European Union(European Commission)	JK was funded by Kone Foundation (http://www.koneensaatio.fi/en/) and the European Union under a Marie Curie International Outgoing Fellowship for Career Development (PIOF-GA-2013-629472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Clark ES, 2011, J BACTERIOL PARASITO, pS4; Crean AJ, 2014, TRENDS ECOL EVOL, V29, P554, DOI 10.1016/j.tree.2014.07.009; Crean AJ, 2013, ECOLOGY, V94, P2575, DOI 10.1890/13-0184.1; Crean AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049167; Egeland TB, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00077; Eilertsen EM, 2009, P ROY SOC B-BIOL SCI, V276, P129, DOI 10.1098/rspb.2008.0884; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Garant D, 2002, EVOL ECOL RES, V4, P537; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Garcia-Gonzalez F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-140; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; Huuskonen H, 2009, BIOL J LINN SOC, V98, P532, DOI 10.1111/j.1095-8312.2009.01315.x; Jensen N, 2014, FUNCT ECOL, V28, P724, DOI 10.1111/1365-2435.12195; Kekalainen J, 2010, EVOLUTION, V64, P3149, DOI 10.1111/j.1558-5646.2010.01084.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kustan JM, 2012, P ROY SOC B-BIOL SCI, V279, P434, DOI 10.1098/rspb.2011.0997; Lupold S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4184; Marshall DJ, 2015, J EXP BIOL, V218, P107, DOI 10.1242/jeb.106427; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Neff BD, 2004, BEHAV ECOL, V15, P327, DOI 10.1093/beheco/arh016; Parker GA, 2013, EVOLUTION, V67, P95, DOI 10.1111/j.1558-5646.2012.01741.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Reichard M, 2007, ANIM BEHAV, V74, P679, DOI 10.1016/j.anbehav.2007.03.005; Ritchie H, 2013, J EXP BIOL, V216, P3104, DOI 10.1242/jeb.087221; Rudolfsen G, 2008, BEHAV ECOL SOCIOBIOL, V62, P561, DOI 10.1007/s00265-007-0480-5; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Wedekind C, 2001, J EVOLUTION BIOL, V14, P980, DOI 10.1046/j.1420-9101.2001.00349.x; Wedekind C, 2008, GENETICA, V132, P199, DOI 10.1007/s10709-007-9164-3; Wiley ML., 1970, B AM MUS NAT HIST, V143, P145; Zajitschek S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0422	36	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0137005	10.1371/journal.pone.0137005	http://dx.doi.org/10.1371/journal.pone.0137005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26389594	Green Published, Green Submitted, gold			2022-12-26	WOS:000361791000005
J	Perez-Rosas, NC; Gomez-Viquez, NL; Dagnino-Acosta, A; Santillan, M; Guerrero-Hernandez, A				Perez-Rosas, Norma C.; Gomez-Viquez, Norma L.; Dagnino-Acosta, Adan; Santillan, Moises; Guerrero-Hernandez, Agustin			Kinetics on Demand Is a Simple Mathematical Solution that Fits Recorded Caffeine-Induced Luminal SR Ca2+ Changes in Smooth Muscle Cells	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; INDUCTION DECAY; CALSEQUESTRIN; STORE; SKELETAL; PROPAGATION; TERMINATION	The process of Ca2+ release from sarcoplasmic reticulum (SR) comprises 4 phases in smooth muscle cells. Phase 1 is characterized by a large increase of the intracellular Ca2+ concentration ([Ca2+](i)) with a minimal reduction of the free luminal SR [Ca2+] ([Ca2+](FSR)). Importantly, active SR Ca2+ ATPases (SERCA pumps) are necessary for phase 1 to occur. This situation cannot be explained by the standard kinetics that involves a fixed amount of luminal Ca2+ binding sites. A new mathematical model was developed that assumes an increasing SR Ca2+ buffering capacity in response to an increase of the luminal SR [Ca2+] that is called Kinetics-on-Demand (KonD) model. This approach can explain both phase 1 and the refractory period associated with a recovered [Ca2+](FSR). Additionally, our data suggest that active SERCA pumps are a requisite for KonD to be functional; otherwise luminal SR Ca2+ binding proteins switch to standard kinetics. The importance of KonD Ca2+ binding properties is twofold: a more efficient Ca2+ release process and that [Ca2+](FSR) and Ca2+-bound to SR proteins ([Ca2+](BSR)) can be regulated separately allowing for Ca2+ release to occur (provided by Ca2+-bound to luminal Ca2+ binding proteins) without an initial reduction of the [Ca2+](FSR).	[Perez-Rosas, Norma C.; Santillan, Moises] CINVESTAV, Unidad Monterrey, Apodaca, Nuevo Leon, Mexico; [Gomez-Viquez, Norma L.] CINVESTAV, Unidad Sur, Dept Farmacobiol, Mexico City 14000, DF, Mexico; [Dagnino-Acosta, Adan] Univ Colima, Ctr Univ Invest Biomed, Colima, Colima, Mexico; [Guerrero-Hernandez, Agustin] CINVESTAV, Dept Bioquim, Mexico City 14000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad de Colima; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Guerrero-Hernandez, A (corresponding author), CINVESTAV, Dept Bioquim, Mexico City 14000, DF, Mexico.	aguerrero@cinvestav.mx	Dagnino-Acosta, Adan/K-6786-2012; Santillan, Moises/A-2942-2008	Santillan, Moises/0000-0001-8605-7451; Dagnino-Acosta, Adan/0000-0001-8903-807X	Consejo Nacional de Ciencia y Tecnologia (MX) [128735, 266919]	Consejo Nacional de Ciencia y Tecnologia (MX)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (MX) grant 128735 to AGH and grant 266919 to NCPR (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Maldonado B, 2003, CELL SIGNAL, V15, P689, DOI 10.1016/S0898-6568(03)00012-3; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; Brochet DXP, 2005, P NATL ACAD SCI USA, V102, P3099, DOI 10.1073/pnas.0500059102; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Cannell MB, 2013, BIOPHYS J, V104, P2149, DOI 10.1016/j.bpj.2013.03.058; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dagnino-Acosta A, 2009, CELL CALCIUM, V46, P188, DOI 10.1016/j.ceca.2009.07.005; Gillespie D, 2012, CELL CALCIUM, V51, P427, DOI 10.1016/j.ceca.2012.02.001; Gomez-Viquez L, 2003, BIOPHYS J, V85, P370, DOI 10.1016/S0006-3495(03)74481-6; GUERRERO A, 1994, J GEN PHYSIOL, V104, P395, DOI 10.1085/jgp.104.2.395; Guerrero-Hernandez A, 2010, CELL CALCIUM, V48, P143, DOI 10.1016/j.ceca.2010.08.001; HAVLIN S, 1995, CHAOS SOLITON FRACT, V6, P171, DOI 10.1016/0960-0779(95)80025-C; HOFER AM, 1995, FASEB J, V9, P788, DOI 10.1096/fasebj.9.9.7601343; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; IKEMOTO N, 1991, BIOCHEMISTRY-US, V30, P5230, DOI 10.1021/bi00235a017; Ikemoto N, 2000, BIOCHEM BIOPH RES CO, V279, P858, DOI 10.1006/bbrc.2000.4031; Keller M, 2007, CARDIOVASC RES, V74, P39, DOI 10.1016/j.cardiores.2007.02.006; Kirber MT, 2000, J PHYSIOL-LONDON, V524, P3, DOI 10.1111/j.1469-7793.2000.t01-4-00003.x; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Laver DR, 2013, J MOL CELL CARDIOL, V54, P98, DOI 10.1016/j.yjmcc.2012.10.009; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Gomez-Viquez NL, 2010, AM J PHYSIOL-CELL PH, V298, pC1038, DOI 10.1152/ajpcell.00222.2009; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Manno C, 2013, J PHYSIOL-LONDON, V591, P423, DOI 10.1113/jphysiol.2012.243444; Maxwell JT, 2012, J PHYSIOL-LONDON, V590, P6037, DOI 10.1113/jphysiol.2012.239434; MESZAROS LG, 1985, J BIOL CHEM, V260, P6076; Murphy RM, 2011, AM J PHYSIOL-HEART C, V300, pH595, DOI 10.1152/ajpheart.00902.2010; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Pozzo-Miller LD, 1999, MICROSC RES TECHNIQ, V46, P370, DOI 10.1002/(SICI)1097-0029(19990915)46:6<370::AID-JEMT5>3.0.CO;2-3; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Steenbergen JF, 1996, J BIOL CHEM, V271, P1821, DOI 10.1074/jbc.271.4.1821; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Zhou YY, 1999, J PHYSIOL-LONDON, V521, P351, DOI 10.1111/j.1469-7793.1999.00351.x; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0138195	10.1371/journal.pone.0138195	http://dx.doi.org/10.1371/journal.pone.0138195			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390403	gold, Green Published, Green Submitted			2022-12-26	WOS:000361791000019
J	Fleck, AT; Schulze, S; Hinrichs, M; Specht, A; Wassmann, F; Schreiber, L; Schenk, MK				Fleck, Alexander T.; Schulze, Sascha; Hinrichs, Martin; Specht, Andre; Wassmann, Friedrich; Schreiber, Lukas; Schenk, Manfred K.			Silicon Promotes Exodermal Casparian Band Formation in Si-Accumulating and Si-Excluding Species by Forming Phenol Complexes	PLOS ONE			English	Article							RICE ORYZA-SATIVA; RADIAL HYDRAULIC CONDUCTIVITY; ZEA-MAYS L.; ENDODERMAL CELL-WALLS; REDUCES SODIUM UPTAKE; CHEMICAL-COMPOSITION; APOPLASTIC BARRIERS; LIGNIN BIOSYNTHESIS; SALINE CONDITIONS; CLIVIA-MINIATA	We studied the effect of Silicon (Si) on Casparian band (CB) development, chemical composition of the exodermal CB and Si deposition across the root in the Si accumulators rice and maize and the Si non-accumulator onion. Plants were cultivated in nutrient solution with and without Si supply. The CB development was determined in stained root cross-sections. The outer part of the roots containing the exodermis was isolated after enzymatic treatment. The exodermal suberin was transesterified with MeOH/BF3 and the chemical composition was measured using gas chromatography-mass spectroscopy (GC-MS) and flame ionization detector (GC-FID). Laser ablation-inductively coupled plasma-mass spectroscopy (LA-ICP-MS) was used to determine the Si deposition across root cross sections. Si promoted CB formation in the roots of Si-accumulator and Si non-accumulator species. The exodermal suberin was decreased in rice and maize due to decreased amounts of aromatic suberin fractions. Si did not affect the concentration of lignin and lignin-like polymers in the outer part of rice, maize and onion roots. The highest Si depositions were found in the tissues containing CB. These data along with literature were used to suggest a mechanism how Si promotes the CB development by forming complexes with phenols.	[Fleck, Alexander T.; Schulze, Sascha; Hinrichs, Martin; Specht, Andre; Schenk, Manfred K.] Leibniz Univ Hannover, Fac Nat Sci, Inst Plant Nutr, D-30419 Hannover, Germany; [Wassmann, Friedrich; Schreiber, Lukas] Univ Bonn, Dept Ecophysiol, Inst Cellular & Mol Bot, D-53115 Bonn, Germany	Leibniz University Hannover; University of Bonn	Fleck, AT (corresponding author), Leibniz Univ Hannover, Fac Nat Sci, Inst Plant Nutr, Herrenhauser Str 2, D-30419 Hannover, Germany.	fleck@pflern.uni-hannover.de	Lukas, Schreiber/AAJ-9201-2020	Lukas, Schreiber/0000-0001-7003-9929	DFG [SCHR 506/12-1]	DFG(German Research Foundation (DFG))	Part of this work was supported by a DFG grant (SCHR 506/12-1) to LS.	ARNON D. I., 1939, PLANT PHYSIOL, V14, P371, DOI 10.1104/pp.14.2.371; BARNUM DW, 1972, INORG CHEM, V11, P1424, DOI 10.1021/ic50112a052; BARNUM DW, 1970, INORG CHEM, V9, P1942, DOI 10.1021/ic50090a038; Barrowclough DE, 2000, J EXP BOT, V51, P547, DOI 10.1093/jexbot/51.344.547; BENNETT DM, 1982, ANN BOT-LONDON, V50, P239, DOI 10.1093/oxfordjournals.aob.a086361; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BRUNDRETT MC, 1988, PROTOPLASMA, V146, P133, DOI 10.1007/BF01405922; Currie HA, 2009, PHYTOCHEMISTRY, V70, P2089, DOI 10.1016/j.phytochem.2009.07.039; Enstone DE, 2002, J PLANT GROWTH REGUL, V21, P335, DOI 10.1007/s00344-003-0002-2; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fang Jiang-yu, 2006, J Zhejiang Univ Sci B, V7, P267, DOI 10.1631/jzus.2006.B0267; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Fleck AT, 2011, J EXP BOT, V62, P2001, DOI 10.1093/jxb/erq392; Franke RB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00004; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gong HJ, 2006, PLANT CELL ENVIRON, V29, P1970, DOI 10.1111/j.1365-3040.2006.01572.x; GONI MA, 1990, GEOCHIM COSMOCHIM AC, V54, P3065, DOI 10.1016/0016-7037(90)90122-2; Haysom MB, 2006, COMMUN SOIL SCI PLAN, V37, P2299, DOI 10.1080/00103620600819420; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; HODSON MJ, 1989, ANN BOT-LONDON, V64, P659, DOI 10.1093/oxfordjournals.aob.a087891; Hose E, 2001, J EXP BOT, V52, P2245, DOI 10.1093/jexbot/52.365.2245; INANAGA S, 1995, SOIL SCI PLANT NUTR, V41, P103, DOI 10.1080/00380768.1995.10419563; Johnson D. B., 1961, TAPPI, V44, P793; KOLATTUKUDY PE, 1974, LIPIDS, V9, P682, DOI 10.1007/BF02532176; Kotula L, 2009, J EXP BOT, V60, P2155, DOI 10.1093/jxb/erp089; Law C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-112; Lenochova Z, 2009, BIOL PLANTARUM, V53, P263, DOI 10.1007/s10535-009-0049-4; LEWIN J, 1969, ANN REV PLANT PHYSIO, V20, P289, DOI 10.1146/annurev.pp.20.060169.001445; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; MA JF, 1989, SOIL SCI PLANT NUTR, V35, P347, DOI 10.1080/00380768.1989.10434768; MELCHIOR W, 1993, PLANT PHYSIOL, V101, P1305, DOI 10.1104/pp.101.4.1305; Meyer CJ, 2011, BOTANY, V89, P119, DOI 10.1139/B10-092; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Mitani N, 2005, J EXP BOT, V56, P1255, DOI 10.1093/jxb/eri121; Mitani N, 2009, PLANT CELL PHYSIOL, V50, P5, DOI 10.1093/pcp/pcn110; Mitani N, 2009, PLANT CELL, V21, P2133, DOI 10.1105/tpc.109.067884; Moore KL, 2011, PLANT PHYSIOL, V156, P913, DOI 10.1104/pp.111.173088; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; NOVOZAMSKY I, 1984, COMMUN SOIL SCI PLAN, V15, P205, DOI 10.1080/00103628409367470; PARRY DW, 1972, ANN BOT-LONDON, V36, P781, DOI 10.1093/oxfordjournals.aob.a084633; PERUMALLA CJ, 1986, CAN J BOT, V64, P1873, DOI 10.1139/b86-248; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranathunge K, 2003, PLANTA, V217, P193, DOI 10.1007/s00425-003-0984-9; Ranathunge K, 2011, PLANT CELL ENVIRON, V34, P1223, DOI 10.1111/j.1365-3040.2011.02318.x; Schreiber L., 2007, P109, DOI 10.1007/978-1-4020-5843-1_8; Schreiber L, 2005, J EXP BOT, V56, P1427, DOI 10.1093/jxb/eri144; SCHREIBER L, 1994, BOT ACTA, V107, P353, DOI 10.1111/j.1438-8677.1994.tb00807.x; Schreiber L, 1999, J EXP BOT, V50, P1267, DOI 10.1093/jexbot/50.337.1267; Shi XH, 2005, PLANT SOIL, V272, P53, DOI 10.1007/s11104-004-3920-2; Shi Y, 2013, J PLANT PHYSIOL, V170, P847, DOI 10.1016/j.jplph.2013.01.018; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Yeo AR, 1999, PLANT CELL ENVIRON, V22, P559, DOI 10.1046/j.1365-3040.1999.00418.x; Zeier J, 1997, PLANT PHYSIOL, V113, P1223, DOI 10.1104/pp.113.4.1223; Zeier J, 1999, PLANTA, V209, P1, DOI 10.1007/s004250050601; Zeier J, 1998, PLANTA, V206, P349, DOI 10.1007/s004250050410; Zimmermann HM, 2000, PLANTA, V210, P302, DOI 10.1007/PL00008138	60	59	60	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138555	10.1371/journal.pone.0138555	http://dx.doi.org/10.1371/journal.pone.0138555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383862	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200126
J	Garvilles, RG; Hasegawa, T; Kimura, H; Sharif, J; Muto, M; Koseki, H; Takahashi, S; Suetake, I; Tajima, S				Garvilles, Ronald Garingalao; Hasegawa, Takashi; Kimura, Hironobu; Sharif, Jafar; Muto, Masahiro; Koseki, Haruhiko; Takahashi, Saori; Suetake, Isao; Tajima, Shoji			Dual Functions of the RFTS Domain of Dnmt1 in Replication-Coupled DNA Methylation and in Protection of the Genome from Aberrant Methylation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE 1; CYTOSINE-5 METHYLTRANSFERASES; IMPRINTED GENE; PROTEIN UHRF1; SRA DOMAIN; MAINTENANCE; COMPLEX; EXPRESSION; PCNA	In mammals, DNA methylation plays important roles in embryogenesis and terminal differentiation via regulation of the transcription-competent chromatin state. The methylation patterns are propagated to the next generation during replication by maintenance DNA methyltransferase, Dnmt1, in co-operation with Uhrf1. In the N-terminal regulatory region, Dnmt1 contains proliferating cell nuclear antigen (PCNA)-binding and replication foci targeting sequence (RFTS) domains, which are thought to contribute to maintenance methylation during replication. To determine the contributions of the N-terminal regulatory domains to the DNA methylation during replication, Dnmt1 lacking the RFTS and/or PCNA-binding domains was ectopically expressed in embryonic stem cells, and then the effects were analyzed. Deletion of both the PCNA-binding and RFTS domains did not significantly affect the global DNA methylation level. However, replication-dependent DNA methylation of the differentially methylated regions of three imprinted genes, Kcnq1ot1/Lit1, Peg3, and Rasgrf1, was impaired in cells expressing the Dnmt1 with not the PCNA-binding domain alone but both the PCNA-binding and RFTS domains deleted. Even in the absence of Uhrf1, which is a prerequisite factor for maintenance DNA methylation, Dnmt1 with both the domains deleted apparently maintained the global DNA methylation level, whilst the wild type and the forms containing the RFTS domain could not perform global DNA methylation under the conditions used. This apparent maintenance of the global DNA methylation level by the Dnmt1 lacking the RFTS domain was dependent on its own DNA methylation activity as well as the presence of de novo-type DNA methyltransferases. We concluded that the RFTS domain, not the PCNA-binding domain, is solely responsible for the replication-coupled DNA methylation. Furthermore, the RFTS domain acts as a safety lock by protecting the genome from replication-independent DNA methylation.	[Garvilles, Ronald Garingalao; Hasegawa, Takashi; Kimura, Hironobu; Takahashi, Saori; Suetake, Isao; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 5650871, Japan; [Sharif, Jafar; Muto, Masahiro; Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Suetake, Isao] JST, CREST, Saitama 3320012, Japan	Osaka University; RIKEN; Japan Science & Technology Agency (JST)	Tajima, S (corresponding author), Osaka Univ, Inst Prot Res, Lab Epigenet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tajima@protein.osaka-u.ac.jp	Koseki, Haruhiko/I-3825-2014; Suetake, Isao/G-3144-2013; Kimura, Hironobu/B-3731-2010; Suetake, Isao/D-4326-2009	Koseki, Haruhiko/0000-0001-8424-5854; Suetake, Isao/0000-0002-1246-8474; Takahashi, Saori/0000-0001-9195-3656	Japan Society for the Promotion of Science; CREST by Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST by Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was partly supported by Grants-in-Aid for Scientific Research B (ST), Scientific Research C (IS) from the Japan Society for the Promotion of Science, and CREST by Japan Science and Technology Agency (IS).	Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Awakumov GV, 2008, NATURE, V455, P822, DOI [10.1038/nature07273, DOI 10.1038/NATURE07273]; Bashtrykov P, 2014, CHEMBIOCHEM, V15, P743, DOI 10.1002/cbic.201300740; Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brown T., 2001, CURR PROTOC MOL BIOL; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mertineit C, 1998, DEVELOPMENT, V125, P889; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Otani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082961; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schneider K, 2013, NUCLEIC ACIDS RES, V41, P4860, DOI 10.1093/nar/gkt191; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Sugiyama Y, 2010, BIOCHEM J, V427, P489, DOI 10.1042/BJ20091856; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Wu BK, 2014, CELL CYCLE, V13, P3222, DOI 10.4161/15384101.2014.950886	55	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137509	10.1371/journal.pone.0137509	http://dx.doi.org/10.1371/journal.pone.0137509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383849	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200026
J	Guo, SM; Han, M; Chen, MX; Ning, Y; Pei, GC; Li, YQ; Dai, W; Ge, SW; Deng, YJ; Guo, YY; Li, XQ; Haller, H; Xu, G; Rong, S				Guo, Shui-Ming; Han, Min; Chen, Mei-Xue; Ning, Yong; Pei, Guang-Chang; Li, Yue-Qiang; Dai, Wei; Ge, Shu-Wang; Deng, Yuan-Jun; Guo, Yan-Yan; Li, Xiao-Qing; Haller, Hermann; Xu, Gang; Rong, Song			Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China	PLOS ONE			English	Article							OXFORD CLASSIFICATION; GLOMERULAR-DISEASE; NATURAL-HISTORY; VALIDATION; SUPAR; ACTIVATION; EXPRESSION; PODOCYTES; FSGS	Background Soluble urokinase receptor (suPAR) may be involved in the pathological mechanisms of focal segmental glomerulosclerosis (FSGS) changes. However, it remains unclear whether suPAR is correlated with the FSGS-like lesions in IgA nephropathy (IgAN). 3 Methods We measured the plasma suPAR levels in 138 patients with IgAN, and then their clinical and pathological relationships were analyzed. Results We found that the plasma suPAR levels were significantly correlated with age and renal function by both univariate and multivariate analysis in our IgAN patient cohort. Female had higher plasma suPAR levels and no significant correlation was observed between plasma suPAR levels and 24-h urine protein and highly sensitive C-reaction protein with multivariate analysis. In our cohort, sixty of these IgAN patients could be diagnosed with a type of FSGS lesions. The plasma suPAR levels were higher in the IgAN patients with FSGS lesions than in the IgAN patients without FSGS lesions by univariate (P < 0.0001) and multivariate (P < 0.001) analysis adjusting for other predictor variables, which might be helpful to differentiate the pathological changes with and without FSGS lesions. And the optimal cutoff value was 1806 pg/ml in this study. The plasma suPAR concentrations were also associated with the degree of tubular atrophy/interstitial fibrosis in both univariate and multivariate analysis. In multivariate analysis, the plasma suPAR levels were correlated with the percentage of crescents, not global sclerosis and arterial lesions. Conclusions Our study suggested that the plasma suPAR levels were associated with age, gender, renal function, the degree of tubular atrophy/interstitial fibrosis and the percentage of crescent formation. The plasma suPAR might be a potential predictor for the presence of FSGS pathological lesions in Chinese patients with IgAN.	[Guo, Shui-Ming; Han, Min; Chen, Mei-Xue; Ning, Yong; Pei, Guang-Chang; Li, Yue-Qiang; Dai, Wei; Ge, Shu-Wang; Deng, Yuan-Jun; Guo, Yan-Yan; Li, Xiao-Qing; Xu, Gang; Rong, Song] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol,Div Internal Med, Wuhan 430074, Hubei, Peoples R China; [Haller, Hermann; Rong, Song] Hannover Med Sch, Dept Nephrol, Hannover, Germany	Huazhong University of Science & Technology; Hannover Medical School	Han, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol,Div Internal Med, Wuhan 430074, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn	deng, qiongxia/A-3206-2017	/0000-0001-9985-1515	National Natural Science Foundation of China [81370798, 81470948]; National Natural Science Foundation of China for Young Scholar [81100485]; Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [2014KYQD01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Young Scholar; Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	This work was supported by grants of the National Natural Science Foundation of China (No. 81370798, 81470948), National Natural Science Foundation of China for Young Scholar (No. 81100485), Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (No. 2014KYQD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, KIDNEY INT, V22, P643; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Coppo R, 2010, KIDNEY INT, V77, P417, DOI 10.1038/ki.2009.473; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; Deegens JK, 2014, NAT REV NEPHROL, V10, P431, DOI 10.1038/nrneph.2014.113; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Hill GS, 2011, KIDNEY INT, V79, P635, DOI 10.1038/ki.2010.466; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Maas RJH, 2014, KIDNEY INT, V85, P711, DOI 10.1038/ki.2013.513; Meijers B, 2015, KIDNEY INT, V87, P210, DOI 10.1038/ki.2014.197; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Palacios CRF, 2013, TRANSPLANTATION, V96, P394, DOI 10.1097/TP.0b013e3182977ab1; Qin DD, 2015, LUPUS, V24, P546, DOI 10.1177/0961203314558857; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; SCHENA FP, 1990, AM J MED, V89, P209; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sinniah R, 1984, Contrib Nephrol, V40, P156; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Theilade S, 2015, J INTERN MED, V277, P362, DOI 10.1111/joim.12269; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Weber CL, 2009, NEPHROL DIAL TRANSPL, V24, P483, DOI 10.1093/ndt/gfn513; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Ye ZC, 2009, CLIN INVEST MED, V32, pE20; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011	37	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138718	10.1371/journal.pone.0138718	http://dx.doi.org/10.1371/journal.pone.0138718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380984	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200150
J	Porter, JR; Weitzner, BD; Lange, OF				Porter, Justin R.; Weitzner, Brian D.; Lange, Oliver F.			A Framework to Simplify Combined Sampling Strategies in Rosetta	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; MOLECULAR-DYNAMICS; CS-ROSETTA; LOOP; ALGORITHMS; EPITOPE	A core task in computational structural biology is the search of conformational space for low energy configurations of a biological macromolecule. Because conformational space has a very high dimensionality, the most successful search methods integrate some form of prior knowledge into a general sampling algorithm to reduce the effective dimensionality. However, integrating multiple types of constraints can be challenging. To streamline the incorporation of diverse constraints, we developed the Broker: an extension of the Rosetta macromolecular modeling suite that can express a wide range of protocols using constraints by combining small, independent modules, each of which implements a different set of constraints. We demonstrate expressiveness of the Broker through several code vignettes. The framework enables rapid protocol development in both biomolecular design and structural modeling tasks and thus is an important step towards exposing the rich functionality of Rosetta's core libraries to a growing community of users addressing a diverse set of tasks in computational biology.	[Porter, Justin R.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Weitzner, Brian D.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Lange, Oliver F.] Tech Univ Munich, Fak Chem, Lehrstuhl Biomol NMR Spektroskopie, D-80290 Munich, Germany	Washington University (WUSTL); Johns Hopkins University; Technical University of Munich	Porter, JR (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	justinrporter@wustl.edu		Weitzner, Brian/0000-0002-1909-0961; Porter, Justin/0000-0002-0340-951X	DAAD [A/11/84304]; RosettaCommons; Human Frontiers in Science Program; DFG [LA 1817/3-1];  [R01 GM078221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221, P41GM103311] Funding Source: NIH RePORTER	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); RosettaCommons; Human Frontiers in Science Program(Human Frontier Science Program); DFG(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JRP was supported by DAAD grant A/11/84304 and a grant from the RosettaCommons. BDW was supported by R01 GM078221. OFL was supported by the Human Frontiers in Science Program and DFG grant LA 1817/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Azoitei ML, 2014, PROTEINS, V82, P2770, DOI 10.1002/prot.24641; Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Baker D, 2012, PROT STRUCT FUNCT BI, DOI [10.1002/prot.23245, DOI 10.1002/PR0T.23245]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Honegger A, 2001, J MOL BIOL, V309, P657, DOI 10.1006/jmbi.2001.4662; Huang P-S, 2011, J MOL BIOL, V6, DOI [10.1371/journal.pone.0024109, DOI 10.1371/J0URNAL.P0NE.0024109]; Inbar Y, 2005, PHYS BIOL, V2, pS156, DOI 10.1088/1478-3975/2/4/S10; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Wollacott AM, 2007, PROTEIN SCI, V16, P165, DOI 10.1110/ps.062270707; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang ZY, 2014, J BIOMOL NMR, V59, P135, DOI 10.1007/s10858-014-9832-4	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138220	10.1371/journal.pone.0138220	http://dx.doi.org/10.1371/journal.pone.0138220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381271	Green Published, gold			2022-12-26	WOS:000361790200072
J	Baum, G; Januar, HI; Ferse, SCA; Kunzmann, A				Baum, Gunilla; Januar, Hedi I.; Ferse, Sebastian C. A.; Kunzmann, Andreas			Local and Regional Impacts of Pollution on Coral Reefs along the Thousand Islands North of the Megacity Jakarta, Indonesia	PLOS ONE			English	Article							BAY; STRESS; EUTROPHICATION; CLASSIFICATION; COMMUNITIES; ASSEMBLAGES; DISTURBANCE; DIVERSITY; HERBIVORY; VARIABLES	Worldwide, coral reefs are challenged by multiple stressors due to growing urbanization, industrialization and coastal development. Coral reefs along the Thousand Islands off Jakarta, one of the largest megacities worldwide, have degraded dramatically over recent decades. The shift and decline in coral cover and composition has been extensively studied with a focus on large-scale gradients (i.e. regional drivers), however special focus on local drivers in shaping spatial community composition is still lacking. Here, the spatial impact of anthropogenic stressors on local and regional scales on coral reefs north of Jakarta was investigated. Results indicate that the direct impact of Jakarta is mainly restricted to inshore reefs, separating reefs in Jakarta Bay from reefs along the Thousand Islands further north. A spatial patchwork of differentially degraded reefs is present along the islands as a result of localized anthropogenic effects rather than regional gradients. Pollution is the main anthropogenic stressor, with over 80% of variation in benthic community composition driven by sedimentation rate, NO2, PO4 and Chlorophyll a. Thus, the spatial structure of reefs is directly related to intense anthropogenic pressure from local as well as regional sources. Therefore, improved spatial management that accounts for both local and regional stressors is needed for effective marine conservation.	[Baum, Gunilla; Ferse, Sebastian C. A.; Kunzmann, Andreas] Bremen GmbH, Dept Ecol, Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany; [Baum, Gunilla] Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany; [Januar, Hedi I.] Indonesian Res Ctr Marine & Fisheries Prod Proc &, Slipi, Jakarta Pusat, Indonesia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen	Baum, G (corresponding author), Bremen GmbH, Dept Ecol, Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany.	gunilla.baum@gmail.com	Kunzmann, Andreas/O-1345-2013; Ferse, Sebastian/AAH-8048-2021; Kunzmann, Andreas/O-5459-2019	Kunzmann, Andreas/0000-0002-9500-4332; Ferse, Sebastian/0000-0003-0930-5356; Kunzmann, Andreas/0000-0002-9500-4332	German Federal Ministry of Education and Research (BMBF) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project [03F0641A]	German Federal Ministry of Education and Research (BMBF) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project	This study was funded by the German Federal Ministry of Education and Research (BMBF, Grant no. 03F0641A, http://www.bmbf.de/en/) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project. The grant was received by AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrar M, 2011, J INDONESIAN CORAL R, V1, P7; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2013, DAILY MAIL; Arifin Z., 2004, LOCAL MILLENIUM ECOS; Badan Pusat Statistik (BPS), 2012, JUML PEND MEN JEN KE; BAK RPM, 1989, NETH J SEA RES, V23, P95, DOI 10.1016/0077-7579(89)90004-5; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; Bell PRF, 2014, AMBIO, V43, P361, DOI 10.1007/s13280-013-0443-1; Bengen DG, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P413, DOI 10.1007/1-4020-3655-8_24; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Blackburn S, 2013, MEGACITIES AND THE COAST: RISK, RESILIENCE AND TRANSFORMATION, P1; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brinkhoff T, 2011, PRINCIPAL AGGLOMERAT; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P3653, DOI 10.1007/s10531-004-4692-y; Cleary DFR, 2014, MAR ECOL PROG SER, V501, P89, DOI 10.3354/meps10678; Cleary DFR, 2008, AQUAT SCI, V70, P419, DOI 10.1007/s00027-008-8077-2; Cordova M. R., 2012, INT C AGR ENG CIGR A; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Damar A, 2012, J TROP BIOL CONSERV, V9, P61; Damar A., 2003, THESIS FORSCHUNGS UN; Death G., 2008, GREAT BARRIER REEF M; DeVantier L, 1995, CONTENDING GLOBAL CH, V10, P1; Dikou A, 2006, MAR POLLUT BULL, V52, P7, DOI 10.1016/j.marpolbul.2005.07.021; Djohani RH, 1994, P IOC WESTPAC 3 INT, P265; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Dutton I. M., 2005, The politics and economics of Indonesia's natural resources, P162; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; English D, 1994, REFERENCE METHODS MA, V61, P72; English S., 1997, SURVEY MANUAL TROPIC, V2; Erdmann M. V., 1998, P COR REEF EV WORKSH, P84; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Farhan AR, 2012, OCEAN COAST MANAGE, V65, P1, DOI 10.1016/j.ocecoaman.2012.04.015; Fauzi A, 2002, COAST MANAGE, V30, P167, DOI 10.1080/089207502753504698; Fox HE, 2006, ECOL APPL, V16, P1631, DOI 10.1890/1051-0761(2006)016[1631:RFBFOC]2.0.CO;2; GESAMP, 2001, PROT OC LAND BAS ACT, P71; Gomez ED, 1988, CORAL REEF MANAGEMEN, P171; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Hosono T, 2011, ESTUAR COAST SHELF S, V92, P297, DOI 10.1016/j.ecss.2011.01.010; Huang DW, 2009, RAFFLES B ZOOL, P69; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; KKP, 2011, STAT PER TANGK IND 2; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Koropitan AF, 2009, ICES J MAR SCI, V66, P336, DOI 10.1093/icesjms/fsp011; Kusumanti I, 2013, THESIS U BREMEN; Madduppa Hawis H., 2013, Biodiversitas, V14, P17; Madduppa HH, 2012, ENVIRON BIOL FISH, V95, P383, DOI 10.1007/s10641-012-0012-7; Ministry of Marine Affairs and Fisheries, 2009, COR TRIANGL IN IND N; Moll H., 1986, UNESCO Reports in Marine Science, V40, P112; Moll H, 1983, THESIS LEIDEN; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Ongkosongo OSR, 1986, P MAB COMAR REG WORK, P133; Pelling M, 2013, MEGACITIES AND THE COAST: RISK, RESILIENCE AND TRANSFORMATION, P200; Rachello-Dolmen PG, 2007, ESTUAR COAST SHELF S, V73, P816, DOI 10.1016/j.ecss.2007.03.017; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Rees JG, 1999, OCEANOL ACTA, V22, P627, DOI 10.1016/S0399-1784(00)88954-9; Rinawati, 2012, J HAZARD MATER, V217, P208, DOI 10.1016/j.jhazmat.2012.03.023; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Sale PF, 2014, MAR POLLUT BULL, V85, P8, DOI 10.1016/j.marpolbul.2014.06.005; Selig ER, 2006, CORAL REEFS CLIMATE, V61, P111, DOI DOI 10.1029/61CE07; SLUITER CP, 1888, NATUURK TIJDSCHR NED, V47, P181; Stoddart DR, 1986, HUMAN INDUCED DAMAGE, V40, P112; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Tomascik Tomas, 1994, P304; Umbgrove J. H. F., 1939, Zool Med Mus Leiden, V22, P1; Uneputty PA, 1997, MAR POLLUT BULL, V34, P652, DOI 10.1016/S0025-326X(97)00006-4; UNESCO, 1994, PROT JOINT GLOB OC F, V29; United Nations, 2014, DEMOGR RES; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Veron JEN, 1986, CORALS AUSTR INDOPAC, P644; VERSTAPPEN HT, 1988, J COASTAL RES, V4, P573; Verstappen HT, 1953, THESIS U UTRECHT, P1; Wenger AS, 2014, J EXP BIOL, V217, P1122, DOI 10.1242/jeb.094409; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Williams GJ, 2015, ECOGRAPHY, V38, P751, DOI 10.1111/ecog.01353; Williams TM, 2000, MAR POLLUT BULL, V40, P277, DOI 10.1016/S0025-326X(99)00226-X; Zaneveld JS, 1952, J SCI RES, V3, P58	89	49	51	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138271	10.1371/journal.pone.0138271	http://dx.doi.org/10.1371/journal.pone.0138271			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378910	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400078
J	Weekes, D; Kashima, TG; Zandueta, C; Perurena, N; Thomas, DP; Sunters, A; Vuillier, C; Bozec, A; El-Emir, E; Miletich, I; Patino-Garcia, A; Lecanda, F; Grigoriadis, AE				Weekes, D.; Kashima, T. G.; Zandueta, C.; Perurena, N.; Thomas, D. P.; Sunters, A.; Vuillier, C.; Bozec, A.; El-Emir, E.; Miletich, I.; Patino-Garcia, A.; Lecanda, F.; Grigoriadis, A. E.			Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTORS; C-FOS PROTOONCOGENE; NUCLEAR TRANSLOCATION; GENE-EXPRESSION; TRANSGENIC MICE; BONE; DIFFERENTIATION; CANCER; OVEREXPRESSION; OSTEOBLASTS	Osteosarcoma is the most common primary malignancy of the skeleton and is prevalent in children and adolescents. Survival rates are poor and have remained stagnant owing to chemoresistance and the high propensity to form lung metastases. In this study, we used in vivo transgenic models of c-fos oncogene-induced osteosarcoma and chondrosarcoma in addition to c-Fos-inducible systems in vitro to investigate downstream signalling pathways that regulate osteosarcoma growth and metastasis. Fgfr1 (fibroblast growth factor receptor 1) was identified as a novel c-Fos/activator protein-1(AP-1)-regulated gene. Induction of c-Fos in vitro in osteoblasts and chondroblasts caused an increase in Fgfr1 RNA and FGFR1 protein expression levels that resulted in increased and sustained activation of mitogen-activated protein kinases (MAPKs), morphological transformation and increased anchorage-independent growth in response to FGF2 ligand treatment. High levels of FGFR1 protein and activated pFRS2 alpha signalling were observed in murine and human osteosarcomas. Pharmacological inhibition of FGFR1 signalling blocked MAPK activation and colony growth of osteosarcoma cells in vitro. Orthotopic injection in vivo of FGFR1-silenced osteosarcoma cells caused a marked twofold to fivefold decrease in spontaneous lung metastases. Similarly, inhibition of FGFR signalling in vivo with the small-molecule inhibitor AZD4547 markedly reduced the number and size of metastatic nodules. Thus deregulated FGFR signalling has an important role in osteoblast transformation and osteosarcoma formation and regulates the development of lung metastases. Our findings support the development of anti-FGFR inhibitors as potential antimetastatic therapy.	[Weekes, D.; Kashima, T. G.; Thomas, D. P.; Sunters, A.; Vuillier, C.; El-Emir, E.; Miletich, I.; Grigoriadis, A. E.] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England; [Zandueta, C.; Perurena, N.; Lecanda, F.] Univ Navarra, Ctr Appl Med Res CIMA, Div Oncol, Adhes & Metastasis Lab, E-31080 Pamplona, Spain; [Bozec, A.] Univ Klinikum Erlangen, Dept Rheumatol & Immunol, Erlangen, Germany; [Patino-Garcia, A.] Univ Navarra, Ctr Appl Med Res CIMA, Lab Pediat, E-31080 Pamplona, Spain; [Patino-Garcia, A.; Lecanda, F.] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Weekes, D.] Kings Coll London, Breakthrough Breast Canc Unit, London SE1 9RT, England; [Sunters, A.] Univ London Royal Vet Coll, London, England	University of London; King's College London; University of Navarra; University of Erlangen Nuremberg; University of Navarra; University of London; King's College London; University of London; University of London Royal Veterinary College	Grigoriadis, AE (corresponding author), Kings Coll London, Guys Hosp, Dept Craniofacial Dev & Stem Cell Biol, Tower Floor 27, London SE1 9RT, England.	agi.grigoriadis@kcl.ac.uk	Patiño-Garcia, Ana/I-4299-2012; Bozec, Aline/M-6942-2015	Patiño-Garcia, Ana/0000-0002-4066-8203; Bozec, Aline/0000-0001-8174-2118; Weekes, Daniel/0000-0001-8083-7617; Zandueta Pascual, Carolina/0000-0002-7931-8649; Miletich, Isabelle/0000-0003-2817-7492; Perurena, Naiara/0000-0003-0874-3389	Bone Cancer Research Trust, UK [BCRT04/07, BCRT09/08]; Wellcome Trust [059344]; Arthritis Research UK [G0538]; Medical Research Council [G78/4785]; 'UTE project FIMA' agreement; Cancer Research Thematic Network of the Health Institute Carlos III [RTICC RD06/0020/0066]; Spanish Ministry of Science and Innovation; European Regional Development Fund (ERDF); AECC grant	Bone Cancer Research Trust, UK; Wellcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 'UTE project FIMA' agreement; Cancer Research Thematic Network of the Health Institute Carlos III; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (ERDF)(European Commission); AECC grant	This manuscript is dedicated to the memory of Dr Takeshi G Kashima, friend and colleague, without whom this work would not progress. We thank Dr M Albert Basson (KCL, London, UK), Dr Ozge Uluckan (CNIO, Madrid, Spain) and Dr Latifa Bakiri (CNIO, Madrid, Spain) for helpful comments and critical reading of the manuscript and Professor Larry J Suva (UAMS, Little Rock, AR, USA) for the microCT analysis. This work was supported in part by: Bone Cancer Research Trust, UK (BCRT04/07; BCRT09/08), Wellcome Trust (059344), Arthritis Research UK (G0538) and Medical Research Council (G78/4785) to AEG; 'UTE project FIMA' agreement, The Cancer Research Thematic Network of the Health Institute Carlos III (RTICC RD06/0020/0066), Spanish Ministry of Science and Innovation and European Regional Development Fund (ERDF) 'Una manera de hacer Europa' and AECC grant to FL. FL is an investigator from the I3 Program.	Amary MF, 2014, CANCER MED-US, V3, P980, DOI 10.1002/cam4.268; Ando Kosei, 2012, Sarcoma, V2012, P523432, DOI 10.1155/2012/523432; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Bodo M, 2002, MOL MED, V8, P393, DOI 10.1007/BF03402020; Bozec A, 2010, J CELL BIOL, V190, P1093, DOI 10.1083/jcb.201002111; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Carter EP, 2015, TRENDS CELL BIOL, V25, P221, DOI 10.1016/j.tcb.2014.11.003; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FERRACINI R, 1995, ONCOGENE, V10, P739; Franchi A, 1998, VIRCHOWS ARCH, V432, P515, DOI 10.1007/s004280050199; Fujiwara M, 2011, TUMOR BIOL, V32, P611, DOI 10.1007/s13277-011-0160-y; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; LADANYI M, 1993, DIAGN MOL PATHOL, V2, P163, DOI 10.1097/00019606-199303000-00024; Marie PJ, 2005, J CELL BIOCHEM, V96, P888, DOI 10.1002/jcb.20582; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Mills IG, 2012, SEMIN CELL DEV BIOL, V23, P165, DOI 10.1016/j.semcdb.2011.09.004; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Ng AJM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-19; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Sabbieti MG, 2005, CELL TISSUE RES, V319, P267, DOI 10.1007/s00441-004-0981-8; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Shimizu T, 2012, MOL CANCER RES, V10, P454, DOI 10.1158/1541-7786.MCR-11-0347; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Sunters A, 1998, DEV GENET, V22, P386, DOI 10.1002/(SICI)1520-6408(1998)22:4<386::AID-DVG8>3.0.CO;2-2; Thomas DP, 2000, J CELL SCI, V113, P439; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; WANG ZQ, 1995, CANCER RES, V55, P6244; WANG ZQ, 1991, EMBO J, V10, P2437, DOI 10.1002/j.1460-2075.1991.tb07783.x; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; WU JX, 1990, ONCOGENE, V5, P989; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	53	38	38	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2852	2861		10.1038/onc.2015.344	http://dx.doi.org/10.1038/onc.2015.344			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26387545	Green Accepted			2022-12-26	WOS:000377473700005
J	Dai, A; Ye, F; Taylor, DW; Hu, GQ; Ginsberg, MH; Taylor, KA				Dai, Aguang; Ye, Feng; Taylor, Dianne W.; Hu, Guiqing; Ginsberg, Mark H.; Taylor, Kenneth A.			The Structure of a Full-length Membrane-embedded Integrin Bound to a Physiological Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; EXTENDED CONFORMATIONS; EXTRACELLULAR SEGMENT; GLYCOPROTEIN-IIB; ACTIVATION; FIBRINOGEN; COMPLEX; ALPHA(IIB)BETA(3)	Increased ligand binding to integrin ("activation") underpins many biological processes, such as leukocyte trafficking, cell migration, host-pathogen interaction, and hemostasis. Integrins exist in several conformations, ranging from compact and bent to extended and open. However, the exact conformation of membrane-embedded, full-length integrin bound to its physiological macromolecular ligand is still unclear. Integrin alpha(IIb)beta(3), the most abundant integrin in platelets, has been a prototype for integrin activation studies. Using negative stain electron microscopy and nanodisc-embedding to provide a membrane-like environment, we visualized the conformation of full-length alpha(IIb)beta(3) in both a Mn2+-activated, ligand-free state and a Mn2+-activated, fibrin-bound state. Activated but ligand-free integrins exist mainly in the compact conformation, whereas fibrin-bound alpha(IIb)beta(3) predominantly exists in a fully extended, headpiece open conformation. Our results show that membrane-embedded, full-length integrin adopts an extended and open conformation when bound to its physiological macromolecular ligand.	[Dai, Aguang; Taylor, Dianne W.; Hu, Guiqing; Taylor, Kenneth A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Hematol & Oncol, La Jolla, CA 92093 USA	State University System of Florida; Florida State University; University of California System; University of California San Diego	Taylor, KA (corresponding author), Florida State Univ, Inst Mol Biophys, 91 Chieftan Way, Tallahassee, FL 32306 USA.	taylor@bio.fsu.edu			Florida State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, R01HL117807, P01HL031950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Florida State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We utilized the instruments at the Biological Science Imaging Resource supported by Florida State University for this study.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Choi WS, 2013, BLOOD, V122, P4165, DOI 10.1182/blood-2013-04-499194; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Coutinho A, 2007, BIOPHYS CHEM, V130, P76, DOI 10.1016/j.bpc.2007.07.007; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kato A, 1997, CRIT REV ONCOL HEMAT, V26, P1, DOI 10.1016/S1040-8428(97)00011-5; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; MULLER B, 1993, J BIOL CHEM, V268, P6800; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; PARISE LV, 1985, J BIOL CHEM, V260, P698; Quinn MJ, 2003, ARTERIOSCL THROM VAS, V23, P945, DOI 10.1161/01.ATV.0000066686.46338.F1; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor DW, 2007, J STRUCT BIOL, V160, P305, DOI 10.1016/j.jsb.2007.04.011; Taylor KA, 1999, J STRUCT BIOL, V128, P75, DOI 10.1006/jsbi.1999.4167; Winkler H, 2009, J STRUCT BIOL, V165, P64, DOI 10.1016/j.jsb.2008.10.004; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	53	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27168	27175		10.1074/jbc.M115.682377	http://dx.doi.org/10.1074/jbc.M115.682377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391523	Green Published, hybrid			2022-12-26	WOS:000364794000026
J	He, PP; OuYang, XP; Li, Y; Lv, YC; Wang, ZB; Yao, F; Xie, W; Tan, YL; Li, L; Zhang, M; Lan, G; Gong, D; Cheng, HP; Zhong, HJ; Liu, D; Huang, C; Li, ZX; Zheng, XL; Yin, WD; Tang, CK				He, Ping-Ping; OuYang, Xin-Ping; Li, Yuan; Lv, Yun-Cheng; Wang, Zong-Bao; Yao, Feng; Xie, Wei; Tan, Yu-Lin; Li, Liang; Zhang, Min; Lan, Gang; Gong, Duo; Cheng, Hai-Peng; Zhong, Hui-Juan; Liu, Dan; Huang, Chong; Li, Zhao-Xia; Zheng, Xi-Long; Yin, Wei-Dong; Tang, Chao-Ke			MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice	PLOS ONE			English	Article							ATTENUATES LIPID-ACCUMULATION; DOWN-REGULATION; CHOLESTEROL EFFLUX; MACROPHAGES; CONTRIBUTES; METABOLISM; RETENTION; SECRETION; OXIDATION; GENE	Recent studies have suggested that miR-590 may play critical roles in cardiovascular disease. This study was designed to determine the effects of miR-590 on lipoprotein lipase (LPL) expression and development of atherosclerosis in apolipoprotein E knockout (apoE(-/-)) mice and explore the potential mechanisms. En face analysis of the whole aorta revealed that miR-590 significantly decreased aortic atherosclerotic plaque size and lipid content in apoE (-/-) mice. Double immunofluorescence staining in cross-sections of the proximal aorta showed that miR-590 agomir reduced CD68 and LPL expression in macrophages in atherosclerotic lesions. MiR-590 agomir down-regulated LPL mRNA and protein expression as analyzed by RT-qPCR and western blotting analyses, respectively. Consistently, miR-590 decreased the expression of CD36 and scavenger receptor A1 (SRA1) mRNA and protein. High-performance liquid chromatography (HPLC) analysis confirmed that treatment with miR-590 agomir reduced lipid levels either in plasma orinabdominal cavity macrophages of apoE(-/-) mice. ELISA analysis showed that miR-590 agomir decreased plasma levels of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), monocyte chemotactic protein-1 (MCP-1), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6). In contrast, treatment with miR-590 antagomir prevented or reversed these effects. Taken together, these results reveal a novel mechanism of miR-590 effects, and may provide new insights into the development of strategies for attenuating lipid accumulation and pro-inflammatory cytokine secretion.	[He, Ping-Ping; OuYang, Xin-Ping; Li, Yuan; Lv, Yun-Cheng; Yao, Feng; Xie, Wei; Tan, Yu-Lin; Li, Liang; Zhang, Min; Lan, Gang; Gong, Duo; Cheng, Hai-Peng; Liu, Dan; Huang, Chong; Yin, Wei-Dong; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res, Hengyang 421001, Hunan, Peoples R China; [He, Ping-Ping; OuYang, Xin-Ping; Wang, Zong-Bao; Yin, Wei-Dong; Tang, Chao-Ke] Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Hunan, Peoples R China; [He, Ping-Ping; Li, Zhao-Xia] Univ South China, Sch Nursing, Hengyang 421001, Hunan, Peoples R China; [OuYang, Xin-Ping] Univ South China, Inst Neurosci, Dept Physiol, Coll Med, Hengyang 421001, Hunan, Peoples R China; [Wang, Zong-Bao; Yin, Wei-Dong] Univ South China, Pharm & Biol Sci Coll, Hengyang 421001, Hunan, Peoples R China; [Zhong, Hui-Juan] Guangzhou Med Univ, Liwan Hosp, Dept Cardiovasc Med, Guangzhou 510170, Guangdong, Peoples R China; [Zheng, Xi-Long] Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta,Cumming Sch Med, Calgary, AB, Canada	University of South China; University of South China; University of South China; University of South China; Guangzhou Medical University; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Yin, WD (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res, Hengyang 421001, Hunan, Peoples R China.	wdy20042004@126.com; tangchaoke@qq.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Sciences Foundation of China [81300158, 81270269]; Aid Program for Science and Technology Department of Human Province [2015JC3083]; Outstanding Young Aid Program for Education Department of Human Province [13B103]; Research and Innovation Aid Program for Graduate Student of Human Province [CX2014B393]; Scientific Research Aid Program for Chinese Medicine of Human Province [201524]; Aid Program for Science and Technology Bureau of HengYang City [2013KS20, 2013KS25]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province [2008-244]; Construct Program of the Key Discipline in Hunan Province, Research and Innovation Aid Program for College Student of University of South China, China [52]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Aid Program for Science and Technology Department of Human Province; Outstanding Young Aid Program for Education Department of Human Province; Research and Innovation Aid Program for Graduate Student of Human Province; Scientific Research Aid Program for Chinese Medicine of Human Province; Aid Program for Science and Technology Bureau of HengYang City; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; Construct Program of the Key Discipline in Hunan Province, Research and Innovation Aid Program for College Student of University of South China, China	The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81300158,81270269), Aid Program for Science and Technology Department of Human Province (2015JC3083), Outstanding Young Aid Program for Education Department of Human Province (13B103), Research and Innovation Aid Program for Graduate Student of Human Province (CX2014B393), Scientific Research Aid Program for Chinese Medicine of Human Province (201524), Aid Program for Science and Technology Bureau of HengYang City (2013KS20, 2013KS25), Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions (2008-244) of Hunan Province, and the Construct Program of the Key Discipline in Hunan Province, Research and Innovation Aid Program for College Student of University of South China (52), China. The funders had key role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Allen RM, 2014, ARTERIOSCL THROM VAS, V34, P1795, DOI 10.1161/ATVBAHA.114.303741; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Chen YN, 2015, STEROIDS, V99, P212, DOI 10.1016/j.steroids.2015.02.020; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; He PP, 2014, BIOCHIMIE, V106, P81, DOI 10.1016/j.biochi.2014.08.003; Hu YW, 2015, ARTERIOSCL THROM VAS, V35, P87, DOI 10.1161/ATVBAHA.114.304296; Iizuka M, 2010, J NUTR SCI VITAMINOL, V56, P421, DOI 10.3177/jnsv.56.421; Jia SJ, 2014, INT IMMUNOPHARMACOL, V23, P54, DOI 10.1016/j.intimp.2014.08.011; Kawashima RL, 2014, BIOCHEM BIOPH RES CO, V450, P1416, DOI 10.1016/j.bbrc.2014.07.015; Khalil MF, 2004, ARTERIOSCL THROM VAS, V24, P2211, DOI 10.1161/01.ATV.0000147163.54024.70; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lavery Danielle L., 2008, V469, P401, DOI 10.1007/978-1-60327-469-25; Liu XY, 2013, ATHEROSCLEROSIS, V226, P398, DOI 10.1016/j.atherosclerosis.2012.12.002; Lv YC, 2014, ATHEROSCLEROSIS, V236, P215, DOI 10.1016/j.atherosclerosis.2014.07.005; Mo ZC, 2014, CIRC J, V78, P2760, DOI 10.1253/circj.CJ-14-0193; Novak J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/275867; Olivier M, 2012, ARTERIOSCL THROM VAS, V32, P2223, DOI 10.1161/ATVBAHA.111.243519; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Petersen LK, 2014, MOL PHARMACEUT, V11, P2815, DOI 10.1021/mp500188g; Qin Bing, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P675, DOI 10.3969/j.issn.1672-7347.2012.07.005; Qiu GS, 2007, J LIPID RES, V48, P385, DOI 10.1194/jlr.M600304-JLR200; Shan HL, 2012, HEART, V98, pE28, DOI 10.1136/heartjnl-2012-302920a.64; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Stachon P, 2014, ARTERIOSCL THROM VAS, V34, P2237, DOI 10.1161/ATVBAHA.114.303585; Staff PO, 2014, PLOS ONE, V9; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Tian Guo-Ping, 2012, Sheng Li Ke Xue Jin Zhan, V43, P345; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang J, 2014, CURR OPIN CARDIOL, V29, P207, DOI 10.1097/HCO.0000000000000050; Wang Y, 2013, ARTERIOSCL THROM VAS, V33, P894, DOI 10.1161/ATVBAHA.113.301309; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Zhao GJ, 2014, ATHEROSCLEROSIS, V235, P519, DOI 10.1016/j.atherosclerosis.2014.05.943; Zhao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074782	38	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138788	10.1371/journal.pone.0138788	http://dx.doi.org/10.1371/journal.pone.0138788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397958	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500108
J	Huang, LH; Pu, ZN; Li, M; Sundell, J				Huang, Lihui; Pu, Zhongnan; Li, Mu; Sundell, Jan			Characterizing the Indoor-Outdoor Relationship of Fine Particulate Matter in Non-Heating Season for Urban Residences in Beijing	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; DAILY MORTALITY; CARDIOVASCULAR-DISEASES; INFILTRATION BEHAVIOR; ULTRAFINE PARTICLES; LOS-ANGELES; PM2.5; TIME; EXPOSURE; RESUSPENSION	Objective Ambient fine particulate matter (PM2.5) pollution is currently a major public health concern in Chinese urban areas. However, PM2.5 exposure primarily occurs indoors. Given such, we conducted this study to characterize the indoor-outdoor relationship of PM2.5 mass concentrations for urban residences in Beijing. Methods In this study, 24-h real-time indoor and ambient PM2.5 mass concentrations were concurrently collected for 41 urban residences in the non-heating season. The diurnal variation of pollutant concentrations was characterized. Pearson correlation analysis was used to examine the correlation between indoor and ambient PM2.5 mass concentrations. Regression analysis with ordinary least square was employed to characterize the influences of a variety of factors on PM2.5 mass concentration. Results Hourly ambient PM2.5 mass concentrations were 3-280 mu g/m(3) with a median of 58 mu g/m(3), and hourly indoor counterpart were 4-193 mu g/m(3) with a median of 34 mu g/m(3). The median indoor/ambient ratio of PM2.5 mass concentration was 0.62. The diurnal variation of residential indoor and ambient PM2.5 mass concentrations tracked with each other well. Strong correlation was found between indoor and ambient PM2.5 mass concentrations on the community basis (coefficients: r >= 0.90, p<0.0001), and the ambient data explained >= 84% variance of the indoor data. Regression analysis suggested that the variables, such as traffic conditions, indoor smoking activities, indoor cleaning activities, indoor plants and number of occupants, had significant influences on the indoor PM2.5 mass concentrations. Conclusions PM2.5 of ambient origin made dominant contribution to residential indoor PM2.5 exposure in the non-heating season under the high ambient fine particle pollution condition. Nonetheless, the large inter-residence variability of infiltration factor of ambient PM2.5 raised the concern of exposure misclassification when using ambient PM2.5 mass concentrations as exposure surrogates. PM2.5 of indoor origin still had minor influence on indoor PM2.5 mass concentrations, particularly at 11:00-13:00 and 22:00-0:00. The predictive models suggested that particles from traffic emission, secondary aerosols, particles from indoor smoking, resuspended particles due to indoor cleaning and particles related to indoor plants contributed to indoor PM2.5 mass concentrations in this study. Real-time ventilation measurements and improvement of questionnaire design to involve more variables subject to built environment were recommended to enhance the performance of the predictive models.	[Huang, Lihui] Changan Univ, Minist Educ, Sch Environm Sci & Engn, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian 710054, Peoples R China; [Huang, Lihui; Pu, Zhongnan; Li, Mu; Sundell, Jan] Tsinghua Univ, Inst Built Environm, Dept Bldg Sci, Beijing 100084, Peoples R China	Chang'an University; Tsinghua University	Huang, LH (corresponding author), Changan Univ, Minist Educ, Sch Environm Sci & Engn, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian 710054, Peoples R China.	hlhfustar@gmail.com			Natural Science Foundation of China [41172212, 41230314]; Chinese Postdoctoral Science Foundation [2014M550739]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study is supported by the Natural Science Foundation of China (41172212, 41230314) and the Chinese Postdoctoral Science Foundation (2014M550739).	Allen R, 2003, ENVIRON SCI TECHNOL, V37, P3484, DOI 10.1021/es021007e; Analitis A, 2006, EPIDEMIOLOGY, V17, P230, DOI 10.1097/01.ede.0000199439.57655.6b; Atkinson RW, 2013, EPIDEMIOLOGY, V24, P44, DOI 10.1097/EDE.0b013e318276ccb8; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P1118, DOI 10.1289/ehp.9759; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; Calogirou A, 1999, ATMOS ENVIRON, V33, P1423, DOI 10.1016/S1352-2310(98)00277-5; Chang HH, 2012, AM J EPIDEMIOL, V175, P91, DOI 10.1093/aje/kwr403; Chen C, 2011, ATMOS ENVIRON, V45, P275, DOI 10.1016/j.atmosenv.2010.09.048; Department of Social Science and Technology Statistics National Bureau of Statistics, 2010, TIM US PATT CHIN; Diapouli E, 2013, J AIR WASTE MANAGE, V63, P1113, DOI 10.1080/10962247.2013.791649; Dong GH, 2013, ATMOS ENVIRON, V77, P968, DOI 10.1016/j.atmosenv.2013.06.034; Fairley D, 1999, ENVIRON HEALTH PERSP, V107, P637, DOI 10.2307/3434455; Fan ZH, 2003, ENVIRON SCI TECHNOL, V37, P1811, DOI 10.1021/es026231i; Finlayson-Pitts B.J., 1986, ATMOSPHERIC CHEM FUN; Gotschi T, 2002, ENVIRON SCI TECHNOL, V36, P1191, DOI 10.1021/es010079n; Gotschi T, 2008, EPIDEMIOLOGY, V19, P690, DOI 10.1097/EDE.0b013e318181650f; Gwynn RC, 2000, ENVIRON HEALTH PERSP, V108, P125, DOI 10.2307/3454510; Hanninen OO, 2004, ATMOS ENVIRON, V38, P6411, DOI 10.1016/j.atmosenv.2004.07.015; Hodas N, 2012, J EXPO SCI ENV EPID, V22, P448, DOI 10.1038/jes.2012.34; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kousa A, 2002, ATMOS ENVIRON, V36, P3031, DOI 10.1016/S1352-2310(02)00232-7; Levy JI, 2003, J EXPO ANAL ENV EPID, V13, P364, DOI 10.1038/sj.jea.7500289; Li YG, 2003, ATMOS ENVIRON, V37, P4277, DOI 10.1016/S1352-2310(03)00527-2; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Long CM, 2004, AEROSOL SCI TECH, V38, P91, DOI 10.1080/027868290502281; Long CM, 2001, ENVIRON SCI TECHNOL, V35, P2089, DOI 10.1021/es001477d; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Meng QY, 2007, ENVIRON SCI TECHNOL, V41, P7315, DOI 10.1021/es070037k; Meng QY, 2005, ENVIRON SCI TECHNOL, V39, P5105, DOI 10.1021/es048226f; Meng QY, 2005, J EXPO ANAL ENV EPID, V15, P17, DOI 10.1038/sj.jea.7500378; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Pellizzari ED, 1999, ATMOS ENVIRON, V33, P721, DOI 10.1016/S1352-2310(98)00229-5; Polidori A, 2007, J AIR WASTE MANAGE, V57, P366, DOI 10.1080/10473289.2007.10465339; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Qian J, 2008, AEROSOL SCI TECH, V42, P566, DOI 10.1080/02786820802220274; Qian J, 2008, J AIR WASTE MANAGE, V58, P502, DOI 10.3155/1047-3289.58.4.502; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Sarnat JA, 2002, ENVIRON SCI TECHNOL, V36, P5305, DOI 10.1021/es025796b; Sarnat SE, 2006, J AIR WASTE MANAGE, V56, P186, DOI 10.1080/10473289.2006.10464449; Wainman T, 2000, ENVIRON HEALTH PERSP, V108, P1139, DOI 10.2307/3434825; Wang CC, 2013, ATMOS ENVIRON, V80, P347, DOI 10.1016/j.atmosenv.2013.08.018; Wang YG, 2010, ENVIRON SCI TECHNOL, V44, P5775, DOI 10.1021/es1001677; Weichenthal S, 2011, ENVIRON HEALTH PERSP, V119, P1373, DOI 10.1289/ehp.1003321; Wheeler AJ, 2011, AEROSOL SCI TECH, V45, P1078, DOI 10.1080/02786826.2011.580798; Wichmann J, 2010, ATMOS ENVIRON, V44, P4536, DOI 10.1016/j.atmosenv.2010.08.023; Williams R, 2000, ATMOS ENVIRON, V34, P4193, DOI 10.1016/S1352-2310(00)00209-0; Zhang YJ, 2012, SCI TOTAL ENVIRON, V435, P14, DOI 10.1016/j.scitotenv.2012.06.092	48	42	44	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138559	10.1371/journal.pone.0138559	http://dx.doi.org/10.1371/journal.pone.0138559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26397734	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500078
J	Bobkova, NV; Lyabin, DN; Medvinskaya, NI; Samokhin, AN; Nekrasov, PV; Nesterova, IV; Aleksandrova, IY; Tatarnikova, OG; Bobylev, AG; Vikhlyantsev, IM; Kukharsky, MS; Ustyugov, AA; Polyakov, DN; Eliseeva, IA; Kretov, DA; Guryanov, SG; Ovchinnikov, LP				Bobkova, N. V.; Lyabin, D. N.; Medvinskaya, N. I.; Samokhin, A. N.; Nekrasov, P. V.; Nesterova, I. V.; Aleksandrova, I. Y.; Tatarnikova, O. G.; Bobylev, A. G.; Vikhlyantsev, I. M.; Kukharsky, M. S.; Ustyugov, A. A.; Polyakov, D. N.; Eliseeva, I. A.; Kretov, D. A.; Guryanov, S. G.; Ovchinnikov, L. P.			The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models	PLOS ONE			English	Article							STAGE EMBRYONIC-DEVELOPMENT; BULBECTOMIZED MICE; TRANSGENIC MICE; YB-1; BRAIN; NEURODEGENERATION; STRESS; CANCER	The Y-box binding protein 1 (Yb-1) is a member of the family of DNA-and RNA binding proteins. It is involved in a wide variety of DNA/RNA-dependent events including cell proliferation and differentiation, stress response, and malignant cell transformation. Previously, Yb-1 was detected in neurons of the neocortex and hippocampus, but its precise role in the brain remains undefined. Here we show that subchronic intranasal injections of recombinant Yb-1, as well as its fragment Yb-1(1-219), suppress impairment of spatial memory in olfactory bulbectomized (ObX) mice with Alzheimer's type degeneration and improve learning in transgenic 5XFAD mice used as a model of cerebral amyloidosis. Yb-1-treated ObX and 5XFAD mice showed a decreased level of brain b-amyloid. In ObX animals, an improved morphological state of neurons was revealed in the neocortex and hippocampus; in 5XFAD mice, a delay in amyloid plaque progression was observed. Intranasally administered Yb-1 penetrated into the brain and could enter neurons. In vitro co-incubation of Yb-1 with monomeric b-amyloid (1-42) inhibited formation of a-amyloid fibrils, as confirmed by electron microscopy. This suggests that Yb-1 interaction with a-amyloid prevents formation of filaments that are responsible for neurotoxicity and neuronal death. Our data are the first evidence for a potential therapeutic benefit of Yb-1 for treatment of Alzheimer's disease.	[Bobkova, N. V.; Medvinskaya, N. I.; Samokhin, A. N.; Nekrasov, P. V.; Nesterova, I. V.; Aleksandrova, I. Y.; Tatarnikova, O. G.] RAS, Inst Cell Biophys, Pushchino, Moscow Region, Russia; [Lyabin, D. N.; Polyakov, D. N.; Eliseeva, I. A.; Kretov, D. A.; Guryanov, S. G.; Ovchinnikov, L. P.] RAS, Inst Prot Res, Pushchino, Moscow Region, Russia; [Bobylev, A. G.; Vikhlyantsev, I. M.] RAS, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Kukharsky, M. S.; Ustyugov, A. A.] RAS, Inst Physiol Act Cpds, Chernogolovka, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences	Ovchinnikov, LP (corresponding author), RAS, Inst Prot Res, Pushchino, Moscow Region, Russia.	ovchinn@vega.protres.ru	Kukharsky, Michail S/L-6754-2013; Polyakov, Dmitry/K-1278-2018; Bobylev, Alexandr/L-5536-2015; Kretov, Dmitry/AAU-6058-2020; Vikhlyantsev, Ivan/N-3866-2017; Ustyugov, Aleksey/D-3112-2012; Nekrasov, Pavel/P-2016-2017; Irina, Eliseeva/J-8175-2015; Ustyugov, Aleksey/AAA-8286-2019; Bobylev, Alexandr/P-1589-2019; Bobkova, Natalia/D-6379-2015; Samokhin, Alexander/C-4865-2015	Kukharsky, Michail S/0000-0001-5080-2544; Polyakov, Dmitry/0000-0003-0425-7789; Bobylev, Alexandr/0000-0002-9477-1214; Vikhlyantsev, Ivan/0000-0001-6063-6789; Ustyugov, Aleksey/0000-0003-1977-4797; Nekrasov, Pavel/0000-0002-5168-5404; Ustyugov, Aleksey/0000-0003-1977-4797; Bobylev, Alexandr/0000-0002-9477-1214; Kretov, Dmitry/0000-0003-1829-8610; Gurianov, Sergei/0000-0003-3058-5460; Samokhin, Alexander/0000-0002-3299-4906	Russian Scientific Foundation [14-14-00879, 14-23-00160]; Russian Foundation for Basic Research [13-04-00881]; Russian Science Foundation [14-14-00879] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Scientific Foundation (http://www.rscf.ru) (#14-14-00879 - molecular and cellular mechanisms of YB-1 involvement in Alzheimer's disease (AD) genesis and YB-1 preparation for in vivo and in vitro experiments; #14-23-00160 - transgenic mice production) and by the Russian Foundation for Basic Research (http://www.rfbr.ru) (#13-04-00881 - behavioral effects of YB-1 and its fragments on olfactory bulbectomized mice used as a model of sporadic AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Aleksandrova IY, 2004, BIOCHEMISTRY-MOSCOW+, V69, P176, DOI 10.1023/B:BIRY.0000018948.04559.ab; Bernstein HG, 2014, BRAIN STRUCT FUNCT; BertoniFreddari C, 1996, ANAL QUANT CYTOL, V18, P209; Bobkova N, 2008, BRAIN RES, V1232, P185, DOI 10.1016/j.brainres.2008.07.036; Bobkova N, 2013, CELL STRESS CHAPERON, V18, P109, DOI 10.1007/s12192-012-0359-x; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Bobkova NV, 2001, B EXP BIOL MED+, V131, P427, DOI 10.1023/A:1017907511482; Bobkova NV, 2005, POSSIBLE ROLE OLFACT; Borre Y, 2012, BEHAV BRAIN RES, V234, P285, DOI 10.1016/j.bbr.2012.07.007; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Douma TN, 2011, PSYCHOPHARMACOLOGY, V216, P537, DOI 10.1007/s00213-011-2245-0; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Guryanov SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036969; Hanssen L, 2011, J IMMUNOL, V187, P298, DOI 10.4049/jimmunol.1100382; Hu J, 2012, NEUROSCI LETT, V506, P180, DOI 10.1016/j.neulet.2011.10.076; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim ER, 2013, CELL CYCLE, V12, P3791, DOI 10.4161/cc.26670; Liang P, 1997, J CELL SCI, V110, P1431; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Miwa A, 2006, BBA-GEN SUBJECTS, V1760, P1675, DOI 10.1016/j.bbagen.2006.08.027; Moiseeva NI, 2013, BIOCHEM MOSC SUPPL S, V7, P21, DOI 10.1134/S1990747812050133; Nesterova I V, 2008, Neurosci Behav Physiol, V38, P349, DOI 10.1007/s11055-008-0048-5; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ostrovskaya RU, 2007, J PSYCHOPHARMACOL, V21, P611, DOI 10.1177/0269881106071335; Peters OM, 2013, J ALZHEIMERS DIS, V36, P589, DOI 10.3233/JAD-130071; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Ugrumov M.V., 2010, MODEL SPORADIC ALZHE; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Yehuda Shlomo, 2014, PharmaNutrition, V2, P12, DOI 10.1016/j.phanu.2013.10.002	39	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138867	10.1371/journal.pone.0138867	http://dx.doi.org/10.1371/journal.pone.0138867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394155	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100110
J	Gil, MD; Palmer, M; Grau, A; Balle, S				Gil, Maria del Mar; Palmer, Miquel; Grau, Amalia; Balle, Salvador			Many Vulnerable or a Few Resilient Specimens? Finding the Optimal for Reintroduction/Restocking Programs	PLOS ONE			English	Article							REARED JAPANESE FLOUNDER; SIZE-DEPENDENT MORTALITY; PARALICHTHYS-OLIVACEUS; POSTRELEASE SURVIVAL; NATURAL MORTALITY; RELEASE; JUVENILE; ENHANCEMENT; FISH; WILD	Most reintroduction and restocking programs consist of releasing captive-raised juveniles. The usefulness of these programs has been questioned, and therefore, quality control is advisable. However, evaluating restocking effectiveness is challenging because mortality estimation is required. Most methods for estimating mortality are based on tag recovery. In the case of fish, juveniles are tagged before release, and fishermen typically recover tags when fish are captured. The statistical models currently available for analyzing these data assume either constant mortality rates, fixed tag non-reporting rates, or both. Here, instead, we proposed a method that considers the mortality rate variability as a function of age/size of the released juveniles. Furthermore, the proposed method can disentangle natural from fishing mortality, analyzing the temporal distribution of the captures reported by fishermen from multiple release events. This method is demonstrated with a restocking program of a top-predator marine fish, the meagre (Argyrosomus regius), in the Balearic Islands. The estimated natural mortality just after release was very high for young fish (m(0) = 0.126 day(-1) for fish 180 days old), but it was close to zero for large/old fish. These large/old fish were more resilient to wild conditions, although a long time was needed to achieve a relevant reduction in natural mortality. Conversely, these large/old fish were more vulnerable to fishing, creating a trade-off in survival. The release age that maximizes the number of survivors after, for example, one year at liberty was estimated to be 1,173 days. However, the production cost of relatively old fish is high, and only a few fish can be produced and released within a realistic budget. Therefore, in the case of the meagre, increasing the number of released fish will have no or scarce effects on restocking success. Conversely, it is advisable implement measures to reduce the high natural mortality of young juveniles and/or the length of time needed to improve fish resilience.	[Gil, Maria del Mar; Grau, Amalia] LIMIA Balear Government, Lab Invest Marines & Aquicultura, Port Dandratx, Balearic Island, Spain; [Gil, Maria del Mar; Palmer, Miquel; Balle, Salvador] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Esporles, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Gil, MD (corresponding author), LIMIA Balear Government, Lab Invest Marines & Aquicultura, Port Dandratx, Balearic Island, Spain.	mmgil@dgpesca.caib.es	Palmer, Miquel/E-3561-2013; Balle, Salvador/F-8575-2013; Gil, Maria del Mar/L-5204-2014	Balle, Salvador/0000-0002-7026-1391; Hernandez Llorente, Maria Dolores/0000-0001-5975-4462; Miquel, Palmer/0000-0002-7875-3673; Grau, Amalia/0000-0002-6461-6985; Gil, Maria del Mar/0000-0002-1044-0312	"Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria" (INIA) belonging to "Ministerio de Economia y Competitividad" (Spanish Government) [RTA-2007 00033-C02-01, RTA-2011 00056-C02-00]	"Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria" (INIA) belonging to "Ministerio de Economia y Competitividad" (Spanish Government)	This work was financially supported by "Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria" (INIA) belonging to "Ministerio de Economia y Competitividad" (Spanish Government), through the projects RTA-2007 00033-C02-01 and RTA-2011 00056-C02-00. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; [Anonymous], QUANTITATIVE FISHERI; Arai T, 2007, J SEA RES, V58, P59, DOI 10.1016/j.seares.2007.01.004; Araki H., 2010, AQUACULTURE S1, V308, P52, DOI DOI 10.1016/j.aquaculture.2010.05.036; Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Bartley D. M., 1996, Biodiversity, science and development: towards a new partnership., P424; Bremner-Harrison S, 2004, ANIM CONSERV, V7, P313, DOI 10.1017/S1367943004001490; Brennan NP, 2006, J EXP MAR BIOL ECOL, V335, P302, DOI 10.1016/j.jembe.2006.04.001; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown JL, 2006, BIOL CONSERV, V131, P453, DOI 10.1016/j.biocon.2006.02.021; Brownie C., 1985, STAT INFERENCE BAND; CADE TJ, 1995, IBIS, V137, pS161, DOI 10.1111/j.1474-919X.1995.tb08438.x; Gil MD, 2014, AQUACULTURE, V434, P78, DOI 10.1016/j.aquaculture.2014.07.032; Gil MD, 2013, SCI MAR, V77, P105, DOI 10.3989/scimar.03688.28A; Ellis T, 2002, J FISH BIOL, V61, P252, DOI 10.1111/j.1095-8649.2002.tb01750.x; Ersbak K., 1983, North American Journal of Fisheries Management, V3, P142, DOI 10.1577/1548-8659(1983)3<142:NDASAA>2.0.CO;2; Fairchild EA, 2004, J FISH BIOL, V65, P69, DOI 10.1111/j.0022-1112.2004.00529.x; Fajardo I, 2000, BIOL CONSERV, V94, P287, DOI 10.1016/S0006-3207(00)00003-3; Furuta S, 1997, NIPPON SUISAN GAKK, V63, P886; Gil MM, 2014, J FISH BIOL, V84, P10, DOI 10.1111/jfb.12241; Gil MM, SCI MAR IN PRESS; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Heino M, 2002, B MAR SCI, V70, P639; Hervas S, 2010, FISH RES, V105, P237, DOI 10.1016/j.fishres.2010.06.001; Hoenig JM, 1998, CAN J FISH AQUAT SCI, V55, P1466, DOI 10.1139/cjfas-55-6-1466; Hossain MAR, 2002, J EXP MAR BIOL ECOL, V267, P1, DOI 10.1016/S0022-0981(01)00340-9; Hurst TP, 1998, CAN J FISH AQUAT SCI, V55, P1122, DOI 10.1139/cjfas-55-5-1122; Iglesias J, 2003, FISHERIES MANAG ECOL, V10, P51, DOI 10.1046/j.1365-2400.2003.00318.x; Ireland SC, 2002, J APPL ICHTHYOL, V18, P642, DOI 10.1046/j.1439-0426.2002.00364.x; Jorgensen C, 2013, J SEA RES, V75, P8, DOI 10.1016/j.seares.2012.04.003; Labbish Ning Chao, 1986, P865; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Leber K. M., 2011, AM FISHERIES SOC S, V76, P1; Leber Kenneth M., 1995, Journal of the World Aquaculture Society, V26, P143, DOI 10.1111/j.1749-7345.1995.tb00237.x; Leber KM, 2005, N AM J FISH MANAGE, V25, P1596, DOI 10.1577/M04-093.1; Leber KM, 1996, FISH B-NOAA, V94, P452; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lorenzen K, 2000, CAN J FISH AQUAT SCI, V57, P2374, DOI 10.1139/cjfas-57-12-2374; Lorenzen K, 2006, FISH RES, V80, P19, DOI 10.1016/j.fishres.2006.03.010; Mayol J, 2000, LLISTA VERMELLA PEIX; McGarvey R, 2009, REV FISH SCI, V17, P291, DOI 10.1080/10641260802664841; Morales-Nin B, 2010, FISH RES, V106, P76, DOI 10.1016/j.fishres.2010.07.006; Pine WE, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:AROTMF]2.0.CO;2; Polacheck T, 2006, CAN J FISH AQUAT SCI, V63, P534, DOI 10.1139/f05-232; Polacheck T, 2010, FISH FISH, V11, P133, DOI 10.1111/j.1467-2979.2010.00360.x; Pollock K.H., 1991, American Fisheries Society Symposium, P423; Quero J.C., 1987, REV TRAV I PECHES, V49, P35; RAY M, 1994, AQUACULTURE, V128, P79, DOI 10.1016/0044-8486(94)90103-1; Ricker W. E., 1975, FISHERIES RES BOARD, V191; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Sarrazin F, 2000, CONSERV BIOL, V14, P488, DOI 10.1046/j.1523-1739.2000.97305.x; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shephard S, 2012, ICES J MAR SCI, V69, P223, DOI 10.1093/icesjms/fsr200; Sogard SM, 1997, B MAR SCI, V60, P1129; Sparrevohn CR, 2007, J SEA RES, V57, P151, DOI 10.1016/j.seares.2006.08.010; Svasand T, 2000, FISH FISH, V1, P173, DOI 10.1046/j.1467-2979.2000.00017.x; Tavecchia G, 2009, BIOL CONSERV, V142, P3005, DOI 10.1016/j.biocon.2009.07.035; TSUKAMOTO K, 1989, J FISH BIOL, V35, P59; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Watanabe S, 2006, J FISH BIOL, V68, P1192, DOI 10.1111/j.0022-1112.2006.01014.x; WILLIS SA, 1995, AM FISH S S, V15, P354; Yamashita Y, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P191; [No title captured]	66	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138501	10.1371/journal.pone.0138501	http://dx.doi.org/10.1371/journal.pone.0138501			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394242	Green Published, gold, Green Submitted			2022-12-26	WOS:000361792100066
J	Lee, ES; Lim, JY; Im, KI; Kim, N; Nam, YS; Jeon, YW; Cho, SG				Lee, Eun-Sol; Lim, Jung-Yeon; Im, Keon-Il; Kim, Nayoun; Nam, Young-Sun; Jeon, Young-Woo; Cho, Seok-Goo			Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model	PLOS ONE			English	Article							REGULATORY T-CELLS; VERSUS-HOST-DISEASE; STROMAL CELLS; RECIPROCAL REGULATION; PREVENTION; INDUCE; GROWTH; PROLIFERATION; SUPPRESSION; TRANSPLANT	Therapeutic effects of combined cell therapy with mesenchymal stem cells (MSCs) and regulatory T cells (Treg cells) have recently been studied in acute graft-versus-host-disease (aGVHD) models. However, the underlying, seemingly synergistic mechanism behind combined cell therapy has not been determined. We investigated the origin of Foxp3(+) Treg cells and interleukin 17 (IL-17(+)) cells in recipients following allogeneic bone marrow transplantation (allo-BMT) to identify the immunological effects of combined cell therapy. Treg cells were generated from eGFP-expressing C57BL/6 mice (Tregegfp cells) to distinguish the transferred Treg cells; recipients were then examined at different time points after BMT. Systemic infusion of MSCs and Treg cells improved survival and GVHD scores, effectively downregulating pro-inflammatory Thxand Th17 cells. These therapeutic effects of combined cell therapy resulted in an increased Foxp3(+) Treg cell population. Compared to single cell therapy, adoptively transferred Tregegfp cells only showed prolonged survival in the combined cell therapy group on day 21 after allogeneic BMT. In addition, Foxp3+ Treg cells, generated endogenously from recipients, significantly increased. Significantly higher levels of Tregegfp cells were also detected in aGVHD target organs in the combined cell therapy group compared to the Treg cells group. Thus, our data indicate that MSCs may induce the long-term survival of transferred Treg cells, particularly in aGVHD target organs, and may increase the repopulation of endogenous Treg cells in recipients after BMT. Together, these results support the potential of combined cell therapy using MSCs and Treg cells for preventing aGVHD.	[Lee, Eun-Sol; Lim, Jung-Yeon; Im, Keon-Il; Kim, Nayoun; Nam, Young-Sun; Jeon, Young-Woo; Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Inst Translat Res & Mol Imaging, Seoul, South Korea; [Lee, Eun-Sol; Lim, Jung-Yeon; Im, Keon-Il; Kim, Nayoun; Nam, Young-Sun; Jeon, Young-Woo; Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Convergent Res Consortium Immunol Dis, Lab Immune Regulat, Seoul, South Korea; [Jeon, Young-Woo; Cho, Seok-Goo] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Blood & Marrow Transplantat Ctr, Dept Hematol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Cho, SG (corresponding author), Catholic Univ Korea, Coll Med, Inst Translat Res & Mol Imaging, Seoul, South Korea.	chosg@catholic.ac.kr		Cho, Seok-Goo/0000-0002-5429-4839	Ministry for Health & Welfare, Republic of Korea [HI14C3417]	Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeegbe D, 2010, BLOOD, V115, P1932, DOI 10.1182/blood-2009-08-238584; Asai O, 1998, J CLIN INVEST, V101, P1835, DOI 10.1172/JCI1268; Ball LM, 2013, BRIT J HAEMATOL, V163, P501, DOI 10.1111/bjh.12545; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chen B, 2010, CLIN EXP IMMUNOL, V159, P292, DOI 10.1111/j.1365-2249.2009.04069.x; Chen X, 2014, J LEUKOC BIOL; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Gaidot A, 2011, BLOOD, V117, P2975, DOI 10.1182/blood-2010-08-299974; Hoogduijn MJ, 2013, STEM CELLS DEV, V22, P2825, DOI 10.1089/scd.2013.0193; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Im KI, 2014, STEM CELLS DEV, V23, P2364, DOI 10.1089/scd.2013.0617; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kim EJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.2; Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z; Kim N, 2013, KOREAN J INTERN MED, V28, P387, DOI 10.3904/kjim.2013.28.4.387; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; KRENGER W, 1995, J IMMUNOL, V155, P585; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070968; Lim JY, 2014, CELL TRANSPLANT, V23, P703, DOI 10.3727/096368913X664577; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Miyake T, 2008, CLIN EXP IMMUNOL, V152, P153, DOI 10.1111/j.1365-2249.2008.03615.x; Park MJ, 2011, ARTHRITIS RHEUM-US, V63, P1668, DOI 10.1002/art.30326; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Schneidawind D, 2013, BLOOD, V122, P3116, DOI 10.1182/blood-2013-08-453126; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; SZEBENI J, 1994, TRANSPLANTATION, V58, P1385; Tobin LM, 2013, CLIN EXP IMMUNOL, V172, P333, DOI 10.1111/cei.12056; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	43	26	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138846	10.1371/journal.pone.0138846	http://dx.doi.org/10.1371/journal.pone.0138846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393514	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100106
J	Zhang, X; Guan, NY; Jia, ZL; Qiu, XG; Luo, ZG				Zhang, Xiang; Guan, Naiyang; Jia, Zhilong; Qiu, Xiaogang; Luo, Zhigang			Semi-Supervised Projective Non-Negative Matrix Factorization for Cancer Classification	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; GENE-EXPRESSION; CLASS DISCOVERY; PREDICTION; PARTS	Advances in DNA microarray technologies have made gene expression profiles a significant candidate in identifying different types of cancers. Traditional learning-based cancer identification methods utilize labeled samples to train a classifier, but they are inconvenient for practical application because labels are quite expensive in the clinical cancer research community. This paper proposes a semi-supervised projective non-negative matrix factorization method (Semi-PNMF) to learn an effective classifier from both labeled and unlabeled samples, thus boosting subsequent cancer classification performance. In particular, Semi-PNMF jointly learns a non-negative subspace from concatenated labeled and unlabeled samples and indicates classes by the positions of the maximum entries of their coefficients. Because Semi-PNMF incorporates statistical information from the large volume of unlabeled samples in the learned subspace, it can learn more representative subspaces and boost classification performance. We developed a multiplicative update rule (MUR) to optimize Semi-PNMF and proved its convergence. The experimental results of cancer classification for two multiclass cancer gene expression profile datasets show that Semi-PNMF outperforms the representative methods.	[Zhang, Xiang; Guan, Naiyang; Luo, Zhigang] Natl Univ Def Technol, Coll Comp, Changsha 410073, Hunan, Peoples R China; [Zhang, Xiang; Guan, Naiyang; Luo, Zhigang] Natl Univ Def Technol, Natl Lab Parallel & Distributed Proc, Changsha 410073, Hunan, Peoples R China; [Jia, Zhilong] Natl Univ Def Technol, Coll Sci, Dept Biol & Chem, Changsha, Hunan, Peoples R China; [Qiu, Xiaogang] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China; National University of Defense Technology - China; National University of Defense Technology - China	Guan, NY (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha 410073, Hunan, Peoples R China.	ny_guan@nudt.edu.cn; zgluo@nudt.edu.cn	Jia, Zhilong/ABA-9776-2020	Jia, Zhilong/0000-0003-2370-5073	Ministry of Education of the People's Republic of China [20134307110017]; National Natural Science Foundation of China [91024030/G03]	Ministry of Education of the People's Republic of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Education of the People's Republic of China Grant Number 20134307110017 (www.moe.edu.cn), PI: Zhigang Luo and National Natural Science Foundation of China Grant Number 91024030/G03 (http://www.nsfc.gov.cn/), PI: Xiaogang Qiu.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anagnostopoulos G, 2007, MULTICLASS CANC CLAS; Bae K, 2004, BIOINFORMATICS, V20, P3423, DOI 10.1093/bioinformatics/bth419; Behrouz M, 2014, BIOINFORMATICS, V20, P3423; Bicciato S, 2003, BIOINFORMATICS, V19, P571, DOI 10.1093/bioinformatics/btg051; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chapelle O., 2005, P 10 INT WORKSH ART, P57; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guan NY, 2012, 2012 11TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2012), VOL 1, P404, DOI 10.1109/ICMLA.2012.73; Guan NY, 2012, IEEE T SIGNAL PROCES, V60, P2882, DOI 10.1109/TSP.2012.2190406; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lan L, 2014, IEEE IJCNN, P3025, DOI 10.1109/IJCNN.2014.6889914; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048238; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Li SZ, 2001, PROC CVPR IEEE, P207; Liu HF, 2012, IEEE T PATTERN ANAL, V34, P1299, DOI 10.1109/TPAMI.2011.217; Maulik U, 2013, IEEE T BIO-MED ENG, V60, P1111, DOI 10.1109/TBME.2012.2225622; Nguyen DV, 2002, BIOINFORMATICS, V18, P1216, DOI 10.1093/bioinformatics/18.9.1216; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Saul LK, 2011, ARXIV11123714; Shahnaz F, 2006, INFORM PROCESS MANAG, V42, P373, DOI 10.1016/j.ipm.2004.11.005; Shi M, 2011, BIOINFORMATICS, V27, P3017, DOI 10.1093/bioinformatics/btr502; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tan YX, 2005, NUCLEIC ACIDS RES, V33, P56, DOI 10.1093/nar/gki144; Tan YX, 2004, COMPUT BIOL CHEM, V28, P235, DOI 10.1016/j.compbiolchem.2004.05.002; Taslaman L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046331; Vapnik V., 1998, STAT LEARNING THEORY; Yang ZR, 2010, IEEE T NEURAL NETWOR, V21, P734, DOI 10.1109/TNN.2010.2041361; Yu Kai, 2009, ADV NEURAL INFORM PR, P2223; Yuan ZJ, 2005, LECT NOTES COMPUT SC, V3540, P333; Zhang H, 2012, LECT NOTES COMPUT SC, V7665, P277, DOI 10.1007/978-3-642-34487-9_34; Zhang SH, 2011, BIOINFORMATICS, V27, pI401, DOI 10.1093/bioinformatics/btr206; Zhang X, 2014, IEEE IJCNN, P1900, DOI 10.1109/IJCNN.2014.6889928	41	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138814	10.1371/journal.pone.0138814	http://dx.doi.org/10.1371/journal.pone.0138814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394323	gold, Green Submitted, Green Published			2022-12-26	WOS:000361792100103
J	Norheim, G; Sanders, H; Mellesdal, JW; Sundfor, I; Chan, H; Brehony, C; Vipond, C; Dold, C; Care, R; Saleem, M; Maiden, MCJ; Derrick, JP; Feavers, I; Pollard, AJ				Norheim, Gunnstein; Sanders, Holly; Mellesdal, Jardar W.; Sundfor, Idunn; Chan, Hannah; Brehony, Carina; Vipond, Caroline; Dold, Chris; Care, Rory; Saleem, Muhammad; Maiden, Martin C. J.; Derrick, Jeremy P.; Feavers, Ian; Pollard, Andrew J.			An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity	PLOS ONE			English	Article							MEMBRANE VESICLE VACCINES; NEISSERIA-MENINGITIDIS; DISEASE; PROTEIN; FRPB; SEQUENCE; GENOME; RESPONSES; SAFETY	Following the introduction of effective protein-polysaccharide conjugate vaccines against capsular group C meningococcal disease in Europe, meningococci of capsular group B remain a major cause of death and can result in debilitating sequelae. The outer membrane proteins PorA and FetA have previously been shown to induce bactericidal antibodies in humans. Despite considerable antigenic variation among PorA and FetA OMPs in meningococci, systematic molecular epidemiological studies revealed this variation is highly structured so that a limited repertoire of antigenic types is congruent with the hyperinvasive meningococcal lineages that have caused most of the meningococcal disease in Europe in recent decades. Here we describe the development of a prototype vaccine against capsular group B meningococcal infection based on a N. meningitidis isolate genetically engineered to have constitutive expression of the outer membrane protein FetA. Deoxycholate outer membrane vesicles (dOMVs) extracted from cells cultivated in modified Frantz medium contained 21.8% PorA protein, 7.7% FetA protein and 0.03 mu g LPS per mu g protein (3%). The antibody response to the vaccine was tested in three mouse strains and the toxicological profile of the vaccine was tested in New Zealand white rabbits. Administration of the vaccine, MenPF-1, when given by intramuscular injection on 4 occasions over a 9 week period, was well tolerated in rabbits up to 50 mu g/dose, with no evidence of systemic toxicity. These data indicated that the MenPF-1 vaccine had a toxicological profile suitable for testing in a phase I clinical trial.	[Norheim, Gunnstein; Dold, Chris; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Norheim, Gunnstein; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Norheim, Gunnstein; Mellesdal, Jardar W.; Sundfor, Idunn] Norwegian Inst Publ Hlth, Oslo, Norway; [Sanders, Holly; Chan, Hannah; Vipond, Caroline; Care, Rory; Feavers, Ian] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Brehony, Carina; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Saleem, Muhammad; Derrick, Jeremy P.] Univ Manchester, Manchester, Lancs, England	University of Oxford; University of Oxford; Norwegian Institute of Public Health (NIPH); National Institute for Biological Standards & Control; University of Oxford; University of Manchester	Norheim, G (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	gunnstein.norheim@fhi.no	Maiden, Martin C J/C-5055-2014; Saleem, Muhammad/W-4014-2017; Dold, Christina/ABA-4237-2021; Maiden, Martin/N-6805-2019	Maiden, Martin C J/0000-0001-6321-5138; Saleem, Muhammad/0000-0002-0994-9701; Maiden, Martin/0000-0001-6321-5138; dold, christina/0000-0003-2314-507X; Brehony, Carina/0000-0002-2967-2762	Strategic Translation Award from the Wellcome Trust [082102/Z/07/A]; National Institute for Health Research Oxford Biomedical Research Centres	Strategic Translation Award from the Wellcome Trust; National Institute for Health Research Oxford Biomedical Research Centres	This study was funded by a Strategic Translation Award from the Wellcome Trust [Award number: 082102/Z/07/A]. AJP receives funding support from the National Institute for Health Research Oxford Biomedical Research Centres and is a Jenner Institute Investigator at the University of Oxford. MCJM is a Wellcome Trust Senior Fellow in Basic Biomedical Sciences and a Jenner Investigator at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigita C, 2003, VACCINE, V21, P950, DOI 10.1016/S0264-410X(02)00546-7; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Cahoon LA, 2011, MOL MICROBIOL, V81, P1136, DOI 10.1111/j.1365-2958.2011.07773.x; European Center for Disease Control, 2011, SURV INV BACT DIS EU; Frasch CE, 2001, METH MOLEC MED, V66, P81, DOI 10.1385/1-59259-148-5:81; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Gorringe A, 2005, VACCINE, V23, P2210, DOI 10.1016/j.vaccine.2005.01.055; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Helm RA, 2010, J BACTERIOL, V192, P3822, DOI 10.1128/JB.00280-10; Holst J, 2005, VACCINE, V23, P2202, DOI 10.1016/j.vaccine.2005.01.058; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Howitz M, 2007, CLIN INFECT DIS, V45, P1327, DOI 10.1086/522190; Jayanthi JW, 2013, NOVEL IMMUNE POTENTI; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kortekaas J, 2007, VACCINE, V25, P72, DOI 10.1016/j.vaccine.2006.07.016; Kortekaas J, 2006, MICROBES INFECT, V8, P2145, DOI 10.1016/j.micinf.2006.04.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Marsay L, 2015, J INFECTION, V71, P326, DOI 10.1016/j.jinf.2015.05.006; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nokleby H, 2007, VACCINE, V25, P3080, DOI 10.1016/j.vaccine.2007.01.022; Norheim G, 2004, VACCINE, V22, P2171, DOI 10.1016/j.vaccine.2003.11.047; Norheim G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003312; PETTERSSON A, 1990, INFECT IMMUN, V58, P3036, DOI 10.1128/IAI.58.9.3036-3041.1990; Pollard AJ, 2014, LANCET, V383, P1103, DOI 10.1016/S0140-6736(14)60226-9; Saleem M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056746; Saleem M, 2012, ACTA CRYSTALLOGR F, V68, P231, DOI 10.1107/S1744309111056028; Sandbu S, 2007, CLIN VACCINE IMMUNOL, V14, P1062, DOI 10.1128/CVI.00094-07; Sanders H, 2013, EXPERT REV VACCINES, V12, P31, DOI [10.1586/erv.12.137, 10.1586/ERV.12.137]; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tsolakos N, 2010, VACCINE, V28, P3211, DOI 10.1016/j.vaccine.2010.02.023; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; vanderLey P, 1996, MICROBIOL-UK, V142, P3269, DOI 10.1099/13500872-142-11-3269; Wedege E, 2007, CLIN VACCINE IMMUNOL, V14, P830, DOI 10.1128/CVI.00039-07; Wedege E, 1998, INFECT IMMUN, V66, P3223, DOI 10.1128/IAI.66.7.3223-3231.1998; Wormann ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-253; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	40	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2015	10	9							e0134353	10.1371/journal.pone.0134353	http://dx.doi.org/10.1371/journal.pone.0134353			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZM	26390123	Green Submitted, gold, Green Published			2022-12-26	WOS:000361791000001
J	Hardcastle, SJ; McNamara, K; Tritton, L				Hardcastle, Sarah J.; McNamara, Keira; Tritton, Larette			Using Visual Methods to Understand Physical Activity Maintenance following Cardiac Rehabilitation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; REFERRAL STRATEGIES; EXERCISE; WOMEN; INTERVENTION; METAANALYSIS; ADHERENCE; PROGRAMS; BELIEFS	Few studies have explored the factors associated with long-term maintenance of exercise following cardiac rehabilitation. The present study used auto-photography and interviews to explore the factors that influence motivation and continued participation in physical activity among post cardiac rehabilitation patients. Twenty-three semi-structured interviews were conducted alongside participant-selected photographs or drawings with participants that had continued participation in physical activity for at least two years following the cardiac rehabilitation programme. Participants were recruited from circuit training classes in East Sussex in the UK. Thematic content analysis revealed seven main themes: fear of death and ill health avoidance, critical incidents, overcoming aging, social influences, being able to enjoy life, provision of routine and structure, enjoyment and psychological well-being. Fear of death, illness avoidance, overcoming aging, and being able to enjoy life were powerful motives for continued participation in exercise. The social nature of the exercise class was also identified as a key facilitator of continued participation. Group-based exercise suited those that continued exercise participation post cardiac rehabilitation and fostered adherence.	[Hardcastle, Sarah J.] Curtin Univ, Sch Psychol & Speech Pathol, Hlth Psychol & Behav Med Res Grp, Perth, WA 6845, Australia; [McNamara, Keira] Brunel Univ, Dept Clin Sci, London, England; [Tritton, Larette] Univ Brighton, Sch Sport & Serv Management, Brighton, E Sussex, England	Curtin University; Brunel University; University of Brighton	Hardcastle, SJ (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Hlth Psychol & Behav Med Res Grp, Perth, WA 6845, Australia.	sarah.hardcastle@curtin.edu.au		Hardcastle, Sarah/0000-0001-8378-3781				Abraham C, 2008, HLTH PSYCHOL; Anfara V. A., 2002, ED RES, V31, P28, DOI DOI 10.3102/0013189X031007028; Angus JE, 2015, J ADV NURS, V71, P1758, DOI 10.1111/jan.12620; Angus JE, 2009, INT J ENV RES PUB HE, V6, P2481, DOI 10.3390/ijerph6092481; Beswick A, 2002, J ADV NUR, V49, P538; Bethell HJN, 1990, BRIT J SPORT MED, V33, P79; Bjarnason-Wehrens B, 2010, EUR J CARDIOV PREV R, V17, P410, DOI [DOI 10.1097/HJR.0b013e328334f42d, 10.1097/HJR.0b013e328334f42d]; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cassidy A, 2011, VISUAL METHODS PSYCH, P208; Clark AM, 2013, CLIN REHABIL, V27, P948, DOI 10.1177/0269215513481046; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Daly John, 2002, Prog Cardiovasc Nurs, V17, P8, DOI 10.1111/j.0889-7204.2002.00614.x; Darr A, 2008, HEART LUNG, V37, P91, DOI 10.1016/j.hrtlng.2007.03.004; Davidson P, 2008, J WOMENS HEALTH, V17, P123, DOI 10.1089/jwh.2007.0386; Doiron-Maillet Nancy, 2003, Can J Cardiovasc Nurs, V13, P14; Everett B, 2008, J CARDIOPULM REHABIL, V28, P61, DOI 10.1097/01.HCR.0000311511.23849.35; Fleury Julie, 2004, J Cardiopulm Rehabil, V24, P296, DOI 10.1097/00008483-200409000-00002; Fleury J, 2009, QUAL HEALTH RES, V19, P677, DOI 10.1177/1049732309334471; Ganesh TG, 2011, SAGE HDB VISUAL RES, P237; Gauntlett D, 2007, CREATIVE EXPLORATION, P92; Grace Sherry L, 2004, J Cardiopulm Rehabil, V24, P171, DOI 10.1097/00008483-200405000-00006; Grace SL, 2011, ARCH INTERN MED, V171, P235, DOI 10.1001/archinternmed.2010.501; Gravely-Witte S, 2010, NAT REV CARDIOL, V7, P87, DOI 10.1038/nrcardio.2009.223; Gregory S, 2006, FAM PRACT, V23, P220, DOI 10.1093/fampra/cmi089; Griffin M, 2010, QUAL RES SPORT EXERC, V2, P153, DOI 10.1080/19398441.2010.488024; Hagger MS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00254; Hardcastle S, 2011, PSYCHOL SPORT EXERC, V12, P314, DOI 10.1016/j.psychsport.2011.01.001; Harper D., 2002, VISUAL STUD, V17, P13, DOI [10.1080/14725860220137345, DOI 10.1080/14725860220137345]; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hevey D, 2007, CARDIOVASCULAR PREVE, P294; Hudson J, 1998, J SPORTS SCI, V16, P83; Jones M, 2007, FAM PRACT, V24, P343, DOI 10.1093/fampra/cmm021; Kwasnicka D, 2015, HEALTH PSYCHOL, V34, P1191, DOI 10.1037/hea0000234; Lysack C, 2015, CANADIAN J OCCUPATIO, V81, P247; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Martin AM, 2012, J AGING PHYS ACTIV, V20, P135, DOI 10.1123/japa.20.2.135; McSweeney J C, 2001, Rehabil Nurs, V26, P132; Mitchell R, 1999, Rehabil Nurs, V24, P236; Moore Shirley M, 2003, J Cardiopulm Rehabil, V23, P40, DOI 10.1097/00008483-200301000-00008; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Neubeck L, 2012, EUR J PREV CARDIOL, V19, P494, DOI 10.1177/1741826711409326; Padgett DK, 2013, QUAL HEALTH RES, V23, P1435, DOI 10.1177/1049732313507752; Petter M, 2009, EUR J CARDIOV PREV R, V16, P515, DOI 10.1097/HJR.0b013e3283299585; Phoenix C, 2014, QUALITATIVE RES, P1; Phoenix C, 2010, J AGING STUD, V24, P167, DOI 10.1016/j.jaging.2008.12.007; Rogerson MC, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-140; Sniehotta FF, 2006, BRIT J HEALTH PSYCH, V11, P23, DOI 10.1348/135910705X43804; Sparkes A.C., 2014, QUALITATIVE RES METH; Spencer, 2011, VISUAL RES METHODS S; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thow M, 2008, PHYSIOTHERAPY, V94, P281, DOI 10.1016/j.physio.2008.06.001; Tierney S, 2011, HEALTH PSYCHOL, V30, P401, DOI 10.1037/a0022848; Tolmie Elizabeth P, 2006, Eur J Cardiovasc Nurs, V5, P228, DOI 10.1016/j.ejcnurse.2006.01.007; Whittemore R, 2000, QUAL HEALTH RES, V10, P260, DOI 10.1177/104973200129118408; Willich S, 2001, EUROPEAN HEART J, V22, P276; Wingham Jenny, 2006, Eur J Cardiovasc Nurs, V5, P289, DOI 10.1016/j.ejcnurse.2006.02.002; Yohannes AM, 2007, CLIN REHABIL, V21, P222, DOI 10.1177/0269215506070771	60	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138218	10.1371/journal.pone.0138218	http://dx.doi.org/10.1371/journal.pone.0138218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381147	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200071
J	Kilburn, TR; Eriksen, HLF; Underbjerg, M; Thorsen, P; Mortensen, EL; Landro, NI; Bakketeig, LS; Grove, J; Svaerke, C; Kesmodel, US				Kilburn, Tina R.; Eriksen, Hanne-Lise Falgreen; Underbjerg, Mette; Thorsen, Poul; Mortensen, Erik Lykke; Landro, Nils Inge; Bakketeig, Leiv S.; Grove, Jakob; Svaerke, Claus; Kesmodel, Ulrik Schioler			Low to Moderate Average Alcohol Consumption and Binge Drinking in Early Pregnancy: Effects on Choice Reaction Time and Information Processing Time in Five-Year-Old Children	PLOS ONE			English	Article							SPECTRUM DISORDERS; LIGHT DRINKING; COGNITIVE DEFICITS; EXPOSURE; ATTENTION; SPEED; MEMORY; BRAIN; RISK; INTELLIGENCE	Background Deficits in information processing may be a core deficit after fetal alcohol exposure. This study was designed to investigate the possible effects of weekly low to moderate maternal alcohol consumption and binge drinking episodes in early pregnancy on choice reaction time (CRT) and information processing time (IPT) in young children. Method Participants were sampled based on maternal alcohol consumption during pregnancy. At the age of 60-64 months, 1,333 children were administered a modified version of the Sternberg paradigm to assess CRT and IPT. In addition, a test of general intelligence (WPPSI-R) was administered. Results Adjusted for a wide range of potential confounders, this study showed no significant effects of average weekly maternal alcohol consumption during pregnancy on CRT or IPT. There was, however, an indication of slower CRT associated with binge drinking episodes in gestational weeks 1-4. Conclusion This study observed no significant effects of average weekly maternal alcohol consumption during pregnancy on CRT or IPT as assessed by the Sternberg paradigm. However, there were some indications of CRT being associated with binge drinking during very early pregnancy. Further large-scale studies are needed to investigate effects of different patterns of maternal alcohol consumption on basic cognitive processes in offspring.	[Kilburn, Tina R.] Aarhus Univ Hosp, Dept Res Child & Adolescent Psychiat, Risskov, Denmark; [Eriksen, Hanne-Lise Falgreen; Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Underbjerg, Mette] Vejlefjord Rehabil Ctr, Stouby, Denmark; [Thorsen, Poul] Lillebaelt Hosp, Dept Obstet & Gynaecol, Kolding, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Landro, Nils Inge] Univ Oslo, Dept Psychol, Clin Neurosci Res Grp, Oslo, Norway; [Bakketeig, Leiv S.] Univ Oslo, Natl Inst Publ Hlth, Oslo, Norway; [Grove, Jakob] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Svaerke, Claus] Aarhus Univ, Clin Epidemiol, Aarhus, Denmark; [Kesmodel, Ulrik Schioler] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8000 Aarhus, Denmark; [Kesmodel, Ulrik Schioler] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen; University of Oslo; University of Oslo; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Kilburn, TR (corresponding author), Aarhus Univ Hosp, Dept Res Child & Adolescent Psychiat, Risskov, Denmark.	tinakilb@rm.dk	Grove, Jakob/K-8112-2015	Grove, Jakob/0000-0003-2284-5744	Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA; Danish National Board of Health; Danish Council for Independent Research (Medical Sciences); Lundbeck Foundation; Health Insurance Foundation; Ludvig & Sara Elsass' Foundation; Aase & Ejnar Danielsen's Foundation; Direktor Jacob Madsen & hustru Olga Madsen's Foundation	Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Danish National Board of Health; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Health Insurance Foundation; Ludvig & Sara Elsass' Foundation; Aase & Ejnar Danielsen's Foundation; Direktor Jacob Madsen & hustru Olga Madsen's Foundation	This study was supported primarily by the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA (http://www.cdc.gov/). Additional support was obtained from The Danish National Board of Health (http://sundhedsstyrelsen.dk/en), the Danish Council for Independent Research (Medical Sciences) (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-medical-sciences), the Lundbeck Foundation (http://www.lundbeckfoundation.com/), the Health Insurance Foundation (http://www.helsefonden.dk/pages.asp?id=63), Ludvig & Sara Elsass' Foundation (http://elsassfonden.dk/), Aase & Ejnar Danielsen's Foundation (http://www.danielsensfond.dk/Default.aspx), and Direktor Jacob Madsen & hustru Olga Madsen's Foundation.	Abel E. L., 1998, FETAL ALCOHOL ABUSE; [Anonymous], 1958, STANDARD PROGR MATRI; Bay B, 2012, ALCOHOL CLIN EXP RES, V36, P807, DOI 10.1111/j.1530-0277.2011.01657.x; Burden MJ, 2005, ALCOHOL CLIN EXP RES, V29, P1473, DOI 10.1097/01.alc.0000175036.34076.a0; Burden MJ, 2005, ALCOHOL CLIN EXP RES, V29, P443, DOI 10.1097/01.ALC.0000156125.50577.EC; Eriksen HLF, 2012, BJOG-INT J OBSTET GY, V119, P1191, DOI 10.1111/j.1471-0528.2012.03394.x; Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200; Gray R, 2009, ADDICTION, V104, P1270, DOI 10.1111/j.1360-0443.2008.02441.x; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Henderson J, 2007, J EPIDEMIOL COMMUN H, V61, P1069, DOI 10.1136/jech.2006.054213; HOVING KL, 1970, PSYCHON SCI, V21, P247; Jacobson SW, 1998, ALCOHOL CLIN EXP RES, V22, P313, DOI 10.1111/j.1530-0277.1998.tb03654.x; Kable JA, 2004, ALCOHOL CLIN EXP RES, V28, P489, DOI 10.1097/01.ALC.0000117837.66107.64; Kelly Y, 2013, BJOG-INT J OBSTET GY, V120, P1340, DOI 10.1111/1471-0528.12246; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kelly YJ, 2012, J EPIDEMIOL COMMUN H, V66, P41, DOI 10.1136/jech.2009.103002; Kesmodel U, 2001, AM J EPIDEMIOL, V154, P777, DOI 10.1093/aje/154.8.777; Kesmodel U, 2001, J EPIDEMIOL COMMUN H, V55, P738, DOI 10.1136/jech.55.10.738; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1222, DOI 10.1111/j.1471-0528.2012.03395.x; Kesmodel US, 2013, ALCOHOL CLIN EXP RES, V37, P1204, DOI 10.1111/acer.12072; Kesmodel US, 2010, SCAND J PUBLIC HEALT, V38, P208, DOI 10.1177/1403494809357093; Kilburn TR, 2007, AVERAGE USE ALCOHOL; Kleiber ML, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-6; Kodituwakku PW, 2007, NEUROSCI BIOBEHAV R, V31, P192, DOI 10.1016/j.neubiorev.2006.06.020; Kodituwakku PW, 2009, DEV DISABIL RES REV, V15, P218, DOI 10.1002/ddrr.73; Kodituwakku PW, 2001, ALCOHOL RES HEALTH, V25, P192; Ma X, 2003, ALCOHOL CLIN EXP RES, V29, P1214; Mackintosh Nicholas John, 2011, IQ HUMAN INTELLIGENC; Maier SE, 1999, NEUROTOXICOL TERATOL, V21, P285, DOI 10.1016/S0892-0362(98)00056-7; May PA, 2013, DRUG ALCOHOL DEPEN, V133, P502, DOI 10.1016/j.drugalcdep.2013.07.013; Mayr U, 2004, TRENDS COGN SCI, V8, P145, DOI 10.1016/j.tics.2004.02.006; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ozer E, 2000, CLIN NEUROPATHOL, V19, P21; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536; Simmons RW, 2010, ALCOHOL, V44, P371, DOI 10.1016/j.alcohol.2010.02.013; Simmons RW, 2006, NEUROTOXICOL TERATOL, V28, P278, DOI 10.1016/j.ntt.2006.01.008; Simmons RW, 2002, ALCOHOL CLIN EXP RES, V26, P1412, DOI 10.1097/01.ALC.0000030563.14827.29; Skogerbo A, 2013, BJOG-INT J OBSTET GY, V120, P1042, DOI 10.1111/1471-0528.12208; Skogerbo A, 2012, BJOG-INT J OBSTET GY, V119, P1201, DOI 10.1111/j.1471-0528.2012.03397.x; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1984, DEV PSYCHOL, V20, P533, DOI 10.1037/0012-1649.20.4.533; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; Underbjerg M, 2012, BJOG-INT J OBSTET GY, V119, P1211, DOI 10.1111/j.1471-0528.2012.03396.x; Wechsler D., 1990, MANUAL WECHSLER PRES; Willford JA, 2010, NEUROTOXICOL TERATOL, V32, P580, DOI 10.1016/j.ntt.2010.06.004	51	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138611	10.1371/journal.pone.0138611	http://dx.doi.org/10.1371/journal.pone.0138611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382068	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200138
J	Liu, BH; Lin, YC; Ho, CS; Yang, CC; Chang, YT; Chang, JF; Li, CY; Cheng, CS; Huang, JY; Lee, YF; Hsu, MH; Lin, FC; Wang, HC; Lo, CF; Yang, SY; Wang, HC				Liu, Bing-Hsien; Lin, Yu-Chen; Ho, Chia-Shin; Yang, Che-Chuan; Chang, Yun-Tsui; Chang, Jui-Feng; Li, Chun-Yuan; Cheng, Cheng-Shun; Huang, Jiun-Yan; Lee, Yen-Fu; Hsu, Ming-Hung; Lin, Feng-Chun; Wang, Hao-Ching; Lo, Chu-Fang; Yang, Shieh-Yueh; Wang, Han-Ching			A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay	PLOS ONE			English	Article							NERVOUS NECROSIS VIRUS; REAL-TIME PCR; MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; WSSV; ICP11; WSBV	Shrimp white spot disease (WSD), which is caused by white spot syndrome virus (WSSV), is one of the world's most serious shrimp diseases. Our objective in this study was to use an immunomagnetic reduction (IMR) assay to develop a highly sensitive, automatic WSSV detection platform targeted against ICP11 (the most highly expressed WSSV protein). After characterizing the magnetic reagents (Fe3O4 magnetic nanoparticles coated with anti ICP11), the detection limit for ICP11 protein using IMR was approximately 2 x 10(-3) ng/ml, and the linear dynamic range of the assay was 0.1 similar to 1 x 10(6) ng/ml. In assays of ICP11 protein in pleopod protein lysates from healthy and WSSV-infected shrimp, IMR signals were successfully detected from shrimp with low WSSV genome copy numbers. We concluded that this IMR assay targeting ICP11 has potential for detecting the WSSV.	[Liu, Bing-Hsien; Lin, Yu-Chen; Ho, Chia-Shin; Yang, Che-Chuan; Chang, Yun-Tsui; Chang, Jui-Feng; Lee, Yen-Fu; Hsu, Ming-Hung; Lin, Feng-Chun; Yang, Shieh-Yueh] MagQu Co Ltd, New Taipei City 231, Taiwan; [Li, Chun-Yuan; Cheng, Cheng-Shun; Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Huang, Jiun-Yan; Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Wang, Hao-Ching] Taipei Med Univ, Grad Inst Translat Med, Coll Med Sci & Technol, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Wang, HC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan.	wanghc@mail.ncku.edu.tw	Wang, Han-Ching/AAT-6086-2021; Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129; Wang, Han-Ching/0000-0001-7283-4942; Wang, Hao-Ching/0000-0003-2396-717X	Agricultural Technology Research Institute in Taiwan [103AG-a5.2-08]	Agricultural Technology Research Institute in Taiwan	This work was supported by Agricultural Technology Research Institute in Taiwan (grant 103AG-a5.2-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BHL, YCL, CSH, CCY, YTC, JFC, YFL, MHH, FCL and SYY are employed by MagQu Co. The funder provided support in the form of salaries for authors [BHL, YCL, CSH, CCY, JFC, YFL, MHH, FCL and SYY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chaivisuthangkura Parin, 2014, World J Virol, V3, P1, DOI 10.5501/wjv.v3.i1.1; Chaivisuthangkura P, 2010, AQUACULTURE, V299, P15, DOI 10.1016/j.aquaculture.2009.12.005; Chang CH, 2012, INT J NANOMED, V7, P4335, DOI 10.2147/IJN.S31030; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Gnoth C, 2014, GEBURTSH FRAUENHEILK, V74, P661, DOI 10.1055/s-0034-1368589; Hong CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206557; Leal CAG, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-150; Liu W, 2002, DIS AQUAT ORGAN, V49, P11, DOI 10.3354/dao049011; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1997, DIS AQUAT ORGAN, V30, P53, DOI 10.3354/dao030053; Lo CF, 1998, FISH PATHOL, V33, P365, DOI 10.3147/jsfp.33.365; Lu MW, 2012, J VIROL METHODS, V181, P68, DOI 10.1016/j.jviromet.2012.01.012; Nunan LM, 2011, J VIROL METHODS, V171, P318, DOI 10.1016/j.jviromet.2010.11.015; Poulos BT, 2001, DIS AQUAT ORGAN, V47, P13, DOI 10.3354/dao047013; Powell JWB, 2006, AQUACULTURE, V257, P167, DOI 10.1016/j.aquaculture.2006.03.010; Pradeep B, 2012, INDIAN J VIROL, V23, P161, DOI 10.1007/s13337-012-0079-y; Sanchez-Paz A, VIROL J, V213, P186; Siriwattanarat R, 2013, ARCH VIROL, V158, P967, DOI 10.1007/s00705-012-1569-3; Sithigorngul P, 2011, J VIROL METHODS, V173, P85, DOI 10.1016/j.jviromet.2011.01.011; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Tsai YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090545; Wang HC, 2007, DIS AQUAT ORGAN, V74, P179, DOI 10.3354/dao074179; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Yang CC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739735; Yang CC, 2012, J NANOBIOTECHNOL, V12, P44; Yang CC, 2011, ACS CHEM NEUROSCI, V2, P500, DOI 10.1021/cn200028j; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048; Yang SY, 2012, J VET DIAGN INVEST, V24, P911, DOI 10.1177/1040638712455796	29	68	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138207	10.1371/journal.pone.0138207	http://dx.doi.org/10.1371/journal.pone.0138207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380977	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200070
J	Sun, ZX; Xie, MX; Xiang, FX; Song, Y; Yu, C; Zhang, YR; Ramdhany, S; Wang, J				Sun, Zhenxing; Xie, Mingxing; Xiang, Feixiang; Song, Yue; Yu, Cheng; Zhang, Yanrong; Ramdhany, Sachin; Wang, Jing			Utility of Real-Time Shear Wave Elastography in the Assessment of Testicular Torsion	PLOS ONE			English	Article							ULTRASOUND ELASTOGRAPHY; BREAST MASSES; PEDIATRIC-PATIENTS; SONOGRAPHY; INFARCTION; LESIONS; US; ELASTICITY; DIAGNOSIS; DISEASE	Real-time shear-wave elastography (SWE) is a newly developed method which can obtain the stiffness of tissues and organs based on tracking of shear wave propagation through a structure. Several studies have demonstrated its potential in the differentiation between diseased and normal tissue in clinical practices, however the applicability to testicular disease has not been well elucidated. We investigated the feasibility and reproducibility of SWE in the detection of testicular torsion. This prospective study comprised 15 patients with complete testicular torsion. Results obtained from SWE along with conventional gray-scale and color Doppler sonography and post-operative pathology were compared. The results revealed that (i) the size of injured testis was increased and the twisted testis parenchyma was heterogeneous. The blood flow signals in injured testis were barely visible or absent; (ii) The Young's modulus, including Emean, Emax, Emin and SD values in the border area of torsional testis were higher than those of normal testis (Emean, 78.07+/-9.01kPa vs 22.0 +/-5.10kPa; Emax, 94.07+/-6.53kPa vs 27.87+/-5.78kPa; Emin, 60.73+/-7.84 kPa vs 18.90 +/-4.39kPa; SD, 7.67+/-0.60 kPa vs 2.30+/-0.36 kPa, [P<0.05]); The Emax and SD values in the central area of the torsional testis were higher than the corresponding area of the normal testis (Emax, 8.23+/-0.30 kPa vs 3.97+/-0.95kPa; SD, 1.5+/-0.26kPa vs 0.67+/-0.35kPa, [P< 0.05])and Emin values was lower than those of normal testicles(0.93+/-0.51kPa vs 1.6 +/-0.36kPa; [P< 0.05]); (iii) The Young's modulus measurement between two physicians showed good agreement. The pathological findings were accordance with SWE measurement. SWE is a non-invasive, convenient and high reproducible method and may serve as an important alternative tool in the diagnosis and monitoring the progression of the acute scrotums, in additional to conventional Doppler sonography.	[Sun, Zhenxing; Xie, Mingxing; Xiang, Feixiang; Song, Yue; Yu, Cheng; Zhang, Yanrong; Ramdhany, Sachin; Wang, Jing] Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Wang, J (corresponding author), Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	jean_wj31@yahoo.com		Xie, Mingxing/0000-0003-4984-1567				Aigner F, 2012, RADIOLOGY, V263, P584, DOI 10.1148/radiol.12111732; Baker LA, 2000, PEDIATRICS, V105, P604, DOI 10.1542/peds.105.3.604; Barr RG, 2012, ULTRASOUND Q, V28, P13, DOI 10.1097/RUQ.0b013e318249f594; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Bhatia K, 2012, ULTRASCHALL MED, V33, P463, DOI [10.1055/s-0032-1325428, 10.1055/s-0032-1325330]; Bhatia KSS, 2012, EUR RADIOL, V22, P2397, DOI 10.1007/s00330-012-2495-1; Bilagi P, 2007, EUR RADIOL, V17, P2810, DOI 10.1007/s00330-007-0674-2; Blaivas M, 2004, EMERG MED CLIN N AM, V22, P723, DOI 10.1016/j.emc.2004.04.002; Cha SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101292; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Chen B, 2014, CHIN J ANAT CLIN, V19, P75; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Cuckow PM, 2000, BJU INT, V86, P349, DOI 10.1046/j.1464-410x.2000.00106.x; Davenport M, 1996, BRIT MED J, V312, P435; Dogra VS, 2003, RADIOLOGY, V227, P18, DOI 10.1148/radiol.2271001744; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2; Garra Brian Stephen, 2007, Ultrasound Q, V23, P255, DOI 10.1097/ruq.0b013e31815b7ed6; Grenier N, 2013, ULTRASOUND CLIN, V8, P551, DOI [10.1016/j.cult.2013.06.002, DOI 10.1016/J.CULT.2013.06.002]; Grenier N, 2012, EUR RADIOL, V22, P2138, DOI 10.1007/s00330-012-2471-9; Guibal A, 2013, EUR RADIOL, V23, P1138, DOI 10.1007/s00330-012-2692-y; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Kadish HA, 1998, PEDIATRICS, V102, P73, DOI 10.1542/peds.102.1.73; Kantarci F, 2012, KOREAN J RADIOL, V13, P820, DOI 10.3348/kjr.2012.13.6.820; Ko KH, 2014, EUR RADIOL, V24, P305, DOI 10.1007/s00330-013-3034-4; Lee SH, 2013, EUR RADIOL, V23, P1015, DOI 10.1007/s00330-012-2686-9; Lesnik G, 2006, ROFO-FORTSCHR RONTG, V178, P165, DOI 10.1055/s-2005-858916; Libertino JA, 1998, RECONSTRUCTIVE UROLO, P587; Liu CC, 2007, KAOHSIUNG J MED SCI, V23, P281, DOI 10.1016/S1607-551X(09)70410-3; Luker GD, 1996, RADIOLOGY, V198, P381, DOI 10.1148/radiology.198.2.8596836; Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311; Nelson ED, 2007, UROLOGY, V70, P1136, DOI 10.1016/j.urology.2007.07.067; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Olgun DC, 2014, J ULTRAS MED, V33, P503, DOI 10.7863/ultra.33.3.503; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Ophir Jonathan, 2002, J Med Ultrason (2001), V29, P155, DOI 10.1007/BF02480847; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Rizvi SAA, 2011, UROL J, V8, P60; Rubens DJ., 2006, ULTRASOUND CLIN, V1, P55, DOI DOI 10.1016/j.cult.2005.09.006; Sarvazyan A, 2011, CURR MED IMAGING, V7, P255, DOI 10.2174/157340511798038684; Secil M, 2006, J CLIN ULTRASOUND, V34, P143, DOI 10.1002/jcu.20197; Singhal A, 2012, J CLIN ULTRASOUND, V40, P243, DOI 10.1002/jcu.21889; Smith RD, 2002, ANZ J SURG, V72, P316, DOI 10.1046/j.1445-2197.2002.02360.x; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Waldert M, 2010, UROLOGY, V75, P1170, DOI 10.1016/j.urology.2009.07.1298; Wen GC, 2013, J DALI U, V12, P53; WILBERT DM, 1993, J UROLOGY, V149, P1475, DOI 10.1016/S0022-5347(17)36420-0; Yoon JH, 2011, AM J ROENTGENOL, V196, P730, DOI 10.2214/AJR.10.4654; Zaleska-Dorobisz U, 2014, ADV CLIN EXP MED, V23, P645, DOI 10.17219/acem/26301; Zoller G, 2000, UROLOGE A, V39, P251, DOI 10.1007/s001200050351	51	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138523	10.1371/journal.pone.0138523	http://dx.doi.org/10.1371/journal.pone.0138523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382244	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200119
J	Tseng, IL; Liu, YM; Wang, SJ; Yeh, HY; Hsieh, CL; Lu, HL; Tseng, YC; Mu, JJ				Tseng, I-Ling; Liu, Yu-Mei; Wang, Shiow-Jen; Yeh, Hung-Yi; Hsieh, Chia-Lun; Lu, Hsueh-Lin; Tseng, Yu-Chuan; Mu, Jung-Jung			Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013	PLOS ONE			English	Article							BETA-LACTAMASE; RESISTANT ENTEROBACTERIACEAE; K. PNEUMONIAE; SURVEILLANCE; OUTBREAK	The emergence of carbapenemase-producing Klebsiella pneumoniae (CPKP) has become a great concern worldwide. In this study, 994 non-duplicate, carbapenem non-susceptible Klebsiella pneumonia isolates were collected in Taiwan from 2011 to 2013 for detection of the carbapenemase genes, assessment of antimicrobial susceptibility and molecular epidemiology studies. Of these 994 isolates, 183 (18.4%) had carbapenemase genes: 157 (15.8%) KPC (145 KPC-2 and 12 KPC-17), 16 (1.6%) IMP-8, 9 (0.9%) VIM-1, and 1 (0.1%) NDM-1. KPC had the highest prevalence rate among the carbapenemases and represented a major epidemic clone circulating in Taiwan. The ST512 and ST258 KPC-2 KPs were first identified in Taiwan and were grouped into a small cluster in the PFGE profile. In addition, the genetic structure encompassing the bla(KPC) gene of the ST512 and ST258 isolates showed a different pattern from that of other KPC isolates. ST11 may be a major sequence type circulating in Taiwan, although a specific minor clone has begun to be observed. This is the first report of ST258 and ST512 KPC-2 KP isolates in Taiwan, whether ST258 and ST512 will become the next endemic problems in Taiwan should be closely monitored.	[Tseng, I-Ling; Liu, Yu-Mei; Wang, Shiow-Jen; Yeh, Hung-Yi; Hsieh, Chia-Lun; Tseng, Yu-Chuan; Mu, Jung-Jung] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Bacterial Enter & Emerging Dis Lab, Taipei, Taiwan; [Lu, Hsueh-Lin] Dev Ctr Biotechnol, Bioengn Grp, Taipei, Taiwan	Centers For Disease Control - Taiwan	Mu, JJ (corresponding author), Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Bacterial Enter & Emerging Dis Lab, Taipei, Taiwan.	jjmu@cdc.gov.tw			Centers for Disease Control	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by Centers for Disease Control (http://www.cdc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2015, J ANTIMICROB CHEMOTH, V70, P89, DOI 10.1093/jac/dku333; Berrazeg M, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.20.20809; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Gagliotti C, 2014, EURO SURVEILLANCE B, V19; Giani T, 2013, EURO SURVEILLANCE B, V18; Hrabak J, 2013, EUROSURVEILLANCE, V18, P6, DOI 10.2807/1560-7917.ES2013.18.45.20626; Hsieh WS, 2014, J ANTIMICROB CHEMOTH, V69, P2871, DOI 10.1093/jac/dku205; Huang SR, 2014, J MICROBIOL IMMUNOL, V47, P187, DOI 10.1016/j.jmii.2012.08.029; Kaiser RM, 2013, DIAGN MICR INFEC DIS, V76, P356, DOI 10.1016/j.diagmicrobio.2013.03.032; Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12; Lee MF, 2008, INT J ANTIMICROB AG, V32, P475, DOI 10.1016/j.ijantimicag.2008.07.009; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robilotti Elizabeth, 2014, F1000Prime Rep, V6, P80, DOI 10.12703/P6-80; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; Yan JJ, 2001, J CLIN MICROBIOL, V39, P4433, DOI 10.1128/JCM.39.12.4433-4439.2001; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	27	25	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138471	10.1371/journal.pone.0138471	http://dx.doi.org/10.1371/journal.pone.0138471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384242	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200108
J	Gomez-Vicente, V; Lax, P; Fernandez-Sanchez, L; Rondon, N; Esquiva, G; Germain, F; de la Villa, P; Cuenca, N				Gomez-Vicente, Violeta; Lax, Pedro; Fernandez-Sanchez, Laura; Rondon, Netxibeth; Esquiva, Gema; Germain, Francisco; de la Villa, Pedro; Cuenca, Nicolas			Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNITS; OXIDATIVE STRESS; MOUSE MODEL; ACTIVATION; TUDCA; DEATH; NEUROTOXICITY; LOCALIZATION; DYSFUNCTION; APOPTOSIS	Retinal ganglion cell degeneration underlies the pathophysiology of diseases affecting the retina and optic nerve. Several studies have previously evidenced the anti-apoptotic properties of the bile constituent, tauroursodeoxycholic acid, in diverse models of photoreceptor degeneration. The aim of this study was to investigate the effects of systemic administration of tauroursodeoxycholic acid on N-methyl-D-aspartate (NMDA)-induced damage in the rat retina using a functional and morphological approach. Tauroursodeoxycholic acid was administered intraperitoneally before and after intravitreal injection of NMDA. Three days after insult, full-field electroretinograms showed reductions in the amplitudes of the positive and negative-scotopic threshold responses, scotopic alpha- and beta-waves and oscillatory potentials. Quantitative morphological evaluation of whole-mount retinas demonstrated a reduction in the density of retinal ganglion cells. Systemic administration of tauroursodeoxycholic acid attenuated the functional impairment induced by NMDA, which correlated with a higher retinal ganglion cell density. Our findings sustain the efficacy of tauroursodeoxycholic acid administration in vivo, suggesting it would be a good candidate for the pharmacological treatment of degenerative diseases coursing with retinal ganglion cell loss.	[Gomez-Vicente, Violeta] Univ Alicante, Dept Opt Farmacol & Anat, E-03080 Alicante, Spain; [Lax, Pedro; Fernandez-Sanchez, Laura; Rondon, Netxibeth; Esquiva, Gema; Cuenca, Nicolas] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain; [Germain, Francisco; de la Villa, Pedro] Univ Alcala de Henares, Dept Biol Sistemas, E-28801 Alcala De Henares, Spain	Universitat d'Alacant; Universitat d'Alacant; Universidad de Alcala	Cuenca, N (corresponding author), Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain.	cuenca@ua.es	Fernandez-Sanchez, Laura/AAB-5663-2019; Esquiva, Gema/AAE-5642-2020; Gómez-Vicente, Violeta/A-6089-2013; Lax, Pedro/M-9074-2014; Cuenca, Nicolas/I-2007-2015; Germain, Francisco/J-7152-2019; de la Villa, Pedro/G-2322-2016; Esquiva, Gema/ABA-6317-2020	Fernandez-Sanchez, Laura/0000-0002-3629-0156; Esquiva, Gema/0000-0002-3951-6464; Gómez-Vicente, Violeta/0000-0002-5696-8673; Lax, Pedro/0000-0001-6931-1008; Cuenca, Nicolas/0000-0002-6767-5710; de la Villa, Pedro/0000-0001-9856-6616; 	Spanish Ministerio de Economia y Competitividad-FEDER [BFU2012-36845]; Instituto de Salud Carlos III RETICS [RD12/0034/0010]; Organizacion Nacional de Ciegos Espanoles; Ministerio de Ciencia e Innovacion [JCI-2009-05224]; Universidad de Alicante [2010-48536273]; Instituto de Salud Carlos III [PI13/02098, RD12/0034/0006]; FUNDALUCE	Spanish Ministerio de Economia y Competitividad-FEDER(Spanish Government); Instituto de Salud Carlos III RETICS(Instituto de Salud Carlos III); Organizacion Nacional de Ciegos Espanoles; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad de Alicante; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FUNDALUCE	This work was supported by project grants from Spanish Ministerio de Economia y Competitividad-FEDER (http://www.mineco.gob.es) #BFU2012-36845, Instituto de Salud Carlos III RETICS (http://www.oftared.com) #RD12/0034/0010 and Organizacion Nacional de Ciegos Espanoles (http://www.once.es) to NC; Ministerio de Ciencia e Innovacion #JCI-2009-05224 to VGV; Universidad de Alicante (http://www.ua.es) #2010-48536273 to GE; Instituto de Salud Carlos III (http://www.isciii.es) #PI13/02098 and RETICS #RD12/0034/0006 to PdV; and FUNDALUCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Martinez L, 2009, MOL VIS, V15, P2373; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Boatright JH, 2006, MOL VIS, V12, P1706; Boatright JH, 2005, INVEST OPHTHALMOL VI, V46; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108090; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; El-Azab MF, 2014, BRIT J PHARMACOL, V171, P1299, DOI 10.1111/bph.12535; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Ferreira IL, 1996, EUR J PHARMACOL, V302, P153, DOI 10.1016/0014-2999(96)00044-1; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Germain F, 2013, CLIN EXP OPHTHALMOL, V41, P593, DOI 10.1111/ceo.12046; Ghaffarieh A, 2012, INT REV NEUROBIOL, V105, P1, DOI 10.1016/B978-0-12-398309-1.00002-0; Kalloniatis M, 2004, VISUAL NEUROSCI, V21, P587, DOI 10.1017/S0952523804214080; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; KOROL S, 1975, BRAIN RES, V97, P235, DOI 10.1016/0006-8993(75)90447-3; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Ohno Y, 2012, EUR J PHARMACOL, V690, P84, DOI 10.1016/j.ejphar.2012.06.035; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Yamashita H, 2011, EXP EYE RES, V93, P75, DOI 10.1016/j.exer.2011.04.006; Yanguas-Casas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-50; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; You Y, 2013, REV NEUROSCIENCE, V24, P301, DOI 10.1515/revneuro-2013-0003; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zheng SJ, 2015, INVEST OPHTH VIS SCI, V56, P1168, DOI 10.1167/iovs.14-15612	49	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137826	10.1371/journal.pone.0137826	http://dx.doi.org/10.1371/journal.pone.0137826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379056	Green Published, gold			2022-12-26	WOS:000361769400030
J	Cheng, J; Dackor, RT; Bradbury, JA; Li, H; DeGraff, LM; Hong, LK; King, D; Lih, FB; Gruzdev, A; Edin, ML; Travlos, GS; Flake, GP; Tomer, KB; Zeldin, DC				Cheng, Jennifer; Dackor, Ryan T.; Bradbury, J. Alyce; Li, Hong; DeGraff, Laura M.; Hong, Lee K.; King, Debra; Lih, Fred B.; Gruzdev, Artiom; Edin, Matthew L.; Travlos, Gregory S.; Flake, Gordon P.; Tomer, Kenneth B.; Zeldin, Darryl C.			Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis	FASEB JOURNAL			English	Article						prostaglandins; airway hyperresponsiveness; lipopolysaccharide; bleomycin	INDUCED PULMONARY-FIBROSIS; PROSTAGLANDIN E-2 PRODUCTION; EPITHELIAL-CELLS; DEFICIENT MICE; MOUSE LUNG; LIPOPOLYSACCHARIDE; EXPRESSION; PROTECTS; SYNTHASE; INJURY	Cyclooxygenase (COX)-2 has been shown to be involved in regulating basal airway function, bacterial LPS-induced airway hyperresponsiveness (AHR) and lung inflammation, and bleomycin-induced lung fibrosis; however, the cellular source of COX-2 that underlies these effects is unknown. We generated mice with alveolar type II (ATII) cell-specific knockdown of COX-2 (AT2CC(-/-)), to examine the role of ATII cell-derived prostaglandins (PGs) in these processes. Specific knockdown of COX-2 was confirmed by real-time RT-PCR and Western blot analyses. LC/MS/MS analysis showed that ATII cells produced PGs. Basal airway responsiveness of AT2CC(-/-) mice was decreased compared to that of wild-type (WT) mice. LPS-induced hypothermic response, infiltration of inflammatory cells into the airway, and lung inflammation were enhanced in AT2CC(-/-) mice relative to WT controls; however, LPS-induced AHR and proinflammatory cytokine and chemokine expression were similar between the genotypes. After 21 d of bleomycin administration, AT2CC(-/-) mice behaved in a manner similar to WT mice. Thus, ATII cell-derived COX-2 plays an important role in regulating basal airway function and LPS-induced lung inflammation, but does not play a role in bleomycin-induced fibrosis. These findings provide insight into the cellular source of COX-2 related to these lung phenotypes.-Cheng, J., Dackor, R. T., Bradbury, J. A., Li, H., DeGraff, L. M., Hong, L. K., King, D., Lih, F. B., Gruzdev, A., Edin, M. L., Travlos, G. S., Flake, G. P., Tomer, K. B., Zeldin, D. C. Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis. FASEB J. 30, 160-173 (2016). www.fasebj.org	[Cheng, Jennifer; Dackor, Ryan T.; Bradbury, J. Alyce; Li, Hong; DeGraff, Laura M.; Hong, Lee K.; King, Debra; Lih, Fred B.; Gruzdev, Artiom; Edin, Matthew L.; Travlos, Gregory S.; Flake, Gordon P.; Tomer, Kenneth B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,Bldg 101,Rm A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019; Li, Hong/ABE-3959-2021	Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X; Hong, Lee/0000-0003-0002-8858	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES050167, Z01 ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZICES102425, ZIAES025043, ZICES102505, ZICES102546, Z01ES050167] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health, National Institute of Environmental Health Sciences, Intramural Research Program Grants Z01 ES050167 (to K.B.T.) and Z01 ES025034 (to D.C.Z.). The authors declare no conflicts of interest.	Bauer AK, 2000, CARCINOGENESIS, V21, P543, DOI 10.1093/carcin/21.4.543; Bonner JC, 2000, AM J PHYSIOL-LUNG C, V278, pL209, DOI 10.1152/ajplung.2000.278.1.L209; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; Card JW, 2007, AM J RESP CELL MOL, V37, P300, DOI 10.1165/rcmb.2007-0057OC; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Ermert L, 2000, AM J PATHOL, V156, P1275, DOI 10.1016/S0002-9440(10)64998-X; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Galvin JR, 2009, J THORAC IMAG, V24, P274, DOI 10.1097/RTI.0b013e3181c1abb7; Garantziotis S, 2004, J CLIN INVEST, V114, P319, DOI 10.1172/jci200422497; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Held HD, 2000, AM J RESP CRIT CARE, V162, P1547, DOI 10.1164/ajrccm.162.4.9912079; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; LEE SH, 1992, J BIOL CHEM, V267, P25934; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Lescuyer P, 2005, ELECTROPHORESIS, V26, P4563, DOI 10.1002/elps.200500292; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Marcet B, 2007, EUR J PHARMACOL, V566, P167, DOI 10.1016/j.ejphar.2007.04.003; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V284, P203, DOI 10.1006/bbrc.2001.4927; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Ragolia L, 2007, PROSTAG OTH LIPID M, V83, P25, DOI 10.1016/j.prostaglandins.2006.09.006; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Swedin L, 2010, PROSTAG OTH LIPID M, V92, P44, DOI 10.1016/j.prostaglandins.2010.02.004; Zeldin DC, 2001, AM J RESP CELL MOL, V25, P457, DOI 10.1165/ajrcmb.25.4.4505	36	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					160	173		10.1096/fj.14-268458	http://dx.doi.org/10.1096/fj.14-268458			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396235	Green Published			2022-12-26	WOS:000367621000018
J	Li, YM; Wu, XY; Zhang, HB; Yan, P; Xue, H; Wu, XB				Li, Yongmin; Wu, Xiaoyou; Zhang, Huabin; Yan, Peng; Xue, Hui; Wu, Xiaobing			Vicariance and Its Impact on the Molecular Ecology of a Chinese Ranid Frog Species-Complex (Odorrana schmackeri, Ranidae)	PLOS ONE			English	Article							HISTORICAL DEMOGRAPHY; POPULATION-GENETICS; CLADISTIC-ANALYSIS; SECONDARY CONTACT; BUFO-GARGARIZANS; TIBETAN PLATEAU; CLIMATE-CHANGE; ANURA RANIDAE; SKY ISLANDS; PHYLOGEOGRAPHY	Paleogeological events and Pleistocene climatic fluctuations have had profound influences on the genetic patterns and phylogeographic structure of species in southern China. In this study, we investigated the population genetic structure and Phylogeography of the Odorrana schmackeri species complex, mountain stream-dwelling odorous frogs, endemic to southern China. We obtained mitochondrial sequences (1,151bp) of the complete ND2 gene and two flanking tRNAs of 511 individuals from 25 sites for phylogeographic analyses. Phylogenetic reconstruction revealed seven divergent evolutionary lineages, with mean pairwise (K2P) sequence distances from 7.8% to 21.1%, except for a closer ND2 distance (3.4%). The complex geological history of southern China drove matrilineal divergence in the O. schmackeri species complex into highly structured geographical units. The first divergence between lineage A+B and other lineages (C-G) had likely been influenced by the uplift of coastal mountains of Southeast China during the Mio-Pliocene period. The subsequent divergences between the lineages C-G may have followed the formation of the Three Gorges and the intensification of the East Asian summer monsoon during the late Pliocene and early Pleistocene. Demographic analyses indicated that major lineages A and C have been experienced recent population expansion (c. 0.045-0.245 Ma) from multiple refugia prior to the Last Glacial Maximum (LGM). Molecular analysis suggest that these seven lineages may represent seven different species, three described species and four cryptic species and should at least be separated into seven management units corresponding to these seven geographic lineages for conservation.	[Li, Yongmin; Wu, Xiaoyou; Zhang, Huabin; Yan, Peng; Xue, Hui; Wu, Xiaobing] Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu, Anhui, Peoples R China; [Li, Yongmin] Fuyang Teachers Coll, Sch Life Sci, Fuyang, Anhui, Peoples R China	Anhui Normal University	Wu, XB (corresponding author), Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu, Anhui, Peoples R China.	wuxb@mail.ahnu.edu.cn			National Natural Science Foundation of China [30870359]; Project of Anhui Province Academic and Technology Leaders; Anhui Provincial Natural Science Foundation [1208085MC51]; Provincial Nature Science Research Project of Anhui Colleges [KJ2015A217, 2015KJ004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Anhui Province Academic and Technology Leaders; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Provincial Nature Science Research Project of Anhui Colleges	This research was supported by the National Natural Science Foundation of China (30870359), the Project of Anhui Province Academic and Technology Leaders and the Anhui Provincial Natural Science Foundation (1208085MC51), and Provincial Nature Science Research Project of Anhui Colleges (KJ2015A217; 2015KJ004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[安芷生 An Zhisheng], 2006, [第四纪研究, Quaternary Sciences], V26, P678; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Beerli P, 1996, EVOLUTION, V50, P1676, DOI 10.1111/j.1558-5646.1996.tb03939.x; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Chen PJ, 1995, 6 S MES TERR EC BIOT, P189; Chen W, 2009, MOL ECOL, V18, P2856, DOI 10.1111/j.1365-294X.2009.04258.x; Chen XH, 2013, MOL PHYLOGENET EVOL, V69, P1196, DOI 10.1016/j.ympev.2013.07.023; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; Ding L, 2011, MOL ECOL, V20, P1905, DOI 10.1111/j.1365-294X.2011.05060.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Fei Liang, 2007, Acta Zootaxonomica Sinica, V32, P989; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Fu JZ, 2005, MOL PHYLOGENET EVOL, V37, P202, DOI 10.1016/j.ympev.2005.03.023; Fu YX, 1997, GENETICS, V147, P915; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Garrigues T, 2005, MOL PHYLOGENET EVOL, V35, P35, DOI 10.1016/j.ympev.2004.11.004; Guest HJ, 2014, J BIOGEOGR, V41, P1070, DOI 10.1111/jbi.12267; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hu YL, 2007, BIOCHEM GENET, V45, P697, DOI 10.1007/s10528-007-9107-9; Huang S, 2007, MOL PHYLOGENET EVOL, V44, P942, DOI 10.1016/j.ympev.2007.05.019; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Hull JM, 2005, MOL ECOL, V14, P159, DOI 10.1111/j.1365-294X.2004.02366.x; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; Ju LX, 2007, PALAEOGEOGR PALAEOCL, V248, P376, DOI 10.1016/j.palaeo.2006.12.012; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Li JJ, 2001, GEOMORPHOLOGY, V41, P125, DOI 10.1016/S0169-555X(01)00110-6; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Li YM, 2014, AMPHIBIA-REPTILIA, V35, P331, DOI 10.1163/15685381-00002958; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu D., 1996, GEOGRAPHY OF ASIA; Liu K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-201; Lu B, 2012, MOL ECOL, V21, P3308, DOI 10.1111/j.1365-294X.2012.05606.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Miller MP, 1997, TOOLS POPULATION GEN; Miraldo A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-170; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qu JY, 2009, MOL PHYLOGENET EVOL, V52, P125, DOI 10.1016/j.ympev.2009.03.015; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Rambaut A, 2007, TRACER VERSION 1 6; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 2001, MOL CLONING LAB MANU; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Starkey DE, 2003, EVOLUTION, V57, P119; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1993, GENETICS, V134, P659; Ursenbacher S, 2006, MOL PHYLOGENET EVOL, V38, P546, DOI 10.1016/j.ympev.2005.08.004; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wang B, 2013, J MOL EVOL, V76, P112, DOI 10.1007/s00239-013-9544-5; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang CB, 2014, MOL PHYLOGENET EVOL, V80, P205, DOI 10.1016/j.ympev.2014.08.015; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; [邬光剑 Wu Guangjian], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P544; Wu YK, 2013, MOL PHYLOGENET EVOL, V66, P380, DOI 10.1016/j.ympev.2012.10.011; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yan J, 2010, MOL ECOL, V19, P2490, DOI 10.1111/j.1365-294X.2010.04660.x; Yang DY, 2006, FORMATION YANGTZE RI; Yang JC, 1993, FEATURES EVOLUTION L; Yu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056066; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang Rong-Zu, 2004, Acta Zoologica Sinica, V50, P841; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhong J, 2008, ZOOL SCI, V25, P811, DOI 10.2108/zsj.25.811; Zhou WW, 2012, MOL ECOL, V21, P960, DOI 10.1111/j.1365-294X.2011.05411.x; Zhou WW, 2013, MOL ECOL, V22, P130, DOI 10.1111/mec.12087	93	10	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138757	10.1371/journal.pone.0138757	http://dx.doi.org/10.1371/journal.pone.0138757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394403	gold, Green Published, Green Submitted			2022-12-26	WOS:000361792100095
J	Nhantumbo, AA; Cantarelli, VV; Caireao, J; Munguambe, AM; Come, CE; Pinto, GD; Zimba, TF; Mandomando, I; Sema, CB; Dias, C; Moraes, MO; Gudo, ES				Nhantumbo, Aquino Albino; Cantarelli, Vlademir Vicente; Caireao, Juliana; Munguambe, Alcides Moniz; Come, Charlotte Elizabeth; Pinto, Gabriela do Carmo; Zimba, Tomas Francisco; Mandomando, Inacio; Sema, Cynthia Baltazar; Dias, Ccero; Moraes, Milton Ozorio; Gudo, Eduardo Samo			Frequency of Pathogenic Paediatric Bacterial Meningitis in Mozambique: The Critical Role of Multiplex Real-Time Polymerase Chain Reaction to Estimate the Burden of Disease	PLOS ONE			English	Article							B STREPTOCOCCAL DISEASE; INFLUENZAE TYPE-B; HAEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; PNEUMOCOCCAL MENINGITIS; NEISSERIA-MENINGITIDIS; MENINGOCOCCAL DISEASE; CEREBROSPINAL-FLUID; UNITED-STATES; PCR ASSAYS	Background In Sub-Saharan Africa, including Mozambique, acute bacterial meningitis (ABM) represents a main cause of childhood mortality. The burden of ABM is seriously underestimated because of the poor performance of culture sampling, the primary method of ABM surveillance in the region. Low quality cerebrospinal fluid (CSF) samples and frequent consumption of antibiotics prior to sample collection lead to a high rate of false-negative results. To our knowledge, this study is the first to determine the frequency of ABM in Mozambique using real-time polymerase chain reaction (qPCR) and to compare results to those of culture sampling. Method Between March 2013 and March 2014, CSF samples were collected at 3 regional hospitals from patients under 5 years of age, who met World Health Organization case definition criteria for ABM. Macroscopic examination, cytochemical study, culture, and qPCR were performed on all samples. Results A total of 369 CSF samples were collected from children clinically suspected of ABM. qPCR showed a significantly higher detection rate of ABM-causing pathogens when compared to culture (52.3% [193/369] versus 7.3% [27/369], p = 0.000). The frequency of Streptococcus pneumoniae, Haemophilus influenzae, group B Streptococci, and Neisseria meningitidis were 32.8% (121/369), 12.2%, (45/369), 3.0% (16/369) and 4.3% (11/369), respectively, significantly higher compared to that obtained on culture (p < 0.001 for each). Conclusion Our findings demonstrate that culture is less effective for the diagnosis of ABM than qPCR. The common use of culture rather than qPCR to identify ABM results in serious underestimation of the burden of the disease, and our findings strongly suggest that qPCR should be incorporated into surveillance activities for ABM. In addition, our data showed that S. pneumoniae represents the most common cause of ABM in children under 5 years of age.	[Nhantumbo, Aquino Albino; Munguambe, Alcides Moniz; Come, Charlotte Elizabeth] Minist Saude, Inst Nacl Saude, Lab Nacl Referencia Microbiol, Maputo, Mozambique; [Cantarelli, Vlademir Vicente] Univ Feevale, Rio Sul, Brazil; [Cantarelli, Vlademir Vicente; Caireao, Juliana; Dias, Ccero] Univ Fed Ciencias Saude Porto Algre, Porto Alegre, RS, Brazil; [Pinto, Gabriela do Carmo] Minist Saude, Inst Nacl Saude, Lab Isolamento Viral, Maputo, Mozambique; [Zimba, Tomas Francisco] Minist Saude, Hosp Cent Maputo, Dept Med, Maputo, Mozambique; [Mandomando, Inacio] Minist Saude, Ctr Invest Saude Manhica, Maputo, Mozambique; [Moraes, Milton Ozorio] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Sema, Cynthia Baltazar; Gudo, Eduardo Samo] Minist Saude, Inst Nacl Saude, Maputo, Mozambique	Universidade Feevale; Centro de Investigacao em Saude de Manhica; Fundacao Oswaldo Cruz	Nhantumbo, AA (corresponding author), Minist Saude, Inst Nacl Saude, Lab Nacl Referencia Microbiol, Maputo, Mozambique.	aquinoalbinonhantumbo@yahoo.com.br	Mandomando, Inacio/ABD-8007-2020; Dias, Cicero A G/A-1451-2017; Moraes, Milton Ozório/G-9753-2011; Cantarelli, Vlademir/E-1970-2016; Moraes, Milton/AFF-1842-2022	Mandomando, Inacio/0000-0002-1078-2187; Dias, Cicero A G/0000-0002-8358-1183; Moraes, Milton Ozório/0000-0003-2653-0037; Nhantumbo, Aquino Albino/0000-0002-1244-0332	WHO [2014405143-0]	WHO(World Health Organization)	Funding provided by WHO Reference: 2014405143-0, creation DFC to support HIB & Surveillance System Activities.	Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Adjei O, 1996, J ANTIMICROB CHEMOTH, V38, P746, DOI 10.1093/jac/38.4.746; Airede KI, 2008, NIGER J CLIN PRACT, V11, P235; Anagaw Belay, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P536, DOI 10.1016/S2221-1691(13)60109-4; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P129; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Berardi A, 2010, Minerva Pediatr, V62, P51; Berardi A, 2013, PEDIATRICS, V131, pE361, DOI 10.1542/peds.2012-1231; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brouwer MC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub3; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Bryant PA, 2004, J CLIN MICROBIOL, V42, P2919, DOI 10.1128/JCM.42.7.2919-2925.2004; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Clinical and Laboratory Standards Institute (CLSI), 2014, PERFORMANCE STANDARD, pM100; COMMEY JOO, 1994, E AFR MED J, V71, P113; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Davis S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S21; Denno Donna M, 2002, West Afr J Med, V21, P233; El Aila NA, 2011, RES MICROBIOL, V162, P499, DOI 10.1016/j.resmic.2011.04.001; Fluegge K, 2006, PEDIATRICS, V117, pE1139, DOI 10.1542/peds.2005-2481; Fraile MDR, 2001, CLIN MICROBIOL INFEC, V7, P25, DOI 10.1046/j.1469-0691.2001.00196.x; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Greve T, 2012, J MED MICROBIOL, V61, P478, DOI 10.1099/jmm.0.036574-0; HassanKing M, 1996, J CLIN MICROBIOL, V34, P2030, DOI 10.1128/JCM.34.8.2030-2032.1996; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jbarai I, 2007, MIKROBIYOL BUL, V41, P495; Ke DB, 2000, CLIN CHEM, V46, P324; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Luksic I, 2013, CROAT MED J, V54, P510, DOI 10.3325/cmj.2013.54.510; Mackenzie GA, 2015, PEDIATR INFECT DIS J, V34, pE107, DOI 10.1097/INF.0000000000000645; Mani R, 2007, J MED MICROBIOL, V25, P108, DOI DOI 10.4103/0255-0857.32715; McKenna DS, 1998, SEMIN PERINATOL, V22, P267, DOI 10.1016/S0146-0005(98)80015-3; Messmer TO, 2004, DIAGN MICR INFEC DIS, V49, P249, DOI 10.1016/j.diagmicrobio.2004.04.013; Milledge J, 2005, ANN TROP PAEDIATR, V25, P101, DOI 10.1179/146532805X45692; Modi S, 2013, J CLIN DIAGN RES, V7, P2704, DOI 10.7860/JCDR/2013/6081.3737; Mokaddas EM, 2007, MICROB DRUG RESIST, V13, P227, DOI 10.1089/mdr.2007.774; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Owusu M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-28; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Poland GA, 2010, CLIN INFECT DIS, V50, pS45, DOI 10.1086/648964; Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863; Roca A, 2009, CLIN INFECT DIS, V48, pS172, DOI 10.1086/596497; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Schrag SJ, 2000, INFECT CONT HOSP EP, V21, P473, DOI 10.1086/501791; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; SCHUCHAT A, 1995, BIOMED PHARMACOTHER, V49, P19, DOI 10.1016/0753-3322(96)82573-X; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Sidikou F, 2003, EMERG INFECT DIS, V9, P1486, DOI 10.3201/eid0911.030462; Sigauque B, 2008, ACTA TROP, V105, P21, DOI 10.1016/j.actatropica.2007.01.006; Swann O, 2014, PEDIATR INFECT DIS J, V33, P560, DOI 10.1097/INF.0000000000000210; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tang LM, 1999, QJM-MON J ASSOC PHYS, V92, P719, DOI 10.1093/qjmed/92.12.719; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Tuyama M, 2008, MEM I OSWALDO CRUZ, V103, P138, DOI 10.1590/S0074-02762008000200003; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; von Mollendorf C, 2015, PEDIATR INFECT DIS J, V34, P27, DOI 10.1097/INF.0000000000000484; Waisbourd-Zinman O, 2010, ISR MED ASSOC J, V12, P225; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; World Health Organization, 2015, VACCINE PREVENTABLE; Wu HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-26; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940; Zimba TF, 2009, J INFECT DEV COUNTR, V3, P723	69	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138249	10.1371/journal.pone.0138249	http://dx.doi.org/10.1371/journal.pone.0138249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393933	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100045
J	Shah, R; O'Neill, SM; Hinkle, C; Caughey, J; Stephan, S; Lynch, E; Bermingham, K; Lynch, G; Ahima, RS; Reilly, MP				Shah, Rachana; O'Neill, Sean M.; Hinkle, Christine; Caughey, Jennifer; Stephan, Stephen; Lynch, Emma; Bermingham, Kate; Lynch, Gina; Ahima, Rexford S.; Reilly, Muredach P.			Metabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese Mice	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; INSULIN-RESISTANCE; TARGETED DELETION; CHEMOKINE; INFLAMMATION; IDENTIFICATION; LACKING; SYSTEM	The fractalkine (CX3CL1-CX3CR1) chemokine system is associated with obesity-related inflammation and type 2 diabetes, but data on effects of Cx3cr1 deficiency on metabolic pathways is contradictory. We examined male C57BL/6 Cx3cr1(-/-) mice on chow and high-fat diet to determine the metabolic effects of Cx3cr1 deficiency. We found no difference in body weight and fat content or feeding and energy expenditure between Cx3cr1(-/-) and WT mice. Cx3cr1(-/-) mice had reduced glucose intolerance assessed by intraperitoneal glucose tolerance tests at chow and high-fat fed states, though there was no difference in glucose-stimulated insulin values. Cx3cr1(-/-) mice also had improved insulin sensitivity at hyperinsulinemic-euglycemic clamp, with higher glucose infusion rate, rate of disposal, and hepatic glucose production suppression compared to WT mice. Enhanced insulin signaling in response to acute intravenous insulin injection was demonstrated in Cx3cr1(-/-) by increased liver protein levels of phosphorylated AKT and GSK3 beta proteins. There were no differences in adipose tissue macrophage populations, circulating inflammatory monocytes, adipokines, lipids, or inflammatory markers. In conclusion, we demonstrate a moderate and reproducible protective effect of Cx3cr1 deficiency on glucose intolerance and insulin resistance.	[Shah, Rachana] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [O'Neill, Sean M.; Hinkle, Christine; Caughey, Jennifer; Stephan, Stephen; Lynch, Emma; Bermingham, Kate; Lynch, Gina; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shah, R (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.	shahr@email.chop.edu; muredach@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019	Shah, Rachana/0000-0001-7866-557X; Reilly, Muredach/0000-0002-3035-9386	National Institutes of Health [R01-DK-090505]; Penn Diabetes Research Center Mouse Phenotyping Core [P30-DK-19525];  [K23-DK095913];  [R01-HL-111694];  [R01-HL-108636];  [R01-HL-107643];  [R01-HL-113147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111694, R01HL113147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, K23DK095913, R01DK090505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Diabetes Research Center Mouse Phenotyping Core; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grant R01-DK-090505 (to MPR) and the Penn Diabetes Research Center Mouse Phenotyping Core grant P30-DK-19525. RS is supported by K23-DK095913. MPR is also supported by R01-HL-111694, R01-HL-108636, R01-HL-107643 and R01-HL-113147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Ebert T, 2014, DIABETIC MED, V31, P1014, DOI 10.1111/dme.12451; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Foussat A, 2000, EUR J IMMUNOL, V30, P87, DOI 10.1002/1521-4141(200001)30:1<87::AID-IMMU87>3.3.CO;2-Z; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Morari J, 2014, DIABETES, V63, P3770, DOI 10.2337/db13-1495; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Polyak A, 2014, BRAIN BEHAV IMMUN, V38, P25, DOI 10.1016/j.bbi.2014.01.010; Routh VH, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00236; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Sirois-Gagnon D, 2010, OBESITY SILVER SPRIN, DOI [10.1038/oby.2010.125, DOI 10.1038/0BY.2010.125]; Sirois-Gagnon D, 2011, OBESITY, V19, P222, DOI 10.1038/oby.2010.125; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; White GE, 2009, BLOOD, V113, P767, DOI 10.1182/blood-2008-11-189860; Yin XY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/715148	28	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138317	10.1371/journal.pone.0138317	http://dx.doi.org/10.1371/journal.pone.0138317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26393344	Green Published, Green Submitted, gold			2022-12-26	WOS:000361792100051
J	Yu, XR; Li, B; Wang, LL; Chen, XY; Wang, WJ; Wang, Z; Xiong, F				Yu, Xurun; Li, Bo; Wang, Leilei; Chen, Xinyu; Wang, Wenjun; Wang, Zhong; Xiong, Fei			Systematic Analysis of Pericarp Starch Accumulation and Degradation during Wheat Caryopsis Development	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; GRANULE DEVELOPMENT; PASTING PROPERTIES; RESISTANT-STARCH; SYNTHASE I; ENDOSPERM; TISSUES; GENES; PLANT	Although wheat (Triticum aestivum L.) pericarp starch granule (PSG) has been well-studied, our knowledge of its features and mechanism of accumulation and degradation during pericarp growth is poor. In the present study, developing wheat caryopses were collected and starch granules were extracted from their pericarp to investigate the morphological and structural characteristics of PSGs using microscopy, X-ray diffraction and Fourier transform infrared spectroscopy techniques. Relative gene expression levels of ADP-glucose pyrophosphorylase (APGase), granule-bound starch synthase II (GBSS II), and a-amylase (AMY) were quantified by quantitative real-time polymerase chain reaction. PSGs presented as single or multiple starch granules and were synthesized both in the amyloplast and chloroplast in the pericarp. PSG degradation occurred in the mesocarp, beginning at 6 days after anthesis. Amylose contents in PSGs were lower and relative degrees of crystallinity were higher at later stages of development than at earlier stages. Short-range ordered structures in the external regions of PSGs showed no differences in the developing pericarp. When hydrolyzed by a-amylase, PSGs at various developmental stages showed high degrees of enzymolysis. Expression levels of AGPase, GBSS II, and AMY were closely related to starch synthesis and degradation. These results help elucidate the mechanisms of accumulation and degradation as well as the functions of PSG during wheat caryopsis development.	[Yu, Xurun; Wang, Leilei; Chen, Xinyu; Wang, Wenjun; Wang, Zhong; Xiong, Fei] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou 225009, Peoples R China; [Li, Bo] Jiangsu Yanjiang Inst Agr Sci, Nantong 226541, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences	Xiong, F (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou 225009, Peoples R China.	feixiong@yzu.edu.cn	Wang, Ji/A-3774-2009	Wang, Ji/0000-0002-0724-7538	National Natural Science Foundation of China (CN) [31171482, 31571573]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Foundation of Excellent Doctoral Dissertation of Yangzhou University	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Foundation of Excellent Doctoral Dissertation of Yangzhou University	Funding: The work was supported by the following: FX, the National Natural Science Foundation of China (CN) (31171482, 31571573) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); and XY, the Foundation of Excellent Doctoral Dissertation of Yangzhou University. The funders played an important role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahuja G, 2014, CARBOHYD POLYM, V114, P87, DOI 10.1016/j.carbpol.2014.08.004; Bechtel DB, 2003, CEREAL CHEM, V80, P175, DOI 10.1094/CCHEM.2003.80.2.175; BRILLOUET JM, 1987, CARBOHYD RES, V159, P109, DOI 10.1016/S0008-6215(00)90009-0; Chen GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0198-2; DUFFUS CM, 1973, PLANTA, V114, P219, DOI 10.1007/BF00389037; Earp CF, 2004, J CEREAL SCI, V39, P21, DOI 10.1016/S0733-5210(03)00060-2; [顾蕴洁 Gu Yunjie], 2002, [作物学报, Acta Agronomica Sinica], V28, P439; Huang CC, 2006, CARBOHYD POLYM, V64, P524, DOI 10.1016/j.carbpol.2005.11.009; Hurkman WJ, 2003, PLANT SCI, V164, P873, DOI 10.1016/S0168-9452(03)00076-1; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Li L, 2007, CARBOHYD POLYM, V67, P630, DOI 10.1016/j.carbpol.2006.08.013; Loussert C, 2008, J CEREAL SCI, V47, P445, DOI 10.1016/j.jcs.2007.05.012; Man JM, 2012, CARBOHYD POLYM, V89, P571, DOI 10.1016/j.carbpol.2012.03.049; Man JianMin, 2012, Acta Agronomica Sinica, V38, P505, DOI 10.3724/SP.J.1006.2012.00505; Moore SA, 2015, CARBOHYD POLYM, V115, P465, DOI 10.1016/j.carbpol.2014.09.014; Morell MK, 2001, EUPHYTICA, V119, P55, DOI 10.1023/A:1017550624902; Mutungi C, 2011, FOOD HYDROCOLLOID, V25, P477, DOI 10.1016/j.foodhyd.2010.07.023; Nakamura T, 1998, PLANT PHYSIOL, V118, P451, DOI 10.1104/pp.118.2.451; Orzechowski S, 2008, ACTA BIOCHIM POL, V55, P435, DOI 10.18388/abp.2008_3049; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin FL, 2012, CARBOHYD POLYM, V88, P690, DOI 10.1016/j.carbpol.2012.01.013; Sarah DL., 2013, ACTA PHYSIOL PLANT, V35, P2927, DOI 10.1007/s11738-013-1323-9; SATO K, 1984, JARQ-JPN AGR RES Q, V18, P79; Sevenou O, 2002, INT J BIOL MACROMOL, V31, P79, DOI 10.1016/S0141-8130(02)00067-3; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shu XL, 2014, FOOD CHEM, V164, P89, DOI 10.1016/j.foodchem.2014.05.014; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Van Hung P, 2007, FOOD CHEM, V105, P749, DOI 10.1016/j.foodchem.2007.01.023; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; Xiong F, 2013, PLANT CELL REP, V32, P1309, DOI 10.1007/s00299-013-1445-y; Yang Y, 2008, FOOD RES INT, V41, P937, DOI 10.1016/j.foodres.2007.10.011; Yu XR, 2015, PROTOPLASMA, V252, P605, DOI 10.1007/s00709-014-0706-0; Yu XR, 2015, J SCI FOOD AGR, V95, P148, DOI 10.1002/jsfa.6696; Zheng YK, 2015, PROTOPLASMA, V252, P705, DOI 10.1007/s00709-014-0705-1; Zheng YK, 2015, PROTOPLASMA, V252, P33, DOI 10.1007/s00709-014-0687-z; Zheng YK, 2011, PLANT CELL REP, V30, P1281, DOI 10.1007/s00299-011-1039-5; Zhou ZQ, 2009, PROTOPLASMA, V236, P49, DOI 10.1007/s00709-009-0046-7	39	15	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2015	10	9							e0138228	10.1371/journal.pone.0138228	http://dx.doi.org/10.1371/journal.pone.0138228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZW	26394305	Green Submitted, Green Published, gold			2022-12-26	WOS:000361792100040
J	Chen, ZX; Tang, N; You, YM; Lan, JB; Liu, YQ; Li, ZG				Chen, Zexiong; Tang, Ning; You, Yuming; Lan, Jianbin; Liu, Yiqing; Li, Zhengguo			Transcriptome Analysis Reveals the Mechanism Underlying the Production of a High Quantity of Chlorogenic Acid in Young Leaves of Lonicera macranthoides Hand.-Mazz	PLOS ONE			English	Article							QUINATE HYDROXYCINNAMOYL TRANSFERASE; PHENYLPROPANOID BIOSYNTHESIS; FUNCTIONAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; JAPONICA THUNB; FLOS-LONICERAE; SWEET-POTATO; RNA-SEQ; COFFEE; GENES	Lonicera macranthoides Hand.-Mazz (L. macranthoides) is a medicinal herb that is widely distributed in southern China. The biosynthetic and metabolic pathways for a core secondary metabolite in L. macranthoides, chlorogenic acid (CGA), have been elucidated in many species. However, the mechanisms of CGA biosynthesis and the related gene regulatory network in L. macranthoides are still not well understood. In this study, CGA content was quantified by high performance liquid chromatography (HPLC), and CGA levels differed significantly among three tissues; specifically, the CGA content in young leaves (YL) was greater than that in young stems (YS), which was greater than that in mature flowers (MF). Transcriptome analysis of L. macranthoides yielded a total of 53,533,014 clean reads (average length 90 bp) and 76,453 unigenes (average length 703 bp). A total of 3,767 unigenes were involved in biosynthesis pathways of secondary metabolites. Of these unigenes, 80 were possibly related to CGA biosynthesis. Furthermore, differentially expressed genes (DEGs) were screened in different tissues including YL, MF and YS. In these tissues, 24 DEGs were found to be associated with CGA biosynthesis, including six phenylalanine ammonia lyase (PAL) genes, six 4-coumarate coenzyme A ligase (4CL) genes, four cinnamate 4-Hydroxylase (C4H) genes, seven hydroxycinnamoyl transferase/hydroxycinnamoyl-CoA quinate transferase HCT/HQT genes and one coumarate 3-hydroxylase (C3H) gene. These results further the understanding of CGA biosynthesis and the related regulatory network in L. macranthoides.	[Chen, Zexiong; Tang, Ning; Li, Zhengguo] Chongqing Univ, Sch Life Sci, Genet Engn Res Ctr, Chongqing 400044, Peoples R China; [Chen, Zexiong; You, Yuming; Lan, Jianbin; Liu, Yiqing] Chongqing Univ Arts & Sci, Coll Forestry & Life Sci, Chongqing 402160, Peoples R China	Chongqing University; Chongqing University of Arts & Sciences	Li, ZG (corresponding author), Chongqing Univ, Sch Life Sci, Genet Engn Res Ctr, Chongqing 400044, Peoples R China.	zhengguoli@cqu.edu.cn	Li, Zhengguo/A-5572-2017; Li, Zhengguo/AAR-5191-2020	Zhengguo, Li/0000-0002-4643-9540	National Natural Science Foundation of China [31200512]; Chongqing City Board of Education [KJ1401103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing City Board of Education	This work was supported by the National Natural Science Foundation of China (31200512) and Chongqing City Board of Education (KJ1401103).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Chen Qiu-Zhu, 2010, Zhong Yao Cai, V33, P920; Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665; Clifford MN, 2004, PLANTA MED, V70, P1103, DOI 10.1055/s-2004-835835; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; Comino C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-14; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P155; Ku SK, 2009, WORLD J GASTROENTERO, V15, P4799, DOI 10.3748/wjg.15.4799; Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259; Lan W, 2007, DRUG DEV IND PHARM, V33, P841, DOI 10.1080/03639040701378019; Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004; Lepelley M, 2012, PLANTA, V236, P313, DOI 10.1007/s00425-012-1613-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Mahesh V, 2007, PLANT MOL BIOL, V64, P145, DOI 10.1007/s11103-007-9141-3; MOLGAARD P, 1988, PHYTOCHEMISTRY, V27, P2411, DOI 10.1016/0031-9422(88)87005-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Peng XX, 2010, PLANTA MED, V76, P1921, DOI 10.1055/s-0030-1250020; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Tian, 2011, CHINA J CHINESE MAT, V3, P1406; Tong Q, 2006, ZHONG YAO CAI, V28, P300; Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765; VILLEGAS RJA, 1986, J BIOL CHEM, V261, P8729; Wan DG, 2008, LISHIZHEN MED MAT ME, V19, P122; Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002; [王颖 WANG Ying], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P1606; Wang Z XC, 2008, STUDY OPTIMAL HARVES, V19, P3; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan Y, 2014, GENE, V534, P408, DOI 10.1016/j.gene.2012.09.051; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; Zhang Cong, 2009, Zhongguo Zhong Yao Za Zhi, V34, P3051; Zhang YQ, 2003, SHANDONG PHARMACEUTI, V22, P32; Zhou RBTQ, 2003, CHINESE HERBAL MED, V26, P399; 向增旭, 2007, [中国中药杂志, China Journal of Chinese Materia Medica], V32, P2554	53	23	25	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137212	10.1371/journal.pone.0137212	http://dx.doi.org/10.1371/journal.pone.0137212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381882	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200017
J	Iverson-Cabral, SL; Wood, GE; Totten, PA				Iverson-Cabral, Stefanie L.; Wood, Gwendolyn E.; Totten, Patricia A.			Analysis of the Mycoplasma genitalium MgpB Adhesin to Predict Membrane Topology, Investigate Antibody Accessibility, Characterize Amino Acid Diversity, and Identify Functional and Immunogenic Epitopes	PLOS ONE			English	Article							REPETITIVE CHROMOSOMAL SEQUENCES; CHRONIC NONGONOCOCCAL URETHRITIS; ANTIGENIC VARIATION; CHLAMYDIA-TRACHOMATIS; PROTEIN SEQUENCES; EMBL-EBI; PNEUMONIAE; INFECTION; GENOME; RECOMBINATION	Mycoplasma genitalium is a sexually transmitted pathogen and is associated with reproductive tract disease that can be chronic in nature despite the induction of a strong antibody response. Persistent infection exacerbates the likelihood of transmission, increases the risk of ascension to the upper tract, and suggests that M. genitalium may possess immune evasion mechanism(s). Antibodies from infected patients predominantly target the MgpB adhesin, which is encoded by a gene that recombines with homologous donor sequences, thereby generating sequence variation within and among strains. We have previously characterized mgpB heterogeneity over the course of persistent infection and have correlated the induction of variant-specific antibodies with the loss of that particular variant from the infected host. In the current study, we examined the membrane topology, antibody accessibility, distribution of amino acid diversity, and the location of functional and antigenic epitopes within the MgpB adhesin. Our results indicate that MgpB contains a single transmembrane domain, that the majority of the protein is surface exposed and antibody accessible, and that the attachment domain is located within the extracellular C-terminus. Not unexpectedly, amino acid diversity was concentrated within and around the three previously defined variable regions (B, EF, and G) of MgpB; while nonsynonymous mutations were twice as frequent as synonymous mutations in regions B and G, region EF had equal numbers of nonsynonymous and synonymous mutations. Interestingly, antibodies produced during persistent infection reacted predominantly with the conserved C-terminus and variable region B. In contrast, infection-induced antibodies reacted poorly with the N-terminus, variable regions EF and G, and intervening conserved regions despite the presence of predicted B cell epitopes. Overall, this study provides an important foundation to define how different segments of the MgpB adhesin contribute to functionality, variability, and immunogenicity during persistent M. genitalium infection.	[Iverson-Cabral, Stefanie L.; Wood, Gwendolyn E.; Totten, Patricia A.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98104 USA; [Totten, Patricia A.] Univ Washington, Dept Global Hlth, Pathobiol Interdisciplinary Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Iverson-Cabral, SL (corresponding author), Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98104 USA.	slic@u.washington.edu			National Institute of Health, NIAID [R21 AI097702, R21 AI1074898, R03 AI082316, R56 AI071175, R21 AI107402]; University of Washington STD/AIDS research training grants [124 NIH/NIAID T32 AI7140-33, 124 NIH/NIAID T32 AI7140-34]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074898, R03AI082316, T32AI007140, R21AI107402, R21AI097702, R56AI071175] Funding Source: NIH RePORTER	National Institute of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington STD/AIDS research training grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work (and support for SLIC, GEW, and PAT) was provided by National Institute of Health, NIAID grants R21 AI097702, R21 AI1074898, R03 AI082316, R56 AI071175, and R21 AI107402. SLIC was additionally supported by University of Washington STD/AIDS research training grants 124 NIH/NIAID T32 AI7140-33 and -34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; BASEMAN JB, 1984, ISRAEL J MED SCI, V20, P866; Borud B, 2010, J BACTERIOL, V192, P2816, DOI 10.1128/JB.00101-10; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; Burgos R, 2012, MOL MICROBIOL, V85, P669, DOI 10.1111/j.1365-2958.2012.08130.x; Clausen HF, 2001, HUM REPROD, V16, P1866, DOI 10.1093/humrep/16.9.1866; Cohen CR, 2007, SEX TRANSM DIS, V34, P274, DOI 10.1097/01.olq.0000237860.61298.54; Collier AM, 1990, ATTACHMENT MYCOPLASM; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; DALLO SF, 1988, J EXP MED, V167, P718, DOI 10.1084/jem.167.2.718; Dhandayuthapani S, 1999, P NATL ACAD SCI USA, V96, P5227, DOI 10.1073/pnas.96.9.5227; Dhandayuthapani S, 2002, ARCH MED RES, V33, P1, DOI 10.1016/S0188-4409(01)00335-6; Drasbek M, 2007, MICROBIOL-SGM, V153, P3791, DOI 10.1099/mic.0.2007/010736-0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FELDNER J, 1979, INFECT IMMUN, V25, P60, DOI 10.1128/IAI.25.1.60-67.1979; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Giacani L, 2010, J IMMUNOL, V184, P3822, DOI 10.4049/jimmunol.0902788; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Horner P, 2003, SEX TRANSM DIS, V30, P129, DOI 10.1097/00007435-200302000-00007; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Iverson-Cabral SL, 2011, CLIN VACCINE IMMUNOL, V18, P1783, DOI 10.1128/CVI.05174-11; JACOBS E, 1990, J CLIN MICROBIOL, V28, P1194, DOI 10.1128/JCM.28.6.1194-1197.1990; JENSEN JS, 1994, INT J EXP PATHOL, V75, P91; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; KENNY GE, 1985, MANUAL CLIN MICROBIO, P407; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lis R, 2015, MYCOPLASMA GENITALIU; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Ma L, 2014, INFECT IMMUN, V82, P1326, DOI 10.1128/IAI.01526-13; Ma LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015660; Ma L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-130; MADER B, 1991, ZBL BAKT-INT J MED M, V274, P507, DOI 10.1016/S0934-8840(11)80088-5; Manhart LE, 2007, AM J PUBLIC HEALTH, V97, P1118, DOI 10.2105/AJPH.2005.074062; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Mavedzenge SN, 2009, AIDS, V23, P611, DOI 10.1097/QAD.0b013e328323da3e; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; MERNAUGH GR, 1993, CLIN INFECT DIS, V17, pS69, DOI 10.1093/clinids/17.Supplement_1.S69; Moi H, 2015, ACTA DERM VENEREOL; MORRISONPLUMMER J, 1987, INFECT IMMUN, V55, P49, DOI 10.1128/IAI.55.1.49-56.1987; MORRISONPLUMMER J, 1986, INFECT IMMUN, V53, P398, DOI 10.1128/IAI.53.2.398-403.1986; Neimark H.C, 1986, BACTERIAL L FORMS, P21; OPITZ O, 1992, J GEN MICROBIOL, V138, P1785, DOI 10.1099/00221287-138-9-1785; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; ROBERTS DD, 1989, J BIOL CHEM, V264, P9289; Schurwanz N, 2009, INFECT IMMUN, V77, P5007, DOI 10.1128/IAI.00268-09; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Svenstrup HF, 2008, FERTIL STERIL, V90, P513, DOI 10.1016/j.fertnstert.2006.12.056; Svenstrup HF, 2006, CLIN VACCINE IMMUNOL, V13, P913, DOI 10.1128/CVI.00048-06; Svenstrup HF, 2003, HUM REPROD, V18, P2103, DOI 10.1093/humrep/deg392; Svenstrup HF, 2002, J MED MICROBIOL, V51, P361, DOI 10.1099/0022-1317-51-5-361; Taylor-Robinson D, 2004, INT J STD AIDS, V15, P21, DOI 10.1258/095646204322637209; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; TULLY JG, 1983, INT J SYST BACTERIOL, V33, P387, DOI 10.1099/00207713-33-2-387; TULLY JG, 1986, J INFECT DIS, V153, P1046, DOI 10.1093/infdis/153.6.1046; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; Wood GE, 2013, INFECT IMMUN, V81, P2938, DOI 10.1128/IAI.01322-12; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	72	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138244	10.1371/journal.pone.0138244	http://dx.doi.org/10.1371/journal.pone.0138244			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381903	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200077
J	Kieselbach, T; Zijnge, V; Granstrom, E; Oscarsson, J				Kieselbach, Thomas; Zijnge, Vincent; Granstrom, Elisabeth; Oscarsson, Jan			Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; ASSISTED-LASER-DESORPTION/IONIZATION; GROEL-LIKE PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ESCHERICHIA-COLI; JP2 CLONE; SUBCELLULAR-LOCALIZATION; MORAXELLA-CATARRHALIS; LEUKOTOXIN; VIRULENCE	Aggregatibacter actinomycetemcomitans is an oral and systemic pathogen associated with aggressive forms of periodontitis and with endocarditis. Outer membrane vesicles (OMVs) released by this species have been demonstrated to deliver effector proteins such as cytolethal distending toxin (CDT) and leukotoxin (LtxA) into human host cells and to act as triggers of innate immunity upon carriage of NOD1-and NOD2-active pathogen-associated molecular patterns (PAMPs). To improve our understanding of the pathogenicity-associated functions that A. actinomycetemcomitans exports via OMVs, we studied the proteome of density gradient-purified OMVs from a rough-colony type clinical isolate, strain 173 (serotype e) using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This analysis yielded the identification of 151 proteins, which were found in at least three out of four independent experiments. Data are available via ProteomeXchange with identifier PXD002509. Through this study, we not only confirmed the vesicle-associated release of LtxA, and the presence of proteins, which are known to act as immunoreactive antigens in the human host, but we also identified numerous additional putative virulence-related proteins in the A. actinomycetemcomitans OMV proteome. The known and putative functions of these proteins include immune evasion, drug targeting, and iron/nutrient acquisition. In summary, our findings are consistent with an OMV-associated proteome that exhibits several offensive and defensive functions, and they provide a comprehensive basis to further disclose roles of A. actinomycetemcomitans OMVs in periodontal and systemic disease.	[Kieselbach, Thomas] Umea Univ, Dept Chem, Umea, Sweden; [Zijnge, Vincent] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, NL-9713 AV Groningen, Netherlands; [Granstrom, Elisabeth; Oscarsson, Jan] Umea Univ, Dept Odontol, Oral Microbiol, Umea, Sweden	Umea University; University of Groningen; Umea University	Oscarsson, J (corresponding author), Umea Univ, Dept Odontol, Oral Microbiol, Umea, Sweden.	jan.oscarsson@umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938	TUA grants from the County Council of Vasterbotten, Sweden; Insamlingsstiftelsen, Medical Faculty, Umea University; Magnus Bergvalls Stiftelse; Faculty of Science and Technology of Umea University; Kempe Foundations	TUA grants from the County Council of Vasterbotten, Sweden; Insamlingsstiftelsen, Medical Faculty, Umea University; Magnus Bergvalls Stiftelse; Faculty of Science and Technology of Umea University; Kempe Foundations	This work was supported by TUA grants from the County Council of Vasterbotten, Sweden (JO), Insamlingsstiftelsen, Medical Faculty, Umea University (JO), and Magnus Bergvalls Stiftelse (JO). The proteomics part of this study was performed at the KBC Proteomics Core facility at Umea University and the Swedish University of Agricultural Sciences. We thank the Faculty of Science and Technology of Umea University, and the Kempe Foundations for grants for instruments and bioinformatics resources of this facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2014, J CLIN PERIODONTOL, V41, P232, DOI 10.1111/jcpe.12209; Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Asikainen SE, 2009, FUTURE MICROBIOL, V4, P495, DOI [10.2217/fmb.09.21, 10.2217/FMB.09.21]; Bai DY, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu006; Bai J, 2014, INFECT IMMUN, V82, P4001, DOI 10.1128/IAI.01416-13; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; BIRDSELL DC, 1967, J BACTERIOL, V93, P427, DOI 10.1128/JB.93.1.427-437.1967; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Brage M, 2011, J PERIODONTAL RES, V46, P170, DOI 10.1111/j.1600-0765.2010.01325.x; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Bulkley D, 2014, CELL REP, V6, P357, DOI 10.1016/j.celrep.2013.12.024; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Crosby JA, 2007, GENE, V388, P83, DOI 10.1016/j.gene.2006.10.004; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Demuth DR, 2003, CELL MICROBIOL, V5, P111, DOI 10.1046/j.1462-5822.2003.00259.x; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; DiRienzo JM, 2014, CELLS-BASEL, V3, P476, DOI 10.3390/cells3020476; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620; Elmi A, 2012, INFECT IMMUN, V80, P4089, DOI 10.1128/IAI.00161-12; Farrell DJ, 2011, CLIN INFECT DIS, V52, pS487, DOI 10.1093/cid/cir164; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Haurat MF, 2015, BIOL CHEM, V396, P95, DOI 10.1515/hsz-2014-0183; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Huang Y, 2013, MOL ORAL MICROBIOL, V28, P1, DOI 10.1111/omi.12005; Jang KS, 2014, J PROTEOMICS, V98, P90, DOI 10.1016/j.jprot.2013.12.014; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Johansson A, 2000, J PERIODONTAL RES, V35, P85, DOI 10.1034/j.1600-0765.2000.035002085.x; Johansson A, 2011, TOXINS, V3, P242, DOI 10.3390/toxins3030242; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kelk P, 2008, INT J MED MICROBIOL, V298, P529, DOI 10.1016/j.ijmm.2007.06.005; Kim JH, 2015, SEMIN CELL DEV BIOL, V40, P97, DOI 10.1016/j.semcdb.2015.02.006; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; KIRBY AC, 1995, J CLIN INVEST, V96, P1185, DOI 10.1172/JCI118150; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; KOGA T, 1993, J PERIODONTAL RES, V28, P475, DOI 10.1111/j.1600-0765.1993.tb02107.x; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Komatsuzawa H, 2002, GENE, V288, P195, DOI 10.1016/S0378-1119(02)00500-0; Kulkarni HM, 2014, MICROBIOL-SGM, V160, P2109, DOI 10.1099/mic.0.079400-0; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee J, 2013, ANTIMICROB AGENTS CH, V57, P2589, DOI 10.1128/AAC.00522-12; Lin FY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102450, DOI 10.1371/J0URNAL.P0NE.0102450]; Lo Sciuto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103784; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Nevot M, 2006, ENVIRON MICROBIOL, V8, P1523, DOI 10.1111/j.1462-2920.2006.01043.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nordstrom T, 2005, J IMMUNOL, V175, P3628, DOI 10.4049/jimmunol.175.6.3628; Olsen I, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27468; Oscarsson J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-206; Paino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070509; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; Park AJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00464; Park SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017629; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Promega, 2015, TECHNICAL BULLETIN, V373; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Rylev M, 2011, J PROTEOMICS, V74, P2972, DOI 10.1016/j.jprot.2011.07.022; SAARELA M, 1992, ORAL MICROBIOL IMMUN, V7, P277, DOI 10.1111/j.1399-302X.1992.tb00588.x; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Siljamaki P, 2014, J PROTEOME RES, V13, P3249, DOI 10.1021/pr500075j; SIMPSON DL, 1988, INFECT IMMUN, V56, P1162, DOI 10.1128/IAI.56.5.1162-1166.1988; Smith KP, 2015, MOL ORAL MICROBIOL, V30, P97, DOI 10.1111/omi.12074; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Sun RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066472; Tan KS, 2002, J PERIODONTAL RES, V37, P268, DOI 10.1034/j.1600-0765.2002.01618.x; Tan TT, 2007, J INFECT DIS, V195, P1661, DOI 10.1086/517611; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thay B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Tsuzukibashi O, 2014, ARCH MICROBIOL, V196, P261, DOI 10.1007/s00203-014-0965-3; Uhlin B.E., 2014, PATHOGENIC ESCHERICH, P161; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; WILSON ME, 1991, J PERIODONTOL, V62, P211, DOI 10.1902/jop.1991.62.3.211; WILSON ME, 1995, INFECT IMMUN, V63, P1062, DOI 10.1128/IAI.63.3.1062-1069.1995; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	119	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138591	10.1371/journal.pone.0138591	http://dx.doi.org/10.1371/journal.pone.0138591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381655	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200135
J	Maleki-Ghaleh, H; Hafezi, M; Hadipour, M; Nadernezhad, A; Aghaie, E; Behnamian, Y; Abu Osman, NA				Maleki-Ghaleh, Hossein; Hafezi, Masoud; Hadipour, Mohammadreza; Nadernezhad, Ali; Aghaie, Ermia; Behnamian, Yashar; Abu Osman, Noor Azuan			Effect of Tricalcium Magnesium Silicate Coating on the Electrochemical and Biological Behavior of Ti-6Al-4V Alloys	PLOS ONE			English	Article							SPRAYED HYDROXYAPATITE COATINGS; SHAPE-MEMORY ALLOY; ELECTROPHORETIC DEPOSITION; IN-VITRO; BIOMEDICAL APPLICATIONS; SURFACE MODIFICATION; PLASMA; IMPLANT; BONE; TITANIUM	In the current study, a sol-gel-synthesized tricalcium magnesium silicate powder was coated on Ti-6Al-4V alloys using plasma spray method. Composition of feed powder was evaluated by X-ray diffraction technique before and after the coating process. Scanning electron microscopy and atomic force microscopy were used to study the morphology of coated substrates. The corrosion behaviors of bare and coated Ti-6Al-4V alloys were examined using potentiodynamic polarization test and electrochemical impedance spectroscopy in stimulated body fluids. Moreover, bare and coated Ti-6Al-4V alloys were characterized in vitro by culturing osteoblast and mesenchymal stem cells for several days. Results demonstrated a meaningful improvement in the corrosion resistance of Ti-6Al-4V alloys coated with tricalcium magnesium silicate compared with the bare counterparts, by showing a decrease in corrosion current density from 1.84 mu A/cm(2) to 0.31 mu A/cm(2). Furthermore, the coating substantially improved the bioactivity of Ti-6Al-4Valloys. Our study on corrosion behavior and biological response of Ti-6Al-4V alloy coated by tricalcium magnesium silicate proved that the coating has considerably enhanced safety and applicability of Ti-6Al-4V alloys, suggesting its potential use in permanent implants and artificial joints.	[Maleki-Ghaleh, Hossein] Sahand Univ Technol, Fac Mat Engn, Tabriz, Iran; [Hafezi, Masoud; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Hafezi, Masoud] Mat & Energy Res Ctr, Nanotechnol & Adv Mat Dept, Biomat Grp, Alborz, Iran; [Hadipour, Mohammadreza] Islamic Azad Univ, Dept Biomat, Sci & Res Branch, Yazd, Iran; [Nadernezhad, Ali] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Aghaie, Ermia; Behnamian, Yashar] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada	Sahand University of Technology; Universiti Malaya; Materials & Energy Research Center (MERC); Islamic Azad University; Sabanci University; University of Alberta	Hafezi, M (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	masoud.hafezi@gmail.com; azuan@um.edu.my	ABU OSMAN, NOOR AZUAN/B-9265-2010; Aghaie, Ermia/X-3970-2019; Nadernezhad, Ali/AAS-1695-2020; Hafezi, Masoud/K-3589-2013	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Aghaie, Ermia/0000-0003-4048-8250; Nadernezhad, Ali/0000-0002-3761-1601; Maleki-Ghaleh, Hossein/0000-0003-2020-6025; Hafezi, Masoud/0000-0002-7199-3180; Behnamian, Yashar/0000-0002-7313-4021	Iran National Science Foundation (INSF) [93022644]; University of Malaya [UM.C/HIR/MOHE/ENG/10 D000010-16001]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); University of Malaya(Universiti Malaya)	This study was supported by the Iran National Science Foundation (INSF) through grant No. 93022644, and High Impact Research Grant UM.C/HIR/MOHE/ENG/10 D000010-16001 from the University of Malaya.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001; Chen H, 2009, SURF COAT TECH, V203, P1785, DOI 10.1016/j.surfcoat.2008.12.023; de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917; Fazan F, 2000, J MATER SCI-MATER M, V11, P787, DOI 10.1023/A:1008901512273; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gu YW, 2003, BIOMATERIALS, V24, P1603, DOI 10.1016/S0142-9612(02)00573-2; Hadipour M, 2015, J CERAM PROCESS RES, V16, P287; Hafezi M, 2014, J MATER SCI, V49, P1297, DOI 10.1007/s10853-013-7813-8; Hallab NJ, 2004, CORROSION BIOCOMPATI, P63; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Kyziol K, 2014, CHEM ENG J, V240, P516, DOI 10.1016/j.cej.2013.10.091; Lima RS, 2007, J THERM SPRAY TECHN, V16, P40, DOI 10.1007/s11666-006-9010-7; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Lu YJ, 2014, CERAM INT, V40, P4559, DOI 10.1016/j.ceramint.2013.08.132; Maleki-Ghaleh H, 2014, J MATER SCI-MATER M, V25, P2605, DOI 10.1007/s10856-014-5283-4; Maleki-Ghaleh H, 2012, SURF COAT TECH, V208, P57, DOI 10.1016/j.surfcoat.2012.08.001; Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]; Mohammadi H, 2014, J CERAM SCI TECHNOL, V5, P1, DOI 10.4416/JC5T2013-00027; Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030; Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9; Ou J, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015015; Patel SS, 2013, THESIS NATL I TECHNO; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Qiu X, 2014, MAT SCI ENG C-MATER, V36, P65, DOI 10.1016/j.msec.2013.11.041; Razavi M, 2014, CERAM INT, V40, P9473, DOI 10.1016/j.ceramint.2014.02.020; Razavi M, 2014, SURF INTERFACE ANAL, V46, P387, DOI 10.1002/sia.5465; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Soballe K., 1993, ACTA ORTHOP SCAND S, V64, P1; Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1; Surowska B., 2010, J ACHIEVEMENTS MAT M, V43, P162; Tan AW, 2014, CERAM INT, V40, P8301, DOI 10.1016/j.ceramint.2014.01.032; Tarafder S, 2010, LANGMUIR, V26, P16625, DOI 10.1021/la101851f; Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019; Xie YT, 2009, ACTA BIOMATER, V5, P2331, DOI 10.1016/j.actbio.2009.03.003; Xue WC, 2005, BIOMATERIALS, V26, P3455, DOI 10.1016/j.biomaterials.2004.09.027; Yang YC, 2001, BIOMATERIALS, V22, P1827, DOI 10.1016/S0142-9612(00)00364-1; Yi D, 2012, BIOMEDICAL MAT, V7, DOI [10.1088/1748-6041/7/6/065004, DOI 10.1088/1748-6041/7/6/065004]; Zalnezhad E, 2014, METALL MATER TRANS A, V45A, P785, DOI 10.1007/s11661-013-2043-x	39	11	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138454	10.1371/journal.pone.0138454	http://dx.doi.org/10.1371/journal.pone.0138454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26383641	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200105
J	Marquez-Miranda, V; Camarada, MB; Araya-Duran, I; Varas-Concha, I; Almonacid, DE; Gonzalez-Nilo, FD				Marquez-Miranda, Valeria; Belen Camarada, Maria; Araya-Duran, Ingrid; Varas-Concha, Ignacio; Eduardo Almonacid, Daniel; Danilo Gonzalez-Nilo, Fernando			Biomimetics: From Bioinformatics to Rational Design of Dendrimers as Gene Carriers	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; PAMAM DENDRIMER; MOLECULAR-DYNAMICS; TRANSFECTION EFFICIENCY; CONFIGURATIONAL ENTROPY; ENHANCED TRANSFECTION; ATOMIC-LEVEL; IN-VITRO; RAS-RAF; ARGININE	Biomimetics, or the use of principles of Nature for developing new materials, is a paradigm that could help Nanomedicine tremendously. One of the current challenges in Nanomedicine is the rational design of new efficient and safer gene carriers. Poly(amidoamine) (PAMAM) dendrimers are a well-known class of nanoparticles, extensively used as nonviral nucleic acid carriers, due to their positively charged end-groups. Yet, there are still several aspects that can be improved for their successful application in in vitro and in vivo systems, including their affinity for nucleic acids as well as lowering their cytotoxicity. In the search of new functional groups that could be used as new dendrimer-reactive groups, we followed a biomimetic approach to determine the amino acids with highest prevalence in protein-DNA interactions. Then we introduced them individually as terminal groups of dendrimers, generating a new class of nanoparticles. Molecular dynamics studies of two systems: PAMAM-Arg and PAMAM-Lys were also performed in order to describe the formation of complexes with DNA. Results confirmed that the introduction of amino acids as terminal groups in a dendrimer increases their affinity for DNA and the interactions in the complexes were characterized at atomic level. We end up by briefly discussing additional modifications that can be made to PAMAM dendrimers to turned them into promising new gene carriers.	[Marquez-Miranda, Valeria; Araya-Duran, Ingrid; Varas-Concha, Ignacio; Eduardo Almonacid, Daniel; Danilo Gonzalez-Nilo, Fernando] Univ Andres Bello, Fac Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile; [Marquez-Miranda, Valeria; Araya-Duran, Ingrid; Danilo Gonzalez-Nilo, Fernando] Fdn Fraunhofer Chile Res, Las Condes, Chile; [Belen Camarada, Maria] Univ Bernardo O Higgins, Lab Bionanotecnol, Santiago, Chile; [Eduardo Almonacid, Daniel; Danilo Gonzalez-Nilo, Fernando] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile	Universidad Andres Bello; Universidad  Bernardo O'Higgins; Universidad de Valparaiso	Gonzalez-Nilo, FD (corresponding author), Univ Andres Bello, Fac Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile.	fernando.gonzalez@unab.cl	González Nilo, Fernando Danilo/M-5368-2017; Marquez, Valeria/AAH-5041-2019; González-Nilo, Fernando/M-5671-2016	González Nilo, Fernando Danilo/0000-0001-6857-3575; González-Nilo, Fernando/0000-0001-6857-3575; Camarada, Maria/0000-0001-5408-3073; Almonacid, Daniel E/0000-0002-1788-2084	Fondecyt [11140107]; Conicyt; Fraunhofer Chile Research; Innova-Chile CORFO [FCR-CSB 09CEII-6991]; Anillo Cientifico [ACT1107]; Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fraunhofer Chile Research; Innova-Chile CORFO; Anillo Cientifico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo	MBC is grateful to Fondecyt for financial support (Initiation Project no 11140107). VMM thanks Conicyt for a PhD Scholarship and CONICYT + PAI/"Concurso Nacional Tesis de Doctorado en la Empresa" 2014 (781413007). FDGN, VMM and IAD thank for support of Fraunhofer Chile Research, Innova-Chile CORFO (FCR-CSB 09CEII-6991) and Anillo Cientifico ACT1107. Centro Interdisciplinario de Neurociencia de Valparaiso (CINV) is a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo.	Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Avila-Salas F, 2012, J PHYS CHEM B, V116, P2031, DOI 10.1021/jp2069122; Biswas S, 2013, PHARMACEUTICALS-BASE, V6, P161, DOI 10.3390/ph6020161; Cakara D, 2003, MACROMOLECULES, V36, P4201, DOI 10.1021/ma0300241; Camarada MB, 2014, CHEM PHYS LETT, V616, P171, DOI 10.1016/j.cplett.2014.10.022; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Choksi A, 2013, INT J PHARMACEUT, V449, P28, DOI 10.1016/j.ijpharm.2013.03.056; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fant K, 2010, MOL PHARMACEUT, V7, P1734, DOI 10.1021/mp1001312; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fraczkiewicz R, 1996, 3 EL COMP CHEM C 199; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hsu STD, 2005, BIOPHYS J, V88, P15, DOI 10.1529/biophysj.104.044933; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karatasos K, 2012, MACROMOL BIOSCI, V12, P225, DOI 10.1002/mabi.201100276; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kim JB, 2006, J CONTROL RELEASE, V114, P110, DOI 10.1016/j.jconrel.2006.05.011; Kim TI, 2009, J CONTROL RELEASE, V136, P132, DOI 10.1016/j.jconrel.2009.01.028; Liang W, 2012, ENDOSOMAL ESCAPE PAT; Liu C, 2014, BIOCONJUGATE CHEM, V25, P521, DOI 10.1021/bc4005156; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Maiti PK, 2004, MACROMOLECULES, V37, P6236, DOI 10.1021/ma035629b; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nam HY, 2008, INT J PHARMACEUT, V363, P199, DOI 10.1016/j.ijpharm.2008.07.021; Nandy B, 2011, J PHYS CHEM B, V115, P217, DOI 10.1021/jp106776v; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Surjit B, 2005, BIOPHYS J, V88, P3147; TOMALIA D, 1994, NATURE, V372, P617, DOI 10.1038/372617a0; Tomalia DA, 2007, DENDRIMERS AN ENABLI; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vergara-Jaque A, 2013, J PHYS CHEM B, V117, P6801, DOI 10.1021/jp4000363; Waite CL, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-38; Wang F, 2014, BIOMATERIALS, V35, P9187, DOI 10.1016/j.biomaterials.2014.07.027; Yu GS, 2011, BIOCONJUGATE CHEM, V22, P1046, DOI 10.1021/bc100479t	44	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138392	10.1371/journal.pone.0138392	http://dx.doi.org/10.1371/journal.pone.0138392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26382062	Green Published, gold, Green Submitted			2022-12-26	WOS:000361790200098
J	van Winkel, R				van Winkel, Ruud		GROUP Investigators	Further Evidence That Cannabis Moderates Familial Correlation of Psychosis-Related Experiences	PLOS ONE			English	Article							STRUCTURED INTERVIEW; ENVIRONMENT; INSTRUMENT; RISK; SCHIZOPHRENIA; RELIABILITY; LIABILITY; SYMPTOMS	Background Familial correlations underlie heritability estimates of psychosis. If gene-environment interactions are important, familial correlation will vary as a function of environmental exposure. Methods Associations between sibling and parental schizotypy (n = 669 pairs, n = 1222 observations), and between sibling schizotypy and patient CAPE psychosis (n = 978 pairs, n = 1723 observations) were examined as a function of sibling cannabis use. This design is based on the prediction that in unaffected siblings who are not exposed, vulnerability for psychosis will remain latent, whereas in case of exposure, latent psychosis vulnerability may become expressed, at the level of schizotypal symptoms, causing the phenotypic correlation between relatives to become "visible" under the influence of cannabis. Results Siblings exposed to recent cannabis use resembled their patient-relative more closely in terms of positive schizotypy (urinalysis(+): B = 0.30, P<.001; urinalysis(-): B = 0.10, p<0.001; p-interaction = 0.0135). Similarly, the familial correlation in positive schizotypy between parent and sibling was significantly greater in siblings recently exposed to cannabis (urinalysis (+): B = 0.78, P<.001; urinalysis(-): B = 0.43, p<0.001; p interaction = 0.0017). Results were comparable when using lifetime cannabis frequency of use as exposure instead of recent use. Parental schizotypy did not predict cannabis use in the healthy sibling, nor in the patient. Similarly, parental cannabis use was not associated with level of schizotypy in the sibling, nor with psychotic symptoms in the patient, making gene-environment correlation unlikely. Conclusion Familial correlation of psychosis-related experiences varies considerably as a function of exposure to cannabis, confirming the importance of gene-cannabis interaction in shifts of expression of psychosis-related experiences.	[van Winkel, Ruud] Univ Psychiat Ctr KU, Leuven, Belgium; [van Winkel, Ruud] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands	Maastricht University	van Winkel, R (corresponding author), Univ Psychiat Ctr KU, Leuven, Belgium.	ruud.vanwinkel@upckuleuven.be	van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014	Myin-Germeys, Inez/0000-0002-3731-4930; Bruggeman, Richard/0000-0002-3238-8471	Geestkracht program of Dutch Health Research Council (ZON-MW) [10-000-1002]; Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Academic Psychiatric Centre Ingeest; Site Amsterdam: Academic Psychiatric Centre Arkin; Site Amsterdam: Academic Psychiatric Centre Dijk en Duin; Site Amsterdam: Academic Psychiatric Centre Rivierduinen; Site Amsterdam: Academic Psychiatric Centre Erasmus MC; Site Amsterdam: Academic Psychiatric Centre GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Amsterdam: Academic Psychiatric Centre Altrecht; Site Amsterdam: Academic Psychiatric Centre Symfora; Site Amsterdam: Academic Psychiatric Centre Meerkanten; Site Amsterdam: Academic Psychiatric Centre Riagg Amersfoort; Site Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Center; GGZ Eindhoven; GGZ Midden-Brabant; GGZ Oost-Brabant; GGZ NoordMidden Limburg; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Jansen-Cilag; Eli Lilly and Company; Astra- Zeneca and Lundbeck; European Community's Seventh Framework Program (Project EU-GEI) [HEALTH-F2-2009-241909]; Site Amsterdam: Academic Psychiatric Centre Delta	Geestkracht program of Dutch Health Research Council (ZON-MW); Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Academic Psychiatric Centre Ingeest; Site Amsterdam: Academic Psychiatric Centre Arkin; Site Amsterdam: Academic Psychiatric Centre Dijk en Duin; Site Amsterdam: Academic Psychiatric Centre Rivierduinen; Site Amsterdam: Academic Psychiatric Centre Erasmus MC; Site Amsterdam: Academic Psychiatric Centre GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Amsterdam: Academic Psychiatric Centre Altrecht; Site Amsterdam: Academic Psychiatric Centre Symfora; Site Amsterdam: Academic Psychiatric Centre Meerkanten; Site Amsterdam: Academic Psychiatric Centre Riagg Amersfoort; Site Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Center; GGZ Eindhoven; GGZ Midden-Brabant; GGZ Oost-Brabant; GGZ NoordMidden Limburg; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Jansen-Cilag; Eli Lilly and Company(Eli Lilly); Astra- Zeneca and Lundbeck; European Community's Seventh Framework Program (Project EU-GEI); Site Amsterdam: Academic Psychiatric Centre Delta	The infrastructure for the GROUP study is funded by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002) and matching funds from participating unversities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Center, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ NoordMidden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants from Jansen-Cilag, Eli Lilly and Company, Astra- Zeneca and Lundbeck. The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bromet EJ, 2011, AM J PSYCHIAT; Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Hanssen M, 2006, J ABNORM PSYCHOL, V115, P5, DOI 10.1037/0021-843X.115.1.5; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559; Khoury MJ, 1993, GENETIC EPIDEMIOLOGY; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Liraud F, 2004, J NERV MENT DIS, V192, P352, DOI 10.1097/01.nmd.000126702.30745.1d; Matheson SL, 2011, SCHIZOPHR RES, V133, P133, DOI 10.1016/j.schres.2011.09.020; Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22; Nimh, 1992, GEN IN FAM INT GEN S; O'Tuathaigh CMP, 2010, NEUROPSYCHOPHARMACOL, V35, P2262, DOI 10.1038/npp.2010.100; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tryon R. C., 1940, YEARBOOK NATIONAL SO, V39, P111; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Winkel R, 2014, ANNU REV CLIN PSYCHO, V10, P767, DOI 10.1146/annurev-clinpsy-032813-153631; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; World Health Organization, 1990, COMP INT DIAGN INT C	30	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137625	10.1371/journal.pone.0137625	http://dx.doi.org/10.1371/journal.pone.0137625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384217	Green Published, gold			2022-12-26	WOS:000361790200028
J	Hatcher, HC; Tesfay, L; Torti, SV; Torti, FM				Hatcher, Heather C.; Tesfay, Lia; Torti, Suzy V.; Torti, Frank M.			Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ALPHA-INDUCED APOPTOSIS; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; HEAVY-CHAIN; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; CELLULAR-REGULATION; EPITHELIAL-CELLS; HEME OXYGENASE-1	Oxidative stress is a major contributor to kidney injury following ischemia reperfusion. Ferritin, a highly conserved iron-binding protein, is a key protein in the maintenance of cellular iron homeostasis and protection from oxidative stress. Ferritin mitigates oxidant stress by sequestering iron and preventing its participation in reactions that generate reactive oxygen species. Ferritin is composed of two subunit types, ferritin H and ferritin L. Using an in vivo model that enables conditional tissue-specific doxycycline-inducible expression of ferritin H in the mouse kidney, we tested the hypothesis that an increased level of H-rich ferritin is renoprotective in ischemic acute renal failure. Prior to induction of ischemia, doxycycline increased ferritin H in the kidneys of the transgenicmice nearly 6.5-fold. Following reperfusion for 24 hours, induction of neutrophil gelatinous-associated lipocalin (NGAL, a urine marker of renal dysfunction) was reduced in the ferritin H overexpressers compared to controls. Histopathologic examination following ischemia reperfusion revealed that ferritin H overexpression increased intact nuclei in renal tubules, reduced the frequency of tubular profiles with luminal cast materials, and reduced activated caspase-3 in the kidney. In addition, generation of 4-hydroxy 2-nonenal protein adducts, a measurement of oxidant stress, was decreased in ischemia-reperfused kidneys of ferritin H overexpressers. These studies demonstrate that ferritin H can inhibit apoptotic cell death, enhance tubular epithelial viability, and preserve renal function by limiting oxidative stress following ischemia reperfusion injury.	[Hatcher, Heather C.; Tesfay, Lia; Torti, Suzy V.; Torti, Frank M.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Torti, Suzy V.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA; [Torti, Suzy V.; Torti, Frank M.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest University	Torti, FM (corresponding author), Univ Connecticut, Hlth Sci Ctr, Dept Internal Med, Farmington, CT 06030 USA.	ftorti@uchc.edu			NIH [R37 DK42412, RO1 CA-171101]; NATIONAL CANCER INSTITUTE [R01CA171101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work described in this study was supported by NIH R37 DK42412 and RO1 CA-171101 (FMT). There was no additional funding received for this study.	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Cantley LG, 2005, NAT CLIN PRACT NEPHR, V1, P22, DOI 10.1038/ncpneph0021; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cozzi A, 2003, FEBS LETT, V537, P187, DOI 10.1016/S0014-5793(03)00114-5; De Vries B, 2004, TRANSPLANTATION, V77, P669, DOI 10.1097/01.TP.0000115002.28575.E7; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Halliwell B., 2007, FREE RADICALS BIOL M; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Jennette J, 2006, HEPINSTALLS PATHOLOG; Kanayama M, 2007, J BIOL CHEM, V282, P24166, DOI 10.1074/jbc.M703212200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kezic A, 2013, AM J NEPHROL, V37, P291, DOI 10.1159/000348496; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; MILLER LL, 1991, P NATL ACAD SCI USA, V88, P4946, DOI 10.1073/pnas.88.11.4946; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; PALLER MS, 1988, AM J PHYSIOL, V255, pF539, DOI 10.1152/ajprenal.1988.255.3.F539; Paragas N, 2012, BBA-MOL CELL RES, V1823, P1451, DOI 10.1016/j.bbamcr.2012.06.014; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Pietsch EC, 2003, BIOCHEM PHARMACOL, V65, P1261, DOI 10.1016/S0006-2952(03)00081-9; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; SHAH SV, 1988, AM J PHYSIOL, V255, pF438, DOI 10.1152/ajprenal.1988.255.3.F438; THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TORTI SV, 1988, J BIOL CHEM, V263, P12638; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WEI Y, 1990, BIOCHEM BIOPH RES CO, V169, P289, DOI 10.1016/0006-291X(90)91466-6; Wilkinson J, 2006, BIOCHEM J, V395, P501, DOI 10.1042/BJ20060063; Yang B, 2006, TRANSPLANTATION, V81, P1442, DOI 10.1097/01.tp.0000209412.77312.69; Yeh CH, 2011, NEUROUROL URODYNAM, V30, P472, DOI 10.1002/nau.20855; ZAGER RA, 1992, J CLIN INVEST, V90, P711, DOI 10.1172/JCI115942; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867	65	23	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138505	10.1371/journal.pone.0138505	http://dx.doi.org/10.1371/journal.pone.0138505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379029	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400107
J	Wang, GF; Liu, GF; Zhang, RH; Ji, RJ; Gao, BQ; Wang, YL; Pan, YS; Li, ZX; Wang, YJ				Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun			Evaluation of Off-Hour Emergency Care in Acute Ischemic Stroke: Results from the China National Stroke Registry	PLOS ONE			English	Article							CASE-FATALITY; PERFORMANCE-MEASURES; WEEKDAY ADMISSION; WEEKEND; MORTALITY; QUALITY; ASSOCIATION; COHORT; TIME	Background and Purpose The quality of after-hour emergency care of patients with acute ischemic stroke is debatable. We therefore, sought to analyze the performance measures, quality of care and clinical outcomes in these patients admitted during off-hours. Methods Our study included 4493 patients from a selected cohort of patients admitted to the hospitals with ischemic stroke in the China National Stroke Registry (CNSR) from September 2007 to August 2008. On-hour presentation was defined as arrival at the emergency department from the scene between 8AM and 5PM from Monday through Friday. Off-hours included the remainder of the on-hours and statutory holidays. The association between off-hour presentation and outcome was analyzed using multivariate logistic-regression models. Results Off-hour presentation was identified in 2672 (59.5%) patients with ischemic stroke. Comparison of patients admitted during off-hours with those admitted during on-hours revealed an unadjusted odds ratio of in-hospital mortality of 1.38 (95% confidence interval, 1.04-1.85), which declined to 1.34 (95% confidence interval, 0.93-1.93) after adjusting for patient characteristics (especially, pre-hospital delay). No difference in 30-day mortality, total death or dependence at three, six and 12 months between two groups was observed. No association between off-hour admission and quality of care was found. Conclusions In the CNSR database, compared with on-hour patients, off-hour patients with acute ischemic stroke admitted to the emergency departments from scene manifested a higher incidence of in-hospital mortality. However, the difference in incidence and quality of care between the groups disappeared after adjusting for pre-hospital delay and other variables.	[Wang, Guifen; Gao, Baoqin] Capital Med Univ, Beijing Tiantan Hosp, Dept Pediat, Beijing, Peoples R China; [Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789	Ministry of Science and Technology; Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China [2008ZX09312-008]; State Key Development Program of Basic Research of China [2009CB521905]; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China; State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); National 11th & 12th Five-year S & T Major Project; Beijing Biobank of Cerebral Vascular Disease	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China (2008ZX09312-008) and State Key Development Program of Basic Research of China (2009CB521905). The grant numbers are the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02) and Beijing Biobank of Cerebral Vascular Disease (D131100005313003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright KC, 2009, CEREBROVASC DIS, V27, P107, DOI 10.1159/000177916; [Anonymous], 1989, STROKE, V20, P1407; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cloud G, 2013, CLIN MED, V13, P444, DOI 10.7861/clinmedicine.13-5-444; Concha OP, 2014, BMJ QUAL SAF, V23, P215, DOI 10.1136/bmjqs-2013-002218; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Janszky I, 2007, STROKE, V38, pE94, DOI 10.1161/STROKEAHA.107.491449; Jauss M, 2009, EUR J NEUROL, V16, P1165, DOI 10.1111/j.1468-1331.2009.02656.x; Kazley AS, 2010, ARCH NEUROL-CHICAGO, V67, P39, DOI 10.1001/archneurol.2009.286; Kim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105799; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Kristiansen NS, 2014, STROKE, V45, P3663, DOI 10.1161/STROKEAHA.114.005535; Manfredini R, 2007, STROKE, V38, pE112, DOI 10.1161/STROKEAHA.107.489898; Martinez-Martinez MM, 2012, EUR J NEUROL, V19, P1140, DOI 10.1111/j.1468-1331.2012.03692.x; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Minister of Health, 1989, ACTS HOSP CLASS; Minister of Health, 2010, SINGL DIS QUAL MAN M, P142; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Reeves MJ, 2010, STROKE, V41, P1573, DOI 10.1161/STROKEAHA.109.577171; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Sorita A, 2014, EUR J INTERN MED, V25, P394, DOI 10.1016/j.ejim.2014.03.012; Streifler JY, 2012, EUR J NEUROL, V19, P643, DOI 10.1111/j.1468-1331.2011.03603.x; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x	31	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138046	10.1371/journal.pone.0138046	http://dx.doi.org/10.1371/journal.pone.0138046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379280	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400047
J	Lau, YL; Lai, MY; Teoh, BT; Abd-Jamil, J; Johari, J; Sam, SS; Tan, KK; AbuBakar, S				Lau, Yee-Ling; Lai, Meng-Yee; Teoh, Boon-Teong; Abd-Jamil, Juraina; Johari, Jefree; Sam, Sing-Sin; Tan, Kim-Kee; AbuBakar, Sazaly			Colorimetric Detection of Dengue by Single Tube Reverse-Transcription-Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; TIME RT-PCR; RAPID DIAGNOSIS; MALAYSIA; ASSAY; DIFFERENTIATION; SEROTYPES; LAMP	Dengue is usually diagnosed by isolation of the virus, serology or molecular diagnostic methods. Several commercial kits for the diagnosis of dengue are existing, but concerns have arisen regarding to the affordability and performance characteristics of these kits. Hence, the loop-mediated isothermal amplification (LAMP) is potentially ideal to be used especially in resource limited environments. Serum was collected from healthy donors and patients diagnosed with dengue infection. RNA extracted from the serum samples were tested by reverse-transcription-LAMP assay developed based on 30-NCR gene sequences for DENV 1-4. Results were interpreted by a turbidity meter in real time or visually at the end of the assay. Sensitivity and specificity of RT-LAMP results were calculated and compared to qRT-PCR and ELISA. RT-LAMP is highly sensitive with the detection limit of 10 RNA copies for all serotypes. Dengue virus RNA was detected in all positive samples using RT-LAMP and none of the negative samples within 30-45 minutes. With continuing efforts in the optimization of this assay, RT-LAMP may provide a simple and reliable test for detecting DENV in areas where dengue is prevalent.	[Lau, Yee-Ling; Lai, Meng-Yee] Univ Malaya, Fac Med, Dept Parasitol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia; [Teoh, Boon-Teong; Abd-Jamil, Juraina; Johari, Jefree; Sam, Sing-Sin; Tan, Kim-Kee; AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia.	lauyeeling@um.edu.my	yee, lai meng/AAC-8621-2021; Sam, Sing-Sin/ABH-1546-2021; JOHARI, JEFREE/D-8065-2015; Lau, Yee Ling/C-6996-2009; Tan, Kim-Kee/P-7285-2014; Teoh, Boon-Teong/ABH-2475-2021; YING, LAU/HHS-2619-2022; abubakar, sazaly/B-3957-2010	Sam, Sing-Sin/0000-0003-2527-5310; Lau, Yee Ling/0000-0002-2037-2165; Tan, Kim-Kee/0000-0002-5816-9146; Teoh, Boon-Teong/0000-0001-6786-5023; abubakar, sazaly/0000-0002-9267-1420; Johari, Jefree/0000-0002-7526-3468	Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/CHAN/14/3]; University Malaya [LR001-2011D]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); University Malaya(Universiti Malaya)	The funding for this study was changed to High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/CHAN/14/3 from the Ministry of Higher Education Malaysia and University Malaya Research Grant LR001-2011D.	AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Cardoso TC, 2010, MOL CELL PROBE, V24, P415, DOI 10.1016/j.mcp.2010.08.003; Cheah W K, 2014, Med J Malaysia, V69 Suppl A, P59; Chee HY, 2003, DENGUE B, V27, P100; Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046; Kobayashi N, 1999, AM J TROP MED HYG, V60, P904, DOI 10.4269/ajtmh.1999.60.904; Lau YL, 2010, J CLIN MICROBIOL, V48, P3698, DOI 10.1128/JCM.00462-10; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nina RD, 2009, J GLOB INFECT DIS, V1, P38, DOI [10.4103/0974-777X.52980, DOI 10.4103/0974-777X.52980]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22; Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011; Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721; WHO, 1997, DENG HAEM FEV DIAGN; Zaayman D, 2009, J VIROL METHODS, V157, P155, DOI 10.1016/j.jviromet.2008.12.014	20	66	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138694	10.1371/journal.pone.0138694	http://dx.doi.org/10.1371/journal.pone.0138694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384248	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200148
J	Lau, Y; Htun, TP; Lim, PI; Ho-Lim, S; Klainin-Yobas, P				Lau, Ying; Htun, Tha Pyai; Lim, Peng Im; Ho-Lim, Sarah; Klainin-Yobas, Piyanee			Maternal, Infant Characteristics, Breastfeeding Techniques, and Initiation: Structural Equation Modeling Approaches	PLOS ONE			English	Article							SKIN-TO-SKIN; CESAREAN-SECTION; MOTHERS EXPERIENCES; SAMPLE-SIZE; BIRTH; DELIVERY; HEALTH; METAANALYSIS; PREVALENCE; PATTERNS	Objectives The aim of this study was to examine the relationships among maternal and infant characteristics, breastfeeding techniques, and exclusive breastfeeding initiation in different modes of birth using structural equation modeling approaches. Methods We examined a hypothetical model based on integrating concepts of a breastfeeding decision-making model, a breastfeeding initiation model, and a social cognitive theory among 952 mother-infant dyads. The LATCH breastfeeding assessment tool was used to evaluate breastfeeding techniques and two infant feeding categories were used (exclusive and nonexclusive breastfeeding). Results Structural equation models (SEM) showed that multiparity was significantly positively associated with breastfeeding techniques and the jaundice of an infant was significantly negatively related to exclusive breastfeeding initiation. A multigroup analysis in the SEM showed no difference between the caesarean section and vaginal delivery groups estimates of breastfeeding techniques on exclusive breastfeeding initiation. Breastfeeding techniques were significantly positively associated with exclusive breastfeeding initiation in the entire sample and in the vaginal deliveries group. However, breastfeeding techniques were not significantly associated with exclusive breastfeeding initiation in the cesarean section group. Maternal age, maternal race, gestations, birth weight of infant, and postnatal complications had no significant impacts on breastfeeding techniques or exclusive breastfeeding initiation in our study. Overall, the models fitted the data satisfactorily (GFI = 0.979-0.987; AGFI = 0.951-0.962; IFI = 0.958-0.962; CFI = 0.955-0.960, and RMSEA = 0.029-0.034). Conclusions Multiparity and jaundice of an infant were found to affect breastfeeding technique and exclusive breastfeeding initiation respectively. Breastfeeding technique was related to exclusive breastfeeding initiation according to the mode of birth. This relationship implies the importance of early effective interventions among first- time mothers with jaundice infants in improving breastfeeding techniques and promoting exclusive breastfeeding initiation.	[Lau, Ying; Htun, Tha Pyai; Klainin-Yobas, Piyanee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore; [Lim, Peng Im] Natl Univ Singapore Hosp, Dept Nursing, Singapore 117548, Singapore; [Ho-Lim, Sarah] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Lau, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore.	nurly@nus.edu.sg	yee, lai meng/AAC-8621-2021; Sam, Sing-Sin/ABH-1546-2021; JOHARI, JEFREE/D-8065-2015; Lau, Yee Ling/C-6996-2009; Tan, Kim-Kee/P-7285-2014; Teoh, Boon-Teong/ABH-2475-2021; YING, LAU/HHS-2619-2022; abubakar, sazaly/B-3957-2010	Sam, Sing-Sin/0000-0003-2527-5310; Lau, Yee Ling/0000-0002-2037-2165; Tan, Kim-Kee/0000-0002-5816-9146; Teoh, Boon-Teong/0000-0001-6786-5023; abubakar, sazaly/0000-0002-9267-1420; Johari, Jefree/0000-0002-7526-3468	National University of Singapore [NUHSRO/2013/147/SU/01, R545000055133]	National University of Singapore(National University of Singapore)	The research was funded by a start-up grant (Ref: NUHSRO/2013/147/SU/01, WBS No: R545000055133) from National University of Singapore.	Adams D, 1997, J Hum Lact, V13, P279, DOI 10.1177/089033449701300412; Alex Marion, 2008, J Pediatr Nurs, V23, P429, DOI 10.1016/j.pedn.2007.12.002; Altuntas N, 2014, BREASTFEED MED, V9, P191, DOI 10.1089/bfm.2014.0018; Arbuckle JL, 2011, IBM SPSS AMOS 20 US; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Bandura A., 1986, SOCIAL COGNITIVE THE; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Brown A, 2013, J ADV NURS, V69, P828, DOI 10.1111/j.1365-2648.2012.06067.x; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne B.M., 2010, STRUCTURAL EQUATION, V396, P7384; Cakmak H, 2007, INT J NURS STUD, V44, P1128, DOI 10.1016/j.ijnurstu.2006.04.018; Carlander AKK, 2010, SEX REPROD HEALTHC, V1, P27, DOI 10.1016/j.srhc.2009.10.001; Celik IH, 2013, J MATERN-FETAL NEO M, V26, P459, DOI 10.3109/14767058.2012.735994; CHALMERS B, 1992, BRIT J OBSTET GYNAEC, V99, P709, DOI 10.1111/j.1471-0528.1992.tb13867.x; Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x; Colen CG, 2014, SOC SCI MED, V109, P55, DOI 10.1016/j.socscimed.2014.01.027; Cottrell BH, 2013, MCN-AM J MATERN-CHIL, V38, P297, DOI 10.1097/NMC.0b013e31829a5606; da Costa SP, 2010, INFANT BEHAV DEV, V33, P61, DOI 10.1016/j.infbeh.2009.11.007; Dann Maureen Hoag, 2005, J Pediatr Health Care, V19, P12; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; Department of Statistics, 2014, SING IN FIG; Santo LCD, 2007, BIRTH-ISS PERINAT C, V34, P212, DOI 10.1111/j.1523-536X.2007.00173.x; DUSDIEKER LB, 1985, SOC SCI MED, V20, P695, DOI 10.1016/0277-9536(85)90058-9; Fraser DM, 2008, OBSTET GYNAECOL REPR, V19, P7; Geraghty SR, 2010, BREASTFEED MED, V5, P135, DOI 10.1089/bfm.2009.0094; Goyal RC, 2011, J FAM COMMUNITY MED, V18, P74, DOI 10.4103/2230-8229.83372; Hair J.F., 2010, MUTIVARIATE DATA ANA, V7th; Hildebrand DA, 2014, J NUTR EDUC BEHAV, V46, P458, DOI 10.1016/j.jneb.2014.05.005; Holmberg KSM, 2014, SEX REPROD HEALTHC, V5, P125, DOI 10.1016/j.srhc.2014.04.001; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Jensen D, 1994, J Obstet Gynecol Neonatal Nurs, V23, P27, DOI 10.1111/j.1552-6909.1994.tb01847.x; Jiang H, 2012, BREASTFEED MED, V7, P526, DOI 10.1089/bfm.2011.0124; Kline R.B., 2011, PRINCIPLES PRACTICE; Kronborg H, 2015, SEX REPROD HEALTHC, V6, P82, DOI 10.1016/j.srhc.2014.08.004; Kronborg H, 2009, BIRTH-ISS PERINAT C, V36, P34, DOI 10.1111/j.1523-536X.2008.00293.x; Kumar SP, 2006, J HUM LACT, V22, P391, DOI 10.1177/0890334406293161; Lee CY, 2008, HONG KONG J GYNECOL, V8, P13; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marshall JL, 2015, MIDWIFERY, P1; Martens PJ, 1997, AM J HUM BIOL, V9, P579, DOI 10.1002/(SICI)1520-6300(1997)9:5<579::AID-AJHB6>3.0.CO;2-P; Mauch CE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-7; Mauri PA, 2012, MIDWIFERY, V28, P816, DOI 10.1016/j.midw.2011.09.010; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; Moore ER, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub3; Phillips G, 2011, MATERN CHILD HLTH J, V15, P1210, DOI 10.1007/s10995-010-0694-4; Pound CM, 2009, PAED CHILD HEALT-CAN, V14, P445, DOI 10.1093/pch/14.7.445; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Raghavan V, 2014, INDIAN J PEDIATR, V81, P743, DOI 10.1007/s12098-013-1200-y; Riordan J, 2001, J Hum Lact, V17, P20, DOI 10.1177/089033440101700105; Riordan J M, 1997, J Obstet Gynecol Neonatal Nurs, V26, P181, DOI 10.1111/j.1552-6909.1997.tb02131.x; Sakalidis VS, 2013, BREASTFEED MED, V8, P79, DOI 10.1089/bfm.2012.0018; Salone LR, 2013, J AM DENT ASSOC, V144, P143, DOI 10.14219/jada.archive.2013.0093; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Scrafford CG, 2013, TROP MED INT HEALTH, V18, P1317, DOI 10.1111/tmi.12189; Stuebe AM, 2014, J WOMENS HEALTH, V23, P404, DOI 10.1089/jwh.2013.4506; Tornese G, 2012, BREASTFEED MED, V7, P423, DOI 10.1089/bfm.2011.0120; Tully KP, 2014, MIDWIFERY, V30, P712, DOI 10.1016/j.midw.2013.10.014; UNICEF, 2009, TRACK PROGR CHILD MA; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Widstrom AM, 2011, ACTA PAEDIATR, V100, P79, DOI 10.1111/j.1651-2227.2010.01983.x; Xiong T, 2011, EUR J PEDIATR, V170, P1247, DOI 10.1007/s00431-011-1454-1; Zanardo V, 2013, EARLY HUM DEV; Zwedberg S, 2015, MIDWIFERY, V31, P215, DOI 10.1016/j.midw.2014.08.014	64	66	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142861	10.1371/journal.pone.0142861	http://dx.doi.org/10.1371/journal.pone.0142861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26384248	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500061
